PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Filhoulaud, G; Guillemain, G; Scharfmann, R				Filhoulaud, Gaelle; Guillemain, Ghislaine; Scharfmann, Raphael			The Hexosamine Biosynthesis Pathway Is Essential for Pancreatic Beta Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAUTERINE GROWTH-RETARDATION; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; EXOCRINE PANCREAS; PROGENITOR CELLS; O-GLYCOSYLATION; KEY ROLE; IN-VIVO; GLUCOSE; DIFFERENTIATION	Pancreatic exocrine and endocrine cells develop during embryonic life from endodermal progenitors. This process depends on activation of a hierarchy of transcription factors. Although information is available regarding the mesodermal signals controlling pancreas development, little is known about the role of environmental factors such as nutrients, including glucose, that also may impact development. Previously, we showed that glucose plays an important and specific role in beta cell development by activating the transition of Neurogenin3-positive endocrine progenitors into beta cells. Here, we examined the implication of glucose metabolism and more precisely the role of the hexosamine biosynthesis pathway (HBP) to understand the mechanisms by which glucose regulates beta cell development. We have established an in vitro model of endocrine and exocrine cells development from embryonic day 13.5 rat pancreases in a manner that replicates in vivo pancreas development perfectly. Using this model, we tested the effect of selective inhibitors and activators of the HBP and found that the HBP has a modest effect on cell proliferation and exocrine cell differentiation. On the other hand, beta cell development is tightly controlled by the HBP. Specifically, HBP activators increase beta cell development, whereas inhibitors repress such development. Importantly, both the HBP and glucose control the same steps in beta cell development.	[Filhoulaud, Gaelle; Guillemain, Ghislaine; Scharfmann, Raphael] Univ Paris 05, Fac Med, Hop Necker, Ctr Rech Croissance & Signalisat,INSERM,U845, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guillemain, G (corresponding author), Univ Paris 05, Fac Med, Hop Necker, Ctr Rech Croissance & Signalisat,INSERM,U845, 156 Rue Vaugirard, F-75015 Paris, France.	ghislaine.guillemain@inserm.fr	Guillemain, Ghislaine/P-7740-2017; scharfmann, raphael/L-3296-2017	Guillemain, Ghislaine/0000-0002-8256-9545; Scharfmann, Raphael/0000-0001-7619-337X	European Union Framework Program; Association pour la Recherche sur le Diabete; Association Franc; Ministere de l'Education Nationale de la Recherche et de la Technologie	European Union Framework Program(European Commission); Association pour la Recherche sur le Diabete(Fondation ARC pour la Recherche sur le Cancer); Association Franc; Ministere de l'Education Nationale de la Recherche et de la Technologie	This work was supported by the 6th European Union Framework Program (Beta- Cell Therapy Integrated Project), the Association pour la Recherche sur le Diabete, and the Association Franc, aise des Diabetiques. 1 Supported by a Convention Industrielle de Formation par la Recherche grant from Servier and the Ministere de l'Education Nationale de la Recherche et de la Technologie.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Attali M, 2007, DIABETES, V56, P1248, DOI 10.2337/db06-1307; Baron AD, 1995, J CLIN INVEST, V96, P2792, DOI 10.1172/JCI118349; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; CARDENAS ML, 1984, EUR J BIOCHEM, V145, P163, DOI 10.1111/j.1432-1033.1984.tb08536.x; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Duvillie B, 2006, DIABETES, V55, P582, DOI 10.2337/diabetes.55.03.06.db05-0839; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guillemain G, 2007, J BIOL CHEM, V282, P15228, DOI 10.1074/jbc.M610986200; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Holemans K, 2003, J PHYSIOL-LONDON, V547, P11, DOI 10.1113/jphysiol.2002.036582; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Miralles F, 1998, DEVELOPMENT, V125, P1017; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; Remacle C, 2007, DIABETES OBES METAB, V9, P196, DOI 10.1111/j.1463-1326.2007.00790.x; Scharfmann R, 2000, DIABETOLOGIA, V43, P1083, DOI 10.1007/s001250051498; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WESSELLS NK, 1966, EXP CELL RES, V43, P680, DOI 10.1016/0014-4827(66)90044-9	62	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24583	24594		10.1074/jbc.M109.025288	http://dx.doi.org/10.1074/jbc.M109.025288			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586915	Green Published, hybrid			2022-12-25	WOS:000269380200068
J	Tardito, S; Isella, C; Medico, E; Marchio, L; Bevilacqua, E; Hatzoglou, M; Bussolati, O; Franchi-Gazzola, R				Tardito, Saverio; Isella, Claudio; Medico, Enzo; Marchio, Luciano; Bevilacqua, Elena; Hatzoglou, Maria; Bussolati, Ovidio; Franchi-Gazzola, Renata			The Thioxotriazole Copper(II) Complex A0 Induces Endoplasmic Reticulum Stress and Paraptotic Death in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PROTEASOME INHIBITION; ER STRESS; IN-VITRO; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; PATHWAY; GENE; EXPRESSION; MUTATIONS	The copper(II) complex A0 induces a type of non-apoptotic cell death also known as paraptosis. Paraptosis involves extensive endoplasmic reticulum vacuolization in the absence of caspase activation. A wide panel of human cancer cell lines was used to demonstrate differences in cytotoxicity by the paraptosis-inducing drug A0 and the metal-based pro-apoptotic drug cisplatin. Gene expression profiling of the human fibrosarcoma HT1080 cells showed that, while cisplatin induced p53 targets, A0 up-regulated genes involved in the unfolded protein response (UPR) and response to heavy metals. The cytotoxic effects of A0 were associated with inhibition of the ubiquitin-proteasome system and accumulation of ubiquitinylated proteins, in a manner dependent on protein synthesis. Cycloheximide inhibited the accumulation of ubiquitinylated proteins and hampered A0-induced cell death process. The occurrence of the UPR during A0-induced death process was shown by the increased abundance of spliced XBP1 mRNA, transient eIF2 alpha phosphorylation, and a series of downstream events, including attenuation of global protein synthesis and increased expression of ATF4, CHOP, BIP, and GADD34. Mouse embryonic fibroblasts expressing a mutant eIF2 alpha, which could not be phosphorylated, were more resistant to A0 than wild type cells, pointing to a pro-death role of eIF2 alpha phosphorylation. A0 may thus represent the prototypical member of a new class of compounds that cause paraptotic cell death via mechanisms involving eIF2 alpha phosphorylation and the UPR.	[Tardito, Saverio; Bussolati, Ovidio; Franchi-Gazzola, Renata] Univ Parma, Dept Expt Med, Unit Gen & Clin Pathol, I-43100 Parma, Italy; [Marchio, Luciano] Univ Parma, Dept Gen & Inorgan Analyt & Phys Chem, I-43100 Parma, Italy; [Isella, Claudio; Medico, Enzo] Univ Torino, Inst Canc Res & Treatment, Oncogenom Ctr, Lab Funct Genom, I-10060 Candiolo, Italy; [Bevilacqua, Elena; Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	University of Parma; University of Parma; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Case Western Reserve University	Franchi-Gazzola, R (corresponding author), Univ Parma, Dept Expt Med, Unit Gen & Clin Pathol, Via Volturno 39, I-43100 Parma, Italy.	renata.franchi@unipr.it	Medico, Enzo/AAC-3185-2021; Bussolati, Ovidio/B-7589-2013; Marchio', Luciano/E-4277-2014; Tardito, Saverio/AAJ-7727-2020; Isella, Claudio/F-7327-2012	Medico, Enzo/0000-0002-3917-2438; Bussolati, Ovidio/0000-0002-4301-2939; Marchio', Luciano/0000-0002-0025-1104; Tardito, Saverio/0000-0002-5294-8683; Isella, Claudio/0000-0003-0679-4756	National Institutes of Health [R01s DK60596, DK53307]; Ministero della Istruzione, della Universita e della Ricerca [PRIN 2007]; Universita degli Studi di Parma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK060596, R01DK053307, R01DK060596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero della Istruzione, della Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi di Parma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01s DK60596 and DK53307 (to M. H.). This work was also supported by Ministero della Istruzione, della Universita e della Ricerca (PRIN 2007 to L. M.) and by Universita degli Studi di Parma (FIL, to R. F. G.).	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Adsule S, 2006, J MED CHEM, V49, P7242, DOI 10.1021/jm060712l; Ahtoniemi T, 2007, MOL PHARMACOL, V71, P30, DOI 10.1124/mol.106.028415; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; ANDREWS PA, 1992, CANCER RES, V52, P1895; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen YJ, 2002, BLOOD, V100, P1373, DOI 10.1182/blood-2002-01-0174; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Dallavalle F, 2002, J INORG BIOCHEM, V92, P95, DOI 10.1016/S0162-0134(02)00545-7; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Ding WX, 2007, APOPTOSIS, V12, P2233, DOI 10.1007/s10495-007-0142-0; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Fombonne J, 2006, APOPTOSIS, V11, P367, DOI 10.1007/s10495-006-4568-6; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Gaccioli F, 2005, J INORG BIOCHEM, V99, P1573, DOI 10.1016/j.jinorgbio.2005.04.017; Galvan V, 2003, J BIOL CHEM, V278, P13325, DOI 10.1074/jbc.M211398200; Hirai S, 2004, HEARING RES, V198, P41, DOI 10.1016/j.heares.2004.07.012; Hong SH, 2007, BIOCHEM PHARMACOL, V74, P557, DOI 10.1016/j.bcp.2007.05.016; Jadus MR, 2003, CANCER GENE THER, V10, P411, DOI 10.1038/sj.cgt.7700583; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Marzano C, 2006, J MED CHEM, V49, P7317, DOI 10.1021/jm0601248; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Muller P, 2007, J BIOL INORG CHEM, V12, P495, DOI 10.1007/s00775-006-0201-y; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Sasaki K, 2003, CELLS TISSUES ORGANS, V175, P34, DOI 10.1159/000073435; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schneider D, 2004, CELL DEATH DIFFER, V11, P760, DOI 10.1038/sj.cdd.4401377; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tardito S, 2006, HISTOCHEM CELL BIOL, V126, P473, DOI 10.1007/s00418-006-0183-4; Tardito S, 2007, J MED CHEM, V50, P1916, DOI 10.1021/jm061174f; Tardito S, 2009, CURR MED CHEM, V16, P1325, DOI 10.2174/092986709787846532; Ustundag Y, 2007, WORLD J GASTROENTERO, V13, P851, DOI 10.3748/wjg.v13.i6.851; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	51	104	106	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24306	24319		10.1074/jbc.M109.026583	http://dx.doi.org/10.1074/jbc.M109.026583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561079	Green Published, hybrid			2022-12-25	WOS:000269380200044
J	Taylor, DR; Parkin, ET; Cocklin, SL; Ault, JR; Ashcroft, AE; Turner, AJ; Hooper, NM				Taylor, David R.; Parkin, Edward T.; Cocklin, Sarah L.; Ault, James R.; Ashcroft, Alison E.; Turner, Anthony J.; Hooper, Nigel M.			Role of ADAMs in the Ectodomain Shedding and Conformational Conversion of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN-CONVERTING ENZYME; HUMAN CEREBROSPINAL-FLUID; CELLULAR PRION; LIPID RAFTS; TRUNCATED FORMS; CULTURED-CELLS; SOLUBLE FORM; METALLOPROTEASE; DISINTEGRIN	The cellular prion protein (PrPC) is essential for the pathogenesis and transmission of prion diseases. PrPC is bound to the plasma membrane via a glycosylphosphatidylinositol anchor, although a secreted, soluble form has also been identified. Previously we reported that PrPC is subject to ectodomain shedding from the membrane by zinc metalloproteinases with a similar inhibition profile to those involved in shedding the amyloid precursor protein. Here we have used gain-of-function (overexpression) and loss-of-function (small interfering RNA knockdown) experiments in cells to identify the ADAMs (a disintegrin and metalloproteinases) involved in the ectodomain shedding of PrPC. These experiments revealed that ADAM9 and ADAM10, but not ADAM17, are involved in the shedding of PrPC and that ADAM9 exerts its effect on PrPC shedding via ADAM10. Using dominant negative, catalytically inactive mutants, we show that the catalytic activity of ADAM9 is required for its effect on ADAM10. Mass spectrometric analysis revealed that ADAM10, but not ADAM9, cleaved PrP between Gly(228) and Arg(229), three residues away from the site of glycosylphosphatidylinositol anchor attachment. The shedding of another membrane protein, the amyloid precursor protein beta-secretase BACE1, by ADAM9 is also mediated via ADAM10. Furthermore, we show that pharmacological inhibition of PrPC shedding or activation of both PrPC and PrPSc shedding by ADAM10 overexpression in scrapie-infected neuroblastoma N2a cells does not alter the formation of proteinase K-resistant PrPSc. Collectively, these data indicate that although PrPC can be shed through the action of ADAM family members, modulation of PrPC or PrPSc ectodomain shedding does not regulate prion conversion.	[Taylor, David R.; Parkin, Edward T.; Cocklin, Sarah L.; Turner, Anthony J.; Hooper, Nigel M.] Univ Leeds, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England; [Ault, James R.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Taylor, David R.; Parkin, Edward T.; Cocklin, Sarah L.; Turner, Anthony J.; Hooper, Nigel M.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Hooper, NM (corresponding author), Univ Leeds, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk	Ault, James R/O-8904-2019; Ault, James/F-2864-2012	Ault, James R/0000-0002-5131-438X; Ault, James/0000-0002-5131-438X; Hooper, Nigel/0000-0002-5811-3484; Parkin, Edward/0000-0003-3270-3184; Taylor, David/0000-0003-1385-3961	Medical Research Council of Great Britain [G9824728]; Wellcome Trust [080229/Z/06/Z]; University of Leeds; MRC [G9824728] Funding Source: UKRI; Medical Research Council [G9824728] Funding Source: researchfish	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council of Great Britain Grant G9824728, Wellcome Trust Grant 080229/Z/06/Z, and the University of Leeds.	Aguzzi A, 2006, J NEUROCHEM, V97, P1726, DOI 10.1111/j.1471-4159.2006.03909.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Heiseke A, 2008, TRAFFIC, V9, P1116, DOI 10.1111/j.1600-0854.2008.00750.x; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Kahl S, 2000, J IMMUNOL, V165, P4463, DOI 10.4049/jimmunol.165.8.4463; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Kim CL, 2004, J GEN VIROL, V85, P3473, DOI 10.1099/vir.0.80113-0; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Parkin E, 2009, J NEUROCHEM, V108, P1464, DOI 10.1111/j.1471-4159.2009.05907.x; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Parkin ET, 2003, J CELL SCI, V116, P3079, DOI 10.1242/jcs.00626; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Yang XY, 1996, J BIOL CHEM, V271, P11493, DOI 10.1074/jbc.271.19.11493	50	107	109	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22590	22600		10.1074/jbc.M109.032599	http://dx.doi.org/10.1074/jbc.M109.032599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19564338	hybrid, Green Published			2022-12-25	WOS:000268963100012
J	Schaaf, CA; Misulovin, Z; Sahota, G; Siddiqui, AM; Schwartz, YB; Kahn, TG; Pirrotta, V; Gause, M; Dorsett, D				Schaaf, Cheri A.; Misulovin, Ziva; Sahota, Gurmukh; Siddiqui, Akbar M.; Schwartz, Yuri B.; Kahn, Tatyana G.; Pirrotta, Vincenzo; Gause, Maria; Dorsett, Dale			Regulation of the Drosophila Enhancer of split and invected-engrailed Gene Complexes by Sister Chromatid Cohesion Proteins	PLOS ONE			English	Article							DE-LANGE-SYNDROME; NIPPED-B; CELL-CYCLE; POLYCOMB; EXPRESSION; MUTATIONS; BINDING; NOTCH; HEDGEHOG; HOMOLOG	The cohesin protein complex was first recognized for holding sister chromatids together and ensuring proper chromosome segregation. Cohesin also regulates gene expression, but the mechanisms are unknown. Cohesin associates preferentially with active genes, and is generally absent from regions in which histone H3 is methylated by the Enhancer of zeste [E(z)] Polycomb group silencing protein. Here we show that transcription is hypersensitive to cohesin levels in two exceptional cases where cohesin and the E(z)-mediated histone methylation simultaneously coat the entire Enhancer of split and invected-engrailed gene complexes in cells derived from Drosophila central nervous system. These gene complexes are modestly transcribed, and produce seven of the twelve transcripts that increase the most with cohesin knockdown genome-wide. Cohesin mutations alter eye development in the same manner as increased Enhancer of split activity, suggesting that similar regulation occurs in vivo. We propose that cohesin helps restrain transcription of these gene complexes, and that deregulation of similarly cohesin-hypersensitive genes may underlie developmental deficits in Cornelia de Lange syndrome.			Schaaf, CA (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	dorsettd@slu.edu		Dorsett, Dale/0000-0002-0507-2762	NHGRI NIH HHS [R01 HG00249, R01 HG000249] Funding Source: Medline; NICHD NIH HHS [P01 HD052683, P01 HD052860-030003, P01 HD052860, P01 HD052860-040003] Funding Source: Medline; NIGMS NIH HHS [T32 GM008802, R01 GM055683-09, R01 GM055683, R01 GM055683-10A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008802, R01GM055683] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BARTKUHN M, 2009, EMBO J          0219; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borck G, 2006, HUM MUTAT, V27, P731, DOI 10.1002/humu.20380; Bray SJ, 1997, PERSPECT DEV NEUROBI, V4, P313; BROWER DL, 1986, EMBO J, V5, P2649, DOI 10.1002/j.1460-2075.1986.tb04547.x; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; CELNIKER SE, 2002, GENOME BIOL, V0003; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; COLEMAN KG, 1987, GENE DEV, V1, P19, DOI 10.1101/gad.1.1.19; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; DREES B, 1987, EMBO J, V6, P2803, DOI 10.1002/j.1460-2075.1987.tb02576.x; Dubey RN, 2007, GENE DEV, V21, P2150, DOI 10.1101/gad.1583807; FELSENFELD AL, 1995, DEVELOPMENT, V121, P1; Fujioka M, 2008, DEVELOPMENT, V135, P4131, DOI 10.1242/dev.024554; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HADJUR S, 2009, NATURE          0520; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hallson G, 2008, P NATL ACAD SCI USA, V105, P12405, DOI 10.1073/pnas.0801698105; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaur M, 2005, AM J MED GENET A, V138A, P27, DOI 10.1002/ajmg.a.30919; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Maeder ML, 2007, GENETICS, V177, P1377, DOI 10.1534/genetics.107.070425; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MISHIRO T, 2009, EMBO J          0326; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; MOAZED D, 1992, DEVELOPMENT, V116, P805; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Revenkova E, 2009, HUM MOL GENET, V18, P418, DOI 10.1093/hmg/ddn369; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; SANICOLA M, 1995, GENETICS, V139, P745; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schulze S, 2001, MOL GEN GENET, V264, P782, DOI 10.1007/s004380000367; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; SHEPARD SB, 1989, GENETICS, V122, P429; Stockard J, 2007, JUDGM DECIS MAK, V2, P9; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Vass S, 2003, CURR BIOL, V13, P208, DOI 10.1016/S0960-9822(03)00047-2; Vrouwe MG, 2007, HUM MOL GENET, V16, P1478, DOI 10.1093/hmg/ddm098; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Welshons WJ, 1956, DROS INFORM SERV, V30, P157; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	80	89	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6202	10.1371/journal.pone.0006202	http://dx.doi.org/10.1371/journal.pone.0006202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587787	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035100015
J	Yamada, Y; Liu, XB; Fang, SG; Tay, FPL; Liu, DX				Yamada, Yoshiyuki; Liu, Xiao Bo; Fang, Shou Guo; Tay, Felicia P. L.; Liu, Ding Xiang			Acquisition of Cell-Cell Fusion Activity by Amino Acid Substitutions in Spike Protein Determines the Infectivity of a Coronavirus in Cultured Cells	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; N-TERMINAL DOMAIN; BRONCHITIS VIRUS; MURINE CORONAVIRUS; CONFORMATIONAL-CHANGES; AVIAN CORONAVIRUS; AMINOPEPTIDASE-N; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; HEPARAN-SULFATE	Coronavirus host and cell specificities are determined by specific interactions between the viral spike (S) protein and host cell receptor(s). Avian coronavirus infectious bronchitis (IBV) has been adapted to embryonated chicken eggs, primary chicken kidney (CK) cells, monkey kidney cell line Vero, and other human and animal cells. Here we report that acquisition of the cell-cell fusion activity by amino acid mutations in the S protein determines the infectivity of IBV in cultured cells. Expression of S protein derived from Vero-and CK-adapted strains showed efficient induction of membrane fusion. However, expression of S protein cloned from the third passage of IBV in chicken embryo (EP3) did not show apparent syncytia formation. By construction of chimeric S constructs and site-directed mutagenesis, a point mutation (L857-F) at amino acid position 857 in the heptad repeat 1 region of S protein was shown to be responsible for its acquisition of the cell-cell fusion activity. Furthermore, a G405-D point mutation in the S1 domain, which was acquired during further propagation of Vero-adapted IBV in Vero cells, could enhance the cell-cell fusion activity of the protein. Re-introduction of L857 back to the S gene of Vero-adapted IBV allowed recovery of variants that contain the introduced L857. However, compensatory mutations in S1 and some distant regions of S2 were required for restoration of the cell-cell fusion activity of S protein carrying L857 and for the infectivity of the recovered variants in cultured cells. This study demonstrates that acquisition of the cell-cell fusion activity in S protein determines the selection and/or adaptation of a coronavirus from chicken embryo to cultured cells of human and animal origins.	[Yamada, Yoshiyuki; Fang, Shou Guo; Tay, Felicia P. L.; Liu, Ding Xiang] Proteos, Inst Mol & Cell Biol, Singapore, Singapore; [Liu, Xiao Bo; Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yamada, Y (corresponding author), Proteos, Inst Mol & Cell Biol, Singapore, Singapore.	dxliu@imcb.a-star.edu.sg	Liu, Ding Xiang/A-2226-2011					ALONSOCAPLEN FV, 1984, VIRUS RES, V1, P153, DOI 10.1016/0168-1702(84)90070-4; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Butler N, 2006, VIROLOGY, V347, P410, DOI 10.1016/j.virol.2005.11.044; CAVANAGH D, 1986, VIRUS RES, V4, P133, DOI 10.1016/0168-1702(86)90037-7; Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651; Chen HY, 2007, AVIAN PATHOL, V36, P269, DOI 10.1080/03079450701447291; de Haan CAM, 2005, J VIROL, V79, P14451, DOI 10.1128/JVI.79.22.14451-14456.2005; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LIU DX, 1992, VIROLOGY, V186, P342, DOI 10.1016/0042-6822(92)90094-6; Madu IG, 2007, AVIAN DIS, V51, P45, DOI 10.1637/0005-2086(2007)051[0045:HSIASA]2.0.CO;2; Matsuyama S, 2002, J VIROL, V76, P11819, DOI 10.1128/JVI.76.23.11819-11826.2002; Miura HS, 2004, J VIROL, V78, P216, DOI 10.1128/JVI.78.1.216-223.2004; Ng LFP, 2002, J VIROL, V76, P6257, DOI 10.1128/JVI.76.12.6257-6267.2002; Ng LFP, 2000, VIROLOGY, V272, P27, DOI 10.1006/viro.2000.0330; SANCHEZ CM, 1992, VIROLOGY, V190, P92, DOI 10.1016/0042-6822(92)91195-Z; Shen S, 2004, VIROLOGY, V326, P288, DOI 10.1016/j.virol.2004.06.016; Shen S, 2003, VIROLOGY, V311, P16, DOI 10.1016/S0042-6822(03)00117-X; TAGUCHI F, 1993, ADV EXP MED BIOL, V342, P171; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; TRACKRAY LB, 2004, VIROLOGY, V324, P510; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; Tsai CW, 1999, J BIOL CHEM, V274, P26085, DOI 10.1074/jbc.274.37.26085; Tsai JC, 2003, J VIROL, V77, P841, DOI 10.1128/JVI.77.2.841-850.2003; Vijgen L, 2005, VIROLOGY, V337, P85, DOI 10.1016/j.virol.2005.04.010; WEGE H, 1982, CURR TOP MICROBIOL, V99, P165; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Winter C, 2008, MICROBES INFECT, V10, P367, DOI 10.1016/j.micinf.2007.12.009; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yamada YK, 1997, VIROLOGY, V227, P215, DOI 10.1006/viro.1996.8313; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Youn S, 2005, VIROLOGY, V332, P206, DOI 10.1016/j.virol.2004.10.045; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003	44	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6130	10.1371/journal.pone.0006130	http://dx.doi.org/10.1371/journal.pone.0006130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572016	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806200006
J	Lafourcade, CA; Zhang, LH; Alger, BE				Lafourcade, Carlos A.; Zhang, Longhua; Alger, Bradley E.			Novel mGluR- and CB1R-Independent Suppression of GABA Release Caused by a Contaminant of the Group I Metabotropic Glutamate Receptor Agonist, DHPG	PLOS ONE			English	Article								Background: Metabotropic glutamate receptors (mGluRs) are ubiquitous throughout the body, especially in brain, where they mediate numerous effects. MGluRs are classified into groups of which group I, comprising mGluRs 1 and 5, is especially important in neuronal communication. Group I actions are often investigated with the selective agonist, S-3,5-dihydroxyphenylglycine ( DHPG). Despite the selectivity of DHPG, its use has often led to contradictory findings. We now report that a particular commercial preparation of DHPG can produce mGluR-independent effects. These findings may help reconcile some discrepant reports. Methods: We carried out electrophysiological recordings in the rat in vitro hippocampal slice preparation, focusing mainly on pharmacologically isolated GABA(A)-receptor-mediated synaptic currents. Principal Findings: While preparations of DHPG from three companies suppressed GABAergic transmission in an mGluR-dependent way, one batch had an additional, unusual effect. Even in the presence of antagonists of mGluRs, it caused a reversible, profound suppression of inhibitory transmission. This mGluR - independent action was not due to a higher potency of the compound, or its ability to cause endocannabinoid-dependent responses. Field potential recordings revealed that glutamatergic transmission was not affected, and quantal analysis of GABA transmission confirmed the unusual effect was on GABA release, and not GABA(A) receptors. We have not identified the responsible factor in the DHPG preparation, but the samples were 99% pure as determined by HPLC and NMR analyses. Conclusions: In certain respects our observations with the anomalous batch strikingly resemble some published reports of unusual DHPG effects. The present findings could therefore contribute to explaining discrepancies in the literature. DHPG is widely employed to study mGluRs in different systems, hence rigorous controls should be performed before conclusions based on its use are drawn.			Lafourcade, CA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Program Neurosci, Baltimore, MD 21201 USA.	balgerlab@gmail.com	Zhang, Longhua/P-1417-2014	Lafourcade, Carlos/0000-0002-6728-1009	NIDA NIH HHS [R01 DA014625] Funding Source: Medline; NIMH NIH HHS [R01 MH07727] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Ansah OB, 2009, EXP NEUROL, V216, P66, DOI 10.1016/j.expneurol.2008.11.005; BAIN AI, 1992, J PHYSIOL-LONDON, V450, P63, DOI 10.1113/jphysiol.1992.sp019116; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GEREAU RW, 1995, J NEUROPHYSIOL, V74, P122, DOI 10.1152/jn.1995.74.1.122; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; ITO I, 1992, NEUROREPORT, V3, P1013, DOI 10.1097/00001756-199211000-00017; Karson MA, 2008, NEUROPHARMACOLOGY, V54, P117, DOI 10.1016/j.neuropharm.2007.06.023; Knopfel T, 2007, BRIT J PHARMACOL, V151, P723, DOI 10.1038/sj.bjp.0707289; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Nadlewska A, 2002, POL J PHARMACOL, V54, P11; Park SY, 2007, ONCOL REP, V17, P81; Salt TE, 1999, BRIT J PHARMACOL, V127, P1057, DOI 10.1038/sj.bjp.0702677; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wisniewski K, 2002, CNS DRUG REV, V8, P101	28	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6122	10.1371/journal.pone.0006122	http://dx.doi.org/10.1371/journal.pone.0006122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568435	Green Submitted, Green Published, gold			2022-12-25	WOS:000267572200020
J	Goransson, H; Edlund, K; Rydaker, M; Rasmussen, M; Winquist, J; Ekman, S; Bergqvist, M; Thomas, A; Lambe, M; Rosenquist, R; Holmberg, L; Micke, P; Botling, J; Isaksson, A				Goransson, Hanna; Edlund, Karolina; Rydaker, Maria; Rasmussen, Markus; Winquist, Johan; Ekman, Simon; Bergqvist, Michael; Thomas, Andrew; Lambe, Mats; Rosenquist, Richard; Holmberg, Lars; Micke, Patrick; Botling, Johan; Isaksson, Anders			Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data	PLOS ONE			English	Article								Background: Technologies based on DNA microarrays have the potential to provide detailed information on genomic aberrations in tumor cells. In practice a major obstacle for quantitative detection of aberrations is the heterogeneity of clinical tumor tissue. Since tumor tissue invariably contains genetically normal stromal cells, this may lead to a failure to detect aberrations in the tumor cells. Principal Finding: Using SNP array data from 44 non-small cell lung cancer samples we have developed a bioinformatic algorithm that accurately models the fractions of normal and tumor cells in clinical tumor samples. The proportion of normal cells in combination with SNP array data can be used to detect and quantify copy number neutral loss-of-heterozygosity (CNNLOH) in the tumor cells both in crude tumor tissue and in samples enriched for tumor cells by laser capture microdissection. Conclusion: Genome-wide quantitative analysis of CNNLOH using the CNNLOH Quantifier method can help to identify recurrent aberrations contributing to tumor development in clinical tumor samples. In addition, SNP-array based analysis of CNNLOH may become important for detection of aberrations that can be used for diagnostic and prognostic purposes.			Goransson, H (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	anders.isaksson@medsci.uu.se	Ekman, Simon/AAB-9387-2021; Botling, Johan/ABA-2586-2020; Wang, Weili/D-1546-2011	Botling, Johan/0000-0003-2226-3517; Rosenquist, Richard/0000-0002-0211-8788; Lambe, Mats/0000-0002-4624-3767; Isaksson, Anders/0000-0001-6576-7825				Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Ishikawa S, 2005, BIOCHEM BIOPH RES CO, V333, P1309, DOI 10.1016/j.bbrc.2005.06.040; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Lamy P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-434; Langdon JA, 2006, GENE CHROMOSOME CANC, V45, P47, DOI 10.1002/gcc.20262; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Micke Patrick, 2005, Methods Mol Biol, V293, P151; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	21	19	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6057	10.1371/journal.pone.0006057	http://dx.doi.org/10.1371/journal.pone.0006057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557126	Green Submitted, Green Published, gold			2022-12-25	WOS:000267424600005
J	Israel, A; Sharan, R; Ruppin, E; Galun, E				Israel, Ariel; Sharan, Roded; Ruppin, Eytan; Galun, Eithan			Increased MicroRNA Activity in Human Cancers	PLOS ONE			English	Article								MicroRNAs (miRNAs) are small regulatory RNAs that act by blocking the translation and increasing the degradation of target transcripts. MiRNAs play a critical role in many biological processes including development and differentiation and many studies have shown that major changes in miRNA levels occur in cancer. Since miRNAs degrade target messages, we used this property to develop a novel computational method aimed at determining the actual biological activity of miRNAs using variations in gene expression. Using the method described here, we quantified miRNA activity in papillary thyroid carcinoma and breast cancer, and found a strong and distinctive signal of increased global miRNA activity, embedded in the pertaining gene expression measurements. Interestingly, we found that in these two cancers, miRNA activity is globally increased, and is associated with a global downregulation of miRNA target genes. This downreguation of miRNA regulated genes is particularly noticeable for genes carrying multiple target sites for miRNAs. Among the miRNA-repressed genes, we found a significant enrichment of known tumor suppressors, thereby suggesting that the increased miRNA activity was indeed tumorigenic.			Israel, A (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Gene Therapy Inst, Jerusalem, Israel.	eithang@hadassah.org.il	Israel, Ariel/AFL-8794-2022; Ruppin, Eytan/R-9698-2017; Galun, Eithan/AAD-9117-2022	Ruppin, Eytan/0000-0002-7862-3940; Galun, Eithan/0000-0002-6243-6702				Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FRANKEL LB, 2007, J BIOL CHEM; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	43	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6045	10.1371/journal.pone.0006045	http://dx.doi.org/10.1371/journal.pone.0006045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557174	Green Submitted, Green Published, gold			2022-12-25	WOS:000267356900007
J	Slipczuk, L; Bekinschtein, P; Katche, C; Cammarota, M; Izquierdo, I; Medina, JH				Slipczuk, Leandro; Bekinschtein, Pedro; Katche, Cynthia; Cammarota, Martin; Izquierdo, Ivan; Medina, Jorge H.			BDNF Activates mTOR to Regulate GluR1 Expression Required for Memory Formation	PLOS ONE			English	Article							LONG-TERM-MEMORY; ANISOMYCIN-INDUCED AMNESIA; LOCAL PROTEIN-SYNTHESIS; CONTEXTUAL FEAR MEMORY; 2 CRITICAL PERIODS; SYNAPTIC PLASTICITY; MESSENGER-RNA; NEUROTROPHIC FACTOR; TRANSLATIONAL CONTROL; MAMMALIAN TARGET	Background: The mammalian target of Rapamycin (mTOR) kinase plays a key role in translational control of a subset of mRNAs through regulation of its initiation step. In neurons, mTOR is present at the synaptic region, where it modulates the activity-dependent expression of locally-translated proteins independently of mRNA synthesis. Indeed, mTOR is necessary for different forms of synaptic plasticity and long-term memory (LTM) formation. However, little is known about the time course of mTOR activation and the extracellular signals governing this process or the identity of the proteins whose translation is regulated by this kinase, during mnemonic processing. Methodology/Principal Findings: Here we show that consolidation of inhibitory avoidance (IA) LTM entails mTOR activation in the dorsal hippocampus at the moment of and 3 h after training and is associated with a rapid and rapamycin-sensitive increase in AMPA receptor GluR1 subunit expression, which was also blocked by intra-hippocampal delivery of GluR1 antisense oligonucleotides (ASO). In addition, we found that pre- or post-training administration of function-blocking anti-BDNF antibodies into dorsal CA1 hampered IA LTM retention, abolished the learning-induced biphasic activation of mTOR and its readout, p70S6K and blocked GluR1 expression, indicating that BDNF is an upstream factor controlling mTOR signaling during fear-memory consolidation. Interestingly, BDNF ASO hindered LTM retention only when given into dorsal CA1 1 h after but not 2 h before training, suggesting that BDNF controls the biphasic requirement of mTOR during LTM consolidation through different mechanisms: an early one involving BDNF already available at the moment of training, and a late one, happening around 3 h post-training that needs de novo synthesis of this neurotrophin. Conclusions/Significance: In conclusion, our findings demonstrate that: 1) mTOR-mediated mRNA translation is required for memory consolidation during at least two restricted time windows; 2) this kinase acts downstream BDNF in the hippocampus and; 3) it controls the increase of synaptic GluR1 necessary for memory consolidation.			Slipczuk, L (corresponding author), Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina.	jmedina@fmed.uba.ar	Cammarota, Martin/AAC-7478-2021; Neurociencia, Inct/I-1011-2013	Cammarota, Martin/0000-0001-9741-5074; Izquierdo, Ivan/0000-0002-7208-0869; Bekinschtein, Pedro/0000-0002-0004-9619; Katche, Cynthia/0000-0002-3428-7615				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Asaki C, 2003, BRAIN RES, V972, P168, DOI 10.1016/S0006-8993(03)02523-X; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; CAMMAROTA M, 1995, NEUROBIOL LEARN MEM, V64, P257, DOI 10.1006/nlme.1995.0008; Carvalho AL, 2008, BRIT J PHARMACOL, V153, pS310, DOI 10.1038/sj.bjp.0707509; CASTREN E, 1993, NEUROREPORT, V4, P895, DOI 10.1097/00001756-199307000-00014; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; FREEMAN FM, 1995, NEUROBIOL LEARN MEM, V63, P291, DOI 10.1006/nlme.1995.1034; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hefferan MP, 2007, J NEUROSCI, V27, P11179, DOI 10.1523/JNEUROSCI.0989-07.2007; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; HERNANDEZ PJ, 2007, NEUROBIOL LEARN MEM; Igaz LM, 2002, J NEUROSCI, V22, P6781; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Jain P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000287; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lorenzini CA, 1996, NEUROBIOL LEARN MEM, V66, P80, DOI 10.1006/nlme.1996.0045; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, P33; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Routtenberg A, 2008, NEUROBIOL LEARN MEM, V89, P225, DOI 10.1016/j.nlm.2007.10.012; Rudy JW, 2008, NEUROBIOL LEARN MEM, V89, P366, DOI 10.1016/j.nlm.2007.07.017; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, PHILOS T R SOC B, V357, P521, DOI 10.1098/rstb.2001.0887; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Tiunova AA, 1998, LEARN MEMORY, V4, P401, DOI 10.1101/lm.4.5.401; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yang PC, 2008, J BIOL CHEM, V283, P2631, DOI 10.1074/jbc.M706954200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	83	195	198	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6007	10.1371/journal.pone.0006007	http://dx.doi.org/10.1371/journal.pone.0006007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462JI	19547753	Green Published, gold, Green Submitted			2022-12-25	WOS:000267347900006
J	Lee, NY; Haney, JC; Sogani, J; Blobe, GC				Lee, Nam Y.; Haney, John C.; Sogani, Julie; Blobe, Gerard C.			Casein kinase 2 beta as a novel enhancer of activin-like receptor-1 signaling	FASEB JOURNAL			English	Article						TGF-beta superfamily signaling; endothelial cell biology; angiogenesis; bone morphogenetic protein; migration	GROWTH-FACTOR-BETA; HEREDITARY HEMORRHAGIC TELANGIECTASIA; ENDOTHELIAL-CELL MIGRATION; SMAD1/5 PHOSPHORYLATION; REGULATORY SUBUNIT; INHIBITS MOS; I RECEPTORS; PROTEIN; ENDOGLIN; CK2	ALK-1 is a transforming growth factor beta (TGF-beta) superfamily receptor that is predominantly expressed in endothelial cells and is essential for angiogenesis, as demonstrated by the embryonic lethal phentoype when targeted for deletion in mice and its mutation in the human disease hereditary hemorrhagic telangiectasia. Although ALK-1 and the endothelial-specific TGF-beta superfamily coreceptor, endoglin, form a heteromeric complex and bind similar TGF-beta superfamily ligands, their signaling mechanisms remain poorly characterized. Here we report the identification of CK2 beta, the regulatory subunit of protein kinase CK2, as a novel enhancer of ALK-1 signaling. The cytoplasmic domain of ALK-1 specifically binds to CK2 beta in vitro and in vivo. NAAIRS mutagenesis studies define amino acid sequences 181-199 of CK2 beta and 207-212 of ALK-1 as the interaction domains, respectively. The ALK-1/CK2 beta interaction specifically enhanced Smad1/5/8 phosphorylation and ALK-1-mediated reporter activation in response to TGF-beta 1 and BMP-9 treatment. In a reciprocal manner, siRNA-mediated silencing of endogenous CK2 beta inhibited TGF-beta 1 and BMP-9-stimulated Smad1/5/8 phosphorylation and ALK-1-mediated reporter activation. Functionally, CK2 beta enhanced the ability of activated or ligand-stimulated ALK-1 to inhibit endothelial cell migration. Similarly, ALK-1 and CK2 beta antagonized endothelial tubule formation in Matrigel. These studies support CK2 beta as an important regulator of ALK-1 signaling and ALK-1-mediated functions in endothelial cells.-Lee, N. Y., Haney, J. C., Sogani, J., Blobe, G. C. Casein kinase 2 beta as a novel enhancer of activin-like receptor-1 signaling. FASEB J. 23, 3712-3721 (2009). www.fasebj.org	[Lee, Nam Y.; Sogani, Julie; Blobe, Gerard C.] Duke Univ, Dept Med, Durham, NC USA; [Haney, John C.] Duke Univ, Dept Surg, Durham, NC USA; [Blobe, Gerard C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Blobe, GC (corresponding author), Box 91004,Res Dr,B534 LSRC, Durham, NC 27708 USA.	gerard.blobe@duke.edu	Lee, Nam/H-3073-2016; Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901	National Institute of Health/National Cancer Institute [R01-CA105255, F32-CA124139, T32-CA093245]; NATIONAL CANCER INSTITUTE [R01CA105255, T32CA093245, F32CA124139] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by National Institute of Health/National Cancer Institute grants R01-CA105255 (to G. C. B.), F32-CA124139 (to N.Y.L), and T32-CA093245 (to J.C.H.). The GST-CK2 beta expression vector was generously supplied by Dr. Jonathan Cooper (Fred Hutchinson Cancer Center, Seattle, WA, USA). Special thanks to Dr. Chandra Tucker and the Yeast Model Systems Genomics Group at Duke University for their assistance with the yeast 2-hybrid screen, and Dr. Kevin Peters (Procter & Gamble Pharmaceuticals) for the endothelial cell library.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bjorling-Poulsen M, 2005, ONCOGENE, V24, P6194, DOI 10.1038/sj.onc.1208762; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bolanos-Garcia VM, 2006, TRENDS BIOCHEM SCI, V31, P654, DOI 10.1016/j.tibs.2006.10.005; Boldyreff B, 1997, FEBS LETT, V403, P197, DOI 10.1016/S0014-5793(97)00010-0; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Bren GD, 2000, J MOL BIOL, V297, P1245, DOI 10.1006/jmbi.2000.3630; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Chen MZ, 1997, MOL CELL BIOL, V17, P1904, DOI 10.1128/MCB.17.4.1904; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guerra B, 2003, ONCOGENE, V22, P4933, DOI 10.1038/sj.onc.1206721; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hagemann C, 1997, FEBS LETT, V403, P200, DOI 10.1016/S0014-5793(97)00011-2; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kristensen LP, 2004, FEBS LETT, V569, P217, DOI 10.1016/j.febslet.2004.05.069; Kusk M, 1999, MOL CELL BIOCHEM, V191, P51, DOI 10.1023/A:1006840613986; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lieberman SL, 2004, DEV BIOL, V268, P271, DOI 10.1016/j.ydbio.2003.12.009; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mo JY, 2002, J BIOL CHEM, V277, P50788, DOI 10.1074/jbc.M210376200; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Ye L, 2008, MOL CANCER RES, V6, P1594, DOI 10.1158/1541-7786.MCR-08-0171	52	17	18	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3712	3721		10.1096/fj.09-131607	http://dx.doi.org/10.1096/fj.09-131607			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19592636	Green Published			2022-12-25	WOS:000271272500009
J	Kuronuma, K; Mitsuzawa, H; Takeda, K; Nishitani, C; Chan, ED; Kuroki, Y; Nakamura, M; Voelker, DR				Kuronuma, Koji; Mitsuzawa, Hiroaki; Takeda, Katsuyuki; Nishitani, Chiaki; Chan, Edward D.; Kuroki, Yoshio; Nakamura, Mari; Voelker, Dennis R.			Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS SYNDROME; ACUTE LUNG INJURY; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; KINASE PHOSPHATASE-1; LPS; ACTIVATION; LIPIDS; GENE	Lipopolysaccharide (LPS), derived from Gram-negative bacteria, is a major cause of acute lung injury and respiratory distress syndrome. Pulmonary surfactant is secreted as a complex mixture of lipids and proteins onto the alveolar surface of the lung. Surfactant phospholipids are essential in reducing surface tension at the air-liquid interface and preventing alveolar collapse at the end of the respiratory cycle. In the present study, we determined that palmitoyl-oleoyl-phosphatidylglycerol and phosphatidylinositol, which are minor components of pulmonary surfactant, and synthetic dimyristoylphosphatidylglycerol regulated the inflammatory response of alveolar macrophages. The anionic lipids significantly inhibited LPS-induced nitric oxide and tumor necrosis factor-alpha production from rat and human alveolar macrophages and a U937 cell line by reducing the LPS-elicited phosphorylation of multiple intracellular protein kinases. The anionic lipids were also effective at attenuating inflammation when administered intratracheally to mice challenged with LPS. Binding studies revealed high affinity interactions between the palmitoyl-oleoyl-phosphatidylglycerol and the Toll-like receptor 4-interacting proteins CD14 and MD-2. Our data clearly identify important anti-inflammatory properties of the minor surfactant phospholipids at the environmental interface of the lung.	[Kuronuma, Koji; Mitsuzawa, Hiroaki; Chan, Edward D.; Nakamura, Mari; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Takeda, Katsuyuki] Natl Jewish Hlth, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; [Nishitani, Chiaki; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	National Jewish Health; National Jewish Health; Sapporo Medical University	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njc.org			National Institutes of Health [PHL 073907]; GCRC [M01-RR00051]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants PHL 073907 and GCRC M01-RR00051.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Atabai K, 2002, THORAX, V57, P452, DOI 10.1136/thorax.57.5.452; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; DING AH, 1988, J IMMUNOL, V141, P2407; DOBBS LG, 1978, AM REV RESPIR DIS, V118, P705, DOI 10.1164/arrd.1978.118.4.705; Flotte TR, 2001, CHEST, V120, p124S, DOI 10.1378/chest.120.3_suppl.124S; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hashimoto M, 2003, J BIOL CHEM, V278, P44205, DOI 10.1074/jbc.M306735200; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hite RD, 2005, AM J PHYSIOL-LUNG C, V288, pL610, DOI 10.1152/ajplung.00273.2004; HONDA Y, 1988, LUNG, V166, P293, DOI 10.1007/BF02714060; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; KUROKI Y, 1994, J BIOL CHEM, V269, P29793; KUROKI Y, 1988, J BIOL CHEM, V263, P3388; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; Markart P, 2007, THORAX, V62, P588, DOI 10.1136/thx.2006.062398; MCCORMACK FX, 1991, AM REV RESPIR DIS, V144, P160, DOI 10.1164/ajrccm/144.1.160; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; O'Reilly D., 1992, BACULOVIRUS EXPRESSI, P109; OBRIEN AD, 1980, J IMMUNOL, V124, P20; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Saydain G, 2002, AM J RESP CRIT CARE, V166, P839, DOI 10.1164/rccm.2104038; Schmidt R, 2002, AM J PHYSIOL-LUNG C, V283, pL1079, DOI 10.1152/ajplung.00484.2001; Schmidt R, 2001, AM J RESP CRIT CARE, V163, P95, DOI 10.1164/ajrccm.163.1.9903029; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wright SM, 2000, J APPL PHYSIOL, V89, P1283, DOI 10.1152/jappl.2000.89.4.1283; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Wuyts A, 1996, J IMMUNOL, V157, P1736; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	57	107	107	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25488	25500		10.1074/jbc.M109.040832	http://dx.doi.org/10.1074/jbc.M109.040832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19584052	Green Published, hybrid			2022-12-25	WOS:000269738000006
J	Gandhi, PS; Page, MJ; Chen, ZW; Bush-Pelc, L; Di Cera, E				Gandhi, Prafull S.; Page, Michael J.; Chen, Zhiwei; Bush-Pelc, Leslie; Di Cera, Enrico			Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C ACTIVATOR; CRYSTAL-STRUCTURE; POTENT ANTICOAGULANT; MURINE THROMBIN; NA+ BINDING; SPECIFICITY; FIBRINOGEN; SITE; ENERGETICS; PROSTASIN	The thrombin mutant W215A/E217A (WE) is a potent anticoagulant both in vitro and in vivo. Previous x-ray structural studies have shown that WE assumes a partially collapsed conformation that is similar to the inactive E* form, which explains its drastically reduced activity toward substrate. Whether this collapsed conformation is genuine, rather than the result of crystal packing or the mutation introduced in the critical 215-217 beta-strand, and whether binding of thrombomodulin to exosite I can allosterically shift the E* form to the active E form to restore activity toward protein C are issues of considerable mechanistic importance to improve the design of an anticoagulant thrombin mutant for therapeutic applications. Here we present four crystal structures of WE in the human and murine forms that confirm the collapsed conformation reported previously under different experimental conditions and crystal packing. We also present structures of human and murine WE bound to exosite I with a fragment of the platelet receptor PAR1, which is unable to shift WE to the E form. These structural findings, along with kinetic and calorimetry data, indicate that WE is strongly stabilized in the E* form and explain why binding of ligands to exosite I has only a modest effect on the E*-E equilibrium for this mutant. The E* -> E transition requires the combined binding of thrombomodulin and protein C and restores activity of the mutant WE in the anticoagulant pathway.	[Gandhi, Prafull S.; Page, Michael J.; Chen, Zhiwei; Bush-Pelc, Leslie; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, POB 8231, St Louis, MO 63110 USA.	enrico@wustl.edu			National Institutes of Health Research Grants [HL49413, HL58141, HL73813]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R01HL049413, R01HL058141, R29HL049413] Funding Source: NIH RePORTER	National Institutes of Health Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grants HL49413, HL58141, and HL73813 ( to E. D. C.).	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; AYALA YH, 1994, J MOL BIOL, V235, P733, DOI 10.1006/jmbi.1994.1024; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrette-Ng IH, 2002, J BIOL CHEM, V277, P39960, DOI 10.1074/jbc.M206978200; Bates SM, 2006, BRIT J HAEMATOL, V134, P3, DOI 10.1111/j.1365-2141.2006.06134.x; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush LA, 2006, J BIOL CHEM, V281, P7183, DOI 10.1074/jbc.M512082200; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Carrell CJ, 2006, BIOPHYS CHEM, V121, P177, DOI 10.1016/j.bpc.2005.12.008; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Di Cera E, 2007, J THROMB HAEMOST, V5, P196; Di Cera E., 1995, THERMODYNAMIC THEORY; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Gruber A, 2006, J THROMB HAEMOST, V4, P392, DOI 10.1111/j.1538-7836.2006.01760.x; Gruber A, 2002, J BIOL CHEM, V277, P27581, DOI 10.1074/jbc.C200237200; Gruber A, 2007, BLOOD, V109, P3733, DOI 10.1182/blood-2006-07-035147; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Marino F, 2007, J BIOL CHEM, V282, P16355, DOI 10.1074/jbc.M701323200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papaconstantinou ME, 2005, J BIOL CHEM, V280, P29393, DOI 10.1074/jbc.C500248200; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Rickert KW, 2008, J BIOL CHEM, V283, P34864, DOI 10.1074/jbc.M805262200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Spraggon G, 2009, PROTEIN SCI, V18, P1081, DOI 10.1002/pro.118; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; Wyman J., 1990, BINDING LINKAGE; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	56	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24098	24105		10.1074/jbc.M109.025403	http://dx.doi.org/10.1074/jbc.M109.025403			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586901	hybrid, Green Published			2022-12-25	WOS:000269380200023
J	Lu, W; Laszlo, CF; Miao, ZX; Chen, H; Wu, SY				Lu, Wei; Laszlo, Csaba F.; Miao, Zhixin; Chen, Hao; Wu, Shiyong			The Role of Nitric-oxide Synthase in the Regulation of UVB Light-induced Phosphorylation of the alpha Subunit of Eukaryotic Initiation Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSFER-RNA-SYNTHETASE; HUMAN ENDOTHELIAL-CELLS; NF-KAPPA-B; TRANSLATIONAL CONTROL; MAMMALIAN HOMOLOG; PROTEIN; ACTIVATION; PEROXYNITRITE; APOPTOSIS	UV light induces phosphorylation of the alpha subunit of the eukaryotic initiation factor 2 (eIF2 alpha) and inhibits global protein synthesis. Both eIF2 kinases, protein kinase-like endoplasmic reticulum kinase (PERK) and general control of nonderepressible protein kinase 2 (GCN2), have been shown to phosphorylate eIF2 alpha in response to UV irradiation. However, the roles of PERK and GCN2 in UV-induced eIF2 alpha phosphorylation are controversial. The one or more upstream signaling pathways that lead to the activation of PERK or GCN2 remain unknown. In this report we provide data showing that both PERK and GCN2 contribute to UV-induced eIF2 alpha phosphorylation in human keratinocyte (HaCaT) and mouse embryonic fibroblast cells. Reduction of expression of PERK or GCN2 by small interfering RNA decreases phosphorylation of eIF2 alpha after UV irradiation. These data also show that nitric-oxide synthase (NOS)-mediated oxidative stress plays a role in regulation of eIF2 alpha phosphorylation upon UV irradiation. Treating the cells with the broad NOS inhibitor N-G-methyl-L-arginine, the free radical scavenger N-acetyl-L-cysteine, or the NOS substrate L-arginine partially inhibits UV-induced eIF2 alpha phosphorylation. The results presented above led us to propose that NOS mediates UV-induced eIF2 alpha phosphorylation by activation of both PERK and GCN2 via oxidative stress and L-arginine starvation signaling pathways.	[Lu, Wei; Laszlo, Csaba F.; Wu, Shiyong] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [Lu, Wei; Laszlo, Csaba F.; Miao, Zhixin; Chen, Hao; Wu, Shiyong] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Wu, Shiyong] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Wu, SY (corresponding author), Ohio Univ, Edison Biotechnol Inst, 101 Konneker Labs,Ridges Bldg 25, Athens, OH 45701 USA.	wus1@ohio.edu	Wu, Shiyong/I-3359-2013; Miao, Zhixin/G-2616-2013	Wu, Shiyong/0000-0002-4104-4160; 	National Institutes of Health [RO1 CA86928, R56 CA086928]; NATIONAL CANCER INSTITUTE [R01CA086928, R56CA086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA86928 (to S. W.) and R56 CA086928 (to S. W.).	Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Beattie PE, 2005, BRIT J DERMATOL, V152, P1001, DOI 10.1111/j.1365-2133.2005.06557.x; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; CLEMENS MJ, 1987, J BIOL CHEM, V262, P767; CRABEEL M, 1985, MOL CELL BIOL, V5, P3139, DOI 10.1128/MCB.5.11.3139; Crow J P, 1995, Adv Pharmacol, V34, P17; CURRAN RD, 1991, FASEB J, V5, P2085, DOI 10.1096/fasebj.5.7.1707021; DELICONSTANTINOS G, 1992, J CARDIOVASC PHARM, V20, pS63, DOI 10.1097/00005344-199204002-00019; DELICONSTANTINOS G, 1995, BRIT J PHARMACOL, V114, P1257, DOI 10.1111/j.1476-5381.1995.tb13341.x; Deliconstantinos G, 1996, EXP PHYSIOL, V81, P1021, DOI 10.1113/expphysiol.1996.sp003986; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Groves JT, 1999, CURR OPIN CHEM BIOL, V3, P226, DOI 10.1016/S1367-5931(99)80036-2; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Huk I, 1997, CIRCULATION, V96, P667; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara K, 2001, FEBS LETT, V506, P135, DOI 10.1016/S0014-5793(01)02898-8; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; KUBASZEWSKI E, 1994, BIOCHEM BIOPH RES CO, V200, P213, DOI 10.1006/bbrc.1994.1436; Kuchel JM, 2003, J INVEST DERMATOL, V121, P587, DOI 10.1046/j.1523-1747.2003.12415.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Malinski T, 2005, AM J CARDIOL, V96, p13I, DOI 10.1016/j.amjcard.2005.07.029; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Ogawa Y, 2008, FREE RADICAL RES, V42, P674, DOI 10.1080/10715760802277396; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Oliver BL, 2005, J CELL PHYSIOL, V204, P45, DOI 10.1002/jcp.20261; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Parker SH, 2006, MOL CELL BIOCHEM, V293, P173, DOI 10.1007/s11010-006-9239-y; Pou S, 1999, J BIOL CHEM, V274, P9573, DOI 10.1074/jbc.274.14.9573; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Skoog D. A., 2007, PRINCIPLES INSTRUMEN, P13; SONENBERG N, 2000, TRANSLATION CONTROL, P547; Sood R, 2000, GENETICS, V154, P787; TYRRELL RM, 1986, PHOTOCHEM PHOTOBIOL, V44, P561, DOI 10.1111/j.1751-1097.1986.tb04709.x; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Weller R, 2002, SKIN PHARMACOL APPL, V15, P348, DOI 10.1159/000064540; Wiswedel I, 2007, FREE RADICAL RES, V41, P1017, DOI 10.1080/10715760701531430; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	48	37	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24281	24288		10.1074/jbc.M109.008821	http://dx.doi.org/10.1074/jbc.M109.008821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586904	hybrid, Green Published			2022-12-25	WOS:000269380200041
J	Shell, SM; Li, ZK; Shkriabai, N; Kvaratskhelia, M; Brosey, C; Serrano, MA; Chazin, WJ; Musich, PR; Zou, Y				Shell, Steven M.; Li, Zhengke; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Brosey, Chris; Serrano, Moises A.; Chazin, Walter J.; Musich, Phillip R.; Zou, Yue			Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-PROTEIN-A; STRUCTURAL BASIS; XPA; BINDING; RECOGNITION; HELIX; DOMAIN; CELLS; ELECTROSTATICS; IRRADIATION	In response to DNA damage, eukaryotic cells activate a series of DNA damage-dependent pathways that serve to arrest cell cycle progression and remove DNA damage. Coordination of cell cycle arrest and damage repair is critical for maintenance of genomic stability. However, this process is still poorly understood. Nucleotide excision repair (NER) and the ATR-dependent cell cycle checkpoint are the major pathways responsible for repair of UV-induced DNA damage. Here we show that ATR physically interacts with the NER factor Xeroderma pigmentosum group A (XPA). Using a mass spectrometry-based protein footprinting method, we found that ATR interacts with a helix-turn-helix motif in the minimal DNA-binding domain of XPA where an ATR phosphorylation site (serine 196) is located. XPA-deficient cells complemented with XPA containing a point mutation of S196A displayed a reduced repair efficiency of cyclobutane pyrimidine dimers as compared with cells complemented with wild-type XPA, although no effect was observed for repair of (6-4) photoproducts. This suggests that the ATR-dependent phosphorylation of XPA may promote NER repair of persistent DNA damage. In addition, a K188A point mutation of XPA that disrupts the ATR-XPA interaction inhibits the nuclear import of XPA after UV irradiation and, thus, significantly reduced DNA repair efficiency. By contrast, the S196A mutation has no effect on XPA nuclear translocation. Taken together, our results suggest that the ATR-XPA interaction mediated by the helix-turn-helix motif of XPA plays an important role in DNA-damage responses to promote cell survival and genomic stability after UV irradiation.	[Shell, Steven M.; Li, Zhengke; Serrano, Moises A.; Musich, Phillip R.; Zou, Yue] E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Brosey, Chris; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Brosey, Chris; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Brosey, Chris; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	East Tennessee State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zou, Y (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA.	zouy@etsu.edu	Classen, Scott/AAY-8176-2020; Li, Zhengke/J-8527-2016; Zou, Yue/ABA-8429-2020	Li, Zhengke/0000-0001-5560-343X; Serrano, Moises/0000-0002-1037-9304; Musich, Phillip/0000-0001-8816-4242	National Institutes of Health [CA86927, AG031503, AI077341, GM065484, CA092584]; NATIONAL CANCER INSTITUTE [R56CA086927, P01CA092584, R01CA086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI077341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065484, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA86927 and AG031503 (to Y. Z.), AI077341 (to M. K.), and GM065484 and CA092584 (to W. J. C.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Aurora R, 1997, J BIOL CHEM, V272, P1413, DOI 10.1074/jbc.272.3.1413; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BLAGDON DE, 1975, BIOPOLYMERS, V14, P241, DOI 10.1002/bip.1975.360140118; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; Buchko GW, 2001, NUCLEIC ACIDS RES, V29, P2635, DOI 10.1093/nar/29.12.2635; Case D, 2006, AMBER 9; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cleaver JE, 1997, BIOCHEM J, V328, P1, DOI 10.1042/bj3280001; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Croteau DL, 2008, DNA REPAIR, V7, P819, DOI 10.1016/j.dnarep.2008.01.018; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Guzder SN, 2006, MOL CELL BIOL, V26, P1135, DOI 10.1128/MCB.26.3.1135-1141.2006; Kobayashi N, 2001, PIGM CELL RES, V14, P94, DOI 10.1034/j.1600-0749.2001.140204.x; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Lerner MG, 2006, APBS PLUGIN PYMOL; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Park CJ, 2006, FEBS J, V273, P1600, DOI 10.1111/j.1742-4658.2006.05189.x; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shell SM, 2008, ADV EXP MED BIOL, V637, P103; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	45	59	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24213	24222		10.1074/jbc.M109.000745	http://dx.doi.org/10.1074/jbc.M109.000745			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586908	hybrid, Green Published			2022-12-25	WOS:000269380200035
J	Argueso, P; Guzman-Aranguez, A; Mantelli, F; Cao, ZY; Ricciuto, J; Panjwani, N				Argueso, Pablo; Guzman-Aranguez, Ana; Mantelli, Flavio; Cao, Zhiyi; Ricciuto, Jessica; Panjwani, Noorjahan			Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CORNEAL-LIMBAL; HUMAN BREAST; DRY EYE; ADHESION; EXPRESSION; CANCER; BINDING; BETA-1,3-GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN; GLYCANS	Maintenance of an intact mucosal barrier is critical to preventing damage to and infection of wet-surfaced epithelia. The mechanism of defense has been the subject of much investigation, and there is evidence now implicating O-glycosylated mucins on the epithelial cell surface. Here we investigate a new role for the carbohydrate-binding protein galectin-3 in stabilizing mucosal barriers through its interaction with mucins on the apical glycocalyx. Using the surface of the eye as a model system, we found that galectin-3 colocalized with two distinct membrane-associated mucins, MUC1 and MUC16, on the apical surface of epithelial cells and that both mucins bound to galectin-3 affinity columns in a galactose-dependent manner. Abrogation of the mucin-galectin interaction in four different mucosal epithelial cell types using competitive carbohydrate inhibitors of galectin binding, beta-lactose and modified citrus pectin, resulted in decreased levels of galectin-3 on the cell surface with concomitant loss of barrier function, as indicated by increased permeability to rose bengal diagnostic dye. Similarly, down-regulation of mucin O-glycosylation using a stable tetracycline-inducible RNA interfering system to knockdown c1galt1 (T-synthase), a critical galactosyltransferase required for the synthesis of core 1 O-glycans, resulted in decreased cell surface O-glycosylation, reduced cell surface galectin-3, and increased epithelial permeability. Taken together, these results suggest that galectin-3 plays a key role in maintaining mucosal barrier function through carbohydrate-dependent interactions with cell surface mucins.	[Argueso, Pablo; Guzman-Aranguez, Ana; Mantelli, Flavio; Ricciuto, Jessica] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Argueso, Pablo; Guzman-Aranguez, Ana; Mantelli, Flavio; Ricciuto, Jessica] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Cao, Zhiyi; Panjwani, Noorjahan] Ctr Vis Res, Dept Ophthalmol, Boston, MA 02114 USA; [Cao, Zhiyi; Panjwani, Noorjahan] New England Eye Ctr, Boston, MA 02114 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Tufts University	Argueso, P (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	pablo.argueso@schepens.harvard.edu	guzman, ana/Y-8286-2019	Argueso, Pablo/0000-0001-7321-9503; Guzman-Aranguez, Ana/0000-0001-6722-2044	National Institutes of Health [R01EY014847, R01EY07088]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007088, R01EY014847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY014847 (to P. A.) and R01EY07088 (to N. P.) (NEI), and a challenge grant from Research to Prevent Blindness (to Tufts medical center).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; ALBERSHEIM P, 1960, ARCH BIOCHEM BIOPHYS, V90, P46, DOI 10.1016/0003-9861(60)90609-3; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Argueso P, 2006, INVEST OPHTH VIS SCI, V47, P113, DOI 10.1167/iovs.05-0735; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bauer H, 1999, EXP CELL RES, V250, P434, DOI 10.1006/excr.1999.4558; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bresalier RS, 1996, CANCER RES, V56, P4354; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443; Davies D E, 2001, Curr Allergy Asthma Rep, V1, P127, DOI 10.1007/s11882-001-0080-9; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2007, OCUL SURF, V5, P179; Glinsky VV, 2001, CANCER RES, V61, P4851; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; HO MK, 1982, J IMMUNOL, V128, P1221; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; INOHARA H, 1995, CANCER RES, V55, P3267; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; Khaldoyanidi SK, 2003, J BIOL CHEM, V278, P4127, DOI 10.1074/jbc.M209590200; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Qin W, 2005, J INTERN MED, V258, P467, DOI 10.1111/j.1365-2796.2005.01558.x; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	37	188	189	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23037	23045		10.1074/jbc.M109.033332	http://dx.doi.org/10.1074/jbc.M109.033332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556244	hybrid, Green Published			2022-12-25	WOS:000268963100056
J	Das, S; Harris, LG; Metge, BJ; Liu, SH; Riker, AI; Samant, RS; Shevde, LA				Das, Shamik; Harris, Lillianne G.; Metge, Brandon J.; Liu, Suhu; Riker, Adam I.; Samant, Rajeev S.; Shevde, Lalita A.			The Hedgehog Pathway Transcription Factor GLI1 Promotes Malignant Behavior of Cancer Cells by Up-regulating Osteopontin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; HUMAN BREAST-CANCER; MDA-MB-435 CELLS; SIGNALING PATHWAY; MELANOMA-CELLS; GROWTH-FACTOR; TUMOR-GROWTH; METASTASIS; EXPRESSION; ACTIVATION	The role of Hedgehog (Hh) signaling as a developmental pathway is well established. Several recent studies have implicated a role for this pathway in multiple cancers. In this study we report that expression of GLI1 and osteopontin (OPN) increase progressively with the progression of melanoma from primary cutaneous cancer to metastatic melanoma in clinically derived specimens. We have further determined that OPN is a direct transcriptional target of GLI1. We have observed that OPN expression is stimulated in the presence of Hh ligands and inhibited in the presence of the Smoothened (SMO) inhibitor, cyclopamine. Transcriptional silencing of GLI1 negatively impacts OPN expression and compromises the ability of cancer cells to proliferate, migrate, and invade in vitro and interferes with their ability to grow as xenografts and spontaneously metastasize in nude mice. These altered attributes could be rescued by re-expressing OPN in the GLI1-silenced cells, suggesting that OPN is a critical downstream effector of active GLI1 signaling. Our observations lead us to conclude that the GLI1-mediated up-regulation of OPN promotes malignant behavior of cancer cells.	[Das, Shamik; Harris, Lillianne G.; Metge, Brandon J.; Liu, Suhu; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Riker, Adam I.] Ochsner Canc Inst, Dept Surg, New Orleans, LA 70121 USA	University of South Alabama; Ochsner Health System	Shevde, LA (corresponding author), MCI 3018,1660 Springhill Ave, Mobile, AL 36604 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	United States Department of Defense IDEA Award [07-1-0400]	United States Department of Defense IDEA Award(United States Department of Defense)	This work was supported by United States Department of Defense IDEA Award 07-1-0400 (to L.A.S.).	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bar-Eli M, 2007, PIGM CELL RES, V20, P341, DOI 10.1111/j.1600-0749.2007.00404.x; Bayless KJ, 1998, J CELL SCI, V111, P1165; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BROWN LF, 1994, AM J PATHOL, V145, P610; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; HU DD, 1995, ANN NY ACAD SCI, V760, P312, DOI 10.1111/j.1749-6632.1995.tb44644.x; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katagiri YU, 1999, CANCER RES, V59, P219; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Lacroix M, 2009, CANCER CHEMOTH PHARM, V63, P567, DOI 10.1007/s00280-008-0776-9; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Nagase H, 1992, Matrix Suppl, V1, P237; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rae JM, 2004, CLIN EXP METASTAS, V21, P543, DOI 10.1007/s10585-004-3759-1; Rangaswami H, 2007, ONCOL REP, V18, P909; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Seftor REB, 1999, CANCER METAST REV, V18, P359, DOI 10.1023/A:1006317125454; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Sharp JA, 1999, LAB INVEST, V79, P869; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Thayer Sarah, 2004, Clin Adv Hematol Oncol, V2, P63; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 1999, ONCOGENE, V18, P4237, DOI 10.1038/sj.onc.1202799; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Urquidi V, 2002, CLIN CANCER RES, V8, P61; Varner J A, 1999, Angiogenesis, V3, P53, DOI 10.1023/A:1009019223744; Wai PY, 2006, SURGERY, V140, P132, DOI 10.1016/j.surg.2006.02.005; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wu YD, 2009, J BIOL CHEM, V284, P640, DOI 10.1074/jbc.M806916200; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xuan YH, 2009, J CANCER RES CLIN, V135, P235, DOI 10.1007/s00432-008-0451-x; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	69	93	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22888	22897		10.1074/jbc.M109.021949	http://dx.doi.org/10.1074/jbc.M109.021949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556240	Green Published, hybrid			2022-12-25	WOS:000268963100042
J	Mccoll, G; Roberts, BR; Gunn, AP; Perez, KA; Tew, DJ; Masters, CL; Barnham, KJ; Cherny, RA; Bush, AI				Mccoll, Gawain; Roberts, Blaine R.; Gunn, Adam P.; Perez, Keyla A.; Tew, Deborah J.; Masters, Colin L.; Barnham, Kevin J.; Cherny, Robert A.; Bush, Ashley I.			The Caenorhabditis elegans A beta(1-42) Model of Alzheimer Disease Predominantly Expresses A beta(3-42)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID PEPTIDE; A-BETA; GLUTAMINYL CYCLASE; INVERTEBRATE MODELS; IN-VITRO; AGGREGATION; PYROGLUTAMATE; PROTEIN; HYPOTHESIS; BRAIN	Transgenic expression of human amyloid beta (A beta) peptide in body wall muscle cells of Caenorhabditis elegans has been used to better understand aspects of Alzheimer disease (AD). In human aging and AD, A beta undergoes post-translational changes including covalent modifications, truncations, and oligomerization. Amino truncated A beta is increasingly recognized as potentially contributing to AD pathogenesis. Here we describe surface-enhanced laser desorption ionization-time of flight mass spectrometry mass spectrometry of A beta peptide in established transgenic C. elegans lines. Surprisingly, the A beta being expressed is not full-length 1-42 (amino acids) as expected but rather a 3-42 truncation product. In vitro analysis demonstrates that A beta(3-42) self-aggregates like A beta(1-42), but more rapidly, and forms fibrillar structures. Similarly, A beta(3-42) is also the more potent initiator of A beta(1-40) aggregation. Seeded aggregation via A beta(3-42) is further enhanced via co-incubation with the transition metal Cu(II). Although unexpected, the C. elegans model of A beta expression can now be co-opted to study the proteotoxic effects and processing of A beta(3-42).	[Mccoll, Gawain; Roberts, Blaine R.; Gunn, Adam P.; Perez, Keyla A.; Tew, Deborah J.; Masters, Colin L.; Barnham, Kevin J.; Cherny, Robert A.; Bush, Ashley I.] Mental Hlth Res Inst, AIB, Parkville, Vic 3052, Australia; [Mccoll, Gawain; Roberts, Blaine R.; Gunn, Adam P.; Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Perez, Keyla A.; Tew, Deborah J.; Barnham, Kevin J.; Cherny, Robert A.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Perez, Keyla A.; Tew, Deborah J.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Bush, AI (corresponding author), Mental Hlth Res Inst, AIB, 155 Oak St, Parkville, Vic 3052, Australia.	a.bush@mhri.edu.au	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Gunn, Adam P/D-5437-2012; McColl, Gawain/Y-8959-2018	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Gunn, Adam P/0000-0002-8181-4975; Roberts, Blaine/0000-0001-5466-0053; McColl, Gawain/0000-0002-6347-6722	Australian Research Council; National Health and Medical Research Council; AGL Shaw Trust; Harold and Cora Brennan Benevolent Trust; Marian and E. H. Flack Trust; Victorian State Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); AGL Shaw Trust; Harold and Cora Brennan Benevolent Trust; Marian and E. H. Flack Trust; Victorian State Government	This work was supported by funds from the Australian Research Council, National Health and Medical Research Council, AGL Shaw Trust, Harold and Cora Brennan Benevolent Trust, the Marian and E. H. Flack Trust, and the Operational Infrastructure Support program of the Victorian State Government.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bianchi Laura, 2006, WormBook, P1; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Bush AI, 2008, J ALZHEIMERS DIS, V15, P223; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fay DS, 1998, J NEUROCHEM, V71, P1616; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Kraemer B, 2007, INT REV NEUROBIOL, V77, P219, DOI 10.1016/S0074-7742(06)77007-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, MECH AGEING DEV, V122, P1639, DOI 10.1016/S0047-6374(01)00291-3; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Maler JM, 2007, PROTEOMICS, V7, P3815, DOI 10.1002/pmic.200700311; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Minniti AN, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-2; Miura T, 2004, J INORG BIOCHEM, V98, P10, DOI 10.1016/j.jinorgbio.2003.10.008; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shirotani K, 2002, NEUROSCI LETT, V327, P25, DOI 10.1016/S0304-3940(02)00351-8; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	50	96	96	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22697	22702		10.1074/jbc.C109.028514	http://dx.doi.org/10.1074/jbc.C109.028514			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19574211	Green Published, hybrid			2022-12-25	WOS:000268963100024
J	Nobbio, L; Sturla, L; Fiorese, F; Usai, C; Basile, G; Moreschi, I; Benvenuto, F; Zocchi, E; De Flora, A; Schenone, A; Bruzzone, S				Nobbio, Lucilla; Sturla, Laura; Fiorese, Fulvia; Usai, Cesare; Basile, Giovanna; Moreschi, Iliana; Benvenuto, Federica; Zocchi, Elena; De Flora, Antonio; Schenone, Angelo; Bruzzone, Santina			P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; PERIPHERAL MYELIN PROTEIN-22; CYCLIC ADP-RIBOSE; ASCORBIC-ACID TREATMENT; P2X(7) RECEPTORS; MOUSE MODEL; PMP22 GENE; EXPRESSION; NERVE; ATP	Charcot-Marie-Tooth (CMT) is the most frequent inherited neuromuscular disorder, affecting 1 person in 2500. CMT1A, the most common form of CMT, is usually caused by a duplication of chromosome 17p11.2, containing the PMP22 (peripheral myelin protein-22) gene; overexpression of PMP22 in Schwann cells (SC) is believed to cause demyelination, although the underlying pathogenetic mechanisms remain unclear. Here we report an abnormally high basal concentration of intracellular calcium ([Ca2+](i)) in SC from CMT1A rats. By the use of specific pharmacological inhibitors and through down-regulation of expression by small interfering RNA, we demonstrate that the high [Ca2+](i) is caused by a PMP22-related overexpression of the P2X7 purinoceptor/channel leading to influx of extracellular Ca2+ into CMT1A SC. Correction of the altered [Ca2+](i) in CMT1A SC by small interfering RNA or with pharmacological inhibitors of P2X7 restores functional parameters of SC (migration and release of ciliary neurotrophic factor), which are typically defective in CMT1A SC. More significantly, stable down-regulation of the expression of P2X7 restores myelination in co-cultures of CMT1A SC with dorsal root ganglion sensory neurons. These results establish a pathogenetic link between high [Ca2+](i) and impaired SC function in CMT1A and identify overexpression of P2X7 as the molecular mechanism underlying both abnormalities. The development of P2X7 inhibitors is expected to provide a new therapeutic strategy for treatment of CMT1A neuropathy.	[Sturla, Laura; Basile, Giovanna; Moreschi, Iliana; Zocchi, Elena; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Sturla, Laura; Basile, Giovanna; Moreschi, Iliana; Zocchi, Elena; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Nobbio, Lucilla; Fiorese, Fulvia; Benvenuto, Federica; Schenone, Angelo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Nobbio, Lucilla; Fiorese, Fulvia; Benvenuto, Federica; Schenone, Angelo] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15-1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Nobbio, Lucilla/J-1213-2018; Bruzzone, Santina/A-4264-2015; schenone, angelo/I-3194-2012	Nobbio, Lucilla/0000-0003-2150-3953; Bruzzone, Santina/0000-0003-2034-3716; schenone, angelo/0000-0002-2604-7830; Usai, Cesare/0000-0001-8863-7759	Telethon [GGP06178] Funding Source: Medline	Telethon(Fondazione Telethon)		Abrams CK, 2002, P NATL ACAD SCI USA, V99, P3980, DOI 10.1073/pnas.261713499; Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brancolini C, 1999, MOL BIOL CELL, V10, P2441, DOI 10.1091/mbc.10.7.2441; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2007, J BIOL CHEM, V282, P5045, DOI 10.1074/jbc.M609802200; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dell'Antonio G, 2002, NEUROSCI LETT, V327, P87, DOI 10.1016/S0304-3940(02)00385-3; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; Di Virgilio F, 2006, NOVART FDN SYMP, V276, P275; Di Virgilio Francesco, 2006, Novartis Found Symp, V276, P253; DIVIRGILIO F, 2006, NOVART FDN SYMP, V276, P259; DYCK PJ, 1989, NEUROLOGY, V39, P1302, DOI 10.1212/WNL.39.10.1302; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grafe P, 1999, J PHYSIOL-LONDON, V515, P377, DOI 10.1111/j.1469-7793.1999.377ac.x; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Liu CL, 2004, AM J PHYSIOL-HEART C, V286, pH1688, DOI 10.1152/ajpheart.00576.2003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarthy TV, 2003, FEBS LETT, V554, P133, DOI 10.1016/S0014-5793(03)01122-0; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Niemann S, 2000, J NEUROSCI, V20, P4120; Nobbio L, 2004, NEUROBIOL DIS, V16, P263, DOI 10.1016/j.nbd.2004.02.007; Nobbio L, 2001, ANN NEUROL, V50, P47, DOI 10.1002/ana.1034; Nobbio L, 2009, J NEUROPATH EXP NEUR, V68, P441, DOI 10.1097/NEN.0b013e31819fa6ba; Pareyson D, 2006, PHARMACOL RES, V54, P436, DOI 10.1016/j.phrs.2006.09.001; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; Saberan-Djoneidi D, 2000, GENE, V248, P223, DOI 10.1016/S0378-1119(00)00116-5; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; SMITH KJ, 1985, J NEUROL SCI, V71, P19, DOI 10.1016/0022-510X(85)90034-6; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; SUTER U, 1995, J NEUROSCI RES, V40, P145, DOI 10.1002/jnr.490400202; SUTER U, 1994, J BIOL CHEM, V269, P25795; Sutko JL, 1997, PHARMACOL REV, V49, P53; ten Asbroek ALMA, 2005, J NEUROSCI RES, V79, P825, DOI 10.1002/jnr.20406; Vigo T, 2005, MOL CELL NEUROSCI, V28, P703, DOI 10.1016/j.mcn.2004.11.016; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	59	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23146	23158		10.1074/jbc.M109.027128	http://dx.doi.org/10.1074/jbc.M109.027128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546221	Green Published, hybrid			2022-12-25	WOS:000268963100066
J	Yezid, H; Konate, K; Debaisieux, S; Bonhoure, A; Beaumelle, B				Yezid, Hocine; Konate, Karidia; Debaisieux, Solene; Bonhoure, Anne; Beaumelle, Bruno			Mechanism for HIV-1 Tat Insertion into the Endosome Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; MOLECULAR-DYNAMICS SIMULATIONS; HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-IMMUNODEFICIENCY-VIRUS; PSEUDOMONAS EXOTOXIN; DIPHTHERIA-TOXIN; T-DOMAIN; PROTEIN; TRANSLOCATION; ACTIVATION	The human immunodeficiency virus, type 1, transactivating protein Tat is a small protein that is strictly required for viral transcription and multiplication within infected cells. The infected cells actively secrete Tat using an unconventional secretion pathway. Extracellular Tat can affect different cell types and induce severe cell dysfunctions ranging from cell activation to cell death. To elicit most cell responses, Tat needs to reach the cell cytosol. To this end, Tat is endocytosed, and low endosomal pH will then trigger Tat translocation to the cytosol. Although this translocation step is critical for Tat cytosolic delivery, how Tat could interact with the endosome membrane is unknown, and the key residues involved in this interaction require identification. We found that, upon acidification below pH 6.0 (i.e. within the endosomal pH range), Tat inserts into model membranes such as monolayers or lipid vesicles. This insertion process relies on Tat single Trp, Trp-11, which is not needed for transactivation and could be replaced by another aromatic residue for membrane insertion. Nevertheless, Trp-11 is strictly required for translocation. Tat conformational changes induced by low pH involve a sensor made of its first acidic residue (Glu/Asp-2) and the end of its basic domain (residues 55-57). Mutation of one of these elements results in membrane insertion above pH 6.5. Tat basic domain is also required for efficient Tat endocytosis and membrane insertion. Together with the strict conservation of Tat Trp among different virus isolates, our results point to an important role for Tat-membrane interaction in the multiplication of human immunodeficiency virus type 1.	[Yezid, Hocine; Debaisieux, Solene; Bonhoure, Anne; Beaumelle, Bruno] Univ Montpellier 2, CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, F-34095 Montpellier 05, France; [Konate, Karidia] CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Beaumelle, B (corresponding author), Univ Montpellier 2, CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, Case 100, F-34095 Montpellier 05, France.	bruno.beaumelle@univ-montp2.fr		Beaumelle, Bruno/0000-0002-4912-9134; Bonhoure, Anne/0000-0002-4664-2848	CNRS; Agence Nationale de Recherches sur le SIDA and Sidaction	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherches sur le SIDA and Sidaction(ANRS)	This work was supported by the CNRS and by grants from the Agence Nationale de Recherches sur le SIDA and Sidaction.	Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Campos B, 1998, BIOCHEMISTRY-US, V37, P8004, DOI 10.1021/bi973142n; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JIANG JX, 1990, J BIOL CHEM, V265, P8636; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mere J, 2005, J BIOL CHEM, V280, P21194, DOI 10.1074/jbc.M412656200; Musse AA, 2003, J BIOL CHEM, V278, P24491, DOI 10.1074/jbc.M302371200; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pantano S, 2005, PROTEINS, V58, P638, DOI 10.1002/prot.20323; Pantano S, 2004, EUR BIOPHYS J BIOPHY, V33, P344, DOI 10.1007/s00249-003-0358-z; Pantano S, 2002, J MOL BIOL, V318, P1331, DOI 10.1016/S0022-2836(02)00217-6; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Rayne F, 2004, J VIROL, V78, P12054, DOI 10.1128/JVI.78.21.12054-12057.2004; Ren JH, 1999, BIOCHEMISTRY-US, V38, P976, DOI 10.1021/bi981576s; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rodriguez M, 2007, J CELL SCI, V120, P1405, DOI 10.1242/jcs.03427; Rosconi MP, 2002, J BIOL CHEM, V277, P16517, DOI 10.1074/jbc.M200442200; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Soane L, 2005, J NEUROCHEM, V95, P230, DOI 10.1111/j.1471-4159.2005.03359.x; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wu RF, 2007, J BIOL CHEM, V282, P37412, DOI 10.1074/jbc.M704481200; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	51	40	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22736	22746		10.1074/jbc.M109.023705	http://dx.doi.org/10.1074/jbc.M109.023705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19549783	Green Published, hybrid			2022-12-25	WOS:000268963100028
J	Reiss-Sklan, E; Levitzki, A; Naveh-Many, T				Reiss-Sklan, Ella; Levitzki, Alexander; Naveh-Many, Tally			The Complex Regulation of HIC (Human I-mfa Domain Containing Protein) Expression	PLOS ONE			English	Article								Human I-mfa domain containing protein (HIC) differentially regulates transcription from viral promoters. HIC affects the Wnt pathway, the JNK/SAPK pathway and the activity of positive transcription elongation factor-b (P-TEFb). Studies exploring HIC function in mammalian cells used ectopically expressed HIC due to undetected endogenous HIC protein. HIC mRNA contains exceptionally long 59 and 39 untranslated regions (UTRs) compared to the average length of mRNA UTRs. Here we show that HIC protein is subject to strict repression at multiple levels. The HIC mRNA UTRs reduce the expression of HIC or of a reporter protein: The HIC 3'-UTR decreases both HIC and reporter mRNA levels, whereas upstream open reading frames located in the 5'-UTR repress the translation of HIC or of the reporter protein. In addition, ectopically expressed HIC protein is degraded by the proteasome, with a half-life of approximately 1 h, suggesting that upon activation, HIC expression in cells may be transient. The strict regulation of HIC expression at the levels of mRNA stability, translation efficiency and protein stability suggests that expression of the HIC protein and its involvement in the various pathways is required only under specific cellular conditions.			Reiss-Sklan, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	tally@cc.huji.ac.il						Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Child SJ, 1999, J BIOL CHEM, V274, P24335, DOI 10.1074/jbc.274.34.24335; CIGOGNINI D, 2006, LEUK RES; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; Kilav R, 2001, J BIOL CHEM, V276, P8727, DOI 10.1074/jbc.M005471200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2009, J BIOTECHNOL, V139, P152, DOI 10.1016/j.jbiotec.2008.10.008; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; PETERSON C, 1991, GENE, V107, P279, DOI 10.1016/0378-1119(91)90328-9; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Young TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001010; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6152	10.1371/journal.pone.0006152	http://dx.doi.org/10.1371/journal.pone.0006152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582149	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806400008
J	Brockmeyer, J; Spelten, S; Kuczius, T; Bielaszewska, M; Karch, H				Brockmeyer, Jens; Spelten, Sabrina; Kuczius, Thorsten; Bielaszewska, Martina; Karch, Helge			Structure and Function Relationship of the Autotransport and Proteolytic Activity of EspP from Shiga Toxin-Producing Escherichia coli	PLOS ONE			English	Article							SERINE-PROTEASE; SECRETION; DOMAIN; RECOGNITION; CLEAVAGE	Background: The serine protease autotransporter EspP is a proposed virulence factor of Shiga toxin-producing Escherichia coli (STEC). We recently distinguished four EspP subtypes (EspP alpha, EspP beta, EspP gamma, and EspP delta), which display large differences in transport and proteolytic activities and differ widely concerning their distribution within the STEC population. The mechanisms underlying these functional variations in EspP subtypes are, however, unknown. Methodology/Principal Findings: The structural basis of proteolytic and autotransport activity was investigated using transposon-based linker scanning mutagenesis, site-directed mutagenesis and structure-function analysis derived from homology modelling of the EspP passenger domain. Transposon mutagenesis of the passenger domain inactivated autotransport when pentapeptide linker insertions occurred in regions essential for overall correct folding or in a loop protruding from the beta-helical core. Loss of proteolytic function was limited to mutations in Domain 1 in the N-terminal third of the EspP passenger. Site-directed mutagenesis demonstrated that His(127), Asp(156) and Ser(263) in Domain 1 form the catalytic triad of EspP. Conclusions/Significance: Our data indicate that in EspP i) the correct formation of the tertiary structure of the passenger domain is essential for efficient autotransport, and ii) an elastase-like serine protease domain in the N-terminal Domain 1 is responsible for the proteolytic phenotype. Lack of stabilizing interactions of Domain 1 with the core structure of the passenger domain ablates proteolytic activity in subtypes EspP beta and EspP delta.			Brockmeyer, J (corresponding author), Univ Munster, Inst Hyg, Munster, Germany.	Jens.Brockmeyer@ukmuenster.de	Bielaszewska, Martina/AAC-9812-2022					Aldick T, 2007, MICROBES INFECT, V9, P282, DOI 10.1016/j.micinf.2006.12.001; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Bielaszewska M, 2005, THROMB HAEMOSTASIS, V94, P312, DOI 10.1160/TH05-04-0265; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Deber CM, 2002, NAT STRUCT BIOL, V9, P318, DOI 10.1038/nsb0502-318; Dutta PR, 2003, J BIOL CHEM, V278, P39912, DOI 10.1074/jbc.M303595200; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; Ferns S, 2007, CHEM WORLD-UK, V4, P35; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Khan AB, 2009, INT J MED MICROBIOL, V299, P247, DOI 10.1016/j.ijmm.2008.08.006; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; KLAUSER T, 1993, J MOL BIOL, V234, P579, DOI 10.1006/jmbi.1993.1613; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Maurer J, 1999, J BACTERIOL, V181, P7014, DOI 10.1128/JB.181.22.7014-7020.1999; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142	50	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6100	10.1371/journal.pone.0006100	http://dx.doi.org/10.1371/journal.pone.0006100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568421	Green Published, Green Submitted, gold			2022-12-25	WOS:000267572200005
J	Palpant, NJ; Szatkowski, ML; Wang, W; Townsend, D; Bedada, FB; Koch, LG; Britton, SL; Metzger, JM				Palpant, Nathan J.; Szatkowski, Michael L.; Wang, Wang; Townsend, DeWayne; Bedada, Fikru B.; Koch, Lauren G.; Britton, Steven L.; Metzger, Joseph M.			Artificial Selection for Whole Animal Low Intrinsic Aerobic Capacity Co-Segregates with Hypoxia-Induced Cardiac Pump Failure	PLOS ONE			English	Article							METABOLIC SYNDROME; HEART-FAILURE; GENE-TRANSFER; CALCIUM; EXPRESSION; ENDURANCE; CA2+; DEFINITION; EXERCISE	Oxygen metabolism is a strong predictor of the general health and fitness of an organism. In this study, we hypothesized that a divergence in intrinsic aerobic fitness would co-segregate with susceptibility for cardiovascular dysfunction. To test this hypothesis, cardiac function was assessed in rats specifically selected over nineteen generations for their low (LCR) and high (HCR) intrinsic aerobic running capacity. As an integrative marker of native aerobic capacity, run time to exhaustion between LCR and HCR rats had markedly diverged by 436% at generation nineteen of artificial selection. In vivo assessment of baseline cardiac function by echocardiography and catheter-based conductance micromanometry showed no marked difference in cardiac performance. However, when challenged by exposure to acute hypoxia, cardiac pump failure occurred significantly earlier in LCR rats compared to HCR animals. Acute cardiac decompensation in LCR rats was exclusively due to the development of intractable irregular ventricular contractions. Analysis of isolated cardiac myocytes showed significantly slower sarcomeric relaxation and delayed kinetics of calcium cycling in LCR myocytes compared to HCR myocytes. This study also revealed that artificial selection for low native aerobic capacity is a novel pathologic stimulus that results in myosin heavy chain isoform switching in the heart as shown by increased levels of beta-MHC in LCR rats. Together, these results provide evidence that alterations in sub-cellular calcium handling and MHC isoform composition are associated with susceptibility to compensatory cardiac remodeling and hypoxia induced pump failure in animals with low intrinsic aerobic capacity.			Palpant, NJ (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	metzgerj@umn.edu	Palpant, Nathan/B-1641-2017; wang, wang/GWQ-7272-2022; Koch, Lauren/D-1258-2010	Palpant, Nathan/0000-0002-9334-8107; Wang, Wang/0000-0001-9093-412X	NCRR NIH HHS [R24 RR017718, R24 RR17718] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Apstein CS, 2005, EUR HEART J, V26, P956, DOI 10.1093/eurheartj/ehi200; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; BOUCHARD C, 1986, MED SCI SPORT EXER, V18, P639; Britton SL, 2003, IUBMB LIFE, V55, P429, DOI 10.1080/1521654031000138578; Bye A, 2008, PHYSIOL GENOMICS, V33, P100, DOI 10.1152/physiolgenomics.00269.2007; BYRON KL, 1996, AM J PHYSIOL, V271; Coutu P, 2002, BIOPHYS J, V82, P2565, DOI 10.1016/S0006-3495(02)75599-9; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; DELCAYRE C, 1992, AM J PHYSIOL, V263, pH1537, DOI 10.1152/ajpheart.1992.263.5.H1537; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Dibb KM, 2007, CELL CALCIUM, V42, P503, DOI 10.1016/j.ceca.2007.04.002; Ford Earl S, 2006, Expert Rev Cardiovasc Ther, V4, P897, DOI 10.1586/14779072.4.6.897; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2003, ETHNIC DIS, V13, P429; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gonzalez NC, 2006, J APPL PHYSIOL, V101, P1288, DOI 10.1152/japplphysiol.01527.2005; Gonzalez NC, 2006, RESP PHYSIOL NEUROBI, V151, P141, DOI 10.1016/j.resp.2005.09.012; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Hieber S, 2009, EUR J ANAESTH, V26, P201, DOI 10.1097/EJA.0b013e3283212cbb; Howlett RA, 2008, J APPL PHYSL; Hunter CJ, 2008, FRONT BIOSCI-LANDMRK, V13, P347, DOI 10.2741/2684; Hussain SO, 2001, AM J PHYSIOL-REG I, V281, pR1787, DOI 10.1152/ajpregu.2001.281.6.R1787; IVESTER CT, 1995, J BIOL CHEM, V270, P21950, DOI 10.1074/jbc.270.37.21950; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kranias E. G., 2007, V45, P523; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Li Chaoyang, 2006, Metabolic Syndrome and Related Disorders, V4, P237, DOI 10.1089/met.2006.4.237; LOISELLE DS, 1982, J MUSCLE RES CELL M, V3, P5, DOI 10.1007/BF00711877; Lujan HL, 2006, AM J PHYSIOL-HEART C, V291, pH2933, DOI 10.1152/ajpheart.00514.2006; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; MORKIN E, 1991, ADV EXP MED BIOL, V308, P143; Oliver MF, 2002, AM J MED, V112, P305, DOI 10.1016/S0002-9343(01)01104-4; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Saupe KW, 2001, J MOL CELL CARDIOL, V33, P261, DOI 10.1006/jmcc.2000.1297; Tardiff JC, 2000, AM J PHYSIOL-HEART C, V278, pH412, DOI 10.1152/ajpheart.2000.278.2.H412; Venetucci LA, 2007, CIRC RES, V100, P105, DOI 10.1161/01.RES.0000252828.17939.00; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wilson GR, 2005, AM FAM PHYSICIAN, V72, P1517; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6117	10.1371/journal.pone.0006117	http://dx.doi.org/10.1371/journal.pone.0006117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568432	Green Submitted, Green Published, gold			2022-12-25	WOS:000267572200016
J	Yang, JC; Madupu, R; Durkin, AS; Ekborg, NA; Pedamallu, CS; Hostetler, JB; Radune, D; Toms, BS; Henrissat, B; Coutinho, PM; Schwarz, S; Field, L; Trindade-Silva, AE; Soares, CAG; Elshahawi, S; Hanora, A; Schmidt, EW; Haygood, MG; Posfai, J; Benner, J; Madinger, C; Nove, J; Anton, B; Chaudhary, K; Foster, J; Holman, A; Kumar, S; Lessard, PA; Luyten, YA; Slatko, B; Wood, N; Wu, B; Teplitski, M; Mougous, JD; Ward, N; Eisen, JA; Badger, JH; Distel, DL				Yang, Joyce C.; Madupu, Ramana; Durkin, A. Scott; Ekborg, Nathan A.; Pedamallu, Chandra S.; Hostetler, Jessica B.; Radune, Diana; Toms, Bradley S.; Henrissat, Bernard; Coutinho, Pedro M.; Schwarz, Sandra; Field, Lauren; Trindade-Silva, Amaro E.; Soares, Carlos A. G.; Elshahawi, Sherif; Hanora, Amro; Schmidt, Eric W.; Haygood, Margo G.; Posfai, Janos; Benner, Jack; Madinger, Catherine; Nove, John; Anton, Brian; Chaudhary, Kshitiz; Foster, Jeremy; Holman, Alex; Kumar, Sanjay; Lessard, Philip A.; Luyten, Yvette A.; Slatko, Barton; Wood, Nicole; Wu, Bo; Teplitski, Max; Mougous, Joseph D.; Ward, Naomi; Eisen, Jonathan A.; Badger, Jonathan H.; Distel, Daniel L.			The Complete Genome of Teredinibacter turnerae T7901: An Intracellular Endosymbiont of Marine Wood-Boring Bivalves (Shipworms)	PLOS ONE			English	Article							VI-SECRETION-SYSTEM; LYRODUS-PEDICELLATUS BIVALVIA; CANDIDATUS ENDOBUGULA SERTULA; PROTEIN SECRETION; RIBOSOMAL-RNA; BURKHOLDERIA-PSEUDOMALLEI; RHIZOBIUM-LEGUMINOSARUM; BACTERIAL SYMBIONTS; MICROBIAL SYMBIONT; NITROGEN-FIXATION	Here we report the complete genome sequence of Teredinibacter turnerae T7901. T. turnerae is a marine gamma proteobacterium that occurs as an intracellular endosymbiont in the gills of wood-boring marine bivalves of the family Teredinidae (shipworms). This species is the sole cultivated member of an endosymbiotic consortium thought to provide the host with enzymes, including cellulases and nitrogenase, critical for digestion of wood and supplementation of the host's nitrogen-deficient diet. T. turnerae is closely related to the free-living marine polysaccharide degrading bacterium Saccharophagus degradans str. 2-40 and to as yet uncultivated endosymbionts with which it coexists in shipworm cells. Like S. degradans, the T. turnerae genome encodes a large number of enzymes predicted to be involved in complex polysaccharide degradation (>100). However, unlike S. degradans, which degrades a broad spectrum (>10 classes) of complex plant, fungal and algal polysaccharides, T. turnerae primarily encodes enzymes associated with deconstruction of terrestrial woody plant material. Also unlike S. degradans and many other eubacteria, T. turnerae dedicates a large proportion of its genome to genes predicted to function in secondary metabolism. Despite its intracellular niche, the T. turnerae genome lacks many features associated with obligate intracellular existence (e.g. reduced genome size, reduced %G+C, loss of genes of core metabolism) and displays evidence of adaptations common to free-living bacteria (e.g. defense against bacteriophage infection). These results suggest that T. turnerae is likely a facultative intracellular ensosymbiont whose niche presently includes, or recently included, free-living existence. As such, the T. turnerae genome provides insights into the range of genomic adaptations associated with intracellular endosymbiosis as well as enzymatic mechanisms relevant to the recycling of plant materials in marine environments and the production of cellulose-derived biofuels.			Yang, JC (corresponding author), Ocean Genome Legacy Inc, Ipswich, MA USA.	distel@oglf.org	Trindade-Silva, Amaro/AAO-5685-2020; Kumar, Sanjay/AAO-2593-2021; Elshahawi, Sherif/I-3595-2019; Henrissat, Bernard/J-2475-2012; Distel, Daniel/A-8047-2017; Hanora, Amro/HCI-0501-2022; Hanora, Amro/N-7957-2017; Soares, Carlos A G/H-9464-2016; Eisen, Jonathan A./H-2706-2019; Pedamallu, Chandra Sekhar/AAV-6723-2020; Pedamallu, Chandra Sekhar/AAV-6745-2020	Trindade-Silva, Amaro/0000-0003-4321-065X; Elshahawi, Sherif/0000-0003-1879-1552; Henrissat, Bernard/0000-0002-3434-8588; Distel, Daniel/0000-0002-3860-194X; Hanora, Amro/0000-0003-4937-7741; Hanora, Amro/0000-0003-4937-7741; Soares, Carlos A G/0000-0001-9058-9266; Eisen, Jonathan A./0000-0002-0159-2197; 				Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASCHTGEN MS, 2008, J BACTERIOL; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENTLEY SD, 2002, NATURE, V3, P417; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Burton EO, 2005, APPL ENVIRON MICROB, V71, P4906, DOI 10.1128/AEM.71.8.4906-4909.2005; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Clarke A J, 1997, BIODEGRADATION CELLU; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Das Soumita, 2003, In Silico Biology, V3, P287; Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Distel DL, 2003, ACS SYM SER, V845, P253; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekborg NA, 2007, APPL ENVIRON MICROB, V73, P7785, DOI 10.1128/AEM.00876-07; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; HALL J, 1989, MOL MICROBIOL, V3, P1211, DOI 10.1111/j.1365-2958.1989.tb00271.x; Haygood MG, 1997, APPL ENVIRON MICROB, V63, P4612, DOI 10.1128/AEM.63.11.4612-4616.1997; Higuchi T, 1985, BIOSYNTHESIS BIODEGR, P505, DOI DOI 10.1016/B978-0-12-347880-1.50022-2; Howard MB, 2004, PROTEIN SCI, V13, P1422, DOI 10.1110/ps.03511604; Howard MB, 2004, J BACTERIOL, V186, P1297, DOI 10.1128/JB.186.5.1297-1303.2004; Howard MB, 2003, J BACTERIOL, V185, P3352, DOI 10.1128/JB.185.11.3352-3360.2003; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jeong H, 2005, NUCLEIC ACIDS RES, V33, P7066, DOI 10.1093/nar/gki1016; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kechris KJ, 2006, P NATL ACAD SCI USA, V103, P9584, DOI 10.1073/pnas.0603534103; Kobayashi M, 2000, CURR OPIN CHEM BIOL, V4, P95, DOI 10.1016/S1367-5931(99)00058-7; Kosugi A, 2002, APPL ENVIRON MICROB, V68, P6399, DOI 10.1128/AEM.68.12.6399-6402.2002; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; Lopanik N, 2004, OECOLOGIA, V139, P131, DOI 10.1007/s00442-004-1487-5; Lopanik N, 2004, J NAT PROD, V67, P1412, DOI 10.1021/np040007k; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Pace HC, 2001, GENOME BIOL, V2; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Plague GR, 2008, J BACTERIOL, V190, P777, DOI 10.1128/JB.01082-07; Podar M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-42; POULSEN OM, 1992, BIOTECHNOL BIOENG, V39, P121, DOI 10.1002/bit.260390118; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Qi M, 2007, APPL ENVIRON MICROB, V73, P6098, DOI 10.1128/AEM.01037-07; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; TEPLITSKI M, 2004, GLOBAL REGULATORY NE; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; VANBRUSSEL AAN, 1986, J BACTERIOL, V165, P517, DOI 10.1128/jb.165.2.517-522.1986; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WARREN RAJ, 1987, GENE, V61, P421, DOI 10.1016/0378-1119(87)90204-6; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Wernegreen JJ, 2005, CURR OPIN GENET DEV, V15, P572, DOI 10.1016/j.gde.2005.09.013; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	104	73	322	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6085	10.1371/journal.pone.0006085	http://dx.doi.org/10.1371/journal.pone.0006085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568419	Green Published, Green Submitted, gold			2022-12-25	WOS:000267572200003
J	Blanchette, CD; Woo, YH; Thomas, C; Shen, N; Sulchek, TA; Hiddessen, AL				Blanchette, Craig D.; Woo, Youn-Hi; Thomas, Cynthia; Shen, Nan; Sulchek, Todd A.; Hiddessen, Amy L.			Decoupling Internalization, Acidification and Phagosomal-Endosomal/lysosomal Fusion during Phagocytosis of InlA Coated Beads in Epithelial Cells	PLOS ONE			English	Article							RICH REPEAT REGION; LISTERIA-MONOCYTOGENES; LEGIONELLA-PNEUMOPHILA; INTRACELLULAR FATE; LYSOSOME FUSION; CONCANAMYCIN-A; E-CADHERIN; V-TYPE; P-TYPE; MATURATION	Background: Phagocytosis has been extensively examined in 'professional' phagocytic cells using pH sensitive dyes. However, in many of the previous studies, a separation between the end of internalization, beginning of acidification and completion of phagosomal-endosomal/lysosomal fusion was not clearly established. In addition, very little work has been done to systematically examine phagosomal maturation in 'non-professional' phagocytic cells. Therefore, in this study, we developed a simple method to measure and decouple particle internalization, phagosomal acidification and phagosomalendosomal/lysosomal fusion in Madin-Darby Canine Kidney (MDCK) and Caco-2 epithelial cells. Methodology/Principal Findings: Our method was developed using a pathogen mimetic system consisting of polystyrene beads coated with Internalin A (InlA), a membrane surface protein from Listeria monocytogenes known to trigger receptor-mediated phagocytosis. We were able to independently measure the rates of internalization, phagosomal acidification and phagosomal-endosomal/lysosomal fusion in epithelial cells by combining the InlA-coated beads (InlA-beads) with antibody quenching, a pH sensitive dye and an endosomal/lysosomal dye. By performing these independent measurements under identical experimental conditions, we were able to decouple the three processes and establish time scales for each. In a separate set of experiments, we exploited the phagosomal acidification process to demonstrate an additional, real-time method for tracking bead binding, internalization and phagosomal acidification. Conclusions/Significance: Using this method, we found that the time scales for internalization, phagosomal acidification and phagosomal-endosomal/lysosomal fusion ranged from 23-32 min, 3-4 min and 74-120 min, respectively, for MDCK and Caco-2 epithelial cells. Both the static and real-time methods developed here are expected to be readily and broadly applicable, as they simply require fluorophore conjugation to a particle of interest, such as a pathogen or mimetic, in combination with common cell labeling dyes. As such, these methods hold promise for future measurements of receptor-mediated internalization in other cell systems, e. g. pathogen-host systems.			Blanchette, CD (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	hiddessen1@llnl.gov						Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BONAZZI M, 2008, CELL MICROBIOL; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Braun L, 2000, MICROBES INFECT, V2, P803, DOI 10.1016/S1286-4579(00)90365-4; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; deChastellier C, 1997, EUR J CELL BIOL, V74, P49; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 2001, BIOCHEMISTRY-US, V40, P2816, DOI 10.1021/bi001759q; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1984, J CELL BIOL, V99, P1936, DOI 10.1083/jcb.99.6.1936; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; JONES TC, 1972, J EXP MED, V136, P1157, DOI 10.1084/jem.136.5.1157; KIELIAN MC, 1986, EMBO J, V5, P3103, DOI 10.1002/j.1460-2075.1986.tb04616.x; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Mast SO, 1942, BIOL BULL-US, V83, P173, DOI 10.2307/1538142; MCNEIL PL, 1983, J CELL BIOL, V97, P692, DOI 10.1083/jcb.97.3.692; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mengaud J, 1996, INFECT IMMUN, V64, P5430, DOI 10.1128/IAI.64.12.5430-5433.1996; Moon EK, 2006, EUKARYOT CELL, V5, P125, DOI 10.1128/EC.5.1.125-131.2006; Moreno A, 2005, CELL CALCIUM, V37, P555, DOI 10.1016/j.ceca.2005.02.002; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; SIBLEY LD, 1985, NATURE, V315, P416, DOI 10.1038/315416a0; Sousa S, 2004, J CELL SCI, V117, P2121, DOI 10.1242/jcs.01066; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; TYCKO B, 1982, CELL, V28, P643, DOI 10.1016/0092-8674(82)90219-7; Vergne I, 1998, ANAL BIOCHEM, V255, P127, DOI 10.1006/abio.1997.2466; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069	50	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6056	10.1371/journal.pone.0006056	http://dx.doi.org/10.1371/journal.pone.0006056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557127	Green Submitted, gold, Green Published			2022-12-25	WOS:000267424600004
J	Hanshaoworakul, W; Simmerman, JM; Narueponjirakul, U; Sanasuttipun, W; Shinde, V; Kaewchana, S; Areechokechai, D; Levy, J; Ungchusak, K				Hanshaoworakul, Wanna; Simmerman, James Mark; Narueponjirakul, Ubolrat; Sanasuttipun, Wiwan; Shinde, Vivek; Kaewchana, Suchada; Areechokechai, Darin; Levy, Jens; Ungchusak, Kumnuan			Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome	PLOS ONE			English	Article								Background: Influenza is often not recognized as an important cause of severe or fatal disease in tropical and subtropical countries in Southeast Asia. The extent to which Oseltamivir treatment may protect against a fatal outcome in severe influenza infections is not known. Thailand's National Avian Influenza Surveillance (NAIS) system affords a unique opportunity to describe the epidemiology of laboratory-confirmed severe and fatal human influenza infections. Methodology/Principal Findings: During January 2004 through December 2006, 11,641 notifications to the NAIS were investigated in 73 of 76 Thai provinces. Clinical and demographic data and respiratory swab specimens were collected and tested by PCR for influenza. Using the NAIS database, we identified all patients with laboratory confirmed human influenza (A/H3N2, A/H1N1 and Type B) infection. A retrospective medical record review was conducted on all fatal cases with laboratory confirmed influenza and from a sample of hospitalized cases in 28 provinces. The association of underlying risk factors, Oseltamivir treatment and risk of a fatal outcome were examined. Human influenza infections were identified in 2,075 (18%) cases. Twenty-two (1%) deaths occurred including seven deaths in children less than ten years of age. Thirty-five percent of hospitalized human influenza infections had chest X-ray confirmed pneumonia. Current or former smoking; advanced age, hypertension and underlying cardiovascular, pulmonary or endocrine disease were associated with a fatal outcome from human influenza infection. Treatment with Oseltamivir was statistically associated with survival with a crude OR of .11 (95% CI: 0.04-0.30) and .13 (95% CI: 0.04-0.40) after controlling for age. Conclusions: Severe and fatal human influenza infections were commonly identified in the NAIS designed to identify avian A/H5N1 cases. Treatment with Oseltamivir is associated with survival in hospitalized human influenza pneumonia patients.			Hanshaoworakul, W (corresponding author), Thailand Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand.	msimmerman@cdc.gov						Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chunsuttiwat S, 2008, RESPIROLOGY, V13, pS36, DOI 10.1111/j.1440-1843.2008.01256.x; Enger C, 2004, PHARMACOEPIDEM DR S, V13, P227, DOI 10.1002/pds.845; EPIDEMIOLOGY B, 2007, ANN EPIDEMIOLOGY SUR, P477; FIORE AE, 2008, MORBIDITY MORTALITY, V57; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Katz MA, 2007, VACCINE, V25, P3827, DOI 10.1016/j.vaccine.2007.01.109; Kitphati R, 2008, CLIN INFECT DIS, V46, P1394, DOI 10.1086/586752; Lee N, 2007, ANTIVIR THER, V12, P501; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nordstrom BL, 2005, CURR MED RES OPIN, V21, P761, DOI 10.1185/030079905X46214; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Prapasiri Prabda, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P706; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; SIMMERMAN JM, 2005, J CLIN MICROBIOLOGY; Suntarattiwong P, 2007, INFLUENZA OTHER RESP, V1, P177, DOI 10.1111/j.1750-2659.2007.00023.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; 2003, VACCINE, V23, P5133	25	123	133	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6051	10.1371/journal.pone.0006051	http://dx.doi.org/10.1371/journal.pone.0006051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557130	Green Submitted, gold, Green Published			2022-12-25	WOS:000267356900012
J	Labrousse, VF; Costes, L; Aubert, A; Darnaudery, M; Ferreira, G; Amedee, T; Laye, S				Labrousse, Virginie F.; Costes, Laurence; Aubert, Agnes; Darnaudery, Muriel; Ferreira, Guillaume; Amedee, Thierry; Laye, Sophie			Impaired Interleukin-1 beta and c-Fos Expression in the Hippocampus Is Associated with a Spatial Memory Deficit in P2X(7) Receptor-Deficient Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECOGNITION MEMORY; OBJECT RECOGNITION; MICROGLIAL CELLS; GENE-EXPRESSION; IN-VITRO; SYNAPTIC-TRANSMISSION; COGNITIVE PERFORMANCE; CYTOKINE PRODUCTION; IL-1-BETA RELEASE	Recent evidence suggests that interleukin-1 beta (IL-1 beta), which was originally identified as a proinflammatory cytokine, is also required in the brain for memory processes. We have previously shown that IL-1 beta synthesis in the hippocampus is dependent on P2X(7) receptor (P2X(7)R), which is an ionotropic receptor of ATP. To substantiate the role of P2X(7)R in both brain IL-1 beta expression and memory processes, we examined the induction of IL-1 beta mRNA expression in the hippocampus of wildtype (WT) and homozygous P2X(7) receptor knockout mice (P2X(7)R(-/-)) following a spatial memory task. The spatial recognition task induced both IL-1 beta mRNA expression and c-Fos protein activation in the hippocampus of WT but not of P2X(7)R(-/-) mice. Remarkably, P2X(7)R(-/-) mice displayed spatial memory impairment in a hippocampal-dependant task, while their performances in an object recognition task were unaltered. Taken together, our results show that P2X(7)R plays a critical role in spatial memory processes and the associated hippocampal IL-1 beta mRNA synthesis and c-Fos activation.	[Labrousse, Virginie F.; Costes, Laurence; Aubert, Agnes; Darnaudery, Muriel; Ferreira, Guillaume; Amedee, Thierry; Laye, Sophie] Univ Bordeaux, CNRS, UMR 1286, INRA,UMR 5226, Bordeaux, France; [Darnaudery, Muriel] Univ Lille Nord France, NEUROSTRESS EA 4347, Villeneuve Dascq, France; [Ferreira, Guillaume] Univ Tours, CNRS, UMR 6175, INRA,UMR 85,Lab Comportement Neurobiol & Adaptat, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Labrousse, VF (corresponding author), Univ Bordeaux, CNRS, UMR 1286, INRA,UMR 5226, Bordeaux, France.	sophie.laye@bordeaux.inra.fr	Laye, Sophie/AAX-2501-2020	Laye, Sophie/0000-0002-3843-1012; DARNAUDERY, Muriel/0000-0003-0209-3880; Ferreira, Guillaume/0000-0001-5984-8143				Armstrong JN, 2002, J NEUROSCI, V22, P5938; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Balschun D, 2003, ANN NY ACAD SCI, V992, P1, DOI 10.1111/j.1749-6632.2003.tb03132.x; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brough D, 2002, MOL CELL NEUROSCI, V19, P272, DOI 10.1006/mcne.2001.1054; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Colomar Aurore, 2003, Journal de la Societe de Biologie, V197, P113; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Contarino A, 1999, BRAIN RES, V835, P1, DOI 10.1016/S0006-8993(98)01158-5; Coogan AN, 1999, EUR J PHARMACOL, V374, P197, DOI 10.1016/S0014-2999(99)00320-9; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Di Virgilio Francesco, 2001, Trends in Pharmacological Sciences, V22, P5; Dillon GM, 2008, NEUROBIOL LEARN MEM, V90, P426, DOI 10.1016/j.nlm.2008.05.008; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Farivar R, 2004, FRONT BIOSCI-LANDMRK, V9, P104, DOI 10.2741/1198; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Ireland MF, 2004, NEUROSCIENCE, V128, P269, DOI 10.1016/j.neuroscience.2004.06.014; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; Mingam R, 2008, BRAIN BEHAV IMMUN, V22, P234, DOI 10.1016/j.bbi.2007.08.007; Nadjar A, 2005, NEUROPSYCHOPHARMACOL, V30, P1492, DOI 10.1038/sj.npp.1300755; NIU L, 2008, HIPPOCAMPUS; Norenberg W, 2000, N-S ARCH PHARMACOL, V362, P324, DOI 10.1007/s002100000311; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Palin K, 2004, BRAIN BEHAV IMMUN, V18, P223, DOI 10.1016/j.bbi.2003.09.002; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; ROTHWELL NJ, 1991, TRENDS PHARMACOL SCI, V12, P430, DOI 10.1016/0165-6147(91)90623-Z; Sanderson DJ, 2007, BEHAV NEUROSCI, V121, P559, DOI 10.1037/0735-7044.121.3.559; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 1998, NEUROSCIENCE, V82, P511; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Werry EL, 2006, J NEUROCHEM, V99, P924, DOI 10.1111/j.1471-4159.2006.04133.x; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Yu Y, 2008, BRAIN RES, V1194, P45, DOI 10.1016/j.brainres.2007.11.064	60	79	82	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6006	10.1371/journal.pone.0006006	http://dx.doi.org/10.1371/journal.pone.0006006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462JI	19547756	Green Published, gold, Green Submitted			2022-12-25	WOS:000267347900005
J	Chen, ZJ; Kastaniotis, AJ; Miinalainen, IJ; Rajaram, V; Wierenga, RK; Hiltunen, JK				Chen, Zhijun; Kastaniotis, Alexander J.; Miinalainen, Ilkka J.; Rajaram, Venkatesan; Wierenga, Rik K.; Hiltunen, J. Kalervo			17 beta-Hydroxysteroid dehydrogenase type 8 and carbonyl reductase type 4 assemble as a ketoacyl reductase of human mitochondrial FAS	FASEB JOURNAL			English	Article						HsKAR; heterotetramer; lipids; fatty acid synthesis; metabolism	FATTY-ACID SYNTHESIS; 2-ENOYL THIOESTER REDUCTASE; CRYSTAL-STRUCTURE; 3-HYDROXYACYL-ACP DEHYDRATASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; KE 6; EXPRESSION; YEAST; CLONING	Mitochondrial fatty acid synthesis (FAS) generates the octanoyl-group that is required for the synthesis of lipoic acid and is linked to mitochondrial RNA metabolism. All of the human enzymes involved in mitochondrial FAS have been characterized except for beta-ketoacyl thioester reductase (HsKAR), which catalyzes the second step in the pathway. We report here the unexpected finding that a heterotetramer composed of human 17 beta-hydroxysteroid dehydrogenase type 8 (Hs17 beta-HSD8) and human carbonyl reductase type 4 (HsCBR4) forms the long-sought HsKAR. Both proteins share sequence similarities to the yeast 3-oxoacyl-(acyl carrier protein) reductase (Oar1p) and the bacterial FabG, although HsKAR is NADH dependent, whereas FabG and Oar1p are NADPH dependent. Hs17 beta-HSD8 and HsCBR4 show a strong genetic interaction in vivo in yeast, where, only if they are expressed together, they rescue the respiratory deficiency and restore the lipoic acid content of oar1 Delta cells. Moreover, these two proteins display a stable physical interaction and form an active heterotetramer. Both Hs17 beta-HSD8 and HsCBR4 are targeted to mitochondria in vivo in cultured HeLa cells. Notably, 17 beta-HSD8 was previously classified as a steroid-metabolizing enzyme, but our data suggest that 17 beta-HSD8 is primarily involved in mitochondrial FAS.-Chen, Z., Kastaniotis, A. J., Miinalainen, I. J., Rajaram, V., Wierenga R. K., Hiltunen, J. K. 17 beta-Hydroxysteroid dehydrogenase type 8 and carbonyl reductase type 4 assemble as a ketoacyl reductase of human mitochondrial FAS. FASEB J. 23, 3682-3691 (2009). www.fasebj.org	[Hiltunen, J. Kalervo] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Hiltunen, JK (corresponding author), Univ Oulu, Bioctr Oulu, POB 3000, FI-90014 Oulu, Finland.	kalervo.hiltunen@oulu.fi	Chen, Zhijun/V-3228-2019	Miinalainen, Ilkka/0000-0002-3922-3442; Venkatesan, Rajaram/0000-0002-7257-1211; Hiltunen, Kalervo/0000-0002-3073-9602; Kastaniotis, Alexander/0000-0003-3624-9214	Sigrid Juselius Foundation; Academy of Finland; NordForsk [070010]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); NordForsk	We thank Dr. Lloyd Ruddock (University of Oulu, Oulu, Finland) for the kind gift of E. coli expression strains and vectors, and Dr. Ulrich Bergmann for mass spectrometric work, as well as Tatu Haataja and Prasad Kasaragod for their help with enzymatic assays. We are grateful to Leena Ollitervo, Katri Nappa, and Johanna Moilanen for technical assistance and to Dr. Aner Gurvitz and Dr. Paivi Pirila for useful discussions. This work was supported by grants from the Sigrid Juselius Foundation, the Academy of Finland, and the NordForsk under the Nordic Centres of Excellence Program in Food, Nutrition, and Health, Project (070010) MitoHealth.	Ando A, 1996, GENOMICS, V35, P600, DOI 10.1006/geno.1996.0405; Autio KJ, 2008, FEBS LETT, V582, P729, DOI 10.1016/j.febslet.2008.01.051; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; AZIZ N, 1993, MOL CELL BIOL, V13, P1847, DOI 10.1128/MCB.13.3.1847; Aziz N, 1996, ENDOCRINOLOGY, V137, P5581, DOI 10.1210/en.137.12.5581; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Chen ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005589; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endo S, 2008, BIOCHEM BIOPH RES CO, V377, P1326, DOI 10.1016/j.bbrc.2008.11.003; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Fomitcheva J, 1998, J BIOL CHEM, V273, P22664, DOI 10.1074/jbc.273.35.22664; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; JOSHI AK, 1993, BIOCHEM J, V296, P143, DOI 10.1042/bj2960143; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Kyuno J, 2008, MECH DEVELOP, V125, P571, DOI 10.1016/j.mod.2008.03.001; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; MAXWELL MM, 1995, J BIOL CHEM, V270, P25213, DOI 10.1074/jbc.270.42.25213; Meier M, 2009, ANN NY ACAD SCI, V1155, P15, DOI 10.1111/j.1749-6632.2009.03702.x; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Moon JY, 2006, HEART VESSELS, V21, P195, DOI 10.1007/s00380-005-0859-z; Mori M, 1998, BBA-MOL CELL RES, V1403, P12, DOI 10.1016/S0167-4889(98)00021-4; Ohno S, 2008, MOL CELL BIOCHEM, V309, P209, DOI 10.1007/s11010-007-9637-9; Pletnev VZ, 2005, J STEROID BIOCHEM, V94, P327, DOI 10.1016/j.jsbmb.2004.12.031; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Reinders J, 2007, MOL IMMUNOL, V44, P848, DOI 10.1016/j.molimm.2006.04.003; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; ZENSEN R, 1992, FEBS LETT, V310, P179, DOI 10.1016/0014-5793(92)81324-F; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhou LY, 2005, J MOL ENDOCRINOL, V35, P103, DOI 10.1677/jme.1.01801	46	39	45	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3682	3691		10.1096/fj.09-133587	http://dx.doi.org/10.1096/fj.09-133587			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19571038				2022-12-25	WOS:000271272500006
J	Brenner, S; Heyes, DJ; Hay, S; Hough, MA; Eady, RR; Hasnain, SS; Scrutton, NS				Brenner, Sibylle; Heyes, Derren J.; Hay, Sam; Hough, Michael A.; Eady, Robert R.; Hasnain, S. Samar; Scrutton, Nigel S.			Demonstration of Proton-coupled Electron Transfer in the Copper-containing Nitrite Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-XYLOSOXIDANS NCIMB-11015; HYDROGEN-ATOM TRANSFER; X-RAY-STRUCTURE; TYPE-2 COPPER; DISSIMILATORY NITRITE; SUBSTRATE-BINDING; ELECTROCHEMICAL APPROACH; RHODOBACTER-SPHAEROIDES; ANGSTROM RESOLUTION; ORDERED MECHANISM	The reduction of nitrite (NO2-) into nitric oxide (NO), catalyzed by nitrite reductase, is an important reaction in the denitrification pathway. In this study, the catalytic mechanism of the copper-containing nitrite reductase from Alcaligenes xylosoxidans (AxNiR) has been studied using single and multiple turnover experiments at pH 7.0 and is shown to involve two protons. A novel steady-state assay was developed, in which deoxyhemoglobin was employed as an NO scavenger. A moderate solvent kinetic isotope effect (SKIE) of 1.3 +/- 0.1 indicated the involvement of one protonation to the rate-limiting catalytic step. Laser photoexcitation experiments have been used to obtain single turnover data in H2O and D2O, which report on steps kinetically linked to inter-copper electron transfer (ET). In the absence of nitrite, a normal SKIE of similar to 1.33 +/- 0.05 was obtained, suggesting a protonation event that is kinetically linked to ET in substrate-free AxNiR. A nitrite titration gave a normal hyperbolic behavior for the deuterated sample. However, in H2O an unusual decrease in rate was observed at low nitrite concentrations followed by a subsequent acceleration in rate at nitrite concentrations of > 10 mM. As a consequence, the observed ET process was faster in D2O than in H2O above 0.1 mM nitrite, resulting in an inverted SKIE, which featured a significant dependence on the substrate concentration with a minimum value of similar to 0.61 +/- 0.02 between 3 and 10 mM. Our work provides the first experimental demonstration of proton-coupled electron transfer in both the resting and substrate-bound AxNiR, and two protons were found to be involved in turnover.	[Hough, Michael A.; Eady, Robert R.; Hasnain, S. Samar] Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Brenner, Sibylle; Heyes, Derren J.; Hay, Sam; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Brenner, Sibylle; Heyes, Derren J.; Hay, Sam; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Liverpool; University of Manchester; University of Manchester	Hasnain, SS (corresponding author), Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.	s.s.hasnain@liverpool.ac.uk; nigel.scrutton@manchester.ac.uk	Hay, Sam/D-5974-2012; Hough, Michael/H-4409-2013	Hay, Sam/0000-0003-3274-0938; Heyes, Derren/0000-0002-7453-1571; Hough, Michael/0000-0001-7377-6713	TgK Scientific Ltd.; Biotechnology and Biological Sciences Research Council [BB/D016290/1, BB/G005850/1]; BBSRC [BB/D01963X/1, BB/D016290/1, BB/G005850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish	TgK Scientific Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by TgK Scientific Ltd. (Ph.D. studentship to S. B.) and by Biotechnology and Biological Sciences Research Council Project Grants BB/D016290/1 (to S. S. H.) and BB/G005850/1 (to N. S. S.).	ABRAHAM ZHL, 1993, BIOCHEM J, V295, P587, DOI 10.1042/bj2950587; Abraham ZHL, 1997, BIOCHEM J, V324, P511, DOI 10.1042/bj3240511; ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; Antonyuk SV, 2003, ACTA CRYSTALLOGR D, V59, P835, DOI 10.1107/S0907444903041441; Antonyuk SV, 2005, P NATL ACAD SCI USA, V102, P12041, DOI 10.1073/pnas.0504207102; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Baker SC, 1997, J MOL BIOL, V269, P440, DOI 10.1006/jmbi.1997.1070; Bernasconi C. F., 1976, RELAXATION KINETICS; Bisswanger H., 2008, ENZYME KINETICS PRIN; BURKHARD O, 1982, J APPL PHYSIOL, V52, P124, DOI 10.1152/jappl.1982.52.1.124; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; Costentin C, 2005, J AM CHEM SOC, V127, P12490, DOI 10.1021/ja053911n; Costentin C, 2008, CHEM REV, V108, P2145, DOI 10.1021/cr068065t; Cukier RI, 1999, J PHYS CHEM A, V103, P5989, DOI 10.1021/jp990329a; Cukier RI, 2004, BBA-BIOENERGETICS, V1655, P37, DOI 10.1016/j.bbabio.2003.06.011; Cukier RI, 1996, J PHYS CHEM-US, V100, P15428, DOI 10.1021/jp961025g; CUKIER RI, 1994, J PHYS CHEM-US, V98, P2377, DOI 10.1021/j100060a027; Cukier RI, 2002, J PHYS CHEM B, V106, P1746, DOI 10.1021/jp012396m; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; CUKIER RI, 1995, J PHYS CHEM-US, V99, P16101, DOI 10.1021/j100043a060; Davidson VL, 2000, ACCOUNTS CHEM RES, V33, P87, DOI 10.1021/ar9900616; Davidson VL, 2004, ARCH BIOCHEM BIOPHYS, V428, P32, DOI 10.1016/j.abb.2004.03.022; Davidson VL, 2002, BIOCHEMISTRY-US, V41, P14633, DOI 10.1021/bi026812k; De Marothy SA, 2007, J COMPUT CHEM, V28, P528, DOI 10.1002/jcc.20567; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; DODD FE, 1995, ACTA CRYSTALLOGR D, V51, P1052, DOI 10.1107/S0907444995007554; Dodd FE, 1997, ACTA CRYSTALLOGR D, V53, P406, DOI 10.1107/S0907444997002667; Dodd FE, 1998, J MOL BIOL, V282, P369, DOI 10.1006/jmbi.1998.2007; Ellis MJ, 2002, J MOL BIOL, V316, P51, DOI 10.1006/jmbi.2001.5304; Ellis MJ, 2001, ACTA CRYSTALLOGR D, V57, P1110, DOI 10.1107/S0907444901008654; Farver O, 1998, FEBS LETT, V436, P239, DOI 10.1016/S0014-5793(98)01120-X; Farver O, 2004, FEBS LETT, V561, P173, DOI 10.1016/S0014-5793(04)00171-1; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; Ghosh S, 2007, J AM CHEM SOC, V129, P10310, DOI 10.1021/ja072841c; Ghosh S, 2009, J AM CHEM SOC, V131, P277, DOI 10.1021/ja806873e; Graige MS, 1999, BIOCHEMISTRY-US, V38, P11465, DOI 10.1021/bi990708u; Hammes-Schiffer S, 2004, BBA-BIOENERGETICS, V1655, P29, DOI 10.1016/j.bbabio.2003.07.009; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; Hammes-Schiffer S, 2001, ACCOUNTS CHEM RES, V34, P273, DOI 10.1021/ar9901117; Hammes-Schiffer S, 2008, J PHYS CHEM B, V112, P14108, DOI 10.1021/jp805876e; Harris RL, 2005, J SYNCHROTRON RADIAT, V12, P13, DOI 10.1107/S0909049504027852; Hough MA, 2005, J MOL BIOL, V350, P300, DOI 10.1016/j.jmb.2005.04.006; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; Ichiki H, 2001, J BACTERIOL, V183, P4149, DOI 10.1128/JB.183.14.4149-4156.2001; Karpefors M, 2000, BIOCHEMISTRY-US, V39, P5045, DOI 10.1021/bi9925221; Kataoka K, 2004, J BIOL CHEM, V279, P53374, DOI 10.1074/jbc.M410198200; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; KEEFFE JR, 1981, J AM CHEM SOC, V103, P2457, DOI 10.1021/ja00399a074; Kobayashi K, 1999, J BIOCHEM, V126, P408, DOI 10.1093/oxfordjournals.jbchem.a022465; Kohzuma T, 2006, INORG CHEM, V45, P8474, DOI 10.1021/ic0609195; Kuznetsova S, 2008, P NATL ACAD SCI USA, V105, P3250, DOI 10.1073/pnas.0707736105; Leskovac, 2003, COMPREHENSIVE ENZYME; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mayer JM, 2004, ANNU REV PHYS CHEM, V55, P363, DOI 10.1146/annurev.physchem.55.091602.094446; MOORE EG, 1976, J BIOL CHEM, V251, P2788; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; Nurizzo D, 1997, STRUCTURE, V5, P1157, DOI 10.1016/S0969-2126(97)00267-0; ORII Y, 1995, PHOTOCHEM PHOTOBIOL, V61, P261, DOI 10.1111/j.1751-1097.1995.tb03969.x; ORII Y, 1993, BIOCHEMISTRY-US, V32, P11910, DOI 10.1021/bi00095a021; Prudencio M, 1999, J BACTERIOL, V181, P2323; Prudencio M, 2002, BIOCHEMISTRY-US, V41, P3430, DOI 10.1021/bi011955c; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Segel IH, 1975, ENZYME KINETICS BEHA; Strange RW, 1999, J MOL BIOL, V287, P1001, DOI 10.1006/jmbi.1999.2648; STRANGE RW, 1995, NAT STRUCT BIOL, V2, P287, DOI 10.1038/nsb0495-287; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Sundararajan M, 2007, J PHYS CHEM B, V111, P5511, DOI 10.1021/jp066852o; Suzuki S, 1999, COORDIN CHEM REV, V190, P245, DOI 10.1016/S0010-8545(99)00069-7; Suzuki S, 1997, J BIOL INORG CHEM, V2, P265, DOI 10.1007/s007750050132; Suzuki S, 2000, ACCOUNTS CHEM RES, V33, P728, DOI 10.1021/ar9900257; THIBBLIN A, 1989, CHEM SOC REV, V18, P209, DOI 10.1039/cs9891800209; Weatherly SC, 2003, J PHYS CHEM B, V107, P372, DOI 10.1021/jp022085r; Wherland S, 2005, CHEMPHYSCHEM, V6, P805, DOI 10.1002/cphc.200400353; Wijma HJ, 2007, J AM CHEM SOC, V129, P8557, DOI 10.1021/ja071274q; Wijma HJ, 2006, J BIOL CHEM, V281, P16340, DOI 10.1074/jbc.M601610200; Wijma HJ, 2004, BIOCHEMISTRY-US, V43, P10467, DOI 10.1021/bi0496687; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200; Zhao YW, 2002, BIOCHEMISTRY-US, V41, P7464, DOI 10.1021/bi0256274; ZUMFT WG, 1987, EUR J BIOCHEM, V168, P301, DOI 10.1111/j.1432-1033.1987.tb13421.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	86	43	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25973	25983		10.1074/jbc.M109.012245	http://dx.doi.org/10.1074/jbc.M109.012245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19586913	hybrid, Green Published			2022-12-25	WOS:000269738000054
J	Jordan, JB; Poppe, L; Haniu, M; Arvedson, T; Syed, R; Li, V; Kohno, H; Kim, H; Schnier, PD; Harvey, TS; Miranda, LP; Cheetham, J; Sasu, BJ				Jordan, John B.; Poppe, Leszek; Haniu, Mitsuru; Arvedson, Tara; Syed, Rashid; Li, Vivian; Kohno, Hiko; Kim, Helen; Schnier, Paul D.; Harvey, Timothy S.; Miranda, Les P.; Cheetham, Janet; Sasu, Barbra J.			Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE HEPCIDIN; CORRELATION NMR-SPECTROSCOPY; BETA-TURN FORMATION; HEREDITARY HEMOCHROMATOSIS; IRON OVERLOAD; COUPLING-CONSTANTS; FERROPORTIN; PROTEINS; EXPRESSION	Hepcidin is a tightly folded 25-residue peptide hormone containing four disulfide bonds, which has been shown to act as the principal regulator of iron homeostasis in vertebrates. We used multiple techniques to demonstrate a disulfide bonding pattern for hepcidin different from that previously published. All techniques confirmed the following disulfide bond connectivity: Cys(1)-Cys(8), Cys(3)-Cys(6), Cys(2)-Cys(4), and Cys(5)-Cys(7). NMR studies reveal a new model for hepcidin that, at ambient temperatures, interconverts between two different conformations, which could be individually resolved by temperature variation. Using these methods, the solution structure of hepcidin was determined at 325 and 253 K in supercooled water. X-ray analysis of a co-crystal with Fab appeared to stabilize a hepcidin conformation similar to the high temperature NMR structure.	[Jordan, John B.; Poppe, Leszek; Syed, Rashid; Li, Vivian; Schnier, Paul D.; Harvey, Timothy S.; Miranda, Les P.; Cheetham, Janet] Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA; [Haniu, Mitsuru; Kohno, Hiko; Kim, Helen] Amgen Inc, Dept Prot Sci, Thousand Oaks, CA 91320 USA; [Arvedson, Tara; Sasu, Barbra J.] Amgen Inc, Dept Hematol, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Jordan, JB (corresponding author), 1 Amgen Ctr Dr,MS 14-2-A, Thousand Oaks, CA 91320 USA.	jbjordan@amgen.com; lpoppe@amgen.com	Harvey, Timothy S/F-9863-2013	Harvey, Timothy S/0000-0001-6270-1943	United States Department of Energy [DE-AC02-05CH11231]	United States Department of Energy(United States Department of Energy (DOE))	We thank Ching Chen for affinity determination of the anti-hepcidin antibody used for Fab generation; Jingwen Zhang for shHepc preparation; Noi Nuanamanee for ehHepc and chHepc production; Ann Hsu for chHepc characterization; and Gregory Dyas and Jacob Corcoran for hepcidin activity determination. We also acknowledge the helpful comments from the reviewers, which allowed us to improve upon the statistical analysis. ALS-Beamline 5.0.2 is supported by the United States Department of Energy under Contract DE-AC02-05CH11231.	Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; ATHERTON E, 1989, SOLID PHASE PEPTIDE, P216; Benitez BAS, 2000, PROTEINS, V40, P168, DOI 10.1002/(SICI)1097-0134(20000701)40:1<168::AID-PROT180>3.0.CO;2-N; Boisbouvier J, 2000, J BIOMOL NMR, V16, P197, DOI 10.1023/A:1008354007926; BRUSCHWEILER R, 1988, J MAGN RESON, V78, P178, DOI 10.1016/0022-2364(88)90171-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHALAL RS, 1965, BR J APPL PHYS, V16, P231; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farnaud S, 2006, BIOMETALS, V19, P527, DOI 10.1007/s10534-005-5883-z; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Fuchs PFJ, 2006, BIOPHYS J, V90, P2745, DOI 10.1529/biophysj.105.074401; Furrer J, 2004, J MAGN RESON, V166, P39, DOI 10.1016/j.jmr.2003.09.013; Gagliardo B, 2008, FEBS J, V275, P3793, DOI 10.1111/j.1742-4658.2008.06525.x; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4; HALLETT J, 1963, P PHYS SOC LOND, V82, P1046, DOI 10.1088/0370-1328/82/6/326; HANSEN PE, 1991, BIOCHEMISTRY-US, V30, P10457, DOI 10.1021/bi00107a014; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HU SFS, 2001, Patent No. 6210924; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jaynes E.T., 2003, PROBABILITY THEORY L; KARPLUS M, 1959, J CHEM PHYS, V30, P15, DOI 10.1063/1.1729866; KESSLER H, 1988, MAGN RESON CHEM, V26, P919, DOI 10.1002/mrc.1260261018; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P783, DOI 10.1006/bcmd.2001.0445; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; PRESS RD, 2001, MOL DIAGN, V6, P347; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Roy CN, 2005, CURR OPIN HEMATOL, V12, P107, DOI 10.1097/00062752-200503000-00001; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Walewska A, 2008, J AM CHEM SOC, V130, P14280, DOI 10.1021/ja804303p; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan XM, 2003, ANN MED, V35, P578, DOI 10.1080/07853890310016342; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	56	165	190	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24155	24167		10.1074/jbc.M109.017764	http://dx.doi.org/10.1074/jbc.M109.017764			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553669	Green Published, hybrid			2022-12-25	WOS:000269380200029
J	Kockx, M; Guo, DL; Traini, M; Gaus, K; Kay, J; Wimmer-Kleikamp, S; Rentero, C; Burnett, JR; Le Goff, W; Van Eck, M; Stow, JL; Jessup, W; Kritharides, L				Kockx, Maaike; Guo, Dongni Lily; Traini, Mathew; Gaus, Katharina; Kay, Jason; Wimmer-Kleikamp, Sabine; Rentero, Carles; Burnett, John R.; Le Goff, Wilfried; Van Eck, Miranda; Stow, Jennifer L.; Jessup, Wendy; Kritharides, Leonard			Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REMNANT LIPOPROTEIN METABOLISM; HEPARAN-SULFATE PROTEOGLYCANS; CHOLESTEROL EFFLUX; CELL-SURFACE; EXTRACELLULAR-MATRIX; DENSITY-LIPOPROTEINS; FOAM CELLS; APOE; ATHEROSCLEROSIS; CALCINEURIN	Cyclosporin A (CsA) is an immunosuppressant that inhibits protein phosphatase 2B (PP2B/calcineurin) and is associated with hyperlipidemia, decreased cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1), and increased risk of atherosclerosis. Apolipoprotein E (apoE) is an important regulator of lipid metabolism and atherosclerosis, the secretion of which from human macrophages is regulated by the serine/threonine protein kinase A (PKA) and intracellular calcium (Ca2+) (Kockx, M., Guo, D. L., Huby, T., Lesnik, P., Kay, J., Sabaretnam, T., Jary, E., Hill, M., Gaus, K., Chapman, J., Stow, J. L., Jessup, W., and Kritharides, L. (2007) Circ. Res. 101, 607-616). As PP2B is Ca2+-dependent and has been linked to PKA-dependent processes, we investigated whether CsA modulated apoE secretion. CsA dose-and time-dependently inhibited secretion of apoE from primary human macrophages and from Chinese hamster ovary cells stably transfected with human apoE and increased cellular apoE levels without affecting apoE mRNA. [S-35] Met kinetic modeling studies showed that CsA inhibited both secretion and degradation of apoE, increasing the half-life of cellular apoE 2-fold. CsA also inhibited secretion from primary human Tangier disease macrophages and from mouse macrophages deficient in ABCA1, indicating that the effect is independent of the known inhibition of ABCA1 by CsA. The role of PP2B in mediating apoE secretion was confirmed using additional peptide and chemical inhibitors of PP2B. Importantly, kinetic modeling, live-cell imaging, and confocal microscopy all indicated that CsA inhibited apoE secretion by mechanisms quite distinct from those of PKA inhibition, most likely inducing accumulation of apoE in the endoplasmic reticulum compartment. Taken together, these results establish a novel mechanism for the pro-atherosclerotic effects of CsA, and establish for the first time a role for PP2B in regulating the intracellular transport and secretion of apoE.	[Kockx, Maaike; Guo, Dongni Lily; Traini, Mathew; Gaus, Katharina; Wimmer-Kleikamp, Sabine; Rentero, Carles; Jessup, Wendy; Kritharides, Leonard] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Kay, Jason; Stow, Jennifer L.] Univ Queensland, Brisbane, Qld 4072, Australia; [Burnett, John R.] Royal Perth Hosp, Dept Core Clin Pathol & Biochem, Perth, WA 6008, Australia; [Burnett, John R.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia; [Le Goff, Wilfried] Univ Paris 06, UMR S551, F-75013 Paris, France; [Van Eck, Miranda] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2311 EZ Leiden, Netherlands; [Kritharides, Leonard] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2139, Australia	University of New South Wales Sydney; University of Queensland; Royal Perth Hospital; University of Western Australia; University of Western Australia; UDICE-French Research Universities; Sorbonne Universite; Leiden University; Leiden University - Excl LUMC; Concord Repatriation General Hospital; University of Sydney	Kritharides, L (corresponding author), Concord Hosp, Dept Cardiol, Sydney, NSW 2139, Australia.	l.kritharides@unsw.edu.au	Le Goff, Wilfried/N-7593-2019; Rentero Alfonso, Carles/L-4430-2017; Le Goff, Wilfried/N-6326-2017; Stow, Jennifer L/I-4723-2013; Kritharides, Leonard/AAQ-2720-2020	Le Goff, Wilfried/0000-0002-7611-9644; Rentero Alfonso, Carles/0000-0003-4684-0278; Le Goff, Wilfried/0000-0002-7611-9644; Stow, Jennifer L/0000-0002-5409-9101; Traini, Mathew/0000-0002-9423-5294; Gaus, Katharina/0000-0002-8009-9658; Kay, Jason/0000-0001-8944-6612	National Health and Medical Research Council of Australia [455251]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia Project Grant 455251.	AlRayyes O, 1996, HEPATOLOGY, V24, P613; APANAY DC, 1994, TRANSPLANTATION, V58, P663; Burgess JW, 2002, J BIOL CHEM, V277, P31318, DOI 10.1074/jbc.M204200200; BURNETT JR, 2007, 89 ANN M END SOC TOR; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; DENG JT, 1995, J LIPID RES, V36, P2129; Duan HW, 1997, J BIOL CHEM, V272, P31156, DOI 10.1074/jbc.272.49.31156; Gaus K, 2001, BIOCHEMISTRY-US, V40, P9363, DOI 10.1021/bi010323n; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Ho YY, 2000, BIOCHEMISTRY-US, V39, P4746, DOI 10.1021/bi992294a; Huang ZH, 2004, J BIOL CHEM, V279, P29195, DOI 10.1074/jbc.M402631200; JI ZS, 1994, J BIOL CHEM, V269, P2764; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2008, ARTERIOSCL THROM VAS, V28, P1060, DOI 10.1161/ATVBAHA.108.164350; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Loor F, 2002, J MED CHEM, V45, P4598, DOI 10.1021/jm0109863; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, J LIPID RES, V40, P1; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; PRINCEN HMG, 1991, BIOCHEM J, V275, P501, DOI 10.1042/bj2750501; Sharom FJ, 1999, BIOCHEM PHARMACOL, V58, P571, DOI 10.1016/S0006-2952(99)00139-2; Terada H, 2003, J NEUROCHEM, V87, P1145, DOI 10.1046/j.1471-4159.2003.02098.x; Tory R, 2008, INT J PHARMACEUT, V358, P219, DOI 10.1016/j.ijpharm.2008.03.026; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Vaziri ND, 2000, J PHARMACOL EXP THER, V294, P778; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; ZANNIS VI, 1986, J BIOL CHEM, V261, P3415; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; Zhao YW, 2000, J BIOL CHEM, V275, P4759, DOI 10.1074/jbc.275.7.4759; Zhao YW, 2002, J BIOL CHEM, V277, P29477, DOI 10.1074/jbc.M200219200; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	43	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24144	24154		10.1074/jbc.M109.032615	http://dx.doi.org/10.1074/jbc.M109.032615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19589783	Green Published, hybrid			2022-12-25	WOS:000269380200028
J	Leverentz, MK; Campbell, RN; Connolly, Y; Whetton, AD; Reece, RJ				Leverentz, Michael K.; Campbell, Robert N.; Connolly, Yvonne; Whetton, Anthony D.; Reece, Richard J.			Mutation of a Phosphorylatable Residue in Put3p Affects the Magnitude of Rapamycin-induced PUT1 Activation in a Gat1p-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE UTILIZATION PATHWAY; CELL-GROWTH CONTROL; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; BINUCLEAR CLUSTER; PROTEIN-KINASES; AMINO-ACID; NITROGEN; GENE; YEAST	Saccharomyces cerevisiae can utilize high quality (e.g. glutamine and ammonia) as well as low quality (e.g. gamma-amino butyric acid and proline) nitrogen sources. The transcriptional activator Put3p allows yeast cells to utilize proline as a nitrogen source through expression of the PUT1 and PUT2 genes. Put3p activates high level transcription of these genes by binding proline directly. However, Put3p also responds to other lower quality nitrogen sources. As nitrogen quality decreases, Put3p exhibits an increase in phosphorylation concurrent with an increase in PUT gene expression. The proline-independent activation of the PUT genes requires both Put3p and the positively acting GATA factors, Gln3p and Gat1p. Conversely, the phosphorylation of Put3p is not dependent on GATA factor activity. Here, we find that the mutation of Put3p at amino acid Tyr-788 modulates the proline-independent activation of PUT1 through Gat1p. The phosphorylation of Put3p appears to influence the association of Gat1p, but not Gln3p, to the PUT1 promoter. Combined, our findings suggest that this may represent a mechanism through which yeast cells rapidly adapt to use proline as a nitrogen source under nitrogen limiting conditions.	[Leverentz, Michael K.; Campbell, Robert N.; Reece, Richard J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Connolly, Yvonne; Whetton, Anthony D.] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	University of Manchester; Paterson Institute for Cancer Research; University of Manchester	Reece, RJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Richard.Reece@manchester.ac.uk		Leverentz, Michael/0000-0003-4931-4732; WHETTON, ANTHONY D/0000-0002-1098-3878	Wellcome Trust; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom ( to R.J.R.). 1 To whom correspondence	AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COURCHESNE WE, 1983, MOL CELL BIOL, V3, P672, DOI 10.1128/MCB.3.4.672; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; desEtages SAG, 1996, GENETICS, V142, P1069; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Huang HL, 2000, MOL CELL BIOL, V20, P892, DOI 10.1128/MCB.20.3.892-899.2000; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Leverentz MK, 2006, BIOCHEM SOC T, V34, P794, DOI 10.1042/BST0340794; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; MARCZAK JE, 1991, MOL CELL BIOL, V11, P2609, DOI 10.1128/MCB.11.5.2609; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Oliveira EMM, 2005, FEMS YEAST RES, V5, P605, DOI 10.1016/j.femsyr.2004.11.011; RAI R, 1995, YEAST, V11, P247, DOI 10.1002/yea.320110307; SADOWSKI I, 1991, P NATL ACAD SCI USA, V88, P10510, DOI 10.1073/pnas.88.23.10510; Saxena D, 2003, EUKARYOT CELL, V2, P552, DOI 10.1128/EC.2.3.552-559.2003; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2003, EMBO J, V22, P5147, DOI 10.1093/emboj/cdg480; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; ter Schure EG, 1998, MICROBIOL-SGM, V144, P1451, DOI 10.1099/00221287-144-5-1451; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; XU SW, 1995, MOL CELL BIOL, V15, P2321; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829	39	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24115	24122		10.1074/jbc.M109.030361	http://dx.doi.org/10.1074/jbc.M109.030361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574222	Green Published, hybrid			2022-12-25	WOS:000269380200025
J	Ors, A; Grimaldi, M; Kimata, Y; Wilkinson, CRM; Jones, N; Yamano, H				Ors, Aslihan; Grimaldi, Margaret; Kimata, Yuu; Wilkinson, Caroline R. M.; Jones, Nic; Yamano, Hiroyuki			The Transcription Factor Atf1 Binds and Activates the APC/C Ubiquitin Ligase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; DNA-BINDING; DESTRUCTION BOX; GENE-EXPRESSION; PROTEIN; ENCODES; STRESS; COMPLEX/CYCLOSOME	Fission yeast Atf1 is a member of the ATF/CREB basic leucine zipper (bZIP) family of transcription factors with strong homology to mammalian ATF2. Atf1 regulates transcription in response to stress stimuli and also plays a role in controlling heterochromatin formation and recombination. However, its DNA binding independent role is poorly studied. Here, we report that Atf1 has a distinct role in regulating the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase. We have identified atf1(+) as a dose-dependent suppressor of apc5-1, a mutation causing mitotic arrest. Remarkably, the suppression is not dependent upon the bZIP domain and is therefore independent of the ability of Atf1 to bind DNA. Interestingly, Atf1 physically binds the APC/C in vivo. Furthermore, we show that addition of purified Atf1 proteins into a cell-free system stimulates ubiquitylation of cyclin B and securin by the APC/C. These results reveal a novel role for Atf1 in cell cycle control through protein-protein interaction.	[Ors, Aslihan; Grimaldi, Margaret; Kimata, Yuu; Yamano, Hiroyuki] Marie Curie Res Inst, Cell Cycle Control Lab, Oxted RH8 0TL, Surrey, England; [Wilkinson, Caroline R. M.; Jones, Nic] Paterson Inst Canc Res, Canc Res UK Cell Regulat Lab, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research	Yamano, H (corresponding author), Marie Curie Res Inst, Cell Cycle Control Lab, Oxted RH8 0TL, Surrey, England.	h.yamano@mcri.ac.uk	Kimata, Yuu/U-2311-2017; Ors, Aslihan/A-3247-2012	Kimata, Yuu/0000-0001-6223-1320; 	Marie Curie Cancer Care; Association for International Cancer Research (AICR); Cancer Research UK [12485] Funding Source: researchfish	Marie Curie Cancer Care; Association for International Cancer Research (AICR); Cancer Research UK(Cancer Research UK)	This work was supported by Marie Curie Cancer Care and the Association for International Cancer Research (AICR).	AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bhoumik A, 2008, J BIOL CHEM, V283, P17605, DOI 10.1074/jbc.M802030200; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RUSSELL PR, 1982, MOL CELL BIOL, V2, P106, DOI 10.1128/MCB.2.2.106; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yoon HJ, 2006, J BIOL CHEM, V281, P32284, DOI 10.1074/jbc.M603867200	41	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23989	23994		10.1074/jbc.M109.018309	http://dx.doi.org/10.1074/jbc.M109.018309			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19584054	hybrid, Green Published			2022-12-25	WOS:000269380200013
J	Saegusa, J; Yamaji, S; Ieguchi, K; Wu, CY; Lam, KS; Liu, FT; Takada, YK; Takada, Y				Saegusa, Jun; Yamaji, Satoshi; Ieguchi, Katsuaki; Wu, Chun-Yi; Lam, Kit S.; Liu, Fu-Tong; Takada, Yoko K.; Takada, Yoshikazu			The Direct Binding of Insulin-like Growth Factor-1 (IGF-1) to Integrin alpha v beta 3 Is Involved in IGF-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; SMOOTH-MUSCLE-CELLS; 1ST 3 DOMAINS; V BETA 3; CRYSTAL-STRUCTURE; ALPHA(V)BETA(3) EXPRESSION; EXTRACELLULAR SEGMENT; FACTOR RECEPTOR; LIGAND-BINDING; ADHESION	It has been proposed that ligand occupancy of integrin alpha v beta 3 with extracellular matrix ligands (e.g. vitronectin) plays a critical role in insulin-like growth factor-1 (IGF-1) signaling. We found that expression of alpha v beta 3 enhanced IGF-1-induced proliferation of Chinese hamster ovary cells in serum-free conditions (in the absence of vitronectin). We hypothesized that the direct integrin binding to IGF-1 may play a role in IGF-1 signaling. We demonstrated that alpha v beta 3 specifically and directly bound to IGF-1 in cell adhesion, enzyme-linked immunosorbent assay-type binding, and surface plasmon resonance studies. We localized the amino acid residues of IGF-1 that are critical for integrin binding by docking simulation and mutagenesis. We found that mutating two Arg residues at positions 36 and 37 in the C-domain of IGF-1 to Glu (the R36E/R37E mutation) effectively reduced integrin binding. Interestingly, although the mutant still bound to IGF1R, it was defective in inducing IGF1R phosphorylation, AKT and ERK1/2 activation, and cell proliferation. Furthermore wild type IGF-1 mediated co-precipitation of alpha v beta 3 and IGF1R, whereas the R36E/R37E mutant did not, suggesting that IGF-1 mediates the interaction between alpha v beta 3 and IGF1R. These results suggest that the direct binding to IGF-1 to integrin alpha v beta 3 plays a role in IGF-1 signaling through ternary complex formation (alpha v beta 3-IGF-IGF1R), and integrin-IGF-1 interaction is a novel target for drug discovery.	[Saegusa, Jun; Yamaji, Satoshi; Ieguchi, Katsuaki; Liu, Fu-Tong; Takada, Yoko K.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Wu, Chun-Yi; Lam, Kit S.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Hematol Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Res 3,Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health Grants [CA113298, CA131015, CA093373]; NATIONAL CANCER INSTITUTE [U19CA113298, R01CA131015, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA113298, CA131015, and CA093373 ( to Y. T.).	Albelda S M, 1992, EXS, V61, P188; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Bojesen SE, 2005, ENDOCR-RELAT CANCER, V12, P945, DOI 10.1677/erc.1.01083; Chattopadhyay N, 2001, J EXP CLIN CANC RES, V20, P269; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Gladson CL, 1996, AM J PATHOL, V148, P1423; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Liapis H, 1996, DIAGN MOL PATHOL, V5, P127, DOI 10.1097/00019606-199606000-00008; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Maile LA, 2006, MOL ENDOCRINOL, V20, P405, DOI 10.1210/me.2005-0241; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; PIGNATELLI M, 1992, HUM PATHOL, V23, P1159, DOI 10.1016/0046-8177(92)90034-Z; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Sengupta S, 2001, J EXP CLIN CANC RES, V20, P585; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Triantafilou M, 2000, HUM IMMUNOL, V61, P453, DOI 10.1016/S0198-8859(00)00103-8; Vonlaufen A, 2001, MODERN PATHOL, V14, P1126, DOI 10.1038/modpathol.3880447; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	34	61	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24106	24114		10.1074/jbc.M109.013201	http://dx.doi.org/10.1074/jbc.M109.013201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19578119	hybrid, Green Published			2022-12-25	WOS:000269380200024
J	Komlodi-Pasztor, E; Trostel, S; Sackett, D; Poruchynsky, M; Fojo, T				Komlodi-Pasztor, E.; Trostel, S.; Sackett, D.; Poruchynsky, M.; Fojo, T.			Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells	ONCOGENE			English	Article						nuclear localization; mutant p53; platinum resistance	WILD-TYPE P53; NUCLEAR-LOCALIZATION SIGNALS; COLORECTAL ADENOCARCINOMA; SUBCELLULAR-LOCALIZATION; N-MYC; PROTEIN; ACCUMULATION; GENE; NEUROBLASTOMA; AMPLIFICATION	Previous studies have described one nuclear localization signal (NLSI) in p53 and speculated on two additional sites termed NLSII and NLSIII. Drug-resistant KB cells selected with cisplatin or oxaliplatin were found to have increased p53 levels and in oxaliplatin-selected cells, a larger p53 predominantly in the cytoplasm. In oxaliplatin-selected cells a single nucleotide deletion in the sequence-encoding amino acid 382, part of NLSIII, resulted in a frame shift and a 420 amino acid protein (p53(420)). We investigated explanations for the cytoplasmic sequestration of p53(420) while assessing the role, if any, of NLSII and NLSIII in p53 nuclear import. We found that neither NLSII nor NLSIII are essential for p53 nuclear localization. Furthermore, we confirmed p53(420) is able to tetramerize, transactivate a p21 promoter, bind dynein and that the reduced nuclear accumulation is not a consequence of increased p53 nuclear export. However, the association of p53(420) with importin-beta, essential for nuclear import, was significantly impaired. We conclude that despite sequence similarity to consensus NLSs neither NLSII nor NLSIII have roles in p53 nuclear transport. We also identified impaired association with importin as a novel mechanism of p53 cytoplasmic sequestration that impairs nuclear transport rendering cells functionally deficient in p53. Oncogene (2009) 28, 3111-3120; doi: 10.1038/onc.2009.166; published online 6 July 2009	[Komlodi-Pasztor, E.; Trostel, S.; Poruchynsky, M.; Fojo, T.] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Sackett, D.] NICHHD, Lab Integrat & Med Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Komlodi-Pasztor, E (corresponding author), NCI, Med Oncol Branch, NIH, 9000 Rockville Pike,B10 R13N260, Bethesda, MD 20892 USA.	komlodie@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010626, ZIABC010625, ZIASC006732] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; BOSARI S, 1995, AM J PATHOL, V147, P790; BOSARI S, 1994, JNCI-J NATL CANCER I, V86, P681, DOI 10.1093/jnci/86.9.681; Bristow RG, 2003, ONCOGENE, V22, P2960, DOI 10.1038/sj.onc.1206405; DANG CV, 1989, J BIOL CHEM, V264, P18019; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; IMAMURA J, 1993, CANCER RES, V53, P4053; Kim IS, 2000, J BIOL CHEM, V275, P23139, DOI 10.1074/jbc.M909256199; LANE DP, 1992, NATURE, V358, P16; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li Q, 2007, ONCOGENE, V26, P7885, DOI 10.1038/sj.onc.1210597; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Lilling G, 2002, CANCER INVEST, V20, P509, DOI 10.1081/CNV-120002151; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Oggionni M, 2005, ONCOLOGY-BASEL, V69, P154, DOI 10.1159/000087839; Ottaggio L, 2000, CARCINOGENESIS, V21, P1631, DOI 10.1093/carcin/21.9.1631; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Scata KA, 2007, ADV EXP MED BIOL, V608, P70; Sembritzki O, 2002, NEURO-ONCOLOGY, V4, P171, DOI 10.1093/neuonc/4.3.171; SHAULSKY G, 1991, ONCOGENE, V6, P2055; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SMITH AE, 1985, PROC R SOC SER B-BIO, V226, P43, DOI 10.1098/rspb.1985.0078; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; Trostel SY, 2006, CELL CYCLE, V5, P2253, DOI 10.4161/cc.5.19.3291; Utama B, 2006, J CELL SCI, V119, P2457, DOI 10.1242/jcs.02974; WEISS J, 1995, BRIT J DERMATOL, V133, P23; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141	37	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3111	3120		10.1038/onc.2009.166	http://dx.doi.org/10.1038/onc.2009.166			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19581934	Green Accepted			2022-12-25	WOS:000269515100003
J	Aygun, O; Xu, XH; Liu, YL; Takahashi, H; Kong, SE; Conaway, RC; Conaway, JW; Svejstrup, JQ				Ayguen, Ozan; Xu, Xiaohua; Liu, Yilun; Takahashi, Hidehisa; Kong, Stephanie E.; Conaway, Ronald C.; Conaway, Joan W.; Svejstrup, Jesper Q.			Direct Inhibition of RNA Polymerase II Transcription by RECQL5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR; REPLICATION FORK; MEDIATOR COMPLEX; HUMAN RECQ5-BETA; SYNDROME GENE; HELICASES; RECOMBINATION; INITIATION; CHROMATIN; IMPAIRMENT	DNA helicases of the RECQ family are important for maintaining genome integrity, from bacteria to humans. Although progress has been made in understanding the biochemical role of some human RECQ helicases, that of RECQL5 remains elusive. We recently reported that RECQL5 interacts with RNA polymerase II (RNAPII), pointing to a role for the protein in transcription. Here, we show that RECQL5 inhibits both initiation and elongation in transcription assays reconstituted with highly purified general transcription factors and RNAPII. Such inhibition is not observed with the related, much more active RECQL1 helicase or with a version of RECQL5 that has normal helicase activity but is impaired in its ability to interact with RNAPII. Indeed, RECQL5 helicase activity is not required for inhibition. We discuss our findings in light of the fact that RECQ5(-/-) mice have elevated levels of DNA recombination and a higher incidence of cancer.	[Ayguen, Ozan; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Xu, Xiaohua; Liu, Yilun] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Takahashi, Hidehisa; Kong, Stephanie E.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Cancer Research UK; Yale University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	xu, xiaohua/D-1152-2011; Hidehisa, Takahashi/E-2175-2012; liu, yi/GXE-9662-2022	Svejstrup, Jesper/0000-0003-4964-6147; Conaway, Joan/0000-0002-2786-0663; xu, xioahua/0000-0003-3790-6386	NIGMS; National Institutes of Health [R37 41628]; European Community [LSHG-CT-2005-512113]; Cancer Research UK; Bloom's Syndrome Foundation; American Cancer Society	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Cancer Research UK(Cancer Research UK); Bloom's Syndrome Foundation; American Cancer Society(American Cancer Society)	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant R37 41628 (to R. C. C). This work was also supported by Integrated Project DNA Repair Grant LSHG-CT-2005-512113 from the European Community, an in-house grant from Cancer Research UK (to J.Q.S.), the Bloom's Syndrome Foundation, and by the American Cancer Society (to Y.L.).	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Jimeno S, 2008, MOL GENET GENOMICS, V280, P327, DOI 10.1007/s00438-008-0368-8; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shimamoto A, 2000, NUCLEIC ACIDS RES, V28, P1647, DOI 10.1093/nar/28.7.1647; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; TAN SY, 1994, J BIOL CHEM, V269, P25684; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Xie Z, 1996, J BIOL CHEM, V271, P11043, DOI 10.1074/jbc.271.19.11043; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	35	46	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23197	23203		10.1074/jbc.M109.015750	http://dx.doi.org/10.1074/jbc.M109.015750			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570979	hybrid, Green Published			2022-12-25	WOS:000269180000004
J	Hol, J; Kuchler, AM; Johansen, FE; Dalhus, B; Haraldsen, G; Oynebraten, I				Hol, Johanna; Kuchler, Axel M.; Johansen, Finn-Eirik; Dalhus, Bjorn; Haraldsen, Guttorm; Oynebraten, Inger			Molecular Requirements for Sorting of the Chemokine Interleukin-8/CXCL8 to Endothelial Weibel-Palade Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; P-SELECTIN EXPRESSION; REGULATED SECRETION; RECEPTOR-BINDING; CELLS; STORAGE; PROTEIN; MECHANISMS; EXOCYTOSIS; GLYCOSAMINOGLYCANS	Sorting of proteins to Weibel-Palade bodies (WPB) of endothelial cells allows rapid regulated secretion of leukocyte-recruiting P-selectin and chemokines as well as procoagulant von Willebrand factor (VWF). Here we show by domain swap studies that the exposed aspartic acid in loop 2 (Ser(44)-Asp(45)-Gly(46)) of the CXC chemokine interleukin (IL)-8 is crucial for targeting to WPB. Loop 2 also governs sorting of chemokines to alpha-granules of platelets, but the fingerprint of the loop 2 of these chemokines differs from that of IL-8. On the other hand, loop 2 of IL-8 closely resembles a surface-exposed sequence of the VWF propeptide, the region of VWF that directs sorting of the protein to WPB. We conclude that loop 2 of IL-8 constitutes a critical signal for sorting to WPB and propose a general role for this loop in the sorting of chemokines to compartments of regulated secretion.	[Kuchler, Axel M.; Johansen, Finn-Eirik; Haraldsen, Guttorm] Univ Oslo, Rikshosp, Univ Hosp, Div Pathol, N-0027 Oslo, Norway; [Hol, Johanna; Kuchler, Axel M.; Johansen, Finn-Eirik; Oynebraten, Inger] Univ Oslo, Rikshosp, Univ Hosp, Inst Pathol, N-0027 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Rikshosp, Univ Hosp, Inst Clin Biochem & Med Microbiol, N-0027 Oslo, Norway; [Oynebraten, Inger] Univ Oslo, Rikshosp, Univ Hosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Haraldsen, G (corresponding author), Univ Oslo, Rikshosp, Univ Hosp, Div Pathol, Sognsvannsveien 20, N-0027 Oslo, Norway.	guttorm.haraldsen@rr-research.no	Haraldsen, Guttorm/I-2680-2013; Øynebråten, Inger/W-3369-2019; Haraldsen, Guttorm/W-4359-2019; Hol, Johanna/AAJ-8586-2020; Dalhus, Bjørn/AAK-2895-2020	Øynebråten, Inger/0000-0001-8914-5676; Hol, Johanna/0000-0001-5837-5006; Haraldsen, Guttorm/0000-0002-0064-9665	Research Council of Norway; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Research Council of Norway and the Norwegian Cancer Society.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; Blandl T, 2003, PROTEIN SCI, V12, P237, DOI 10.1110/ps.0228603; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Denis CV, 2001, P NATL ACAD SCI USA, V98, P4072, DOI 10.1073/pnas.061307098; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; El-Golli N, 2005, J BIOL CHEM, V280, P30329, DOI 10.1074/jbc.M503847200; Eppihimer MJ, 1997, AM J PHYSIOL-GASTR L, V273, pG1326, DOI 10.1152/ajpgi.1997.273.6.G1326; Gorr SU, 2001, MOL CELL ENDOCRINOL, V172, P1, DOI 10.1016/S0303-7207(00)00342-7; Haberichter SL, 2000, BLOOD, V96, P1808, DOI 10.1182/blood.V96.5.1808.h8001808_1808_1815; Haberichter SL, 2006, PEDIATR BLOOD CANCER, V46, P547, DOI 10.1002/pbc.20658; Haberichter SL, 2005, BLOOD, V105, P145, DOI 10.1182/blood-2004-02-0464; Haberichter SL, 2002, ARTERIOSCL THROM VAS, V22, P921, DOI 10.1161/01.ATV.0000017063.36768.87; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; Harrison-Lavoie KJ, 2006, TRAFFIC, V7, P647, DOI 10.1111/j.1600-0854.2006.00415.x; Hartwell DM, 1998, J CELL BIOL, V143, P1129, DOI 10.1083/jcb.143.4.1129; HEBERT CA, 1990, J IMMUNOL, V145, P3033; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Karchin R, 2004, PROTEINS, V55, P508, DOI 10.1002/prot.20008; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Krieger E, 2004, PROTEINS, V54, P768, DOI 10.1002/prot.10590; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lowman HB, 1997, PROTEIN SCI, V6, P598; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; POWER CA, 1995, CYTOKINE, V7, P479, DOI 10.1006/cyto.1995.0065; Rajagopalan L, 2007, BIOPHYS J, V93, P2129, DOI 10.1529/biophysj.107.108761; ROMANI DW, 2003, EXP CELL RES, V286, P67; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Shahbazi S, 2007, J THROMB HAEMOST, V5, P1956, DOI 10.1111/j.1538-7836.2007.02681.x; Singh I, 1999, CLIN TRANSPLANT, V13, P76, DOI 10.1034/j.1399-0012.1999.130103.x; TARTAKOFF A, 1978, J CELL BIOL, V79, P694, DOI 10.1083/jcb.79.3.694; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; Ye JQ, 2001, BIOCHEMISTRY-US, V40, P7820, DOI 10.1021/bi010252s	51	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23532	23539		10.1074/jbc.M900874200	http://dx.doi.org/10.1074/jbc.M900874200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19578117	Green Published, hybrid			2022-12-25	WOS:000269180000038
J	Koo, BH; Park, MY; Jeon, OH; Kim, DS				Koo, Bon-Hun; Park, Michael Y.; Jeon, Ok-Hee; Kim, Doo-Sik			Regulatory Mechanism of Matrix Metalloprotease-2 Enzymatic Activity by Factor Xa and Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; VEIN ENDOTHELIAL-CELLS; PRO-MMP-2 ACTIVATION; TISSUE INHIBITOR; PROGELATINASE-A; IV COLLAGENASE; GELATINASE-A; IN-VIVO; EFFICIENT ACTIVATION; TUMOR INVASION	Matrix metalloprotease (MMP)-2 plays a key role in many biological and pathological processes related to cell migration, invasion, and mitogenesis. MMP-2 is synthesized as a zymogen that is activated through either a conformational change or proteolysis of the propeptide. Several activating enzymes for pro-MMP-2 have been proposed, including metalloproteases and serine proteases. The mechanism of pro-MMP-2 activation by metalloproteases is well established, and the most studied activation mechanism involves cleavage of the propeptide by membrane type 1-MMP (MT1-MMP). In contrast, serine protease activation has not been thoroughly studied, although studies suggest that MT1-MMP may be involved in activation by thrombin and plasmin. Here, we demonstrate that factor Xa mediates MT1-MMP-independent processing of pro-MMP-2 in vascular smooth muscle cells and endothelial cells. Factor Xa and thrombin directly cleaved the propeptide on the carboxyl terminal sides of the Arg(98) and Arg(101) residues, whereas plasmin only cleaved the propeptide downstream of Arg(101). Moreover, processed MMP-2 showed enzymatic activity that was enhanced by intermolecular autoproteolytic processing at the Asn(109)-Tyr peptide bond. In addition to its role in activation, factor Xa rapidly degraded MMP-2, thereby restricting excessive MMP-2 activity. Thrombin also degraded MMP-2, but the degradation was reduced greatly under cell-associated conditions, resulting in an increase in processed MMP-2. Overall, factor Xa and thrombin regulate MMP-2 enzymatic activity through its activation and degradation. Thus, the net enzymatic activity results from a balance between MMP-2 activation and degradation.	[Koo, Bon-Hun; Park, Michael Y.; Jeon, Ok-Hee; Kim, Doo-Sik] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Natl Res Lab, Seoul 120749, South Korea	Yonsei University	Kim, DS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Natl Res Lab, 134 Sinchon Dong, Seoul 120749, South Korea.	dskim@yonsei.ac.kr			Korean government (MOST) [ROA-2004-000-10297-0, 2009-0081759]	Korean government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This work was supported by a Korea Science and Engineering Foundation grant funded by the Korean government (MOST Grants ROA-2004-000-10297-0 and 2009-0081759).	Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Blanc-Brude OP, 2001, AM J PHYSIOL-CELL PH, V281, pC681, DOI 10.1152/ajpcell.2001.281.2.C681; Bono F, 1997, J CELL PHYSIOL, V172, P36, DOI 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Callahan MK, 2004, J NEUROIMMUNOL, V153, P150, DOI 10.1016/j.jneuroim.2004.05.004; Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; CRABBE T, 1994, FEBS LETT, V345, P14, DOI 10.1016/0014-5793(94)00412-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Ellerbroek SM, 1999, CANCER RES, V59, P1635; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; Gilles C, 1996, INT J CANCER, V65, P209; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Herbert JM, 1998, J CLIN INVEST, V101, P993, DOI 10.1172/JCI1833; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Jackson MT, 2009, ARTHRITIS RHEUM-US, V60, P780, DOI 10.1002/art.24303; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Koo BH, 2003, J BIOL CHEM, V278, P52578, DOI 10.1074/jbc.M310007200; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; LONSDALEECCLES JD, 1980, BIOCHIM BIOPHYS ACTA, V612, P401, DOI 10.1016/0005-2744(80)90123-0; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nakada M, 2001, CANCER RES, V61, P8896; Nguyen M, 1999, LAB INVEST, V79, P467; Nie J, 2003, CANCER RES, V63, P6758; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; RAGOSTA M, 1994, CIRCULATION, V89, P1262, DOI 10.1161/01.CIR.89.3.1262; Rauch BH, 2002, CIRC RES, V90, P1122, DOI 10.1161/01.RES.0000019240.72809.76; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; Wang ZB, 2009, NEUROSCI LETT, V451, P199, DOI 10.1016/j.neulet.2009.01.003; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	53	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23375	23385		10.1074/jbc.M109.036848	http://dx.doi.org/10.1074/jbc.M109.036848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581306	hybrid, Green Published			2022-12-25	WOS:000269180000022
J	Zhong, DS; Xiong, L; Liu, TR; Liu, XJ; Liu, XG; Chen, J; Sun, SY; Khuri, FR; Zong, YP; Zhou, QH; Zhou, W				Zhong, Diansheng; Xiong, Li; Liu, Tongrui; Liu, Xiuju; Liu, Xiangguo; Chen, Jing; Sun, Shi-Yong; Khuri, Fadlo R.; Zong, Yaping; Zhou, Qinghua; Zhou, Wei			The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER RADIOTHERAPY; INSULIN; GROWTH; 2-DEOXY-D-GLUCOSE; GLUCOSE; KINASE; CELLS; PHOSPHORYLATION; ANTICANCER; METABOLISM	Recent molecular studies indicate that aerobic glycolysis plays an important role in tumorigenesis and is a valid target for cancer therapy. Although 2-deoxyglucose (2-DG) is well characterized as a glycolytic inhibitor, we recently discovered that it activates a prosurvival oncoprotein, AKT, through PI3K. In this study, we discovered that 2-DG treatments disrupted the binding between insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP3) so that the free form of IGF-1 could be released from the IGF-1.IGFBP3 complex to activate IGF-1 receptor (IGF1R) signaling. Because IGF1R signaling is involved, PI3K/AKT constitutes only one of the prosurvival pathways that are activated by 2-DG treatment; we validated that MEK-ERK signaling was also induced in an IGF1R-dependent manner in some cancer cell lines. Furthermore, our phospho-specific antibody microarray analysis indicated that 2-DG up-regulated the phosphorylation of 64 sites within various signaling pathways in H460 cells. Chemical inhibition of IGF1R reduced 57 of these up-regulations. These data suggest that 2-DG-induced activation of many survival pathways can be jointly attenuated through IGF1R inhibition. Our in vitro analysis demonstrated that treatment with a combination of subtoxic doses of 2-DG and the IGF1R inhibitor II reduced cancer cell proliferation 90% and promoted significant apoptosis.	[Zhong, Diansheng; Liu, Tongrui; Liu, Xiuju; Liu, Xiangguo; Chen, Jing; Sun, Shi-Yong; Khuri, Fadlo R.; Zhou, Wei] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xiong, Li] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Zhou, Wei] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Zhou, Wei] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Zhong, Diansheng; Zhou, Qinghua] Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Envi, Tianjin 300052, Peoples R China; [Zong, Yaping] Full Moon Biosyst Inc, Sunnyvale, CA 94085 USA	Emory University; Emory University; Emory University; Emory University; Tianjin Medical University	Zhou, W (corresponding author), 1365 Clifton Rd NE,Ste C4084, Atlanta, GA 30322 USA.	wzhou2@emory.edu	Liu, Xiangguo/G-1091-2010; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Xiong, Li/0000-0001-7354-0428; Liu, Xiangguo/0000-0002-1879-3817	National Institutes of Health [PO1 CA116676-030002, RO1 CA118470-01]; NATIONAL CANCER INSTITUTE [P01CA116676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grants PO1 CA116676-030002 (to W.Z.) and RO1 CA118470-01 (to S.-Y. S.) from NCI.	Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Chang YS, 2004, ONCOGENE, V23, P6569, DOI 10.1038/sj.onc.1207882; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; KARCZMAR GS, 1992, CANCER RES, V52, P71; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; MCCOMB RB, 1964, CANCER RES, V24, P198; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; SRIDHAR R, 1979, IN VITRO CELL DEV B, V15, P685; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559	24	86	89	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23225	23233		10.1074/jbc.M109.005280	http://dx.doi.org/10.1074/jbc.M109.005280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574224	Green Published, hybrid			2022-12-25	WOS:000269180000007
J	Hainzl, O; Lapina, MC; Buchner, J; Richter, K				Hainzl, Otmar; Lapina, Maria Claribel; Buchner, Johannes; Richter, Klaus			The Charged Linker Region Is an Important Regulator of Hsp90 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP90; N-TERMINAL DOMAIN; ATPASE CYCLE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; STEROID-RECEPTOR; CLIENT PROTEIN; YEAST; HYDROLYSIS	Hsp90 is an ATP-dependent molecular chaperone which assists the maturation of a large set of target proteins. Members of the highly conserved Hsp90 family are found from bacteria to higher eukaryotes, with homologues in different organelles. The core architecture of Hsp90 is defined by the N-terminal ATP binding domain followed by the middle domain and the C-terminal dimerization domain. A long, highly charged linker between the N-terminal domain and the middle domain is a feature characteristic for Hsp90s of eukaryotic organisms. We set out to clarify the function of this linker by studying the effects of deletions in this region in vivo and in vitro. Here we show that increasing deletions in the charged linker region lead to defects ranging from mild temperature sensitivity to a lethal phenotype. The lethal deletion variants investigated in this study still exhibit ATPase activity. Deletion of the charged linker ultimately causes a loss of Hsp90 regulation by co-chaperones, as the sensitivity for Aha1-mediated ATPase acceleration declines, and binding of p23/Sba1 is lost in non-viable deletion constructs. In vivo client assays additionally demonstrated that the deletion of the linker had a pronounced effect on the ability of Hsp90 to facilitate client activation. A partial reconstruction of the linker sequence showed that the supplementation by artificial sequences can rescue the functionality of Hsp90 and restore the conformational flexibility of the protein, required for the processing of client proteins.	[Buchner, Johannes] Tech Univ Munich, Ctr Integrated Prot Sci, D-85747 Garching, Germany; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich; Technical University of Munich	Buchner, J (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@ch.tum.de	Richter, Klaus/A-2673-2010; Buchner, Johannes/A-2651-2010	Richter, Klaus/0000-0002-8952-9642; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie (to J. B. and K. R.).	Ahner A, 2005, ARCH BIOCHEM BIOPHYS, V435, P32, DOI 10.1016/j.abb.2004.11.005; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brodsky JL, 1998, BIOCHEMISTRY-US, V37, P18045, DOI 10.1021/bi980900g; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; FARRELLY FW, 1984, J BIOL CHEM, V259, P5745; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109	55	106	107	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22559	22567		10.1074/jbc.M109.031658	http://dx.doi.org/10.1074/jbc.M109.031658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553666	Green Published, hybrid			2022-12-25	WOS:000268963100009
J	Wang, YF; Rathinam, R; Walch, A; Alahari, SK				Wang, Yanfang; Rathinam, Rajamani; Walch, Amelia; Alahari, Suresh K.			ST14 (Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MICRORNA EXPRESSION PROFILES; MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; OVARIAN-CANCER; METASTASIS; INVASION; PROTEIN; PROGNOSIS	MicroRNAs are noncoding, endogenous small RNAs that regulate target genes by cleavage of the targeted mRNA or translational repression. We investigated the microRNA-ome using 2-color microarrays in a highly invasive human breast cancer cell line, MDA-MB-231 (subline 4175) and a noninvasive breast epithelial cell line, MCF10A. We found 13 microRNAs that were up-regulated, and nine were down-regulated significantly in 4175 cells (p < 0.05, -fold change > 2) compared with MCF10A cells. Interestingly, miR-27b and its putative target gene, ST14 (suppressor of tumorigenicity 14), had inverse expression pattern in breast cancer cells. The 3'-untranslated region of ST14 contains a regulatory element for miR-27b, and our luciferase experiments indicate that antisense miR-27b enhances ST14 expression in cancer cells. Furthermore, antagomir of miR-27b suppressed cell invasion in 4175 cells, whereas pre-miR-27b stimulated invasion in moderately invasive ZR75 breast cancer cells. In addition, ST14 reduces cell proliferation as well as cell migration and invasion. Analysis of human breast tumors revealed that miR-27b expression increases during cancer progression, paralleling a decrease in ST14 expression. Furthermore, our data indicate that ST14 inhibits cells from entering into S phase by up-regulating p27, which results in down-regulation of cyclin E-CDK2 complexes, suggesting ST14 reduces cell growth through its effects on cell cycle-related proteins. Introduction of miR-27b into ST14-expressing cells did not suppress the effect on cell growth. These findings suggest that ST14 plays an important role in several biological processes, and some effects are not completely dependent on miR-27b regulation.	[Wang, Yanfang; Rathinam, Rajamani; Walch, Amelia; Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Alahari, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu			National Institutes of Health [CA 115706]; National Institutes of Health COBRE [RR078766]; Louisiana Board of Regents [LEQSF-RD-A-14]; Louisiana Cancer Research Consortium;  [BCTR0600278]; NATIONAL CANCER INSTITUTE [R01CA115706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; Louisiana Cancer Research Consortium; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 115706 and National Institutes of Health COBRE Grant RR078766. This work was also supported by Susan Komen Grant BCTR0600278, Louisiana Board of Regents Grant LEQSF-RD-A-14, and funds from Louisiana Cancer Research Consortium (to S. K. A.).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; DeGregori J, 2006, MOL CELL BIOL, V26, P1165, DOI 10.1128/MCB.26.4.1165-1169.2006; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hwang ES, 2009, EXP BIOL MED, V234, P105, DOI 10.3181/0806-RM-190; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Parr C, 2007, CLIN CANCER RES, V13, P3568, DOI 10.1158/1078-0432.CCR-06-2357; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sun Li-feng, 2004, Zhonghua Yi Xue Za Zhi, V84, P843; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Tsui KH, 2008, ANTICANCER RES, V28, P1993; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang Y, 1998, CYTOGENET CELL GENET, V83, P56, DOI 10.1159/000015125; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	78	82	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23094	23106		10.1074/jbc.M109.012617	http://dx.doi.org/10.1074/jbc.M109.012617			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546220	hybrid, Green Published			2022-12-25	WOS:000268963100061
J	Vitour, D; Dabo, S; Pour, MA; Vilasco, M; Vidalain, PO; Jacob, Y; Mezel-Lemoine, M; Paz, S; Arguello, M; Lin, R; Tangy, F; Hiscott, J; Meurs, EF				Vitour, Damien; Dabo, Stephanie; Pour, Malek Ahmadi; Vilasco, Myriam; Vidalain, Pierre-Olivier; Jacob, Yves; Mezel-Lemoine, Mariana; Paz, Suzanne; Arguello, Meztli; Lin, Rongtuan; Tangy, Frederic; Hiscott, John; Meurs, Eliane F.			Polo-like Kinase 1 (PLK1) Regulates Interferon (IFN) Induction by MAVS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; KAPPA-B KINASE; RIG-I; BOX DOMAIN; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; IKK-EPSILON; HELICASE; CANCER; RECOGNITION	The mitochondria-bound adapter MAVS participates in IFN induction by recruitment of downstream partners such as members of the TRAF family, leading to activation of NF-kappa B, and the IRF3 pathways. A yeast two-hybrid search for MAVS-interacting proteins yielded the Polo-box domain (PBD) of the mitotic Polo-like kinase PLK1. We showed that PBD associates with two different domains of MAVS in both dependent and independent phosphorylation events. The phosphodependent association requires the phosphopeptide binding ability of PBD. It takes place downstream of the proline-rich domain of MAVS, within an STP motif, characteristic of the binding of PLK1 to its targets, where the central Thr(234) residue is phosphorylated. Its phosphoindependent association takes place at the C terminus of MAVS. PLK1 strongly inhibits the ability of MAVS to activate the IRF3 and NF-kappa B pathways and to induce IFN. Reciprocally, depletion of PLK1 can increase IFN induction in response to RIG-I/SeV or RIG-I/poly(I)-poly(C) treatments. This inhibition is dependent on the phosphoindependent association of PBD at the C terminus of MAVS where it disrupts the association of MAVS with its downstream partner TRAF3. IFN induction was strongly inhibited in cells arrested in G2/M by nocodazole, which provokes increased expression of endogenous PLK1. Interestingly, depletion of PLK1 from these nocodazole-treated cells could restore, at least partially, IFN induction. Altogether, these data demonstrate a new function for PLK1 as a regulator of IFN induction and provide the basis for the development of inhibitors preventing the PLK1/MAVS association to sustain innate immunity.	[Vitour, Damien; Dabo, Stephanie; Pour, Malek Ahmadi; Vilasco, Myriam; Meurs, Eliane F.] Inst Pasteur, Unit Hepacivirus & Innate Immun, F-75015 Paris, France; [Vidalain, Pierre-Olivier; Mezel-Lemoine, Mariana; Tangy, Frederic; Meurs, Eliane F.] Inst Pasteur, Lab Viral Genom & Vaccinat, F-75015 Paris, France; [Jacob, Yves] Inst Pasteur, Unit Genet Papillomavirus & Human Canc, F-75015 Paris, France; [Paz, Suzanne; Arguello, Meztli; Lin, Rongtuan; Hiscott, John] McGill Univ, Lady Davis Inst Med Res, Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Lady Davis Institute; McGill University	Meurs, EF (corresponding author), Inst Pasteur, 28 Rue Dr Roux, F-75724 Paris 15, France.	eliane.meurs@pasteur.fr	Vidalain, Pierre-Olivier/F-9778-2019; Lin, Rongtuan/A-1442-2008	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Lin, Rongtuan/0000-0002-2238-3503; Jacob, Yves/0000-0001-9125-2374; Paz, Suzanne/0000-0002-0465-7144	Research Transversal Program; Pasteur Institute; Agence Nationale pour la Recherche contre le SIDA (ANRS)	Research Transversal Program; Pasteur Institute; Agence Nationale pour la Recherche contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported in part by grants from a Research Transversal Program (186), from the Pasteur Institute, and by the Agence Nationale pour la Recherche contre le SIDA (ANRS) (to E. F. M.).	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bostik P, 2004, J VIROL, V78, P1464, DOI 10.1128/JVI.78.3.1464-1472.2004; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Chang F, 2004, MOL BIOL CELL, V15, P1793, DOI 10.1091/mbc.E03-09-0691; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; DICKSON RB, 1986, CANCER RES, V46, P1707; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Patel D, 2004, CANCER RES, V64, P1299, DOI 10.1158/0008-5472.CAN-03-2917; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Reagan-Shaw S, 2005, FASEB J, V19, P611, DOI 10.1096/fj.04-2910fje; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Spankuch B, 2007, ONCOGENE, V26, P5793, DOI 10.1038/sj.onc.1210355; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Vilasco M, 2006, HEPATOLOGY, V44, P1635, DOI 10.1002/hep.21432; VITOUR D, 2007, SCI STKE, pPE20, DOI DOI 10.1126/STKE.38442007PE20; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	57	72	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21797	21809		10.1074/jbc.M109.018275	http://dx.doi.org/10.1074/jbc.M109.018275			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546225	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000268783700004
J	Poffenberger, MC; Straka, N; El Warry, N; Fang, D; Shanina, I; Horwitz, MS				Poffenberger, Maya C.; Straka, Nadine; El Warry, Nahida; Fang, Dianne; Shanina, Iryna; Horwitz, Marc S.			Lack of IL-6 during Coxsackievirus Infection Heightens the Early Immune Response Resulting in Increased Severity of Chronic Autoimmune Myocarditis	PLOS ONE			English	Article								Background: Chronic myocarditis is often initiated by viral infection, the most common of which is coxsackievirus infection. The precise mechanism by which viral infection leads to chronic autoimmune pathology is poorly understood, however it is clear that the early immune response plays a critical role. Previous results have shown that the inflammatory cytokine interleukin (IL)-6 is integral to the development of experimental-induced autoimmune myocarditis. However, the function of IL-6 during viral-mediated autoimmunity has yet to be elucidated. Methods and Results: To address the requirement of IL-6 during disease induction, IL-6 deficient mice were infected with coxsackievirus B3 (CB3). Following infection, mice lacking IL-6 developed increased chronic autoimmune disease pathology compared to wild type controls without a corresponding change in the level of viral replication in the heart. This increase in disease severity was accompanied by elevated levels of TNF-alpha, MCP-1, IL-10, activated T cells and cardiac infiltrating macrophage/monocytes. Injection of recombinant IL-6 early following infection in the IL-6 deficient mice was sufficient to lower the serum cytokines TNF-alpha and IL-10 as well as the serum chemokines MCP-1, MIP-1 beta, RANTES and MIG with a corresponding decrease in the chronic disease pathology strongly suggests an important regulatory role for IL-6 during the early response. Conclusions: While IL-6 plays a pathogenic role in experimental-induced autoimmune disease, its function following viral-induced autoimmunity is not reprised. By regulating the early immune response and thereby controlling the severity of chronic disease, IL-6 directs the outcome of chronic autoimmune myocarditis.			Poffenberger, MC (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	mhorwitz@interchange.ubc.ca						Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Bettelli E, 2003, J AUTOIMMUN, V20, P265, DOI 10.1016/S0896-8411(03)00048-9; Betti M, 2006, ANN ONCOL, V17, P235; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; BROWN CA, 1995, AM J MED, V99, P309, DOI 10.1016/S0002-9343(99)80164-8; Calabrese F, 2004, MODERN PATHOL, V17, P1108, DOI 10.1038/modpathol.3800158; Deng CS, 2002, J IMMUNOL, V169, P1077, DOI 10.4049/jimmunol.169.2.1077; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Girndt M, 2003, NEPHROL DIAL TRANSPL, V18, P1976, DOI 10.1093/ndt/gfg311; Gluck B, 2001, J MOL CELL CARDIOL, V33, P1615, DOI 10.1006/jmcc.2001.1416; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Hofmann P, 2001, J MED VIROL, V64, P487, DOI 10.1002/jmv.1076; Horwitz MS, 2000, NAT MED, V6, P693, DOI 10.1038/76277; Kanda T, 2004, JPN HEART J, V45, P183, DOI 10.1536/jhj.45.183; Kanda T, 1996, CIRC RES, V78, P848, DOI 10.1161/01.RES.78.5.848; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1995, ANN NY ACAD SCI, V762, P308; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kubota T, 1997, J Card Fail, V3, P117, DOI 10.1016/S1071-9164(97)90045-2; LANE JR, 1992, J EXP MED, V175, P1123, DOI 10.1084/jem.175.4.1123; LANE JR, 1991, CELL IMMUNOL, V136, P219, DOI 10.1016/0008-8749(91)90396-S; Nishii M, 2004, J AM COLL CARDIOL, V44, P1292, DOI 10.1016/j.jacc.2004.01.055; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Richer MJ, 2007, FUTURE VIROL, V2, P283, DOI 10.2217/17460794.2.3.283; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SCHMITT M, 2000, PATIENT CARE NURSE P, V3, P61; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Tanaka T, 2001, J MOL CELL CARDIOL, V33, P1627, DOI 10.1006/jmcc.2001.1428; Watanabe K, 2001, CIRCULATION, V104, P1098, DOI 10.1161/hc3501.096190; Yajima T, 2006, CIRCULATION, V114, P2364, DOI 10.1161/CIRCULATIONAHA.106.642454; Zhao HF, 2005, GUT, V54, P1759, DOI 10.1136/gut.2004.049403	36	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6207	10.1371/journal.pone.0006207	http://dx.doi.org/10.1371/journal.pone.0006207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587788	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035100018
J	Semmens, BX; Ward, EJ; Moore, JW; Darimont, CT				Semmens, Brice X.; Ward, Eric J.; Moore, Jonathan W.; Darimont, Chris T.			Quantifying Inter- and Intra-Population Niche Variability Using Hierarchical Bayesian Stable Isotope Mixing Models	PLOS ONE			English	Article							WIDTH; DELTA-C-13; ECOLOGY; UNCERTAINTY; DIMORPHISM; DIVERSITY; EVOLUTION; MARINE; RATIOS; PREY	Variability in resource use defines the width of a trophic niche occupied by a population. Intra-population variability in resource use may occur across hierarchical levels of population structure from individuals to subpopulations. Understanding how levels of population organization contribute to population niche width is critical to ecology and evolution. Here we describe a hierarchical stable isotope mixing model that can simultaneously estimate both the prey composition of a consumer diet and the diet variability among individuals and across levels of population organization. By explicitly estimating variance components for multiple scales, the model can deconstruct the niche width of a consumer population into relevant levels of population structure. We apply this new approach to stable isotope data from a population of gray wolves from coastal British Columbia, and show support for extensive intra-population niche variability among individuals, social groups, and geographically isolated subpopulations. The analytic method we describe improves mixing models by accounting for diet variability, and improves isotope niche width analysis by quantitatively assessing the contribution of levels of organization to the niche width of a population.			Semmens, BX (corresponding author), Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA USA.	Brice.Semmens@noaa.gov	Bond, Alexander L/A-3786-2010					Aitchison J, 1986, STAT ANAL COMPOSITIO; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BEST N, 1995, CODA MANUAL VERSION; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Darimont CT, 2004, J BIOGEOGR, V31, P1867, DOI 10.1111/j.1365-2699.2004.01141.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Egozcue JJ, 2006, GEOL SOC SPEC PUBL, V264, P145, DOI 10.1144/GSL.SP.2006.264.01.11; Elton C. S., 1927, ANIMAL ECOLOGY; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; FRY B, 1978, ECOLOGY, V59, P498, DOI 10.2307/1936580; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Giraldeau L.A., 2000, MG BEH ECOL; GOSSCUSTARD JD, 1984, J ANIM ECOL, V53, P233, DOI 10.2307/4354; HUTCHINSON GE, 1957, S QUANTITATIVE BIOL, P415; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Plummer M., 2003, P 3 INT WORKSH DISTR; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; Reimchen TE, 2008, BEHAVIOUR, V145, P561, DOI 10.1163/156853908792451449; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Roughgarden J., 1979, THEORY POPULATION GE; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	49	162	162	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6187	10.1371/journal.pone.0006187	http://dx.doi.org/10.1371/journal.pone.0006187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587790	Green Published, gold			2022-12-25	WOS:000268035100011
J	Waite, AL; Schaner, P; Richards, N; Balci-Peynircioglu, B; Masters, SL; Brydges, SD; Fox, M; Hong, A; Yilmaz, E; Kastner, DL; Reinherz, EL; Gumucio, DL				Waite, Andrea L.; Schaner, Philip; Richards, Neil; Balci-Peynircioglu, Banu; Masters, Seth L.; Brydges, Susannah D.; Fox, Michelle; Hong, Arthur; Yilmaz, Engin; Kastner, Daniel L.; Reinherz, Ellis L.; Gumucio, Deborah L.			Pyrin Modulates the Intracellular Distribution of PSTPIP1	PLOS ONE			English	Article								PSTPIP1 is a cytoskeleton-associated adaptor protein that links PEST-type phosphatases to their substrates. Mutations in PSTPIP1 cause PAPA syndrome (Pyogenic sterile Arthritis, Pyoderma gangrenosum, and Acne), an autoinflammatory disease. PSTPIP1 binds to pyrin and mutations in pyrin result in familial Mediterranean fever (FMF), a related autoinflammatory disorder. Since disease-associated mutations in PSTPIP1 enhance pyrin binding, PAPA syndrome and FMF are thought to share a common pathoetiology. The studies outlined here describe several new aspects of PSTPIP1 and pyrin biology. We document that PSTPIP1, which has homology to membrane-deforming BAR proteins, forms homodimers and generates membrane-associated filaments in native and transfected cells. An extended FCH (Fes-Cip4 homology) domain in PSTPIP1 is necessary and sufficient for its self-aggregation. We further show that the PSTPIP1 filament network is dependent upon an intact tubulin cytoskeleton and that the distribution of this network can be modulated by pyrin, indicating that this is a dynamic structure. Finally, we demonstrate that pyrin can recruit PSTPIP1 into aggregations (specks) of ASC, another pyrin binding protein. ASC specks are associated with inflammasome activity. PSTPIP1 molecules with PAPA-associated mutations are recruited by pyrin to ASC specks with particularly high efficiency, suggesting a unique mechanism underlying the robust inflammatory phenotype of PAPA syndrome.			Waite, AL (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dgumucio@umich.edu	YILMAZ, ENGIN/I-8278-2013; Masters, Seth L/N-2886-2013; PEYNIRCIOGLU, BANU/I-8337-2013; YILMAZ, Engin/W-4160-2018	Masters, Seth L/0000-0003-4763-576X; YILMAZ, Engin/0000-0001-8873-7645; Hong, Arthur/0000-0001-6516-6819	NHLBI NIH HHS [T32-HL07505] Funding Source: Medline; NIAID NIH HHS [R01- AI053262, R01 AI053262] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALCIPEYNIRCIOG.B, 2008, J CELL PHYSL; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Golla A, 2002, EUR J HUM GENET, V10, P217, DOI 10.1038/sj.ejhg.5200789; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Meunier B, 2009, EUR J CELL BIOL, V88, P91, DOI 10.1016/j.ejcb.2008.08.006; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Ryan JG, 2008, CURR TOP MICROBIOL, V321, P169; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Wu Y, 1998, J BIOL CHEM, V273, P30487, DOI 10.1074/jbc.273.46.30487; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Yeung YG, 1998, J BIOL CHEM, V273, P30638, DOI 10.1074/jbc.273.46.30638; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; NAT GENET, V17, P25; CELL, V90, P797	37	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6147	10.1371/journal.pone.0006147	http://dx.doi.org/10.1371/journal.pone.0006147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584923	Green Published, gold			2022-12-25	WOS:000267806400004
J	Kock, I; Bulgakova, NA; Knust, E; Sinning, I; Panneels, V				Kock, Ines; Bulgakova, Natalia A.; Knust, Elisabeth; Sinning, Irmgard; Panneels, Valerie			Targeting of Drosophila Rhodopsin Requires Helix 8 but Not the Distal C-Terminus	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; POST-GOLGI TRAFFICKING; CRYSTAL-STRUCTURE; PROTEIN; RECEPTOR; MORPHOGENESIS; MUTATIONS; TRANSPORT; GENE; PHOTOTRANSDUCTION	Background: The fundamental role of the light receptor rhodopsin in visual function and photoreceptor cell development has been widely studied. Proper trafficking of rhodopsin to the photoreceptor membrane is of great importance. In human, mutations in rhodopsin involving its intracellular mislocalization, are the most frequent cause of autosomal dominant Retinitis Pigmentosa, a degenerative retinal pathology characterized by progressive blindness. Drosophila is widely used as an animal model in visual and retinal degeneration research. So far, little is known about the requirements for proper rhodopsin targeting in Drosophila. Methodology/Principal Findings: Different truncated fly-rhodopsin Rh1 variants were expressed in the eyes of Drosophila and their localization was analyzed in vivo or by immunofluorescence. A mutant lacking the last 23 amino acids was found to properly localize in the rhabdomeres, the light-sensing organelle of the photoreceptor cells. This constitutes a major difference to trafficking in vertebrates, which involves a conserved QVxPA motif at the very C-terminus. Further truncations of Rh1 indicated that proper localization requires the last amino acid residues of a region called helix 8 following directly the last transmembrane domain. Interestingly, the very C-terminus of invertebrate visual rhodopsins is extremely variable but helix 8 shows conserved amino acid residues that are not conserved in vertebrate homologs. Conclusions/Significance: Despite impressive similarities in the folding and photoactivation of vertebrate and invertebrate visual rhodopsins, a striking difference exists between mammalian and fly rhodopsins in their requirements for proper targeting. Most importantly, the distal part of helix 8 plays a central role in invertebrates. Since the last amino acid residues of helix 8 are dispensable for rhodopsin folding and function, we propose that this domain participates in the recognition of targeting factors involved in transport to the rhabdomeres.			Kock, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, INF328, Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Knust, Elisabeth/B-4338-2017; Sinning, Irmgard/A-2982-2010	Panneels, Valerie/0000-0001-8899-3366; Bulgakova, Natalia/0000-0002-3780-8164				Ahmad ST, 2007, FASEB J, V21, P449, DOI 10.1096/fj.06-6530com; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arendt D, 2003, INT J DEV BIOL, V47, P563; Bentrop J, 2003, COMP SER PHOTOCHEM, V3, P40; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Deretic D, 1998, EYE, V12, P526, DOI 10.1038/eye.1998.141; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Lehmann N, 2007, J MOL BIOL, V366, P1129, DOI 10.1016/j.jmb.2006.11.098; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pichaud F, 2001, DEVELOPMENT, V128, P815; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Voie AM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P510; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WEISS ER, 1994, BIOCHEMISTRY-US, V33, P7587, DOI 10.1021/bi00190a011; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6101	10.1371/journal.pone.0006101	http://dx.doi.org/10.1371/journal.pone.0006101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572012	Green Accepted, Green Published, gold			2022-12-25	WOS:000267806200001
J	Aceves-Luquero, CI; Agarwal, A; Callejas-Valera, JL; Arias-Gonzalez, L; Esparis-Ogando, A; Ovalle, LD; Bellon-Echeverria, I; de la Cruz-Morcillo, MA; Moya, EMG; Gimeno, IM; Gomez, JC; Deininger, MW; Pandiella, A; Prieto, RS				Aceves-Luquero, Clara I.; Agarwal, Anupriya; Callejas-Valera, Juan L.; Arias-Gonzalez, Laura; Esparis-Ogando, Azucena; del Peso Ovalle, Luis; Bellon-Echeverria, Itxaso; de la Cruz-Morcillo, Miguel A.; Galan Moya, Eva M.; Moreno Gimeno, Inmaculada; Gomez, Juan C.; Deininger, Michael W.; Pandiella, Atanasio; Sanchez Prieto, Ricardo			ERK2, but Not ERK1, Mediates Acquired and "De novo" Resistance to Imatinib Mesylate: Implication for CML Therapy	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE DOMAIN MUTATIONS; ABL TYROSINE KINASE; BCR-ABL; JAK/STAT PATHWAYS; INHIBITOR STI571; ACTIVATION; CELLS; BCR/ABL; APOPTOSIS	Resistance to Imatinib Mesylate (IM) is a major problem in Chronic Myelogenous Leukaemia management. Most of the studies about resistance have focused on point mutations on BCR/ABL. However, other types of resistance that do not imply mutations in BCR/ABL have been also described. In the present report we aim to study the role of several MAPK in IM resistance not associate to BCR/ABL mutations. Therefore we used an experimental system of resistant cell lines generated by co-culturing with IM (K562, Lama 84) as well as primary material from resistant and responder patient without BCR/ABL mutations. Here we demonstrate that Erk5 and p38MAPK signaling pathways are not implicated in the acquired resistance phenotype. However, Erk2, but not Erk1, is critical for the acquired resistance to IM. In fact, Bcr/Abl activates preferentially Erk2 in transient transfection in a dose dependent fashion through the c-Abl part of the chimeric protein. Finally, we present evidences demonstrating how constitutive activation of Erk2 is a de novo mechanism of resistance to IM. In summary our data support the use of therapeutic approaches based on Erk2 inhibition, which could be added to the therapeutic armamentarium to fight CML, especially when IM resistance develops secondary to Erk2 activation.	[Aceves-Luquero, Clara I.; Callejas-Valera, Juan L.; Arias-Gonzalez, Laura; Bellon-Echeverria, Itxaso; de la Cruz-Morcillo, Miguel A.; Galan Moya, Eva M.; Moreno Gimeno, Inmaculada; Gomez, Juan C.; Sanchez Prieto, Ricardo] UCLM, Fac Med, CRIB, Albacete, Spain; [Agarwal, Anupriya; Deininger, Michael W.] Oregon Hlth & Sci Univ, Inst Canc, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Esparis-Ogando, Azucena; Pandiella, Atanasio] CSIC USAL, Inst Biol Mol & Celular Canc, Salamanca, Spain; [del Peso Ovalle, Luis] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain	Universidad de Castilla-La Mancha; Oregon Health & Science University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Autonomous University of Madrid	Aceves-Luquero, CI (corresponding author), UCLM, Fac Med, CRIB, Albacete, Spain.	ricardo.sanchez@uclm.es	Pandiella, Atanasio/O-5180-2014; Sanchez-Prieto, Ricardo/AAY-4271-2021; Esparís-Ogando, Aucena/O-5326-2017; Galan-Moya, Eva M/I-2912-2015; Sanchez-Prieto, Ricardo/B-6877-2008; 2009, Secribsal/A-1266-2012; Prieto, Ricardo/AAZ-7221-2021; del Peso, Luis/K-9391-2014; Moreno, Inmaculada/D-3955-2018; Arias-González, Laura/D-9517-2016; Romo, José A./J-3024-2012	Pandiella, Atanasio/0000-0002-4704-8971; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Esparís-Ogando, Aucena/0000-0003-4550-4192; Galan-Moya, Eva M/0000-0001-5758-7592; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; del Peso, Luis/0000-0003-4014-5688; Moreno, Inmaculada/0000-0001-6910-7509; Arias-González, Laura/0000-0003-2132-9350; Romo, José A./0000-0003-2907-580X; Bellon-Echeverria, Itxaso/0000-0002-3135-8799; de la Cruz-Morcillo, Miguel Angel/0000-0002-6674-1333				AGARWAL A, 2008, LEUKEMIA; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Barnes DJ, 2005, ONCOGENE, V24, P6432, DOI 10.1038/sj.onc.1208796; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Buschbeck M, 2005, EMBO REP, V6, P63, DOI 10.1038/sj.embor.7400316; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dan S, 1998, CELL DEATH DIFFER, V5, P710, DOI 10.1038/sj.cdd.4400400; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; GAIGER A, 1995, BLOOD, V86, P2371, DOI 10.1182/blood.V86.6.2371.bloodjournal8662371; Galan-Moya EM, 2008, INT J CANCER, V122, P289, DOI 10.1002/ijc.23063; Garicochea B, 1998, LEUKEMIA RES, V22, P1003, DOI 10.1016/S0145-2126(98)00076-9; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HWANG CY, 2009, MOL CELL BIOL; Konig H, 2008, LEUKEMIA, V22, P748, DOI 10.1038/sj.leu.2405086; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lahaye T, 2005, CANCER-AM CANCER SOC, V103, P1659, DOI 10.1002/cncr.20922; Lange T, 2005, CELL CYCLE, V4, P1761, DOI 10.4161/cc.4.12.2261; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; LIU E, 1988, P NATL ACAD SCI USA, V85, P1952, DOI 10.1073/pnas.85.6.1952; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Martinelli G, 2005, LEUKEMIA, V19, P1872, DOI 10.1038/sj.leu.2403950; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; MONTIELDUARTE C, 2007, LEUK RES; Morinaga K, 2008, INT J CANCER, V122, P2621, DOI 10.1002/ijc.23435; Nguyen TK, 2007, BLOOD, V109, P4006, DOI 10.1182/blood-2006-09-045039; O'Hare T, 2007, CLIN LYMPHOMA MYELOM, V7, pS120, DOI 10.3816/CLM.2007.s.012; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sanchez-Arevalo LV, 2005, BIOCH J 1, V387, P231; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Sherbenou DW, 2007, LEUKEMIA, V21, P489, DOI 10.1038/sj.leu.2404554; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wong S, 2003, BLOOD, V101, P4088, DOI 10.1182/blood-2002-11-3376; Yu CR, 2002, CANCER RES, V62, P188	51	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6124	10.1371/journal.pone.0006124	http://dx.doi.org/10.1371/journal.pone.0006124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568437	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200022
J	Ackbarow, T; Sen, D; Thaulow, C; Buehler, MJ				Ackbarow, Theodor; Sen, Dipanjan; Thaulow, Christian; Buehler, Markus J.			Alpha-Helical Protein Networks Are Self-Protective and Flaw-Tolerant	PLOS ONE			English	Article								Alpha-helix based protein networks as they appear in intermediate filaments in the cell's cytoskeleton and the nuclear membrane robustly withstand large deformation of up to several hundred percent strain, despite the presence of structural imperfections or flaws. This performance is not achieved by most synthetic materials, which typically fail at much smaller deformation and show a great sensitivity to the existence of structural flaws. Here we report a series of molecular dynamics simulations with a simple coarse-grained multi-scale model of alpha-helical protein domains, explaining the structural and mechanistic basis for this observed behavior. We find that the characteristic properties of alpha-helix based protein networks are due to the particular nanomechanical properties of their protein constituents, enabling the formation of large dissipative yield regions around structural flaws, effectively protecting the protein network against catastrophic failure. We show that the key for these self protecting properties is a geometric transformation of the crack shape that significantly reduces the stress concentration at corners. Specifically, our analysis demonstrates that the failure strain of alpha-helix based protein networks is insensitive to the presence of structural flaws in the protein network, only marginally affecting their overall strength. Our findings may help to explain the ability of cells to undergo large deformation without catastrophic failure while providing significant mechanical resistance.			Ackbarow, T (corresponding author), MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbuehler@mit.edu	Buehler, Markus J./C-4580-2008	Buehler, Markus J./0000-0002-4173-9659				Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ackbarow T, 2007, J MATER SCI, V42, P8771, DOI 10.1007/s10853-007-1719-2; Ackbarow T, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/035111; AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; BUEHLER M, J ENG MECH ASCE, V135, P422; Buehler MJ, 2008, NANO RES, V1, P63, DOI 10.1007/s12274-008-8006-7; Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002; Buehler MJ, 2007, J MECH MATER STRUCT, V2, P1019, DOI 10.2140/jomms.2007.2.1019; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Buehler MJ, 2003, NATURE, V426, P141, DOI 10.1038/nature02096; BUEHLER MJ, 2007, PHYS REV LETT, V99; COURTNEY TH, 1990, MECH BEHAV MAT; Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Fantner GE, 2006, BIOPHYS J, V90, P1411, DOI 10.1529/biophysj.105.069344; Fantner GE, 2007, NANO LETT, V7, P2491, DOI 10.1021/nl0712769; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; GENT AN, 1991, J MATER SCI, V26, P3392, DOI 10.1007/BF01124691; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kageshima M, 2001, CHEM PHYS LETT, V343, P77, DOI 10.1016/S0009-2614(01)00678-9; Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lantz MA, 1999, CHEM PHYS LETT, V315, P61, DOI 10.1016/S0009-2614(99)01201-4; Lawn P.R, 1993, CAMBRIDGE SOLID STAT, Vsecond; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pugno NM, 2004, PHILOS MAG, V84, P2829, DOI 10.1080/14786430412331280382; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; TSAI DH, 1979, J CHEM PHYS, V70, P1375, DOI 10.1063/1.437577; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; Wietz DA, 2008, P NATL ACAD SCI USA, V105, P1105, DOI 10.1073/pnas.0711639105	45	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6015	10.1371/journal.pone.0006015	http://dx.doi.org/10.1371/journal.pone.0006015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547709	gold, Green Published, Green Submitted			2022-12-25	WOS:000267347900012
J	Lopez, IA; Rosenblatt, MI; Kim, C; Galbraith, GC; Jones, SM; Kao, LY; Newman, D; Liu, WX; Yeh, S; Pushkin, A; Abuladze, N; Kurtz, I				Lopez, Ivan A.; Rosenblatt, Mark I.; Kim, Charles; Galbraith, Gary C.; Jones, Sherri M.; Kao, Liyo; Newman, Debra; Liu, Weixin; Yeh, Stacey; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira			Slc4a11 Gene Disruption in Mice CELLULAR TARGETS OF SENSORINEURONAL ABNORMALITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY ENDOTHELIAL DYSTROPHY; MOUSE MODEL; INNER-EAR; AUDITORY IMPAIRMENT; PERCEPTIVE DEAFNESS; CORNEAL-DYSTROPHY; HARBOYAN-SYNDROME; MUTATIONS; TRANSPORTER; GROWTH	NaBC1 (the SLC4A11 gene) belongs to the SLC4 family of sodium-coupled bicarbonate (carbonate) transporter proteins and functions as an electrogenic sodium borate cotransporter. Mutations in SLC4A11 cause either corneal abnormalities (corneal hereditary dystrophy type 2) or a combined auditory and visual impairment (Harboyan syndrome). The role of NaBC1 in sensory systems is poorly understood, given the difficulty of studying patients with NaBC1 mutations. We report our findings in Slc4a11(-/-) mice generated to investigate the role of NaBC1 in sensorineural systems. In wild-type mice, specific NaBC1 immunoreactivity was detected in fibrocytes of the spiral ligament, from the basal to the apical portion of the cochlea. NaBC1 immunoreactivity was present in the vestibular labyrinth, in stromal cells underneath the non-immunoreactive sensory epithelia of the macula utricle, sacule, and crista ampullaris, and the membranous vestibular labyrinth was collapsed. Both auditory brain response and vestibular evoked potential waveforms were significantly abnormal in Slc4a11(-/-) mice. In the cornea, NaBC1 was highly expressed in the endothelial cell layer with less staining in epithelial cells. However, unlike humans, the corneal phenotype was mild with a normal slit lamp evaluation. Corneal endothelial cells were morphologically normal; however, both the absolute height of the corneal basal epithelial cells and the relative basal epithelial cell/total corneal thickness were significantly increased in Slc4a11(-/-) mice. Our results demonstrate for the first time the importance of NaBC1 in the audio-vestibular system and provide support for the hypothesis that SLC4A11 should be considered a potential candidate gene in patients with isolated sensorineural vestibular hearing abnormalities.	[Kao, Liyo; Newman, Debra; Liu, Weixin; Yeh, Stacey; Pushkin, Alexander; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [Lopez, Ivan A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck, Los Angeles, CA 90095 USA; [Rosenblatt, Mark I.; Kim, Charles] Weill Cornell Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10021 USA; [Jones, Sherri M.] E Carolina Univ, Dept Commun Sci & Disorders, Greenville, NC 27858 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of North Carolina; East Carolina University	Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Room 7-155,Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ikurtz@mednet.UCLA.edu	Lopez, Ivan A/U-2177-2019; lopez, ivan/GSM-8495-2022	Lopez, Ivan A/0000-0001-5205-7293; 	National Institutes of Health [EY015829, EY019561, DC006443, DK077162, DK058563, DK063125]; NATIONAL EYE INSTITUTE [K08EY015829, R21EY019561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK063125, R01DK058563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants EY015829 and EY019561 (to M. R.); DC006443 (to S. J.); and DK077162, DK058563, and DK063125 (to I. K.)	Abramowicz MJ, 2002, J MED GENET, V39, P110, DOI 10.1136/jmg.39.2.110; Abuin A, 2007, Handb Exp Pharmacol, P129; Aldave AJ, 2007, CORNEA, V26, P896, DOI 10.1097/ICO.0b013e318074bb01; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Delprat B, 2005, MOL CELL BIOL, V25, P847, DOI 10.1128/MCB.25.2.847-853.2005; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Desir J, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-28; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; Gates P, 2005, INTERN MED J, V35, P488, DOI 10.1111/j.1445-5994.2005.00891.x; Handzel O, 2006, OTOL NEUROTOL, V27, P57, DOI 10.1097/01.mao.0000188658.36327.8f; Hemadevi B, 2008, ARCH OPHTHALMOL-CHIC, V126, P700, DOI 10.1001/archopht.126.5.700; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; HUANG CM, 1977, BRAIN RES, V137, P291; Ishiyama Gail, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P332, DOI 10.1097/01.moo.0000244191.51560.22; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Jones SM., 2008, BALANCE FUNCTION ASS, P379; Jones T.A., 2007, AUDITORY EVOKED POTE, P622; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kumar A, 2007, MOL VIS, V13, P39; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Lopez IA, 2005, DEV BRAIN RES, V160, P63, DOI 10.1016/j.devbrainres.2005.08.008; Magli A, 1997, OPHTHALMIC GENET, V18, P87, DOI 10.3109/13816819709057120; Megerian CA, 2008, HEARING RES, V237, P90, DOI 10.1016/j.heares.2008.01.002; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mizuta K, 2008, NEUROSCI LETT, V434, P104, DOI 10.1016/j.neulet.2008.01.036; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Park M, 2005, CELL CYCLE, V4, P24, DOI 10.4161/cc.4.1.1394; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; PEYMAN GA, 1977, A GRAEF ARCH KLIN EX, V201, P257, DOI 10.1007/BF02385183; Ping JL, 2007, J NEUROSCI METH, V161, P11, DOI 10.1016/j.jneumeth.2006.10.001; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramprasad Vedam L, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9487; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Sultana A, 2007, MOL VIS, V13, P1327; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; TUFT SJ, 1986, INVEST OPHTH VIS SCI, V27, P1199; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028	44	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26882	26896		10.1074/jbc.M109.008102	http://dx.doi.org/10.1074/jbc.M109.008102			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19586905	Green Published, hybrid			2022-12-25	WOS:000269969600069
J	Ferreira, P; Hernandez-Ortega, A; Herguedas, B; Martinez, AT; Medina, M				Ferreira, Patricia; Hernandez-Ortega, Aitor; Herguedas, Beatriz; Martinez, Angel T.; Medina, Milagros			Aryl-alcohol Oxidase Involved in Lignin Degradation A MECHANISTIC STUDY BASED ON STEADY AND PRE-STEADY STATE KINETICS AND PRIMARY AND SOLVENT ISOTOPE EFFECTS WITH TWO ALCOHOL SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTALLOGRAPHY REVEALS; FUNGUS PLEUROTUS-ERYNGII; GLUCOSE-OXIDASE; CHOLINE OXIDASE; CRYSTAL-STRUCTURE; CHOLESTEROL OXIDASE; CATALYTIC MECHANISM; ASPERGILLUS-NIGER; CELLOBIOSE DEHYDROGENASE; BETAINE-ALDEHYDE	Aryl-alcohol oxidase (AAO) is a FAD-containing enzyme in the GMC (glucose-methanol-choline oxidase) family of oxidoreductases. AAO participates in fungal degradation of lignin, a process of high ecological and biotechnological relevance, by providing the hydrogen peroxide required by ligninolytic peroxidases. In the Pleurotus species, this peroxide is generated in the redox cycling of p-anisaldehyde, an extracellular fungal metabolite. In addition to p-anisyl alcohol, the enzyme also oxidizes other polyunsaturated primary alcohols. Its reaction mechanism was investigated here using p-anisyl alcohol and 2,4-hexadien-1-ol as two AAO model substrates. Steady state kinetic parameters and enzyme-monitored turnover were consistent with a sequential mechanism in which O-2 reacts with reduced AAO before release of the aldehyde product. Pre-steady state analysis revealed that the AAO reductive half-reaction is essentially irreversible and rate limiting during catalysis. Substrate and solvent kinetic isotope effects under steady and presteady state conditions (the latter showing similar to 9-fold slower enzyme reduction when alpha-bideuterated substrates were used, and similar to 13-fold slower reduction when both substrate and solvent effects were simultaneously evaluated) revealed a synchronous mechanism in which hydride transfer from substrate alpha-carbon to FAD and proton abstraction from hydroxyl occur simultaneously. This significantly differs from the general mechanism proposed for other members of the GMC oxidoreductase family that implies hydride transfer from a previously stabilized substrate alkoxide.	[Martinez, Angel T.] CSIC, CIB, E-28040 Madrid, Spain; [Ferreira, Patricia; Herguedas, Beatriz; Medina, Milagros] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Ferreira, Patricia; Herguedas, Beatriz; Medina, Milagros] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, E-50009 Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Zaragoza; University of Zaragoza	Martinez, AT (corresponding author), CSIC, CIB, Ramiro Maeztu 9, E-28040 Madrid, Spain.	atmartinez@cib.csic.es; mmedina@unizar.es	Herguedas, Beatriz/AAB-8665-2022; Martínez, Angel T/G-7284-2017; Neila, Patricia Ferreira/Y-4803-2019; Medina, Milagros/F-8310-2012	Martínez, Angel T/0000-0002-1584-2863; Medina, Milagros/0000-0001-8743-0182; Ferreira Neila, Patricia/0000-0003-4076-6118; Herguedas, Beatriz/0000-0003-2044-4795	Spanish Projects [BIO2005-03569, BIO2007-65890-C02-01, BIO2008-01533]; BIORENEW Project of the European Union [NMP2-CT-2006-026456]	Spanish Projects(Spanish Government); BIORENEW Project of the European Union(European Commission)	This work was supported by the Spanish Projects BIO2005-03569, BIO2007-65890-C02-01, and BIO2008-01533, and the BIORENEW Project of the European Union (Contract NMP2-CT-2006-026456).	Bannwarth M, 2004, BIOCHEMISTRY-US, V43, P11683, DOI 10.1021/bi048609q; BRIGHT HJ, 1967, J BIOL CHEM, V242, P994; CLELAND WW, 1982, METHOD ENZYMOL, V87, P625; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Fan F, 2006, BIOCHEMISTRY-US, V45, P1979, DOI 10.1021/bi0517537; Ferreira P, 2005, BIOCHEM J, V389, P731, DOI 10.1042/BJ20041903; Ferreira P, 2006, FEBS J, V273, P4878, DOI 10.1111/j.1742-4658.2006.05488.x; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; FREDERICK KR, 1990, J BIOL CHEM, V265, P3793; Gadda G, 2003, BBA-PROTEINS PROTEOM, V1650, P4, DOI 10.1016/S1570-9639(03)00188-2; Gadda G, 2003, BBA-PROTEINS PROTEOM, V1646, P112, DOI 10.1016/S1570-9639(03)00003-7; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Ghanem M, 2003, BIOCHEMISTRY-US, V42, P15179, DOI 10.1021/bi035435o; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; GUILLEN F, 1994, APPL ENVIRON MICROB, V60, P2811; GUILLEN F, 1992, EUR J BIOCHEM, V209, P603, DOI 10.1111/j.1432-1033.1992.tb17326.x; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Hernandez-Ortega A, 2008, FLAVINS FLAVOPROTEIN, P303; Kass IJ, 1998, BIOORG MED CHEM LETT, V8, P2663, DOI 10.1016/S0960-894X(98)00478-8; Kass IJ, 1998, BIOCHEMISTRY-US, V37, P17990, DOI 10.1021/bi982115+; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lyubimov AY, 2006, NAT CHEM BIOL, V2, P259, DOI 10.1038/nchembio784; MARTINEZ AT, 1994, FEMS MICROBIOL REV, V13, P265, DOI 10.1016/0168-6445(94)90084-1; Martinez AT, 2005, INT MICROBIOL, V8, P195; MASSEY V, 1995, FASEB J, V9, P473, DOI 10.1096/fasebj.9.7.7737454; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; MULLER F, 1969, J BIOL CHEM, V244, P4007; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Romero E, 2009, BBA-PROTEINS PROTEOM, V1794, P689, DOI 10.1016/j.bbapap.2008.11.013; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Rotsaert FAJ, 2003, BIOCHEMISTRY-US, V42, P4049, DOI 10.1021/bi027092k; Ruiz-Duenas FJ, 2006, PROTEIN EXPRES PURIF, V45, P191, DOI 10.1016/j.pep.2005.06.003; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Varela E, 2000, BBA-PROTEIN STRUCT M, V1481, P202, DOI 10.1016/S0167-4838(00)00127-8; Varela E, 1999, BIOCHEM J, V341, P113, DOI 10.1042/0264-6021:3410113; Witt S, 2000, BIOCHEM J, V347, P553, DOI 10.1042/0264-6021:3470553	44	49	49	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24840	24847		10.1074/jbc.M109.011593	http://dx.doi.org/10.1074/jbc.M109.011593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574215	Green Published, hybrid			2022-12-25	WOS:000269734000018
J	Loque, D; Mora, SI; Andrade, SLA; Pantoja, O; Frommer, WB				Loque, Dominique; Mora, Silvia I.; Andrade, Susana L. A.; Pantoja, Omar; Frommer, Wolf B.			Pore Mutations in Ammonium Transporter AMT1 with Increased Electrogenic Ammonium Transport Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; NEUROTRANSMITTER TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS ROOTS; CHANNEL AMTB; NH4+; MECHANISM; REVEALS	AMT/Mep ammonium transporters mediate high affinity ammonium/ammonia uptake in bacteria, fungi, and plants. The Arabidopsis AMT1 proteins mediate uptake of the ionic form of ammonium. AMT transport activity is controlled allosterically via a highly conserved cytosolic C terminus that interacts with neighboring subunits in a trimer. The C terminus is thus capable of modulating the conductivity of the pore. To gain insight into the underlying mechanism, pore mutants suppressing the inhibitory effect of mutations in the C-terminal trans-activation domain were characterized. AMT1; 1 carrying the mutation Q57H in transmembrane helix I (TMH I) showed increased ammonium uptake but reduced capacity to take up methylammonium. To explore whether the transport mechanism was altered, the AMT1; 1-Q57H mutant was expressed in Xenopus oocytes and analyzed electrophysiologically. AMT1; 1-Q57H was characterized by increased ammonium-induced and reduced methylammonium-induced currents. AMT1; 1-Q57H possesses a 100x lower affinity for ammonium (K-m) and a 10-fold higher V-max as compared with the wild type form. To test whether the trans-regulatory mechanism is conserved in archaeal homologs, AfAmt-2 from Archaeoglobus fulgidus was expressed in yeast. The transport function of AfAmt-2 also depends on trans-activation by the C terminus, and mutations in pore-residues corresponding to Q57H of AMT1; 1 suppress nonfunctional AfAmt-2 mutants lacking the activating C terminus. Altogether, our data suggest that bacterial and plant AMTs use a conserved allosteric mechanism to control ammonium flux, potentially using a gating mechanism that limits flux to protect against ammonium toxicity.	Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Loque, Dominique] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Mora, Silvia I.; Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; [Andrade, Susana L. A.] Univ Freiburg, Dept Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	Carnegie Institution for Science; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Universidad Nacional Autonoma de Mexico; University of Freiburg	Frommer, WB (corresponding author), 260 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Loque, Dominique/A-8153-2008; Frommer, Wolf B/A-8256-2008; Andrade, Susana L. A./D-5119-2012; Frommer, Wolf B/K-5042-2017; Pantoja, Omar/H-5981-2012	Frommer, Wolf B/0000-0001-6465-0115; Andrade, Susana L. A./0000-0003-2267-8499; Frommer, Wolf B/0000-0001-6465-0115; Pantoja, Omar/0000-0002-6538-9059	National Science Foundation Arabidopsis 2010 Program [MCB-0618402]	National Science Foundation Arabidopsis 2010 Program(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Arabidopsis 2010 Program Grant MCB-0618402 (to W. B. F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; ILESS DC, 2006, PLOS BIOL, V4, pE351; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Loque D, 2006, PLANT J, V48, P522, DOI 10.1111/j.1365-313X.2006.02887.x; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Tremblay PL, 2009, MOL MICROBIOL, V71, P12, DOI 10.1111/j.1365-2958.2008.06514.x; WANG MY, 1994, PLANT PHYSIOL, V104, P899, DOI 10.1104/pp.104.3.899; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	39	40	43	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24988	24995		10.1074/jbc.M109.020842	http://dx.doi.org/10.1074/jbc.M109.020842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19581303	Green Published, hybrid			2022-12-25	WOS:000269734000034
J	Ranjan, R; Thompson, EA; Yoon, K; Smart, RC				Ranjan, R.; Thompson, E. A.; Yoon, K.; Smart, R. C.			C/EBP alpha expression is partially regulated by C/EBP beta in response to DNA damage and C/EBP alpha-deficient fibroblasts display an impaired G(1) checkpoint	ONCOGENE			English	Article						C/EBP; DNA damage response; G(1)/S transition; p53	CCAAT/ENHANCER-BINDING-PROTEIN; TERMINAL ADIPOCYTE DIFFERENTIATION; CELL-CYCLE CHECKPOINTS; TRANSCRIPTION FACTORS; GENE PROMOTER; ONCOGENIC RAS; ANTIPROLIFERATIVE ROLE; DOWN-REGULATION; NUCLEAR FACTOR; PROLIFERATION	We observed that CCAAT/enhancer-binding protein (C/EBP)alpha is highly inducible in primary fibroblasts by DNA-damaging agents that induce strand breaks, alkylate and crosslink DNA as well as those that produce bulky DNA lesions. Fibroblasts deficient in C/EBP alpha (C/EBP alpha(-/-)) display an impaired G(1) checkpoint as evidenced by an inappropriate entry into the S-phase in response to DNA damage, and these cells also display an enhanced G(1)/S transition in response to mitogens. The induction of C/EBP alpha by DNA damage in fibroblasts does not require p53. Electrophoretic mobility shift assay (EMSA) analysis of nuclear extracts prepared from ultraviolet B (UVB)- and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-treated fibroblasts showed increased binding of C/EBP beta to a C/EBP consensus sequence and chromatin immunoprecipitation (ChIP) analysis also showed increased C/EBP beta binding to the C/EBP alpha promoter. To determine whether C/EBP beta has a function in the regulation of C/EBP alpha, we treated C/EBP beta(-/-) fibroblasts with UVB or MNNG. We observed that C/EBP alpha induction was impaired in both UVB- and MNNG-treated C/EBP beta(-/-) fibroblasts. Our study shows a novel function for C/EBP beta in the regulation of C/EBP alpha in response to DNA damage and provides definitive genetic evidence that C/EBP alpha has a critical role in the DNA damage G(1) checkpoint. Oncogene (2009) 28, 3235-3245; doi: 10.1038/onc.2009.176; published online 6 July 2009	[Ranjan, R.; Thompson, E. A.; Smart, R. C.] N Carolina State Univ, Cell Signaling & Canc Grp, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Yoon, K.] Natl Canc Ctr, Div Common Canc, Lung Canc Branch, Goyang Si, Gyeonggi Do, South Korea	University of North Carolina; North Carolina State University; National Cancer Center - Korea (NCC)	Smart, RC (corresponding author), N Carolina State Univ, Cell Signaling & Canc Grp, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA.	rcsmart@ncsu.edu		Smart, Robert/0000-0002-6767-6756	National Cancer Institute [CA46637]; National Institute of Environmental Health Sciences [ES12473]; NIEHS [ES007046]; NATIONAL CANCER INSTITUTE [R29CA046637, R01CA046637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012473, T32ES007046] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Cancer Institute (CA46637), the National Institute of Environmental Health Sciences (ES12473), and a training grant from the NIEHS (ES007046). We thank Brian Sayers for his technical support with DNA-damaging agents.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Diehl AM, 1996, J BIOL CHEM, V271, P7343, DOI 10.1074/jbc.271.13.7343; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; DROUET C, 1991, J IMMUNOL, V147, P1694; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Halmos B, 2002, CANCER RES, V62, P528; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hulla JE, 2001, CARCINOGENESIS, V22, P89, DOI 10.1093/carcin/22.1.89; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Osada S, 1996, J BIOL CHEM, V271, P3891; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shim M, 2005, CANCER RES, V65, P861; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takai N, 2005, MOL CANCER RES, V3, P261, DOI 10.1158/1541-7786.MCR-04-0110; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V319, P235, DOI 10.1016/j.bbrc.2004.04.176; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Watkins PJ, 1996, CANCER RES, V56, P1063; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xu L, 2001, CANCER RES, V61, P3176; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	65	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3235	3245		10.1038/onc.2009.176	http://dx.doi.org/10.1038/onc.2009.176			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19581927	Green Accepted			2022-12-25	WOS:000269673400006
J	Peschiaroli, A; Scialpi, F; Bernassola, F; Pagano, M; Melino, G				Peschiaroli, A.; Scialpi, F.; Bernassola, F.; Pagano, M.; Melino, G.			The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73	ONCOGENE			English	Article						ubiquitin; F-box proteins; p73; degradation; proteasome	SCF UBIQUITIN-LIGASE; TRCP-MEDIATED DEGRADATION; KINASE C-ABL; TUMOR-SUPPRESSOR; BETA-TRCP; APOPTOTIC RESPONSE; REGULATES P73; P53; FAMILY; P63	The transcription factor p73, a member of the p53 family, mediates cell-cycle arrest and apoptosis in response to DNA damage-induced cellular stress, acting thus as a proapoptotic gene. Similar to p53, p73 activity is regulated by post-translational modi. cation, including phosphorylation, acetylation and ubiquitylation. In C. elegans, the F-box protein FSN-1 controls germline apoptosis by regulating CEP-1, the single ancestral p53 family member. Here we report that FBXO45, the human ortholog of FSN-1, binds specifically to p73 triggering its proteasome-dependent degradation. Importantly, SCFFBXO45 ubiquitylates p73 both in vivo and in vitro. Moreover, siRNA-mediated depletion of FBXO45 stabilizes p73 and concomitantly induces cell death in a p53-independent manner. All together, these results show that the orphan F-box protein FBXO45 regulates the stability of p73, highlighting a conserved pathway evolved from nematode to human by which the p53 members are regulated by an SCF-dependent mechanism. Oncogene (2009) 28, 3157-3166; doi: 10.1038/onc.2009.177; published online 6 July 2009	[Peschiaroli, A.; Melino, G.] Univ Roma Tor Vergata, IDI IRCCS Biochem Lab, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Pagano, M.] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY USA; [Pagano, M.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA; [Melino, G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England	University of Rome Tor Vergata; New York University; Howard Hughes Medical Institute; New York University; University of Leicester	Melino, G (corresponding author), Univ Roma Tor Vergata, IDI IRCCS Biochem Lab, Dept Expt Med & Biochem Sci, Via Montpellier 1, I-00133 Rome, Italy.	gerry.melino@uniroma2.it		PESCHIAROLI, ANGELO/0000-0001-6311-2382; pagano, michele/0000-0003-3210-2442	Medical Research Council, UK; EU [LSHB-CT-019067]; Alleanza contro il Cancro [ACC12]; MIUR/PRIN [RBIP06LCA9_0023]; AIRC [2008-20105471]; ISS [N526D5]; Italian Human ProteomeNet [RBRN07BMCT_007]; Telethon [GGPO4110]; National Institutes of Health [R01-GM57587, R37-CA76584, R21-CA125173]; Multiple Myeloma Research Fundation; Philip Morris USA Inc.; Philip Morris International; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R21CA125173, R37CA076584, R21CA161108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Alleanza contro il Cancro; MIUR/PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); ISS; Italian Human ProteomeNet; Telethon(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Fundation; Philip Morris USA Inc.; Philip Morris International; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V De Laurenzi for critically reading the manuscript. This study has been supported by the Medical Research Council, UK; grants from EU EPISTEM (LSHB-CT-019067), 'Alleanza contro il Cancro' (ACC12), MIUR/PRIN (RBIP06LCA9_0023), AIRC (2008-20105471), ISS 'Program Italia-USA' N526D5, Italian Human ProteomeNet RBRN07BMCT_007 and Telethon (GGPO4110) to GM; and grants from the National Institutes of Health (R01-GM57587, R37-CA76584 and R21-CA125173) and Multiple Myeloma Research Fundation to MP. Research described in this article was also supported in part by Philip Morris USA Inc. and Philip Morris International to GM. MP is an Investigator with the Howard Hughes Medical Institute.	Abida WM, 2007, J BIOL CHEM, V282, P1797, DOI 10.1074/jbc.M609001200; Agami R, 1999, NATURE, V399, P809; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bernassola F, 2004, J EXP MED, V199, P1545, DOI 10.1084/jem.20031943; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chopin V, 2002, BRIT J PHARMACOL, V135, P79, DOI 10.1038/sj.bjp.0704456; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Gao MX, 2008, CELL DEATH DIFFER, V15, P1054, DOI 10.1038/cdd.2008.30; Gong JG, 1999, NATURE, V399, P806; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Koida N, 2008, J BIOL CHEM, V283, P8555, DOI 10.1074/jbc.M710608200; Levrero M, 1999, CELL DEATH DIFFER, V6, P1146, DOI 10.1038/sj.cdd.4400624; Maisse C, 2004, CELL DEATH DIFFER, V11, P685, DOI 10.1038/sj.cdd.4401376; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2003, ANN NY ACAD SCI, V1010, P9, DOI 10.1196/annals.1299.002; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Perez-Losada J, 2005, ONCOGENE, V24, P5521, DOI 10.1038/sj.onc.1208799; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soond SM, 2008, CELL CYCLE, V7, P1214, DOI 10.4161/cc.7.9.5777; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Watson IR, 2006, NEOPLASIA, V8, P655, DOI 10.1593/neo.06439; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704	54	72	74	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3157	3166		10.1038/onc.2009.177	http://dx.doi.org/10.1038/onc.2009.177			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19581926	Green Accepted			2022-12-25	WOS:000269515100007
J	Chen, YL; Liu, B; Zhou, ZN; Hu, RY; Fei, C; Xie, ZH; Ding, XY				Chen, Yue-Lei; Liu, Bin; Zhou, Zhen-Ning; Hu, Rui-Ying; Fei, Cong; Xie, Zhi-Hui; Ding, Xiaoyan			Smad6 Inhibits the Transcriptional Activity of Tbx6 by Mediating Its Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; PRESOMITIC MESODERM; DOMAIN PROTEIN; EXPRESSION; WNT; DIFFERENTIATION; BINDING; DOWNSTREAM; ACTIVATION; MUTATIONS	Members of the bone morphogenetic protein (BMP) and T-box gene families play several critical roles in the early embryonic development and tissue homeostasis. Although BMP proteins are the upstream regulators of T-box genes, few studies have investigated the molecular mechanisms between these two protein families. Here, we report that Tbx6 interacts directly with Smad6, an inhibitory Smad that antagonizes the BMP signal. This interaction is mediated through the Mad homology 2 (MH2) domain of Smad6 and residues 90 - 180 of Tbx6. We demonstrate that Smad6 facilitates the degradation of Tbx6 protein through recruitment of Smurf1, a ubiquitin E3 ligase. Consequently, Smad6 reduces Tbx6-mediated Myf-5 gene activation. Furthermore, specific knockdown of endogenous Smad6 and Smurf1 by small interfering RNA increases the protein levels of Tbx6 and enhance the expression of Tbx6 target genes. Collectively, these findings reveal that Smad6 serves as a critical mediator of BMP signal via a functional interaction with Tbx6, thus regulating the activation of Tbx6 downstream genes during cell differentiation.	[Chen, Yue-Lei; Liu, Bin; Zhou, Zhen-Ning; Hu, Rui-Ying; Fei, Cong; Xie, Zhi-Hui; Ding, Xiaoyan] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Grad Sch,Lab Mol Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ding, XY (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Grad Sch,Lab Mol Cell Biol, Shanghai 200031, Peoples R China.	xyding@sunm.shcnc.ac.cn			National Basic Research Program of China [2005CB522704, 2007CB947903, 2009CB941101]; National Natural Science Foundation of China [30623003, 30771077,, 30871411]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 2005CB522704, 2007CB947903, and 2009CB941101 from the National Basic Research Program of China and Grants 30623003, 30771077, and 30871411 from the National Natural Science Foundation of China ( to X. D.).	Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 2003, BIOCHEM BIOPH RES CO, V310, P121, DOI 10.1016/j.bbrc.2003.08.127; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hamaguchi T, 2004, DEV BIOL, V265, P355, DOI 10.1016/j.ydbio.2003.09.034; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; He Z, 2005, BIOCHEM BIOPH RES CO, V335, P676, DOI 10.1016/j.bbrc.2005.07.129; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Lin GF, 2003, DEV DYNAM, V226, P51, DOI 10.1002/dvdy.10215; Lou X, 2006, CELL RES, V16, P771, DOI 10.1038/sj.cr.7310093; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Mayer RJ, 2000, NAT REV MOL CELL BIO, V1, P145; Mei WY, 2001, FEBS LETT, V505, P47, DOI 10.1016/S0014-5793(01)02688-6; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Uchiyama H, 2001, DEV GROWTH DIFFER, V43, P657; Wang Q, 2007, J BIOL CHEM, V282, P10742, DOI 10.1074/jbc.M610997200; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	43	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23481	23490		10.1074/jbc.M109.007864	http://dx.doi.org/10.1074/jbc.M109.007864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561075	Green Published, hybrid			2022-12-25	WOS:000269180000033
J	Li, N; Brun, T; Cnop, M; Cunha, DA; Eizirik, DL; Maechler, P				Li, Ning; Brun, Thierry; Cnop, Miriam; Cunha, Daniel A.; Eizirik, Decio L.; Maechler, Pierre			Transient Oxidative Stress Damages Mitochondrial Machinery Inducing Persistent beta-Cell Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT DIABETES-MELLITUS; INS-1E INSULINOMA CELLS; PANCREATIC-ISLETS; UNCOUPLING PROTEIN-2; GENE-EXPRESSION; COMPLEX-I; SECRETION; MOUSE; MUTATIONS	Transient exposure of beta-cells to oxidative stress interrupts the transduction of signals normally coupling glucose metabolism to insulin secretion. We investigated putative persistence of effects induced by one transient oxidative stress (200 mu M H2O2, 10 min) on insulin secreting cells following recovery periods of days and weeks. Three days after oxidative stress INS-1E cells and rat islets exhibited persistent dysfunction. In particular, the secretory response to 15 mM glucose was reduced by 40% in INS-1E cells stressed 3 days before compared with naive cells. Compared with non-stressed INS-1E cells, we observed reduced oxygen consumption (-43%) and impaired glucose-induced ATP generation (-46%). These parameters correlated with increased mitochondrial reactive oxygen species formation (+60%) accompanied with down-regulation of subunits of the respiratory chain and decreased expression of genes responsible for mitochondrial biogenesis (TFAM, -24%; PGC-1 alpha, -67%). Three weeks after single oxidative stress, both mitochondrial respiration and secretory responses were recovered. Moreover, such recovered INS-1E cells exhibited partial resistance to a second transient oxidative stress and up-regulation of UCP2 (+78%) compared with naive cells. In conclusion, one acute oxidative stress induces beta-cell dysfunction lasting over days, explained by persistent damages in mitochondrial components.	[Maechler, Pierre] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Univ Med Ctr, CH-1211 Geneva 4, Switzerland; [Cnop, Miriam; Cunha, Daniel A.; Eizirik, Decio L.] Univ Libre Bruxelles, Erasmus Hosp, Expt Med Lab, B-1070 Brussels, Belgium; [Cnop, Miriam] Univ Libre Bruxelles, Erasmus Hosp, Div Endocrinol, B-1070 Brussels, Belgium	University of Geneva; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Maechler, P (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Univ Med Ctr, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch		Maechler, Pierre/0000-0002-2005-1433; Cnop, Miriam/0000-0002-5112-1692; LI, Ning/0000-0002-1626-5519; BRUN, Thierry/0000-0002-1659-4283	Swiss National Science Foundation; Bristol-Myers Squibb Company; Hans Wilsdorf Foundation, Geneva, Switzerland; Research Foundation of the European Association for the study of Diabetes, the European Union Integrated Project EuroDia [LSHM-CT2006-518153]; Belgium Fonds National de la Recherche Scientifique-Recherche Scientifique Medicale	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Hans Wilsdorf Foundation, Geneva, Switzerland; Research Foundation of the European Association for the study of Diabetes, the European Union Integrated Project EuroDia; Belgium Fonds National de la Recherche Scientifique-Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by the Swiss National Science Foundation ( to P. M.), the European Foundation for the Study of Diabetes (EFSD) through an EFSD fellowship supported by Bristol-Myers Squibb Company (to N.L.), a fellowship from the Hans Wilsdorf Foundation, Geneva, Switzerland (to N.L.), the Research Foundation of the European Association for the study of Diabetes, the European Union Integrated Project EuroDia LSHM-CT2006-518153 in the Framework Programme 6 of the European Community ( to M. C. and D. L. E.), and the Belgium Fonds National de la Recherche Scientifique-Recherche Scientifique Medicale ( to M. C. and D. L. E.).	Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Boengler K, 2007, J MOL CELL CARDIOL, V43, P610, DOI 10.1016/j.yjmcc.2007.08.004; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Delgado EHB, 2006, NEUROCHEM RES, V31, P1021, DOI 10.1007/s11064-006-9111-1; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; EIZIRIK DL, 1988, DIABETES, V37, P916, DOI 10.2337/diabetes.37.7.916; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Li WG, 2001, J BIOL CHEM, V276, P29251, DOI 10.1074/jbc.M102124200; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MOREIRA JE, 1991, VIRCHOWS ARCH B, V60, P337, DOI 10.1007/BF02899565; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; SANDLER S, 1989, ENDOCRINOLOGY, V124, P1492, DOI 10.1210/endo-124-3-1492; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Tampo Y, 2003, CIRC RES, V92, P56, DOI 10.1161/01.RES.0000048195.15637.AC; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	47	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23602	23612		10.1074/jbc.M109.024323	http://dx.doi.org/10.1074/jbc.M109.024323			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19546218	hybrid, Green Published			2022-12-25	WOS:000269180000046
J	Lin, YP; Greenwood, A; Nicholson, LK; Sharma, Y; McDonough, SP; Chang, YF				Lin, Yi-Pin; Greenwood, Alex; Nicholson, Linda K.; Sharma, Yogendra; McDonough, Sean P.; Chang, Yung-Fu			Fibronectin Binds to and Induces Conformational Change in a Disordered Region of Leptospiral Immunoglobulin-like Protein B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM; BORRELIA-BURGDORFERI; SECONDARY STRUCTURE; INTERROGANS; SPECTRA; LIGB; RELAXATION; EXPRESSION; ADHERENCE; MSCRAMM	Leptospira interrogans is a pathogenic spirochete that causes disease in both humans and animals. LigB (Leptospiral immunoglobulin-like protein B) contributes to the binding of Leptospira to extracellular matrix proteins such as fibronectin (Fn), fibrinogen, laminin, and collagen. A high affinity Fn-binding region of LigB has been recently localized to Lig-BCen2, which contains the partial eleventh and full twelfth immunoglobulin-like repeats (LigBCen2R) and 47 amino acids of the non-repeat region (LigBCen2NR) of LigB. In this study, LigBCen2NR was shown to bind to the N-terminal domain (NTD) of Fn (K-D = 379 nM) by an enzyme-linked immunosorbent assay and isothermal titration calorimetry. Interestingly, this sequence was not observed to adopt secondary structure by far UV circular dichroism or by differential scanning calorimetry, in agreement with computer-based secondary structure predictions. A low partition coefficient (K-av) measured with gel permeation chromatography, a high hydrodynamic radius (R-h) measured with dynamic light scattering, and the insensitivity of the intrinsic viscosity to guanidine hydrochloride treatment all suggest that LigBCen2NR possesses an extended and disordered structure. Two-dimensional N-15-H-1 HSQC NMR spectra of intact LigBCen2 in the absence and presence of NTD are consistent with these observations, suggesting the presence of both a beta-rich region and an unstructured region in LigBCen2 and that the latter of these selectively interacts with NTD. Upon binding to NTD, LigBCen2NR was observed by CD to adopt a beta-strand-rich structure, suggestive of the known beta-zipper mode of NTD binding.	[Lin, Yi-Pin; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Greenwood, Alex; Nicholson, Linda K.] Cornell Univ, Coll Agr & Life Sci, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Cornell University; Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	Greenwood, Alex/GWU-8292-2022		National Institutes of Health biophysics training grant; Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC); National Science Foundation [MCB-0641582]	National Institutes of Health biophysics training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by a National Institutes of Health biophysics training grant (to A.G.). This work was also supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (CAT), the Biotechnology Research and Development Corporation (BRDC), and National Science Foundation Grant MCB-0641582 (to L.K.N.).	Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Berezov A, 2001, J MED CHEM, V44, P2565, DOI 10.1021/jm000527m; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; FAINE S, 1999, LEPTOSPIRA LEPTOSPIR, P67; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; ODERMATT E, 1982, J MOL BIOL, V159, P109, DOI 10.1016/0022-2836(82)90034-1; OHNO H, 1986, BIOCHEM J, V235, P553, DOI 10.1042/bj2350553; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; STEVENS ES, 1987, J MOL BIOL, V197, P743, DOI 10.1016/0022-2836(87)90481-5; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; TANFORD C, 1967, J AM CHEM SOC, V89, P5023, DOI 10.1021/ja00995a034; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; WELSH EJ, 1983, BIOPOLYMERS, V22, P821, DOI 10.1002/bip.360220305; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62	51	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23547	23557		10.1074/jbc.M109.031369	http://dx.doi.org/10.1074/jbc.M109.031369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581300	Green Published, hybrid			2022-12-25	WOS:000269180000040
J	Narayan, K; Perkins, EM; Murphy, GE; Dalai, SK; Edidin, M; Subramaniam, S; Sadegh-Nasseri, S				Narayan, Kedar; Perkins, Edward M.; Murphy, Gavin E.; Dalai, Sarat K.; Edidin, Michael; Subramaniam, Sriram; Sadegh-Nasseri, Scheherazade			Staphylococcal Enterotoxin A Induces Small Clusters of HLA-DR1 on B Cells	PLOS ONE			English	Article								The superantigen SEA causes non-specific hyperactivation of T and B cells at low concentrations. Studies of mutants or soluble proteins suggest SEA is bivalent for its ligand, MHC class II. However, the interaction between these molecules on intact cells is unknown. On primary mouse B cells expressing the MHC class II allele HLA-DR1, measurements of Forster Resonance Energy Transfer between HLA-DR1 molecules on SEA-treated cells indicated specific clustering, not observed in untreated or monovalent superantigen treated cells. Tomographic visualization and electron microscopy of immunogold-labeled SEA-treated B cells revealed small clusters of surface HLA-DR1 (<= 4 gold labels). These results present direct visual evidence of SEA-mediated clustering of MHC class II molecules on treated antigen presenting cells, and provide a new structural approach to addressing problems of this nature.			Narayan, K (corresponding author), Johns Hopkins Med Inst, Grad Program Immunol, Baltimore, MD 21205 USA.	ssadegh@jhmi.edu	Perkins, Edward/B-8276-2009	Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720; Subramaniam, Sriram/0000-0003-4231-4115; Perkins, Edward/0000-0002-3077-7422	NATIONAL CANCER INSTITUTE [ZIABC010278, ZIABC010825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053549] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [1R01 AI063764, R01 AI063764] Funding Source: Medline; NIGMS NIH HHS [R01 GM 53549] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Cuff L, 2003, J MOL GRAPH MODEL, V21, P473, DOI 10.1016/S1093-3263(02)00206-1; DELLABONA P, 1990, CELL, V62, P1115, DOI 10.1016/0092-8674(90)90388-U; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; Dowd JE, 1996, MOL IMMUNOL, V33, P1267, DOI 10.1016/S0161-5890(96)00085-5; FAST DJ, 1989, INFECT IMMUN, V57, P291, DOI 10.1128/IAI.57.1.291-294.1989; Fooksman DR, 2006, J IMMUNOL, V176, P6673, DOI 10.4049/jimmunol.176.11.6673; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; HERMAN A, 1991, P NATL ACAD SCI USA, V88, P9954, DOI 10.1073/pnas.88.22.9954; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lei L, 2001, J LEUKOCYTE BIOL, V70, P80; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MEHINDATE K, 1995, J EXP MED, V182, P1573, DOI 10.1084/jem.182.5.1573; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P3463; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; Perkins Edward M, 2007, Methods Mol Biol, V372, P467, DOI 10.1007/978-1-59745-365-3_33; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Pless DD, 2005, INFECT IMMUN, V73, P5358, DOI 10.1128/IAI.73.9.5358-5366.2005; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Thibodeau J, 1997, RES IMMUNOL, V148, P217, DOI 10.1016/S0923-2494(97)80864-4; Thibodeau J, 1997, J IMMUNOL, V158, P3698; Tiedemann RE, 1996, J IMMUNOL, V157, P3958; Tiedemann RE, 1995, P NATL ACAD SCI USA, V92, P12156, DOI 10.1073/pnas.92.26.12156; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010	44	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6188	10.1371/journal.pone.0006188	http://dx.doi.org/10.1371/journal.pone.0006188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587800	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035100012
J	Paparatto, D; Fletcher, D; Piwowar, K; Baldino, K; Morel, C; Dunaway, S				Paparatto, Domenica; Fletcher, Dane; Piwowar, Karen; Baldino, Kimberly; Morel, Charlotte; Dunaway, Stephen			The Schizosaccharomyces pombe Checkpoint Kinases Chk1 and Cds1 Are Important for Cell Survival in Response to Cisplatin	PLOS ONE			English	Article								Background: DNA damage checkpoints insure that the integrity of genomic DNA is faithfully maintained throughout the eukaryotic cell cycle. In the presence of damaged DNA, checkpoints are triggered to delay cell cycle progression to allow for DNA repair. In fission yeast, the kinases Chk1 and Cds1 are major components of these DNA damage checkpoint pathways. Both Chk1 and Cds1 are important for viability in the presence of several DNA damaging agents. In this study we hypothesized that Chk1 and Cds1 play a vital role in fission yeast cells ability to survive exposure to the DNA damaging agent cisplatin. Cisplatin is a potent chemotherapeutic drug that interacts with DNA and causes both inter-and intra-strand DNA cross-links. Methodology/Principal Findings: Here, we demonstrated that treatment with cisplatin in fission yeast causes a Chk1-dependent DNA damage signal. chk1(-) cells were sensitive to cisplatin and Chk1 was phosphorylated in response to cisplatin treatment. We also showed that a Chk1-dependent DNA damage checkpoint pathway is activated in a dose-dependent fashion in cells challenged with cisplatin. Furthermore the Cds1 checkpoint kinase was also important for viability in cisplatin challenged cells. In cds1(-) cells, cisplatin treatment reduced cell viability and this phenotype was exacerbated in a chk1(-)/cds1(-) background. Conclusions/Significance: Thus, we conclude that the concerted effort of both major checkpoint kinases in fission yeast, Chk1 and Cds1, protect cells from cisplatin induced DNA damage. These observations are significant because they suggest that various classes of inter-strand crosslinking agents may generate slightly different lesions as work by others did not observe loss of viability in cds1(-) cells treated with other crosslinking agents like nitrogen mustard.			Paparatto, D (corresponding author), Drew Univ, Dept Biol, Madison, NJ 07940 USA.	sdunaway@drew.edu	Baldino, Kimberly/HHS-1856-2022	Baldino, Kimberly/0000-0003-3935-4538				ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Baber-Furnari BA, 2000, MOL BIOL CELL, V11, P1; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; Dunaway S, 2004, METHODS, V33, P260, DOI 10.1016/j.ymeth.2003.11.022; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Grossmann KF, 1999, MUTAT RES-DNA REPAIR, V434, P29, DOI 10.1016/S0921-8777(99)00011-7; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Lambert S, 2003, MOL CELL BIOL, V23, P4728, DOI 10.1128/MCB.23.13.4728-4737.2003; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perego P, 1998, MOL PHARMACOL, V54, P213, DOI 10.1124/mol.54.1.213; Qin J, 2003, RADIAT RES, V159, P139, DOI 10.1667/0033-7587(2003)159[0139:MAOTDD]2.0.CO;2; Rhind N, 1998, GENETICS, V149, P1729; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Rhind N, 2000, J CELL SCI, V113, P3889; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan S, 2001, CURR GENET, V38, P299, DOI 10.1007/s002940000172; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1993, GENETICS, V134, P63; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6181	10.1371/journal.pone.0006181	http://dx.doi.org/10.1371/journal.pone.0006181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587778	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035100008
J	Soltis, BW; Sanders, JW; Putnam, SD; Tribble, DR; Riddle, MS				Soltis, Bryony W.; Sanders, John W.; Putnam, Shannon D.; Tribble, David R.; Riddle, Mark S.			Self Reported Incidence and Morbidity of Acute Respiratory Illness among Deployed US Military in Iraq and Afghanistan	PLOS ONE			English	Article								Background: Historically, respiratory infections have had a significant impact on U. S. military missions. Deployed troops are particularly at high risk due to close living conditions, stressful work environments and increased exposure to pathogens. To date, there are limited data available on acute respiratory illness (ARI) among troops deployed in support of ongoing military operations, specifically Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF). Methods: Using self-report data from two sources collected from troops deployed to Iraq, Afghanistan and the surrounding region, we analyzed incidence and risk factors for ARI. Military personnel on mid-deployment Rest & Recuperation (R&R) or during redeployment were eligible to participate in the voluntary self-report survey. Results: Overall, 39.5% reported having at least one ARI. Of these, 18.5% sought medical care and 33.8% reported having decreased job performance. The rate of self-reported ARI was 15 episodes per 100 person-months among those taking the voluntary survey, and 24.7 episodes per 100 person-months among those taking the clinic health questionnaire. Negative binomial regression analysis found female sex, Navy branch of service and lack of flush toilets to be independently associated with increased rates of ARI. Deployment to OIF, increasing age and higher rank were also positively associated with ARI risk. Conclusions: The overall percentage of deployed military personnel reporting at least one acute respiratory illness decreased since earlier parts of OIF/OEF. However, the reported effect on job performance increased tremendously. The most important factors associated with increased respiratory infection are female sex, Navy branch of service, lack of improved latrine facilities, deployment to OIF, increasing age and higher rank.			Soltis, BW (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med, Bethesda, MD 20814 USA.	mark.riddle@med.navy.mil	Putnam, Shan D/F-2345-2013; Riddle, Mark/A-8029-2011; Riddle, Mark/R-8788-2019	Putnam, Shan D/0000-0001-8353-4400; Riddle, Mark/0000-0002-0607-7880				Brundage JF, 1996, PEDIATRICS, V97, P964; CROSS ER, 1992, MIL MED, V157, P649, DOI 10.1093/milmed/157.12.649; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; HYAMS KC, 1995, CLIN INFECT DIS, V20, P1497, DOI 10.1093/clinids/20.6.1497; LIM ML, 2004, MIL MED; PAPARELLO SF, 1993, MIL MED, V158, P392, DOI 10.1093/milmed/158.6.392; RICHARDS AL, 1993, AM J PUBLIC HEALTH, V83, P1326, DOI 10.2105/AJPH.83.9.1326; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Sanders JW, 2005, AM J TROP MED HYG, V73, P713, DOI 10.4269/ajtmh.2005.73.713; 1995, NCCE NEWS, V3, pS1	10	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6177	10.1371/journal.pone.0006177	http://dx.doi.org/10.1371/journal.pone.0006177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584919	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806500008
J	Suvorova, ES; Lucas, O; Weisend, CM; Rollins, MF; Merrill, GF; Capecchi, MR; Schmidt, EE				Suvorova, Elena S.; Lucas, Olivier; Weisend, Carla M.; Rollins, MaryClare F.; Merrill, Gary F.; Capecchi, Mario R.; Schmidt, Edward E.			Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes	PLOS ONE			English	Article								Background: Metabolically active cells require robust mechanisms to combat oxidative stress. The cytoplasmic thioredoxin reductase/thioredoxin (Txnrd1/Txn1) system maintains reduced protein dithiols and provides electrons to some cellular reductases, including peroxiredoxins. Principal Findings: Here we generated mice in which the txnrd1 gene, encoding Txnrd1, was specifically disrupted in all parenchymal hepatocytes. Txnrd1-deficient livers exhibited a transcriptome response in which 56 mRNAs were induced and 12 were repressed. Based on the global hybridization profile, this represented only 0.3% of the liver transcriptome. Since most liver mRNAs were unaffected, compensatory responses were evidently effective. Nuclear pre-mRNA levels indicated the response was transcriptional. Twenty-one of the induced genes contained known antioxidant response elements (AREs), which are binding sites for the oxidative and chemical stress-induced transcription factor Nrf2. Txnrd1-deficient livers showed increased accumulation of nuclear Nrf2 protein and chromatin immunoprecipitation on the endogenous nqo1 and aox1 promoters in fibroblasts indicated that Txnrd1 ablation triggered in vivo assembly of Nrf2 on each. Conclusions: Chronic deletion of Txnrd1 results in induction of the Nrf2 pathway, which contributes to an effective compensatory response.			Suvorova, ES (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	eschmidt@montana.edu			NCRR NIH HHS [2P20RR020285] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arner E. S., 2009, BIOCH BIOPHYS ACTA; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avellini C, 2007, TRANSPL P, V39, P1755, DOI 10.1016/j.transproceed.2007.05.082; Badea TC, 2003, J NEUROSCI, V23, P2314; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; BERNHEIM F, 1948, J BIOL CHEM, V174, P257; Bondareva AA, 2007, FREE RADICAL BIO MED, V43, P911, DOI 10.1016/j.freeradbiomed.2007.05.026; Camacho L, 2000, B ENVIRON CONTAM TOX, V64, P191, DOI 10.1007/s001289910029; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V168, P30, DOI 10.1016/j.cbi.2006.10.013; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Lahoz A, 2008, RAPID COMMUN MASS SP, V22, P240, DOI 10.1002/rcm.3359; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Onai K, 1997, GENETICS, V146, P101; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; RUSSEL M, 1988, P NATL ACAD SCI USA, V85, P990, DOI 10.1073/pnas.85.4.990; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; Schmidt EE, 2003, J BIOL CHEM, V278, P6168, DOI 10.1074/jbc.M211205200; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Sengupta A, 2008, BIOCHEM J, V413, P151, DOI 10.1042/BJ20080277; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Umemura T, 2006, TOXICOL SCI, V90, P111, DOI 10.1093/toxsci/kfj076; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; WUARIN J, 1992, J CELL SCI, P123; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	60	72	72	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6158	10.1371/journal.pone.0006158	http://dx.doi.org/10.1371/journal.pone.0006158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584930	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806400013
J	Glazer, AN; Kechris, KJ				Glazer, Alexander N.; Kechris, Katerina J.			Conserved Amino Acid Sequence Features in the alpha Subunits of MoFe, VFe, and FeFe Nitrogenases	PLOS ONE			English	Article								Background: This study examines the structural features and phylogeny of the a subunits of 69 full-length NifD (MoFe subunit), VnfD (VFe subunit), and AnfD (FeFe subunit) sequences. Methodology/Principal Findings: The analyses of this set of sequences included BLAST scores, multiple sequence alignment, examination of patterns of covariant residues, phylogenetic analysis and comparison of the sequences flanking the conserved Cys and His residues that attach the FeMo cofactor to NifD and that are also conserved in the alternative nitrogenases. The results show that NifD nitrogenases fall into two distinct groups. Group I includes NifD sequences from many genera within Bacteria, including all nitrogen-fixing aerobes examined, as well as strict anaerobes and some facultative anaerobes, but no archaeal sequences. In contrast, Group II NifD sequences were limited to a small number of archaeal and bacterial sequences from strict anaerobes. The VnfD and AnfD sequences fall into two separate groups, more closely related to Group II NifD than to Group I NifD. The pattern of perfectly conserved residues, distributed along the full length of the Group I and II NifD, VnfD, and AnfD, confirms unambiguously that these polypeptides are derived from a common ancestral sequence. Conclusions/Significance: There is no indication of a relationship between the patterns of covariant residues specific to each of the four groups discussed above that would give indications of an evolutionary pathway leading from one type of nitrogenase to another. Rather the totality of the data, along with the phylogenetic analysis, is consistent with a radiation of Group I and II NifDs, VnfD and AnfD from a common ancestral sequence. All the data presented here strongly support the suggestion made by some earlier investigators that the nitrogenase family had already evolved in the last common ancestor of the Archaea and Bacteria.			Glazer, AN (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	glazer@berkeley.edu		Kechris, Katerina/0000-0002-3725-5459	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016922] Funding Source: NIH RePORTER; NIAAA NIH HHS [K01-AA016922, K01 AA016922] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Betancourt DA, 2008, APPL ENVIRON MICROB, V74, P3471, DOI 10.1128/AEM.02694-07; Bickel PJ, 2002, P NATL ACAD SCI USA, V99, P14764, DOI 10.1073/pnas.222508899; Boison G, 2006, ARCH MICROBIOL, V186, P367, DOI 10.1007/s00203-006-0150-4; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Eady RR, 2003, COORDIN CHEM REV, V237, P23, DOI 10.1016/S0010-8545(02)00248-5; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fani R, 2000, J MOL EVOL, V51, P1; Henson BJ, 2004, J MOL EVOL, V58, P390, DOI 10.1007/s00239-003-2560-0; Kechris KJ, 2006, P NATL ACAD SCI USA, V103, P9584, DOI 10.1073/pnas.0603534103; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIRN J, 1992, NATURE, V360, P553, DOI DOI 10.1038/360553A0; NORMAND P, 1992, MOL BIOL EVOL, V9, P495; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rees D. C., 2005, PHILOS T A, V363; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Schrock RR, 2005, PHILOS T R SOC A, V363, P959, DOI 10.1098/rsta.2004.1541; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; WANG SZ, 1988, BIOCHEMISTRY-US, V27, P2800, DOI 10.1021/bi00408a021; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221	19	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6136	10.1371/journal.pone.0006136	http://dx.doi.org/10.1371/journal.pone.0006136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578539	Green Submitted, gold, Green Published			2022-12-25	WOS:000267806300008
J	Ozkucur, N; Monsees, TK; Perike, S; Do, HQ; Funk, RHW				Oezkucur, Nurdan; Monsees, Thomas K.; Perike, Srikanth; Do, Hoa Quynh; Funk, Richard H. W.			Local Calcium Elevation and Cell Elongation Initiate Guided Motility in Electrically Stimulated Osteoblast-Like Cells	PLOS ONE			English	Article								Background: Investigation of the mechanisms of guided cell migration can contribute to our understanding of many crucial biological processes, such as development and regeneration. Endogenous and exogenous direct current electric fields (dcEF) are known to induce directional cell migration, however the initial cellular responses to electrical stimulation are poorly understood. Ion fluxes, besides regulating intracellular homeostasis, have been implicated in many biological events, including regeneration. Therefore understanding intracellular ion kinetics during EF-directed cell migration can provide useful information for development and regeneration. Methodology/Principal Findings: We analyzed the initial events during migration of two osteogenic cell types, rat calvarial and human SaOS-2 cells, exposed to strong (10-15 V/cm) and weak (<= 5 V/cm) dcEFs. Cell elongation and perpendicular orientation to the EF vector occurred in a time- and voltage-dependent manner. Calvarial osteoblasts migrated to the cathode as they formed new filopodia or lamellipodia and reorganized their cytoskeleton on the cathodal side. SaOS-2 cells showed similar responses except towards the anode. Strong dcEFs triggered a rapid increase in intracellular calcium levels, whereas a steady state level of intracellular calcium was observed in weaker fields. Interestingly, we found that dcEF-induced intracellular calcium elevation was initiated with a local rise on opposite sides in calvarial and SaOS-2 cells, which may explain their preferred directionality. In calcium-free conditions, dcEFs induced neither intracellular calcium elevation nor directed migration, indicating an important role for calcium ions. Blocking studies using cadmium chloride revealed that voltage-gated calcium channels (VGCCs) are involved in dcEF-induced intracellular calcium elevation. Conclusion/Significance: Taken together, these data form a time scale of the morphological and physiological rearrangements underlying EF-guided migration of osteoblast-like cell types and reveal a requirement for calcium in these reactions. We show for the first time here that dcEFs trigger different patterns of intracellular calcium elevation and positional shifting in osteogenic cell types that migrate in opposite directions.			Ozkucur, N (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Anat, Dresden, Germany.	Nurdan.Oezkucur@tu-dresden.de	Ozkucur, Nurdan/D-4275-2011; Funk, Richard HW/I-1780-2013; Do, Hoa/AAL-1505-2020	Do, Hoa/0000-0001-7361-6066; Perike, Srikanth/0000-0002-3045-0278				Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; BINDERMAN I, 1985, BIOCHIM BIOPHYS ACTA, V844, P273, DOI 10.1016/0167-4889(85)90127-2; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Cho MR, 1996, FASEB J, V10, P1552, DOI 10.1096/fasebj.10.13.8940302; CIVITELLI R, 1987, J CELL PHYSIOL, V131, P434, DOI 10.1002/jcp.1041310316; COOPER MS, 1986, J CELL BIOL, V102, P1384, DOI 10.1083/jcb.102.4.1384; Curtze S, 2004, J CELL SCI, V117, P2721, DOI 10.1242/jcs.01119; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fang KS, 1999, J CELL SCI, V112, P1967; FERRIER J, 1986, J CELL PHYSIOL, V129, P283, DOI 10.1002/jcp.1041290303; FERRIER J, 1987, J CELL PHYSIOL, V130, P344, DOI 10.1002/jcp.1041300306; Funk RHW, 2006, CELLS TISSUES ORGANS, V182, P59, DOI 10.1159/000093061; Funk RHW, 2009, PROG HISTOCHEM CYTO, V43, P177, DOI 10.1016/j.proghi.2008.07.001; Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097; Ho Mei-Ling, 1999, Kaohsiung Journal of Medical Sciences, V15, P248; Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; RODAN SB, 1987, CANCER RES, V47, P4961; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Stull JT, 1998, ACTA PHYSIOL SCAND, V164, P471, DOI 10.1111/j.1365-201X.1998.tb10699.x; Titushkin IA, 2004, IEEE T PLASMA SCI, V32, P1614, DOI 10.1109/TPS.2004.832625; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; WILTINK A, 1994, CALCIFIED TISSUE INT, V54, P278, DOI 10.1007/BF00295951; Zhao M, 1996, INVEST OPHTH VIS SCI, V37, P2548; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	33	58	62	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6131	10.1371/journal.pone.0006131	http://dx.doi.org/10.1371/journal.pone.0006131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19584927	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806300005
J	Morrow, G; Nicol, SC				Morrow, Gemma; Nicol, Stewart C.			Cool Sex? Hibernation and Reproduction Overlap in the Echidna	PLOS ONE			English	Article							BODY-TEMPERATURE; GROWTH	During hibernation there is a slowing of all metabolic processes, and thus it is normally considered to be incompatible with reproduction. In Tasmania the egg-laying mammal, the echidna (Tachyglossus aculeatus) hibernates for several months before mating in mid-winter, and in previous studies we observed males with females that were still hibernating. We monitored the reproductive activity of radio-tracked echidnas by swabbing the reproductive tract for sperm while external temperature loggers provided information on the timing of hibernation. Additional information was provided by camera traps and ultrasound imaging. More than a third of the females found in mating groups were torpid, and the majority of these had mated. Some females re-entered deep torpor for extended periods after mating. Ultrasound examination showed a developing egg in the uterus of a female that had repeatedly re-entered torpor. The presence of fresh sperm in cloacal swabs taken from this female on three occasions after her presumed date of fertilization indicated she mated several times after being fertilized. The mating of males with torpid females is the result of extreme competition between promiscuous males, while re-entry into hibernation by pregnant females could improve the possibility of mating with a better quality male.			Morrow, G (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	s.c.nicol@utas.edu.au		Morrow, Gemma/0000-0002-4391-0165				BARNES BM, 1986, BIOL REPROD, V35, P1289, DOI 10.1095/biolreprod35.5.1289; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Crichton Elizabeth G., 2000, P295, DOI 10.1016/B978-012195670-7/50008-4; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F., 2008, HYPOMETABOLISM ANIMA, P297; Geiser Fritz, 1996, P81; GRIFFITHS M, 1999, ENCY REPROD, P295; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnston SD, 2007, AM NAT, V170, pE162, DOI 10.1086/522847; Jones R. C., 2004, Australian Mammalogy, V26, P199; Kilen SM, 1999, ENCY REPROD, P127; Koehler CE, 2000, J MAMMAL, V81, P234, DOI 10.1644/1545-1542(2000)081<0234:PNGABB>2.0.CO;2; Morrow GE, AUSTR J ZOO IN PRESS; Nicol S, 2002, COMP BIOCHEM PHYS B, V131, P603, DOI 10.1016/S1096-4959(02)00018-0; Nicol S, 2006, J THERM BIOL, V31, P483, DOI 10.1016/j.jtherbio.2006.05.001; Nicol SC, 2008, COMP BIOCHEM PHYS A, V150, P189, DOI 10.1016/j.cbpa.2006.08.039; RACEY PA, 1981, J REPROD FERTIL, V61, P123; RACEY PA, 2000, REPROD BIOL BATS, P361; Rismiller P.D., 1996, P23; Rismiller PD, 2003, COMP BIOCHEM PHYS A, V136, P851, DOI 10.1016/S1095-6433(03)00225-3; Rismiller PD, 2000, J MAMMAL, V81, P1, DOI 10.1644/1545-1542(2000)081<0001:FOBARI>2.0.CO;2; Rose RW, 1997, J ZOOL, V243, P523, DOI 10.1111/j.1469-7998.1997.tb02798.x; Schmid J, 2003, COMP BIOCHEM PHYS A, V136, P903, DOI 10.1016/S1095-6433(03)00240-X; STRAHAN R, 2008, MAMMALS AUSTR NEW HO, P880; TAGGART DA, 1998, SPERM COMPETITION SE; VANPE C, AUSTR J ZOO IN PRESS; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0	28	43	43	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6070	10.1371/journal.pone.0006070	http://dx.doi.org/10.1371/journal.pone.0006070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562080	Green Accepted, Green Published, gold			2022-12-25	WOS:000267465900006
J	Zhang, HM; Dang, HW; Yeh, CK; Zhang, BX				Zhang, Hong-Mei; Dang, Howard; Yeh, Chih-Ko; Zhang, Bin-Xian			Linoleic Acid-Induced Mitochondrial Ca2+ Efflux Causes Peroxynitrite Generation and Protein Nitrotyrosylation	PLOS ONE			English	Article								It is well known that excessive non-esterified fatty acids in diabetes contribute to the pathogenesis of renal complications although the mechanism remains elusive. Enhanced oxidative stress has been hypothesized as a unified factor contributing to diabetic complications and increased protein nitrotyrosylation has been reported in the kidneys of diabetic patients. In the current manuscript we described that linoleic acid (LA) caused mitochondrial Ca2+ efflux and peroxynitrite production, along with increased nitrotyrosine levels of cellular proteins in primary human mesangial cells. The peroxynitrite production by LA was found to depend on mitochondrial Ca2+ efflux. Downregulation of hsp90 beta 1, which has been previously shown to be essential for polyunsaturated fatty acid-induced mitochondrial Ca2+ efflux, significantly diminished LA-responsive mitochondrial Ca2+ efflux and the coupled peroxynitrite generation, implicating a critical role of hsp90 beta 1 in the LA responses. Our results further demonstrated that mitochondrial complexes I and III were directly involved in the LA-induced peroxynitrite generation. Using the well established type 2 diabetic animal model db/db mice, we observed a dramatically enhanced LA responsive mitochondrial Ca2+ efflux and protein nitrotyrosylation in the kidney. Our study thus demonstrates a cause-effect relationship between LA and peroxynitrite or protein nitrotyrosylation and provides a novel mechanism for lipid-induced nephropathy in diabetes.			Zhang, HM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	zhangb2@uthscsa.edu		Yeh, Chih-Ko/0000-0001-6611-9942	NHLBI NIH HHS [HL075011, R01 HL075011] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075011] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; DAS AM, 1990, CARDIOVASC RES, V24, P411, DOI 10.1093/cvr/24.5.411; Drel VR, 2006, FREE RADICAL BIO MED, V40, P1454, DOI 10.1016/j.freeradbiomed.2005.12.034; Duplain H, 2008, J PHYSIOL-LONDON, V586, P4011, DOI 10.1113/jphysiol.2008.154302; Feldkamp T, 2006, AM J PHYSIOL-RENAL, V290, pF465, DOI 10.1152/ajprenal.00305.2005; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Hendrickson SC, 1997, MOL CELL BIOCHEM, V166, P85, DOI 10.1023/A:1006886601825; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kanski J, 2005, J BIOL CHEM, V280, P24261, DOI 10.1074/jbc.M501773200; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Lacza Z, 2006, NITRIC OXIDE-BIOL CH, V14, P162, DOI 10.1016/j.niox.2005.05.011; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Parihar MS, 2008, BIOCHEM BIOPH RES CO, V366, P23, DOI 10.1016/j.bbrc.2007.11.056; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Sheu JN, 2006, FOOD CHEM TOXICOL, V44, P409, DOI 10.1016/j.fct.2005.08.014; SILVER BJ, 1989, P NATL ACAD SCI USA, V86, P1056, DOI 10.1073/pnas.86.3.1056; Thuraisingham RC, 2000, KIDNEY INT, V57, P1968, DOI 10.1046/j.1523-1755.2000.00046.x; Yi L, 2007, CHEM PHYS LIPIDS, V150, P204, DOI 10.1016/j.chemphyslip.2007.08.002; Zhang BX, 2006, AM J PHYSIOL-CELL PH, V290, pC1321, DOI 10.1152/ajpcell.00335.2005; Zhang H, 2008, J BIOL CHEM, V283, P7580, DOI 10.1074/jbc.M707192200; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6048	10.1371/journal.pone.0006048	http://dx.doi.org/10.1371/journal.pone.0006048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557129	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600003
J	Wise, JL; Crout, RJ; McNeil, DW; Weyant, RJ; Marazita, ML; Wenger, SL				Wise, Jasen L.; Crout, Richard J.; McNeil, Daniel W.; Weyant, Robert J.; Marazita, Mary L.; Wenger, Sharon L.			Human Telomere Length Correlates to the Size of the Associated Chromosome Arm	PLOS ONE			English	Article								The majority of human telomere length studies have focused on the overall length of telomeres within a cell. In fact, very few studies have examined telomere length for individual chromosome arms. The objective of this study was to examine the relationship between chromosome arm size and the relative length of the associated telomere. Quantitative Fluorescence In Situ Hybridization (Q-FISH) was used to measure the relative telomere length of each chromosome arm in metaphases from cultured lymphocytes of 17 individuals. A statistically significant positive correlation (r = 0.6) was found between telomere length and the size of the associated chromosome arm, which was estimated based on megabase pair measurements from http://www.ncbi.nlm.nih.gov/projects/mapview/.			Wise, JL (corresponding author), W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA.	jasenwise@gmail.com		Weyant, Robert/0000-0002-5252-9120	NIDCR NIH HHS [5 R01-DE014899, R01 DE014899] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; *INT CTR BIOT INF, 2008, NAT CTR BIOT INF MAP; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Polk Deborah E, 2008, BMC Oral Health, V8, P18, DOI 10.1186/1472-6831-8-18; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Slijepcevic P, 1999, CYTOGENET CELL GENET, V85, P196, DOI 10.1159/000015292; Slijepcevic Predrag, 2001, Methods in Cell Science, V23, P17, DOI 10.1023/A:1013177128297; Sridevi V., 2002, Cytologia (Tokyo), V67, P185, DOI 10.1508/cytologia.67.185; Suda T, 2002, BIOCHEM BIOPH RES CO, V291, P210, DOI 10.1006/bbrc.2002.6425; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	15	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6013	10.1371/journal.pone.0006013	http://dx.doi.org/10.1371/journal.pone.0006013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547752	Green Published, gold, Green Accepted			2022-12-25	WOS:000267347900011
J	Chou, YH; Kuo, WL; Rosner, MR; Tang, WJ; Goldman, RD				Chou, Ying-Hao; Kuo, Wen-Liang; Rosner, Marsha Rich; Tang, Wei-Jen; Goldman, Robert D.			Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme	FASEB JOURNAL			English	Article						phosphorylation; metalloprotease; cytoskeleton	PHOSPHORYLATION SITES; PROGENITOR CELLS; NESTIN; VIMENTIN; PROTEINS; EXPRESSION; STEM; REORGANIZATION; DEGRADATION; RECOGNITION	The intermediate filament (IF) protein nestin coassembles with vimentin and promotes the disassembly of these copolymers when vimentin is hyperphosphorylated during mitosis. The aim of this study is to determine the function of these nonfilamentous particles by identifying their interacting partners. In this study, we report that these disassembled vimentin/nestin complexes interact with insulin degrading enzyme (IDE). Both vimentin and nestin interact with IDE in vitro, but vimentin binds IDE with a higher affinity than nestin. Although the interaction between vimentin and IDE is enhanced by vimentin phosphorylation at Ser-55, the interaction between nestin and IDE is phosphorylation independent. Further analyses show that phosphorylated vimentin plays the dominant role in targeting IDE to the vimentin/nestin particles in vivo, while the requirement for nestin is related to its ability to promote vimentin IF disassembly. The binding of IDE to either nestin or phosphorylated vimentin regulates IDE activity differently, depending on the substrate. The insulin degradation activity of IDE is suppressed similar to 50% by either nestin or phosphorylated vimentin, while the cleavage of bradykinin-mimetic peptide by IDE is increased 2- to 3-fold. Taken together, our data demonstrate that the nestin-mediated disassembly of vimentin IFs generates a structure capable of sequestering and modulating the activity of IDE.-Chou, Y.-H., Kuo, W.-L., Rich Rosner, M., Tang, W.-J., Goldman, R. D. Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme. FASEB J. 23, 3734-3742 (2009). www.fasebj.org	[Goldman, Robert D.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kuo, Wen-Liang] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Rosner, Marsha Rich; Tang, Wei-Jen] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago	Goldman, RD (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-goldman@northwestern.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Edward Kuczmarski and Dr. Stephen Adam for critically reading the manuscript and for suggestions. This research is supported by a grant from the National Institute of General Medical Sciences to R. D. G.	Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Chou YH, 1996, J CELL SCI, V109, P817; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fawcett J, 2007, ARCH BIOCHEM BIOPHYS, V468, P128, DOI 10.1016/j.abb.2007.09.019; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Inagaki M, 1997, J BIOCHEM, V121, P407; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES JCR, 1985, J CELL BIOL, V100, P93, DOI 10.1083/jcb.100.1.93; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2006, NATURE, V441, P296, DOI 10.1038/441296a; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Rutka JT, 1999, INT J DEV NEUROSCI, V17, P503, DOI 10.1016/S0736-5748(99)00049-0; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEJERSEN T, 1993, J CELL SCI, V106, P1291; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Sultana S, 1998, AM J PATHOL, V153, P1157, DOI 10.1016/S0002-9440(10)65660-X; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Wakamatsu Y, 2007, DEVELOPMENT, V134, P2425, DOI 10.1242/dev.02862; Weirich G, 2008, BIOL CHEM, V389, P1441, DOI 10.1515/BC.2008.157	56	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3734	3742		10.1096/fj.09-137455	http://dx.doi.org/10.1096/fj.09-137455			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19584300	Green Published, Bronze			2022-12-25	WOS:000271272500011
J	Chiu, WC; Chang, CP; Wang, CC				Chiu, Wen-Chih; Chang, Chia-Pei; Wang, Chien-Chia			Evolutionary Basis of Converting a Bacterial tRNA Synthetase into a Yeast Cytoplasmic or Mitochondrial Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONYL-TRANSFER-RNA; ELONGATION FACTOR-I; SACCHAROMYCES-CEREVISIAE; BINDING DOMAIN; MULTISYNTHETASE COMPLEX; RABBIT LIVER; GENE ENCODES; AMINOACYLATION; TRANSLATION; FEATURES	Previous studies showed that cytoplasmic and mitochondrial forms of yeast valyl-tRNA synthetase (ValRS) are specified by the VAS1 gene through alternative initiation of translation. Sequence comparison suggests that the yeast cytoplasmic (or mature mitochondrial) ValRS contains an N-terminal appendage that acts in cis as a nonspecific tRNA-binding domain (TRBD) and is absent from its bacterial relatives. We show here that Escherichia coli ValRS can substitute for the mitochondrial and cytoplasmic functions of VAS1 by fusion of a mitochondrial targeting signal and a TRBD, respectively. In addition, the bacterial ValRS gene can be converted into a dual functional yeast gene encoding both cytoplasmic and mitochondrial activities by fusion of a DNA sequence specifying both the mitochondrial targeting signal and TRBD. In vitro assays suggested that fusion of a nonspecific TRBD to the bacterial enzyme significantly enhanced its yeast tRNA-binding and aminoacylation activities. These results not only underscore the necessity of retaining a TRBD for functioning of a tRNA synthetase in yeast cytoplasm, but also provide insights into the evolution of tRNA synthetase genes.	[Chiu, Wen-Chih; Chang, Chia-Pei; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jhongli 32001, Taiwan	National Central University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli 32001, Taiwan.	dukewang@cc.ncu.edu.tw			National Science Council, Taipei, Taiwan [NSC97-2311-B-008-002-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC97-2311-B-008-002-MY3 from the National Science Council, Taipei, Taiwan ( to C.-C.W.).	BEC G, 1994, J BIOL CHEM, V269, P2086; BEC G, 1989, J BIOL CHEM, V264, P21131; BEC G, 1989, J BIOL CHEM, V264, P21138; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chen SJ, 2009, J BIOL CHEM, V284, P818, DOI 10.1074/jbc.M804378200; DIETRICH A, 1992, ANNU REV CELL BIOL, V8, P115, DOI 10.1146/annurev.cb.08.110192.000555; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Francin M, 2006, BIOCHEMISTRY-US, V45, P10153, DOI 10.1021/bi0606905; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; MIRANDE M, 1992, EUR J BIOCHEM, V203, P459, DOI 10.1111/j.1432-1033.1992.tb16570.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MOTORIN YA, 1991, EUR J BIOCHEM, V201, P325, DOI 10.1111/j.1432-1033.1991.tb16289.x; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Schimmel P, 1999, TRENDS BIOCHEM SCI, V24, P127, DOI 10.1016/S0968-0004(99)01369-9; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; VENEMA RC, 1991, J BIOL CHEM, V266, P12574; Wang CC, 2000, J BIOL CHEM, V275, P17180, DOI 10.1074/jbc.M001057200; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508	38	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23954	23960		10.1074/jbc.M109.031047	http://dx.doi.org/10.1074/jbc.M109.031047			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574213	Green Published, hybrid			2022-12-25	WOS:000269380200009
J	Hill, KK; Roemer, SC; Jones, DNM; Churchill, MEA; Edwards, DP				Hill, Krista K.; Roemer, Sarah C.; Jones, David N. M.; Churchill, Mair E. A.; Edwards, Dean P.			A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER PROTEIN; ESTROGEN RELATED RECEPTOR-2; STEROID-HORMONE RECEPTORS; NMR CHEMICAL-SHIFTS; INTRINSIC DISORDER; ANDROGEN RECEPTOR; NUCLEAR RECEPTORS; STRUCTURAL BASIS; IN-VITRO; TRANSCRIPTIONAL-ACTIVATION	Progesterone receptor (PR) belongs to the nuclear receptor family of ligand-dependent transcription factors and mediates the major biological effects of progesterone. Transcriptional coactivators that are recruited by PR through the carboxyl-terminal ligand binding domain have been studied extensively. Much less is known about co-activators that interact with other regions of receptors. Jun dimerization protein 2 (JDP2) is a PR co-activator that enhances the transcriptional activity of the amino-terminal domain by increasing the alpha-helical content and stability of the intrinsically disordered amino-terminal domain. To gain insights into the mechanism of JDP2 co-activation of PR, the structural basis of JDP2-PR interaction was analyzed using NMR. The smallest regions of each protein needed for efficient protein interaction were used for NMR and included the basic region plus leucine zipper (bZIP) domain of JDP2 and the core zinc modules of the PR DNA binding domain plus the intrinsically disordered carboxyl-terminal extension (CTE) of the DNA binding domain. Chemical shift changes in PR upon titration with JDP2 revealed that most of the residues involved in binding of JDP2 reside within the CTE. The importance of the CTE for binding JDP2 was confirmed by peptide competition and mutational analyses. Point mutations within CTE sites identified by NMR and a CTE domain swapping experiment also confirmed the functional importance of JDP2 interaction with the CTE for enhancement of PR transcriptional activity. These studies provide insights into the role and functional importance of the CTE for co-activator interactions.	[Hill, Krista K.; Jones, David N. M.; Churchill, Mair E. A.] Univ Colorado Denver, Program Mol Biol, Sch Med, Aurora, CO 80045 USA; [Roemer, Sarah C.; Jones, David N. M.; Churchill, Mair E. A.] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Baylor College of Medicine	Churchill, MEA (corresponding author), Univ Colorado Denver, Program Mol Biol, Sch Med, 12801 E,17th Ave,POB 6511,MS 8303, Aurora, CO 80045 USA.	mair.churchill@ucdenver.edu	Jones, David N/C-5764-2013; Churchill, Mair E. A./C-5549-2014	Churchill, Mair E. A./0000-0003-0862-235X	NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059456, R01GM079154] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA046934] Funding Source: Medline; NIGMS NIH HHS [R01 GM059456, R01 GM079154, R01 GM079154-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Berjanskii MV, 2007, NUCLEIC ACIDS RES, V35, pW531, DOI 10.1093/nar/gkm328; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Choudhry MA, 2006, MOL ENDOCRINOL, V20, P2052, DOI 10.1210/me.2005-0486; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dow LK, 2000, BIOCHEMISTRY-US, V39, P9725, DOI 10.1021/bi000723v; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edwards DP, 2002, J STEROID BIOCHEM, V83, P173, DOI 10.1016/S0960-0760(02)00265-0; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; Goddard T.D., SPARKY 3; GRONEMEYER H, 1995, NATURE, V375, P190, DOI 10.1038/375190a0; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hsieh JC, 1999, BIOCHEMISTRY-US, V38, P16347, DOI 10.1021/bi9916574; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Lavery DN, 2006, BIOCHEM SOC T, V34, P1054, DOI 10.1042/BST0341054; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Loven MA, 2004, MOL ENDOCRINOL, V18, P2649, DOI 10.1210/me.2003-0195; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Melvin VS, 2004, J BIOL CHEM, V279, P14763, DOI 10.1074/jbc.M313335200; Melvin VS, 2002, J BIOL CHEM, V277, P25115, DOI 10.1074/jbc.M110400200; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Miotto B, 2006, MOL CELL BIOL, V26, P5969, DOI 10.1128/MCB.00696-06; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Peterson BR, 1996, P NATL ACAD SCI USA, V93, P13671, DOI 10.1073/pnas.93.24.13671; Poukka H, 2000, J CELL SCI, V113, P2991; Poukka H, 2000, J BIOL CHEM, V275, P571, DOI 10.1074/jbc.275.1.571; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Romine LE, 1998, MOL ENDOCRINOL, V12, P664, DOI 10.1210/me.12.5.664; Schultz-Norton JR, 2007, NUCLEIC ACIDS RES, V35, P5028, DOI 10.1093/nar/gkm533; Sem DS, 1997, J BIOL CHEM, V272, P18038, DOI 10.1074/jbc.272.29.18038; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Verrier CS, 1997, MOL ENDOCRINOL, V11, P1009, DOI 10.1210/me.11.8.1009; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Wood JR, 2001, MOL ENDOCRINOL, V15, P1114, DOI 10.1210/me.15.7.1114; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	74	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24415	24424		10.1074/jbc.M109.003244	http://dx.doi.org/10.1074/jbc.M109.003244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553667	Green Published, hybrid			2022-12-25	WOS:000269380200054
J	Jang, SW; Liu, X; Fu, H; Rees, H; Yepes, M; Levey, A; Ye, KQ				Jang, Sung-Wuk; Liu, Xia; Fu, Haian; Rees, Howard; Yepes, Manuel; Levey, Allan; Ye, Keqiang			Interaction of Akt-phosphorylated SRPK2 with 14-3-3 Mediates Cell Cycle and Cell Death in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DEPENDENT KINASE INHIBITORS; ALZHEIMERS-DISEASE BRAIN; PROTEIN-SPECIFIC KINASE; RNA SPLICING FACTORS; MAMMALIAN-CELLS; SYMPATHETIC NEURONS; SUBCELLULAR-LOCALIZATION; POSTMITOTIC NEURONS; PROMOTE SURVIVAL	Terminally differentiated neurons are unable to reenter the cell cycle. Aberrant cell cycle activation provokes neuronal cell death, whereas cell cycle inhibition elevates neuronal survival. However, the molecular mechanism regulating the cell cycle and cell death in mature neurons remains elusive. Here we show that SRPK2, a protein kinase specific for the serine/arginine (SR) family of splicing factors, triggers cell cycle progression in neurons and induces apoptosis through regulation of nuclear cyclin D1. Akt phosphorylates SRPK2 on Thr-492 and promotes its nuclear translocation leading to cyclin D1 up-regulation, cell cycle reentry, and neuronal apoptosis. In addition, SRPK2 phosphorylates SC35 and, thus, inactivates p53, resulting in cyclin D1 up-regulation. 14-3-3 binding to SRPK2, regulated by Akt phosphorylation, inhibits these events. We find that SRPK2 is phosphorylated in ischemia-attacked brain, correlating with the observed increase in cyclin D1 levels. Hence, phosphatidylinositol 3-kinase/Akt mediates the cell cycle and cell death machinery in the nervous system through phosphorylation of SRPK2.	[Jang, Sung-Wuk; Liu, Xia; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Rees, Howard; Yepes, Manuel; Levey, Allan] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Rees, Howard; Yepes, Manuel; Levey, Allan] Emory Univ, Sch Med, Ctr Neurol Dis, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu	Yepes, Manuel/C-3576-2011; Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X	National Institutes of Health [RO1 NS060680]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS060680 (to K. Y.).	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Arendt T, 1996, NEUROREPORT, V7, P3047; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Busser J, 1998, J NEUROSCI, V18, P2801; CANMAN CE, 1994, COLD SPRING HARB SYM, V59, P277, DOI 10.1101/SQB.1994.059.01.032; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; McShea A, 1997, AM J PATHOL, V150, P1933; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vincent I, 1997, J NEUROSCI, V17, P3588; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002	50	90	100	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24512	24525		10.1074/jbc.M109.026237	http://dx.doi.org/10.1074/jbc.M109.026237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592491	hybrid, Green Published			2022-12-25	WOS:000269380200063
J	Kapoor, N; Bartoszewski, R; Qadri, YJ; Bebok, Z; Bubien, JK; Fuller, CM; Benos, DJ				Kapoor, Niren; Bartoszewski, Rafal; Qadri, Yawar J.; Bebok, Zsuzsanna; Bubien, James K.; Fuller, Catherine M.; Benos, Dale J.			Knockdown of ASIC1 and Epithelial Sodium Channel Subunits Inhibits Glioblastoma Whole Cell Current and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; SENSITIVE NA+ CHANNELS; MALIGNANT GLIOMA; FLUID ABSORPTION; ENAC; PHOSPHORYLATION; CONTRIBUTES; TERMINI; SITES; LUNG	High grade gliomas such as glioblastoma multiforme express multiple members of the epithelial sodium channel (ENaC)/Degenerin family, characteristically displaying a basally active amiloride-sensitive cation current not seen in normal human astrocytes or lower grade gliomas. Using quantitative real time PCR, we have shown higher expression of ASIC1, alpha ENaC, and gamma ENaC in D54-MG human glioblastoma multiforme cells compared with primary human astrocytes. We hypothesize that this glioma current is mediated by a hybrid channel composed of a mixture of ENaC and acid-sensing ion channel (ASIC) subunits. To test this hypothesis we made dominant negative cDNAs for ASIC1, alpha ENaC, gamma ENaC, and delta ENaC. D54-MG cells transfected with the dominant negative constructs for ASIC1, alpha ENaC, or gamma ENaC showed reduced protein expression and a significant reduction in the amiloride-sensitive whole cell current as compared with untransfected D54-MG cells. Knocking down alpha ENaC or gamma ENaC also abolished the high P-K(+)/P-Na(+) of D54-MG cells. Knocking down gamma ENaC in D54-MG cells reduced delta ENaC protein expression but had no effect on either the whole cell current or K+ permeability. Using coimmunoprecipitation we show interactions between ASIC1, alpha ENaC, and gamma ENaC, consistent with these subunits interacting with each other to form an ion channel in glioma cells. We also found a significant inhibition of D54-MG cell migration after ASIC1, alpha ENaC, or gamma ENaC knockdown, consistent with the hypothesis that ENaC/Degenerin subunits play an important role in glioma cell biology.	[Kapoor, Niren; Benos, Dale J.] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [Bartoszewski, Rafal; Bebok, Zsuzsanna; Benos, Dale J.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Qadri, Yawar J.; Bubien, James K.; Fuller, Catherine M.; Benos, Dale J.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama, Dept Neurobiol, 1918 Univ Blvd, Birmingham, AL 35294 USA.	Benos@uab.edu	Bartoszewski, Rafal A/D-6311-2011; Fuller, Cathy/B-4046-2011	Bartoszewski, Rafal A/0000-0002-2864-6757; Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health [CA101952, DK37206]; NATIONAL CANCER INSTITUTE [R01CA101952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grant CA101952 and DK37206.	Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Brockway LM, 2002, AM J PHYSIOL-CELL PH, V283, pC126, DOI 10.1152/ajpcell.00457.2001; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chigaev A, 2001, AM J PHYSIOL-RENAL, V280, pF1030, DOI 10.1152/ajprenal.2001.280.6.F1030; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Edinger RS, 2006, J BIOL CHEM, V281, P9110, DOI 10.1074/jbc.M509232200; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Ettaiche M, 2004, J NEUROSCI, V24, P1005, DOI 10.1523/JNEUROSCI.4698-03.2004; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Folkesson HG, 2008, AM J PHYSIOL-LUNG C, V294, pL399, DOI 10.1152/ajplung.00523.2007; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Grunder S, 2000, NEUROREPORT, V11, P1607; Guggino WB, 2000, P NATL ACAD SCI USA, V97, P9827, DOI 10.1073/pnas.97.18.9827; Hegde M, 2004, J PHARMACOL EXP THER, V310, P67, DOI 10.1124/jpet.103.065029; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Immke D C, 2001, ScientificWorldJournal, V1, P510; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V245, P589, DOI 10.1006/bbrc.1998.8483; ISMAILOV II, 1994, J BIOL CHEM, V269, P22193; Jahr H, 2005, BIOCHEM BIOPH RES CO, V337, P349, DOI 10.1016/j.bbrc.2005.09.054; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jernigan NL, 2006, AM J PHYSIOL-RENAL, V291, pF1184, DOI 10.1152/ajprenal.00177.2006; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Naves LA, 2005, BRAZ J MED BIOL RES, V38, P1561, DOI 10.1590/S0100-879X2005001100001; O'Brodovich H, 2008, AM J PHYSIOL-LUNG C, V294, pL401, DOI 10.1152/ajplung.00431.2007; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Ross SB, 2007, AM J PHYSIOL-CELL PH, V293, pC1181, DOI 10.1152/ajpcell.00066.2007; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Schwab A, 2001, NEWS PHYSIOL SCI, V16, P29, DOI 10.1152/physiologyonline.2001.16.1.29; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Swift Pauline A, 2004, Am J Pharmacogenomics, V4, P161, DOI 10.2165/00129785-200404030-00003; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	58	96	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24526	24541		10.1074/jbc.M109.037390	http://dx.doi.org/10.1074/jbc.M109.037390			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561078	Green Published, hybrid			2022-12-25	WOS:000269380200064
J	Liu, WC; Ouyang, XS; Yang, JJ; Liu, JG; Li, QS; Gu, YP; Fukata, M; Lin, T; He, JC; Abreu, M; Unkeless, JC; Mayer, L; Xiong, HB				Liu, Weicheng; Ouyang, Xinshou; Yang, Jianjun; Liu, Jianguo; Li, Qingshan; Gu, Yongpeng; Fukata, Masayuki; Lin, Tony; He, John Cijiang; Abreu, Maria; Unkeless, Jay C.; Mayer, Lloyd; Xiong, Huabao			AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; AUTOIMMUNE INFLAMMATION; DENDRITIC CELLS; ADAPTIVE IMMUNITY; CROHNS-DISEASE; P40 EXPRESSION; C-REL; IL-12	Interleukin (IL)-23, a new member of the IL-12 family, plays a central role in the Th17 immune response and in autoimmune diseases. It is clear that activated macrophages and dendritic cells produce IL-23, but the molecular mechanisms whereby inflammatory signals stimulate IL-23 expression are not fully understood. We demonstrate that induction of IL-23 p19 gene expression by LPS depends on the TLR4 and MyD88 pathways. All three MAPK pathways (ERK, JNK, and p38) that are activated by lipopolysaccharide (LPS) stimulation were shown to exert a positive effect on p19 expression. We cloned a 1.3-kb putative p19 promoter and defined its transcription initiation sites by the 5'-rapid amplification of cDNA ends method. By analyzing IL-23 p19 promoter mutants, we have identified a promoter region (-413 to + 10) that contains several important elements, including NF-kappa B and AP-1. In addition to NF-kappa B, we have demonstrated that the proximal AP-1 site is important for p19 promoter activation. Mutation of the AP-1 site resulted in the loss of p19 promoter activation. Electrophoretic mobility shift assay (EMSA) analysis showed that c-Jun and c-Fos bind to the AP-1 site, which was confirmed by a chromatin immunoprecipitation assay. Furthermore, co-transfection of c-Jun and ATF2 synergistically induced p19 promoter activation, and c-Jun and ATF2 formed a protein complex, demonstrated by co-immunoprecipitation. Finally, LPS-stimulated peritoneal macrophages from IL-10-deficient mice expressed significantly higher IL-23 p19 than macrophages from wild type mice, and the addition of recombinant IL-10 strongly inhibited LPS-induced p19 expression. Thus, this study suggests that MyD88-dependent Toll-like receptor signaling induces IL-23 p19 gene expression through both MAPKs and NF-kappa B.	[Liu, Weicheng; Ouyang, Xinshou; Yang, Jianjun; Li, Qingshan; Gu, Yongpeng; Fukata, Masayuki; Lin, Tony; Abreu, Maria; Unkeless, Jay C.; Mayer, Lloyd; Xiong, Huabao] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [He, John Cijiang] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Liu, Jianguo] St Louis Univ, Sch Med, Dept Med, Div Immunobiol, St Louis, MO 63104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Saint Louis University	Xiong, HB (corresponding author), Mt Sinai Sch Med, Inst Immunol, Box 1630,1 Gustave L Levy Pl, New York, NY 10029 USA.	Huabao.Xiong@mssm.edu	yang, jian/HIK-0188-2022; liu, weicheng/D-4173-2013		National Institutes of Health [P01 DK072201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK072201 ( to H. X.).	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Feng GJ, 1999, J IMMUNOL, V163, P6403; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	42	104	112	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24006	24016		10.1074/jbc.M109.025528	http://dx.doi.org/10.1074/jbc.M109.025528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592489	Green Published, hybrid			2022-12-25	WOS:000269380200015
J	Miesbauer, M; Pfeiffer, NV; Rambold, AS; Muller, V; Kiachopoulos, S; Winklhofer, KF; Tatzelt, J				Miesbauer, Margit; Pfeiffer, Natalie V.; Rambold, Angelika S.; Mueller, Veronika; Kiachopoulos, Sophia; Winklhofer, Konstanze F.; Tatzelt, Joerg			alpha-Helical Domains Promote Translocation of Intrinsically Disordered Polypeptides into the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SCRAPIE PRION PROTEIN; C-TERMINAL DOMAIN; SIGNAL SEQUENCES; QUALITY-CONTROL; RIBOSOME; DISEASE; CELLS; GLYCOSYLATION; CONFORMATION	Co-translational import into the endoplasmic reticulum (ER) is primarily controlled by N-terminal signal sequences that mediate targeting of the ribosome-nascent chain complex to the Sec61/translocon and initiate the translocation process. Here we show that after targeting to the translocon the secondary structure of the nascent polypeptide chain can significantly modulate translocation efficiency. ER-targeted polypeptides dominated by unstructured domains failed to efficiently translocate into the ER lumen and were subjected to proteasomal degradation via a co-translocational/preemptive pathway. Productive ER import could be reinstated by increasing the amount of alpha-helical domains, whereas more effective ER signal sequences had only a minor effect on ER import efficiency of unstructured polypeptides. ER stress and overexpression of p58(IPK) promoted the co-translocational degradation pathway. Moreover polypeptides with unstructured domains at their N terminus were specifically targeted to proteasomal degradation under these conditions. Our study indicates that extended unstructured domains are signals to dispose ER-targeted proteins via a co-translocational, preemptive quality control pathway.	[Tatzelt, Joerg] Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Tatzelt, J (corresponding author), Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de		Winklhofer, Konstanze/0000-0002-7256-8231; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB 596]; Max Planck Society; Bundesministerium fur Bildung und Forschung [DIP5.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the Bundesministerium fur Bildung und Forschung (BioDisc, DIP5.1).	Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Eberl H, 2002, BIOPHYS CHEM, V96, P293, DOI 10.1016/S0301-4622(02)00015-7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gallo M, 2005, INT J IMMUNOPATH PH, V18, P95, DOI 10.1177/039463200501800111; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Heller U, 2003, J BIOL CHEM, V278, P36139, DOI 10.1074/jbc.M304002200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; von Bergen M, 2006, NEURODEGENER DIS, V3, P197, DOI 10.1159/000095257; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2	53	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24384	24393		10.1074/jbc.M109.023135	http://dx.doi.org/10.1074/jbc.M109.023135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561072	Green Published, hybrid			2022-12-25	WOS:000269380200051
J	Cheng, SB; Amici, SA; Ren, XQ; Mckay, SB; Treuil, MW; Lindstrom, JM; Rao, J; Anand, R				Cheng, Shi-Bin; Amici, Stephanie A.; Ren, Xiao-Qin; McKay, Susan B.; Treuil, Magdalen W.; Lindstrom, Jon M.; Rao, Jayaraman; Anand, Rene			Presynaptic Targeting of alpha 4 beta 2 Nicotinic Acetylcholine Receptors Is Regulated by Neurexin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT SUBSTANTIA-NIGRA; ALPHA-NEUREXINS; SYNAPSE FORMATION; INHIBITORY SYNAPSES; CELL-ADHESION; CA2+ CHANNELS; MICE LACKING; NEUROLIGIN; SUBUNIT	The mechanisms involved in the targeting of neuronal nicotinic acetylcholine receptors (AChRs), critical for their functional organization at neuronal synapses, are not well understood. We have identified a novel functional association between alpha 4 beta 2 AChRs and the presynaptic cell adhesion molecule, neurexin-1 beta. In non-neuronal tsA 201 cells, recombinant neurexin-1 beta and mature alpha 4 beta 2 AChRs form complexes. alpha 4 beta 2 AChRs and neurexin-1 beta also coimmunoprecipitate from rat brain lysates. When exogenous alpha 4 beta 2 AChRs and neurexin-1 beta are coexpressed in hippocampal neurons, they are robustly targeted to hemi-synapses formed between these neurons and cocultured tsA 201 cells expressing neuroligin-1, a postsynaptic binding partner of neurexin-1 beta. The extent of synaptic targeting is significantly reduced in similar experiments using a mutant neurexin-1 beta lacking the extracellular domain. Additionally, when alpha 4 beta 2 AChRs, alpha 7 AChRs, and neurexin-1 beta are coexpressed in the same neuron, only the alpha 4 beta 2 AChR colocalizes with neurexin-1 beta at presynaptic terminals. Collectively, these data suggest that neurexin-1 beta targets alpha 4 beta 2 AChRs to presynaptic terminals, which mature by trans-synaptic interactions between neurexins and neuroligins. Interestingly, human neurexin-1 gene dysfunctions have been implicated in nicotine dependence and in autism spectrum disorders. Our results provide novel insights as to possible mechanisms by which dysfunctional neurexins, through downstream effects on alpha 4 beta 2 AChRs, may contribute to the etiology of these neurological disorders.	[Amici, Stephanie A.; McKay, Susan B.; Anand, Rene] Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA; [Treuil, Magdalen W.; Rao, Jayaraman] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA; [Cheng, Shi-Bin; Ren, Xiao-Qin] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Lindstrom, Jon M.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Pennsylvania	Anand, R (corresponding author), Ohio State Univ, Coll Med, Dept Pharmacol, 796 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	anand.20@osu.edu			National Institutes of Health [RO1 DA019675, RO1 NS011323]; Millennium Trust Health Excellence Fund HEF [(2002-2007)-SCP-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026240, R01DA019675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Trust Health Excellence Fund HEF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA019675 (to R. A.) and RO1 NS011323 (to J.M.L.). This work was also supported by the Millennium Trust Health Excellence Fund HEF (2002-2007)-SCP-01 (to R. A. and J.R.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ANAND R, 1991, J BIOL CHEM, V266, P11192; Arroyo-Jimenez MD, 1999, J NEUROSCI, V19, P6475; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Conroy WG, 2007, DEV BIOL, V307, P79, DOI 10.1016/j.ydbio.2007.04.017; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Goslin K., 1998, CULTURING NERVE CELL, P339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Hata Y, 1996, J NEUROSCI, V16, P2488; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; Marubio LM, 2003, EUR J NEUROSCI, V17, P1329, DOI 10.1046/j.1460-9568.2003.02564.x; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Ross BS, 2008, DEV NEUROBIOL, V68, P409, DOI 10.1002/dneu.20598; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WHITING PJ, 1988, J NEUROSCI, V8, P3395; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	54	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23251	23259		10.1074/jbc.M109.017384	http://dx.doi.org/10.1074/jbc.M109.017384			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567877	Green Published, hybrid			2022-12-25	WOS:000269180000010
J	Guttilla, IK; White, BA				Guttilla, Irene K.; White, Bruce A.			Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION; PROSTATE-CANCER; FKHR FOXO1; PHOSPHORYLATION; MICRORNAS; EXPRESSION; GROWTH; TRANSACTIVATION	The FOXO1 transcription factor orchestrates the regulation of genes involved in the apoptotic response, cell cycle checkpoints, and cellular metabolism. FOXO1 is a putative tumor suppressor, and the expression of this gene is dysregulated in some cancers, including prostate and endometrial cancers. However, the molecular mechanism resulting in aberrant expression of human FOXO1 in cancer cells is poorly understood. We show here that FOXO1 mRNA is down-regulated in breast tumor samples as compared with normal breast tissue. Silencing of the microRNA processing enzymes, Drosha and Dicer, led to an increase in FOXO1 expression. We also identified functional and specific microRNA target sites in the FOXO1 3'-untranslated region for miR-27a, miR-96, and miR-182, microRNAs that have previously been linked to oncogenic transformation. The three microRNAs, miR-27a, miR-96 and miR-182, were observed to be highly expressed in MCF-7 breast cancer cells, in which the level of FOXO1 protein is very low. Antisense inhibitors to each of these microRNAs led to a significant increase in endogenous FOXO1 expression and to a decrease in cell number in a manner that was blocked by FOXO1 siRNA. Overexpression of FOXO1 resulted in decreased cell viability because of inhibition of cell cycle traverse and induction of cell death. We have identified a novel mechanism of FOXO1 regulation, and targeting of FOXO1 by microRNAs may contribute to transformation or maintenance of an oncogenic state in breast cancer cells.	[White, Bruce A.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Guttilla, Irene K.; White, Bruce A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	White, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	bwhite@nso2.uchc.edu		Guttilla Reed, Irene/0000-0002-6617-1465				Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Goto T, 2008, BRIT J CANCER, V98, P1068, DOI 10.1038/sj.bjc.6604279; Goto T, 2008, ONCOGENE, V27, P9, DOI 10.1038/sj.onc.1210626; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	40	491	523	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23204	23216		10.1074/jbc.M109.031427	http://dx.doi.org/10.1074/jbc.M109.031427			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574223	Green Published, hybrid			2022-12-25	WOS:000269180000005
J	Schonauer, MS; Kastaniotis, AJ; Kursu, VAS; Hiltunen, JK; Dieckmann, CL				Schonauer, Melissa S.; Kastaniotis, Alexander J.; Kursu, V. A. Samuli; Hiltunen, J. Kalervo; Dieckmann, Carol L.			Lipoic Acid Synthesis and Attachment in Yeast Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOATE-PROTEIN LIGASE; ACYL CARRIER PROTEIN; PYRUVATE-DEHYDROGENASE COMPLEX; ALPHA-KETOGLUTARATE DEHYDROGENASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; BOVINE LIVER; GENE	Lipoic acid is a sulfur-containing cofactor required for the function of several multienzyme complexes involved in the oxidative decarboxylation of alpha-keto acids and glycine. Mechanistic details of lipoic acid metabolism are unclear in eukaryotes, despite two well defined pathways for synthesis and covalent attachment of lipoic acid in prokaryotes. We report here the involvement of four genes in the synthesis and attachment of lipoic acid in Saccharomyces cerevisiae. LIP2 and LIP5 are required for lipoylation of all three mitochondrial target proteins: Lat1 and Kgd2, the respective E2 subunits of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, and Gcv3, the H protein of the glycine cleavage enzyme. LIP3, which encodes a lipoate-protein ligase homolog, is necessary for lipoylation of Lat1 and Kgd2, and the enzymatic activity of Lip3 is essential for this function. Finally, GCV3, encoding the H protein target of lipoylation, is itself absolutely required for lipoylation of Lat1 and Kgd2. We show that lipoylated Gcv3, and not glycine cleavage activity per se, is responsible for this function. Demonstration that a target of lipoylation is required for lipoylation is a novel result. Through analysis of the role of these genes in protein lipoylation, we conclude that only one pathway for de novo synthesis and attachment of lipoic acid exists in yeast. We propose a model for protein lipoylation in which Lip2, Lip3, Lip5, and Gcv3 function in a complex, which may be regulated by the availability of acetyl-CoA, and which in turn may regulate mitochondrial gene expression.	[Dieckmann, Carol L.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Kastaniotis, Alexander J.; Kursu, V. A. Samuli; Hiltunen, J. Kalervo] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Kastaniotis, Alexander J.; Kursu, V. A. Samuli; Hiltunen, J. Kalervo] Univ Oulu, Bioctr, FI-90014 Oulu, Finland	University of Arizona; University of Arizona; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Dieckmann, CL (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, POB 210106, Tucson, AZ 85721 USA.	dieckman@u.arizona.edu		Hiltunen, Kalervo/0000-0002-3073-9602; Kastaniotis, Alexander/0000-0003-3624-9214	National Institutes of Health [GM34893, T3208659]; National Science Foundation Integrative Graduate Education and Research Traineeship Program in Evolutionary, Functional, and Computational Genomics, University of Arizona; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Integrative Graduate Education and Research Traineeship Program in Evolutionary, Functional, and Computational Genomics, University of Arizona; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34893 (to C. L. D.).; Supported by National Institutes of Health Grant T3208659 (Graduate Training in Biochemistry and Molecular Biology) and a fellowship from the National Science Foundation Integrative Graduate Education and Research Traineeship Program in Evolutionary, Functional, and Computational Genomics, University of Arizona.	Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Booker SJ, 2004, CHEM BIOL, V11, P10, DOI 10.1016/j.chembiol.2004.01.002; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 1999, EUR J BIOCHEM, V260, P761, DOI 10.1046/j.1432-1327.1999.00204.x; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; HERBERT A. A., 1970, Methods in Enzymology, V18A, P269, DOI 10.1016/0076-6879(71)18314-0; HERBERT AA, 1975, ARCH MICROBIOL, V106, P259, DOI 10.1007/BF00446532; HERBERT AA, 1968, J GEN MICROBIOL, V53, P363, DOI 10.1099/00221287-53-3-363; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; Kang SG, 2007, GENE, V393, P53, DOI 10.1016/j.gene.2007.01.011; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; KRESZE GB, 1981, EUR J BIOCHEM, V119, P573, DOI 10.1111/j.1432-1033.1981.tb05646.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Marvin ME, 2001, FEMS MICROBIOL LETT, V199, P131, DOI 10.1016/S0378-1097(01)00170-7; MCGRAW P, 1983, J BIOL CHEM, V258, P9459; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Morikawa T, 2001, FEBS LETT, V498, P16, DOI 10.1016/S0014-5793(01)02469-3; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Reche PA, 2000, PROTEIN SCI, V9, P1922, DOI 10.1110/ps.9.10.1922; REED LJ, 1990, J BIOL CHEM, V265, P8971; REMES AM, 1992, PEDIATRICS, V89, P730; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; SULO P, 1993, J BIOL CHEM, V268, P17634; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	51	92	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23234	23242		10.1074/jbc.M109.015594	http://dx.doi.org/10.1074/jbc.M109.015594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570983	hybrid, Green Published			2022-12-25	WOS:000269180000008
J	Carafoli, F; Clout, NJ; Hohenester, E				Carafoli, Federico; Clout, Naomi J.; Hohenester, Erhard			Crystal Structure of the LG1-3 Region of the Laminin alpha 2 Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; DYSTROGLYCAN-BINDING; INTEGRIN-BINDING; CELL-ADHESION; GLOBULAR DOMAIN; MOLECULAR DISSECTION; TERTIARY STRUCTURE; LIGAND-BINDING; LG MODULES; LONG-ARM	Laminins are large heterotrimeric glycoproteins with many essential functions in basement membrane assembly and function. Cell adhesion to laminins is mediated by a tandem of five laminin G-like (LG) domains at the C terminus of the alpha chain. Integrin binding requires an intact LG1-3 region, as well as contributions from the coiled coil formed by the alpha, beta, and gamma chains. We have determined the crystal structure at 2.8-angstrom resolution of the LG1-3 region of the laminin alpha 2 chain (alpha 2LG1-3). The three LG domains adopt typical beta-sandwich folds, with canonical calcium binding sites in LG1 and LG2. LG2 and LG3 interact through a substantial interface, but LG1 is completely dissociated from the LG2-3 pair. We suggest that the missing gamma chain tail may be required to stabilize the interaction between LG1 and LG2-3 in the biologically active conformation. A global analysis of N-linked glycosylation sites shows that the beta-sandwich faces of LG1 are free of carbohydrate modifications in all five laminin alpha chains, suggesting that these surfaces may harbor the integrin binding site. The alpha 2LG1-3 structure provides the first atomic view of the integrin binding region of laminins.	[Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Dept Life Sci, Prince Consort Rd, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk			Wellcome Trust Senior Research Fellowship; BBSRC [BB/D524840/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524840/1] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Senior Research Fellowship (to E.H.) (Refs. 054334 and 083942).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BRUCH M, 1989, EUR J BIOCHEM, V185, P271, DOI 10.1111/j.1432-1033.1989.tb15112.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kikkawa Y, 2006, DEV BIOL, V296, P265, DOI 10.1016/j.ydbio.2006.04.463; Kim JM, 2005, EXP CELL RES, V304, P317, DOI 10.1016/j.yexcr.2004.11.009; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Navdaev Alexei, 2008, Exp Cell Res, V314, P489, DOI 10.1016/j.yexcr.2007.10.027; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Shang ML, 2001, J BIOL CHEM, V276, P33045, DOI 10.1074/jbc.M100798200; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Talts JF, 1999, FEBS LETT, V458, P319, DOI 10.1016/S0014-5793(99)01180-1; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; Taniguchi Y, 2009, J BIOL CHEM, V284, P7820, DOI 10.1074/jbc.M809332200; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500	54	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22786	22792		10.1074/jbc.M109.026658	http://dx.doi.org/10.1074/jbc.M109.026658			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553699	Green Published, hybrid			2022-12-25	WOS:000268963100032
J	Taulet, N; Comunale, F; Favard, C; Charrasse, S; Bodin, S; Gauthier-Rouviere, C				Taulet, Nicolas; Comunale, Franck; Favard, Cyril; Charrasse, Sophie; Bodin, Stephane; Gauthier-Rouviere, Cecile			N-cadherin/p120 Catenin Association at Cell-Cell Contacts Occurs in Cholesterol-rich Membrane Domains and Is Required for RhoA Activation and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; P120 CATENIN; BETA-CATENIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN CYTOSKELETON; C2C12 MYOBLASTS; ALPHA-CATENIN; ADHESION; P120-CATENIN; JUNCTIONS	p120 catenin is a major regulator of cadherin stability at cell-cell contacts and a modulator of Rho GTPase activities. In C2C12 myoblasts, N-cadherin is stabilized at cell contacts through its association with cholesterol-rich membrane domains or lipid rafts (LR) and acts as an adhesion-activated receptor that activates RhoA, an event required for myogenesis induction. Here, we report that association of p120 catenin with N-cadherin at cell contacts occurs specifically in LR. We demonstrate that interaction of p120 catenin with N-cadherin is required for N-cadherin association with LR and for its stabilization at cell contacts. LR disruption inhibits myogenesis induction and N-cadherin-dependent RhoA activation as does the perturbation of the N-cadherin-p120 catenin complex after p120 catenin knockdown. Finally, we observe an N-cadherin-dependent accumulation of RhoA at phosphatidylinositol 4,5-bisphosphate- enriched cell contacts which is lost after LR disruption. Thus, a functional N-cadherin-catenin complex occurs in cholesterol-rich membrane microdomains which allows the recruitment of RhoA and the regulation of its activity during myogenesis induction.	[Taulet, Nicolas; Comunale, Franck; Charrasse, Sophie; Bodin, Stephane; Gauthier-Rouviere, Cecile] Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol,Inst Federatif Rech 122, F-34293 Montpellier, France; [Taulet, Nicolas; Comunale, Franck; Charrasse, Sophie; Bodin, Stephane; Gauthier-Rouviere, Cecile] Univ Montpellier 1, CNRS, UMR 5237, Ctr Rech Biochim Macromol,Inst Federatif Rech 122, F-34293 Montpellier, France; [Favard, Cyril] Domaine Univ St Jerome, Inst Fresnel, F-13397 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite	Gauthier-Rouviere, C (corresponding author), Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol,Inst Federatif Rech 122, 1919 Route Mende, F-34293 Montpellier, France.	cecile.gauthier@crbm.cnrs.fr	Favard, Cyril/P-6392-2016	Favard, Cyril/0000-0002-8304-2980; Comunale, Franck/0000-0001-8838-2151	Ligue Nationale contre le Cancer (Equipe labellisee); Association Francaise contre les Myopathies; Agence Nationale de la Recherche; Association Francaise pour la Recherche contre le Cancer	Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise pour la Recherche contre le Cancer	This work was supported in part by the Ligue Nationale contre le Cancer (Equipe labellisee), Association Francaise contre les Myopathies, Agence Nationale de la Recherche, and Association Francaise pour la Recherche contre le Cancer.	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Comunale F, 2007, BIOL CELL, V99, P503, DOI 10.1042/BC20070011; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; El Sayegh TY, 2007, MOL BIOL CELL, V18, P3026, DOI 10.1091/mbc.E06-12-1159; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kanno M, 2008, EXP CELL RES, V314, P1683, DOI 10.1016/j.yexcr.2008.01.031; Knudsen KA, 1990, CURR OPIN CELL BIOL, V2, P902, DOI 10.1016/0955-0674(90)90090-2; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	40	38	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23137	23145		10.1074/jbc.M109.017665	http://dx.doi.org/10.1074/jbc.M109.017665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546217	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000268963100065
J	Li, Y; Zhou, Z; Alimandi, M; Chen, C				Li, Y.; Zhou, Z.; Alimandi, M.; Chen, C.			WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer	ONCOGENE			English	Article						WWP1; ErbB4; PY motif; WW domain; ubiquitination; degradation	ESTROGEN-RECEPTOR; INTRACELLULAR DOMAIN; MITOTIC PROGRESSION; EPITHELIAL-CELLS; EXPRESSION; HER4; GROWTH; DIFFERENTIATION; FAMILY; PHOSPHORYLATION	ErbB4, a member of the epidermal growth factor receptor family, plays a role in normal breast and breast cancer development by regulating mammary epithelial cell proliferation, survival and differentiation. In this study, we show that WWP1, a C2-WW-HECT type E3 ubiquitin ligase, binds, ubiquitinates and destructs ErbB4-CYT1, but much less efficiently for CYT2, isoforms (both JMa and JMb). The protein-protein interaction occurs primarily between the first and third WW domains of WWP1 and the second PY motif of ErbB4. Knockdown of WWP1 by two different small interfering RNAs increases the endogenous ErbB4 protein levels in both MCF7 and T47D breast cancer cell lines. In addition, overexpression of the wild type, but not the catalytic inactive WWP1, dramatically decreases the endogenous ErbB4 protein levels in MCF7. Importantly, we found that WWP1 negatively regulates the heregulin-beta 1-stimulated ErbB4 activity as measured by the serum response element report assay and the BRCA1 mRNA expression. After a systematic screening of all WWP1 family members by small interfering RNA, we found that AIP4/Itch and HECW1/NEDL1 also negatively regulate the ErbB4 protein expression in T47D. Interestingly, the protein expression levels of both WWP1 and ErbB4 are higher in estrogen receptor-alpha-positive than in estrogen receptor-alpha-negative breast cancer cell lines. These data suggest that WWP1 and its family members suppress the ErbB4 expression and function in breast cancer. Oncogene (2009) 28, 2948-2958; doi:10.1038/onc.2009.162; published online 29 June 2009	[Li, Y.; Zhou, Z.; Chen, C.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Alimandi, M.] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy	Albany Medical College; Sapienza University Rome	Chen, C (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MS355,Mail Code 165,47 New Scotland Ave, Albany, NY 12208 USA.	chenc@mail.amc.edu	Alimandi, Maurizio/AAG-9246-2019	Alimandi, Maurizio/0000-0002-1409-6803	Department of Defense BCRP [W81XWH-08-1-0557]; PCRP IDEA [W81XWH-07-1-0191]; American Cancer Society; Komen for the Cure [BCTR0503705]	Department of Defense BCRP(United States Department of Defense); PCRP IDEA; American Cancer Society(American Cancer Society); Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	This work was supported in part by grants from the Department of Defense BCRP concept award (W81XWH-08-1-0557) and PCRP IDEA award (W81XWH-07-1-0191), a Research Scholar Award from the American Cancer Society and a Grant (BCTR0503705, Chen, C) from Komen for the Cure.	Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Barnes NLP, 2005, CLIN CANCER RES, V11, P2163, DOI 10.1158/1078-0432.CCR-04-1633; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Chen C, 2007, INT J CANCER, V121, P2834; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen CS, 2009, INT J CANCER, V124, P2829, DOI 10.1002/ijc.24266; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Feng SM, 2007, MOL ENDOCRINOL, V21, P1861, DOI 10.1210/me.2006-0101; Feng SM, 2009, MOL CELL BIOL, V29, P892, DOI 10.1128/MCB.00595-08; Huu NSN, 2008, J PATHOL, V216, P93, DOI 10.1002/path.2385; Jackson-Fisher AJ, 2006, ONCOGENE, V25, P5664, DOI 10.1038/sj.onc.1209574; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Muraoka-Cook RS, 2008, MOL ENDOCRINOL, V22, P2307, DOI 10.1210/me.2008-0055; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muraoka-Cook RS, 2006, MOL CELL BIOL, V26, P6412, DOI 10.1128/MCB.01950-05; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Pitfield SE, 2006, ONCOL RES, V16, P179, DOI 10.3727/000000006783981134; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Strunk KE, 2007, CANCER RES, V67, P6582, DOI 10.1158/0008-5472.CAN-06-4145; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Suo ZH, 2001, VIRCHOWS ARCH, V439, P62, DOI 10.1007/s004280000392; Tang CK, 1999, CANCER RES, V59, P5315; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vidal GA, 2007, ONCOGENE, V26, P462, DOI 10.1038/sj.onc.1209794; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	38	57	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2009	28	33					2948	2958		10.1038/onc.2009.162	http://dx.doi.org/10.1038/onc.2009.162			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19561640				2022-12-25	WOS:000269142800003
J	Ahmed, K; Tunaru, S; Langhans, CD; Hanson, J; Michalski, CW; Kolker, S; Jones, PM; Okun, JG; Offermanns, S				Ahmed, Kashan; Tunaru, Sorin; Langhans, Claus-Dieter; Hanson, Julien; Michalski, Christoph W.; Koelker, Stefan; Jones, Patricia M.; Okun, Juergen G.; Offermanns, Stefan			Deorphanization of GPR109B as a Receptor for the beta-Oxidation Intermediate 3-OH-octanoic Acid and Its Role in the Regulation of Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY SELECTIVE AGONISTS; PROTEIN-COUPLED RECEPTOR; 3-HYDROXY FATTY-ACIDS; NICOTINIC-ACID; MOLECULAR-IDENTIFICATION; PUMA-G; HM74; ADIPOCYTES; PATHWAY; OBESITY	The orphan G-protein-coupled receptor GPR109B is the result of a recent gene duplication of the nicotinic acid and ketone body receptor GPR109A being found in humans but not in rodents. Like GPR109A, GPR109B is predominantly expressed in adipocytes and is supposed to mediate antilipolytic effects. Here we show that GPR109B serves as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid, which has antilipolytic activity on human but not on murine adipocytes. GPR109B is coupled toG(i)-type G-proteins and is activated by 2- and 3-OH-octanoic acid with EC50 values of about 4 and 8 mu M, respectively. Interestingly, 3-OH-octanoic acid plasma concentrations reach micromolar concentrations under conditions of increased beta-oxidation rates, like in diabetic ketoacidosis or under a ketogenic diet. These data suggest that the ligand receptor pair 3-OH-octanoic acid/GPR109B mediates in humans a negative feedback regulation of adipocyte lipolysis to counteract prolipolytic influences under conditions of physiological or pathological increases in beta-oxidation rates.	[Ahmed, Kashan; Tunaru, Sorin; Hanson, Julien; Offermanns, Stefan] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; [Langhans, Claus-Dieter; Koelker, Stefan; Okun, Juergen G.] Univ Childrens Hosp Heidelberg, Div Inherited Metab Dis, Dept Gen Pediat, D-69120 Heidelberg, Germany; [Hanson, Julien] Univ Liege, Dept Med Chem, Ctr Interfac Rech Med, B-4000 Liege, Belgium; [Michalski, Christoph W.] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany; [Jones, Patricia M.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Dept Pathol, Dallas, TX 75235 USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Liege; Technical University of Munich; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Offermanns, S (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@mpi-bn.mpg.de	Tunaru, Sorin/G-8516-2011; Michalski, Christoph/U-9167-2019; Hanson, Julien/A-8242-2008; Offermanns, Stefan/L-3313-2017	Tunaru, Sorin/0000-0002-6005-1737; Hanson, Julien/0000-0001-7063-7590; Offermanns, Stefan/0000-0001-8676-6805	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	This work was supported in part by a grant from the German Research Foundation.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Costa CG, 1998, CLIN CHEM, V44, P463; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; HAGENFELDT L, 1990, J PEDIATR-US, V116, P387, DOI 10.1016/S0022-3476(05)82826-4; HOSHI M, 1973, J NEUROCHEM, V21, P709, DOI 10.1111/j.1471-4159.1973.tb06017.x; Irukayama-Tomobe Y, 2009, P NATL ACAD SCI USA, V106, P3930, DOI 10.1073/pnas.0811844106; Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590; Jones PM, 2000, J INHERIT METAB DIS, V23, P745, DOI 10.1023/A:1005643201489; Jones PM, 2002, CLIN CHEM, V48, P176; KISHIMOTO Y, 1963, J LIPID RES, V4, P139; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Nordli DR, 1992, MEDICAL TREATMENT EP, P455; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; RODBELL M, 1964, J BIOL CHEM, V239, P375; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; SENIOR B, 1968, NATURE, V219, P83, DOI 10.1038/219083a0; Skinner PJ, 2007, BIOORG MED CHEM LETT, V17, P6619, DOI 10.1016/j.bmcl.2007.09.058; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Westman Eric C, 2003, Curr Atheroscler Rep, V5, P476, DOI 10.1007/s11883-003-0038-6; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zellner C, 2005, HUM MUTAT, V25, P18, DOI 10.1002/humu.20121	31	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21928	21933		10.1074/jbc.M109.019455	http://dx.doi.org/10.1074/jbc.M109.019455			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19561068	Green Published, hybrid			2022-12-25	WOS:000268783700017
J	Sun, WJ; Sun, CK; Zhao, H; Lin, H; Han, QQ; Wang, JY; Ma, H; Chen, B; Xiao, ZF; Dai, JW				Sun, Wenjie; Sun, Changkai; Zhao, Hui; Lin, Hang; Han, Qianqian; Wang, Jingyu; Ma, Hui; Chen, Bing; Xiao, Zhifeng; Dai, Jianwu			Improvement of Sciatic Nerve Regeneration Using Laminin-Binding Human NGF-beta	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; GROWTH-FACTOR; WALLERIAN DEGENERATION; DOMAIN; CELLS; INJURY; MANAGEMENT; PERONEAL; GRAFTS; AGRIN	Background: Sciatic nerve injuries often cause partial or total loss of motor, sensory and autonomic functions due to the axon discontinuity, degeneration, and eventual death which finally result in substantial functional loss and decreased quality of life. Nerve growth factor (NGF) plays a critical role in peripheral nerve regeneration. However, the lack of efficient NGF delivery approach limits its clinical applications. We reported here by fusing with the N-terminal domain of agrin (NtA), NGF-beta could target to nerve cells and improve nerve regeneration. Methods: Laminin-binding assay and sustained release assay of NGF-beta fused with NtA (LBD-NGF) from laminin in vitro were carried out. The bioactivity of LBD-NGF on laminin in vitro was also measured. Using the rat sciatic nerve crush injury model, the nerve repair and functional restoration by utilizing LBD-NGF were tested. Findings: LBD-NGF could specifically bind to laminin and maintain NGF activity both in vitro and in vivo. In the rat sciatic nerve crush injury model, we found that LBD-NGF could be retained and concentrated at the nerve injury sites to promote nerve repair and enhance functional restoration following nerve damages. Conclusion: Fused with NtA, NGF-beta could bind to laminin specifically. Since laminin is the major component of nerve extracellular matrix, laminin binding NGF could target to nerve cells and improve the repair of peripheral nerve injuries.			Sun, WJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn	Lin, Hang/AFO-8482-2022; Lin, Hang/D-3003-2012; SUN, CHANG/GXM-3680-2022	Lin, Hang/0000-0002-0781-6630; 				Apfel SC, 1998, NEUROLOGY, V51, P695, DOI 10.1212/WNL.51.3.695; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; CHAUDHRY V, 1992, MUSCLE NERVE, V15, P687, DOI 10.1002/mus.880150610; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; DELLON AL, 1989, ANN PLAS SURG, V23, P197, DOI 10.1097/00000637-198909000-00002; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; George LT, 2003, J RECONSTR MICROSURG, V19, P41, DOI 10.1055/s-2003-37190; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gu ZY, 2002, PROTEIN EXPRES PURIF, V25, P174, DOI 10.1006/prep.2002.1624; Haller MF, 1998, J CONTROL RELEASE, V53, P1, DOI 10.1016/S0168-3659(97)00232-0; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kline DG, 1998, J NEUROSURG, V89, P13, DOI 10.3171/jns.1998.89.1.0013; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Kordower JH, 1996, NEUROSCIENCE, V72, P63, DOI 10.1016/0306-4522(95)00543-9; Korompilias AV, 2006, MICROSURG, V26, P288, DOI 10.1002/micr.20241; LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862; LONGO FM, 1984, BRAIN RES, V309, P105, DOI 10.1016/0006-8993(84)91014-X; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; MARKOWSKA AL, 1994, J NEUROSCI, V14, P4815; MartinezSerrano A, 1996, J NEUROSCI, V16, P4604; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; Martins RS, 2006, ARQ NEURO-PSIQUIAT, V64, P750, DOI 10.1590/S0004-282X2006000500010; Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041; Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Rosberg HE, 2005, SCAND J PLAST RECONS, V39, P360, DOI 10.1080/02844310500340046; Rossi L, 2002, INT J RADIAT ONCOL, V53, P1319, DOI 10.1016/S0360-3016(02)02865-1; SHIH A, 1994, J BIOL CHEM, V269, P27679; Soussand J, 2001, NEUROREPORT, V12, P1073, DOI 10.1097/00001756-200104170-00041; Starr PA, 1999, CELL TRANSPLANT, V8, P37, DOI 10.1177/096368979900800113; Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422; Stoll G, 1999, BRAIN PATHOL, V9, P313; Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417; TONG XJ, 1994, BRAIN RES, V663, P155, DOI 10.1016/0006-8993(94)90473-1; Tuszynski MH, 1996, GENE THER, V3, P305; Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1; YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553; Yurchenco PD, 2002, METHOD CELL BIOL, V69, P111, DOI 10.1016/S0091-679X(02)69010-7	48	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6180	10.1371/journal.pone.0006180	http://dx.doi.org/10.1371/journal.pone.0006180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587785	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035100007
J	Jubault, T; Monetta, L; Strafella, AP; Lafontaine, AL; Monchi, O				Jubault, Thomas; Monetta, Laura; Strafella, Antonio P.; Lafontaine, Anne-Louise; Monchi, Oury			L-Dopa Medication in Parkinson's Disease Restores Activity in the Motor Cortico-Striatal Loop but Does Not Modify the Cognitive Network	PLOS ONE			English	Article								Background: The goal of this study was to evaluate the effects of L-Dopa medication in Parkinson's disease (PD) on brain activation during the performance of a set-shifting task. Using fMRI, we have previously studied the patterns of activity observed in patients with PD after overnight removal of dopaminergic medication compared with control participants during the performance of different stages of the Wisconsin Card Sorting Task (WCST). The results revealed decreased cortical activity in the PD group compared to controls in the conditions that significantly required striatum, while increased cortical activity was observed when striatum was not involved. However, the effect of dopaminergic medication in PD patients on those patterns of activity has not yet been studied. Methodology/Principal Findings: Here, eleven PD patients at early stage of the disease taking L-Dopa medication were recruited and underwent two fMRI sessions while performing the WCST: one session while taking their normal dose of medication and the other following overnight dopaminergic medication withdrawal. We found that L-dopa medication helped restoring a normal pattern of activity when matching and not planning was required, by increasing cortical activity in the premotor cortex. This effect was even stronger in the motor loop, i.e. when the putamen was required for controls, when matching following negative feedback. However, the medication did not change the pattern of activity in conditions relying primarily on a cognitive loop, i.e. when the caudate nucleus was required. Conclusions/Significance: These studies provide explanation at the neural level regarding the relatively poor effects of L-Dopa on the cognitive deficits observed in PD.			Jubault, T (corresponding author), Inst Univ Geriatrie Montreal, Unite Neuroimagerie Fonct, Montreal, PQ, Canada.	oury.monchi@umontreal.ca	Monchi, Oury/N-8417-2019; Monetta, Laura/AAK-7657-2020	Monetta, Laura/0000-0002-4534-761X				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Cools R, 2002, BRAIN, V125, P584, DOI 10.1093/brain/awf052; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Emre M, 2004, CURR OPIN NEUROL, V17, P399, DOI 10.1097/01.wco.0000137529.30750.ab; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Hirano S, 2008, J NEUROSCI, V28, P4201, DOI 10.1523/JNEUROSCI.0582-08.2008; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Lange KW, 1995, J NEURAL TRANSM-SUPP, P423; LANGSTON JW, 1992, MOVEMENT DISORD, P2; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; Mattay VS, 2002, ANN NEUROL, V51, P156, DOI 10.1002/ana.10078; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Nandhagopal R, 2008, NEUROLOGY, V70, P1478, DOI 10.1212/01.wnl.0000310432.92489.90; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; SCHUBERT T, 2002, EFFECTS PALLIDAL DEE, P8; TAYLOR AE, 1986, FRONTAL LOBE DYSFUNC, P845; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	27	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6154	10.1371/journal.pone.0006154	http://dx.doi.org/10.1371/journal.pone.0006154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584921	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806400010
J	Dong, M; Fu, YF; Du, TT; Jing, CB; Fu, CT; Chen, Y; Jin, Y; Deng, M; Liu, TX				Dong, Mei; Fu, Yan-Fang; Du, Ting-Ting; Jing, Chang-Bin; Fu, Chun-Tang; Chen, Yi; Jin, Yi; Deng, Min; Liu, Ting Xi			Heritable and Lineage-Specific Gene Knockdown in Zebrafish Embryo	PLOS ONE			English	Article								Background: Reduced expression of developmentally important genes and tumor suppressors due to haploinsufficiency or epigenetic suppression has been shown to contribute to the pathogenesis of various malignancies. However, methodology that allows spatio-temporally knockdown of gene expression in various model organisms such as zebrafish has not been well established, which largely limits the potential of zebrafish as a vertebrate model of human malignant disorders. Principal Finding: Here, we report that multiple copies of small hairpin RNA (shRNA) are expressed from a single transcript that mimics the natural microRNA-30e precursor (mir-shRNA). The mir-shRNA, when microinjected into zebrafish embryos, induced an efficient knockdown of two developmentally essential genes chordin and alpha-catenin in a dose-controllable fashion. Furthermore, we designed a novel cassette vector to simultaneously express an intronic mir-shRNA and a chimeric red fluorescent protein driven by lineage-specific promoter, which efficiently reduced the expression of a chromosomally integrated reporter gene and an endogenously expressed gata-1 gene in the developing erythroid progenitors and hemangioblasts, respectively. Significance: This methodology provides an invaluable tool to knockdown developmental important genes in a tissue-specific manner or to establish animal models, in which the gene dosage is critically important in the pathogenesis of human disorders. The strategy should be also applicable to other model organisms.			Dong, M (corresponding author), Chinese Acad Sci, Lab Dev & Dis, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	mdeng@sibs.ac.cn; txliu@sibs.ac.cn	Jing, Changbin/X-2726-2019	Jing, Changbin/0000-0003-0037-2712; Du, Ting-Ting/0000-0003-0333-8739				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUER M, 2008, GENE THER; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; FU YF, 2008, BLOOD; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Leung AYH, 2005, DEV BIOL, V277, P235, DOI 10.1016/j.ydbio.2004.09.032; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Long QM, 1997, DEVELOPMENT, V124, P4105; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; MENG X, 2008, NAT BIOTECHNOL; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang L, 2008, DEV DYNAM, V237, P2139, DOI 10.1002/dvdy.21630; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6125	10.1371/journal.pone.0006125	http://dx.doi.org/10.1371/journal.pone.0006125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582161	Green Published, gold			2022-12-25	WOS:000267806300003
J	Yang, CT; Zeng, XH; Xia, XM; Lingle, CJ				Yang, Cheng-Tao; Zeng, Xu-Hui; Xia, Xiao-Ming; Lingle, Christopher J.			Interactions between beta Subunits of the KCNMB Family and Slo3: beta 4 Selectively Modulates Slo3 Expression and Function	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; LARGE-CONDUCTANCE; POTASSIUM CHANNELS; SURFACE EXPRESSION; BK CHANNELS; VOLTAGE; CA2+; INACTIVATION; SPERMATOZOA; CURRENTS	Background: The pH and voltage-regulated Slo3 K+ channel, a homologue of the Ca2+- and voltage-regulated Slo1 K+ channel, is thought to be primarily expressed in sperm, but the properties of Slo3 studied in heterologous systems differ somewhat from the native sperm KSper pH-regulated current. There is the possibility that critical partners that regulate Slo3 function remain unidentified. The extensive amino acid identity between Slo3 and Slo1 suggests that auxiliary beta subunits regulating Slo1 channels might coassemble with and modulate Slo3 channels. Four distinct beta subunits composing the KCNMB family are known to regulate the function and expression of Slo1 Channels. Methodology/Principal Findings: To examine the ability of the KCNMB family of auxiliary beta subunits to regulate Slo3 function, we co-expressed Slo3 and each beta subunit in heterologous expression systems and investigated the functional consequences by electrophysiological and biochemical analyses. The beta 4 subunit produced an 8-10 fold enhancement of Slo3 current expression in Xenopus oocytes and a similar enhancement of Slo3 surface expression as monitored by YFP-tagged Slo3 or biotin labeled Slo3. Neither beta 1, beta 2, nor beta 3 mimicked the ability of beta 4 to increase surface expression, although biochemical tests suggested that all four beta subunits are competent to coassemble with Slo3. Fluorescence microscopy from beta 4 KO mice, in which an eGFP tag replaced the deleted exon, revealed that beta 4 gene promoter is active in spermatocytes. Furthermore, quantitative RT-PCR demonstrated that beta 4 and Slo3 exhibit comparable mRNA abundance in both testes and sperm. Conclusions/Significance: These results argue that, for native mouse Slo3 channels, the beta 4 subunit must be considered as a potential interaction partner and, furthermore, that KCNMB subunits may have functions unrelated to regulation of the Slo1 alpha subunit.			Yang, CT (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	zengx@morpheus.wustl.edu; clingle@morpheus.wustl.edu		Lingle, Christopher/0000-0002-9916-3795	NIGMS NIH HHS [R01 GM068580, GM081748, GM068580, R01 GM081748] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081748, R01GM068580] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Koutsouki E, 2007, BIOCHEM BIOPH RES CO, V363, P18, DOI 10.1016/j.bbrc.2007.07.181; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Lingle CJ, 2006, J NEUROSCI METH, V158, P121, DOI 10.1016/j.jneumeth.2006.05.027; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Strobaek D, 1996, NEUROPHARMACOLOGY, V35, P903, DOI 10.1016/0028-3908(96)00096-2; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2007, J NEUROSCI, V27, P4707, DOI 10.1523/JNEUROSCI.0758-07.2007; ZHANG X, J GEN PHYSL, V128, P301; Zhang X, 2006, J GEN PHYSIOL, V128, P317, DOI 10.1085/jgp.200609552	31	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6135	10.1371/journal.pone.0006135	http://dx.doi.org/10.1371/journal.pone.0006135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578543	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806300007
J	Sitkiewicz, I; Green, NM; Guo, N; Bongiovanni, AM; Witkin, SS; Musser, JM				Sitkiewicz, Izabela; Green, Nicole M.; Guo, Nina; Bongiovanni, Ann Marie; Witkin, Steven S.; Musser, James M.			Transcriptome Adaptation of Group B Streptococcus to Growth in Human Amniotic Fluid	PLOS ONE			English	Article								Background: Streptococcus agalactiae (group B Streptococcus) is a bacterial pathogen that causes severe intrauterine infections leading to fetal morbidity and mortality. The pathogenesis of GBS infection in this environment is poorly understood, in part because we lack a detailed understanding of the adaptation of this pathogen to growth in amniotic fluid. To address this knowledge deficit, we characterized the transcriptome of GBS grown in human amniotic fluid (AF) and compared it with the transcriptome in rich laboratory medium. Methods: GBS was grown in Todd Hewitt-yeast extract medium and human AF. Bacteria were collected at mid-logarithmic, late-logarithmic and stationary growth phase. We performed global expression microarray analysis using a custom-made Affymetrix GeneChip. The normalized hybridization values derived from three biological replicates at each growth point were obtained. AF/THY transcript ratios representing greater than a 2-fold change and P-value exceeding 0.05 were considered to be statistically significant. Principal Findings: We have discovered that GBS significantly remodels its transcriptome in response to exposure to human amniotic fluid. GBS grew rapidly in human AF and did not exhibit a global stress response. The majority of changes in GBS transcripts in AF compared to THY medium were related to genes mediating metabolism of amino acids, carbohydrates, and nucleotides. The majority of the observed changes in transcripts affects genes involved in basic bacterial metabolism and is connected to AF composition and nutritional requirements of the bacterium. Importantly, the response to growth in human AF included significant changes in transcripts of multiple virulence genes such as adhesins, capsule, and hemolysin and IL-8 proteinase what might have consequences for the outcome of host-pathogen interactions. Conclusions/Significance: Our work provides extensive new information about how the transcriptome of GBS responds to growth in AF, and thus new leads for pathogenesis research.			Sitkiewicz, I (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland.	JMMusser@tmhs.org	Witkin, Steven/AAW-8602-2021; Witkin, Steven/AAF-3812-2019; Sitkiewicz, Izabela/G-5058-2011	Witkin, Steven/0000-0002-3502-3929; Sitkiewicz, Izabela/0000-0001-8228-9917; Bongiovanni, Ann Marie/0000-0001-9801-570X				APPELBAUM PC, 1977, AM J OBSTET GYNECOL, V128, P868, DOI 10.1016/0002-9378(77)90055-2; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Darmstadt GL, 2000, INFECT IMMUN, V68, P1215, DOI 10.1128/IAI.68.3.1215-1221.2000; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; EVANS HE, 1977, OBSTET GYNECOL, V49, P35; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hagio Y, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P2369; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; LARSEN B, 1983, GYNECOL OBSTET INVES, V15, P26, DOI 10.1159/000299390; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Lin X, 2008, J BACTERIOL, V190, P4367, DOI 10.1128/JB.01898-07; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Malke H, 2007, J MED MICROBIOL, V56, P707, DOI 10.1099/jmm.0.46984-0; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; MATHAI M, 1984, BRIT J OBSTET GYNAEC, V91, P560, DOI 10.1111/j.1471-0528.1984.tb04803.x; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; MESAVAGE WC, 1985, PEDIATR RES, V19, P1021, DOI 10.1203/00006450-198510000-00014; NATANSON S, 1995, J INFECT DIS, V171, P871, DOI 10.1093/infdis/171.4.871; NAZIR MA, 1987, AM J PERINAT, V4, P59, DOI 10.1055/s-2007-999738; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; PINE L, 1972, INFECT IMMUN, V5, P668, DOI 10.1128/IAI.5.5.668-680.1972; Samen U, 2004, J BACTERIOL, V186, P1398, DOI 10.1128/JB.186.5.1398-1408.2004; SCANE TMN, 1986, BRIT J OBSTET GYNAEC, V93, P577, DOI 10.1111/j.1471-0528.1986.tb07956.x; SCANE TMN, 1984, BRIT J OBSTET GYNAEC, V91, P342, DOI 10.1111/j.1471-0528.1984.tb05920.x; SCHUCHAT A, 1994, EPIDEMIOL REV, V16, P374, DOI 10.1093/oxfordjournals.epirev.a036159; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shet A, 2004, INDIAN J MED RES, V120, P141; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sitkiewicz Izabela, 2009, BMC Microbiol, V9, P32, DOI 10.1186/1471-2180-9-32; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; van Scheltema PNA, 2008, GYNECOL OBSTET INVES, V66, P227, DOI 10.1159/000147168	46	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6114	10.1371/journal.pone.0006114	http://dx.doi.org/10.1371/journal.pone.0006114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568429	Green Submitted, gold, Green Published			2022-12-25	WOS:000267572200013
J	De Blas, GA; Darszon, A; Ocampo, AY; Serrano, CJ; Castellano, LE; Hernandez-Gonzalez, EO; Chirinos, M; Larrea, F; Beltran, C; Trevino, CL				De Blas, Gerardo A.; Darszon, Alberto; Ocampo, Ana Y.; Serrano, Carmen J.; Castellano, Laura E.; Hernandez-Gonzalez, Enrique O.; Chirinos, Mayel; Larrea, Fernando; Beltran, Carmen; Trevino, Claudia L.			TRPM8, a Versatile Channel in Human Sperm	PLOS ONE			English	Article								Background: The transient receptor potential channel (TRP) family includes more than 30 proteins; they participate in various Ca2+ dependent processes. TRPs are functionally diverse involving thermal, chemical and mechanical transducers which modulate the concentration of intracellular Ca2+ ([Ca2+](i)). Ca2+ triggers and/or regulates principal sperm functions during fertilization such as motility, capacitation and the acrosome reaction. Nevertheless, the presence of the TRPM subfamily in sperm has not been explored. Principal Findings: Here we document with RT-PCR, western blot and immunocitochemistry analysis the presence of TRPM8 in human sperm. We also examined the participation of this channel in sperm function using specific agonists (menthol and temperature) and antagonists (BCTC and capsazepine). Computer-aided sperm analysis revealed that menthol did not significantly alter human sperm motility. In contrast, menthol induced the acrosome reaction in human sperm. This induction was inhibited about 70% by capsazepine (20 mM) and 80% by BCTC (1.6 mM). Activation of TRPM8 either by temperature or menthol induced [Ca2+](i) increases in human sperm measured by fluorescence in populations or individual sperm cells, effect that was also inhibited by capsazepine (20 mM) and BCTC (1.6 mM). However, the progesterone and ZP(3)-induced acrosome reaction was not inhibited by capsazepine or BCTC, suggesting that TRPM8 activation triggers this process by a different signaling pathway. Conclusions: This is the first report dealing with the presence of a thermo sensitive channel (TRPM8) in human sperm. This channel could be involved in cell signaling events such as thermotaxis or chemotaxis.			De Blas, GA (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62191, Morelos, Mexico.	ctrevino@ibt.unam.mx	Hernández-González, Enrique/AAU-8526-2020; Chirinos, Mayel/I-2896-2019; babakinejad, babak/G-2674-2012; Larrea, Fernando/AAC-1900-2021	Chirinos, Mayel/0000-0003-0023-5195; Darszon, Alberto/0000-0002-2502-0505; Trevino, Claudia L/0000-0002-7281-0534; SERRANO, CARMEN J./0000-0002-7047-9120	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD038082-07A1, R01 HD038082] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Appendino G, 2008, CURR PHARM DESIGN, V14, P2, DOI 10.2174/138161208783330781; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Bahat A, 2006, MOL CELL ENDOCRINOL, V252, P115, DOI 10.1016/j.mce.2006.03.027; Benjamin ER, 2006, BIOCHEM PHARMACOL, V72, P770, DOI 10.1016/j.bcp.2006.06.003; Caballero-Campo P, 2006, BIOL REPROD, V74, P760, DOI 10.1095/biolreprod.105.047522; Castellano LE, 2003, FEBS LETT, V541, P69, DOI 10.1016/S0014-5793(03)00305-3; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Corkidi G, 2008, BIOCHEM BIOPH RES CO, V373, P125, DOI 10.1016/j.bbrc.2008.05.189; Darszon A, 2007, Soc Reprod Fertil Suppl, V65, P229; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Henshall SM, 2003, CANCER RES, V63, P4196; Ishijima Sumio, 2007, Soc Reprod Fertil Suppl, V65, P327; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Montell C, 2008, CURR BIOL, V18, pR123, DOI 10.1016/j.cub.2007.12.001; MORENILLAPALAO C, 2009, J BIOL CHEM; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; PEDRETTI A, 2009, BIOCH BIOPHYS ACTA; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Sato Y, 2000, J ANDROL, V21, P99; SHI QX, 1995, BIOL REPROD, V52, P373, DOI 10.1095/biolreprod52.2.373; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Trevino CL, 2006, J CELL PHYSIOL, V206, P449, DOI 10.1002/jcp.20487; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T., 2007, V179, P329; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Wood CD, 2007, DEV BIOL, V306, P525, DOI 10.1016/j.ydbio.2007.03.036; Woolley DM, 2007, BIOL CELL, V99, P663, DOI 10.1042/BC20070050; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	52	81	81	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6095	10.1371/journal.pone.0006095	http://dx.doi.org/10.1371/journal.pone.0006095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19582168	Green Submitted, Green Published, gold			2022-12-25	WOS:000267515700013
J	Enyeart, JA; Enyeart, JJ				Enyeart, Judith A.; Enyeart, John J.			Metabolites of an Epac-Selective cAMP Analog Induce Cortisol Synthesis by Adrenocortical Cells through a cAMP-Independent Pathway	PLOS ONE			English	Article								Adrenal zona fasciculata (AZF) cells express a cAMP-activated guanine nucleotide exchange protein (Epac2) that may function in ACTH-stimulated cortisol synthesis. Experiments were done to determine whether cAMP analogs that selectively activate Epacs could induce cortisol synthesis and the expression of genes coding for steroidogenic proteins in bovine AZF cells. Treatment of AZF cells with the Epac-selective cAMP analog (ESCA) 8CPT-2'-OMe-cAMP induced large (>100 fold), concentration-dependent, delayed increases in cortisol synthesis and the expression of mRNAs coding for the steroid hydroxylases CYP11a1, CYP17, CYP21, and the steroid acute regulatory protein (StAR). However, a non-hydrolyzable analog of this ESCA, Sp-8CPT-2'-OMe-cAMP, failed to stimulate cortisol production even at concentrations that activated Rap1, a downstream effector of Epac2. Accordingly, putative metabolites of 8CPT-2'-OMe-cAMP, including 8CPT-2'-OMe-5'AMP, 8CPT-2'-OMe-adenosine, and 8CPT-adenine all induced cortisol synthesis and steroid hydroxylase mRNA expression with a temporal pattern, potency, and effectiveness similar to the parent compound. At concentrations that markedly stimulated cortisol production, none of these metabolites significantly activated cAMP-dependent protein kinase (PKA). These results show that one or more metabolites of the ESCA 8CPT-2'-OMe-cAMP induce cortico-steroidogenesis by activating a panel of genes that code for steroidogenic proteins. The remarkable increases in cortisol synthesis observed in this study appear to be mediated by a novel cAMP-, Epac- and PKA-independent signaling pathway.			Enyeart, JA (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, Columbus, OH 43210 USA.	enyeart.1@osu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047875] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK047875, R01-DK47875] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLGREN R, 1990, J BIOL CHEM, V265, P3313; BARBARA JG, 1995, J PHYSIOL-LONDON, V488, P609, DOI 10.1113/jphysiol.1995.sp020994; BONDY P K, 1985, P816; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Enyeart JA, 2003, MOL PHARMACOL, V64, P132, DOI 10.1124/mol.64.1.132; Enyeart JJ, 1997, J GEN PHYSIOL, V110, P679, DOI 10.1085/jgp.110.6.679; Enyeart JJ, 1996, J GEN PHYSIOL, V108, P251, DOI 10.1085/jgp.108.4.251; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; LUND J, 1990, J BIOL CHEM, V265, P3304; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; MOYLE WR, 1973, J BIOL CHEM, V248, P2409; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Parker KL, 1995, VITAM HORM, V51, P339, DOI 10.1016/S0083-6729(08)61044-4; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PENHOAT A, 1989, P NATL ACAD SCI USA, V86, P4798; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Price N., 1999, FUNDAMENTALS ENZYMOL; RAIKHINSTEIN M, 1994, BBA-MOL CELL RES, V1220, P329, DOI 10.1016/0167-4889(94)90157-0; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STOCCO DM, 2001, ANNU REV PHYSIOL, V63, P213; VENEPALLY P, 1995, J BIOL CHEM, V270, P25402, DOI 10.1074/jbc.270.43.25402; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Waterman MR, 1997, FASEB J, V11, P419, DOI 10.1096/fasebj.11.6.9194522; WATERMAN MR, 1994, J BIOL CHEM, V269, P27783; WATERMAN MR, 1988, RECENT PROG HORM RES, V45, P532; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Yamazaki T, 1998, ENDOCRINOLOGY, V139, P4765, DOI 10.1210/en.139.12.4765; ZUBER MX, 1986, J BIOL CHEM, V261, P2475	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6088	10.1371/journal.pone.0006088	http://dx.doi.org/10.1371/journal.pone.0006088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564912	Green Published, Green Submitted, gold			2022-12-25	WOS:000267515700007
J	Yan, YT; Kolachala, V; Dalmasso, G; Nguyen, H; Laroui, H; Sitaraman, SV; Merlin, D				Yan, Yutao; Kolachala, Vasantha; Dalmasso, Guillaume; Nguyen, Hang; Laroui, Hamed; Sitaraman, Shanthi V.; Merlin, Didier			Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis	PLOS ONE			English	Article							CD4(+) T-CELLS; INTESTINAL INFLAMMATION; ANIMAL-MODELS; TNF-ALPHA; MICE; INDUCTION; DISEASE; STRESS; RATS; PERMEABILITY	Background: Inflammatory bowel diseases (IBD), including mainly ulcerative colitis (UC) and Crohn's disease (CD), are inflammatory disorders of the gastrointestinal tract caused by an interplay of genetic and environmental factors. Murine colitis model induced by Dextran Sulfate Sodium (DSS) is an animal model of IBD that is commonly used to address the pathogenesis of IBD as well as to test efficacy of therapies. In this study we systematically analyzed clinical parameters, histological changes, intestinal barrier properties and cytokine profile during the colitic and recovery phase. Methods: C57BL/6 mice were administered with 3.5% of DSS in drinking water for various times. Clinical and histological features were determined using standard criteria. Myeloperoxidase (MPO) activity, transepithelial permeability and proinflammatory mediators were determined in whole colon or proximal and distal parts of colon. Results: As expected after administration of DSS, mice manifest loss of body weight, shortening of colon length and bloody feces. Histological manifestations included shortening and loss of crypts, infiltration of lymphocytes and neutrophil, symptoms attenuated after DSS withdrawal. The MPO value, as inflammation indicator, also increases significantly at all periods of DSS treatment, and even after DSS withdrawal, it still held at very high levels. Trans-mucosal permeability increased during DSS treatment, but recovered to almost control level after DSS withdrawal. The production of proinflammatory mediators by colonic mucosa were enhanced during DSS treatment, and then recovered to pre-treated level after DSS withdrawal. Finally, enhanced expression of proinflammatory mediators also revealed a different profile feature in proximal and distal parts of the colon. Conclusion: Experimental colitis induced by DSS is a good animal model to study the mechanisms underlying the pathogenesis and intervention against IBD, especially UC.			Yan, YT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	yyan2@emory.edu	Nguyen, Hang/N-2441-2018; Dalmasso, Guillaume/N-2443-2018	Nguyen, Hang/0000-0001-7431-5126; Dalmasso, Guillaume/0000-0002-3433-870X	NIDDK NIH HHS [R24-DK-064399, R01-DK55850, R24 DK064399, R01-DK-061941, R01 DK061941, R01 DK055850] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R01DK061941, R24DK064399] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki Y, 2000, CLIN EXP IMMUNOL, V119, P264; Azuma YT, 2008, J CELL PHYSIOL, V216, P111, DOI 10.1002/jcp.21381; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; COOPER HS, 1993, LAB INVEST, V69, P238; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Elson CO, 1996, AM J MED, V100, P656, DOI 10.1016/S0002-9343(96)00049-6; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Hibi T, 2002, J GASTROENTEROL, V37, P409, DOI 10.1007/s005350200060; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Plevy SE, 1997, J IMMUNOL, V159, P6276; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARTOR RB, 1988, INFECT IMMUN, V56, P2101, DOI 10.1128/IAI.56.8.2101-2108.1988; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; Schwartz L, 2008, AM J PHYSIOL-GASTR L, V295, pG934, DOI 10.1152/ajpgi.90296.2008; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7; Venkatraman A, 2000, SCAND J GASTROENTERO, V35, P1053; Wirtz S, 1999, J IMMUNOL, V162, P1884; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	37	265	273	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6073	10.1371/journal.pone.0006073	http://dx.doi.org/10.1371/journal.pone.0006073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562033	Green Published, gold, Green Submitted			2022-12-25	WOS:000267465900008
J	Merbl, Y; Itzchak, R; Vider-Shalit, T; Louzoun, Y; Quintana, FJ; Vadai, E; Eisenbach, L; Cohen, IR				Merbl, Yifat; Itzchak, Royi; Vider-Shalit, Tal; Louzoun, Yoram; Quintana, Francisco J.; Vadai, Ezra; Eisenbach, Lea; Cohen, Irun R.			A Systems Immunology Approach to the Host-Tumor Interaction: Large-Scale Patterns of Natural Autoantibodies Distinguish Healthy and Tumor-Bearing Mice	PLOS ONE			English	Article								Traditionally, immunology has considered a meaningful antibody response to be marked by large amounts of high-affinity antibodies reactive with the specific inciting antigen; the detection of small amounts of low-affinity antibodies binding to seemingly unrelated antigens has been considered to be beneath the threshold of immunological meaning. A systems-biology approach to immunology, however, suggests that large-scale patterns in the antibody repertoire might also reflect the functional state of the immune system. To investigate such global patterns of antibodies, we have used an antigen-microarray device combined with informatic analysis. Here we asked whether antibody-repertoire patterns might reflect the state of an implanted tumor. We studied the serum antibodies of inbred C57BL/6 mice before and after implantation of syngeneic 3LL tumor cells of either metastatic or non-metastatic clones. We analyzed patterns of IgG and IgM autoantibodies binding to over 300 self-antigens arrayed on slides using support vector machines and genetic algorithm techniques. We now report that antibody patterns, but not single antibodies, were informative: 1) mice, even before tumor implantation, manifest both individual and common patterns of low-titer natural autoantibodies; 2) the patterns of these autoantibodies respond to the growth of the tumor cells, and can distinguish between metastatic and non-metastatic tumor clones; and 3) curative tumor resection induces dynamic changes in these low-titer autoantibody patterns. The informative patterns included autoantibodies binding to self-molecules not known to be tumor-associated antigens (including insulin, DNA, myosin, fibrinogen) as well as to known tumor-associated antigens (including p53, cytokeratin, carbonic anhydrases, tyrosinase). Thus, low-titer autoantibodies that are not the direct products of tumor-specific immunization can still generate an immune biomarker of the body-tumor interaction. System-wide profiling of autoantibody repertoires can be informative.			Merbl, Y (corresponding author), Harvard Univ, Sch Med, Syst Biol Dept, Boston, MA 02115 USA.	Irun.cohen@weizmann.ac.il	Quintana, Francisco Javier/AAB-6915-2020; louzoun, yoram/F-5874-2011	louzoun, yoram/0000-0003-1714-6148; Eisenbach, Lea R/0000-0002-4816-1968; Merbl, Yifat/0000-0002-3465-2221	NIAID NIH HHS [1 R01 AI61062-01, R01 AI061062] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061062] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOSER B, 1992, P 5 ANN WORKSH COMP, V5, P144; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Cohen I. R., 2000, TENDING ADAMS GARDEN; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; Cohen IR, 2007, NAT REV IMMUNOL, V7, P569, DOI 10.1038/nri2102; DRUCKER CJC, 1997, NIPS, V9, P155; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; FRANCISCO J, 2008, P NATL ACAD SCI US; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; Harwanegg C, 2005, CLIN CHEM LAB MED, V43, P1321, DOI 10.1515/CCLM.2005.226; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; LYDYARD PM, 1990, SCAND J IMMUNOL, V31, P33, DOI 10.1111/j.1365-3083.1990.tb02740.x; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; MOUTHON L, 1995, J IMMUNOL, V154, P5769; PLAKSIN D, 1988, P NATL ACAD SCI USA, V85, P4463, DOI 10.1073/pnas.85.12.4463; Quintana FJ, 2006, LUPUS, V15, P428, DOI 10.1191/0961203306lu2328oa; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2003, J AUTOIMMUN, V21, P65, DOI 10.1016/S0896-8411(03)00064-7; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; *THEOD EV MPAAE, 2004, MACHINE LEARNING, V55; Wilcox RR, 2001, FUNDAMENTALS MODERN	26	29	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6053	10.1371/journal.pone.0006053	http://dx.doi.org/10.1371/journal.pone.0006053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557135	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356900013
J	Prehn-Kristensen, A; Wiesner, C; Bergmann, TO; Wolff, S; Jansen, O; Mehdorn, HM; Ferstl, R; Pause, BM				Prehn-Kristensen, Alexander; Wiesner, Christian; Bergmann, Til Ole; Wolff, Stephan; Jansen, Olav; Mehdorn, Hubertus Maximilian; Ferstl, Roman; Pause, Bettina M.			Induction of Empathy by the Smell of Anxiety	PLOS ONE			English	Article								The communication of stress/anxiety between conspecifics through chemosensory signals has been documented in many vertebrates and invertebrates. Here, we investigate how chemosensory anxiety signals conveyed by the sweat of humans (N = 49) awaiting an academic examination are processed by the human brain, as compared to chemosensory control signals obtained from the same sweat donors in a sport condition. The chemosensory stimuli were pooled according to the donation condition and administered to 28 participants (14 males) synchronously to breathing via an olfactometer. The stimuli were perceived with a low intensity and accordingly only about half of the odor presentations were detected by the participants. The fMRI results (event-related design) show that chemosensory anxiety signals activate brain areas involved in the processing of social emotional stimuli (fusiform gyrus), and in the regulation of empathic feelings (insula, precuneus, cingulate cortex). In addition, neuronal activity within attentional (thalamus, dorsomedial prefrontal cortex) and emotional (cerebellum, vermis) control systems were observed. The chemosensory perception of human anxiety seems to automatically recruit empathy-related resources. Even though the participants could not attentively differentiate the chemosensory stimuli, emotional contagion seems to be effectively mediated by the olfactory system.			Prehn-Kristensen, A (corresponding author), Univ Kiel, Ctr Integrat Psychiat, Kiel, Germany.	bettina.pause@uni-duesseldorf.de	Mehdorn, Maximilian/D-2495-2010; Bergmann, Til Ole/F-9453-2010; Prehn-Kristensen, Alexander/A-3234-2019; Jansen, Olav/D-2547-2010	Bergmann, Til Ole/0000-0002-2282-6618; Prehn-Kristensen, Alexander/0000-0002-3510-9888; Wiesner, Christian/0000-0003-1287-4955; Lauwereyns, Jan/0000-0003-0551-2550				ABEL EL, 1994, HORM BEHAV, V28, P139, DOI 10.1006/hbeh.1994.1011; Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; [Anonymous], 2014, PHEROMONES ANIMAL BE; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damasio Anthony, 2003, LOOKING SPINOZA SORR; Dicke M, 2003, TRENDS PLANT SCI, V8, P403, DOI 10.1016/S1360-1385(03)00183-3; FANSELOW MS, 1985, BEHAV NEUROSCI, V99, P589, DOI 10.1037/0735-7044.99.3.589; Frisch K. V., 1941, ZEITSCHR VERGLEICH PHYSIOL, V29, P46; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hideaki IA, 2008, PHYSIOL BEHAV, V93, P606, DOI 10.1016/j.physbeh.2007.10.021; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Kimberley TJ, 2008, J NEUROIMAGING, V18, P18, DOI 10.1111/j.1552-6569.2007.00163.x; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kiyokawa Y, 2007, CHEM SENSES, V32, P57, DOI 10.1093/chemse/bjl036; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Laux L., 1981, STATE TRAIT ANGSTINV; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Lukins R, 1997, J BEHAV THER EXP PSY, V28, P97, DOI 10.1016/S0005-7916(97)00006-2; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; LUNDSTROM JN, 2008, HUM BRAIN MAP   1209; Moynihan JA, 2000, J NEUROIMMUNOL, V102, P145, DOI 10.1016/S0165-5728(99)00173-3; MUJICAPARODI LR, 2008, NATURE P; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Sobel N., 2003, HDB OLFACTION GUSTAT, P251; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Vigouroux M, 2005, J NEUROSCI METH, V142, P35, DOI 10.1016/j.jneumeth.2004.07.010; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	54	163	169	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5987	10.1371/journal.pone.0005987	http://dx.doi.org/10.1371/journal.pone.0005987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551135	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356500003
J	Ruf, IK; Houmani, JL; Sample, JT				Ruf, Ingrid K.; Houmani, Jennifer L.; Sample, Jeffery T.			Epstein-Barr Virus Independent Dysregulation of UBP43 Expression Alters Interferon-Stimulated Gene Expression in Burkitt Lymphoma	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; INDUCED APOPTOSIS; ENCODED RNAS; C-MYC; ISG15; CELLS; PHENOTYPE; USP18; TUMORIGENICITY; IDENTIFICATION	Epstein-Barr virus (EBV) persists as a life-long latent infection within memory B cells, but how EBV may circumvent the innate immune response within this virus reservoir is unclear. Recent studies suggest that the latency-associated non-coding RNAs of EBV may actually induce type I (antiviral) interferon production, raising the question of how EBV counters the negative consequences this is likely to have on viral persistence. We addressed this by examining the type I interferon response in Burkitt lymphoma (BL) cell lines, the only in vitro model of the restricted program of EBV latency-gene expression in persistently infected B cells in vivo. Importantly, we observed no effect of EBV on interferon alpha-induced signaling or evidence of type I interferon production, suggesting that EBV in this latent state is silent to the cell's innate antiviral surveillance. We did uncover, however, a defect in the negative feedback control of interferon signaling in a subpopulation of BL lines as was revealed by prolonged interferon-stimulated gene transcription consistent with sustained tyrosine phosphorylation on STAT1 and STAT2. This was due to inadequate induction of expression of the ubiquitin-specific protease UBP43, which removes the ubiquitin-like ISG15 polypeptide conjugated to proteins (ISGylation) in response to type I interferons. Results here are consistent with previous findings in genetically engineered Ubp43(-/-) murine cells that UBP43 down-regulates interferon signaling, independent of its ISG15 isopeptidase activity, by precluding the protein kinase JAK1 from the interferon receptor. This natural deficiency in UBP43 expression may therefore provide a useful model to further probe the biological roles of UBP43 and ISGylation.			Ruf, IK (corresponding author), Shriners Hosp Children, Div Res, Portland, OR 97201 USA.	iruf@uci.edu			NCI NIH HHS [R01 CA056639, CA62203, P30 CA062203, R01 CA073544, P30 CA021765, CA21765, CA056639, CA073544] Funding Source: Medline; NIAID NIH HHS [T32 AI007319, T32-AI007319] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056639, P30CA062203, R01CA073544, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007319] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Geiger TR, 2006, J VIROL, V80, P11638, DOI 10.1128/JVI.01570-06; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Kang DC, 2001, GENE, V267, P233, DOI 10.1016/S0378-1119(01)00384-5; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Knobeloch KP, 2005, MOL CELL BIOL, V25, P11030, DOI 10.1128/MCB.25.24.11030-11034.2005; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Komano J, 1998, J VIROL, V72, P9150, DOI 10.1128/JVI.72.11.9150-9156.1998; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li XL, 2001, CYTOKINE, V14, P247, DOI 10.1006/cyto.2001.0887; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Rempel LA, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-13; Ritchie KJ, 2002, GENE DEV, V16, P2207, DOI 10.1101/gad.1010202; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Ruf IK, 1999, MOL CELL BIOL, V19, P1651; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; SAMPLE J, 1992, J VIROL, V66, P4654, DOI 10.1128/JVI.66.8.4654-4661.1992; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; SHIMIZU N, 1994, J VIROL, V68, P6069, DOI 10.1128/JVI.68.9.6069-6073.1994; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yan M, 2007, BLOOD, V110, P305, DOI 10.1182/blood-2006-07-033209; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6023	10.1371/journal.pone.0006023	http://dx.doi.org/10.1371/journal.pone.0006023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551150	gold, Green Published, Green Submitted			2022-12-25	WOS:000267356500008
J	Seeba, F; Klump, GM				Seeba, Folkert; Klump, Georg M.			Stimulus Familiarity Affects Perceptual Restoration in the European Starling (Sturnus vulgaris)	PLOS ONE			English	Article							AUDITORY INDUCTION; BIRDSONG; ORGANIZATION; SIGNALS; SPEECH	Background: Humans can easily restore a speech signal that is temporally masked by an interfering sound (e.g., a cough masking parts of a word in a conversation), and listeners have the illusion that the speech continues through the interfering sound. This perceptual restoration for human speech is affected by prior experience. Here we provide evidence for perceptual restoration in complex vocalizations of a songbird that are acquired by vocal learning in a similar way as humans learn their language. Methodology/Principal Findings: European starlings were trained in a same/different paradigm to report salient differences between successive sounds. The birds' response latency for discriminating between a stimulus pair is an indicator for the salience of the difference, and these latencies can be used to evaluate perceptual distances using multidimensional scaling. For familiar motifs the birds showed a large perceptual distance if discriminating between song motifs that were muted for brief time periods and complete motifs. If the muted periods were filled with noise, the perceptual distance was reduced. For unfamiliar motifs no such difference was observed. Conclusions/Significance: The results suggest that starlings are able to perceptually restore partly masked sounds and, similarly to humans, rely on prior experience. They may be a suitable model to study the mechanism underlying experience-dependent perceptual restoration.			Seeba, F (corresponding author), Carl von Ossietzky Univ Oldenburg, Anim Physiol & Behav Grp, Inst Biol & Environm Sci, D-26111 Oldenburg, Germany.	folkert.seeba@uni-oldenburg.de						BASHFORD JA, 1987, PERCEPT PSYCHOPHYS, V42, P431, DOI 10.3758/BF03209750; Braaten RE, 1999, PSYCHOL SCI, V10, P162, DOI 10.1111/1467-9280.00125; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Bregman A.S., 1990, AUDITORY SCENE ANAL; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; COULSON JC, 1960, J ANIM ECOL, V29, P251, DOI 10.2307/2203; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Dooling R.J., 1995, METHODS COMP PSYCHOA, P307; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EENS M, 1989, ARDEA, V77, P75; EENS M, 1992, ANIM BEHAV, V44, P1131, DOI 10.1016/S0003-3472(05)80325-2; Gentner TQ, 2008, J ACOUST SOC AM, V124, P1350, DOI 10.1121/1.2945705; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gentner TQ, 2004, J COMP PHYSIOL A, V190, P1001, DOI 10.1007/s00359-004-0556-x; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002203; Hausberger M, 1995, BEHAV PROCESS, V35, P83, DOI 10.1016/0376-6357(95)00053-4; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; KLUMP GM, 1999, ARO MIDW RES M; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Miller CT, 2001, NAT NEUROSCI, V4, P783, DOI 10.1038/90481; Mooney R, 2002, J COMP PHYSIOL A, V188, P879, DOI 10.1007/s00359-002-0353-3; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; Petkov CI, 2003, J NEUROSCI, V23, P9155; Samuel AG, 1996, J EXP PSYCHOL GEN, V125, P28, DOI 10.1037/0096-3445.125.1.28; Sugita Y, 1997, NEUROREPORT, V8, P1155, DOI 10.1097/00001756-199703240-00019; Theunissen FE, 2006, CURR OPIN NEUROBIOL, V16, P400, DOI 10.1016/j.conb.2006.07.003; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; Warren RE, 1999, P SOC PHOTO-OPT INS, V3855, P134, DOI 10.1117/12.371271; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392	34	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5974	10.1371/journal.pone.0005974	http://dx.doi.org/10.1371/journal.pone.0005974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551146	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356500002
J	Xu, DS; Sharma, C; Hemler, ME				Xu, Daosong; Sharma, Chandan; Hemler, Martin E.			Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein	FASEB JOURNAL			English	Article						Alzheimer's disease; alpha-secretase; pericellular proteolysis	ALPHA-SECRETASE ADAM10; DISINTEGRIN-LIKE; CELL; INTEGRIN; ASSOCIATION; ACTIVATION; PALMITOYLATION; EXPRESSION; PROMOTES; CD81	Using mass spectrometry, we identified ADAM10 (a membrane-associated metalloproteinase) as a partner for TSPAN12, a tetraspanin protein. TSPAN12-ADAM10 interaction was confirmed by reciprocal coimmunoprecipitation in multiple tumor cell lines. TSPAN12, to a greater extent than other tetraspanins (CD81, CD151, CD9, and CD82), associated with ADAM10 but not with ADAM17. Overexpression of TSPAN12 enhanced ADAM10-dependent shedding of amyloid precursor protein (APP) in MCF7 (breast cancer) and SH-SY5Y (neuroblastoma) cell lines. Conversely, siRNA ablation of endogenous TSPAN12 markedly diminished APP proteolysis in both cell lines. Furthermore, TSPAN12 overexpression enhanced ADAM10 prodomain maturation, whereas TSPAN12 ablation diminished ADAM10 maturation. A palmitoylation-deficient TSPAN12 mutant failed to associate with ADAM10, inhibited ADAM10-dependent proteolysis of APP, and inhibited ADAM10 maturation, most likely by interfering with endogenous wild-type TSPAN12. In conclusion, TSPAN12 serves as a novel and robust partner for ADAM10 and promotes ADAM10 maturation, thereby facilitating ADAM10-dependent proteolysis of APP. This novel mode of regulating APP cleavage is of relevance to Alzheimer's disease therapy.-Xu, D., Sharma, C., Hemler, M. E. Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J. 23, 3674-3681 (2009). www.fasebj.org	[Hemler, Martin E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Hemler, ME (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	martin_hemler@dfci.harvard.edu			National Institutes of Health [GM38903, CA102034]; NATIONAL CANCER INSTITUTE [R01CA102034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM38903 and CA102034 to M. E. H.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Anderegg U, 2009, J INVEST DERMATOL, V129, P1471, DOI 10.1038/jid.2008.323; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Herlevsen M, 2003, J CELL SCI, V116, P4373, DOI 10.1242/jcs.00760; Imbimbo BP, 2008, CURR TOP MED CHEM, V8, P54, DOI 10.2174/156802608783334015; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lafleur MA, 2009, MOL BIOL CELL, V20, P2030, DOI 10.1091/mbc.E08-11-1149; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; RUBINSTEIN E, 1994, EUR J IMMUNOL, V24, P3005, DOI 10.1002/eji.1830241213; Rubinstein E, 2006, SEMIN CELL DEV BIOL, V17, P254, DOI 10.1016/j.semcdb.2006.02.012; Serru V, 2000, BBA-PROTEIN STRUCT M, V1478, P159, DOI 10.1016/S0167-4838(00)00022-4; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Stone AL, 1999, J PROTEIN CHEM, V18, P447, DOI 10.1023/A:1020692710029; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	50	100	105	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3674	3681		10.1096/fj.09-133462	http://dx.doi.org/10.1096/fj.09-133462			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19587294	Green Published			2022-12-25	WOS:000271272500005
J	Huang, XJ; Beullens, M; Zhang, JH; Zhou, Y; Nicolaescu, E; Lesage, B; Hu, Q; Wu, JH; Bollen, M; Shi, YY				Huang, Xiaojuan; Beullens, Monique; Zhang, Jiahai; Zhou, Yi; Nicolaescu, Emilia; Lesage, Bart; Hu, Qi; Wu, Jihui; Bollen, Mathieu; Shi, Yunyu			Structure and Function of the Two Tandem WW Domains of the Pre-mRNA Splicing Factor FBP21 (Formin-binding Protein 21)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND RECOGNITION; PROTEOMIC ANALYSIS; BACKBONE DYNAMICS; DIPOLAR COUPLINGS; MAMMALIAN-CELLS; CHEMICAL-SHIFT; GROUP-II/III; SH2 DOMAINS; NMR; COMPLEX	Human FBP21 (formin-binding protein 21) contains a matrin-type zinc finger and two tandem WW domains. It is a component of the spliceosomes and interacts with several established splicing factors. Here we demonstrate for the first time that FBP21 is an activator of pre-mRNA splicing in vivo and that its splicing activation function and interaction with the splicing factor SIPP1 (splicing factor that interacts with PQBP1 and PP1) are both mediated by the two tandem WW domains of group III. We determined the solution structure of the tandem WW domains of FBP21 and found that the WW domains recognize peptide ligands containing either group II (PPLP) or group III (PPR) motifs. The binding interfaces involve both the XP and XP2 grooves of the two WW domains. Significantly, the tandem WW domains of FBP21 are connected by a highly flexible region, enabling their simultaneous interaction with two proline-rich motifs of SIPP1. The strong interaction between SIPP1 and FBP21 can be explained by the conjugation of two low affinity interactions with the tandem WW domains. Our study provides a structural basis for understanding the molecular mechanism underlying the functional implication of FBP21 and the biological specificity of tandem WW domains.	[Beullens, Monique; Nicolaescu, Emilia; Lesage, Bart; Bollen, Mathieu] Katholieke Univ Leuven, Lab Biosignaling & Therapeut, Dept Mol Cell Biol, Fac Med, B-3000 Louvain, Belgium; [Huang, Xiaojuan; Zhang, Jiahai; Zhou, Yi; Hu, Qi; Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Microscale & Sch Life Sci, Hefei 230026, Anhui, Peoples R China	KU Leuven; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Bollen, M (corresponding author), Katholieke Univ Leuven, Lab Biosignaling & Therapeut, Dept Mol Cell Biol, Fac Med, B-3000 Louvain, Belgium.	Mathieu.Bollen@med.kuleuven.be; yyshi@ustc.edu.cn	Zhou, Yi/P-1039-2015; hu, qi/K-1462-2014; Shi, Yunyu/B-3240-2009	Zhou, Yi/0000-0002-1650-4591; Shi, Yunyu/0000-0002-1348-4759	Chinese National Natural Science Foundation [30670426]; Chinese National Fundamental Research Project [2006CB806507, 2006CB910201]; Chinese National High Tech R D Program [2006AA02A315]; Fund for Scientific Research-Flanders [G.0670.09N]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese National Fundamental Research Project; Chinese National High Tech R D Program(National High Technology Research and Development Program of China); Fund for Scientific Research-Flanders(FWO)	This work was supported by Chinese National Natural Science Foundation Grant 30670426, Chinese National Fundamental Research Project Grants 2006CB806507 and 2006CB910201, the Chinese National High Tech R & D Program Grant 2006AA02A315, and the Fund for Scientific Research-Flanders Grant G.0670.09N.	Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Babini E, 2006, STRUCTURE, V14, P1029, DOI 10.1016/j.str.2006.04.004; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Braddock DT, 2001, J AM CHEM SOC, V123, P8634, DOI 10.1021/ja016234f; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cramer P, 2001, FEBS LETT, V498, P179, DOI 10.1016/S0014-5793(01)02485-1; Dancheck B, 2008, BIOCHEMISTRY-US, V47, P12346, DOI 10.1021/bi801308y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kato Y, 2006, PROTEINS, V63, P227, DOI 10.1002/prot.20880; Kato Y, 2006, J BIOL CHEM, V281, P40321, DOI 10.1074/jbc.M609321200; Katoh M, 2004, INT J MOL MED, V13, P473; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Meiyappan M, 2007, J MOL BIOL, V372, P970, DOI 10.1016/j.jmb.2007.06.064; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; OPELLA SJ, 1994, METHOD ENZYMOL, V239, P536; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; Pires JR, 2005, J MOL BIOL, V348, P399, DOI 10.1016/j.jmb.2005.02.056; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Ramirez-Espain X, 2007, J MOL BIOL, V373, P1255, DOI 10.1016/j.jmb.2007.08.052; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	58	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25375	25387		10.1074/jbc.M109.024828	http://dx.doi.org/10.1074/jbc.M109.024828			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592703	hybrid, Green Published			2022-12-25	WOS:000269734000070
J	Carr, HS; Cai, CL; Keinanen, K; Frost, JA				Carr, Heather S.; Cai, Chunlin; Keinanen, Kari; Frost, Jeffrey A.			Interaction of the RhoA Exchange Factor Net1 with Discs Large Homolog 1 Protects It from Proteasome-mediated Degradation and Potentiates Net1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; PDZ DOMAIN; MESENCHYMAL TRANSITIONS; SIGNALING PATHWAYS; FAMILY GTPASES; TGF-BETA; COMPLEX; BINDING; PROTEINS; CADHERIN	Net1 is a nuclear Rho guanine nucleotide exchange factor that is specific for the RhoA subfamily of small G proteins. Truncated forms of Net1 are transforming in NIH3T3 cells, and this activity requires cytoplasmic localization of Net1 as well as the presence of a COOH-terminal PDZ binding site. We have previously shown that Net1 interacts with PDZ domain-containing proteins within the Discs Large (Dlg) family and relocalizes them to the nucleus. In the present work, we demonstrate that Net1 binds directly to the first two PDZ domains of Dlg1 and that both PDZ domains are required for maximal interaction in cells. Furthermore, we show that Net1 is an unstable protein in MCF7 breast epithelial cells and that interaction with Dlg1 significantly enhances Net1 stability. Stabilization by Dlg1 significantly increases the ability of Net1 to stimulate RhoA activation in cells. The stability of endogenous Net1 is strongly enhanced by cell-cell contact, and this correlates with a dramatic increase in the interaction between Net1 and Dlg1. Importantly, disruption of E-cadherin-mediated cell contacts, either by depletion of external calcium or by treatment with transforming growth factor beta, leads to a rapid loss of the interaction between Net1 and Dlg1 and a subsequent increase in the ubiquitylation of Net1. These results indicate that Net1 requires interaction with PDZ domain proteins, such as Dlg1, to protect it from proteasome-mediated degradation and to maximally stimulate RhoA and that this interaction is regulated by cell-cell contact.	[Carr, Heather S.; Frost, Jeffrey A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Cai, Chunlin; Keinanen, Kari] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	University of Texas System; University of Texas Health Science Center Houston; University of Helsinki	Frost, JA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Jeffrey.a.frost@uth.tmc.edu	Keinanen, Kari/E-9122-2010	Frost, Jeffrey/0000-0001-9722-1536	National Institutes of Health [5R01CA116356-02]; Susan G. Komen Breast Cancer Foundation Award [BCTR123806]; Academy of Finland [110900]; NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation Award(Susan G. Komen Breast Cancer Foundation); Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01CA116356-02 (to J. A. F.). This work was also supported by Susan G. Komen Breast Cancer Foundation Award BCTR123806 (to J. A. F.) and by Academy of Finland Grant 110900 (to K. K.).	Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; BOGGS B, 1987, MOL CELL BIOL, V7, P2700, DOI 10.1128/MCB.7.8.2700; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Burbelo PD, 1999, P NATL ACAD SCI USA, V96, P9083, DOI 10.1073/pnas.96.16.9083; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Chan AML, 1996, ONCOGENE, V12, P1259; Dobrosotskaya IY, 2001, BIOCHEM BIOPH RES CO, V283, P969, DOI 10.1006/bbrc.2001.4880; Erasmus JC, 2006, METHOD ENZYMOL, V406, P402, DOI 10.1016/S0076-6879(06)06029-0; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gilcrease MZ, 2009, CANCER EPIDEM BIOMAR, V18, P80, DOI 10.1158/1055-9965.EPI-08-0842; Harris BZ, 2001, J CELL SCI, V114, P3219; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mzali R, 2005, FASEB J, V19, P1911, DOI 10.1096/fj.05-4030fje; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Peiretti F, 2003, J CELL SCI, V116, P1949, DOI 10.1242/jcs.00415; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Reiter LT, 2006, HUM MOL GENET, V15, P2825, DOI 10.1093/hmg/ddl225; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Surena AL, 2009, BBA-MOL CELL RES, V1793, P264, DOI 10.1016/j.bbamcr.2008.09.005; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu XC, 2006, BIOCHEM BIOPH RES CO, V351, P328, DOI 10.1016/j.bbrc.2006.09.172; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	44	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24269	24280		10.1074/jbc.M109.029439	http://dx.doi.org/10.1074/jbc.M109.029439			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586902	Green Published, hybrid			2022-12-25	WOS:000269380200040
J	Choudhury, R; McGovern, A; Ridley, C; Cain, SA; Baldwin, A; Wang, MC; Guo, C; Mironov, A; Drymoussi, Z; Trump, D; Shuttleworth, A; Baldock, C; Kielty, CM				Choudhury, Rawshan; McGovern, Amanda; Ridley, Caroline; Cain, Stuart A.; Baldwin, Andrew; Wang, Ming-Chuan; Guo, Chun; Mironov, Aleksandr, Jr.; Drymoussi, Zoe; Trump, Dorothy; Shuttleworth, Adrian; Baldock, Clair; Kielty, Cay M.			Differential Regulation of Elastic Fiber Formation by Fibulin-4 and-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; RECESSIVE CUTIS LAXA; SMOOTH-MUSCLE-CELLS; LYSYL-OXIDASE; FIBRILLIN-1 INTERACTIONS; HUMAN TROPOELASTIN; IN-VIVO; TISSUE LOCALIZATION; DEPENDENT MANNER; HYBRID DOMAIN	Fibulin-4 and -5 are extracellular glycoproteins with essential non-compensatory roles in elastic fiber assembly. We have determined how they interact with tropoelastin, lysyl oxidase, and fibrillin-1, thereby revealing how they differentially regulate assembly. Strong binding between fibulin-4 and lysyl oxidase enhanced the interaction of fibulin-4 with tropoelastin, forming ternary complexes that may direct elastin cross-linking. In contrast, fibulin-5 did not bind lysyl oxidase strongly but bound tropoelastin in terminal and central regions and could concurrently bind fibulin-4. Both fibulins differentially bound N-terminal fibrillin-1, which strongly inhibited their binding to lysyl oxidase and tropoelastin. Knockdown experiments revealed that fibulin-5 controlled elastin deposition on microfibrils, although fibulin-4 can also bind fibrillin-1. These experiments provide a molecular account of the distinct roles of fibulin-4 and -5 in elastic fiber assembly and how they act in concert to chaperone cross-linked elastin onto microfibrils.	[Choudhury, Rawshan; McGovern, Amanda; Cain, Stuart A.; Baldwin, Andrew; Wang, Ming-Chuan; Guo, Chun; Mironov, Aleksandr, Jr.; Drymoussi, Zoe; Shuttleworth, Adrian; Baldock, Clair; Kielty, Cay M.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Ridley, Caroline; Trump, Dorothy] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Kielty, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	cay.kielty@manchester.ac.uk	Guo, Chun/AAM-5894-2020; Cain, Stuart A/G-2836-2017	Guo, Chun/0000-0002-1540-3166; Mironov, Aleksandr/0000-0002-1497-328X; Drymoussi, Zoe/0000-0001-6683-9114; Baldwin, Andrew/0000-0002-8331-6769; Baldock, Clair/0000-0003-3497-1959; Ridley, Caroline/0000-0002-5483-0320; Cain, Stuart/0000-0001-8417-1058; McGovern, Amanda/0000-0001-7727-3283	Wellcome Trust [081930, 072291]; Medical Research Council [G0200246]; European Union [LSHM-CT-2005-018960]; MRC [G0200246] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grants 081930 and 072291, Medical Research Council Grant G0200246, and European Union Grant LSHM-CT-2005-018960.	Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; FORNIERI C, 1987, J CELL BIOL, V105, P1463, DOI 10.1083/jcb.105.3.1463; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Gheduzzi D, 2005, MATRIX BIOL, V24, P15, DOI 10.1016/j.matbio.2004.12.001; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Hu QR, 2006, J INVEST DERMATOL, V126, P283, DOI 10.1038/sj.jid.5700047; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Mellody KT, 2006, J BIOL CHEM, V281, P31854, DOI 10.1074/jbc.M602743200; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nonaka R, 2009, CLIN BIOCHEM, V42, P713, DOI 10.1016/j.clinbiochem.2008.12.020; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Tu YD, 2008, BIOMACROMOLECULES, V9, P1739, DOI 10.1021/bm7013153; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06	55	89	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24553	24567		10.1074/jbc.M109.019364	http://dx.doi.org/10.1074/jbc.M109.019364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570982	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000269380200066
J	Grobe, N; Zhang, B; Fisinger, U; Kutchan, TM; Zenk, MH; Guengerich, FP				Grobe, Nadja; Zhang, Baichen; Fisinger, Ursula; Kutchan, Toni M.; Zenk, Meinhart H.; Guengerich, F. Peter			Mammalian Cytochrome P450 Enzymes Catalyze the Phenol-coupling Step in Endogenous Morphine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS SYNTHESIZE MORPHINE; RAT-LIVER; BENZYLISOQUINOLINE ALKALOIDS; BERBERIS-STOLONIFERA; CYP2D6 MODULATION; MOLECULAR-CLONING; O-DEMETHYLATION; HUMAN BRAIN; SALUTARIDINE; CODEINE	A cytochrome P450 (P450) enzyme in porcine liver that catalyzed the phenol-coupling reaction of the substrate (R)-reticuline to salutaridine was previously purified to homogeneity (Amann, T., Roos, P. H., Huh, H., and Zenk, M. H. (1995) Heterocycles 40, 425-440). This reaction was found to be catalyzed by human P450s 2D6 and 3A4 in the presence of (R)-reticuline and NADPH to yield not a single product, but rather (-)-isoboldine, (-)-corytuberine, (-)-pallidine, and salutaridine, the paraortho coupled established precursor of morphine in the poppy plant and most likely also in mammals. (S)-Reticuline, a substrate of both P450 enzymes, yielded the phenol-coupled alkaloids (-)-isoboldine, (-)-corytuberine, (-)-pallidine, and sinoacutine; none of these serve as a morphine precursor. Catalytic efficiencies were similar for P450 2D6 and P450 3A4 in the presence of cytochrome b(5) with (R)-reticuline as substrate. The mechanism of phenol coupling is not yet established; however, we favor a single cycle of iron oxidation to yield salutaridine and the three other alkaloids from (R)-reticuline. The total yield of salutaridine formed can supply the 10 nM concentration of morphine found in human neuroblastoma cell cultures and in brain tissues of mice.	[Grobe, Nadja; Zhang, Baichen; Kutchan, Toni M.; Zenk, Meinhart H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Fisinger, Ursula] Univ Munich, Lehrstuhl Pharmazeut Biol, D-80333 Munich, Germany; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Donald Danforth Plant Science Center; University of Munich; Vanderbilt University; Vanderbilt University	Zenk, MH (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	mhzenk@danforthcenter.org	Kutchan, Toni/L-4625-2013		National Institutes of Health [R21 DA0224418, R37 CA090426]; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DA0224418 and R37 CA090426 and the Deutsche Forschungsgemeinschaft.	Agarwal V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002337; AMANN T, 1991, TETRAHEDRON LETT, V32, P3675, DOI 10.1016/S0040-4039(00)79765-6; AMANN T, 1995, HETEROCYCLES, V40, P425; Barton DHR, 1957, SOME BIOGENETIC ASPE; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Boettcher C, 2006, J IMMUNOL, V176, P5703, DOI 10.4049/jimmunol.176.10.5703; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; DAYER P, 1988, BIOCHEM BIOPH RES CO, V152, P411, DOI 10.1016/S0006-291X(88)80729-0; DONNERER J, 1986, P NATL ACAD SCI USA, V83, P4566, DOI 10.1073/pnas.83.12.4566; Eichhorn J, 1998, PHYTOCHEMISTRY, V49, P1037, DOI 10.1016/S0031-9422(97)01024-8; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2002, J BIOL CHEM, V277, P33711, DOI 10.1074/jbc.M205146200; Hanna IH, 2001, J BIOL CHEM, V276, P39553, DOI 10.1074/jbc.M106841200; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hiroi T, 1998, BIOCHEM BIOPH RES CO, V249, P838, DOI 10.1006/bbrc.1998.9232; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; KAMETANI T, 1977, BIOORG CHEM, V6, P249, DOI 10.1016/0045-2068(77)90026-8; KAMETANI T, 1980, HETEROCYCLES, V14, P963, DOI 10.3987/R-1980-07-0963; KODAIRA H, 1988, P NATL ACAD SCI USA, V85, P1267, DOI 10.1073/pnas.85.4.1267; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; MEIER UH, 1997, TETRAHEDRON LETT, V38, P7357; MIKUS G, 1991, XENOBIOTICA, V21, P1501, DOI 10.3109/00498259109044400; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Nasreen A, 1996, TETRAHEDRON LETT, V37, P8161, DOI 10.1016/0040-4039(96)01852-7; Oscarson M, 1997, MOL PHARMACOL, V52, P1034, DOI 10.1124/mol.52.6.1034; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Raith K, 2003, J AM SOC MASS SPECTR, V14, P1262, DOI 10.1016/S1044-0305(03)00539-7; Rueffer M, 1998, FEBS LETT, V438, P111, DOI 10.1016/S0014-5793(98)01282-4; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Sagner S, 1998, PHYTOCHEMISTRY, V47, P375, DOI 10.1016/S0031-9422(97)00590-6; Siegle I, 2001, PHARMACOGENETICS, V11, P237, DOI 10.1097/00008571-200104000-00007; STADLER R, 1993, J BIOL CHEM, V268, P823; WEITZ CJ, 1987, NATURE, V330, P674, DOI 10.1038/330674a0; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yu AM, 2002, J PHARMACOL EXP THER, V303, P1291, DOI 10.1124/jpet.102.039891; Yue QY, 1997, EUR J CLIN PHARMACOL, V52, P41, DOI 10.1007/s002280050247; ZENK MH, 1994, PURE APPL CHEM, V66, P2023, DOI 10.1351/pac199466102023; ZENK MH, 1989, J CHEM SOC CHEM COMM, P1725, DOI 10.1039/c39890001725; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357	41	39	39	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24425	24431		10.1074/jbc.M109.011320	http://dx.doi.org/10.1074/jbc.M109.011320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561069	Green Published, hybrid			2022-12-25	WOS:000269380200055
J	Ito, T; Suzuki, S; Kanaji, S; Shiraishi, H; Ohta, S; Arima, K; Tanaka, G; Tamada, T; Honjo, E; Garcia, KC; Kuroki, R; Izuhara, K				Ito, Takachika; Suzuki, Shoichi; Kanaji, Sachiko; Shiraishi, Hiroshi; Ohta, Shoichiro; Arima, Kazuhiko; Tanaka, Go; Tamada, Taro; Honjo, Eijiro; Garcia, K. Christopher; Kuroki, Ryota; Izuhara, Kenji			Distinct Structural Requirements for Interleukin-4 (IL-4) and IL-13 Binding to the Shared IL-13 Receptor Facilitate Cellular Tuning of Cytokine Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION	Both interleukin-4 (IL-4) and IL-13 can bind to the shared receptor composed of the IL-4 receptor alpha chain and the IL-13 receptor alpha 1 chain (IL-13R alpha 1); however, the mechanisms by which these ligands bind to the receptor chains are different, enabling the principal functions of these ligands to be different. We have previously shown that the N-terminal Ig-like domain in IL-13R alpha 1, called the D1 domain, is the specific and critical binding unit for IL-13. However, it has still remained obscure which amino acid has specific binding capacity to IL-13 and why the D1 domain acts as the binding site for IL-13, but not IL-4. To address these questions, in this study we performed mutational analyses for the D1 domain, combining the structural data to identify the amino acids critical for binding to IL-13. Mutations of Lys-76, Lys-77, or Ile-78 in c' strand in which the crystal structure showed interaction with IL-13, and those of Trp-65 and Ala-79 adjacent to the interacting site, resulted in significant impairment of IL-13 binding, demonstrating that these amino acids generate the binding site. Furthermore, mutations of Val-35, Leu-38, or Val-42 at the N-terminal beta-strand also resulted in loss of IL-13 binding, probably from decreased structural stability. None of the mutations employed here affected IL-4 binding. These results demonstrate that the D1 domain of IL-13R alpha 1 acts as an affinity converter, through direct cytokine interactions, that allows the shared receptor to respond differentially to IL-4 and IL-13.	[Ito, Takachika; Suzuki, Shoichi; Kanaji, Sachiko; Shiraishi, Hiroshi; Arima, Kazuhiko; Tanaka, Go; Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan; [Ito, Takachika] Saga Med Sch, Dept Emergency Med, Saga 8498501, Japan; [Ohta, Shoichiro; Izuhara, Kenji] Saga Med Sch, Dept Lab Med, Saga 8498501, Japan; [Tamada, Taro; Honjo, Eijiro; Kuroki, Ryota] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Neutron Sci Res Ctr, Mol Struct Biol Grp, Tokai, Ibaraki 3191195, Japan; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Saga University; Saga University; Saga University; Japan Atomic Energy Agency; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Izuhara, K (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp	Arima, Kazuhiko/I-8962-2014	Arima, Kazuhiko/0000-0002-0607-8787; Tamada, Taro/0000-0003-1419-8022	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grant-in-aids for scientific research from the Japan Society for the Promotion of Science.	Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Honjo E, 2008, PROTEIN EXPRES PURIF, V60, P25, DOI 10.1016/j.pep.2008.03.020; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Madhankumar AB, 2002, J BIOL CHEM, V277, P43194, DOI 10.1074/jbc.M205047200; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	18	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24289	24296		10.1074/jbc.M109.007286	http://dx.doi.org/10.1074/jbc.M109.007286			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586918	hybrid, Green Published			2022-12-25	WOS:000269380200042
J	Kim, MH; Sasaki, K; Imai, R				Kim, Myung-Hee; Sasaki, Kentaro; Imai, Ryozo			Cold Shock Domain Protein 3 Regulates Freezing Tolerance in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING PROTEIN; MESSENGER-RNA; TRANSCRIPTIONAL ADAPTER; ESCHERICHIA-COLI; STRESS TOLERANCE; GENE-EXPRESSION; LOW-TEMPERATURE; CSPA FAMILY; ACCLIMATION; ACID	In response to cold, Escherichia coli produces cold shock proteins (CSPs) that have essential roles in cold adaptation as RNA chaperones. Here, we demonstrate that Arabidopsis cold shock domain protein 3 (AtCSP3), which shares a cold shock domain with bacterial CSPs, is involved in the acquisition of freezing tolerance in plants. AtCSP3 complemented a cold-sensitive phenotype of the E. coli CSP quadruple mutant and displayed nucleic acid duplex melting activity, suggesting that AtCSP3 also functions as an RNA chaperone. Promoter-GUS transgenic plants revealed tissue-specific expression of AtCSP3 in shoot and root apical regions. When exposed to low temperature, GUS activity was extensively induced in a broader region of the roots. In transgenic plants expressing an AtCSP3-GFP fusion, GFP signals were detected in both the nucleus and cytoplasm. An AtCSP3 knock-out mutant (atcsp3-2) was sensitive to freezing compared with wild-type plants under non-acclimated and cold-acclimated conditions, whereas expression of C-repeat-binding factors and their downstream genes during cold acclimation was not altered in the atcsp3-2 mutant. Overexpression of AtCSP3 in transgenic plants conferred enhanced freezing tolerance over wild-type plants. Together, the data demonstrated an essential role of RNA chaperones for cold adaptation in higher plants.	[Kim, Myung-Hee; Sasaki, Kentaro; Imai, Ryozo] Natl Agr Res Ctr Hokkaido Reg, Crop Cold Tolerance Res Team, Toyohira Ku, Sapporo, Hokkaido 0628555, Japan	National Agriculture & Food Research Organization - Japan	Imai, R (corresponding author), Natl Agr Res Ctr Hokkaido Reg, Crop Cold Tolerance Res Team, Toyohira Ku, Hitsujigaoka 1, Sapporo, Hokkaido 0628555, Japan.	rzi@affrc.go.jp			Japan Society for the Promotion of Science [19380063]; National Agriculture and Food Research Organization (NARO)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Agriculture and Food Research Organization (NARO)	This work was supported in part by Grants from Japan Society for the Promotion of Science (KAKENHI Scientific Research B 19380063) and National Agriculture and Food Research Organization (NARO) ( Development of Innovative Crops through the Molecular Analysis of Useful Genes 3202) ( to R. I. and K. S., respectively).	[Anonymous], 2012, FROST SURVIVAL PLANT, DOI DOI 10.1002/joc.4518; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURTIS OF, 1930, AM J BOT, V17, P1047; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Fusaro AF, 2007, PLANTA, V225, P1339, DOI 10.1007/s00425-006-0444-4; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Higashi K, 2003, J BIOL CHEM, V278, P5156, DOI 10.1074/jbc.M208724200; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Karlson D, 2003, PLANT PHYSIOL, V131, P12, DOI 10.1104/pp.014472; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Lasham A, 2003, J BIOL CHEM, V278, P35516, DOI 10.1074/jbc.M303920200; LIN CT, 1992, PLANT PHYSIOL, V99, P519, DOI 10.1104/pp.99.2.519; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nakaminami K, 2005, FEBS LETT, V579, P4887, DOI 10.1016/j.febslet.2005.07.074; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2002, J BIOL CHEM, V277, P46706, DOI 10.1074/jbc.M208118200; Pisarev AV, 2002, J BIOL CHEM, V277, P15445, DOI 10.1074/jbc.M111954200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; SCHWABE WW, 1954, J EXP BOT, V5, P389, DOI 10.1093/jxb/5.3.389; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; Takahashi H, 1997, J PLANT RES, V110, P163, DOI 10.1007/BF02509304; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Weber MHW, 2002, NUCLEIC ACIDS RES, V30, P375, DOI 10.1093/nar/30.1.375; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	46	85	95	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23454	23460		10.1074/jbc.M109.025791	http://dx.doi.org/10.1074/jbc.M109.025791			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556243	hybrid, Green Published			2022-12-25	WOS:000269180000030
J	Naranuntarat, A; Jensen, LT; Pazicni, S; Penner-Hahn, JE; Culotta, VC				Naranuntarat, Amornrat; Jensen, Laran T.; Pazicni, Samuel; Penner-Hahn, James E.; Culotta, Valeria C.			The Interaction of Mitochondrial Iron with Manganese Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; PROTEIN; BIOGENESIS; SCAFFOLD; TRANSPORTER; GENE; ISCU; SPECIFICITY; CELLS; SITE	Superoxide dismutase 2 (SOD2) is one of the rare mitochondrial enzymes evolved to use manganese as a cofactor over the more abundant element iron. Although mitochondrial iron does not normally bind SOD2, iron will misincorporate into Saccharomyces cerevisiae Sod2p when cells are starved for manganese or when mitochondrial iron homeostasis is disrupted by mutations in yeast grx5, ssq1, and mtm1. We report here that such changes in mitochondrial manganese and iron similarly affect cofactor selection in a heterologously expressed Escherichia coli Mn-SOD, but not a highly homologous Fe-SOD. By x-ray absorption near edge structure and extended x-ray absorption fine structure analyses of isolated mitochondria, we find that misincorporation of iron into yeast Sod2p does not correlate with significant changes in the average oxidation state or coordination chemistry of bulk mitochondrial iron. Instead, small changes in mitochondrial iron are likely to promote iron-SOD2 interactions. Iron binds Sod2p in yeast mutants blocking late stages of iron-sulfur cluster biogenesis (grx5, ssq1, and atm1), but not in mutants defective in the upstream Isu proteins that serve as scaffolds for iron-sulfur biosynthesis. In fact, we observed a requirement for the Isu proteins in iron inactivation of yeast Sod2p. Sod2p activity was restored in mtm1 and grx5 mutants by depleting cells of Isu proteins or using a dominant negative Isu1p predicted to stabilize iron binding to Isu1p. In all cases where disruptions in iron homeostasis inactivated Sod2p, we observed an increase in mitochondrial Isu proteins. These studies indicate that the Isu proteins and the iron-sulfur pathway can donate iron to Sod2p.	[Culotta, Valeria C.] Johns Hopkins Univ, Dept Environm Hlth Sci, Div Toxicol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Pazicni, Samuel; Penner-Hahn, James E.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Div Toxicol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Jensen, Amornrat/AAO-3411-2020; Penner-Hahn, James/GYD-3750-2022	Jensen, Amornrat/0000-0003-2528-8795; Penner-Hahn, James/0000-0003-0314-1274; Pazicni, Samuel/0000-0002-4775-7794; Jensen, Laran/0000-0003-3199-1743	National Institutes of Health [ES-08996, GM-38047]; Johns Hopkins University NIEHS Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008996, P30ES003819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038047, R29GM038047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University NIEHS Center(Johns Hopkins University); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES-08996 (to V.C.C.) and GM-38047 (awarded to J.E.P.-H.) and the Johns Hopkins University NIEHS Center.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Agar JN, 2000, J AM CHEM SOC, V122, P2136, DOI 10.1021/ja9944195; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Balzan R, 1999, BIOCHEM BIOPH RES CO, V256, P63, DOI 10.1006/bbrc.1999.0285; Bekri S, 2000, BLOOD, V96, P3256; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; BEYER WF, 1991, J BIOL CHEM, V266, P303; CARLIOZ A, 1988, J BIOL CHEM, V263, P1555; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Duttaroy A, 2003, GENETICS, V165, P2295; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hudder BN, 2007, J BIOL INORG CHEM, V12, P1029, DOI 10.1007/s00775-007-0275-1; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Jensen LT, 2004, J BIOL CHEM, V279, P29938, DOI 10.1074/jbc.M402795200; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knieszner H, 2005, J BIOL CHEM, V280, P28966, DOI 10.1074/jbc.M503031200; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; NILSSON R, 2009, CELL METAB IN PRESS; Popescu BFG, 2007, J INORG BIOCHEM, V101, P957, DOI 10.1016/j.jinorgbio.2007.03.004; PRIVALLE CT, 1992, J BIOL CHEM, V267, P9140; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; SIKORSKI RS, 1989, GENETICS, V122, P19; Tobin DA, 2003, J AM CHEM SOC, V125, P9962, DOI 10.1021/ja035927o; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vance CK, 2001, BIOCHEMISTRY-US, V40, P13079, DOI 10.1021/bi0113317; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Weng TC, 2005, J SYNCHROTRON RADIAT, V12, P506, DOI 10.1107/S0909049504034193; Whittaker JW, 2003, BIOCHEM SOC T, V31, P1318; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	49	56	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22633	22640		10.1074/jbc.M109.026773	http://dx.doi.org/10.1074/jbc.M109.026773			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561359	Green Published, hybrid			2022-12-25	WOS:000268963100016
J	Sommerfeld, A; Reinehr, R; Haussinger, D				Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter			Bile Acid-induced Epidermal Growth Factor Receptor Activation in Quiescent Rat Hepatic Stellate Cells Can Trigger Both Proliferation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-INDUCED APOPTOSIS; HEPATOCYTE APOPTOSIS; LIVER-INJURY; TYROSINE PHOSPHORYLATION; CD95 LIGAND; KINASE; JNK; MECHANISMS; FIBROSIS; FAS	Bile acids have been reported to induce epidermal growth factor receptor (EGFR) activation and subsequent proliferation of activated hepatic stellate cells (HSC), but the underlying mechanisms and whether quiescent HSC are also a target for bile acid-induced proliferation or apoptosis remained unclear. Therefore, primary rat HSC were cultured for up to 48 h and analyzed for their proliferative/apoptotic responses toward bile acids. Hydrophobic bile acids, i.e. taurolithocholate 3-sulfate, taurochenodeoxycholate, and glycochenodeoxycholate, but not taurocholate or tauroursodeoxycholate, induced Yes-dependent EGFR phosphorylation. Simultaneously, hydrophobic bile acids induced phosphorylation of the NADPH oxidase subunit p47(phox) and formation of reactive oxygen species (ROS). ROS production was sensitive to inhibition of acidic sphingomyelinase, protein kinase C zeta, and NADPH oxidases. All maneuvers which prevented bile acid-induced ROS formation also prevented Yes and subsequent EGFR phosphorylation. Taurolithocholate 3-sulfate-induced EGFR activation was followed by extracellular signal-regulated kinase 1/2, but not c-Jun N-terminal kinase (JNK) activation, and stimulated HSC proliferation. When, however, a JNK signal was induced by coadministration of cycloheximide or hydrogen peroxide (H2O2), activated EGFR associated with CD95 and triggered EGFR-mediated CD95-tyrosine phosphorylation and subsequent formation of the death-inducing signaling complex. In conclusion, hydrophobic bile acids lead to a NADPH oxidase-driven ROS generation followed by a Yes-mediated EGFR activation in quiescent primary rat HSC. This proliferative signal shifts to an apoptotic signal when a JNK signal simultaneously comes into play.	[Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016					Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Cariers A, 2002, CELL PHYSIOL BIOCHEM, V12, P179, DOI 10.1159/000066277; Chieco P, 1997, HISTOCHEM J, V29, P875, DOI 10.1023/A:1026446008712; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Fischer R, 2002, GASTROENTEROLOGY, V123, P845, DOI 10.1053/gast.2002.35384; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2004, J BIOL CHEM, V279, P10364, DOI 10.1074/jbc.M311997200; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021; SAWITZA I, 2009, HEPATOLOGY IN PRESS; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702	36	36	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22173	22183		10.1074/jbc.M109.005355	http://dx.doi.org/10.1074/jbc.M109.005355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553664	hybrid, Green Published			2022-12-25	WOS:000268783700042
J	Walker, MP; Tian, LP; Matera, AG				Walker, Michael P.; Tian, Liping; Matera, A. Gregory			Reduced Viability, Fertility and Fecundity in Mice Lacking the Cajal Body Marker Protein, Coilin	PLOS ONE			English	Article								Background: Coilin is the signature protein of the Cajal body, a conserved nuclear organelle involved in multiple aspects of small ribonucleoprotein (RNP) biogenesis. Coilin is required for Cajal body homeostasis in both plants and animals. Mice lacking coilin are viable when the mutation is crossed to an outbred strain but only partially viable when crossed to inbred lines. Methodology/Principal Findings: In order to clarify this issue, we backcrossed the coilin deletion onto the C57BL6/J background for ten generations and then investigated the consequences of coilin removal on overall viability and reproductive success. We conclude that semi-lethal phenotype observed in mixed-background crosses is due to loss of the Coilin gene (or a very tightly-linked locus). Interestingly, coilin knockout embryos die relatively late in gestation, between E13.5 and birth. We show that the maternal contribution of coilin is not important for organismal viability. Importantly, coilin knockout mice display significant fertility and fecundity defects. Mutant males that escape the embryonic lethality display reduced testis size, however, both males and females contribute to the observed reduction in reproductive fitness. Conclusions/Significance: The evolutionary conservation of coilin from plants to animals suggests that the protein plays an important role, perhaps coordinating the activities of various RNA-processing machineries. Our observations are consistent with the idea that coilin functions to ensure robust organismal development, especially during periods of rapid growth.			Walker, MP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	matera@unc.edu		Matera, A. Gregory/0000-0002-6406-0630	NIGMS NIH HHS [T32-GM08613, T32 GM008613] Funding Source: Medline; NINDS NIH HHS [R01-NS041617, R01 NS041617] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041617] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Bauer DW, 1997, MOL BIOL CELL, V8, P73, DOI 10.1091/mbc.8.1.73; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gangwani L, 2005, MOL CELL BIOL, V25, P2744, DOI 10.1128/MCB.25.7.2744-2756.2005; GREEN RC, 1991, EPILEPSIA, V32, P22, DOI 10.1111/j.1528-1157.1991.tb05605.x; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Kiss AM, 2002, NUCLEIC ACIDS RES, V30, P4643, DOI 10.1093/nar/gkf592; Klingauf M, 2006, MOL BIOL CELL, V17, P4972, DOI 10.1091/mbc.E06-06-0513; LAFARGA M, 2009, CHROMOSOMA IN PRESS; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Nesic D, 2004, J CELL SCI, V117, P4423, DOI 10.1242/jcs.01308; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; RASKA I, 1991, EXP CELL RES, V195, P27, DOI 10.1016/0014-4827(91)90496-H; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Tucker KE, 2000, J STRUCT BIOL, V129, P269, DOI 10.1006/jsbi.2000.4234; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y	40	64	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6171	10.1371/journal.pone.0006171	http://dx.doi.org/10.1371/journal.pone.0006171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587784	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035100003
J	Schaarschmidt, G; Wegner, F; Schwarz, SC; Schmidt, H; Schwarz, J				Schaarschmidt, Grit; Wegner, Florian; Schwarz, Sigrid C.; Schmidt, Hartmut; Schwarz, Johannes			Characterization of Voltage-Gated Potassium Channels in Human Neural Progenitor Cells	PLOS ONE			English	Article							K+ CHANNELS; TRANSIENT OUTWARD; DOPAMINERGIC DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL-CHANGES; COLORIMETRIC ASSAY; PEPTIDE INHIBITOR; DELAYED RECTIFIER; PRECURSOR CELLS; IONIC CURRENTS	Background: Voltage-gated potassium ( K-v) channels are among the earliest ion channels to appear during brain development, suggesting a functional requirement for progenitor cell proliferation and/or differentiation. We tested this hypothesis, using human neural progenitor cells (hNPCs) as a model system. Methodology/Principal Findings: In proliferating hNPCs a broad spectrum of Kv channel subtypes was identified using quantitative real-time PCR with a predominant expression of the A-type channel Kv4.2. In whole-cell patch-clamp recordings Kv currents were separated into a large transient component characteristic for fast-inactivating A-type potassium channels ( I-A) and a small, sustained component produced by delayed-rectifying channels (I-K). During differentiation the expression of I-A as well as A-type channel transcripts dramatically decreased, while IK producing delayed-rectifiers were upregulated. Both Kv currents were differentially inhibited by selective neurotoxins like phrixotoxin-1 and a-dendrotoxin as well as by antagonists like 4-aminopyridine, ammoniumchloride, tetraethylammonium chloride and quinidine. In viability and proliferation assays chronic inhibition of the A-type currents severely disturbed the cell cycle and precluded proper hNPC proliferation, while the blockade of delayed-rectifiers by a-dendrotoxin increased proliferation. Conclusions/Significance: These findings suggest that A-type potassium currents are essential for proper proliferation of immature multipotent hNPCs.			Schaarschmidt, G (corresponding author), Univ Leipzig, Dept Neurol, Leipzig, Germany.	grit.schaarschmidt@medizin.uni-leipzig.de	Schmidt, Hartmut/F-7058-2010					Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P91, DOI 10.1113/jphysiol.1985.sp015542; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENISHIN CG, 1988, MOL PHARMACOL, V34, P152; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chagot B, 2004, PROTEIN SCI, V13, P1197, DOI 10.1110/ps.03584304; CLARK RB, 1995, BRIT J PHARMACOL, V115, P335, DOI 10.1111/j.1476-5381.1995.tb15882.x; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Deng P, 2004, DEV BRAIN RES, V153, P97, DOI 10.1016/j.devbrainres.2004.08.001; Dieterlen MT, 2009, J NEUROSCI METH, V178, P15, DOI 10.1016/j.jneumeth.2008.11.007; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; FISHMAN MC, 1981, P NATL ACAD SCI-BIOL, V78, P5245, DOI 10.1073/pnas.78.8.5245; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jelitai M, 2007, J NEUROSCI RES, V85, P1606, DOI 10.1002/jnr.21282; Johnston D., 1995, FDN CELLULAR NEUROPH, P676, DOI [10.1097/00004691-199703000-00009, DOI 10.1097/00004691-199703000-00009]; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; KEHL SJ, 1991, BRIT J PHARMACOL, V103, P1807, DOI 10.1111/j.1476-5381.1991.tb09867.x; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Milosevic J, 2006, CELL TISSUE RES, V324, P377, DOI 10.1007/s00441-005-0147-3; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Milosevic J, 2002, INVEST NEW DRUG, V20, P229, DOI 10.1023/A:1016281109100; Milosevic J, 2007, STEM CELLS DEV, V16, P625, DOI 10.1089/scd.2006.0113; Milosevic J, 2006, J NEUROCHEM, V99, P913, DOI 10.1111/j.1471-4159.2006.04132.x; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; PORSTMANN T, 1985, J IMMUNOL METHODS, V82, P169, DOI 10.1016/0022-1759(85)90236-4; Reiff DF, 1999, NEUROSCIENCE, V92, P1103, DOI 10.1016/S0306-4522(99)00044-5; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Ribera AB, 1999, ANN NY ACAD SCI, V868, P399, DOI 10.1111/j.1749-6632.1999.tb11301.x; Robertson B, 1997, TRENDS PHARMACOL SCI, V18, P474, DOI 10.1016/S0165-6147(97)90686-6; ROGAWSKI MA, 1985, ANN NY ACAD SCI, V448, P403, DOI 10.1111/j.1749-6632.1985.tb29934.x; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Schaarschmidt G, 2009, J NEUROCHEM, V109, P238, DOI 10.1111/j.1471-4159.2009.05954.x; Schmidt H, 2000, J NEUROBIOL, V44, P392, DOI 10.1002/1097-4695(20000915)44:4<392::AID-NEU3>3.0.CO;2-M; Schmidt K, 1999, BRAIN RES, V843, P145, DOI 10.1016/S0006-8993(99)01938-1; Schwarz J, 2006, NEURODEGENER DIS, V3, P45, DOI 10.1159/000092092; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shi J, 2007, EUR J NEUROSCI, V25, P3499, DOI 10.1111/j.1460-9568.2007.05624.x; Shibata R, 2000, J NEUROSCI, V20, P4145; Smith DO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001604; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; Spitzer NC, 2000, BRAIN RES BULL, V53, P547, DOI 10.1016/S0361-9230(00)00388-9; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; Stephens GJ, 1996, PFLUG ARCH EUR J PHY, V431, P435, DOI 10.1007/BF02207283; STEWART RR, 1995, J NEUROBIOL, V28, P419, DOI 10.1002/neu.480280403; Storch A, 2004, CELL TISSUE RES, V318, P15, DOI 10.1007/s00441-004-0923-5; Storch A, 2003, J CHEM NEUROANAT, V26, P133, DOI 10.1016/S0891-0618(03)00067-X; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Vautier F, 2004, GLIA, V48, P337, DOI 10.1002/glia.20088; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WANG ZG, 1995, J PHARMACOL EXP THER, V272, P184; Wegner F, 2008, J NEUROCHEM, V107, P1056, DOI 10.1111/j.1471-4159.2008.05688.x; Yasuda T, 2008, MOL CELL NEUROSCI, V37, P284, DOI 10.1016/j.mcn.2007.10.003	70	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6168	10.1371/journal.pone.0006168	http://dx.doi.org/10.1371/journal.pone.0006168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584922	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806500005
J	Kim, GH; Samant, SA; Earley, JU; Svensson, EC				Kim, Gene H.; Samant, Sadhana A.; Earley, Judy U.; Svensson, Eric C.			Translational Control of FOG-2 Expression in Cardiomyocytes by MicroRNA-130a	PLOS ONE			English	Article								MicroRNAs are increasingly being recognized as regulators of embryonic development; however, relatively few microRNAs have been identified to regulate cardiac development. FOG-2 (also known as zfpm2) is a transcriptional co-factor that we have previously shown is critical for cardiac development. In this report, we demonstrate that FOG-2 expression is controlled at the translational level by microRNA-130a. We identified a conserved region in the FOG-2 39 untranslated region predicted to be a target for miR-130a. To test the functional significance of this site, we generated an expression construct containing the luciferase coding region fused with the 39 untranslated region of FOG-2 or a mutant version lacking this microRNA binding site. When these constructs were transfected into NIH 3T3 fibroblasts (which are known to express miR-130a), we observed a 3.3-fold increase in translational efficiency when the microRNA target site was disrupted. Moreover, knockdown of miR-130a in fibroblasts resulted in a 3.6-fold increase in translational efficiency. We also demonstrate that cardiomyocytes express miR-130a and can attenuate translation of mRNAs with a FOG-2 39 untranslated region. Finally, we generated transgenic mice with cardiomyocyte over-expression of miR-130a. In the hearts of these mice, FOG-2 protein levels were reduced by as much as 80%. Histological analysis of transgenic embryos revealed ventricular wall hypoplasia and ventricular septal defects, similar to that seen in FOG-2 deficient hearts. These results demonstrate the importance of miR-130a for the regulation of FOG-2 protein expression and suggest that miR-130a may also play a role in the regulation of cardiac development.			Kim, GH (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	esvensso@medicine.bsd.uchicago.edu	Huang, H/E-9490-2010	Kim, Gene/0000-0001-6461-1992	NHLBI NIH HHS [R01 HL071063, F32 HL093992] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL093992, R01HL071063] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Hake S, 2003, CURR BIOL, V13, pR851, DOI 10.1016/j.cub.2003.10.021; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Knotts S, 1996, DEV DYNAM, V206, P182, DOI 10.1002/(SICI)1097-0177(199606)206:2<182::AID-AJA7>3.0.CO;2-E; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PARMACEK MS, 1992, MOL CELL BIOL, V12, P1967, DOI 10.1128/MCB.12.5.1967; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; RINDT H, 1993, J BIOL CHEM, V268, P5332; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; THUM T, 2008, CARDIOVASCULAR RES; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	43	40	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6161	10.1371/journal.pone.0006161	http://dx.doi.org/10.1371/journal.pone.0006161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582148	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806400016
J	Stewart, L; Gosling, R; Griffin, J; Gesase, S; Campo, J; Hashim, R; Masika, P; Mosha, J; Bousema, T; Shekalaghe, S; Cook, J; Corran, P; Ghani, A; Riley, EM; Drakeley, C				Stewart, Laveta; Gosling, Roly; Griffin, Jamie; Gesase, Samwel; Campo, Joseph; Hashim, Ramadan; Masika, Paul; Mosha, Jacklin; Bousema, Teun; Shekalaghe, Seif; Cook, Jackie; Corran, Patrick; Ghani, Azra; Riley, Eleanor M.; Drakeley, Chris			Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; PARASITE PREVALENCE; AREA; INTENSITY; ENDEMICITY; ANTIBODIES; MORBIDITY; INFECTION; TANZANIA; AFRICA	Background: Malaria transmission intensity is a crucial determinant of malarial disease burden and its measurement can help to define health priorities. Rapid, local estimates of transmission are required to focus resources better but current entomological and parasitological methods for estimating transmission intensity are limited in this respect. An alternative is determination of antimalarial antibody age-specific sero-prevalence to estimate sero-conversion rates (SCR), which have been shown to correlate with transmission intensity. This study evaluated SCR generated from samples collected from health facility attendees as a tool for a rapid assessment of malaria transmission intensity. Methodology and Principal Findings: The study was conducted in north east Tanzania. Antibodies to Plasmodium falciparum merozoite antigens MSP-1(19) and AMA-1 were measured by indirect ELISA. Age-specific antibody prevalence was analysed using a catalytic conversion model based on maximum likelihood to generate SCR. A pilot study, conducted near Moshi, found SCRs for AMA-1 were highly comparable between samples collected from individuals in a conventional cross-sectional survey and those collected from attendees at a local health facility. For the main study, 3885 individuals attending village health facilities in Korogwe and Same districts were recruited. Both malaria parasite prevalence and sero-positivity were higher in Korogwe than in Same. MSP-1(19) and AMA-1 SCR rates for Korogwe villages ranged from 0.03 to 0.06 and 0.07 to 0.21 respectively. In Same district there was evidence of a recent reduction in transmission, with SCR among those born since 1998 [MSP-1(19) 0.002 to 0.008 and AMA-1 0.005 to 0.014] being 5 to 10 fold lower than among individuals born prior to 1998 [MSP-1(19) 0.02 to 0.04 and AMA-1 0.04 to 0.13]. Current health facility specific estimates of SCR showed good correlations with malaria incidence rates in infants in a contemporaneous clinical trial (MSP-1(19) r(2) = 0.78, p, 0.01 & AMA-1 r(2) = 0.91, p < 0.001). Conclusions: SCRs generated from age-specific anti-malarial antibody prevalence data collected via health facility surveys were robust and credible. Analysis of SCR allowed detection of a recent drop in malaria transmission in line with recent data from other areas in the region. This health facility-based approach represents a potential tool for rapid assessment of recent trends in malaria transmission intensity, generating valuable data for local and national malaria control programs to target, monitor and evaluate their control strategies.			Stewart, L (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	Chris.Drakeley@lshtm.ac.uk	Bousema, Teun/N-3574-2014; Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020; Ghani, Azra/B-8560-2009	Bousema, Teun/0000-0003-2666-094X; Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Mosha, Jacklin/0000-0001-7940-8903; Ghani, Azra/0000-0002-0007-4910	Medical Research Council [G0600719B] Funding Source: researchfish; Wellcome Trust [078925] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; BRUCECHWATT LJ, 1973, LANCET, V2, P547; Byass P, 2008, LANCET, V372, P1523, DOI 10.1016/S0140-6736(08)61631-1; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRAPER C. C., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P137, DOI 10.1016/0035-9203(57)90058-5; DRAPER CC, 1972, AM J TROP MED HYG, V21, P696, DOI 10.4269/ajtmh.1972.21.696; DRUILHE P, 1986, INFECT IMMUN, V53, P393, DOI 10.1128/IAI.53.2.393-397.1986; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GOSLING RD, 2009, LANCET IN PRESS; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; GREENWOOD BM, 2008, TRENDS PARASITOL; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Kachur SP, 2006, LANCET, V368, P10, DOI 10.1016/S0140-6736(06)68945-9; Lusingu JPA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-26; Masika PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-120; MATOLA YG, 1981, T ROY SOC TROP MED H, V75, P811, DOI 10.1016/0035-9203(81)90418-1; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McCullagh P, 1989, GEN LINEAR MODELS; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; NOOR AM, 2008, LANCET; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B	45	126	127	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6083	10.1371/journal.pone.0006083	http://dx.doi.org/10.1371/journal.pone.0006083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562032	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000267465900014
J	Oosterveer, MH; van Dijk, TH; Tietge, UJF; Boer, T; Havinga, R; Stellaard, F; Groen, AK; Kuipers, F; Reijngoud, DJ				Oosterveer, Maaike H.; van Dijk, Theo H.; Tietge, Uwe J. F.; Boer, Theo; Havinga, Rick; Stellaard, Frans; Groen, Albert K.; Kuipers, Folkert; Reijngoud, Dirk-Jan			High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; LOW-DENSITY-LIPOPROTEIN; LIVER-X-RECEPTOR; ACETYL-COA CARBOXYLASE-1; ELEMENT-BINDING PROTEIN; POOL IN-VIVO; INSULIN-RESISTANCE; VLDL PRODUCTION; CHOLESTEROL; DIET	Background: High-fat diets promote hepatic lipid accumulation. Paradoxically, these diets also induce lipogenic gene expression in rodent liver. Whether high expression of these genes actually results in an increased flux through the de novo lipogenic pathway in vivo has not been demonstrated. Methodology/Principal Findings: To interrogate this apparent paradox, we have quantified de novo lipogenesis in C57Bl/6J mice fed either chow, a high-fat or a n-3 polyunsaturated fatty acid (PUFA)-enriched high-fat diet. A novel approach based on mass isotopomer distribution analysis (MIDA) following 1-C-13 acetate infusion was applied to simultaneously determine de novo lipogenesis, fatty acid elongation as well as cholesterol synthesis. Furthermore, we measured very low density lipoprotein-triglyceride (VLDL-TG) production rates. High-fat feeding promoted hepatic lipid accumulation and induced the expression of lipogenic and cholesterogenic genes compared to chow-fed mice: induction of gene expression was found to translate into increased oleate synthesis. Interestingly, this higher lipogenic flux (+74 mu g/g/h for oleic acid) in mice fed the high-fat diet was mainly due to an increased hepatic elongation of unlabeled palmitate (+66 mu g/g/h) rather than to elongation of de novo synthesized palmitate. In addition, fractional cholesterol synthesis was increased, i.e. 5.8 +/- 0.4% vs. 8.1 +/- 0.6% for control and high fat-fed animals, respectively. Hepatic VLDL-TG production was not affected by high-fat feeding. Partial replacement of saturated fat by fish oil completely reversed the lipogenic effects of high-fat feeding: hepatic lipogenic and cholesterogenic gene expression levels as well as fatty acid and cholesterol synthesis rates were normalized. Conclusions/Significance: High-fat feeding induces hepatic fatty acid synthesis in mice, by chain elongation and subsequent desaturation rather than de novo synthesis, while VLDL-TG output remains unaffected. Suppression of lipogenic fluxes by fish oil prevents from high fat diet-induced hepatic steatosis in mice.			Oosterveer, MH (corresponding author), Univ Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands.	m.h.oosterveer@med.umcg.nl	oosterveer, maaike h/C-3374-2013	Kuipers, Folkert/0000-0003-2518-737X; Reijngoud, Dirk-Jan/0000-0003-1157-4491				Alwayn IPJ, 2005, TRANSPLANTATION, V79, P606, DOI 10.1097/01.TP.0000150023.86487.44; Bandsma RHJ, 2001, DIABETES, V50, P2591, DOI 10.2337/diabetes.50.11.2591; Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Bederman IR, 2004, J BIOL CHEM, V279, P43207, DOI 10.1074/jbc.M403838200; BENHIZIA F, 1994, AM J PHYSIOL-ENDOC M, V267, pE975, DOI 10.1152/ajpendo.1994.267.6.E975; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cheema SK, 1999, J NUTR, V129, P1718, DOI 10.1093/jn/129.9.1718; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; DELGADO TC, 2008, NMR BIOMED; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; FRASER R, 1970, J LIPID RES, V11, P60; Gautier T, 2007, J LIPID RES, V48, P30, DOI 10.1194/jlr.M600205-JLR200; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; GIBBONS GF, 1992, BIOCHEM J, V287, P749, DOI 10.1042/bj2870749; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HELLERSTEIN MK, 1991, AM J PHYSIOL, V261, pE479, DOI 10.1152/ajpendo.1991.261.4.E479; HELLERSTEIN MK, 1991, J BIOL CHEM, V266, P10912; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Jung HR, 1999, BIOCHEM J, V343, P473, DOI 10.1042/0264-6021:3430473; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; LIN YG, 1995, BBA-LIPID LIPID MET, V1256, P88, DOI 10.1016/0005-2760(95)00006-X; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; MURPHY MC, 1993, BRIT J NUTR, V70, P727, DOI 10.1079/BJN19930168; MUSKIET FAJ, 1983, J CHROMATOGR, V278, P231, DOI 10.1016/S0378-4347(00)84782-9; NEESE RA, 1993, AM J PHYSIOL, V264, pE136, DOI 10.1152/ajpendo.1993.264.1.E136; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Park Y, 2003, J LIPID RES, V44, P455, DOI 10.1194/jlr.M200282-JLR200; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qi KM, 2008, CLIN NUTR, V27, P424, DOI 10.1016/j.clnu.2008.02.001; RUMSEY SC, 1995, J BIOL CHEM, V270, P10008, DOI 10.1074/jbc.270.17.10008; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Tamura S, 2005, J CLIN INVEST, V115, P1139, DOI 10.1172/JCI200524930; van der Meer RW, 2008, J CLIN ENDOCR METAB, V93, P2702, DOI 10.1210/jc.2007-2524; van der Veen JN, 2007, J LIPID RES, V48, P337, DOI 10.1194/jlr.M600170-JLR200; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wiegman CH, 2003, DIABETES, V52, P1081, DOI 10.2337/diabetes.52.5.1081; ZHANG Y, 1994, J BIOL CHEM, V269, P11025	52	113	118	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6066	10.1371/journal.pone.0006066	http://dx.doi.org/10.1371/journal.pone.0006066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557132	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600014
J	Vogtlander, NPJ; Visch, HJ; Bakker, MAH; Berden, JHM; van der Vlag, J				Vogtlander, Nils P. J.; Visch, Henk Jan; Bakker, Marinka A. H.; Berden, Jo H. M.; van der Vlag, Johan			Ligation of alpha-Dystroglycan on Podocytes Induces Intracellular Signaling: A New Mechanism for Podocyte Effacement?	PLOS ONE			English	Article								Background: alpha-Dystroglycan is a negatively charged glycoprotein that covers the apical and basolateral membrane of the podocyte. Its transmembrane binding to the cytoskeleton is regulated via tyrosine phosphorylation (pY892) of beta-dystroglycan. At the basolateral side alpha-dystroglycan binds the glomerular basement membrane. At the apical membrane, it plays a role in the maintenance of the filtration slit. In this study, we evaluated whether ligation of alpha-dystroglycan with specific antibodies or natural ligands induces intracellular signaling, and whether there is an effect on podocyte architecture. Methodology/Principal Findings: Conditionally immortalized podocytes were exposed in vitro to antibodies to alpha-dystroglycan, and to fibronectin, biglycan, laminin and agrin. Intracellular calcium fluxes, phosphorylation of beta-dystroglycan and podocyte architecture were studied. Antibodies to alpha-dystroglycan could specifically induce calcium signaling. Fibronectin also induced calcium signaling, and led to dephosphorylation of pY892 in beta-dystroglycan. Ligation of alpha-dystroglycan resulted in an altered actin architecture, a decreased number of podocyte pedicles and a more flattened appearance of the podocyte. Conclusions/Significance: We conclude that ligation of alpha-dystroglycan on podocytes induces intracellular calcium signaling, which leads to an altered cytoskeleton architecture akin to the situation of foot process effacement. In particular the ability of fibronectin to induce intracellular signaling events is of interest, since the expression and excretion of this protein is upregulated in several proteinuric diseases. Therefore, fibronectin-induced signaling via dystroglycan may be a novel mechanism for foot process effacement in proteinuric diseases.			Vogtlander, NPJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Div Nephrol, Nijmegen Ctr Mol Life Sci,Nephrol Res Lab, NL-6525 ED Nijmegen, Netherlands.	j.vandervlag@nier.umcn.nl	Van der Vlag, Johan/E-4636-2010; Berden, J.H.M./H-8009-2014	Van der Vlag, Johan/0000-0001-7843-5918; 				Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Blattner SM, 2005, CURR OPIN NEPHROL HY, V14, P404, DOI 10.1097/01.mnh.0000172730.67746.5b; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; Cohen MP, 2007, AM J PHYSIOL-RENAL, V292, pF789, DOI 10.1152/ajprenal.00201.2006; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ferletta M, 2003, MOL BIOL CELL, V14, P2088, DOI 10.1091/mbc.E03-01-0852; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hunt JL, 2005, J AM SOC NEPHROL, V16, P1593, DOI 10.1681/ASN.2004080679; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; James M, 2000, J CELL SCI, V113, P1717; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kilis-Pstrusinska Katarzyna, 2002, Med Sci Monit, V8, pCR713; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Kubosawa H, 1998, VIRCHOWS ARCH, V433, P449, DOI 10.1007/s004280050273; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Kuroda M, 2002, KIDNEY INT, V62, P780, DOI 10.1046/j.1523-1755.2002.00524.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lee S, 2007, NEPHROL DIAL TRANSPL, V22, P396, DOI 10.1093/ndt/gfl598; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; Meier M, 2007, DIABETES, V56, P346, DOI 10.2337/db06-0891; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moss J, 1998, AMYLOID, V5, P43, DOI 10.3109/13506129809007289; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Raats CJI, 2000, AM J PATHOL, V156, P1749, DOI 10.1016/S0002-9440(10)65046-8; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Rudiger F, 1999, KIDNEY INT, V56, P1700, DOI 10.1046/j.1523-1755.1999.00729.x; Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2001, FASEB J, V15, P559; Senatorski G, 1998, RES EXP MED, V198, P199, DOI 10.1007/s004330050103; Sharma SK, 2002, ANAL BIOCHEM, V307, P187, DOI 10.1016/S0003-2697(02)00008-8; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Soylemezoglu O, 1997, NEPHROL DIAL TRANSPL, V12, P1883, DOI 10.1093/ndt/12.9.1883; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Visch HJ, 2004, J BIOL CHEM, V279, P40328, DOI 10.1074/jbc.M408068200; Vogtlander NPJ, 2006, KIDNEY INT, V69, P1526, DOI 10.1038/sj.ki.5000138; Vogtlander NPJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1345, DOI 10.1369/jhc.4A6596.2005; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711	65	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5979	10.1371/journal.pone.0005979	http://dx.doi.org/10.1371/journal.pone.0005979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543532	gold, Green Published, Green Submitted			2022-12-25	WOS:000267237400006
J	Gesell, A; Rolf, M; Ziegler, J; Chavez, MLD; Huang, FC; Kutchan, TM				Gesell, Andreas; Rolf, Megan; Ziegler, Joerg; Chavez, Maria Luisa Diaz; Huang, Fong-Chin; Kutchan, Toni M.			CYP719B1 Is Salutaridine Synthase, the C-C Phenol-coupling Enzyme of Morphine Biosynthesis in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 REDUCTASES; COPTIS-JAPONICA CELLS; PAPAVER-SOMNIFERUM; MOLECULAR-CLONING; HETEROLOGOUS EXPRESSION; BENZYLISOQUINOLINE ALKALOIDS; METHYLENEDIOXY BRIDGE; BERBERIS-STOLONIFERA; GENE TRANSCRIPT; CULTURES	Morphine is a powerful analgesic natural product produced by the opium poppy Papaver somniferum. Although formal syntheses of this alkaloid have been reported, the morphine molecule contains five stereocenters and a C-C phenol linkage that to date render a total synthesis of morphine commercially unfeasible. The C-C phenol-coupling reaction along the biosynthetic pathway to morphine in opium poppy is catalyzed by the cytochrome P450-dependent oxygenase salutaridine synthase. We report herein on the identification of salutaridine synthase as a member of the CYP719 family of cytochromes P450 during a screen of recombinant cytochromes P450 of opium poppy functionally expressed in Spodoptera frugiperda Sf9 cells. Recombinant CYP719B1 is a highly stereo-and regioselective enzyme; of forty-one compounds tested as potential substrates, only (R)reticuline and (R)-norreticuline resulted in formation of a product (salutaridine and norsalutaridine, respectively). To date, CYP719s have been characterized catalyzing only the formation of a methylenedioxy bridge in berberine biosynthesis (canadine synthase, CYP719A1) and in benzo[c]phenanthridine biosynthesis (stylopine synthase, CYP719A14). Previously identified phenol-coupling enzymes of plant alkaloid biosynthesis belong only to the CYP80 family of cytochromes. CYP719B1 therefore is the prototype for a new family of plant cytochromes P450 that catalyze formation of a phenol-couple.	[Rolf, Megan; Chavez, Maria Luisa Diaz; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Gesell, Andreas; Ziegler, Joerg; Chavez, Maria Luisa Diaz; Kutchan, Toni M.] Leibniz Inst Pflanzenbiochem, D-06120 Halle, Saale, Germany; [Huang, Fong-Chin; Kutchan, Toni M.] Univ Munich, Mol Biol Lab, D-80333 Munich, Germany	Donald Danforth Plant Science Center; Leibniz Institut fur Pflanzenbiochemie; University of Munich	Kutchan, TM (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tmkutchan@danforthcenter.org	Ziegler, Jörg/W-7645-2019; Kutchan, Toni/L-4625-2013	Gesell, Andreas/0000-0002-9614-7079; Augustin, Megan/0000-0002-8430-6466	Deutsche Forschungsgemeinschaft, Bonn, Germany; Fonds der Chemischen Industrie, Frankfurt, Germany; Mallinckrodt Foundation, St. Louis, MO	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Fonds der Chemischen Industrie, Frankfurt, Germany(Fonds der Chemischen Industrie); Mallinckrodt Foundation, St. Louis, MO	This work was supported in part by the Deutsche Forschungsgemeinschaft, Bonn, Germany, Fonds der Chemischen Industrie, Frankfurt, Germany, and the Mallinckrodt Foundation, St. Louis, MO.	Bak S, 1997, PLANT J, V11, P191, DOI 10.1046/j.1365-313X.1997.11020191.x; BARTON DHR, 1967, J CHEM SOC C, P128, DOI 10.1039/j39670000128; BJORKLUND JA, 1995, J AM CHEM SOC, V117, P1533, DOI 10.1021/ja00110a009; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; EILERT U, 1985, J PLANT PHYSIOL, V119, P65, DOI 10.1016/S0176-1617(85)80216-9; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; GOTOH O, 1992, J BIOL CHEM, V267, P83; Grobe N, 2009, J BIOL CHEM, V284, P24425, DOI 10.1074/jbc.M109.011320; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; HOLTON TA, 1993, NATURE, V366, P276, DOI 10.1038/366276a0; Huang FC, 2000, PHYTOCHEMISTRY, V53, P555, DOI 10.1016/S0031-9422(99)00600-7; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; KAMETANI T, 1971, J CHEM SOC C, P1021, DOI 10.1039/j39710001021; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; KUTCHAN TM, 1994, PHYTOCHEMISTRY, V35, P353, DOI 10.1016/S0031-9422(00)94763-0; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Lewis NG, 1999, CURR OPIN PLANT BIOL, V2, P153, DOI 10.1016/S1369-5266(99)80030-2; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Niemetz R, 2005, PHYTOCHEMISTRY, V66, P2001, DOI 10.1016/j.phytochem.2005.01.009; Novak BH, 2000, CURR ORG CHEM, V4, P343, DOI 10.2174/1385272003376292; OKEEFE DP, 1989, PLANT PHYSIOL, V89, P1141, DOI 10.1104/pp.89.4.1141; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; RUEFFER M, 1994, PHYTOCHEMISTRY, V36, P1219, DOI 10.1016/S0031-9422(00)89640-5; Rupasinghe Sanjeewa, 2006, Phytochemistry Reviews, V5, P473, DOI 10.1007/s11101-006-9028-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STADLER R, 1993, J BIOL CHEM, V268, P823; SZANTAY C, 1982, J ORG CHEM, V47, P594, DOI 10.1021/jo00342a051; UMEMOTO N, 1993, FEBS LETT, V330, P169, DOI 10.1016/0014-5793(93)80266-W; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; ZENK MH, 1989, J CHEM SOC CHEM COMM, P1725, DOI 10.1039/c39890001725; Ziegler J, 2005, PLANTA, V222, P458, DOI 10.1007/s00425-005-1550-4; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	40	106	121	4	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24432	24442		10.1074/jbc.M109.033373	http://dx.doi.org/10.1074/jbc.M109.033373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19567876	hybrid, Green Published			2022-12-25	WOS:000269380200056
J	Guan, HP; Goldstein, JL; Brown, MS; Liang, G				Guan, Hong-Ping; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng			Accelerated Fatty Acid Oxidation in Muscle Averts Fasting-induced Hepatic Steatosis in SJL/J Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-SYNTHESIS; CHOLESTEROL; DEFICIENCY; METABOLISM; INSULIN; SCAP	The accumulation of triglycerides (TG) in the liver, designated hepatic steatosis, is characteristically associated with obesity and insulin resistance, but it can also develop after fasting. Here, we show that fasting-induced hepatic steatosis is under genetic control in inbred mice. After a 24-h fast, C57BL/6J mice and SJL/J mice both lost more than 20% of body weight and similar to 60% of total body TG. In C57BL/6J mice, TG accumulated in liver, producing frank steatosis. In striking contrast, SJL/J mice failed to accumulate any hepatic TG even though they lost nearly as much adipose tissue mass as the C57BL/6J mice. Mice from five other inbred strains developed fasting-induced steatosis like the C57BL/6J mice. Measurements of the uptake of free fatty acids (FA) in vivo and in vitro demonstrated that SJL/J mice were protected from steatosis because their heart and skeletal muscle took up and oxidized twice as much FA as compared with C57BL/6J mice. As a result of this muscle diversion, serum-free FA and ketone bodies rose much less after fasting in SJL/J mice as compared with C57BL/6J mice. When livers of SJL/J and C57BL/6J mice were perfused with similar concentrations of FA, the livers took up and esterified similar amounts. We conclude that SJL/J mice express one or more variant genes that lead to enhanced FA uptake and oxidation in muscle, thereby sparing the liver from FA overload in the fasting state.	[Guan, Hong-Ping; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu		Guan, Hong-Ping/0000-0002-2282-3193	National Institutes of Health [HL20948, DK81182]; Moss Heart Foundation; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Foundation; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by Grants HL20948 and DK81182 from the National Institutes of Health. This work was also supported by the Moss Heart Foundation and Perot Family Foundation.	Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CRISPENS CG, 1973, LAB ANIM SCI, V23, P408; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Havel RJ, 1997, P NUTR SOC, V56, P659, DOI 10.1079/PNS19970065; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Vafiadaki E, 2001, NEUROREPORT, V12, P625, DOI 10.1097/00001756-200103050-00039; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097	22	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24644	24652		10.1074/jbc.M109.034397	http://dx.doi.org/10.1074/jbc.M109.034397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581301	Green Published, hybrid			2022-12-25	WOS:000269380200073
J	Hsu, YH; Burke, JE; Li, S; Woods, VL; Dennis, EA				Hsu, Yuan-Hao; Burke, John E.; Li, Sheng; Woods, Virgil L., Jr.; Dennis, Edward A.			Localizing the Membrane Binding Region of Group VIA Ca2+-independent Phospholipase A(2) Using Peptide Amide Hydrogen/Deuterium Exchange Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUTERIUM-EXCHANGE; CRYSTAL-STRUCTURE; PROTEIN-KINASE; EXPRESS GROUP; CONFORMATIONAL-CHANGES; HYDROGEN-EXCHANGE; PANCREATIC-ISLETS; C2 DOMAIN; PSI-BLAST; CELLS	The Group VIA-2 Ca2+-independent phospholipase A(2) (GVIA-2 iPLA(2)) is composed of seven consecutive N-terminal ankyrin repeats, a linker region, and a C-terminal phospholipase catalytic domain. No structural information exists for this enzyme, and no information is known about the membrane binding surface. We carried out deuterium exchange experiments with the GVIA-2 iPLA(2) in the presence of both phospholipid substrate and the covalent inhibitor methyl arachidonoyl fluorophosphonate and located regions in the protein that change upon lipid binding. No changes were seen in the presence of only methyl arachidonoyl fluorophosphonate. The region with the greatest change upon lipid binding was region 708-730, which showed a >70% decrease in deuteration levels at numerous time points. No decreases in exchange due to phospholipid binding were seen in the ankyrin repeat domain of the protein. To locate regions with changes in exchange on the enzyme, we constructed a computational homology model based on homologous structures. This model was validated by comparing the deuterium exchange results with the predicted structure. Our model combined with the deuterium exchange results in the presence of lipid substrate have allowed us to propose the first structural model of GVIA-2 iPLA(2) as well as the interfacial lipid binding region.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Burke, John E.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Hsu, Yuan-Hao; Burke, John E.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; edennis@ucsd.edu	hsu, yuan-hao/B-5744-2009; Burke, John/A-5659-2013; Burke, John/H-3922-2019; Dennis, Edward A./M-5554-2019	Burke, John/0000-0003-1668-2109; Burke, John/0000-0001-7904-9859; Dennis, Edward A./0000-0003-3738-3140	National Institutes of Health [GM20501, CA099835, CA118595, AI076961]; NATIONAL CANCER INSTITUTE [R21CA118595, R33CA099835, R21CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020501, R01GM020501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM20501 (to E. A. D.) and CA099835, CA118595, and AI076961 (to V. L. W.).	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 2006, BBA-MOL CELL BIOL L, V1761, P1344, DOI 10.1016/j.bbalip.2006.07.013; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Forsell PKAL, 1999, EUR J BIOCHEM, V262, P575, DOI 10.1046/j.1432-1327.1999.00418.x; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; Kim MY, 2002, PROTEIN SCI, V11, P1320, DOI 10.1110/ps.3140102; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Yan XG, 2002, PROTEIN SCI, V11, P2113, DOI 10.1110/ps.0204402; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	44	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23652	23661		10.1074/jbc.M109.021857	http://dx.doi.org/10.1074/jbc.M109.021857			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556238	hybrid, Green Published			2022-12-25	WOS:000269180000051
J	Johnson, MP; Ruban, AV				Johnson, Matthew P.; Ruban, Alexander V.			Photoprotective Energy Dissipation in Higher Plants Involves Alteration of the Excited State Energy of the Emitting Chlorophyll(s) in the Light Harvesting Antenna II (LHCII)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED PEA THYLAKOIDS; PHOTOSYSTEM-II; EXCITATION-ENERGY; A FLUORESCENCE; XANTHOPHYLL CYCLE; MOLECULAR-MECHANISM; ALPHA-FLUORESCENCE; ABSORBENCY CHANGES; CRYSTAL-STRUCTURE; CATION FORMATION	Non-photochemical quenching (NPQ), a mechanism of energy dissipation in higher plants protects photosystem II ( PSII) reaction centers from damage by excess light. NPQ involves a reduction in the chlorophyll excited state lifetime in the PSII harvesting antenna (LHCII) by a quencher. Yet, little is known about the effect of the quencher on chlorophyll excited state energy and dynamics. Application of picosecond time-resolved fluorescence spectroscopy demonstrated that NPQ involves a red-shift (60 +/- 5 cm(-1)) and slight enhancement of the vibronic satellite of the main PSII lifetime component present in intact chloroplasts. Whereas this fluorescence red-shift was enhanced by the presence of zeaxanthin, it was not dependent upon it. The red-shifted fluorescence of intact chloroplasts in the NPQ state was accompanied by red-shifted chlorophyll a absorption. Nearly identical absorption and fluorescence changes were observed in isolated LHCII complexes quenched in a low detergent media, suggesting that the mechanism of quenching is the same in both systems. In both cases, the extent of the fluorescence red-shift was shown to correlate with the lifetime of a component. The alteration in the energy of the emitting chlorophyll(s) in intact chloroplasts and isolated LHCII was also accompanied by changes in lutein 1 observed in their 77K fluorescence excitation spectra. We suggest that the characteristic red-shifted fluorescence emission reflects an altered environment of the emitting chlorophyll( s) in LHCII brought about by their closer interaction with lutein 1 in the quenching locus.	[Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd,Fogg Bldg, London E1 4NS, England.	a.ruban@qmul.ac.uk		Johnson, Matthew/0000-0002-1663-0205	UKBBSRC; Royal Society	UKBBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London)	This work was supported by grants (to A. V. R.) from UKBBSRC and The Royal Society.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BILGER W, 1994, PLANTA, V193, P238, DOI 10.1007/BF00192536; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Broess K, 2006, BIOPHYS J, V91, P3776, DOI 10.1529/biophysj.106.085068; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Engelmann ECM, 2005, BBA-BIOENERGETICS, V1706, P276, DOI 10.1016/j.bbabio.2004.11.009; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Gilmore AM, 1996, PHOTOSYNTH RES, V48, P171, DOI 10.1007/BF00041007; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Holzwarth AR, 2008, PHOTOSYNTHESIS ENERG, P77; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Melkozernov AN, 2001, PHOTOSYNTH RES, V70, P129, DOI 10.1023/A:1017909325669; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Moise N, 2004, BBA-BIOENERGETICS, V1657, P47, DOI 10.1016/j.bbabio.2004.04.003; MULLINEAUX CW, 1993, BIOCHIM BIOPHYS ACTA, V1141, P23, DOI 10.1016/0005-2728(93)90184-H; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pieper J, 1999, J PHYS CHEM A, V103, P2422, DOI 10.1021/jp983958d; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; QUICK WP, 1984, P ROY SOC LOND B BIO, V226, P237; REES D, 1992, PHOTOSYNTH RES, V31, P11, DOI 10.1007/BF00049532; Richter M, 1999, BIOCHEMISTRY-US, V38, P12718, DOI 10.1021/bi983009a; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; RUBAN AV, 1991, BIOCHIM BIOPHYS ACTA, V1059, P355, DOI 10.1016/S0005-2728(05)80221-X; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; Scott M, 2006, BIOCHEMISTRY-US, V45, P8952, DOI 10.1021/bi060767p; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; van Oort B, 2007, J PHYS CHEM B, V111, P7631, DOI 10.1021/jp070573z; Vasil'ev S, 1998, BIOCHEMISTRY-US, V37, P11046, DOI 10.1021/bi9806854; Vasilev S, 1997, BIOCHEMISTRY-US, V36, P7503, DOI 10.1021/bi9625253; Veerman J, 2007, PLANT PHYSIOL, V145, P997, DOI 10.1104/pp.107.106872; Wagner B, 1996, J PHOTOCH PHOTOBIO B, V36, P339, DOI 10.1016/S1011-1344(96)07391-5; Yan HC, 2007, BIOCHEM BIOPH RES CO, V355, P457, DOI 10.1016/j.bbrc.2007.01.172	56	78	78	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23592	23601		10.1074/jbc.M109.013557	http://dx.doi.org/10.1074/jbc.M109.013557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567871	hybrid, Green Published			2022-12-25	WOS:000269180000045
J	Maegawa, GHB; Tropak, MB; Buttner, JD; Rigat, BA; Fuller, M; Pandit, D; Tang, LI; Kornhaber, GJ; Hamuro, Y; Clarke, JTR; Mahuran, DJ				Maegawa, Gustavo H. B.; Tropak, Michael B.; Buttner, Justin D.; Rigat, Brigitte A.; Fuller, Maria; Pandit, Deepangi; Tang, Liangiie; Kornhaber, Gregory J.; Hamuro, Yoshitomo; Clarke, Joe T. R.; Mahuran, Don J.			Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BETA-GLUCOSIDASE; LYSOSOMAL STORAGE DISORDERS; MASS-SPECTROMETRY; PHARMACOLOGICAL CHAPERONES; ISOFAGOMINE INCREASES; ENDOPLASMIC-RETICULUM; CHEMICAL CHAPERONES; GM2 GANGLIOSIDOSIS; H/D EXCHANGE; TAY-SACHS	Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a deficiency of glucocerebrosidase (GCase). The identification of small molecules acting as agents for enzyme enhancement therapy is an attractive approach for treating different forms of GD. A thermal denaturation assay utilizing wild type GCase was developed to screen a library of 1,040 Food and Drug Administration-approved drugs. Ambroxol (ABX), a drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified and found to be a pH-dependent, mixed-type inhibitor of GCase. Its inhibitory activity was maximal at neutral pH, found in the endoplasmic reticulum, and undetectable at the acidic pH of lysosomes. The pH dependence of ABX to bind and stabilize the enzyme was confirmed by monitoring the rate of hydrogen/deuterium exchange at increasing guanidine hydrochloride concentrations. ABX treatment significantly increased N370S and F213I mutant GCase activity and protein levels in GD fibroblasts. These increases were primarily confined to the lysosome-enriched fraction of treated cells, a finding confirmed by confocal immunofluorescence microscopy. Additionally, enhancement of GCase activity and a reduction in glucosylceramide storage was verified in ABX-treated GD lymphoblasts (N370S/N370S). Hydrogen/deuterium exchange mass spectrometry revealed that upon binding of ABX, amino acid segments 243-249, 310-312, and 386-400 near the active site of GCase are stabilized. Consistent with its mixed-type inhibition of GCase, modeling studies indicated that ABX interacts with both active and non-active site residues. Thus, ABX has the biochemical characteristics of a safe and effective enzyme enhancement therapy agent for the treatment of patients with the most common GD genotypes.	[Maegawa, Gustavo H. B.; Tropak, Michael B.; Buttner, Justin D.; Rigat, Brigitte A.; Clarke, Joe T. R.; Mahuran, Don J.] Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Maegawa, Gustavo H. B.; Clarke, Joe T. R.] Hosp Sick Children, Res Inst, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Maegawa, Gustavo H. B.; Clarke, Joe T. R.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Fuller, Maria] Univ Adelaide, Lysosomal Dis Res Unit, SA Pathol Womens & Childrens Hosp, Adelaide, SA 5005, Australia; [Fuller, Maria] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Pandit, Deepangi; Tang, Liangiie; Kornhaber, Gregory J.; Hamuro, Yoshitomo] ExSar Corp, Monmouth Jct, NJ 08852 USA; [Mahuran, Don J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; SA Pathology; University of Adelaide; University of Adelaide; University of Toronto	Mahuran, DJ (corresponding author), Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Rm 9146A,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hex@sickkids.ca		Maegawa, Gustavo/0000-0001-6933-4138	David M. C. Ju Foundation; Life for Luke Foundation; Canadian Institutes of Health Research Team Grant [CTP-82944]	David M. C. Ju Foundation; Life for Luke Foundation; Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by the David M. C. Ju Foundation ( to B. R.), the Life for Luke Foundation (to G. M.), and Canadian Institutes of Health Research Team Grant CTP-82944 (to D. M.).	Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bembi B, 2008, ACTA PAEDIATR, V97, P81, DOI 10.1111/j.1651-2227.2008.00643.x; BIANCHI M, 1990, AGENTS ACTIONS, V31, P275, DOI 10.1007/BF01997619; Boston-Howes W, 2008, EXP NEUROL, V213, P229, DOI 10.1016/j.expneurol.2008.06.010; BROWN CA, 1993, AM J HUM GENET, V53, P497; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; COLOMBO L, 1990, J CHROMATOGR-BIOMED, V530, P141, DOI 10.1016/S0378-4347(00)82313-0; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; COUET W, 1989, INT J CLIN PHARM TH, V27, P467; Cox TM, 2008, J INHERIT METAB DIS, V31, P319, DOI 10.1007/s10545-008-0779-z; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuller M, 2008, MOL GENET METAB, V93, P437, DOI 10.1016/j.ymgme.2007.11.011; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; Goker-Alpan O, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028019; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; Grabowski GA, 2008, EXPERT OPIN EMERG DR, V13, P197, DOI [10.1517/14728214.13.1.197, 10.1517/14728214.13.1.197 ]; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Hein LK, 2007, MOL GENET METAB, V92, P336, DOI 10.1016/j.ymgme.2007.08.001; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Lee HJ, 2004, PHARMACOL RES, V49, P93, DOI 10.1016/j.phrs.2003.07.011; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lin H, 2004, BBA-MOL BASIS DIS, V1689, P219, DOI 10.1016/j.bbadis.2004.03.007; Liu C., 2003, ADV MED STAT, P1051, DOI DOI 10.1142/9789812388759_0028; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Malerba M, 2008, EXPERT OPIN DRUG MET, V4, P1119, DOI 10.1517/17425255.4.8.1119 ; Martin DR, 2008, MOL GENET METAB, V94, P212, DOI 10.1016/j.ymgme.2008.02.004; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Meijer LA, 2004, J VET PHARMACOL THER, V27, P219, DOI 10.1111/j.1365-2885.2004.00584.x; Molina G, 2004, AM J OBSTET GYNECOL, V191, P2177, DOI 10.1016/j.ajog.2004.07.043; OOSTERHUIS B, 1993, EUR J CLIN PHARMACOL, V44, P237, DOI 10.1007/BF00271364; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Porto C, 2009, MOL THER, V17, P964, DOI 10.1038/mt.2009.53; Powell KD, 2003, BIOCHEMISTRY-US, V42, P4962, DOI 10.1021/bi034096w; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Rigat B, 2009, MOL GENET METAB, V96, P225, DOI 10.1016/j.ymgme.2008.12.008; Rojpibulstit M, 2003, CLIN DRUG INVEST, V23, P273, DOI 10.2165/00044011-200323040-00007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Sidransky E, 1997, J MED GENET, V34, P876, DOI 10.1136/jmg.34.10.876-a; Sidransky E, 1997, Adv Pediatr, V44, P73; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Tang LJ, 2007, ANAL CHEM, V79, P8728, DOI 10.1021/ac071380a; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Tropak MB, 2008, CHEMBIOCHEM, V9, P2650, DOI 10.1002/cbic.200800304; Tropak MB, 2007, FEBS J, V274, P4951, DOI 10.1111/j.1742-4658.2007.06040.x; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; TSAI P, 1992, PEDIATR RES, V31, P503, DOI 10.1203/00006450-199205000-00019; Wang HY, 2007, EUR J NEUROSCI, V26, P633, DOI 10.1111/j.1460-9568.2007.05663.x; Wauer R R, 1989, Eur Respir J Suppl, V3, p57S; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Weiser T, 2008, CNS NEUROSCI THER, V14, P17, DOI 10.1111/j.1527-3458.2007.00032.x; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yang B, 2002, EUR RESPIR J, V19, P952, DOI 10.1183/09031936.02.00253302; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zimmer KP, 1999, J PATHOL, V188, P407	72	214	226	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23502	23516		10.1074/jbc.M109.012393	http://dx.doi.org/10.1074/jbc.M109.012393			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19578116	Green Published, hybrid			2022-12-25	WOS:000269180000035
J	Lu, HS; Murata-Kamiya, N; Saito, Y; Hatakeyama, M				Lu, Huaisheng; Murata-Kamiya, Naoko; Saito, Yasuhiro; Hatakeyama, Masanori			Role of Partitioning-defective 1/Microtubule Affinity-regulating Kinases in the Morphogenetic Activity of Helicobacter pylori CagA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; NUCLEOTIDE EXCHANGE FACTOR; FOCAL ADHESION KINASE; C-ELEGANS EMBRYOS; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; IV SECRETION; POLARITY; DYNAMICS; MICROTUBULES	Helicobacter pylori CagA plays a key role in gastric carcinogenesis. Upon delivery into gastric epithelial cells, CagA binds and deregulates SHP-2 phosphatase, a bona fide oncoprotein, thereby causing sustained ERK activation and impaired focal adhesions. CagA also binds and inhibits PAR1b/MARK2, one of the four members of the PAR1 family of kinases, to elicit epithelial polarity defect. In nonpolarized gastric epithelial cells, CagA induces the hummingbird phenotype, an extremely elongated cell shape characterized by a rear retraction defect. This morphological change is dependent on CagA-deregulated SHP-2 and is thus thought to reflect the oncogenic potential of CagA. In this study, we investigated the role of the PAR1 family of kinases in the hummingbird phenotype. We found that CagA binds not only PAR1b but also other PAR1 isoforms, with order of strength as follows: PAR1b > PAR1d >= PAR1a > PAR1c. Binding of CagA with PAR1 isoforms inhibits the kinase activity. This abolishes the ability of PAR1 to destabilize microtubules and thereby promotes disassembly of focal adhesions, which contributes to the hummingbird phenotype. Consistently, PAR1 knockdown potentiates induction of the hummingbird phenotype by CagA. The morphogenetic activity of CagA was also found to be augmented through inhibition of non-muscle myosin II. Because myosin II is functionally associated with PAR1, perturbation of PAR1-regulated myosin II by CagA may underlie the defect of rear retraction in the hummingbird phenotype. Our findings reveal that CagA systemically inhibits PAR1 family kinases and indicate that malfunctioning of microtubules and myosin II by CagA-mediated PAR1 inhibition cooperates with deregulated SHP-2 in the morphogenetic activity of CagA.	[Lu, Huaisheng; Murata-Kamiya, Naoko; Saito, Yasuhiro; Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Murata-Kamiya, Naoko; Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Ctr Infect Associated Canc, Sapporo, Hokkaido 0600815, Japan; [Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo 1130033, Japan	Hokkaido University; Hokkaido University; University of Tokyo	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kwan KM, 2005, DEVELOPMENT, V132, P4599, DOI 10.1242/dev.02041; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; PALAZZO AF, 2002, SCI STKE, V139, pPE31; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; PARSA I, 1988, CANCER RES, V48, P2265; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	71	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23024	23036		10.1074/jbc.M109.001008	http://dx.doi.org/10.1074/jbc.M109.001008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553659	Green Published, hybrid			2022-12-25	WOS:000268963100055
J	Eroukhmanoff, F; Svensson, EI				Eroukhmanoff, Fabrice; Svensson, Erik I.			Contemporary Parallel Diversification, Antipredator Adaptations and Phenotypic Integration in an Aquatic Isopod	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; FRESH-WATER ISOPOD; SWIMMING PERFORMANCE; POECILIA-RETICULATA; ADAPTIVE EVOLUTION; PERCA-FLUVIATILIS; ASELLUS-AQUATICUS; LACERTID LIZARDS; UNIQUE FEATURES; PREY BEHAVIOR	It is increasingly being recognized that predation can be a strong diversifying agent promoting ecological divergence. Adaptations against different predatory regimes can emerge over short periods of time and include many different traits. We studied antipredator adaptations in two ecotypes of an isopod (Asellus aquaticus) that have, diverged in parallel in two Swedish lakes over the last two decades. We quantified differences in escape speed, morphology and behavior for isopods from different ecotypes present in these lakes. Isopods from the source habitat (reed) coexist with mainly invertebrate predators. They are more stream-profiled and have higher escape speeds than isopods in the newly colonized stonewort habitat, which has higher density of fish predators. Stonewort isopods also show more cautious behaviors and had higher levels of phenotypic integration between coloration and morphological traits than the reed isopods. Colonization of a novel habitat with a different predation regime has thus strengthened the correlations between pigmentation and morphology and weakened escape performance. The strong signature of parallelism for these phenotypic traits indicates that divergence is likely to be adaptive and is likely to have been driven by differences in predatory regimes. Furthermore, our results indicate that physical performance, behavior and morphology can change rapidly and in concert as new habitats are colonized.			Eroukhmanoff, F (corresponding author), Lund Univ, Sect Anim Ecol, Lund, Sweden.	fabrice.eroukhmanoff@zooekol.lu.se	eroukhmanoff, fabrice/D-1414-2015; Eroukhmanoff, Fabrice/F-8319-2010; Svensson, Erik/E-8324-2010	Svensson, Erik/0000-0001-9006-016X				Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; [Anonymous], [No title captured]; Bell MA, 2004, EVOLUTION, V58, P814; Eroukhmanoff F, 2008, J EVOLUTION BIOL, V21, P514, DOI 10.1111/j.1420-9101.2007.01488.x; Eroukhmanoff F, 2009, J EVOLUTION BIOL, V22, P1098, DOI 10.1111/j.1420-9101.2009.01723.x; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; FRY JD, 1993, EVOLUTION, V47, P327, DOI 10.1111/j.1558-5646.1993.tb01224.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2003, INTEGR COMP BIOL, V43, P431, DOI 10.1093/icb/43.3.431; Gordon SP, 2009, AM NAT, V174, P34, DOI 10.1086/599300; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Hargeby A, 2005, FRESHWATER BIOL, V50, P2053, DOI 10.1111/j.1365-2427.2005.01446.x; Hargeby A, 2005, J EVOLUTION BIOL, V18, P713, DOI 10.1111/j.1420-9101.2004.00837.x; Hargeby A, 2004, EVOLUTION, V58, P81; HARGEBY A, 1994, HYDROBIOLOGIA, V280, P83; Hargeby A, 2007, ECOSYSTEMS, V10, P29, DOI 10.1007/s10021-006-9008-5; Hemmi JM, 2003, NATURE, V421, P160, DOI 10.1038/nature01247; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Kuchta SR, 2008, EVOLUTION, V62, P984, DOI 10.1111/j.1558-5646.2008.00338.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Langerhans RB, 2006, EVOLUTION, V60, P362; LYTHGOE JN, 1983, NATURE, V301, P656, DOI 10.1038/301656a0; Magwene PM, 2001, EVOLUTION, V55, P1734; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Mikolajewski DJ, 2006, EVOLUTION, V60, P1306; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Pettersson LB, 2000, OIKOS, V88, P200, DOI 10.1034/j.1600-0706.2000.880122.x; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; RASK M, 1985, HYDROBIOLOGIA, V121, P27, DOI 10.1007/BF00035226; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Rohlf FJ, 1996, SYST BIOL, V45, P344, DOI 10.2307/2413569; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Stoks R, 2003, EVOLUTION, V57, P574; Stoks R, 2006, AM NAT, V168, pS50, DOI 10.1086/509045; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; Taylor JRA, 2003, SCIENCE, V301, P209, DOI 10.1126/science.1085987; Urban MC, 2007, P NATL ACAD SCI USA, V104, P14377, DOI 10.1073/pnas.0704645104; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Vanhooydonck B, 2003, FUNCT ECOL, V17, P160, DOI 10.1046/j.1365-2435.2003.00716.x; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; Wagner BMA, 1998, HYDROBIOLOGIA, V368, P75, DOI 10.1023/A:1003213224327; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Wang IJ, 2008, EVOLUTION, V62, P2742, DOI 10.1111/j.1558-5646.2008.00507.x; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wilson RS, 2002, J EXP BIOL, V205, P1145	54	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6173	10.1371/journal.pone.0006173	http://dx.doi.org/10.1371/journal.pone.0006173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587791	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035100005
J	Gurry, T; Kahramanogullari, O; Endres, RG				Gurry, Thomas; Kahramanogullari, Ozan; Endres, Robert G.			Biophysical Mechanism for Ras-Nanocluster Formation and Signaling in Plasma Membrane	PLOS ONE			English	Article								Ras GTPases are lipid-anchored G proteins, which play a fundamental role in cell signaling processes. Electron micrographs of immunogold-labeled Ras have shown that membrane-bound Ras molecules segregate into nanocluster domains. Several models have been developed in attempts to obtain quantitative descriptions of nanocluster formation, but all have relied on assumptions such as a constant, expression-level independent ratio of Ras in clusters to Ras monomers (cluster/monomer ratio). However, this assumption is inconsistent with the law of mass action. Here, we present a biophysical model of Ras clustering based on short-range attraction and long-range repulsion between Ras molecules in the membrane. To test this model, we performed Monte Carlo simulations and compared statistical clustering properties with experimental data. We find that we can recover the experimentally-observed clustering across a range of Ras expression levels, without assuming a constant cluster/monomer ratio or the existence of lipid rafts. In addition, our model makes predictions about the signaling properties of Ras nanoclusters in support of the idea that Ras nanoclusters act as an analog-digital-analog converter for high fidelity signaling.			Gurry, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Integrated Syst Biol, London, England.	r.endres@imperial.ac.uk			Biotechnology and Biological Sciences Research Council [BB/G000131/1] Funding Source: Medline; BBSRC [BB/G000131/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Arai Y, 2006, BIOCHEM BIOPH RES CO, V343, P809, DOI 10.1016/j.bbrc.2006.03.031; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BOS JL, 1989, CANCER RES, V49, P4682; BRUNGER AT, 1990, P NATL ACAD SCI USA, V87, P4849, DOI 10.1073/pnas.87.12.4849; Cheng XD, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe14; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Endres RG, 2007, PLOS COMPUT BIOL, V3, P1385, DOI 10.1371/journal.pcbi.0030150; Endres RG, 2009, BIOPHYS J, V96, P453, DOI 10.1016/j.bpj.2008.10.021; Gorfe AA, 2004, J AM CHEM SOC, V126, P15277, DOI 10.1021/ja046607n; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; HENIS YI, 2008, MOL MEMBR BIOL, V29, P1; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Mattfeldt T, 2006, J MICROSC-OXFORD, V223, P107, DOI 10.1111/j.1365-2818.2006.01604.x; Mattfeldt T, 2005, J MICROSC-OXFORD, V220, P131, DOI 10.1111/j.1365-2818.2005.01521.x; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; NIV H, 2004, J CELL BIOL, V165, P725; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SYMONS M, 2001, SCI STKE, V68, pPE1; Szymanska E, 2009, EXP CELL RES, V315, P981, DOI 10.1016/j.yexcr.2009.01.023; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tkacik G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002774; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609	53	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6148	10.1371/journal.pone.0006148	http://dx.doi.org/10.1371/journal.pone.0006148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587789	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035100002
J	Xu, YJ; Lei, ZY; Huang, H; Dui, W; Liang, XH; Ma, J; Jiao, RJ				Xu, Yanjuan; Lei, Zhiyong; Huang, Hai; Dui, Wen; Liang, Xuehong; Ma, Jun; Jiao, Renjie			dRecQ4 Is Required for DNA Synthesis and Essential for Cell Proliferation in Drosophila	PLOS ONE			English	Article								Background: The family of RecQ DNA helicases plays an important role in the maintenance of genomic integrity. Mutations in three of the five known RecQ family members in humans, BLM, WRN and RecQ4, lead to disorders that are characterized by predisposition to cancer and premature aging. Methodology/Principal Findings: To address the in vivo functions of Drosophila RecQ4 (dRecQ4), we generated mutant alleles of dRecQ4 using the targeted gene knock-out technique. Our data show that dRecQ4 mutants are homozygous lethal with defects in DNA replication, cell cycle progression and cell proliferation. Two sets of experiments suggest that dRecQ4 also plays a role in DNA double strand break repair. First, mutant animals exhibit sensitivity to gamma irradiation. Second, the efficiency of DsRed reconstitution via single strand annealing repair is significantly reduced in the dRecQ4 mutant animals. Rescue experiments further show that both the N-terminal domain and the helicase domain are essential to dRecQ4 function in vivo. The N-terminal domain is sufficient for the DNA repair function of dRecQ4. Conclusions/Significance: Together, our results show that dRecQ4 is an essential gene that plays an important role in not only DNA replication but also DNA repair and cell cycle progression in vivo.			Jiao, RJ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	rjiao@sun5.ibp.ac.cn	Ma, Jun/GLT-4809-2022; Huang, Hai/CZY-9855-2022; Jiao, Renjie/AAE-8902-2019	Ma, Jun/0000-0002-1609-3294; Huang, Hai/0000-0003-2331-6238; 				Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bagherieh-Najjar MB, 2005, PLANT J, V43, P789, DOI 10.1111/j.1365-313X.2005.02501.x; Balraj P, 2002, MUTAT RES-FUND MOL M, V508, P99, DOI 10.1016/S0027-5107(02)00189-6; BOUBRIAK I, 2008, BIOGERONTOLOGY; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Burks LM, 2007, GENE, V391, P26, DOI 10.1016/j.gene.2006.11.019; Cabral REC, 2008, MUTAT RES-FUND MOL M, V643, P41, DOI 10.1016/j.mrfmmm.2008.06.002; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chou TB, 1996, GENETICS, V144, P1673; Dietschy T, 2007, CELL MOL LIFE SCI, V64, P796, DOI 10.1007/s00018-007-6468-5; Durand F, 2002, ANN DERMATOL VENER, V129, P892; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Hartung F, 2006, NUCLEIC ACIDS RES, V34, P4438, DOI 10.1093/nar/gkl576; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Ichikawa Koji, 2002, Nihon Yakurigaku Zasshi, V119, P219; Jiao R, 2007, ONCOGENE, V26, P3811, DOI 10.1038/sj.onc.1210150; Jiao RJ, 2004, MOL CELL BIOL, V24, P4710, DOI 10.1128/MCB.24.11.4710-4719.2004; Jin WD, 2008, HUM GENET, V123, P643, DOI 10.1007/s00439-008-0518-4; Kawasaki K, 2002, NUCLEIC ACIDS RES, V30, P3682, DOI 10.1093/nar/gkf487; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kumata Y, 2007, BBA-MOL CELL RES, V1773, P556, DOI 10.1016/j.bbamcr.2007.01.005; Kusano K, 1999, GENETICS, V151, P1027; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Larizza L, 2006, CANCER LETT, V232, P107, DOI 10.1016/j.canlet.2005.07.042; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; NAKAYAMA M, 2008, DNA REPAIR AMST; Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Preston CR, 2006, GENETICS, V172, P1055, DOI 10.1534/genetics.105.050138; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Saunders RDC, 2008, AGING CELL, V7, P418, DOI 10.1111/j.1474-9726.2008.00388.x; Sekelsky JJ, 1999, NUCLEIC ACIDS RES, V27, P3762, DOI 10.1093/nar/27.18.3762; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; SMITH PJ, 1982, MUTAT RES, V94, P213, DOI 10.1016/0027-5107(82)90183-X; Trowbridge K, 2007, GENETICS, V176, P1993, DOI 10.1534/genetics.106.070060; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Wu L, 2008, BIOESSAYS, V30, P291, DOI 10.1002/bies.20735; XU T, 1993, DEVELOPMENT, V117, P1223; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	57	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6107	10.1371/journal.pone.0006107	http://dx.doi.org/10.1371/journal.pone.0006107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572017	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806200002
J	Sober, S; Org, E; Kepp, K; Juhanson, P; Eyheramendy, S; Gieger, C; Lichtner, P; Klopp, N; Veldre, G; Viigimaa, M; Doring, A; Putku, M; Kelgo, P; Shaw-Hawkins, S; Howard, P; Onipinla, A; Dobson, RJ; Newhouse, SJ; Brown, M; Dominiczak, A; Connell, J; Samani, N; Farrall, M; Caulfield, MJ; Munroe, PB; Illig, T; Wichmann, HE; Meitinger, T; Laan, M				Sober, Siim; Org, Elin; Kepp, Katrin; Juhanson, Peeter; Eyheramendy, Susana; Gieger, Christian; Lichtner, Peter; Klopp, Norman; Veldre, Gudrun; Viigimaa, Margus; Doering, Angela; Putku, Margus; Kelgo, Piret; Shaw-Hawkins, Sue; Howard, Philip; Onipinla, Abiodun; Dobson, Richard J.; Newhouse, Stephen J.; Brown, Morris; Dominiczak, Anna; Connell, John; Samani, Nilesh; Farrall, Martin; Caulfield, Mark J.; Munroe, Patricia B.; Illig, Thomas; Wichmann, H. Erich; Meitinger, Thomas; Laan, Maris		Kooperative Gesundheitsforsch; HYPertens ESTonia Study; MRC British Genet Hypertens Study	Targeting 160 Candidate Genes for Blood Pressure Regulation with a Genome-Wide Genotyping Array	PLOS ONE			English	Article								The outcome of Genome-Wide Association Studies (GWAS) has challenged the field of blood pressure (BP) genetics as previous candidate genes have not been among the top loci in these scans. We used Affymetrix 500K genotyping data of KORA S3 cohort (n = 1,644; Southern-Germany) to address (i) SNP coverage in 160 BP candidate genes; (ii) the evidence for associations with BP traits in genome-wide and replication data, and haplotype analysis. In total, 160 gene regions (genic region +/- 10 kb) covered 2,411 SNPs across 11.4 Mb. Marker densities in genes varied from 0 (n = 11) to 0.6 SNPs/kb. On average 52.5% of the HAPMAP SNPs per gene were captured. No evidence for association with BP was obtained for 1,449 tested SNPs. Considerable associations (P < 10(-3)) were detected for the genes, where > 50% of HAPMAP SNPs were tagged. In general, genes with higher marker density (> 0.2 SNPs/ kb) revealed a better chance to reach close to significance associations. Although, none of the detected P-values remained significant after Bonferroni correction (P < 0.05/2319, P < 2.15 x 10(-5)), the strength of some detected associations was close to this level: rs10889553 (LEPR) and systolic BP (SBP) (P = 4.5 x 10(-5)) as well as rs10954174 (LEP) and diastolic BP (DBP) (P = 5.20 x 10(-5)). In total, 12 markers in 7 genes (ADRA2A, LEP, LEPR, PTGER3, SLC2A1, SLC4A2, SLC8A1) revealed considerable association (P < 10(-3)) either with SBP, DBP, and/or hypertension (HYP). None of these were confirmed in replication samples (KORA S4, HYPEST, BRIGHT). However, supportive evidence for the association of rs10889553 (LEPR) and rs11195419 (ADRA2A) with BP was obtained in meta-analysis across samples stratified either by body mass index, smoking or alcohol consumption. Haplotype analysis highlighted LEPR and PTGER3. In conclusion, the lack of associations in BP candidate genes may be attributed to inadequate marker coverage on the genome-wide arrays, small phenotypic effects of the loci and/or complex interaction with life-style and metabolic parameters.			Sober, S (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	maris.laan@ut.ee	Org, Elin/AAJ-9631-2021; Newhouse, Stephen J/C-9330-2011; Meitinger, Thomas/O-1318-2015; Dominiczak, Anna F/P-9390-2017; Wichmann, Heinz Erich/AAA-5695-2022; Dobson, Richard j/C-9269-2011; Viigimaa, Margus/AAX-3864-2020; Laan, Maris/A-4100-2011; Dominiczak, Anna F/D-2262-2009	Newhouse, Stephen J/0000-0002-1843-9842; Dominiczak, Anna F/0000-0003-4913-3608; Dobson, Richard j/0000-0003-4224-9245; Laan, Maris/0000-0002-8519-243X; Meitinger, Thomas/0000-0002-8838-8403; Org, Elin/0000-0001-8688-9717; Munroe, Patricia/0000-0002-4176-2947; Org, Elin/0000-0003-1451-9375; Eyheramendy, Susana/0000-0003-4723-9660; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Viigimaa, Margus/0000-0001-5575-5978; Gieger, Christian/0000-0001-6986-9554; Caulfield, Mark/0000-0001-9295-3594; Brown, Morris/0000-0001-8409-1082	British Heart Foundation [PG02/128, FS/05/061/19501] Funding Source: Medline; Howard Hughes Medical Institute [55005617] Funding Source: Medline; Medical Research Council [G9521010D, G9521010, G0400874] Funding Source: Medline; Wellcome Trust [070191/Z/03/Z, 076113/B/04/Z] Funding Source: Medline; Medical Research Council [G9817803B] Funding Source: researchfish; MRC [G0400874, G9521010] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; de Luis DA, 2008, J DIABETES COMPLICAT, V22, P199, DOI 10.1016/j.jdiacomp.2006.10.006; Ehret GB, 2008, EUR J HUM GENET, V16, P1507, DOI 10.1038/ejhg.2008.102; Finley JC, 2004, J APPL PHYSIOL, V96, P2231, DOI 10.1152/japplphysiol.00527.2003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garenc C, 2002, MOL MED, V8, P88, DOI 10.1007/BF03402078; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; HARRAP SB, 1994, LANCET, V344, P169, DOI 10.1016/S0140-6736(94)92762-6; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jiao Jie, 2004, Zhonghua Nei Ke Za Zhi, V43, P276; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Koh JM, 2002, EUR J ENDOCRINOL, V147, P777, DOI 10.1530/eje.0.1470777; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LOCKETTE W, 1995, AM J HYPERTENS, V8, P390, DOI 10.1016/0895-7061(95)00024-J; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Rosmond R, 2002, J INTERN MED, V251, P252, DOI 10.1046/j.1365-2796.2002.00961.x; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Ukkola O, 2001, INT J OBESITY, V25, P1604, DOI 10.1038/sj.ijo.0801810; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zhang YY, 2007, ATHEROSCLEROSIS, V191, P121, DOI 10.1016/j.atherosclerosis.2006.02.043; Zheng Y, 1999, Zhonghua Nei Ke Za Zhi, V38, P174	40	88	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6034	10.1371/journal.pone.0006034	http://dx.doi.org/10.1371/journal.pone.0006034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562039	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000267465900002
J	Kim, K; Wang, L; Hwang, I				Kim, Kwangmi; Wang, Lin; Hwang, Inkyu			A Novel Flow Cytometric High Throughput Assay for a Systematic Study on Molecular Mechanisms Underlying T Cell Receptor-Mediated Integrin Activation	PLOS ONE			English	Article								Lymphocyte function-associated antigen 1 (LFA-1), a member of beta 2-integrin family, exerts multiple roles in host T cell immunity and has been identified as a useful drug-development target for inflammatory and autoimmune diseases. Applying the findings that primary resting T cells absorb nanometric membrane vesicles derived from antigen presenting cells (APC) via dual receptor/ligand interactions of T cell receptor (TCR) with cognate peptide-major histocompatibility complex (MHC) complex (pMHC) and LFA-1 with its ligand, intercellular adhesion molecule-1 (ICAM-1), and that signaling cascades triggered by TCR/pMHC interaction take a part in the vesicle-absorption, we established a cell-based high throughput assay for systematic investigation, via isolation of small molecules modulating the level of vesicle-absorption, of molecular mechanisms underlying the T cell absorption of APC-derived vesicles, i.e., structural basis of TCR/pMHC and LFA1/ICAM-1 interactions and TCR-mediated LFA-1 activation. As primary T cells along with physiological ligands expressed in biological membrane are used and also individual cells in assay samples are analyzed by flow cytometry, results obtained using the assay system hold superior physiological and therapeutic relevance as well as statistical precision.			Kim, K (corresponding author), Scripps Res Inst, Dept Chem & Biol Chem, La Jolla, CA 92037 USA.	inkyu@scripps.edu		Hwang, Inkyu/0000-0001-8997-6090	NIAID NIH HHS [R56 AI066146, AI066146, R01 AI066146] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066146, R56AI066146] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; BROGDEN RN, 1986, DRUGS, V32, P27, DOI 10.2165/00003495-198600324-00004; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Chan SC, 1998, PLANTA MED, V64, P153, DOI 10.1055/s-2006-957394; CHEETHAM SC, 1993, NEUROPHARMACOLOGY, V32, P737, DOI 10.1016/0028-3908(93)90181-2; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; DUSTIN ML, 1992, J IMMUNOL, V148, P2654; Edgar VA, 1998, CELL SIGNAL, V10, P721, DOI 10.1016/S0898-6568(98)00016-3; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; Fang NB, 1998, P NATL ACAD SCI USA, V95, P3380, DOI 10.1073/pnas.95.7.3380; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang I, 2001, J IMMUNOL, V166, P5099, DOI 10.4049/jimmunol.166.8.5099; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Molokanova E, 2000, J GEN PHYSIOL, V115, P685, DOI 10.1085/jgp.115.6.685; Mousa SA, 2004, METH MOLEC MED, V93, P157; Nishibori M, 2003, J PHARMACOL SCI, V92, P7; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Singh N, 2004, BIOCHEMISTRY-US, V43, P14577, DOI 10.1021/bi0483561; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; WANGE RL, 2000, SCI STKE, pRE1; WILEMAN T, 1991, CELL REGUL, V2, P753, DOI 10.1091/mbc.2.9.753; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	45	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6044	10.1371/journal.pone.0006044	http://dx.doi.org/10.1371/journal.pone.0006044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557182	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356900006
J	Scalapino, KJ; Daikh, DI				Scalapino, Kenneth J.; Daikh, David I.			Suppression of Glomerulonephritis in NZB/NZW Lupus Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells	PLOS ONE			English	Article								Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause characterized by expansion of autoreactive lymphocytes. Regulatory T cells (T(regs)) are a component of the normal immune system and contribute to the maintenance of peripheral tolerance. T(reg) abnormalities have been associated with several autoimmune diseases and there is interest in the role of T(regs) in SLE. We previously demonstrated that transfer of expanded CD4(+)CD25(+)CD62L(HI) T(regs) slows the development of lupus in (NZBxNZW)F(1) (B/W) mice. However in the absence of T(reg) specific surface antigens, cell purification remains a compromise between the breadth and purity of the population isolated. Importantly, purified populations always contain Foxp3(-) effector T cells (T(effs)) that theoretically could exacerbate autoimmunity in the recipient. Here we explore the impact of transferring the more comprehensive, but less pure T(reg) subset defined by CD4(+)CD25(+) expression on development of murine lupus. All cells were FACS sorted and expanded prior to adoptive transfer. Development of proteinuria and survival were measured. We found that exogenous expansion of CD4(+)CD25(+) cells produced a population containing 70-85% CD4(+)Foxp3(+) T(regs). Expanded T(regs) had higher CTLA-4 and Foxp3 expression, increased in vitro suppression capacity, and prolonged in vivo survival as compared to freshly isolated cells. Adoptive transfer of expanded CD4(+)CD25(+) T(regs) inhibited the onset of glomerulonephritis and prolonged survival in mice. Importantly the population of T(eff) contained within the adoptively transferred cells had reduced survival and proliferation capacity as compared to either co-transferred T(regs) or transferred T(effs) expanded in the absence of T(regs). These studies demonstrate that adoptive transfer of expanded CD4(+)CD25(+)Foxp3(+) T(regs) has the capacity to inhibit the onset of murine lupus and that this capacity is significant despite transfer of co-cultured T(eff) cells. These data indicate that when co-expanded with regulatory T cells, exogenously activated T(effs) from autoimmune patients may not pose a significant risk of promoting disease.			Scalapino, KJ (corresponding author), San Francisco VA Med Ctr, Arthrit Sect, San Francisco, CA USA.	daikh@itsa.ucsf.edu						Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bach JF, 2001, ANNU REV IMMUNOL, V19, P131, DOI 10.1146/annurev.immunol.19.1.131; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Buenafe AC, 2004, J NEUROSCI RES, V76, P129, DOI 10.1002/jnr.20066; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Cunnane G, 2004, ARTHRITIS RHEUM-US, V50, P1539, DOI 10.1002/art.20147; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Ermann J, 2001, J IMMUNOL, V167, P4271, DOI 10.4049/jimmunol.167.8.4271; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Itoh M, 1999, J IMMUNOL, V162, P5317; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; La Cava A, 2004, J IMMUNOL, V173, P3542, DOI 10.4049/jimmunol.173.5.3542; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mekala DJ, 2005, BLOOD, V105, P2090, DOI 10.1182/blood-2004-09-3579; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Monk CR, 2005, ARTHRITIS RHEUM, V52, P1180, DOI 10.1002/art.20976; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Qiao M, 2007, IMMUNOLOGY, V120, P447, DOI 10.1111/j.1365-2567.2007.02544.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; Wu HY, 2004, LUPUS, V13, P192, DOI 10.1191/0961203303lu1002oa	36	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6031	10.1371/journal.pone.0006031	http://dx.doi.org/10.1371/journal.pone.0006031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551149	Green Submitted, Green Published, gold			2022-12-25	WOS:000267356500015
J	Corera, AT; Doucet, G; Fon, EA				Corera, Amadou T.; Doucet, Guy; Fon, Edward A.			Long-Term Potentiation in Isolated Dendritic Spines	PLOS ONE			English	Article								Background: In brain, N-methyl-D-aspartate ( NMDA) receptor ( NMDAR) activation can induce long-lasting changes in synaptic alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor (AMPAR) levels. These changes are believed to underlie the expression of several forms of synaptic plasticity, including long-term potentiation (LTP). Such plasticity is generally believed to reflect the regulated trafficking of AMPARs within dendritic spines. However, recent work suggests that the movement of molecules and organelles between the spine and the adjacent dendritic shaft can critically influence synaptic plasticity. To determine whether such movement is strictly required for plasticity, we have developed a novel system to examine AMPAR trafficking in brain synaptosomes, consisting of isolated and apposed pre- and postsynaptic elements. Methodology/Principal Findings: We report here that synaptosomes can undergo LTP-like plasticity in response to stimuli that mimic synaptic NMDAR activation. Indeed, KCl-evoked release of endogenous glutamate from presynaptic terminals, in the presence of the NMDAR co-agonist glycine, leads to a long-lasting increase in surface AMPAR levels, as measured by [(3)H]-AMPA binding; the increase is prevented by an NMDAR antagonist 2-amino-5-phosphonopentanoic acid (AP5). Importantly, we observe an increase in the levels of GluR1 and GluR2 AMPAR subunits in the postsynaptic density (PSD) fraction, without changes in total AMPAR levels, consistent with the trafficking of AMPARs from internal synaptosomal compartments into synaptic sites. This plasticity is reversible, as the application of AMPA after LTP depotentiates synaptosomes. Moreover, depotentiation requires proteasome-dependent protein degradation. Conclusions/Significance: Together, the results indicate that the minimal machinery required for LTP is present and functions locally within isolated dendritic spines.			Corera, AT (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	ted.fon@mcgill.ca						Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; BEIQUE JC, 2006, P NATL ACAD SCI US; BERNARD J, 1992, J NEUROCHEM, V58, P387, DOI 10.1111/j.1471-4159.1992.tb09323.x; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hunt CA, 1996, J NEUROSCI, V16, P1380; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MASSICOTTE G, 1990, MOL PHARMACOL, V37, P278; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Newpher TM, 2009, TRENDS CELL BIOL; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; RAO A, 1991, J NEUROSCI, V11, P2881; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	55	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6021	10.1371/journal.pone.0006021	http://dx.doi.org/10.1371/journal.pone.0006021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547754	Green Submitted, Green Published, gold			2022-12-25	WOS:000267347900016
J	Conaway, HH; Persson, E; Halen, M; Granholm, S; Svensson, O; Pettersson, U; Lie, A; Lerner, UH				Conaway, H. Herschel; Persson, Emma; Halen, Marie; Granholm, Susanne; Svensson, Olle; Pettersson, Ulrika; Lie, Anita; Lerner, Ulf H.			Retinoids inhibit differentiation of hematopoetic osteoclast progenitors	FASEB JOURNAL			English	Article						osteoporosis; c-Fos; NFAT2; ATRA	BONE-MINERAL DENSITY; NF-KAPPA-B; VITAMIN-A; HYPERVITAMINOSIS-A; TRANSCRIPTION FACTORS; RECEPTOR ACTIVATOR; ACID; RISK; RESORPTION; PEPTIDE	Whether vitamin A promotes skeletal fragility, has no effect on fracture rate, or protects against bone loss is unclear. In the present study, effects of retinoids on osteoclast differentiation in cultured mouse bone marrow cells (BMCs), bone marrow macrophages (BMMs), spleen cells, and RAW264.7 cells were evaluated by analyzing osteoclast formation and expression of genes important in signal transduction and osteoclast function. All-trans-retinoic acid (ATRA) did not stimulate osteoclastogenesis in BMCs, but inhibited hormone and RANKL-induced gene expression and formation of osteoclasts. In BMMs, spleen cells, and RAW264.7 cells, osteoclast differentiation and formation stimulated by M-CSF/RANKL were inhibited (IC50 = 0.3 nM) by ATRA. The effect was exerted at an early step of RANKL-induced differentiation. ATRA also abolished increases of the transcription factors c-Fos and NFAT2 stimulated by RANKL and suppressed down-regulation of the antiosteoclastogenic transcription factor MafB. By comparing effects of several compounds structurally related to ATRA, as well as by using receptor antagonists, evaluation pointed to inhibition being mediated by RAR alpha, with no involvement of PPAR beta/delta. The results suggest that activation of RAR alpha by retinoids in myeloid hematopoietic precursor cells decreases osteoclast formation by altering expression of the transcription factors c-Fos, NFAT2, and MafB.-Conaway, H. H., Persson, E., Halen, M., Granholm, S., Svensson, O., Pettersson, U., Lie, A., Lerner, U. H. Retinoids inhibit differentiation of hematopoetic osteoclast progenitors. FASEB J. 23, 3526-3538 (2009). www.fasebj.org	[Persson, Emma; Halen, Marie; Granholm, Susanne; Lie, Anita; Lerner, Ulf H.] Umea Univ, Dept Oral Cell Biol, SE-90187 Umea, Sweden; [Svensson, Olle] Umea Univ, Dept Orthoped Surg, SE-90187 Umea, Sweden; [Pettersson, Ulrika] Umea Univ, Dept Clin Pharmacol, SE-90187 Umea, Sweden; [Conaway, H. Herschel] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	Umea University; Umea University; Umea University; University of Arkansas System; University of Arkansas Medical Sciences	Lerner, UH (corresponding author), Umea Univ, Dept Oral Cell Biol, SE-90187 Umea, Sweden.	lerner@odont.umu.se		Lerner, Ulf/0000-0002-3579-1960; Pettersson Kymmer, Ulrika/0000-0002-0557-9803	Swedish Science Council [07525]; Swedish Rheumatism Association; Royal 80 Year Foundation of King Gustav V; Faculty of Medicine at Umea University; County Council of Vasterbotten	Swedish Science Council; Swedish Rheumatism Association; Royal 80 Year Foundation of King Gustav V; Faculty of Medicine at Umea University; County Council of Vasterbotten	This project was supported by grants from the Swedish Science Council (project 07525), the Swedish Rheumatism Association, the Royal 80 Year Foundation of King Gustav V, the Faculty of Medicine at Umea University, and the County Council of Vasterbotten. We are grateful for the excellent drawing of the figures by Ingrid Bostrom. We gratefully thank Dr. Tim Arnett (University College London, London, UK) for providing ivory slices.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bocher V, 2002, ANN NY ACAD SCI, V967, P7; Caire-Juvera G, 2009, AM J CLIN NUTR, V89, P323, DOI 10.3945/ajcn.2008.26451; Conaway HH, 1997, J ENDOCRINOL, V155, P513, DOI 10.1677/joe.0.1550513; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; FRANKEL TL, 1986, J NUTR, V116, P578, DOI 10.1093/jn/116.4.578; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; GRIGORIADIS AE, 1995, TRENDS GENET, V11, P436, DOI 10.1016/S0168-9525(00)89142-8; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ishimi Y, 1999, J CLIN BIOCHEM NUTR, V27, P113; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; Lerner UH, 2000, MATRIX BIOL, V19, P107, DOI 10.1016/S0945-053X(00)00052-4; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mano H, 2000, J BIOL CHEM, V275, P8126, DOI 10.1074/jbc.275.11.8126; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Nakashima T, 2008, ARCH BIOCHEM BIOPHYS, V473, P166, DOI 10.1016/j.abb.2008.04.004; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ribaya-Mercado JD, 2007, NUTR REV, V65, P425, DOI 10.1111/j.1753-4887.2007.tb00268.x; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wang XX, 2002, J BONE MINER RES, V17, P91, DOI 10.1359/jbmr.2002.17.1.91; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Yonezawa T, 2007, BIOCHEM BIOPH RES CO, V355, P10, DOI 10.1016/j.bbrc.2006.12.237	45	40	41	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3526	3538		10.1096/fj.09-132548	http://dx.doi.org/10.1096/fj.09-132548			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19546303				2022-12-25	WOS:000270354300029
J	Hong, S; Derfoul, A; Pereira-Mouries, L; Hall, DJ				Hong, Sohee; Derfoul, Assia; Pereira-Mouries, Lucilia; Hall, David J.			A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes	FASEB JOURNAL			English	Article						osteoarthritis; transcription; collagen 2(alpha 1); chromatin	II COLLAGEN; ARTICULAR-CARTILAGE; TRANSCRIPTIONAL CONTROL; EXTRACELLULAR-MATRIX; INDUCED ARTHRITIS; HDAC INHIBITORS; TRICHOSTATIN-A; EXPRESSION; CANCER; CELLS	The role of histone deacetylase 1 and 2 (HDAC1 and HDAC2) in regulating cartilage-specific gene expression was explored in primary human chondrocytes. HDAC1 and HDAC2 protein levels were elevated in chondrocytes from osteoarthritic patients, consistent with a down-regulation of some cartilage marker genes. When expressed in these cells, HDAC1 and HDAC2 repressed aggrecan and collagen 2(alpha 1) expression but differed in their repression of collagen 9(alpha 1), collagen 11(alpha 1), dermatopontin, and cartilage oligomeric matrix protein (COMP). To identify the basis of these differences between HDAC1 and HDAC2, their carboxy-terminal domains (CTDs) were deleted, which led to proteins that retained enzymatic activity but were unable to repress cartilage gene expression. Further, exchange of the CTDs between HDAC1 and HDAC2 led to proteins that were enzymatically active but displayed altered target gene specificity, indicating that these CTDs can function independently of HDAC enzymatic activity, to target the HDACs to specific genes. The Snail transcription factor was identified as a mediator of HDAC1 and HDAC2 repression of the collagen 2(alpha 1) gene, via its interaction with the HDAC1 and 2 CTDs. The data indicate that the CTD serves a novel function within HDAC1 and HDAC2, to mediate repression of cartilage-specific gene expression in human chondrocytes.-Hong, S., Derfoul, A., Pereira-Mouries, L., Hall, D. J. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 23, 3539-3552 (2009). www.fasebj.org	[Hong, Sohee; Derfoul, Assia; Pereira-Mouries, Lucilia; Hall, David J.] NIAMSD, Cartilage Mol Genet Grp, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Hall, DJ (corresponding author), 50 S Dr,Rm 1524, Bethesda, MD 20892 USA.	halld@mail.nih.gov		Pereira Mouries, Lucilia/0000-0001-5836-6011	National Institutes of Arthritis and Musculoskeletal and Skin Diseases within the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041141, ZIAAR041141] Funding Source: NIH RePORTER	National Institutes of Arthritis and Musculoskeletal and Skin Diseases within the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the National Disease Research Interchange (Philadelphia, PA, USA) for providing the human cartilage tissue samples. We also thank Dr. Ed Seto (Moffitt Cancer Center, Tampa, FL, USA) for the gift of the HDAC2 expression plasmid. The HDAC1 expression plasmid was provided by Origene Technologies (Rockville, MD, USA). This work was supported by the Intramural Research Program of the National Institutes of Arthritis and Musculoskeletal and Skin Diseases within the National Institutes of Health (Bethesda, MD, USA).	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Chung YL, 2003, MOL THER, V8, P707, DOI 10.1016/S1525-0016(03)00235-1; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; FRUTOS CA, 2007, DEV CELL, V13, P872; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Glaser KB, 2003, MOL CANCER THER, V2, P151; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Lallemand F, 1999, EXP CELL RES, V247, P432, DOI 10.1006/excr.1998.4370; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Matyas JR, 2002, ARTHRITIS RHEUM, V46, P1536, DOI 10.1002/art.10331; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; McLaughlin F, 2004, BIOCHEM PHARMACOL, V68, P1139, DOI 10.1016/j.bcp.2004.05.034; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sakimura R, 2007, CLIN CANCER RES, V13, P275, DOI 10.1158/1078-0432.CCR-06-1696; Salminen H, 2001, ARTHRITIS RHEUM-US, V44, P947; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; VanLint C, 1996, GENE EXPRESSION, V5, P245; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Whetstine JR, 2005, MOL CELL, V18, P483, DOI 10.1016/j.molcel.2005.04.006; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Yagi R, 2005, J ORTHOP RES, V23, P1128, DOI 10.1016/j.orthres.2004.12.016; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Young DA, 2005, FEBS J, V272, P1912, DOI 10.1111/j.1742-4658.2005.04622.x	42	79	84	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3539	3552		10.1096/fj.09-133215	http://dx.doi.org/10.1096/fj.09-133215			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19561124	Green Published			2022-12-25	WOS:000270354300030
J	Jansen, IDC; Mardones, P; Lecanda, F; de Vries, TJ; Recalde, S; Hoeben, KA; Schoenmaker, T; Ravesloot, JH; van Borren, MMGJ; van Eijden, TM; Bronckers, ALJJ; Kellokumpu, S; Medina, JF; Everts, V; Elferink, RPJO				Jansen, Ineke D. C.; Mardones, Pablo; Lecanda, Fernando; de Vries, Teun J.; Recalde, Sergio; Hoeben, Kees A.; Schoenmaker, Ton; Ravesloot, Jan-Hindrik; van Borren, Marcel M. G. J.; van Eijden, Theo M.; Bronckers, Antonius L. J. J.; Kellokumpu, Sakari; Medina, Juan F.; Everts, Vincent; Elferink, Ronald P. J. Oude			Ae2(a,b)-Deficient mice exhibit osteopetrosis of long bones but not of calvaria	FASEB JOURNAL			English	Article						osteoclast; osteoclastogenesis; skull; solute carriers; tibia	OSTEOCLAST PRECURSOR CELLS; ANION-EXCHANGER SLC4A2; AE2 CL-/HCO3-EXCHANGER; TARGETED DISRUPTION; MOLECULAR-CLONING; PH REGULATION; C-FMS; DEFICIENCY; RESORPTION; DIFFERENTIATION	Extracellular acidification by osteoclasts is essential to bone resorption. During proton pumping, intracellular pH (pH(i)) is thought to be kept at a near-neutral level by chloride/bicarbonate exchange. Here we show that the Na+-independent chloride/bicarbonate anion exchanger 2 (Ae2) is relevant for this process in the osteoclasts from the long bones of Ae2(a,b)(-/-) mice ( deficient in the main isoforms Ae2a, Ae2b(1), and Ae2b(2)). Although the long bones of these mice had normal numbers of multinucleated osteoclasts, these cells lacked a ruffled border and displayed impaired bone resorption activity, resulting in an osteopetrotic phenotype of long bones. Moreover, in vitro osteoclastogenesis assays using long-bone marrow cells from Ae2(a,b)(-/-) mice suggested a role for Ae2 in osteoclast formation, as fusion of preosteoclasts for the generation of active multinucleated osteoclasts was found to be slightly delayed. In contrast to the abnormalities observed in the long bones, the skull of Ae2(a,b)(-/-) mice showed no alterations, indicating that calvaria osteoclasts may display normal resorptive activity. Microfluorimetric analysis of osteoclasts from normal mice showed that, in addition to Ae2 activity, calvaria osteoclasts-but not long-bone osteoclasts-possess a sodium-dependent bicarbonate transporting activity. Possibly, this might compensate for the absence of Ae2 in calvaria osteoclasts of Ae2(a,b)(-/-) mice.-Jansen, I. D. C., Mardones, P., Lecanda, F., de Vries, T. J., Recalde, S., Hoeben, K. A., Schoenmaker, T., Ravesloot, J.-H., van Borren, M. M. G. J., van Eijden, T. M., Bronckers, A. L. J. J., Kellokumpu, S., Medina, J. F., Everts, V., Oude Elferink, R. P. J. Ae2(a,b)-deficient mice exhibit osteopetrosis of long bones but not of calvaria. FASEB J. 23, 3470-3481 ( 2009). www.fasebj.org	[Jansen, Ineke D. C.] Vrije Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Periodontol, Res Inst MOVE, NL-1081 BT Amsterdam, Netherlands; [Jansen, Ineke D. C.; de Vries, Teun J.; Schoenmaker, Ton; Everts, Vincent] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Periodontol, Amsterdam, Netherlands; [Jansen, Ineke D. C.; de Vries, Teun J.; Schoenmaker, Ton; Bronckers, Antonius L. J. J.; Everts, Vincent] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands; [van Eijden, Theo M.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Funct Anat, Amsterdam, Netherlands; [Mardones, Pablo; Elferink, Ronald P. J. Oude] Univ Amsterdam, Acad Med Ctr, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands; [Hoeben, Kees A.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Ravesloot, Jan-Hindrik; van Borren, Marcel M. G. J.] Univ Amsterdam, Acad Med Ctr, Dept Physiol, NL-1105 AZ Amsterdam, Netherlands; [Lecanda, Fernando; Recalde, Sergio; Medina, Juan F.] Univ Navarra, Sch Med, E-31080 Pamplona, Spain; [Lecanda, Fernando; Recalde, Sergio; Medina, Juan F.] Univ Navarra, CIMA, E-31080 Pamplona, Spain; [Kellokumpu, Sakari] Univ Oulu, Dept Biochem, Oulu, Finland; [Medina, Juan F.] Univ Navarra, Div Gene Therapy & Hepatol, CIMA & Clin, E-31080 Pamplona, Spain; [Medina, Juan F.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain	Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Navarra; University of Navarra; Finland National Institute for Health & Welfare; University of Oulu; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Jansen, IDC (corresponding author), Vrije Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Periodontol, Res Inst MOVE, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	ineke.jansen@vumc.nl	Mardones Hiche, Pablo/B-8544-2009; Recalde, Sergio/D-1815-2017; Mardones, Pablo/ABG-3418-2021	Recalde, Sergio/0000-0002-9328-9725; de Vries, Teun/0000-0001-6464-5172; Schoenmaker, Ton/0000-0001-6649-374X	Spanish Ministerio de Education y Ciencia [SAF2005-02468, SAF2006-07818]; Instituto de Salud Carlos III [FIS-01/0777]; NWO [912-02-073]; The Royal Academy of Sciences, KNAW; NIH [DE 13508-06]	Spanish Ministerio de Education y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NWO(Netherlands Organization for Scientific Research (NWO)); The Royal Academy of Sciences, KNAW; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. P. Leenen ( Department of Immunology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands) for the ER-MP12 and ER-MP20 antibodies. This work was supported through the UTE for CIMA project; by grants awarded by the Spanish Ministerio de Education y Ciencia (SAF2005-02468 and SAF2006-07818) and Instituto de Salud Carlos III (FIS-01/0777 and Ciberehd) to J. F. M; and by three different grants from The Netherlands to R.P.J.O.E. (NWO, program 912-02-073), T. J. D. ( The Royal Academy of Sciences, KNAW), and A. L. J. J. B. (NIH; DE 13508-06). We thank E. Saez, S. Sarvide, A. Concepcion, C. Zandueta, and Dr. J. T. Salas for their valuable help.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Aranda V, 2004, BIOCHEM BIOPH RES CO, V319, P1040, DOI 10.1016/j.bbrc.2004.05.080; Borthwick KJ, 2003, J MED GENET, V40, P115, DOI 10.1136/jmg.40.2.115; Bronckers ALJJ, 2009, J EXP ZOOL PART B, V312B, P375, DOI 10.1002/jez.b.21267; Creemers LB, 1997, BIOTECHNIQUES, V22, P656, DOI 10.2144/97224bm19; de Vries TJ, 2005, J CELL BIOCHEM, V94, P954, DOI 10.1002/jcb.20326; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; El Zohairy AA, 2003, DENT MATER, V19, P575, DOI 10.1016/S0109-5641(02)00107-0; Everts V, 1999, FASEB J, V13, P1219, DOI 10.1096/fasebj.13.10.1219; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Holappa K, 2001, J HISTOCHEM CYTOCHEM, V49, P259, DOI 10.1177/002215540104900213; Josephsen K, 2009, P NATL ACAD SCI USA, V106, P1638, DOI 10.1073/pnas.0811682106; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; Lecanda J, 2000, BIOCHEM BIOPH RES CO, V276, P117, DOI 10.1006/bbrc.2000.3439; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; Medina JF, 2003, P NATL ACAD SCI USA, V100, P15847, DOI 10.1073/pnas.2536127100; Medina JF, 1997, GENOMICS, V39, P74, DOI 10.1006/geno.1996.4467; Medina JF, 2000, BIOCHEM BIOPH RES CO, V267, P228, DOI 10.1006/bbrc.1999.1951; Muller-Berger S, 2001, PFLUG ARCH EUR J PHY, V442, P718, DOI 10.1007/s004240100592; Perez-Amodio S, 2006, CALCIFIED TISSUE INT, V79, P245, DOI 10.1007/s00223-005-0289-z; RAVESLOOT JH, 1995, J GEN PHYSIOL, V105, P177, DOI 10.1085/jgp.105.2.177; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Salas JT, 2008, GASTROENTEROLOGY, V134, P1482, DOI 10.1053/j.gastro.2008.02.020; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Samuelson LC, 2003, ANNU REV PHYSIOL, V65, P383, DOI 10.1146/annurev.physiol.65.092101.142213; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TETI A, 1989, J CLIN INVEST, V83, P227, DOI 10.1172/JCI113863; THESINGH CW, 1985, BONE, V6, P43, DOI 10.1016/8756-3282(85)90406-5; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Wang Z, 1996, J BIOL CHEM, V271, P7835, DOI 10.1074/jbc.271.13.7835; Wu J, 2008, P NATL ACAD SCI USA, V105, P16934, DOI 10.1073/pnas.0808763105; Yamane T, 1997, BLOOD, V90, P3516, DOI 10.1182/blood.V90.9.3516	48	52	52	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3470	3481		10.1096/fj.08-122598	http://dx.doi.org/10.1096/fj.08-122598			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19564250				2022-12-25	WOS:000270354300024
J	Ye, B; Nerbonne, JM				Ye, Bin; Nerbonne, Jeanne M.			Proteolytic Processing of HCN2 and Co-assembly with HCN4 in the Generation of Cardiac Pacemaker Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; NUCLEOTIDE-GATED CHANNELS; VENTRICULAR MYOCYTES; SINOATRIAL NODE; EXPRESSION; HEART; TERMINUS; CURRENTS; DOMAIN; MICE	In sino-atrial and atrio-ventricular nodal cells, hyperpolarization-activated cyclic nucleotide-gated (HCN) inward current carrying cationic channels, I-f, are expressed that contribute importantly to the diastolic depolarization critical for cardiac pacemaker activity. Although previous studies have demonstrated myocardial expression of both the HCN2 and HCN4 subunits, the specific roles of these subunits in the generation of functional myo-cardial I-f channels remain unclear. To explore the molecular compositions of functional cardiac I-f channels, antibodies targeted against specific C- and N-terminal sequences in HCN2 and HCN4 were exploited to examine HCN2 and HCN4 subunit expression in adult (mouse) heart and to immunoprecipitate endogenous HCN-encoded cardiac I-f channel complexes. Western blot experiments revealed that although the full-length HCN2 (105 kDa) and HCN4 (160 kDa) proteins are readily detected in transiently transfected HEK-293 cells and in adult (mouse) brain, the molecular mass of the HCN2 protein in the myocardium is similar to 60 kDa. In addition, the myocardial 60-kDa HCN2 protein lacks the C terminus, which contains the cAMP binding domain. In heterologous cells, the C-terminal-truncated HCN2 protein co-assembles with HCN4 to form functional heteromeric HCN channels, which activate faster than homomeric HCN2 or homomeric HCN4 channels, and display properties similar to endogenous myocardial I-f channels Taken together, these results suggest that functional myocardial I-f channels reflect the heteromeric assembly of HCN2 and HCN4 subunits and further that the HCN4 subunit underlies the cAMP-mediated regulation of cardiac I-f channels.	[Ye, Bin] Univ Wisconsin, Div Cardiovasc Med, Dept Med, Madison, WI 53706 USA; [Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Ye, B (corresponding author), Univ Wisconsin, Div Cardiovasc Med, Dept Med & Publ Hlth, Rm 24,1300 Univ Ave, Madison, WI 53706 USA.	bye@medicine.wisc.edu			National Institutes of Health, NHLBI [R01 HL034161]; Scientist Development [0435030N]; American Heart Association National Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Scientist Development; American Heart Association National Center(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health, NHLBI, Grant R01 HL034161 (to J.M.N.) and by Scientist Development Grant 0435030N (to B.Y.) from the American Heart Association National Center.	Altomare C, 2003, J PHYSIOL-LONDON, V549, P347, DOI 10.1113/jphysiol.2002.027698; Barbuti A, 2008, ANN NY ACAD SCI, V1123, P213, DOI 10.1196/annals.1420.024; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Herrmann S, 2007, PFLUG ARCH EUR J PHY, V454, P517, DOI 10.1007/s00424-007-0224-4; Hoppe UC, 1998, CIRCULATION, V97, P55, DOI 10.1161/01.CIR.97.1.55; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Qu JH, 2002, PFLUG ARCH EUR J PHY, V444, P597, DOI 10.1007/s00424-002-0860-7; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Xue T, 2002, CIRC RES, V90, P1267, DOI 10.1161/01.RES.0000024390.97889.C6; Ye B, 2003, PHYSIOL GENOMICS, V12, P187, DOI 10.1152/physiolgenomics.00117.2002; Ye B, 2008, BIOCHEMISTRY-US, V47, P12312, DOI 10.1021/bi8009295; Zicha S, 2005, CARDIOVASC RES, V66, P472, DOI 10.1016/j.cardiores.2005.02.011	32	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25553	25559		10.1074/jbc.M109.007583	http://dx.doi.org/10.1074/jbc.M109.007583			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19574228	hybrid, Green Published			2022-12-25	WOS:000269738000012
J	Branham, MT; Bustos, MA; De Blas, GA; Rehmann, H; Zarelli, VEP; Trevino, CL; Darszon, A; Mayorga, LS; Tomes, CN				Branham, Maria T.; Bustos, Matias A.; De Blas, Gerardo A.; Rehmann, Holger; Zarelli, Valeria E. P.; Trevino, Claudia L.; Darszon, Alberto; Mayorga, Luis S.; Tomes, Claudia N.			Epac Activates the Small G Proteins Rap1 and Rab3A to Achieve Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SOLUBLE ADENYLYL-CYCLASE; GTP-BINDING PROTEIN; CA2+-INDUCED CA2+ RELEASE; PHOSPHOLIPASE-C-EPSILON; EXCHANGE FACTOR; ACROSOMAL EXOCYTOSIS; SPERM ACROSOME; ZONA-PELLUCIDA; CYCLIC-AMP; SIGNAL-TRANSDUCTION	Exocytosis of the acrosome (the acrosome reaction) relies on cAMP production, assembly of a proteinaceous fusion machinery, calcium influx from the extracellular medium, and mobilization from inositol 1,4,5-trisphosphate-sensitive intracellular stores. Addition of cAMP to human sperm suspensions bypasses some of these requirements and elicits exocytosis in a protein kinase A-and extracellular calcium-independent manner. The relevant cAMP target is Epac, a guanine nucleotide exchange factor for the small GTPase Rap. We show here that a soluble adenylyl cyclase synthesizes the cAMP required for the acrosome reaction. Epac stimulates the exchange of GDP for GTP on Rap1, upstream of a phospholipase C. The Epac-selective cAMP analogue 8-pCPT-2'-O-Me-cAMP induces a phospholipase C-dependent calcium mobilization in human sperm suspensions. In addition, our studies identify a novel connection between cAMP and Rab3A, a secretory granule-associated protein, revealing that the latter functions downstream of soluble adenylyl cyclase/cAMP/Epac but not of Rap1. Challenging sperm with calcium or 8-pCPT-2'-O-Me-cAMP boosts the exchange of GDP for GTP on Rab3A. Recombinant Epac does not release GDP from Rab3A in vitro, suggesting that the Rab3A-GEF activation by cAMP/Epac in vivo is indirect. We propose that Epac sits at a critical point during the exocytotic cascade after which the pathway splits into two limbs, one that assembles the fusion machinery into place and another that elicits intracellular calcium release.	[Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Lab Biol Celular & Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, RA-5500 Mendoza, Argentina; [Rehmann, Holger] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Rehmann, Holger] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [De Blas, Gerardo A.; Trevino, Claudia L.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Universidad Nacional Autonoma de Mexico	Tomes, CN (corresponding author), Univ Nacl Cuyo, Lab Biol Celular & Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, CC 56, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar		Trevino, Claudia L/0000-0002-7281-0534; Mayorga, Luis S/0000-0002-5995-0671; Bustos, Matias A./0000-0001-9625-1127; Darszon, Alberto/0000-0002-2502-0505	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5951]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT2006-1036]; Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [49113, 42605]; PAPIIT [IN204109, IN211809]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported in part by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 5951, Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT2006-1036, Argentina (to C.N.T.), Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) Grants 49113 (to A.D.) and 42605 (to C.L.T.), and PAPIIT Grants IN204109 ( to C.L.T.) and IN211809 (to A.D.).	Aivatiadou E, 2007, MOL BIOL CELL, V18, P1530, DOI 10.1091/mbc.E06-10-0902; Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; Beltran C, 2007, BIOCHEM BIOPH RES CO, V358, P1128, DOI 10.1016/j.bbrc.2007.05.061; Berruti G, 2003, CELL MOL BIOL, V49, P381; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Chin EC, 2004, J ENDOCRINOL, V183, P51, DOI 10.1677/joe.1.05550; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; D'Silva NJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1667, DOI 10.1152/ajpcell.1998.274.6.C1667; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Garde J, 1996, FEBS LETT, V391, P263, DOI 10.1016/0014-5793(96)00749-1; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Iida H, 1999, DEV BIOL, V211, P144, DOI 10.1006/dbio.1999.9302; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kinukawa M, 2006, FEBS LETT, V580, P1515, DOI 10.1016/j.febslet.2006.01.078; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kowluru A, 1997, BIOCHEM PHARMACOL, V54, P1097, DOI 10.1016/S0006-2952(97)00314-6; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Kwan EP, 2007, DIABETES, V56, P2579, DOI 10.2337/db06-1207; Lang Thorsten, 2008, V184, P107; LEISER M, 1995, ENDOCRINOLOGY, V136, P2521, DOI 10.1210/en.136.6.2521; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Nakagaki I, 2000, PFLUG ARCH EUR J PHY, V440, P828, DOI 10.1007/s004240000372; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Ohnishi H, 1997, J CLIN INVEST, V100, P3044, DOI 10.1172/JCI119859; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PRYDE JG, 1986, BIOCHEM J, V233, P525, DOI 10.1042/bj2330525; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; REGAZZI R, 2007, MOL MECH EXOCYTOSIS, P28; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Tomes Claudia Nora, 2007, Soc Reprod Fertil Suppl, V65, P275; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Ward CR, 1999, MOL REPROD DEV, V53, P413, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;413::AID-MRD7&gt;3.0.CO;2-W; Wuttke M S, 2001, JOP, V2, P154; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng Yi, 2003, EMBO Reports, V4, P463, DOI 10.1038/sj.embor.embor831	102	76	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24825	24839		10.1074/jbc.M109.015362	http://dx.doi.org/10.1074/jbc.M109.015362			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19546222	Green Published, hybrid			2022-12-25	WOS:000269734000017
J	Enomoto, M; Hayakawa, S; Itsukushima, S; Ren, DY; Matsuo, M; Tamada, K; Oneyama, C; Okada, M; Takumi, T; Nishita, M; Minami, Y				Enomoto, M.; Hayakawa, S.; Itsukushima, S.; Ren, D. Y.; Matsuo, M.; Tamada, K.; Oneyama, C.; Okada, M.; Takumi, T.; Nishita, M.; Minami, Y.			Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling	ONCOGENE			English	Article						Wnt5a; Ror2; MMP-13; invadopodia; osteosarcoma	RECEPTOR TYROSINE KINASE; BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; TUMOR-SUPPRESSOR; INVASION; WNT-5A; ROR2; EXPRESSION; PATHWAY; CANCER	The receptor tyrosine kinase Ror2 regulates cell migration by acting as a receptor or co-receptor for Wnt5a. Although Wnt5a has been implicated in the invasiveness of several types of tumors, the role of Ror2 in tumor invasion remains elusive. Here we show that osteosarcoma cell lines SaOS-2 and U2OS show invasive properties in vitro by activating Wnt5a/Ror2 signaling in a cell-autonomous manner. The suppressed expression of either Wnt5a or Ror2 in osteosarcoma cells inhibits cell invasiveness accompanying decreased invadopodia formation. Gene-expression pro. ling identified matrix metalloproteinase 13 (MMP-13) as one of the genes whose expression is downregulated in SaOS-2 cells following suppression of Ror2 expression. Reduced expression or activity of MMP-13 suppresses invasiveness of SaOS-2 cells. Moreover, expression of MMP-13 and cell invasiveness by Wnt5a/Ror2 signaling can be abrogated by an inhibitor of the Src-family protein tyrosine kinases (SFKs), suggesting the role of the SFKs in MMP-13 expression through Wnt5a/Ror2 signaling. We further show that activation of an SFK is inhibited by the suppressed expression of Ror2. Collectively, these results indicate that Wnt5a/Ror2 signaling involves the activation of a SFK, leading to MMP-13 expression, and that constitutively active Wnt5a/Ror2 signaling confers invasive properties on osteosarcoma cells in a cell-autonomous manner. Oncogene (2009) 28, 3197-3208; doi: 10.1038/onc.2009.175; published online 29 June 2009	[Nishita, M.] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Enomoto, M.; Matsuo, M.] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Tamada, K.; Takumi, T.] Osaka Biosci Inst, Osaka, Japan; [Oneyama, C.; Okada, M.] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, Osaka, Japan	Kobe University; Kobe University; Osaka University	Nishita, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nishita@med.kobe-u.ac.jp; minami@kobe-u.ac.jp			a Grant-in-Aid for Scientific Research in Priority Areas (YM); a Grant-in-Aid for Scientific Research (B) (YM); a Grant from the Global Center of Excellence Program 'Education and Research on Signal Transduction Medicine in the Coming Generation' (YM),; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Hyogo Science and Technology Association (MN) and a Grant from Takeda Science Foundation (MN)	a Grant-in-Aid for Scientific Research in Priority Areas (YM)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); a Grant-in-Aid for Scientific Research (B) (YM)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); a Grant from the Global Center of Excellence Program 'Education and Research on Signal Transduction Medicine in the Coming Generation' (YM),(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association (MN) and a Grant from Takeda Science Foundation (MN)	We thank M Endo for critical reading of the paper. We also thank K Mizuno for pEYFP-Actin. This work was supported by a Grant-in-Aid for Scientific Research in Priority Areas (YM), a Grant-in-Aid for Scientific Research (B) (YM), a Grant from the Global Center of Excellence Program 'Education and Research on Signal Transduction Medicine in the Coming Generation' (YM), a Grant-in-Aid for Young Scientists (B) (MN) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, a Grant from Hyogo Science and Technology Association (MN) and a Grant from Takeda Science Foundation (MN).	Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Albini A, 1998, Pathol Oncol Res, V4, P230; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Dass CR, 2006, CLIN EXP METASTAS, V23, P367, DOI 10.1007/s10585-006-9046-6; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; IOZZO RV, 1995, CANCER RES, V55, P3495; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	34	133	140	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3197	3208		10.1038/onc.2009.175	http://dx.doi.org/10.1038/onc.2009.175			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19561643	Bronze			2022-12-25	WOS:000269673400003
J	Argiriadi, MA; Xiang, T; Wu, CB; Ghayur, T; Borhani, DW				Argiriadi, Maria A.; Xiang, Tao; Wu, Chengbin; Ghayur, Tariq; Borhani, David W.			Unusual Water-mediated Antigenic Recognition of the Proinflammatory Cytokine Interleukin-18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; LIGAND-BINDING; T-CELLS; PROTEIN; IL-18; REFINEMENT; ANTIBODY; IDENTIFICATION; MOLECULES; RESIDUES	The unique cytokine interleukin-18 (IL-18) acts synergistically with IL-12 to regulate T-helper 1 and 2 lymphocytes and, as such, seems to underlie the pathogenesis of various autoimmune and allergic diseases. Several anti-IL-18 agents are in clinical development, including the recombinant human antibody ABT-325, which is entering trials for autoimmune diseases. Given competing cytokine/receptor and cytokine/receptor decoy interactions, understanding the structural basis for recognition is critical for effective development of anti-cytokine therapies. Here we report three crystal structures: the murine antibody 125-2H Fab fragment bound to human IL-18, at 1.5 angstrom resolution; the 125-2H Fab (2.3 angstrom); and the ABT-325 Fab (1.5 angstrom). These structures, along with human/mouse IL-18 chimera binding data, allow us to make three key observations relevant to the biology and antigenic recognition of IL-18 and related cytokines. First, several IL-18 residues shift dramatically (> 10 angstrom) upon binding 125-2H, compared with unbound IL-18 (Kato, Z., Jee, J., Shikano, H., Mishima, M., Ohki, I., Ohnishi, H., Li, A., Hashimoto, K., Matsukuma, E., Omoya, K., Yamamoto, Y., Yoneda, T., Hara, T., Kondo, N., and Shirakawa, M. (2003) Nat. Struct. Biol. 10, 966-971). IL-18 thus exhibits plasticity that may be common to its interactions with other receptors. Related cytokines may exhibit similar plasticity. Second, ABT-325 and 125-2H differ significantly in combining site character and architecture, thus explaining their ability to bind IL-18 simultaneously at distinct epitopes. These data allow us to define the likely ABT-325 epitope and thereby explain the distinct neutralizing mechanisms of both antibodies. Third, given the high 125-2H potency, 10 well ordered water molecules are trapped upon complex formation in a cavity between two IL-18 loops and all six 125-2H complementarity-determining regions. Thus, counterintuitively, tight and specific antibody binding may in some cases be water-mediated.	[Argiriadi, Maria A.; Xiang, Tao; Borhani, David W.] Abbott Labs, Dept Biochem, Worcester, MA 01605 USA; [Argiriadi, Maria A.; Xiang, Tao; Borhani, David W.] Abbott Labs, Dept Chem, Worcester, MA 01605 USA; [Wu, Chengbin; Ghayur, Tariq] Abbott Labs, Dept Biol, Worcester, MA 01605 USA	Abbott Laboratories; Abbott Laboratories; Abbott Laboratories	Argiriadi, MA (corresponding author), Abbott Labs, Dept Biochem, 100 Res Dr, Worcester, MA 01605 USA.	maria.argiriadi@abbott.com	Borhani, David/O-2692-2019	Borhani, David/0000-0002-8486-8792				Azam T, 2003, J IMMUNOL, V171, P6574, DOI 10.4049/jimmunol.171.12.6574; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Binkowski TA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-45; Bombardieri M, 2007, EXPERT OPIN BIOL TH, V7, P31, DOI 10.1517/14712598.7.1.31; Brady KD, 1998, BIOCHEMISTRY-US, V37, P8508, DOI 10.1021/bi9803325; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cohen GH, 2005, ACTA CRYSTALLOGR D, V61, P628, DOI 10.1107/S0907444905007870; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; EVANS PR, 1997, JOINT CCP4 ESF EACBM, V33; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GHAYUR T, 2005, Patent No. 2005047307; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krumm B, 2008, P NATL ACAD SCI USA, V105, P20711, DOI 10.1073/pnas.0809086106; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LESLIE AGW, 1992, CCP4 ESF EACMB NEWSL, V26; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Losy J, 2001, ACTA NEUROL SCAND, V104, P171, DOI 10.1034/j.1600-0404.2001.00356.x; Ludwiczek O, 2005, EUR CYTOKINE NETW, V16, P27; Mazza G, 1999, J MOL BIOL, V287, P773, DOI 10.1006/jmbi.1999.2645; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plater-Zyberk C, 2001, J CLIN INVEST, V108, P1825, DOI 10.1172/JCI200112097; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taniguchi M, 1997, J IMMUNOL METHODS, V206, P107, DOI 10.1016/S0022-1759(97)00094-X; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu CB, 2003, J IMMUNOL, V170, P5571, DOI 10.4049/jimmunol.170.11.5571; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Yamamoto Y, 2004, BIOCHEM BIOPH RES CO, V317, P181, DOI 10.1016/j.bbrc.2004.03.024; Yamamura M, 2001, ARTHRITIS RHEUM, V44, P275, DOI 10.1002/1529-0131(200102)44:2<275::AID-ANR44>3.3.CO;2-2; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	60	23	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24478	24489		10.1074/jbc.M109.023887	http://dx.doi.org/10.1074/jbc.M109.023887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553661	Green Published, hybrid			2022-12-25	WOS:000269380200060
J	He, DH; Su, YL; Usatyuk, PV; Spannhake, EW; Kogut, P; Solway, J; Natarajan, V; Zhao, YT				He, Donghong; Su, Yanlin; Usatyuk, Peter V.; Spannhake, Ernst Wm.; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong			Lysophosphatidic Acid Enhances Pulmonary Epithelial Barrier Integrity and Protects Endotoxin-induced Epithelial Barrier Disruption and Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; AIRWAY SMOOTH-MUSCLE; KAPPA-B ACTIVATION; KINASE-C-DELTA; E-CADHERIN; CELL-ADHESION; INTERLEUKIN-8 SECRETION; INDUCED TRANSACTIVATION; IL-13 RECEPTOR-ALPHA-2; MOLECULAR-CLONING	Lysophosphatidic acid (LPA), a bioactive phospholipid, induces a wide range of cellular effects, including gene expression, cytoskeletal rearrangement, and cell survival. We have previously shown that LPA stimulates secretion of pro-and anti-inflammatory cytokines in bronchial epithelial cells. This study provides evidence that LPA enhances pulmonary epithelial barrier integrity through protein kinase C (PKC) delta- and zeta-mediated E-cadherin accumulation at cell-cell junctions. Treatment of human bronchial epithelial cells (HBEpCs) with LPA increased transepithelial electrical resistance (TER) by similar to 2.0-fold and enhanced accumulation of E-cadherin to the cell-cell junctions through G alpha(i)-coupled LPA receptors. Knockdown of E-cadherin with E-cadherin small interfering RNA or pretreatment with EGTA (0.1 mM) prior to LPA (1 mu M) treatment attenuated LPA-induced increases in TER in HBEpCs. Furthermore, LPA induced tyrosine phosphorylation of focal adhesion kinase (FAK) and overexpression of the FAK inhibitor, and FAK-related non-kinase-attenuated LPA induced increases in TER and E-cadherin accumulation at cell-cell junctions. Overexpression of dominant negative protein kinase delta and zeta attenuated LPA-induced phosphorylation of FAK, accumulation of E-cadherin at cell-cell junctions, and an increase in TER. Additionally, lipopolysaccharide decreased TER and induced E-cadherin relocalization from cell-cell junctions to cytoplasm in a dose-dependent fashion, which was restored by LPA post-treatment in HBEpCs. Intratracheal post-treatment with LPA (5 mu M) reduced LPS-induced neutrophil influx, protein leak, and E-cadherin shedding in bronchoalveolar lavage fluids in a murine model of acute lung injury. These data suggest a protective role of LPA in airway inflammation and remodeling.	[He, Donghong; Su, Yanlin; Usatyuk, Peter V.; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Spannhake, Ernst Wm.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 20215 USA	University of Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhao, YT (corresponding author), 929 E 57th St,Ctr Integrat Sci Bldg,Rm W403M, Chicago, IL 60637 USA.	yzhao@medicine.bsd.uchicago.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	National Institutes of Health [RO1 HL091916, RO1 HL079396]; American Cancer Society-Institutional Research [58-044-47]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091916, R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL091916 (to Y. Z.) and RO1 HL079396 (to V. N.). This work was also supported by American Cancer Society-Institutional Research Grant 58-044-47 (to Y. Z.).	Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Budinger GRS, 2006, CLIN CHEST MED, V27, P655, DOI 10.1016/j.ccm.2006.06.007; Bush KT, 2000, AM J PHYSIOL-RENAL, V278, pF847, DOI 10.1152/ajprenal.2000.278.5.F847; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; COLLARESBUZATO CB, 1994, BBA-MOL CELL RES, V1222, P147, DOI 10.1016/0167-4889(94)90163-5; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Eckert JJ, 2005, DEV BIOL, V288, P234, DOI 10.1016/j.ydbio.2005.09.037; Ediger TL, 2000, J PHARMACOL EXP THER, V294, P1076; Ediger TL, 2002, AM J PHYSIOL-LUNG C, V282, pL91, DOI 10.1152/ajplung.2002.282.1.L91; Eutamene H, 2005, EUR RESPIR J, V25, P789, DOI 10.1183/09031936.05.00064704; Evans SM, 2002, AM J RESP CELL MOL, V27, P446, DOI 10.1165/rcmb.4776; Fan H, 2008, MOL MED, V14, P422, DOI 10.2119/2007-00106.Fan; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Gourgoulianis KI, 1999, MEDIAT INFLAMM, V8, P261, DOI 10.1080/09629359990432; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hashimoto T, 2003, J PHARMACOL SCI, V91, P8, DOI 10.1254/jphs.91.8; He DH, 2008, BIOCHEM J, V412, P153, DOI 10.1042/BJ20071649; HULSMANN AR, 1994, AM J RESP CRIT CARE, V149, P519, DOI 10.1164/ajrccm.149.2.8306055; Huntley GW, 2002, NEUROSCIENTIST, V8, P221, DOI 10.1177/1073858402008003008; Hybertson BM, 1997, J APPL PHYSIOL, V82, P226, DOI 10.1152/jappl.1997.82.1.226; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Jaggi M, 2005, CANCER RES, V65, P483; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; OTTO T, 1993, UROL RES, V21, P359, DOI 10.1007/BF00296837; Postma FR, 2001, CURR BIOL, V11, P121, DOI 10.1016/S0960-9822(01)00030-6; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Saatian B, 2006, BIOCHEM J, V393, P657, DOI 10.1042/BJ20050791; Sugiura T, 2002, J LIPID RES, V43, P2049, DOI 10.1194/jlr.M200242-JLR200; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takuwa Y, 2002, J BIOCHEM, V131, P767, DOI 10.1093/oxfordjournals.jbchem.a003163; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Toews ML, 1997, J APPL PHYSIOL, V83, P1216, DOI 10.1152/jappl.1997.83.4.1216; Tokumura A, 2002, BBA-MOL CELL BIOL L, V1582, P18, DOI 10.1016/S1388-1981(02)00133-6; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Vernooy JHJ, 2001, AM J RESP CELL MOL, V24, P569, DOI 10.1165/ajrcmb.24.5.4156; Wang LX, 2003, J BIOL CHEM, V278, P39931, DOI 10.1074/jbc.M302896200; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yin F, 2005, INVEST OPHTH VIS SCI, V46, P1927, DOI 10.1167/iovs.04-1256; Zabner J, 2003, J APPL PHYSIOL, V95, P394, DOI 10.1152/japplphysiol.01134.2002; Zhao YT, 2005, BIOCHEM J, V385, P493, DOI 10.1042/BJ20041160; Zhao YT, 2007, CELL SIGNAL, V19, P2329, DOI 10.1016/j.cellsig.2007.07.005; Zhao YT, 2007, J BIOL CHEM, V282, P10172, DOI 10.1074/jbc.M611210200; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zhao Y, 2009, AM J RESP CELL MOL, V40, P19, DOI 10.1165/rcmb.2008-0105OC	60	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24123	24132		10.1074/jbc.M109.007393	http://dx.doi.org/10.1074/jbc.M109.007393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586906	Green Published, hybrid			2022-12-25	WOS:000269380200026
J	Kim, J; Park, SI; Ahn, C; Kim, H; Yim, J				Kim, Jaekwang; Park, Sang Ick; Ahn, Chiyoung; Kim, Heuijong; Yim, Jeongbin			Guanine Deaminase Functions as Dihydropterin Deaminase in the Biosynthesis of Aurodrosopterin, a Minor Red Eye Pigment of Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE; DIHYDRONEOPTERIN TRIPHOSPHATE; POLYACRYLAMIDE-GEL; MELANOGASTER; IDENTIFICATION; PURIFICATION; PTERIDINES; SYNTHASE; SEPIAPTERIN; PROTEINS	Dihydropterin deaminase, which catalyzes the conversion of 7,8-dihydropterin to 7,8-dihydrolumazine, was purified 5850-fold to apparent homogeneity from Drosophila melanogaster. Its molecular mass was estimated to be 48 kDa by gel filtration and SDS-PAGE, indicating that it is a monomer under native conditions. The pI value, temperature, and optimal pH of the enzyme were 5.5, 40 degrees C, and 7.5, respectively. Interestingly the enzyme had much higher activity for guanine than for 7,8-dihydropterin. The specificity constant (k(cat)/K-m) for guanine (8.6 x 10(6) M-1.s(-1)) was 860-fold higher than that for 7,8-dihydropterin (1.0 x 10(4) M-1.s(-1)). The structural gene of the enzyme was identified by matrix- assisted laser desorption/ionization time-offlight mass spectrometry analysis as CG18143, located at region 82A1 on chromosome 3R. The cloned and expressed CG18143 exhibited both 7,8-dihydropterin and guanine deaminase activities. Flies with mutations in CG18143, SUPor-P/Df(3R)A321R1 transheterozygotes, had severely decreased activities in both deaminases compared with the wild type. Among several red eye pigments, the level of aurodrosopterin was specifically decreased in the mutant, and the amount of xanthine and uric acid also decreased considerably to 76 and 59% of the amounts in the wild type, respectively. In conclusion, dihydropterin deaminase encoded by CG18143 plays a role in the biosynthesis of aurodrosopterin by providing one of its precursors, 7,8-dihydrolumazine, from 7,8-dihydropterin. Dihydropterin deaminase also functions as guanine deaminase, an important enzyme for purine metabolism.	[Kim, Jaekwang; Kim, Heuijong; Yim, Jeongbin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Park, Sang Ick] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Seoul 122701, South Korea; [Ahn, Chiyoung] Korea Food & Drug Adm, Adv Therapy Prod Div, Biopharmaceut & Herbal Med Bur, Seoul 122704, South Korea	Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Yim, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	jyim@snu.ac.kr		Kim, Jaekwang/0000-0002-7312-4077	Korean Government (Ministry of Education and Human Resources Development) [KRF-2008313-E00068]; Brain Korea 21 project	Korean Government (Ministry of Education and Human Resources Development)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2008313-E00068 funded by the Korean Government (Ministry of Education and Human Resources Development) and by the second stage of the Brain Korea 21 project in 2009.	Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; AWDEH ZL, 1968, NATURE, V219, P66, DOI 10.1038/219066a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canbolat O, 1996, BREAST CANCER RES TR, V37, P189, DOI 10.1007/BF01806500; FAN CL, 1976, BIOCHEM GENET, V14, P271, DOI 10.1007/BF00484766; FARKAS WR, 1978, SCIENCE, V199, P786, DOI 10.1126/science.622568; FORREST HS, 1960, HELV CHIM ACTA, V43, P1005, DOI 10.1002/hlca.19600430408; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GUPTA NK, 1985, ARCH BIOCHEM BIOPHYS, V236, P266, DOI 10.1016/0003-9861(85)90626-5; HILLIKER AJ, 1992, P NATL ACAD SCI USA, V89, P4343, DOI 10.1073/pnas.89.10.4343; KAUFMAN S, 1967, J BIOL CHEM, V242, P3934; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; KIM NS, 1996, GENETICS, V42, P1157; KRIVI GG, 1979, BIOCHEM GENET, V17, P371, DOI 10.1007/BF00498976; KUZMITS R, 1980, ENZYME, V25, P148, DOI 10.1159/000459240; Lederer E, 1940, BIOL REV CAMB PHILOS, V15, P273; Liaw SH, 2004, J BIOL CHEM, V279, P35479, DOI 10.1074/jbc.M405304200; MACKAY WJ, 1983, GENETICS, V105, P35; MASSIE HR, 1991, EXP GERONTOL, V26, P609, DOI 10.1016/0531-5565(91)90078-Z; Park D, 2000, BBA-GENE STRUCT EXPR, V1492, P247, DOI 10.1016/S0167-4781(00)00084-1; PARK YS, 1990, BIOCHIM BIOPHYS ACTA, V1038, P186, DOI 10.1016/0167-4838(90)90203-R; REMBOLD H, 1971, BIOCHIM BIOPHYS ACTA, V230, P117, DOI 10.1016/0304-4165(71)90059-6; REMBOLD H, 1972, ANGEW CHEM INT EDIT, V11, P1061, DOI 10.1002/anie.197210611; ROSEMAN RR, 1995, GENETICS, V141, P1061; ROSSI CA, 1978, BIOCHIM BIOPHYS ACTA, V526, P235, DOI 10.1016/0005-2744(78)90308-X; SCHWINCK I, 1971, Genetics, V68, pS59; SCHWINCK I, 1973, Archiv fuer Genetik, V46, P41; TAKIKAWA SI, 1983, INSECT BIOCHEM, V13, P361, DOI 10.1016/0020-1790(83)90018-5; TARAS MJ, 1981, STANDARD METHODS EXA, P350; THEOBALD N, 1978, CHEM BER-RECL, V111, P3385, DOI 10.1002/cber.19781111013; VISCONTINI M, 1957, HELV CHIM ACTA, V40, P579, DOI 10.1002/hlca.19570400311; WIEDERRECHT GJ, 1984, J BIOL CHEM, V259, P2195; YIM JB, 1993, HELV CHIM ACTA, V76, P1970, DOI 10.1002/hlca.19930760516; YIM JJ, 1976, J BIOL CHEM, V251, P5087; YIM JJ, 1981, INSECT BIOCHEM, V11, P363, DOI 10.1016/0020-1790(81)90069-X; YIM JJ, 1977, SCIENCE, V198, P1168, DOI 10.1126/science.412253	36	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23426	23435		10.1074/jbc.M109.016493	http://dx.doi.org/10.1074/jbc.M109.016493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567870	Green Published, hybrid			2022-12-25	WOS:000269180000027
J	Ribeiro, FM; Ferreira, LT; Paquet, M; Cregan, T; Ding, QM; Gros, R; Ferguson, SSG				Ribeiro, Fabiola M.; Ferreira, Lucimar T.; Paquet, Maryse; Cregan, Tamara; Ding, Qingming; Gros, Robert; Ferguson, Stephen S. G.			Phosphorylation-independent Regulation of Metabotropic Glutamate Receptor 5 Desensitization and Internalization by G Protein-coupled Receptor Kinase 2 in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED INTERNALIZATION; DOMINANT-NEGATIVE MUTANT; BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; SYNERGISTIC REGULATION; SELECTIVE REGULATION; HOMOLOGY DOMAIN; SEQUESTRATION; GRK2; 1A	The uncoupling of metabotropic glutamate receptors (mGluRs) from heterotrimeric G proteins represents an essential feedback mechanism that protects neurons against receptor overstimulation that may ultimately result in damage. The desensitization of mGluR signaling is mediated by both second messenger-dependent protein kinases and G protein-coupled receptor kinases (GRKs). Unlike mGluR1, the attenuation of mGluR5 signaling in HEK 293 cells is reported to be mediated by a phosphorylation-dependent mechanism. However, the mechanisms regulating mGluR5 signaling and endocytosis in neurons have not been investigated. Here we show that a 2-fold overexpression of GRK2 leads to the attenuation of endogenous mGluR5-mediated inositol phosphate (InsP) formation in striatal neurons and siRNA knockdown of GRK2 expression leads to enhanced mGluR5-mediated InsP formation. Expression of a catalytically inactive GRK2-K220R mutant also effectively attenuates mGluR5 signaling, but the expression of a GRK2-D110A mutant devoid in G alpha(q/11) binding increases mGluR5 signaling in response to agonist stimulation. Taken together, these results indicate that the attenuation of mGluR5 responses in striatal neurons is phosphorylation-independent. In addition, we find that mGluR5 does not internalize in response to agonist treatment in striatal neuron, but is efficiently internalized in cortical neurons that have higher levels of endogenous GRK2 protein expression. When overexpressed in striatal neurons, GRK2 promotes agonist-stimulated mGluR5 internalization. Moreover, GRK2-mediated promotion of mGluR5 endocytosis does not require GRK2 catalytic activity. Thus, we provide evidence that GRK2 mediates phosphorylation-independent mGluR5 desensitization and internalization in neurons.	[Ferguson, Stephen S. G.] Univ Western Ontario, Robarts Res Inst, Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, London, ON N6A 5K8, Canada; [Ding, Qingming; Gros, Robert] Univ Western Ontario, Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5K8, Canada; [Gros, Robert; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Ferguson, SSG (corresponding author), Univ Western Ontario, Robarts Res Inst, Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.	ferguson@robarts.ca	Gros, Robert/AAV-2237-2020; Ribeiro, Fabiola/E-8831-2013; Gros, Robert/A-3010-2009	Gros, Robert/0000-0002-3667-8011; Ribeiro, Fabiola/0000-0001-7042-9433; Gros, Robert/0000-0002-3667-8011	Canadian Institutes of Health Research (CIHR) [MA-15506, MOP82756]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant MA-15506 ( to S. S. G. F.) and CIHR Grant MOP82756 ( to R. G.).	Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Baig AH, 2002, ENDOCR RES, V28, P281, DOI 10.1081/ERC-120016798; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Mangmool S, 2006, J BIOL CHEM, V281, P31940, DOI 10.1074/jbc.M602832200; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; Mundell SJ, 2003, J NEUROCHEM, V84, P294, DOI 10.1046/j.1471-4159.2003.01515.x; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Ribeiro FM, 2007, EUR J NEUROSCI, V26, P3437, DOI 10.1111/j.1460-9568.2007.05967.x; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Sorensen SD, 2003, NEUROPHARMACOLOGY, V44, P699, DOI 10.1016/S0028-3908(03)00053-4; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; TSUGA H, 1994, J BIOL CHEM, V269, P32522; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082	42	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23444	23453		10.1074/jbc.M109.000778	http://dx.doi.org/10.1074/jbc.M109.000778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564331	hybrid, Green Published			2022-12-25	WOS:000269180000029
J	Zhao, H; Sagert, J; Hwang, DS; Waite, JH				Zhao, Hua; Sagert, Jason; Hwang, Dong Soo; Waite, J. Herbert			Glycosylated Hydroxytryptophan in a Mussel Adhesive Protein from Perna viridis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-ANALYSIS; C-MANNOSYLATION; PROTECTIVE-COATINGS; CROSS-LINKING; GREEN MUSSEL; TRYPTOPHAN; 5-HYDROXYTRYPTOPHAN; LINKAGE; MIMICS	The 3,4-dihydroxyphenyl-L-alanine (Dopa)-containing proteins of mussel byssus play a critical role in wet adhesion and have inspired versatile new synthetic strategies for adhesives and coatings. Apparently, however, not all mussel adhesive proteins are beholden to Dopa chemistry. The cDNA-deduced sequence of Pvfp-1, a highly aromatic and redox active byssal coating protein in the green mussel Perna viridis, suggests that Dopa may be replaced by a post-translational modification of tryptophan. The N-terminal tryptophan-rich domain of Pvfp-1 contains 42 decapeptide repeats with the consensus sequences ATPKPW(1)TAW(2)K and APPPAW(1)TAW(2)K. A small collagen domain (18 Gly-X-Y repeats) is also present. Tandem mass spectrometry of isolated tryptic decapeptides has detected both C-2-hexosylated tryptophan(W-1) and C-2-hexosylated hydroxytryptophan (W-2), the latter of which is redox active. The UV absorbance spectrum of W-2 is consistent with 7-hydroxytryptophan, which represents an intriguing new theme for bioinspired opportunistic wet adhesion.	[Sagert, Jason; Hwang, Dong Soo; Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Zhao, Hua] ASTAR, Inst Chem & Engn Sci, Ind Biotechnol Dept, Singapore 627833, Singapore	University of California System; University of California Santa Barbara; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2)	Waite, JH (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	waite@lifesci.ucsb.edu	Hwang, Dong Soo/C-7291-2011	Hwang, Dong Soo/0000-0002-2487-2255	National Institutes of Health [R01 DE018468]; National Science Foundation [MRSEC DMR05-20415]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE018468. This work was also supported by National Science Foundation Grant MRSEC DMR05-20415.	Benson AJ, 2001, J SHELLFISH RES, V20, P21; Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8; EK A, 1953, J AM CHEM SOC, V75, P500, DOI 10.1021/ja01098a519; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Gutsche B, 1999, BIOCHEM J, V343, P11, DOI 10.1042/0264-6021:3430011; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; HOFSTEENGE J, 1996, TECH PROTEIN CHEM, V8, P163; Holten-Andersen N, 2008, J DENT RES, V87, P701, DOI 10.1177/154405910808700808; Holten-Andersen N, 2007, NAT MATER, V6, P669, DOI 10.1038/nmat1956; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; HUGLI TE, 1972, J BIOL CHEM, V247, P2828; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; KNIGHT JA, 1983, CLIN CHEM, V29, P1969; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Li JSS, 2005, J BIOL CHEM, V280, P38513, DOI 10.1074/jbc.M508449200; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; Manabe S, 2003, CHEM-EUR J, V9, P1435, DOI 10.1002/chem.200390163; MAVES KK, 1993, IMMUNOL RES, V12, P233, DOI 10.1007/BF02918255; MAYS C, 1981, BIOCHEMISTRY-US, V20, P2810, DOI 10.1021/bi00513a016; Munte CE, 2008, FEBS J, V275, P1163, DOI 10.1111/j.1742-4658.2008.06277.x; Nicholson Shaun, 2003, Mar Pollut Bull, V46, P1040, DOI 10.1016/S0025-326X(03)00152-8; Ohkawa K, 2004, BIOFOULING, V20, P101, DOI 10.1080/08927010410001681246; PEREDO AG, 2002, MOL CELL PROTEOMICS, V1, P11; Sagert J, 2006, BIOLOGICAL ADHESIVES, P125, DOI 10.1007/978-3-540-31049-5_7; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; Tsuda M, 2005, J NAT PROD, V68, P1277, DOI 10.1021/np050076e; Waite J.H., 1992, Results and Problems in Cell Differentiation, V19, P27; WAITE JH, 1991, ANAL BIOCHEM, V192, P429, DOI 10.1016/0003-2697(91)90560-G; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WAITE JH, 1981, ANAL BIOCHEM, V111, P131, DOI 10.1016/0003-2697(81)90240-2; Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002; Wu Z, 1996, BIOORG CHEM, V24, P127, DOI 10.1006/bioo.1996.0012; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101	41	39	42	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23344	23352		10.1074/jbc.M109.022517	http://dx.doi.org/10.1074/jbc.M109.022517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19584055	Green Published, hybrid			2022-12-25	WOS:000269180000019
J	Hung, KH; Titus, M; Chiang, SC; Stumph, WE				Hung, Ko-Hsuan; Titus, Mitchell; Chiang, Shu-Chi; Stumph, William E.			A Map of Drosophila melanogaster Small Nuclear RNA-activating Protein Complex (DmSNAPc) Domains Involved in Subunit Assembly and DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL-SEQUENCE-ELEMENT; TRANSCRIPTION FACTOR; POLYMERASE-II; GENE-TRANSCRIPTION; IN-VITRO; U6 GENES; SNAP(C); PROMOTER; TBP; U1	Transcription of genes coding for the small nuclear RNAs (snRNAs) is dependent upon a unique transcription factor known as the small nuclear RNA-activating protein complex (SNAPc). SNAPc binds to an essential proximal sequence element located about 40-65 base pairs upstream of the snRNA transcription start site. In the fruit fly Drosophila melanogaster, DmSNAPc contains three distinct polypeptides (DmSNAP190, DmSNAP50, and DmSNAP43) that are stably associated with each other and bind to the DNA as a complex. We have used mutational analysis to identify domains within each subunit that are involved in complex formation with the other two subunits in vivo. We have also identified domains in each subunit required for sequence-specific DNA binding. With one exception, domains required for subunit-subunit interactions lie in the most evolutionarily conserved regions of the proteins. However, DNA binding by DmSNAPc is dependent not only upon the conserved regions but is also highly dependent upon domains outside the conserved regions. Comparison with functional domains identified in human SNAPc indicates many parallels but also reveals significant differences in this ancient yet rapidly evolving system.	[Hung, Ko-Hsuan; Titus, Mitchell; Chiang, Shu-Chi; Stumph, William E.] San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; [Hung, Ko-Hsuan; Chiang, Shu-Chi] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Titus, Mitchell; Stumph, William E.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Stumph, WE (corresponding author), San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA.	wstumph@sciences.sdsu.edu			National Science Foundation [MCB-0641350, MCB-0842770]; California Metabolic Research Foundation; Div Of Molecular and Cellular Bioscience [0842770] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); California Metabolic Research Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0641350 and MCB-0842770 and the California Metabolic Research Foundation.	Bai L, 1996, MOL CELL BIOL, V16, P5419; Barakat NH, 2008, FEBS LETT, V582, P2413, DOI 10.1016/j.febslet.2008.06.003; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2003, P NATL ACAD SCI USA, V100, P80, DOI 10.1073/pnas.262609399; Hanzlowsky A, 2006, PROTEIN EXPRES PURIF, V48, P215, DOI 10.1016/j.pep.2006.02.015; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Henry RW, 1996, EMBO J, V15, P7129, DOI 10.1002/j.1460-2075.1996.tb01104.x; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; Hinkley CS, 2003, J BIOL CHEM, V278, P18649, DOI 10.1074/jbc.M204247200; Jawdekar GW, 2006, J BIOL CHEM, V281, P31050, DOI 10.1074/jbc.M603810200; Lai HT, 2008, FEBS LETT, V582, P3734, DOI 10.1016/j.febslet.2008.09.059; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; Ma B, 2001, J BIOL CHEM, V276, P5027, DOI 10.1074/jbc.M009301200; Ma BC, 2002, MOL CELL BIOL, V22, P8067, DOI 10.1128/MCB.22.22.8067-8078.2002; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; WALDSCHMIDT R, 1991, EMBO J, V10, P2595, DOI 10.1002/j.1460-2075.1991.tb07801.x; WANANDI I, 1993, J BIOL CHEM, V268, P6629; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; Yoon JB, 1996, MOL CELL BIOL, V16, P1; YOON JB, 1995, MOL CELL BIOL, V15, P2019; ZAMROD Z, 1993, MOL CELL BIOL, V13, P5918, DOI 10.1128/MCB.13.9.5918	28	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22568	22579		10.1074/jbc.M109.027961	http://dx.doi.org/10.1074/jbc.M109.027961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556241	Green Published, hybrid			2022-12-25	WOS:000268963100010
J	Zoltewicz, JS; Ashique, AM; Choe, Y; Lee, G; Taylor, S; Phamluong, K; Solloway, M; Peterson, AS				Zoltewicz, J. Susie; Ashique, Amir M.; Choe, Youngshik; Lee, Gena; Taylor, Stacy; Phamluong, Khanhky; Solloway, Mark; Peterson, Andrew S.			Wnt Signaling Is Regulated by Endoplasmic Reticulum Retention	PLOS ONE			English	Article								Precise regulation of Wnt signaling is important in many contexts, as in development of the vertebrate forebrain, where excessive or ectopic Wnt signaling leads to severe brain defects. Mutation of the widely expressed oto gene causes loss of the anterior forebrain during mouse embryogenesis. Here we report that oto is the mouse ortholog of the gpi deacylase gene pgap1, and that the endoplasmic reticulum (ER)-resident Oto protein has a novel and deacylase-independent function during Wnt maturation. Oto increases the hydrophobicities of Wnt3a and Wnt1 by promoting the addition of glycophosphatidylinositol (gpi)-like anchors to these Wnts, which results in their retention in the ER. We also report that oto-deficient embryos exhibit prematurely robust Wnt activity in the Wnt1 domain of the early neural plate. We examine the effect of low oto expression on Wnt1 in vitro by knocking down endogenous oto expression in 293 and M14 melanoma cells using shRNA. Knockdown of oto results in increased Wnt1 secretion which is correlated with greatly enhanced canonical Wnt activity. These data indicate that oto deficiency increases Wnt signaling in vivo and in vitro. Finally, we address the mechanism of Oto-mediated Wnt retention under oto-abundant conditions, by cotransfecting Wnt1 with gpi-specific phospholipase D (GPI-PLD). The presence of GPI-PLD in the secretory pathway results in increased secretion of soluble Wnt1, suggesting that the gpi-like anchor lipids on Wnt1 mediate its retention in the ER. These data now provide a mechanistic framework for understanding the forebrain defects in oto mice, and support a role for Oto-mediated Wnt regulation during early brain development. Our work highlights a critical role for ER retention in regulating Wnt signaling in the mouse embryo, and gives insight into the notoriously inefficient secretion of Wnts.			Zoltewicz, JS (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	susiezolt@gmail.com; peterson.andrew@gene.com			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017627] Funding Source: NIH RePORTER; NIDA NIH HHS [5 R01 DA017627-07, R01 DA017627] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Andoniadou CL, 2007, DEVELOPMENT, V134, P1499, DOI 10.1242/dev.02829; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bischoff M, 2006, PLOS BIOL, V4, P2262, DOI 10.1371/journal.pbio.0040396; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Castiglia D, 2008, GENE CHROMOSOME CANC, V47, P614, DOI 10.1002/gcc.20567; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chou SJ, 2006, DEV BIOL, V292, P533, DOI 10.1016/j.ydbio.2005.12.053; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Danielian PS, 1997, DEV BIOL, V192, P300, DOI 10.1006/dbio.1997.8762; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Heeg-Truesdell E, 2006, DEV BIOL, V298, P71, DOI 10.1016/j.ydbio.2006.06.015; Hirata T, 2006, DEVELOPMENT, V133, P3993, DOI 10.1242/dev.02585; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Hooper NM, 2001, PROTEOMICS, V1, P748, DOI 10.1002/1615-9861(200106)1:6<748::AID-PROT748>3.3.CO;2-K; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lewis SL, 2007, MECH DEVELOP, V124, P157, DOI 10.1016/j.mod.2006.10.001; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mann KJ, 2004, BIOCHEM J, V378, P641, DOI 10.1042/BJ20031326; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nambiar RM, 2004, DEV BIOL, V267, P165, DOI 10.1016/j.ydbio.2003.11.019; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Onai T, 2004, DEV CELL, V7, P95, DOI 10.1016/j.devcel.2004.06.004; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; PARKIN NT, 1993, GENE DEV, V7, P2181, DOI 10.1101/gad.7.11.2181; PARR BA, 1993, DEVELOPMENT, V119, P247; Popperl H, 1997, DEVELOPMENT, V124, P2997; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rowitch DH, 1998, DEVELOPMENT, V125, P2735; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Ueda Y, 2007, J BIOL CHEM, V282, P30373, DOI 10.1074/jbc.M705601200; Umland SP, 2004, AM J RESP CELL MOL, V30, P530, DOI 10.1165/rcmb.2003-0220OC; URBANIAK MD, 2005, J BIOL CHEM; van de Water S, 2001, DEVELOPMENT, V128, P3877; Vieira C, 2005, DEV BIOL, V284, P351, DOI 10.1016/j.ydbio.2005.05.031; Wada S, 2008, DEV GROWTH DIFFER, V50, P215, DOI [10.1111/j.1440-169x.2008.01012.x, 10.1111/j.1440-169X.2008.01012.x]; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamamoto A, 2005, CELL, V120, P223, DOI 10.1016/j.cell.2004.11.051; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zoltewicz JS, 1999, DEVELOPMENT, V126, P5085; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	78	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6191	10.1371/journal.pone.0006191	http://dx.doi.org/10.1371/journal.pone.0006191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19593386	Green Published, gold, Green Submitted			2022-12-25	WOS:000268035300006
J	Haddow, AD; Odoi, A				Haddow, Andrew D.; Odoi, Agricola			The Incidence Risk, Clustering, and Clinical Presentation of La Crosse Virus Infections in the Eastern United States, 2003-2007	PLOS ONE			English	Article								Background: Although La Crosse virus (LACV) is one of the most common causes of pediatric arboviral infections in the United States, little has been done to assess its geographic distribution, identify areas of higher risk of disease, and to provide a national picture of its clinical presentation. Therefore, the objective of this study was to investigate the geographic distribution of LACV infections reported in the United States, to identify hot-spots of infection, and to present its clinical picture. Methods and Findings: Descriptive and cluster analyses were performed on probable and confirmed cases of LACV infections reported to the Centers for Disease Control and Prevention from 2003-2007. A total of 282 patients had reported confirmed LACV infections during the study period. Of these cases the majority (81 percent) presented during the summer, occurred in children 15 years and younger (83.3 percent), and were found in male children (64.9 percent). Clinically, the infections presented as meningioencephalitis (56.3 percent), encephalitis (20.7 percent), meningitis (17.2 percent), or uncomplicated fever (5 percent). Deaths occurred in 1.9 percent of confirmed cases, and in 8.6 percent of patients suffering from encephalitis. The majority of these deaths were in patients 15 years and younger. The county-level incidence risk among counties (n = 136) reporting both probable and confirmed cases for children 15 years and younger (n = 355) ranged from 0.2 to 228.7 per 100,000 persons. The southern United States experienced a significantly higher (p < 0.05) incidence risk during the months of June, July, August, and October then the northern United States. There was significant (p < 0.05) clustering of high risk in several geographic regions with three deaths attributed to complications from LAC encephalitis occurring in two of these hot-spots of infections. Conclusions: Both the incidence risk and case fatality rates were found to be higher than previously reported. We detected clustering in four geographic regions, a shift from the prior geographic distributions, and developed maps identifying high-risk areas. These findings are useful for raising awareness among health care providers regarding areas at a high risk of infections and for guiding targeted multifaceted interventions by public health officials.			Haddow, AD (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	adhaddow@gmail.com	Odoi, Agricola/I-9532-2019; Haddow, Andrew/A-7507-2011; Haddow, Andrew/C-5902-2008	Odoi, Agricola/0000-0001-5050-6737; Haddow, Andrew/0000-0002-8957-2608				ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; BALFOUR HH, 1973, PEDIATRICS, V52, P680; BATES M, 1946, AM J TROP MED, V26, P585, DOI 10.4269/ajtmh.1946.s1-26.585; BEATY BJ, 1991, CURR TOP MICROBIOL, V169, P27; BERNARDINELLI L, 1992, STAT MED, V11, P983, DOI 10.1002/sim.4780110802; Bithell JF, 2000, STAT MED, V19, P2203, DOI 10.1002/1097-0258(20000915/30)19:17/18<2203::AID-SIM564>3.0.CO;2-U; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; *CDC, 2004, NEUR NONN DOM ARB DI; CHUN RWM, 1968, NEUROLOGY, V18, P369; Darsie R.F. Jr, 1981, Mosquito Systematics Supplement, V1, P1; Gabitzsch ES, 2006, J MED ENTOMOL, V43, P850, DOI 10.1603/0022-2585(2006)43[850:EOLCVI]2.0.CO;2; Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99; GRIMSTAD PR, 1984, AM J EPIDEMIOL, V119, P913, DOI 10.1093/oxfordjournals.aje.a113814; Gundersen C B, 1983, Prog Clin Biol Res, V123, P169; HILTY MD, 1972, AM J DIS CHILD, V124, P530, DOI 10.1001/archpedi.1972.02110160068006; Huang C, 1997, VIRUS RES, V48, P143, DOI 10.1016/S0168-1702(97)01437-8; HURWITZ ES, 1983, VECTOR-BORNE ZOONOT, V32, P595; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; KAPPUS KD, 1982, AM J TROP MED HYG, V31, P556, DOI 10.4269/ajtmh.1982.31.556; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; KSIAZEK TG, 1977, AM J TROP MED HYG, V26, P815, DOI 10.4269/ajtmh.1977.26.815; LaBeaud AD, 2006, PEDIATR INFECT DIS J, V25, P751, DOI 10.1097/01.inf.0000227830.73271.65; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; MILLER BR, 1979, AM J TROP MED HYG, V28, P897, DOI 10.4269/ajtmh.1979.28.897; MONATH TPC, 1970, AM J EPIDEMIOL, V92, P40, DOI 10.1093/oxfordjournals.aje.a121178; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; MOULTON DW, 1971, AM J TROP MED HYG, V20, P474, DOI 10.4269/ajtmh.1971.20.474; Nasci RS, 2000, J MED ENTOMOL, V37, P559, DOI 10.1603/0022-2585-37.4.559; ODOI A, 2003, CANADA INT J HLTH GE, V2, P5, DOI DOI 10.1186/1476-072X-2-5; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Reimann CA, 2008, AM J TROP MED HYG, V79, P974, DOI 10.4269/ajtmh.2008.79.974; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P230, DOI 10.1093/oxfordjournals.aje.a120511; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tsai T F, 1991, Infect Dis Clin North Am, V5, P73; *US BUR CENS, 2000, DEC CENS SUM FIL 1; *US BUR CENS, CART BOUND FIL; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; WATTS DM, 1972, J MED ENTOMOL, V9, P125, DOI 10.1093/jmedent/9.2.125; MMWR MORB MORTAL WKL, V37, P79	43	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6145	10.1371/journal.pone.0006145	http://dx.doi.org/10.1371/journal.pone.0006145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582158	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806300014
J	Gundemir, S; Johnson, GVW				Gundemir, Soner; Johnson, Gail V. W.			Intracellular Localization and Conformational State of Transglutaminase 2: Implications for Cell Death	PLOS ONE			English	Article								Transglutaminase 2 (TG2) is a multifunctional enzyme that has guanine nucleotide binding and GTP hydrolyzing activity in addition to its transamidating function. Studies show that TG2 is a player in mediating cell death processes. However, there is far from a consensus about the role of this enzyme in cell death processes as it appears to be dependent upon the cell type, stimuli, subcellular localization and conformational state of the enzyme. The purpose of this study was to dissect the role of TG2 in the cell death processes. To this end, we created and characterized 4 distinct point mutants of TG2, each of which differs from the wild type by its conformation or by lacking an important function. We also prepared these mutants as nuclear targeted proteins. By overexpressing mutant or wild type forms of TG2 in HEK 293 cells, we investigated the modulatory role of the protein in the cell death process in response to three stressors: thapsigargin, hyperosmotic stress and oxygen/glucose deprivation (OGD). All of the TG2 constructs, except the R580A mutant (which cannot bind guanine nucleotides and is therefore more prone to exhibit transamidating activity), either did not significantly affect the cell death processes or were protective. However in the case of the R580A mutant, cell death in response to high thapsigargin concentrations, was significantly increased. Intriguingly, nuclear localization of R580A-TG2 was sufficient to counteract the pro-death role of cytoplasmic R580A-TG2. In addition, nuclear localization of TG2 significantly facilitated its protective role against OGD. Our data support the hypothesis that the transamidation activity of TG2, which is mostly quiescent except in extreme stress conditions, is necessary for its pro-death role. In addition, nuclear localization of TG2 generally plays a key role in its protective function against cell death processes, either counteracting the detrimental effect or strengthening the protective role of the protein.			Gundemir, S (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404; Gundemir, Soner/0000-0002-9997-3552	NATIONAL INSTITUTE ON AGING [R01AG012396] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG012396, AG012396] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Akimov SS, 2001, J CELL SCI, V114, P2989; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Bailey CDC, 2004, MOL CELL NEUROSCI, V25, P493, DOI 10.1016/j.mcn.2003.11.016; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Boehm JE, 2002, J BIOL CHEM, V277, P20127, DOI 10.1074/jbc.C200147200; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Casadio R, 1999, EUR J BIOCHEM, V262, P672, DOI 10.1046/j.1432-1327.1999.00437.x; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Jones RA, 1997, J CELL SCI, V110, P2461; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Krasnikov BF, 2005, BIOCHEMISTRY-US, V44, P7830, DOI 10.1021/bi0500877; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Piacentini M, 2002, J NEUROCHEM, V81, P1061; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Szondy Z, 2006, CELL DEATH DIFFER, V13, P1827, DOI 10.1038/sj.cdd.4401889; THORPE GHG, 1986, METHOD ENZYMOL, V133, P331; Tucholski J, 1999, J NEUROCHEM, V73, P1871; Tucholski J, 2002, J NEUROCHEM, V81, P780, DOI 10.1046/j.1471-4159.2002.00859.x; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288	43	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6123	10.1371/journal.pone.0006123	http://dx.doi.org/10.1371/journal.pone.0006123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568436	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200021
J	Deb, C; Lee, CM; Dubey, VS; Daniel, J; Abomoelak, B; Sirakova, TD; Pawar, S; Rogers, L; Kolattukudy, PE				Deb, Chirajyoti; Lee, Chang-Muk; Dubey, Vinod S.; Daniel, Jaiyanth; Abomoelak, Bassam; Sirakova, Tatiana D.; Pawar, Santosh; Rogers, Linda; Kolattukudy, Pappachan E.			A Novel In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen	PLOS ONE			English	Article								Background: Mycobacterium tuberculosis (Mtb) becomes dormant and phenotypically drug resistant when it encounters multiple stresses within the host. Inability of currently available drugs to kill latent Mtb is a major impediment to curing and possibly eradicating tuberculosis (TB). Most in vitro dormancy models, using single stress factors, fail to generate a truly dormant Mtb population. An in vitro model that generates truly dormant Mtb cells is needed to elucidate the metabolic requirements that allow Mtb to successfully go through dormancy, identify new drug targets, and to screen drug candidates to discover novel drugs that can kill dormant pathogen. Methodology/Principal Findings: We developed a novel in vitro multiple-stress dormancy model for Mtb by applying combined stresses of low oxygen (5%), high CO2 (10%), low nutrient (10% Dubos medium) and acidic pH (5.0), conditions Mtb is thought to encounter in the host. Under this condition, Mtb stopped replicating, lost acid-fastness, accumulated triacylglycerol (TG) and wax ester (WE), and concomitantly acquired phenotypic antibiotic-resistance. Putative neutral lipid biosynthetic genes were up-regulated. These genes may serve as potential targets for new antilatency drugs. The triacylglycerol synthase1 (tgs1) deletion mutant, with impaired ability to accumulate TG, exhibited a lesser degree of antibiotic tolerance and complementation restored antibiotic tolerance. Transcriptome analysis with microarray revealed the achievement of dormant state showing repression of energy generation, transcription and translation machineries and induction of stress-responsive genes. We adapted this model for drug screening using the Alamar Blue dye to quantify the antibiotic tolerant dormant cells. Conclusions/Significance: The new in vitro multiple stress dormancy model efficiently generates Mtb cells meeting all criteria of dormancy, and this method is adaptable to high-throughput screening for drugs that can kill dormant Mtb. A critical link between storage-lipid accumulation and development of phenotypic drug-resistance in Mtb was established. Storage lipid biosynthetic genes may be appropriate targets for novel drugs that can kill latent Mtb.			Deb, C (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	pk@mail.ucf.edu	Lee, ChangMuk/C-9988-2010; kolattukudy, pappachan e/A-1350-2012	Lee, ChangMuk/0000-0001-9258-395X; 	NIAID NIH HHS [R01 AI035272] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035272] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander PE, 2007, CAN J INFECT DIS MED, V18, P289, DOI 10.1155/2007/986794; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; BURDON KL, 1946, J BACTERIOL, V52, P665, DOI 10.1128/JB.52.6.665-678.1946; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; COOPER A, 2005, ANIMAL MODELS TUBERC; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; DANNENBERG AM, 1997, PATHOGENESIS PULMONA; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; DUBOS RJ, 1953, J EXP MED, V97, P357, DOI 10.1084/jem.97.3.357; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; JACKSON SK, 1989, BRIT J EXP PATHOL, V70, P435; Karakousis PC, 2008, J ANTIMICROB CHEMOTH, V61, P323, DOI 10.1093/jac/dkm485; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; KIKUCHI S, 1992, ARCH BIOCHEM BIOPHYS, V295, P318, DOI 10.1016/0003-9861(92)90524-Z; KOLATTUK.PE, 1967, BIOCHEMISTRY-US, V6, P2705, DOI 10.1021/bi00861a010; KOLATTUK.PE, 1970, BIOCHEMISTRY-US, V9, P1095, DOI 10.1021/bi00807a007; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W; KORNBERG HL, 1957, NATURE, V180, P35, DOI 10.1038/180035a0; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; NYKA W, 1977, Materia Medica Polona, V9, P175; NYKA W, 1963, AM REV RESPIR DIS, V88, P670; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Palomino JC, 1999, EUR J CLIN MICROBIOL, V18, P380, DOI 10.1007/PL00015025; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Saviola B, 2003, INFECT IMMUN, V71, P1379, DOI 10.1128/IAI.71.3.1379-1388.2003; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2004, TUBERCULOSIS, V84, P138, DOI 10.1016/j.tube.2003.12.008; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Waltermann M, 2007, BIOCHIMIE, V89, P230, DOI 10.1016/j.biochi.2006.07.013; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; *WHO, 2008, TUB FACTS, P5; YAJKO DM, 1995, J CLIN MICROBIOL, V33, P2324, DOI 10.1128/JCM.33.9.2324-2327.1995; Yang Y, 2002, MED PHYS, V29, P2024, DOI 10.1118/1.1500767; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	66	285	296	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6077	10.1371/journal.pone.0006077	http://dx.doi.org/10.1371/journal.pone.0006077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562030	gold, Green Published, Green Submitted			2022-12-25	WOS:000267465900012
J	Nicke, A; Kuan, YH; Masin, M; Rettinger, J; Marquez-Klaka, B; Bender, O; Gorecki, DC; Murrell-Lagnado, RD; Soto, F				Nicke, Annette; Kuan, Yung-Hui; Masin, Marianela; Rettinger, Juergen; Marquez-Klaka, Benjamin; Bender, Olaf; Gorecki, Dariusz C.; Murrell-Lagnado, Ruth D.; Soto, Florentina			A Functional P2X7 Splice Variant with an Alternative Transmembrane Domain 1 Escapes Gene Inactivation in P2X7 Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR FUNCTION; PERMEABILITY DYNAMICS; LARGE-PORE; ATP; CHANNELS; SUBUNITS; CELLS; BRAIN; IDENTIFICATION; POLYMORPHISM	The ATP-activated P2X7 receptor channel is involved in immune function and inflammatory pain and represents an important drug target. Here we describe a new P2X7 splice variant (P2X7(k)), containing an alternative intracellular N terminus and first transmembrane domain encoded by a novel exon 1 in the rodent P2rx7 gene. Whole cell patch clamp recordings of the rat isoform expressed in HEK293 cells revealed an 8-fold higher sensitivity to the agonist Bz-ATP and much slower deactivation kinetics when compared with the P2X7(a) receptor. Permeability measurements in Xenopus oocytes show a high permeability for N-methyl-D-glucamine immediately upon activation, suggesting that the P2X7(k) channel is constitutively dilated upon opening. The rates of agonist-induced dye uptake and membrane blebbing in HEK cells were also increased. PCR analyses and biochemical analysis by SDS-PAGE and BN-PAGE indicate that the P2X7(k) variant escapes gene deletion in one of the available P2X7(-/-) mice strains and is strongly expressed in the spleen. Taken together, we describe a novel P2X7 isoform with distinct functional properties that contributes to the diversity of P2X7 receptor signaling. Its presence in one of the P2X7(-/-) strains has important implications for our understanding of the role of this receptor in health and disease.	[Nicke, Annette; Kuan, Yung-Hui; Marquez-Klaka, Benjamin; Bender, Olaf] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Masin, Marianela; Soto, Florentina] MPI Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Masin, Marianela; Murrell-Lagnado, Ruth D.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Rettinger, Juergen] MPI Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England	Max Planck Society; University of Cambridge; Max Planck Society; University of Portsmouth	Nicke, A (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	anicke@gwdg.de		Murrell-Lagnado, Ruth/0000-0003-2743-7977; Nicke, Annette/0000-0001-6798-505X; Gorecki, Dariusz/0000-0003-3584-1654	Deutsche Forschungsgemeinschaft [NI 592/4, NI 592/5]; German Israeli Foundation; Interreg IV; Biotechnology and Biological Sciences and Research Council [BB/F001320/1]; Biotechnology and Biological Sciences Research Council [BB/F001320/1] Funding Source: researchfish; BBSRC [BB/F001320/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Interreg IV; Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants NI 592/4 and NI 592/5 to A. N.), the German Israeli Foundation (to F. S.), the Interreg IV (AdMiN) (to D. C. G.), and the Biotechnology and Biological Sciences and Research Council (Grant BB/F001320/1to R. M.-L.).	Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kim M, 2001, J BIOL CHEM, V276, P23262, DOI 10.1074/jbc.M102253200; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; MCINNES IB, 2007, AM COLL RHEUMATOL; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Paukert M, 2002, FEBS LETT, V513, P253, DOI 10.1016/S0014-5793(02)02324-4; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Sanchez-Nogueiro J, 2005, FEBS LETT, V579, P3783, DOI 10.1016/j.febslet.2005.05.073; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor SRJ, 2009, J LEUKOCYTE BIOL, V85, P978, DOI 10.1189/jlb.0408251; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Vial C, 2004, BIOCHEM J, V382, P101, DOI 10.1042/BJ20031910; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059	49	146	148	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25813	25822		10.1074/jbc.M109.033134	http://dx.doi.org/10.1074/jbc.M109.033134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19546214	Green Published, hybrid			2022-12-25	WOS:000269738000039
J	Pores-Fernando, AT; Ranaghan, MYD; Zweifach, A				Pores-Fernando, Arun T.; Ranaghan, Michelle Y. D.; Zweifach, Adam			No Specific Subcellular Localization of Protein Kinase C Is Required for Cytotoxic T Cell Granule Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTERS; PKC-THETA; SECRETORY LYSOSOMES; ANTIGEN RECEPTOR; IL-2 PROMOTER; CD8(+) CTL; DELTA; LYMPHOCYTES; SUBSTRATE; SIGNAL	Cytotoxic T cells kill virus-infected cells and tumor cells by releasing lytic granules that contain cell-killing contents. Exocytosis requires calcium influx and protein kinase C (PKC) activation. Here, we extend our previous finding regarding the lack of isoform specificity of PKCs in the granule release step, showing that mutant constitutively active PKC delta can substitute for phorbol esters and support exocytosis. PKC delta, a novel PKC isoform, was recently shown to play a role in lytic granule reorientation. Surprisingly, however, our results suggested that mutant PKC delta did not localize to the plasma membrane (PM). To test directly whether PKC has to be in the PM to drive exocytosis, we generated mutants of various PKC isoforms that were tethered either to the outer mitochondrial membrane or to the PM. Tethered mutant PKC delta s were able to promote exocytosis as effectively as the untethered version. The substrates of PKCs involved in lytic granule exocytosis are currently unknown, but subcellular localization is believed to be a critical factor in determining PKC accessibility to substrates. That there is no requirement for specific PKC localization in lytic granule exocytosis may have important implications for the identity of PKC substrates.	[Pores-Fernando, Arun T.; Ranaghan, Michelle Y. D.; Zweifach, Adam] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Zweifach, A (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	adam.zweifach@uconn.edu			National Institutes of Health [R01 AI054839]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI054839 (to A. Z.).	Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Fierro AF, 2004, J BIOL CHEM, V279, P25646, DOI 10.1074/jbc.M400296200; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Grybko MJ, 2007, J LEUKOCYTE BIOL, V81, P509, DOI 10.1189/jlb.0206109; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mochly-Rosen D, 1998, FASEB J, V12, P35; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Pardo J, 2003, INT IMMUNOL, V15, P1441, DOI 10.1093/intimm/dxg141; Pores-Fernando AT, 2008, BIOCHEM BIOPH RES CO, V371, P630, DOI 10.1016/j.bbrc.2008.04.028; Pores-Fernando AT, 2005, J PHYSIOL-LONDON, V567, P891, DOI 10.1113/jphysiol.2005.089565; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Puente LG, 2000, J IMMUNOL, V165, P6865, DOI 10.4049/jimmunol.165.12.6865; Puente LG, 2006, EUR J IMMUNOL, V36, P1009, DOI 10.1002/eji.200535277; Puente LG, 2005, MOL IMMUNOL, V42, P1177, DOI 10.1016/j.molimm.2004.11.012; Radoja S, 2006, CRIT REV IMMUNOL, V26, P265, DOI 10.1615/CritRevImmunol.v26.i3.40; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Rybin VO, 2006, AM J PHYSIOL-CELL PH, V290, pC750, DOI 10.1152/ajpcell.00395.2005; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Wan QJ, 2000, J BIOL CHEM, V275, P12136, DOI 10.1074/jbc.275.16.12136; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101	33	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25107	25115		10.1074/jbc.M109.011866	http://dx.doi.org/10.1074/jbc.M109.011866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592494	hybrid, Green Published			2022-12-25	WOS:000269734000045
J	Shewmaker, F; McGlinchey, RP; Thurber, KR; McPhie, P; Dyda, F; Tycko, R; Wickner, RB				Shewmaker, Frank; McGlinchey, Ryan P.; Thurber, Kent R.; McPhie, Peter; Dyda, Fred; Tycko, Robert; Wickner, Reed B.			The Functional Curli Amyloid Is Not Based on In-register Parallel beta-Sheet Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; HET-S PRION; NUCLEAR-MAGNETIC-RESONANCE; THIN AGGREGATIVE FIMBRIAE; ESCHERICHIA-COLI; EXPERIMENTAL CONSTRAINTS; SALMONELLA-ENTERITIDIS; SECONDARY STRUCTURE; FIBRILS; PROTEIN	The extracellular curli proteins of Enterobacteriaceae form fibrous structures that are involved in biofilm formation and adhesion to host cells. These curli fibrils are considered a functional amyloid because they are not a consequence of misfolding, but they have many of the properties of protein amyloid. We confirm that fibrils formed by CsgA and CsgB, the primary curli proteins of Escherichia coli, possess many of the hallmarks typical of amyloid. Moreover we demonstrate that curli fibrils possess the cross-beta structure that distinguishes protein amyloid. However, solid state NMR experiments indicate that curli structure is not based on an in-register parallel beta-sheet architecture, which is common to many human disease-associated amyloids and the yeast prion amyloids. Solid state NMR and electron microscopy data are consistent with a beta-helix-like structure but are not sufficient to establish such a structure definitively.	[Wickner, Reed B.] NIDDK, Lab Biochem & Genet, Natl Inst Hlth, Bethesda, MD 20892 USA; [Thurber, Kent R.; Tycko, Robert] NIDDK, Labs Chem Phys, Natl Inst Hlth, Bethesda, MD 20892 USA; [Dyda, Fred] NIDDK, Labs Mol Biol, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, Natl Inst Hlth, Bldg 8,Rm 207,8 Ctr Dr, Bethesda, MD 20892 USA.	wickner@helix.nih.gov			NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024950, Z01DK024964, ZIADK024964, Z01DK024949, ZIADK024948, ZIADK024949, ZIADK075031, ZIADK075018] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the NIDDK, National Institutes of Health.	Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Ishii Y, 2001, CHEM PHYS, V266, P231, DOI 10.1016/S0301-0104(01)00250-6; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Mackay JP, 2001, STRUCTURE, V9, P83, DOI 10.1016/S0969-2126(00)00559-1; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McPhie P, 2001, ANAL BIOCHEM, V293, P109, DOI 10.1006/abio.2001.5113; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Podrabsky JE, 2001, AM J PHYSIOL-REG I, V280, pR123, DOI 10.1152/ajpregu.2001.280.1.R123; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Virchow R, 1853, CR HEBD ACAD SCI, V37, P860; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	53	100	104	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25065	25076		10.1074/jbc.M109.007054	http://dx.doi.org/10.1074/jbc.M109.007054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574225	Green Published, hybrid			2022-12-25	WOS:000269734000041
J	Xu, Q; Traag, BA; Willemse, J; McMullan, D; Miller, MD; Elsliger, MA; Abdubek, P; Astakhova, T; Axelrod, HL; Bakolitsa, C; Carlton, D; Chen, C; Chiu, HJ; Chruszcz, M; Clayton, T; Das, D; Deller, MC; Duan, L; Ellrott, K; Ernst, D; Farr, CL; Feuerhelm, J; Grant, JC; Grzechnik, A; Grzechnik, SK; Han, GW; Jaroszewski, L; Jin, KK; Klock, HE; Knuth, MW; Kozbial, P; Krishna, SS; Kumar, A; Marciano, D; Minor, W; Mommaas, AM; Morse, AT; Nigoghossian, E; Nopakun, A; Okach, L; Oommachen, S; Paulsen, J; Puckett, C; Reyes, R; Rife, CL; Sefcovic, N; Tien, HJ; Trame, CB; van den Bedem, H; Wang, SR; Weekes, D; Hodgson, KO; Wooley, J; Deacon, AM; Godzik, A; Lesley, SA; Wilson, IA; Wezel, GP				Xu, Qingping; Traag, Bjorn A.; Willemse, Joost; McMullan, Daniel; Miller, Mitchell D.; Elsliger, Marc-Andre; Abdubek, Polat; Astakhova, Tamara; Axelrod, Herbert L.; Bakolitsa, Constantina; Carlton, Dennis; Chen, Connie; Chiu, Hsiu-Ju; Chruszcz, Maksymilian; Clayton, Thomas; Das, Debanu; Deller, Marc C.; Duan, Lian; Ellrott, Kyle; Ernst, Dustin; Farr, Carol L.; Feuerhelm, Julie; Grant, Joanna C.; Grzechnik, Anna; Grzechnik, Slawomir K.; Han, Gye Won; Jaroszewski, Lukasz; Jin, Kevin K.; Klock, Heath E.; Knuth, Mark W.; Kozbial, Piotr; Krishna, S. Sri; Kumar, Abhinav; Marciano, David; Minor, Wladek; Mommaas, A. Mieke; Morse, Andrew T.; Nigoghossian, Edward; Nopakun, Amanda; Okach, Linda; Oommachen, Silvya; Paulsen, Jessica; Puckett, Christina; Reyes, Ron; Rife, Christopher L.; Sefcovic, Natasha; Tien, Henry J.; Trame, Christine B.; van den Bedem, Henry; Wang, Shuren; Weekes, Dana; Hodgson, Keith O.; Wooley, John; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.; van Wezel, Gilles P.			Structural and Functional Characterizations of SsgB, a Conserved Activator of Developmental Cell Division in Morphologically Complex Actinomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); PROTEIN; SPORULATION; GENE; EXPRESSION; GROWTH; FTSZ; LOCALIZATION; INTEGRATION; CRYSTALS	SsgA-like proteins (SALPs) are a family of homologous cell division-related proteins that occur exclusively in morphologically complex actinomycetes. We show that SsgB, a subfamily of SALPs, is the archetypal SALP that is functionally conserved in all sporulating actinomycetes. Sporulation-specific cell division of Streptomyces coelicolor ssgB mutants is restored by introduction of distant ssgB orthologues from other actinomycetes. Interestingly, the number of septa (and spores) of the complemented null mutants is dictated by the specific ssgB orthologue that is expressed. The crystal structure of the SsgB from Thermobifida fusca was determined at 2.6 angstrom resolution and represents the first structure for this family. The structure revealed similarities to a class of eukaryotic "whirly" single-stranded DNA/RNA-binding proteins. However, the electro-negative surface of the SALPs suggests that neither SsgB nor any of the other SALPs are likely to interact with nucleotide substrates. Instead, we show that a conserved hydrophobic surface is likely to be important for SALP function and suggest that proteins are the likely binding partners.	[Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Xu, Qingping; McMullan, Daniel; Miller, Mitchell D.; Elsliger, Marc-Andre; Abdubek, Polat; Astakhova, Tamara; Axelrod, Herbert L.; Bakolitsa, Constantina; Carlton, Dennis; Chen, Connie; Chiu, Hsiu-Ju; Clayton, Thomas; Das, Debanu; Deller, Marc C.; Duan, Lian; Ellrott, Kyle; Ernst, Dustin; Farr, Carol L.; Feuerhelm, Julie; Grant, Joanna C.; Grzechnik, Anna; Grzechnik, Slawomir K.; Han, Gye Won; Jaroszewski, Lukasz; Jin, Kevin K.; Klock, Heath E.; Knuth, Mark W.; Kozbial, Piotr; Krishna, S. Sri; Kumar, Abhinav; Marciano, David; Morse, Andrew T.; Nigoghossian, Edward; Nopakun, Amanda; Okach, Linda; Oommachen, Silvya; Paulsen, Jessica; Puckett, Christina; Reyes, Ron; Rife, Christopher L.; Sefcovic, Natasha; Tien, Henry J.; Trame, Christine B.; van den Bedem, Henry; Weekes, Dana; Hodgson, Keith O.; Wooley, John; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Xu, Qingping; Miller, Mitchell D.; Axelrod, Herbert L.; Chiu, Hsiu-Ju; Das, Debanu; Jin, Kevin K.; Kumar, Abhinav; Oommachen, Silvya; Reyes, Ron; Rife, Christopher L.; Trame, Christine B.; van den Bedem, Henry; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Traag, Bjorn A.; Willemse, Joost; van Wezel, Gilles P.] Leiden Univ, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands; [McMullan, Daniel; Abdubek, Polat; Chen, Connie; Ernst, Dustin; Feuerhelm, Julie; Grant, Joanna C.; Klock, Heath E.; Knuth, Mark W.; Nigoghossian, Edward; Okach, Linda; Paulsen, Jessica; Puckett, Christina; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Astakhova, Tamara; Duan, Lian; Ellrott, Kyle; Grzechnik, Slawomir K.; Jaroszewski, Lukasz; Krishna, S. Sri; Morse, Andrew T.; Wooley, John; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Bakolitsa, Constantina; Jaroszewski, Lukasz; Kozbial, Piotr; Krishna, S. Sri; Sefcovic, Natasha; Weekes, Dana; Godzik, Adam] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Chruszcz, Maksymilian; Minor, Wladek; Wang, Shuren] Leiden Univ, Med Ctr, Midwest Ctr Struct Genom, NL-2300 RC Leiden, Netherlands; [Mommaas, A. Mieke] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Elect Microscopy, NL-2300 RC Leiden, Netherlands	Scripps Research Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Leiden University; Leiden University - Excl LUMC; Novartis; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of Virginia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wilson, IA (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, BCC206,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; g.wezel@chem.leidenuniv.nl	Han, Gye Won/GLQ-8724-2022; Godzik, Adam/AAW-1467-2020; subramanian, srikrishna/D-5004-2009; subramanian, srikrishna/N-3018-2019; Godzik, Adam/A-7279-2009; Han, Gye Won/GLQ-8673-2022; Minor, Wladek/F-3096-2014; Chruszcz, Maksymilian/E-6407-2011; Han, Gye Won/GLT-1531-2022; Willemse, Joost/B-1861-2008; van Wezel, Gilles/ABC-7854-2021	Han, Gye Won/0000-0003-4107-835X; Godzik, Adam/0000-0002-2425-852X; subramanian, srikrishna/0000-0002-3263-1048; subramanian, srikrishna/0000-0002-3263-1048; Godzik, Adam/0000-0002-2425-852X; Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Willemse, Joost/0000-0001-9312-6021; van Wezel, Gilles/0000-0003-0341-1561; Miller, Mitchell/0000-0003-1626-4943; Bakolitsa, Constantina/0000-0002-6980-9831; Marciano, David/0000-0001-8868-2138; Deller, Marc/0000-0001-8070-6502; Elsliger, Marc Andre/0000-0002-1989-7626	National Institutes of Health, NIGMS [U54 GM074898, U54 GM074942]; Netherlands Council for Scientific Research ECHO [700.54.002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM074898] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Netherlands Council for Scientific Research ECHO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants U54 GM074898 and U54 GM074942 (to the Protein Structure Initiative, which supported the structural genomics project) and Netherlands Council for Scientific Research ECHO Grant 700.54.002 (to G. P. v. W.).	Autret S, 2001, DEV CELL, V1, P10, DOI 10.1016/S1534-5807(01)00014-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; CHATER KF, 1972, J GEN MICROBIOL, V72, P9, DOI 10.1099/00221287-72-1-9; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; Elliot MA, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P419; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Flardh K, 2000, MOL MICROBIOL, V38, P737, DOI 10.1046/j.1365-2958.2000.02177.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hopwood DA, 2007, STREPTOMYCES NATURE; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kawamoto S, 1997, MICROBIOL-UK, V143, P1077, DOI 10.1099/00221287-143-4-1077; Keijser BJF, 2003, FEMS MICROBIOL LETT, V225, P59, DOI 10.1016/S0378-1097(03)00481-6; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kormanec J, 2002, MOL GENET GENOMICS, V267, P536, DOI 10.1007/200438-002-0687-0; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; LYDIATE DJ, 1985, GENE, V35, P223, DOI 10.1016/0378-1119(85)90001-0; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Mazza P, 2006, MOL MICROBIOL, V60, P838, DOI 10.1111/j.1365-2958.2006.05134.x; MCCORMICK JR, 1994, MOL MICROBIOL, V14, P243, DOI 10.1111/j.1365-2958.1994.tb01285.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Noens EEE, 2005, MOL MICROBIOL, V58, P929, DOI 10.1111/j.1365-2958.2005.04883.x; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Traag BA, 2008, ANTON LEEUW INT J G, V94, P85, DOI 10.1007/s10482-008-9225-3; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van Wezel GP, 2000, J BACTERIOL, V182, P5653, DOI 10.1128/JB.182.20.5653-5662.2000; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WILDERMUTH H, 1970, J GEN MICROBIOL, V60, P51, DOI 10.1099/00221287-60-1-51; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	55	19	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25268	25279		10.1074/jbc.M109.018564	http://dx.doi.org/10.1074/jbc.M109.018564			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19567872	Green Published, hybrid			2022-12-25	WOS:000269734000060
J	Yang, QY; Low, CB; Karthik, BC; Wang, Y; Ryo, A; Yao, SQ; Yang, DW; Liou, YC				Yang, Qiaoyun; Low, Choon Bing; Karthik, Balakrishna Chandrababu; Wang, Yu; Ryo, Akihide; Yao, Shao Q.; Yang, Daiwen; Liou, Yih-Cherng			Pin1 Catalyzes Conformational Changes of Thr-187 in p27(Kip1) and Mediates Its Stability through a Polyubiquitination Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL-ISOMERASE PIN1; CELL-CYCLE PROGRESSION; DEPENDENT KINASES; CDK INHIBITORS; S-PHASE; PHOSPHORYLATION; P27; CANCER; TRANSFORMATION; LOCALIZATION	The cis-trans peptidylprolyl isomerase Pin1 plays a critical role in regulating a subset of phosphoproteins by catalyzing conformational changes on the phosphorylated Ser/Thr-Pro motifs. The phosphorylation-directed ubiquitination is one of the major mechanisms to regulate the abundance of p27(Kip1). In this study, we demonstrate that Pin1 catalyzes the cis-trans conformational changes of p27(Kip1) and further mediates its stability through the polyubiquitination mechanism. Our results show that the phosphorylated Thr-187-Pro motif in p27(Kip1) is a key Pin1-binding site. In addition, NMR analyses show that this phosphorylated Thr-187-Pro site undergoes conformational change catalyzed by Pin1. Moreover, in Pin1 knock-out mouse embryonic fibroblasts, p27(Kip1) has a shorter lifetime and displays a higher degree of polyubiquitination than in Pin1 wildtype mouse embryonic fibroblasts, suggesting that Pin1 plays a critical role in regulating p27(Kip1) degradation. Additionally, Pin1 dramatically reduces the interaction between p27(Kip1) and Cks1, possibly via isomerizing the cis-trans conformation of p27(Kip1). Our study thus reveals a novel regulatory mechanism for p27(Kip1) stability and sheds new light on the biological function of Pin1 as a general regulator of protein stability.	[Yang, Qiaoyun; Low, Choon Bing; Karthik, Balakrishna Chandrababu; Wang, Yu; Ryo, Akihide; Yao, Shao Q.; Yang, Daiwen; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Yao, Shao Q.] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Ryo, Akihide] Natl Inst Infect Dis 1, AIDS Res Ctr, Res Grp 1, Tokyo 2080011, Japan	National University of Singapore; National University of Singapore; National Institute of Infectious Diseases (NIID)	Liou, YC (corresponding author), 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	Yao, Shao Q/B-8825-2008; yang, daiwen/H-8408-2012	yang, daiwen/0000-0002-6804-0071	Biomedical Research Council, the Agency for Science, Research, and Technology [06/1/21/19/473]; National University of Singapore [R-154-000-403-112]	Biomedical Research Council, the Agency for Science, Research, and Technology(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	This work was supported by Grant 06/1/21/19/473 from the Biomedical Research Council, the Agency for Science, Research, and Technology, and in part by Facility Research Council Grant R-154-000-403-112 from the National University of Singapore ( to Y.C.L.).	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Brenkman AB, 2008, CANCER RES, V68, P7597, DOI 10.1158/0008-5472.CAN-08-1059; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Kaldis P, 2007, CELL, V128, P241, DOI 10.1016/j.cell.2007.01.006; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Reed SI, 2002, CELL CYCLE, V1, P389, DOI 10.4161/cc.1.6.261; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Ryo A, 2007, J BIOL CHEM, V282, P36671, DOI 10.1074/jbc.M704145200; Ryo A, 2009, TRENDS BIOCHEM SCI, V34, P162, DOI 10.1016/j.tibs.2008.12.004; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seeliger MA, 2003, NAT STRUCT BIOL, V10, P718, DOI 10.1038/nsb962; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sun HY, 2008, ANGEW CHEM INT EDIT, V47, P1698, DOI 10.1002/anie.200703473; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	61	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23980	23988		10.1074/jbc.M109.022814	http://dx.doi.org/10.1074/jbc.M109.022814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19584057	hybrid, Green Published			2022-12-25	WOS:000269380200012
J	Barth, S; Edlich, F; Berchner-Pfannschmidt, U; Gneuss, S; Jahreis, G; Hasgall, PA; Fandrey, J; Wenger, RH; Camenisch, G				Barth, Sandra; Edlich, Frank; Berchner-Pfannschmidt, Utta; Gneuss, Silke; Jahreis, Guenther; Hasgall, Philippe A.; Fandrey, Joachim; Wenger, Roland H.; Camenisch, Gieri			Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; BCL-2 REGULATOR FKBP38; PROLYL-HYDROXYLASE; HIF-ALPHA; NITRIC-OXIDE; TRANSCRIPTIONAL ACTIVITY; ORNITHINE-DECARBOXYLASE; PROTEASOMAL DEGRADATION; RESPONSIVE ELEMENT; OXYGEN	Prolyl-4-hydroxylase domain (PHD) proteins are 2-oxoglutarate and dioxygen-dependent enzymes that mediate the rapid destruction of hypoxia-inducible factor alpha subunits. Whereas PHD1 and PHD3 proteolysis has been shown to be regulated by Siah2 ubiquitin E3 ligase-mediated polyubiquitylation and proteasomal destruction, protein regulation of the main oxygen sensor responsible for hypoxia-inducible factor alpha regulation, PHD2, remained unknown. We recently reported that the FK506-binding protein (FKBP) 38 specifically interacts with PHD2 and determines PHD2 protein stability in a peptidylprolyl cis-trans isomerase-independent manner. Using peptide array binding assays, fluorescence spectroscopy, and fluorescence resonance energy transfer analysis, we defined a minimal linear glutamate-rich PHD2 binding domain in the N-terminal part of FKBP38 and showed that this domain forms a high affinity complex with PHD2. Vice versa, PHD2 interacted with a non-linear N-terminal motif containing the MYND (myeloid, Nervy, and DEAF-1)-type Zn2+ finger domain with FKBP38. Biochemical fractionation and immunofluorescence analysis demonstrated that PHD2 subcellular localization overlapped with FKBP38 in the endoplasmic reticulum and mitochondria. An additional fraction of PHD2 was found in the cytoplasm. In cellulo PHD2/FKBP38 association, as well as regulation of PHD2 protein abundance by FKBP38, is dependent on membrane-anchored FKBP38 localization mediated by the C-terminal transmembrane domain. Mechanistically our data indicate that PHD2 protein stability is regulated by a ubiquitin-independent proteasomal pathway involving FKBP38 as adaptor protein that mediates proteasomal interaction. We hypothesize that FKBP38-bound PHD2 is constantly degraded whereas cytosolic PHD2 is stable and able to function as an active prolyl-4-hydroxylase.	[Barth, Sandra; Hasgall, Philippe A.; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Barth, Sandra; Hasgall, Philippe A.; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Edlich, Frank; Jahreis, Guenther] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Berchner-Pfannschmidt, Utta; Gneuss, Silke; Fandrey, Joachim] Univ Duisburg Essen, Inst Physiol, D-45122 Essen, Germany	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Max Planck Society; University of Duisburg Essen	Camenisch, G (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gieri.camenisch@access.uzh.ch	Wenger, Roland H./B-7953-2009; Fandrey, Joachim/AAA-3524-2021	Wenger, Roland H./0000-0001-7592-4839; Fandrey, Joachim/0000-0001-9585-0531	European Commission/State Secretariat for Education and Research (SER) [EUROXY LSHC-CT-2003-502932/SBF 03.0647-2]; Swiss National Science Foundation [3100A0-104219]; Deutsche Forschungsgemeinschaft [FA 225/19-3]	European Commission/State Secretariat for Education and Research (SER)(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Forschungskredit der Universitat Zurrich (to G. C.), the Sassella-Stiftung (to G. C. and S. B.), the Hartmann Muller-Stiftung (to G. C.), the Krebsliga des Kanton Zurrich (to G. C.), the Olga Mayenfisch Stiftung (to G. C.), 6th Framework Programme of the European Commission/State Secretariat for Education and Research (SER) Grant EUROXY LSHC-CT-2003-502932/SBF 03.0647-2 (to R. H. W.), Swiss National Science Foundation Grant 3100A0-104219 (to R. H. W. and G. C.), and Deutsche Forschungsgemeinschaft Grant FA 225/19-3 (to J. F.).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Bader N, 2006, BIOL CHEM, V387, P1351, DOI 10.1515/BC.2006.169; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Khan Z, 2006, AM J PATHOL, V169, P1251, DOI 10.2353/ajpath.2006.060360; Knowles HJ, 2003, CANCER RES, V63, P1764; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lausen J, 2004, J BIOL CHEM, V279, P49281, DOI 10.1074/jbc.M407239200; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wirthner R, 2007, METHOD ENZYMOL, V435, P43, DOI 10.1016/S0076-6879(07)35003-9; Wotzlaw C, 2007, FASEB J, V21, P700, DOI 10.1096/fj.06-6280com; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	78	56	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23046	23058		10.1074/jbc.M109.032631	http://dx.doi.org/10.1074/jbc.M109.032631			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546213	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000268963100057
J	Qin, YB; Li, L; Pan, WJ; Wu, DQ				Qin, Yuanbo; Li, Lin; Pan, Weijun; Wu, Dianqing			Regulation of Phosphatidylinositol Kinases and Metabolism by Wnt3a and Dvl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDES; PHOSPHORYLATION; MECHANISM; DISEASE; AXIN	Wnt signaling plays important roles in various physiological and pathophysiological processes. The pathway that leads to beta-catenin stabilization is initiated by Wnt binding to its cell surface receptors, which induces the formation of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) via activation of phosphatidylinositol 4-phosphate 5-kinase (PIP5K) type I. Here, we show that Wnt also stimulated the production of phosphatidylinositol 4-phosphate (PtdIns(4)P), which depended on Frizzled (Fz), Dishevelled (Dvl), and phosphatidylinositol 4-kinase (PI4K) type II alpha in HEK293T cells. Dvl directly interacted with and activated PI4KII alpha by increasing its V-max for ATP and PtdIns. In addition, Dvl regulated PI4KII alpha and PIP5KI via different domains. Moreover, Dvl, PI4KII alpha, and PIP5KI appeared to form a ternary complex upon Wnt3a stimulation. This complex may allow efficient production of PtdIns(4,5)P-2 from PtdIns, which is far more abundant than PtdIns(4)P in cells. Therefore, this study provides new insights into the mechanism by which Wnt3a regulates the production of PtdIns(4,5)P-2.	[Qin, Yuanbo; Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Qin, Yuanbo; Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Qin, Yuanbo; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Qin, Yuanbo; Li, Lin] Chinese Acad Sci, Ctr Cell Signaling, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Yale University; Yale University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Pan, WJ (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, 333 Cedar St, New Haven, CT 06520 USA.	weijun.pan@yale.edu; dan.wu@yale.edu			National Institutes of Health; NSFC; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health grants (to D. W.). This work was also supported by NSFC grants (to L. L.).	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clarke JH, 2007, BIOCHEM SOC SYMP, V74, P149, DOI 10.1042/BSS2007c14; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	22	54	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22544	22548		10.1074/jbc.M109.014399	http://dx.doi.org/10.1074/jbc.M109.014399			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561074	Green Published, hybrid			2022-12-25	WOS:000268963100007
J	Jiang, Y; Luo, W; Howe, PH				Jiang, Y.; Luo, W.; Howe, P. H.			Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions	ONCOGENE			English	Article						Disabled-2 (Dab2); Axin-protein phosphatase 1 (PP1); Wnt-beta-catenin signaling	BETA-CATENIN; DISABLED-2 DAB2; PHOSPHORYLATION; PATHWAY; ENDOCYTOSIS; ACTIVATION; ADAPTER; AP-2; LRP6	Wnt/beta-catenin signaling plays a pivotal role in modulating cellular proliferation, differentiation, tissue organization and embryonic development. Earlier, we found that the endocytic adaptor disabled-2 (Dab2) could attenuate Wnt/beta-catenin signaling by stabilizing Axin and preventing its translocation to the membrane. Recently, protein phosphatase 1 (PP1) has been shown to interact with, and dephosphorylate Axin, leading to its destabilization. Here, we show that Dab2 functions upstream of PP1 to block the interaction between Axin and PP1, inhibiting Axin dephosphorylation and thereby stabilizing its expression, ultimately leading to inhibition of Wnt/beta-catenin. We show that Dab2 acts as a competitive inhibitor of PP1 by binding to the same C-terminal domain of Axin. Both PP1 and Axin bind to the N-terminus of Dab2 and a Dab2 truncation mutant consisting of the N-terminal phosphotyrosine binding domain blocks PP1-Axin interactions and inhibits Wnt signaling. We confirm the inhibitory effect of Dab2 on Wnt/beta-catenin signaling in zebrafish embryos, showing that its ectopic expression phenocopies Axin overexpression resulting in altered dorsoventral patterning. We conclude that Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing PP1 from binding Axin. Oncogene (2009) 28, 2999-3007; doi:10.1038/onc.2009.157; published online 6 July 2009	[Luo, W.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Ctr Children, Salt Lake City, UT USA; [Jiang, Y.; Howe, P. H.] Cleveland Clin, Dept Canc Biol NB4, Lerner Res Inst, Cleveland, OH 44195 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation	Howe, PH (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, NB4, Cleveland, OH 44195 USA.	howep@ccf.org			National Cancer Institute [CA55536, CA80095]; NATIONAL CANCER INSTITUTE [R01CA055536, R01CA080095, R29CA055536] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr S Takada for the generous provision of control Wnt-3A-producing mouse L cells and Drs Furuhashi, Wu, Zeng and He for generous provision of the Myc-Axin, Flag-tagged LRP5 plasmids and LRP5/6 antibody, respectively. We also thank Dr David Virshup and Dr Sheng-Cai Lin for generous provision of PP1 and Axin reagents. We are also grateful to Drs Sanjay Pimplikar and Ping Song for all their help with the zebrafish studies. This work was supported by Grant CA55536 and CA80095 from the National Cancer Institute to PHH.	Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Jiang Y, 2008, ONCOGENE, V27, P1865, DOI 10.1038/sj.onc.1210829; Jones WM, 2003, CURR BIOL, V13, pR479, DOI 10.1016/S0960-9822(03)00407-X; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Smith ER, 2001, J BIOL CHEM, V276, P47303, DOI 10.1074/jbc.M106158200; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	20	36	40	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2009	28	33					2999	3007		10.1038/onc.2009.157	http://dx.doi.org/10.1038/onc.2009.157			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19581931	Green Accepted			2022-12-25	WOS:000269142800008
J	Sung, I; Kwak, JH; Na, HJ; Kim, JK; Ding, Y; Choi, ME				Kim, Sung Il; Kwak, Joon Hyeok; Na, Hee-Jun; Kim, Jin Kuk; Ding, Yan; Choi, Mary E.			Transforming Growth Factor-beta (TGF-beta 1) Activates TAK1 via TAB1-mediated Autophosphorylation, Independent of TGF-beta Receptor Kinase Activity in Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; IL-1 SIGNALING PATHWAY; KAPPA-B; FIBRONECTIN SYNTHESIS; EPITHELIAL-CELLS; GENE-EXPRESSION; SMAD PROTEINS; JNK PATHWAY; I RECEPTOR; P38 MAPK	Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine that signals through the interaction of type I (T beta RI) and type II (T beta RII) receptors to activate distinct intracellular pathways. TAK1 is a serine/threonine kinase that is rapidly activated by TGF-beta 1. However, the molecular mechanism of TAK1 activation is incompletely understood. Here, we propose a mechanism whereby TAK1 is activated by TGF-beta 1 in primary mouse mesangial cells. Under unstimulated conditions, endogenous TAK1 is stably associated with T beta RI. TGF-beta 1 stimulation causes rapid dissociation from the receptor and induces TAK1 phosphorylation. Deletion mutant analysis indicates that the juxtamembrane region including the GS domain of T beta RI is crucial for its interaction with TAK1. Both T beta RI-mediated TAK1 phosphorylation and TGF-beta 1-induced TAK1 phosphorylation do not require kinase activity of T beta RI. Moreover, T beta RI-mediated TAK1 phosphorylation correlates with the degree of its association with T beta RI and requires kinase activity of TAK1. TAB1 does not interact with TGF-beta receptors, but TAB1 is indispensable for TGF-beta 1-induced TAK1 activation. We also show that TRAF6 and TAB2 are required for the interaction of TAK1 with T beta RI and TGF-beta 1-induced TAK1 activation in mouse mesangial cells. Taken together, our data indicate that TGF-beta 1-induced interaction of T beta RI and T beta RII triggers dissociation of TAK1 from T beta RI, and subsequently TAK1 is phosphorylated through TAB1-mediated autophosphorylation and not by the receptor kinase activity of T beta RI.	[Kim, Sung Il; Kwak, Joon Hyeok; Na, Hee-Jun; Kim, Jin Kuk; Ding, Yan; Choi, Mary E.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Renal Div, Boston, MA 02115 USA; [Kim, Jin Kuk] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon 420767, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Soonchunhyang University	Choi, ME (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Renal Div, 4 Blackfan Circle,HIM 5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu			National Institutes of Health [R01DK57661]; American Society of Nephrology; American Heart Association [0665379U]; National Kidney Foundation of the Alleghenies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; American Heart Association(American Heart Association); National Kidney Foundation of the Alleghenies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK57661 (NIDDK). This work was also supported by an M. James Scherbenske grant from the American Society of Nephrology (to M. E. C.) and Beginning Grant-in-Aid 0665379U from the American Heart Association and the National Kidney Foundation of the Alleghenies (to S. I. K.).	Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Choi ME, 1999, AM J PHYSIOL-RENAL, V276, pF88, DOI 10.1152/ajprenal.1999.276.1.F88; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Ono K, 2003, BIOCHEM BIOPH RES CO, V307, P332, DOI 10.1016/S0006-291X(03)01207-5; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Terada Y, 1999, KIDNEY INT, V56, P1378, DOI 10.1046/j.1523-1755.1999.00665.x; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	71	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22285	22296		10.1074/jbc.M109.007146	http://dx.doi.org/10.1074/jbc.M109.007146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19556242	hybrid, Green Published			2022-12-25	WOS:000268783700052
J	Sy, SMH; Huen, MSY; Chen, JJ				Sy, Shirley M. -H.; Huen, Michael S. Y.; Chen, Junjie			MRG15 Is a Novel PALB2-interacting Factor Involved in Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMO DOMAIN; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; DNA-DAMAGE; REPAIR; BRCA2; PALB2; CONSERVATION; PARTNER; DIRECTS	PALB2 is an integral component of the BRCA complex important for recombinational DNA repair. However, exactly how this activity is regulated in vivo remains unexplored. Here we provide evidence to show that MRG15 is a novel PALB2-associated protein that ensures regulated recombination events. We found that the direct interaction between MRG15 and PALB2 is mediated by an evolutionarily conserved region on PALB2. Intriguingly, although damage-induced RAD51 foci formation and mitomycin C sensitivity appeared normal in MRG15-binding defective PALB2 mutants, these cells exhibited a significant increase in gene conversion rates. Consistently, we found that abrogation of the PALB2-MRG15 interaction resulted in elevated sister chromatid exchange frequencies. Our results suggest that loss of the PALB2-MRG15 interaction relieved the cells with the suppression of sister chromatid exchange and therefore led to a hyper-recombination phenotype in the gene conversion assay. Together, our study indicated that although PALB2 is required for proficient homologous recombination, it could also govern the choice of templates used in homologous recombination repair.	[Sy, Shirley M. -H.; Huen, Michael S. Y.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd,Unit 66,Rm Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org	Huen, Michael Shing Yan/E-9862-2010	Sy, Ming Hui/0000-0002-2731-6692	National Institutes of Health [CA089239, CA092312, CA100109]; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312 and CA100109 (to J.C.).	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Garcia SN, 2007, FEBS LETT, V581, P5275, DOI 10.1016/j.febslet.2007.10.017; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	19	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21127	21131		10.1074/jbc.C109.023937	http://dx.doi.org/10.1074/jbc.C109.023937			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19553677	Green Published, hybrid			2022-12-25	WOS:000268564400005
J	Jagarlamudi, K; Liu, L; Adhikari, D; Reddy, P; Idahl, A; Ottander, U; Lundin, E; Liu, K				Jagarlamudi, Krishna; Liu, Lian; Adhikari, Deepak; Reddy, Pradeep; Idahl, Annika; Ottander, Ulrika; Lundin, Eva; Liu, Kui			Oocyte-Specific Deletion of Pten in Mice Reveals a Stage-Specific Function of PTEN/PI3K Signaling in Oocytes in Controlling Follicular Activation	PLOS ONE			English	Article								Immature ovarian primordial follicles are essential for maintenance of the reproductive lifespan of female mammals. Recently, it was found that overactivation of the phosphatidylinositol 3-kinase (PI3K) signaling in oocytes of primordial follicles by an oocyte-specific deletion of Pten (phosphatase and tensin homolog deleted on chromosome ten), the gene encoding PI3K negative regulator PTEN, results in premature activation of the entire pool of primordial follicles, indicating that activation of the PI3K pathway in oocytes is important for control of follicular activation. To investigate whether PI3K signaling in oocytes of primary and further developed follicles also plays a role at later stages in follicular development and ovulation, we conditionally deleted the Pten gene from oocytes of primary and further developed follicles by using transgenic mice expressing zona pellucida 3 (Zp3) promoter-mediated Cre recombinase. Our results show that Pten was efficiently deleted from oocytes of primary and further developed follicles, as indicated by the elevated phosphorylation of the major PI3K downstream component Akt. However, follicular development was not altered and oocyte maturation was also normal, which led to normal fertility with unaltered litter size in the mutant mice. Our data indicate that properly controlled PTEN/PI3K-Akt signaling in oocytes is essential for control of the development of primordial follicles whereas overactivation of PI3K signaling in oocytes does not appear to affect the development of growing follicles. This suggests that there is a stage-specific function of PTEN/PI3K signaling in mouse oocytes that controls follicular activation.			Jagarlamudi, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	eva.lundin@medbio.umu.se; kui.liu@medchem.umu.se	Adhikari, Deepak/H-6176-2013; Reddy, Pradeep/G-1770-2014	Adhikari, Deepak/0000-0003-0656-9858; Reddy, Pradeep/0000-0002-9173-3845; Adhikari, Deepak/0000-0002-3404-8753; Liu, Lian/0000-0001-5868-4482				Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hoshino Y, 2004, MOL REPROD DEV, V69, P77, DOI 10.1002/mrd.20150; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Kubiak JZ, 2008, INT J DEV BIOL, V52, P201, DOI 10.1387/ijdb.072337jk; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Liu K, 2006, FRONT BIOSCI-LANDMRK, V11, P126, DOI 10.2741/1785; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu L, 2007, J MOL ENDOCRINOL, V38, P137, DOI 10.1677/jme.1.02027; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257	21	88	96	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6186	10.1371/journal.pone.0006186	http://dx.doi.org/10.1371/journal.pone.0006186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587782	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035100010
J	Lone, AG; Deslandes, V; Nash, JHE; Jacques, M; MacInnes, JI				Lone, Abdul G.; Deslandes, Vincent; Nash, John H. E.; Jacques, Mario; MacInnes, Janet I.			Modulation of Gene Expression in Actinobacillus pleuropneumoniae Exposed to Bronchoalveolar Fluid	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; NONTYPABLE HAEMOPHILUS-INFLUENZAE; ANAEROBIC NITRATE REDUCTASE; MYCOBACTERIUM-BOVIS BCG; NADH-QUINONE REDUCTASE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; VIRULENCE PROPERTIES; SELECTIVE CAPTURE; FATTY-ACID	Background: Actinobacillus pleuropneumoniae, the causative agent of porcine contagious pleuropneumonia, is an important pathogen of swine throughout the world. It must rapidly overcome the innate pulmonary immune defenses of the pig to cause disease. To better understand this process, the objective of this study was to identify genes that are differentially expressed in a medium that mimics the lung environment early in the infection process. Methods and Principal Findings: Since bronchoalveolar lavage fluid (BALF) contains innate immune and other components found in the lungs, we examined gene expression of a virulent serovar 1 strain of A. pleuropneumoniae after a 30 min exposure to BALF, using DNA microarrays and real-time PCR. The functional classes of genes found to be up-regulated most often in BALF were those encoding proteins involved in energy metabolism, especially anaerobic metabolism, and in cell envelope, DNA, and protein biosynthesis. Transcription of a number of known virulence genes including apxIVA and the gene for SapF, a protein which is involved in resistance to antimicrobial peptides, was also up-regulated in BALF. Seventy-nine percent of the genes that were up-regulated in BALF encoded a known protein product, and of these, 44% had been reported to be either expressed in vivo and/or involved in virulence. Conclusions: The results of this study suggest that in early stages of infection, A. pleuropneumoniae may modulate expression of genes involved in anaerobic energy generation and in the synthesis of proteins involved in cell wall biogenesis, as well as established virulence factors. Given that many of these genes are thought to be expressed in vivo or involved in virulence, incubation in BALF appears, at least partially, to simulate in vivo conditions and may provide a useful medium for the discovery of novel vaccine or therapeutic targets.			Lone, AG (corresponding author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada.	macinnes@uoguelph.ca	Jacques, Mario/D-4901-2015; Deslandes, Vincent/AIF-4404-2022; Nash, John HE/P-2384-2017	Deslandes, Vincent/0000-0003-2970-5496; Nash, John HE/0000-0003-2925-8710				Baltes N, 2005, INFECT IMMUN, V73, P4614, DOI 10.1128/IAI.73.8.4614-4619.2005; Baltes N, 2004, INFECT IMMUN, V72, P6711, DOI 10.1128/IAI.72.11.6711-6716.2004; Baltes N, 2004, VET MICROBIOL, V102, P67, DOI 10.1016/j.vetmic.2004.05.002; Baltes N, 2003, INFECT IMMUN, V71, P6784, DOI 10.1128/IAI.71.12.6784-6792.2003; Baltes N, 2007, VET MICROBIOL, V123, P110, DOI 10.1016/j.vetmic.2007.03.026; Bandara AB, 2003, INFECT IMMUN, V71, P3320, DOI 10.1128/IAI.71.6.3320-3328.2003; BANNAN JD, 1993, J BACTERIOL, V175, P7228, DOI 10.1128/JB.175.22.7228-7235.1993; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; BUETTNER FF, 2009, PROTEOMICS      0402; BYRD W, 1989, INFECT IMMUN, V57, P3901, DOI 10.1128/IAI.57.12.3901-3906.1989; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Chen HY, 2000, BIOCHEM BIOPH RES CO, V269, P743, DOI 10.1006/bbrc.1999.1506; Chiu HC, 2007, HELICOBACTER, V12, P74; Cho WS, 2001, J COMP PATHOL, V125, P34, DOI 10.1053/jcpa.2001.0474; CLIFTON SW, 1994, GENE, V146, P95, DOI 10.1016/0378-1119(94)90840-0; Contreras I, 1997, MICROBIOL-UK, V143, P2665, DOI 10.1099/00221287-143-8-2665; COSTA C, 1990, FEBS LETT, V276, P67, DOI 10.1016/0014-5793(90)80508-G; Cruz WT, 1996, INFECT IMMUN, V64, P83, DOI 10.1128/IAI.64.1.83-90.1996; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; DIDEBERG O, 1982, NATURE, V299, P469, DOI 10.1038/299469a0; DIESTERHAFT MD, 1973, J BIOL CHEM, V248, P6062; DiRita VJ, 2000, PHILOS T R SOC B, V355, P657, DOI 10.1098/rstb.2000.0606; Ekerhovd E, 2001, HUM REPROD, V16, P1334, DOI 10.1093/humrep/16.7.1334; Ellis G, 1998, CLIN BIOCHEM, V31, P195, DOI 10.1016/S0009-9120(98)00015-0; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Foote SJ, 2008, J BACTERIOL, V190, P1495, DOI 10.1128/JB.01845-07; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Fuller TE, 1999, MICROB PATHOGENESIS, V27, P311, DOI 10.1006/mpat.1999.0309; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P39, DOI 10.1006/mpat.2000.0364; Green J, 1997, MOL MICROBIOL, V24, P593, DOI 10.1046/j.1365-2958.1997.3801737.x; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hughes J M B, 2007, Chron Respir Dis, V4, P205, DOI 10.1177/1479972307084446; INZANA TJ, 1988, INFECT IMMUN, V56, P1880, DOI 10.1128/IAI.56.8.1880-1889.1988; INZANA TJ, 1991, MICROB PATHOGENESIS, V11, P305, DOI 10.1016/0882-4010(91)90016-4; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; JENKINS DE, 1991, J BACTERIOL, V173, P1992, DOI 10.1128/jb.173.6.1992-1996.1991; Jolly L, 2000, J BACTERIOL, V182, P1280, DOI 10.1128/JB.182.5.1280-1285.2000; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; KELLY JA, 1985, J BIOL CHEM, V260, P6449; Kendall M, 2002, AM J PHYSIOL-LUNG C, V282, pL109, DOI 10.1152/ajplung.2002.282.1.L109; Kharat AS, 2006, ACTA BIOCHIM POL, V53, P729, DOI 10.18388/abp.2006_3300; Kizil G, 2000, J MED MICROBIOL, V49, P669, DOI 10.1099/0022-1317-49-7-669; Kogure K, 1998, CURR OPIN BIOTECH, V9, P278, DOI 10.1016/S0958-1669(98)80059-1; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Labrie J, 2002, J ENDOTOXIN RES, V8, P27, DOI [10.1179/096805102125000065, 10.1177/09680519020080010301]; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Maeda T, 2008, MICROB BIOTECHNOL, V1, P30, DOI 10.1111/j.1751-7915.2007.00003.x; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; MAYES PA, 2000, HARPERS BIOCH, P190; MENGINLECREULX D, 2005, J BIOL CHEM, V272, P1243; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Oikawa T, 2006, J BIOTECHNOL, V125, P503, DOI 10.1016/j.jbiotec.2006.04.002; Osicka R, 2001, INFECT IMMUN, V69, P5509; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; Rycroft AN, 2000, VET J, V159, P18, DOI 10.1053/tvjl.1999.0403; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sato H, 2009, INT J CHEM ENG, V2009, DOI 10.1155/2009/843274; Schaller A, 1999, MICROBIOL-SGM, V145, P2105, DOI 10.1099/13500872-145-8-2105; SCHELLENBERG GD, 1984, J BIOL CHEM, V259, P6826; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnapp D, 1998, AM J RESP CELL MOL, V19, P352, DOI 10.1165/ajrcmb.19.3.3384; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; SCHUMANN P, 1998, MATURATION PHENOMENO, V3, P95; Schwab U, 2009, MICROB PATHOGENESIS, V46, P185, DOI 10.1016/j.micpath.2008.12.006; SEBUNYA TNK, 1983, J AM VET MED ASSOC, V182, P1331; Sheehan BJ, 2003, INFECT IMMUN, V71, P3960, DOI 10.1128/IAI.71.7.3960-3970.2003; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; SOLTES GA, 1994, MICROBIOL-SGM, V140, P839, DOI 10.1099/00221287-140-4-839; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; SWEET G, 1990, J BACTERIOL, V172, P424, DOI 10.1128/JB.172.1.424-430.1990; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNEMOTO T, 1993, J BIOENERG BIOMEMBR, V25, P385, DOI 10.1007/BF00762464; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; Wood GE, 1998, GENE, V209, P51, DOI 10.1016/S0378-1119(98)00031-6; WREN JD, 2009, BIOINFORMATICS  0515; Wright JR, 2006, AM J PHYSIOL-LUNG C, V291, pL847, DOI 10.1152/ajplung.00261.2006; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Yan AX, 2008, J BACTERIOL, V190, P8230, DOI 10.1128/JB.01242-08; Yu BJ, 2006, FEMS MICROBIOL LETT, V254, P245, DOI 10.1111/j.1574-6968.2005.00026.x; Zaas AK, 2005, TRENDS CARDIOVAS MED, V15, P195, DOI 10.1016/j.tcm.2005.07.001; ZEBALLOS GA, 1995, CIRCULATION, V91, P2982, DOI 10.1161/01.CIR.91.12.2982; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	105	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6139	10.1371/journal.pone.0006139	http://dx.doi.org/10.1371/journal.pone.0006139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578537	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806300009
J	Gombert, WM; Krumm, A				Gombert, Wendy M.; Krumm, Anton			Targeted Deletion of Multiple CTCF-Binding Elements in the Human C-MYC Gene Reveals a Requirement for CTCF in C-MYC Expression	PLOS ONE			English	Article								Background: Insulators and domain boundaries both shield genes from adjacent enhancers and inhibit intrusion of heterochromatin into transgenes. Previous studies examined the functional mechanism of the MYC insulator element MINE and its CTCF binding sites in the context of transgenes that were randomly inserted into the genome by transfection. However, the contribution of CTCF binding sites to both gene regulation and maintenance of chromatin has not been tested at the endogenous MYC gene. Methodology/Principal Findings: To determine the impact of CTCF binding on MYC expression, a series of mutant human chromosomal alleles was prepared in homologous recombination-efficient DT40 cells and individually transferred by microcell fusion into murine cells. Functional tests reported here reveal that deletion of CTCF binding elements within the MINE does not impact the capacity of this locus to correctly organize an 'accessible' open chromatin domain, suggesting that these sites are not essential for the formation of a competent, transcriptionally active locus. Moreover, deletion of the CTCF site at the MYC P2 promoter reduces transcription but does not affect promoter acetylation or serum-inducible transcription. Importantly, removal of either CTCF site leads to DNA methylation of flanking sequences, thereby contributing to progressive loss of transcriptional activity. Conclusions: These findings collectively demonstrate that CTCF-binding at the human MYC locus does not repress transcriptional activity but is required for protection from DNA methylation.			Gombert, WM (corresponding author), Black Lowe & Graham PLLC, Seattle, WA USA.	akrumm@u.washington.edu			NCI NIH HHS [CA109597, R01 CA109597] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ameres SL, 2005, EMBO J, V24, P358, DOI 10.1038/sj.emboj.7600531; Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Butcher DT, 2007, EUR J CANCER, V43, P210, DOI 10.1016/j.ejca.2006.09.002; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Caiafa P, 2009, J CELL PHYSIOL, V219, P265, DOI 10.1002/jcp.21691; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Dieken Ellen S., 1996, Methods (Orlando), V9, P56, DOI 10.1006/meth.1996.0008; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Farris SD, 2005, J BIOL CHEM, V280, P25298, DOI 10.1074/jbc.M501784200; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; LUGO TG, 1987, MOL CELL BIOL, V7, P2814, DOI 10.1128/MCB.7.8.2814; Marsden MD, 2003, MOL CELL BIOL, V23, P3516, DOI 10.1128/MCB.23.10.3516-3526.2003; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832; ZLATANOVA J, 2009, CELL MOL LIFE SCI; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	38	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6109	10.1371/journal.pone.0006109	http://dx.doi.org/10.1371/journal.pone.0006109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568426	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200010
J	Theys, N; Clippe, A; Bouckenooghe, T; Reusens, B; Remacle, C				Theys, Nicolas; Clippe, Andre; Bouckenooghe, Thomas; Reusens, Brigitte; Remacle, Claude			Early Low Protein Diet Aggravates Unbalance between Antioxidant Enzymes Leading to Islet Dysfunction	PLOS ONE			English	Article								Background: Islets from adult rat possess weak antioxidant defense leading to unbalance between superoxide dismutase (SOD) and hydrogen peroxide-inactivating enzymatic activities, catalase (CAT) and glutathione peroxidase (GPX) rending them susceptible to oxidative stress. We have shown that this vulnerability is influenced by maternal diet during gestation and lactation. Methodology/Principal Findings: The present study investigated if low antioxidant activity in islets is already observed at birth and if maternal protein restriction influences the development of islet antioxidant defenses. Rats were fed a control diet (C group) or a low protein diet during gestation (LP) or until weaning (LPT), after which offspring received the control diet. We found that antioxidant enzymatic activities varied with age. At birth and after weaning, normal islets possessed an efficient GPX activity. However, the antioxidant capacity decreased thereafter increasing the potential vulnerability to oxidative stress. Maternal protein malnutrition changed the antioxidant enzymatic activities in islets of the progeny. At 3 months, SOD activity was increased in LP and LPT islets with no concomitant activation of CAT and GPX. This unbalance could lead to higher hydrogen peroxide production, which may concur to oxidative stress causing defective insulin gene expression due to modification of critical factors that modulate the insulin promoter. We found indeed that insulin mRNA level was reduced in both groups of malnourished offspring compared to controls. Analyzing the expression of such critical factors, we found that c-Myc expression was strongly increased in islets from both protein-restricted groups compared to controls. Conclusion and Significance: Modification in antioxidant activity by maternal low protein diet could predispose to pancreatic islet dysfunction later in life and provide new insights to define a molecular mechanism responsible for intrauterine programming of endocrine pancreas.			Theys, N (corresponding author), Univ Catholique Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium.	claude.remacle@uclouvain.be						Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; EL KI, 2006, AM J PHYSIOL-ENDOC M, V291, pE835; Elouil H, 2005, DIABETOLOGIA, V48, P496, DOI 10.1007/s00125-004-1664-4; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Goosse K, 2009, J ENDOCRINOL, V200, P177, DOI 10.1677/JOE-08-0234; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Janssens BJ, 2000, J EXP BIOL, V203, P3717; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lortz S, 2005, DIABETOLOGIA, V48, P1541, DOI 10.1007/s00125-005-1822-3; Merezak S, 2004, DIABETOLOGIA, V47, P669, DOI 10.1007/s00125-004-1357-z; Merezak S, 2001, J ENDOCRINOL, V171, P299, DOI 10.1677/joe.0.1710299; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PALLARDO FV, 1991, BIOCHEM J, V274, P891, DOI 10.1042/bj2740891; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Remacle C, 2007, DIABETES OBES METAB, V9, P196, DOI 10.1111/j.1463-1326.2007.00790.x; Reusens B, 2008, DIABETOLOGIA, V51, P836, DOI 10.1007/s00125-008-0956-5; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Robertson RP, 2007, FEBS LETT, V581, P3743, DOI 10.1016/j.febslet.2007.03.087; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Sparre T, 2003, DIABETOLOGIA, V46, P1497, DOI 10.1007/s00125-003-1208-3; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; Tabatabaie T, 2003, DIABETES, V52, P1994, DOI 10.2337/diabetes.52.8.1994; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; TARRYADKINS JL, 2009, FASEB J; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Vento M, 2003, J PEDIATR-US, V142, P240, DOI 10.1067/mpd.2003.91; Wu L, 2004, J BIOL CHEM, V279, P12126, DOI 10.1074/jbc.M307097200; Zraika S, 2006, DIABETOLOGIA, V49, P1254, DOI 10.1007/s00125-006-0212-9	52	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6110	10.1371/journal.pone.0006110	http://dx.doi.org/10.1371/journal.pone.0006110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568427	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200011
J	Westermark, P; Lundmark, K; Westermark, GT				Westermark, Per; Lundmark, Katarzyna; Westermark, Gunilla T.			Fibrils from Designed Non-Amyloid-Related Synthetic Peptides Induce AA-Amyloidosis during Inflammation in an Animal Model	PLOS ONE			English	Article								Background: Mouse AA-amyloidosis is a transmissible disease by a prion-like mechanism where amyloid fibrils act by seeding. Synthetic peptides with no amyloid relationship can assemble into amyloid-like fibrils and these may have seeding capacity for amyloid proteins. Principal Findings: Several synthetic peptides, designed for nanotechnology, have been examined for their ability to produce fibrils with Congo red affinity and concomitant green birefringence, affinity for thioflavin S and to accelerate AA-amyloidosis in mice. It is shown that some amphiphilic fibril-forming peptides not only produced Congo red birefringence and showed affinity for thioflavin S, but they also shortened the lag phase for systemic AA-amyloidosis in mice when they were given intravenously at the time of inflammatory induction with silver nitride. Peptides, not forming amyloid-like fibrils, did not have such properties. Conclusions: These observations should caution researchers and those who work with synthetic peptides and their derivatives to be aware of the potential health concerns.			Westermark, P (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	Per.Westermark@genpat.uu.se						AXELRAD MA, 1982, LAB INVEST, V47, P139; Bergstrom J, 2006, BIOCHEM BIOPH RES CO, V348, P532, DOI 10.1016/j.bbrc.2006.07.140; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cui D, 2002, PATHOL INT, V52, P40, DOI 10.1046/j.1440-1827.2002.01309.x; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Fu XY, 2004, FEBS LETT, V563, P179, DOI 10.1016/S0014-5793(04)00295-9; GANOWIAK K, 1994, BIOCHEM BIOPH RES CO, V199, P306, DOI 10.1006/bbrc.1994.1229; Ge FX, 2007, LAB INVEST, V87, P633, DOI 10.1038/labinvest.3700559; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Hardt F, 1976, Int Rev Exp Pathol, V16, P273; HOFFMAN JS, 1984, J EXP MED, V159, P641, DOI 10.1084/jem.159.2.641; HUSBY G, 1994, AMYLOID, V1, P119, DOI 10.3109/13506129409148635; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; NGUYEN J, 1995, BIOCHEMISTRY-US, V34, P4186, DOI 10.1021/bi00013a006; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stevens FJ, 2004, AMYLOID, V11, P71, DOI 10.1080/13506120412331272296; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; WESTERMARK P, 1974, HISTOCHEMISTRY, V38, P27, DOI 10.1007/BF00490217; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y	35	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6041	10.1371/journal.pone.0006041	http://dx.doi.org/10.1371/journal.pone.0006041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19582162	Green Published, gold, Green Submitted			2022-12-25	WOS:000267515700002
J	Wong, R; Piper, MDW; Wertheim, B; Partridge, L				Wong, Richard; Piper, Matthew D. W.; Wertheim, Bregje; Partridge, Linda			Quantification of Food Intake in Drosophila	PLOS ONE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; FEEDING-BEHAVIOR; RECEPTOR GENE; POPULATIONS; RESISTANCE; DEMOGRAPHY; TREHALOSE; INSIGHTS; DEATH	Measurement of food intake in the fruit fly Drosophila melanogaster is often necessary for studies of behaviour, nutrition and drug administration. There is no reliable and agreed method for measuring food intake of flies in undisturbed, steady state, and normal culture conditions. We report such a method, based on measurement of feeding frequency by proboscis-extension, validated by short-term measurements of food dye intake. We used the method to demonstrate that (a) female flies feed more frequently than males, (b) flies feed more often when housed in larger groups and (c) fly feeding varies at different times of the day. We also show that alterations in food intake are not induced by dietary restriction or by a null mutation of the fly insulin receptor substrate chico. In contrast, mutation of takeout increases food intake by increasing feeding frequency while mutation of ovo(D) increases food intake by increasing the volume of food consumed per proboscis-extension. This approach provides a practical and reliable method for quantification of food intake in Drosophila under normal, undisturbed culture conditions.			Wong, R (corresponding author), UCL, Inst Healthy Ageing, London, England.	l.partridge@ucl.ac.uk	Wong, Richard/H-5189-2015; Partridge, Linda/A-5501-2010; Piper, Matthew/C-1714-2008; Wertheim, Bregje/B-6436-2009; Partridge, Linda/E-7342-2015	Wong, Richard/0000-0002-4382-1568; Piper, Matthew/0000-0003-3245-7219; Wertheim, Bregje/0000-0001-8555-1925; Partridge, Linda/0000-0001-9615-0094	Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline; Natural Environment Research Council [NE/C508085/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Crawley M.J, 2005, STAT INTRO; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JOHNSON MB, 1985, J MORPHOL, V184, P51, DOI 10.1002/jmor.1051840106; Kennington WJ, 2001, HEREDITY, V87, P363, DOI 10.1046/j.1365-2540.2001.00925.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KIMURA M T, 1977, Kontyu, V45, P571; KING RC, 1955, J EXP ZOOL, V130, P71, DOI 10.1002/jez.1401300105; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lints F.A., 1988, DROSOPHILA MODEL ORG; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Oishi K, 2004, NEUROREPORT, V15, P739, DOI 10.1097/00001756-200403220-00034; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Weindruch R., 1988, RETARDATION AGING DI; Wertheim B, 2006, ECOL ENTOMOL, V31, P216, DOI 10.1111/j.1365-2311.2006.00757.x; Wong R, 2008, NAT METHODS, V5, P214, DOI 10.1038/nmeth0308-214; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	41	148	151	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6063	10.1371/journal.pone.0006063	http://dx.doi.org/10.1371/journal.pone.0006063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557170	gold, Green Published, Green Submitted			2022-12-25	WOS:000267424600011
J	Ross, TM; Mahmood, K; Crevar, CJ; Schneider-Ohrum, K; Heaton, PM; Bright, RA				Ross, Ted M.; Mahmood, Kutub; Crevar, Corey J.; Schneider-Ohrum, Kirsten; Heaton, Penny M.; Bright, Rick A.			A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets	PLOS ONE			English	Article								There is need for improved human influenza vaccines, particularly for older adults who are at greatest risk for severe disease, as well as to address the continuous antigenic drift within circulating human subtypes of influenza virus. We have engineered an influenza virus-like particle (VLP) as a new generation vaccine candidate purified from the supernatants of Sf9 insect cells following infection by recombinant baculoviruses to express three influenza virus proteins, hemagglutinin (HA), neuraminidase (NA), and matrix 1 (M1). In this study, a seasonal trivalent VLP vaccine (TVV) formulation, composed of influenza A H1N1 and H3N2 and influenza B VLPs, was evaluated in mice and ferrets for the ability to elicit antigen-specific immune responses. Animals vaccinated with the TVV formulation had hemagglutination-inhibition (HAI) antibody titers against all three homologous influenza virus strains, as well as HAI antibodies against a panel of heterologous influenza viruses. HAI titers elicited by the TVV were statistically similar to HAI titers elicited in animals vaccinated with the corresponding monovalent VLP. Mice vaccinated with the TVV had higher level of influenza specific CD8+ T cell responses than a commercial trivalent inactivated vaccine (TIV). Ferrets vaccinated with the highest dose of the VLP vaccine and then challenged with the homologous H3N2 virus had the lowest titers of replicating virus in nasal washes and showed no signs of disease. Overall, a trivalent VLP vaccine elicits a broad array of immunity and can protect against influenza virus challenge.			Ross, TM (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	tmr15@pitt.edu						Askonas BA, 1982, BASIC APPLIED INFLUE, P159; Bower JF, 2005, CURR HIV RES, V3, P191, DOI 10.2174/1570162053506937; Bower JF, 2004, VIROLOGY, V328, P292, DOI 10.1016/j.virol.2004.07.031; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen WS, 2002, J VIROL, V76, P10332, DOI 10.1128/JVI.76.20.10332-10337.2002; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; KOVACSOVICSBANKOWSKI M, 1994, EUR J IMMUNOL, V24, P2421; LIN YL, 1981, J EXP MED, V154, P225, DOI 10.1084/jem.154.2.225; LUBECK MD, 1979, VIROLOGY, V95, P269, DOI 10.1016/0042-6822(79)90430-6; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; McBurney SP, 2007, VIROLOGY, V358, P334, DOI 10.1016/j.virol.2006.08.032; MCMICHAEL AJ, 1986, J GEN VIROL, V67, P719, DOI 10.1099/0022-1317-67-4-719; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MONTO AS, 1973, LANCET, V1, P623, DOI 10.1016/S0140-6736(73)92196-X; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Palese P., 2007, FIELDS VIROLOGY; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1977, J VIROL, V24, P170, DOI 10.1128/JVI.24.1.170-176.1977; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; SCHULMAN JL, 1969, B WORLD HEALTH ORGAN, V41, P425; Szucs TD, 2001, INFECT CONT HOSP EP, V22, P472, DOI 10.1086/503405; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; TOWNSEND ARM, 1982, NATURE, V300, P655, DOI 10.1038/300655a0; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2001, WORLD HLTH REP 2001, P49; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Young KR, 2006, AIDS RES HUM RETROV, V22, P99, DOI 10.1089/aid.2006.22.99	37	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6032	10.1371/journal.pone.0006032	http://dx.doi.org/10.1371/journal.pone.0006032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19554101	Green Published, gold, Green Accepted			2022-12-25	WOS:000267356500016
J	Tamehiro, N; Mujawar, Z; Zhou, SP; Zhuang, DZ; Hornemann, T; von Eckardstein, A; Fitzgerald, ML				Tamehiro, Norimasa; Mujawar, Zahedi; Zhou, Suiping; Zhuang, Debbie Z.; Hornemann, Thorsten; von Eckardstein, Arnold; Fitzgerald, Michael L.			Cell Polarity Factor Par3 Binds SPTLC1 and Modulates Monocyte Serine Palmitoyltransferase Activity and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; APOE-DEFICIENT MICE; E-KNOCKOUT MICE; CHOLESTEROL EFFLUX; SPHINGOLIPID METABOLISM; SPHINGOMYELIN SYNTHESIS; PERMEABILITY BARRIER; PLASMA SPHINGOMYELIN; INHIBITOR MYRIOCIN; ATHEROSCLEROSIS	Elevated sphingolipids have been associated with increased cardiovascular disease. Conversely, atherosclerosis is reduced in mice by blocking de novo synthesis of sphingolipids catalyzed by serine palmitoyltransferase (SPT). The SPT enzyme is composed of the SPTLC1 and -2 subunits, and here we describe a novel protein-protein interaction between SPTLC1 and the PDZ protein Par3 (partitioning defective protein 3). Mammalian SPTLC1 orthologs have a highly conserved C terminus that conforms to a type II PDZ protein interaction motif, and by screening PDZ domain protein arrays with an SPTLC1 C-terminal peptide, we found it bound the third PDZ domain of Par3. Overlay and immuno-precipitation assays confirmed this interaction and indicate Par3 is able to associate with the SPTLC1/2 holoenzyme by binding the C-terminal SPTLC1 PDZ motif. The physiologic existence of the SPTLC1/2-Par3 complex was detected in mouse liver and macrophages, and short interfering RNA inhibition of Par3 in human THP-1 monocytes significantly reduced SPT activity and de novo ceramide synthesis by nearly 40%. Given monocyte recruitment into inflamed vessels is thought to promote atherosclerosis, and because Par3 and sphingolipids have been associated with polarized cell migration, we tested whether the ability of THP-1 monocytes to migrate toward MCP- 1 (monocyte chemoattractant protein 1) depended upon Par3 and SPTLC1 expression. Knockdown of Par3 significantly reduced MCP1-induced chemotaxis of THP-1 monocytes, as did knockdown of SPTLC1, and this Par3 effect depended upon SPT activity and was blunted by ceramide treatment. In conclusion, protein arrays were used to identify a novel SPTLC1-Par3 interaction that associates with increased monocyte serine palmitoyltransferase activity and chemotaxis toward inflammatory signals.	[Fitzgerald, Michael L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit,Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Hornemann, Thorsten; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Zurich; University Zurich Hospital	Fitzgerald, ML (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit,Ctr Computat & Integrat Biol, 185 Cambridge St, Boston, MA 02114 USA.	mfitzgerald@ccib.mgh.harvard.edu			NHLBI [HL074136]; American Heart Association [09GRNT2260352]; Uehara Memorial Foundation; Nagai Foundation of Tokyo; Japan Heart Foundation; American Heart Association; Massachusetts Biomedical Research Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); Nagai Foundation of Tokyo; Japan Heart Foundation; American Heart Association(American Heart Association); Massachusetts Biomedical Research Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by National Institutes of Health Grant HL074136 from NHLBI (to M.L.F.). This work was also supported by an American Heart Association Grant-in-Aid 09GRNT2260352 to M.L.F.) and by fellowship training grants from the Uehara Memorial Foundation, the Nagai Foundation of Tokyo, and the Japan Heart Foundation (to N.T.), the American Heart Association (to Z.M.), and the Massachusetts Biomedical Research Corporation (to S.Z.).	Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Glaros EN, 2008, J LIPID RES, V49, P1677, DOI 10.1194/jlr.E800005-JLR200; Glaros EN, 2007, BIOCHEM PHARMACOL, V73, P1340, DOI 10.1016/j.bcp.2006.12.023; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jeong TS, 1998, J CLIN INVEST, V101, P905, DOI 10.1172/JCI870; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Krishnamurthy K, 2007, J BIOL CHEM, V282, P3379, DOI 10.1074/jbc.M607779200; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Stevenson NJ, 2004, J IMMUNOL, V173, P3243, DOI 10.4049/jimmunol.173.5.3243; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wei J, 2009, BBA-MOL CELL BIOL L, V1791, P746, DOI 10.1016/j.bbalip.2009.03.016; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	45	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24881	24890		10.1074/jbc.M109.014365	http://dx.doi.org/10.1074/jbc.M109.014365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592499	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000269734000022
J	Taylor, AI; Beavil, RL; Sutton, BJ; Calvert, RA				Taylor, Alexander I.; Beavil, Rebecca L.; Sutton, Brian J.; Calvert, Rosaleen A.			A Monomeric Chicken IgY Receptor Binds IgY with 2:1 Stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-ALPHA-RI; CRYSTAL-STRUCTURES; IMMUNE-RESPONSES; COMPLEX; FRAGMENT; LIGAND; CELLS; GLYCOSYLATION; ANTIBODY; DISTINCT	IgY is the principal serum antibody in birds and reptiles, and an IgY-like molecule was the evolutionary precursor of both mammalian IgG and IgE. A receptor for IgY on chicken monocytes, chicken leukocyte receptor AB1 (CHIR-AB1), lies in the avian leukocyte receptor cluster rather than the classical Fc receptor cluster where the genes for mammalian IgE and IgG receptors are found. IgG and IgE receptors bind to the lower hinge region of their respective antibodies with 1:1 stoichiometry, whereas the myeloid receptor for IgA, Fc alpha RI, and the IgG homeostasis receptor, FcRn, which are found in the mammalian leukocyte receptor cluster, bind with 2:1 stoichiometry between the heavy chain constant domains 2 and 3 of each heavy chain. In this paper, the extracellular domain of CHIRAB1 was expressed in a soluble form and shown to be a monomer that binds to IgY-Fc with 2:1 stoichiometry. The two binding sites have similar affinities:K-a1 = 7.22 +/- 0.22 x 10(5) M-1 and K-a2 = 3.63 +/- 1.03 x 10(6) M-1 (comparable with the values reported for IgA binding to its receptor). The affinity constants for IgY and IgY-Fc binding to immobilized CHIR-AB1 are 9.07 +/- 0.07 x 10(7) and 6.11 +/- 0.02 x 10(8) M-1, respectively, in agreement with values obtained for IgY binding to chicken monocyte cells and comparable with reported values for human IgA binding to neutrophils. Although the binding site for CHIRAB1 on IgY is not known, the data reported here with a monomeric receptor binding to IgY at two sites with low affinity suggest an IgA-like interaction.	[Taylor, Alexander I.; Beavil, Rebecca L.; Sutton, Brian J.; Calvert, Rosaleen A.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London	Calvert, RA (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	rosy.calvert@kcl.ac.uk		Taylor, Alexander/0000-0001-7684-1437	Wellcome Trust VIP; Biotechnology and Biological Sciences Research Council (UK); BBSRC [BB/D011418/1] Funding Source: UKRI; MRC [G0501494] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011418/1] Funding Source: researchfish; Medical Research Council [G0400503B, G0501494] Funding Source: researchfish	Wellcome Trust VIP(Wellcome Trust); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Wellcome Trust VIP award and by the Biotechnology and Biological Sciences Research Council (UK).	Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Bakema JE, 2008, J IMMUNOL, V181, P4080, DOI 10.4049/jimmunol.181.6.4080; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Davison TF, 2003, BRIT POULTRY SCI, V44, P6, DOI 10.1080/0007166031000085364; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; FAITH RE, 1973, IMMUNOLOGY, V25, P151; Fayngerts SA, 2007, IMMUNOGENETICS, V59, P493, DOI 10.1007/s00251-007-0208-8; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laun K, 2006, PLOS GENET, V2, P707, DOI 10.1371/journal.pgen.0020073; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; McDonnell JM, 2001, NAT STRUCT BIOL, V8, P437, DOI 10.1038/87603; Miah SMS, 2008, J IMMUNOL, V180, P2922; Nice EC, 1999, BIOESSAYS, V21, P339, DOI 10.1002/(SICI)1521-1878(199904)21:4<339::AID-BIES11>3.0.CO;2-C; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; RAYCHAUDHURI G, 1985, MOL IMMUNOL, V22, P1009, DOI 10.1016/0161-5890(85)90104-X; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Taylor AI, 2008, J BIOL CHEM, V283, P16384, DOI 10.1074/jbc.M801321200; Taylor AI, 2009, BIOCHEMISTRY-US, V48, P558, DOI 10.1021/bi8019993; Taylor AI, 2007, IMMUNOGENETICS, V59, P323, DOI 10.1007/s00251-007-0195-9; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Viertboeck BC, 2009, J IMMUNOL, V182, P1533, DOI 10.4049/jimmunol.182.3.1533; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193	36	13	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24168	24175		10.1074/jbc.M109.020263	http://dx.doi.org/10.1074/jbc.M109.020263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592496	Green Published, hybrid			2022-12-25	WOS:000269380200030
J	Areste, C; Mutocheluh, M; Blackbourn, DJ				Areste, Cristina; Mutocheluh, Mohamed; Blackbourn, David J.			Identification of Caspase-mediated Decay of Interferon Regulatory Factor-3, Exploited by a Kaposi Sarcoma-associated Herpesvirus Immunoregulatory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INNATE ANTIVIRAL RESPONSE; KAPPA-B KINASE; VIRUS-INFECTION; IMMUNE MODULATION; BETA ENHANCEOSOME; IRF-3 ACTIVATION; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION	Upon virus infection, the cell mounts an innate type I interferon (IFN) response to limit the spread. This response is orchestrated by the constitutively expressed IFN regulatory factor (IRF)-3 protein, which becomes post-translationally activated. Although the activation events are understood in detail, the negative regulation of this innate response is less well understood. Many viruses, including Kaposi sarcoma-associated herpesvirus (KSHV), have evolved defense strategies against this IFN response. Thus, KSHV encodes a viral IRF (vIRF)-2 protein, sharing homology with cellular IRFs and is a known inhibitor of the innate IFN response. Here, we show that vIRF-2 mediates IRF-3 inactivation by a mechanism involving caspase-3, although vIRF-2 itself is not pro-apoptotic. Importantly, we also show that caspase-3 participates in normal IRF-3 turnover in the absence of vIRF-2, during the antiviral response induced by poly(I:C) transfection. These data provide unprecedented insight into negative regulation of IRF-3 following activation of the type I IFN antiviral response and the mechanism by which KSHV vIRF-2 inhibits this innate response.	[Areste, Cristina; Mutocheluh, Mohamed; Blackbourn, David J.] Univ Birmingham, Canc Res UK Canc Ctr, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England	Cancer Research UK; University of Birmingham	Blackbourn, DJ (corresponding author), Univ Birmingham, Canc Res UK Canc Ctr, Sch Canc Sci, Coll Med & Dent Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	d.j.blackbourn@bham.ac.uk		Blackbourn, David/0000-0002-6703-4497; Mutocheluh, Mohamed/0000-0002-1396-5085	Medical Research Council [G0400408]; Cancer Research UK [C7934]; MRC [G0400408] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (Grant G0400408) and Cancer Research UK (Grant C7934) (to D. J. B.). Author's Choice -Final version full access.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Burysek L, 1999, J HUMAN VIROL, V2, P19; Burysek L, 2001, J VIROL, V75, P2345, DOI 10.1128/JVI.75.5.2345-2352.2001; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Cunningham C, 2003, J GEN VIROL, V84, P1471, DOI 10.1099/vir.0.19015-0; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Kirchhoff S, 2002, J IMMUNOL, V168, P1226, DOI 10.4049/jimmunol.168.3.1226; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rezaee SAR, 2006, J GEN VIROL, V87, P1781, DOI 10.1099/vir.0.81919-0; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Saira K, 2007, J VIROL, V81, P3077, DOI 10.1128/JVI.02064-06; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; Wu WF, 2006, J BIOL CHEM, V281, P10682, DOI 10.1074/jbc.M511759200; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	53	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23272	23285		10.1074/jbc.M109.033290	http://dx.doi.org/10.1074/jbc.M109.033290			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553679	Green Published, hybrid			2022-12-25	WOS:000269180000012
J	Deng, Y; Guo, Y; Watson, H; Au, WC; Shakoury-Elizeh, M; Basrai, MA; Bonifacino, JS; Philpott, CC				Deng, Yi; Guo, Yan; Watson, Hadiya; Au, Wei-Chun; Shakoury-Elizeh, Minoo; Basrai, Munira A.; Bonifacino, Juan S.; Philpott, Caroline C.			Gga2 Mediates Sequential Ubiquitin-independent and Ubiquitin-dependent Steps in the Trafficking of ARN1 from the trans-Golgi Network to the Vacuole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEINS; EPSIN-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; FERRICHROME TRANSPORTER; MULTIVESICULAR BODY; STRUCTURAL BASIS; SORTING-SIGNAL; ENTH DOMAIN; YEAST; RECOGNITION	In Saccharomyces cerevisiae, ARN1 encodes a transporter for the uptake of ferrichrome, an important nutritional source of iron. In the absence of ferrichrome, Arn1p is sorted directly from the trans-Golgi network (TGN) to the vacuolar lumen via the vacuolar protein-sorting pathway. Arn1p is mis-sorted to the plasma membrane in cells lacking Gga2p, a monomeric clathrin-adaptor protein involved in vesicular transport from the TGN. Although Ggas have been characterized as ubiquitin receptors, we show here that ubiquitin binding by Gga2 was not required for the TGN-to-endosome trafficking of Arn1, but it was required for subsequent sorting of Arn1 into the multivesicular body. In a ubiquitin-binding mutant of Gga2, Arn1p accumulated on the vacuolar membrane in a ubiquitinated form. The yeast epsins Ent3p and Ent4p were also involved in TGN-to-vacuole sorting of Arn1p. Amino-terminal sequences of Arn1p were required for vacuolar protein sorting, as mutation of ubiquitinatable lysine residues resulted in accumulation on the vacuolar membrane, and mutation of either a THN or YGL sequence resulted in mis-sorting to the plasma membrane. These studies suggest that Gga2 is involved in sorting at both the TGN and multivesicular and that the first step can occur without ubiquitin binding.	[Deng, Yi; Guo, Yan; Shakoury-Elizeh, Minoo; Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Watson, Hadiya; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Au, Wei-Chun; Basrai, Munira A.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Philpott, CC (corresponding author), Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Basrai, Munira/AAV-4422-2020	Deng, Yi/0000-0003-1378-015X; Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health Intramural Research Programs of the NIDDK; Eunice Kennedy Shriver NICHD; NCI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010822, ZIABC010822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054512, Z01DK054512] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Programs of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Programs of the NIDDK (to Y.D., Y.G., M.S.-E., and C.C.P.), the Eunice Kennedy Shriver NICHD (to H.W.and J.S.B.), and the NCI (to W.-C.A.and M.B.).	Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2002, MOL BIOL CELL, V13, P3078, DOI 10.1091/mbc.E02-02-0078; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Costaguta G, 2006, MOL BIOL CELL, V17, P3907, DOI 10.1091/mbc.E06-05-0410; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Eugster A, 2004, MOL BIOL CELL, V15, P3031, DOI 10.1091/mbc.e03-11-0793; Froissard M, 2007, TRAFFIC, V8, P1601, DOI 10.1111/j.1600-0854.2007.00627.x; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Heymann P, 2000, BIOMETALS, V13, P65, DOI 10.1023/A:1009250017785; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; KAISER CA, 2002, GUIDE YEAST GENETICS; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mattera R, 2004, J BIOL CHEM, V279, P31409, DOI 10.1074/jbc.M402183200; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Moore RE, 2003, P NATL ACAD SCI USA, V100, P5664, DOI 10.1073/pnas.1030323100; Mullins C, 2001, MOL CELL BIOL, V21, P7981, DOI 10.1128/MCB.21.23.7981-7994.2001; Pelham HRB, 2004, CURR BIOL, V14, pR357, DOI 10.1016/j.cub.2004.04.027; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; SHERMAN F, 1991, P3; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200	54	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23830	23841		10.1074/jbc.M109.030015	http://dx.doi.org/10.1074/jbc.M109.030015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574226	Green Published, hybrid			2022-12-25	WOS:000269180000066
J	Dong, XC; Yang, B; Li, YJ; Zhong, C; Ding, JP				Dong, Xianchi; Yang, Bei; Li, Yingjie; Zhong, Chen; Ding, Jianping			Molecular Basis of the Acceleration of the GDP-GTP Exchange of Human Ras Homolog Enriched in Brain by Human Translationally Controlled Tumor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; BINDING PARTNER; DIRECT TARGET; RHEB GTPASE; MTOR; TCTP; RAPTOR; COMPLEX	Ras homolog enriched in brain (Rheb), a small GTPase, positively regulates the mTORC1 pathway. The GDP-GTP exchange of Rheb has been suggested to be facilitated by translationally controlled tumor protein (TCTP). Here we demonstrate that human TCTP (hTCTP) interacts with human Rheb (hRheb) and accelerates its GDP release in vitro and that hTCTP activates the mTORC1 pathway in vivo. To investigate the underlying mechanism, we built structure models of GDP-and GTP-bound hRheb in complexes with hTCTP and performed molecular dynamics simulations of the models, which predict key residues involved in the interactions and region of hRheb undergoing conformational change during the GDP-GTP exchange. These results are verified with site-directed mutagenesis and in vitro biochemical and in vivo cell biological analyses. Furthermore, a crystal structure of the E12V mutant hTCTP, which lacks the guanine nucleotide exchange factor activity, shows that the deficiency appears to be caused by loss of a salt-bridging interaction with Lys-45 of hRheb. These data collectively provide insights into the molecular mechanisms of how hTCTP interacts with hRheb and activates the mTORC1 pathway.	[Dong, Xianchi; Yang, Bei; Li, Yingjie; Zhong, Chen; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Dong, Xianchi; Yang, Bei; Li, Yingjie; Zhong, Chen; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Struct Biol, Shanghai 200031, Peoples R China; [Dong, Xianchi; Yang, Bei; Li, Yingjie] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Zhong, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	czhong@sibs.ac.cn; jpding@sibs.ac.cn	Dong, Xianchi/C-1393-2015; Yang, Bei/AAD-9831-2021	Dong, Xianchi/0000-0001-5121-1236; Yang, Bei/0000-0001-5389-3859; ding, jian ping/0000-0001-7029-7346	Ministry of Science and Technology of China [2006CB806501, 2006AA02Z112, 2006AA02A313, 2007CB914302]; National Natural Science Foundation of China [30770480, 30730028, 90713046]; Chinese Academy of Sciences [KSCX2-YW-R-107, SIBS2007KIP202, SIBS2008002]; Science and Technology Commission of Shanghai Municipality [07XD14032, 08QA14076]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Ministry of Science and Technology of China (Grants 2006CB806501, 2006AA02Z112, 2006AA02A313, and 2007CB914302), the National Natural Science Foundation of China (Grants 30770480, 30730028, and 90713046), the Chinese Academy of Sciences (Grants KSCX2-YW-R-107, SIBS2007KIP202, and SIBS2008002), and the Science and Technology Commission of Shanghai Municipality (Grants 07XD14032 and 08QA14076).	Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; MAKRIDES S, 1988, NUCLEIC ACIDS RES, V16, P2349, DOI 10.1093/nar/16.5.2349; MONTAGNE J, 2001, SCI STKE, pPE36; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Szilagyi A, 2005, PHYS BIOL, V2, pS1, DOI 10.1088/1478-3975/2/2/S01; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	45	48	54	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23754	23764		10.1074/jbc.M109.012823	http://dx.doi.org/10.1074/jbc.M109.012823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570981	Green Published, hybrid			2022-12-25	WOS:000269180000060
J	Li, JX; Qian, XG; Hu, JB; Sha, BD				Li, Jingzhi; Qian, Xinguo; Hu, Junbin; Sha, Bingdong			Molecular Chaperone Hsp70/Hsp90 Prepares the Mitochondrial Outer Membrane Translocon Receptor Tom71 for Preprotein Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR; PROTEIN IMPORT; CRYSTAL-STRUCTURE; TPR DOMAIN; IDENTIFICATION; RECOGNITION; CHIP	The preproteins targeted to the mitochondria are transported through the translocase of the outer membrane complex. Tom70/Tom71 is a major surface receptor of the translocase of the outer membrane complex for mitochondrial preproteins. The preproteins are escorted to Tom70/Tom71 by molecular chaperones Hsp70 and Hsp90. Here we present the high resolution crystal structures of Tom71 and the protein complexes between Tom71 and the Hsp70/Hsp90 C terminus. The crystal structures indicate that Tom70/Tom71 may exhibit two distinct states. In the closed state, the N-terminal domain of Tom70/Tom71 partially blocks the preprotein-binding pocket. In the open state, the N-terminal domain moves away, and the preprotein-binding pocket is fully exposed. The complex formation between the C-terminal EEVD motif of Hsp70/Hsp90 and Tom71 could lock Tom71 in the open state where the preprotein-binding pocket of Tom71 is ready to receive preproteins. The interactions between Hsp70/Hsp90 and Tom71 N-terminal domain generate conformational changes that may increase the volume of the preprotein-binding pocket. The complex formation of Hsp70/Hsp90 and Tom71 also generates significant domain rearrangement within Tom71, which may position the preprotein-binding pocket closer to Hsp70/Hsp90 to facilitate the preprotein transfer from the molecular chaperone to Tom71. Therefore, molecular chaperone Hsp70/Hsp90 may function to prepare the mitochondrial outer membrane receptor Tom71 for preprotein loading.	[Li, Jingzhi; Qian, Xinguo; Hu, Junbin; Sha, Bingdong] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sha, BD (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, MCLM 364,1918 Univ Blvd, Birmingham, AL 35294 USA.	bdsha@uab.edu			National Institutes of Health [R01 DK56203, R01 GM65959]; Army Research Office [51894LS]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080261, R01GM065959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK56203 and R01 GM65959. This work was also supported by Army Research Office Grant 51894LS.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beddoe T, 2004, J BIOL CHEM, V279, P46448, DOI 10.1074/jbc.M405639200; Beddoe T, 2002, BBA-MOL CELL RES, V1592, P35, DOI 10.1016/S0167-4889(02)00262-8; Bomer U, 1996, FEBS LETT, V382, P153, DOI 10.1016/0014-5793(96)00156-1; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koh JY, 2001, MOL CELL BIOL, V21, P7576, DOI 10.1128/MCB.21.22.7576-7586.2001; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	31	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23852	23859		10.1074/jbc.M109.023986	http://dx.doi.org/10.1074/jbc.M109.023986			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581297	hybrid, Green Published			2022-12-25	WOS:000269180000068
J	Torrado, M; Revuelta, J; Gonzalez, C; Corzana, F; Bastida, A; Asensio, JL				Torrado, Mario; Revuelta, Julia; Gonzalez, Carlos; Corzana, Francisco; Bastida, Agatha; Luis Asensio, Juan			Role of Conserved Salt Bridges in Homeodomain Stability and DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK PROTEIN; RESIDUES; RESOURCE; THERMOSTABILITY; STABILIZATION; SPECTROSCOPY; RECOGNITION; SPECIFICITY; MUTATIONS; DYNAMICS	The sequence information available for homeodomains reveals that salt bridges connecting pairs 19/30, 31/42, and 17/52 are frequent, whereas aliphatic residues at these sites are rare and mainly restricted to proteins from homeotherms. We have analyzed the influence of salt and hydrophobic bridges at these sites on the stability and DNA binding properties of human Hesx-1 homeodomain. Regarding the protein stability, our analysis shows that hydrophobic side chains are clearly preferred at positions 19/30 and 31/42. This stabilizing influence results from the more favorable packing of the aliphatic side chains with the protein core, as illustrated by the three-dimensional solution structure of a thermostable variant, herein reported. In contrast only polar side chains seem to be tolerated at positions 17/52. Interestingly, despite the significant influence of pairs 19/30 and 31/42 on the stability of the homeodomain, their effect on DNA binding ranges from modest to negligible. The observed lack of correlation between binding strength and conformational stability in the analyzed variants suggests that salt/hydrophobic bridges at these specific positions might have been employed by evolution to independently modulate both properties.	[Torrado, Mario; Revuelta, Julia; Bastida, Agatha; Luis Asensio, Juan] CSIC, Inst Quim Organ Gen, Dept Quim Organ Biol, E-28006 Madrid, Spain; [Gonzalez, Carlos] CSIC, Inst Quim Fis Rocasolano, Grp RMN, E-28006 Madrid, Spain; [Corzana, Francisco] Univ La Rioja, Dept Quim, Unidad Asociada, CSIC, E-26006 Logrono, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de La Rioja	Asensio, JL (corresponding author), CSIC, Inst Quim Organ Gen, Dept Quim Organ Biol, Juan Cierva 3, E-28006 Madrid, Spain.	iqoa110@iqog.csic.es	Bastida, Agatha/K-1607-2014; Gonzalez, Carlos/A-4734-2013; Asensio, Juan L./J-1996-2015; Corzana, Francisco/B-1310-2015	Bastida, Agatha/0000-0002-5141-9595; Gonzalez, Carlos/0000-0001-8796-1282; Asensio, Juan L./0000-0001-7536-5221; Revuelta, Julia/0000-0001-6225-7336; Corzana, Francisco/0000-0001-5597-8127	Spanish "Plan Nacional" (Ministerio de Ciencia y Technologia) [CTQ2007-67403/BQU, CTQ2004-04994/BQU]	Spanish "Plan Nacional" (Ministerio de Ciencia y Technologia)	This work was supported by Spanish "Plan Nacional" (Ministerio de Ciencia y Technologia) Research Grants CTQ2007-67403/BQU and CTQ2004-04994/BQU.	Banerjee-Basu S, 2003, NUCLEIC ACIDS RES, V31, P304, DOI 10.1093/nar/gkg118; Banerjee-Basu S, 2000, NUCLEIC ACIDS RES, V28, P329, DOI 10.1093/nar/28.1.329; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P291, DOI 10.1093/nar/29.1.291; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Billeter M, 1996, PROG BIOPHYS MOL BIO, V66, P211, DOI 10.1016/S0079-6107(97)00006-0; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; CLARKE ND, 1995, PROTEIN SCI, V4, P2269, DOI 10.1002/pro.5560041104; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dahiyat BI, 1997, P NATL ACAD SCI USA, V94, P10172, DOI 10.1073/pnas.94.19.10172; de la Mata I, 2002, CHEMBIOCHEM, V3, P726, DOI 10.1002/1439-7633(20020802)3:8<726::AID-CBIC726>3.0.CO;2-C; Fodor E, 2005, BIOCHEMISTRY-US, V44, P12480, DOI 10.1021/bi050835s; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Gonzalez M, 2001, BIOCHEMISTRY-US, V40, P4923, DOI 10.1021/bi0022341; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LIM WA, 1991, J MOL BIOL, V219, P359, DOI 10.1016/0022-2836(91)90570-V; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marti DN, 2000, BIOCHEMISTRY-US, V39, P12804, DOI 10.1021/bi001242e; Marti DN, 2003, J MOL BIOL, V330, P621, DOI 10.1016/S0022-2836(03)00623-5; Martin A, 2002, J MOL BIOL, V318, P1341, DOI 10.1016/S0022-2836(02)00243-7; Max KEA, 2007, J MOL BIOL, V369, P1087, DOI 10.1016/j.jmb.2007.04.016; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Rios MAD, 2005, BIOCHEMISTRY-US, V44, P1243, DOI 10.1021/bi0484441; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHEEK RM, 1989, METHOD ENZYMOL, V177, P204; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stollar EJ, 2003, J BIOL CHEM, V278, P43699, DOI 10.1074/jbc.M308029200; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wunderlich M, 2005, J MOL BIOL, V347, P1063, DOI 10.1016/j.jmb.2005.02.014; WYMAN J, 1948, ADV PROTEIN CHEM, V4, P407, DOI 10.1016/S0065-3233(08)60011-X; Yang QS, 1996, PROG BIOCHEM BIOPHYS, V23, P29	39	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23765	23779		10.1074/jbc.M109.012054	http://dx.doi.org/10.1074/jbc.M109.012054			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561080	Green Published, hybrid			2022-12-25	WOS:000269180000061
J	Enoki, S; Watanabe, R; Iino, R; Noji, H				Enoki, Sawako; Watanabe, Rikiya; Iino, Ryota; Noji, Hiroyuki			Single-molecule Study on the Temperature-sensitive Reaction of F-1-ATPase with a Hybrid F-1 Carrying a Single beta(E190D)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; ATP SYNTHASE; BETA-SUBUNIT; CATALYTIC SUBUNITS; ROTATION; MECHANISM; MOTOR; RESOLUTION	F-1-ATPase is a rotary molecular motor in which the gamma-subunit rotates against the alpha(3)beta(3) cylinder. The unitary gamma-rotation is a 120 degrees step comprising 80 and 40 degrees substeps, each of these initiated by ATP binding and ADP release and by ATP hydrolysis and inorganic phosphate release, respectively. In our previous study on gamma-rotation at low temperatures, a highly temperature-sensitive (TS) reaction step of F-1-ATPase from thermophilic Bacillus PS3 was found below 9 degrees C as an intervening pause before the 80 substep at the same angle for ATP binding and ADP release. However, it remains unclear as to which reaction step the TS reaction corresponds. In this study, we found that the mutant F-1(beta E190D) from thermophilic Bacillus PS3 showed a clear pause of the TS reaction below 18 degrees C. In an attempt to identify the catalytic state of the TS reaction, the rotation of the hybrid F-1, carrying a single copy of beta E190D, was observed at 18 degrees C. The hybrid F-1 showed a pause of the TS reaction at the same angle as for the ATP binding of the incorporated beta E190D, although kinetic analysis revealed that the TS reaction is not the ATP binding step. These findings suggest that the TS reaction is a structural rearrangement of beta before or after ATP binding.	[Enoki, Sawako; Watanabe, Rikiya; Iino, Ryota; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Osaka University	Noji, H (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	hnoji@sanken.osaka-u.ac.jp	Watanabe, Rikiya/AAO-1390-2021; Iino, Ryota/B-7746-2011	Watanabe, Rikiya/0000-0001-7146-2745; Iino, Ryota/0000-0003-0110-5704				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTSUBO M, 1987, BIOCHEM BIOPH RES CO, V146, P705, DOI 10.1016/0006-291X(87)90586-9; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; PARK MY, 1994, J BIOCHEM-TOKYO, V116, P1139, DOI 10.1093/oxfordjournals.jbchem.a124640; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	24	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23169	23176		10.1074/jbc.M109.026401	http://dx.doi.org/10.1074/jbc.M109.026401			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561076	Green Published, hybrid			2022-12-25	WOS:000268963100068
J	Hornemann, S; von Schroetter, C; Damberger, FF; Wuthrich, K				Hornemann, Simone; von Schroetter, Christine; Damberger, Fred F.; Wuethrich, Kurt			Prion Protein-Detergent Micelle Interactions Studied by NMR in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; LIPID-MEMBRANES; TRANSMEMBRANE FORM; ENDOPLASMIC-RETICULUM; CHEMICAL-SHIFTS; DISEASE; PEPTIDE; DOMAIN; CONVERSION; TOPOLOGY	Cellular prion proteins, PrPC, carrying the amino acid substitutions P102L, P105L, or A117V, which confer increased susceptibility to human transmissible spongiform encephalopathies, are known to form structures that include transmembrane polypeptide segments. Herein, we investigated the interactions between dodecylphosphocholine micelles and the polypeptide fragments 90-231 of the recombinant mouse PrP variants carrying the amino acid replacements P102L, P105L, A117V, A113V/A115V/A118V, K110I/H111I, M129V, P105L/M129V, and A117V/M129V. Wild-type mPrP-(90-231) and mPrP [M129V]-(91-231) showed only weak interactions with dodecylphosphocholine micelles in aqueous solution at pH 7.0, whereas discrete interaction sites within the polypeptide segment 102-127 were identified for all other aforementioned mPrP variants by NMR chemical shift mapping. These model studies thus provide evidence that amino acid substitutions within the polypeptide segment 102-127 affect the interactions of PrPC with membranous structures, which might in turn modulate the physiological function of the protein in health and disease.	[Hornemann, Simone; von Schroetter, Christine; Damberger, Fred F.; Wuethrich, Kurt] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hornemann, S (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	simone.hornemann@usz.ch	Damberger, Fred F/A-8938-2011	Damberger, Fred F/0000-0002-8457-3409; Wuthrich, Kurt/0000-0001-8739-6965	Swiss National Science Foundation; ETH Zurich through the National Center of Competence in Research "Structural Biology,"; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich through the National Center of Competence in Research "Structural Biology,"(Swiss National Science Foundation (SNSF)); European Union(European Commission)	This project was supported by the Swiss National Science Foundation and the ETH Zurich through the National Center of Competence in Research "Structural Biology," and by a grant from the European Union.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Beswick V, 1996, BIOCHEMISTRY-US, V35, P14717, DOI 10.1021/bi961710d; Boettcher JM, 2007, BIOMOL NMR ASSIGM, V1, P167, DOI 10.1007/s12104-007-9063-7; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; DeMarco ML, 2009, J NEUROCHEM, V109, P60, DOI 10.1111/j.1471-4159.2009.05892.x; Dupiereux I, 2005, BIOCHEM BIOPH RES CO, V331, P894, DOI 10.1016/j.bbrc.2005.04.012; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Harris B, 2003, CLIO MED, V71, P85; Harrison CF, 2007, J NEUROCHEM, V103, P1709, DOI 10.1111/j.1471-4159.2007.04936.x; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HILLER S, 2006, THESIS ETH ZURICH, P98; Hiller S, 2008, ANGEW CHEM INT EDIT, V47, P977, DOI 10.1002/anie.200703367; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Keller R., 2004, COMPUTER AIDED RESON, V1; KITAMOTO T, 1994, J PHILOS T R SOC L B, V343, P391; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Malmendal A, 2005, BIOCHEMISTRY-US, V44, P6502, DOI 10.1021/bi050088z; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Ott CM, 2007, J BIOL CHEM, V282, P11163, DOI 10.1074/jbc.M607660200; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Pillot T, 1997, J MOL BIOL, V274, P381, DOI 10.1006/jmbi.1997.1382; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Ruan KH, 2002, BIOCHEM J, V368, P721, DOI 10.1042/BJ20021001; Rymer DL, 2000, J NEUROCHEM, V75, P2536, DOI 10.1046/j.1471-4159.2000.0752536.x; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; So SP, 2000, J BIOL CHEM, V275, P40679, DOI 10.1074/jbc.M005752200; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stewart RS, 2001, J BIOL CHEM, V276, P2212, DOI 10.1074/jbc.M006763200; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	59	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22713	22721		10.1074/jbc.M109.000430	http://dx.doi.org/10.1074/jbc.M109.000430			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546219	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000268963100026
J	Putcha, BDK; Fernandez, EJ				Putcha, Balananda-Dhurjati K.; Fernandez, Elias J.			Direct Interdomain Interactions Can Mediate Allosterism in the Thyroid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; ESTROGEN RESPONSE ELEMENTS; NUCLEAR HORMONE-RECEPTORS; LIGAND-BINDING DOMAIN; ANDROGEN RECEPTOR; DNA-BINDING; COREGULATOR INTERACTIONS; STRUCTURAL DETERMINANTS; COACTIVATOR RECRUITMENT; ALPHA	The thyroid (TR) and retinoid X receptors (RXR) belong to the nuclear receptor (NR) superfamily of ligand-mediated transcription factors. At the molecular level, TR activity is specifically modulated by interactions with the ligand 3,3',5 triiodo-L-thyronine (T3), RXR, DNA, and co-activators such as SRC1, occurring in concert or sequentially. Although binding sites for DNA and coregulators such as SRC1 are distinct and at distal regions of these receptors, cell-based and EMSA studies have suggested that these molecules can regulate binding of each other to the receptor. We present evidence of direct, DNA-dependent, communication between the DNA and ligand binding domains (DBD and LBD) that can allosterically regulate interactions with SRC1 and DNA, respectively, using isothermal titration calorimetry (ITC) and cell-based assays. Additionally, we note that interdomain communication is affected by RXR in RXR:TR. We also noticed a DNA-dependent cross-talk between RXR and TR within RXR:TR. Finally, we suggest that differences in transactivation on different TRE may be the consequence of different affinities between TRE and RXR:TR.	[Putcha, Balananda-Dhurjati K.; Fernandez, Elias J.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Fernandez, EJ (corresponding author), M407, Knoxville, TN 37996 USA.	elias.fernandez@utk.edu	Fernandez, Elias/AAX-8405-2021	Fernandez, Elias/0000-0003-4374-0669	National Institutes of Health [DK066394]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK066394 (to E.J.F.).	Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Claret FX, 1996, MOL CELL BIOL, V16, P219; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Diallo EM, 2005, PROTEIN EXPRES PURIF, V40, P292, DOI 10.1016/j.pep.2005.01.007; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gonzalez MI, 2001, J BIOL CHEM, V276, P6420, DOI 10.1074/jbc.M008689200; Greenspan NS, 1999, NAT BIOTECHNOL, V17, P936, DOI 10.1038/13590; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Herdick M, 2000, MOL PHARMACOL, V57, P1206; Ikeda M, 1996, J BIOL CHEM, V271, P23096, DOI 10.1074/jbc.271.38.23096; Kahlen JP, 1997, NUCLEIC ACIDS RES, V25, P4307, DOI 10.1093/nar/25.21.4307; Kersten S, 1997, J BIOL CHEM, V272, P12771, DOI 10.1074/jbc.272.19.12771; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LEHMANN JM, 1993, MOL CELL BIOL, V13, P7698, DOI 10.1128/MCB.13.12.7698; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; Makowski A, 2003, MOL ENDOCRINOL, V17, P273, DOI 10.1210/me.2002-0310; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Meijsing SH, 2007, MOL CELL BIOL, V27, P2442, DOI 10.1128/MCB.01570-06; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mengeling BJ, 2008, MOL CELL ENDOCRINOL, V280, P47, DOI 10.1016/j.mce.2007.09.011; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Moore JMR, 2005, MOL CELL PROTEOMICS, V4, P475, DOI 10.1074/mcp.R500001-MCP200; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Mouchon A, 1999, MOL CELL BIOL, V19, P3073; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wright E, 2007, BIOCHEMISTRY-US, V46, P862, DOI 10.1021/bi061627i; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	40	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22517	22524		10.1074/jbc.M109.026682	http://dx.doi.org/10.1074/jbc.M109.026682			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561066	Green Published, hybrid			2022-12-25	WOS:000268963100004
J	Yuan, K; Li, N; Jiang, K; Zhu, TG; Huo, YD; Wang, C; Lu, J; Shaw, A; Thomas, K; Zhang, JC; Mann, D; Liao, J; Jin, CJ; Yao, XB				Yuan, Kai; Li, Na; Jiang, Kai; Zhu, Tongge; Huo, Yuda; Wang, Chong; Lu, Jing; Shaw, Andrew; Thomas, Kelwyn; Zhang, Jiancun; Mann, David; Liao, Jian; Jin, Changjiang; Yao, Xuebiao			PinX1 Is a Novel Microtubule-binding Protein Essential for Accurate Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; MITOTIC CHECKPOINT; CENP-E; SPINDLE MICROTUBULES; NDC80 COMPLEX; IMPORTIN-BETA; KINETOCHORE; ATTACHMENT; LOCALIZATION; CENTROMERE	Mitosis is an orchestration of dynamic interactions between spindle microtubules and chromosomes, which is mediated by protein structures that include the kinetochores, and other protein complexes present on chromosomes. PinX1 is a potent telomerase inhibitor in interphase; however, its function in mitosis is not well documented. Here we show that PinX1 is essential for faithful chromosome segregation. Deconvolution microscopic analyses show that PinX1 localizes to nucleoli and telomeres in interphase and relocates to the periphery of chromosomes and the outer plate of the kinetochores in mitosis. Our deletion analyses mapped the kinetochore localization domain of PinX1 to the central region and its chromosome periphery localization domain to the C terminus. Interestingly, the kinetochore localization of PinX1 is dependent on Hec1 and CENP-E. Our biochemical characterization revealed that PinX1 is a novel microtubule-binding protein. Our real time imaging analyses show that suppression of PinX1 by small interference RNA abrogates faithful chromosome segregation and results in anaphase chromatid bridges in mitosis and micronuclei in interphase, suggesting an essential role of PinX1 in chromosome stability. Taken together, the results indicate that PinX1 plays an important role in faithful chromosome segregation in mitosis.	[Yuan, Kai; Li, Na; Jiang, Kai; Zhu, Tongge; Huo, Yuda; Wang, Chong; Lu, Jing; Zhang, Jiancun; Liao, Jian; Jin, Changjiang; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Yuan, Kai; Li, Na; Jiang, Kai; Zhu, Tongge; Huo, Yuda; Wang, Chong; Lu, Jing; Zhang, Jiancun; Liao, Jian; Jin, Changjiang; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Yuan, Kai; Jiang, Kai; Shaw, Andrew; Mann, David] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Thomas, Kelwyn] Morehouse Sch Med, Dept Biochem, Atlanta, GA 30310 USA; [Zhang, Jiancun] Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China	Morehouse School of Medicine; Morehouse School of Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Jin, CJ (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	jincj@ustc.edu.cn; yaoxb@ustc.edu.cn	Yuan, Kai/A-1294-2009; Yao, Xuebiao/P-5771-2014; Yuan, Kai/ABH-2688-2020	Yuan, Kai/0000-0001-7002-5703; 	National Institutes of Health [DK-56292, CA89019, CA92080, CA118948]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H10]; Chinese 973 [2002CB713700, 2010CB912103, 2007CB914503, 2006CB943600]; Chinese 863 [2006AA02A247]; Chinese Natural Science Foundation [30270654, 30070349, 90508002, 30121001]; China National Key Projects for Infectious Disease [2008ZX10002021]; American Cancer Society [RPG-99-173-01]; Georgia Cancer Coalition Breast Cancer; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE [P50CA089019, U56CA092080, U54CA118948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973(National Basic Research Program of China); Chinese 863(National High Technology Research and Development Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National Key Projects for Infectious Disease; American Cancer Society(American Cancer Society); Georgia Cancer Coalition Breast Cancer; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, CA89019, CA92080, and CA118948. This work was also supported by Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H10, Chinese 973 Projects 2002CB713700, 2010CB912103, 2007CB914503, and 2006CB943600, Chinese 863 Project 2006AA02A247, Chinese Natural Science Foundation Grants 30270654, 30070349, 90508002, and 30121001, China National Key Projects for Infectious Disease Grant 2008ZX10002021, American Cancer Society Grant RPG-99-173-01, a Georgia Cancer Coalition Breast Cancer research grant, and an Atlanta Clinical and Translational Science Award Chemical Biology grant (to X. Y.).	Banik SSR, 2004, J BIOL CHEM, V279, P51745, DOI 10.1074/jbc.M408131200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Lin J, 2007, BIOCHEM BIOPH RES CO, V353, P946, DOI 10.1016/j.bbrc.2006.12.123; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Oh BK, 2007, GENE, V400, P35, DOI 10.1016/j.gene.2007.05.015; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Tahara K, 2008, J CELL BIOL, V180, P493, DOI 10.1083/jcb.200708003; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wright K, 1998, ONCOGENE, V17, P1185, DOI 10.1038/sj.onc.1202028; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	40	37	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23072	23082		10.1074/jbc.M109.001990	http://dx.doi.org/10.1074/jbc.M109.001990			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553660	Green Published, hybrid			2022-12-25	WOS:000268963100059
J	Davis, JH; Baker, TA; Sauer, RT				Davis, Joseph H.; Baker, Tania A.; Sauer, Robert T.			Engineering Synthetic Adaptors and Substrates for Controlled ClpXP Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEASE; SPECIFICITY-ENHANCING FACTOR; ATP-DEPENDENT PROTEASES; ZINC-BINDING DOMAIN; DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; RECOGNITION SIGNALS; STRUCTURAL BASIS; SSPB ADAPTER	Facile control of targeted intracellular protein degradation has many potential uses in basic science and biotechnology. One promising approach to this goal is to redesign adaptor proteins, which can regulate proteolytic specificity by tethering substrates to energy-dependent AAA + proteases. Using the ClpXP protease, we have probed the minimal biochemical functions required for adaptor function by designing and characterizing variant substrates, adaptors, and ClpX enzymes. We find that substrate tethering mediated by heterologous interaction domains and a small bridging molecule mimics substrate delivery by the wild-type system. These results show that simple tethering is sufficient for synthetic adaptor function. In our engineered system, tethering and proteolysis depend on the presence of the macrolide rapamycin, providing a foundation for engineering highly specific degradation of target proteins in cells. Importantly, this degradation is regulated by a small molecule without the need for new adaptor or enzyme biosynthesis.	[Davis, Joseph H.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Davis, Joseph H./0000-0002-8858-8907; Sauer, Robert/0000-0002-1719-5399	National Institutes of Health [AI-16892, GM-48224]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224, R01GM048224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-16892 and GM-48224.	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FLEMING MP, 1972, BMJ-BRIT MED J, V1, P726, DOI 10.1136/bmj.1.5802.726; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Krahn JM, 2007, BIOCHEMISTRY-US, V46, P14878, DOI 10.1021/bi701532r; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2005, NAT STRUCT MOL BIOL, V12, P520, DOI 10.1038/nsmb934; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McGinness KE, 2007, J BIOL CHEM, V282, P11465, DOI 10.1074/jbc.M610671200; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; PATTISHALL KH, 1977, J BIOL CHEM, V252, P2319; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; SMITH SL, 1979, J BIOL CHEM, V254, P6222; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; STONE D, 1979, J BIOL CHEM, V254, P857; Thibault G, 2006, EMBO J, V25, P3367, DOI 10.1038/sj.emboj.7601223; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200	46	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21848	21855		10.1074/jbc.M109.017624	http://dx.doi.org/10.1074/jbc.M109.017624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549779	Green Published, hybrid			2022-12-25	WOS:000268783700008
J	Umeda, M; Murata-Kamiya, N; Saito, Y; Ohba, Y; Takahashi, M; Hatakeyama, M				Umeda, Mayumi; Murata-Kamiya, Naoko; Saito, Yasuhiro; Ohba, Yusuke; Takahashi, Masayuki; Hatakeyama, Masanori			Helicobacter pylori CagA Causes Mitotic Impairment and Induces Chromosomal Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; C-ELEGANS EMBRYOS; MAMMALIAN-CELLS; TYROSINE PHOSPHORYLATION; INCREASED RISK; PROTEIN; SPINDLE; KINASES; CANCER; ADENOCARCINOMA	Infection with cagA-positive Helicobacter pylori is the strongest risk factor for the development of gastric carcinoma. The cagA gene product CagA, which is delivered into gastric epithelial cells, specifically binds to and aberrantly activates SHP-2 oncoprotein. CagA also interacts with and inhibits partitioning-defective 1 (PAR1)/MARK kinase, which phosphorylates microtubule-associated proteins to destabilize microtubules and thereby causes epithelial polarity defects. In light of the notion that microtubules are not only required for polarity regulation but also essential for the formation of mitotic spindles, we hypothesized that CagA-mediated PAR1 inhibition also influences mitosis. Here, we investigated the effect of CagA on the progression of mitosis. In the presence of CagA, cells displayed a delay in the transition from prophase to metaphase. Furthermore, a fraction of the CagA-expressing cells showed spindle misorientation at the onset of anaphase, followed by chromosomal segregation with abnormal division axis. The effect of CagA on mitosis was abolished by elevated PAR1 expression. Conversely, inhibition of PAR1 kinase elicited mitotic delay similar to that induced by CagA. Thus, CagA-mediated inhibition of PAR1, which perturbs microtubule stability and thereby causes microtubule-based spindle dysfunction, is involved in the prophase/metaphase delay and subsequent spindle misorientation. Consequently, chronic exposure of cells to CagA induces chromosomal instability. Our findings reveal a bifunctional role of CagA as an oncoprotein: CagA elicits uncontrolled cell proliferation by aberrantly activating SHP-2 and at the same time induces chromosomal instability by perturbing the microtubule-based mitotic spindle. The dual function of CagA may cooperatively	[Hatakeyama, Masanori] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Umeda, Mayumi; Murata-Kamiya, Naoko; Takahashi, Masayuki; Hatakeyama, Masanori] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600815, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido 0600815, Japan; [Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo 1130033, Japan	Hokkaido University; Hokkaido University; Hokkaido University; University of Tokyo	Hatakeyama, M (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp	Ohba, Yusuke/E-7944-2011; Takahashi, Masayuki/D-8079-2012	Takahashi, Masayuki/0000-0002-5923-2813	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; BLASER MJ, 1995, CANCER RES, V55, P2111; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; MARSHALL BJ, 1984, LANCET, V1, P1311; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; PREUSS U, 1995, MOL BIOL CELL, V6, P1397, DOI 10.1091/mbc.6.10.1397; Rudi J, 1997, DIGEST DIS SCI, V42, P1652, DOI 10.1023/A:1018849112533; Rugge M, 1999, CANCER-AM CANCER SOC, V85, P2506, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2506::AID-CNCR3>3.3.CO;2-9; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shimoyama T, 1998, J CLIN PATHOL, V51, P225, DOI 10.1136/jcp.51.3.225; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Torres J, 1998, INT J CANCER, V78, P298, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;298::AID-IJC6&gt;3.0.CO;2-Q; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; VANDRE DD, 1991, J CELL SCI, V98, P577; Varmark H, 2004, J CELL BIOCHEM, V91, P904, DOI 10.1002/jcb.20013; Watts JL, 1996, DEVELOPMENT, V122, P3133; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Yamazaki S, 2003, J INFECT DIS, V187, P334, DOI 10.1086/367807	48	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22166	22172		10.1074/jbc.M109.035766	http://dx.doi.org/10.1074/jbc.M109.035766			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546211	Green Published, hybrid			2022-12-25	WOS:000268783700041
J	Ruedi, EA; Hughes, KA				Ruedi, Elizabeth A.; Hughes, Kimberly A.			Age, but Not Experience, Affects Courtship Gene Expression in Male Drosophila melanogaster	PLOS ONE			English	Article								Mutation screens in model organisms have helped identify the foundation of many fundamental organismal phenotypes. An emerging question in evolutionary and behavioral biology is the extent to which these "developmental'' genes contribute to the subtle individual variation that characterizes natural populations. A related question is whether individual differences arise from static differences in gene expression that arose during previous life stages, or whether they are due to dynamic regulation of expression during the life stage under investigation. Here, we address these questions using genes that have been discovered to control the development of normal courtship behavior in male Drosophila melanogaster. We examined whether these genes have static or dynamic expression in the heads of adult male flies of different ages and with different levels of social experience. We found that 16 genes of the 25 genes examined were statically expressed, and 9 genes were dynamically expressed with changes related to adult age. No genes exhibited rapid dynamic expression changes due to social experience or age*experience interaction. We therefore conclude that a majority of fly "courtship'' genes are statically expressed, while a minority are regulated in adults with respect to age, but not with respect to relevant social experience. These results are consistent with those from a recent microarray analysis that found none of the canonical courtship genes changed expression in male flies after brief exposure to females.			Ruedi, EA (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	earuedi@ncsu.edu	Ruedi, Elizabeth/L-4955-2013	Ruedi, Elizabeth/0000-0003-3025-1567				Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; Bogue CW, 2003, J APPL PHYSIOL, V94, P2502, DOI 10.1152/japplphysiol.00209.2003; CARNEY GE, 2007, BMC GENOMICS, V8; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; DEBELLE JS, 1987, BEHAV GENET, V17, P620; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Diagana TT, 2002, J NEUROSCI, V22, P428, DOI 10.1523/JNEUROSCI.22-02-00428.2002; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Drapeau MD, 2003, BIOCHEM BIOPH RES CO, V311, P1, DOI 10.1016/j.bbrc.2003.09.106; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Eisen JS, 1996, CELL, V87, P969, DOI 10.1016/S0092-8674(00)81792-4; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Everitt B.S., 2005, R S PLUS COMPANION M; Fitzpatrick MJ, 2004, AM NAT, V163, P800, DOI 10.1086/386297; Gaines P, 2000, GENETICS, V154, P1627; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grosjean Y, 2004, BEHAV PROCESS, V65, P7, DOI 10.1016/S0376-6357(03)00148-7; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Hafen E., 1997, NATURE, V389, P559; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Johnson D., 1998, APPL MULTIVARIATE ME; Kaun KR, 2008, J EXP BIOL, V211, P3160, DOI 10.1242/jeb.010124; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Leloup JC, 2000, BIOESSAYS, V22, P84; Liu WC, 2005, P NATL ACAD SCI USA, V102, P10724, DOI 10.1073/pnas.0504677102; Markow TA, 1996, EVOL BIOL, V29, P73; MCROBERT SP, 1988, EVOLUTION, V42, P1093, DOI 10.1111/j.1558-5646.1988.tb02528.x; MELLO CV, 1994, J NEUROSCI, V14, P6652; MEYER D, 2002, BENCHMARKING SUPPORT, P78; Moehring AJ, 2004, GENETICS, V167, P1249, DOI 10.1534/genetics.103.024372; Orgad S, 2000, GENETICS, V155, P1267; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Promislow DEL, 2000, J EVOLUTION BIOL, V13, P955, DOI 10.1046/j.1420-9101.2000.00240.x; Rosato E, 1997, BIOESSAYS, V19, P1075, DOI 10.1002/bies.950191206; Ruedi EA, 2008, BEHAV GENET, V38, P424, DOI 10.1007/s10519-008-9204-5; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schug MD, 1998, MOL ECOL, V7, P57, DOI 10.1046/j.1365-294x.1998.00304.x; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sinclair BJ, 2007, PHYSIOL ENTOMOL, V32, P322, DOI 10.1111/j.1365-3032.2007.00585.x; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stern DL, 2000, NATURE, V408, P529, DOI 10.1038/35046183; Strambi C, 1999, INT REV CYTOL, V190, P137, DOI 10.1016/S0074-7696(08)62147-6; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tarone AM, 2005, GENET RES, V86, P31, DOI 10.1017/S0016672305007706; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; Toivonen JM, 2001, GENETICS, V159, P241; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Villella A, 2005, P NATL ACAD SCI USA, V102, P16550, DOI 10.1073/pnas.0507056102; White SA, 2002, J EXP BIOL, V205, P2567; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X	63	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6150	10.1371/journal.pone.0006150	http://dx.doi.org/10.1371/journal.pone.0006150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582156	gold, Green Submitted, Green Published			2022-12-25	WOS:000267806400006
J	Mailer, RKW; Falk, K; Rotzschke, O				Mailer, Reiner K. W.; Falk, Kirsten; Rotzschke, Olaf			Absence of Leucine Zipper in the Natural FOXP3 Delta 2 Delta 7 Isoform Does Not Affect Dimerization but Abrogates Suppressive Capacity	PLOS ONE			English	Article								Background: Phenotype and function of regulatory T cells (Treg) largely depend on the presence of the transcription factor FOXP3. In contrast to mice, human Treg cells express isoforms of this protein. Besides the full length version (FOXP3fl), an isoform lacking the exon 2 (FOXP3 Delta 2) is co-expressed in comparable amounts. Recently, a third splice variant has been described that in addition to exon 2 also misses exon 7 (FOXP3 Delta 2 Delta 7). Exon 7 encodes for a leucine zipper motif commonly used as structural dimerization element. Mutations in exon 7 have been linked to IPEX, a severe autoimmune disease suggested to be caused by impaired dimerization of the FOXP3 protein. Principal Findings: This study shows that the lack of exon 7 does not affect (homo-) dimerization. Moreover, the interaction of FOXP3 Delta 2 Delta 7 to RUNX1, NFAT and NF-kB appeared to be unchanged in co-immunoprecipitation experiments and reporter gene assays, when compared to FOXP3fl and FOXP3 Delta 2. Nevertheless, retroviral transduction with FOXP3 Delta 2 Delta 7 failed to induce the typical Treg-associated phenotype. The expression of FOXP3-induced surface molecules such as CD25 and CTLA-4 were not enhanced in FOXP3 Delta 2 Delta 7 transduced CD4+ T cells, which also failed to exhibit any suppressive capacity. Notably, however, co-expression of FOXP3fl with FOXP3 Delta 2 Delta 7 resulted in a reduction of CD25 expression by a dominant negative effect. Conclusions: The leucine zipper of FOXP3 does not mediate dimerization or interaction with NFAT, NF-kB and RUNX1, but is indispensable for the characteristic phenotype and function in Treg cells. FOXP3 Delta 2 Delta 7 could play a role in regulating the function of the other FOXP3 isoforms and may be involved in cancer pathogenesis, as it is overexpressed by certain malignant cells.			Mailer, RKW (corresponding author), Max Delbruck Ctr Mol Med, MDC, Berlin, Germany.	falk@mdc-berlin.de; olaf_rotzschke@immunol.a-star.edu.sg	Mailer, Reiner/AAC-1991-2022; Roetzschke, Olaf/GXH-0012-2022	Mailer, Reiner/0000-0001-8279-3355				Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Krejsgaard T, 2008, LEUKEMIA, V22, P2230, DOI 10.1038/leu.2008.224; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lebel R, 2007, BIOCHEMISTRY-US, V46, P10279, DOI 10.1021/bi700076m; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	34	31	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6104	10.1371/journal.pone.0006104	http://dx.doi.org/10.1371/journal.pone.0006104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568423	Green Published, gold, Green Accepted			2022-12-25	WOS:000267572200007
J	Smith, MR; Burgess, HJ; Fogg, LF; Eastman, CI				Smith, Mark R.; Burgess, Helen J.; Fogg, Louis F.; Eastman, Charmane I.			Racial Differences in the Human Endogenous Circadian Period	PLOS ONE			English	Article								The length of the endogenous period of the human circadian clock (tau) is slightly greater than 24 hours. There are individual differences in tau, which influence the phase angle of entrainment to the light/dark (LD) cycle, and in doing so contribute to morningness-eveningness. We have recently reported that tau measured in subjects living on an ultradian LD cycle averaged 24.2 hours, and is similar to tau measured using different experimental methods. Here we report racial differences in tau. Subjects lived on an ultradian LD cycle (1.5 hours sleep, 2.5 hours wake) for 3 days. Circadian phase assessments were conducted before and after the ultradian days to determine the change in circadian phase, which was attributed to tau. African American subjects had a significantly shorter tau than subjects of other races. We also tested for racial differences in our previous circadian phase advancing and phase delaying studies. In the phase advancing study, subjects underwent 4 days of a gradually advancing sleep schedule combined with a bright light pulse upon awakening each morning. In the phase delaying study, subjects underwent 4 days of a gradually delaying sleep schedule combined with evening light pulses before bedtime. African American subjects had larger phase advances and smaller phase delays, relative to Caucasian subjects. The racial differences in tau and circadian phase shifting have important implications for understanding normal phase differences between individuals, for developing solutions to the problems of jet lag and shift work, and for the diagnosis and treatment of circadian rhythm based sleep disorders such as advanced and delayed sleep phase disorder.			Smith, MR (corresponding author), Rush Univ, Med Ctr, Dept Behav Sci, Biol Rhythms Res Lab, Chicago, IL 60612 USA.	ceastman@rush.edu		Eastman, Charmane/0000-0002-4057-1233	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR007677] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL086934] Funding Source: Medline; NINR NIH HHS [R01 NR007677] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; Aschoff J., 1965, CIRCADIAN CLOCKS, P262; Burgess HJ, 2008, J BIOL RHYTHM, V23, P374, DOI 10.1177/0748730408318592; Burgess HJ, 2008, J PHYSIOL-LONDON, V586, P639, DOI 10.1113/jphysiol.2007.143180; CAMPBELL SS, 1993, SLEEP, V16, P638; Carskadon MA, 1999, NEUROSCI LETT, V260, P129, DOI 10.1016/S0304-3940(98)00971-9; Crosby B, 2005, PEDIATRICS, V115, P225, DOI 10.1542/peds.2004-0815D; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Durrence H Heith, 2006, Behav Sleep Med, V4, P29, DOI 10.1207/s15402010bsm0401_3; Hall MH, 2009, SLEEP, V32, P73; Hiddinga AE, 1997, J SLEEP RES, V6, P156, DOI 10.1046/j.1365-2869.1997.00047.x; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kendall AR, 2001, J BIOL RHYTHM, V16, P87, DOI 10.1177/074873040101600110; Lee C, 2006, CHRONOBIOL INT, V23, P859, DOI 10.1080/07420520600827160; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Profant J, 2002, AM J HUM BIOL, V14, P321, DOI 10.1002/ajhb.10032; Rao U, 1999, J PSYCHIATR RES, V33, P419, DOI 10.1016/S0022-3956(99)00019-9; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; SACK RL, 1992, J CLIN ENDOCR METAB, V75, P127, DOI 10.1210/jc.75.1.127; Smith MR, 2009, SLEEP MED, V10, P287, DOI 10.1016/j.sleep.2008.05.005; Smith MR, 2009, CHRONOBIOL INT, V26, P709, DOI 10.1080/07420520902927742; Stepnowsky CJ, 2003, SLEEP, V26, P329, DOI 10.1093/sleep/26.3.329; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; WEITZMAN ED, 1982, NEUROBIOL AGING, V3, P299, DOI 10.1016/0197-4580(82)90018-5; Wever R.A., 1979, CIRCADIAN SYSTEM MAN; WEVER RA, 1984, EXPERIENTIA, V40, P1226, DOI 10.1007/BF01946652; White T. M., 2003, CHRONOBIOL INT, V20, P1193; WIRZJUSTICE A, 1984, NATURWISSENSCHAFTEN, V71, P316, DOI 10.1007/BF00396615; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265	35	69	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6014	10.1371/journal.pone.0006014	http://dx.doi.org/10.1371/journal.pone.0006014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564915	Green Submitted, gold, Green Published			2022-12-25	WOS:000267515700001
J	Arsham, AM; Neufeld, TP				Arsham, Andrew M.; Neufeld, Thomas P.			A Genetic Screen in Drosophila Reveals Novel Cytoprotective Functions of the Autophagy- Lysosome Pathway	PLOS ONE			English	Article								The highly conserved autophagy-lysosome pathway is the primary mechanism for breakdown and recycling of macromolecular and organellar cargo in the eukaryotic cell. Autophagy has recently been implicated in protection against cancer, neurodegeneration, and infection, and interest is increasing in additional roles of autophagy in human health, disease, and aging. To search for novel cytoprotective features of this pathway, we carried out a genetic mosaic screen for mutations causing increased lysosomal and/or autophagic activity in the Drosophila melanogaster larval fat body. By combining Drosophila genetics with live-cell imaging of the fluorescent dye LysoTracker Red and fixed-cell imaging of autophagy-specific fluorescent protein markers, the screen was designed to identify essential metazoan genes whose disruption causes increased flux through the autophagy-lysosome pathway. The screen identified a large number of genes associated with the protein synthesis and ER-secretory pathways (e. g. aminoacyl tRNA synthetases, Oligosaccharyl transferase, Sec61 alpha), and with mitochondrial function and dynamics (e. g. Rieske iron-sulfur protein, Dynamin-related protein 1). We also observed that increased lysosomal and autophagic activity were consistently associated with decreased cell size. Our work demonstrates that disruption of the synthesis, transport, folding, or glycosylation of ER-targeted proteins at any of multiple steps leads to autophagy induction. In addition to illuminating cytoprotective features of autophagy in response to cellular damage, this screen establishes a genetic methodology for investigating cell biological phenotypes in live cells, in the context of viable wild type organisms.			Arsham, AM (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	neufe003@umn.edu		Arsham, Andrew/0000-0002-5274-8710; Neufeld, Thomas/0000-0001-5659-4811	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062509, GM62509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Call GB, 2007, GENETICS, V177, P689, DOI 10.1534/genetics.107.077735; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; *FLYBASE, FLYBASE GEN REP DMEL; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kanuka H, 2005, BBA-GEN SUBJECTS, V1726, P225, DOI 10.1016/j.bbagen.2005.06.020; Kanuka H, 2003, P NATL ACAD SCI USA, V100, P11723, DOI 10.1073/pnas.1934748100; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh SW, 2003, GENETICS, V163, P195; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; RODRIGUEZHERNAN.A, 2009, AUTOPHAGY, V5; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; WINSLOW AR, 2008, BIOCH BIOPHYS ACTA; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200	45	61	62	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6068	10.1371/journal.pone.0006068	http://dx.doi.org/10.1371/journal.pone.0006068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562034	Green Published, gold, Green Submitted			2022-12-25	WOS:000267465900004
J	Lightcap, CM; Kari, G; Arias-Romero, LE; Chernoff, J; Rodeck, U; Williams, JC				Lightcap, Christine M.; Kari, Gabor; Arias-Romero, Luis E.; Chernoff, Jonathan; Rodeck, Ulrich; Williams, John C.			Interaction with LC8 Is Required for Pak1 Nuclear Import and Is Indispensable for Zebrafish Development	PLOS ONE			English	Article								Pak1 (p21 activated kinase 1) is a serine/threonine kinase implicated in regulation of cell motility and survival and in malignant transformation of mammary epithelial cells. In addition, the dynein light chain, LC8, has been described to cooperate with Pak1 in malignant transformation of breast cancer cells. Pak1 itself may aid breast cancer development by phosphorylating nuclear proteins, including estrogen receptor alpha. Recently, we showed that the LC8 binding site on Pak1 is adjacent to the nuclear localization sequence (NLS) required for Pak1 nuclear import. Here, we demonstrate that the LC8-Pak1 interaction is necessary for epidermal growth factor (EGF)-induced nuclear import of Pak1 in MCF-7 cells, and that this event is contingent upon LC8-mediated Pak1 dimerization. In contrast, Pak2, which lacks an LC8 binding site but contains a nuclear localization sequence identical to that in Pak1, remains cytoplasmic upon EGF stimulation of MCF-7 cells. Furthermore, we show that severe developmental defects in zebrafish embryos caused by morpholino injections targeting Pak are partially rescued by co-injection of wild-type human Pak1, but not by co-injection of mutant Pak1 mRNA disrupting either the LC8 binding or the NLS site. Collectively, these results suggest that LC8 facilitates nuclear import of Pak1 and that this function is indispensable during vertebrate development.			Lightcap, CM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jwilliams@coh.org	Arias-Romero, Luis/A-5035-2010; Chernoff, Jonathan/I-7631-2014	Arias-Romero, Luis/0000-0002-1212-4049; Chernoff, Jonathan/0000-0002-4803-7836; Arias-Romero, Luis E./0000-0001-5676-2483	NCI NIH HHS [R01 CA117884, R01 CA81008, R01 CA081008] Funding Source: Medline; NCRR NIH HHS [S10-RR022316, S10 RR022316] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081008, R01CA117884] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022316] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Akinmade D, 2008, BRIT J CANCER, V98, P1132, DOI 10.1038/sj.bjc.6604261; ALLEN JD, 2009, BLOOD; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Davidson W, 2008, CELL CYCLE, V7, P1224, DOI 10.4161/cc.7.9.5786; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Tharakan R, 2008, MOL CELL ENDOCRINOL, V295, P70, DOI 10.1016/j.mce.2008.07.018; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104	27	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6025	10.1371/journal.pone.0006025	http://dx.doi.org/10.1371/journal.pone.0006025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557173	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600002
J	Mckay, BR; De Lisio, M; Johnston, APW; O'Reilly, CE; Phillips, SM; Tarnopolsky, MA; Parise, G				Mckay, Bryon R.; De Lisio, Michael; Johnston, Adam P. W.; O'Reilly, Ciara E.; Phillips, Stuart M.; Tarnopolsky, Mark A.; Parise, Gianni			Association of Interleukin-6 Signalling with the Muscle Stem Cell Response Following Muscle-Lengthening Contractions in Humans	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; EXERCISE-INDUCED INCREASE; SATELLITE CELLS; MESSENGER-RNA; RECEPTOR EXPRESSION; CYCLE PROGRESSION; GENE-EXPRESSION; UP-REGULATION; IL-6 GENE; IN-VITRO	Background: The regulation of muscle stem cells in humans in response to muscle injury remains largely undefined. Recently, interleukin-6 (IL-6) has been implicated in muscle stem cell (satellite cell)-mediated muscle hypertrophy in animals; however, the role of IL-6 in the satellite cell (SC) response following muscle-lengthening contractions in humans has not been studied. Methodology/Principal Findings: Eight subjects (age 22 +/- 1 y; 79 +/- 8 kg) performed 300 maximal unilateral lengthening contractions (3.14 rad. s(-1)) of the knee extensors. Blood and muscle samples were collected before and at 4, 24, 72, and 120 hours post intervention. IL-6, IL-6 receptor (IL-6R alpha), cyclin D1, suppressor of cytokine signling-3 (SOCS3) mRNA were measured using quantitative RT-PCR and serum IL-6 protein was measured using an ELISA kit. JAK2 and STAT3 phosphorylated and total protein was measured using western blotting techniques. Immunohistochemical analysis of muscle cross-sections was performed for the quantification of SCs (Pax7(+) cells) as well as the expression of phosphorylated STAT3, IL-6, IL-6R alpha, and PCNA across all time-points. The SC response, as defined by an amplification of Pax7(+) cells, was rapid, increasing by 24 h and peaking 72 h following the intervention. Muscle IL-6 mRNA increased following the intervention, which correlated strongly (R-2 = 0.89, p, 0.002) with an increase in serum IL-6 concentration. SC IL-6R alpha protein was expressed on the fiber, but was also localized to the SC, and IL-6(+) SC increased rapidly following muscle-lengthening contractions and returned to basal levels by 72 h post-intervention, demonstrating an acute temporal expression of IL-6 with SC. Phosphorylated STAT3 was evident in SCs 4 h after lengthening contraction, and the downstream genes, cyclin D1 and SOCS3 were significantly elevated 24 hours after the intervention. Conclusions/Significance: The increased expression of STAT3 responsive genes and expression of IL-6 within SCs demonstrate that IL-6/STAT3 signaling occurred in SCs, correlating with an increase in SC proliferation, evidenced by increased Pax7(+)/PCNA(+) cell number in the early stages of the time-course. Collectively, these data illustrate that IL-6 is an important signaling molecule associated with the SC response to acute muscle-lengthening contractions in humans.			Mckay, BR (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098				ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bamman MM, 2001, AM J PHYSIOL-ENDOC M, V280, pE383; Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Beaton LJ, 2002, MED SCI SPORT EXER, V34, P798, DOI 10.1097/00005768-200205000-00012; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bruunsgaard H, 1997, J PHYSIOL-LONDON, V499, P833, DOI 10.1113/jphysiol.1997.sp021972; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Gallucci S, 1998, INT IMMUNOL, V10, P267, DOI 10.1093/intimm/10.3.267; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Helge JW, 2003, J PHYSIOL-LONDON, V546, P299, DOI 10.1113/jphysiol.2002.030437; Hennessey JV, 1997, J APPL PHYSIOL, V82, P1739, DOI 10.1152/jappl.1997.82.6.1739; Hiscock N, 2005, AM J PHYSIOL-ENDOC M, V289, pE2, DOI 10.1152/ajpendo.00274.2004; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Keller C, 2005, J APPL PHYSIOL, V99, P2075, DOI 10.1152/japplphysiol.00590.2005; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Keller P, 2005, FASEB J, V19, P1181, DOI 10.1096/fj.04-3278fje; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Masuda M, 2002, CANCER RES, V62, P3351; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Tomiya A, 2004, AM J SPORT MED, V32, P503, DOI 10.1177/0095399703258788; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; ULLUM H, 1994, J APPL PHYSIOL, V77, P93, DOI 10.1152/jappl.1994.77.1.93; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Weigert C, 2007, AM J PHYSIOL-CELL PH, V293, pC1139, DOI 10.1152/ajpcell.00142.2007; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	62	105	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6027	10.1371/journal.pone.0006027	http://dx.doi.org/10.1371/journal.pone.0006027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19554087	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356500011
J	Yamamoto, R; Ariely, D; Chi, W; Langleben, DD; Elman, I				Yamamoto, Rinah; Ariely, Dan; Chi, Won; Langleben, Daniel D.; Elman, Igor			Gender Differences in the Motivational Processing of Babies Are Determined by Their Facial Attractiveness	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INFANT FACES; BEAUTIFUL; REWARD; BEHAVIOR; MOTHER; RAT	Background: This study sought to determine how esthetic appearance of babies may affect their motivational processing by the adults. Methodology and Principal Findings: Healthy men and women were administered two laboratory-based tasks: a) key pressing to change the viewing time of normal-looking babies and of those with abnormal facial features (e.g., cleft palate, strabismus, skin disorders, Down's syndrome and fetal alcohol syndrome) and b) attractiveness ratings of these images. Exposure to the babies' images produced two different response patterns: for normal babies, there was a similar effort by the two groups to extend the visual processing with lower attractiveness ratings by men; for abnormal babies, women exerted greater effort to shorten the viewing time despite attractiveness ratings comparable to the men. Conclusions: These results indicate that gender differences in the motivational processing of babies include excessive (relative to the esthetic valuation) motivation to extend the viewing time of normal babies by men vs. shortening the exposure to the abnormal babies by women. Such gender-specific incentive sensitization phenomenon may reflect an evolutionary-derived need for diversion of limited resources to the nurturance of healthy offspring.			Yamamoto, R (corresponding author), McLean Hosp, Clin Psychopathol Lab, Boston, MA USA.	ielman@partners.org	Langleben, Daniel D/K-7407-2014; Elman, Igor/O-2884-2017	Elman, Igor/0000-0002-1345-2677	NIDA NIH HHS [DA015036, DA017959] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017959, T32DA015036] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Badr LK, 2001, INFANT BEHAV DEV, V24, P129; BARDEN RC, 1989, CHILD DEV, V60, P819, DOI 10.1111/j.1467-8624.1989.tb03513.x; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BERMAN PW, 1975, SEX ROLES, V1, P311; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BRADSHAW CM, 1976, J EXP ANAL BEHAV, V26, P135, DOI 10.1901/jeab.1976.26-135; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Darwin G., 1871, P423; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; FELDMAN SS, 1978, CHILD DEV, V49, P617, DOI 10.1111/j.1467-8624.1978.tb02361.x; FLEMING AS, 1981, PHYSIOL BEHAV, V27, P863, DOI 10.1016/0031-9384(81)90054-8; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; GLOCKER ML, 2009, P NATL ACAD SCI US; Hibbard RA, 2007, PEDIATRICS, V119, P1018, DOI 10.1542/peds.2007-0565; Karlsgodt KH, 2003, AM J DRUG ALCOHOL AB, V29, P539, DOI 10.1081/ADA-120023457; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Lee A, 2000, BEHAV BRAIN RES, V108, P213, DOI 10.1016/s0166-4328(98)00109-0; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; STEPHAN CW, 1984, CHILD DEV, V55, P576, DOI 10.2307/1129969; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; Weiss Meira, 1994, CONDITIONAL LOVE PAR; WILSONCROFT WE, 1969, BEHAV RES METH INSTR, V1, P229	31	42	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6042	10.1371/journal.pone.0006042	http://dx.doi.org/10.1371/journal.pone.0006042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462MF	19554100	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356500020
J	Erdelyi, K; Bai, P; Kovacs, I; Szabo, E; Mocsar, G; Kakuk, A; Szabo, C; Gergely, P; Virag, L				Erdelyi, Katalin; Bai, Peter; Kovacs, Istvan; Szabo, Eva; Mocsar, Gabor; Kakuk, Annamaria; Szabo, Csaba; Gergely, Pal; Virag, Laszlo			Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells	FASEB JOURNAL			English	Article						DNA damage; gene silencing; apoptosis; necrosis; hydrogen peroxide; apoptosis-inducing factor	APOPTOSIS-INDUCING FACTOR; DNA-DAMAGE; POLYMERASE INHIBITORS; NEURONAL DEATH; INTACT-CELLS; PROTECTS; METABOLISM; DEPLETION; ISOFORMS; NECROSIS	Activation of poly(ADP-ribose) polymerase-1 (PARP1) has been shown to mediate cell death induced by genotoxic stimuli. The role of poly(ADP-ribose) glycohydrolase (PARG), the enzyme responsible for polymer degradation, has been largely unexplored in the regulation of cell death. Using lentiviral gene silencing we generated A549 lung adenocarcinoma cell lines with stably suppressed PARG and PARP1 expression (shPARG and shPARP1 cell lines, respectively) and determined parameters of apoptotic and necrotic cell death following hydrogen peroxide exposure. shPARG cells accumulated large amounts of poly-(ADP-ribosyl)ated proteins and exhibited reduced PARP activation. Hydrogen peroxide-induced cell death is regulated by PARG in a dual fashion. Whereas the shPARG cell line (similarly to shPARP1 cells) was resistant to the necrotic effect of high concentrations of hydrogen peroxide, these cells exhibited stronger apoptotic response. Both shPARP1 and especially shPARG cells displayed a delayed repair of DNA breaks and exhibited reduced clonogenic survival following hydrogen peroxide treatment. Translocation of apoptosis-inducing factor could not be observed, but cells could be saved by methyl pyruvate and alpha-ketoglutarate, indicating that energy failure may mediate cytotoxicity in our model. These data indicate that PARG is a survival factor at mild oxidative damage but contributes to the apoptosis-necrosis switch in severely damaged cells.-Erdelyi, K., Bai, P., Kovacs, I., Szabo, E., Mocsar, G., Kakuk, A., Szabo, C., Gergely, P., Virag, L. Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells. FASEB J. 23, 3553-3563 (2009). www.fasebj.org	[Erdelyi, Katalin; Bai, Peter; Kovacs, Istvan; Kakuk, Annamaria; Gergely, Pal; Virag, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, H-4032 Debrecen, Hungary; [Szabo, Eva] Univ Debrecen, Med & Hlth Sci Ctr, Dept Dermatol, H-4032 Debrecen, Hungary; [Mocsar, Gabor] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary; [Erdelyi, Katalin; Mocsar, Gabor; Gergely, Pal; Virag, Laszlo] Hungarian Acad Sci, Res Ctr Mol Med, Cell Biol & Signaling Res Grp, Debrecen, Hungary; [Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA	University of Debrecen; University of Debrecen; University of Debrecen; Hungarian Academy of Sciences; University of Texas System; University of Texas Medical Branch Galveston	Virag, L (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, Elettudomanyi Epulet 3-311,Nagyerdei Krt 98, H-4032 Debrecen, Hungary.	lvirag@dote.hu	Virag, Laszlo/E-6124-2010; Szabo, Csaba/ABG-2644-2021; Szabo, Eva/B-8574-2011; Bai, Peter/C-8005-2014; Gergely, Pál/A-5547-2008; Szabo, Csaba/D-1882-2013	Virag, Laszlo/0000-0002-7099-6718	Hungarian Ministry of Health [12/2006]; Hungarian National Science Research Fund [OTKA K60780, K75864, K60620, NNF 78498, K77600]; University of Debrecen Medical and Health Science Center [Mec-1/2008]; U. S. National Institutes of Health [NIH R01 GM060915]; Hungarian Academy of Sciences; Istvan Szechenyi Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060915] Funding Source: NIH RePORTER	Hungarian Ministry of Health; Hungarian National Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); University of Debrecen Medical and Health Science Center; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Istvan Szechenyi Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Hungarian Ministry of Health (12/2006), the Hungarian National Science Research Fund (OTKA K60780, K75864, K60620, NNF 78498, K77600), the University of Debrecen Medical and Health Science Center (Mec-1/2008), and the U. S. National Institutes of Health (NIH R01 GM060915). E.S. and P. B. were supported by a Bolyai Fellowship from the Hungarian Academy of Sciences. L. V. was supported by an Istvan Szechenyi Fellowship. We thank Krisztian Csomos for his help with the lentiviral system. The excellent technical assistance of Ms. Erzsebet Herbaly is greatly appreciated.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Bai P, 2001, FREE RADICAL BIO MED, V31, P1616, DOI 10.1016/S0891-5849(01)00756-0; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; BURKLE A, 1993, CARCINOGENESIS, V14, P559, DOI 10.1093/carcin/14.4.559; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Diaz-Hernandez JI, 2007, CELL DEATH DIFFER, V14, P1211, DOI 10.1038/sj.cdd.4402117; Diefenbach J, 2005, CELL MOL LIFE SCI, V62, P721, DOI 10.1007/s00018-004-4503-3; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Erdelyi K, 2005, MOL PHARMACOL, V68, P895, DOI 10.1124/mol.105.012518; Falsig J, 2004, EUR J PHARMACOL, V497, P7, DOI 10.1016/j.ejphar.2004.06.042; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Haince JF, 2006, BBA-MOL CELL RES, V1763, P226, DOI 10.1016/j.bbamcr.2005.11.015; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hegedus C, 2008, FEBS LETT, V582, P1672, DOI 10.1016/j.febslet.2008.04.023; Huang Q, 2009, CELL DEATH DIFFER, V16, P264, DOI 10.1038/cdd.2008.151; Jo CH, 2008, CELL TISSUE RES, V334, P423, DOI 10.1007/s00441-008-0696-3; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Meyer RG, 2007, EXP CELL RES, V313, P2920, DOI 10.1016/j.yexcr.2007.03.043; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Nanavaty UB, 2002, EXP LUNG RES, V28, P591, DOI 10.1080/01902140260426715; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Tentori L, 2001, CELL DEATH DIFFER, V8, P817, DOI 10.1038/sj.cdd.4400863; Virag L, 1998, J IMMUNOL, V161, P3753; Virag L, 1998, IMMUNOLOGY, V94, P345, DOI 10.1046/j.1365-2567.1998.00534.x; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wong HR, 1998, AM J PHYSIOL-LUNG C, V275, pL836, DOI 10.1152/ajplung.1998.275.4.L836; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	44	85	91	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3553	3563		10.1096/fj.09-133264	http://dx.doi.org/10.1096/fj.09-133264			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19571039	Green Published			2022-12-25	WOS:000270354300031
J	Cui, YX; Freedman, JH				Cui, Yuxia; Freedman, Jonathan H.			Cadmium Induces Retinoic Acid Signaling by Regulating Retinoic Acid Metabolic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAROTENE 15,15'-DIOXYGENASE ACTIVITY; INDUCED LIMB DEFECTS; BETA-CAROTENE; CAENORHABDITIS-ELEGANS; 15,15'-MONOOXYGENASE GENE; MATERNAL EXPOSURE; SPECIAL EMPHASIS; MOUSE EMBRYOS; PROVITAMIN-A; WISTAR RAT	The transition metal cadmium is an environmental teratogen. In addition, cadmium and retinoic acid can act synergistically to induce forelimb malformations. The molecular mechanism underlying the teratogenicity of cadmium and the synergistic effect with retinoic acid has not been addressed. An evolutionarily conserved gene, beta,beta-carotene 15,15'-monooxygenase (BCMO), which is involved in retinoic acid biosynthesis, was studied in both Caenorhabditis elegans and murine Hepa 1-6 cells. In C. elegans, bcmo-1 was expressed in the intestine and was cadmium inducible. Similarly, in Hepa 1-6 cells, Bcmo1 was induced by cadmium. Retinoic acid-mediated signaling increased after 24-h exposures to 5 and 10 mu M cadmium in Hepa 1-6 cells. Examination of gene expression demonstrated that the induction of retinoic acid signaling by cadmium may be mediated by overexpression of Bcmo1. Furthermore, cadmium inhibited the expression of Cyp26a1 and Cyp26b1, which are involved in retinoic acid degradation. These results indicate that cadmium-induced teratogenicity may be due to the ability of the metal to increase the levels of retinoic acid by disrupting the expression of retinoic acid-metabolizing genes.	[Cui, Yuxia; Freedman, Jonathan H.] NIEHS, Comparat Genom Grp, Mol Toxicol Lab, Natl Inst Hlth, Durham, NC 27709 USA; [Cui, Yuxia] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Freedman, JH (corresponding author), NIEHS, Mol Toxicol Lab, NIH, Mail Drop E1-05,POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	freedma1@niehs.nih.gov			National Institutes of Health [U19ES011375, R01ES009949]; NIH; NIEHS [Z01ES102045]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES011375, ZIAES102045, Z01ES102045, R01ES009949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant U19ES011375 and R01ES009949 (to J. H. F.) and by the Intramural Research Program of NIH and NIEHS (Grant Z01ES102045).	*AG TOX SUBST DIS, 2007, CERCLA PRIOR LIST HA; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; DE SK, 1990, TOXICOLOGY, V64, P89, DOI 10.1016/0300-483X(90)90102-M; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 1998, BIOCHEM BIOPH RES CO, V249, P467, DOI 10.1006/bbrc.1998.9160; During A, 2000, BRIT J NUTR, V84, P117; Elsaid AF, 2007, MOL GENET METAB, V92, P258, DOI 10.1016/j.ymgme.2007.05.018; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Franssen-van Hal NLW, 2005, ARCH BIOCHEM BIOPHYS, V439, P32, DOI 10.1016/j.abb.2005.05.001; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; GOYER RA, 1991, FUND APPL TOXICOL, V16, P22, DOI 10.1016/0272-0590(91)90130-V; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HOLT D, 1987, ARCH TOXICOL, V59, P443, DOI 10.1007/BF00316212; Hovland DN, 1999, TERATOLOGY, V60, P13, DOI 10.1002/(SICI)1096-9926(199907)60:1<13::AID-TERA6>3.0.CO;2-B; Hovland DN, 2000, GENOMICS, V63, P193, DOI 10.1006/geno.1999.6069; IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 1993, BER CADM MERC EXP GL; Jin TY, 1998, NEUROTOXICOLOGY, V19, P529; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Koizumi S, 2003, J OCCUP HEALTH, V45, P331, DOI 10.1539/joh.45.331; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; LAYTON WM, 1979, TERATOLOGY, V19, P229, DOI 10.1002/tera.1420190213; Lee GS, 2006, BIRTH DEFECTS RES A, V76, P19, DOI 10.1002/bdra.20201; LEVIN AA, 1987, TERATOLOGY, V36, P163, DOI 10.1002/tera.1420360203; Liao XY, 2007, TOXICOL APPL PHARM, V225, P47, DOI 10.1016/j.taap.2007.06.005; MAHALIK MP, 1995, TOXICOL LETT, V76, P195, DOI 10.1016/0378-4274(95)80003-V; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MESSERLE K, 1982, TERATOLOGY, V25, P61, DOI 10.1002/tera.1420250109; MILAIRE J, 1985, TERATOLOGY, V32, P433, DOI 10.1002/tera.1420320313; Mostbock S, 2002, GEN PHYSIOL BIOPHYS, V21, P443; Nishijo M, 2002, OCCUP ENVIRON MED, V59, P394, DOI 10.1136/oem.59.6.394; PADMANABHAN R, 1990, REPROD TOXICOL, V4, P291, DOI 10.1016/0890-6238(90)90041-S; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Perlmann T, 2002, NAT GENET, V31, P7, DOI 10.1038/ng877; Piasek M, 2001, REPROD TOXICOL, V15, P673, DOI 10.1016/S0890-6238(01)00174-5; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; RAMSEY FL, 2002, STAT SLEUTH COURSE M, P162; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Ronco AM, 2005, BIOMETALS, V18, P233, DOI 10.1007/s10534-005-0583-2; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Scott WJ, 2005, REPROD TOXICOL, V19, P479, DOI 10.1016/j.reprotox.2004.11.013; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Soukupova D, 1991, Funct Dev Morphol, V1, P3; Stiernagle Theresa, 2006, WormBook, P1; SULSTON J, 1988, NEMATODE CAENORHABDI, P123; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sunderman F W Jr, 1992, IARC Sci Publ, P249; Takeda A, 2003, J NUTR SCI VITAMINOL, V49, P69, DOI 10.3177/jnsv.49.69; Takitani K, 2006, EUR J NUTR, V45, P320, DOI 10.1007/s00394-006-0601-3; Thompson J, 2001, TERATOLOGY, V64, P87, DOI 10.1002/tera.1050; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAALKES MP, 1992, CRIT REV TOXICOL, V22, P175, DOI 10.3109/10408449209145323; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S	62	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24925	24932		10.1074/jbc.M109.026609	http://dx.doi.org/10.1074/jbc.M109.026609			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19556237	Green Published, hybrid			2022-12-25	WOS:000269734000026
J	Freeman, L; Buisson, M; Tarbouriech, N; Van der Heyden, A; Labbe, P; Burmeister, WP				Freeman, Lucy; Buisson, Marlyse; Tarbouriech, Nicolas; Van der Heyden, Angeline; Labbe, Pierre; Burmeister, Wim P.			The Flexible Motif V of Epstein-Barr Virus Deoxyuridine 5 '-Triphosphate Pyrophosphatase Is Essential for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FELINE IMMUNODEFICIENCY VIRUS; DUTP PYROPHOSPHATASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; NUCLEOTIDE COMPLEXES; MONOMERIC DUTPASE; MECHANISM; TRIPHOSPHATE; PHOSPHATE	Deoxyuridine 5'-triphosphate pyrophosphatases (dUTPases) are ubiquitous enzymes essential for hydrolysis of dUTP, thus preventing its incorporation into DNA. Although Epstein-Barr virus (EBV) dUTPase is monomeric, it has a high degree of similarity with the more frequent trimeric form of the enzyme. In both cases, the active site is composed of five conserved sequence motifs. Structural and functional studies of mutants based on the structure of EBV dUTPase gave new insight into the mechanism of the enzyme. A first mutant allowed us to exclude a role in enzymatic activity for the disulfide bridge involving the beginning of the disordered C terminus. Sequence alignments revealed two groups of dUTPases, based on the position in sequence of a conserved aspartic acid residue close to the active site. Single mutants of this residue in EBV dUTPase showed a highly impaired catalytic activity, which could be partially restored by a second mutation, making EBV dUTPase more similar to the second group of enzymes. Deletion of the flexible C-terminal tail carrying motif V resulted in a protein completely devoid of enzymatic activity, crystallizing with unhydrolyzed Mg2+-dUTP complex in the active site. Point mutations inside motif V highlighted the essential role of lid residue Phe(273). Magnesium appears to play a role mainly in substrate binding, since in absence of Mg2+, the K-m of the enzyme is reduced, whereas the k(cat) is less affected.	[Burmeister, Wim P.] Univ Grenoble, UVHCI, CNRS, UMI3265,UJF,EMBL, F-38042 Grenoble 9, France; [Van der Heyden, Angeline; Labbe, Pierre] Univ Grenoble, Dept Chim Mol, F-38042 Grenoble 9, France; [Burmeister, Wim P.] Inst Univ France, F-75005 Paris, France; [Buisson, Marlyse] Hop Michallon, Virol Lab, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France; CHU Grenoble Alpes	Burmeister, WP (corresponding author), Univ Grenoble, UVHCI, CNRS, UMI3265,UJF,EMBL, BP 181, F-38042 Grenoble 9, France.	wpb@embl.fr		tarbouriech, nicolas/0000-0002-0206-3959; Burmeister, Wim/0000-0003-0876-6118; VAN DER HEYDEN, Angeline/0000-0003-0369-3765	Region Rhone-Alpes	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	Supported by the Region Rhone-Alpes via the "Cluster 10 Infectiologie."	Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Bajaj M, 2007, ACTA CRYSTALLOGR F, V63, P409, DOI 10.1107/S1744309107016004; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bergman AC, 1998, FEBS LETT, V441, P327, DOI 10.1016/S0014-5793(98)01575-0; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HALENBECK R, 1989, BIO-TECHNOL, V7, P710, DOI 10.1038/nbt0789-710; Harkiolaki M, 2004, STRUCTURE, V12, P41, DOI 10.1016/j.str.2003.11.016; HUANG SL, 1982, BIOCHEMISTRY-US, V21, P951, DOI 10.1021/bi00534a021; Kovari J, 2008, PROTEINS, V71, P308, DOI 10.1002/prot.21757; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, INT CCP4 ESF EACMB N, V26; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Palmen LG, 2008, BIOCHEMISTRY-US, V47, P7863, DOI 10.1021/bi800325j; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prasad GS, 1996, PROTEIN SCI, V5, P2429, DOI 10.1002/pro.5560051205; Prasad GS, 2000, ACTA CRYSTALLOGR D, V56, P1100, DOI 10.1107/S0907444900009197; Quesada-Soriano I, 2008, BBA-PROTEINS PROTEOM, V1784, P1347, DOI 10.1016/j.bbapap.2008.05.014; Samal A, 2007, ACTA CRYSTALLOGR D, V63, P571, DOI 10.1107/S0907444907007871; Tarbouriech N, 2005, STRUCTURE, V13, P1299, DOI 10.1016/j.str.2005.06.009; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 1998, FEBS LETT, V421, P83, DOI 10.1016/S0014-5793(97)01545-7; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015	35	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25280	25289		10.1074/jbc.M109.019315	http://dx.doi.org/10.1074/jbc.M109.019315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586911	hybrid, Green Published			2022-12-25	WOS:000269734000061
J	Koski, MK; Hieta, R; Hirsila, M; Ronka, A; Myllyharju, J; Wierenga, RK				Koski, M. Kristian; Hieta, Reija; Hirsila, Maija; Ronka, Anna; Myllyharju, Johanna; Wierenga, Rik K.			The Crystal Structure of an Algal Prolyl 4-Hydroxylase Complexed with a Proline-rich Peptide Reveals a Novel Buried Tripeptide Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOGLUTARATE DIOXYGENASE; ANGSTROM RESOLUTION; KEY ENZYMES; HIF-ALPHA; HYPOXIA; HYDROXYPROLINE; RECOGNITION; REFINEMENT; COLLAGENS; MECHANISM	Plant and algal prolyl 4-hydroxylases (P4Hs) are key enzymes in the synthesis of cell wall components. These monomeric enzymes belong to the 2-oxoglutarate dependent superfamily of enzymes characterized by a conserved jelly-roll framework. This algal P4H has high sequence similarity to the catalytic domain of the vertebrate, tetrameric collagen P4Hs, whereas there are distinct sequence differences with the oxygen-sensing hypoxia-inducible factor P4H subfamily of enzymes. We present here a 1.98-angstrom crystal structure of the algal Chlamydomonas reinhardtii P4H-1 complexed with Zn2+ and a proline-rich (SerPro)(5) substrate. This ternary complex captures the competent mode of binding of the peptide substrate, being bound in a left handed (poly) L-proline type II conformation in a tunnel shaped by two loops. These two loops are mostly disordered in the absence of the substrate. The importance of these loops for the function is confirmed by extensive mutagenesis, followed up by enzyme kinetic characterizations. These loops cover the central Ser-Pro-Ser tripeptide of the substrate such that the hydroxylation occurs in a highly buried space. This novel mode of binding does not depend on stacking interactions of the proline side chains with aromatic residues. Major conformational changes of the two peptide binding loops are predicted to be a key feature of the catalytic cycle. These conformational changes are probably triggered by the conformational switch of Tyr(140), as induced by the hydroxylation of the proline residue. The importance of these findings for understanding the specific binding and hydroxylation of (X-Pro-Gly)(n) sequences by collagen P4Hs is also discussed.	[Hieta, Reija; Hirsila, Maija; Ronka, Anna; Myllyharju, Johanna; Wierenga, Rik K.] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Koski, M. Kristian; Wierenga, Rik K.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Hieta, Reija; Hirsila, Maija; Ronka, Anna; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, POB 3000, FIN-90014 Oulu, Finland.	rik.wierenga@oulu.fi		Hieta, Reija/0000-0001-5724-6253	Academy of Finland [200966, 115124, 1114344, 1211128]; Sigrid Juselius Foundation and Fibrogen Inc.	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation and Fibrogen Inc.(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland Grants 200966 (to R. K. W.), 115124 (to M. K. K.), and 1114344 and 1211128 (to J.M.) and by the Sigrid Juselius Foundation and Fibrogen Inc. (to J.M.).	Adair W.S., 1990, P15; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Bourenkov GP, 2006, ACTA CRYSTALLOGR D, V62, P58, DOI 10.1107/S0907444905033998; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Gorres KL, 2008, BIOCHEMISTRY-US, V47, P9447, DOI 10.1021/bi8009373; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KASKA DD, 1987, BIOCHEM J, V241, P483, DOI 10.1042/bj2410483; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Loenarz C, 2009, ANGEW CHEM INT EDIT, V48, P1784, DOI 10.1002/anie.200805427; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zhang ZH, 2002, FEBS LETT, V517, P7, DOI 10.1016/S0014-5793(02)02520-6	48	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25290	25301		10.1074/jbc.M109.014050	http://dx.doi.org/10.1074/jbc.M109.014050			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553701	Green Published, hybrid			2022-12-25	WOS:000269734000062
J	Oussaief, L; Hippocrate, A; Ramirez, V; Rampanou, A; Zhang, W; Meyers, D; Cole, P; Khelifa, R; Joab, I				Oussaief, Lassad; Hippocrate, Aurelie; Ramirez, Vanessa; Rampanou, Aurore; Zhang, Wei; Meyers, David; Cole, Philip; Khelifa, Ridha; Joab, Irene			Phosphatidylinositol 3-Kinase/Akt Pathway Targets Acetylation of Smad3 through Smad3/CREB-binding Protein Interaction CONTRIBUTION TO TRANSFORMING GROWTH FACTOR beta 1-INDUCED EPSTEIN-BARR VIRUS REACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; TGF-BETA; ACTIVATION; CELLS; EXPRESSION; GENE; INHIBITORS; 5-BROMODEOXYURIDINE; PHOSPHORYLATION; TRANSACTIVATION	Epstein-Barr virus, a ubiquitous human herpesvirus, is associated with the development of carcinomas and lymphomas. We previously showed that transforming growth factor beta 1 (TGF-beta 1) mediated the virus to enter the lytic cycle, which is triggered by expression of Z Epstein-Barr virus replication activator (ZEBRA), through the ERK 1/2 MAPK signaling pathway. We report here that Akt, activated downstream from ERK 1/2, was required for TGF-beta 1-induced ZEBRA expression and enabled Smad3, a mediator of TGF-beta 1 signaling, to be acetylated by direct interaction with the co-activator CREB-binding protein and then to regulate TGF-beta 1-induced ZEBRA expression.	[Oussaief, Lassad; Hippocrate, Aurelie; Rampanou, Aurore; Joab, Irene] Univ Paris 11, INSERM, Hop Paul Brousse, UMR542, F-94807 Villejuif, France; [Oussaief, Lassad; Khelifa, Ridha] Habib Thameur Hosp, Viral & Mol Tumor Diagnost Unit, Tunis 1008, Tunisia; [Ramirez, Vanessa] Univ Costa Rica, Invest Heath Inst, San Jose 1000, Costa Rica; [Zhang, Wei] INSERM, U716, F-75010 Paris, France; [Meyers, David; Cole, Philip] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Tunis-El-Manar; Hopital Habib Thameur; Universidad Costa Rica; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University	Joab, I (corresponding author), Univ Paris 11, INSERM, Hop Paul Brousse, UMR542, Batiment Andre Lwoff,14 Ave Paul Vaillant Couturi, F-94807 Villejuif, France.	irene.joab@inserm.fr			French network Herpesviruses and Cancer, Association pour la Recherche sur le Cancer Grant [3572]; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Tunisian Ministry of Higher Education, Research and Technology; INSERM; Institut Francilien de Recherche en Nephrologie et Transplantation; Association Nouvelles Recherches Biomedicales; Association pour l'Utilisation du Rein Artificiel; Naturalia and Biologia	French network Herpesviruses and Cancer, Association pour la Recherche sur le Cancer Grant; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Tunisian Ministry of Higher Education, Research and Technology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Francilien de Recherche en Nephrologie et Transplantation; Association Nouvelles Recherches Biomedicales; Association pour l'Utilisation du Rein Artificiel; Naturalia and Biologia	This work was supported by the French network Herpesviruses and Cancer, Association pour la Recherche sur le Cancer Grant 3572, Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), Tunisian Ministry of Higher Education, Research and Technology, INSERM, Institut Francilien de Recherche en Nephrologie et Transplantation, Association Nouvelles Recherches Biomedicales, Association pour l'Utilisation du Rein Artificiel, and Naturalia and Biologia.	Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Desgranges C, 1975, IARC Sci Publ, P191; El Mchichi B, 2007, CELL DEATH DIFFER, V14, P1826, DOI 10.1038/sj.cdd.4402187; Fahmi H, 2000, J VIROL, V74, P5810, DOI 10.1128/JVI.74.13.5810-5818.2000; Fukagawa Y, 2008, ELECTROPHORESIS, V29, P3192, DOI 10.1002/elps.200800086; GERBER P, 1972, P NATL ACAD SCI USA, V69, P83, DOI 10.1073/pnas.69.1.83; Gruffat H, 2002, EMBO REP, V3, P141, DOI 10.1093/embo-reports/kvf031; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; HAMPAR B, 1972, P NATL ACAD SCI USA, V69, P78, DOI 10.1073/pnas.69.1.78; HENLE W, 1971, J INFECT DIS, V124, P58, DOI 10.1093/infdis/124.1.58; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Iwakiri D, 2004, J IMMUNOL, V172, P1561, DOI 10.4049/jimmunol.172.3.1561; KIEFF, 2007, EPSTEIN BARR VIRUS I; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Liang CL, 2002, J BIOL CHEM, V277, P23345, DOI 10.1074/jbc.M107420200; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; Ragoczy T, 1999, J VIROL, V73, P9858, DOI 10.1128/JVI.73.12.9858-9866.1999; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Touitou R, 2003, J GEN VIROL, V84, P949, DOI 10.1099/vir.0.18687-0; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; ZURHAUSEN H, 1978, NATURE, V272, P373	38	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23912	23924		10.1074/jbc.M109.036483	http://dx.doi.org/10.1074/jbc.M109.036483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19589780	Green Published, hybrid			2022-12-25	WOS:000269380200005
J	Patel, A; Dharmarajan, V; Vought, VE; Cosgrove, MS				Patel, Anamika; Dharmarajan, Venkatasubramanian; Vought, Valarie E.; Cosgrove, Michael S.			On the Mechanism of Multiple Lysine Methylation by the Human Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 LYSINE-4; H3-LYS(4) METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; MOLECULAR REGULATION; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; FUNCTIONAL-ANALYSIS; MASS-SPECTROMETRY; TRITHORAX FAMILY; STRUCTURAL BASIS	Transcription in eukaryotic genomes depends on enzymes that regulate the degree of histone H3 lysine 4 (H3K4) methylation. The mixed lineage leukemia protein-1 (MLL1) is a member of the SET1 family of H3K4 methyltransferases and is frequently rearranged in acute leukemias. Despite sequence comparisons that predict that SET1 family enzymes should only monomethylate their substrates, mono-, di-, and trimethylation of H3K4 has been attributed to SET1 family complexes in vivo and in vitro. To better understand this paradox, we have biochemically reconstituted and characterized a five-component 200-kDa MLL1 core complex containing human MLL1, WDR5, RbBP5, Ash2L, and DPY-30. We demonstrate that the isolated MLL1 SET domain is a slow monomethyltransferase and that tyrosine 3942 of MLL1 prevents di- and trimethylation of H3K4. In contrast, a complex containing the MLL1 SET domain, WDR5, RbBP5, Ash2L, and DPY-30, displays a marked similar to 600-fold increase in enzymatic activity but only to the dimethyl form of H3K4. Single turnover kinetic experiments reveal that the reaction leading to H3K4 dimethylation involves the transient accumulation of a monomethylated species, suggesting that the MLL1 core complex uses a non-processive mechanism to catalyze multiple lysine methylation. We have also discovered that the non-SET domain components of the MLL1 core complex possess a previously unrecognized methyltransferase activity that catalyzes H3K4 dimethylation within the MLL1 core complex. Our results suggest that the mechanism of multiple lysine methylation by the MLL1 core complex involves the sequential addition of two methyl groups at two distinct active sites within the complex.	[Patel, Anamika; Dharmarajan, Venkatasubramanian; Vought, Valarie E.; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	mscosgro@syr.edu			March of Dimes Birth Defects Foundation [5-FY06-585]; Leukemia Research Foundation [RSG-09-245-01-DMC]; American Cancer Society; Syracuse University; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Leukemia Research Foundation; American Cancer Society(American Cancer Society); Syracuse University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by research grants from the March of Dimes Birth Defects Foundation (Grant 5-FY06-585), from the Leukemia Research Foundation, a Research Scholar Grant (RSG-09-245-01-DMC) from the American Cancer Society (to M. S. C.), and by funds from Syracuse University.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dirk LMA, 2007, BIOCHEMISTRY-US, V46, P3905, DOI 10.1021/bi6023644; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fersht A., 1999, STRUCTURE MECH PROTE, P143; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Houston CT, 2000, ANAL CHEM, V72, P3311, DOI 10.1021/ac991499m; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P19; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Dijk K, 2005, PLANT CELL, V17, P2439, DOI 10.1105/tpc.105.034165; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	64	155	169	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24242	24256		10.1074/jbc.M109.014498	http://dx.doi.org/10.1074/jbc.M109.014498			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19556245	hybrid, Green Published			2022-12-25	WOS:000269380200038
J	Cammer, M; Gevrey, JC; Lorenz, M; Dovas, A; Condeelis, J; Cox, D				Cammer, Michael; Gevrey, Jean-Claude; Lorenz, Mike; Dovas, Athanassios; Condeelis, John; Cox, Dianne			The Mechanism of CSF-1-induced Wiskott-Aldrich Syndrome Protein Activation in Vivo A ROLE FOR PHOSPHATIDYLINOSITOL 3-KINASE AND Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP FAMILY PROTEINS; TUMOR-CELL MIGRATION; N-WASP; ACTIN POLYMERIZATION; ARP2/3 COMPLEX; N-WASP-ARP2/3 COMPLEX; MAMMARY-TUMORS; MACROPHAGES; CDC42; PHOSPHORYLATION	A role for Wiskott-Aldrich syndrome protein (WASP) in chemotaxis to various agents has been demonstrated in monocyte-derived cell types. Although WASP has been shown to be activated by multiple mechanisms in vitro, it is unclear how WASP is regulated in vivo. A WASP biosensor (WASPbs), which uses intramolecular fluorescence resonance energy transfer to report WASP activation in vivo, was constructed, and following transfection of macrophages, activation of WASPbs upon treatment with colony-stimulating factor-1 (CSF-1) was detected globally as early as 30 s and remained localized to protrusive regions at later time points. Similar results were obtained when endogenous WASP activation was determined using conformation-sensitive antibodies. In vivo CSF-1-induced WASP activation was fully Cdc42-dependent. Activation of WASP in response to treatment with CSF-1 was also shown to be phosphatidylinositol 3-kinase-dependent. However, treatment with the Src family kinase inhibitors PP2 or SU6656 or disruption of the major tyrosine phosphorylation site of WASPbs (Y291F mutation) did not reduce the level of CSF-1-induced WASP activation. Our results indicate that WASP activation downstream of CSF-1R is phosphatidylinositol 3-kinase- and Cdc42-dependent consistent with an involvement of these molecules in macrophage migration. However, although tyrosine phosphorylation of WASP has been proposed to stimulate WASP activity, we found no evidence to indicate that this occurs in vivo.	[Cammer, Michael; Gevrey, Jean-Claude; Lorenz, Mike; Dovas, Athanassios; Condeelis, John; Cox, Dianne] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cox, Dianne] Yeshiva Univ, Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cammer, Michael; Condeelis, John] Yeshiva Univ, Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cox, D (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave,MRRC306, Bronx, NY 10461 USA.	dcox@aecom.yu.edu		Cox, Dianne/0000-0002-0591-9767; Cammer, Michael/0000-0003-4930-1739	National Institutes of Health [RO1 GM071828, GM38511, P01 CA100324]; NATIONAL CANCER INSTITUTE [P01CA100324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828, R01GM038511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM071828 (to D. C.), GM38511 (to J. C.), and P01 CA100324 (to	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Aharinejad Seyedhossein, 2007, Methods Mol Biol, V361, P227; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Badolato R, 1998, J IMMUNOL, V161, P1026; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kato M, 1999, J BIOL CHEM, V274, P27225, DOI 10.1074/jbc.274.38.27225; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pivniouk VI, 2003, INT IMMUNOL, V15, P1431, DOI 10.1093/intimm/dxg148; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Sukumvanich P, 2004, CELL MOTIL CYTOSKEL, V59, P141, DOI 10.1002/cm.20030; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Ward ME, 2004, P NATL ACAD SCI USA, V101, P970, DOI 10.1073/pnas.0306258101; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	53	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23302	23311		10.1074/jbc.M109.036384	http://dx.doi.org/10.1074/jbc.M109.036384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561083	hybrid, Green Published			2022-12-25	WOS:000269180000015
J	Danko, S; Daiho, T; Yamasaki, K; Liu, XY; Suzuki, H				Danko, Stefania; Daiho, Takashi; Yamasaki, Kazuo; Liu, Xiaoyu; Suzuki, Hiroshi			Formation of the Stable Structural Analog of ADP-sensitive Phosphoenzyme of Ca2+-ATPase with Occluded Ca2+ by Beryllium Fluoride STRUCTURAL CHANGES DURING PHOSPHORYLATION AND ISOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; INSENSITIVE PHOSPHOENZYME; BINDING-SITES; ADENOSINE-TRIPHOSPHATASE; CONFORMATIONAL-CHANGES; REACTION-MECHANISM; CATALYTIC SITE; PHOSPHOSERINE PHOSPHATASE; CRYSTAL-STRUCTURE	As a stable analog for ADP-sensitive phosphorylated intermediate of sarcoplasmic reticulum Ca2+-ATPase E1PCa(2)center dot Mg, a complex of E1Ca(2)center dot BeFx, was successfully developed by addition of beryllium fluoride and Mg2+ to the Ca2+-bound state, E1Ca(2). In E1Ca(2)center dot BeFx, most probably E1Ca(2)center dot BeF3-, two Ca2+ are occluded at high affinity transport sites, its formation required Mg2+ binding at the catalytic site, and ADP decomposed it to E1Ca(2), as in E1PCa(2)center dot Mg. Organization of cytoplasmic domains in E1Ca(2)center dot BeFx was revealed to be intermediate between those in E1Ca(2)center dot AlF4- ADP (transition state of E1PCa(2) formation) and E2 center dot BeF3-(ADP-insensitive phosphorylated intermediate E2P center dot Mg). Trinitrophenyl-AMP (TNP-AMP) formed a very fluorescent (superfluorescent) complex with E1Ca(2)center dot BeFx in contrast to no superfluorescence of TNP-AMP bound to E1Ca(2)center dot AlFx. E1Ca(2)center dot BeFx with bound TNP-AMP slowly decayed to E1Ca(2), being distinct from the superfluorescent complex of TNP-AMP with E2 center dot BeF3-, which was stable. Tryptophan fluorescence revealed that the transmembrane structure of E1Ca(2)center dot BeFx mimics E1PCa(2)center dot Mg, and between those of E1Ca(2)center dot AlF4-center dot ADP and E2 center dot BeF3-. E1Ca(2)center dot BeFx at low 50-100 mu M Ca2+ was converted slowly to E2 center dot BeF3- releasing Ca2+, mimicking E1PCa(2)center dot Mg -> E2P center dot Mg + 2Ca(2+)center dot Ca2+ replacement of Mg2+ at the catalytic site at approximately millimolar high Ca2+ decomposed E1Ca(2)center dot BeFx to E1Ca(2). Notably, E1Ca(2)center dot BeFx was perfectly stabilized for at least 12 days by 0.7 mM lumenal Ca2+ with 15 mM Mg2+. Also, stable E1Ca(2)center dot BeFx was produced from E2 center dot BeF3- at 0.7 mM lumenal Ca2+ by binding two Ca2+ to lumenally oriented low affinity transport sites, as mimicking the reverse conversion E2P center dot Mg + 2Ca(2+) -> E1PCa(2)center dot Mg.	[Danko, Stefania; Daiho, Takashi; Yamasaki, Kazuo; Liu, Xiaoyu; Suzuki, Hiroshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College		hisuzuki@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; CHAMPEIL P, 1986, FEBS LETT, V206, P93, DOI 10.1016/0014-5793(86)81347-3; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DUPONT Y, 1982, BIOCHEM BIOPH RES CO, V106, P1272, DOI 10.1016/0006-291X(82)91250-5; DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0; DUPONT Y, 1983, FEBS LETT, V156, P93, DOI 10.1016/0014-5793(83)80255-5; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gonzalez DA, 2006, BIOPHYS CHEM, V124, P27, DOI 10.1016/j.bpc.2006.05.025; HASSELBACH W, 1981, FED PROC, V40, P2657; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HIRATSUKA T, 1982, BIOCHIM BIOPHYS ACTA, V719, P509, DOI 10.1016/0304-4165(82)90240-9; Holdensen AN, 2009, J BIOL CHEM, V284, P12258, DOI 10.1074/jbc.M900977200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; KANAZAWA T, 1975, J BIOL CHEM, V250, P113; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KUBOTA T, 1993, BIOCHIM BIOPHYS ACTA, V1163, P131, DOI 10.1016/0167-4838(93)90174-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWITZ JR, 1983, PRINCIPLES FLUORESCE; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Meissner G, 1974, Methods Enzymol, V32, P475; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; MYUNG J, 1994, BIOCHEMISTRY-US, V33, P8775, DOI 10.1021/bi00195a020; NAKAMOTO RK, 1984, J BIOL CHEM, V259, P2961; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; OBARA M, 1988, J BIOL CHEM, V263, P3690; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; SUZUKI H, 1995, J BIOL CHEM, V270, P3089, DOI 10.1074/jbc.270.7.3089; SUZUKI H, 1994, BIOCHEMISTRY-US, V33, P8240, DOI 10.1021/bi00193a010; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; WATANABE T, 1982, J BIOL CHEM, V257, P1510; WEBB MR, 1981, J BIOL CHEM, V256, P4884; Webb RJ, 2000, J BIOL CHEM, V275, P977, DOI 10.1074/jbc.275.2.977; YAMADA S, 1980, J BIOL CHEM, V255, P3108; YAMAMOTO T, 1968, J BIOCHEM-TOKYO, V64, P137, DOI 10.1093/oxfordjournals.jbchem.a128873; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093	74	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22722	22735		10.1074/jbc.M109.029702	http://dx.doi.org/10.1074/jbc.M109.029702			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561071	Green Published, hybrid			2022-12-25	WOS:000268963100027
J	Banerjee, A; Sammarco, MC; Ditch, S; Wang, J; Grabczyk, E				Banerjee, Ayan; Sammarco, Mimi C.; Ditch, Scott; Wang, Jeffrey; Grabczyk, Ed			A Novel Tandem Reporter Quantifies RNA Polymerase II Termination in Mammalian Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL TERMINATION; SACCHAROMYCES-CEREVISIAE; TRIPLET REPEAT; GENE; PURIFICATION; ELONGATION; EXPRESSION; INITIATION; CLEAVAGE; PROMOTER	Background: Making the correct choice between transcription elongation and transcription termination is essential to the function of RNA polymerase II, and fundamental to gene expression. This choice can be influenced by factors modifying the transcription complex, factors modifying chromatin, or signals mediated by the template or transcript. To aid in the study of transcription elongation and termination we have developed a transcription elongation reporter system that consists of tandem luciferase reporters flanking a test sequence of interest. The ratio of expression from the reporters provides a measure of the relative rates of successful elongation through the intervening sequence. Methodology/Principal Findings: Size matched fragments containing the polyadenylation signal of the human beta-actin gene (ACTB) and the human beta-globin gene (HBB) were evaluated for transcription termination using this new ratiometric tandem reporter assay. Constructs bearing just 200 base pairs on either side of the consensus poly(A) addition site terminated 98% and 86% of transcription for ACTB and HBB sequences, respectively. The nearly 10-fold difference in readthrough transcription between the two short poly(A) regions was eclipsed when additional downstream poly(A) sequence was included for each gene. Both poly(A) regions proved very effective at termination when 1100 base pairs were included, stopping 99.6% of transcription. To determine if part of the increased termination was simply due to the increased template length, we inserted several kilobases of heterologous coding sequence downstream of each poly(A) region test fragment. Unexpectedly, the additional length reduced the effectiveness of termination of HBB sequences 2-fold and of ACTB sequences 3- to 5-fold. Conclusions/Significance: The tandem construct provides a sensitive measure of transcription termination in human cells. Decreased Xrn2 or Senataxin levels produced only a modest release from termination. Our data support overlap in allosteric and torpedo mechanisms of transcription termination and suggest that efficient termination is ensured by redundancy.			Banerjee, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	egrabc@lsuhsc.edu		Sammarco, Mimi/0000-0001-9491-5735	NINDS NIH HHS [R01 NS046567-01A2, R01 NS046567, R01NS046567, R01 NS046567-03, R01 NS046567-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046567] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Grabczyk E, 1999, ANAL BIOCHEM, V267, P241, DOI 10.1006/abio.1998.2962; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Marzluff W F Jr, 1978, Methods Cell Biol, V19, P317; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Sammarco MC, 2008, J BIOL CHEM, V283, P4578, DOI 10.1074/jbc.M703456200; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; West S, 2006, RNA, V12, P655, DOI 10.1261/rna.2232406; West S, 2009, MOL CELL, V33, P354, DOI 10.1016/j.molcel.2009.01.008; Weston RJ, 2004, Z NATURFORSCH C, V59, P39; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	33	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6193	10.1371/journal.pone.0006193	http://dx.doi.org/10.1371/journal.pone.0006193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587781	gold, Green Submitted, Green Published			2022-12-25	WOS:000268035100014
J	Fleming, JN; Shulman, HM; Nash, RA; Johnson, PY; Wight, TN; Gown, A; Schwartz, SM				Fleming, Jo Nadine; Shulman, Howard M.; Nash, Richard A.; Johnson, Pamela Y.; Wight, Thomas N.; Gown, Allen; Schwartz, Stephen M.			Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; BONE-MARROW-TRANSPLANTATION; GROWTH-FACTOR; STIMULATORY AUTOANTIBODIES; GASTROINTESTINAL-TRACT; CLINICAL-TRIALS; CELL APOPTOSIS; PDGF RECEPTOR; IN-VIVO; BETA	Background: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus-host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix of SSc skin. We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc. Methodology/Principal Findings: We analyzed skin biopsies of normal controls (n = 24), patients with SSc (n = 30) and c-GVHD with dermal fibrosis (n = 133)). Immunostaining was employed to identify vessels, vascular smooth muscle, dermal matrix, and cell proliferation. C-GVHD and SSc had similar dermal matrix composition and vascular smooth muscle pathology, including intimal hyperplasia. SSc, however, differed significantly from c-GVHD in three ways. First, there were significantly fewer (p = 0.00001) average vessels in SSc biopsies (9.8) when compared with c-GVHD (16.5). Second, in SSc, endothelial markers were decreased significantly (19/19 and 12/14 for VE cadherin and vWF (p = <0.0001 and <0.05), respectively). In contrast, 0/13 c-GVHD biopsies showed loss of staining with canonical endothelial markers. Third, c-GVHD contained areas of microvascular endothelial proliferation not present in the SSc biopsies. Conclusions/Significance: The sclerosis associated with c-GVHD appears to resemble wound healing. Focal capillary proliferation occurs in early c-GVHD. In contrast, loss of canonical endothelial markers and dermal capillaries is seen in SSc, but not in c-GVHD. The loss of VE cadherin in SSc, in particular, may be related to microvascular rarefaction because VE cadherin is necessary for angiogenesis. C-GVHD is a suitable model for studying dermal fibrosis but may not be applicable for studying the microvascular alterations characteristic of SSc.			Fleming, JN (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	flemij@u.washington.edu			NCI NIH HHS [P01 CA018029, CA-18029] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Brat DJ, 2001, AM J PATHOL, V158, P789, DOI 10.1016/S0002-9440(10)64025-4; Choi JJ, 2003, J RHEUMATOL, V30, P1529; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Eilertsen AL, 2008, J THROMB HAEMOST, V6, P928, DOI 10.1111/j.1538-7836.2008.02970.x; Fernandez-Mateos P, 1998, VOX SANG, V75, P37; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hymes SR, 2006, BIOL BLOOD MARROW TR, V12, P1101, DOI 10.1016/j.bbmt.2006.08.043; Janin A, 2002, BLOOD, V99, P2940, DOI 10.1182/blood.V99.8.2940; Jass JR, 2001, J CELL MOL MED, V5, P327, DOI 10.1111/j.1582-4934.2001.tb00169.x; Jimenez SA, 2002, CURR OPIN RHEUMATOL, V14, P671, DOI 10.1097/00002281-200211000-00008; Kaur H, 2009, EXP EYE RES, V88, P960, DOI 10.1016/j.exer.2008.12.006; KIELTY CM, 1992, J CELL SCI, V103, P445; Lakos G, 2004, METH MOLEC MED, V102, P377; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; McGaha T, 2001, J INVEST DERMATOL, V116, P136, DOI 10.1046/j.1523-1747.2001.00217.x; Mitchell RN, 2007, CIRC RES, V100, P967, DOI 10.1161/01.RES.0000261982.76892.09; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Nash RA, 2006, ARTHRITIS RHEUM-US, V54, P1982, DOI 10.1002/art.21908; Nishida T, 2004, BONE MARROW TRANSPL, V33, P1143, DOI 10.1038/sj.bmt.1704512; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; POTTINGER BE, 1989, THROMB RES, V53, P387, DOI 10.1016/0049-3848(89)90317-4; Ratanatharathorn V, 2003, BIOL BLOOD MARROW TR, V9, P505, DOI 10.1016/S1083-8791(03)00216-7; RIESSEN R, 1994, AM J PATHOL, V144, P962; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Sgonc R, 1999, ARTHRITIS RHEUM-US, V42, P581, DOI 10.1002/1529-0131(199904)42:3<581::AID-ANR28>3.0.CO;2-9; Shiao SL, 2007, J IMMUNOL, V179, P4397, DOI 10.4049/jimmunol.179.7.4397; Shimura K, 2008, BIOL BLOOD MARROW TR, V14, P426, DOI 10.1016/j.bbmt.2008.02.001; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Socie G, 2004, BLOOD, V103, P50, DOI 10.1182/blood-2003-03-0909; Svegliati S, 2007, BLOOD, V110, P237, DOI 10.1182/blood-2007-01-071043; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008; Zhang Y, 2002, J IMMUNOL, V168, P3088, DOI 10.4049/jimmunol.168.6.3088	45	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6203	10.1371/journal.pone.0006203	http://dx.doi.org/10.1371/journal.pone.0006203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587802	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035100016
J	Pistollato, F; Rampazzo, E; Abbadi, S; Della Puppa, A; Scienza, R; D'Avella, D; Denaro, L; Kronnie, GT; Panchision, DM; Basso, G				Pistollato, Francesca; Rampazzo, Elena; Abbadi, Sara; Della Puppa, Alessandro; Scienza, Renato; D'Avella, Domenico; Denaro, Luca; Kronnie, Geertruy te; Panchision, David M.; Basso, Giuseppe			Molecular Mechanisms of HIF-1 alpha Modulation Induced by Oxygen Tension and BMP2 in Glioblastoma Derived Cells	PLOS ONE			English	Article								Background: Glioblastoma multiforme (GBM) is one of most common and still poorly treated primary brain tumors. In search for new therapeutic approaches, Bone Morphogenetic Proteins (BMPs) induce astroglial commitment in GBM-derived cells in vitro. However, we recently suggested that hypoxia, which is characteristic of the brain niche where GBM reside, strongly counter-acts BMP effects. It seems apparent that a more complete understanding of the biology of GBM cells is needed, in particular considering the role played by hypoxia as a signaling pathways regulator. HIF-1 alpha is controlled at the transcriptional and translational level by mTOR and, alike BMP, also mTOR pathway modulates glial differentiation in central nervous system (CNS) stem cells. Methodology/Principal Findings: Here, we investigate the role of mTOR signaling in the regulation of HIF-1 alpha stability in primary GBM-derived cells maintained under hypoxia (2% oxygen). We found that GBM cells, when acutely exposed to high oxygen tension, undergo Akt/mTOR pathway activation and that BMP2 acts in an analogous way. Importantly, repression of Akt/mTOR signaling is maintained by HIF-1 alpha through REDD1 upregulation. On the other hand, BMP2 counter-acts HIF-1 alpha stability by modulating intracellular succinate and by controlling proline hydroxylase 2 (PHD2) protein through inhibition of FKBP38, a PHD2 protein regulator. Conclusions/Significance: In this study we elucidate the molecular mechanisms by which two pro-differentiating stimuli, BMP2 and acute high oxygen exposure, control HIF-1 alpha stability. We previously reported that both these stimuli, by inducing astroglial differentiation, affect GBM cells growth. We also found differences in high oxygen and BMP2 sensitivity between GBM cells and normal cells that should be further investigated to better define tumor cell biology.			Pistollato, F (corresponding author), Univ Padua, Dept Pediat, Hemato Oncol Lab, Padua, Italy.	francesca.pistollato@unipd.it	Kronnie, Geertruy te/L-1014-2016; Della+Puppa, Alessandro/AAL-1050-2021	D'AVELLA, Domenico/0000-0001-9077-412X; BASSO, GIUSEPPE/0000-0002-2634-9302; /0000-0001-5636-1006; DENARO, LUCA/0000-0002-2529-6149; te Kronnie, Geertruy/0000-0001-7143-4795				Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Birner P, 2001, CANCER, V92, P165, DOI 10.1002/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Diabira S, 2008, MED HYPOTHESES, V70, P96, DOI 10.1016/j.mehy.2007.04.024; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fuh B, 2009, BRIT J CANCER, V100, P106, DOI 10.1038/sj.bjc.6604793; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; GARCIA JA, 2006, SCI STKE, pPE25; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gillespie DL, 2007, CLIN CANCER RES, V13, P2441, DOI 10.1158/1078-0432.CCR-06-2692; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Indraccolo S, 2002, GENE, V283, P199, DOI 10.1016/S0378-1119(01)00857-5; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; KAMEGAI A, 1990, ACTA HISTOCHEM, V89, P25, DOI 10.1016/S0065-1281(11)80310-7; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Levine S, 2002, J APPL PHYSIOL, V92, P1205, DOI 10.1152/japplphysiol.00116.2001; Ljungkvist ASE, 2007, RADIAT RES, V167, P127, DOI 10.1667/RR0719.1; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; PISTOLLATO F, 2008, STEM CELLS      1002; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; WARBURG O, 1956, SCIENCE, V124, P269; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537	42	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6206	10.1371/journal.pone.0006206	http://dx.doi.org/10.1371/journal.pone.0006206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587783	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035100017
J	Karagatzides, JD; Butler, JL; Ellison, AM				Karagatzides, Jim D.; Butler, Jessica L.; Ellison, Aaron M.			The Pitcher Plant Sarracenia purpurea Can Directly Acquire Organic Nitrogen and Short-Circuit the Inorganic Nitrogen Cycle	PLOS ONE			English	Article								Background: Despite the large stocks of organic nitrogen in soil, nitrogen availability limits plant growth in many terrestrial ecosystems because most plants take up only inorganic nitrogen, not organic nitrogen. Although some vascular plants can assimilate organic nitrogen directly, only recently has organic nitrogen been found to contribute significantly to the nutrient budget of any plant. Carnivorous plants grow in extremely nutrient-poor environments and carnivory has evolved in these plants as an alternative pathway for obtaining nutrients. We tested if the carnivorous pitcher plant Sarracenia purpurea could directly take up intact amino acids in the field and compared uptake of organic and inorganic forms of nitrogen across a gradient of nitrogen deposition. We hypothesized that the contribution of organic nitrogen to the nitrogen budget of the pitcher plant would decline with increasing nitrogen deposition. Methodology and Principal Findings: At sites in Canada (low nitrogen deposition) and the United States (high nitrogen deposition), individual pitchers were fed two amino acids, glycine and phenylalanine, and inorganic nitrogen (as ammonium nitrate), individually and in mixture. Plants took up intact amino acids. Acquisition of each form of nitrogen provided in isolation exceeded uptake of the same form in mixture. At the high deposition site, uptake of organic nitrogen was higher than uptake of inorganic nitrogen. At the low deposition site, uptake of all three forms of nitrogen was similar. Completeness of the associated detritus-based food web that inhabits pitcher-plant leaves and breaks down captured prey had no effect on nitrogen uptake. Conclusions and Significance: By taking up intact amino acids, Sarracenia purpurea can short-circuit the inorganic nitrogen cycle, thus minimizing potential bottlenecks in nitrogen availability that result from the plant's reliance for nitrogen mineralization on a seasonally reconstructed food web operating on infrequent and irregular prey capture.			Karagatzides, JD (corresponding author), Harvard Univ, Petersham, MA USA.	aellison@fas.harvard.edu		Ellison, Aaron/0000-0003-4151-6081				ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Atkin OK, 1996, PLANT CELL ENVIRON, V19, P695, DOI 10.1111/j.1365-3040.1996.tb00404.x; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; Bledzki LA, 1998, HYDROBIOLOGIA, V385, P193, DOI 10.1023/A:1003566729588; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; Bridgham SD, 1996, WETLANDS, V16, P45, DOI 10.1007/BF03160645; Butler JL, 2007, FUNCT ECOL, V21, P835, DOI 10.1111/j.1365-2435.2007.01307.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; CHAPIN CT, 1995, CAN J BOT, V73, P728, DOI 10.1139/b95-079; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CLARKSON DT, 1985, ANNU REV PLANT PHYS, V36, P77, DOI 10.1146/annurev.pp.36.060185.000453; Clemmensen KE, 2008, OECOLOGIA, V155, P771, DOI 10.1007/s00442-008-0962-9; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; DAMMAN A W H, 1990, Aquilo Ser Botanica, V28, P5; Darwin C., 1875, INSECTIVOROUS PLANTS; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Ellison AM, 2002, P NATL ACAD SCI USA, V99, P4409, DOI 10.1073/pnas.022057199; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; Environment Canada, 2004, CAN AC DEP SCI ASS; Finzi AC, 2005, ECOLOGY, V86, P3345, DOI 10.1890/04-1460; FISH D, 1978, AM MIDL NAT, V99, P172, DOI 10.2307/2424941; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; GIVNISH TJ, 1989, PLANT ANIMAL INTERAC, P242; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; Gotelli NJ, 2002, ECOLOGY, V83, P2758, DOI 10.2307/3072013; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Heard SB, 1998, AM MIDL NAT, V139, P79, DOI 10.1674/0003-0031(1998)139[0079:CROIPB]2.0.CO;2; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Henry HAL, 2002, PLANT CELL ENVIRON, V25, P665, DOI 10.1046/j.1365-3040.2002.00849.x; Hepburn JS S., 1927, T WAGNER FREE I SCI, V11, P1; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Jones D. L., 2004, WATER AIR SOIL POLL, V4, P169; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lipson DA, 1999, BIOL FERT SOILS, V29, P257, DOI 10.1007/s003740050550; Lloyd F.E., 1942, CARNIVOROUS PLANTS; LUTTGE U, 1965, PLANTA, V66, P331, DOI 10.1007/BF00387533; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; MELIN E, 1953, NATURE, V171, P134, DOI 10.1038/171134a0; Miller AE, 2003, PLANT SOIL, V250, P283, DOI 10.1023/A:1022867103109; Miller AE, 2007, ECOLOGY, V88, P1832, DOI 10.1890/06-0946.1; MILLER ROBERT H., 1965, SOIL SCI, V100, P323, DOI 10.1097/00010694-196511000-00006; Nadelhoffer K., 1994, STABLE ISOTOPES ECOL, P22; *NADP PROGR OFF, 2009, NRSP3 NADP; NAEEM S, 1988, ECOL MONOGR, V58, P215, DOI 10.2307/2937026; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; Newell SJ, 1998, AM J BOT, V85, P88, DOI 10.2307/2446558; Nordin A, 2004, ECOLOGY, V85, P955, DOI 10.1890/03-0084; Nordin A, 2001, OECOLOGIA, V129, P125, DOI 10.1007/s004420100698; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; PLUMMER GL, 1964, BOT GAZ, V125, P245, DOI 10.1086/336280; POREMBSKI S, 2000, INSELBERGS BIOTIC DI, P524; Raab TK, 1999, ECOLOGY, V80, P2408, DOI 10.1890/0012-9658(1999)080[2408:SAAUAS]2.0.CO;2; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Senwo ZN, 1998, BIOL FERT SOILS, V26, P235, DOI 10.1007/s003740050373; Stark JM, 2000, METHODS IN ECOSYSTEM SCIENCE, P215; SWAN JMA, 1970, ECOLOGY, V51, P829, DOI 10.2307/1933975; VIRTANEN AI, 1946, NATURE, V158, P515, DOI 10.1038/158515a0; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; von Felten S, 2008, ECOLOGY, V89, P878, DOI 10.1890/07-1015.1; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; [No title captured]	67	26	26	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6164	10.1371/journal.pone.0006164	http://dx.doi.org/10.1371/journal.pone.0006164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582167	Green Submitted, gold, Green Published			2022-12-25	WOS:000267806400018
J	Farin, K; Di Segni, A; Mor, A; Pinkas-Kramarski, R				Farin, Keren; Di Segni, Ayelet; Mor, Adam; Pinkas-Kramarski, Ronit			Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions	PLOS ONE			English	Article								Background: The ErbB receptor tyrosine kinases and nucleolin are major contributors to malignant transformation. Recently we have found that cell-surface ErbB receptors interact with nucleolin via their cytoplasmic tail. Overexpression of ErbB1 and nucleolin leads to receptor phosphorylation, dimerization and anchorage independent growth. Methodology/Principal Findings: In the present study we explored the regions of nucleolin and ErbB responsible for their interaction. Using mutational analyses, we addressed the structure-function relationship of the interaction between ErbB1 and nucleolin. We identified the ErbB1 nuclear localization domain as nucleolin interacting region. This region is important for nucleolin-associated receptor activation. Notably, though the tyrosine kinase domain is important for nucleolin-associated receptor activation, it is not involved in nucleolin/ErbB interactions. In addition, we demonstrated that the 212 c-terminal portion of nucleolin is imperative for the interaction with ErbB1 and ErbB4. This region of nucleolin is sufficient to induce ErbB1 dimerization, phosphorylation and growth in soft agar. Conclusions/Significance: The oncogenic potential of ErbB depends on receptor levels and activation. Nucleolin affects ErbB dimerization and activation leading to enhanced cell growth. The C-terminal region of nucleolin and the ErbB1 NLS-domain mediate this interaction. Moreover, when the C-terminal 212 amino acids region of nucleolin is expressed with ErbB1, it can enhance anchorage independent cell growth. Taken together these results offer new insight into the role of ErbB1 and nucleolin interaction in malignant cells.			Farin, K (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X				Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Casalini P, 2004, J CELL PHYSIOL, V200, P343, DOI 10.1002/jcp.20007; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Ginisty H, 1999, J CELL SCI, V112, P761; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulz M, 2001, BIOCHEM BIOPH RES CO, V280, P476, DOI 10.1006/bbrc.2000.4141; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Storck S, 2008, BIOL CELL; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	48	23	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6128	10.1371/journal.pone.0006128	http://dx.doi.org/10.1371/journal.pone.0006128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578540	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806300004
J	Aton, SJ; Seibt, J; Dumoulin, MC; Coleman, T; Shiraishi, M; Frank, MG				Aton, Sara J.; Seibt, Julie; Dumoulin, Michelle C.; Coleman, Tammi; Shiraishi, Mia; Frank, Marcos G.			The Sedating Antidepressant Trazodone Impairs Sleep-Dependent Cortical Plasticity	PLOS ONE			English	Article							SLOW-WAVE SLEEP; MEMORY CONSOLIDATION; OCULAR DOMINANCE; VISUAL-CORTEX; PREFRONTAL CORTEX; LOCUS-COERULEUS; ZOLPIDEM; RECEPTORS; TRANSIENT; BLOCKADE	Background: Recent findings indicate that certain classes of hypnotics that target GABA(A) receptors impair sleep-dependent brain plasticity. However, the effects of hypnotics acting at monoamine receptors (e.g., the antidepressant trazodone) on this process are unknown. We therefore assessed the effects of commonly-prescribed medications for the treatment of insomnia (trazodone and the non-benzodiazepine GABAA receptor agonists zaleplon and eszopiclone) in a canonical model of sleep-dependent, in vivo synaptic plasticity in the primary visual cortex (V1) known as ocular dominance plasticity. Methodology/Principal Findings: After a 6-h baseline period of sleep/wake polysomnographic recording, cats underwent 6 h of continuous waking combined with monocular deprivation (MD) to trigger synaptic remodeling. Cats subsequently received an i.p. injection of either vehicle, trazodone (10 mg/kg), zaleplon (10 mg/kg), or eszopiclone (1-10 mg/kg), and were allowed an 8-h period of post-MD sleep before ocular dominance plasticity was assessed. We found that while zaleplon and eszopiclone had profound effects on sleeping cortical electroencephalographic (EEG) activity, only trazodone (which did not alter EEG activity) significantly impaired sleep-dependent consolidation of ocular dominance plasticity. This was associated with deficits in both the normal depression of V1 neuronal responses to deprived-eye stimulation, and potentiation of responses to non-deprived eye stimulation, which accompany ocular dominance plasticity. Conclusions/Significance: Taken together, our data suggest that the monoamine receptors targeted by trazodone play an important role in sleep-dependent consolidation of synaptic plasticity. They also demonstrate that changes in sleep architecture are not necessarily reliable predictors of how hypnotics affect sleep-dependent neural functions.			Aton, SJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	mgf@mail.med.upenn.edu		Bridi, Michelle/0000-0001-5533-5092; Seibt, Julie/0000-0002-1081-9680; Aton, Sara/0000-0002-2921-0509	NATIONAL EYE INSTITUTE [T32EY007143, F32EY017766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY017766, T32 EY007143, F32 EY017766-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM007517] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Benca RM, 2005, PSYCHIAT SERV, V56, P332, DOI 10.1176/appi.ps.56.3.332; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Drover DR, 2004, CLIN PHARMACOKINET, V43, P227, DOI 10.2165/00003088-200443040-00002; DYCK RH, 1993, J NEUROSCI, V13, P4316; Eiland LS, 2007, ANN PHARMACOTHER, V41, P1181, DOI 10.1345/aph.1K049; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Eschenko O, 2008, CEREB CORTEX, V18, P2596, DOI 10.1093/cercor/bhn020; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Frank MG, 2006, NEUROSCIENTIST, V12, P477, DOI 10.1177/1073858406293552; Frank MG, 2006, NEUROREPORT, V17, P1459, DOI 10.1097/01.wnr.0000233100.05408.e4; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2008, J NEUROSCI, V28, P5513, DOI 10.1523/JNEUROSCI.5374-07.2008; Gauthier P, 1997, PSYCHOPHARMACOLOGY, V130, P139, DOI 10.1007/s002130050221; Giorgetti M, 2004, EUR J PHARMACOL, V488, P1, DOI 10.1016/j.ejphar.2004.01.036; Greenblatt DJ, 1998, CLIN PHARMACOL THER, V64, P553, DOI 10.1016/S0009-9236(98)90139-4; GREENBLATT DJ, 1987, CLIN PHARMACOL THER, V42, P193, DOI 10.1038/clpt.1987.132; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; GU W, 1994, EUR J NEUROSCI, V7, P1146; HARIA M, 1994, DRUG AGING, V4, P331, DOI 10.2165/00002512-199404040-00006; Higashima M, 1998, NEUROSCI LETT, V245, P77, DOI 10.1016/S0304-3940(98)00178-5; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Judge SJ, 2006, EUR NEUROPSYCHOPHARM, V16, P612, DOI 10.1016/j.euroneuro.2006.01.010; Kallepalli BR, 1997, J CHILD ADOL PSYCHOP, V7, P97, DOI 10.1089/cap.1997.7.97; KANEKO M, 2008, TRKB KINASE REQUIRED; KASAMATSU T, 1985, EXP BRAIN RES, V59, P507; Kemppainen RJ, 1996, EUR J ENDOCRINOL, V134, P602, DOI 10.1530/eje.0.1340602; Kirkwood A, 2000, P NATL ACAD SCI USA, V97, P1951, DOI 10.1073/pnas.070044697; Kojic L, 1997, DEV BRAIN RES, V101, P299, DOI 10.1016/S0165-3806(97)00083-7; Kraus RL, 2007, NEUROPHARMACOLOGY, V53, P308, DOI 10.1016/j.neuropharm.2007.05.011; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; Lenhart SE, 2001, ANN PHARMACOTHER, V35, P1449; Levi G, 1997, ISRAEL J PSYCHIAT, V34, P187; LIAO DS, 2004, J NEUROPHYSIOL; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Morin AK, 2007, PHARMACOTHERAPY, V27, P89, DOI 10.1592/phco.27.1.89; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Mukaida K, 2007, ANESTH ANALG, V104, P836, DOI 10.1213/01.ane.0000255200.42574.22; Najib J, 2006, CLIN THER, V28, P491, DOI 10.1016/j.clinthera.2006.04.014; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; NISHIKAWA T, 1986, BRAIN RES, V371, P123, DOI 10.1016/0006-8993(86)90817-6; Owens JA, 2003, PEDIATRICS, V111, pE628, DOI 10.1542/peds.111.5.e628; Penalva RG, 2003, EUR J NEUROSCI, V17, P1896, DOI 10.1046/j.1460-9568.2003.02612.x; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; PETTIGREW JD, 1978, NATURE, V271, P761, DOI 10.1038/271761a0; RANDALL W, 1985, BEHAV NEUROSCI, V99, P1162, DOI 10.1037/0735-7044.99.6.1162; RASCH B, 2008, NAT NEUROSCI; Rasch BH, 2006, J COGNITIVE NEUROSCI, V18, P793, DOI 10.1162/jocn.2006.18.5.793; Roth T, 2001, SLEEP MED, V2, P379, DOI 10.1016/S1389-9457(01)00071-5; Saccomani L, 2000, J CHILD ADOL PSYCHOP, V10, P307, DOI 10.1089/cap.2000.10.307; SATO H, 1989, J NEUROPHYSIOL, V62, P946, DOI 10.1152/jn.1989.62.4.946; SCATTON B, 1986, J PHARMACOL EXP THER, V237, P659; Seibi J, 2008, SLEEP, V31, P1381; Shinomiya K, 2003, EUR J PHARMACOL, V460, P139, DOI 10.1016/S0014-2999(02)02915-1; TAYLOR DP, 1986, RECEPTOR BINDING DRU; Tesoro S, 2007, PEDIATR ANESTH, V17, P1008, DOI 10.1111/j.1460-9592.2007.02267.x; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; UEBELE VN, NEUROREPORT IN PRESS; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; Wagner J, 2000, SLEEP MED REV, V4, P551, DOI 10.1053/smrv.2000.0126; Wan H, 2004, EUR J NEUROSCI, V20, P2214, DOI 10.1111/j.1460-9568.2004.03688.x; Wang YC, 1997, EXP BRAIN RES, V114, P321, DOI 10.1007/PL00005640; Yoshimoto Y, 1999, EUR NEUROPSYCHOPHARM, V9, P29, DOI 10.1016/S0924-977X(97)00102-8; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; ZUBIETA JK, 1992, J CLIN PSYCHOPHARM, V12, P346	72	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6078	10.1371/journal.pone.0006078	http://dx.doi.org/10.1371/journal.pone.0006078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568418	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200002
J	Zhou, HZ; Wang, YB; Wang, W; Jia, JY; Li, Y; Wang, QY; Wu, YF; Tang, J				Zhou, Hongzhe; Wang, Yunbo; Wang, Wei; Jia, Junying; Li, Yuan; Wang, Qiyu; Wu, Yanfang; Tang, Jie			Generation of Monoclonal Antibodies against Highly Conserved Antigens	PLOS ONE			English	Article								Background: Therapeutic antibody development is one of the fastest growing areas of the pharmaceutical industry. Generating high-quality monoclonal antibodies against a given therapeutic target is very crucial for the success of the drug development. However, due to immune tolerance, some proteins that are highly conserved between mice and humans are not very immunogenic in mice, making it difficult to generate antibodies using a conventional approach. Methodology/Principal Findings: In this report, the impaired immune tolerance of NZB/W mice was exploited to generate monoclonal antibodies against highly conserved or self-antigens. Using two highly conserved human antigens (MIF and HMGB1) and one mouse self-antigen (TNF-alpha) as examples, we demonstrate here that multiple clones of high affinity, highly specific antibodies with desired biological activities can be generated, using the NZB/W mouse as the immunization host and a T cell-specific tag fused to a recombinant antigen to stimulate the immune system. Conclusions/Significance: We developed an efficient and universal method for generating surrogate or therapeutic antibodies against "difficult antigens" to facilitate the development of therapeutic antibodies.			Zhou, HZ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Key Lab Biomacromol, Ctr Infect & Immun, Beijing 100080, Peoples R China.	jtang@ibp.ac.cn						Andrievskaia O, 2006, CLIN VACCINE IMMUNOL, V13, P98, DOI 10.1128/CVI.13.1.98-105.2006; BELL DA, 1973, CLIN IMMUNOL IMMUNOP, V1, P293, DOI 10.1016/0090-1229(73)90046-9; Cvetkovic I, 2006, INT IMMUNOPHARMACOL, V6, P1527, DOI 10.1016/j.intimp.2006.06.009; DOBERSEN MJ, 1985, NEUROCHEM RES, V10, P499, DOI 10.1007/BF00964654; FISHER CL, 1988, CLIN IMMUNOL IMMUNOP, V46, P205, DOI 10.1016/0090-1229(88)90183-3; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GOLDINGS EA, 1980, J EXP MED, V152, P730, DOI 10.1084/jem.152.3.730; HURPIN CM, 1992, HYBRIDOMA, V11, P677, DOI 10.1089/hyb.1992.11.677; JACQUEMART F, 1988, HYBRIDOMA, V7, P323, DOI 10.1089/hyb.1988.7.323; Larson DF, 2006, CRIT CARE, V10, DOI 10.1186/cc4899; Lohnas GL, 1998, J IMMUNOL, V161, P6518; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PENNINGTON JE, 1993, CLIN INFECT DIS, V17, pS515, DOI 10.1093/clinids/17.Supplement_2.S515; RATHJEN DA, 1986, HYBRIDOMA, V5, P255, DOI 10.1089/hyb.1986.5.255; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Sinclair NRS, 2004, FRONT BIOSCI-LANDMRK, V9, P3019, DOI 10.2741/1456; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; VORDERMEIER HM, 1991, J IMMUNOL, V147, P1023; Wither J, 2000, IMMUNOLOGY, V99, P345, DOI 10.1046/j.1365-2567.2000.00981.x; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019	20	38	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6087	10.1371/journal.pone.0006087	http://dx.doi.org/10.1371/journal.pone.0006087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564921	Green Published, Green Submitted, gold			2022-12-25	WOS:000267515700006
J	Elias, J; Mazzi, D; Dorn, S				Elias, Jan; Mazzi, Dominique; Dorn, Silvia			No Need to Discriminate? Reproductive Diploid Males in a Parasitoid with Complementary Sex Determination	PLOS ONE			English	Article								Diploid males in hymenopterans are generally either inviable or sterile, thus imposing a severe genetic load on populations. In species with the widespread single locus complementary sex determination (sl-CSD), sex depends on the genotype at one single locus with multiple alleles. Haploid (hemizygous) individuals are always males. Diploid individuals develop into females when heterozygous and into males when homozygous at the sex determining locus. Our comparison of the mating and reproductive success of haploid and diploid males revealed that diploid males of the braconid parasitoid Cotesia glomerata sire viable and fertile diploid daughters. Females mated to diploid males, however, produced fewer daughters than females mated to haploid males. Nevertheless, females did not discriminate against diploid males as mating partners. Diploid males initiated courtship display sooner than haploid males and were larger in body size. Although in most species so far examined diploid males were recognized as genetic dead ends, we present a second example of a species with sl-CSD and commonly occurring functionally reproductive diploid males. Our study suggests that functionally reproductive diploid males might not be as rare as hitherto assumed. We argue that the frequent occurrence of inbreeding in combination with imperfect behavioural adaptations towards its avoidance promote the evolution of diploid male fertility.			Elias, J (corresponding author), ETH, Inst Plant Sci, Swiss Fed Inst Technol Zurich, CH-8092 Zurich, Switzerland.	dominique.mazzi@ipw.agrl.ethz.ch						ADAMS J, 1977, GENETICS, V86, P583; ANTOLIN MF, 1992, ECOL ENTOMOL, V17, P1, DOI 10.1111/j.1365-2311.1992.tb01032.x; Antolin MF, 2003, HEREDITY, V91, P373, DOI 10.1038/sj.hdy.6800337; Ayabe T, 2004, CHROMOSOME RES, V12, P215, DOI 10.1023/B:CHRO.0000021880.83639.4b; Beukeboom LW, 2000, GENOME, V43, P939, DOI 10.1139/gen-43-6-939; BEUKEBOOM LW, 1995, BIOESSAYS, V17, P813, DOI 10.1002/bies.950170911; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; De Boer JG, 2007, J EVOLUTION BIOL, V20, P340, DOI 10.1111/j.1420-9101.2006.01193.x; de Boer JG, 2008, GENETICS, V180, P1525, DOI 10.1534/genetics.107.083907; Dorn S, 2007, PHYSIOL ENTOMOL, V32, P199, DOI 10.1111/j.1365-3032.2007.00576.x; ELAGOZE M, 1994, B ENTOMOL RES, V84, P213, DOI 10.1017/S0007485300039717; FOSTER RL, 1992, J KANSAS ENTOMOL SOC, V65, P238; Gu HN, 2003, ECOL ENTOMOL, V28, P422, DOI 10.1046/j.1365-2311.2003.00535.x; Gu HN, 2003, ANIM BEHAV, V66, P259, DOI 10.1006/anbe.2003.2185; Hartley Christopher S., 2003, Journal of Hymenoptera Research, V12, P272; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Herzner G, 2006, BIOL J LINN SOC, V89, P433, DOI 10.1111/j.1095-8312.2006.00684.x; HOAGE TR, 1968, J ULTRA MOL STRUCT R, V24, P6, DOI 10.1016/S0022-5320(68)80014-0; HOGGE MAF, 1975, J SUBMICR CYTOL PATH, V7, P81; HUNG ACF, 1974, ANN ENTOMOL SOC AM, V67, P909, DOI 10.1093/aesa/67.6.909; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Krieger MJB, 1999, HEREDITY, V82, P142, DOI 10.1038/sj.hdy.6884600; Laing J.E., 1982, Biocontrol News and Information, V3, P7; Lee JM, 1998, J INSECT BEHAV, V11, P419, DOI 10.1023/A:1020958831972; Liebert AE, 2005, BIOL LETT-UK, V1, P200, DOI 10.1098/rsbl.2004.0284; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Mattiacci L, 2001, J CHEM ECOL, V27, P2233, DOI 10.1023/A:1012278804105; MORITZ RFA, 1994, HEREDITY, V73, P98, DOI 10.1038/hdy.1994.104; NAITO T, 1991, J HERED, V82, P101, DOI 10.1093/oxfordjournals.jhered.a111042; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P705, DOI 10.1303/aez.2004.705; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Oldroyd BP, 2008, GENETICS, V180, P359, DOI 10.1534/genetics.108.090415; OWEN RE, 1994, HEREDITY, V72, P219, DOI 10.1038/hdy.1994.31; PAGE RE, 1980, GENETICS, V96, P263; PETTERS RM, 1980, J HERED, V71, P353, DOI 10.1093/oxfordjournals.jhered.a109385; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2022, R LANG ENV STAT COMP; Reece SE, 2007, ANIM BEHAV, V74, P1163, DOI 10.1016/j.anbehav.2006.10.027; Sarkar D., 2008, LATTICE LATTICE GRAP; SMITH SG, 1971, CAN J GENET CYTOL, V13, P617, DOI 10.1139/g71-089; Stahlhut JK, 2004, HEREDITY, V92, P189, DOI 10.1038/sj.hdy.6800394; Stahlhut JK, 2004, MOL ECOL, V13, P631, DOI 10.1046/j.1365-294X.2004.02090.x; STOUTHAMER R, 1992, ENVIRON ENTOMOL, V21, P427, DOI 10.1093/ee/21.3.427; Stouthamer R, 2001, P ROY SOC B-BIOL SCI, V268, P617, DOI 10.1098/rspb.2000.1404; Tagawa J, 2000, ENTOMOL EXP APPL, V97, P193, DOI 10.1023/A:1004007802543; TAGAWA J, 1981, APPL ENTOMOL ZOOL, V16, P345, DOI 10.1303/aez.16.345; Takahashi NC, 2001, EVOLUTION, V55, P1897, DOI 10.1111/j.0014-3820.2001.tb00839.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; van Vugt JFA, 2003, GENOME, V46, P580, DOI [10.1139/g03-044, 10.1139/G03-044]; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Wang Q, 2003, HEREDITY, V91, P430, DOI 10.1038/sj.hdy.6800340; Wanner H, 2007, AGR ECOSYST ENVIRON, V118, P143, DOI 10.1016/j.agee.2006.05.005; WERREN JH, 1981, NATURE, V293, P467, DOI 10.1038/293467a0; Whiting PW, 1940, J MORPHOL, V66, P323, DOI 10.1002/jmor.1050660208; Whiting PW, 1943, GENETICS, V28, P365; Woyke J., 1963, Journal of Apicultural Research London, V2, P73; Wu Zhishan, 2003, Entomologia Sinica, V10, P81; Yamauchi K, 2001, INSECT SOC, V48, P28, DOI 10.1007/PL00001741; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zhou Y, 2007, BIOL CONTROL, V40, P273, DOI 10.1016/j.biocontrol.2006.11.002; Zhou Y, 2006, HEREDITY, V96, P487, DOI 10.1038/sj.hdy.6800829	68	38	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6024	10.1371/journal.pone.0006024	http://dx.doi.org/10.1371/journal.pone.0006024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551142	Green Submitted, gold, Green Published			2022-12-25	WOS:000267356500009
J	Suomela, S; Elomaa, O; Skoog, T; Ala-Aho, R; Jeskanen, L; Parssinen, J; Latonen, L; Grenman, R; Kere, J; Kahari, VM; Saarialho-Kere, U				Suomela, Sari; Elomaa, Outi; Skoog, Tiina; Ala-aho, Risto; Jeskanen, Leila; Parssinen, Jenita; Latonen, Leena; Grenman, Reidar; Kere, Juha; Kahari, Veli-Matti; Saarialho-Kere, Ulpu			CCHCR1 Is Up-Regulated in Skin Cancer and Associated with EGFR Expression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; OKADAIC ACID; GENE-EXPRESSION; CANDIDATE GENE; MATRIX METALLOPROTEINASE-21; KERATINOCYTE PROLIFERATION; PSORIATIC PLAQUES; SQUAMOUS-CELL; TISSUE-REPAIR; ACTIVATION	Despite chronic inflammation, psoriatic lesions hardly ever progress to skin cancer. Aberrant function of the CCHCR1 gene (Coiled-Coil alpha-Helical Rod protein 1, HCR) within the PSORS1 locus may contribute to the onset of psoriasis. As CCHCR1 is expressed in certain cancers and regulates keratinocyte (KC) proliferation in a transgenic mouse model, we studied its relation to proliferation in cutaneous squamous cell cancer (SCC) cell lines by expression arrays and quantitative RT-PCR and in skin tumors by immunohistochemistry. CCHCR1 protein was detected in the pushing border of SCC and lining basal cell carcinoma islands. Different from psoriasis, Ki67 had a similar expression pattern as CCHCR1. The most intense CCHCR1 staining occurred in areas positive for epidermal growth factor receptor (EGFR). Expression of CCHCR1 mRNA was upregulated 30-80% in SCC lines when compared to normal KCs and correlated positively with Ki67 expression. The most aggressive and invasive tumor cell lines (RT3, FaDu) expressed CCHCR1 mRNA less than non-tumorigenic HaCaT cells. Moreover, the tumor promoters okadaic acid and menadione downregulated CCHCR1 mRNA. We conclude that both in psoriasis and the early stages of KC transformation, CCHCR1 may function as a negative regulator of proliferation, but beyond a certain point in oncogenesis cannot control this phenomenon any longer.			Suomela, S (corresponding author), Univ Helsinki, Cent Hosp, Dept Dermatol, FIN-00170 Helsinki, Finland.	ulpu.saarialho-kere@helsinki.fi	Kahari, Veli-Matti/T-4925-2019; Skoog, Tiina/B-8598-2014; Latonen, Leena/C-8787-2016; Kere, Juha/AAX-9117-2021; Skoog, Tiina/N-3525-2019; Kähäri, Veli-Matti/E-5144-2011; Kere, Juha/A-9179-2008	Kahari, Veli-Matti/0000-0003-2421-9368; Latonen, Leena/0000-0003-4502-2193; Kere, Juha/0000-0003-1974-0271; Skoog, Tiina/0000-0002-0148-0654; Kähäri, Veli-Matti/0000-0003-2421-9368; Kere, Juha/0000-0003-1974-0271				Ahokas K, 2003, LAB INVEST, V83, P1887, DOI 10.1097/01.LAB.0000106721.86126.39; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Beier JI, 2006, FEBS LETT, V580, P1859, DOI 10.1016/j.febslet.2006.02.048; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; Cordero JB, 2002, J BIOL CHEM, V277, P38965, DOI 10.1074/jbc.M203736200; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; De Angelis T, 2002, J INVEST DERMATOL, V118, P759, DOI 10.1046/j.1523-1747.2002.01755.x; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Freeman MR, 2007, STEROIDS, V72, P210, DOI 10.1016/j.steroids.2006.11.012; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lebeau S, 2005, BRIT J DERMATOL, V152, P1248, DOI 10.1111/j.1365-2133.2005.06687.x; Matias WG, 1999, HUM EXP TOXICOL, V18, P634, DOI 10.1191/096032799678839473; Meves A, 2002, ARCH DERMATOL RES, V294, P243, DOI 10.1007/s00403-002-0315-1; Mielnicki LM, 1996, BIOCHEM BIOPH RES CO, V228, P586, DOI 10.1006/bbrc.1996.1702; Nickoloff BJ, 2001, J CUTAN PATHOL, V28, P57, DOI 10.1034/j.1600-0560.2001.280201.x; Nickoloff BJ, 2006, J INVEST DERM SYMP P, V11, P16, DOI 10.1038/sj.jidsymp.5650010; Paltiel O, 2004, ARCH DERMATOL, V140, P805, DOI 10.1001/archderm.140.7.805; Pivarcsi A, 2001, ARCH DERMATOL RES, V293, P206, DOI 10.1007/s004030100217; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Rittie L, 2007, AM J PATHOL, V170, P2089, DOI 10.2353/ajpath.2007.060537; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; SCHONTHAL AH, 1995, SEMIN CANCER BIOL, V6, P239, DOI 10.1006/scbi.1995.0031; Skoog T, 2006, EXP DERMATOL, V15, P775, DOI 10.1111/j.1600-0625.2006.00460.x; Skoog T, 2009, J INVEST DERMATOL, V129, P119, DOI 10.1038/jid.2008.206; Suomela S, 2003, J INVEST DERMATOL, V121, P1360, DOI 10.1046/j.1523-1747.2003.12642.x; Tiala I, 2008, HUM MOL GENET, V17, P1043, DOI 10.1093/hmg/ddm377; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Verdier-Sevain S, 2004, FASEB J, V18, P1252, DOI 10.1096/fj.03-1088fje; Westermarck J, 1998, MATRIX BIOL, V17, P547, DOI 10.1016/S0945-053X(98)90107-X; WESTERMARCK J, 1994, CELL GROWTH DIFFER, V5, P1205; Wierzbicka E, 2006, BRIT J DERMATOL, V155, P213, DOI 10.1111/j.1365-2133.2006.07299.x; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zorzou MP, 2004, ACTA DERM-VENEREOL, V84, P308, DOI 10.1080/00015550410024634	42	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6030	10.1371/journal.pone.0006030	http://dx.doi.org/10.1371/journal.pone.0006030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551138	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356500014
J	Tomshine, JC; Severson, SR; Wigle, DA; Sun, ZF; Beleford, DAT; Shridhar, V; Horazdovsky, BF				Tomshine, Jin C.; Severson, Sandra R.; Wigle, Dennis A.; Sun, Zhifu; Beleford, Daniah A. T.; Shridhar, Vijayalakshmi; Horazdovsky, Bruce F.			Cell Proliferation and Epidermal Growth Factor Signaling in Non-small Cell Lung Adenocarcinoma Cell Lines Are Dependent on Rin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TUMOR-SUPPRESSOR GENE; FACTOR RECEPTOR; EGF RECEPTOR; TRANSDUCTION PATHWAYS; MULTIVESICULAR BODIES; DOWN-REGULATION; EARLY ENDOSOMES; ENDOCYTOSIS; RAB5	Rin1 is a Rab5 guanine nucleotide exchange factor that plays an important role in Ras-activated endocytosis and growth factor receptor trafficking in fibroblasts. In this study, we show that Rin1 is expressed at high levels in a large number of non-small cell lung adenocarcinoma cell lines, including Hop62, H650, HCC4006, HCC827, EKVX, HCC2935, and A549. Rin1 depletion from A549 cells resulted in a decrease in cell proliferation that was correlated to a decrease in epidermal growth factor receptor (EGFR) signaling. Expression of wild type Rin1 but not the Rab5 guanine nucleotide exchange factor-deficient Rin1 (Rin1 Delta) complemented the Rin1 depletion effects, and overexpression of Rin1 Delta had a dominant negative effect on cell proliferation. Rin1 depletion stabilized the cell surface levels of EGFR, suggesting that internalization was necessary for robust signaling in A549 cells. In support of this conclusion, introduction of either dominant negative Rab5 or dominant negative dynamin decreased A549 proliferation and EGFR signaling. These data demonstrate that proper internalization and endocytic trafficking are critical for EGFR-mediated signaling in A549 cells and suggest that up-regulation of Rin1 in A549 cell lines may contribute to their proliferative nature.	[Tomshine, Jin C.; Severson, Sandra R.; Horazdovsky, Bruce F.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wigle, Dennis A.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Beleford, Daniah A. T.; Shridhar, Vijayalakshmi] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Sun, Zhifu] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Horazdovsky, BF (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	horazdovsky.bruce@mayo.edu		Sun, Zhifu/0000-0001-8461-7523				Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Clague MJ, 2001, J CELL SCI, V114, P3075; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FOX CF, 1979, J SUPRAMOL STR CELL, V12, P517, DOI 10.1002/jss.400120411; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gill DJ, 2007, BIOCHEM SOC SYMP, V74, P47, DOI 10.1042/BSS2007c05; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hunker CM, 2006, EXP CELL RES, V312, P1106, DOI 10.1016/j.yexcr.2005.12.021; Hunker CM, 2006, ANTICANCER RES, V26, P905; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NESTEROV A, 1994, ARCH BIOCHEM BIOPHYS, V313, P351, DOI 10.1006/abbi.1994.1398; Oksvold MP, 2000, J HISTOCHEM CYTOCHEM, V48, P21, DOI 10.1177/002215540004800103; PARTON RG, 1992, J CELL SCI, V103, P335; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; RACHWAL WJ, 1995, BRIT J CANCER, V72, P56, DOI 10.1038/bjc.1995.277; Senda K, 2007, ONCOL REP, V17, P1171; Shuster MI, 2000, GENE CHROMOSOME CANC, V28, P153, DOI 10.1002/(SICI)1098-2264(200006)28:2<153::AID-GCC4>3.0.CO;2-9; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Witters L, 1999, BREAST CANCER RES TR, V53, P41, DOI 10.1023/A:1006127527107; Zainabadi K, 2005, GENOMICS, V85, P704, DOI 10.1016/j.ygeno.2005.02.014; Zhang M, 2004, ACTA PHARMACOL SIN, V25, P61	46	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26331	26339		10.1074/jbc.M109.033514	http://dx.doi.org/10.1074/jbc.M109.033514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19570984	Green Published, hybrid			2022-12-25	WOS:000269969600013
J	Hardy, JA; Wells, JA				Hardy, Jeanne A.; Wells, James A.			Dissecting an Allosteric Switch in Caspase-7 Using Chemical and Mutational Probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INHIBITORS; STRUCTURAL BASIS; CELL-DEATH; ACTIVATION; APOPTOSIS; MECHANISM; SITE; SPECIFICITY; SUBSTRATE; PURIFICATION	Apoptotic caspases, such as caspase-7, are stored as inactive protease zymogens, and when activated, lead to a fate-determining switch to induce cell death. We previously discovered small molecule thiol-containing inhibitors that when tethered revealed an allosteric site and trapped a conformation similar to the zymogen form of the enzyme. We noted three structural transitions that the compounds induced: (i) breaking of an interaction between Tyr-223 and Arg-187 in the allosteric site, which prevents proper ordering of the catalytic cysteine; (ii) pinning the L2' loop over the allosteric site, which blocks critical interactions for proper ordering of the substrate-binding groove; and (iii) a hinge-like rotation at Gly-188 positioned after the catalytic Cys-186 and Arg-187. Here we report a systematic mutational analysis of these regions to dissect their functional importance to mediate the allosteric transition induced by these compounds. Mutating the hinge Gly-188 to the restrictive proline causes a massive similar to 6000-fold reduction in catalytic efficiency. Mutations in the Arg-187-Tyr-223 couple have a far less dramatic effect (3-20-fold reductions). Interestingly, although the allosteric couple mutants still allow binding and allosteric inhibition, they partially relieve the mutual exclusivity of binding between inhibitors at the active and allosteric sites. These data highlight a small set of residues critical for mediating the transition from active to inactive zymogen-like states.	[Hardy, Jeanne A.; Wells, James A.] Sunesis Pharmaceut, San Francisco, CA 94080 USA		Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Box 2552, San Francisco, CA 94143 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016	Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM65048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Postdoctoral Fellowship GM65048 (to J. H.).	Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; ASBOTH B, 1985, BIOCHEMISTRY-US, V24, P606, DOI 10.1021/bi00324a010; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chereau D, 2003, BIOCHEMISTRY-US, V42, P4151, DOI 10.1021/bi020593l; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Nuttall ME, 2001, DRUG DISCOV TODAY, V6, P85, DOI 10.1016/S1359-6446(00)01601-9; OBrien T, 2009, CRC ENZYM INHIB SER, P1; Reed JC, 2000, CURR OPIN BIOTECH, V11, P586, DOI 10.1016/S0958-1669(00)00148-8; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Yeretssian G, 2008, CYTOKINE, V43, P380, DOI 10.1016/j.cyto.2008.07.015	31	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26063	26069		10.1074/jbc.M109.001826	http://dx.doi.org/10.1074/jbc.M109.001826			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19581639	hybrid, Green Published			2022-12-25	WOS:000269738000062
J	Ravindra, KC; Selvi, BR; Arif, M; Reddy, BAA; Thanuja, GR; Agrawal, S; Pradhan, SK; Nagashayana, N; Dasgupta, D; Kundu, TK				Ravindra, Kodihalli C.; Selvi, B. Ruthrotha; Arif, Mohammed; Reddy, B. A. Ashok; Thanuja, Gali R.; Agrawal, Shipra; Pradhan, Suman Kalyan; Nagashayana, Natesh; Dasgupta, Dipak; Kundu, Tapas K.			Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P300 HISTONE ACETYLTRANSFERASE; ENHANCED RAMAN-SPECTROSCOPY; GLOBAL GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; CANCER CELLS; CHROMATIN TRANSCRIPTION; PROTEIN ACETYLATION; SMALL MOLECULES; HUMAN-DISEASE; DNA-DAMAGE	Lysine acetyltransferases (KATs), p300 (KAT3B), and its close homologue CREB-binding protein (KAT3A) are probably the most widely studied KATs with well documented roles in various cellular processes. Hence, the dysfunction of p300 may result in the dysregulation of gene expression leading to the manifestation of many disorders. The acetyltransferase activity of p300/CREB-binding protein is therefore considered as a target for new generation therapeutics. We describe here a natural compound, plumbagin (RTK1), isolated from Plumbago rosea root extract, that inhibits histone acetyltransferase activity potently in vivo. Interestingly, RTK1 specifically inhibits the p300-mediated acetylation of p53 but not the acetylation by another acetyltransferase, p300/CREB-binding protein-associated factor, PCAF, in vivo. RTK1 inhibits p300 histone acetyltransferase activity in a noncompetitive manner. Docking studies and site-directed mutagenesis of the p300 histone acetyltransferase domain suggest that a single hydroxyl group of RTK1 makes a hydrogen bond with the lysine 1358 residue of this domain. In agreement with this, we found that indeed the hydroxyl group-substituted plumbagin derivatives lost the acetyltransferase inhibitory activity. This study describes for the first time the chemical entity (hydroxyl group) required for the inhibition of acetyltransferase activity.	[Ravindra, Kodihalli C.; Selvi, B. Ruthrotha; Arif, Mohammed; Reddy, B. A. Ashok; Thanuja, Gali R.; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India; [Agrawal, Shipra] Int Technol Pk Bangalore, Inst Bioinformat & Appl Biotechnol, Bangalore 560066, Karnataka, India; [Nagashayana, Natesh] Cent Govt Hlth Scheme Dispensary 3, Bangalore 560004, Karnataka, India; [Pradhan, Suman Kalyan; Dasgupta, Dipak] Saha Inst Nucl Phys, Div Biophys, Kolkata 700064, W Bengal, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Saha Institute of Nuclear Physics	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	B.A.Reddy, Ashok/AAD-2839-2021; Pradhan, Suman/O-4518-2015; Gali Ramamoorthy, Thanuja/AFV-8484-2022	Gali Ramamoorthy, Thanuja/0000-0003-3314-0352; Bharathavikru, Ruthrotha Selvi/0000-0002-3096-7461; Kundu, Tapas/0000-0001-7790-214X; MOHAMMED, ARIF/0000-0003-1300-5081	Department of Biotechnology, Government of India,; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Biotechnology, Government of India,(Department of Biotechnology (DBT) India); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Government of India, and Jawaharlal Nehru Centre for Advanced Scientific Research.	Acharya BR, 2008, BIOCHEMISTRY-US, V47, P7838, DOI 10.1021/bi800730q; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Arif M, 2007, J PHYS CHEM B, V111, P11877, DOI 10.1021/jp0762931; Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Batta Kiran, 2007, Subcell Biochem, V41, P193; Biel M, 2004, ANGEW CHEM INT EDIT, V43, P3974, DOI 10.1002/anie.200453879; Chan HM, 2001, J CELL SCI, V114, P2363; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Davidson SM, 2005, CHEMBIOCHEM, V6, P162, DOI 10.1002/cbic.200400246; DINDA B, 1995, INDIAN J CHEM B, V34, P525; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Goodman RH, 2000, GENE DEV, V14, P1553; Grant PA, 1999, SEMIN CELL DEV BIOL, V10, P169, DOI 10.1006/scdb.1999.0298; Heery DM, 2007, DRUG DISCOV TODAY, V12, P88, DOI 10.1016/j.drudis.2006.11.012; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Mantelingu K, 2007, J PHYS CHEM B, V111, P4527, DOI 10.1021/jp067655s; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sarli V, 2007, CHEM BIOL, V14, P605, DOI 10.1016/j.chembiol.2007.06.001; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; SWAMINATHAN V, 2007, CHROMATIN DIS, V41, P397; Varier RA, 2006, CURR PHARM DESIGN, V12, P1975, DOI 10.2174/138161206777442092; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	36	97	98	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24453	24464		10.1074/jbc.M109.023861	http://dx.doi.org/10.1074/jbc.M109.023861			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570987	Green Published, hybrid			2022-12-25	WOS:000269380200058
J	Verstak, B; Nagpal, K; Bottomley, SP; Golenbock, DT; Hertzog, PJ; Mansell, A				Verstak, Brett; Nagpal, Kamalpreet; Bottomley, Stephen P.; Golenbock, Douglas T.; Hertzog, Paul J.; Mansell, Ashley			MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2-and TLR4-mediated NF-kappa B Proinflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; CUTTING EDGE; TIR-DOMAIN; ACTIVATION; TLR4; MOLECULE; PATHWAY; TRIF; TOLL-LIKE-RECEPTOR-4	Toll/interleukin-1 (TIR)receptor-containing adapters are critical in orchestrating the different signal transduction pathways following Toll-like receptor (TLR) activation. MyD88 adapter-like (Mal), also termed TIRAP, is involved in bridging MyD88 to the receptor complex for TLR-2 and TLR4 signaling in response to bacterial infection. We have previously reported an interaction between Mal and tumor necrosis factor receptor-associated factor 6 (TRAF6) via a TRAF6-binding motif, the disruption of which inhibited TLR-mediated NF-kappa B-luciferase reporter activity. Given the recent report of intracellular TRAM localization promoting sequential signaling in TLR4 responses, we further characterized Mal interaction with TRAF6, the cellular localization, and the outcomes of disrupting this association on TLR inflammatory responses. We found that Mal and TRAF6 directly interact in response to TLR2 and TLR4 stimulation, although membrane localization is not necessary to facilitate interaction. Critically, reconstitution of murine Mal-deficient macrophages with MalE190A, containing a mutation within the TRAF6-binding motif, fails to reconstitute the proinflammatory response to TLR2 and TLR4 ligands compared with wild type Mal. Furthermore, Mal interaction with TRAF6 mediates Ser phosphorylation of the p65 subunit of NF-kappa B and thus controls transcriptional activation but not nuclear translocation of NF-kappa B. This study characterizes the novel role for Mal in facilitating the direct recruitment of TRAF6 to the plasma membrane, which is necessary for TLR2- and TLR4-induced transactivation of NF-kappa B and regulation of the subsequent pro-inflammatory response.	[Verstak, Brett; Hertzog, Paul J.; Mansell, Ashley] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Verstak, Brett] Univ Massachusetts, Sch Med, Cooperat Res Ctr Chron Inflammatory Dis, Worcester, MA 01605 USA; [Nagpal, Kamalpreet; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01605 USA; [Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Monash University	Mansell, A (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	ashley.mansell@med.monash.edu.au	Hertzog, Paul J/G-6734-2013; Mansell, Ashley/B-9553-2008; Hertzog, Paul J/I-7053-2013	Hertzog, Paul J/0000-0002-1373-8472; Mansell, Ashley/0000-0002-6540-1281; Hertzog, Paul J/0000-0002-1373-8472				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Watts C, 2008, NAT IMMUNOL, V9, P343, DOI 10.1038/ni0408-343; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	33	156	164	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24192	24203		10.1074/jbc.M109.023044	http://dx.doi.org/10.1074/jbc.M109.023044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592497	Green Published, hybrid			2022-12-25	WOS:000269380200033
J	Mull, BB; Cox, J; Bui, T; Keyomarsi, K				Mull, B. B.; Cox, J.; Bui, T.; Keyomarsi, K.			Post-translational modification and stability of low molecular weight cyclin E	ONCOGENE			English	Article						cyclin E; phosphorylation; low molecular weight form; stability; cell cycle	BREAST-CANCER; UBIQUITIN LIGASE; TRANSGENIC MICE; IN-VIVO; PHOSPHORYLATION; INSTABILITY; CELLS; FORMS; CDK2; TUMORIGENESIS	Our laboratory has previously described the presence of five tumor-specific low molecular weight isoforms of cyclin E in both tumor cell lines and breast cancer patient biopsies. We have also shown that one of these low forms arises from an alternate start site, whereas the other four appear as two sets of doublets following cleavage through an elastase-like enzyme. However, the origin of both sets of doublets was unknown. Here, we demonstrate that the larger isoform of each doublet is the result of phosphorylation at a key degradation site. Through site-directed mutagenesis of different phosphorylation sites within the cyclin E protein, we discovered that phosphorylation of threonine 395 is responsible for generating the larger isoform of each doublet. Because phosphorylation of threonine 395 has been linked to the proteasome-mediated degradation of full length cyclin E, we examined the stability of T395A phospho-mutants in both non-tumorigenic mammary epithelial cells and tumor cells. The results revealed that the low molecular weight isoforms appear to be stable in both a tumor cell line and a non-tumor forming cell line regardless of the presence of this critical phosphorylation site. The stability of low molecular weight cyclin E may have implications for both tumorigenesis and treatment of tumors expressing them. Oncogene (2009) 28, 3167-3176; doi: 10.1038/onc.2009.182; published online 29 June 2009	[Keyomarsi, K.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 0066, Houston, TX 77030 USA; [Mull, B. B.; Keyomarsi, K.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Keyomarsi, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 0066, 1515 Holcombe Blvd, Houston, TX 77030 USA.	kkeyomar@mdanderson.org	Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849; Mull, Benjamin/0000-0001-8379-873X	National Institutes of Health [CA87458]; National Cancer Institute [P50CA116199]; Clayton Foundation [W81XWH-05-1-0255 03]; NATIONAL CANCER INSTITUTE [P50CA116199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clayton Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the following grants: National Institutes of Health CA87458 (to K Keyomarsi); National Cancer Institute P50CA116199 (project 2 to K Keyomarsi); Clayton Foundation (to K Keyomarsi) Department of Defense W81XWH-05-1-0255 03 (to B Mull).	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Akli S, 2007, CANCER RES, V67, P7212, DOI 10.1158/0008-5472.CAN-07-0599; Bales E, 2005, CANCER RES, V65, P692; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Delk NA, 2009, CANCER RES, V69, P2817, DOI 10.1158/0008-5472.CAN-08-4182; Harwell RM, 2000, CANCER RES, V60, P481; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Karsunky H, 1999, ONCOGENE, V18, P7816, DOI 10.1038/sj.onc.1203205; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nguyen HH, 2008, P NATL ACAD SCI USA, V105, P19750, DOI 10.1073/pnas.0806581105; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Smith APL, 2006, ONCOGENE, V25, P7245, DOI 10.1038/sj.onc.1209713; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wingate H, 2003, CELL CYCLE, V2, P461, DOI 10.4161/cc.2.5.464; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200	29	6	7	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3167	3176		10.1038/onc.2009.182	http://dx.doi.org/10.1038/onc.2009.182			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19561641	Bronze			2022-12-25	WOS:000269515100008
J	Narita, N; Tanemura, A; Murali, R; Scolyer, RA; Huang, S; Arigami, T; Yanagita, S; Chong, KK; Thompson, JF; Morton, DL; Hoon, DS				Narita, N.; Tanemura, A.; Murali, R.; Scolyer, R. A.; Huang, S.; Arigami, T.; Yanagita, S.; Chong, K. K.; Thompson, J. F.; Morton, D. L.; Hoon, D. S.			Functional RET G691S polymorphism in cutaneous malignant melanoma	ONCOGENE			English	Article						RET; polymorphism; mutation; melanoma; desmoplastic; BRAF	DESMOPLASTIC MELANOMA; NEUROTROPHIC FACTOR; TYROSINE KINASE; BRAF MUTATIONS; THYROID-CARCINOMA; CANCER; INHIBITION; CELLS; GENE; PROTOONCOGENE	RET proto-oncogene encodes a receptor tyrosine kinase whose ligand is glial cell line-derived neurotrophic factor (GDNF), and its polymorphism at G691S juxtamembrane region (RETp) is a germline polymorphism. Cutaneous melanomas, particularly the desmoplastic subtype, are highly neurotropic; thus we sought to determine the frequency of RETp in cutaneous melanoma and its functional responsiveness to GDNF. RETp was assessed in 71 non-desmoplastic cutaneous melanomas (non-DMs) and 70 desmoplastic melanomas (DMs). Melanoma cell lines with RETp, RET wild type (RETwt), BRAF V600E mutation (BRAFmt) or BRAF wild type (BRAFwt) were assessed for functional activity. RETp frequency was significantly higher in DMs (61%) than in non-DMs (31%, P<0.001). BRAFmt was detected in only 11% of DMs. GDNF stimulation significantly amplified cell proliferation, migration and invasion in RETp, but not in RETwt melanoma cells. GDNF stimulation of RETp cell lines enhanced phosphorylation of extracellular signal-regulated kinase (ERK) and Akt of the RET-RAS-RAF-ERK and RET-phosphatidylinositol 3-kinase (PI3K)-Akt pathways, respectively. GDNF response of RETp cells in signal transduction and other functional studies were not affected by BRAFmt. The study demonstrates that RETp is frequently found in cutaneous melanoma, particularly desmoplastic subtypes, and responds to GDNF inducing events favorable for tumor progression. Oncogene (2009) 28, 3058-3068; doi:10.1038/onc.2009.164; published online 29 June 2009	[Narita, N.; Tanemura, A.; Huang, S.; Arigami, T.; Yanagita, S.; Chong, K. K.; Hoon, D. S.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA; [Murali, R.; Scolyer, R. A.] Royal Prince Alfred Hosp, Sydney Canc Ctr, Dept Anat Pathol, Camperdown, NSW 2050, Australia; [Murali, R.; Scolyer, R. A.; Thompson, J. F.] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney Melanoma Unit, Camperdown, NSW 2050, Australia; [Morton, D. L.] St Johns Hlth Ctr, John Wayne Canc Inst, Div Surg Oncol, Santa Monica, CA 90404 USA	John Wayne Cancer Institute; University of Sydney; Melanoma Institute Australia; University of Sydney; John Wayne Cancer Institute	Hoon, DS (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	hoon@jwci.org	Scolyer, Richard/AAE-8511-2019; Narita, Norihiko/AAA-4801-2022; Thompson, John/F-9075-2013; Hoon, Dave SB/C-7146-2018; MURALI, RAJMOHAN/A-7960-2008	Scolyer, Richard/0000-0002-8991-0013; Narita, Norihiko/0000-0001-9765-9669; Thompson, John/0000-0002-2816-2496; Hoon, Dave SB/0000-0003-1915-3683; MURALI, RAJMOHAN/0000-0001-6988-4295	National Institutes of Health; National Cancer Institute [P0 CA029605, CA012582]; Ruth and Martin H Weil Foundation; Leslie and Susan Gonda Foundation; Melanoma Foundation of the University of Sydney, Australia; NATIONAL CANCER INSTITUTE [P01CA012582, P01CA029605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth and Martin H Weil Foundation; Leslie and Susan Gonda Foundation; Melanoma Foundation of the University of Sydney, Australia(University of Sydney); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Sandy L Nguyen and Linhda Nguyen for expert editorial assistance and Emily H Liang for technical assistance. This work was supported by the National Institutes of Health, National Cancer Institute (Project II P0 CA029605 and CA012582 grants to DH); Ruth and Martin H Weil Foundation (to DH); the Leslie and Susan Gonda Foundation (to DH) and the Melanoma Foundation of the University of Sydney, Australia (to JT, RS, RM).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bounacer A, 2002, BRIT J CANCER, V86, P1929, DOI 10.1038/sj.bjc.6600371; Busam KJ, 2005, ADV ANAT PATHOL, V12, P92, DOI 10.1097/01.pap.0000155071.86944.a6; Busam KJ, 2005, J INVEST DERMATOL, V124, P412, DOI 10.1111/j.0022-202X.2004.23600.x; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; CECCHERINI I, 1994, ONCOGENE, V9, P3025; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davison JM, 2005, CANCER-AM CANCER SOC, V103, P788, DOI 10.1002/cncr.20861; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P3579, DOI 10.1210/jc.2003-031898; Fujiwara Y, 1999, CANCER RES, V59, P1567; Goto Y, 2006, CANCER RES, V66, P4443, DOI 10.1158/0008-5472.CAN-05-2505; Goto Y, 2008, MOL CANCER THER, V7, P3642, DOI 10.1158/1535-7163.MCT-08-0582; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Hoon DSB, 2001, J INVEST DERMATOL, V117, P375, DOI 10.1046/j.0022-202x.2001.01417.x; IWAMOTO T, 1993, ONCOGENE, V8, P1087; Jaroszewski DE, 2001, AM J SURG, V182, P590, DOI 10.1016/S0002-9610(01)00819-4; Kodama Y, 2005, CANCER SCI, V96, P143, DOI 10.1111/j.1349-7006.2005.00023.x; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Livestro DP, 2005, J CLIN ONCOL, V23, P6739, DOI 10.1200/JCO.2005.04.515; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mologni L, 2006, J MOL ENDOCRINOL, V37, P199, DOI 10.1677/jme.1.01999; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Quinn MJ, 1998, CANCER-AM CANCER SOC, V83, P1128, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.3.CO;2-Y; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Selek U, 2004, INT J RADIAT ONCOL, V59, P1097, DOI 10.1016/j.ijrobp.2003.12.037; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Shinozaki M, 2007, CLIN CANCER RES, V13, P2068, DOI 10.1158/1078-0432.CCR-06-2120; Stephens LA, 2005, THYROID, V15, P100, DOI 10.1089/thy.2005.15.100; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Weber F, 2008, J CLIN ENDOCR METAB, V93, P1097, DOI 10.1210/jc.2008-0212; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037	42	55	63	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2009	28	34					3058	3068		10.1038/onc.2009.164	http://dx.doi.org/10.1038/onc.2009.164			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	487ZU	19561646	Green Accepted			2022-12-25	WOS:000269319000005
J	Pruitt, RN; Chagot, B; Cover, M; Chazin, WJ; Spiller, B; Lacy, DB				Pruitt, Rory N.; Chagot, Benjamin; Cover, Michael; Chazin, Walter J.; Spiller, Ben; Lacy, D. Borden			Structure-Function Analysis of Inositol Hexakisphosphate-induced Autoprocessing in Clostridium difficile Toxin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE DOMAIN; RTX TOXIN; CLEAVAGE; CELLS; GLUCOSYLATION; SITE	The action of Clostridium difficile toxins A and B depends on inactivation of host small G-proteins by glucosylation. Cellular inositol hexakisphosphate (InsP6) induces an autocatalytic cleavage of the toxins, releasing an N-terminal glucosyltransferase domain into the host cell cytosol. We have defined the cysteine protease domain (CPD) responsible for autoprocessing within toxin A (TcdA) and report the 1.6 angstrom x-ray crystal structure of the domain bound to InsP6. InsP6 is bound in a highly basic pocket that is separated from an unusual active site by a beta-flap structure. Functional studies confirm an intramolecular mechanism of cleavage and highlight specific residues required for InsP6-induced TcdA processing. Analysis of the structural and functional data in the context of sequences from similar and diverse origins highlights a C-terminal extension and a pi-cation interaction within the beta-flap that appear to be unique among the large clostridial cytotoxins.	[Pruitt, Rory N.; Cover, Michael; Spiller, Ben; Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.; Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Spiller, Ben] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lacy, DB (corresponding author), A-5301 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Lacy, D. Borden/AFQ-2203-2022; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; Lacy, Borden/0000-0003-2273-8121; Cover, Michael/0000-0003-4136-3599	National Institutes of Health [RO1 GM075156]; Cellular and Molecular Microbiology Training; Germs and Defense Summer Science Academy; Vanderbilt University Medical Center development; United States Department of Energy; Office of Science; Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Microbiology Training; Germs and Defense Summer Science Academy; Vanderbilt University Medical Center development; United States Department of Energy(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM075156 (to W. J. C.). This work was also supported by a Cellular and Molecular Microbiology Training Grant (to R. N. P.), the Germs and Defense Summer Science Academy (to M. C.), and Vanderbilt University Medical Center development funds. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; MCFARLAND LV, 1986, AM J INFECT CONTROL, V14, P99, DOI 10.1016/0196-6553(86)90018-0; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2009, PROTEIN SCI, V18, P856, DOI 10.1002/pro.78; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	29	89	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21934	21940		10.1074/jbc.M109.018929	http://dx.doi.org/10.1074/jbc.M109.018929			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553670	Green Published, hybrid			2022-12-25	WOS:000268783700018
J	Hocknull, SA; White, MA; Tischler, TR; Cook, AG; Calleja, ND; Sloan, T; Elliott, DA				Hocknull, Scott A.; White, Matt A.; Tischler, Travis R.; Cook, Alex G.; Calleja, Naomi D.; Sloan, Trish; Elliott, David A.			New Mid-Cretaceous (Latest Albian) Dinosaurs from Winton, Queensland, Australia	PLOS ONE			English	Article							CARNOSAUR DINOSAURIA; SP NOV.; THEROPODA; SAUROPOD; GEN.; PHYLOGENY	Background: Australia's dinosaurian fossil record is exceptionally poor compared to that of other similar-sized continents. Most taxa are known from fragmentary isolated remains with uncertain taxonomic and phylogenetic placement. A better understanding of the Australian dinosaurian record is crucial to understanding the global palaeobiogeography of dinosaurian groups, including groups previously considered to have had Gondwanan origins, such as the titanosaurs and carcharodontosaurids. Methodology/Principal Findings: We describe three new dinosaurs from the late Early Cretaceous (latest Albian) Winton Formation of eastern Australia, including; Wintonotitan wattsi gen. et sp. nov., a basal titanosauriform; Diamantinasaurus matildae gen. et sp. nov., a derived lithostrotian titanosaur; and Australovenator wintonensis gen. et sp. nov., an allosauroid. We compare an isolated astragalus from the Early Cretaceous of southern Australia; formerly identified as Allosaurus sp., and conclude that it most-likely represents Australovenator sp. Conclusion/Significance: The occurrence of Australovenator from the Aptian to latest Albian confirms the presence in Australia of allosauroids basal to the Carcharodontosauridae. These new taxa, along with the fragmentary remains of other taxa, indicate a diverse Early Cretaceous sauropod and theropod fauna in Australia, including plesiomorphic forms (e. g. Wintonotitan and Australovenator) and more derived forms (e. g. Diamantinasaurus).			Hocknull, SA (corresponding author), Queensland Museum, Hendra, Qld, Australia.	scott.hocknull@qm.qld.gov.au	Calleja, Neville/E-3895-2019	Calleja, Neville/0000-0003-1800-2103; Hocknull, Scott/0000-0003-4157-8434; White, Matt/0000-0002-4765-0356				AGNOLIN FL, 2005, AMEGHINIANA S4, V42, pR13; Apesteguia S, 2005, LIFE O PAST, P321; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; BLAKEY R, 2009, MOLLEWIDE PLATE TECT; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; BURGER D, 1986, GEOL SOC AUST SPEC P, V12, P53; Canudo JI, 2008, J VERTEBR PALEONTOL, V28, P712, DOI 10.1671/0272-4634(2008)28[712:ANSTSG]2.0.CO;2; Clifford HT, 2005, REV PALAEOBOT PALYNO, V134, P71, DOI 10.1016/j.revpalbo.2004.12.001; Cook Alex G., 2005, Memoirs of the Queensland Museum, V51, P406; COOMBS W P JR, 1981, Memoirs of the Queensland Museum, V20, P351; Currie Philip J., 2006, Journal of the Paleontological Society of Korea, V22, P173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dettmann ME, 2009, CRETACEOUS RES, V30, P339, DOI 10.1016/j.cretres.2008.07.015; Dettmann Mary E., 2000, Memoirs of the Queensland Museum, V45, P285; Riga BJG, 2009, CRETACEOUS RES, V30, P135, DOI 10.1016/j.cretres.2008.06.006; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; HOCKNULL S, 2006, AUSTR AGE DINOSAURS, V4, P67; HOCKNULL S, 2005, AUSTR AGE DINOSAURS, V3, P27; Hocknull S. A., 2008, Memoirs of the Queensland Museum, V52, P212; Hocknull Scott A., 1997, Memoirs of the Queensland Museum, V42, P223; Hocknull Scott A., 2000, Memoirs of the Queensland Museum, V45, P405; Jell P. A., 2004, Memoirs of the Queensland Museum, V50, P1; Kemp A, 1997, J VERTEBR PALEONTOL, V17, P26, DOI 10.1080/02724634.1997.10010949; LONG J.A., 1998, DINOSAURS AUSTR NZ O; Longman H. A., 1933, Memoirs of the Queensland Museum, V10, P131; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; McLoughlin Stephen, 1995, Memoirs of the Queensland Museum, V38, P273; MOLNAR RE, 1981, ALCHERINGA, V5, P141, DOI 10.1080/03115518108565427; MOLNAR RE, 1985, J PALEONTOL, V59, P1511; MOLNAR RE, 2000, ASOCIACION PALEONTOL, V7, P139; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Salisbury S, 2007, J VERTEBR PALEONTOL, V27, p138A; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; SCANLON J, 2006, EVOLUTION BIOGEOGRAP, pCH15; Scanlon J.D., 2008, T KANSAS ACAD SCI, P131; SENIOR BR, 1978, GEOLOGY GEOPHYS B, V167, P1; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith ND, 2008, P ROYAL SOC B, V275, P1647; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Vickers-Rich P., 1993, WILDLIFE GONDWANA; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P1; WELLES SP, 1983, J PALEONTOL, V57, P196; Wilson J.H., 2009, THE J, V1, P1; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325	51	166	171	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6190	10.1371/journal.pone.0006190	http://dx.doi.org/10.1371/journal.pone.0006190			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19584929	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806300016
J	Abbas, AR; Wolslegel, K; Seshasayee, D; Modrusan, Z; Clark, HF				Abbas, Alexander R.; Wolslegel, Kristen; Seshasayee, Dhaya; Modrusan, Zora; Clark, Hilary F.			Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus	PLOS ONE			English	Article								Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease with a complex spectrum of cellular and molecular characteristics including several dramatic changes in the populations of peripheral leukocytes. These changes include general leukopenia, activation of B and T cells, and maturation of granulocytes. The manifestation of SLE in peripheral blood is central to the disease but is incompletely understood. A technique for rigorously characterizing changes in mixed populations of cells, microarray expression deconvolution, has been applied to several areas of biology but not to SLE or to blood. Here we demonstrate that microarray expression deconvolution accurately quantifies the constituents of real blood samples and mixtures of immune-derived cell lines. We characterize a broad spectrum of peripheral leukocyte cell types and states in SLE to uncover novel patterns including: specific activation of NK and T helper lymphocytes, relationships of these patterns to each other, and correlations to clinical variables and measures. The expansion and activation of monocytes, NK cells, and T helper cells in SLE at least partly underlie this disease's prominent interferon signature. These and other patterns of leukocyte dynamics uncovered here correlate with disease severity and treatment, suggest potential new treatments, and extend our understanding of lupus pathology as a complex autoimmune disease involving many arms of the immune system.			Abbas, AR (corresponding author), Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA.	abbas@gene.com						Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P23, DOI 10.1093/bioinformatics/bth915; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Chan RWY, 2006, RHEUMATOLOGY, V45, P951, DOI 10.1093/rheumatology/kel029; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; DAVIS P, 1977, ANN RHEUM DIS, V36, P157, DOI 10.1136/ard.36.2.157; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Green MRJ, 2007, ARTHRITIS RHEUM-US, V56, P303, DOI 10.1002/art.22326; Green MRJ, 2005, CLIN EXP IMMUNOL, V141, P165, DOI 10.1111/j.1365-2249.2005.02822.x; Hahn BH, 2005, ANN NY ACAD SCI, V1051, P433, DOI 10.1196/annals.1361.085; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; Lit LCW, 2007, J RHEUMATOL, V34, P89; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Maas K, 2002, J IMMUNOL, V169, P5, DOI 10.4049/jimmunol.169.1.5; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Pisetsky DS, 2008, AUTOIMMUN REV, V8, P69, DOI 10.1016/j.autrev.2008.07.028; Rastin Maryam, 2007, Iran J Immunol, V4, P110; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Richez C, 2009, J IMMUNOL, V182, P820, DOI 10.4049/jimmunol.182.2.820; RIVERO SJ, 1978, ARTHRITIS RHEUM, V21, P295, DOI 10.1002/art.1780210302; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Speed T., 2003, STAT ANAL GENE EXPRE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RDC, 2019, R LANG ENV STAT COMP; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Xu LT, 2004, NAT MED, V10, P411, DOI 10.1038/nm1005; Zimmer J, 2008, EUR J IMMUNOL, V38, P2942, DOI 10.1002/eji.200838813	35	271	277	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6098	10.1371/journal.pone.0006098	http://dx.doi.org/10.1371/journal.pone.0006098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568420	Green Published, Green Submitted, gold			2022-12-25	WOS:000267572200004
J	Liu, DH; Shen, XD; Zhai, Y; Lam, WS; Liao, JY; Busuttil, RW; Ghobrial, RM				Liu, Dahai; Shen, Xiu-Da; Zhai, Yuan; Lam, Wengsi; Liao, Jingying; Busuttil, Ronald W.; Ghobrial, Rafik M.			Intragraft Selection of the T Cell Receptor Repertoire by Class I MHC Sequences in Tolerant Recipients	PLOS ONE			English	Article							EXTRACTED HISTOCOMPATIBILITY ANTIGEN; INFECTIOUS TOLERANCE; ALLOGRAFT-REJECTION; IMMUNE-RESPONSE; PEPTIDES; TRANSPLANTATION; DETERMINANT; CYCLOSPORINE; RECOGNITION; MULTIPLE	Background: Allograft tolerance of ACI (RT1(a)) recipients to WF (RT1(u)) hearts can be induced by allochimeric class I MHC molecules containing donor-type (RT1A(u)) immunogenic epitopes displayed on recipient-type (RT1A(a)) sequences. Here, we sought the mechanisms by which allochimeric sequences may affect responding T cells through T cell receptor (TCA) repertoire restriction. Methodology/Principal Findings: The soluble [alpha(u)(1h)]-RT1.A(a) allochimeric molecule was delivered into ACI recipients of WF hearts in the presence of sub-therapeutic dose of cyclosporine (CsA). The TCR V beta spectrotyping of the splenocytes and cardiac allografts showed that the V beta gene families were differentially expressed within the TCR repertoire in allochimericor high-dose CsA-treated tolerant recipients at day + 5 and + 7 of post-transplantation. However, at day 30 of post-transplantation the allochimeric molecule-treated rats showed the restriction of TCR repertoire with altered dominant size peaks representing preferential clonal expansion of V beta 7, V beta 11, V beta 13, V beta 14, and V beta 15 genes. Moreover, we found a positive correlation between the alteration of Vb profile, restriction of TCR repertoire, and the establishment of allograft tolerance. Conclusions: Our findings indicate that presentation of allochimeric MHC class I sequences that partially mimic donor and recipient epitopes may induce unique tolerant state by selecting alloresponsive V beta genes.			Liu, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA.	RMGhobrial@tmhs.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042223, R01AI023847, R01AI049945] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042223, R01 AI049945, R01 AI023847, R01 AI49945, AI42223, R01 AI23847] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENICHOU G, 1994, J IMMUNOL, V153, P938; Binder J, 1996, TRANSPLANTATION, V61, P804, DOI 10.1097/00007890-199603150-00022; Bradley J A, 1996, Int Rev Immunol, V13, P245, DOI 10.3109/08830189609061751; Brouard S, 1999, J IMMUNOL, V162, P3367; CLAYTON JP, 1989, J EXP MED, V169, P1681, DOI 10.1084/jem.169.5.1681; COCHET M, 1992, EUR J IMMUNOL, V22, P2639, DOI 10.1002/eji.1830221025; Colovai A I, 1996, Int Rev Immunol, V13, P161, DOI 10.3109/08830189609061745; DIDLAKE R, 1988, TRANSPLANTATION, V46, P743, DOI 10.1097/00007890-198811000-00022; Frasca L, 2000, TRANSPLANTATION, V70, P631, DOI 10.1097/00007890-200008270-00017; Gagne K, 2000, J IMMUNOL, V164, P1553, DOI 10.4049/jimmunol.164.3.1553; GAMMON G, 1990, J IMMUNOL, V144, P1571; GAMMON G, 1987, IMMUNOL REV, V98, P53; Ghobrial RR, 1996, TRANSPLANTATION, V62, P1002, DOI 10.1097/00007890-199610150-00020; GOTO S, 1992, TRANSPLANTATION, V53, P705; Guillet M, 2002, J IMMUNOL, V168, P5088, DOI 10.4049/jimmunol.168.10.5088; ITO T, 1990, TRANSPLANTATION, V49, P422, DOI 10.1097/00007890-199002000-00038; Kumar V, 1996, J EXP MED, V184, P1609, DOI 10.1084/jem.184.5.1609; Liu ZR, 1996, J CLIN INVEST, V98, P1150, DOI 10.1172/JCI118898; LIU ZR, 1993, J IMMUNOL, V150, P3180; Maini MK, 1999, IMMUNOL TODAY, V20, P262, DOI 10.1016/S0167-5699(99)01472-3; Melchior B, 2005, EXP NEUROL, V192, P373, DOI 10.1016/j.expneurol.2004.11.031; Murphy B, 1999, J AM SOC NEPHROL, V10, P1346; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Onodera K, 1997, J IMMUNOL, V158, P1572; Onodera K, 1997, TRANSPL P, V29, P1290, DOI 10.1016/S0041-1345(96)00522-2; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; REEMTSEN B, 1999, SURG FORUM, V3, P395; Sayegh M H, 1996, Int Rev Immunol, V13, P221, DOI 10.3109/08830189609061749; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; Sebille F, 2001, J IMMUNOL, V167, P3082, DOI 10.4049/jimmunol.167.6.3082; Semiletova NV, 2005, TRANSPLANTATION, V80, P1535, DOI 10.1097/01.tp.0000188952.10692.18; SHIRWAN H, 1995, TRANSPLANTATION, V59, P401, DOI 10.1097/00007890-199502150-00016; SHIRWAN H, 1993, J IMMUNOL, V151, P5228; SHOSKES DA, 1994, IMMUNOL TODAY, V15, P32, DOI 10.1016/0167-5699(94)90023-X; Singer JS, 2001, TRANSPLANTATION, V72, P1408, DOI 10.1097/00007890-200110270-00014; Sitaru AG, 2002, HUM IMMUNOL, V63, P871, DOI 10.1016/S0198-8859(02)00452-4; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; Steinman L, 2001, J CLIN IMMUNOL, V21, P93, DOI 10.1023/A:1011020225433; Vella JP, 1997, TRANSPLANTATION, V64, P795, DOI 10.1097/00007890-199709270-00001; Vignes C, 2000, J IMMUNOL, V165, P96, DOI 10.4049/jimmunol.165.1.96; von Boehmer H, 2006, J IMMUNOL, V176, P3, DOI 10.4049/jimmunol.176.1.3; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2; Zhai Y, 2001, TRANSPLANTATION, V71, P1701, DOI 10.1097/00007890-200106270-00001	44	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6076	10.1371/journal.pone.0006076	http://dx.doi.org/10.1371/journal.pone.0006076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562081	gold, Green Submitted, Green Published			2022-12-25	WOS:000267465900011
J	Trudel, S; Kelly, M; Fritsch, J; Nguyen-Khoa, T; Therond, P; Couturier, M; Dadlez, M; Debski, J; Touqui, L; Vallee, B; Ollero, M; Edelman, A; Brouillard, F				Trudel, Stephanie; Kelly, Mairead; Fritsch, Janine; Nguyen-Khoa, Thao; Therond, Patrice; Couturier, Martine; Dadlez, Michal; Debski, Janusz; Touqui, Lhousseine; Vallee, Benoit; Ollero, Mario; Edelman, Aleksander; Brouillard, Franck			Peroxiredoxin 6 Fails to Limit Phospholipid Peroxidation in Lung from Cftr-Knockout Mice Subjected to Oxidative Challenge	PLOS ONE			English	Article								Oxidative stress plays a prominent role in the pathophysiology of cystic fibrosis (CF). Despite the presence of oxidative stress markers and a decreased antioxidant capacity in CF airway lining fluid, few studies have focused on the oxidant/antioxidant balance in CF cells. The aim of the current study was to investigate the cellular levels of reactive oxygen species (ROS), oxidative damage and enzymatic antioxidant defenses in the lung of Cftr-knockout mice in basal conditions and as a response to oxidative insult. The results show that endogenous ROS and lipid peroxidation levels are higher in Cftr(-/-) lung when compared to wild-type (Cftr(+/+)) in basal conditions, despite a strong enzymatic antioxidant response involving superoxide dismutases, glutathione peroxidases and peroxiredoxin 6 (Prdx6). The latter has the unique capacity to directly reduce membrane phospholipid hydroperoxides (PL-OOH). A dramatic increase in PL-OOH levels in Cftr(-/-) lung consecutive to in vivo oxidative challenge by paraquat (PQ) unmasks a susceptibility to phospholipid peroxidation. PQ strongly decreases Prdx6 expression in Cftr(-/-) mice compared to Cftr(+/+). Similar results were obtained after P. aeruginosa LPS challenge. Two-dimensional gel analysis of Prdx6 revealed one main molecular form in basal conditions and a PQ-induced form only detected in Cftr(+/+) lung. Mass spectrometry experiments suggested that, as opposed to the main basal form, the one induced by PQ is devoid of overoxidized catalytic Cys47 and could correspond to a fully active form that is not induced in Cftr(-/-) lung. These results highlight a constitutive redox imbalance and a vulnerability to oxidative insult in Cftr(-/-) lung and present Prdx6 as a key component in CF antioxidant failure. This impaired PL-OOH detoxification mechanism may enhance oxidative damage and stress-related signaling, contributing to an exaggerated inflammatory response in CF lung.			Trudel, S (corresponding author), Univ Paris 05, Fac Med, INSERM, U845, Paris, France.	aleksander.edelman@inserm.fr	Ollero, Mario/AAJ-3545-2020; Debski, Janusz/I-4721-2015; Debski, Janusz/D-8138-2015; Ollero, Mario/Q-6147-2018	Debski, Janusz/0000-0002-8898-7692; Debski, Janusz/0000-0002-0171-7797; Ollero, Mario/0000-0003-3590-706X; Dadlez, Michal/0000-0001-8811-5176; NGUYEN-KHOA, Thao/0000-0003-3738-7299				Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Chen JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003367; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Cottart CH, 2007, PEDIATR RES, V62, P528, DOI 10.1203/PDR.0b013e318155a61d; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2007, FREE RADICAL BIO MED, V42, P1017, DOI 10.1016/j.freeradbiomed.2006.12.031; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Fujii T, 2001, EUR J BIOCHEM, V268, P218, DOI 10.1046/j.1432-1033.2001.01843.x; Fukuhara R, 2005, COMP BIOCHEM PHYS B, V141, P428, DOI 10.1016/j.cbpc.2005.05.002; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Halliwell B, 1997, J NEUROCHEM, V69, P1330; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; Kim HS, 2003, AM J PHYSIOL-LUNG C, V285, pL363, DOI 10.1152/ajplung.00078.2003; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Medjane S, 2005, AM J PHYSIOL-LUNG C, V289, pL816, DOI 10.1152/ajplung.00466.2004; Montuschi P, 2000, THORAX, V55, P205, DOI 10.1136/thorax.55.3.205; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ollero M, 2006, PROTEOMICS, V6, P4084, DOI 10.1002/pmic.200600028; Pak JH, 2006, EXP EYE RES, V82, P899, DOI 10.1016/j.exer.2005.10.017; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; QU F, 2008, CHEM BIOL INTERACT; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; Saadane A, 2005, J ALLERGY CLIN IMMUN, V115, P405, DOI 10.1016/j.jaci.2004.10.044; Saadane A, 2006, J ALLERGY CLIN IMMUN, V117, P1163, DOI 10.1016/j.jaci.2006.01.052; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Simpson D, 2000, MOL VIS, V6, P178; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Starosta V, 2006, CHEST, V129, P431, DOI 10.1378/chest.129.2.431; THEROND P, 1993, LIPIDS, V28, P245, DOI 10.1007/BF02536647; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Velsor LW, 2001, AM J PHYSIOL-LUNG C, V281, pL31, DOI 10.1152/ajplung.2001.281.1.L31; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2004, FREE RADICAL BIO MED, V37, P1736, DOI 10.1016/j.freeradbiomed.2004.09.006; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	56	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6075	10.1371/journal.pone.0006075	http://dx.doi.org/10.1371/journal.pone.0006075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562038	gold, Green Submitted, Green Published			2022-12-25	WOS:000267465900010
J	Baker, ME; Chang, DJ; Chandsawangbhuwana, C				Baker, Michael E.; Chang, David J.; Chandsawangbhuwana, Charlie			3D Model of Lamprey Estrogen Receptor with Estradiol and 15 alpha-Hydroxy-Estradiol	PLOS ONE			English	Article								Background: Lamprey, basal vertebrate, is an important model system for understanding early events in vertebrate evolution. Lamprey contains orthologs of the estrogen receptor [ER], progesterone receptor and corticoid receptor. A perplexing property of lamprey is that 15 alpha-hydroxy-steroids are active steroids. For example, 15 alpha-hydroxy-estradiol [15 alpha-OH-E2] is the estrogen, instead of estradiol [E2]. To investigate how 15 alpha-OH-E2 binds lamprey ER, we constructed a 3D model of the lamprey ER with E2 and 15 alpha-OH-E2. Methodology: We used the 3D structure of human ER alpha as a template to construct a 3D model of lamprey ER. E2 and 15 alpha-OH-E2 were inserted into the 3D model of lamprey ER and 15 alpha-OH-E2 was inserted into human ERa. Then the each steroid-protein complex was refined using Discover 3 from Insight II software. To determine if lamprey ER had some regions that were unique among vertebrate ERs, we used the ligand-binding domain of lamprey ER as a query for a BLAST search of GenBank. Principal Findings: Our 3D model of lamprey ER with 15 alpha-OH-E2 shows that Sd on Met-409 can form a hydrogen bond with the 15 alpha-hydroxyl on 15 alpha-OH-E2. In human ER alpha, the corresponding residue Ile-424 has a van der Waals contact with 15 alpha-OH-E2. BLAST analysis of GenBank indicates that among vertebrate ERs, only lamprey ER contains a methionine at this position. Thus, the contact between S delta on Met-409 and 15 alpha-OH-E2 is unique. Interestingly, BLAST finds that five New World monkeys and a sturgeon contain a valine instead of isoleucine. Significance: In addition to shedding light on the structure of the ER in a basal vertebrate, our 3D model of lamprey ER should prove useful in virtual screening of chemical libraries to identify compounds for controlling reproduction in sea lamprey, an environmental pest in Lake Michigan.			Baker, ME (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbaker@ucsd.edu	Baker, Michael/ABB-8508-2020	Baker, Michael/0000-0003-4387-3269				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker ME, 2003, BIOESSAYS, V25, P396, DOI 10.1002/bies.10252; Baker ME, 2001, J MOL ENDOCRINOL, V26, P119, DOI 10.1677/jme.0.0260119; Baker ME, 1997, MOL CELL ENDOCRINOL, V135, P101, DOI 10.1016/S0303-7207(97)00207-4; Baker ME, 2008, BIOCHEM BIOPH RES CO, V371, P724, DOI 10.1016/j.bbrc.2008.04.152; Baker ME, 2007, ENDOCRINOLOGY, V148, P3551, DOI 10.1210/en.2007-0547; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; Bryan MB, 2006, GEN COMP ENDOCR, V146, P149, DOI 10.1016/j.ygcen.2005.11.003; Bryan MB, 2004, STEROIDS, V69, P473, DOI 10.1016/j.steroids.2004.04.004; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Escriva H, 2000, BIOESSAYS, V22, P717; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Hsieh RW, 2008, STEROIDS, V73, P59, DOI 10.1016/j.steroids.2007.08.014; Katsu Y, 2008, ENDOCRINOLOGY, V149, P6300, DOI 10.1210/en.2008-0670; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lowartz S, 2003, COMP BIOCHEM PHYS A, V134, P365, DOI 10.1016/S1095-6433(02)00285-4; Lowartz SM, 2004, COMP BIOCHEM PHYS B, V138, P119, DOI 10.1016/j.cbpc.2004.02.015; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Mizuta T, 2007, ENDOCRINOLOGY, V148, P3554, DOI 10.1210/en.2007-0109; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Paris M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-219; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauka-Spengler T, 2008, BIOL BULL-US, V214, P303, DOI 10.2307/25470671; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775	31	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6038	10.1371/journal.pone.0006038	http://dx.doi.org/10.1371/journal.pone.0006038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557178	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356900002
J	Teng, NJ; Jin, B; Wang, QL; Hao, HQ; Ceulemans, R; Kuang, TY; Lin, JX				Teng, Nianjun; Jin, Biao; Wang, Qinli; Hao, Huaiqing; Ceulemans, Reinhart; Kuang, Tingyun; Lin, Jinxing			No Detectable Maternal Effects of Elevated CO2 on Arabidopsis thaliana Over 15 Generations	PLOS ONE			English	Article								Maternal environment has been demonstrated to produce considerable impact on offspring growth. However, few studies have been carried out to investigate multi-generational maternal effects of elevated CO2 on plant growth and development. Here we present the first report on the responses of plant reproductive, photosynthetic, and cellular characteristics to elevated CO2 over 15 generations using Arabidopsis thaliana as a model system. We found that within an individual generation, elevated CO2 significantly advanced plant flowering, increased photosynthetic rate, increased the size and number of starch grains per chloroplast, reduced stomatal density, stomatal conductance, and transpiration rate, and resulted in a higher reproductive mass. Elevated CO2 did not significantly influence silique length and number of seeds per silique. Across 15 generations grown at elevated CO2 concentrations, however, there were no significant differences in these traits. In addition, a reciprocal sowing experiment demonstrated that elevated CO2 did not produce detectable maternal effects on the offspring after fifteen generations. Taken together, these results suggested that the maternal effects of elevated CO2 failed to extend to the offspring due to the potential lack of genetic variation for CO2 responsiveness, and future plants may not evolve specific adaptations to elevated CO2 concentrations.	[Teng, Nianjun; Wang, Qinli; Hao, Huaiqing; Kuang, Tingyun; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China; [Teng, Nianjun] Nanjing Agr Univ, Coll Horticulture, Nanjing, Peoples R China; [Jin, Biao] Yangzhou Univ, Coll Horticulture & Plant Protect, Yangzhou, Peoples R China; [Ceulemans, Reinhart] Univ Antwerp, Dept Biol, Antwerp, Belgium	Chinese Academy of Sciences; Institute of Botany, CAS; Nanjing Agricultural University; Yangzhou University; University of Antwerp	Teng, NJ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Environm Mol Physiol, Beijing, Peoples R China.	kuangty@ibcas.ac.cn; linjx@ibcas.ac.cn	Ceulemans, Reinhart J M/F-2109-2016	Ceulemans, Reinhart J M/0000-0003-4773-9358; Lin, Jinxing/0000-0001-9338-1356	National Science Fund of China [30700081, 30730009, 30870436, 90211005, 30225005]; International Foundation for Science [C/4560-1]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); International Foundation for Science(International Foundation for Science)	This work was supported by the National Science Fund of China (30700081, 30730009, 30870436, 90211005), the National Science Fund of China for Distinguished Young Scholars (30225005), and funding from the International Foundation for Science for Dr. Nianjun Teng (Reference No.C/4560-1).	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 2001, CLIMATE CHANGE 2001; BAZZAZ FA, 1995, P NATL ACAD SCI USA, V92, P8161, DOI 10.1073/pnas.92.18.8161; Bezemer TM, 1998, GLOB CHANGE BIOL, V4, P687, DOI 10.1046/j.1365-2486.1998.00184.x; Ceulemans R, 2002, GLOBAL CHANGE BIOL, V8, P153, DOI 10.1046/j.1354-1013.2001.00461.x; Cheng SH, 1998, PLANT PHYSIOL, V116, P715, DOI 10.1104/pp.116.2.715; Collins S, 2006, ECOL LETT, V9, P129, DOI 10.1111/j.1461-0248.2005.00854.x; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Edwards GR, 2001, NEW PHYTOL, V150, P359, DOI 10.1046/j.1469-8137.2001.00100.x; Erhardt A, 2005, OECOLOGIA, V146, P311, DOI 10.1007/s00442-005-0182-5; Ferris R, 2001, PLANT CELL ENVIRON, V24, P305, DOI 10.1046/j.1365-3040.2001.00684.x; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Gibeaut DM, 2001, J PLANT PHYSIOL, V158, P569, DOI 10.1078/0176-1617-00229; HATTENSCHWILER S, 1997, GLOBAL CHANGE BIOL, V3, P436; He JS, 2003, NEW PHYTOL, V157, P229, DOI 10.1046/j.1469-8137.2003.00660.x; Hou GuiLing, 2007, Acta Botanica Boreali-Occidentalia Sinica, V27, P1499; Idso SB, 1997, GLOB CHANGE BIOL, V3, P89, DOI 10.1046/j.1365-2486.1997.00053.x; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Jitla DS, 1997, PLANT PHYSIOL, V115, P15, DOI 10.1104/pp.115.1.15; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Kohut R, 2003, ENVIRON INT, V29, P171, DOI 10.1016/S0160-4120(02)00160-5; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Leishman MR, 1999, NEW PHYTOL, V144, P455, DOI 10.1046/j.1469-8137.1999.00544.x; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Steinger T, 2000, OECOLOGIA, V123, P475, DOI 10.1007/s004420000342; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Teng Nian-Jun, 2006, Zhiwu Shengtai Xuebao, V30, P1054; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Thurig B, 2003, GLOBAL CHANGE BIOL, V9, P873, DOI 10.1046/j.1365-2486.2003.00581.x; Wang XZ, 2005, AM J BOT, V92, P826, DOI 10.3732/ajb.92.5.826; Ward JK, 2000, OECOLOGIA, V123, P330, DOI 10.1007/s004420051019; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; Wieneke S, 2004, GLOBAL CHANGE BIOL, V10, P1389, DOI 10.1111/j.1365-2486.2004.00813.x; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; WU L, 1972, NATURE, V238, P167, DOI 10.1038/238167a0	45	20	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6035	10.1371/journal.pone.0006035	http://dx.doi.org/10.1371/journal.pone.0006035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557175	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356900001
J	Niino, Y; Hotta, K; Oka, K				Niino, Yusuke; Hotta, Kohji; Oka, Kotaro			Simultaneous Live Cell Imaging Using Dual FRET Sensors with a Single Excitation Light	PLOS ONE			English	Article								Fluorescence resonance energy transfer (FRET) between fluorescent proteins is a powerful tool for visualization of signal transduction in living cells, and recently, some strategies for imaging of dual FRET pairs in a single cell have been reported. However, these necessitate alteration of excitation light between two different wavelengths to avoid the spectral overlap, resulting in sequential detection with a lag time. Thus, to follow fast signal dynamics or signal changes in highly motile cells, a single-excitation dual-FRET method should be required. Here we reported this by using four-color imaging with a single excitation light and subsequent linear unmixing to distinguish fluorescent proteins. We constructed new FRET sensors with Sapphire/RFP to combine with CFP/YFP, and accomplished simultaneous imaging of cAMP and cGMP in single cells. We confirmed that signal amplitude of our dual FRET measurement is comparable to of conventional single FRET measurement. Finally, we demonstrated to monitor both intracellular Ca(2+) and cAMP in highly motile cardiac myocytes. To cancel out artifacts caused by the movement of the cell, this method expands the applicability of the combined use of dual FRET sensors for cell samples with high motility.			Niino, Y (corresponding author), Keio Univ, Sch Fundamental Sci & Technol, Ctr Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473				Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Ducros M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004418; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; GATTI G, 1988, BIOCHEM J, V255, P753, DOI 10.1042/bj2550753; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hartley R., 2004, ROBOTICA; Hiraoka Y, 2002, CELL STRUCT FUNCT, V27, P367, DOI 10.1247/csf.27.367; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Sato M, 2000, ANAL CHEM, V72, P5918, DOI 10.1021/ac0006167; Sawano A, 2002, BIOPHYS J, V82, P1076, DOI 10.1016/S0006-3495(02)75467-2; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Yaroslavsky L. P., 1985, DIGITAL PICTURE PROC; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	35	87	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6036	10.1371/journal.pone.0006036	http://dx.doi.org/10.1371/journal.pone.0006036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551140	gold, Green Published, Green Submitted			2022-12-25	WOS:000267356500018
J	Camprubi-Robles, M; Planells-Cases, R; Ferrer-Montiel, A				Camprubi-Robles, M.; Planells-Cases, R.; Ferrer-Montiel, A.			Differential contribution of SNARE-dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors	FASEB JOURNAL			English	Article						proalgesic agents; pain; analgesia; receptor; protein kinase C; CGRP	PROTEIN-KINASE-C; VANILLOID RECEPTOR TRPV1; NERVE GROWTH-FACTOR; SENSORY NEURONS; THERMAL HYPERALGESIA; DRG NEURONS; REGULATED EXOCYTOSIS; ACTIVATED CURRENTS; HEAT HYPERALGESIA; TYROSINE KINASE	Potentiation of the pain-integrator ion channel transient receptor potential vanilloid type 1 (TRPV1) underlies thermal hyperalgesia mediated by a variety of proinflammatory factors. Two complementary mechanisms of TRPV1 inflammatory sensitization have been proposed, namely a decrease of its activation threshold and an increment of its surface expression in nociceptors. Here we investigated the involvement of regulated exocytosis to the inflammatory sensitization of TRPV1 in rat neonatal dorsal root ganglion neurons by proalgesic agents. The contribution of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-dependent exocytosis was evaluated using a small peptide patterned after the synaptosomal-associated protein of 25 kDa (SNAP-25) protein that acts as a specific and potent inhibitor of neuronal exocytosis. We found that TRPV1 sensitization mediated by nerve growth factor, ATP, and IGF-I was accompanied by a higher channel expression in the neuronal plasma membrane, which was prevented by blockade of regulated exocytosis. In contrast, TRPV1 sensitization caused by bradykinin, IL-1 beta, and artemin was insensitive to inhibition of SNARE-dependent vesicular fusion and was not due to an increase in TRPV1 surface expression. Therefore, it appears that some, but not all, proinflammatory agents sensitize rat nociceptors by promoting the recruitment of TRPV1 channels to the neuronal surface. These findings support the tenet that SNARE complex-mediated exocytosis of TRPV1 may be a valid therapeutic target to treat inflammatory pain.-Camprubi-Robles, M., Planells-Cases, R., Ferrer-Montiel, A. Differential contribution of SNARE-dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors. FASEB J. 23, 3722-3733 (2009). www.fasebj.org	[Camprubi-Robles, M.; Ferrer-Montiel, A.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; [Planells-Cases, R.] Ctr Invest Principe Felipe, Valencia, Spain	Universidad Miguel Hernandez de Elche; Prince Felipe Research Center	Ferrer-Montiel, A (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Av Univ S-N, Alicante 03202, Spain.	aferrer@umh.es	Ferrer-Montiel, Antonio/C-3072-2015	Ferrer-Montiel, Antonio/0000-0002-2973-6607	el Ministerio de Ciencia e Innovacion (MICINN) [SAF2006-2580, SAF2007-63193]; Consolider-Ingenio [CSD2008-00005]; la Fundacio la Marato de TV3; la Generalitat Valenciana; Fondo Social Europeo	el Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); la Fundacio la Marato de TV3; la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by grants from el Ministerio de Ciencia e Innovacion (MICINN) (SAF2006-2580 to A.F.-M. and SAF2007-63193 to R.P.-C.); Consolider-Ingenio 2010 ( MICINN, CSD2008-00005 to A.F.-M and R.P.-C.); and la Fundacio la Marato de TV3 ( to A.F.-M. and R.P.-C.). M.C.-R. is a fellowship recipient from la Generalitat Valenciana, and R. P. C. is a recipient of the Fondo Social Europeo. A.F.-M. and M.C.-R. are inventors of compound DD04107 and have filed a patent application.	Blanes-Mira C, 2002, Int J Cosmet Sci, V24, P303, DOI 10.1046/j.1467-2494.2002.00153.x; Blanes-Mira C, 2004, J NEUROCHEM, V88, P124, DOI 10.1046/j.1471-4159.2003.02133.x; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Fischbach T, 2007, J NEUROPHYSIOL, V98, P929, DOI 10.1152/jn.01096.2006; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Klionsky L, 2006, J PHARMACOL EXP THER, V319, P192, DOI 10.1124/jpet.106.108092; Lakshmi S, 2005, CELL MOL NEUROBIOL, V25, P819, DOI 10.1007/s10571-005-4936-8; Lee SY, 2005, ARCH PHARM RES, V28, P405, DOI 10.1007/BF02977669; LEWIN GR, 1992, EUR J NEUROSCI, V4, P700, DOI 10.1111/j.1460-9568.1992.tb00179.x; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; Malin SA, 2008, PAIN, V138, P484, DOI 10.1016/j.pain.2008.01.026; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Messeguer A, 2006, CURR NEUROPHARMACOL, V4, P1, DOI 10.2174/157015906775202995; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; O'Dell DK, 2007, BIOORGAN MED CHEM, V15, P6164, DOI 10.1016/j.bmc.2007.06.032; Obreja O, 2002, FASEB J, V16, P1497, DOI 10.1096/fj.02-0101com; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Sugiura T, 2002, J NEUROPHYSIOL, V88, P544, DOI 10.1152/jn.2002.88.1.544; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	45	77	79	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3722	3733		10.1096/fj.09-134346	http://dx.doi.org/10.1096/fj.09-134346			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19584302				2022-12-25	WOS:000271272500010
J	Zaborske, JM; Narasimhan, J; Jiang, L; Wek, SA; Dittmar, KA; Freimoser, F; Pan, T; Wek, RC				Zaborske, John M.; Narasimhan, Jana; Jiang, Li; Wek, Sheree A.; Dittmar, Kimberly A.; Freimoser, Florien; Pan, Tao; Wek, Ronald C.			Genome-wide Analysis of tRNA Charging and Activation of the eIF2 Kinase Gcn2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAEMOPHILUS-INFLUENZAE YBAK; UNCHARGED TRANSFER-RNA; AMINO-ACID STARVATION; FACTOR 2-ALPHA KINASE; TRANSLATIONAL CONTROL; PROTEIN-KINASE; GENE-EXPRESSION; EIF2-ALPHA KINASE; SYNAPTIC PLASTICITY; SACCHAROMYCES-CEREVISIAE	When cells are subjected to nutritional stress, uncharged tRNAs accumulate and activate Gcn2p phosphorylation of eukaryotic initiation factor-2 (eIF2) and the general amino acid control pathway. The Gcn2p regulatory domain homologous to histidyl-tRNA synthetases is proposed to bind to uncharged tRNA, directly contributing to activation of Gcn2p. Here we apply a microarray technology to analyze genome-wide changes in tRNA charging in yeast upon activation of Gcn2p in response to amino acid starvation and high salinity, a stress not directly linked to nutritional deficiency. This microarray technology is applicable for all eukaryotic cells. Strains were starved for histidine, leucine, or tryptophan and shown to rapidly induce Gcn2p phosphorylation of eIF2. The relative charging level of all tRNAs was measured before and after starvation, and Gcn2p activation and the intracellular levels of the starved amino acid correlate with the observed decrease in tRNA charging. Interestingly, in some cases, tRNAs not charged with the starved amino acid became deacylated more rapidly than tRNAs charged with the starved amino acid. This increase in uncharged tRNA levels occurred although the intracellular levels for these non-starved amino acids remained unchanged. Additionally, treatment of a wild-type strain with high salinity stress showed transient changes in the charging of several different tRNAs. These results suggest that Gcn2p can be activated by many different tRNA species in the cell. These results also depict a complex cellular relationship between tRNA charging, amino acid availability, and non-nutrient stress. These relationships are best revealed by simultaneous monitoring of the charging level of all tRNAs.	[Zaborske, John M.; Dittmar, Kimberly A.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Narasimhan, Jana; Jiang, Li; Wek, Sheree A.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Freimoser, Florien] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pan, T (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	taopan@uchicago.edu; rwek@iupui.edu	Freimoser, Florian/A-6152-2014	Freimoser, Florian/0000-0001-7607-3108	National Institutes of Health [R01GM49164, T32GM007183-33]; Ajinomoto Inc., Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Inc., Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM49164 (to R. C. W.) from the National Institutes of Health and National Institutes of Health Training Grant T32GM007183-33) (to J.Z.). This work was also supported by a grant from Ajinomoto Inc., Japan (to T. P.)	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; Goossens A, 2001, J BIOL CHEM, V276, P30753, DOI 10.1074/jbc.M102960200; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kaiser C. S., 1994, METHODS YEAST GENETI, P207; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; MESSENGUY F, 1980, EUR J BIOCHEM, V108, P439, DOI 10.1111/j.1432-1033.1980.tb04740.x; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Palmer LK, 2002, GENETICS, V161, P563; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Qiu HF, 2002, GENE DEV, V16, P1271, DOI 10.1101/gad.979402; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2004, TOP CURR GENET, V7, P171; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	56	93	97	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25254	25267		10.1074/jbc.M109.000877	http://dx.doi.org/10.1074/jbc.M109.000877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19546227	hybrid, Green Published			2022-12-25	WOS:000269734000059
J	Miyata, M; Rikitake, Y; Takahashi, M; Nagamatsu, Y; Yamauchi, Y; Ogita, H; Hirata, K; Takai, Y				Miyata, Muneaki; Rikitake, Yoshiyuki; Takahashi, Motonori; Nagamatsu, Yuichi; Yamauchi, Yusuke; Ogita, Hisakazu; Hirata, Ken-ichi; Takai, Yoshimi			Regulation by Afadin of Cyclical Activation and Inactivation of Rap1, Rac1, and RhoA Small G Proteins at Leading Edges of Moving NIH3T3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; NECL-5/POLIOVIRUS RECEPTOR; CELLULAR MORPHOLOGY; FOCAL COMPLEXES; BINDING PROTEIN; JUNCTIONS; ADHESION; CDC42; AF-6; INTERACTS	Cyclical activation and inactivation of Rho family small G proteins, such as Rho, Rac, and Cdc42, are needed for moving cells to form leading edge structures in response to chemoattractants. However, the mechanisms underlying the dynamic regulation of their activities are not fully understood. We recently showed that another small G protein, Rap1, plays a crucial role in the platelet-derived growth factor (PDGF)-induced formation of leading edge structures and activation of Rac1 in NIH3T3 cells. We showed here that knockdown of afadin, an actin-binding protein, in NIH3T3 cells resulted in a failure to develop leading edge structures in association with an impairment of the activation of Rap1 and Rac1 and inactivation of RhoA in response to PDGF. Overexpression of a constitutively active mutant of Rap1 (Rap1-CA) and knockdown of SPA-1, a Rap1 GTPase-activating protein that was negatively regulated by afadin by virtue of binding to it, in afadin-knockdown NIH3T3 cells restored the formation of leading edge structures and the reduction of the PDGF-induced activation of Rac1 and inactivation of RhoA, suggesting that the inactivation of Rap1 by SPA-1 is responsible for inhibition of the formation of leading edge structures. The effect of Rap1-CA on the restoration of the formation of leading edge structures and RhoA inactivation was diminished by additional knockdown of ARAP1, a Rap-activated Rho GAP, which localized at the leading edges of moving NIH3T3 cells. These results indicate that afadin regulates the cyclical activation and inactivation of Rap1, Rac1, and RhoA through SPA-1 and ARAP1.	[Miyata, Muneaki; Rikitake, Yoshiyuki; Takahashi, Motonori; Nagamatsu, Yuichi; Yamauchi, Yusuke; Ogita, Hisakazu; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan; [Rikitake, Yoshiyuki; Takahashi, Motonori; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Yamauchi, Yusuke/D-2780-2015; Ogita, Hisakazu/AAE-4416-2020	Yamauchi, Yusuke/0000-0001-7854-927X; Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Foundation for Applied Enzymology	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	This work was supported by grants-in-aid for Scientific Research and for Cancer Research and, in part, by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2006-2008) and a research grant from the Japan Foundation for Applied Enzymology.	Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Ikeda W, 2001, ONCOGENE, V20, P3457, DOI 10.1038/sj.onc.1204463; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; Nakahara H, 2003, GENES CELLS, V8, P1019, DOI 10.1111/j.1365-2443.2003.00695.x; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	33	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24595	24609		10.1074/jbc.M109.016436	http://dx.doi.org/10.1074/jbc.M109.016436			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19589776	Green Published, hybrid			2022-12-25	WOS:000269380200069
J	Yamaji, N; Little, MJ; Nishio, H; Billen, B; Villegas, E; Nishiuchi, Y; Tytgat, J; Nicholson, GM; Corzo, G				Yamaji, Nahoko; Little, Michelle J.; Nishio, Hideki; Billen, Bert; Villegas, Elba; Nishiuchi, Yuji; Tytgat, Jan; Nicholson, Graham M.; Corzo, Gerardo			Synthesis, Solution Structure, and Phylum Selectivity of a Spider delta-Toxin That Slows Inactivation of Specific Voltage-gated Sodium Channel Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPION ALPHA-TOXINS; LETHAL NEUROTOXIN; PEPTIDE TOXINS; ATRAX-ROBUSTUS; RAT-BRAIN; MOLECULAR-MECHANISMS; MISSULENA-BRADLEYI; MEMBRANE PATCHES; BINDING; INSECT	Magi 4, now renamed delta-hexatoxin-Mg1a, is a 43-residue neurotoxic peptide from the venom of the hexathelid Japanese funnel-web spider (Macrothele gigas) with homology to delta-hexatoxins from Australian funnel-web spiders. It binds with high affinity to receptor site 3 on insect voltage-gated sodium (Na-V) channels but, unlike delta-hexatoxins, does not compete for the related site 3 in rat brain despite being previously shown to be lethal by intracranial injection. To elucidate differences in Na-V channel selectivity, we have undertaken the first characterization of a peptide toxin on a broad range of mammalian and insect Na-V channel subtypes showing that delta-hexatoxin-Mg1a selectively slows channel inactivation of mammalian Na(V)1.1, Na(V)1.3, and Na(V)1.6 but more importantly shows higher affinity for insect Na(V)1 (para) channels. Consequently, delta-hexatoxin-Mg1a induces tonic repetitive firing of nerve impulses in insect neurons accompanied by plateau potentials. In addition, we have chemically synthesized and folded delta-hexatoxin-Mg1a, ascertained the bonding pattern of the four disulfides, and determined its three-dimensional solution structure using NMR spectroscopy. Despite modest sequence homology, we show that key residues important for the activity of scorpion alpha-toxins and delta-hexatoxins are distributed in a topologically similar manner in delta-hexatoxin-Mg1a. However, subtle differences in the toxin surfaces are important for the novel selectivity of delta-hexatoxin-Mg1a for certain mammalian and insect Na-V channel subtypes. As such, delta-hexatoxin-Mg1a provides us with a specific tool with which to study channel structure and function and determinants for phylum-and tissue-specific activity.	[Little, Michelle J.; Nicholson, Graham M.] Univ Technol Sydney, Dept Med & Mol Biosci, Neurotoxin Res Grp, Sydney, NSW 2007, Australia; [Yamaji, Nahoko] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Nishio, Hideki; Nishiuchi, Yuji] Peptide Inst Inc, Prot Res Fdn, Osaka 5628686, Japan; [Billen, Bert; Tytgat, Jan] Univ Leuven, Toxicol Lab, B-3000 Leuven, Belgium; [Villegas, Elba] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Corzo, Gerardo] Univ Nacl Autonoma Mexico, Inst Biotecnologia, Cuernavaca 62210, Morelos, Mexico	University of Technology Sydney; Suntory Holdings Ltd; KU Leuven; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Nicholson, GM (corresponding author), Univ Technol Sydney, Dept Med & Mol Biosci, Neurotoxin Res Grp, Sydney, NSW 2007, Australia.	Graham.Nicholson@uts.edu.au; corzo@ibt.unam.mx	Corzo, Gerardo/B-3778-2014; Nicholson, Graham M/E-8136-2010; Tytgat, Jan/F-1560-2010	Corzo, Gerardo/0000-0002-9513-1622; Nicholson, Graham M/0000-0002-4277-4296; Tytgat, Jan/0000-0003-1778-6022; Villegas Villarreal, Elba Cristina/0000-0003-1795-0427	Direccion General de Asuntos del Personal Academico [IN220809-3]; CONACyT [49773/24968]; Australian Research Council Discovery [DP0559396]; Australian postgraduate award [G.0330.06, OT-05-64, UA p6/31]	Direccion General de Asuntos del Personal Academico; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Australian Research Council Discovery(Australian Research Council); Australian postgraduate award(Australian Government)	This work was supported in part by Direccion General de Asuntos del Personal Academico Grants IN220809-3 and CONACyT 49773/24968 (to G. C.), Australian Research Council Discovery Grant DP0559396 (to G. M. N.), an Australian postgraduate award (to M. J. L.), Grants G.0330.06 (F. W. O. Vlaanderen), OT-05-64 (Katholieke Universiteit Leuven), and UA p6/31 (Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy) (to B. B. and J. T.).	Birinyi-Strachan LC, 2005, NEUROPHARMACOLOGY, V49, P669, DOI 10.1016/j.neuropharm.2005.04.024; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FERNANDEZ JM, 1984, J PHYSIOL-LONDON, V356, P565, DOI 10.1113/jphysiol.1984.sp015483; Fletcher JI, 1997, STRUCTURE, V5, P1525, DOI 10.1016/S0969-2126(97)00301-8; Gilles N, 2002, EUR J BIOCHEM, V269, P1500, DOI 10.1046/j.1432-1033.2002.02799.x; Gilles N, 2000, J NEUROCHEM, V75, P1735, DOI 10.1046/j.1471-4159.2000.0751735.x; Gilles N, 1999, J NEUROSCI, V19, P8730, DOI 10.1523/JNEUROSCI.19-20-08730.1999; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Gordon Dalia, 1997, Invertebrate Neuroscience, V3, P103, DOI 10.1007/BF02480365; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Grolleau F, 2000, J EXP BIOL, V203, P1633; Grolleau F, 2001, J EXP BIOL, V204, P711; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunning SJ, 2008, FEBS J, V275, P4045, DOI 10.1111/j.1742-4658.2008.06545.x; Gunning SJ, 2003, FEBS LETT, V554, P211, DOI 10.1016/S0014-5793(03)01175-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krimm I, 1999, J MOL BIOL, V285, P1749, DOI 10.1006/jmbi.1998.2418; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leipold E, 2004, MOL PHARMACOL, V65, P685, DOI 10.1124/mol.65.3.685; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Little MJ, 1998, FEBS LETT, V439, P246, DOI 10.1016/S0014-5793(98)01378-7; Little MJ, 1998, J BIOL CHEM, V273, P27076, DOI 10.1074/jbc.273.42.27076; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; NICHOLSON GM, 1994, PFLUG ARCH EUR J PHY, V428, P400, DOI 10.1007/BF00724524; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Nicholson GM, 2002, EUR J PHARMACOL, V452, P35, DOI 10.1016/S0014-2999(02)02239-2; Oliveira JS, 2004, J BIOL CHEM, V279, P33323, DOI 10.1074/jbc.M404344200; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Pallaghy PK, 1997, FEBS LETT, V419, P191, DOI 10.1016/S0014-5793(97)01452-X; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x; Rash LD, 2000, BRIT J PHARMACOL, V130, P1817, DOI 10.1038/sj.bjp.0703494; ROY ML, 1992, J NEUROSCI, V12, P2104; SCHREIBMAYER W, 1987, BIOCHIM BIOPHYS ACTA, V901, P273, DOI 10.1016/0005-2736(87)90124-6; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHEUMACK DD, 1985, FEBS LETT, V181, P154, DOI 10.1016/0014-5793(85)81132-7; STRICHARTZ GR, 1986, J GEN PHYSIOL, V88, P413, DOI 10.1085/jgp.88.3.413; Szeto TH, 2000, FEBS LETT, V470, P293, DOI 10.1016/S0014-5793(00)01339-9; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Waxman SG, 2002, NOVART FDN SYMP, V241, P34; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Wuthrich K, 1986, NMR PROTEINS NUCL AC	58	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24568	24582		10.1074/jbc.M109.030841	http://dx.doi.org/10.1074/jbc.M109.030841			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592486	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000269380200067
J	Poor, CB; Chen, PR; Duguid, E; Rice, PA; He, C				Poor, Catherine B.; Chen, Peng R.; Duguid, Erica; Rice, Phoebe A.; He, Chuan			Crystal Structures of the Reduced, Sulfenic Acid, and Mixed Disulfide Forms of SarZ, a Redox Active Global Regulator in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS OHRR; OXIDATION-SENSING MECHANISM; PSEUDOMONAS-AERUGINOSA; MARR FAMILY; ORGANIC HYDROPEROXIDES; BIOFILM FORMATION; VIRULENCE GENES; PEROXIDE SENSOR; REPRESSOR; PROTEINS	SarZ is a global transcriptional regulator that uses a single cysteine residue, Cys(13), to sense peroxide stress and control metabolic switching and virulence in Staphylococcus aureus. SarZ belongs to the single-cysteine class of OhrR-MgrA proteins that play key roles in oxidative resistance and virulence regulation in various bacteria. We present the crystal structures of the reduced form, sulfenic acid form, and mixed disulfide form of SarZ. Both the sulfenic acid and mixed disulfide forms are structurally characterized for the first time for this class of proteins. The Cys(13) sulfenic acid modification is stabilized through two hydrogen bonds with surrounding residues, and the overall DNA-binding conformation is retained. A further reaction of the Cys(13) sulfenic acid with an external thiol leads to formation of a mixed disulfide bond, which results in an allosteric change in the DNA-binding domains, disrupting DNA binding. Thus, the crystal structures of SarZ in three different states provide molecular level pictures delineating the mechanism by which this class of redox active regulators undergoes activation. These structures help to understand redox-mediated virulence regulation in S. aureus and activation of the MarR family proteins in general.	[Poor, Catherine B.; Chen, Peng R.; Duguid, Erica; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Duguid, Erica; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Duguid, Erica/0000-0003-4319-1030	National Institutes of Health [AI074658]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; National Science Foundation Graduate Research Fellowship; United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074658 (to C. H.). This work was also supported by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award, a National Science Foundation Graduate Research Fellowship (to C. B. P.), and by funds from the National Institutes of Health and the United States Department of Energy (to Beamlines 23-ID-B, 19BM, and 14BM).	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Ingavale S, 2005, INFECT IMMUN, V73, P1423, DOI 10.1128/IAI.73.3.1423-1431.2005; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Manna AC, 2003, INFECT IMMUN, V71, P343, DOI 10.1128/IAI.71.1.343-353.2003; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Soonsanga S, 2008, J BACTERIOL, V190, P5738, DOI 10.1128/JB.00576-08; Soonsanga S, 2008, MOL MICROBIOL, V68, P978, DOI 10.1111/j.1365-2958.2008.06200.x; Soonsanga S, 2007, J BACTERIOL, V189, P7069, DOI 10.1128/JB.00879-07; Tamber S, 2009, INFECT IMMUN, V77, P419, DOI 10.1128/IAI.00859-08; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Truong-Bolduc QC, 2005, J BACTERIOL, V187, P2395, DOI 10.1128/JB.187.7.2395-2405.2005; Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	48	74	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23517	23524		10.1074/jbc.M109.015826	http://dx.doi.org/10.1074/jbc.M109.015826			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19586910	Green Published, hybrid			2022-12-25	WOS:000269180000036
J	Hwang, HW; Lee, JR; Chou, KY; Suen, CS; Hwang, MJ; Chen, C; Shieh, RC; Chau, LY				Hwang, Hsuan-Wen; Lee, Jay-Ron; Chou, Kuan-Yu; Suen, Ching-Shu; Hwang, Ming-Jing; Chen, Chinpan; Shieh, Ru-Chi; Chau, Lee-Young			Oligomerization Is Crucial for the Stability and Function of Heme Oxygenase-1 in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE ALPHA-HELICES; MEMBRANE-PROTEINS; CYTOCHROME-P450 REDUCTASE; DRIVE ASSOCIATION; CRYSTAL-STRUCTURE; COILED COILS; RESIDUES; MOTIF; DIMERIZATION; DEGRADATION	Heme oxygenase-1 (HO-1), a stress-inducible enzyme anchored in the endoplasmic reticulum (ER) by a single transmembrane segment (TMS) located at the C terminus, interacts with NADPH cytochrome P450 reductase and biliverdin reductase to catalyze heme degradation to biliverdin and its metabolite, bilirubin. Previous studies suggested that HO-1 functions as a monomer. Using chemical cross-linking, co-immunoprecipitation, and fluorescence resonance energy transfer (FRET) experiments, here we showed that HO-1 forms dimers/oligomers in the ER. However, oligomerization was not observed with a truncated HO-1 lacking the C-terminal TMS (amino acids 266-285), which exhibited cytosolic and nuclear localization, indicating that the TMS is essential for the self-assembly of HO-1 in the ER. To identify the interface involved in the TMS-TMS interaction, residue Trp-270, predicted by molecular modeling as a potential interfacial residue of TMS alpha-helices, was mutated, and the effects on protein subcellular localization and activity assessed. The results showed that the W270A mutant was present exclusively in the ER and formed oligomers with similar activity to those of the wild type HO-1. Interestingly, the W270N mutant was localized not only in the ER, but also in the cytosol and nucleus, suggesting it is susceptible to proteolytic cleavage. Moreover, the microsomal HO activity of the W270N mutant was significantly lower than that of the wild type. The W270N mutation appears to interfere with the oligomeric state, as revealed by a lower FRET efficiency. Collectively, these data suggest that oligomerization, driven by TMS-TMS interactions, is crucial for the stabilization and function of HO-1 in the ER.	[Hwang, Hsuan-Wen; Lee, Jay-Ron; Chou, Kuan-Yu; Suen, Ching-Shu; Hwang, Ming-Jing; Chen, Chinpan; Shieh, Ru-Chi; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Shieh, RC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	ruchi@ibms.sinica.edu.tw; lyc@ibms.sinica.edu.tw	Hwang, Ming-jing/E-9210-2012; Chen, Chinpan/O-4202-2018; Chau, Lee-Young/N-7659-2018	Hwang, Ming-jing/0000-0002-9657-5663; Chau, Lee-Young/0000-0002-6316-2328	National Science Council of Taiwan [NSC-95-2320-B-001-028-MY3, NSC-952320-B-001-008]; Academia Sinica Investigatorship	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica Investigatorship(Academia Sinica - Taiwan)	This work was supported in parts by grants from the National Science Council of Taiwan (to R.-C.S., NSC-95-2320-B-001-028-MY3; to L.-Y.C., NSC-952320- B-001-008), and an Academia Sinica Investigatorship (to L.-Y.C.).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Arkin IT, 2002, BBA-BIOMEMBRANES, V1565, P347, DOI 10.1016/S0005-2736(02)00580-1; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Higashimoto Y, 2008, BIOCHEM BIOPH RES CO, V367, P852, DOI 10.1016/j.bbrc.2008.01.016; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Yang NC, 2004, J BIOMED SCI, V11, P799, DOI 10.1159/000081827; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	31	43	43	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22672	22679		10.1074/jbc.M109.028001	http://dx.doi.org/10.1074/jbc.M109.028001			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556236	Green Published, hybrid			2022-12-25	WOS:000268963100021
J	Kao, J; Salari, K; Bocanegra, M; Choi, YL; Girard, L; Gandhi, J; Kwei, KA; Hernandez-Boussard, T; Wang, P; Gazdar, AF; Minna, JD; Pollack, JR				Kao, Jessica; Salari, Keyan; Bocanegra, Melanie; Choi, Yoon-La; Girard, Luc; Gandhi, Jeet; Kwei, Kevin A.; Hernandez-Boussard, Tina; Wang, Pei; Gazdar, Adi F.; Minna, John D.; Pollack, Jonathan R.			Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery	PLOS ONE			English	Article							ESTROGEN-RECEPTOR EXPRESSION; COPY NUMBER ALTERATION; BASAL-LIKE SUBTYPE; STEM-CELLS; SIGNALING PATHWAY; INTERFERON-ALPHA; PROTEIN; KINASE; ACTIVATION; GENOME	Background: Breast cancer cell lines have been used widely to investigate breast cancer pathobiology and new therapies. Breast cancer is a molecularly heterogeneous disease, and it is important to understand how well and which cell lines best model that diversity. In particular, microarray studies have identified molecular subtypes-luminal A, luminal B, ERBB2-associated, basal-like and normal-like-with characteristic gene-expression patterns and underlying DNA copy number alterations (CNAs). Here, we studied a collection of breast cancer cell lines to catalog molecular profiles and to assess their relation to breast cancer subtypes. Methods: Whole-genome DNA microarrays were used to profile gene expression and CNAs in a collection of 52 widely-used breast cancer cell lines, and comparisons were made to existing profiles of primary breast tumors. Hierarchical clustering was used to identify gene-expression subtypes, and Gene Set Enrichment Analysis (GSEA) to discover biological features of those subtypes. Genomic and transcriptional profiles were integrated to discover within high-amplitude CNAs candidate cancer genes with coordinately altered gene copy number and expression. Findings: Transcriptional profiling of breast cancer cell lines identified one luminal and two basal-like (A and B) subtypes. Luminal lines displayed an estrogen receptor (ER) signature and resembled luminal-A/B tumors, basal-A lines were associated with ETS-pathway and BRCA1 signatures and resembled basal-like tumors, and basal-B lines displayed mesenchymal and stem/progenitor-cell characteristics. Compared to tumors, cell lines exhibited similar patterns of CNA, but an overall higher complexity of CNA (genetically simple luminal-A tumors were not represented), and only partial conservation of subtype-specific CNAs. We identified 80 high-level DNA amplifications and 13 multi-copy deletions, and the resident genes with concomitantly altered gene-expression, highlighting known and novel candidate breast cancer genes. Conclusions: Overall, breast cancer cell lines were genetically more complex than tumors, but retained expression patterns with relevance to the luminal-basal subtype distinction. The compendium of molecular profiles defines cell lines suitable for investigations of subtype-specific pathobiology, cancer stem cell biology, biomarkers and therapies, and provides a resource for discovery of new breast cancer genes.			Kao, J (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	pollack1@stanford.edu	Califano, Andrea/F-7239-2012	Wang, Pei/0000-0002-6890-6453; Salari, Keyan/0000-0001-7940-4558	NATIONAL CANCER INSTITUTE [R01CA097139, T32CA009302, T32CA009151] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097139, T32 CA009151, T32 CA009302, CA97139] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bergamaschi A, 2008, MOL ONCOL, V2, P327, DOI 10.1016/j.molonc.2008.09.004; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Charafe-Jauffret E, 2007, INT J CANCER, V121, P1779, DOI 10.1002/ijc.22923; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; GUDAS JM, 1995, CLIN CANCER RES, V1, P235; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; HolstHansen C, 1996, CLIN EXP METASTAS, V14, P297; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; HULLEMAN E, 2008, J CELL MOL MED; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lindvall C, 2003, CANCER RES, V63, P1743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Manabe R, 2002, J CELL SCI, V115, P1497; Marhaba R, 2004, J MOL HISTOL, V35, P211; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Potemski P, 2007, HISTOPATHOLOGY, V51, P829, DOI 10.1111/j.1365-2559.2007.02886.x; Qi C, 2005, BIOCHEM BIOPH RES CO, V328, P393, DOI 10.1016/j.bbrc.2004.12.187; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; REYNOLDS JE, 1994, CANCER RES, V54, P6348; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Samanta AK, 2004, J BIOL CHEM, V279, P7576, DOI 10.1074/jbc.M311659200; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Streicher KL, 2007, ONCOGENE, V26, P2104, DOI 10.1038/sj.onc.1210002; Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tari AM, 1999, ONCOGENE, V18, P1325, DOI 10.1038/sj.onc.1202422; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Zhang H T, 1999, Angiogenesis, V3, P211, DOI 10.1023/A:1009085422384; ZHANG L, 2008, J BIOL CHEM	102	523	538	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6146	10.1371/journal.pone.0006146	http://dx.doi.org/10.1371/journal.pone.0006146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582160	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806300015
J	Cook, KM; Hilton, ST; Mecinovic, J; Motherwell, WB; Figg, WD; Schofield, CJ				Cook, Kristina M.; Hilton, Stephen T.; Mecinovic, Jasmin; Motherwell, William B.; Figg, William D.; Schofield, Christopher J.			Epidithiodiketopiperazines Block the Interaction between Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) and p300 by a Zinc Ejection Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; STRUCTURAL BASIS; METAL-COMPLEXES; IN-VIVO; GLIOTOXIN; TRANSCRIPTION; SPORIDESMIN; CELLS; INHIBITOR; PATHWAY	The hypoxic response in humans is regulated by the hypoxia-inducible transcription factor system; inhibition of hypoxia-inducible factor (HIF) activity has potential for the treatment of cancer. Chetomin, a member of the epidithiodiketopiperazine (ETP) family of natural products, inhibits the interaction between HIF-alpha and the transcriptional coactivator p300. Structure-activity studies employing both natural and synthetic ETP derivatives reveal that only the structurally unique ETP core is required and sufficient to block the interaction of HIF-1 alpha and p300. In support of both cell-based and animal work showing that the cytotoxic effect of ETPs is reduced by the addition of Zn2+ through an unknown mechanism, our mechanistic studies reveal that ETPs react with p300, causing zinc ion ejection. Cell studies with both natural and synthetic ETPs demonstrated a decrease in vascular endothelial growth factor and antiproliferative effects that were abrogated by zinc supplementation. The results have implications for the design of selective ETPs and for the interaction of ETPs with other zinc ion-binding protein targets involved in gene expression.	[Cook, Kristina M.; Figg, William D.] NCI, NIH, Bethesda, MD 20814 USA; [Cook, Kristina M.; Mecinovic, Jasmin; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Cook, Kristina M.; Mecinovic, Jasmin; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Hilton, Stephen T.] Univ London, Sch Pharm, Dept Pharmaceut & Biol Chem, London WC1N 1AX, England; [Motherwell, William B.] UCL, Dept Chem, London WC1H 0AJ, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Oxford; University of London; University College London; University of London School of Pharmacy; University of London; University College London	Figg, WD (corresponding author), 10 Ctr Dr,9000 Rockville Pike,Bldg 10,Rm 5A01, Bethesda, MD 20892 USA.	wdfigg@helix.nih.gov	Cook, Kristina/B-8012-2008; Figg, William D/M-2411-2016; Hilton, Stephen/C-2699-2008; Mecinovic, Jasmin/F-9694-2015; Hilton, Stephen/AAM-6617-2020; Hilton, Stephen/P-4493-2019	Hilton, Stephen/0000-0001-8782-4499; Mecinovic, Jasmin/0000-0002-5559-3822; Hilton, Stephen/0000-0001-8782-4499; Cook, Kristina/0000-0002-0503-7166; Schofield, Christopher/0000-0002-0290-6565	National Institutes of Health [Z01SC 006538]; Cancer Research UK; The Wellcome Trust; Biochemical and Biotechnology Research Council; NATIONAL CANCER INSTITUTE [ZIASC006538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); The Wellcome Trust(Wellcome TrustEuropean Commission); Biochemical and Biotechnology Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant Z01SC 006538. This work was also supported by grants from Cancer Research UK, The Wellcome Trust, and the Biochemical and Biotechnology Research Council.	Aliev AE, 2006, TETRAHEDRON LETT, V47, P2387, DOI 10.1016/j.tetlet.2006.01.156; Bernardo PH, 2003, J BIOL CHEM, V278, P46549, DOI 10.1074/jbc.M304825200; Chai CLL, 2000, REDOX REP, V5, P257, DOI 10.1179/135100000101535799; Choi HS, 2007, BIOCHEM BIOPH RES CO, V359, P523, DOI 10.1016/j.bbrc.2007.05.139; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DELANO WL, 2002, PYMOL VERSION 99 PYM; Duncan EJ, 2005, TOXICOL LETT, V159, P164, DOI 10.1016/j.toxlet.2005.05.005; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Fox EM, 2008, FUNGAL GENET BIOL, V45, P671, DOI 10.1016/j.fgb.2007.10.005; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; FUKUYAMA T, 1981, TETRAHEDRON, V37, P2045, DOI 10.1016/S0040-4020(01)97960-8; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Goodman RH, 2000, GENE DEV, V14, P1553; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hilton ST, 2004, SYNLETT, P2609, DOI 10.1055/s-2004-834823; Hilton ST, 2005, BIOORG MED CHEM LETT, V15, P2239, DOI 10.1016/j.bmcl.2005.03.022; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; JIANG H, 1993, AUST J CHEM, V46, P1743, DOI 10.1071/CH9931743; JORDAN TW, 1986, J CELL SCI, V85, P33; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lienard BMR, 2007, CHEMMEDCHEM, V2, P175, DOI 10.1002/cmdc.200600250; Loo JA, 1996, J MED CHEM, V39, P4313, DOI 10.1021/jm960253w; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Selevsek N, 2006, J AM SOC MASS SPECTR, V17, P1000, DOI 10.1016/j.jasms.2006.03.010; SEYA H, 1986, J CHEM SOC PERK T 1, P109, DOI 10.1039/p19860000109; SHIGEMATSU N, 1994, J ANTIBIOT, V47, P311, DOI 10.7164/antibiotics.47.311; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Tibodeau JD, 2009, ANTIOXID REDOX SIGN, V11, P1097, DOI 10.1089/ARS.2008.2318; Vigushin DM, 2004, MED ONCOL, V21, P21, DOI 10.1385/MO:21:1:21; Woodcock JC, 2001, J INORG BIOCHEM, V85, P187, DOI 10.1016/S0162-0134(01)00193-3; Woodcock JC, 2001, J INORG BIOCHEM, V84, P225, DOI 10.1016/S0162-0134(01)00173-8	40	136	148	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26831	26838		10.1074/jbc.M109.009498	http://dx.doi.org/10.1074/jbc.M109.009498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19589782	Green Published, hybrid			2022-12-25	WOS:000269969600064
J	Di Pasquale, E; Brivanlou, AH				Di Pasquale, Elisa; Brivanlou, Ali H.			Bone Morphogenetic Protein 15 (BMP15) Acts as a BMP and Wnt Inhibitor during Early Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; PREMATURE OVARIAN FAILURE; INCREASED OVULATION RATE; XENOPUS-EMBRYOS; NEURAL INDUCTION; TGF-BETA; PREIMPLANTATION EMBRYOS; GENE-EXPRESSION; MOUSE OOCYTES; STEM-CELLS	Bone morphogenetic protein 15 (BMP15) belongs to an unusual subgroup of the transforming growth factor beta (TGF beta)superfamily of signaling ligands as it lacks a key cysteine residue in the mature region required for proper intermolecular dimerization. Naturally occurring BMP15 mutation leads to early ovarian failure in humans, and BMP15 has been shown to activate the Smad1/5/8 pathway in that context. Despite its important role in germ cell specification, the embryological function of BMP15 remains unknown. Surprisingly, we find that during early Xenopus embryogenesis BMP15 acts solely as an inhibitor of the Smad1/5/8 pathway and the Wnt pathway. BMP15 gain-of-function leads to embryos with secondary ectopic heads and to direct neural induction in intact explants. BMP15 inhibits BMP4-mediated epidermal induction in dissociated explants. BMP15 strongly inhibits BRE response induced by BMP4 and blocks phosphorylation and activation of Smad1/5/8 MH2-domain. Mechanistically, BMP15 protein specifically interacts with BMP4 protein, suggesting inhibition upstream of receptor binding. Loss-of-function experiments using morpholinos or a naturally occurring human BMP15 dominant-negative mutant (BMP15-Y235C) leads to embryos lacking head. BMP15-Y235C also eliminates the inhibitory activity of BMP15 on BRE (BMP-responsive element). Finally, we show that BMP15 inhibits the canonical branch of the Wnt pathway, upstream of beta-catenin. We, thus, demonstrate that BMP15 is necessary and sufficient for the specification of dorso-anterior structures and highlight novel mechanisms of BMP15 function that strongly suggest a reinterpretation of its function in ovaries specially for ovarian failure.	[Di Pasquale, Elisa; Brivanlou, Ali H.] Rockefeller Univ, Mol Embryol Lab, New York, NY 10065 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Mol Embryol Lab, New York, NY 10065 USA.	brvnlou@rockefeller.edu	Di Pasquale, Elisa/ABI-6252-2020; Di Pasquale, Elisa/A-4751-2014; Di Pasquale, Elisa/ABI-6210-2020	Di Pasquale, Elisa/0000-0003-2373-5635; Di Pasquale, Elisa/0000-0003-2373-5635; 	National Institutes of Health [HD32105]; Rockefeller University Women and Science Fellowship Program; University of Milan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032105, R55HD032105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Women and Science Fellowship Program; University of Milan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD32105 (to A. H. B.).; Supported by funds from the Rockefeller University Women and Science Fellowship Program and from the University of Milan, Department of Medical Science, Laboratory of Experimental Endocrinology (Istituto Auxologico Italiano). Present address: Multimedica IRCCS-MultiLab, Via Fantoli 16/15, 20138 Milan, Italy.	Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Laitinen M, 1998, MECH DEVELOP, V78, P135, DOI 10.1016/S0925-4773(98)00161-0; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; McNatty KP, 2005, MOL CELL ENDOCRINOL, V234, P57, DOI 10.1016/j.mce.2004.08.013; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pennetier S, 2004, BIOL REPROD, V71, P1359, DOI 10.1095/biolreprod.104.030288; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Sharov AA, 2003, EMBO J, V22, P2992, DOI 10.1093/emboj/cdg291; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zeng FY, 2003, BIOL REPROD, V68, P31, DOI 10.1095/biolreprod.102.007674	40	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26127	26136		10.1074/jbc.M109.036608	http://dx.doi.org/10.1074/jbc.M109.036608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19553676	Green Published, hybrid			2022-12-25	WOS:000269738000068
J	Uranishi, H; Zolotukhin, AS; Lindtner, S; Warming, S; Zhang, GM; Bear, J; Copeland, NG; Jenkins, NA; Pavlakis, GN; Felber, BK				Uranishi, Hiroaki; Zolotukhin, Andrei S.; Lindtner, Susan; Warming, Soren; Zhang, Gen-Mu; Bear, Jenifer; Copeland, Neal G.; Jenkins, Nancy A.; Pavlakis, George N.; Felber, Barbara K.			The RNA-binding Motif Protein 15B (RBM15B/OTT3) Acts as Cofactor of the Nuclear Export Receptor NXF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA EYE DEVELOPMENT; TRANSPORT ELEMENT RTE; HNRNP-LIKE PROTEINS; MESSENGER-RNA; SPLIT-ENDS; MENTAL-RETARDATION; SIGNALING PATHWAY; GENETIC SCREEN; FAMILY-MEMBERS; TARGET GENES	The human SPEN family proteins SHARP, RBM15/OTT1, and RBM15B/OTT3 share the structural domain architecture but show distinct functional properties. Here, we examined the function of OTT3 and compared it with its paralogues RBM15 and SHARP. We found that OTT3, like RBM15, has post-transcriptional regulatory activity, whereas SHARP does not, supporting a divergent role of RBM15 and OTT3. OTT3 shares with RBM15 the association with the splicing factor compartment and the nuclear envelope as well as the binding to mRNA export factors NXF1 and Aly/REF. Mutational analysis revealed direct interaction of OTT3 and RBM15 with NXF1 via their C-terminal regions. Biochemical and subcellular localization studies showed that OTT3 and RBM15 also interact with each other in vivo, further supporting a shared function. Genetic knockdown of RBM15 in mouse is embryonically lethal, indicating that OTT3 cannot compensate for the RBM15 loss, which supports the notion that these proteins, in addition to sharing similar activities, likely have distinct biological roles.	[Uranishi, Hiroaki; Lindtner, Susan; Pavlakis, George N.] NCI, Human Retrovirus Sect, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Zolotukhin, Andrei S.; Zhang, Gen-Mu; Bear, Jenifer; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Warming, Soren; Copeland, Neal G.; Jenkins, Nancy A.] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Felber, BK (corresponding author), POB B,Bldg 535,Rm 209, Frederick, MD 21702 USA.	felberb@mail.nih.gov	Warming, Soren/ABD-5729-2021	Warming, Soren/0000-0002-5721-0741	National Institutes of Health Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC010750, Z01BC010334, Z01BC010750, ZIABC010334] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bear J, 1999, MOL CELL BIOL, V19, P6306; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chang JL, 2008, DEV BIOL, V314, P100, DOI 10.1016/j.ydbio.2007.11.023; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doroquez DB, 2007, MECH DEVELOP, V124, P792, DOI 10.1016/j.mod.2007.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Golovanov AP, 2006, RNA, V12, P1933, DOI 10.1261/rna.212106; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Hansen A, 2007, NAT METHODS, V4, P35, DOI 10.1038/NMETH977; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Jemc J, 2006, GENETICS, V173, P279, DOI 10.1534/genetics.106.055558; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Lin HV, 2003, DEVELOPMENT, V130, P3125, DOI 10.1242/dev.00527; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Nappi F, 2001, J VIROL, V75, P4558, DOI 10.1128/JVI.75.10.4558-4569.2001; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Raffel GD, 2009, MOL CELL BIOL, V29, P333, DOI 10.1128/MCB.00370-08; Rebay I, 2000, GENETICS, V154, P695; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Saito K, 2004, BIOCHEM BIOPH RES CO, V321, P291, DOI 10.1016/j.bbrc.2004.06.140; Schreiber SL, 2002, GENESIS, V33, P141, DOI 10.1002/gene.10102; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Shmulevich I., 2002, COMPUTATIONAL STAT A, V1st, P125; Smulevitch S, 2005, J VIROL, V79, P2356, DOI 10.1128/JVI.79.4.2356-2365.2005; Smulevitch S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-6; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tabernero C, 1996, J VIROL, V70, P5998, DOI 10.1128/JVI.70.9.5998-6011.1996; Takano K, 2007, NUCLEIC ACIDS RES, V35, P2513, DOI 10.1093/nar/gkm125; Tan W, 2005, NUCLEIC ACIDS RES, V33, P3855, DOI 10.1093/nar/gki706; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Yabe D, 2007, GENESIS, V45, P300, DOI 10.1002/dvg.20296; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zolotukhin AS, 2008, VIROLOGY, V377, P88, DOI 10.1016/j.virol.2008.04.002	56	37	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26106	26116		10.1074/jbc.M109.040113	http://dx.doi.org/10.1074/jbc.M109.040113			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19586903	Green Published, hybrid			2022-12-25	WOS:000269738000066
J	Malhotra, S; Kovats, S; Zhang, WG; Coggeshall, KM				Malhotra, Shikha; Kovats, Susan; Zhang, Weiguo; Coggeshall, K. Mark			B Cell Antigen Receptor Endocytosis and Antigen Presentation to T Cells Require Vav and Dynamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TYROSINE PHOSPHORYLATION; COSTIMULATORY MOLECULES; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; ADAPTER MOLECULE; HUMORAL IMMUNITY; LIPID RAFTS; RHO GTPASES; IN-VIVO	Antigen binding to the B cell antigen receptor (BCR) initiates an array of signaling events. These include endocytosis of ligand-receptor complexes via clathrin-coated pits, trafficking of the internalized ligand to lysosomes, degradation of the associated proteins to peptides, and peptide presentation on nascent major histocompatibility complex class II to T cells. The signal transduction events supporting BCR internalization are not well understood. We have identified a pathway supporting BCR internalization that includes the Vav1 and/or Vav3 isoforms and the GTPase dynamin. Vav1 and -3 are not required for B cell development and maturation, nor for a variety of BCR-induced signaling events nor for BCR signaling leading to major histocompatibility complex class II and CD80 expression, but Vav1 and/or -3 are absolutely required for BCR endocytosis and BCR-induced Rac-GTP loading. This is the first demonstration of a link between Vav and Rac in BCR internalization leading to antigen presentation to T cells.	[Malhotra, Shikha; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Malhotra, Shikha; Coggeshall, K. Mark] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Kovats, Susan] Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK 73104 USA; [Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; Duke University	Coggeshall, KM (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	mark-coggeshall@omrf.ouhsc.edu		Kovats, Susan/0000-0001-5479-9952	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056156] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI056156] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Arai C, 2003, EUR J IMMUNOL, V33, P1806, DOI 10.1002/eji.200324018; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hayney MS, 1997, VACCINE, V15, P3, DOI 10.1016/S0264-410X(96)00133-8; He YY, 2006, ONCOGENE, V25, P1521, DOI 10.1038/sj.onc.1209184; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Jacob A, 1999, J BIOL CHEM, V274, P13704, DOI 10.1074/jbc.274.19.13704; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KRUSKALL MS, 1992, J EXP MED, V175, P495, DOI 10.1084/jem.175.2.495; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; MARSHALL LS, 1993, J CLIN IMMUNOL, V13, P165, DOI 10.1007/BF00919969; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Mutch CM, 2007, INT IMMUNOL, V19, P19, DOI 10.1093/intimm/dxl118; Natarajan K, 2001, J IMMUNOL, V167, P114, DOI 10.4049/jimmunol.167.1.114; Neumann-Haefelin C, 2007, GENES IMMUN, V8, P181, DOI 10.1038/sj.gene.6364368; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Poland GA, 2008, VACCINE, V26, P6183, DOI 10.1016/j.vaccine.2008.06.057; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; SHASTRI N, 1986, J IMMUNOL, V137, P911; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; SONG WX, 1995, J IMMUNOL, V155, P4255; Stephenson LM, 2006, J IMMUNOL, V177, P8620, DOI 10.4049/jimmunol.177.12.8620; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Swat W, 2003, INT IMMUNOL, V15, P215, DOI 10.1093/intimm/dxg021; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WEBB CF, 1989, J IMMUNOL, V143, P3934; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zuckerman JN, 1996, J MED VIROL, V50, P283, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt;283::AID-JMV1&gt;3.0.CO;2-4	61	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24088	24097		10.1074/jbc.M109.014209	http://dx.doi.org/10.1074/jbc.M109.014209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586920	Green Published, hybrid			2022-12-25	WOS:000269380200022
J	Wort, SJ; Ito, M; Chou, PC; Mc Master, SK; Badiger, R; Jazrawi, E; de Souza, P; Evans, TW; Mitchell, JA; Pinhu, L; Ito, K; Adcock, IM				Wort, Stephen J.; Ito, Misako; Chou, Pai-Chien; Mc Master, Shaun K.; Badiger, Rekha; Jazrawi, Elen; de Souza, Patricia; Evans, Timothy W.; Mitchell, Jane A.; Pinhu, Liao; Ito, Kaz; Adcock, Ian M.			Synergistic Induction of Endothelin-1 by Tumor Necrosis Factor alpha and Interferon gamma Is due to Enhanced NF-kappa B Binding and Histone Acetylation at Specific kappa B Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PREPROENDOTHELIN-1 GENE-EXPRESSION; REGULATORY FACTOR-I; PULMONARY-HYPERTENSION; TNF-ALPHA; TRANSCRIPTIONAL REGULATION; ARTERY; RELEASE; PROMOTER; INTERLEUKIN-1	Endothelin-1 (ET-1) is a potent vasoconstrictor and co-mitogen for vascular smooth muscle and is implicated in pulmonary vascular remodeling and the development of pulmonary arterial hypertension. Vascular smooth muscle is an important source of ET-1. Here we demonstrate synergistic induction of preproET-1 message RNA and release of mature peptide by a combination of tumor necrosis factor alpha(TNF alpha) and interferon gamma(IFN gamma) in primary human pulmonary artery smooth muscle cells. This induction was prevented by pretreatment with the histone acetyltransferase inhibitor anacardic acid. TNF alpha induced a rapid and prolonged pattern of nuclear factor (NF)-kappa B p65 subunit activation and binding to the native preproET-1 promoter. In contrast, IFN gamma induced a delayed activation of interferon regulatory factor-1 without any effect on NF-kappa B p65 nuclear localization or consensus DNA binding. However, we found cooperative p65 binding and histone H4 acetylation at distinct kappa B sites in the preproET-1 promoter after stimulation with both TNF alpha and IFN gamma. This was associated with enhanced recruitment of RNA polymerase II to the ATG start site and read-through of the ET-1 coding region. Understanding such mechanisms is crucial in determining the key control points in ET-1 release. This has particular relevance to developing novel treatments targeted at the inflammatory component of pulmonary vascular remodeling.	[Wort, Stephen J.; Mc Master, Shaun K.; Badiger, Rekha; Jazrawi, Elen; de Souza, Patricia; Evans, Timothy W.; Mitchell, Jane A.; Pinhu, Liao] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Crit Care, London SW3 6LY, England; [Ito, Misako; Chou, Pai-Chien; Ito, Kaz; Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, London SW3 6LY, England	Imperial College London; Imperial College London	Wort, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Crit Care, Dovehouse St, London SW3 6LY, England.	s.wort@imperial.ac.uk	Adcock, Ian/L-3217-2019; Ito, Kazuhiro/AAF-5994-2019; Mitchell, Jane A/A-1991-2009	Adcock, Ian/0000-0003-2101-8843	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Aziz SM, 1997, CELL BIOL INT, V21, P801, DOI 10.1006/cbir.1997.0200; BOBIK A, 1990, AM J PHYSIOL, V258, pC408, DOI 10.1152/ajpcell.1990.258.3.C408; CASLIN AW, 1990, HISTOPATHOLOGY, V16, P9, DOI 10.1111/j.1365-2559.1990.tb01054.x; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; INOUE A, 1989, J BIOL CHEM, V264, P14954; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; JAHNKE A, 1995, IMMUNOBIOLOGY, V193, P305, DOI 10.1016/S0171-2985(11)80559-0; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Keslacy S, 2007, MOL PHARMACOL, V71, P609, DOI 10.1124/mol.106.030171; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Langleben D, 2007, CLIN CHEST MED, V28, P117, DOI 10.1016/j.ccm.2006.11.002; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEE ME, 1991, J BIOL CHEM, V266, P19034; Lesprit P, 1998, AM J RESP CRIT CARE, V157, P907, DOI 10.1164/ajrccm.157.3.9707095; MARSDEN PA, 1992, AM J PHYSIOL, V262, pC854, DOI 10.1152/ajpcell.1992.262.4.C854; Molet S, 2000, J ALLERGY CLIN IMMUN, V105, P333, DOI 10.1016/S0091-6749(00)90084-8; Negi S, 2008, CHEM-EUR J, V14, P3236, DOI 10.1002/chem.200701320; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Sawa Y, 1997, CIRCULATION, V96, P280; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V161, P1220, DOI 10.1016/0006-291X(89)91372-7; Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x; Tchekneva E, 2000, AM J PHYSIOL-LUNG C, V278, pL813, DOI 10.1152/ajplung.2000.278.4.L813; Tchekneva E, 1998, J CLIN INVEST, V101, P1389, DOI 10.1172/JCI622; Upton PD, 2001, AM J RESP CELL MOL, V24, P170, DOI 10.1165/ajrcmb.24.2.4210; Voelkel NF, 1995, EUR RESPIR J, V8, P2129, DOI 10.1183/09031936.95.08122129; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923; Wort SJ, 2002, MOL PHARMACOL, V62, P1147, DOI 10.1124/mol.62.5.1147; Wort SJ, 2001, AM J RESP CELL MOL, V25, P104, DOI 10.1165/ajrcmb.25.1.4331; Wort SJ, 2000, J CARDIOVASC PHARM, V36, pS410; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOSHIZUMI M, 1990, BIOCHEM BIOPH RES CO, V166, P324, DOI 10.1016/0006-291X(90)91948-R	45	58	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24297	24305		10.1074/jbc.M109.032524	http://dx.doi.org/10.1074/jbc.M109.032524			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592490	hybrid, Green Published			2022-12-25	WOS:000269380200043
J	Houde, N; Chamoux, E; Bisson, M; Roux, S				Houde, Nicolas; Chamoux, Estelle; Bisson, Martine; Roux, Sophie			Transforming Growth Factor-beta 1 (TGF-beta 1) Induces Human Osteoclast Apoptosis by Up-regulating Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GIANT-CELL TUMOR; P38 MAP KINASE; TGF-BETA; (TGF-BETA)-INDUCED APOPTOSIS; EPITHELIAL-CELLS; BONE; EXPRESSION; SMAD; RECEPTOR	Transforming growth factor-beta 1 (TGF-beta 1) is the most abundant TGF-beta isoform detected in bone and is an important functional modulator of osteoclasts. TGF-beta 1 can induce osteoclast apoptosis; however, the apoptotic pathways involved in this process are not known. We show here that human osteoclasts express both type-I and type-II TGF-beta receptors. In the absence of survival factors, TGF-beta 1 (1 ng/ml) induced osteoclast apoptosis. The expression of activated caspase-9, but not that of caspase-8, was increased by TGF-beta 1 stimulation, and the rate of TGF-beta 1-induced apoptosis was significantly lower in the presence of a caspase-9 inhibitor. To study further the mechanisms involved in TGF-beta 1-induced osteoclast apoptosis, we investigated TGF-beta 1 signaling, which primarily involves the Smad pathway, but also other pathways that may interfere with intracellular modulators of apoptosis, such as mitogen-activated protein (MAP) kinases and Bcl2 family members. We show here that early events consisted of a trend toward increased expression of extracellular signal-regulated kinase (ERK), and then TGF-beta 1 significantly induced the activation of p38 and Smad2 in a time-dependent manner. These signaling cascades may activate the intrinsic apoptosis pathway, which involves Bim, the expression of which was increased in the presence of TGF-beta 1. Furthermore, the rate of TGF-beta 1-induced osteoclast apoptosis was lower when Bim expression was suppressed, and inhibiting the Smad pathway abolished Bim up-regulation following TGF-beta stimulation. This could correspond to a regulatory mechanism involved in the inhibition of osteoclast activity by TGF-beta 1.	[Houde, Nicolas; Chamoux, Estelle; Bisson, Martine; Roux, Sophie] Univ Sherbrooke, Fac Med, Div Rheumatol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Roux, S (corresponding author), 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	sophie.roux@usherbrooke.ca			Arthritis Society	Arthritis Society	This study was funded by grants from the Arthritis Society (to S. R.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunetti G, 2007, ANN NY ACAD SCI, V1116, P316, DOI 10.1196/annals.1402.011; Chamoux E, 2008, J CELL PHYSIOL, V216, P536, DOI 10.1002/jcp.21430; CHENU C, 1988, P NATL ACAD SCI USA, V85, P5683, DOI 10.1073/pnas.85.15.5683; Colucci S, 2007, APOPTOSIS, V12, P1623, DOI 10.1007/s10495-007-0095-3; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fox SW, 2008, BIOCHEM BIOPH RES CO, V366, P123, DOI 10.1016/j.bbrc.2007.11.120; Franchi A, 2001, APPL IMMUNOHISTO M M, V9, P170, DOI 10.1097/00022744-200106000-00010; Fuller K, 2000, J CELL SCI, V113, P2445; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Karsdal MA, 2001, J BIOL CHEM, V276, P39350, DOI 10.1074/jbc.M008738200; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; ORCEL P, 1990, J CELL PHYSIOL, V142, P293, DOI 10.1002/jcp.1041420211; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Roux S, 1996, J CELL PHYSIOL, V168, P489, DOI 10.1002/(SICI)1097-4652(199609)168:3<489::AID-JCP1>3.3.CO;2-R; Roux S, 2005, BIOCHEM BIOPH RES CO, V333, P42, DOI 10.1016/j.bbrc.2005.05.092; ROUX S, 2007, CELL APOPTOTIC SIGNA, P163; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Teramoto T, 1998, BIOCHEM BIOPH RES CO, V251, P56, DOI 10.1006/bbrc.1998.9411; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; ZHENG MH, 1994, AM J PATHOL, V145, P1095	40	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23397	23404		10.1074/jbc.M109.019372	http://dx.doi.org/10.1074/jbc.M109.019372			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574221	Green Published, hybrid			2022-12-25	WOS:000269180000024
J	Moriarty, TJ; Chaconas, G				Moriarty, Tara J.; Chaconas, George			Identification of the Determinant Conferring Permissive Substrate Usage in the Telomere Resolvase, ResT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR PLASMID PROPHAGE; BORRELIA-BURGDORFERI; CRYSTAL-STRUCTURE; HAIRPIN TELOMERES; VIBRIO-HARVEYI; CLUSTAL-W; DNA; PROTEIN; SEQUENCE; GENOME	Linear genome stability requires specialized telomere replication and protection mechanisms. A common solution to this problem in non-eukaryotes is the formation of hairpin telomeres by telomere resolvases (also known as protelomerases). These enzymes perform a two-step transesterification on replication intermediates to generate hairpin telomeres using an active site similar to that of tyrosine recombinases and type IB topoisomerases. Unlike phage telomere resolvases, the telomere resolvase from the Lyme disease pathogen Borrelia burgdorferi (ResT) is a permissive enzyme that resolves several types of telomere in vitro. However, the ResT region and residues mediating permissive substrate usage have not been identified. The relapsing fever Borrelia hermsii ResT exhibits a more restricted substrate usage pattern than B. burgdorferi ResT and cannot efficiently resolve a Type 2 telomere. In this study, we determined that all relapsing fever ResTs process Type 2 telomeres inefficiently. Using a library of chimeric and mutant B. hermsii/B. burgdorferi ResTs, we mapped the determinants in B. burgdorferi ResT conferring the ability to resolve multiple Type 2 telomeres. Type 2 telomere resolution was dependent on a single proline in the ResT catalytic region that was conserved in all Lyme disease but not relapsing fever ResTs and that is part of a 2-amino acid insertion absent from phage telomere resolvase sequences. The identification of a permissive substrate usage determinant explains the ability of B. burgdorferi ResT to process the 19 unique telomeres found in its segmented genome and will aid further studies on the structure and function of this essential enzyme.	[Moriarty, Tara J.; Chaconas, George] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Chaconas, George] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Chaconas, G (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	chaconas@ucalgary.ca	Moriarty, Tara J./K-1684-2016	Moriarty, Tara J./0000-0002-1751-5145	Canadian Institutes of Health Research (CIHR) [MOP-53086]; Canada Research Chairs (CRC) Program; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (Grant MOP-53086), the Canada Research Chairs (CRC) Program, and the Alberta Heritage Foundation for Medical Research (AHFMR).	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Casjens SR, 2004, J BACTERIOL, V186, P1818, DOI 10.1128/JB.186.6.1818-1832.2004; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; Davis NA, 1999, J MOL BIOL, V291, P249, DOI 10.1006/jmbi.1999.2947; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Deneke J, 2002, J BIOL CHEM, V277, P10410, DOI 10.1074/jbc.M111769200; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; GONZALEZ A, 1986, NUCLEIC ACIDS RES, V14, P6835, DOI 10.1093/nar/14.17.6835; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; HINNEBUSCH J, 1991, J BACTERIOL, V173, P7233, DOI 10.1128/jb.173.22.7233-7239.1991; HIROCHIKA H, 1982, PLASMID, V7, P59, DOI 10.1016/0147-619X(82)90027-0; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2009, MOL MICROBIOL, V71, P1117, DOI 10.1111/j.1365-2958.2008.06584.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; LIN YS, 1993, MOL MICROBIOL, V10, P923, DOI 10.1111/j.1365-2958.1993.tb00964.x; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Malinin A Iu, 1992, Mol Gen Mikrobiol Virusol, P19; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MELLADO RP, 1980, VIROLOGY, V104, P84, DOI 10.1016/0042-6822(80)90367-0; Mouw KW, 2007, MOL MICROBIOL, V63, P1319, DOI 10.1111/j.1365-2958.2007.05586.x; Oakey HJ, 2000, J APPL MICROBIOL, V89, P702, DOI 10.1046/j.1365-2672.2000.01169.x; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; PATEL DJ, 1985, BIOCHEMISTRY-US, V24, P936, DOI 10.1021/bi00325a019; Picardeau M, 1998, MICROBIOL-UK, V144, P1981, DOI 10.1099/00221287-144-7-1981; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; SAVILAHTI H, 1993, J VIROL, V67, P4696, DOI 10.1128/JVI.67.8.4696-4703.1993; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tourand Y, 2003, MOL MICROBIOL, V48, P901, DOI 10.1046/j.1365-2958.2003.03485.x; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200	56	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23293	23301		10.1074/jbc.M109.023549	http://dx.doi.org/10.1074/jbc.M109.023549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561077	Green Published, hybrid			2022-12-25	WOS:000269180000014
J	Tsalkova, T; Blumenthal, DK; Mei, FC; White, MA; Cheng, XD				Tsalkova, Tamara; Blumenthal, Donald K.; Mei, Fang C.; White, Mark A.; Cheng, Xiaodong			Mechanism of Epac Activation STRUCTURAL AND FUNCTIONAL ANALYSES OF Epac2 HINGE MUTANTS WITH CONSTITUTIVE AND REDUCED ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; EXCHANGE FACTOR EPAC; CYCLIC-AMP; CRYSTAL-STRUCTURE; CAMP; RAP1; PKA; NUCLEOTIDES; SUBUNIT; COMPLEX	Epac2 is a member of the family of exchange proteins directly activated by cAMP (Epac). Our previous studies suggest a model of Epac activation in which cAMP binding to the enzyme induces a localized "hinge" motion that reorients the regulatory lobe relative to the catalytic lobe without inducing large conformational changes within individual lobes. In this study, we identified the location of the major hinge in Epac2 by normal mode motion correlation and structural alignment analyses. Targeted mutagenesis was then performed to test the functional importance of hinge bending for Epac activation. We show that substitution of the conserved residue phenylalanine 435 with glycine (F435G) facilitates the hinge bending and leads to a constitutively active Epac2 capable of stimulating nucleotide exchange in the absence of cAMP. In contrast, substitution of the same residue with a bulkier side chain, tryptophan (F435W), impedes the hinge motion and results in a dramatic decrease in Epac2 catalytic activity. Structural parameters determined by small angle x-ray scattering further reveal that whereas the F435G mutant assumes a more extended conformation in the absence of cAMP, the F435W mutant is incapable of adopting the fully extended and active conformation in the presence of cAMP. These findings demonstrate the importance of hinge motion in Epac activation. Our study also suggests that phenylalanine at position 435 is the optimal size side chain to keep Epac closed and inactive in the absence of cAMP while still allowing the proper hinge motion for full Epac extension and activation in the presence of cAMP.	[Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Tsalkova, Tamara; Mei, Fang C.; White, Mark A.; Cheng, Xiaodong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Utah System of Higher Education; University of Utah	Cheng, XD (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	xcheng@utmb.edu	White, Mark Andrew/B-1723-2012; Cheng, Xiaodong/O-8176-2019	White, Mark Andrew/0000-0003-1057-4203; Cheng, Xiaodong/0000-0002-3479-1694; Blumenthal, Donald/0000-0002-8614-1167	National Institutes of Health, NIGMS [GM066170]; American Heart Association [0755049Y]; NIEHS Center [ES006676]; United States Department of Energy [DE-FG02-05ER64026]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant GM066170, American Heart Association Grant-in-Aid 0755049Y, and NIEHS Center Grant ES006676. X-ray scattering data were collected at the University of Utah using facilities that are supported by United States Department of Energy Grant DE-FG02-05ER64026 ( to Jill Trewhella).	Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Flores SC, 2008, PROTEINS, V73, P299, DOI 10.1002/prot.22060; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x	24	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23644	23651		10.1074/jbc.M109.024950	http://dx.doi.org/10.1074/jbc.M109.024950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553663	Green Published, hybrid			2022-12-25	WOS:000269180000050
J	Zhang, AS; Yang, F; Wang, JH; Tsukamoto, H; Enns, CA				Zhang, An-Sheng; Yang, Fan; Wang, Jiaohong; Tsukamoto, Hidekazu; Enns, Caroline A.			Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-METABOLISM; JUVENILE HEMOCHROMATOSIS; PROTEIN CORECEPTOR; SOLUBLE HEMOJUVELIN; RECEPTOR NEOGENIN; MOUSE-LIVER; OVERLOAD; DRAGON; CELLS; BMP6	Hemojuvelin (HJV) is a glycosylphosphatidylinositol-linked protein and binds both bone morphogenic proteins (BMPs) and neogenin. Cellular HJV acts as aBMP co-receptor to enhance the transcription of hepcidin, a key iron regulatory hormone secreted predominantly by liver hepatocytes. In this study we characterized the role of neogenin in HJV-regulated hepcidin expression. Both HJV and neogenin were expressed in liver hepatocytes. Knockdown of neogenin decreased BMP4-induced hepcidin mRNA levels by 16-fold in HJV-expressing HepG2 cells but only by about 2-fold in cells transfected with either empty vector or G99V mutant HJV that does not bind BMPs. Further studies indicated that disruption of the HJV-neogenin interaction is responsible for a marked suppression of hepcidin expression. Moreover, in vivo studies showed that hepatic hepcidin mRNA could be significantly suppressed by blocking the interaction of HJV with full-length neogenin with a soluble fragment of neogenin in mice. Together, these results suggest that the HJV-neogenin interaction is required for the BMP-mediated induction of hepcidin expression when HJV is expressed. Combined with our previous studies, our results support that hepatic neogenin possesses two functions, mediation of cellular HJV release, and stimulation of HJV-enhanced hepcidin expression.	[Zhang, An-Sheng; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Yang, Fan] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Wang, Jiaohong; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA 90073 USA	Oregon Health & Science University; California Institute of Technology; University of Southern California	Zhang, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu	Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/GYU-4249-2022	Zhu, Ren-Yuan/0000-0003-3091-7461; 	National Institutes of Health [DK080765, P50AA11199, R24AA12885]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 (to A.-S.Z.), P50AA11199 (to H.T.), and R24AA12885 (to H.T.).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Camaschella C, 2002, SEMIN HEMATOL, V39, P242, DOI 10.1053/shem.2002.35635; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng YF, 2005, MOL CELL BIOL, V25, P4010, DOI 10.1128/MCB.25.10.4010-4022.2005; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; LUXON BA, 2000, LIVER DIS DIAGNOSIS, P3; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Schaffar G, 2008, J NEUROCHEM, V107, P418, DOI 10.1111/j.1471-4159.2008.05621.x; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Xia Y, 2005, ENDOCRINOLOGY, V146, P3614, DOI 10.1210/en.2004-1676; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	40	64	65	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22580	22589		10.1074/jbc.M109.027318	http://dx.doi.org/10.1074/jbc.M109.027318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19564337	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000268963100011
J	Muller, KM; Schillinger, F; Do, DH; Leopold, DA				Mueller, Kai-Markus; Schillinger, Frieder; Do, David H.; Leopold, David A.			Dissociable Perceptual Effects of Visual Adaptation	PLOS ONE			English	Article							TILTED LINES; CORTEX; ORIENTATION; CONTRAST; CURVATURE; RESPONSES; DISCRIMINATION; REPRESENTATION; NORMALIZATION; MACAQUE	Neurons in the visual cortex are responsive to the presentation of oriented and curved line segments, which are thought to act as primitives for the visual processing of shapes and objects. Prolonged adaptation to such stimuli gives rise to two related perceptual effects: a slow change in the appearance of the adapting stimulus (perceptual drift), and the distortion of subsequently presented test stimuli (adaptational aftereffects). Here we used a psychophysical nulling technique to dissociate and quantify these two classical observations in order to examine their underlying mechanisms and their relationship to one another. In agreement with previous work, we found that during adaptation horizontal and vertical straight lines serve as attractors for perceived orientation and curvature. However, the rate of perceptual drift for different stimuli was not predictive of the corresponding aftereffect magnitudes, indicating that the two perceptual effects are governed by distinct neural processes. Finally, the rate of perceptual drift for curved line segments did not depend on the spatial scale of the stimulus, suggesting that its mechanisms lie outside strictly retinotopic processing stages. These findings provide new evidence that the visual system relies on statistically salient intrinsic reference stimuli for the processing of visual patterns, and point to perceptual drift as an experimental window for studying the mechanisms of visual perception.			Muller, KM (corresponding author), NIMH, NIH, Unit Cognit Neurophysiol & Imaging, Neuropsychol Lab, Bethesda, MD 20892 USA.	leopoldd@mail.nih.gov	Schillinger, Frieder/AAE-9088-2021	Schillinger, Frieder/0000-0002-3499-9313; Leopold, David/0000-0002-1345-6360	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002898, ZIAMH002838] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 MH002898-02] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; BARLOW H, 1989, COMP NEUR S, P54; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; CAMPBELL FW, 1971, VISION RES, V11, P833, DOI 10.1016/0042-6989(71)90005-8; Clifford C.W.G., 2005, FITTING MIND WORLD A; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; COREN S, 1967, PERCEPT PSYCHOPHYS, V2, P621, DOI 10.3758/BF03210280; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; DOBBINS A, 1989, VISION RES, V29, P1371, DOI 10.1016/0042-6989(89)90193-4; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; FAHLE M, 1991, VISION RES, V31, P2149, DOI 10.1016/0042-6989(91)90170-A; Frisby J.P., 1979, SEEING ILLUSION BRAI; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Gibson JJ, 1937, J EXP PSYCHOL, V20, P553, DOI 10.1037/h0057585; Gibson JJ, 1979, ECOLOGICAL APPROACH; GREENLEE MW, 1987, VISION RES, V27, P1041, DOI 10.1016/0042-6989(87)90017-4; HARTMANN L, 1923, SOURCE BOOK GESTALT; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; HELD R, 1963, AM J PSYCHOL, V76, P146, DOI 10.2307/1420015; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Jiang F, 2006, PSYCHOL SCI, V17, P493, DOI 10.1111/j.1467-9280.2006.01734.x; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; Kohler Wolfgang, 1944, PROC AMER PHIL SOC, V88, P269; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Liu T, 2007, NEURON, V55, P313, DOI 10.1016/j.neuron.2007.06.030; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; Meng X, 2005, VISION RES, V45, P3402, DOI 10.1016/j.visres.2005.05.016; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; MORANT RB, 1965, AM J PSYCHOL, V78, P218, DOI 10.2307/1420493; MULLER KM, 2009, VISUAL ADAPTATION CO; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; PRENTICE WCH, 1950, J EXP PSYCHOL, V40, P355, DOI 10.1037/h0058231; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEKULER R, 1974, VISION RES, V14, P151, DOI 10.1016/0042-6989(74)90133-3; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; TAYLOR MM, 1972, 72RP818 DCIEM; TEMPLETON WB, 1972, PERCEPT PSYCHOPHYS, V12, P422, DOI 10.3758/BF03205853; Webster M. A., 2005, FITTING MIND WORLD A; Wenderoth P, 1999, AUST NZ J OPHTHALMOL, V27, P271, DOI 10.1046/j.1440-1606.1999.00191.x; WENDEROTH P, 1989, PERCEPT PSYCHOPHYS, V46, P338, DOI 10.3758/BF03204987; Westheimer G, 1998, VISION RES, V38, P1097, DOI 10.1016/S0042-6989(97)00248-4; WOLFE JM, 1984, VISION RES, V24, P1959, DOI 10.1016/0042-6989(84)90030-0; WOLFE JM, 1986, INVEST OPHTH VIS SCI, V27, P538; Xu XM, 2007, J COMP NEUROL, V501, P741, DOI 10.1002/cne.21277	63	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6183	10.1371/journal.pone.0006183	http://dx.doi.org/10.1371/journal.pone.0006183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	471DN	19593384	Green Submitted, Green Published, gold			2022-12-25	WOS:000268035300004
J	Kategaya, LS; Changkakoty, B; Biechele, T; Conrad, WH; Kaykas, A; DasGupta, R; Moon, RT				Kategaya, Lorna S.; Changkakoty, Binita; Biechele, Travis; Conrad, William H.; Kaykas, Ajamete; DasGupta, Ramanuj; Moon, Randall T.			Bili Inhibits Wnt/beta-Catenin Signaling by Regulating the Recruitment of Axin to LRP6	PLOS ONE			English	Article								Background: Insights into how the Frizzled/LRP6 receptor complex receives, transduces and terminates Wnt signals will enhance our understanding of the control of the Wnt/beta-catenin pathway. Methodology/Principal Findings: In pursuit of such insights, we performed a genome-wide RNAi screen in Drosophila cells expressing an activated form of LRP6 and a beta-catenin-responsive reporter. This screen resulted in the identification of Bili, a Band4.1-domain containing protein, as a negative regulator of Wnt/beta-catenin signaling. We found that the expression of Bili in Drosophila embryos and larval imaginal discs significantly overlaps with the expression of Wingless (Wg), the Drosophila Wnt ortholog, which is consistent with a potential function for Bili in the Wg pathway. We then tested the functions of Bili in both invertebrate and vertebrate animal model systems. Loss-of-function studies in Drosophila and zebrafish embryos, as well as human cultured cells, demonstrate that Bili is an evolutionarily conserved antagonist of Wnt/beta-catenin signaling. Mechanistically, we found that Bili exerts its antagonistic effects by inhibiting the recruitment of AXIN to LRP6 required during pathway activation. Conclusions: These studies identify Bili as an evolutionarily conserved negative regulator of the Wnt/beta-catenin pathway.			Kategaya, LS (corresponding author), Univ Washington, Howard Hughes Med Inst, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	rtmoon@u.washington.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Dasgupta, Ramanuj/0000-0001-9015-3729				Bejsovec A, 2006, ONCOGENE, V25, P7442, DOI 10.1038/sj.onc.1210051; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Erter CE, 2001, DEVELOPMENT, V128, P3571; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	24	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6129	10.1371/journal.pone.0006129	http://dx.doi.org/10.1371/journal.pone.0006129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572019	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806200005
J	Airoldi, I; Di Carlo, E; Cocco, C; Caci, E; Cilli, M; Sorrentino, C; Sozzi, G; Ferrini, S; Rosini, S; Bertolini, G; Truini, M; Grossi, F; Galietta, LJV; Ribatti, D; Pistoia, V				Airoldi, Irma; Di Carlo, Emma; Cocco, Claudia; Caci, Emanuela; Cilli, Michele; Sorrentino, Carlo; Sozzi, Gabriella; Ferrini, Silvano; Rosini, Sandra; Bertolini, Giulia; Truini, Mauro; Grossi, Francesco; Galietta, Luis Juan Vicente; Ribatti, Domenico; Pistoia, Vito			IL-12 Can Target Human Lung Adenocarcinoma Cells and Normal Bronchial Epithelial Cells Surrounding Tumor Lesions	PLOS ONE			English	Article								Background: Non small cell lung cancer (NSCLC) is a leading cause of cancer death. We have shown previously that IL-12rb2 KO mice develop spontaneously lung adenocarcinomas or bronchioalveolar carcinomas. Aim of the study was to investigate i) IL-12Rb2 expression in human primary lung adenocarcinomas and in their counterparts, i. e. normal bronchial epithelial cells (NBEC), ii) the direct anti-tumor activity of IL-12 on lung adenocarcinoma cells in vitro and vivo, and the mechanisms involved, and iii) IL-12 activity on NBEC. Methodology/Principal Findings: Stage I lung adenocarcinomas showed significantly (P = 0.012) higher frequency of IL-12Rb2 expressing samples than stage II/III tumors. IL-12 treatment of IL-12R(+) neoplastic cells isolated from primary adenocarcinoma (n = 6) inhibited angiogenesis in vitro through down-regulation of different pro-angiogenic genes (e. g. IL-6, VEGF-C, VEGF-D, and laminin-5), as assessed by chorioallantoic membrane (CAM) assay and PCR array. In order to perform in vivo studies, the Calu6 NSCLC cell line was transfected with the IL-12RB2 containing plasmid (Calu6/beta 2). Similar to that observed in primary tumors, IL-12 treatment of Calu6/beta 2(+) cells inhibited angiogenesis in vitro. Tumors formed by Calu6/beta 2 cells in SCID/NOD mice, inoculated subcutaneously or orthotopically, were significantly smaller following IL-12 vs PBS treatment due to inhibition of angiogenesis, and of IL-6 and VEGF-C production. Explanted tumors were studied by histology, immuno-histochemistry and PCR array. NBEC cells were isolated and cultured from lung specimens of non neoplastic origin. NBEC expressed IL-12R and released constitutively tumor promoting cytokines (e. g. IL-6 and CCL2). Treatment of NBEC with IL-12 down-regulated production of these cytokines. Conclusions: This study demonstrates that IL-12 inhibits directly the growth of human lung adenocarcinoma and targets the adjacent NBEC. These novel anti-tumor activities of IL-12 add to the well known immune-modulatory properties of the cytokine and may provide a rational basis for the development of a clinical trial.			Airoldi, I (corresponding author), G Gaslini Inst Children, Dept Expt & Lab Med, AIRC Tumor Immunol Unit, Genoa, Italy.	irmaairoldi@ospedale-gaslini.ge.it	Grossi, Francesco/AAL-5024-2021; Bertolini, Giulia/K-7165-2016; Cilli, Michele/AAB-8529-2019; Galietta, Luis JV/HCG-8692-2022; Di Carlo, Emma/L-1024-2016; Cocco, Claudia/K-8595-2018; airoldi, irma/I-6169-2017; sozzi, gabriella/G-8259-2011	Grossi, Francesco/0000-0001-8412-3136; Bertolini, Giulia/0000-0002-8495-4594; Cocco, Claudia/0000-0003-0120-0955; airoldi, irma/0000-0002-4352-8396; sozzi, gabriella/0000-0001-9360-6914; Galietta, Luis/0000-0001-8686-3461; Grossi, Francesco/0000-0003-2694-968X; Cilli, Michele/0000-0003-4083-8986; Sorrentino, Carlo/0000-0002-6553-7429; Ferrini, Silvano/0000-0001-7254-2616; DI CARLO, EMMA/0000-0001-7778-1042	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Airoldi I, 2006, CANCER RES, V66, P3978, DOI 10.1158/0008-5472.CAN-05-4418; Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Airoldi I, 2004, J CLIN INVEST, V113, P1651, DOI 10.1172/JCI20042303; AIROLDI I, 2008, BLOOD; Airoldi I, 2007, P NATL ACAD SCI USA, V104, P3996, DOI 10.1073/pnas.0609028104; Bonomi P, 2000, J CLIN ONCOL, V18, P623, DOI 10.1200/JCO.2000.18.3.623; Broderick L, 2006, CLIN IMMUNOL, V118, P159, DOI 10.1016/j.clim.2005.09.008; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cascone T, 2006, CURR OPIN ONCOL, V18, P151, DOI 10.1097/01.cco.0000208788.99570.0e; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Dias S, 1998, INT J CANCER, V78, P361, DOI 10.1002/(SICI)1097-0215(19981029)78:3<361::AID-IJC17>3.0.CO;2-9; Duda DG, 2000, CANCER RES, V60, P1111; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Galietta LJV, 1998, AM J PHYSIOL-LUNG C, V275, pL917, DOI 10.1152/ajplung.1998.275.5.L917; Galietta LJV, 1998, IN VITRO CELL DEV-AN, V34, P478; Galietta LJV, 2000, AM J PHYSIOL-LUNG C, V278, pL1186, DOI 10.1152/ajplung.2000.278.6.L1186; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; Halin C, 2002, NAT BIOTECHNOL, V20, P264, DOI 10.1038/nbt0302-264; Kaspar M, 2007, CANCER RES, V67, P4940, DOI 10.1158/0008-5472.CAN-07-0283; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Krubasik D, 2008, INT J CANCER, V122, P1261, DOI 10.1002/ijc.23234; LANDIS JR, 1977, BIOMETRICS, V33, P174; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ribatti D, 1997, J VASC RES, V34, P455, DOI 10.1159/000159256; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Saintigny P, 2007, LUNG CANCER, V58, P205, DOI 10.1016/j.lungcan.2007.06.021; Scavelli C, 2004, LEUKEMIA, V18, P1054, DOI 10.1038/sj.leu.2403355; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sobin, 2009, UICC TNM CLASSIFICAT; Spinella F, 2009, CANCER RES, V69, P2669, DOI 10.1158/0008-5472.CAN-08-1879; Stormes KA, 2005, BREAST CANCER RES TR, V89, P209, DOI 10.1007/s10549-004-5328-3; Suzuki M, 2007, ANN SURG ONCOL, V14, P2636, DOI 10.1245/s10434-006-9310-7; Takizawa H, 2006, BRIT J CANCER, V95, P75, DOI 10.1038/sj.bjc.6603209; TRAVIS WD, 1999, HISTOLOGIC TYPING TU; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227	45	31	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6119	10.1371/journal.pone.0006119	http://dx.doi.org/10.1371/journal.pone.0006119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19582164	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200018
J	Fahrenfort, I; Steijaert, M; Sjoerdsma, T; Vickers, E; Ripps, H; van Asselt, J; Endeman, D; Klooster, J; Numan, R; ten Eikelder, H; von Gersdorff, H; Kamermans, M				Fahrenfort, Iris; Steijaert, Marvin; Sjoerdsma, Trijntje; Vickers, Evan; Ripps, Harris; van Asselt, Jorrit; Endeman, Duco; Klooster, Jan; Numan, Robert; ten Eikelder, Huub; von Gersdorff, Henrique; Kamermans, Maarten			Hemichannel-Mediated and pH-Based Feedback from Horizontal Cells to Cones in the Vertebrate Retina	PLOS ONE			English	Article								Background: Recent studies designed to identify the mechanism by which retinal horizontal cells communicate with cones have implicated two processes. According to one account, horizontal cell hyperpolarization induces an increase in pH within the synaptic cleft that activates the calcium current (Ca2+-current) in cones, enhancing transmitter release. An alternative account suggests that horizontal cell hyperpolarization increases the Ca2+-current to promote transmitter release through a hemichannel-mediated ephaptic mechanism. Methodology/Principal Findings: To distinguish between these mechanisms, we interfered with the pH regulating systems in the retina and studied the effects on the feedback responses of cones and horizontal cells. We found that the pH buffers HEPES and Tris partially inhibit feedback responses in cones and horizontal cells and lead to intracellular acidification of neurons. Application of 25 mM acetate, which does not change the extracellular pH buffer capacity, does lead to both intracellular acidification and inhibition of feedback. Because intracellular acidification is known to inhibit hemichannels, the key experiment used to test the pH hypothesis, i.e. increasing the extracellular pH buffer capacity, does not discriminate between a pH-based feedback system and a hemichannel-mediated feedback system. To test the pH hypothesis in a manner independent of artificial pH-buffer systems, we studied the effect of interfering with the endogenous pH buffer, the bicarbonate/carbonic anhydrase system. Inhibition of carbonic anhydrase allowed for large changes in pH in the synaptic cleft of bipolar cell terminals and cone terminals, but the predicted enhancement of the cone feedback responses, according to the pH-hypothesis, was not observed. These experiments thus failed to support a proton mediated feedback mechanism. The alternative hypothesis, the hemichannel-mediated ephaptic feedback mechanism, was therefore studied experimentally, and its feasibility was buttressed by means of a quantitative computer model of the cone/horizontal cell synapse. Conclusion: We conclude that the data presented in this paper offers further support for physiologically relevant ephaptic interactions in the retina.			Fahrenfort, I (corresponding author), Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl		Vickers, Evan/0000-0002-7053-4740	NEI NIH HHS [F32 EY006516, EY-06516, EY14043, R01 EY014043, R01 EY006516] Funding Source: Medline; NIDDK NIH HHS [T32 DK007680, 2 T32 DK007680-16] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006516, F32EY006516, R01EY014043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; BYZOV AL, 1986, VISION RES, V26, P33, DOI 10.1016/0042-6989(86)90069-6; Cadetti L, 2006, J NEUROPHYSIOL, V95, P1992, DOI 10.1152/jn.01042.2005; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Davenport CM, 2008, J NEUROSCI, V28, P456, DOI 10.1523/JNEUROSCI.2735-07.2008; David Rose B, 2001, CLIN PHYSL ACID BASE; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dmitriev AV, 2006, J NEUROPHYSIOL, V95, P1419, DOI 10.1152/jn.00098.2005; Dmitriev AV, 2004, J NEUROPHYSIOL, V91, P2404, DOI 10.1152/jn.00881.2003; Fahrenfort I, 2004, VISUAL NEUROSCI, V21, P501, DOI 10.1017/S095252380421402X; FAHRENFORT I, 2004, PROG BRAIN RES, V147; GERSCHENFELD HM, 1980, PROC R SOC SER B-BIO, V206, P465, DOI 10.1098/rspb.1980.0008; Gunawardana SC, 2002, DIABETES, V51, P105, DOI 10.2337/diabetes.51.1.105; Hanitzsch R, 2001, VISION RES, V41, P2165, DOI 10.1016/S0042-6989(01)00116-X; Hille B., 1992, IONIC CHANNELS EXCIT; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KAMERMANS M, 1991, J GEN PHYSIOL, V97, P819, DOI 10.1085/jgp.97.4.819; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Kamermans M, 1996, VISION RES, V36, P4105, DOI 10.1016/S0042-6989(96)00143-5; Kamermans M, 2001, J PHYSIOL-LONDON, V534, P489, DOI 10.1111/j.1469-7793.2001.t01-1-00489.x; KAMERMANS M, 2002, INVEST OPHTHALMOL VI, V43; Klooster J, 2004, J COMP NEUROL, V474, P58, DOI 10.1002/cne.20114; Klooster J, 2001, J COMP NEUROL, V441, P155, DOI 10.1002/cne.1404; Kraaij DA, 2000, J GEN PHYSIOL, V115, P3, DOI 10.1085/jgp.115.1.3; Kraaij DA, 2000, J NEUROPHYSIOL, V84, P1256, DOI 10.1152/jn.2000.84.3.1256; MALCHOW RP, 1993, J NEUROSCI RES, V35, P237, DOI 10.1002/jnr.490350303; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nagelhus EA, 2005, P NATL ACAD SCI USA, V102, P8030, DOI 10.1073/pnas.0503021102; NAHAS GG, 1962, PHARMACOL REV, V14, P447; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; OAKLEY B, 1989, J PHYSIOL-LONDON, V419, P353, DOI 10.1113/jphysiol.1989.sp017876; Ochrietor JD, 2005, EXP EYE RES, V81, P492, DOI 10.1016/j.exer.2005.03.010; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Ripps H, 2002, J NEUROSCI METH, V121, P81, DOI 10.1016/S0165-0270(02)00243-1; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; Stryer L, 1981, Biochem Soc Symp, P39; TACHIBANA M, 1983, J PHYSIOL-LONDON, V345, P329, DOI 10.1113/jphysiol.1983.sp014981; TAKAHASHI K, 1995, ZOOL SCI, V12, P29, DOI 10.2108/zsj.12.29; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; Tatsukawa T, 2005, VISUAL NEUROSCI, V22, P317, DOI 10.1017/S0952523805223076; Thoreson WB, 2008, J NEUROSCI, V28, P5691, DOI 10.1523/JNEUROSCI.0403-08.2008; THORESON WB, 1990, VISUAL NEUROSCI, V5, P571, DOI 10.1017/S0952523800000730; Tombaugh GC, 1997, J NEUROPHYSIOL, V77, P639, DOI 10.1152/jn.1997.77.2.639; TORNQVIST K, 1988, J NEUROSCI, V8, P2279; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Vigh J, 1999, VISUAL NEUROSCI, V16, P159, DOI 10.1017/S095252389916111X; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; WEILER R, 1984, BRAIN RES, V298, P1, DOI 10.1016/0006-8993(84)91141-7; WINKLER BS, 1986, EXP EYE RES, V42, P585, DOI 10.1016/0014-4835(86)90048-5; WITKOVSKY P, 1995, P NATL ACAD SCI USA, V92, P3556, DOI 10.1073/pnas.92.8.3556; WU SM, 1994, ANNU REV PHYSIOL, V56, P141; WU SM, 1991, J NEUROPHYSIOL, V65, P1197, DOI 10.1152/jn.1991.65.5.1197; Yamamoto K, 2008, ZOOL SCI, V25, P419, DOI 10.2108/zsj.25.419; YANG XL, 1988, J NEUROSCI, V8, P2269; YANG XL, 1988, J NEUROSCI, V8, P2259; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200	70	60	60	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6090	10.1371/journal.pone.0006090	http://dx.doi.org/10.1371/journal.pone.0006090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564917	gold, Green Submitted, Green Published			2022-12-25	WOS:000267515700009
J	Liszekova, D; Polakovicova, M; Beno, M; Farkas, R				Liszekova, Denisa; Polakovicova, Maja; Beno, Milan; Farkas, Robert			Molecular Determinants of Juvenile Hormone Action as Revealed by 3D QSAR Analysis in Drosophila	PLOS ONE			English	Article							QUANTITATIVE STRUCTURE-ACTIVITY; GROWTH-REGULATORS; ADULT DEVELOPMENT; NUCLEAR RECEPTOR; DRUG-DELIVERY; BINDING; METAMORPHOSIS; INHIBITORS; MIMICS; INSECTICIDES	Background: Postembryonic development, including metamorphosis, of many animals is under control of hormones. In Drosophila and other insects these developmental transitions are regulated by the coordinate action of two principal hormones, the steroid ecdysone and the sesquiterpenoid juvenile hormone (JH). While the mode of ecdysone action is relatively well understood, the molecular mode of JH action remains elusive. Methodology/Principal Findings: To gain more insights into the molecular mechanism of JH action, we have tested the biological activity of 86 structurally diverse JH agonists in Drosophila melanogaster. The results were evaluated using 3D QSAR analyses involving CoMFA and CoMSIA procedures. Using this approach we have generated both computer-aided and species-specific pharmacophore fingerprints of JH and its agonists, which revealed that the most active compounds must possess an electronegative atom (oxygen or nitrogen) at both ends of the molecule. When either of these electronegative atoms are replaced by carbon or the distance between them is shorter than 11.5 angstrom or longer than 13.5 angstrom, their biological activity is dramatically decreased. The presence of an electron-deficient moiety in the middle of the JH agonist is also essential for high activity. Conclusions/Significance: The information from 3D QSAR provides guidelines and mechanistic scope for identification of steric and electrostatic properties as well as donor and acceptor hydrogen-bonding that are important features of the ligand-binding cavity of a JH target protein. In order to refine the pharmacophore analysis and evaluate the outcomes of the CoMFA and CoMSIA study we used pseudoreceptor modeling software PrGen to generate a putative binding site surrogate that is composed of eight amino acid residues corresponding to the defined molecular interactions.			Liszekova, D (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Lab Dev Genet, Bratislava, Slovakia.	ueenfark@savba.sk	Beňová Liszeková, Denisa/ABB-1723-2021; Beno, Milan/ABA-4161-2021; Farkas, Robert/ABB-1990-2021	Farkas, Robert/0000-0002-9138-7567; Beno, Milan/0000-0003-3838-791X				ASHBURNE.M, 1970, NATURE, V227, P187, DOI 10.1038/227187a0; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Basak SC, 2006, J CHEM INF MODEL, V46, P65, DOI 10.1021/ci050215y; Bassoli A, 1998, J CHEM SOC PERK T 2, P1449, DOI 10.1039/a709167b; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; Carlberg C, 2006, CURR TOP MED CHEM, V6, P1243, DOI 10.2174/156802606777864908; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Ghafourian T, 2004, J CONTROL RELEASE, V99, P113, DOI 10.1016/j.jconrel.2004.06.010; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Gurrath M, 1998, PERSPECT DRUG DISCOV, V12, P135, DOI 10.1023/A:1017034122059; HENRICK CA, 1973, J AGR FOOD CHEM, V21, P354, DOI 10.1021/jf60187a043; HENRICK CA, 1995, AGROCHEMICALS NATURA, P47; Holdgate GA, 2005, DRUG DISCOV TODAY, V10, P1543, DOI 10.1016/S1359-6446(05)03610-X; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; IWAMURA H, 1985, ENVIRON HEALTH PERSP, V61, P307, DOI 10.2307/3430081; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; KAZNOWSKI CE, 1985, J INSECT PHYSIOL, V31, P801, DOI 10.1016/0022-1910(85)90073-3; Kelly MD, 2005, J MED CHEM, V48, P1069, DOI 10.1021/jm049524q; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klebe G, 1999, J COMPUT AID MOL DES, V13, P1, DOI 10.1023/A:1008047919606; Li JW, 2002, J CONTROL RELEASE, V82, P1, DOI 10.1016/S0168-3659(02)00007-X; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; MADHAVAN K, 1973, J INSECT PHYSIOL, V19, P441, DOI 10.1016/0022-1910(73)90119-4; Manivannan E, 2005, BIOORG MED CHEM LETT, V15, P4496, DOI 10.1016/j.bmcl.2005.07.014; MARENGO E, 1992, CHEMOMETR INTELL LAB, V16, P37, DOI 10.1016/0169-7439(92)80076-G; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Muthas D, 2005, BIOORGAN MED CHEM, V13, P5371, DOI 10.1016/j.bmc.2005.06.048; NAKAYAMA A, 1984, J MED CHEM, V27, P1493, DOI 10.1021/jm00377a019; NIWA A, 1989, J AGR FOOD CHEM, V37, P462, DOI 10.1021/jf00086a042; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; PECHINE JM, 1985, ANAL BIOCHEM, V145, P177, DOI 10.1016/0003-2697(85)90344-6; POSTLETHWAIT JH, 1974, BIOL BULL-US, V147, P119, DOI 10.2307/1540573; PUNJA N, 1973, NATURE-NEW BIOL, V242, P94, DOI 10.1038/newbio242094a0; Recanatini M, 2000, J MED CHEM, V43, P2007, DOI 10.1021/jm990971t; Reichelt J, 2005, BIOINFORMATICS, V21, P1291, DOI 10.1093/bioinformatics/bti138; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; RIDDIFORD LM, 1991, GEN COMP ENDOCR, V82, P172, DOI 10.1016/0016-6480(91)90181-5; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Rochel N, 2006, CURR TOP MED CHEM, V6, P1229, DOI 10.2174/156802606777864926; Rogerson FM, 2004, MOL CELL ENDOCRINOL, V217, P203, DOI 10.1016/j.mce.2003.10.021; ROLLER H, 1967, ANGEW CHEM INT EDIT, V6, P179, DOI 10.1002/anie.196701792; SCHMIALEK P, 1961, Z NATURFORSCH PT B, VB 16, P461; SEHNAL F, 1976, J INSECT PHYSIOL, V22, P673, DOI 10.1016/0022-1910(76)90232-8; Slama K., 1985, P357; Slama K., 1974, INSECT HORMONES BIOA; Spitz IM, 1996, ANNU REV PHARMACOL, V36, P47; STAAL GB, 1975, ANNU REV ENTOMOL, V20, P417, DOI 10.1146/annurev.en.20.010175.002221; Stanton DT, 2004, J CHEM INF COMP SCI, V44, P1010, DOI 10.1021/ci034284t; Tervo AJ, 2003, J COMPUT AID MOL DES, V17, P797, DOI 10.1023/B:JCAM.0000021831.47952.a7; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; VEDANI A, 1995, J AM CHEM SOC, V117, P4987, DOI 10.1021/ja00122a030; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; Wilcox RE, 2000, J MED CHEM, V43, P3005, DOI 10.1021/jm990526y; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004; Zamora I, 2003, J MED CHEM, V46, P25, DOI 10.1021/jm011051p; Zbinden P, 1998, QUANT STRUCT-ACT REL, V17, P122, DOI 10.1002/(SICI)1521-3838(199804)17:02<122::AID-QSAR122>3.3.CO;2-C; Zhou XF, 2005, PHARM RES-DORDR, V22, P1989, DOI 10.1007/s11095-005-8112-0; Zhou XF, 2002, DEVELOPMENT, V129, P2259	64	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6001	10.1371/journal.pone.0006001	http://dx.doi.org/10.1371/journal.pone.0006001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547707	Green Published, gold, Green Submitted			2022-12-25	WOS:000267347900001
J	Thompson, CH; Olivetti, PR; Fuller, MD; Freeman, CS; McMaster, D; French, RJ; Pohl, J; Kubanek, J; Mccarty, NA				Thompson, Christopher H.; Olivetti, Pedro R.; Fuller, Matthew D.; Freeman, Cody S.; McMaster, Denis; French, Robert J.; Pohl, Jan; Kubanek, Julia; Mccarty, Nael A.			Isolation and Characterization of a High Affinity Peptide Inhibitor of ClC-2 Chloride Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEIURUS-QUINQUESTRIATUS-HEBRAEUS; SCORPION TOXINS; CHARYBDOTOXIN BLOCK; POTASSIUM CHANNEL; MOLECULAR-BASIS; VOLTAGE; VENOM; PURIFICATION; INVOLVEMENT; SELECTIVITY	The ClC protein family includes voltage-gated chloride channels and chloride/proton exchangers. In eukaryotes, ClC proteins regulate membrane potential of excitable cells, contribute to epithelial transport, and aid in lysosomal acidification. Although structure/function studies of ClC proteins have been aided greatly by the available crystal structures of a bacterial ClC chloride/proton exchanger, the availability of useful pharmacological tools, such as peptide toxin inhibitors, has lagged far behind that of their cation channel counterparts. Here we report the isolation, from Leiurus quinquestriatus hebraeus venom, of a peptide toxin inhibitor of the ClC-2 chloride channel. This toxin, GaTx2, inhibits ClC-2 channels with a voltage-dependent apparent K-D of similar to 20 pM, making it the highest affinity inhibitor of any chloride channel. GaTx2 slows ClC-2 activation by increasing the latency to first opening by nearly 8-fold but is unable to inhibit open channels, suggesting that this toxin inhibits channel activation gating. Finally, GaTx2 specifically inhibits ClC-2 channels, showing no inhibitory effect on a battery of other major classes of chloride channels and voltage-gated potassium channels. GaTx2 is the first peptide toxin inhibitor of any ClC protein. The high affinity and specificity displayed by this toxin will make it a very powerful pharmacological tool to probe ClC-2 structure/function.	[Thompson, Christopher H.; Olivetti, Pedro R.; Fuller, Matthew D.; Freeman, Cody S.; Kubanek, Julia; Mccarty, Nael A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Fuller, Matthew D.] Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Pohl, Jan] Emory Univ, Microchem & Prote Facil, Atlanta, GA 30322 USA; [Mccarty, Nael A.] Emory Univ, Childrens Healthcare Atlanta & Dept Pediat, Atlanta, GA 30322 USA; [McMaster, Denis; French, Robert J.] Univ Calgary, Peptide Synth Core Facil, Calgary, AB T2N 4N1, Canada; [French, Robert J.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Kubanek, Julia] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; University of Calgary; University of Calgary; University System of Georgia; Georgia Institute of Technology	Mccarty, NA (corresponding author), 2015 Uppergate Dr, Atlanta, GA 30322 USA.	namccar@emory.edu		Kubanek, Julia/0000-0003-4482-1831	National Institutes of Health [DK066409]; Canadian Institutes of Health Research; Cystic Fibrosis Foundation; Children's Healthcare of Atlanta, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066409, R01DK056481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Healthcare of Atlanta, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK066409. This work was also supported by the National Institutes of Health National Center for Research Resources, the Canadian Institutes of Health Research, the Cystic Fibrosis Foundation, and Children's Healthcare of Atlanta, Inc.	Abdel-Mottaleb Y, 2006, FEBS LETT, V580, P6254, DOI 10.1016/j.febslet.2006.10.029; Accardi A, 2003, J GEN PHYSIOL, V122, P277, DOI 10.1085/jgp.200308834; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; Blanc E, 1996, PROTEINS, V24, P359, DOI 10.1002/(SICI)1097-0134(199603)24:3&lt;359::AID-PROT9&gt;3.0.CO;2-B; Buisine E, 1997, J PEPT RES, V49, P545; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Cheng G, 2007, CARDIOVASC RES, V73, P198, DOI 10.1016/j.cardiores.2006.10.012; CHICCHI GG, 1988, J BIOL CHEM, V263, P10192; Clark S, 1998, J PHYSIOL-LONDON, V506, P665, DOI 10.1111/j.1469-7793.1998.665bv.x; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de Santiago JA, 2005, J GEN PHYSIOL, V126, P591, DOI 10.1085/jgp.200509310; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; Donough Mc, 2003, CALCIUM CHANNEL PHAR; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Fuller MD, 2007, J BIOL CHEM, V282, P37545, DOI 10.1074/jbc.M708079200; Fuller MD, 2004, AM J PHYSIOL-CELL PH, V287, pC1328, DOI 10.1152/ajpcell.00162.2004; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kharrat R, 1996, EUR J BIOCHEM, V242, P491, DOI 10.1111/j.1432-1033.1996.0491r.x; Matulef K, 2008, ACS CHEM BIOL, V3, P419, DOI 10.1021/cb800083a; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Picollo A, 2007, J MEMBRANE BIOL, V216, P73, DOI 10.1007/s00232-007-9034-z; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Thompson CH, 2005, J MEMBRANE BIOL, V208, P65, DOI 10.1007/s00232-005-0818-8; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200; Zerrouk H, 1996, INT J PEPT PROT RES, V48, P514	40	33	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					26051	26062		10.1074/jbc.M109.031724	http://dx.doi.org/10.1074/jbc.M109.031724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19574231	hybrid, Green Published			2022-12-25	WOS:000269738000061
J	Avila-Perez, M; Vreede, J; Tang, YF; Bende, O; Losi, A; Gartner, W; Hellingwerf, K				Avila-Perez, Marcela; Vreede, Jocelyne; Tang, Yifen; Bende, Onno; Losi, Aba; Gaertner, Wolfgang; Hellingwerf, Klaas			In Vivo Mutational Analysis of YtvA from Bacillus subtilis MECHANISM OF LIGHT ACTIVATION OF THE GENERAL STRESS RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVIRONMENTAL SIGNALING PATHWAY; TRANSCRIPTION FACTOR SIGMA(B); NTP-BINDING-PROPERTIES; ARABIDOPSIS NPH1; KINASE-ACTIVITY; RECEPTOR YTVA; PROTEIN YTVA; DOMAIN; PHOTORECEPTOR; PHOSPHORYLATION	The general stress response of Bacillus subtilis can be activated by stimuli such as the addition of salt or ethanol and with blue light. In the latter response, YtvA activates sigma(B) through a cascade of Rsb proteins, organized in stressosomes. YtvA is composed of an N-terminal LOV (light, oxygen, and voltage) domain and a C-terminal STAS (sulfate transporter and anti-sigma factor) domain and shows light-modulated GTP binding in vitro. Here, we examine the mechanism of YtvA-mediated activation of sigma(B) in vivo with site-directed mutagenesis. Constitutive off and constitutive on mutations have been identified. Disruption of GTP binding in the STAS domain eliminates light activation of sigma(B). In contrast, modification of sites relevant for phosphorylation of STAS domains does not affect the stress response significantly. The data obtained are integrated into a model for the structure of full-length YtvA, which presumably functions as a dimer.	[Avila-Perez, Marcela; Bende, Onno; Hellingwerf, Klaas] Swammerdam Inst Life Sci, NL-1018 WV Amsterdam, Netherlands; [Vreede, Jocelyne] Univ Amsterdam, Computat Chem & Phys Grp, Vant Hoff Inst Mol Sci, NL-1018 WV Amsterdam, Netherlands; [Tang, Yifen; Losi, Aba; Gaertner, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany	University of Amsterdam; University of Amsterdam; Max Planck Society	Hellingwerf, K (corresponding author), Swammerdam Inst Life Sci, Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl	Vreede, Jocelyne/G-4525-2010; Losi, Aba/M-8709-2015	Losi, Aba/0000-0003-0497-2723; Gartner, Wolfgang/0000-0002-6898-7011				Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; BOYLAN SA, 1992, J BACTERIOL, V174, P3695, DOI 10.1128/JB.174.11.3695-3706.1992; Buttani V, 2007, EUR BIOPHYS J BIOPHY, V36, P831, DOI 10.1007/s00249-007-0155-1; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kang CM, 1998, MOL MICROBIOL, V30, P189, DOI 10.1046/j.1365-2958.1998.01052.x; KENNEY TJ, 1987, J BACTERIOL, V169, P3329, DOI 10.1128/jb.169.7.3329-3339.1987; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, PHOTOCHEM PHOTOBIOL, V80, P150, DOI 10.1562/2004-03-17-RC-116.1; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; NAJAFI SMA, 1995, J BACTERIOL, V177, P2912, DOI 10.1128/jb.177.10.2912-2913.1995; Najafi SMA, 1996, J BACTERIOL, V178, P6632, DOI 10.1128/jb.178.22.6632-6634.1996; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Quin M, 2008, ACTA CRYSTALLOGR F, V64, P196, DOI 10.1107/S1744309108003849; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT	48	61	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24958	24964		10.1074/jbc.M109.033316	http://dx.doi.org/10.1074/jbc.M109.033316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19581299	Green Published, hybrid			2022-12-25	WOS:000269734000030
J	Ikonomov, OC; Sbrissa, D; Ijuin, T; Takenawa, T; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Ijuin, Takeshi; Takenawa, Tadaomi; Shisheva, Assia			Sac3 Is an Insulin-regulated Phosphatidylinositol 3,5-Bisphosphate Phosphatase GAIN IN INSULIN RESPONSIVENESS THROUGH Sac3 DOWN-REGULATION IN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GLUT4 STORAGE-VESICLES; 3T3-L1 ADIPOCYTES; REVERSIBLE OXIDATION; LIPID PHOSPHATASES; MAMMALIAN ORTHOLOG; PIKFYVE; KINASE; PTEN; INSIGHTS	Insulin-regulated stimulation of glucose entry and mobilization of fat/muscle-specific glucose transporter GLUT4 onto the cell surface require the phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) pathway for optimal performance. The reduced insulin responsiveness observed under ablation of the PtdIns(3,5)P-2-synthesizing PIKfyve and its associated activator ArPIKfyve in 3T3L1 adipocytes suggests that dysfunction of the PtdIns(3,5)P-2-specific phosphatase Sac3 may yield the opposite effect. Paradoxically, as uncovered recently, in addition to turnover Sac3 also supports PtdIns(3,5)P-2 biosynthesis by allowing optimal PIKfyve-ArPIKfyve association. These opposing inputs raise the key question as to whether reduced Sac3 protein levels and/or hydrolyzing activity will produce gain in insulin responsiveness. Here we report that small interfering RNA-mediated knockdown of endogenous Sac3 by similar to 60%, which resulted in a slight but significant elevation of PtdIns(3,5)P-2 in 3T3L1 adipocytes, increased GLUT4 translocation and glucose entry in response to insulin. In contrast, ectopic expression of Sac3(WT), but not phosphatase-deficient Sac3(D488A), reduced GLUT4 surface abundance in the presence of insulin. Endogenous Sac3 physically assembled with PIKfyve and ArPIKfyve in both membrane and soluble fractions of 3T3L1 adipocytes, but this remained insulin-insensitive. Importantly, acute insulin markedly reduced the in vitro C8-PtdIns(3,5)P-2 hydrolyzing activity of Sac3. The insulin-sensitive Sac3 pool likely controls a discrete PtdIns(3,5)P-2 subfraction as the high pressure liquid chromatography-measurable insulin-dependent elevation in total [H-3] inositol-PtdIns(3,5)P-2 was minor. Together, our data identify Sac3 as an insulin-sensitive phosphatase whose down-regulation increases insulin responsiveness, thus implicating Sac3 as a novel drug target in insulin resistance.	[Ikonomov, Ognian C.; Sbrissa, Diego; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Ijuin, Takeshi; Takenawa, Tadaomi] Kobe Univ, Sch Med, Dept Lipid Biochem, Kobe, Hyogo 6500017, Japan	Wayne State University; Kobe University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu	Ijuin, Takeshi/H-7016-2017	Ijuin, Takeshi/0000-0002-0618-1776	National Institutes of Health Grant [DK58058]; American Diabetes Association Grant [1-05-RA-120]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grant(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058) ( to A. S.). This work was also supported by American Diabetes Association Grant 1-05-RA-120.	Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Pattaranit Ratchada, 2008, Science Progress, V91, P285, DOI 10.3184/003685008X361343; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Sbrissa D, 2005, J BIOL CHEM, V280, P7883, DOI 10.1074/jbc.M412729200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; SHISHEVA A, 1993, ENDOCRINOLOGY, V133, P1562, DOI 10.1210/en.133.4.1562; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	42	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23961	23971		10.1074/jbc.M109.025361	http://dx.doi.org/10.1074/jbc.M109.025361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19578118	hybrid, Green Published			2022-12-25	WOS:000269380200010
J	Kunkel, MT; Garcia, EL; Kajimoto, T; Hall, RA; Newton, AC				Kunkel, Maya T.; Garcia, Erin L.; Kajimoto, Taketoshi; Hall, Randy A.; Newton, Alexandra C.			The Protein Scaffold NHERF-1 Controls the Amplitude and Duration of Localized Protein Kinase D Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODED FLUORESCENT REPORTER; PDZ DOMAIN; RECEPTOR-ACTIVITY; BETA-CATENIN; PHOSPHORYLATION; BINDING; ASSOCIATION; FAMILY; EXCHANGER; EBP50	Protein kinase D (PKD) transduces an abundance of signals downstream of diacylglycerol production. The mammalian PKD family consists of three isoforms, PKD1, PKD2, and PKD3; of these PKD1 and PKD2 contain PDZ-binding motifs at their carboxyl termini. Here we show that membrane-localized NHERF scaffold proteins provide a nexus for tightly controlled PKD signaling via a PDZ domain interaction. Using a proteomic array containing 96 purified PDZ domains, we have identified the first PDZ domain of NHERF-1 as an interaction partner for the PDZ-binding motifs of both PKD1 and PKD2. A fluorescence resonance energy transfer-based translocation assay reveals a transient association of PKD1 and PKD2 with NHERF-1 in live cells that is triggered by phorbol ester stimulation and, importantly, differs strikingly from the sustained translocation to plasma membrane. Targeting a fluorescence resonance energy transfer-based kinase activity reporter for PKD to NHERF scaffolds reveals a unique signature of PKD activation at the scaffold that is distinct from that of general cytosolic or plasma membrane activity. Specifically, agonist-evoked activation of PKD at the scaffold is rapid and sustained but blunted in magnitude when compared with cytosolic PKD. Thus, live cell imaging of PKD activity demonstrates ultrasensitive control of kinase signaling at the scaffold compared with bulk activity in the cytosol or at the plasma membrane.	[Kunkel, Maya T.; Kajimoto, Taketoshi; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Garcia, Erin L.; Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	University of California System; University of California San Diego; Emory University	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Hall, Randy/0000-0002-8318-8728	National Institutes of Health [P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK54441 (to A. C. N.).	Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; De Kimpe L, 2009, CELL SIGNAL, V21, P253, DOI 10.1016/j.cellsig.2008.10.015; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan MQ, 2003, J BIOL CHEM, V278, P2824, DOI 10.1074/jbc.M211523200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	47	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24653	24661		10.1074/jbc.M109.024547	http://dx.doi.org/10.1074/jbc.M109.024547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581308	Green Published, hybrid			2022-12-25	WOS:000269380200074
J	Oh, J; Hur, MW; Lee, CE				Oh, J.; Hur, M-W; Lee, C-E			SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis	ONCOGENE			English	Article						SOCS1; apoptosis; ROS; PTPs; Jaks thioredoxin	TUMOR-NECROSIS-FACTOR; HYDROGEN-PEROXIDE; CELL-DEATH; REDOX REGULATION; MAPK PATHWAYS; NADPH OXIDASE; ACTIVATION; INHIBITION; INDUCTION; PHOSPHORYLATION	Suppressors of cytokine signaling (SOCS) are negative regulators of cytokine-induced signal transduction, which play multiple roles in cell growth, differentiation and apoptosis. In this study, the regulatory role of SOCS in oxidative stress-induced apoptosis was investigated. In Jurkat T cells and mouse splenocytes, we have found that SOCS1 is induced in response to tumor necrosis factor-alpha or H2O2, concomitant with the activation of Jaks which act as important mediators of reactive oxygen species (ROS)-induced apoptosis upstream of p38 mitogen-activated protein kinase. Using SOCS1 overexpressing or knockdown Jurkat T-cell systems we clearly demonstrate that, SOCS1 inhibits the ROS-mediated apoptosis. The antiapoptotic action of SOCS1 was exerted not only by suppressing Jaks, but also by sustaining protein tyrosine phosphatase (PTP) activities. Notably, SOCS1-transduced cells displayed increase in thioredoxin levels and decrease in ROS generation induced by oxidative stress. In addition, the Jak-inhibiting and PTP-sustaining effect of SOCS1 was significantly reduced on thioredoxin ablation. Moreover, coimmunoprecipitation data revealed molecular interaction of SHP1 or CD45 with thioredoxin, which was promoted in SOCS1-transfected cells. Together, our data strongly suggest that both the protection of PTPs by thioredoxin from ROS attack and the attenuation of Jaks account for the antiapoptotic function of SOCS1 in immune cells under oxidative stress. Oncogene (2009) 28, 3145-3156; doi: 10.1038/onc.2009.169; published online 29 June 2009	[Oh, J.; Lee, C-E] Sungkyunkwan Univ, Dept Biol Sci, Immunol Lab, Inst Basic Sci, Suwon 440746, South Korea; [Hur, M-W] Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Brain Korea Project Med Sci 21, Seoul 120749, South Korea	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Yonsei University	Lee, CE (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Immunol Lab, Inst Basic Sci, 300 Cheon Cheon Dong, Suwon 440746, South Korea.	celee@skku.edu		Hur, Man-Wook/0000-0002-3416-1334	Brain Korea 21 program; KOSEF [2008-01752]; KRF [314-2008-1: E00030]; MOHW [A084298]; Seoul Graduate Student Scholarship	Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); KOSEF(Korea Science and Engineering Foundation); KRF(National Research Foundation of Korea); MOHW(Ministry of Health & Welfare (MOHW), Republic of Korea); Seoul Graduate Student Scholarship	This work was supported by Brain Korea 21 program and research grants from KOSEF (2008-01752), KRF (314-2008-1: E00030) and MOHW (A084298). J Oh was supported in part by the 2005 Seoul Graduate Student Scholarship.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Cao Q, 2004, J BIOL CHEM, V279, P4292, DOI 10.1074/jbc.M308351200; Chong MMW, 2002, J BIOL CHEM, V277, P27945, DOI 10.1074/jbc.M110214200; Cuncic C, 1999, J BIOL INORG CHEM, V4, P354, DOI 10.1007/s007750050322; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; FIALKOW L, 1993, J BIOL CHEM, V268, P17131; Han SI, 2008, BMB REP, V41, P1; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Jang JY, 2006, CELL IMMUNOL, V241, P14, DOI 10.1016/j.cellimm.2006.07.006; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim SH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-64; Kimura A, 2004, INT IMMUNOL, V16, P991, DOI 10.1093/intimm/dxh102; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Masuhiro Y, 2008, J BIOL CHEM, V283, P31575, DOI 10.1074/jbc.M800328200; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Odaka C, 2003, J IMMUNOL, V171, P1507, DOI 10.4049/jimmunol.171.3.1507; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rusanescu G, 2005, EMBO J, V24, P305, DOI 10.1038/sj.emboj.7600522; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; To KF, 2004, BRIT J CANCER, V91, P1335, DOI 10.1038/sj.bjc.6602133; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshida T, 2004, J EXP MED, V199, P1701, DOI 10.1084/jem.20031675	38	35	40	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3145	3156		10.1038/onc.2009.169	http://dx.doi.org/10.1038/onc.2009.169			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19561639				2022-12-25	WOS:000269515100006
J	Kawano, S; Ikeda, W; Kishimoto, M; Ogita, H; Takai, Y				Kawano, Satoshi; Ikeda, Wataru; Kishimoto, Megumi; Ogita, Hisakazu; Takai, Yoshimi			Silencing of ErbB3/ErbB2 Signaling by Immunoglobulin-like Necl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR TSLC1; MALE-INFERTILITY; RECEPTOR; GENE; SUPERFAMILY; ERBB2; HETERODIMERIZATION; IDENTIFICATION; LOCALIZATION	ErbB2 and ErbB3, members of the EGF receptor/ErbB family, form a heterodimer upon binding of a ligand, inducing the activation of Rac small G protein and Akt protein kinase for cell movement and survival, respectively. The enhanced ErbB3/ErbB2 signaling causes tumorigenesis, invasion, and metastasis. We found here that the ErbB3/ErbB2 signaling is regulated by immunoglobulin-like Necl-2, which is down-regulated in various cancer cells and serves as a tumor suppressor. The extracellular region of ErbB3, but not ErbB2, interacted in cis with that of Necl-2. This interaction reduced the ligand-induced, ErbB2-catalyzed tyrosine phosphorylation of ErbB3 and inhibited the consequent ErbB3-mediated activation of Rac and Akt, resulting in the inhibition of cancer cell movement and survival. These inhibitory effects of Necl-2 were mediated by the protein-tyrosine phosphatase PTPN13 which interacted with the cytoplasmic tail of Necl-2. We describe here this novel mechanism for silencing of the ErbB3/ErbB2 signaling by Necl-2.	[Kawano, Satoshi; Ikeda, Wataru; Kishimoto, Megumi; Ogita, Hisakazu; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan	Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020; Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058; Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research and for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2007, 2008).	Abaan OD, 2008, CANCER METAST REV, V27, P205, DOI 10.1007/s10555-008-9114-2; Amann J, 2005, CANCER RES, V65, P226; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; CHADENEAU C, 1994, J BIOL CHEM, V269, P15601; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Fujita E, 2006, MOL CELL BIOL, V26, P718, DOI 10.1128/MCB.26.2.718-726.2006; Fukami T, 2002, GENE, V295, P7, DOI 10.1016/S0378-1119(02)00835-1; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mao XL, 2003, CANCER RES, V63, P7979; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Murakami Y, 2002, ONCOGENE, V21, P6936, DOI 10.1038/sj.onc.1205825; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yageta M, 2002, CANCER RES, V62, P5129; Yamada D, 2006, MOL CELL BIOL, V26, P3610, DOI 10.1128/MCB.26.9.3610-3624.2006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yip YL, 2002, CANCER IMMUNOL IMMUN, V50, P569, DOI 10.1007/s002620100226; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	47	45	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23793	23805		10.1074/jbc.M109.025155	http://dx.doi.org/10.1074/jbc.M109.025155			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561085	hybrid, Green Published			2022-12-25	WOS:000269180000063
J	Kim, Y; Deshpande, A; Dai, YS; Kim, JJ; Lindgren, A; Conway, A; Clark, AT; Wong, DT				Kim, Yong; Deshpande, Amit; Dai, Yanshan; Kim, Jeffrey J.; Lindgren, Anne; Conway, Anne; Clark, Amander T.; Wong, David T.			Cyclin-dependent Kinase 2-associating Protein 1 Commits Murine Embryonic Stem Cell Differentiation through Retinoblastoma Protein Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; GROWTH SUPPRESSOR; FAMILY PROTEINS; G(1) CONTROL; DNA-DAMAGE; ES CELLS; PRB; PLURIPOTENCY; ACTIVATION; EXPRESSION	Mouse embryonic stem cells (mESCs) maintain pluripotency and indefinite self-renewal through yet to be defined molecular mechanisms. Leukemia inhibitory factor has been utilized to maintain the symmetrical self-renewal and pluripotency of mESCs in culture. It has been suggested that molecules with significant cellular effects on retinoblastoma protein (pRb) or its related pathways should have functional impact on mESC proliferation and differentiation. However, the involvement of pRb in pluripotent differentiation of mESCs has not been extensively elaborated. In this paper, we present novel experimental data indicating that Cdk2ap1 (cyclin-dependent kinase 2-associating protein 1), an inhibitor of G(1)/S transition through down-regulation of CDK2 and an essential gene for early embryonic development, confers competency for mESC differentiation. Targeted disruption of Cdk2ap1 in mESCs resulted in abrogation of leukemia inhibitory factor withdrawal-induced differentiation, along with altered pRb phosphorylation. The differentiation competency of the Cdk2ap1(-/-) mESCs was restored upon the ectopic expression of Cdk2ap1 or a non-phosphorylatable pRb mutant (mouse Ser(788)-> Ala), suggesting that the CDK2AP1-mediated differentiation of mESCs was elicited through the regulation of pRb. Further analysis on mESC maintenance or differentiation-related gene expression supports the phosphorylation at serine 788 in pRb plays a significant role for the CDK2AP1-mediated differentiation of mESCs. These data clearly demonstrate that CDK2AP1 is a competency factor in the proper differentiation of mESCs by modulating the phosphorylation level of pRb. This sheds light on the role of the establishment of the proper somatic cell type cell cycle regulation for mESCs to enter into the differentiation process.	[Kim, Yong; Deshpande, Amit; Dai, Yanshan; Kim, Jeffrey J.; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; [Kim, Yong; Deshpande, Amit; Dai, Yanshan; Kim, Jeffrey J.; Wong, David T.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Kim, Yong; Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wong, David T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Wong, David T.] Univ Calif Los Angeles, Div Head & Neck Surgery Otolaryngol, Los Angeles, CA 90095 USA; [Lindgren, Anne; Conway, Anne; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Coll Letters & Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave,73-017 CHS, Los Angeles, CA 90095 USA.	thadyk@ucla.edu; dtww@ucla.edu	Dai, Yanshan/B-8577-2009	Dai, Yanshan/0000-0001-5048-7417	National Institutes of Health Public Service [T32 DE 007296-08, R01 DE 14857]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296, R01DE014857] Funding Source: NIH RePORTER	National Institutes of Health Public Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Public Service Grants T32 DE 007296-08 (to Y.K.) and R01 DE 14857 (to D. T. W.).	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Ernst M, 1999, J BIOL CHEM, V274, P9729, DOI 10.1074/jbc.274.14.9729; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Jori FP, 2007, MOL CELL NEUROSCI, V34, P299, DOI 10.1016/j.mcn.2006.11.009; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim Y, 2005, J BIOL CHEM, V280, P23273, DOI 10.1074/jbc.M412929200; Kim Y, 2005, ONCOGENE, V24, P407, DOI 10.1038/sj.onc.1208222; Kim Y, 2001, INT J ORAL BIOL  DEC, V2001, P87; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; LeCouter JE, 1996, ONCOGENE, V12, P1433; Lee S, 2003, MOL REPROD DEV, V64, P405, DOI 10.1002/mrd.10232; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; McLear JA, 2006, MOL CELL NEUROSCI, V33, P260, DOI 10.1016/j.mcn.2006.07.012; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Prost S, 1998, FEBS LETT, V425, P499, DOI 10.1016/S0014-5793(98)00296-8; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shintani S, 2001, CLIN CANCER RES, V7, P2776; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Sidle A, 1996, CRIT REV BIOCHEM MOL, V31, P237, DOI 10.3109/10409239609106585; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0	44	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23405	23414		10.1074/jbc.M109.026088	http://dx.doi.org/10.1074/jbc.M109.026088			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564334	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000269180000025
J	Park, JW; Mieyal, JJ; Rhee, SG; Chock, PB				Park, Ji Won; Mieyal, John J.; Rhee, Sue Goo; Chock, P. Boon			Deglutathionylation of 2-Cys Peroxiredoxin Is Specifically Catalyzed by Sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; MAMMALIAN PEROXIREDOXIN; REDUCE PEROXIDES; ACTIVE-SITE; GLUTATHIONYLATION; THIOREDOXIN; PROTEINS; IDENTIFICATION	Reversible protein glutathionylation plays a key role in cellular regulation and cell signaling and protects protein thiols from hyperoxidation. Sulfiredoxin (Srx), an enzyme that catalyzes the reduction of Cys-sulfinic acid derivatives of 2-Cys peroxiredoxins (2-Cys Prxs), has been shown to catalyze the deglutathionylation of actin. We show that deglutathionylation of 2-Cys Prx, a family of peroxidases, is specifically catalyzed by Srx. Using the ubiquitously expressed member of 2-Cys Prx, Prx I, we revealed the following. (i) Among its four Cys residues, Cys(52), Cys(83), and Cys(173) can be glutathionylated in vitro. Deglutathionylation with Cys mutants showed that Cys(83) and Cys(173) were preferentially catalyzed by Srx, with glutathionylated Srx as the reaction intermediate, whereas glutaredoxin I was more favorable for deglutathionylating Cys(52). (ii) Studies using site-directed mutagenesis coupled with binding and deglutathionylation activities revealed that Pro(174) and Pro(179) of Prx I and Tyr(92) of Srx are essential for both activities. Furthermore, relative to glutaredoxin I, Srx exhibited negligible deglutathionylation activity for glutathionylated cysteine and glutathionylated BSA. These results indicate that Srx is specific for deglutathionylating Prx I due to its favorable affinity for Prx I. To assess the biological relevance of these observations, we showed that Prx I is glutathionylated in A549 and HeLa cells under modest levels of H2O2. In addition, the level of glutathionylated Prx I was substantially elevated in small interfering RNA-mediated Srx-knocked down cells, whereas the reverse was observed in Srx-overexpressing cells. However, glutathionylation of Prx V, not known to bind to Srx, was not affected by the change in Srx expression levels.	[Rhee, Sue Goo] Ewha Womans Univ, Ctr Cell Signaling Res, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Park, Ji Won; Chock, P. Boon] NHLBI, Biochem Lab, Biochem & Biophys Ctr, Div Intramural Res,NIH, Bethesda, MD 20892 USA; [Mieyal, John J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Mieyal, John J.] Louis B Stokes Cleveland Vet Affairs Med Res Ctr, Cleveland, OH 44106 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Rhee, SG (corresponding author), Ewha Womans Univ, Ctr Cell Signaling Res, Div Life & Pharmaceut Sci, 210 Sci Ctr Bldg,Block C,Dae Hyun Dong 11, Seoul 120750, South Korea.	rheesg@ewha.ac.kr; chockp@mail.nih.gov			National Institutes of Health [2 PO1 AG 15885]; NHLBI; Intramural Research Program; Brain Korea21; Korean Science and Engineering Foundation; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program; Brain Korea21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Korean Science and Engineering Foundation(Korea Science and Engineering Foundation); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health, NHLBI, Intramural Research Program and by National Institutes of Health Research Grant 2 PO1 AG 15885 (to J.J.M.). This study was also supported in part by a Brain Korea21 grant (to J.W.P.), by BioR and D Program grants of Korean Science and Engineering Foundation (to S. G. R.), and by a Merit Review research grant from the Department of Veterans Affairs (to J.J.M.).	Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chock P. B., 1996, PRINCIPLES MED BIOL, P201; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Gravina Mieyal S.A, 1995, BIOTHIOLS HLTH DIS, P305; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	39	93	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23364	23374		10.1074/jbc.M109.021394	http://dx.doi.org/10.1074/jbc.M109.021394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561357	Green Published, hybrid			2022-12-25	WOS:000269180000021
J	Fatma, N; Kubo, E; Takamura, Y; Ishihara, K; Garcia, C; Beebe, DC; Singh, DP				Fatma, Nigar; Kubo, Eri; Takamura, Yoshihiro; Ishihara, Keiichi; Garcia, Claudia; Beebe, David C.; Singh, Dhirendra P.			Loss of NF-kappa B Control and Repression of Prdx6 Gene Transcription by Reactive Oxygen Species-driven SMAD3-mediated Transforming Growth Factor beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELENIUM GLUTATHIONE-PEROXIDASE; LENS EPITHELIAL-CELLS; MICE LACKING SMAD3; TGF-BETA; OXIDATIVE STRESS; C-MYC; PROTEIN TRANSDUCTION; TARGETED DISRUPTION; ANTIOXIDANT DEFENSE; 1-CYS PEROXIREDOXIN		[Fatma, Nigar; Takamura, Yoshihiro; Ishihara, Keiichi; Singh, Dhirendra P.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Kubo, Eri] Univ Fukui, Dept Ophthalmol, Fukui 9101193, Japan; [Garcia, Claudia; Beebe, David C.] Washington Univ, St Louis, MO 63110 USA	University of Nebraska System; University of Nebraska Medical Center; University of Fukui; Washington University (WUSTL)	Singh, DP (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, 985840 Nebraska Med Ctr, Omaha, NE 68198 USA.	dpsingh@unmc.edu	Ishihara, Keiichi/M-5743-2019		National Institutes of Health, NEI [EY-13394, EY017613]; Research for Preventing Blindness; NATIONAL EYE INSTITUTE [R01EY017613, R01EY013394] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research for Preventing Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants EY-13394 and EY017613 (to D.P.S.). This work was also supported by a grant from Research for Preventing Blindness (to R.P.B.).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Baker JC, 1997, CURR OPIN GENET DEV, V7, P467, DOI 10.1016/S0959-437X(97)80072-X; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Chu SH, 2003, PHARMACOLOGY, V69, P12, DOI 10.1159/000071244; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Datto MB, 1999, MOL CELL BIOL, V19, P2495; de Iongh RU, 2005, CELLS TISSUES ORGANS, V179, P43, DOI 10.1159/000084508; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Dunker N, 2003, CELL TISSUE RES, V313, P1, DOI 10.1007/s00441-003-0761-x; Dwivedi DJ, 2006, AM J PATHOL, V168, P69, DOI 10.2353/ajpath.2006.041089; Fatma N, 2005, CELL DEATH DIFFER, V12, P734, DOI 10.1038/sj.cdd.4401597; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Frank S, 1997, ONCOGENE, V14, P915, DOI 10.1038/sj.onc.1200905; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; HIGUCHI M, 1992, J IMMUNOTHER, V12, P41, DOI 10.1097/00002371-199207000-00005; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hua XX, 2000, J BIOL CHEM, V275, P33205, DOI 10.1074/jbc.C000568200; Iakoubova OA, 1997, GENOMICS, V42, P474, DOI 10.1006/geno.1997.4762; Jin G, 1997, J BIOL CHEM, V272, P26620, DOI 10.1074/jbc.272.42.26620; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KERR LD, 1988, J BIOL CHEM, V263, P16999; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Kretz-Remy C, 2001, J BIOL CHEM, V276, P43723, DOI 10.1074/jbc.M010821200; Kubo E, 2006, MECH AGEING DEV, V127, P249, DOI 10.1016/j.mad.2005.10.003; Kubo E, 2004, BIOCHEM BIOPH RES CO, V314, P1050, DOI 10.1016/j.bbrc.2004.01.002; Kubo E, 2008, AM J PHYSIOL-CELL PH, V294, pC842, DOI 10.1152/ajpcell.00540.2007; Kumin A, 2007, J CELL BIOL, V179, P747, DOI 10.1083/jcb.200706090; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Maruno Kevin A, 2002, Clin Exp Optom, V85, P76; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mostert V, 1999, FEBS LETT, V460, P23, DOI 10.1016/S0014-5793(99)01298-3; Munz B, 1997, BIOCHEM J, V326, P579, DOI 10.1042/bj3260579; Nakai M, 2000, J NEUROCHEM, V74, P647, DOI 10.1046/j.1471-4159.2000.740647.x; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Pak JH, 2006, EXP EYE RES, V82, P899, DOI 10.1016/j.exer.2005.10.017; Park CK, 2008, J CANCER RES CLIN, V134, P255, DOI 10.1007/s00432-007-0282-1; Phelan SA, 2003, FREE RADICAL BIO MED, V35, P1110, DOI 10.1016/S0891-5849(03)00462-3; Piette J, 1997, BIOL CHEM, V378, P1237; Power JHT, 2002, AM J PATHOL, V161, P885, DOI 10.1016/S0002-9440(10)64249-6; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sharma P, 2003, J BIOL CHEM, V278, P20037, DOI 10.1074/jbc.M212016200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Sparling NE, 2003, REDOX REP, V8, P87, DOI 10.1179/135100003125001404; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Uberti D, 2004, BIOCHEM PHARMACOL, V67, P1743, DOI 10.1016/j.bcp.2004.01.012; Wang XS, 2004, ATHEROSCLEROSIS, V177, P61, DOI 10.1016/j.atherosclerosis.2004.06.007; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Wang Y, 2006, ANTIOXID REDOX SIGN, V8, P229, DOI 10.1089/ars.2006.8.229; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	92	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22758	22772		10.1074/jbc.M109.016071	http://dx.doi.org/10.1074/jbc.M109.016071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553668	Green Published, hybrid			2022-12-25	WOS:000268963100030
J	Liu, J; Wang, ZK; Jiang, K; Zhang, LY; Zhao, LL; Hua, SS; Yan, F; Yang, Y; Wang, DM; Fu, CH; Ding, X; Guo, Z; Yao, XB				Liu, Jing; Wang, Zhikai; Jiang, Kai; Zhang, Liangyu; Zhao, Lingli; Hua, Shasha; Yan, Feng; Yang, Yong; Wang, Dongmei; Fu, Chuanhai; Ding, Xia; Guo, Zhen; Yao, Xuebiao			PRC1 Cooperates with CLASP1 to Organize Central Spindle Plasticity in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC PARIETAL-CELLS; MITOTIC SPINDLE; CHROMOSOMAL PASSENGERS; MICROTUBULE DYNAMICS; CYTOKINESIS; PROTEIN; CHECKPOINT; PHOSPHORYLATION; KINETOCHORES; CENTROMERES	During cell division, chromosome segregation is governed by the interaction of spindle microtubules with the kinetochore. A dramatic remodeling of interpolar microtubules into an organized central spindle between the separating chromatids is required for the initiation and execution of cytokinesis. Central spindle organization requires mitotic kinesins, microtubule-bundling protein PRC1, and Aurora B kinase complex. However, the precise role of PRC1 in central spindle organization has remained elusive. Here we show that PRC1 recruits CLASP1 to the central spindle at early anaphase onset. CLASP1 belongs to a conserved microtubule-binding protein family that mediates the stabilization of overlapping microtubules of the central spindle. PRC1 physically interacts with CLASP1 and specifies its localization to the central spindle. Repression of CLASP1 leads to sister-chromatid bridges and depolymerization of spindle midzone microtubules. Disruption of PRC1-CLASP1 interaction by a membrane-permeable peptide abrogates accurate chromosome segregation, resulting in sister chromatid bridges. These findings reveal a key role for the PRC1-CLASP1 interaction in achieving a stable anti-parallel microtubule organization essential for faithful chromosome segregation. We propose that PRC1 forms a link between stabilization of CLASP1 association with central spindle microtubules and anti-parallel microtubule elongation.	[Ding, Xia] Beijing Univ Chinese Med, Dept Med, Beijing 100086, Peoples R China; [Liu, Jing; Wang, Zhikai; Jiang, Kai; Zhang, Liangyu; Zhao, Lingli; Hua, Shasha; Yan, Feng; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Liu, Jing; Wang, Zhikai; Jiang, Kai; Zhang, Liangyu; Zhao, Lingli; Hua, Shasha; Yan, Feng; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Jiang, Kai; Yan, Feng; Yang, Yong; Fu, Chuanhai; Guo, Zhen] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Beijing University of Chinese Medicine; Morehouse School of Medicine	Ding, X (corresponding author), Beijing Univ Chinese Med, Dept Med, Beijing 100086, Peoples R China.	xiading@yahoo.com; zhenguo@ustc.edu.cn; yaoxb@ustc.edu.cn	Yang, Yong/U-4781-2019; Yang, Yong/P-8322-2018; Fu, Chuanhai/G-8303-2016; Zhang, Liangyu/ABE-4868-2021; Yao, Xuebiao/P-5771-2014	Fu, Chuanhai/0000-0003-4354-3796; Zhang, Liangyu/0000-0002-2701-0773	National Institutes of Health [DK-56292, CA89019, CA92080]; Chinese 973 Projects [2002CB713700, 2010CB912103, 2007CB914503, 2009CB861703]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10]; Chinese Natural Science Foundation [39925018, 90508002, 30870990]; China National Key Projects for Infectious Disease [2008ZX10002-021]; Anhui Province Chemical Biology [08040102005]; Atlanta Clinical ant Translation Science Institute; NATIONAL CANCER INSTITUTE [U56CA092080, P50CA089019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Projects(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National Key Projects for Infectious Disease; Anhui Province Chemical Biology; Atlanta Clinical ant Translation Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, CA89019, and CA92080 (to X. Y.). This work was also supported by Chinese 973 Projects 2002CB713700, 2010CB912103, 2007CB914503, and 2009CB861703, Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H-10, Chinese Natural Science Foundation Grants 39925018 and 90508002 (to X. Y.) and 30870990 (to X. D.), China National Key Projects for Infectious Disease Grant 2008ZX10002-021, a Georgia Cancer Coalition Breast Cancer research grant, Anhui Province Chemical Biology Key Project Grant 08040102005, and an Atlanta Clinical ant Translation Science Institute research grant.	Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2006, GENES CELLS, V11, P845, DOI 10.1111/j.1365-2443.2006.00990.x; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mollinari C, 2005, MOL BIOL CELL, V16, P1043, DOI 10.1091/mbc.E04-04-0346; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Smertenko AP, 2006, J CELL SCI, V119, P3227, DOI 10.1242/jcs.03051; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; YAO XB, 1993, AM J PHYSIOL, V265, pC36, DOI 10.1152/ajpcell.1993.265.1.C36; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	35	43	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23059	23071		10.1074/jbc.M109.009670	http://dx.doi.org/10.1074/jbc.M109.009670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561070	Green Published, hybrid			2022-12-25	WOS:000268963100058
J	Noland, RC; Koves, TR; Seiler, SE; Lum, H; Lust, RM; Ilkayeva, O; Stevens, RD; Hegardt, FG; Muoio, DM				Noland, Robert C.; Koves, Timothy R.; Seiler, Sarah E.; Lum, Helen; Lust, Robert M.; Ilkayeva, Olga; Stevens, Robert D.; Hegardt, Fausto G.; Muoio, Deborah M.			Carnitine Insufficiency Caused by Aging and Overnutrition Compromises Mitochondrial Performance and Metabolic Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-L-CARNITINE; SKELETAL-MUSCLE MITOCHONDRIA; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ARTIFICIAL SELECTION; DIABETES-MELLITUS; GLUCOSE DISPOSAL; UP-REGULATION; BIOSYNTHESIS; DEFICIENCY	In addition to its essential role in permitting mitochondrial import and oxidation of long chain fatty acids, carnitine also functions as an acyl group acceptor that facilitates mitochondrial export of excess carbons in the form of acylcarnitines. Recent evidence suggests carnitine requirements increase under conditions of sustained metabolic stress. Accordingly, we hypothesized that carnitine insufficiency might contribute to mitochondrial dysfunction and obesity-related impairments in glucose tolerance. Consistent with this prediction whole body carnitine dimunition was identified as a common feature of insulin-resistant states such as advanced age, genetic diabetes, and diet-induced obesity. In rodents fed a lifelong (12 month) high fat diet, compromised carnitine status corresponded with increased skeletal muscle accumulation of acylcarnitine esters and diminished hepatic expression of carnitine biosynthetic genes. Diminished carnitine reserves in muscle of obese rats was accompanied by marked perturbations in mitochondrial fuel metabolism, including low rates of complete fatty acid oxidation, elevated incomplete beta-oxidation, and impaired substrate switching from fatty acid to pyruvate. These mitochondrial abnormalities were reversed by 8 weeks of oral carnitine supplementation, in concert with increased tissue efflux and urinary excretion of acetylcarnitine and improvement of whole body glucose tolerance. Acetylcarnitine is produced by the mitochondrial matrix enzyme, carnitine acetyltransferase (CrAT). A role for this enzyme in combating glucose intolerance was further supported by the finding that CrAT overexpression in primary human skeletal myocytes increased glucose uptake and attenuated lipid-induced suppression of glucose oxidation. These results implicate carnitine insufficiency and reduced CrAT activity as reversible components of the metabolic syndrome.	[Noland, Robert C.; Koves, Timothy R.; Seiler, Sarah E.; Lum, Helen; Ilkayeva, Olga; Stevens, Robert D.; Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Muoio, Deborah M.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lust, Robert M.] E Carolina Univ, Dept Physiol, Greenville, NC 27834 USA; [Hegardt, Fausto G.] Univ Barcelona, Sch Pharm, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, E-08028 Barcelona, Spain	Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona	Muoio, DM (corresponding author), 4321 Med Pk Dr, Durham, NC 27704 USA.	Muoio@duke.edu	Koves, Tim/I-4806-2012; Noland, Robert/N-1982-2017; Muoio, Debbie Marie/E-1147-2012	Koves, Tim/0000-0001-8763-5866; Muoio, Deborah/0000-0003-3760-9277; Noland, Robert/0000-0001-5543-3450	National Institutes of Health [P30-AG028716, R01-AG028930, F32-DK080609]; American Diabetes Association; John A. Hartford Duke Center for Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK080609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028930, P30AG028716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); John A. Hartford Duke Center for Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-AG028716 and R01-AG028930 (to D. M. M.) and F32-DK080609 (to R. N.). This work was also supported by the American Diabetes Association (to D. M. M.) and a John A. Hartford Duke Center for Excellence Award (to T. R. K).	Ames BN, 2004, ANN NY ACAD SCI, V1033, P108, DOI 10.1196/annals.1320.010; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Arrigoni-Martelli E, 2001, DRUG EXP CLIN RES, V27, P27; Aureli T, 1999, EUR J BIOCHEM, V263, P287, DOI 10.1046/j.1432-1327.1999.00524.x; BECKER TC, 1994, J BIOL CHEM, V269, P21234; BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; Brass EP, 2003, CLIN PHARMACOL THER, V73, P338, DOI 10.1016/S0009-9236(02)17636-3; BRASS EP, 1995, CLIN THER, V17, P176, DOI 10.1016/0149-2918(95)80017-4; CAPALDO B, 1991, DIABETES RES CLIN PR, V14, P191, DOI 10.1016/0168-8227(91)90020-E; CEDERBLAD G, 1987, AM J CLIN NUTR, V45, P725, DOI 10.1093/ajcn/45.4.725; CHASE JFA, 1967, BIOCHEM J, V104, P510, DOI 10.1042/bj1040510; Citak EC, 2006, PEDIATR HEMAT ONCOL, V23, P381, DOI 10.1080/08880010600646704; DAVIS AT, 1986, J NUTR, V116, P760, DOI 10.1093/jn/116.5.760; Dhitavat S, 2002, NEUROCHEM RES, V27, P501, DOI 10.1023/A:1019800703683; Farkas V, 1996, BIOCHEM PHARMACOL, V52, P1429, DOI 10.1016/S0006-2952(96)00507-2; FARRELL S, 1986, BIOCHIM BIOPHYS ACTA, V876, P175, DOI 10.1016/0005-2760(86)90332-2; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Fischer GM, 2000, BBA-MOL BASIS DIS, V1501, P200, DOI 10.1016/S0925-4439(00)00023-5; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Haqq AM, 2005, CONTEMP CLIN TRIALS, V26, P616, DOI 10.1016/j.cct.2005.09.003; Huang W, 1999, BIOCHEM PHARMACOL, V58, P1361, DOI 10.1016/S0006-2952(99)00219-1; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kaido M, 1997, EUR NEUROL, V38, P302, DOI 10.1159/000113399; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LligonaTrulla L, 1997, J LIPID RES, V38, P1454; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; MIKHAIL MM, 1976, CLIN CHIM ACTA, V71, P207, DOI 10.1016/0009-8981(76)90532-5; Mingrone G, 1999, J AM COLL NUTR, V18, P77, DOI 10.1080/07315724.1999.10718830; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Okamoto Maya, 2006, J Clin Forensic Med, V13, P26, DOI 10.1016/j.jcfm.2005.05.004; Okudaira N, 2001, PHARMACEUT RES, V18, P439, DOI 10.1023/A:1011042008169; Otsuka M, 1999, J NUTR SCI VITAMINOL, V45, P163, DOI 10.3177/jnsv.45.163; PIEKLIK JR, 1975, J BIOL CHEM, V250, P4445; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Rahbar AR, 2005, EUR J CLIN NUTR, V59, P592, DOI 10.1038/sj.ejcn.1602109; RANDLE PJ, 1963, LANCET, V1, P785; REBOUCHE CJ, 1986, J NUTR, V116, P751; Ricciolini R, 1998, J NEUROCHEM, V71, P2510; ROE CR, 1983, ARCH DIS CHILD, V58, P916, DOI 10.1136/adc.58.11.916; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Winter SC, 2003, J INHERIT METAB DIS, V26, P171, DOI 10.1023/A:1024433100257; Wood JC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e19	63	235	244	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22840	22852		10.1074/jbc.M109.032888	http://dx.doi.org/10.1074/jbc.M109.032888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553674	Green Published, hybrid			2022-12-25	WOS:000268963100038
J	Chernyavsky, AI; Arredondo, J; Qian, J; Galitovskiy, V; Grando, SA				Chernyavsky, Alexander I.; Arredondo, Juan; Qian, Jing; Galitovskiy, Valentin; Grando, Sergei A.			Coupling of Ionic Events to Protein Kinase Signaling Cascades upon Activation of alpha 7 Nicotinic Receptor COOPERATIVE REGULATION OF alpha(2)-INTEGRIN EXPRESSION AND Rho KINASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TOBACCO TOXICITY; CONFORMATIONALLY RESTRICTED ANALOG; ADRENAL CHROMAFFIN CELLS; ACETYLCHOLINE-RECEPTOR; CA2+ INFLUX; CATECHOLAMINE SECRETION; HUMAN KERATINOCYTES; ORAL KERATINOCYTES; DIRECTIONAL MIGRATION; CHOLINERGIC CONTROL	Defining the signaling mechanisms and effector proteins mediating phenotypic and mechanical plasticity of keratinocytes (KCs) during wound epithelialization is one of the major goals in epithelial cell biology. The acetylcholine (ACh)-gated ion channels, or nicotinic ACh receptors (nAChRs), mediate the nicotinergic signaling that controls crawling locomotion of KCs. To elucidate relative contributions of the ionic and protein kinase-mediated events elicited due to activation of alpha 7 nAChRs, we quantitated expression of alpha(2)-integrin gene at the mRNA and protein levels and also measured Rho kinase activity in KCs stimulated with the alpha 7 agonist AR-R17779 while blocking the Na+ or Ca2+ entry and/or inhibiting signaling kinases. The results demonstrated the existence of the two-component signaling systems coupling the ionic events and protein kinase signaling cascades downstream of alpha 7 nAChR to simultaneous upregulation of alpha(2)-integrin expression and activation of Rho kinase. The Raf/MEK1/ERK1/2 cascade up-regulating alpha(2)-integrin was activated due to both Ca2+-dependent recruitment of Ca2+/calmodulin-dependent protein kinase II and protein kinase C and Ca2+-independent activation of Ras. Likewise the phosphatidylinositol 3-kinase-mediated activation of Rho kinase was elicited due to both Ca2+ entry-dependent involvement of Ca2+/calmodulin-dependent protein kinase II and Ca2+-independent activation of Jak2. Thus, although the initial signals emanating from activated alpha 7 nAChR are different in nature the pathways intersect at common effector molecules providing for a common end point effect. This novel paradigm of nAChR-mediated coordination of the ionic and metabolic signaling events can allow an auto/paracrine ACh to simultaneously alter gene expression and induce reciprocal changes in the cytoskeleton and contractile system of KCs required to compete a particular step of wound epithelialization.	[Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu			National Institutes of Health [GM62136, DE14173, ES014384]; Institute for Science and Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Science and Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62136, DE14173, and ES014384 (to S. A. G.). This work was also supported by a research grant from the Institute for Science and Health (to S. A. G.).	Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2008, FASEB J, V22, P1356, DOI 10.1096/fj.07-9965.com; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Denda M, 2006, EXP DERMATOL, V15, P455, DOI 10.1111/j.0906-6705.2006.00430.x; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Genersch E, 2000, J CELL SCI, V113, P4319; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; GRANDO SA, 1995, J INVEST DERMATOL, V105, P774, DOI 10.1111/1523-1747.ep12325606; Grando SA, 1996, J INVEST DERMATOL, V107, P412, DOI 10.1111/1523-1747.ep12363399; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; HOCHSTRATE P, 1995, GLIA, V15, P43, DOI 10.1002/glia.440150106; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Koshi R, 2007, J PERIODONTAL RES, V42, P518, DOI 10.1111/j.1600-0765.2007.00976.x; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; Kurzen H, 2004, J INVEST DERMATOL, V123, P937, DOI 10.1111/j.0022-202X.2004.23425.x; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Leabu M, 2005, J CELL PHYSIOL, V202, P754, DOI 10.1002/jcp.20163; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Macor JE, 2004, J ORG CHEM, V69, P6493, DOI 10.1021/jo049404q; Mullen G, 2000, J MED CHEM, V43, P4045, DOI 10.1021/jm000249r; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J DENT RES, V79, P939; NUTTER TJ, 1995, J GEN PHYSIOL, V105, P701, DOI 10.1085/jgp.105.6.701; Palma E, 1998, P NATL ACAD SCI USA, V95, P10246, DOI 10.1073/pnas.95.17.10246; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Singh G S, 1975, Recent Adv Stud Cardiac Struct Metab, V7, P401; SORENSON RL, 1995, ENDOCRINOLOGY, V136, P4092, DOI 10.1210/en.136.9.4092; SORIMACHI M, 1994, JPN J PHYSIOL, V44, P343, DOI 10.2170/jjphysiol.44.343; STEINBACH JH, 1990, CIBA F SYMP, V152, P53; Szasz BK, 2005, NEUROPHARMACOLOGY, V49, P400, DOI 10.1016/j.neuropharm.2005.03.023; TACHIKAWA E, 1994, NEUROSCI LETT, V177, P155, DOI 10.1016/0304-3940(94)90890-7; Taylor SC, 2000, J NEUROCHEM, V75, P1583, DOI 10.1046/j.1471-4159.2000.0751583.x; Tournier JM, 2006, AM J PATHOL, V168, P55, DOI 10.2353/ajpath.2006.050333; vanHoek ML, 1997, BIOCHEM J, V326, P271, DOI 10.1042/bj3260271; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wityak J, 2004, BIOORG MED CHEM LETT, V14, P1483, DOI 10.1016/j.bmcl.2004.01.012; Zia SH, 2000, J PHARMACOL EXP THER, V293, P973	60	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22140	22148		10.1074/jbc.M109.011395	http://dx.doi.org/10.1074/jbc.M109.011395			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549780	Green Published, hybrid			2022-12-25	WOS:000268783700038
J	Zmijewski, JW; Banerjee, S; Abraham, E				Zmijewski, Jaroslaw W.; Banerjee, Sami; Abraham, Edward			S-Glutathionylation of the Rpn2 Regulatory Subunit Inhibits 26 S Proteasomal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PROTEIN-DEGRADATION; KAPPA-B ACTIVATION; OXIDATIVE STRESS; NEUTROPHIL ACTIVATION; HYDROGEN-PEROXIDE; LUNG INJURY; SIGNAL-TRANSDUCTION; REDOX REGULATION; 20S PROTEASOME; NITRIC-OXIDE	Although increased intracellular concentrations of hydrogen peroxide (H2O2) are associated with inhibition of 26 S proteasomal activity, the mechanisms responsible for such effects have not been well delineated. In the present studies, we found that direct exposure of purified 26 S proteasomes to H2O2 had negligible effects on their activity, whereas incubation with glutathione and H2O2 produced >80% decrease in chymotrypsin-like and trypsin-like activities. Rpn1 and Rpn2, which are subunits of the 19 S regulatory particle, undergo S-glutathionylation after exposure of purified 26 S proteasomes to glutathione and H2O2, as well as in HEK 293 cells and neutrophils incubated with H2O2. Increased oxidation of Rpn1 and Rpn2 cysteine thiols was also found in lung extracts from mice in which catalase was inactivated, a condition associated with augmented intracellular concentrations of H2O2 and diminished 26 S proteasomal activity. Although unoxidized Rpn2 enhanced 20 S proteolytic function in vitro, such potentiation was not found when the 20 S core particle was incubated with oxidized Rpn2. The composition of 26 S proteasomes was not altered after exposure to glutathione and H2O2, with similar amounts of Rpn1 and Rpn2 in control or oxidized 26 S proteasomal complexes. These findings identify S-glutathionylation of Rpn2 as a contributory mechanism for H2O2-induced inhibition of 26 S proteasomal function.	[Abraham, Edward] Univ Alabama, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Zmijewski, Jaroslaw W.; Abraham, Edward] Univ Alabama, Ctr Free Radical Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Abraham, E (corresponding author), Univ Alabama, Sch Med, Dept Med, BDB 420,1530 3rd Ave S, Birmingham, AL 35294 USA.	eabraham@uab.edu			National Institutes of Health [HL62221, GM87748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62221 and GM87748.	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Barlow CA, 2008, APOPTOSIS, V13, P681, DOI 10.1007/s10495-008-0203-z; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Chen C, 2002, J BIOCHEM MOL TOXIC, V16, P227, DOI 10.1002/jbt.10043; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi KS, 2006, PREP BIOCHEM BIOTECH, V36, P65, DOI 10.1080/10826060500388520; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200; Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205; Fink MP, 2002, CURR OPIN CLIN NUTR, V5, P167, DOI 10.1097/00075197-200203000-00009; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hosler MR, 2003, INT J BIOCHEM CELL B, V35, P685, DOI 10.1016/S1357-2725(02)00397-7; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; KOECHLING UM, 1994, ALCOHOL, V11, P235, DOI 10.1016/0741-8329(94)90036-1; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kotamraju S, 2005, METHOD ENZYMOL, V396, P526, DOI 10.1016/S0076-6879(05)96044-8; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; MINHAS HS, 1995, BIOCHEM PHARMACOL, V49, P1475, DOI 10.1016/0006-2952(94)00518-Q; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Pajonk F, 2002, FREE RADICAL BIO MED, V32, P536, DOI 10.1016/S0891-5849(02)00743-8; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; SCHMITT J, 1993, MOL BIOL REP, V18, P223, DOI 10.1007/BF01674434; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shelton MD, 2008, MOL CELLS, V25, P332; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang QE, 2005, MOL CARCINOGEN, V42, P53, DOI 10.1002/mc.20065; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; de Pina MZ, 2008, J BIOL CHEM, V283, P12373, DOI 10.1074/jbc.M706832200; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	67	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22213	22221		10.1074/jbc.M109.028902	http://dx.doi.org/10.1074/jbc.M109.028902			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549781	hybrid, Green Published			2022-12-25	WOS:000268783700046
J	Asai, Y; Tasaka, Y; Nomura, K; Nomura, T; Casadio, M; Morasso, P				Asai, Yoshiyuki; Tasaka, Yuichi; Nomura, Kunihiko; Nomura, Taishin; Casadio, Maura; Morasso, Pietro			A Model of Postural Control in Quiet Standing: Robust Compensation of Delay-Induced Instability Using Intermittent Activation of Feedback Control	PLOS ONE			English	Article							CONTROLLING CHAOS; ANKLE STIFFNESS; BALANCE CONTROL; BODY SWAY; MOVEMENTS; SYSTEMS; STABILITY; WALKING; STANCE; BRAIN	The main purpose of this study is to compare two different feedback controllers for the stabilization of quiet standing in humans, taking into account that the intrinsic ankle stiffness is insufficient and that there is a large delay inducing instability in the feedback loop: 1) a standard linear, continuous-time PD controller and 2) an intermittent PD controller characterized by a switching function defined in the phase plane, with or without a dead zone around the nominal equilibrium state. The stability analysis of the first controller is carried out by using the standard tools of linear control systems, whereas the analysis of the intermittent controllers is based on the use of Poincare maps defined in the phase plane. When the PD-control is off, the dynamics of the system is characterized by a saddle-like equilibrium, with a stable and an unstable manifold. The switching function of the intermittent controller is implemented in such a way that PD-control is 'off' when the state vector is near the stable manifold of the saddle and is 'on' otherwise. A theoretical analysis and a related simulation study show that the intermittent control model is much more robust than the standard model because the size of the region in the parameter space of the feedback control gains ( P vs. D) that characterizes stable behavior is much larger in the latter case than in the former one. Moreover, the intermittent controller can use feedback parameters that are much smaller than the standard model. Typical sway patterns generated by the intermittent controller are the result of an alternation between slow motion along the stable manifold of the saddle, when the PD-control is off, and spiral motion away from the upright equilibrium determined by the activation of the PD-control with low feedback gains. Remarkably, overall dynamic stability can be achieved by combining in a smart way two unstable regimes: a saddle and an unstable spiral. The intermittent controller exploits the stabilizing effect of one part of the saddle, letting the system evolve by alone when it slides on or near the stable manifold; when the state vector enters the strongly unstable part of the saddle it switches on a mild feedback which is not supposed to impose a strict stable regime but rather to mitigate the impending fall. The presence of a dead zone in the intermittent controller does not alter the stability properties but improves the similarity with biological sway patterns. The two types of controllers are also compared in the frequency domain by considering the power spectral density (PSD) of the sway sequences generated by the models with additive noise. Different from the standard continuous model, whose PSD function is similar to an over-damped second order system without a resonance, the intermittent control model is capable to exhibit the two power law scaling regimes that are typical of physiological sway movements in humans.			Asai, Y (corresponding author), Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan.	taishin@bpe.es.osaka-u.ac.jp	Casadio, Maura/AAH-2861-2022; Casadio, Maura/AFM-0496-2022; Nomura, Taishin/J-8408-2012; Taylor, Graham/A-4027-2012	Nomura, Taishin/0000-0002-6545-2097; 				BAHILL AT, 1979, SCI AM, V240, P108, DOI 10.1038/scientificamerican0179-108; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; CHOW CC, 1995, PHYS REV E, V52, P907, DOI 10.1103/PhysRevE.52.907; Chow CC, 1999, HUM MOVEMENT SCI, V18, P725, DOI 10.1016/S0167-9457(99)00035-4; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gibson JJ, 1950, PERCEPTION VISUAL WO; Hanneton S, 1997, BIOL CYBERN, V77, P381, DOI 10.1007/s004220050398; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Loram ID, 2005, J PHYSIOL-LONDON, V564, P281, DOI 10.1113/jphysiol.2004.073437; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Milton JG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/48001; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; MORASSO P, 1983, ACTA PSYCHOL, V54, P83, DOI 10.1016/0001-6918(83)90025-2; Nomura K, 2009, GAIT POSTURE, V29, P654, DOI 10.1016/j.gaitpost.2009.02.001; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Peterka RJ, 2000, BIOL CYBERN, V82, P335, DOI 10.1007/s004220050587; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Stepan G, 2000, MATH COMPUT MODEL, V31, P199, DOI 10.1016/S0895-7177(00)00039-X; Tanaka G, 2008, PHYSICA D, V237, P2616, DOI 10.1016/j.physd.2008.03.044; Utkin V., 1992, SLIDING MODES CONTRO; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; Yamasaki T, 2003, BIOL CYBERN, V88, P468, DOI 10.1007/s00422-003-0402-1	36	201	202	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6169	10.1371/journal.pone.0006169	http://dx.doi.org/10.1371/journal.pone.0006169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468HA	19584944	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806500006
J	Boda, C; Courtioux, B; Roques, P; Pervieux, L; Vatunga, G; Josenando, T; Ayenengoye, CR; Bouteille, B; Jauberteau, MO; Bisser, S				Boda, Caroline; Courtioux, Bertrand; Roques, Pierre; Pervieux, Lynda; Vatunga, Gedeon; Josenando, Theophile; Ayenengoye, Constant Roger; Bouteille, Bernard; Jauberteau, Marie-Odile; Bisser, Sylvie			Immunophenotypic Lymphocyte Profiles in Human African Trypanosomiasis	PLOS ONE			English	Article								Human African trypanosomiasis ( HAT) is a deadly vector-born disease caused by an extracellular parasite, the trypanosome. Little is known about the cellular immune responses elicited by this parasite in humans. We used multiparameter flow cytometry to characterize leukocyte immunophenotypes in the blood and cerebrospinal fluid ( CSF) of 33 HAT patients and 27 healthy controls identified during a screening campaign in Angola and Gabon. We evaluated the subsets and activation markers of B and T lymphocytes. Patients had a higher percentage of CD19(+) B lymphocytes and activated B lymphocytes in the blood than did controls, but lacked activated CD4+ T lymphocytes ( CD25(+)). Patients displayed no increase in the percentage of activated CD8+ T cells (HLA-DR(+), CD69(+) or CD25(+)), but memory CD8 T-cell levels (CD8(+)CD45RA(-)) were significantly lower in patients than in controls, as were effector CD8 T-cell levels ( CD8(+)CD45RA(+)CD62L(-)). No relationship was found between these blood immunophenotypes and disease severity ( stage 1 vs 2). However, CD19(+) B-cell levels in the CSF increased with disease severity. The patterns of T and B cell activation in HAT patients suggest that immunomodulatory mechanisms may operate during infection. Determinations of CD19(+) B-cell levels in the CSF could improve disease staging.			Boda, C (corresponding author), Univ Limoges, Inst Neurol Trop, Fac Med, IFR GEIST 145,EA NeuroEpidemiol Trop & Comparee 3, Limoges, France.	bertrand.courtioux@unilim.fr	Roques, Pierre/M-2212-2013; Bouteille, Bernard/T-6519-2019; Bouteille, Bernard/M-4547-2018	Roques, Pierre/0000-0003-1825-1054; Bouteille, Bernard/0000-0001-9661-0302; Jauberteau, Marie-Odile/0000-0002-8811-8948				Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AMEVIGBE MDD, 1992, AM J TROP MED HYG, V47, P652, DOI 10.4269/ajtmh.1992.47.652; ANTHOONS JAMS, 1986, Z PARASITENKD, V72, P443, DOI 10.1007/BF00927888; Ayed Z, 1997, AM J TROP MED HYG, V57, P1; Bakhiet M, 1996, J INTERF CYTOK RES, V16, P427, DOI 10.1089/jir.1996.16.427; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Bisser S, 2006, INT J PARASITOL, V36, P529, DOI 10.1016/j.ijpara.2006.02.001; Bisser S, 2002, J NEUROL SCI, V193, P127, DOI 10.1016/S0022-510X(01)00655-4; BODA C, 2005, TRIVANDRUM RES SIGNP, P255; BOUTEILLE B, 2003, ENCY NEUROLOGICAL SC, V2, P587; De Baetselier P, 2001, INT J PARASITOL, V31, P575, DOI 10.1016/S0020-7519(01)00170-9; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Heinrich A, 2006, ACTA NEUROL SCAND, V113, P248, DOI 10.1111/j.1600-0404.2005.00562.x; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; KAZYUMBA G, 1986, CLIN EXP IMMUNOL, V65, P10; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; LUMSDEN WHR, 1977, T ROY SOC TROP MED H, V71, P421, DOI 10.1016/0035-9203(77)90043-8; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; Millar AE, 1999, INFECT IMMUN, V67, P3334, DOI 10.1128/IAI.67.7.3334-3338.1999; MINOPRIO P, 1989, IMMUNOL REV, V112, P183, DOI 10.1111/j.1600-065X.1989.tb00558.x; Mirkin GA, 1997, CLIN EXP IMMUNOL, V107, P328, DOI 10.1111/j.1365-2249.1997.267-ce1166.x; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Namangala B, 2000, PARASITE IMMUNOL, V22, P361, DOI 10.1046/j.1365-3024.2000.00314.x; Namangala B, 2001, J LEUKOCYTE BIOL, V69, P387; Piedras J, 1997, CYTOMETRY, V30, P28, DOI 10.1002/(SICI)1097-0320(19970215)30:1<28::AID-CYTO4>3.0.CO;2-B; Radwanska M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000078; REINITZ DM, 1990, INFECT IMMUN, V58, P2337, DOI 10.1128/IAI.58.7.2337-2342.1990; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; SENDASHONGA CN, 1986, PARASITE IMMUNOL, V8, P443, DOI 10.1111/j.1365-3024.1986.tb00860.x; SILEGHEM M, 1989, EUR J IMMUNOL, V19, P119, DOI 10.1002/eji.1830190119; SILEGHEM M, 1989, EUR J IMMUNOL, V19, P829, DOI 10.1002/eji.1830190508; Tabel H, 2008, IMMUNOL REV, V225, P128, DOI 10.1111/j.1600-065X.2008.00675.x; Vincendeau P, 2006, AN ACAD BRAS CIENC, V78, P645, DOI 10.1590/S0001-37652006000400004; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6184	10.1371/journal.pone.0006184	http://dx.doi.org/10.1371/journal.pone.0006184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584913	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806500011
J	Boualem, A; Troadec, C; Kovalski, I; Sari, MA; Perl-Treves, R; Bendahmane, A				Boualem, Adnane; Troadec, Christelle; Kovalski, Irina; Sari, Marie-Agnes; Perl-Treves, Rafael; Bendahmane, Abdelhafid			A Conserved Ethylene Biosynthesis Enzyme Leads to Andromonoecy in Two Cucumis Species	PLOS ONE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; SEX EXPRESSION; MULTIGENE FAMILY; ACID SYNTHASE; ACC SYNTHASE; SATIVUS; GENE; FLOWERS; FRUIT; CUCURBITACEAE	Andromonoecy is a widespread sexual system in angiosperms, characterized by plants carrying both male and bisexual flowers. Monoecy is characterized by the presence of both male and female flowers on the same plant. In cucumber, these sexual forms are controlled by the identity of the alleles at the M locus. In melon, we recently showed that the transition from monoecy to andromonoecy result from a mutation in 1-aminocyclopropane-1-carboxylic acid synthase (ACS) gene, CmACS-7. To isolate the andromonoecy gene in cucumber we used a candidate gene approach in combination with genetical and biochemical analysis. We demonstrated co-segregation of CsACS2, a close homolog of CmACS-7, with the M locus. Sequence analysis of CsACS2 in cucumber accessions identified four CsACS2 isoforms, three in andromonoecious and one in monoecious lines. To determine whether the andromonoecious phenotype is due to a loss of ACS enzymatic activity, we expressed the four isoforms in Escherichia coli and assayed their activity in vitro. Like in melon, the isoforms from the andromonoecious lines showed reduced to no enzymatic activity and the isoform from the monoecious line was active. Consistent with this, the mutations leading andromonoecy were clustered in the active site of the enzyme. Based on this, we concluded that active CsACS2 enzyme leads to the development of female flowers in monoecious lines, whereas a reduction of enzymatic activity yields hermaphrodite flowers. Consistent with this, CsACS2, like CmACS-7 in melon, is expressed specifically in carpel primordia of buds determined to develop carpels. Following ACS expression, inter-organ communication is likely responsible for the inhibition of stamina development. In both melon and cucumber, flower unisexuality seems to be the ancestral situation, as the majority of Cucumis species are monoecious. Thus, the ancestor gene of CmACS-7/CsACS2 likely have controlled the stamen development before speciation of Cucumis sativus (cucumber) and Cucumis melo (melon) that have diverged over 40 My ago. The isolation of the genes for andromonoecy in Cucumis species provides a molecular basis for understanding how sexual systems arise and are maintained within and between species.	[Boualem, Adnane; Troadec, Christelle; Bendahmane, Abdelhafid] CNRS, INRA, Unite Rech Genom Vegetale, UMR1165, Evry, France; [Kovalski, Irina; Perl-Treves, Rafael] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Sari, Marie-Agnes] Univ Paris 05, CNRS, Lab Chim & Biochim Pharmacol & Toxicol, UMR 8601, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Bar Ilan University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Boualem, A (corresponding author), CNRS, INRA, Unite Rech Genom Vegetale, UMR1165, Evry, France.	bendahm@evry.inra.fr	Boualem, Adnane/ABC-5019-2021	Boualem, Adnane/0000-0003-4428-6496; Bendahmane, Abdelhafid/0000-0003-3246-868X; Berger, Frederic/0000-0002-3609-8260; TROADEC, Christelle/0000-0003-1927-7352				Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; BAUDRACCOARNAS S, 1995, 18 CUC GEN COOP, P50; BERTIN R I, 1982, Evolutionary Theory, V6, P25; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; FRIEDLANDER M, 1977, PLANT CELL PHYSIOL, V18, P1343, DOI 10.1093/oxfordjournals.pcp.a075556; GALUN E, 1961, GENETICA, V32, P134, DOI 10.1007/BF01816091; Huai Q, 2001, J BIOL CHEM, V276, P38210; Kamachi S, 1997, PLANT CELL PHYSIOL, V38, P1197, DOI 10.1093/oxfordjournals.pcp.a029106; Kater MM, 2001, PLANT CELL, V13, P481, DOI 10.1105/tpc.13.3.481; Kirkbride JH, 1993, BIOSYSTEMATIC MONOGR; Knopf RR, 2006, PLANT CELL PHYSIOL, V47, P1217, DOI 10.1093/pcp/pcj092; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; KUBICKI B, 1969, GENET POL, V10, P101; Little HA, 2007, SEX PLANT REPROD, V20, P123, DOI 10.1007/s00497-007-0049-5; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; MIBUS H, 2000, INVESTIGATIONS SEX E; Miller JS, 2003, AM J BOT, V90, P707, DOI 10.3732/ajb.90.5.707; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Papadopoulou E, 2005, SEX PLANT REPROD, V18, P131, DOI 10.1007/s00497-005-0006-0; Perl-Treves R., 2006, FLOWER DEV MANIPULAT, P117; PERLTREVES R, 1999, SEX DETERMINATION PL, P189; Ralph SG, 2007, PLANT PHYSIOL, V143, P410, DOI 10.1104/pp.106.089425; Renner SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-58; ROTTMANN WH, 1991, J MOL BIOL, V222, P937, DOI 10.1016/0022-2836(91)90587-V; Saito S, 2007, J EXP BOT, V58, P2897, DOI 10.1093/jxb/erm141; Tarun AS, 1998, P NATL ACAD SCI USA, V95, P9796, DOI 10.1073/pnas.95.17.9796; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Vallejo-Marin M, 2007, EVOLUTION, V61, P404, DOI 10.1111/j.1558-5646.2007.00031.x; WHITE MF, 1994, P NATL ACAD SCI USA, V91, P12428, DOI 10.1073/pnas.91.26.12428; WOLFENDEN R, 1967, J BIOL CHEM, V242, P977; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yamasaki S, 2000, PLANT CELL PHYSIOL, V41, P608, DOI 10.1093/pcp/41.5.608; Yamasaki S, 2003, SEX PLANT REPROD, V16, P103, DOI 10.1007/s00497-003-0183-7; Yamasaki S, 2003, PLANT CELL ENVIRON, V26, P537, DOI 10.1046/j.1365-3040.2003.00984.x; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yin TJ, 1995, AM J BOT, V82, P1537, DOI 10.2307/2446182	40	91	108	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6144	10.1371/journal.pone.0006144	http://dx.doi.org/10.1371/journal.pone.0006144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578542	Green Published, gold			2022-12-25	WOS:000267806300013
J	Dormuth, CR; Maclure, M; Carney, G; Schneeweiss, S; Bassett, K; Wright, JM				Dormuth, Colin R.; Maclure, Malcolm; Carney, Greg; Schneeweiss, Sebastian; Bassett, Ken; Wright, James M.			Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin	PLOS ONE			English	Article								Objective: Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial infarction (AMI) in a two meta-analyses of clinical trials. Our objective is to estimate the magnitude of the association in real-world patients previously treated with metformin. Research Design and Methods: We conducted a nested case control study in British Columbia using health care databases on 4.3 million people. Our cohort consisted of 158,578 patients with Type 2 diabetes who used metformin as first-line drug treatment. We matched 2,244 cases of myocardial infarction (AMI) with up to 4 controls. Conditional logistic regression models were used to estimate matched odds ratios for AMI associated with treatment with rosiglitazone, pioglitazone and sulfonylureas. Results: In our cohort of prior metformin users, adding rosiglitazone for up to 6 months was not associated with an increased risk of AMI compared to adding a sulfonylurea (odds ratio [OR] 1.38; 95% confidence interval [CI], 0.91-2.10), or compared to adding pioglitazone (OR for rosi versus pio 1.41; 95% CI, 0.74-2.66). There were also no significant differences between rosiglitazone, pioglitazone and sulfonylureas for longer durations of treatment. Though not significantly different from sulfonylureas, there was a transient increase in AMI risk associated with the first 6 months of treatment with a glitazone compared to not using the treatment (OR 1.53; 95% CI, 1.13-2.07) Conclusions: In our British Columbia cohort of patients who received metformin as first-line pharmacotherapy for Type 2 diabetes mellitus, further treatment with rosiglitazone did not increase the risk of AMI compared to patients who were treated with pioglitazone or a sulfonylurea. Though not statistically significantly different compared from each other, an increased risk of AMI observed after starting rosiglitazone or sulfonylureas is a matter of concern that requires more research.			Dormuth, CR (corresponding author), Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada.	colin.dormuth@ti.ubc.ca	Carney, Greg/T-5180-2019; Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X; Dormuth, Colin/0000-0001-8577-8783				Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Glynn RJ, 1999, AM J EPIDEMIOL, V149, P541; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; ROMANO PS, 1994, MED CARE, V32, P81, DOI 10.1097/00005650-199401000-00006; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; *UGDP, 1970, DIABETES S2, V19, P747; Williams JI, 1996, INVENTORY STUDIES AC; 2006, BC HLTH DATA WAREHOU	17	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2009	4	6							e6080	10.1371/journal.pone.0006080	http://dx.doi.org/10.1371/journal.pone.0006080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463IE	19562036	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424700001
J	Ricketts, C; Zeegers, MP; Lubinski, J; Maher, ER				Ricketts, Christopher; Zeegers, Maurice P.; Lubinski, Jan; Maher, Eamonn R.			Analysis of Germline Variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in Familial and Sporadic Renal Cell Carcinoma	PLOS ONE			English	Article								Background: The investigation of rare familial forms of kidney cancer has provided important insights into the biology of sporadic renal cell carcinoma (RCC). In particular, the identification of the von Hippel Lindau (VHL) familial cancer syndrome gene (VHL) provided the basis for the discovery that VHL is somatically inactivated in most sporadic clear cell RCC. Many cases of familial RCC do not have mutations in known RCC susceptibility genes and there is evidence that genetic modifiers may influence the risk of RCC in VHL disease patients. Hence we hypothesised that low- penetrance functional genetic variants in pathways related to the VHL protein (pVHL) function might (a) modify the phenotypic expression of VHL disease and/or (b) predispose to sporadic RCC. Methodology/Principal Findings: We tested this hypothesis for functional polymorphisms in CDH1 (rs16260), IGFBP3 (rs2854744), MMP1 (rs1799750), MMP3 (rs679620), STK15 (rs2273535) and VEGF (rs1570360). We observed that variants of MMP1 and MMP3 were significant modifiers of RCC risk (and risks of retinal angioma and cerebellar haemangioblastoma) in VHL disease patients. In addition, higher frequencies of the MMP1 rs1799750 2G allele (p = 0.017, OR 1.49, 95% CI 1.06-2.08) and the MMP1/MMP3 rs1799750/rs679620 2G/G haplotype (OR 1.45, 95% CI 1.01-2.10) were detected in sporadic RCC patients than in controls (n = 295). Conclusions/Significance: These findings (a) represent the first example of genetic modifiers of RCC risk in VHL disease, (b) replicate a previous report of an association between MMP1/MMP3 variants and sporadic RCC and (c) further implicate MMP1/MMP3-related pathways in the pathogenesis of familial and sporadic RCC.			Ricketts, C (corresponding author), Univ Birmingham, Sch Med, Canc Res UK Renal Mol Oncol Grp, Dept Med & Mol Genet, Birmingham, W Midlands, England.	e.r.maher@bham.ac.uk	MAHER, EAMONN R/A-9507-2008; Ricketts, Christopher/AAV-9580-2020	MAHER, EAMONN R/0000-0002-6226-6918; Lubinski, Jan/0000-0003-2931-3003; Zeegers, Maurice/0000-0002-2387-083X	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Foster RE, 2007, GENE CHROMOSOME CANC, V46, P311, DOI 10.1002/gcc.20403; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hammerschmied CG, 2007, ONCOL REP, V17, P3; Heighway J, 2005, ANN HUM GENET, V69, P127, DOI 10.1046/j.1529-8817.2004.00135.x; Hirata H, 2004, CARCINOGENESIS, V25, P2379, DOI 10.1093/carcin/bgh254; Hirata H, 2003, INT J CANCER, V106, P372, DOI 10.1002/ijc.11229; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Hung RJ, 2005, JNCI-J NATL CANCER I, V97, P567, DOI 10.1093/jnci/dji101; Ito T, 1999, MODERN PATHOL, V12, P669; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kanamori Y, 1999, CANCER RES, V59, P4225; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kimura MT, 2005, CANCER RES, V65, P3548, DOI 10.1158/0008-5472.CAN-04-2149; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LI LC, 2000, CANCER RES, P873; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Ong KR, 2007, HUM MUTAT, V28, P143, DOI 10.1002/humu.20385; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Prior SJ, 2006, AM J PHYSIOL-HEART C, V290, pH1848, DOI 10.1152/ajpheart.01033.2005; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; RIGEL DS, 1991, DERMATOL CLIN, V9, P631; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Rutter JL, 1998, CANCER RES, V58, P5321; *STATACORP, 2005, STAT SOFTW REL 9 0 C; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Teh BT, 1997, LANCET, V349, P848, DOI 10.1016/S0140-6736(05)61751-5; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Webster AR, 1998, AM J HUM GENET, V63, P1025, DOI 10.1086/302037; Woodward ER, 2000, J MED GENET, V37, P348, DOI 10.1136/jmg.37.5.348; Zatyka M, 2002, CANCER RES, V62, P3803; Zhang JH, 2004, CARCINOGENESIS, V25, P2519, DOI 10.1093/carcin/bgh269; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu Y, 2001, CANCER RES, V61, P7825; Zinzindohoue F, 2004, ANTICANCER RES, V24, P2021	50	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6037	10.1371/journal.pone.0006037	http://dx.doi.org/10.1371/journal.pone.0006037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551141	gold, Green Published, Green Submitted			2022-12-25	WOS:000267356500019
J	Henderson, K; Stella, SL; Kobylewski, S; Eckhert, CD				Henderson, Kimberly; Stella, Salvatore L., Jr.; Kobylewski, Sarah; Eckhert, Curtis D.			Receptor Activated Ca2+ Release Is Inhibited by Boric Acid in Prostate Cancer Cells	PLOS ONE			English	Article							DIETARY BORON; CALCIUM; BORATE; GROWTH; TOXICITY; CHANNELS; STORES; ENTRY; POOL	Background: The global disparity in cancer incidence remains a major public health problem. We focused on prostate cancer since microscopic disease in men is common, but the incidence of clinical disease varies more than 100 fold worldwide. Ca2+ signaling is a central regulator of cell proliferation, but has received little attention in cancer prevention. We and others have reported a strong dose-dependent reduction in the incidence of prostate and lung cancer within populations exposed to boron (B) in drinking water and food; and in tumor and cell proliferation in animal and cell culture models. Methods/Principal Findings: We examined the impact of B on Ca2+ stores using cancer and non-cancer human prostate cell lines, Ca2+ indicators Rhod-2 AM and Indo-1 AM and confocal microscopy. In DU-145 cells, inhibition of Ca2+ release was apparent following treatment with Ringers containing RyR agonists cADPR, 4CmC or caffeine and respective levels of BA (50 mu M), (1, 10 mu M) or (10, 20, 50,150 mu M). Less aggressive LNCaP cancer cells required 20 mu M BA and the non-tumor cell line PWR1E required 150 mu M BA to significantly inhibit caffeine stimulated Ca2+ release. BA (10 mu M) and the RyR antagonist dantroline (10 beta M) were equivalent in their ability to inhibit ER Ca2+ loss. Flow cytometry and confocal microscopy analysis showed exposure of DU-145 cells to 50 mu M BA for 1 hr decreased stored [Ca2+] by 32%. Conclusion/Significance: We show B causes a dose dependent decrease of Ca2+ release from ryanodine receptor sensitive stores. This occurred at BA concentrations present in blood of geographically disparate populations. Our results suggest higher BA blood levels lower the risk of prostate cancer by reducing intracellular Ca2+ signals and storage.			Henderson, K (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA.	ceckhert@ucla.edu		Stella Jr., Salvatore/0000-0003-1971-2537				[Anonymous], 1995, CALCIUM CELL CYCLES, P1; BARR RD, 1993, J LAB CLIN MED, V121, P614; Barranco WT, 2007, CANCER CAUSE CONTROL, V18, P583, DOI 10.1007/s10552-007-9023-7; Barranco WT, 2009, CELL BIOL TOXICOL, V25, P309, DOI 10.1007/s10565-008-9085-7; Barranco WT, 2004, CANCER LETT, V216, P21, DOI 10.1016/j.canlet.2004.06.001; Barranco WT, 2006, BRIT J CANCER, V94, P884, DOI 10.1038/sj.bjc.6603009; Bennett A, 1999, J NUTR, V129, P2236, DOI 10.1093/jn/129.12.2236; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Corey E. J, 2003, CHEM ENG NEWS, V81, P40; Cui Y, 2004, ONCOL REP, V11, P887; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Fessenden JD, 2006, J BIOL CHEM, V281, P21022, DOI 10.1074/jbc.M600670200; Gallardo-Williams MT, 2004, TOXICOL PATHOL, V32, P73, DOI 10.1080/01926230490260899; Golovina VA, 1999, AM J PHYSIOL-CELL PH, V277, pC343, DOI 10.1152/ajpcell.1999.277.2.C343; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Gonzalez A, 2007, CANCER CAUSE CONTROL, V18, P1131, DOI 10.1007/s10552-007-9052-2; Humez S, 2004, J CELL PHYSIOL, V201, P201, DOI 10.1002/jcp.20049; Hunt CD, 2001, J AM DIET ASSOC, V101, P1058, DOI 10.1016/S0002-8223(01)00260-7; *IPCS, 1998, BOR ENV HLTH CRIT WH, P61; Kaufmann A, 2008, ANESTHESIOLOGY, V109, P457, DOI 10.1097/ALN.0b013e318182a93b; Kim DH, 2006, J CHROMATOGR A, V1115, P246, DOI 10.1016/j.chroma.2006.02.066; Kim DH, 2004, J MASS SPECTROM, V39, P743, DOI 10.1002/jms.645; Kim DH, 2003, J MASS SPECTROM, V38, P632, DOI 10.1002/jms.476; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Legrand G, 2001, J BIOL CHEM, V276, P47608, DOI 10.1074/jbc.M107011200; Li N, 2008, J CELL PHYSIOL, V216, P172, DOI 10.1002/jcp.21385; LIOU J, 2005, CURRENT BIO, P1235; Lopez JJ, 2008, BIOCHEM PHARMACOL, V75, P2157, DOI 10.1016/j.bcp.2008.03.010; Mahabir S, 2008, AM J EPIDEMIOL, V167, P1070, DOI 10.1093/aje/kwn021; Mariot P, 2000, PROSTATE, V43, P205; Matsumoto Hiroko, 2003, J Oral Sci, V45, P139; MINTA A, 1989, J BIOL CHEM, V264, P8171; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; MORITA K, 2006, J PHARM SCI; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pahl MV, 2001, TOXICOL SCI, V60, P252, DOI 10.1093/toxsci/60.2.252; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Rowe RI, 1999, J EXP BIOL, V202, P1649; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; TANKANO J, 2005, P NATL ACAD SCI USA, V102, P12276; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Watson WD, 2003, J NEUROCHEM, V87, P30, DOI 10.1046/j.1471-4159.2003.01962.x; Wayman CP, 1996, BRIT J PHARMACOL, V117, P566, DOI 10.1111/j.1476-5381.1996.tb15228.x; WOODS WG, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3431956; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k	51	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6009	10.1371/journal.pone.0006009	http://dx.doi.org/10.1371/journal.pone.0006009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19554099	Green Published, gold, Green Submitted			2022-12-25	WOS:000267347900008
J	Mikkelsen, H; Ball, G; Giraud, C; Filloux, A				Mikkelsen, Helga; Ball, Genevieve; Giraud, Caroline; Filloux, Alain			Expression of Pseudomonas aeruginosa CupD Fimbrial Genes Is Antagonistically Controlled by RcsB and the EAL-Containing PvrR Response Regulators	PLOS ONE			English	Article								Pseudomonas aeruginosa is a gram-negative pathogenic bacterium with a high adaptive potential that allows proliferation in a broad range of hosts or niches. It is also the causative agent of both acute and chronic biofilm-related infections in humans. Three cup gene clusters (cupA-C), involved in the assembly of cell surface fimbriae, have been shown to be involved in biofilm formation by the P. aeruginosa strains PAO1 or PAK. In PA14 isolates, a fourth cluster, named cupD, was identified within a pathogenicity island, PAPI-I, and may contribute to the higher virulence of this strain. Expression of the cupA genes is controlled by the HNS-like protein MvaT, whereas the cupB and cupC genes are under the control of the RocS1A1R two-component system. In this study, we show that cupD gene expression is positively controlled by the response regulator RcsB. As a consequence, CupD fimbriae are assembled on the cell surface, which results in a number of phenotypes such as a small colony morphotype, increased biofilm formation and decreased motility. These behaviors are compatible with the sessile bacterial lifestyle. The balance between planktonic and sessile lifestyles is known to be linked to the intracellular levels of c-di-GMP with high levels favoring biofilm formation. We showed that the EAL domain-containing PvrR response regulator counteracts the activity of RcsB on cupD gene expression. The action of PvrR is likely to involve c-di-GMP degradation through phosphodiesterase activity, confirming the key role of this second messenger in the balance between bacterial lifestyles. The regulatory network between RcsB and PvrR remains to be elucidated, but it stands as a potential model system to study how the equilibrium between the two lifestyles could be influenced by therapeutic agents that favor the planktonic lifestyle. This would render the pathogen accessible for the immune system or conventional antibiotic treatment.			Mikkelsen, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, S Kensington Campus, London, England.	a.filloux@imperial.ac.uk		Giraud, Caroline/0000-0002-8294-3218	BBSRC [BB/F019645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019645/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alibaud L, 2008, CELL MICROBIOL, V10, P729, DOI 10.1111/j.1462-5822.2007.01080.x; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jonas K, 2009, FUTURE MICROBIOL, V4, P341, DOI [10.2217/fmb.09.7, 10.2217/FMB.09.7]; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sambrook J., 2002, MOL CLONING LAB MANU; Sarker MR, 1997, MOL MICROBIOL, V23, P410, DOI 10.1046/j.1365-2958.1997.t01-1-00190.x; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; STARKEY M, 2009, J BACTERIOLOGY  0327; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Vallet I, 2004, J BACTERIOL, V186, P2880, DOI 10.1128/JB.186.9.2880-2890.2004; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; VENTRE I, 2004, VIRULENCE GENE REGUL, V2, P257; Virlogeux I, 1996, J BACTERIOL, V178, P1691, DOI 10.1128/jb.178.6.1691-1698.1996; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004	50	65	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6018	10.1371/journal.pone.0006018	http://dx.doi.org/10.1371/journal.pone.0006018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547710	gold, Green Published, Green Submitted			2022-12-25	WOS:000267347900014
J	Johnsen, U; Dambeck, M; Zaiss, H; Fuhrer, T; Soppa, J; Sauer, U; Schonheit, P				Johnsen, Ulrike; Dambeck, Michael; Zaiss, Henning; Fuhrer, Tobias; Soppa, Joerg; Sauer, Uwe; Schoenheit, Peter			D-Xylose Degradation Pathway in the Halophilic Archaeon Haloferax volcanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE PATHWAY; EVOLUTIONARY INSIGHT; DEHYDROGENASE; METABOLISM; PURIFICATION; GLUCOSE; IDENTIFICATION; CONSTRUCTION; DEHYDRATASE; EXPRESSION	The pathway of D-xylose degradation in archaea is unknown. In a previous study we identified in Haloarcula marismortui the first enzyme of xylose degradation, an inducible xylose dehydrogenase (Johnsen, U., and Schonheit, P. (2004) J. Bacteriol. 186, 6198-6207). Here we report a comprehensive study of the complete D-xylose degradation pathway in the halophilic archaeon Haloferax volcanii. The analyses include the following: (i) identification of the degradation pathway in vivo following C-13-labeling patterns of proteinogenic amino acids after growth on [C-13]xylose; (ii) identification of xylose-induced genes by DNA microarray experiments; (iii) characterization of enzymes; and (iv) construction of in-frame deletion mutants and their functional analyses in growth experiments. Together, the data indicate that D-xylose is oxidized exclusively to the tricarboxylic acid cycle intermediate alpha-ketoglutarate, involving D-xylose dehydrogenase (HVO_B0028), a novel xylonate dehydratase (HVO_B0038A), 2-keto-3-deoxyxylonate dehydratase (HVO_B0027), and alpha-ketoglutarate semialdehyde dehydrogenase (HVO_B0039). The functional involvement of these enzymes in xylose degradation was proven by growth studies of the corresponding in-frame deletion mutants, which all lost the ability to grow on D-xylose, but growth on glucose was not significantly affected. This is the first report of an archaeal D-xylose degradation pathway that differs from the classical D-xylose pathway in most bacteria involving the formation of xylulose 5-phosphate as an intermediate. However, the pathway shows similarities to proposed oxidative pentose degradation pathways to alpha-ketoglutarate in few bacteria, e.g. Azospirillum brasilense and Caulobacter crescentus, and in the archaeon Sulfolobus solfataricus.	[Johnsen, Ulrike; Zaiss, Henning; Schoenheit, Peter] Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany; [Dambeck, Michael; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Fuhrer, Tobias; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Kiel; Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schonheit, P (corresponding author), Univ Kiel, Inst Allgemeine Mikrobiol, Bot Garten 1-9, D-24118 Kiel, Germany.	peter.schoenheit@ifam.uni-kiel.de	Sauer, Uwe/Y-3556-2019; Fuhrer, Tobias/B-5667-2013	Fuhrer, Tobias/0000-0001-5006-6874; Soppa, Jorg/0000-0002-6132-5840				Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Chen CN, 2008, J MOL BIOL, V384, P604, DOI 10.1016/j.jmb.2008.09.055; Connaris H, 1999, BIOTECHNOL BIOENG, V64, P38, DOI 10.1002/(SICI)1097-0290(19990705)64:1<38::AID-BIT4>3.0.CO;2-7; Dauner M, 2000, BIOTECHNOL PROGR, V16, P642, DOI 10.1021/bp000058h; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Johnsen U, 2001, ARCH MICROBIOL, V175, P52, DOI 10.1007/s002030000237; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Soppa J, 2008, ARCH MICROBIOL, V190, P197, DOI 10.1007/s00203-008-0376-4; SOPPA J, 1994, SYST APPL MICROBIOL, V16, P725; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van de Werken Harmen J. G., 2008, P71; Wanner C, 2002, J BACTERIOL, V184, P3114, DOI 10.1128/JB.184.11.3114-3121.2002; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	29	76	86	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2009	284	40					27290	27303		10.1074/jbc.M109.003814	http://dx.doi.org/10.1074/jbc.M109.003814			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	499OJ	19584053	hybrid, Green Published			2022-12-25	WOS:000270232300030
J	Liu, N; Wang, GY; Lee, KC; Guan, Y; Chen, HL; Cai, ZW				Liu, Ning; Wang, Genyan; Lee, Kim Chung; Guan, Yi; Chen, Honglin; Cai, Zongwei			Mutations in influenza virus replication and transcription: detection of amino acid substitutions in hemagglutinin of an avian influenza virus (H1N1)	FASEB JOURNAL			English	Article						polymorphism of viral antigen; mass spectrometric sequencing; infection; receptor; mutation; replication and transcription	ANTIGENIC DRIFT; A VIRUSES; IDENTIFICATION; EVOLUTION; SEQUENCE; GENE	Influenza A viruses are RNA viruses that contain negative-sense, single-stranded, and segmented RNA genome, which depends on virally encoded RNA-dependent RNA polymerase and cellular DNA-dependent RNA polymerase for replication of viral genome and transcription of viral mRNA, respectively. Hemagglutinin ( HA), one of the major surface proteins of the influenza virus, is responsible for virus attachment to the receptor of host cells to initiate an infection. Amino acid ( AA) substitutions in HA may cause changes in virus antigenicity and even receptor specificity. To detect the AA substitutions within HA at protein level, nanoelectrospray-MS/MS was used to analyze tryptic digestion of HA antigen directly purified from virus particles of an avian influenza virus, A/WDK/JX/12416/2005 (H1N1), of which the HA gene was sequenced as a reference. The comparison of the sequences obtained from analysis of viral genome and peptide found seven variations between HA gene and protein, namely E103K, R130K, T169I, I338V, N387S, S398I/L, and I399S in HA. Because influenza virus uses different polymerase machineries for replication and transcription, these substitutions could be introduced in the viral genome through replication process but not in viral mRNA in the transcription. The results, for the first time, provided experimental evidence showing differences in AA sequence obtained from direct analysis of viral protein derived from viral genome.-Liu, N., Wang, G., Lee, K. C., Guan, Y., Chen, H., Cai, Z. Mutations in influenza virus replication and transcription: detection of amino acid substitutions in hemagglutinin of an avian influenza virus ( H1N1). FASEB J. 23, 3377-3382 ( 2009). www.fasebj.org	[Guan, Yi; Chen, Honglin] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Guan, Yi; Chen, Honglin] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Liu, Ning; Lee, Kim Chung; Cai, Zongwei] Hong Kong Baptist Univ, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Liu, Ning] Jilin Univ, Changchun 130023, Peoples R China; [Wang, Genyan; Guan, Yi; Chen, Honglin] Shantou Univ, Int Inst Infect & Immun, Shantou, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong Baptist University; Jilin University; Shantou University	Chen, HL (corresponding author), Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	hlchen@hkucc.hku.hk; zwcai@hkbu.edu.hk	Chen, Honglin/C-4224-2009; Cai, Zongwei/ABD-4001-2020	Chen, Honglin/0000-0001-5108-8338; Cai, Zongwei/0000-0002-8724-7684; Liu, Ning/0000-0002-7925-8535; Guan, Yi/0000-0001-6057-9243	Research Grants Council of the Hong Kong SAR [HKU 7500/06M, HKU 7488/05M]; Area of Excellence Scheme of the University [AoE/M-12/06]; research fund for the control of infectious diseases, Hong Kong SAR; Li Ka Shing Foundation; Hong Kong Baptist University [FRG/07-08/II-21]	Research Grants Council of the Hong Kong SAR(Hong Kong Research Grants Council); Area of Excellence Scheme of the University; research fund for the control of infectious diseases, Hong Kong SAR; Li Ka Shing Foundation; Hong Kong Baptist University	This work was supported by the Research Grants Council of the Hong Kong SAR (HKU 7500/06M and HKU 7488/05M); the Area of Excellence Scheme of the University Grants Committee (AoE/M-12/06); the research fund for the control of infectious diseases, Hong Kong SAR; the Li Ka Shing Foundation; and a faculty research grant from Hong Kong Baptist University (FRG/07-08/II-21).	Carr MJ, 2008, J VIROL METHODS, V153, P257, DOI 10.1016/j.jviromet.2008.07.011; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KINNUNEN L, 1992, RES VIROLOGY, V143, P11, DOI 10.1016/S0923-2516(06)80071-3; Liu N, 2009, J AM SOC MASS SPECTR, V20, P312, DOI 10.1016/j.jasms.2008.10.010; Liu N, 2009, TALANTA, V78, P1492, DOI 10.1016/j.talanta.2009.01.057; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; ROCHA E, 1991, J VIROL, V65, P2340, DOI 10.1128/JVI.65.5.2340-2350.1991; Rudneva IA, 2005, J GEN VIROL, V86, P2831, DOI 10.1099/vir.0.81185-0; SLEIGH MJ, 1981, J VIROL, V37, P845, DOI 10.1128/JVI.37.3.845-853.1981; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80	12	10	12	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3377	3382		10.1096/fj.09-134072	http://dx.doi.org/10.1096/fj.09-134072			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19553505				2022-12-25	WOS:000270354300015
J	van Miltenburg, MHAM; Lalai, R; de Bont, H; van Waaij, E; Beggs, H; Danen, EHJ; van de Water, B				van Miltenburg, Martine H. A. M.; Lalai, Reshma; de Bont, Hans; van Waaij, Eveline; Beggs, Hilary; Danen, Erik H. J.; van de Water, Bob			Complete focal adhesion kinase deficiency in the mammary gland causes ductal dilation and aberrant branching morphogenesis through defects in Rho kinase-dependent cell contractility	FASEB JOURNAL			English	Article						adhesion signaling; lactation; myoepithelial cells; luminal epithelial cells	GENE-EXPRESSION; BETA-1-INTEGRIN; DIFFERENTIATION; INTEGRIN; TISSUE; FAK; ORGANIZATION; REGULATOR; DELETION; POLARITY	The adult, virgin mammary gland is a highly organized branched ductal network comprising two major cell types: myoepithelial and luminal epithelial cells. To study the role and mechanism of focal adhesion kinase (FAK)-mediated signaling in mammary gland development and differentiation, we used a conditional Fak-knockout mammary epithelial cell (MEC) transplantation model. Conditional Cre recombinase (Cre)-mediated Fak deletion in primary cultured MECs isolated from FAK(lox/lox)/Rosa26Cre-ERT2 donor mice caused loss of FAK in all mammary cells. Transplantation of Fak-knockout MECs in a cleared mammary fat pad of immunedeficient recipient mice resulted in development of new but dilated virgin ducts with a disrupted myoepithelial and luminal epithelial cell multilayer and aberrant ductal morphogenesis during pregnancy. In the absence of FAK, MECs spread poorly, showed enhanced Rho kinase (ROCK)-mediated cytoskeletal contractility, and failed to respond to receptor-mediated cytoskeletal remodeling. Likewise, FAK deficiency fully inhibited branching morphogenesis of mammary gland organoids in a ROCK-dependent manner. Altogether these data suggest a model in which FAK coordinates contractile forces in MECs to maintain the bilayered cellular organization of myoepithelial and luminal epithelial cells in ducts, thus allowing proper mammary gland development and function.-Van Miltenburg, M. H. A. M., Lalai, R., de Bont, H., van Waaij, E., Beggs, H., Danen, E. H. J., van de Water, B. Complete focal adhesion kinase deficiency in the mammary gland causes ductal dilation and aberrant branching morphogenesis through defects in ROCK-dependent cell contractility. FASEB J. 23, 3482-3493 ( 2009). www.fasebj.org	[van Miltenburg, Martine H. A. M.; Lalai, Reshma; de Bont, Hans; van Waaij, Eveline; Danen, Erik H. J.; van de Water, Bob] Leiden Univ, LACDR, Div Toxicol, NL-2300 RA Leiden, Netherlands; [Beggs, Hilary] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	Leiden University; Leiden University - Excl LUMC; University of California System; University of California San Francisco	van de Water, B (corresponding author), Leiden Univ, LACDR, Div Toxicol, Einsteinweg 55,POB 9502, NL-2300 RA Leiden, Netherlands.	water_b@lacdr.leidenuniv.nl		danen, erik/0000-0002-0491-6345	Dutch Cancer Society [KWF-UL 2006-3538, UL 2007-3860]; European Union FP7 Health [201862]; Netherlands Organisation for Scientific Research [911-02-022]; Netherlands Toxicogenomics Center	Dutch Cancer Society(KWF Kankerbestrijding); European Union FP7 Health; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Toxicogenomics Center	We thank Sjef Verbeek ( Leiden University Medical Center, Leiden, The Netherlands) for Rosa26Cre-ERT2 mice, Jos Jonkers ( The Netherlands Cancer Institute, Amsterdum, The Netherlands) for Rag2<SUP>-/-</SUP>gamma c<SUP>-/-</SUP> mice, and Daniel Streblow ( Oregon Health and Science University, Portland, OR, USA) for adenoviral HA-tagged FAK. We thank Marjo de Graauw and Leo Price for suggestions and critical reading of the manuscript and the members of the Division of Toxicology of the Leiden/Amsterdam Center for Drug Research for valuable discussion and support. This work was supported by grants from the Dutch Cancer Society (KWF-UL 2006-3538 and UL 2007-3860), European Union FP7 Health ( grant 201862; Metafight project), the Netherlands Organisation for Scientific Research ( grant 911-02-022), and the Netherlands Toxicogenomics Center.	Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bissell MJ, 2003, BREAST CANCER RES, V5, P117, DOI 10.1186/bcr579; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; de Graauw M, 2005, J BIOL CHEM, V280, P29885, DOI 10.1074/jbc.M412708200; DEUGNIER MA, 1995, DEV DYNAM, V204, P107, DOI 10.1002/aja.1002040202; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; ILLC D, 1995, NATURE, V377, P539; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Lollivier V, 2006, J PHYSIOL-LONDON, V570, P125, DOI 10.1113/jphysiol.2005.097816; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Ren XD, 2000, J CELL SCI, V113, P3673; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435	31	24	24	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3482	3493		10.1096/fj.08-123398	http://dx.doi.org/10.1096/fj.08-123398			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19584305				2022-12-25	WOS:000270354300025
J	McGill, MA; Dho, SE; Weinmaster, G; McGlade, CJ				McGill, Melanie A.; Dho, Sascha E.; Weinmaster, Gerry; McGlade, C. Jane			Numb Regulates Post-endocytic Trafficking and Degradation of Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFY CELL FATE; MAMMALIAN NUMB; LIGAND ENDOCYTOSIS; UBIQUITIN LIGASE; DOWN-REGULATION; ASYMMETRIC LOCALIZATION; ALPHA-ADAPTIN; PROTEIN; RECEPTOR; ACTIVATION	Notch is a transmembrane receptor that controls cell fate decisions during development and tissue homeostasis. Both activation and attenuation of the Notch signal are tightly regulated by endocytosis. The adaptor protein Numb acts as an inhibitor of Notch and is known to function within the intracellular trafficking pathways. However, a role for Numb in regulating Notch trafficking has not been defined. Here we show that mammalian Notch1 is constitutively internalized and trafficked to both recycling and late endosomal compartments, and we demonstrate that changes in Numb expression alter the dynamics of Notch1 trafficking. Overexpression of Numb promotes sorting of Notch1 through late endosomes for degradation, whereas depletion of Numb facilitates Notch1 recycling. Numb mutants that do not interact with the ubiquitin-protein isopeptide ligase, Itch, or that lack motifs important for interaction with endocytic proteins fail to promote Notch1 degradation. Our data suggest that Numb inhibits Notch1 activity by regulating post-endocytic sorting events that lead to Notch1 degradation.	[McGill, Melanie A.; Dho, Sascha E.; McGlade, C. Jane] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [McGill, Melanie A.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Weinmaster, Gerry] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	McGlade, CJ (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jmcglade@sickkids.ca			Canadian Cancer Society [016125]; National Institutes of Health [R37 NS031885]; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031885] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Canadian Cancer Society Grant 016125 (to C. J. M.) and, in whole or in part, by National Institutes of Health Grant R37 NS031885 from NINDS (to G. W.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Commisso C, 2007, MOL BIOL CELL, V18, P1, DOI 10.1091/mbc.E06-08-0753; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Klueg KM, 1999, J CELL SCI, V112, P3289; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Nilsson L, 2008, GENETICS, V179, P375, DOI 10.1534/genetics.108.087247; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; SHEN Q, 2002, SCI STKE, pPE52; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	76	159	164	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26427	26438		10.1074/jbc.M109.014845	http://dx.doi.org/10.1074/jbc.M109.014845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19567869	Green Published, hybrid			2022-12-25	WOS:000269969600024
J	Clarkson, NG; Brown, MH				Clarkson, Nicholas G.; Brown, Marion H.			Inhibition and Activation by CD244 Depends on CD2 and Phospholipase C-gamma 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; LINKED LYMPHOPROLIFERATIVE DISEASE; HUMAN NK CELLS; RECEPTOR 2B4 CD244; T-CELL; CYTOPLASMIC DOMAIN; CUTTING EDGE; SIGNAL-TRANSDUCTION; INFECTED-CELLS; SH3 DOMAIN	Regulation by the NK and T cell surface receptor CD244 in mice and humans depends both on engagement at the cell surface by CD48 and intracellular interactions with SAP and EAT-2. Relevance to human disease by manipulating CD244 in mouse models is complicated by rodent CD2 also binding CD48. We distinguish between contributions of mouse CD244 and CD2 on engagement of CD48 in a mouse T cell hybridoma. CD2 and CD244 both contribute positively to the immune response as mutation of proline-rich motifs or tyrosine motifs in the tails of CD2 and CD244, respectively, result in a decrease in antigen-specific interleukin-2 production. Inhibitory effects of mouse CD244 are accounted for by competition with CD2 at the cell surface for CD48. In humans CD2 and CD244 are engaged separately at the cell surface but biochemical data suggest a potential conserved intracellular link between the two receptors through FYN kinase. We identify a novel signaling mechanism for CD244 through its potential to recruit phospholipase C-gamma 1 via the conserved phosphorylated tyrosine motif in the tail of the adaptor protein EAT-2, which we show is important for function.	[Clarkson, Nicholas G.; Brown, Marion H.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, MH (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	marion.brown@path.ox.ac.uk			Medical Research Council [G0400808]; MRC [G0400808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0400808.	BELL GM, 1992, MOL CELL BIOL, V12, P5548, DOI 10.1128/MCB.12.12.5548; Bell GM, 1996, J EXP MED, V183, P169, DOI 10.1084/jem.183.1.169; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Boles KS, 1999, TISSUE ANTIGENS, V54, P27, DOI 10.1034/j.1399-0039.1999.540103.x; BROWN MH, 1988, EUR J IMMUNOL, V18, P1223, DOI 10.1002/eji.1830180812; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; CHANG HC, 1990, J EXP MED, V172, P351, DOI 10.1084/jem.172.1.351; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Clarkson NG, 2007, J BIOL CHEM, V282, P25385, DOI 10.1074/jbc.M704483200; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Eissmann P, 2006, J IMMUNOL, V177, P3170, DOI 10.4049/jimmunol.177.5.3170; Endt J, 2007, EUR J IMMUNOL, V37, P193, DOI 10.1002/eji.200636341; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Fukai I, 2000, EUR J IMMUNOL, V30, P3507, DOI 10.1002/1521-4141(2000012)30:12<3507::AID-IMMU3507>3.0.CO;2-O; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; HE Q, 1988, CELL, V54, P979, DOI 10.1016/0092-8674(88)90112-2; Hofmann G, 2005, BIOCHEMISTRY-US, V44, P13043, DOI 10.1021/bi050814y; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Lin HM, 1998, J BIOL CHEM, V273, P19914, DOI 10.1074/jbc.273.31.19914; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nishizawa K, 1998, P NATL ACAD SCI USA, V95, P14897, DOI 10.1073/pnas.95.25.14897; OHNO H, 1991, J IMMUNOL, V147, P2100; PANCHAMOORTHY G, 1994, MOL CELL BIOL, V14, P6372, DOI 10.1128/MCB.14.9.6372; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Schleinitz N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003278; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Stepp SE, 1999, EUR J IMMUNOL, V29, P2392, DOI 10.1002/(SICI)1521-4141(199908)29:08<2392::AID-IMMU2392>3.3.CO;2-I; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200	65	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24725	24734		10.1074/jbc.M109.028209	http://dx.doi.org/10.1074/jbc.M109.028209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586919	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000269734000007
J	Kajander, T; Sachs, JN; Goldman, A; Regan, L				Kajander, Tommi; Sachs, Jonathan N.; Goldman, Adrian; Regan, Lynne			Electrostatic Interactions of Hsp-organizing Protein Tetratricopeptide Domains with Hsp70 and Hsp90 COMPUTATIONAL ANALYSIS AND PROTEIN ENGINEERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY; BINDING; DESIGN; RECOGNITION; INHIBITORS; STABILITY; DYNAMICS; INSIGHTS; MODELS	The Hsp-organizing protein (HOP) binds to the C termini of the chaperones Hsp70 and Hsp90, thus bringing them together so that substrate proteins can be passed from Hsp70 to Hsp90. Because Hsp90 is essential for the correct folding and maturation of many oncogenic proteins, it has become a significant target for anti-cancer drug design. HOP binds to Hsp70 and Hsp90 via two independent tetratricopeptide (TPR) domains, TPR1 and TPR2A, respectively. We have analyzed ligand binding using Poisson-Boltzmann continuum electrostatic calculations, free energy perturbation, molecular dynamics simulations, and site-directed mutagenesis to delineate the contribution of different interactions to the affinity and specificity of the TPR-peptide interactions. We found that continuum electrostatic calculations could be used to guide protein design by removing unfavorable interactions to increase binding affinity, with an 80-fold increase in affinity for TPR2A. Contributions at buried charged residues, however, were better predicted by free energy perturbation calculations. We suggest using a combination of the two approaches for increasing the accuracy of results, with free energy perturbation calculations used only at selected buried residues of the ligand binding pocket. Finally we present the crystal structure of TPR2A in complex with its non-cognate Hsp70 ligand, which provides insight on the origins of specificity in TPR domain-peptide recognition.	[Kajander, Tommi; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, FIN-00014 Helsinki, Finland; [Kajander, Tommi; Regan, Lynne] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Regan, Lynne] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Helsinki; Yale University; Yale University; University of Minnesota System; University of Minnesota Twin Cities	Kajander, T (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, POB 65, FIN-00014 Helsinki, Finland.	tommi.kajander@helsinki.fi		Kajander, Tommi/0000-0002-5094-227X; Goldman, Adrian/0000-0001-8032-9700	Helsingin Sanomat Centennial foundation, Finland; National Research Service Award [5F32GM071134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071134] Funding Source: NIH RePORTER	Helsingin Sanomat Centennial foundation, Finland; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported partly by a post doctoral Fellowship from the Helsingin Sanomat Centennial foundation, Finland.; Supported by National Research Service Award Grant 5F32GM071134.	BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; BHANDARKAR M, 2003, NAMD USERS GUIDE VER; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chipot C, 2008, J CHEM THEORY COMPUT, V4, P2150, DOI 10.1021/ct800313k; Cortajarena AL, 2008, ACS CHEM BIOL, V3, P161, DOI 10.1021/cb700260z; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Cortajarena AL, 2004, PROTEIN ENG DES SEL, V17, P399, DOI 10.1093/protein/gzh047; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILSON MK, 1987, NATURE, V330, P84, DOI 10.1038/330084a0; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Havranek JJ, 1999, P NATL ACAD SCI USA, V96, P11145, DOI 10.1073/pnas.96.20.11145; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; Henin J, 2005, J AM CHEM SOC, V127, P8478, DOI 10.1021/ja050581y; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lu ND, 2004, J COMPUT CHEM, V25, P28, DOI 10.1002/jcc.10369; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morozov AV, 2003, J PHYS CHEM B, V107, P2075, DOI 10.1021/jp0267555; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1998, ACTA CRYSTALLOGR D, V54, P817, DOI 10.1107/S0907444997019434; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; Sham YY, 1998, BIOPHYS J, V74, P1744, DOI 10.1016/S0006-3495(98)77885-3; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Simonson T, 2001, CURR OPIN STRUC BIOL, V11, P243, DOI 10.1016/S0959-440X(00)00197-4; Spector S, 2000, BIOCHEMISTRY-US, V39, P872, DOI 10.1021/bi992091m; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Yi F, 2008, ACS CHEM BIOL, V3, P645, DOI 10.1021/cb800162x; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	42	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25364	25374		10.1074/jbc.M109.033894	http://dx.doi.org/10.1074/jbc.M109.033894			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586912	hybrid, Green Published			2022-12-25	WOS:000269734000069
J	Al-Zahrani, AS; Kondabagil, K; Gao, S; Kelly, N; Ghosh-Kumar, M; Rao, VB				Al-Zahrani, Abdulrahman S.; Kondabagil, Kiran; Gao, Song; Kelly, Noreen; Ghosh-Kumar, Manjira; Rao, Venigalla B.			The Small Terminase, gp16, of Bacteriophage T4 Is a Regulator of the DNA Packaging Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; LARGE SUBUNIT; ATPASE CENTER; COMPARATIVE GENOMICS; NUCLEOTIDE EXCHANGE; PROTEIN GP17; PHAGE-T4; MECHANISM; GENES; SITE	Tailed bacteriophages and herpes viruses use powerful molecular motors to translocate DNA into a preassembled prohead and compact the DNA to near crystalline density. The phage T4 motor, a pentamer of 70-kDa large terminase, gp17, is the fastest and most powerful motor reported to date. gp17 has an ATPase activity that powers DNA translocation and a nuclease activity that cuts concatemeric DNA and generates the termini of viral genome. An 18-kDa small terminase, gp16, is also essential, but its role in DNA packaging is poorly understood. gp16 forms oligomers, most likely octamers, exhibits no enzymatic activities, but stimulates the gp17-ATPase activity, and inhibits the nuclease activity. Extensive mutational and biochemical analyses show that gp16 contains three domains, a central oligomerization domain, and N- and C-terminal domains that are essential for ATPase stimulation. Stimulation occurs not by nucleotide exchange or enhanced ATP binding but by triggering hydrolysis of gp17-bound ATP, a mechanism reminiscent of GTPase-activating proteins. gp16 does not have an arginine finger but its interaction with gp17 seems to position a gp17 arginine finger into the catalytic pocket. gp16 inhibits DNA translocation when gp17 is associated with the prohead. gp16 restricts gp17-nuclease such that the putative packaging initiation cut is made but random cutting is inhibited. These results suggest that the phage T4 packaging machine consists of a motor (gp17) and a regulator (gp16). The gp16 regulator is essential to coordinate the gp17 motor ATPase, translocase, and nuclease activities, otherwise it could be suicidal to the virus.	[Al-Zahrani, Abdulrahman S.; Kondabagil, Kiran; Gao, Song; Kelly, Noreen; Ghosh-Kumar, Manjira; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Science Foundation [MCB-423528, MCB-0923873]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grants MCB-423528 and MCB-0923873 (to V. B. R.) from the National Science Foundation.	Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; ALZAHRANI A, 2006, THESIS CATHOLIC U AM; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; BECKER A, 1978, P NATL ACAD SCI USA, V75, P4199, DOI 10.1073/pnas.75.9.4199; Black LW, 2006, J BIOL CHEM, V281, P25635, DOI 10.1074/jbc.M602093200; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Feiss Michael, 2005, P5; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Goetzinger KR, 2003, J MOL BIOL, V331, P139, DOI 10.1016/S0022-2836(03)00636-3; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hwang Y, 1996, J MOL BIOL, V261, P524, DOI 10.1006/jmbi.1996.0480; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Kondabagil KR, 2006, J MOL BIOL, V358, P67, DOI 10.1016/j.jmb.2006.01.078; Kuebler D, 1998, J MOL BIOL, V281, P803, DOI 10.1006/jmbi.1998.1952; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Lin H, 1997, J BIOL CHEM, V272, P3495, DOI 10.1074/jbc.272.6.3495; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; LUFTIG RB, 1972, J VIROL, V10, P545, DOI 10.1128/JVI.10.3.545-554.1972; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitchell MS, 2006, J BIOL CHEM, V281, P518, DOI 10.1074/jbc.M507719200; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Miyazaki Satoshi, 2002, Journal of Structural and Functional Genomics, V2, P37, DOI 10.1023/A:1014418700858; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; SKORUPSKI K, 1992, J MOL BIOL, V223, P977, DOI 10.1016/0022-2836(92)90256-J; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUMNERSMITH M, 1981, VIROLOGY, V111, P642, DOI 10.1016/0042-6822(81)90363-9; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; YANG Q, 2005, BIOCHEMISTRY-US, V38, P14238; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609	55	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24490	24500		10.1074/jbc.M109.025007	http://dx.doi.org/10.1074/jbc.M109.025007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561086	Green Published, hybrid			2022-12-25	WOS:000269380200061
J	Arredondo, SA; Chen, TF; Riggs, AF; Gilbert, HF; Georgiou, G				Arredondo, Silvia A.; Chen, Tiffany F.; Riggs, Austen F.; Gilbert, Hiram F.; Georgiou, George			Role of Dimerization in the Catalytic Properties of the Escherichia coli Disulfide Isomerase DsbC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION; CRYSTAL-STRUCTURE; ACTIVE-SITE; REDOX STATES; PROTEIN; THIOREDOXIN; EXPRESSION; ISOMERIZATION; SUBUNITS; COMPLEX	The bacterial protein-disulfide isomerase DsbC is a homodimeric V-shaped enzyme that consists of a dimerization domain, two alpha-helical linkers, and two opposing thioredoxin fold catalytic domains. The functional significance of the two catalytic domains of DsbC is not well understood yet. We have engineered heterodimer-like DsbC derivatives covalently linked via (Gly(3)-Ser) flexible linkers. We either inactivated one of the catalytic sites (CGYC), or entirely removed one of the catalytic domains while maintaining the putative binding area intact. Variants having a single active catalytic site display significant levels of isomerase activity. Furthermore, mDsbC[H45D]-dim[D53H], a DsbC variant lacking an entire catalytic domain but with an intact dimerization domain, also showed isomerase activity, albeit at lower levels. In addition, the absence of the catalytic domain allowed this protein to catalyze in vivo oxidation. Our results reveal that two catalytic domains in DsbC are not essential for disulfide bond isomerization and that a determining feature in isomerization is the availability of a substrate binding domain.	[Arredondo, Silvia A.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Chen, Tiffany F.; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Riggs, Austen F.; Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Riggs, Austen F.] Univ Texas Austin, Neurobiol Sect, Sch Biol Sci, Austin, TX 78712 USA; [Gilbert, Hiram F.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Baylor College of Medicine	Georgiou, G (corresponding author), 1 Univ Stn Stop C0400, Austin, TX 78712 USA.	gg@che.utexas.edu			National Institutes of Health Grant [GM55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55090.	Arredondo S, 2008, J BIOL CHEM, V283, P31469, DOI 10.1074/jbc.M803346200; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BIZUB D, 1991, J BIOL CHEM, V266, P4951; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; Ke HM, 2006, BIOCHEMISTRY-US, V45, P15100, DOI 10.1021/bi061511m; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; KORTT AA, 1994, EUR J BIOCHEM, V221, P151, DOI 10.1111/j.1432-1033.1994.tb18724.x; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; LIANG H, 1993, P NATL ACAD SCI USA, V90, P7010, DOI 10.1073/pnas.90.15.7010; Liu XQ, 2001, J BIOL CHEM, V276, P1146, DOI 10.1074/jbc.M004929200; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; LYLES MM, 1994, J BIOL CHEM, V269, P30946; MARTINEZGALISTEO E, 1993, BIOCHIMIE, V75, P803, DOI 10.1016/0300-9084(93)90131-B; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; PREDKI PF, 1995, BIOCHEMISTRY-US, V34, P9834, DOI 10.1021/bi00031a003; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Robinson CR, 1996, BIOCHEMISTRY-US, V35, P109, DOI 10.1021/bi9521194; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Segatori L, 2004, P NATL ACAD SCI USA, V101, P10018, DOI 10.1073/pnas.0403003101; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; VUORI K, 1992, J BIOL CHEM, V267, P7211; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yeh SM, 2007, ACTA CRYSTALLOGR D, V63, P465, DOI 10.1107/S0907444907003320; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; Zhang Z, 2002, PROTEIN EXPRES PURIF, V26, P218, DOI 10.1016/S1046-5928(02)00502-8; Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007	53	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23972	23979		10.1074/jbc.M109.010199	http://dx.doi.org/10.1074/jbc.M109.010199			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581640	hybrid, Green Published			2022-12-25	WOS:000269380200011
J	Chien, YC; Masica, DL; Gray, JJ; Nguyen, S; Vali, H; Mckee, MD				Chien, Yung-Ching; Masica, David L.; Gray, Jeffrey J.; Nguyen, Sarah; Vali, Hojatollah; Mckee, Marc D.			Modulation of Calcium Oxalate Dihydrate Growth by Selective Crystal-face Binding of Phosphorylated Osteopontin and Polyaspartate Peptide Showing Occlusion by Sectoral (Compositional) Zoning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL EPITHELIAL-CELLS; KIDNEY-STONE FORMATION; INTRACRYSTALLINE PROTEINS; IN-VITRO; MONOHYDRATE CRYSTALS; MEMBRANE INTERACTION; BONE SIALOPROTEIN; URINARY CRYSTALS; ACIDIC PROTEINS; EXPRESSION	Calcium oxalate dihydrate (COD) mineral and the urinary protein osteopontin/uropontin (OPN) are commonly found in kidney stones. To investigate the effects of OPN on COD growth, COD crystals were grown with phosphorylated OPN or a polyaspartic acid-rich peptide of OPN (DDLDDDDD, poly-Asp(86-93)). Crystals grown with OPN showed increased dimensions of the {110} prismatic faces attributable to selective inhibition at this crystallographic face. At high concentrations of OPN, elongated crystals with dominant {110} faces were produced, often with intergrown, interpenetrating twin crystals. Poly-Asp(86-93) dose-dependently elongated crystal morphology along the {110} faces in a manner similar to OPN. In crystal growth studies using fluorescently tagged poly-Asp(86-93) followed by imaging of crystal interiors using confocal microscopy, sectoral (compositional) zoning in COD was observed resulting from selective binding and incorporation (occlusion) of peptide exclusively into {110} crystal sectors. Computational modeling of poly-Asp(86-93) adsorption to COD {110} and {101} surfaces also suggests increased stabilization of the COD {110} surface and negligible change to the natively stable {101} surface. Ultrastructural, colloidal-gold immunolocalization of OPN by transmission electron microscopy in human stones confirmed an intracrystalline distribution of OPN. In summary, OPN and its poly-Asp(86-93) sequence similarly affect COD mineral growth; the {110} crystallographic faces become enhanced and dominant attributable to {110} face inhibition by the protein/peptide, and peptides can incorporate into the mineral phase. We, thus, conclude that the poly-Asp(86-93) domain is central to the OPN ability to interact with the {110} faces of COD, where it binds to inhibit crystal growth with subsequent intracrystalline incorporation (occlusion).	[Chien, Yung-Ching; Nguyen, Sarah; Vali, Hojatollah; Mckee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; [Masica, David L.; Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Vali, Hojatollah; Mckee, Marc D.] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University; Johns Hopkins University; Johns Hopkins University; McGill University	Mckee, MD (corresponding author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	marc.mckee@mcgill.ca	Vali, Hojatollah/F-3511-2012; McKee, Marc D/E-2187-2011; Gray, Jeffrey J./B-5682-2008	Vali, Hojatollah/0000-0003-3464-9943; McKee, Marc D/0000-0001-8349-965X; Gray, Jeffrey J./0000-0001-6380-2324	Canadian Institutes of Health Research [MT11360]; Arnold and Mabel Beckman Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [0846324] Funding Source: National Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arnold and Mabel Beckman Foundation; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by Canadian Institutes of Health Research Grant MT11360 (to M. D. M.) and by the Arnold and Mabel Beckman Foundation.	ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; AIZENBERG J, 1995, FASEB J, V9, P262, DOI 10.1096/fasebj.9.2.7781928; Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213; Asplin JR, 1998, KIDNEY INT, V53, P194, DOI 10.1046/j.1523-1755.1998.00739.x; BARTHOLOMEW RS, 1979, AM J OPHTHALMOL, V88, P1026, DOI 10.1016/0002-9394(79)90410-0; BERG W, 1979, EUR UROL, V5, P136; BERG W, 1976, European Urology, V2, P92; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BROWN LF, 1992, MOL BIOL CELL, V3, P1169, DOI 10.1091/mbc.3.10.1169; Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x; Chauvet MC, 2005, J STRUCT BIOL, V151, P12, DOI 10.1016/j.jsb.2005.04.005; Chien YC, 2008, J STRUCT BIOL, V163, P84, DOI 10.1016/j.jsb.2008.04.008; Chutipongtanate S, 2005, J CLIN INVEST, V115, P3613, DOI 10.1172/JCI25342; DAUDON M, 2008, 2 INT UR RES S; Daudon Michel, 2004, Rev Med Suisse Romande, V124, P455; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Dowty E., 2002, SHAPE WINDOWS PROFES; DOYLE IR, 1991, CLIN CHEM, V37, P1589; Durrbaum D, 2001, UROL RES, V29, P83, DOI 10.1007/s002400000163; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; Elhadj S, 2006, CRYST GROWTH DES, V6, P197, DOI 10.1021/cg050288+; ELLIOT JS, 1980, J UROLOGY, V123, P324, DOI 10.1016/S0022-5347(17)55918-2; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Fleming DE, 2003, J BONE MINER RES, V18, P1282, DOI 10.1359/jbmr.2003.18.7.1282; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GIBSON RI, 1974, AM MINERAL, V59, P1177; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grover PK, 2008, AM J PHYSIOL-RENAL, V294, pF355, DOI 10.1152/ajprenal.00529.2007; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; Hunter GK, 2009, CELLS TISSUES ORGANS, V189, P44, DOI 10.1159/000151430; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Khan SR, 1997, WORLD J UROL, V15, P236, DOI 10.1007/BF01367661; Kim IW, 2006, CRYST GROWTH DES, V6, P5, DOI 10.1021/cg0502183; Kleinman Jack G., 2004, Nephron Physiology, V98, pP43, DOI 10.1159/000080263; KOHRI K, 1993, J BIOL CHEM, V268, P15180; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Koul HK, 1999, J AM SOC NEPHROL, V10, pS417; Langdon A, 2009, CALCIFIED TISSUE INT, V84, P240, DOI 10.1007/s00223-008-9215-5; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEPAGE L, 1982, J PHARM SCI, V71, P1059, DOI 10.1002/jps.2600710927; LEWIS RD, 1974, ARCH PATHOL, V98, P149; Lieske JC, 1999, J AM SOC NEPHROL, V10, pS422; Lieske JC, 1997, KIDNEY INT, V52, P1291, DOI 10.1038/ki.1997.454; Lieske JC, 1996, CALCIFIED TISSUE INT, V58, P195, DOI 10.1007/s002239900033; LOPEZ CA, 1993, LAB INVEST, V69, P355; Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v; MANDEL N, 1994, J AM SOC NEPHROL, V5, pS37; MANDEL NS, 1987, J UROLOGY, V138, P557, DOI 10.1016/S0022-5347(17)43258-7; MANDEL NS, 1989, J UROLOGY, V142, P1516, DOI 10.1016/S0022-5347(17)39145-0; Masica DL, 2009, BIOPHYS J, V96, P3082, DOI 10.1016/j.bpj.2009.01.033; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; MCKEE MD, 1995, J BONE MINER RES, V10, P1913; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; O'Young J, 2009, CELLS TISSUES ORGANS, V189, P51, DOI 10.1159/000151724; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Palmer D., 2005, CRYSTAL MAKER; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; Pedraza CE, 2008, J CELL BIOCHEM, V103, P1379, DOI 10.1002/jcb.21515; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; REEDER RJ, 1987, GEOCHIM COSMOCHIM AC, V51, P187, DOI 10.1016/0016-7037(87)90230-4; Rittling SR, 1999, EXP NEPHROL, V7, P103; Ryall RL, 2005, BJU INT, V96, P654, DOI 10.1111/j.1464-410X.2005.05701.x; RYALL RL, 1985, UROL RES, V13, P285; Ryall RL, 2001, J STRUCT BIOL, V134, P5, DOI 10.1006/jsbi.2001.4363; Ryall RL, 2007, UROL RES, V35, P1, DOI 10.1007/s00240-007-0078-4; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1993, J DAIRY RES, V60, P189, DOI 10.1017/S0022029900027503; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Taller A, 2007, BIOPHYS J, V93, P1768, DOI 10.1529/biophysj.106.101881; Tawada T, 1999, UROL RES, V27, P238, DOI 10.1007/s002400050116; TAZZOLI V, 1980, AM MINERAL, V65, P327; Thurgood LA, 2008, UROL RES, V36, P103, DOI 10.1007/s00240-008-0139-3; Touryan LA, 2001, J CRYST GROWTH, V233, P380, DOI 10.1016/S0022-0248(01)01441-5; Verkoelen CF, 2000, KIDNEY INT, V57, P1072, DOI 10.1046/j.1523-1755.2000.00934.x; Wang LJ, 2006, LANGMUIR, V22, P7279, DOI 10.1021/la060897z; WERNESS PG, 1981, J CRYST GROWTH, V53, P166, DOI 10.1016/0022-0248(81)90063-4; Wesson JA, 1998, KIDNEY INT, V53, P952, DOI 10.1111/j.1523-1755.1998.00839.x; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Wesson JA, 2006, CURR OPIN NEPHROL HY, V15, P386, DOI 10.1097/01.mnh.0000232879.50716.6f; Wesson Jeffrey A., 1996, Scanning Microscopy, V10, P415; WIESSNER JH, 1986, J UROLOGY, V135, P835, DOI 10.1016/S0022-5347(17)45871-X; Worcester EM, 1996, SEMIN NEPHROL, V16, P474; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yasui T, 2001, UROL RES, V29, P50, DOI 10.1007/s002400000152	87	58	60	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23491	23501		10.1074/jbc.M109.021899	http://dx.doi.org/10.1074/jbc.M109.021899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581305	Green Published, hybrid			2022-12-25	WOS:000269180000034
J	Gonzalez, V; Guo, KX; Hurley, L; Sun, D				Gonzalez, Veronica; Guo, Kexiao; Hurley, Laurence; Sun, Daekyu			Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE HYPERSENSITIVE ELEMENT; INTRAMOLECULAR G-QUADRUPLEX; PROXIMAL PROMOTER REGION; PRE-RIBOSOMAL-RNA; POLYMERASE-I TRANSCRIPTION; REMODELING COMPLEX NORC; RELEVANT G-QUADRUPLEX; HUMAN TELOMERIC DNA; GENE-EXPRESSION; MESSENGER-RNA	myc is a proto-oncogene that plays an important role in the promotion of cellular growth and proliferation. Understanding the regulation of c-myc is important in cancer biology, as it is overexpressed in a wide variety of human cancers, including most gynecological, breast, and colon cancers. We previously demonstrated that a guanine-rich region upstream of the P1 promoter of c-myc that controls 85-90% of the transcriptional activation of this gene can form an intramolecular G-quadruplex (G4) that functions as a transcriptional repressor element. In this study, we used an affinity column to purify proteins that selectively bind to the human c-myc G-quadruplex. We found that nucleolin, a multifunctional phosphoprotein, binds in vitro to the c-myc G-quadruplex structure with high affinity and selectivity when compared with other known quadruplex structures. In addition, we demonstrate that upon binding, nucleolin facilitates the formation and increases the stability of the c-myc G-quadruplex structure. Furthermore, we provide evidence that nucleolin overexpression reduces the activity of a c-myc promoter in plasmid presumably by inducing and stabilizing the formation of the c-myc G-quadruplex. Finally, we show that nucleolin binds to the c-myc promoter in HeLa cells, which indicates that this interaction occurs in vivo. In summary, nucleolin may induce c-myc G4 formation in vivo.	[Hurley, Laurence] BIO5 Inst, Tucson, AZ 85721 USA; [Gonzalez, Veronica; Hurley, Laurence; Sun, Daekyu] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Guo, Kexiao] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Hurley, Laurence] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona	Hurley, L (corresponding author), BIO5 Inst, 1657 E Helen St, Tucson, AZ 85721 USA.	hurley@pharmacy.arizona.edu; sun@pharmacy.arizona.edu			National Institutes of Health [GM085585, CA94166, CA95060]; NATIONAL CANCER INSTITUTE [P30CA023074, P50CA095060, R01CA094166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM085585 and CA94166 and CA95060 (Under-represented Minority Supplements).	Alarcon-Vargas D, 2004, J BIOL CHEM, V279, P5008, DOI 10.1074/jbc.M312054200; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Allain FHT, 2000, J MOL BIOL, V303, P227, DOI 10.1006/jmbi.2000.4118; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; Bouvet P, 1997, EMBO J, V16, P5235, DOI 10.1093/emboj/16.17.5235; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; BRYS A, 1994, P NATL ACAD SCI USA, V91, P4915, DOI 10.1073/pnas.91.11.4915; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Chang CC, 2004, ANAL CHEM, V76, P4490, DOI 10.1021/ac049510s; Chang CC, 2003, ANAL CHEM, V75, P6177, DOI 10.1021/ac034789i; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DANG CV, 1995, C MYC FUNCTION NEOPL, P85; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Dexheimer TS, 2009, MOL CANCER THER, V8, P1363, DOI 10.1158/1535-7163.MCT-08-1093; DRYGIN D, 2008, P 99 ANN M AM ASS CA; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 1999, J CELL SCI, V112, P761; Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Khateb S, 2004, NUCLEIC ACIDS RES, V32, P4145, DOI 10.1093/nar/gkh745; Khateb S, 2007, NUCLEIC ACIDS RES, V35, P5775, DOI 10.1093/nar/gkm636; Kim MY, 2003, CANCER RES, V63, P3247; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Lemarteleur T, 2004, BIOCHEM BIOPH RES CO, V323, P802, DOI 10.1016/j.bbrc.2004.08.150; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Roger B, 2003, CHROMOSOMA, V111, P399, DOI 10.1007/s00412-002-0221-5; Scaggiante B, 2006, FEBS J, V273, P1350, DOI 10.1111/j.1742-4658.2006.05143.x; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Seri M, 2000, NAT GENET, V26, P103; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Strohner R, 2004, MOL CELL BIOL, V24, P1791, DOI 10.1128/MCB.24.4.1791-1798.2004; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806	97	219	224	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23622	23635		10.1074/jbc.M109.018028	http://dx.doi.org/10.1074/jbc.M109.018028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581307	hybrid, Green Published			2022-12-25	WOS:000269180000048
J	Tzatsos, A				Tzatsos, Alexandros			Raptor Binds the SAIN (Shc and IRS-1 NPXY Binding) Domain of Insulin Receptor Substrate-1 (IRS-1) and Regulates the Phosphorylation of IRS-1 at Ser-636/639 by mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; DEPENDENT PHOSPHORYLATION; SERINE PHOSPHORYLATION; PROTEIN-KINASE; S6 KINASE; TOS MOTIF; RAPAMYCIN; PATHWAY; AKT/PKB; DEGRADATION	In normal physiological states mTOR phosphorylates and activates Akt. However, under diabetic-mimicking conditions mTOR inhibits phosphatidylinositol (PI) 3-kinase/Akt signaling by phosphorylating insulin receptor substrate-1 (IRS-1) at Ser-636/639. The molecular basis for the differential effect of mTOR signaling on Akt is poorly understood. Here, it has been shown that knockdown of mTOR, Raptor, and mLST8, but not Rictor and mSin1, suppresses insulin-stimulated phosphorylation of IRS-1 at Ser-636/639 and stabilizes IRS-1 after long term insulin stimulation. This phosphorylation depends on the PI 3-kinase/PDK1 axis but is Akt-independent. At the molecular level, Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of IRS-1 and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR. IRS-1 lacking the SAIN domain does not interact with Raptor, is not phosphorylated at Ser-636/639, and favorably interacts with PI 3-kinase. Overall, these data provide new insights in the molecular mechanisms by which mTORC1 inhibits PI 3-kinase/Akt signaling at the level of IRS-1 and suggest that mTOR signaling toward Akt is scaffold-dependent.	Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Tzatsos, A (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Simches Res Bldg,CPZN 4100,185 Cambridge St, Boston, MA 02114 USA.	atzatsos@partners.org		Tzatsos, Alexandros/0000-0002-8476-4328	E. Nestora	E. Nestora	This work was supported by E. Nestora.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rodgers BD, 2001, J ENDOCRINOL, V168, P325, DOI 10.1677/joe.0.1680325; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002	39	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22525	22534		10.1074/jbc.M109.027748	http://dx.doi.org/10.1074/jbc.M109.027748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561084	Green Published, hybrid			2022-12-25	WOS:000268963100005
J	Amat, R; Planavila, A; Chen, SL; Iglesias, R; Giralt, M; Villarroya, F				Amat, Ramon; Planavila, Anna; Chen, Shen Liang; Iglesias, Roser; Giralt, Marta; Villarroya, Francesc			SIRT1 Controls the Transcription of the Peroxisome Proliferator-activated Receptor-gamma Co-activator-1 alpha (PGC-1 alpha) Gene in Skeletal Muscle through the PGC-1 alpha Autoregulatory Loop and Interaction with MyoD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-FUNCTION; COACTIVATOR PGC-1-ALPHA; PROTEIN; EXPRESSION; ALPHA; DIFFERENTIATION; DEACETYLASE; INCREASES; OXIDATION; EXERCISE	Peroxisome proliferator activated receptor-gamma co-activator-1 alpha (PGC-1 alpha) is a transcriptional co-activator that coordinately regulates the expression of distinct sets of metabolism-related genes in different tissues. Here we show that PGC-1 alpha expression is reduced in skeletal muscles from mice lacking the sirtuin family deacetylase SIRT1. Conversely, SIRT1 activation or overexpression in differentiated C2C12 myotubes increased PGC-1 alpha mRNA expression. The transcription-promoting effects of SIRT1 occurred through stimulation of PGC-1 alpha promoter activity and were enhanced by co-transfection of myogenic factors, such as myocyte enhancer factor 2 (MEF2) and, especially, myogenic determining factor (MyoD). SIRT1 bound to the proximal promoter region of the PGC-1 alpha gene, an interaction potentiated by MEF2C or MyoD, which also interact with this region. In the presence of MyoD, SIRT1 promoted a positive autoregulatory PGC-1 alpha expression loop, such that overexpression of PGC-1 alpha increased PGC-1 alpha promoter activity in the presence of co-expressed MyoD and SIRT1. Chromatin immunoprecipitation showed that SIRT1 interacts with PGC-1 alpha promoter and increases PGC-1 alpha recruitment to its own promoter region. Immunoprecipitation assays further showed that SIRT1-PGC-1 alpha interactions are enhanced by MyoD. Collectively, these data indicate that SIRT1 controls PGC-1 alpha gene expression in skeletal muscle and that MyoD is a key mediator of this action. The involvement of MyoD in SIRT1-dependent PGC-1 alpha expression may help to explain the ability of SIRT1 to drive muscle-specific gene expression and metabolism. Autoregulatory control of PGC-1 alpha gene transcription seems to be a pivotal mechanism for conferring a transcription-activating response to SIRT1 in skeletal muscle.	[Amat, Ramon; Planavila, Anna; Iglesias, Roser; Giralt, Marta; Villarroya, Francesc] Univ Barcelona, Dept Bioquim & Biol Mol, Inst Biomed, E-08028 Barcelona, Spain; [Amat, Ramon; Planavila, Anna; Iglesias, Roser; Giralt, Marta; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain; [Chen, Shen Liang] Natl Cent Univ, Dept Life Sci, Jhongli 32054, Taiwan	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; National Central University	Villarroya, F (corresponding author), Univ Barcelona, Dept Bioquim & Biol Mol, Inst Biomed, Avda Diagonal 645, E-08028 Barcelona, Spain.	fvillarroya@ub.edu	Giralt, Marta/A-4756-2013; Iglesias, Roser/C-5561-2017; Amat, Ramon/F-2681-2010; Villarroya, Francesc/K-4357-2014	Giralt, Marta/0000-0001-7968-4190; Iglesias, Roser/0000-0002-7107-8097; Amat, Ramon/0000-0001-8284-2540; Anna, Planavila Porta/0000-0001-5474-4724; Villarroya, Francesc/0000-0003-1266-9142	Ministerio de Ciencia e Innovacion, Spain [SAF2008-01896]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is supported by Grant SAF2008-01896 from the Ministerio de Ciencia e Innovacion, Spain.	Amat R, 2007, J BIOL CHEM, V282, P34066, DOI 10.1074/jbc.M707114200; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Baldan A, 2004, NUCLEIC ACIDS RES, V32, P4742, DOI 10.1093/nar/gkh806; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Chang JH, 2006, ENDOCRINOLOGY, V147, P3093, DOI 10.1210/en.2005-1317; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nadal A, 2002, BIOCHEM J, V366, P289, DOI 10.1042/BJ20020598; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pilegaard H, 2003, DIABETES, V52, P657, DOI 10.2337/diabetes.52.3.657; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Solanes G, 2000, FASEB J, V14, P2141; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017	31	166	171	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21872	21880		10.1074/jbc.M109.022749	http://dx.doi.org/10.1074/jbc.M109.022749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553684	Green Published, hybrid			2022-12-25	WOS:000268783700011
J	Kumasaka, T; Aritake, K; Ago, H; Irikura, D; Tsurumura, T; Yamamoto, M; Miyano, M; Urade, Y; Hayaishi, O				Kumasaka, Takashi; Aritake, Kosuke; Ago, Hideo; Irikura, Daisuke; Tsurumura, Toshiharu; Yamamoto, Masaki; Miyano, Masashi; Urade, Yoshihiro; Hayaishi, Osamu			Structural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; BETA-TRACE; TRICHROMATIC CONCEPT; SELECTIVE INHIBITOR; D SYNTHETASE; ACTIVE-SITE; BINDING; PROTEIN; IDENTIFICATION; MICE	Lipocalin type prostaglandin D synthase (L-PGDS) is a multifunctional protein acting as a somnogen (PGD(2))-producing enzyme, an extracellular transporter of various lipophilic ligands, and an amyloid-beta chaperone in human cerebrospinal fluid. In this study, we determined the crystal structures of two different conformers of mouse L-PGDS, one with an open cavity of the beta-barrel and the other with a closed cavity due to the movement of the flexible E-F loop. The upper compartment of the central large cavity contains the catalytically essential Cys(65) residue and its network of hydrogen bonds with the polar residues Ser(45), Thr(67), and Ser(81), whereas the lower compartment is composed of hydrophobic amino acid residues that are highly conserved among other lipocalins. SH titration analysis combined with site-directed mutagenesis revealed that the Cys(65) residue is activated by its interaction with Ser(45) and Thr(67) and that the S45A/T67A/S81A mutant showed less than 10% of the L-PGDS activity. The conformational change between the open and closed states of the cavity indicates that the mobile calyx contributes to the multiligand binding ability of L-PGDS.	[Kumasaka, Takashi; Ago, Hideo; Irikura, Daisuke; Yamamoto, Masaki; Miyano, Masashi] RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan; [Aritake, Kosuke; Irikura, Daisuke; Tsurumura, Toshiharu; Urade, Yoshihiro; Hayaishi, Osamu] Osaka Biosci Inst, Dept Mol & Behav Biol, Osaka 5650874, Japan	RIKEN	Miyano, M (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan.	miyano@spring8.or.jp	Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Miyano, Masashi/R-2785-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X	JAXA, Takeda Foundation; Takeda Pharmaceutical Co., Ltd; Ono Pharmaceutical Co., Ltd; Japan Society for the Promotion of Science [19590094]; Japan Foundation for Applied Enzymology; Osaka City	JAXA, Takeda Foundation(Takeda Science Foundation (TSF)); Takeda Pharmaceutical Co., Ltd(Takeda Pharmaceutical Company Ltd); Ono Pharmaceutical Co., Ltd(Ono Pharmaceutical Co Ltd); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Osaka City	This work was supported in part by a grant from the JAXA, Takeda Foundation (to Y.U.), a grant from Takeda Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. (to O.H.), Japan Society for the Promotion of Science Grant 19590094 (to K.A.), a grant from the Japan Foundation for Applied Enzymology (to K.A.), and a grant from Osaka City.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Inoue K, 2009, J BIOCHEM, V145, P169, DOI 10.1093/jb/mvn154; Irikura D, 2003, J BIOCHEM, V133, P29, DOI 10.1093/jb/mvg006; Irikura D, 2009, J BIOL CHEM, V284, P7623, DOI 10.1074/jbc.M808593200; Jemth P, 2000, J BIOL CHEM, V275, P8618, DOI 10.1074/jbc.275.12.8618; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kumasaka T, 2002, STRUCTURE, V10, P1205, DOI 10.1016/S0969-2126(02)00830-4; Liu JF, 2008, BIOCHIMIE, V90, P1637, DOI 10.1016/j.biochi.2008.06.003; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; NEWCOMER ME, 1993, STRUCTURE, V1, P7, DOI 10.1016/0969-2126(93)90004-Z; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Pinzar E, 2000, J BIOL CHEM, V275, P31239, DOI 10.1074/jbc.M000750200; Pregel MJ, 1997, J BIOL CHEM, V272, P23552, DOI 10.1074/jbc.272.38.23552; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1989, J BIOL CHEM, V264, P1041; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; URADE Y, 2006, FUNCTIONAL STRUCTURA, P135; Urade Y., 2006, LIPOCALINS, V9, P99; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738	50	34	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22344	22352		10.1074/jbc.M109.018341	http://dx.doi.org/10.1074/jbc.M109.018341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546224	hybrid, Green Published			2022-12-25	WOS:000268783700057
J	Sakai, K; Nakamura, T; Matsumoto, K; Nakamura, T				Sakai, Katsuya; Nakamura, Takahiro; Matsumoto, Kunio; Nakamura, Toshikazu			Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HEPARAN-SULFATE; GEFITINIB RESISTANCE; 4-KRINGLE ANTAGONIST; VASCULAR DEVELOPMENT; MOUSE EMBRYOS; TUMOR-GROWTH; G(1) PHASE; MATRIX; CELL	NK4, a fragment of hepatocyte growth factor (HGF), exerts bifunctional action as a competitive antagonist against HGF and its receptor c-Met and an angiogenesis inhibitor. Here we studied the anti-angiogenic mechanism of NK4. In cultured human endothelial cells, NK4 inhibited DNA synthesis induced not only by HGF but also by either basic fibroblast growth factor or vascular endothelial growth factor. Even if c-Met expression was diminished by small interference RNA, NK4 inhibited basic fibroblast growth factor-induced DNA synthesis, indicating that anti-angiogenic action of NK4 is c-Met-independent. Affinity purification with NK4-immobilized beads revealed that NK4 binds to perlecan. Consistent with this, NK4 colocalized with perlecan in endothelial cells. Perlecan is a multidomain heparan sulfate proteoglycan that interacts with basement membrane components such as fibronectin. NK4 inhibited extracellular assembly of fibronectin, by which fibronectin-dependent endothelial cell spreading was inhibited by NK4. Knockdown of perlecan expression by small interference RNA significantly abrogated the inhibitory effect of NK4 on fibronectin assembly and cell spreading. In NK4-treated endothelial cells, tyrosine phosphorylation of focal adhesion kinase and Rac activation were reduced, whereas overexpression of activated Rac recovered the DNA synthesis in NK4-treated endothelial cells. These results indicate that the association between NK4 and perlecan impairs fibronectin assembly, thereby inhibiting anchorage-dependent signaling. The identified mechanism for angiostatic action provides further proof of significance for NK4 in the treatment of cancer and potentially for vascular regulation as well.	[Sakai, Katsuya; Nakamura, Toshikazu] Osaka Univ, Ctr Adv Sci & Innovat, Kringle Pharma Joint Res Div Regenerat Drug Disco, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Nakamura, Takahiro; Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa 9200934, Japan	Osaka University; Kanazawa University	Nakamura, T (corresponding author), Osaka Univ, Ctr Adv Sci & Innovat, Kringle Pharma Joint Res Div Regenerat Drug Disco, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nakamura@casi.osaka-u.ac.jp	Matsumoto, Kunio/D-8441-2015	Matsumoto, Kunio/0000-0002-6532-4482; Sakai, Katsuya/0000-0002-0443-1786	Ministry of Education, Culture, Science, Sports, and Technology of Japan [18013031, 18015031]; 21st Century Global Center of Excellence program; National Institute of Biomedical Innovation	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants 18013031 (to To. N.) and 18015031 (to K. M.), by the 21st Century Global Center of Excellence program (to T. N.), and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chung CY, 1997, J CELL SCI, V110, P1413; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; HEREMANS A, 1990, J BIOL CHEM, V265, P8716; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; ISEMURA M, 1987, J BIOL CHEM, V262, P8926; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Klass CM, 2000, J CELL SCI, V113, P493; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Kuba K, 2000, CANCER RES, V60, P6737; Kuba K, 2000, BIOCHEM BIOPH RES CO, V279, P846, DOI 10.1006/bbrc.2000.4034; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsumoto K, 2005, BIOCHEM BIOPH RES CO, V333, P316, DOI 10.1016/j.bbrc.2005.05.131; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Mercurius KO, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-18; Merkulova-Rainon T, 2003, J BIOL CHEM, V278, P37400, DOI 10.1074/jbc.M212768200; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 1997, CANCER RES, V57, P3305; NICOSIA RF, 1987, AM J PATHOL, V128, P78; Pozzi M, 1998, J CELL BIOL, V142, P587; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Tomioka D, 2001, CANCER RES, V61, P7518; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643	45	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22491	22499		10.1074/jbc.M109.025148	http://dx.doi.org/10.1074/jbc.M109.025148			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553700	hybrid, Green Published			2022-12-25	WOS:000268783700070
J	Shemon, AN; Eves, EM; Clark, MC; Heil, G; Granovsky, A; Zeng, LC; Imamoto, A; Koide, S; Rosner, MR				Shemon, Anne N.; Eves, Eva M.; Clark, Matthew C.; Heil, Gary; Granovsky, Alexey; Zeng, Lingchun; Imamoto, Akira; Koide, Shohei; Rosner, Marsha Rich			Raf Kinase Inhibitory Protein Protects Cells against Locostatin-Mediated Inhibition of Migration	PLOS ONE			English	Article								Background: Raf Kinase Inhibitory Protein (RKIP, also PEBP1), a member of the Phosphatidylethanolamine Binding Protein family, negatively regulates growth factor signaling by the Raf/MAP kinase pathway. Since an organic compound, locostatin, was reported to bind RKIP and inhibit cell migration by a Raf-dependent mechanism, we addressed the role of RKIP in locostatin function. Methods/Findings: We analyzed locostatin interaction with RKIP and examined the biological consequences of locostatin binding on RKIP function. NMR studies show that a locostatin precursor binds to the conserved phosphatidylethanolamine binding pocket of RKIP. However, drug binding to the pocket does not prevent RKIP association with its inhibitory target, Raf-1, nor affect RKIP phosphorylation by Protein Kinase C at a regulatory site. Similarly, exposure of wild type, RKIP-depleted HeLa cells or RKIP-deficient (RKIP(-/-)) mouse embryonic fibroblasts (MEFs) to locostatin has no effect on MAP kinase activation. Locostatin treatment of wild type MEFs causes inhibition of cell migration following wounding. RKIP deficiency impairs migration further, indicating that RKIP protects cells against locostatin-mediated inhibition of migration. Locostatin treatment of depleted or RKIP(-/-)MEFs reveals cytoskeletal disruption and microtubule abnormalities in the spindle. Conclusions/Significance: These results suggest that locostatin's effects on cytoskeletal structure and migration are caused through mechanisms independent of its binding to RKIP and Raf/MAP kinase signaling. The protective effect of RKIP against drug inhibition of migration suggests a new role for RKIP in potentially sequestering toxic compounds that may have deleterious effects on cells.			Shemon, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	skoide@uchicago.edu; m-rosner@uchicago.edu		Koide, Shohei/0000-0001-5473-4358	NATIONAL CANCER INSTITUTE [R01CA112310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER; NCI NIH HHS [CA112310, R01 CA112310] Funding Source: Medline; NINDS NIH HHS [R01 NS033858, NS033858] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Clark MC, 2006, J BIOMOL NMR, V36, P4, DOI 10.1007/s10858-005-4424-y; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; DANGIGARIMELLA S, 2009, EMBO J; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; GRANOVSKY AE, 2009, MOL CELL BIOL; Granovsky AE, 2008, CELL RES, V18, P452, DOI 10.1038/cr.2008.43; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuo PH, 2008, ALCOHOL CLIN EXP RES, V32, P785, DOI 10.1111/j.1530-0277.2008.00642.x; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mc Henry KT, 2008, J CELL BIOCHEM, V103, P972, DOI 10.1002/jcb.21470; Mc Henry KT, 2002, CHEMBIOCHEM, V3, P1105, DOI 10.1002/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S; Schuierer MM, 2006, BIOCHEM BIOPH RES CO, V342, P1083, DOI 10.1016/j.bbrc.2006.02.083; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Theroux S, 2007, BRAIN RES BULL, V71, P559, DOI 10.1016/j.brainresbull.2006.11.010; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	25	22	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6028	10.1371/journal.pone.0006028	http://dx.doi.org/10.1371/journal.pone.0006028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551145	Green Published, gold			2022-12-25	WOS:000267356500012
J	Stetak, A; Horndli, F; Maricq, AV; van den Heuvel, S; Hajnal, A				Stetak, Attila; Hoerndli, Frederic; Maricq, Andres V.; van den Heuvel, Sander; Hajnal, Alex			Neuron-Specific Regulation of Associative Learning and Memory by MAGI-1 in C. elegans	PLOS ONE			English	Article								Background: Identifying the molecular mechanisms and neural circuits that control learning and memory are major challenges in neuroscience. Mammalian MAGI/S-SCAM is a multi-PDZ domain synaptic scaffolding protein that interacts with a number of postsynaptic signaling proteins and is thereby thought to regulate synaptic plasticity [1,2,3]. Principal Findings: While investigating the behavioral defects of C. elegans nematodes carrying a mutation in the single MAGI ortholog magi-1, we have identified specific neurons that require MAGI-1 function for different aspects of associative learning and memory. Various sensory stimuli and a food deprivation signal are associated in RIA interneurons during learning, while additional expression of MAGI-1 in glutamatergic AVA, AVD and possibly AVE interneurons is required for efficient memory consolidation, i.e. the ability to retain the conditioned changes in behavior over time. During associative learning, MAGI-1 in RIA neurons controls in a cell non-autonomous fashion the dynamic remodeling of AVA, AVD and AVE synapses containing the ionotropic glutamate receptor (iGluR) GLR-1 [4]. During memory consolidation, however, MAGI-1 controls GLR-1 clustering in AVA and AVD interneurons cell-autonomously and depends on the ability to interact with the beta-catenin HMP-2. Significance: Together, these results indicate that different aspects of associative learning and memory in C. elegans are likely carried out by distinct subsets of interneurons. The synaptic scaffolding protein MAGI-1 plays a critical role in these processes in part by regulating the clustering of iGluRs at synapses.			Stetak, A (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Basel, Switzerland.	a.stetak@unibas.ch	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; Hajnal, Alex/0000-0002-4098-3721	NCI NIH HHS [CA095281, P01 CA095281] Funding Source: Medline; NINDS NIH HHS [R01 NS035812] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Cassata G, 2000, GENESIS, V27, P141, DOI 10.1002/1526-968X(200008)27:4<141::AID-GENE20>3.0.CO;2-K; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kuhara A, 2006, J NEUROSCI, V26, P9355, DOI 10.1523/JNEUROSCI.0517-06.2006; Lisman J., 2006, SCI STKE, V2006, pr; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; Morrison GE, 2001, BEHAV NEUROSCI, V115, P640, DOI 10.1037//0735-7044.115.3.640; Morrison GE, 1997, BEHAV NEUROSCI, V111, P564, DOI 10.1037/0735-7044.111.3.564; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rose JK, 2003, J NEUROSCI, V23, P9595; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686	32	42	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6019	10.1371/journal.pone.0006019	http://dx.doi.org/10.1371/journal.pone.0006019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551147	Green Published, gold			2022-12-25	WOS:000267356500007
J	Massion, PP; Zou, Y; Uner, H; Kiatsimkul, P; Wolf, HJ; Baron, AE; Byers, T; Jonsson, S; Lam, S; Hirsch, FR; Miller, YE; Franklin, WA; Varella-Garcia, M				Massion, Pierre P.; Zou, Yong; Uner, Hasmet; Kiatsimkul, Porntip; Wolf, Holly J.; Baron, Anna E.; Byers, Tim; Jonsson, Steinn; Lam, Stephen; Hirsch, Fred R.; Miller, York E.; Franklin, Wilbur A.; Varella-Garcia, Marileila			Recurrent Genomic Gains in Preinvasive Lesions as a Biomarker of Risk for Lung Cancer	PLOS ONE			English	Article								Lung carcinoma development is accompanied by field changes that may have diagnostic significance. We have previously shown the importance of chromosomal aneusomy in lung cancer progression. Here, we tested whether genomic gains in six specific loci, TP63 on 3q28, EGFR on 7p12, MYC on 8q24, 5p15.2, and centromeric regions for chromosomes 3 (CEP3) and 6 (CEP6), may provide further value in the prediction of lung cancer. Bronchial biopsy specimens were obtained by LIFE bronchoscopy from 70 subjects (27 with prevalent lung cancers and 43 individuals without lung cancer). Twenty six biopsies were read as moderate dysplasia, 21 as severe dysplasia and 23 as carcinoma in situ (CIS). Four-micron paraffin sections were submitted to a 4-target FISH assay (LAVysion, Abbott Molecular) and reprobed for TP63 and CEP 3 sequences. Spot counts were obtained in 30-50 nuclei per specimen for each probe. Increased gene copy number in 4 of the 6 probes was associated with increased risk of being diagnosed with lung cancer both in unadjusted analyses (odds ratio = 11, p, 0.05) and adjusted for histology grade (odds ratio = 17, p, 0.05). The most informative 4 probes were TP63, MYC, CEP3 and CEP6. The combination of these 4 probes offered a sensitivity of 82% for lung cancer and a specificity of 58%. These results indicate that specific cytogenetic alterations present in preinvasive lung lesions are closely associated with the diagnosis of lung cancer and may therefore have value in assessing lung cancer risk.			Massion, PP (corresponding author), Vet Adm Med Ctr, Vanderbilt Ingram Canc Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37203 USA.	pierre.massion@vanderbilt.edu			NATIONAL CANCER INSTITUTE [P50CA058187, R01CA102353, P30CA046934, R01CA055769, P50CA090949, U01CA085070] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA055769, P50 CA090949, U01-CA85070, CA55769, U01 CA085070, CA46934, P30 CA046934, P50 CA058187, CA58187, R01 CA102353, CA90949] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Balsara BR, 1997, CANCER RES, V57, P2116; BERGH JCS, 1990, AM REV RESPIR DIS, V142, pS20, DOI 10.1164/ajrccm/142.6_Pt_2.S20; Bota S, 2001, AM J RESP CRIT CARE, V164, P1688, DOI 10.1164/ajrccm.164.9.2012147; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; Bubendorf L, 2005, AM J CLIN PATHOL, V123, P516, DOI 10.1309/F5ADJUWVD2WFL8J5; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FRANKLIN WA, 2004, TUMOURS LUNG PLEURA, P68; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Garnis C, 2004, GENE CHROMOSOME CANC, V39, P93, DOI 10.1002/gcc.10294; Garnis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-9; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Halling KC, 2006, CHEST, V130, P694, DOI 10.1378/chest.130.3.694; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Hirsch FR, 2008, CLIN CANCER RES, V14, P6317, DOI 10.1158/1078-0432.CCR-08-0539; Jonsson S, 2008, AM J RESP CRIT CARE, V177, P342, DOI 10.1164/rccm.200708-1142OC; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; Massion PP, 2003, CANCER RES, V63, P7113; Massion PP, 2002, CANCER RES, V62, P3636; MASSION PP, 2002, GENOMIC TECHNOLOGIES; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; Prudkin Ludmila, 2006, Ann Diagn Pathol, V10, P306, DOI 10.1016/j.anndiagpath.2006.06.011; Rahman SMJ, 2005, AM J RESP CRIT CARE, V172, P1556, DOI 10.1164/rccm.200502-274OC; Ried T, 1997, J MOL MED-JMM, V75, P801, DOI 10.1007/s001090050169; Salaun M, 2008, AM J RESP CRIT CARE, V177, P880, DOI 10.1164/rccm.200704-598OC; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Sokolova IA, 2002, CANCER CYTOPATHOL, V96, P306, DOI 10.1002/cncr.10720; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; TESTA JR, 1994, GENE CHROMOSOME CANC, V11, P178, DOI 10.1002/gcc.2870110307; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Varella-Garcia M, 2003, ONCOLOGIST, V8, P45, DOI 10.1634/theoncologist.8-1-45; Varella-Garcia M, 2007, AM J RESP CRIT CARE, V176, P505, DOI 10.1164/rccm.200609-1329OC; Varella-Garcia M, 2009, J THORAC ONCOL, V4, P318, DOI 10.1097/JTO.0b013e31819667a3; Wardwell NR, 2005, SEMIN ONCOL, V32, P259, DOI 10.1053/j.seminoncol.2005.02.009; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Yakut T, 2006, LUNG CANCER, V54, P293, DOI 10.1016/j.lungcan.2006.08.011; Ye CJ, 2007, CYTOGENET GENOME RES, V118, P237, DOI 10.1159/000108306; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	55	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5611	10.1371/journal.pone.0005611	http://dx.doi.org/10.1371/journal.pone.0005611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19547694	Green Submitted, Green Published, gold			2022-12-25	WOS:000267228800001
J	Yuan, W; Wang, Y; Heinecke, JW; Fu, XY				Yuan, Wei; Wang, Yi; Heinecke, Jay W.; Fu, Xiaoyun			Hypochlorous Acid Converts the gamma-Glutamyl Group of Glutathione Disulfide to 5-Hydroxybutyrolactam, a Potential Marker for Neutrophil Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE-CHLORIDE; MYELOPEROXIDASE-DERIVED OXIDANTS; OXIDATIVE CROSS-LINKING; AMINO-ACIDS; RESPIRATORY BURST; THIOLS; INFLAMMATION; SULFONAMIDE; MECHANISM; ALDEHYDES	In healthy cells, glutathione disulfide (GSSG) is rapidly reduced back to glutathione (GSH) by glutathione reductase to maintain redox status. The ratio of GSH/GSSG has been used as an indicator of oxidative stress. However, hypochlorous acid (HOCl) generated by the myeloperoxidase-H2O2-Cl- system of neutrophils converts GSH to irreversible oxidation products. Although several such products have been identified, yields of these compounds are very low in biological systems, and they cannot account quantitatively for thiol loss. In the current studies, we use liquid chromatography-mass spectrometry (LC-MS) to demonstrate that HOCl and chloramines oxidize GSSG to two irreversible products in high yield. The products, termed M-45 and M-90, are, respectively, 45 or 90 atomic mass units lighter than GSSG. The reaction pathway involves chloramine and aldehyde intermediates, and converts the gamma-glutamyl residues of GSSG to 5-hydroxybutyrolactam. Importantly, M-45 and M-90 were resistant to reduction by glutathione reductase. Moreover, the monohydroxylbutyrolactam M-45 accounted for >90% of the endogenous GSH oxidation products generated by activated neutrophils. Because the reaction pathway involves chlorinating intermediates, hydroxylbutyrolactams are likely to be specific products of HOCl, which is generated only by myeloperoxidase. Therefore, our observations implicate M-45 as a potential biomarker for myeloperoxidase activity in vivo.	[Yuan, Wei; Heinecke, Jay W.; Fu, Xiaoyun] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wang, Yi; Fu, Xiaoyun] Puget Sound Blood Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Puget Sound Blood Center	Fu, XY (corresponding author), 921 Terry Ave, Seattle, WA 98104 USA.	xyfu@psbcresearch.org	Wang, Yi/C-2871-2013; Yuan, Wei/C-4938-2012		National Institutes of Health [HL075381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075381.	Anderson MM, 2003, DIABETES, V52, P2137, DOI 10.2337/diabetes.52.8.2137; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Ashfaq S, 2006, J AM COLL CARDIOL, V47, P1005, DOI 10.1016/j.jacc.2005.09.063; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Carr AC, 1997, BIOCHEM J, V327, P275, DOI 10.1042/bj3270275; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; den Hartog GJM, 2002, BIOL CHEM, V383, P709; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Harwood DT, 2008, CHEM RES TOXICOL, V21, P1011, DOI 10.1021/tx800050n; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; HUGHES MN, 1968, J CHEM SOC A, V2, P450; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kleinman WA, 2000, BIOCHEM PHARMACOL, V60, P19, DOI 10.1016/S0006-2952(00)00293-8; Lang CA, 2000, J LAB CLIN MED, V135, P402, DOI 10.1067/mlc.2000.105977; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Nagy P, 2007, CHEM RES TOXICOL, V20, P79, DOI 10.1021/tx060184g; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ogino T, 1997, FREE RADICAL BIO MED, V23, P445, DOI 10.1016/S0891-5849(97)00115-9; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Pullar JM, 2001, J BIOL CHEM, V276, P22120, DOI 10.1074/jbc.M102088200; Queralt JJ, 2002, CHEM PHYS, V280, P1, DOI 10.1016/S0301-0104(02)00487-1; Rabenstein D.L., 1989, COENZYMES COFACTORS, V3, P67; Rodes J, 2007, TXB HEPATOLOGY BASIC; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Serru V, 2001, CLIN CHEM, V47, P1321; Staubmann R, 1999, PHYTOCHEMISTRY, V50, P337, DOI 10.1016/S0031-9422(98)00531-7; Thomas E L, 1986, Methods Enzymol, V132, P569; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; Winterbourn CC, 1997, BIOCHEM J, V326, P87, DOI 10.1042/bj3260087; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	45	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26908	26917		10.1074/jbc.M109.005496	http://dx.doi.org/10.1074/jbc.M109.005496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19584048	hybrid, Green Published			2022-12-25	WOS:000269969600071
J	Cherrier, T; Suzanne, S; Redel, L; Calao, M; Marban, C; Samah, B; Mukerjee, R; Schwartz, C; Gras, G; Sawaya, BE; Zeichner, SL; Aunis, D; Van Lint, C; Rohr, O				Cherrier, T.; Suzanne, S.; Redel, L.; Calao, M.; Marban, C.; Samah, B.; Mukerjee, R.; Schwartz, C.; Gras, G.; Sawaya, B. E.; Zeichner, S. L.; Aunis, D.; Van Lint, C.; Rohr, O.			p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1	ONCOGENE			English	Article						CTIP2; p21(WAF1); SUV39H1; HIV-1	CELL-CYCLE ARREST; HISTONE DEACETYLASE INHIBITORS; MICROGLIAL CELLS; T-LYMPHOCYTES; HIV-1 VPR; TRANSCRIPTIONAL ACTIVATION; P21/WAF1/CIP1 GENE; DNA-REPLICATION; NURD COMPLEX; IN-VIVO	Mainly regulated at the transcriptional level, the cellular cyclin-dependent kinase inhibitor, CDKN1A/p21(WAF1) (p21), is a major cell cycle regulator of the response to DNA damage, senescence and tumor suppression. Here, we report that COUP-TF-interacting protein 2 (CTIP2), recruited to the p21 gene promoter, silenced p21 gene transcription through interactions with histone deacetylases and methyltransferases. Importantly, treatment with the specific SUV39H1 inhibitor, chaetocin, repressed histone H3 lysine 9 trimethylation at the p21 gene promoter, stimulated p21 gene expression and induced cell cycle arrest. In addition, CTIP2 and SUV39H1 were recruited to the silenced p21 gene promoter to cooperatively inhibit p21 gene transcription. Induction of p21(WAF1) gene upon human immunodeficiency virus 1 (HIV-1) infection benefits viral expression in macrophages. Here, we report that CTIP2 further abolishes Vpr-mediated stimulation of p21, thereby indirectly contributing to HIV-1 latency. Altogether, our results suggest that CTIP2 is a constitutive p21 gene suppressor that cooperates with SUV39H1 and histone methylation to silence the p21 gene transcription. Oncogene (2009) 28, 3380-3389; doi: 10.1038/onc.2009.193; published online 6 July 2009	[Cherrier, T.; Suzanne, S.; Redel, L.; Marban, C.; Schwartz, C.; Aunis, D.; Rohr, O.] Univ Strasbourg, INSERM, Inst Virol, U575, F-67000 Strasbourg, France; [Samah, B.; Gras, G.] Serv Neurovirol, CEA, UMRE 01, Fontenay Aux Roses, France; [Mukerjee, R.; Sawaya, B. E.] Temple Univ, Dept Neurol, Sch Med, Mol Virol Lab, Philadelphia, PA 19122 USA; [Zeichner, S. L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Zeichner, S. L.] George Washington Univ, Childrens Res Inst, Dept Pediat & Microbiol, Washington, DC USA; [Zeichner, S. L.] George Washington Univ, Childrens Res Inst, Dept Immunol, Washington, DC USA; [Zeichner, S. L.] George Washington Univ, Childrens Res Inst, Dept Trop Med, Washington, DC USA; [Calao, M.; Van Lint, C.] Univ Libre Bruxelles, Inst Biol & Med Mol, Mol Virol Lab, Gosselies, Belgium; [Rohr, O.] IUT Louis Pasteur Schiltigheim, Schiltigheim, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Children's National Health System; George Washington University; George Washington University; George Washington University; Universite Libre de Bruxelles	Rohr, O (corresponding author), Univ Strasbourg, INSERM, Inst Virol, U575, 3 Rue Koeberle, F-67000 Strasbourg, France.	cvlint@ulb.ac.be; olivier.rohr@iutlpa.u-strasbg.fr	Dominique, Aunis/W-1419-2019; CHERRIER, Thomas/F-8727-2018	CHERRIER, Thomas/0000-0002-0707-9204; ROHR, Olivier/0000-0001-8992-2025	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de Recherches sur le SIDA (ANRS); Sidaction; French Ministry of Research [ACI JC 5364]; Fonds National de la Recherche Scientifique (FNRS, Belgium); Action de Recherche concertee du Ministere de la Communaute Francaise [04/09-309]; Internationale Brachet Stiftung (IBS); Region Wallonne-Commission Europeenne FEDER; Theyskens-Mineur Foundation; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de Recherches sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Action de Recherche concertee du Ministere de la Communaute Francaise; Internationale Brachet Stiftung (IBS); Region Wallonne-Commission Europeenne FEDER; Theyskens-Mineur Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr D Kardassis for providing us with p21-LUC plasmids and Dr Yannick Goumon for his technical support. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), by grants from the Agence Nationale de Recherches sur le SIDA (ANRS) to OR and CVL, from Sidaction to OR and TC and from the French Ministry of Research ('ACI JC 5364' to OR and doctoral grant to TC and SS) The work in CVL's laboratory was supported by grants from the 'Fonds National de la Recherche Scientifique' (FNRS, Belgium), the Televie-Program of the FNRS, from the 'Action de Recherche concertee du Ministere de la Communaute Francaise (ULB, ARC program no. 04/09-309), from the Internationale Brachet Stiftung (IBS), from the Region Wallonne-Commission Europeenne FEDER (Intergenes Project, Interreg III program) and from the Theyskens-Mineur Foundation. CVL is 'Directeur de Recherches' of the FNRS. This work was supported by NIH to BES.	Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Anderson MR, 2008, CULT HEALTH SEX, V10, P1, DOI 10.1080/13691050701516363; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Clark E, 2000, J VIROL, V74, P5040, DOI 10.1128/JVI.74.11.5040-5052.2000; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372; Marban C, 2005, NUCLEIC ACIDS RES, V33, P2318, DOI 10.1093/nar/gki529; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Moon HS, 2006, MOL CELLS, V21, P7; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Rohr O, 2003, J VIROL, V77, P5415, DOI 10.1128/JVI.77.9.5415-5427.2003; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Sowa Y, 1999, CANCER RES, V59, P4266; Suzuki T, 2000, INT J CANCER, V88, P992, DOI 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Vazquez N, 2005, J VIROL, V79, P4479, DOI 10.1128/JVI.79.7.4479-4491.2005; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Yoshizuka N, 2005, J VIROL, V79, P11366, DOI 10.1128/JVI.79.17.11366-11381.2005; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971	44	91	93	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3380	3389		10.1038/onc.2009.193	http://dx.doi.org/10.1038/onc.2009.193			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19581932	Green Published, Green Accepted			2022-12-25	WOS:000270103300005
J	Motshwene, PG; Moncrieffe, MC; Grossmann, JG; Kao, C; Ayaluru, M; Sandercock, AM; Robinson, CV; Latz, E; Gay, NJ				Motshwene, Precious G.; Moncrieffe, Martin C.; Grossmann, J. Guenter; Kao, Cheng; Ayaluru, Murali; Sandercock, Alan M.; Robinson, Carol V.; Latz, Eicke; Gay, Nicholas J.			An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH DOMAIN; STRUCTURAL BASIS; MASS-SPECTROMETRY; INNATE IMMUNITY; HIGH-RESOLUTION; TIR-DOMAIN; COMPLEX; PROTEIN; SCATTERING; REGULATOR	Toll-like receptors (TLRs) mediate responses to pathogen-associated molecules as part of the vertebrate innate immune response to infection. Receptor dimerization is coupled to downstream signal transduction by the recruitment of a post-receptor complex containing the adaptor protein MyD88 and the IRAK protein kinases. In this work, we show that the death domains of human MyD88 and IRAK-4 assemble into closed complexes having unusual stoichiometries of 7:4 and 8:4, the Myddosome. Formation of the Myddosome is likely to be a key event for TLR4 signaling in vivo as we show here that pathway activation requires that the receptors cluster into lipid rafts. Taken together, these findings indicate that TLR activation causes the formation of a highly oligomeric signaling platform analogous to the death-inducing signaling complex of the Fas receptor pathway.	[Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Grossmann, J. Guenter] Univ Liverpool, Mol Biophys Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Sandercock, Alan M.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Kao, Cheng; Ayaluru, Murali] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01655 USA	University of Cambridge; University of Liverpool; University of Cambridge; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk	Murali, Ayaluru/G-3401-2014; Latz, Eicke/H-3951-2014	Murali, Ayaluru/0000-0001-6406-6840; Latz, Eicke/0000-0003-1488-5666; Motshwene, Precious/0000-0002-0230-9410; robinson, carol/0000-0001-7829-5505	UK Medical Research Council; Biotechnology and Biological Science Research Council; South African National Research Foundation; BBSRC [BB/G009295/1] Funding Source: UKRI; MRC [G0400007] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009295/1] Funding Source: researchfish; Medical Research Council [G0400007] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); South African National Research Foundation(National Research Foundation - South Africa); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the UK Medical Research Council and Biotechnology and Biological Science Research Council (to N.G.).; Supported by the South African National Research Foundation.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	41	246	261	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25404	25411		10.1074/jbc.M109.022392	http://dx.doi.org/10.1074/jbc.M109.022392			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592493	Green Published, hybrid			2022-12-25	WOS:000269734000072
J	Wiley, DJ; Shrestha, N; Yang, J; Atis, N; Dayton, K; Schesser, K				Wiley, David J.; Shrestha, Niraj; Yang, Jing; Atis, Nadege; Dayton, Kevin; Schesser, Kurt			The Activities of the Yersinia Protein Kinase A (YpkA) and Outer Protein J (YopJ) Virulence Factors Converge on an eIF2 alpha Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED EIF-2-ALPHA KINASE; FACTOR 2-ALPHA KINASE; NF-KAPPA-B; SCHIZOSACCHAROMYCES-POMBE; SIGNAL-TRANSDUCTION; EFFECTOR YOPJ; FISSION YEAST; ACTIVATION; PHOSPHORYLATION; EXPRESSION	The Yersinia protein kinase A (YpkA) and outer protein J (YopJ) are co-expressed from a single transcript and are injected directly into eukaryotic cells by the plague bacterium Yersinia pestis. When overexpressed in vertebrate or yeast cells, YpkA disrupts the actin-based cytoskeletal system by an unknown mechanism, whereas YopJ obstructs inductive chemokine expression by inhibiting MAPK and NF-kappa B signaling. Previously, we showed that the fission yeast Schizosaccharomyces pombe was sensitive to the kinase activity of YpkA. Here, we screened yeast for cellular processes important for YpkA activity and found that the eIF2 alpha kinases mollify the toxicity imparted by the kinase activity of YpkA. Specifically, strains lacking the eIF2 alpha kinase Hri2 were particularly sensitive to YpkA. Unexpectedly, the activity of YopJ, which conferred a phenotype consistent with its inhibitory effect on MAPK signaling, was also found to be dependent on Hri2. When expressed in S. pombe, YopJ sensitized cells to osmotic and oxidative stresses through a Hri2-dependent mechanism. However, when co-expressed with YpkA, YopJ protected cells from YpkA-mediated toxicity, and this protection was entirely dependent on Hri2. In contrast, YopJ did not confer protection against the toxic effects of the Yersinia virulence factor YopE. These findings are the first to functionally link YpkA and YopJ and suggest that eIF2 alpha kinases, which are critically important in antiviral defenses and protection against environmental stresses, also play a role in bacterial virulence.	[Wiley, David J.; Shrestha, Niraj; Yang, Jing; Atis, Nadege; Dayton, Kevin; Schesser, Kurt] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami	Schesser, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, 1600 NW 10th Ave, Miami, FL 33136 USA.	kschesser@med.miami.edu			NIAID; National Institutes of Health Public Health Service [AI53459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053459] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Public Health Service Grant AI53459.	BARTRA S, 2001, BMC MICROBIOL, V1, pE22; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Bauer BN, 2001, BIOCHEMISTRY-US, V40, P11543, DOI 10.1021/bi010983s; Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Dunand-Sauthier I, 2005, EUKARYOT CELL, V4, P1785, DOI 10.1128/EC.4.11.1785-1793.2005; FAGARD R, 1981, P NATL ACAD SCI-BIOL, V78, P866, DOI 10.1073/pnas.78.2.866; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; KEENEY JB, 1994, GENETICS, V136, P849; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Meijer LK, 2000, CELL MICROBIOL, V2, P231, DOI 10.1046/j.1462-5822.2000.00049.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Uma S, 1998, EXP CELL RES, V238, P273, DOI 10.1006/excr.1997.3860; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200	46	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24744	24753		10.1074/jbc.M109.010140	http://dx.doi.org/10.1074/jbc.M109.010140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553678	hybrid, Green Published			2022-12-25	WOS:000269734000009
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Identification of Residues in the Drug Translocation Pathway of the Human Multidrug Resistance P-glycoprotein by Arginine Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED ATPASE ACTIVITY; 1ST TRANSMEMBRANE SEGMENT; BINDING SITE; CROSS-LINKING; MUTATIONAL ANALYSIS; PROMOTE MATURATION; CYSTIC-FIBROSIS; MOLECULAR-BASIS; HUMAN MDR1; TRANSPORTER	P-glycoprotein (P-gp, ATP-binding cassette B1) is a drug pump that extracts toxic drug substrates from the plasma membrane and catalyzes their ATP-dependent efflux. To map the residues in the drug translocation pathway, we performed arginine-scanning mutagenesis on all transmembrane (TM) segments (total = 237 residues) of a P-gp processing mutant (G251V) defective in folding (15% maturation efficiency) (glycosylation state used to monitor folding). The rationale was that arginines introduced into the drug-binding sites would mimic drug rescue and enhance maturation of wild-type or processing mutants of P-gp. It was found that 38 of the 89 mutants that matured had enhanced maturation. Enhancer mutations were found in 11 of the 12 TM segments with the largest number found in TMs 6 and 12 (seven in each), TMs that are critical for P-gp-drug substrate interactions. Modeling of the TM segments showed that the enhancer arginines were found on the hydrophilic face, whereas inhibitory arginines were located on a hydrophobic face that may be in contact with the lipid bilayer. It was found that many of the enhancer arginines caused large alterations in P-gp-drug interactions in ATPase assays. For example, mutants A302R (TM5), L339R (TM6), G872R (TM10), F942R (TM11), Q946R (TM11), V982R (TM12), and S993R (TM12) reduced the apparent affinity for verapamil by similar to 10-fold, whereas the F336R (TM6) and M986R (TM12) mutations caused at least a 10-fold increase in apparent affinity for rhodamine B. The results suggest that P-gp contains a large aqueous-filled drug translocation pathway with multiple drug-binding sites that can accommodate the bulky arginine side chains to promote folding of the protein.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Cancer Society [19074]; Canadian Institutes of Health Research [25043]; Cystic Fibrosis Foundation [CLARKE-08GO]	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by Canadian Cancer Society Grant 19074, Canadian Institutes of Health Research Grant 25043, and Cystic Fibrosis Foundation Grant CLARKE-08GO.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Becker JP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-3; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1999, BIOCHEMISTRY-US, V38, P6630, DOI 10.1021/bi983038l; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Gannon MK, 2009, J MED CHEM, V52, P3328, DOI 10.1021/jm900253g; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1994, J BIOL CHEM, V269, P7750; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; Loo TW, 1996, J BIOL CHEM, V271, P15414, DOI 10.1074/jbc.271.26.15414; Muller M, 1996, J BIOL CHEM, V271, P1877; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Qu Q, 2002, BIOCHEMISTRY-US, V41, P4744, DOI 10.1021/bi0120897; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Rothnie A, 2005, FEBS LETT, V579, P3984, DOI 10.1016/j.febslet.2005.06.030; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Stockner T, 2009, FEBS J, V276, P964, DOI 10.1111/j.1742-4658.2008.06832.x; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; TANGWAI DF, 1995, BIOCHEMISTRY-US, V34, P32, DOI 10.1021/bi00001a005; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926	52	66	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24074	24087		10.1074/jbc.M109.023267	http://dx.doi.org/10.1074/jbc.M109.023267			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581304	Green Published, hybrid			2022-12-25	WOS:000269380200021
J	Martianez, T; Frances, S; Lopez, JM				Martianez, Tania; Frances, Silvia; Lopez, Jose M.			Generation of Digital Responses in Stress Sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CELLULAR-ENERGY; POSITIVE-FEEDBACK; XENOPUS OOCYTES; CYTOCHROME-C; JNK; APOPTOSIS; PHOSPHORYLATION; PATHWAY	Ultrasensitivity, hysteresis (a form of biochemical memory), and all-or-none (digital) responses are important signaling properties for the control of irreversible processes and are well characterized in the c-Jun N-terminal kinase (JNK)system using Xenopus oocytes. Our aim was to study these properties in the AMP-activated protein kinase (AMPK) signaling system under stress conditions that could engage a cell death program, and compare them to the JNK responses. After characterization of Xenopus AMPK, we show here that the response to antimycin (nonapoptotic) was slightly cooperative and graded (analog) in individual oocytes, whereas the response to sorbitol (which induced cytochrome c release and caspase activation) was ultra-sensitive, digital in single cells, and without hysteresis, hallmarks of a monostable system. Moreover, initial graded responses of AMPK and JNK turned into digital during a critical period for the execution of the cell death program, although single cell analysis did not show complete correlation between AMPK or JNK activation and cytochrome c release. We propose a model where the life or death decision in the cell is made by integration of multiple digital signals from stress sensors.	[Lopez, Jose M.] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Bioquim, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M,Campus Bellaterra, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.es	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262	Fondo de Investigaciones Sanitarias (FIS) [PI 05/1748]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III)	This work was supported by Grant PI 05/1748 from Fondo de Investigaciones Sanitarias (FIS).	Aleu J, 2003, J PHYSIOL-LONDON, V547, P209, DOI 10.1113/jphysiol.2002.029660; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; KIRBY KS, 1965, BIOCHEM J, V96, P266, DOI 10.1042/bj0960266; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; RIESKE JS, 1967, J BIOL CHEM, V242, P4888; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sehy JV, 2004, MAGN RESON MED, V52, P239, DOI 10.1002/mrm.20132; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tran TH, 2007, J BIOL CHEM, V282, P20340, DOI 10.1074/jbc.M702210200; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007	36	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23902	23911		10.1074/jbc.M109.026054	http://dx.doi.org/10.1074/jbc.M109.026054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570986	Green Published, hybrid			2022-12-25	WOS:000269380200004
J	Dang, YJ; Low, WK; Xu, J; Gehring, NH; Dietz, HC; Romo, D; Liu, JO				Dang, Yongjun; Low, Woon-Kai; Xu, Jing; Gehring, Niels H.; Dietz, Harry C.; Romo, Daniel; Liu, Jun O.			Inhibition of Nonsense-mediated mRNA Decay by the Natural Product Pateamine A through Eukaryotic Initiation Factor 4AIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON-JUNCTION COMPLEX; ZEALAND MARINE SPONGE; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; UPF1 PHOSPHORYLATION; MAMMALIAN-CELLS; QUALITY-CONTROL; PROTEIN-KINASE; CORE COMPLEX; HUMAN SMG-1	Nonsense-mediated mRNA decay (NMD) in mammalian cells is a key mechanism for the removal of mRNA containing premature stop codons and is mediated by the coordinated function of numerous proteins that dynamically associate with the exon junction complex. The information communicated by these interactions and the functional consequences from a mechanistic perspective, however, are not completely documented. Herein, we report that the natural product pateamine A ( PatA) is capable of inhibiting NMD through direct interaction with eIF4AIII, which is independent of its inhibition of translation initiation. Furthermore, we have characterized the mechanisms by which PatA and cycloheximide modulate NMD. Unlike CHX, PatA was found to inhibit NMD by a novel mechanism that is independent of the phosphorylation of Up-frameshift protein 1.	[Dang, Yongjun; Low, Woon-Kai; Xu, Jing; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Gehring, Niels H.] Univ Heidelberg, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Gehring, Niels H.] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Gehring, Niels H.] Univ Heidelberg, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Romo, Daniel] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Texas A&M University System; Texas A&M University College Station	Liu, JO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu	dang, yongjun/A-8095-2011; dang, yongjun/M-6531-2016	dang, yongjun/0000-0001-7237-1132; Xu, Jing/0000-0002-3307-2719	National Institutes of Health from the NCI [CA 100211]; Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA100211] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 100211 from the NCI. This work was also supported by the Keck Foundation.	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen ZZ, 2005, GENETICS, V171, P403, DOI 10.1534/genetics.105.045674; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Clement SL, 2006, NAT STRUCT MOL BIOL, V13, P299, DOI 10.1038/nsmb0406-299; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Holbrook JA, 2006, EMBO REP, V7, P722, DOI 10.1038/sj.embor.7400721; Hood KA, 2001, APOPTOSIS, V6, P207, DOI 10.1023/A:1011340827558; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Low WK, 2007, CHEM BIOL, V14, P715, DOI 10.1016/j.chembiol.2007.05.012; Lykke-Andersen J, 2004, NAT STRUCT MOL BIOL, V11, P305, DOI 10.1038/nsmb0404-305; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; NORTHCOTE PT, 1991, TETRAHEDRON LETT, V32, P6411, DOI 10.1016/0040-4039(91)80182-6; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Romo D, 2004, J AM CHEM SOC, V126, P10582, DOI 10.1021/ja040065s; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Stroupe ME, 2006, J MOL BIOL, V360, P743, DOI 10.1016/j.jmb.2006.05.049; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002	58	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23613	23621		10.1074/jbc.M109.009985	http://dx.doi.org/10.1074/jbc.M109.009985			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570977	Green Published, hybrid			2022-12-25	WOS:000269180000047
J	Fukuda, A; Nakadai, T; Shimada, M; Hisatake, K				Fukuda, Aya; Nakadai, Tomoyoshi; Shimada, Miho; Hisatake, Koji			Heterogeneous Nuclear Ribonucleoprotein R Enhances Transcription from the Naturally Configured c-fos Promoter in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SERUM RESPONSE FACTOR; HBV-ENCODED COACTIVATOR; TERMINAL REPEAT DOMAIN; MAP KINASE PATHWAY; MEDIATOR COMPLEX; FUNCTIONAL-ANALYSIS; PROTEIN CBP; ACTIVATION; CREB	Transcription of a proto-oncogene c-fos is induced rapidly to high levels by various extracellular stimuli. To explore the molecular mechanism of c-fos gene induction, we established a defined in vitro transcription system for the c-fos promoter that consists of purified activators (SRF, Elk-1, cAMP-responsive element-binding protein, and ATF1), general transcription factors, and RNA polymerase II. In this reconstituted transcription system, activation of c-fos transcription was highly dependent upon coactivators such as PC4 and Mediator, indicating a very weak activation potential of the activators in the context of an unaltered promoter structure. This heightened coactivator dependence, however, allowed us to identify from HeLa nuclear extract a coactivator-like activity termed transcriptional regulator of c-fos (TREF) that enhanced c-fos transcription but not GAL4-VP16-dependent transcription. TREF cooperated with Mediator to enhance c-fos transcription by similar to 60-fold over its basal level and, like Mediator, stimulated activator-independent (basal) transcription as well. Further purification of TREF revealed that it consists of at least three distinct components, one of which was purified to near homogeneity and identified as heterogeneous nuclear ribonucleoprotein R. Recombinant heterogeneous nuclear ribonucleoprotein R enhanced transcription from the c-fos promoter and displayed cooperativity with PC4 and Mediator, thus demonstrating its direct transcriptional activity.	[Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Dept Biochem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Nakadai, Tomoyoshi; Shimada, Miho] Saitama Med Univ, Fac Med, Dept Mol Biol, Saitama 3500495, Japan	University of Tsukuba; University of Tsukuba; Saitama Medical University	Hisatake, K (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kojihisa@md.tsukuba.ac.jp		Nishimura, Ken/0000-0002-0716-4142; Hisatake, Koji/0000-0002-5795-3115	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research ( to A. F. and K. H.) and Special Coordination Funds for Promoting Science and Technology ( to A. F.) of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Chan HM, 2001, J CELL SCI, V114, P2363; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525-6535.2004; Fukuda A, 2002, P NATL ACAD SCI USA, V99, P1206, DOI 10.1073/pnas.251674198; Fukuda A, 2001, GENES CELLS, V6, P707, DOI 10.1046/j.1365-2443.2001.00456.x; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Haviv I, 1998, MOL CELL BIOL, V18, P1562, DOI 10.1128/MCB.18.3.1562; Haviv I, 1996, EMBO J, V15, P3413, DOI 10.1002/j.1460-2075.1996.tb00707.x; Haviv I, 1998, GENE DEV, V12, P1217, DOI 10.1101/gad.12.8.1217; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Huang J, 2008, CELL MOL BIOL LETT, V13, P303, DOI 10.2478/s11658-008-0002-0; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lukac DM, 1997, J VIROL, V71, P7227, DOI 10.1128/JVI.71.10.7227-7239.1997; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; REASON AJ, 1992, J BIOL CHEM, V267, P16911; REINBERG D, 1987, J BIOL CHEM, V262, P3322; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5291, DOI 10.1073/pnas.89.12.5291	57	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23472	23480		10.1074/jbc.M109.013656	http://dx.doi.org/10.1074/jbc.M109.013656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581295	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000269180000032
J	Griffon, N; Jin, WJ; Petty, TJ; Millar, J; Badellino, KO; Saven, JG; Marchadier, DH; Kempner, ES; Billheimer, J; Glick, JM; Rader, DJ				Griffon, Nathalie; Jin, Weijin; Petty, Thomas J.; Millar, John; Badellino, Karen O.; Saven, Jeffery G.; Marchadier, Dawn H.; Kempner, Ellis S.; Billheimer, Jeffrey; Glick, Jane M.; Rader, Daniel J.			Identification of the Active Form of Endothelial Lipase, a Homodimer in a Head-to-Tail Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIPOPROTEIN-LIPASE; HUMAN HEPATIC LIPASE; RADIATION INACTIVATION; HEPARIN-BINDING; PROTEIN STRUCTURES; PANCREATIC LIPASE; SUBSTRATE-SPECIFICITY; CHIMERIC LIPASE; CATALYTIC SITE; HDL METABOLISM	Endothelial lipase (EL) is a member of a subfamily of lipases that act on triglycerides and phospholipids in plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase. EL has a tropism for high density lipoprotein, and its level of phospholipase activity is similar to its level of triglyceride lipase activity. Inhibition or loss-of-function of EL in mice results in an increase in high density lipoprotein cholesterol, making it a potential therapeutic target. Although hepatic lipase and lipoprotein lipase have been shown to function as homodimers, the active form of EL is not known. In these studies, the size and conformation of the active form of EL were determined. Immunoprecipitation experiments suggested oligomerization. Ultracentrifugation experiments showed that the active form of EL had a molecular weight higher than the molecular weight of a simple monomer but less than a dimer. A construct encoding a covalent head-to-tail homodimer of EL (EL-EL) was expressed and had similar lipolytic activity to EL. The functional molecular weights determined by radiation inactivation were similar for EL and the covalent homodimer EL-EL. We previously showed that EL could be cleaved by proprotein convertases, such as PC5, resulting in loss of activity. In cells overexpressing PC5, the covalent homodimeric EL-EL appeared to be more stable, with reduced cleavage and conserved lipolytic activity. A comparative model obtained using other lipase structures suggests a structure for the head-to-tail EL homodimer that is consistent with the experimental findings. These data confirm the hypothesis that EL is active as a homodimer in head-to-tail conformation.	[Griffon, Nathalie; Jin, Weijin; Millar, John; Marchadier, Dawn H.; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Griffon, Nathalie; Jin, Weijin; Millar, John; Marchadier, Dawn H.; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Glick, Jane M.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Kempner, Ellis S.] NIAMS, NIH, Bethesda, MD 20892 USA; [Petty, Thomas J.; Saven, Jeffery G.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Badellino, Karen O.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Pennsylvania; University of Pennsylvania	Rader, DJ (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, 654 BRBII-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Petty, Tom/A-6758-2011	Petty, Tom/0000-0002-4007-6515	NHLBI [HL55323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055323, R37HL055323] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL55323 from the NHLBI (to D.J.R.).	Badellino KO, 2004, CURR OPIN CARDIOL, V19, P392, DOI 10.1097/01.hco.0000130161.89169.02; BELFRAGE P, 1969, J LIPID RES, V10, P341; Ben-Zeev O, 1999, METH MOL B, V109, P257; BENGTSSON G, 1981, EUR J BIOCHEM, V113, P547, DOI 10.1111/j.1432-1033.1981.tb05097.x; Berryman DE, 1998, BBA-PROTEIN STRUCT M, V1382, P217, DOI 10.1016/S0167-4838(97)00150-7; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; Broedl UC, 2004, FASEB J, V18, P1891, DOI 10.1096/fj.03-1307fje; Brown RJ, 2007, J LIPID RES, V48, P1132, DOI 10.1194/jlr.M600535-JLR200; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; DICHEK HL, 1993, J LIPID RES, V34, P1393; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; DUGI KA, 1992, J BIOL CHEM, V267, P25086; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; GARFINKEL AS, 1983, J LIPID RES, V24, P775; Gauster M, 2005, J LIPID RES, V46, P977, DOI 10.1194/jlr.M400500-JLR200; Griffon N, 2006, J LIPID RES, V47, P1803, DOI 10.1194/jlr.M500552-JLR200; HARMON JT, 1985, METHOD ENZYMOL, V117, P65; Hill JS, 1998, J BIOL CHEM, V273, P30979, DOI 10.1074/jbc.273.47.30979; Hill JS, 1996, J BIOL CHEM, V271, P22931, DOI 10.1074/jbc.271.37.22931; IVERIUS PH, 1976, J BIOL CHEM, V251, P7791; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Keiper T, 2001, J LIPID RES, V42, P1180; KEMPNER ES, 1979, ANAL BIOCHEM, V92, P2, DOI 10.1016/0003-2697(79)90617-1; Kobayashi J, 1996, J BIOL CHEM, V271, P26296, DOI 10.1074/jbc.271.42.26296; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Lookene A, 1997, J BIOL CHEM, V272, P766, DOI 10.1074/jbc.272.2.766; Lutz EP, 2004, J BIOL CHEM, V279, P238, DOI 10.1074/jbc.M310559200; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McCoy MG, 2002, J LIPID RES, V43, P921; Miller GC, 2004, J LIPID RES, V45, P2080, DOI 10.1194/jlr.M400162-JLR200; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; OLIVECRONA T, 1985, J BIOL CHEM, V260, P6888; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoonderwoerd K, 1996, BIOCHEM J, V318, P463, DOI 10.1042/bj3180463; Sendak RA, 1998, J LIPID RES, V39, P1310; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WONG H, 1991, P NATL ACAD SCI USA, V88, P11290, DOI 10.1073/pnas.88.24.11290; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594; Zhang LY, 2005, J BIOL CHEM, V280, P42580, DOI 10.1074/jbc.M507252200	47	34	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23322	23330		10.1074/jbc.M109.037002	http://dx.doi.org/10.1074/jbc.M109.037002			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567873	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000269180000017
J	Clifford, RJ; Kaplan, JH				Clifford, Rebecca J.; Kaplan, Jack H.			Regulation of Na,K-ATPase Subunit Abundance by Translational Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; BETA-SUBUNIT; ALPHA-SUBUNIT; MDCK CELLS; GENE-EXPRESSION; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; TRANSGENIC MICE; MESSENGER-RNA	The Na,K-ATPase is an alpha beta heterodimer responsible for maintaining fluid and electrolyte homeostasis in mammalian cells. We engineered Madin-Darby canine kidney cell lines expressing alpha(1)FLAG, beta(1)FLAG, or beta 2MYC subunits via a tetracycline-regulated promoter and a line expressing both stable beta 1MYC and tetracycline-regulated beta(1)FLAG to examine regulatory mechanisms of sodium pump subunit expression. When overexpression of exogenous beta(1)FLAG increased total beta subunit levels by > 200% without changes in alpha subunit abundance, endogenous beta(1) subunit (beta E-1) abundance decreased. beta E-1 down-regulation did not occur during beta 2MYC overexpression, indicating isoform specificity of the repression mechanism. Measurements of RNA stability and content indicated that decreased beta subunit expression was not accompanied by any change in mRNA levels. In addition, the degradation rate of beta subunits was not altered by beta(1)FLAG overexpression. Cells stably expressing beta 1MYC, when induced to express beta(1)FLAG subunits, showed reduced beta 1MYC and beta E-1 subunit abundance, indicating that these effects occur via the coding sequences of the down-regulated polypeptides. In a similar way, Madin-Darby canine kidney cells overexpressing exogenous beta(1)FLAG subunits exhibited a reduction of endogenous alpha(1) subunits (alpha E-1) with no change in alpha mRNA levels or beta subunits. The reduction in alpha E-1 compensated for alpha(1)FLAG subunit expression, resulting in unchanged total alpha subunit abundance. Thus, regulation of alpha subunit expression maintained its native level, whereas beta subunit was not as tightly regulated and its abundance could increase substantially over native levels. These effects also occurred in human embryonic kidney cells. These data are the first indication that cellular sodium pump subunit abundance is modulated by translational repression. This mechanism represents a novel, potentially important mechanism for regulation of Na,K-ATPase expression.	[Clifford, Rebecca J.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [GM-39500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-39500.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Barwe SP, 2007, J MOL BIOL, V365, P706, DOI 10.1016/j.jmb.2006.10.029; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BOWEN JW, 1987, AM J PHYSIOL, V252, pC179, DOI 10.1152/ajpcell.1987.252.2.C179; CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3; CAPLAN MJ, 1986, J BIOL CHEM, V261, P2860; Clifford RJ, 2008, AM J PHYSIOL-RENAL, V295, pF1314, DOI 10.1152/ajprenal.90406.2008; CORTHESYTHEULAZ I, 1991, AM J PHYSIOL, V261, pC124, DOI 10.1152/ajpcell.1991.261.1.C124; DEVARAJAN P, 1992, J BIOL CHEM, V267, P22435; Dickey CA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-7; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; FARLEY RA, 1986, BIOCHIM BIOPHYS ACTA, V873, P136, DOI 10.1016/0167-4838(86)90199-8; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Gatto C, 2001, AM J PHYSIOL-CELL PH, V281, pC982, DOI 10.1152/ajpcell.2001.281.3.C982; GonzalezGaray ML, 1996, J CELL BIOL, V135, P1525, DOI 10.1083/jcb.135.6.1525; Grindstaff KK, 1996, J BIOL CHEM, V271, P23211, DOI 10.1074/jbc.271.38.23211; Harris ZL, 1996, EUR RESPIR J, V9, P472, DOI 10.1183/09031936.96.09030472; HAYASHI Y, 1983, BIOCHIM BIOPHYS ACTA, V748, P153, DOI 10.1016/0167-4838(83)90291-1; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KYTE J, 1971, J BIOL CHEM, V246, P4157; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Laughery MD, 2007, AM J PHYSIOL-RENAL, V292, pF1718, DOI 10.1152/ajprenal.00360.2006; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; MILLER RP, 1988, BIOCHIM BIOPHYS ACTA, V954, P50, DOI 10.1016/0167-4838(88)90054-4; MIRCHEFF AK, 1992, AM J PHYSIOL, V262, pC470, DOI 10.1152/ajpcell.1992.262.2.C470; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Pontiggia L, 1997, BIOCHEM BIOPH RES CO, V231, P755, DOI 10.1006/bbrc.1997.6188; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; RUIZ A, 1995, GENE, V155, P179, DOI 10.1016/0378-1119(94)00812-7; Shao Y, 2004, AM J PHYSIOL-CELL PH, V286, pC580, DOI 10.1152/ajpcell.00117.2003; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; SWEADNER KJ, 1979, J BIOL CHEM, V254, P6060; TANG MJ, 1992, AM J PHYSIOL, V263, pC436, DOI 10.1152/ajpcell.1992.263.2.C436; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wang G, 2007, MOL CELL BIOCHEM, V294, P73, DOI 10.1007/s11010-006-9247-y; Weber P, 1998, J NEUROSCI, V18, P9192; Wendt CH, 2000, J BIOL CHEM, V275, P41396, DOI 10.1074/jbc.M004759200; Wendt CH, 1998, AM J PHYSIOL-CELL PH, V274, pC356, DOI 10.1152/ajpcell.1998.274.2.C356; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; YANG-FENG T L, 1988, Genomics, V2, P128, DOI 10.1016/0888-7543(88)90094-8; You LC, 2000, METAB ENG, V2, P210, DOI 10.1006/mben.1999.0139; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	56	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22905	22915		10.1074/jbc.M109.030536	http://dx.doi.org/10.1074/jbc.M109.030536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553675	Green Published, hybrid			2022-12-25	WOS:000268963100044
J	Zhang, W; Yang, J; Liu, YJ; Chen, X; Yu, TX; Jia, JH; Liu, CM				Zhang, Wen; Yang, Jun; Liu, Yajuan; Chen, Xi; Yu, Tianxin; Jia, Jianhang; Liu, Chunming			PR55 alpha, a Regulatory Subunit of PP2A, Specifically Regulates PP2A-mediated beta-Catenin Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; WNT SIGNALING PATHWAY; CRYSTAL-STRUCTURE; NAKED CUTICLE; PHOSPHORYLATION; HOLOENZYME; APC; IDENTIFICATION; DEGRADATION; REPRESSION	A central question in Wnt signaling is the regulation of beta-catenin phosphorylation and degradation. Multiple kinases, including CKI alpha and GSK3, are involved in beta-catenin phosphorylation. Protein phosphatases such as PP2A and PP1 have been implicated in the regulation of beta-catenin. However, which phosphatase dephosphorylates beta-catenin in vivo and how the specificity of beta-catenin dephosphorylation is regulated are not clear. In this study, we show that PP2A regulates beta-catenin phosphorylation and degradation in vivo. We demonstrate that PP2A is required for Wnt/beta-catenin signaling in Drosophila. Moreover, we have identified PR55 alpha as the regulatory subunit of PP2A that controls beta-catenin phosphorylation and degradation. PR55 alpha, but not the catalytic subunit, PP2Ac, directly interacts with beta-catenin. RNA interference knockdown of PR55 alpha elevates beta-catenin phosphorylation and decreases Wnt signaling, whereas overexpressing PR55 alpha enhances Wnt signaling. Taken together, our results suggest that PR55 alpha specifically regulates PP2A-mediated beta-catenin dephosphorylation and plays an essential role in Wnt signaling.	[Yang, Jun; Yu, Tianxin; Liu, Chunming] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Zhang, Wen; Liu, Yajuan; Chen, Xi; Jia, Jianhang; Liu, Chunming] Univ Kentucky, Lucille P Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Kentucky	Liu, CM (corresponding author), 741 S Limestone,B375 BBSRB, Lexington, KY 40506 USA.	chunming.liu@uky.edu	Yu, T.X./B-9806-2011	Jia, Jianhang/0000-0002-9313-3843	National Institutes of Health [R01GM079684, R01DK071976]; Charlotte Geyer Foundation; NATIONAL CANCER INSTITUTE [R21CA112007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant R01GM079684.; Supported by National Institutes of Health Grant R01DK071976 and an award from the Charlotte Geyer Foundation.	Adams Deanna G., 2007, V365, P101; Bajpai R, 2004, DEVELOPMENT, V131, P1007, DOI 10.1242/dev.00980; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Creyghton MP, 2006, P NATL ACAD SCI USA, V103, P5397, DOI 10.1073/pnas.0507237103; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yamamoto H, 2001, J BIOL CHEM, V276, P26875, DOI 10.1074/jbc.M100443200; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	33	81	84	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22649	22656		10.1074/jbc.M109.013698	http://dx.doi.org/10.1074/jbc.M109.013698			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19556239	Green Published, hybrid			2022-12-25	WOS:000268963100018
J	Lorizate, M; Brugger, B; Akiyama, H; Glass, B; Muller, B; Anderluh, G; Wieland, FT; Krausslich, HG				Lorizate, Maier; Bruegger, Britta; Akiyama, Hisashi; Glass, Baerbel; Mueller, Barbara; Anderluh, Gregor; Wieland, Felix T.; Kraeusslich, Hans-Georg			Probing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; 2-PHOTON FLUORESCENCE MICROSCOPY; PORE-FORMING TOXIN; GIANT UNILAMELLAR VESICLES; CYTOLYSIN EQUINATOXIN-II; FREE STANDING BILAYERS; MURINE LEUKEMIA-VIRUS; LIPID RAFTS; PLASMA-MEMBRANE; SEA-ANEMONE	Viruses acquire their envelope by budding from a host cell membrane, but viral lipid composition may differ from that of the budding membrane. We have previously reported that the HIV-1 membrane is highly enriched in cholesterol, sphingolipids, and other raft lipids, suggesting that the virus may bud from pre-existing or virus-induced lipid rafts. Here, we employed the environmentally sensitive fluorescent dye Laurdan to study the membrane lateral structure of HIV-1 derived from different cell lines. Differences in viral membrane order detected by Laurdan staining were shown by mass spectrometry to be due to differences in lipid composition. Isogenic viruses from two different cell lines were both strongly enriched in raft lipids and displayed a liquid-ordered membrane, but these effects were significantly more pronounced for HIV-1 from the T-cell line MT-4 compared with virus from 293T cells. Host-dependent differences in the lipidomes predominantly affected the ratio of sphingomyelins (including dihydrosphingomyelin) to phosphatidylcholine, whereas cholesterol contents were similar. Accordingly, treatment of infectious HIV-1 with the sphingomyelin-binding toxins Equinatoxin-II or lysenin showed differential inhibition of infectivity. Liposomes consisting of lipids that had been extracted from viral particles exhibited slightly less liquid order than the respective viral membranes, which is likely to be due to absence of membrane proteins and to loss of lipid asymmetry. Synthetic liposomes consisting of a quaternary lipid mixture emulating the viral lipids showed a liquid order similar to liposomes derived from virion lipids. Thus, Laurdan staining represents a rapid and quantitative method to probe viral membrane liquid order and may prove useful in the search for lipid active drugs.	[Lorizate, Maier; Akiyama, Hisashi; Glass, Baerbel; Mueller, Barbara; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Virol, D-69120 Heidelberg, Germany; [Bruegger, Britta; Wieland, Felix T.] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Ljubljana	Krausslich, HG (corresponding author), Univ Klinikum Heidelberg, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Anderluh, Gregor/C-6905-2014; Muller, Barbara/AAC-4483-2020; Lorizate, Maier/S-1151-2018	Anderluh, Gregor/0000-0002-9916-8465; Lorizate, Maier/0000-0001-8173-2788; Akiyama, Hisashi/0000-0001-9228-0465; Muller, Barbara/0000-0001-5726-5585				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; AGY MB, 1990, VIROLOGY, V177, P251, DOI 10.1016/0042-6822(90)90478-A; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Bagatolli LA, 2003, CHEM PHYS LIPIDS, V122, P137, DOI 10.1016/S0009-3084(02)00184-6; Bagatolli LA, 2000, CHEM PHYS LIPIDS, V105, P135, DOI 10.1016/S0009-3084(00)00118-3; Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bonev BB, 2003, BIOPHYS J, V84, P2382, DOI 10.1016/S0006-3495(03)75044-9; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Goni FM, 2008, BBA-MOL CELL BIOL L, V1781, P665, DOI 10.1016/j.bbalip.2008.09.002; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hatch SC, 2009, J VIROL, V83, P3496, DOI 10.1128/JVI.02249-08; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nguyen DH, 1999, MOL MICROBIOL, V33, P659, DOI 10.1046/j.1365-2958.1999.01518.x; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Oswald-Richter K, 2006, J VIROL, V80, P11767, DOI 10.1128/JVI.00213-06; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sekizawa Y, 1997, GENE, V191, P97, DOI 10.1016/S0378-1119(97)00047-4; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	61	66	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22238	22247		10.1074/jbc.M109.029256	http://dx.doi.org/10.1074/jbc.M109.029256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553682	Green Published, hybrid			2022-12-25	WOS:000268783700048
J	Singh, A; Kong, QZ; Luo, X; Petersen, RB; Meyerson, H; Singh, N				Singh, Ajay; Kong, Qingzhong; Luo, Xiu; Petersen, Robert B.; Meyerson, Howard; Singh, Neena			Prion Protein (PrP) Knock-Out Mice Show Altered Iron Metabolism: A Functional Role for PrP in Iron Uptake and Transport	PLOS ONE			English	Article								Despite overwhelming evidence implicating the prion protein (PrP) in prion disease pathogenesis, the normal function of this cell surface glycoprotein remains unclear. In previous reports we demonstrated that PrP mediates cellular iron uptake and transport, and aggregation of PrP to the disease causing PrP-scrapie (PrP(Sc)) form results in imbalance of iron homeostasis in prion disease affected human and animal brains. Here, we show that selective deletion of PrP in transgenic mice (PrP(KO)) alters systemic iron homeostasis as reflected in hematological parameters and levels of total iron and iron regulatory proteins in the plasma, liver, spleen, and brain of PrP(KO) mice relative to matched wild type controls. Introduction of radiolabeled iron ((59)FeCl(3)) to Wt and PrP(KO) mice by gastric gavage reveals inefficient transport of (59)Fe from the duodenum to the blood stream, an early abortive spike of erythropoiesis in the long bones and spleen, and eventual decreased (59)Fe content in red blood cells and all major organs of PrP(KO) mice relative to Wt controls. The iron deficient phenotype of PrP(KO) mice is reversed by expressing Wt PrP in the PrP(KO) background, demonstrating a functional role for PrP in iron uptake and transport. Since iron is required for essential metabolic processes and is also potentially toxic if mismanaged, these results suggest that loss of normal function of PrP due to aggregation to the PrP(Sc) form induces imbalance of brain iron homeostasis, resulting in disease associated neurotoxicity.			Singh, A (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	neena.singh@case.edu	Petersen, Robert/B-5075-2011	Petersen, Robert/0000-0002-3154-0072	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035962, R29NS035962, R01NS039089] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS039089, NS35962, R01 NS035962, NS39089, R29 NS035962] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; HANAZAWA S, 1991, INFECT IMMUN, V59, P1972, DOI 10.1128/IAI.59.6.1972-1977.1991; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 1998, J COMP NEUROL, V398, P420; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; PEPPRIELL JE, 1982, BLOOD, V60, P635; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Vyoral D, 1998, BIOL TRACE ELEM RES, V61, P263, DOI 10.1007/BF02789087; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zivny JH, 2008, BLOOD CELL MOL DIS, V40, P302, DOI 10.1016/j.bcmd.2007.09.009	30	74	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6115	10.1371/journal.pone.0006115	http://dx.doi.org/10.1371/journal.pone.0006115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568430	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200014
J	VerMilyea, MD; O'Neill, LP; Turner, BM				VerMilyea, Matthew D.; O'Neill, Laura P.; Turner, Bryan M.			Transcription-Independent Heritability of Induced Histone Modifications in the Mouse Preimplantation Embryo	PLOS ONE			English	Article							CHROMATIN MODIFICATIONS; NUCLEAR REORGANIZATION; EPIGENETIC MEMORY; VALPROIC ACID; DEACETYLASE; CELL; ACETYLATION; PLURIPOTENCY; METHYLATION; INHIBITION	Enzyme-catalyzed, post-translational modifications of core histones have been implicated in the complex changes in gene expression that drive early mammalian development. However, until recently the small number of cells available from the preimplantation embryo itself has prevented quantitative analysis of histone modifications at key regulator genes. The possible involvement of histone modifications in the embryo's response to extracellular signals, or as determinants of cell fate or lineage progression, remains unclear. Here we describe the use of a recently-developed chromatin immunoprecipitation technique (CChIP) to assay histone modification levels at key regulator genes (Pou5f1, Nanog, Cdx2, Hoxb1, Hoxb9) as mouse embryos progress from 8-cell to blastocyst in culture. Only by the blastocyst stage, when the embryonic (Inner Cell Mass) and extra-embryonic (Trophoblast) lineages are compared, do we see the expected association between histone modifications previously linked to active and silent chromatin, and transcriptional state. To explore responses to an environmental signal, we exposed embryos to the histone deacetylase inhibitor, anti-epileptic and known teratogen valproic acid (VPA), during progression from 8-cell to morula stage. Such treatment increased H4 acetylation and H3 lysine 4 methylation at the promoters of Hoxb1 and Hoxb9, but not the promoters of Pou5f1, Nanog, Cdx2 or the housekeeping gene Gapdh. Despite the absence of detectable Hoxb transcription, these VPA-induced changes were heritable, following removal of the inhibitor, at least until the blastocyst stage. The selective hyperacetylation of Hoxb promoters in response to a histone deacetylase inhibitor, suggests that Hox genes have a higher turnover of histone acetates than other genes in the preimplantation embryo. To explain the heritability, through mitosis, of VPA-induced changes in histone modification at Hoxb promoters, we describe how an epigenetic feed-forward loop, based on cross-talk between H3 acetylation and H3K4 methylation, might generate a persistently increased steady-state level of histone acetylation in response to a transient signal.			VerMilyea, MD (corresponding author), RIKEN, Ctr Dev Biol, Lab Mammalian Mol Embryol, Kobe, Hyogo, Japan.	b.m.turner@bham.ac.uk			Biotechnology and Biological Sciences Research Council Funding Source: Medline; Cancer Research UK [C1015/A9077] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Faiella A, 2000, HUM MOL GENET, V9, P227, DOI 10.1093/hmg/9.2.227; Gerstner T, 2008, EXPERT OPIN PHARMACO, V9, P285, DOI 10.1517/14656566.9.2.285 ; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; MARMORSTEIN R, 2008, BIOCH BIOPH IN PRESS; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878; WORRAD DM, 1995, DEVELOPMENT, V121, P2949; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844	41	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6086	10.1371/journal.pone.0006086	http://dx.doi.org/10.1371/journal.pone.0006086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564914	Green Published, Green Submitted, gold			2022-12-25	WOS:000267515700005
J	Demongeot, J; Fouquet, Y; Tayyab, M; Vuillerme, N				Demongeot, Jacques; Fouquet, Yannick; Tayyab, Muhammad; Vuillerme, Nicolas			Understanding Physiological and Degenerative Natural Vision Mechanisms to Define Contrast and Contour Operators	PLOS ONE			English	Article							LATERAL INHIBITION; LIENARD SYSTEMS; CONE FUNCTION; TREE-REPRESENTATION; NEURAL-NETWORKS; VELOCITY-FIELD; EDGE-DETECTION; ROD; ENHANCEMENT; IMAGES	Background: Dynamical systems like neural networks based on lateral inhibition have a large field of applications in image processing, robotics and morphogenesis modeling. In this paper, we will propose some examples of dynamical flows used in image contrasting and contouring. Methodology: First we present the physiological basis of the retina function by showing the role of the lateral inhibition in the optical illusions and pathologic processes generation. Then, based on these biological considerations about the real vision mechanisms, we study an enhancement method for contrasting medical images, using either a discrete neural network approach, or its continuous version, i.e. a non-isotropic diffusion reaction partial differential system. Following this, we introduce other continuous operators based on similar biomimetic approaches: a chemotactic contrasting method, a viability contouring algorithm and an attentional focus operator. Then, we introduce the new notion of mixed potential Hamiltonian flows; we compare it with the watershed method and we use it for contouring. Conclusions: We conclude by showing the utility of these biomimetic methods with some examples of application in medical imaging and computed assisted surgery.			Demongeot, J (corresponding author), Univ Grenoble 1, TIMC IMAG, CNRS, UJF,UMR 5525, La Tronche, France.	Jacques.Demongeot@imag.fr	Nicolas, Vuillerme/C-6692-2009; Demongeot, Jacques/AAZ-2539-2020; Demongeot, Jacques/GQI-1558-2022; VUILLERME, Nicolas/U-5767-2019	Nicolas, Vuillerme/0000-0002-5202-4173; Demongeot, Jacques/0000-0002-8335-9240; VUILLERME, Nicolas/0000-0003-3773-393X				AIRES JOV, 2003, ICAR 03 COIMBRA, P638; Amor HB, 2008, LECT NOTES ARTIF INT, V5317, P973, DOI 10.1007/978-3-540-88636-5_92; Arkachar P, 2007, NEUROCOMPUTING, V70, P991, DOI 10.1016/j.neucom.2006.03.017; ATTWELL D, 1983, J PHYSIOL-LONDON, V336, P313, DOI 10.1113/jphysiol.1983.sp014583; BAINVILLE E, 1995, 3D RECONSTRUCTION US; Benabid A L, 1992, Acta Neurochir Suppl (Wien), V54, P93; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P153; BENABID AL, 1991, ADV TECHNICAL STANDA, P4; Benabid AL, 1992, COMPUTERS STEREOTACT, P230; BENABID AL, 1992, IEEE NEUROSCIENCES T, P157; BENABID AL, 1992, COMPUTERS STEREOTACT, P330; BERTHOMMIER F, 1989, IEE CONF PUBL, P287; BERTHOMMIER F, 1991, NATO ADV SCI I B-PHY, V260, P219; BERTHOMMIER F, 1993, P PARCO 93 PAR COMP, P477; Bertrand G, 1997, J ELECTRON IMAGING, V6, P395, DOI 10.1117/12.276856; BERTRAND G, 1997, SPIE, V3168, P136; Bertrand G, 2007, IMAGE VISION COMPUT, V25, P447, DOI 10.1016/j.imavis.2006.04.017; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; BILOTTA J, 1991, VISION RES, V31, P577, DOI 10.1016/0042-6989(91)90108-H; BLANKENSHIP T, 1987, ACOUST IMAGING, P187; Bosch H., 1998, ICANN 98. Proceedings of the 8th International Conference on Artificial Neural Networks, P1021; Brunie L, 1995, Technol Health Care, V3, P91; BURR DC, 1990, VISION CODING EFFICI, P185; BURR EG, 1947, ROYAL SOC CANADA, V41, P45; Bzostek A, 1998, LECT NOTES COMPUT SC, V1496, P1041, DOI 10.1007/BFb0056293; CATTE F, 1992, SIAM J NUMER ANAL, V29, P182, DOI 10.1137/0729012; CHEN Y, 1995, COMPUT VIS IMAGE UND, V61, P325, DOI 10.1006/cviu.1995.1026; CHOU WS, 1993, PATTERN RECOGN, V26, P351, DOI 10.1016/0031-3203(93)90043-V; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; CINQUIN P, 1989, IARP 89 MED HEALTHCA, P63; CINQUIN P, 1992, INNOV TECH BIOL MED, V13, P373; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; COSNARD M, 1985, CR ACAD SCI I-MATH, V300, P551; COTTET GH, 1993, MATH COMPUT, V61, P659, DOI 10.1090/S0025-5718-1993-1195422-2; COTTET GH, 1991, CR ACAD SCI I-MATH, V312, P217; COTTET GH, 1995, IMAGE SEGMENTATION U; Demongeot J, 1996, CR ACAD SCI II B, V323, P747; Demongeot J, 2003, CR BIOL, V326, P487, DOI 10.1016/S1631-0691(03)00114-8; Demongeot J, 2003, P IEEE, V91, P1723, DOI 10.1109/JPROC.2003.817878; Demongeot J, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P50, DOI 10.1109/ISBI.2002.1029190; Demongeot J, 2002, CR BIOL, V325, P367, DOI 10.1016/S1631-0691(02)01459-2; DEMONGEOT J, 1989, CR ACAD SCI I-MATH, V309, P699; DEMONGEOT J, 2005, SURGETICA 04, P301; DEMONGEOT J, 2000, 16 IM WORLD C 2000 E, P127; DEMONGEOT J, 1995, CHIRURGIE, V120, P300; DEMONGEOT J, 1995, ICANN 95, P41; DEMONGEOT J, 2004, WSEAS T BIOL INF SC, V1, P618; DEMONGEOT J, 2007, IEEE EMBC 07, P3474; Demongeot J, 2007, CR MATH, V344, P121, DOI 10.1016/j.crma.2006.10.016; Demongeot J, 2007, CR MATH, V344, P191, DOI 10.1016/j.crma.2006.10.013; DERICHE R, 1990, IEEE T PATTERN ANAL, V12, P78, DOI 10.1109/34.41386; Dickinson SJ, 1997, COMPUT VIS IMAGE UND, V67, P239, DOI 10.1006/cviu.1997.0532; Doyen L., 1995, Journal of Mathematical Imaging and Vision, V5, P99, DOI 10.1007/BF01250522; ELENA A, 2008, IEEE BIBE 08, P234; EMMECHE C, 1991, SEMIOTICA, V84, P1, DOI 10.1515/semi.1991.84.1-2.1; EYSEL UT, 1987, EXP BRAIN RES, V68, P606; Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; FANG N, 1993, PATTERN RECOGN LETT, V14, P397, DOI 10.1016/0167-8655(93)90118-W; FAUGERAS O, 1999, LECT NOTES COMPUTER, V1406, P379; Fay D. A., 1991, IJCNN-91-Seattle: International Joint Conference on Neural Networks (Cat. No.91CH3049-4), P621, DOI 10.1109/IJCNN.1991.155250; Forest L, 2006, B MATH BIOL, V68, P753, DOI 10.1007/s11538-005-9004-5; Forest L, 2006, J THEOR BIOL, V241, P241, DOI 10.1016/j.jtbi.2005.11.029; Forest L, 2008, ACTA BIOTHEOR, V56, P51, DOI 10.1007/s10441-008-9030-4; FORTIN T, 1997, DENTOMAXILLOFAC RAD, V26, P284; Fourier J., 1808, NOUVEAU B SCI SOC PH, VI, P112; FRANCOIS O, 1992, NEURAL NETWORKS, V5, P277, DOI 10.1016/S0893-6080(05)80025-5; Girman S, 2005, VISION RES, V45, P343, DOI 10.1016/j.visres.2004.08.023; Glade N, 2007, CR MATH, V344, P253, DOI 10.1016/j.crma.2006.11.014; GOLDBERG SH, 1983, SCIENCE, V221, P180, DOI 10.1126/science.6857279; HAMMOND P, 1971, J PHYSIOL-LONDON, V213, P475, DOI 10.1113/jphysiol.1971.sp009394; HERVE T, 1990, P NATL ACAD SCI USA, V87, P806, DOI 10.1073/pnas.87.2.806; HERVE T, 1988, NEURAL NETWORKS, V1, P297; Ionescu G, 1999, LECT NOTES COMPUT SC, V1679, P768; Jiang TT, 2006, LECT NOTES COMPUT SC, V3953, P633, DOI 10.1007/11744078_49; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; KERGOSIEN YL, 1985, 4 SEM EC BIOL THEOR, P11; KHELLAF A, 1991, IEEE T MED IMAGING, V10, P589, DOI 10.1109/42.108593; KICHENASSAMY S, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P810, DOI 10.1109/ICCV.1995.466855; KOBAYASHI H, 1993, NEURAL NETWORKS, V6, P327, DOI 10.1016/0893-6080(93)90002-E; KOBAYASHI H, 1991, IEEE IJCNN, P1007, DOI 10.1109/IJCNN.1991.170530; Kobayashi N., 1994, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ77D-II, P502; KOBAYASHI Y, 1999, MULTIMEDIA COMPUTING, P578; KOENDERINK JJ, 1979, BIOL CYBERN, V32, P211, DOI 10.1007/BF00337644; KWON TM, 1992, C SYST MAN CYB, P416; Lavallee S., 1989, MEDINFO 89. Proceedings of the Sixth Conference on Medical Informatics, P613; LAVALLEE S, 1989, COMPUTER ASSISTED RA, P416; Leitner F, 1995, ACTA BIOTHEOR, V43, P299, DOI 10.1007/BF00713555; LEITNER F, 1990, CURVES SURFACES, P279; LEITNER F, 1991, PIXELS FEATURES, V2, P253; LENEGRATE A, 1992, CVGIP-GRAPH MODEL IM, V54, P13, DOI 10.1016/1049-9652(92)90030-2; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Li ZP, 2000, SPATIAL VISION, V13, P25, DOI 10.1163/156856800741009; Lorenz T., 2001, Computing and Visualization in Science, V4, P41, DOI 10.1007/s007910100056; LU JA, 1994, OPT ENG, V33, P2151, DOI 10.1117/12.172254; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; MAILLOUX GE, 1989, IEEE T MED IMAGING, V8, P143, DOI 10.1109/42.24862; MARTIN JP, 1988, DIAGN IMAG MAG, V1, P194; Mattes J, 2001, PROC SPIE, V4322, P602, DOI 10.1117/12.431134; Mattes J., 1998, Parallel Processing Letters, V8, P63, DOI 10.1142/S0129626498000092; Mattes J, 2000, LECT NOTES COMPUT SC, V1953, P392; Mattes J, 1999, LECT NOTES COMPUT SC, V1568, P298; Mattes J, 1999, LECT NOTES COMPUT SC, V1679, P646; Mattes J, 1999, ST CLASS DAT ANAL, P205; Mattes J, 1995, LECT NOTES COMPUT SC, V919, P275, DOI 10.1007/BFb0046640; MATTES J, 2000, ICARCV 2000, P3; MEIGNEN S, 1998, APPL CONTRASTAGE DIM; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; MEUNIER J, 1988, SPIE MED IMAG, V914, P20; MEYER F, 1992, 8 C REC FORM INT ART, P847; Michon F, 2008, DEVELOPMENT, V135, P2797, DOI 10.1242/dev.018341; Moini A., 2000, VISION CHIPS; MONTANVERT A, 1991, IEEE T PATTERN ANAL, V13, P307, DOI 10.1109/34.88566; Mumford D., 1985, Proceedings CVPR '85: IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No. 85CH2145-1), P22; NABET B, 1992, NEURAL NETWORKS, V5, P891, DOI 10.1016/S0893-6080(05)80085-1; NAKAHIRA H, 1993, J VLSI SIGNAL PROC, V5, P133, DOI 10.1007/BF01581290; NEYCENSSAC F, 1993, CVGIP-GRAPH MODEL IM, V55, P447, DOI 10.1006/cgip.1993.1034; OSHER S, 2006, J COMPUT PHYS, V169, P463; Ouchchane L, 2007, LECT NOTES COMPUT SC, V4370, P137; OUTRATA JV, 1990, MATH OPER RES, V15, P626, DOI 10.1287/moor.15.4.626; PATTEE HH, 1977, INT J GEN SYST, V3, P259, DOI 10.1080/03081077708934771; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; RADCLIFFE T, 1994, MED PHYS, V21, P761, DOI 10.1118/1.597336; RICHARD M, 2000, SPIE, V3831, P125; Rizzi A, 2003, PATTERN RECOGN LETT, V24, P1663, DOI 10.1016/S0167-8655(02)00323-9; Robineau F, 2007, IEEE T BIO-MED ENG, V54, P711, DOI 10.1109/TBME.2006.889180; Sethian J A, 1999, LEVEL SET METHODS FA; SHI BE, 1993, IEEE T CIRCUITS-II, V40, P320, DOI 10.1109/82.227372; SOLOMON JA, 1993, VISION RES, V33, P2671, DOI 10.1016/0042-6989(93)90227-N; TAYYAB M, 2008, THESIS U J FOURIER G; Thom R., 1983, PARABOLES CATASTROPH; TOBORG ST, 1991, IEEE T COMPUT, V40, P1368, DOI 10.1109/12.106222; TOET A, 1992, OPT ENG, V31, P1026, DOI 10.1117/12.56155; Tonnelier A, 1999, NEURAL NETWORKS, V12, P1213, DOI 10.1016/S0893-6080(99)00068-4; Tschumperle D, 2002, IEEE SIGNAL PROC MAG, V19, P16, DOI 10.1109/MSP.2002.1028349; TSCHUMPERLE D, 2000, 12 C RFIA 00 PAR FEB, V2, P247; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; VINOD VV, 1994, IEEE T SYST MAN CYB, V24, P365, DOI 10.1109/21.278988; VONBEKESY G, 1967, J GEN PHYSIOL, V50, P519, DOI 10.1085/jgp.50.3.519; WAXMAN AM, 1988, SPIE, V1001, P1093; Weickert J, 1999, INT J COMPUT VISION, V31, P111, DOI 10.1023/A:1008009714131; Williams GA, 2005, VISUAL NEUROSCI, V22, P807, DOI 10.1017/S095252380522610X; SIGNAL PROCESSING IN; [No title captured]	147	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6010	10.1371/journal.pone.0006010	http://dx.doi.org/10.1371/journal.pone.0006010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547712	Green Submitted, gold, Green Published			2022-12-25	WOS:000267347900009
J	Baudot, AD; Jeandel, PY; Mouska, X; Maurer, U; Tartare-Deckert, S; Raynaud, SD; Cassuto, JP; Ticchioni, M; Deckert, M				Baudot, A. D.; Jeandel, P. Y.; Mouska, X.; Maurer, U.; Tartare-Deckert, S.; Raynaud, S. D.; Cassuto, J. P.; Ticchioni, M.; Deckert, M.			The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKC delta and proteasome-dependent regulation of Mcl-1 expression	ONCOGENE			English	Article						B-CLL; Syk; survival; PKCdelta; Mcl-1; proteasome	ACUTE LYMPHOBLASTIC-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; RECEPTOR-TYPE-O; ANTIGEN-RECEPTOR; IN-VITRO; C-DELTA; APOPTOSIS; ACTIVATION; PHOSPHORYLATION; PATHWAY	B-cell chronic lymphocytic leukemia (B-CLL) is characterized by accumulation of mature monoclonal CD5+ B cells. The disease results mainly from a failure of cells to undergo apoptosis, a process largely influenced by the existence of constitutively activated components of B-cell receptor signaling and the deregulated expression of antiapoptotic molecules. Recent evidence pointing to a critical role of spleen tyrosine kinase (Syk) in ligand-independent BCR signaling prompted us to examine its role in primary B-CLL cell survival. We demonstrate that pharmacological inhibition of constitutive Syk activity and silencing by siRNA led to a dramatic decrease of cell viability in CLL samples (n = 44), regardless of clinical and biological status and induced typical apoptotic cell death with mitochondrial failure followed by caspase 3-dependent cell death. We also provide functional and biochemical evidence that Syk regulated B-CLL cell survival through a novel pathway involving PKC delta and a proteasome-dependent regulation of the anti-apoptotic protein Mcl-1. Together, our observations are consistent with a model wherein PKC delta downstream of Syk stabilizes Mcl-1 through inhibitory phosphorylation of GSK3 by Akt. We conclude that Syk constitutes a key regulator of B-CLL cell survival, emphasizing the clinical utility of Syk inhibition in hematopoietic malignancies. Oncogene (2009) 28, 3261-3273; doi:10.1038/onc.2009.179; published online 6 July 2009	[Baudot, A. D.; Mouska, X.; Ticchioni, M.; Deckert, M.] Hop Archet, INSERM, UMR576, F-06202 Nice 3, France; [Baudot, A. D.; Jeandel, P. Y.; Tartare-Deckert, S.; Deckert, M.] Univ Nice Sophia Antipolis, Nice, France; [Jeandel, P. Y.] CHU Nice, Dept Internal Med, Nice, France; [Maurer, U.] Univ Freiburg, Inst Mol Med & Cell Res, D-7800 Freiburg, Germany; [Tartare-Deckert, S.] INSERM, UMR895, Nice, France; [Raynaud, S. D.] CHU Nice, Genet Lab, Nice, France; [Cassuto, J. P.] CHU Nice, Dept Clin Hematol, Nice, France; [Ticchioni, M.] CHU Nice, Immunol Lab, Nice, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice	Deckert, M (corresponding author), Hop Archet, INSERM, UMR576, 1 Route St Antoine Ginestiere, F-06202 Nice 3, France.	deckert@unice.fr	TARTARE-DECKERT, Sophie/P-6057-2015; Deckert, Marcel/T-3566-2019; Ticchioni, Michel/P-8095-2016; Deckert, Marcel/M-4998-2016; Jeandel, Pierre-Yves/ABD-6658-2020	TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Deckert, Marcel/0000-0003-2094-559X; Mouska, Xavier/0000-0002-4263-543X	INSERM; ARC [3111]; INCa [PL-06-026]; TxCell (Valbonne, France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); TxCell (Valbonne, France)	This work was supported by INSERM, ARC (Grant No 3111), and INCa (Grant PL-06-026). ADB is a recipient of an INSERM-Region Provence Alpes Cote d'Azur PhD fellowship in partnership with TxCell (Valbonne, France). M Deckert is a recipient of a Contrat d'Interface Clinique with the Department of Clinical Hematology, CHU de Nice. We thank P Gounon (CCMA, Faculte des Sciences, Nice) for electron microscopy analysis, and M. Ciosi (INRA-CNRS, SophiaAntipolis) for statistical analysis.	Barragan M, 2002, BLOOD, V99, P2969, DOI 10.1182/blood.V99.8.2969; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; Chen LG, 2005, BLOOD, V105, P2036, DOI 10.1182/blood-2004-05-1715; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Crespo M, 2006, CLIN CANCER RES, V12, P726, DOI 10.1158/1078-0432.CCR-05-1531; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; Deglesne PA, 2006, CANCER RES, V66, P7158, DOI 10.1158/0008-5472.CAN-06-0085; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Feldman AL, 2008, LEUKEMIA, V22, P1139, DOI 10.1038/leu.2008.77; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Goodman PA, 2001, ONCOGENE, V20, P3969, DOI 10.1038/sj.onc.1204515; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Holler C, 2009, BLOOD, V113, P2791, DOI 10.1182/blood-2008-06-160713; Kipps TJ, 2003, CURR OPIN HEMATOL, V10, P312, DOI 10.1097/00062752-200307000-00010; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Lanham S, 2003, BLOOD, V101, P1087, DOI 10.1182/blood-2002-06-1822; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Leseux L, 2006, BLOOD, V108, P4156, DOI 10.1182/blood-2006-05-026203; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Moshynska O, 2004, JNCI-J NATL CANCER I, V96, P673, DOI 10.1093/jnci/djh122; Motiwala T, 2007, CLIN CANCER RES, V13, P3174, DOI 10.1158/1078-0432.CCR-06-1720; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; Petlickovski A, 2005, BLOOD, V105, P4820, DOI 10.1182/blood-2004-07-2669; Plate JMD, 2004, LEUKEMIA LYMPHOMA, V45, P1519, DOI 10.1080/10428190410001683642; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539; Saxena A, 2004, AM J HEMATOL, V75, P22, DOI 10.1002/ajh.10453; Semichon M, 1997, LEUKEMIA, V11, P1921, DOI 10.1038/sj.leu.2400832; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Ticchioni M, 2007, ONCOGENE, V26, P7081, DOI 10.1038/sj.onc.1210519; TOKER A, 1994, J BIOL CHEM, V269, P32358; Veldurthy A, 2008, BLOOD, V112, P1443, DOI 10.1182/blood-2007-11-123984; Wong BR, 2004, EXPERT OPIN INV DRUG, V13, P743, DOI 10.1517/13543784.13.7.743; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316	48	85	88	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3261	3273		10.1038/onc.2009.179	http://dx.doi.org/10.1038/onc.2009.179			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19581935				2022-12-25	WOS:000269893700001
J	Caceres, PS; Ares, GR; Ortiz, PA				Caceres, Paulo S.; Ares, Gustavo R.; Ortiz, Pablo A.			cAMP Stimulates Apical Exocytosis of the Renal Na+-K+-2Cl(-) Cotransporter NKCC2 in the Thick Ascending Limb ROLE OF PROTEIN KINASE A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY COLLECTING DUCT; RAT-KIDNEY; CA2+ MOBILIZATION; ADENYLYL-CYCLASE; CYCLIC-AMP; PHOSPHORYLATION; PKA; ACTIVATION; VASOPRESSIN; MECHANISM	The apical renal Na+-K+-2Cl(-) cotransporter NKCC2 mediates NaCl absorption by the thick ascending limb (TAL) of Henle's loop. cAMP stimulates NKCC2 by enhancing steady-state apical membrane levels of this protein; however, the trafficking and signaling mechanisms by which this occurs have not been studied. Here, we report that stimulation of endogenous cAMP levels with either forskolin/3-isobutyl-1-methylxanthine (IBMX) or the V2 receptor agonist [deamino-Cys(1),D-Arg(8)] vasopressin increases steady-state surface NKCC2 and that the protein kinase A (PKA) inhibitor H-89 blocks this effect. Confocal imaging of apical surface NKCC2 in isolated perfused TALs confirmed a stimulatory effect of cAMP on apical trafficking that was blocked by PKA inhibition. Selective stimulation of PKA with the agonist N-6-benzoyl-cAMP (500 mu M) stimulated steady-state surface NKCC2, whereas the Epac-selective agonist 8-p-chlorophenylthio-2'-O-methyl-cAMP (100 and 250 mu M) had no effect. To explore the trafficking mechanism by which cAMP increases apical NKCC2, we measured cumulative apical membrane exocytosis and NKCC2 exocytic insertion in TALs. By monitoring apical FM1-43 fluorescence, we observed rapid stimulation of apical exocytosis (2 min) by forskolin/IBMX. We also found constitutive exocytic insertion of NKCC2 in TALs over time, which was increased by 3-fold in the presence of forskolin/IBMX. PKA inhibition blunted cAMP-stimulated exocytic insertion but did not affect the rate of constitutive exocytosis. We conclude that cAMP stimulates steady-state apical surface NKCC2 by stimulating exocytic insertion and that this process is highly dependent on PKA but not Epac.	[Caceres, Paulo S.; Ares, Gustavo R.; Ortiz, Pablo A.] Henry Ford Hosp, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Caceres, Paulo S.; Ortiz, Pablo A.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ortiz, PA (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, E&R Bldg,Rm 7041,2799 W Grand Blvd, Detroit, MI 48202 USA.	portiz1@hfhs.org		Ortiz, Pablo/0000-0002-7512-7255; Caceres, Paulo/0000-0003-0197-8177	National Institutes of Health [R01 HL080409-05, P01 HL090550-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409, P01HL090550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL080409-05 and P01 HL090550-01 (Subproject 2; to P. A. O.).	Ameen NA, 2003, AM J PHYSIOL-CELL PH, V284, pC429, DOI 10.1152/ajpcell.00261.2002; Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Clayton A, 2005, J BIOL CHEM, V280, P23451, DOI 10.1074/jbc.M502242200; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Dilly KW, 2004, J BIOL CHEM, V279, P40778, DOI 10.1074/jbc.M406010200; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GAPSTUR SM, 1988, AM J PHYSIOL, V255, pF292, DOI 10.1152/ajprenal.1988.255.2.F292; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Katsura T, 1997, Am J Physiol, V272, pF817; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li Y, 2008, AM J PHYSIOL-RENAL, V295, pF525, DOI 10.1152/ajprenal.00448.2007; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; MOLONY DA, 1987, AM J PHYSIOL, V252, pF177, DOI 10.1152/ajprenal.1987.252.1.F177; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Peng Y, 2001, AM J PHYSIOL-RENAL, V280, pF34, DOI 10.1152/ajprenal.2001.280.1.F34; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606	38	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24965	24971		10.1074/jbc.M109.037135	http://dx.doi.org/10.1074/jbc.M109.037135			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592485	Green Published, hybrid			2022-12-25	WOS:000269734000031
J	Howell, JJ; Stoffel, M				Howell, Jessica J.; Stoffel, Markus			Nuclear Export-independent Inhibition of Foxa2 by Insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE B; CAENORHABDITIS-ELEGANS; MEDIATED PHOSPHORYLATION; GLUCOSE-HOMEOSTASIS; FACTOR FKHR; C-ELEGANS; BINDING; MOUSE; SIGNALS	The Forkhead box A2 transcription factor (Foxa2/HNF-3 beta) has been shown to be a key regulator of genes involved in the maintenance of glucose and lipid homeostasis in the liver. It is constitutively inactivated in several hyperinsulinemic/obese mouse models, thereby enhancing their metabolic phenotypes. Foxa2 is activated under fasting conditions but is inhibited by insulin signaling via phosphatidylinositol 3-kinase/AKT in a phosphorylation-dependent manner, which results in its nuclear exclusion. However, the mechanism and relative importance of its nuclear export has not yet been elucidated. Here we show that Foxa2 contains a functional nuclear export signal and is excluded from the nucleus via a CRM1-dependent pathway in response to insulin signaling. Furthermore, direct evidence is provided that nuclear export-defective Foxa2 is phosphorylated and inactivated by insulin in vitro and in vivo. These data demonstrate for the first time that phosphorylation itself is the main event regulating the activity of Foxa2, suggesting that export-independent mechanisms have evolved to ensure inhibition of Foxa2 under conditions in which insulin signaling is present.	[Stoffel, Markus] ETH, Inst Mol Syst Biol, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; Rockefeller Univ, New York, NY 10021 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Rockefeller University	Stoffel, M (corresponding author), ETH, Inst Mol Syst Biol, Swiss Fed Inst Technol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	stoffel@imsb.biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817; Howell, Jessica/0000-0002-9736-5211	SystemsX.ch (Swiss Initiative in Systems Biology)	SystemsX.ch (Swiss Initiative in Systems Biology)	This work was supported in part by a LiverX Grant from SystemsX.ch (Swiss Initiative in Systems Biology).	ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CALNAN DR, ONCOGENE, V27, P2276; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GOTTLIEB S, 1994, GENETICS, V137, P107; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tsai WC, 2003, ENDOCRINOLOGY, V144, P5615, DOI 10.1210/en.2003-0481; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wolfrum C, 2008, J BIOL CHEM, V283, P16940, DOI 10.1074/jbc.M801930200; Yanai H, 2006, J VIROL, V80, P1121, DOI 10.1128/JVI.80.3.1121-1129.2006; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	40	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24816	24824		10.1074/jbc.M109.042135	http://dx.doi.org/10.1074/jbc.M109.042135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589781	Green Published, hybrid			2022-12-25	WOS:000269734000016
J	Cohen, L; Moran, Y; Sharon, A; Segal, D; Gordon, D; Gurevitz, M				Cohen, Lior; Moran, Yehu; Sharon, Amir; Segal, Daniel; Gordon, Dalia; Gurevitz, Michael			Drosomycin, an Innate Immunity Peptide of Drosophila melanogaster, Interacts with the Fly Voltage-gated Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPION BETA-TOXINS; NA+ CHANNELS; ANTIMICROBIAL PEPTIDE; ANTIFUNGAL PEPTIDES; FUNCTIONAL SURFACE; INSECT; SELECTIVITY; DIVERGENCE; EXPRESSION; EVOLUTION	Several peptide families, including insect antimicrobial peptides, plant protease inhibitors, and ion channel gating modifiers, as well as blockers from scorpions, bear a common CS alpha beta scaffold. The high structural similarity between two peptides containing this scaffold, drosomycin and a truncated scorpion beta-toxin, has prompted us to examine and compare their biological effects. Drosomycin is the most expressed antimicrobial peptide in Drosophila melanogaster immune response. A truncated scorpion beta-toxin is capable of binding and inducing conformational alteration of voltage-gated sodium channels. Here, we show that both peptides (i) exhibit anti-fungal activity at micromolar concentrations; (ii) enhance allosterically at nano-molar concentration the activity of Lqh alpha IT, a scorpion alpha toxin that modulates the inactivation of the D. melanogaster voltage-gated sodium channel (DmNa(v)1); and ( iii) inhibit the facilitating effect of the polyether brevetoxin-2 on DmNa(v)1 activation. Thus, the short CS alpha beta scaffold of drosomycin and the truncated scorpion toxin can maintain more than one bioactivity, and, in light of this new observation, we suggest that the biological role of peptides bearing this scaffold should be carefully examined. As for drosomycin, we discuss the intriguing possibility that it has additional functions in the fly, as implied by its tight interaction with DmNa(v)1.	[Cohen, Lior; Moran, Yehu; Sharon, Amir; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, Dept Plant Sci, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Segal, Daniel] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Cohen, L (corresponding author), Tel Aviv Univ, Dept Plant Sci, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	lcohen76@cc.huji.ac.il; mamgur@post.tau.ac.il		Moran, Yehu/0000-0001-9928-9294; Segal, Daniel/0000-0002-6777-505X	United States-Israel Binational Agricultural Research and Development [IS-3928-06, IS-4066-07]; Israeli Science Foundation [1008/05, 107/08]	United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the United States-Israel Binational Agricultural Research and Development Grants IS-3928-06 ( to M. G. and D. G.) and IS-4066-07 ( to D. G. and M. G.) and by Israeli Science Foundation Grants 1008/05 ( to D. G. and M. G.) and 107/08 ( to M. G. and D. G.).	Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2004, J BIOL CHEM, V279, P8206, DOI 10.1074/jbc.M307531200; Cohen L, 2008, J BIOL CHEM, V283, P15169, DOI 10.1074/jbc.M801229200; Cohen L, 2006, FASEB J, V20, P1933, DOI 10.1096/fj.05-5545fje; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Froy O, 1998, FASEB J, V12, P1793, DOI 10.1096/fasebj.12.15.1793; GORDON D, 1993, FEBS LETT, V315, P125, DOI 10.1016/0014-5793(93)81147-R; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Lazzaro BP, 2005, GENETICS, V169, P2023, DOI 10.1534/genetics.104.034249; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Moran Y, 2007, BIOCHEM J, V406, P41, DOI 10.1042/BJ20070233; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; POLI MA, 1986, MOL PHARMACOL, V30, P129; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; Takagi Y, 1998, NEUROSCI LETT, V244, P149, DOI 10.1016/S0304-3940(98)00145-1; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Yang WY, 2006, GENE, V379, P26, DOI 10.1016/j.gene.2006.03.017; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6; Zilberberg N, 1996, BIOCHEMISTRY-US, V35, P10215, DOI 10.1021/bi9528309	27	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23558	23563		10.1074/jbc.M109.023358	http://dx.doi.org/10.1074/jbc.M109.023358			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574227	Green Published, hybrid			2022-12-25	WOS:000269180000041
J	Jin, Y; An, XJ; Ye, ZL; Cully, B; Wu, JP; Li, J				Jin, Yi; An, Xiaojin; Ye, Zelian; Cully, Brittany; Wu, Jiaping; Li, Jian			RGS5, a Hypoxia-inducible Apoptotic Stimulator in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; GENE-EXPRESSION; ANGIOTENSIN-II; PROLIFERATION; REGULATOR; FAMILY; VEGF; DIFFERENTIATION; INDUCTION	Endothelial cells rapidly respond to changes in oxygen homeostasis by regulating gene expression. Regulator of G protein signaling 5 (RGS5) is a negative regulator of G protein-mediated signaling that is strongly expressed in vessels during angiogenesis; however, the role of RGS5 in hypoxia has not been fully understood. Under hypoxic conditions, we found that the expression of RGS5, but not other RGS, was induced in human umbilical vein endothelial cells (HUVEC). RGS5 mRNA was increased when HUVEC were incubated with chemicals that stabilized hypoxia-inducible factor-1 alpha (HIF-1 alpha), whereas hypoxia-stimulated RGS5 promoter activity was absent in HIF-1 beta(-/-) cells. Vascular endothelial growth factor (VEGF), which is regulated by HIF-1, did not appear to be involved in hypoxia-induced RGS5 expression; however, VEGF-mediated activation of p38 but not ERK1/2 was increased by RGS5. Overexpression of RGS5 in HUVEC exhibited a reduced growth rate without affecting the cell proliferation. Annexin V assay revealed that RGS5 induced apoptosis with significantly increased activation of caspase-3 and the Bax/Bcl-2 ratio. Small interfering RNA-specific for RGS5, caspase-3 inhibitor, and p38 inhibitor resulted in an attenuation of RGS5-stimulated apoptosis. Matrigel assay proved that RGS5 significantly impaired the angiogenic effect of VEGF and stimulated apoptosis in vivo. We concluded that RGS5 is a novel HIF-1-dependent, hypoxia-induced gene that is involved in the induction of endothelial apoptosis. Moreover, RGS5 antagonizes the angiogenic effect of VEGF by increasing the activation of p38 signaling, suggesting that RGS5 could be an important target for apoptotic therapy.	[Li, Jian] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Ctr Life Sci, Boston, MA 02215 USA; [Jin, Yi; An, Xiaojin; Ye, Zelian; Li, Jian] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Peking University	Li, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Ctr Life Sci, CLS 909,3 Blackfan Circle, Boston, MA 02215 USA.	jli@bidmc.harvard.edu		Jin, Yi/0000-0001-9704-973X	National Institutes of Health [HLR01082837]; American Heart Association [0265494T]; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HLR01082837 (to J.L.). This work was also supported by American Heart Association Grant-in-aid 0265494T (to J.L.) and the China Scholarship Council (to J.Y. and X. A.).	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bell SE, 2001, J CELL SCI, V114, P2755; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Brunelle JK, 2002, APOPTOSIS, V7, P475, DOI 10.1023/A:1020668923852; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Grant SL, 2000, MOL PHARMACOL, V57, P460, DOI 10.1124/mol.57.3.460; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kirsch T, 2001, BRAIN RES, V910, P106, DOI 10.1016/S0006-8993(01)02670-1; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Mandriota SJ, 2000, AM J PATHOL, V156, P2077, DOI 10.1016/S0002-9440(10)65079-1; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sodhi A, 2000, CANCER RES, V60, P4873; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Stempien-Otero A, 1999, J BIOL CHEM, V274, P8039, DOI 10.1074/jbc.274.12.8039; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zeng HY, 2002, J BIOL CHEM, V277, P4003, DOI 10.1074/jbc.M110842200	43	45	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23436	23443		10.1074/jbc.M109.032664	http://dx.doi.org/10.1074/jbc.M109.032664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564336	Green Published, hybrid			2022-12-25	WOS:000269180000028
J	Tse, KWK; Dang-Lawson, M; Lee, RL; Vong, D; Bulic, A; Buckbinder, L; Gold, MR				Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Buckbinder, Leonard; Gold, Michael R.			B Cell Receptor-induced Phosphorylation of Pyk2 and Focal Adhesion Kinase Involves Integrins and the Rap GTPases and Is Required for B Cell Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES RAP1-INDUCED ADHESION; RICH TYROSINE KINASE-2; CYTOSKELETAL REARRANGEMENT; ACTIN POLYMERIZATION; INDUCED ACTIVATION; SYNAPSE FORMATION; SIGNALING EVENTS; MIGRATION; PROTEIN; LYMPHOCYTES	Signaling by the B cell receptor (BCR) promotes integrin-mediated adhesion and cytoskeletal reorganization. This results in B cell spreading, which enhances the ability of B cells to bind antigens and become activated. Proline-rich tyrosine kinase (Pyk2) and focal adhesion kinase (FAK) are related cytoplasmic tyrosine kinases that regulate cell adhesion, cell morphology, and cell migration. In this report we show that BCR signaling and integrin signaling collaborate to induce the phosphorylation of Pyk2 and FAK on key tyrosine residues, a modification that increases the kinase activity of Pyk2 and FAK. Activation of the Rap GTPases is critical for BCR-induced integrin activation as well as for BCR- and integrin-induced reorganization of the actin cytoskeleton. We now show that Rap activation is essential for BCR- induced phosphorylation of Pyk2 and for integrin-induced phosphorylation of Pyk2 and FAK. Moreover Rap-dependent phosphorylation of Pyk2 and FAK required an intact actin cytoskeleton as well as actin dynamics, suggesting that Rap regulates Pyk2 and FAK via its effects on the actin cytoskeleton. Importantly B cell spreading induced by BCR/integrin co-stimulation or by integrin engagement was inhibited by short hairpin RNA-mediated knockdown of either Pyk2 or FAK expression and by treatment with PF-431396, a chemical inhibitor that blocks the kinase activities of both Pyk2 and FAK. Thus Pyk2 and FAK are downstream targets of the Rap GTPases that play a key role in regulating B cell morphology.	[Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Gold, Michael R.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Gold, Michael R.] Univ British Columbia, Inst Life Sci, I3 Res Grp, Vancouver, BC V6T 1Z3, Canada; [Buckbinder, Leonard] Pfizer Global Res & Dev, Groton, CT 06340 USA; [Tse, Kathy W. K.; Dang-Lawson, May; Lee, Rosaline L.; Vong, Doris; Bulic, Anica; Gold, Michael R.] Univ British Columbia, Inst Life Sci, CELL Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; Pfizer; University of British Columbia	Gold, MR (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mgold@interchange.ubc.ca	Gold, Michael/AAF-2081-2021	Gold, Michael/0000-0003-1222-3191	Canadian Institutes of Health Research Operating [68865]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Operating Grant 68865 (to M. R. G.) and by graduate student fellowships (to K. W. K. T.) from the Michael Smith Foundation for Health Research and the Natural Sciences and Engineering Research Council of Canada.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ambrose HE, 2004, IMMUNOLOGY, V111, P400, DOI 10.1111/j.1365-2567.2004.01824.x; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Astier A, 1997, J BIOL CHEM, V272, P228; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davey EJ, 1998, J IMMUNOL, V160, P5366; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Elenstrom C, 1989, GROWTH FACTORS, V2, P73, DOI 10.3109/08977198909069083; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; FREEDMAN AS, 1993, J IMMUNOL, V150, P1645; FREUNDLICH B, 1983, J IMMUNOL METHODS, V62, P31, DOI 10.1016/0022-1759(83)90107-2; Giannoni E, 2003, J BIOL CHEM, V278, P36763, DOI 10.1074/jbc.M302686200; Gismondi A, 2003, J IMMUNOL, V170, P3065, DOI 10.4049/jimmunol.170.6.3065; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Manie SN, 1996, BLOOD, V87, P1855; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Mlinaric-Rascan I, 2001, FEBS LETT, V498, P26, DOI 10.1016/S0014-5793(01)02474-7; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Robertson LK, 2005, J IMMUNOL, V175, P8138, DOI 10.4049/jimmunol.175.12.8138; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Ruusala A, 2008, MOL CELL BIOL, V28, P1802, DOI 10.1128/MCB.00201-07; SantosArgumedo L, 1997, IMMUNOLOGY, V90, P147, DOI 10.1046/j.1365-2567.1997.00126.x; Sarkar S, 2002, LEUKEMIA LYMPHOMA, V43, P1663, DOI 10.1080/1042819021000003009; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Westerberg L, 2001, BLOOD, V98, P1086, DOI 10.1182/blood.V98.4.1086; Xiong WC, 1998, J CELL SCI, V111, P1981; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049	68	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22865	22877		10.1074/jbc.M109.013169	http://dx.doi.org/10.1074/jbc.M109.013169			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561089	hybrid, Green Published			2022-12-25	WOS:000268963100040
J	Hubbard, RE; Fallah, N; Searle, SD; Mitnitski, A; Rockwood, K				Hubbard, Ruth E.; Fallah, Nader; Searle, Samuel D.; Mitnitski, Arnold; Rockwood, Kenneth			Impact of Exercise in Community-Dwelling Older Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; FUNCTIONAL DECLINE; ELDERLY SUBJECTS; HEALTH-STATUS; FRAILTY; PERFORMANCE; PROGRAM; PEOPLE; RISK; ACCUMULATION	Background: Concern has been expressed that preventive measures in older people might increase frailty by increasing survival without improving health. We investigated the impact of exercise on the probabilities of health improvement, deterioration and death in community-dwelling older people. Methods and Principal Findings: In the Canadian Study of Health and Aging, health status was measured by a frailty index based on the number of health deficits. Exercise was classified as either high or low/no exercise, using a validated, self-administered questionnaire. Health status and survival were re-assessed at 5 years. Of 6297 eligible participants, 5555 had complete data. Across all grades of frailty, death rates for both men and women aged over 75 who exercised were similar to their peers aged 65 to 75 who did not exercise. In addition, while all those who exercised had a greater chance of improving their health status, the greatest benefits were in those who were more frail ( e. g. improvement or stability was observed in 34% of high exercisers versus 26% of low/no exercisers for those with 2 deficits compared with 40% of high exercisers versus 22% of low/no exercisers for those with 9 deficits at baseline). Conclusions: In community-dwelling older people, exercise attenuated the impact of age on mortality across all grades of frailty. Exercise conferred its greatest benefits to improvements in health status in those who were more frail at baseline. The net effect of exercise should therefore be to improve health status at the population level.			Hubbard, RE (corresponding author), Dalhousie Univ, Geriatr Med Res Unit, Halifax, NS, Canada.	ruth.hubbard@cdha.nshealth.ca	Fallah, Nader/D-4145-2012; Mitnitski, Arnold/C-7543-2012; Rockwood, Kenneth/AAD-8951-2019; Hubbard, Ruth E/G-5414-2010	Fallah, Nader/0000-0002-7746-4773; Hubbard, Ruth E/0000-0002-8688-5836				Abate M, 2007, Eura Medicophys, V43, P407; ADDISON J, SPECTATOR       0712, P1711; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; Bulat T, 2007, CLIN INTERV AGING, V2, P655; Davis HS, 2001, INT PSYCHOGERIATR, V13, P177, DOI 10.1017/S1041610202008128; Dupre ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1175; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; FOOTMAN T, 2008, POSTPONING INEVITABL; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Heyn PC, 2008, J NUTR HEALTH AGING, V12, P401, DOI 10.1007/BF02982674; Hubbard RE, 2009, AGE AGEING, V38, P115, DOI 10.1093/ageing/afn252; Izaks Gerbrand J, 2003, BMC Geriatr, V3, P7, DOI 10.1186/1471-2318-3-7; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Landi F, 2007, J CLIN EPIDEMIOL, V60, P518, DOI 10.1016/j.jclinepi.2006.09.010; Lang IA, 2007, J AM GERIATR SOC, V55, P1836, DOI 10.1111/j.1532-5415.2007.01426.x; Latham NK, 2004, J GERONTOL A-BIOL, V59, P48; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lee Y, 2008, INT J GERIATR PSYCH, V23, P249, DOI 10.1002/gps.1870; Mangin D, 2007, BMJ-BRIT MED J, V335, P285, DOI 10.1136/bmj.39241.630741.BE1; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski AB, 2004, J GERONTOL A-BIOL, V59, P627, DOI 10.1093/gerona/59.6.M627; Mitnitski A, 2007, EXP GERONTOL, V42, P1109, DOI 10.1016/j.exger.2007.08.002; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Pel-Littel RE, 2009, J NUTR HEALTH AGING, V13, P390, DOI 10.1007/s12603-009-0051-8; Reznick A Z, 1992, EXS, V62, P423; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Rockwood K, 2007, AGE AGEING, V36, P225, DOI 10.1093/ageing/afl160; Rydwik E, 2004, AGE AGEING, V33, P13, DOI 10.1093/ageing/afh001; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2007, AGING CLIN EXP RES, V19, P145; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Weerdesteyn V, 2006, GERONTOLOGY, V52, P131, DOI 10.1159/000091822; Wolf SL, 2006, J GERONTOL A-BIOL, V61, P184, DOI 10.1093/gerona/61.2.184	44	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6174	10.1371/journal.pone.0006174	http://dx.doi.org/10.1371/journal.pone.0006174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468HA	19584926	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806500007
J	Joshi, H; Dave, R; Venugopalan, VP				Joshi, Hiren; Dave, Rachna; Venugopalan, Vayalam P.			Competition Triggers Plasmid-Mediated Enhancement of Substrate Utilisation in Pseudomonas putida	PLOS ONE			English	Article							CONTACT-DEPENDENT INHIBITION; BACTERIA; GROWTH; GENE	Competition between species plays a central role in the activity and structure of communities. Stable co-existence of diverse organisms in communities is thought to be fostered by individual tradeoffs and optimization of competitive strategies along resource gradients. Outside the laboratory, microbes exist as multispecies consortia, continuously interacting with one another and the environment. Survival and proliferation of a particular species is governed by its competitive fitness. Therefore, bacteria must be able to continuously sense their immediate environs for presence of competitors and prevailing conditions. Here we present results of our investigations on a novel competition sensing mechanism in the rhizosphere-inhabiting Pseudomonas putida KT2440, harbouring gfpmut3b-modified Kan(R) TOL plasmid. We monitored benzyl alcohol (BA) degradation rate, along with GFP expression profiling in mono species and dual species cultures. Interestingly, enhanced plasmid expression (monitored using GFP expression) and consequent BA degradation were observed in dual species consortia, irrespective of whether the competitor was a BA degrader (Pseudomonas aeruginosa) or a non-degrader (E. coli). Attempts at elucidation of the mechanistic aspects of induction indicated the role of physical interaction, but not of any diffusible compounds emanating from the competitors. This contention is supported by the observation that greater induction took place in presence of increasing number of competitors. Inert microspheres mimicking competitor cell size and concentration did not elicit any significant induction, further suggesting the role of physical cell-cell interaction. Furthermore, it was also established that cell wall compromised competitor had minimal induction capability. We conclude that P. putida harbouring pWW0 experience a competitive stress when grown as dual-species consortium, irrespective of the counterpart being BA degrader or not. The immediate effect of this stress is a marked increase in expression of TOL, leading to rapid utilization of the available carbon source and massive increase in its population density. The plausible mechanisms behind the phenomenon are hypothesised and practical implications are indicated and discussed.			Joshi, H (corresponding author), BARC Facil, Water & Steam Chem Div, Biofouling & Biofilm Proc Sect, Kalpakkam, Tamil Nadu, India.	vpv@igcar.gov.in	Joshi, Hiren/AGJ-2262-2022	Joshi, Hiren/0000-0002-2774-7695				An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Camesano TA, 2002, BIOMACROMOLECULES, V3, P661, DOI 10.1021/bm015648y; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Hsu SB, 2002, MATH BIOSCI, V179, P183, DOI 10.1016/S0025-5564(02)00105-0; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Jena SS, 2006, BIOPHYS J, V91, P2699, DOI 10.1529/biophysj.106.086520; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Kojic M, 1999, BBA-GENE STRUCT EXPR, V1489, P413, DOI 10.1016/S0167-4781(99)00210-9; LEVIN BR, 1980, GENETICS, V94, P425; Maselli A, 2002, MICROBIOL-SGM, V148, P413, DOI 10.1099/00221287-148-2-413; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nancharaiah YV, 2003, APPL ENVIRON MICROB, V69, P4846, DOI 10.1128/AEM.69.8.4846-4852.2003; Ramos-Gonzalez MI, 1998, J BACTERIOL, V180, P3421; SELVA L, 2009, P NATL ACAD IN PRESS; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; Slechta ES, 2006, TRENDS MICROBIOL, V14, P58, DOI 10.1016/j.tim.2005.12.003; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wegrzyn G, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-2; Yuan SL, 2006, MATH BIOSCI, V202, P1, DOI 10.1016/j.mbs.2006.04.003	24	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6065	10.1371/journal.pone.0006065	http://dx.doi.org/10.1371/journal.pone.0006065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557171	Green Published, gold, Green Submitted			2022-12-25	WOS:000267424600013
J	Mure, LS; Cornut, PL; Rieux, C; Drouyer, E; Denis, P; Gronfier, C; Cooper, HM				Mure, Ludovic S.; Cornut, Pierre-Loic; Rieux, Camille; Drouyer, Elise; Denis, Philippe; Gronfier, Claude; Cooper, Howard M.			Melanopsin Bistability: A Fly's Eye Technology in the Human Retina	PLOS ONE			English	Article								In addition to rods and cones, the human retina contains light-sensitive ganglion cells that express melanopsin, a photopigment with signal transduction mechanisms similar to that of invertebrate rhabdomeric photopigments (IRP). Like fly rhodopsins, melanopsin acts as a dual-state photosensitive flip-flop in which light drives both phototransduction responses and chromophore photoregeneration that bestows independence from the retinoid cycle required by rods and cones to regenerate photoresponsiveness following bleaching by light. To explore the hypothesis that melanopsin in humans expresses the properties of a bistable photopigment in vivo we used the pupillary light reflex (PLR) as a tool but with methods designed to study invertebrate photoreceptors. We show that the pupil only attains a fully stabilized state of constriction after several minutes of light exposure, a feature that is consistent with typical IRP photoequilibrium spectra. We further demonstrate that previous exposure to long wavelength light increases, while short wavelength light decreases the amplitude of pupil constriction, a fundamental property of IRP difference spectra. Modelling these responses to invertebrate photopigment templates yields two putative spectra for the underlying R and M photopigment states with peaks at 481 nm and 587 nm respectively. Furthermore, this bistable mechanism may confer a novel form of "photic memory'' since information of prior light conditions is retained and shapes subsequent responses to light. These results suggest that the human retina exploits fly-like photoreceptive mechanisms that are potentially important for the modulation of non-visual responses to light and highlights the ubiquitous nature of photoswitchable photosensors across living organisms.			Mure, LS (corresponding author), INSERM, Stem Cell & Brain Res Inst, Dept Chronobiol, U846, F-69500 Bron, France.	howard.cooper@inserm.fr	Mure, Ludovic/AAR-9132-2021; COOPER, HOWARD/M-7304-2014; Gronfier, Claude/C-1243-2008	Mure, Ludovic/0000-0002-2485-1032; Gronfier, Claude/0000-0002-6549-799X				ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; Arendt D, 2003, INT J DEV BIOL, V47, P563; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Clarke RJ, 2003, J NEUROPHYSIOL, V89, P3179, DOI 10.1152/jn.01131.2002; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyabya O, 2006, INVEST OPHTH VIS SCI, V47, P1636, DOI 10.1167/iovs.05-1459; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Giesbers ME, 2008, PHOTOCHEM PHOTOBIOL, V84, P990, DOI 10.1111/j.1751-1097.2008.00347.x; GOLDMAN LJ, 1975, J GEN PHYSIOL, V66, P383, DOI 10.1085/jgp.66.3.383; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Link B, 2006, INVEST OPHTH VIS SCI, V47, P4947, DOI 10.1167/iovs.06-0021; LISMAN JE, 1976, J GEN PHYSIOL, V68, P487, DOI 10.1085/jgp.68.5.487; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2006, P NATL ACAD SCI USA, V103, P10153, DOI 10.1073/pnas.0603955103; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; PEPE IM, 1992, J PHOTOCH PHOTOBIO B, V13, P5, DOI 10.1016/1011-1344(92)80035-T; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rollag MD, 2008, J BIOL RHYTHM, V23, P396, DOI 10.1177/0748730408323067; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; STAVENGA DG, 1975, PHOTOCHEM PHOTOBIOL, V21, P105, DOI 10.1111/j.1751-1097.1975.tb06636.x; STAVENGA DG, 1976, J COMP PHYSIOL, V111, P137, DOI 10.1007/BF00605529; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Young RSL, 2008, VISION RES, V48, P862, DOI 10.1016/j.visres.2007.12.016; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925	42	126	133	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5991	10.1371/journal.pone.0005991	http://dx.doi.org/10.1371/journal.pone.0005991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551136	gold, Green Published, Green Submitted			2022-12-25	WOS:000267356500004
J	Petrera, NS; Stafford, AR; Leslie, BA; Kretz, CA; Fredenburgh, JC; Weitz, JI				Petrera, Nicolas S.; Stafford, Alan R.; Leslie, Beverly A.; Kretz, Colin A.; Fredenburgh, James C.; Weitz, Jeffrey I.			Long Range Communication between Exosites 1 and 2 Modulates Thrombin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-BINDING EXOSITE; HEPARIN-COFACTOR-II; FACTOR-V ACTIVATION; PROTHROMBIN FRAGMENT-2; CRYSTAL-STRUCTURE; ALLOSTERIC LINKAGE; BOVINE PROTHROMBIN; INHIBITS THROMBIN; ALPHA-THROMBIN; GAMMA'-PEPTIDE	Although exosites 1 and 2 regulate thrombin activity by binding substrates and cofactors and by allosterically modulating the active site, it is unclear whether there is direct allosteric linkage between the two exosites. To begin to address this, we first titrated a thrombin variant fluorescently labeled at exosite 1 with exosite 2 ligands, HD22 (a DNA aptamer), gamma'-peptide (an analog of the COOH terminus of the gamma'-chain of fibrinogen) or heparin. Concentration-dependent and saturable changes in fluorescence were elicited, supporting inter-exosite linkage. To explore the functional consequences of this phenomenon, we evaluated the capacity of exosite 2 ligands to inhibit thrombin binding to gamma(A)/gamma(A)-fibrin, an interaction mediated solely by exosite 1. When gamma(A)/gamma(A)-fibrinogen was clotted with thrombin in the presence of HD22, gamma'-peptide, or prothrombin fragment 2 there was a dose-dependent and saturable decrease in thrombin binding to the resultant fibrin clots. Furthermore, HD22 reduced the affinity of thrombin for gamma(A)/gamma(A)-fibrin 6-fold and accelerated the dissociation of thrombin from preformed gamma(A)/gamma(A)-fibrin clots. Similar responses were obtained when surface plasmon resonance was used to monitor the interaction of thrombin with gamma(A)/gamma(A)-fibrinogen or fibrin. There is bidirectional communication between the exosites, because exosite 1 ligands, HD1 (a DNA aptamer) or hirudin-(54- 65) (an analog of the COOH terminus of hirudin), inhibited the exosite 2-mediated interaction of thrombin with immobilized gamma'-peptide. These findings provide evidence for long range allosteric linkage between exosites 1 and 2 on thrombin, revealing further complexity to the mechanisms of thrombin regulation.	[Weitz, Jeffrey I.] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Med & Biochem, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Biomed Sci, Hamilton, ON L8V 1C3, Canada	McMaster University; McMaster University	Weitz, JI (corresponding author), Henderson Res Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	jweitz@thrombosis.hhscr.org	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550	Canadian Institutes of Health Research [MOP3992, CTP 79846]; Heart and Stroke Foundation of Ontario [T4729, T4730]; Ontario Research and Development Challenge Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric)	This work was supported, in part, by the Canadian Institutes of Health Research (Grants MOP3992 and CTP 79846), the Heart and Stroke Foundation of Ontario ( Grants T4729 and T4730), and the Ontario Research and Development Challenge Fund.	ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Baglia FA, 2002, J BIOL CHEM, V277, P1662, DOI 10.1074/jbc.M108319200; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; CHURCH WR, 1991, J BIOL CHEM, V266, P8384; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Duffy EJ, 1997, BIOCHEM J, V321, P361, DOI 10.1042/bj3210361; ESMON CT, 1982, J BIOL CHEM, V257, P7944; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; HENRIKSEN RA, 1988, BIOCHEMISTRY-US, V27, P9160, DOI 10.1021/bi00426a013; HORTIN GL, 1991, J BIOL CHEM, V266, P6866; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; Kim Y, 2008, P NATL ACAD SCI USA, V105, P5664, DOI 10.1073/pnas.0711803105; Kretz CA, 2006, J BIOL CHEM, V281, P37477, DOI 10.1074/jbc.M607359200; Lancellotti S, 2008, J BIOL CHEM, V283, P30193, DOI 10.1074/jbc.M803659200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Liaw PCY, 1998, J BIOL CHEM, V273, P8932, DOI 10.1074/jbc.273.15.8932; LIU LW, 1991, J BIOL CHEM, V266, P16977; LIU LW, 1991, J BIOL CHEM, V266, P23632; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NASKI MC, 1990, J BIOL CHEM, V265, P13484; OLSON ST, 1982, J BIOL CHEM, V257, P4891; OWEN WG, 1974, J BIOL CHEM, V249, P594; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; Sakharov DV, 1997, J BIOL CHEM, V272, P14477, DOI 10.1074/jbc.272.22.14477; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; YAMAGISHI R, 1987, FEBS LETT, V225, P109, DOI 10.1016/0014-5793(87)81140-7; YE J, 1991, J BIOL CHEM, V266, P23016; YE J, 1992, J BIOL CHEM, V267, P11023	48	53	56	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25620	25629		10.1074/jbc.M109.000042	http://dx.doi.org/10.1074/jbc.M109.000042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19589779	hybrid, Green Published			2022-12-25	WOS:000269738000020
J	Ragheb, D; Bompiani, K; Dalal, S; Klemba, M				Ragheb, Daniel; Bompiani, Kristin; Dalal, Seema; Klemba, Michael			Evidence for Catalytic Roles for Plasmodium falciparum Aminopeptidase P in the Food Vacuole and Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; LEUCYL AMINOPEPTIDASE; PROTEOLYTIC ACTIVITY; HEMOGLOBIN; SPECIFICITY; INHIBITION; EXPRESSION; PROTEASES; MALARIA	The metalloenzyme aminopeptidase P catalyzes the hydrolysis of amino acids from the amino termini of peptides with a prolyl residue in the second position. The human malaria parasite Plasmodium falciparum expresses a homolog of aminopeptidase P during its asexual intraerythrocytic cycle. P. falciparum aminopeptidase P (PfAPP) shares with mammalian cytosolic aminopeptidase P a three-domain, homodimeric organization and is most active with Mn(II) as the cofactor. A distinguishing feature of PfAPP is a 120-amino acid amino-terminal extension that appears to be removed from the mature protein. PfAPP is present in the food vacuole and cytosol of the parasite, a distribution that suggests roles in vacuolar hemoglobin catabolism and cytosolic peptide turnover. To evaluate the plausibility of these putative functions, the stability and kinetic properties of recombinant PfAPP were evaluated at the acidic pH of the food vacuole and at the near-neutral pH of the cytosol. PfAPP exhibited high stability at 37 degrees C in the pH range 5.0-7.5. In contrast, recombinant human cytosolic APP1 was unstable and formed a high molecular weight aggregate at acidic pH. At both acidic and slightly basic pH values, PfAPP efficiently hydrolyzed the amino-terminal X-Pro bond of the nonapeptide bradykinin and of two globin pentapeptides that are potential in vivo substrates. These results provide support for roles for PfAPP in peptide catabolism in both the food vacuole and the cytosol and suggest that PfAPP has evolved a dual distribution in response to the metabolic needs of the intraerythrocytic parasite.	[Ragheb, Daniel; Bompiani, Kristin; Dalal, Seema; Klemba, Michael] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu			National Institutes of Health [AI077638]; Thomas F. and Kate Miller Jeffress Memorial Trust; Institute for Biomedical and Public Health Studies at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas F. and Kate Miller Jeffress Memorial Trust; Institute for Biomedical and Public Health Studies at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077638. This work was also supported by a grant from the Thomas F. and Kate Miller Jeffress Memorial Trust and by the Institute for Biomedical and Public Health Studies at Virginia Tech.	Allary M, 2002, PARASITOLOGY, V125, P1, DOI 10.1017/S0031182002001828; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Beyer BB, 2005, BIOCHEMISTRY-US, V44, P1768, DOI 10.1021/bi047886u; Chavant P, 2005, INT J PARASITOL, V35, P1425, DOI 10.1016/j.ijpara.2005.05.009; CORNISHBOWDEN A, 2004, FUNDAMENTALS ENZYME, P140; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; D'souza VM, 2000, BIOCHEMISTRY-US, V39, P3817, DOI 10.1021/bi9925827; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; ERAHIN C, 1999, J CARDIOVASC PHARM, V34, P604; Ersahin C, 2005, ARCH BIOCHEM BIOPHYS, V435, P303, DOI 10.1016/j.abb.2004.12.023; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Graham SC, 2006, BIOCHEMISTRY-US, V45, P964, DOI 10.1021/bi0518904; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Graham SC, 2008, ARCH BIOCHEM BIOPHYS, V469, P200, DOI 10.1016/j.abb.2007.10.009; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Hatabu T, 2006, EXP PARASITOL, V112, P179, DOI 10.1016/j.exppara.2005.11.012; Hauser F, 2001, J BIOL CHEM, V276, P31732, DOI 10.1074/jbc.M103179200; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; HELLERSTEIN S, 1970, J LAB CLIN MED, V76, P10; HOOPER NM, 1992, HYPERTENSION, V19, P281, DOI 10.1161/01.HYP.19.3.281; HOOPER NM, 1988, FEBS LETT, V229, P340, DOI 10.1016/0014-5793(88)81152-9; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; KITAMURA S, 1995, BRIT J PHARMACOL, V114, P6, DOI 10.1111/j.1476-5381.1995.tb14897.x; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Kulkarni G, 2002, J BIOCHEM, V131, P445, DOI 10.1093/oxfordjournals.jbchem.a003120; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laurent V, 2001, EUR J BIOCHEM, V268, P5430, DOI 10.1046/j.0014-2956.2001.02483.x; Li X, 2008, J BIOL CHEM, V283, P22858, DOI 10.1074/jbc.M710274200; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; MARUYAMA S, 1994, BIOSCI BIOTECH BIOCH, V58, P2107, DOI 10.1271/bbb.58.2107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; MILLER CG, 1983, J BACTERIOL, V153, P350, DOI 10.1128/JB.153.1.350-356.1983; ORAWSKI AT, 1995, BIOCHEMISTRY-US, V34, P11227, DOI 10.1021/bi00035a032; ORAWSKI AT, 1987, MOL CELL BIOCHEM, V75, P123; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Siripurkpong P, 2002, J BIOL CHEM, V277, P41009, DOI 10.1074/jbc.M204852200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Stockel-Maschek A, 2003, ANAL BIOCHEM, V322, P60, DOI 10.1016/S0003-2697(03)00464-0; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; VANHOOF G, 1992, BIOCHEM PHARMACOL, V44, P479, DOI 10.1016/0006-2952(92)90439-P; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236; YOSHIMOTO T, 1994, ARCH BIOCHEM BIOPHYS, V311, P28, DOI 10.1006/abbi.1994.1204	66	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24806	24815		10.1074/jbc.M109.018424	http://dx.doi.org/10.1074/jbc.M109.018424			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574214	Green Published, hybrid			2022-12-25	WOS:000269734000015
J	Schilling, SH; Hjelmeland, AB; Radiloff, DR; Liu, IM; Wakeman, TP; Fielhauer, JR; Foster, EH; Lathia, JD; Rich, JN; Wang, XF; Datto, MB				Schilling, Stephen H.; Hjelmeland, Anita B.; Radiloff, Daniel R.; Liu, Irwin M.; Wakeman, Timothy P.; Fielhauer, Jeffrey R.; Foster, Erika H.; Lathia, Justin D.; Rich, Jeremy N.; Wang, Xiao-Fan; Datto, Michael B.			NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWNSTREAM-REGULATED GENE-2; METASTASIS SUPPRESSOR GENE; HUMAN COLON-CARCINOMA; GROWTH-FACTOR-BETA; N-MYC; DOWN-REGULATION; NEURITE OUTGROWTH; TUMOR-METASTASIS; PROSTATE-CANCER; BREAST-CANCER	NDRG4 is a largely unstudied member of the predominantly tumor suppressive N-Myc downstream-regulated gene (NDRG) family. Unlike its family members NDRG1-3, which are ubiquitously expressed, NDRG4 is expressed almost exclusively in the heart and brain. Given this tissue-specific expression pattern and the established tumor suppressive roles of the NDRG family in regulating cellular proliferation, we investigated the cellular and biochemical functions of NDRG4 in the context of astrocytes and glioblastoma multiforme (GBM) cells. We show that, in contrast to NDRG2, NDRG4 expression is elevated in GBM and NDRG4 is required for the viability of primary astrocytes, established GBM cell lines, and both CD133(+) (cancer stem cell (CSC)-enriched) and CD133(-) primary GBM xenograft cells. While NDRG4 overexpression has no effect on cell viability, NDRG4 knockdown causes G(1) cell cycle arrest followed by apoptosis. The initial G(1) arrest is associated with a decrease in cyclin D1 expression and an increase in p27(Kip1) expression, and the subsequent apoptosis is associated with a decrease in the expression of XIAP and survivin. As a result of these effects on cell cycle progression and survival, NDRG4 knockdown decreases the tumorigenic capacity of established GBM cell lines and GBM CSC-enriched cells that have been implanted intracranially into immunocompromised mice. Collectively, these data indicate that NDRG4 is required for cell cycle progression and survival, thereby diverging in function from its tumor suppressive family member NDRG2 in astrocytes and GBM cells.	[Rich, Jeremy N.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Hjelmeland, Anita B.; Lathia, Justin D.; Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Fielhauer, Jeffrey R.; Foster, Erika H.; Datto, Michael B.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Schilling, Stephen H.; Radiloff, Daniel R.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Integrated Toxicol & Environm Hlth Program, Durham, NC 27710 USA; [Lathia, Justin D.; Rich, Jeremy N.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	wang0011@mc.duke.edu; michael.datto@duke.edu	Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022; Rich, Jeremy N./A-9501-2012		National Institutes of Health [1R01GM083000]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM083000.	Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Choi SC, 2007, EXP MOL MED, V39, P705, DOI 10.1038/emm.2007.77; Dang C, 2006, ONCOL REP, V16, P513; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Felsberg J, 2006, NEUROPATH APPL NEURO, V32, P517, DOI 10.1111/j.1365-2990.2006.00759.x; Fotovati A, 2006, CLIN CANCER RES, V12, P3010, DOI 10.1158/1078-0432.CCR-05-1962; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hongo S, 2006, J CELL BIOCHEM, V98, P185, DOI 10.1002/jcb.20763; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kim KT, 2004, J BIOL CHEM, V279, P38597, DOI 10.1074/jbc.M400781200; Kim YJ, 2009, INT J CANCER, V124, P7, DOI 10.1002/ijc.23945; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Kogiku M, 2008, J CLIN NEUROSCI, V15, P1198, DOI 10.1016/j.jocn.2007.11.012; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kurdistani SK, 1998, CANCER RES, V58, P4439; Kyuno J, 2003, BIOCHEM BIOPH RES CO, V309, P52, DOI 10.1016/S0006-291X(03)01522-5; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Ma JJ, 2008, BIOL PHARM BULL, V31, P1316, DOI 10.1248/bpb.31.1316; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Naumann U, 2007, GENE THER, V14, P147, DOI 10.1038/sj.gt.3302845; Nishimoto S, 2003, EUR J BIOCHEM, V270, P2521, DOI 10.1046/j.1432-1033.2003.03626.x; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 1999, BIOCHEM BIOPH RES CO, V266, P208, DOI 10.1006/bbrc.1999.1780; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Shah MA, 2005, CLIN CANCER RES, V11, P3296, DOI 10.1158/1078-0432.CCR-04-2417; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; Tepel M, 2008, INT J CANCER, V123, P2080, DOI 10.1002/ijc.23705; Uematsu M, 2005, J NEURO-ONCOL, V72, P231, DOI 10.1007/s11060-004-2353-3; Waddell DS, 2004, J BIOL CHEM, V279, P29236, DOI 10.1074/jbc.M400880200; Wakeman TP, 2004, MUTAT RES-FUND MOL M, V554, P241, DOI 10.1016/j.mrfmmm.2004.05.006; Wang JF, 2009, J ENDOCRINOL, V201, P15, DOI 10.1677/JOE-08-0296; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Yamauchi Y, 1999, MOL BRAIN RES, V68, P149, DOI 10.1016/S0169-328X(99)00084-4; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303; Zhao W, 2001, BBA-GENE STRUCT EXPR, V1519, P134, DOI 10.1016/S0167-4781(01)00210-X; Zhen HN, 2007, INT J ONCOL, V31, P1111; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	58	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25160	25169		10.1074/jbc.M109.012484	http://dx.doi.org/10.1074/jbc.M109.012484			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592488	Green Published, hybrid			2022-12-25	WOS:000269734000050
J	Claudinon, J; Gonnord, P; Beslard, E; Marchetti, M; Mitchell, K; Boularan, C; Johannes, L; Eid, P; Lamaze, C				Claudinon, Julie; Gonnord, Pauline; Beslard, Emilie; Marchetti, Marta; Mitchell, Keith; Boularan, Cedric; Johannes, Ludger; Eid, Pierre; Lamaze, Christophe			Palmitoylation of Interferon-alpha (IFN-alpha) Receptor Subunit IFNAR1 Is Required for the Activation of Stat1 and Stat2 by IFN-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; UBIQUITINATION; ENDOCYTOSIS; CELLS; CHAIN; LOCALIZATION; DEGRADATION; TRAFFICKING	Type I interferons (IFNs) bind IFNAR receptors and activate Jak kinases and Stat transcription factors to stimulate the transcription of genes downstream from IFN-stimulated response elements. In this study, we analyze the role of protein palmitoylation, a reversible post-translational lipid modification, in the functional properties of IFNAR. We report that pharmacological inhibition of protein palmitoylation results in severe defects of IFN receptor endocytosis and signaling. We generated mutants of the IFNAR1 subunit of the type I IFN receptor, in which each or both of the two cysteines present in the cytoplasmic domain are replaced by alanines. We show that cysteine 463 of IFNAR1, the more proximal of the two cytoplasmic cysteines, is palmitoylated. A thorough microscopic and biochemical analysis of the palmitoylation-deficient IFNAR1 mutant revealed that IFNAR1 palmitoylation is not required for receptor endocytosis, intracellular distribution, or stability at the cell surface. However, the lack of IFNAR1 palmitoylation affects selectively the activation of Stat2, which results in a lack of efficient Stat1 activation and nuclear translocation and IFN-alpha-activated gene transcription. Thus, receptor palmitoylation is a previously undescribed mechanism of regulating signaling activity by type I IFNs in the Jak/Stat pathway.	[Claudinon, Julie; Gonnord, Pauline; Beslard, Emilie; Marchetti, Marta; Mitchell, Keith; Johannes, Ludger; Lamaze, Christophe] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Claudinon, Julie; Gonnord, Pauline; Beslard, Emilie; Marchetti, Marta; Mitchell, Keith; Johannes, Ludger; Lamaze, Christophe] Univ Paris 11, CNRS, UMR144, F-94807 Villejuif, France; [Eid, Pierre] Univ Paris 11, INSERM, UMR542, F-94807 Villejuif, France; [Boularan, Cedric] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Eid, P (corresponding author), Hop Paul Brousse, 14 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	pierre.eid@inserm.fr; christophe.lamaze@curie.fr	Lamaze, Christophe/M-4912-2017; Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; LAMAZE, Christophe/0000-0001-5430-2707	Association pour la Recherche sur le Cancer [3143]; Agence Nationale de la Recherche [BLAN0211]; Ligue Contre le Cancer; Fondation de France	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France)	This work was supported in part by Association pour la Recherche sur le Cancer Grant 3143 and Agence Nationale de la Recherche Grant BLAN0211.; Both authors contributed equally to this work.; Supported by a predoctoral fellowship from Ligue Contre le Cancer.; Supported by a postdoctoral fellowship from Fondation de France.; Supported by an Association pour Ia Recherche sur le Cancer doctoral fellowship.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Baychelier F, 2007, CELL SIGNAL, V19, P2080, DOI 10.1016/j.cellsig.2007.05.011; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Cherukuri A, 2004, J BIOL CHEM, V279, P31973, DOI 10.1074/jbc.M404410200; Claudinon J, 2007, BIOCHIMIE, V89, P735, DOI 10.1016/j.biochi.2007.03.014; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Ducker CE, 2006, MOL CANCER THER, V5, P1647, DOI 10.1158/1535-7163.MCT-06-0114; Flaumenhaft R, 2005, HEMATOLOGY, V10, P511, DOI 10.1080/10245330500141507; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Krishnan K, 1998, J BIOL CHEM, V273, P19495, DOI 10.1074/jbc.273.31.19495; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Kumaran J, 2007, FASEB J, V21, P3288, DOI 10.1096/fj.07-8585com; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; MOUILLAC B, 1992, J BIOL CHEM, V267, P21733; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Nadeau OW, 1999, J BIOL CHEM, V274, P4045, DOI 10.1074/jbc.274.7.4045; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; UDDIN S, 1995, J BIOL CHEM, V270, P24627, DOI 10.1074/jbc.270.42.24627; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	55	28	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24328	24340		10.1074/jbc.M109.021915	http://dx.doi.org/10.1074/jbc.M109.021915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561067	Green Published, hybrid			2022-12-25	WOS:000269380200046
J	Zhang, Y; Leung, DYM; Nordeen, SK; Goleva, E				Zhang, Yong; Leung, Donald Y. M.; Nordeen, Steven K.; Goleva, Elena			Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MAP KINASE; TRANSCRIPTIONAL ACTIVATION; GENE-TRANSCRIPTION; NEGATIVE REGULATOR; INDUCED APOPTOSIS; P38 MAPK; EXPRESSION; PHOSPHORYLATION; GROWTH	Although glucocorticoids suppress proliferation of many cell types and are used in the treatment of certain cancers, trials of glucocorticoid therapy in breast cancer have been a disappointment. Another suggestion that estrogens may affect glucocorticoid action is that the course of some inflammatory diseases tends to be more severe and less responsive to corticosteroid treatment in females. To date, the molecular mechanism of cross-talk between estrogens and glucocorticoids is poorly understood. Here we show that, in both MCF-7 and T47D breast cancer cells, estrogen inhibits glucocorticoid induction of the MKP-1 (mitogen-activated protein kinase phosphatase-1) and serum/glucocorticoid-regulated kinase genes. Estrogen did not affect glucocorticoid-induced glucocorticoid receptor (GR) nuclear translocation but reduced ligand-induced GR phosphorylation at Ser-211, which is associated with the active form of GR. We show that estrogen increases expression of protein phosphatase 5 (PP5), which mediates the dephosphorylation of GR at Ser-211. Gene knockdown of PP5 abolished the estrogen-mediated suppression of GR phosphorylation and induction of MKP-1 and serum/glucocorticoid-regulated kinase. More importantly, after PP5 knockdown estrogen-promoted cell proliferation was significantly suppressed by glucocorticoids. This study demonstrates cross-talk between estrogen-induced PP5 and GR action. It also reveals that PP5 inhibition may antagonize estrogen-promoted events in response to corticosteroid therapy.	[Zhang, Yong; Leung, Donald Y. M.; Goleva, Elena] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Nordeen, Steven K.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Goleva, E (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St,K1016A, Denver, CO 80206 USA.	golevae@njhealth.org			National Institutes of Health, NIAID [1R01AI070140]; University of Colorado Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070140] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Colorado Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI070140 from NIAID. This work was also supported by the University of Colorado Cancer Center.	Altucci L, 1996, ONCOGENE, V12, P2315; [Anonymous], US CANC STAT 2004 IN; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Chen B, 2005, INT J ONCOL, V27, P327; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Fagan JK, 2001, ANN ALLERG ASTHMA IM, V86, P177, DOI 10.1016/S1081-1206(10)62688-9; Golden T, 2004, CANCER LETT, V215, P95, DOI 10.1016/j.canlet.2004.03.027; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Herold CI, 2008, CLIN BREAST CANCER, V8, P50, DOI 10.3816/CBC.2008.n.003; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Ikeda K, 2004, MOL ENDOCRINOL, V18, P1131, DOI 10.1210/me.2003-0308; Im JY, 2008, CHEM-BIOL INTERACT, V172, P235, DOI 10.1016/j.cbi.2008.01.007; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jenkins BD, 2001, TRENDS ENDOCRIN MET, V12, P122, DOI 10.1016/S1043-2760(00)00357-X; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keith BD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-84; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Krishnan AV, 2001, J STEROID BIOCHEM, V77, P29, DOI 10.1016/S0960-0760(01)00030-9; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kushner P J, 2000, Novartis Found Symp, V230, P20, DOI 10.1002/0470870818.ch3; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lee WL, 2008, TAIWAN J OBSTET GYNE, V47, P24, DOI 10.1016/S1028-4559(08)60051-0; Levin ER, 2001, J APPL PHYSIOL, V91, P1860, DOI 10.1152/jappl.2001.91.4.1860; Li LB, 2004, J ALLERGY CLIN IMMUN, V114, P1059, DOI 10.1016/j.jaci.2004.08.005; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Ludwig Breast Cancer Study Group, 1985, Cancer Res, V45, P4454; McGuire W L, 1980, Recent Prog Horm Res, V36, P135; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Mouhieddine OB, 1996, ENDOCRINOLOGY, V137, P287, DOI 10.1210/en.137.1.287; Nabholtz Jean-Marc A, 2008, Ther Clin Risk Manag, V4, P189; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; NORDEEN SK, 1994, ENDOCRINOLOGY, V134, P1723, DOI 10.1210/en.134.4.1723; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Sengupta S, 2008, ADV EXP MED BIOL, V630, P206; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tantisira KG, 2008, AM J RESP CRIT CARE, V178, P325, DOI 10.1164/rccm.200708-1174OC; Urban G, 2003, J BIOL CHEM, V278, P9747, DOI 10.1074/jbc.M210993200; Urban G, 2001, J BIOL CHEM, V276, P27638, DOI 10.1074/jbc.M103512200; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wang XH, 2005, NEUROPSYCHOPHARMACOL, V30, P242, DOI 10.1038/sj.npp.1300606; Wang Z, 2003, J BIOL CHEM, V278, P50897, DOI 10.1074/jbc.M310297200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weinshilboum R, 2008, ADV EXP MED BIOL, V630, P220; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e	67	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24542	24552		10.1074/jbc.M109.021469	http://dx.doi.org/10.1074/jbc.M109.021469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19586900	hybrid, Green Published			2022-12-25	WOS:000269380200065
J	Maji, SK; Loo, RRO; Inayathullah, M; Spring, SM; Vollers, SS; Condron, MM; Bitan, G; Loo, JA; Teplow, DB				Maji, Samir K.; Loo, Rachel R. Ogorzalek; Inayathullah, Mohammed; Spring, Sean M.; Vollers, Sabrina S.; Condron, Margaret M.; Bitan, Gal; Loo, Joseph A.; Teplow, David B.			Amino Acid Position-specific Contributions to Amyloid beta-Protein Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PHOTOINDUCED CROSS-LINKING; A-BETA; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; COGNITIVE FUNCTION; IN-VIVO; SYNAPTIC PLASTICITY; UNMODIFIED PROTEINS; SECRETED OLIGOMERS	Understanding the structural and assembly dynamics of the amyloid beta-protein (A beta) has direct relevance to the development of therapeutic agents for Alzheimer disease. To elucidate these dynamics, we combined scanning amino acid substitution with a method for quantitative determination of the A beta oligomer frequency distribution, photo-induced cross-linking of unmodified proteins (PICUP), to perform "scanning PICUP." Tyr, a reactive group in PICUP, was substituted at position 1, 10, 20, 30, or 40 ( for A beta 40) or 42 ( for A beta 42). The effects of these substitutions were probed using circular dichroism spectroscopy, thioflavin T binding, electron microscopy, PICUP, and mass spectrometry. All peptides displayed a random coil -> alpha/beta -> beta transition, but substitution-dependent alterations in assembly kinetics and conformer complexity were observed. Tyr(1)-substituted homologues of A beta 40 and A beta 42 assembled the slowest and yielded unusual patterns of oligomer bands in gel electrophoresis experiments, suggesting oligomer compaction had occurred. Consistent with this suggestion was the observation of relatively narrow [Tyr(1)] A beta 40 fibrils. Substitution of A beta 40 at the C terminus decreased the population conformational complexity and substantially extended the highest order of oligomers observed. This latter effect was observed in both A beta 40 and A beta 42 as the Tyr substitution position number increased. The ability of a single substitution (Tyr(1)) to alter A beta assembly kinetics and the oligomer frequency distribution suggests that the N terminus is not a benign peptide segment, but rather that A beta conformational dynamics and assembly are affected significantly by the competition between the N and C termini to form a stable complex with the central hydrophobic cluster.	[Maji, Samir K.; Inayathullah, Mohammed; Spring, Sean M.; Vollers, Sabrina S.; Condron, Margaret M.; Bitan, Gal; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Loo, Rachel R. Ogorzalek; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Loo, Rachel R. Ogorzalek; Bitan, Gal; Loo, Joseph A.; Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Bitan, Gal; Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teplow, DB (corresponding author), 635 Charles E Young Dr S,Rm 445, Los Angeles, CA 90095 USA.	dteplow@ucla.edu	Maji, Samir K. K./B-9640-2019; Inayathullah, Mohammed/C-6953-2015; Bitan, Gal/U-2204-2019	Maji, Samir K. K./0000-0002-9110-1565; Inayathullah, Mohammed/0000-0001-7646-1709; Bitan, Gal/0000-0001-7046-3754; Vollers, Sabrina/0000-0002-6772-0155	National Institutes of Health [AG018921, AG027818, RR020004]; Zenith Award from the Alzheimer's Association; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818, R01AG018921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zenith Award from the Alzheimer's Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG018921, AG027818, and RR020004. This work was also supported by a Zenith Award from the Alzheimer's Association.	Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Castellanos-Serra L, 1999, ELECTROPHORESIS, V20, P732, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<732::AID-ELPS732>3.3.CO;2-H; Chellgren BW, 2006, J MOL BIOL, V361, P362, DOI 10.1016/j.jmb.2006.06.044; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Ezra D, 2004, MICROBIOL-SGM, V150, P785, DOI 10.1099/mic.0.26645-0; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Fradinger Erica A., 2005, P83; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Head E, 2008, J NEUROSCI, V28, P3555, DOI 10.1523/JNEUROSCI.0208-08.2008; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hetenyi C, 2002, BIOCHEM BIOPH RES CO, V292, P931, DOI 10.1006/bbrc.2002.6745; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Maji SK, 2005, BIOCHEMISTRY-US, V44, P13365, DOI 10.1021/bi0508284; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Qahwash I, 2003, J BIOL CHEM, V278, P23187, DOI 10.1074/jbc.M213298200; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Small D H, 1998, Amyloid, V5, P301, DOI 10.3109/13506129809007304; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Szegedi V, 2005, NEUROBIOL DIS, V18, P499, DOI 10.1016/j.nbd.2004.12.008; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	78	68	68	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23580	23591		10.1074/jbc.M109.038133	http://dx.doi.org/10.1074/jbc.M109.038133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19567875	hybrid, Green Published			2022-12-25	WOS:000269180000044
J	Lonhienne, TG; Forwood, JK; Marfori, M; Robin, G; Kobe, B; Carroll, BJ				Lonhienne, Thierry G.; Forwood, Jade K.; Marfori, Mary; Robin, Gautier; Kobe, Bostjan; Carroll, Bernard J.			Importin-beta Is a GDP-to-GTP Exchange Factor of Ran IMPLICATIONS FOR THE MECHANISM OF NUCLEAR IMPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; BINDING-PROTEIN; PORE COMPLEX; RCC1; ALPHA; P97; NTF2; NUCLEOPORINS; ASSOCIATION	Ran-GTP interacts strongly with importin-beta, and this interaction promotes the release of the importin-alpha-nuclear localization signal cargo from importin-beta. Ran-GDP also interacts with importin-beta, but this interaction is 4 orders of magnitude weaker than the Ran-GTP.importin-beta interaction. Here we use the yeast complement of nuclear import proteins to show that the interaction between Ran-GDP and importin-beta promotes the dissociation of GDP from Ran. The release of GDP from the Ran-GDP-importin-beta complex stabilizes the complex, which cannot be dissociated by importin-alpha. Although Ran has a higher affinity for GDP compared with GTP, Ran in complex with importin-beta has a higher affinity for GTP. This feature is responsible for the generation of Ran-GTP from Ran-GDP by importin-beta. Ran- binding protein-1 (RanBP1) activates this reaction by forming a trimeric complex with Ran-GDP and importin-beta. Importin-alpha inhibits theGDPexchange reaction by sequestering importin-beta, whereas RanBP1 restores the GDP nucleotide exchange by importin-beta by forming a tetrameric complex with importin-beta, Ran, and importin-alpha. The exchange is also inhibited by nuclear-transport factor-2 (NTF2). We suggest a mechanism for nuclear import, additional to the established RCC1 (Ran-guanine exchange factor)-dependent pathway that incorporates these results.	[Lonhienne, Thierry G.; Marfori, Mary; Kobe, Bostjan; Carroll, Bernard J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Lonhienne, Thierry G.; Carroll, Bernard J.] Univ Queensland, Australian Res Council Ctr Excellence Integrat Le, St Lucia, Qld 4072, Australia; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia; [Marfori, Mary; Robin, Gautier; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Marfori, Mary; Robin, Gautier; Kobe, Bostjan] Univ Queensland, Special Res Ctr Funct & Appl Genom, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; Charles Sturt University; University of Queensland; University of Queensland	Lonhienne, TG (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.	t.lonhienne@uq.edu.au	Forwood, Jade K/K-4123-2014; Kobe, Bostjan/D-1292-2009; Lonhienne, Thierry/A-5828-2011; Carroll, Bernard/C-7690-2009	Forwood, Jade K/0000-0003-3267-9997; Kobe, Bostjan/0000-0001-9413-9166; Christie, Mary/0000-0002-0955-665X; Carroll, Bernard/0000-0002-1976-8269	Australian Research Council (ARC); ARC Centre of Excellence for Integrative Legume Research	Australian Research Council (ARC)(Australian Research Council); ARC Centre of Excellence for Integrative Legume Research(Australian Research Council)	This research was funded by an Australian Research Council (ARC) Discovery Grant (to B.K., B.J.C., and T.G.L.) and by the ARC Centre of Excellence for Integrative Legume Research (to B.J.C.).	Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; CORBETT AH, 1995, J CELL BIOL, V130, P1017, DOI 10.1083/jcb.130.5.1017; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dickmanns A, 1996, J CELL SCI, V109, P1449; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Joseph J, 2006, J CELL SCI, V119, P3481, DOI 10.1242/jcs.03071; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Kunzler M, 2001, GENETICS, V157, P1089; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lounsbury KM, 1996, J BIOL CHEM, V271, P2357, DOI 10.1074/jbc.271.5.2357; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Meier I, 2009, CURR OPIN PLANT BIOL, V12, P87, DOI 10.1016/j.pbi.2008.09.001; MELCHIOR F, 1995, CURR OPIN CELL BIOL, V7, P310, DOI 10.1016/0955-0674(95)80084-0; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; Ohba T, 1996, J BIOL CHEM, V271, P14665, DOI 10.1074/jbc.271.25.14665; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; Schwoebel ED, 1998, J BIOL CHEM, V273, P35170, DOI 10.1074/jbc.273.52.35170; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Yamada M, 1998, CURR BIOL, V8, P1339, DOI 10.1016/S0960-9822(07)00566-0; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516	49	23	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22549	22558		10.1074/jbc.M109.019935	http://dx.doi.org/10.1074/jbc.M109.019935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19549784	Green Published, hybrid			2022-12-25	WOS:000268963100008
J	Khalil, A; Jauniaux, E; Cooper, D; Harrington, K				Khalil, Asma; Jauniaux, Eric; Cooper, Derek; Harrington, Kevin			Pulse Wave Analysis in Normal Pregnancy: A Prospective Longitudinal Study	PLOS ONE			English	Article							CENTRAL ARTERIAL-PRESSURE; AUGMENTATION INDEX; HYPERTENSIVE DISORDERS; AORTIC PRESSURE; STIFFNESS; REFLECTIONS; FORM	Background: Outside pregnancy, arterial pulse wave analysis provides valuable information in hypertension and vascular disease. Studies in pregnancy using this technique show that vascular stiffness is raised in women with established pre-eclampsia. We aimed to establish normal ranges for parameters of pulse wave analysis in normal pregnancy and to compare different ethnic groups. Methodology/Principal Findings: This prospective study was conducted at The Homerton University Hospital, London between January 2006 and March 2007. Using applanation tonometry, the radial artery pulse waveform was recorded and the aortic waveform derived. Augmentation pressure (AP) and Augmentation Index at heart rate 75/min (AIx-75), measures of arterial stiffness, were calculated. We recruited 665 women with singleton pregnancies. Women who developed pre-eclampsia (n = 24, 3.6%) or gestational hypertension (n = 36, 5.4%) were excluded. We also excluded 47 women with other pregnancy complications or incomplete follow-up, leaving 541 healthy normotensive pregnant women for subsequent analysis. In the overall group of 541 women, there were no significant changes in AP or AIx-75 as pregnancy progressed. In 45 women followed longitudinally, AP and AIx-75 fell significantly from the first to the second trimester, then rose again in the third (P<0.001). The two main ethnic groups represented were Caucasian (n = 229) and Afrocaribbean (n = 216). There were no significant differences in AP or AIx-75 in any trimester between these two ethnic groups. Conclusions: This study is the largest to date of pulse wave analysis in normal pregnancy, the first to report on a subset of women studied longitudinally, and the first to investigate the effect of ethnicity. These data provide the foundation for further investigation into the potential role of this technique in vascular disorders in pregnancy.			Khalil, A (corresponding author), Univ London, Univ London Queen Mary & Westfield Coll, Homerton Univ Hosp NHS Trust, London E1 4NS, England.	asmakhalil79@googlemail.com	Khall, Asma/AAC-1459-2020	Khall, Asma/0000-0003-2802-7670				Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chen CH, 1997, CIRCULATION, V95, P1827; Covic A, 2000, KIDNEY INT, V57, P2634, DOI 10.1046/j.1523-1755.2000.00124.x; Elvan-Taspinar A, 2005, AM J HYPERTENS, V18, P337, DOI 10.1016/j.amjhyper.2004.10.020; Elvan-Taspinar A, 2004, AM J HYPERTENS, V17, P941, DOI 10.1016/j.amjhyper.2004.05.018; IZZO OL, 2005, AM J HYPERTENS S 2, V18, pS1, DOI DOI 10.1016/j.amjhyper.2004.10.008; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Kelly R, 1989, J VASC MED BIOL, V3, P142; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Macedo ML, 2008, HYPERTENSION, V51, P1047, DOI 10.1161/HYPERTENSIONAHA.107.106062; Nichols W, 1998, MCDONALDS BLOOD FLOW; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Nichols WW, 2002, CURR OPIN CARDIOL, V17, P543, DOI 10.1097/00001573-200209000-00016; Nurnberger J, 2002, J HYPERTENS, V20, P2407, DOI 10.1097/00004872-200212000-00020; O'Rourke M, 1994, Blood Press, V3, P33, DOI 10.3109/08037059409101519; O'Rourke M F, 2003, Minerva Med, V94, P229; O'Rourke MF, 2004, BLOOD PRESS MONIT, V9, P179, DOI 10.1097/00126097-200408000-00002; O'Rourke MF, 2004, J HYPERTENS, V22, P431, DOI 10.1097/00004872-200402000-00030; O'Rourke MF, 2003, HYPERTENSION, V42, pE15, DOI 10.1161/01.HYP.0000095611.09419.F2; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; ORourke MF, 1996, J HYPERTENS, V14, pS147; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Ronnback M, 2005, HYPERTENS PREGNANCY, V24, P171, DOI 10.1081/PRG-200059871; Smith SA, 2004, AM J OBSTET GYNECOL, V190, P472, DOI 10.1016/j.ajog.2003.08.028; Spasojevic M, 2005, BJOG-INT J OBSTET GY, V112, P1475, DOI 10.1111/j.1471-0528.2005.00701.x; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x	27	70	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6134	10.1371/journal.pone.0006134	http://dx.doi.org/10.1371/journal.pone.0006134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578538	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000267806300006
J	Tomasi, D; Volkow, ND; Wang, RL; Telang, F; Wang, GJ; Chang, L; Ernst, T; Fowler, JS				Tomasi, Dardo; Volkow, Nora D.; Wang, Ruiliang; Telang, Frank; Wang, Gene-Jack; Chang, Linda; Ernst, Thomas; Fowler, Joanna S.			Dopamine Transporters in Striatum Correlate with Deactivation in the Default Mode Network during Visuospatial Attention	PLOS ONE			English	Article								Background: Dopamine and dopamine transporters (DAT, which regulate extracellular dopamine in the brain) are implicated in the modulation of attention but their specific roles are not well understood. Here we hypothesized that dopamine modulates attention by facilitation of brain deactivation in the default mode network (DMN). Thus, higher striatal DAT levels, which would result in an enhanced clearance of dopamine and hence weaker dopamine signals, would be associated to lower deactivation in the DMN during an attention task. Methodology/Principal Findings: For this purpose we assessed the relationship between DAT in striatum (measured with positron emission tomography and [C-11] cocaine used as DAT radiotracer) and brain activation and deactivation during a parametric visual attention task (measured with blood oxygenation level dependent functional magnetic resonance imaging) in healthy controls. We show that DAT availability in caudate and putamen had a negative correlation with deactivation in ventral parietal regions of the DMN (precuneus, BA 7) and a positive correlation with deactivation in a small region in the ventral anterior cingulate gyrus (BA 24/32). With increasing attentional load, DAT in caudate showed a negative correlation with load-related deactivation increases in precuneus. Conclusions/Significance: These findings provide evidence that dopamine transporters modulate neural activity in the DMN and anterior cingulate gyrus during visuospatial attention. Our findings suggest that dopamine modulates attention in part by regulating neuronal activity in posterior parietal cortex including precuneus (region involved in alertness) and cingulate gyrus (region deactivated in proportion to emotional interference). These findings suggest that the beneficial effects of stimulant medications (increase dopamine by blocking DAT) in inattention reflect in part their ability to facilitate the deactivation of the DMN.			Tomasi, D (corresponding author), NIAAA, Bethesda, MD USA.	tomasi@bnl.gov	Tomasi, Dardo/J-2127-2015		NCRR NIH HHS [5-M01-RR-10710, M01 RR010710] Funding Source: Medline; NIAAA NIH HHS [2 R01 AA09481, R01 AA009481] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550, R01AA009481] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Caparelli EC, 2008, BIOMED SIGNAL PROCES, V3, P107, DOI 10.1016/j.bspc.2007.11.003; Caparelli EC, 2003, NEUROIMAGE, V20, P1411, DOI 10.1016/S1053-8119(03)00339-2; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Chang L, 2006, BRAIN, V129, P1096, DOI 10.1093/brain/awl064; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; CULHAM JC, 1997, INVEST OPHTH VIS SCI, V38, pS1174; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DREHER J, 2008, P NAT ACAD IN PRESS; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Hennig J, 2001, MAGNET RESON MED, V46, P6, DOI 10.1002/mrm.1153; HERRERAMARSCHITZ M, 1989, NEUROSCI LETT, V97, P266, DOI 10.1016/0304-3940(89)90608-3; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; LEWIS MS, 1979, BRAIN RES, V164, P328, DOI 10.1016/0006-8993(79)90031-3; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Nagahama Y, 1999, NEUROIMAGE, V10, P193, DOI 10.1006/nimg.1999.0451; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siessmeier T, 2006, EUR J NEUROSCI, V24, P305, DOI 10.1111/j.1460-9568.2006.04903.x; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Swanson JM, 2002, BEHAV BRAIN RES, V130, P73, DOI 10.1016/S0166-4328(01)00433-8; Tomasi D, 2008, NEUROSCIENCE, V151, P1006, DOI 10.1016/j.neuroscience.2007.08.040; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Tomasi D, 2004, NEUROIMAGE, V23, P1414, DOI 10.1016/j.neuroimage.2004.07.065; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2007, PSYCHIAT RES-NEUROIM, V155, P189, DOI 10.1016/j.pscychresns.2007.03.002; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tomasi DG, 2007, J MAGN RESON IMAGING, V26, P1340, DOI 10.1002/jmri.21143; Tomasi DG, 2007, J CEREBR BLOOD F MET, V27, P33, DOI 10.1038/sj.jcbfm.9600314; VOLKOW ND, 1995, J NUCL MED, V36, P2162; Volkow ND, 2002, EUR NEUROPSYCHOPHARM, V12, P557, DOI 10.1016/S0924-977X(02)00104-9; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wong AC, 1999, NEUROSCIENCE, V89, P221, DOI 10.1016/S0306-4522(98)00284-X; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	75	110	110	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6102	10.1371/journal.pone.0006102	http://dx.doi.org/10.1371/journal.pone.0006102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564918	gold, Green Published, Green Submitted			2022-12-25	WOS:000267515700016
J	Le, T; Chiarella, J; Simen, BB; Hanczaruk, B; Egholm, M; Landry, ML; Dieckhaus, K; Rosen, MI; Kozal, MJ				Le, Thuy; Chiarella, Jennifer; Simen, Birgitte B.; Hanczaruk, Bozena; Egholm, Michael; Landry, Marie L.; Dieckhaus, Kevin; Rosen, Marc I.; Kozal, Michael J.			Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use	PLOS ONE			English	Article								Background: It is largely unknown how frequently low-abundance HIV drug-resistant variants at levels under limit of detection of conventional genotyping (< 20% of quasi-species) are present in antiretroviral-experienced persons experiencing virologic failure. Further, the clinical implications of low-abundance drug-resistant variants at time of virologic failure are unknown. Methodology/Principal Findings: Plasma samples from 22 antiretroviral-experienced subjects collected at time of virologic failure (viral load 1380 to 304,000 copies/mL) were obtained from a specimen bank (from 2004-2007). The prevalence and profile of drug-resistant mutations were determined using Sanger sequencing and ultra-deep pyrosequencing. Genotypes were interpreted using Stanford HIV database algorithm. Antiretroviral treatment histories were obtained by chart review and correlated with drug-resistant mutations. Low-abundance drug-resistant mutations were detected in all 22 subjects by deep sequencing and only in 3 subjects by Sanger sequencing. In total they accounted for 90 of 247 mutations (36%) detected by deep sequencing; the majority of these (95%) were not detected by standard genotyping. A mean of 4 additional mutations per subject were detected by deep sequencing (p < 0.0001, 95% Cl: 2.85-5.53). The additional low-abundance drug-resistant mutations increased a subject's genotypic resistance to one or more antiretrovirals in 17 of 22 subjects (77%). When correlated with subjects' antiretroviral treatment histories, the additional low-abundance drug-resistant mutations correlated with the failing antiretroviral drugs in 21% subjects and correlated with historical antiretroviral use in 79% subjects (OR, 13.73; 95% Cl, 2.5-74.3, p = 0.0016). Conclusions/Significance: Low-abundance HIV drug-resistant mutations in antiretroviral-experienced subjects at time of virologic failure can increase a subject's overall burden of resistance, yet commonly go unrecognized by conventional genotyping. The majority of unrecognized resistant mutations correlate with historical antiretroviral use. Ultra-deep sequencing can provide important historical resistance information for clinicians when planning subsequent antiretroviral regimens for highly treatment-experienced patients, particularly when their prior treatment histories and longitudinal genotypes are not available.			Le, T (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	Thuy.Le@yale.edu	Simen, Birgitte/A-3574-2010	Simen, Birgitte/0000-0003-0503-0973; , Michael/0000-0002-7719-7396; Kozal, Michael/0000-0002-3100-8254	NATIONAL INSTITUTE ON DRUG ABUSE [K02DA017277] Funding Source: NIH RePORTER; NIDA NIH HHS [K02 DA017277] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Devereux HL, 2001, J MED VIROL, V65, P218, DOI 10.1002/jmv.2023; Dykes C, 2004, J INFECT DIS, V189, P1091, DOI 10.1086/382033; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Hanna GJ, 2000, J INFECT DIS, V181, P904, DOI 10.1086/315329; Harrigan PR, 2005, J INFECT DIS, V191, P1325, DOI 10.1086/428852; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kapoor A, 2004, J VIROL, V78, P7112, DOI 10.1128/JVI.78.13.7112-7123.2004; Korn K, 2003, J CLIN MICROBIOL, V41, P3559, DOI 10.1128/JCM.41.8.3559-3565.2003; Kozal Michael J, 2006, MedGenMed, V8, P72; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Kuritzkes DR, 2001, P NATL ACAD SCI USA, V98, P13485, DOI 10.1073/pnas.251559398; Lalonde MS, 2007, J CLIN MICROBIOL, V45, P2604, DOI 10.1128/JCM.00431-07; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; PAREDES R, 2008, 15 C RETR OPP INF BO; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Roquebert B, 2006, AIDS, V20, P287, DOI 10.1097/01.aids.0000202650.03279.69; Rosen MI, 2007, AIDS PATIENT CARE ST, V21, P30, DOI 10.1089/apc.2006.0028; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Shafer RW, 1997, J CLIN MICROBIOL, V35, P520, DOI 10.1128/JCM.35.2.520-522.1997; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Yerly S, 2008, ANTIVIR THER, V13, pA110; ZACCARELLI M, 2008, 6 EUR HIV DRUG RES W	35	102	105	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6079	10.1371/journal.pone.0006079	http://dx.doi.org/10.1371/journal.pone.0006079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562031	Green Submitted, gold, Green Published			2022-12-25	WOS:000267465900013
J	Zhao, HJ; Ma, ZM; Tibshirani, R; Higgins, JPT; Ljungberg, B; Brooks, JD				Zhao, Hongjuan; Ma, Zongming; Tibshirani, Robert; Higgins, John P. T.; Ljungberg, Borje; Brooks, James D.			Alteration of Gene Expression Signatures of Cortical Differentiation and Wound Response in Lethal Clear Cell Renal Cell Carcinomas	PLOS ONE			English	Article								Clear cell renal cell carcinoma (ccRCC) is the most common malignancy of the adult kidney and displays heterogeneity in clinical outcomes. Through comprehensive gene expression profiling, we have identified previously a set of transcripts that predict survival following nephrectomy independent of tumor stage, grade, and performance status. These transcripts, designated as the SPC (supervised principal components) gene set, show no apparent biological or genetic features that provide insight into renal carcinogenesis or tumor progression. We explored the relationship of this gene list to a set of genes expressed in different anatomical segments of the normal kidney including the cortex (cortex gene set) and the glomerulus (glomerulus gene set), and a gene set expressed after serum stimulation of quiescent fibroblasts (the core serum response or CSR gene set). Interestingly, the normal cortex, glomerulus (part of the normal renal cortex), and CSR gene sets captured more than 1/5 of the genes in the highly prognostic SPC gene set. Based on gene expression patterns alone, the SPC gene set could be used to sort samples from normal adult kidneys by the anatomical regions from which they were dissected. Tumors whose gene expression profiles most resembled the normal renal cortex or glomerulus showed better survival than those that did not, and those with expression features more similar to CSR showed poorer survival. While the cortex, glomerulus, and CSR signatures predicted survival independent of traditional clinical parameters, they were not independent of the SPC gene list. Our findings suggest that critical biological features of lethal ccRCC include loss of normal cortical differentiation and activation of programs associated with wound healing.			Zhao, HJ (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu		Ljungberg, Borje/0000-0002-4121-3753	NCI NIH HHS [K01 CA123532, CA123532, CA111782, R01 CA111782, K01 CA123532-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA123532, R01CA111782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bates RC, 2005, CANCER BIOL THER, V4, P365; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; De Mulder PHM, 2007, ANN ONCOL, V18, P98, DOI 10.1093/annonc/mdm303; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Galfano A, 2008, UROL INT, V80, P113, DOI 10.1159/000112599; Higgins JPT, 2004, MOL BIOL CELL, V15, P649, DOI 10.1091/mbc.E03-06-0432; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katoh M, 2005, INT J ONCOL, V27, P1677; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Mancini V, 2008, UROL ONCOL-SEMIN ORI, V26, P225, DOI 10.1016/j.urolonc.2007.05.017; OBERLING C, 1960, NATURE, V186, P402, DOI 10.1038/186402a0; Riss J, 2006, CANCER RES, V66, P7216, DOI 10.1158/0008-5472.CAN-06-0040; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tannenbaum M, 1971, Pathol Annu, V6, P249; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	23	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6039	10.1371/journal.pone.0006039	http://dx.doi.org/10.1371/journal.pone.0006039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557179	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356900003
J	Jean-Francois, F; Desbat, B; Dufourc, EJ				Jean-Francois, Frantz; Desbat, Bernard; Dufourc, Erick J.			Selectivity of cateslytin for fungi: the role of acidic lipid-ergosterol membrane fluidity in antimicrobial action	FASEB JOURNAL			English	Article						cholesterol; domains; NMR; infrared	AMYLOID-BETA-PEPTIDE; SOLID-STATE H-2-NMR; PHOSPHOLIPID-BILAYER; BACTERIAL-MEMBRANES; MAGNETIC-RESONANCE; ORDER PARAMETERS; CHOLESTEROL; STEROLS; DOMAINS; MODE	The specificity of the stress-produced antimicrobial peptide cateslytin to fungi membranes has been investigated using complex membrane models made of zwitterionic and negatively charged lipids, cholesterol, or ergosterol. Noninvasive solid-state NMR of deuterated neutral and negatively charged lipids, together with IR spectroscopy, afforded following both changes in membrane fluidity and in peptide secondary structure. Cateslytin, by adopting an aggregated antiparallel beta-sheeted structure at membrane interfaces, induces a fluid/rigid membrane separation on ergosterol-containing models only. This effect is accounted for by a 2-fold electronic interaction: attractive dipole-dipole between basic arginine residues and negatively charged lipid head groups, and attractive cation-pi between arginine and the conjugated pi electrons of the ergosterol fused-ring system. This complex leads to fluid/thinner membranes that laterally separate out from rigid/thicker membranes that are not bound by cateslytin. The boundary defects occurring between domains span several angstroms, as probed by NMR of perdeuterated lipids, and are proposed to trigger peptide permeation through membranes. The intrinsic greater membrane fluidity of ergosterol/acidic lipid components in fungi is shown to be one of the key factors for specific cateslytin biological action.-Jean-Francois, F., Desbat, B., Dufourc, E. J. Selectivity of cateslytin for fungi: the role of acidic lipid-ergosterol membrane fluidity in antimicrobial action. FASEB J. 23, 3692-3701 (2009). www.fasebj.org	[Jean-Francois, Frantz; Desbat, Bernard; Dufourc, Erick J.] Univ Bordeaux 1, CNRS, ENITAB, IECB,UMR 5248, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Dufourc, EJ (corresponding author), Univ Bordeaux, UMR CBMN 5248, CNRS, ENITAB,IECB, 2 Rue Robert Escarpit, F-33607 Pessac, France.	jean-francois@magnet.fsu.edu; e.dufourc@iecb.u-bordeaux.fr	DUFOURC, Erick Joel/AAA-4992-2020; Jean-Francois, Frantz/AAH-9429-2019	DUFOURC, Erick Joel/0000-0002-8221-9326; 	Aquitaine government; CNRS; Ministry of Research	Aquitaine government; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	We are grateful to Dr. Thierry Buffeteau (UMR ISM 5255, Bordeaux) for the use of the ATR holder. We thank the Aquitaine government, CNRS, and the Ministry of Research for equipment and funding.	Alarcon JM, 2006, PEPTIDES, V27, P95, DOI 10.1016/j.peptides.2005.07.004; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Arnt L, 2006, J PHYS CHEM B, V110, P3527, DOI 10.1021/jp054339p; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; BLOOM M, 1981, CHEM PHYS LETT, V80, P198, DOI 10.1016/0009-2614(81)80089-9; Bonev B, 2001, PHYS CHEM CHEM PHYS, V3, P2904, DOI 10.1039/b103352m; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buchoux S, 2008, BIOPHYS J, V95, P3840, DOI 10.1529/biophysj.107.128322; Castano S, 2005, BBA-BIOMEMBRANES, V1715, P81, DOI 10.1016/j.bbamem.2005.07.008; CORNELL BA, 1982, BIOCHIM BIOPHYS ACTA, V689, P337, DOI 10.1016/0005-2736(82)90267-X; Davis JH, 2009, BIOPHYS J, V96, P521, DOI 10.1016/j.bpj.2008.09.042; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DOULIEZ JP, 1995, J CHIM PHYS PCB, V92, P1721, DOI 10.1051/jcp/1995921721; Douliez JP, 1996, J PHYS CHEM-US, V100, P18450, DOI 10.1021/jp961220v; DOULIEZ JP, 1995, BIOPHYS J, V68, P1727, DOI 10.1016/S0006-3495(95)80350-4; Dufourc E.J., 2006, CHEM BIOL, P113, DOI [10.1002/9780470319253.ch8, DOI 10.1002/9780470319253.CH8]; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; Epand RF, 2006, BBA-BIOMEMBRANES, V1758, P1343, DOI 10.1016/j.bbamem.2006.01.018; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FABIAN H, 2002, HDB VIBRATIONAL SPEC, V5, P3399; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Hsueh YW, 2005, BIOPHYS J, V88, P1799, DOI 10.1529/biophysj.104.051375; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jean-Francois F, 2007, EUR BIOPHYS J BIOPHY, V36, P1019, DOI 10.1007/s00249-007-0169-8; Jean-Francois F, 2008, BIOPHYS J, V95, P5748, DOI 10.1529/biophysj.108.136655; Khemtemourian L, 2006, ANAL CHEM, V78, P5348, DOI 10.1021/ac060207w; LEONARD A, 1991, BIOCHIMIE, V73, P1295, DOI 10.1016/0300-9084(91)90092-F; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Loffler J, 2000, FEMS MICROBIOL LETT, V185, P59, DOI 10.1016/S0378-1097(00)00071-9; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mason AJ, 2007, BIOPHYS J, V93, P4289, DOI 10.1529/biophysj.107.116681; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; Olofsson A, 2007, J MOL BIOL, V374, P186, DOI 10.1016/j.jmb.2007.08.064; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; POTT T, 1995, BIOPHYS J, V68, P965, DOI 10.1016/S0006-3495(95)80272-9; Samuelsen O, 2005, FEBS LETT, V579, P3421, DOI 10.1016/j.febslet.2005.05.017; SCHINDLER H, 1975, BIOCHEMISTRY-US, V14, P2283, DOI 10.1021/bi00682a001; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	56	16	16	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3692	3701		10.1096/fj.09-135574	http://dx.doi.org/10.1096/fj.09-135574			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19571037				2022-12-25	WOS:000271272500007
J	Ziera, T; Irlbacher, H; Fromm, A; Latouche, C; Krug, SM; Fromm, M; Jaisser, F; Borden, SA				Ziera, Tim; Irlbacher, Horst; Fromm, Anja; Latouche, Celine; Krug, Susanne M.; Fromm, Michael; Jaisser, Frederic; Borden, Steffen A.			Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel	FASEB JOURNAL			English	Article						aldosterone; chromatin imunoprecipition; ERK/MAPK signaling; reporter gene assays; site-directed mutagenesis	ALDOSTERONE-INDUCED GENE; GLUCOCORTICOID-RECEPTOR; SCAFFOLD PROTEIN; COLLECTING DUCT; RAF ACTIVATION; RABBIT NEPHRON; NA+ TRANSPORT; EXPRESSION; CELLS; BINDING	Aldosterone is the principal hormonal regulator of sodium homeostasis in vertebrates. It exerts its actions through the mineralocorticoid receptor (MR) that regulates the transcription of specific target genes. In recent years, a number of MR target genes have been identified that are involved in the regulation of the epithelial sodium channel (ENaC), a key modulator of renal sodium absorption. Here we report the identification of cnksr3 as a direct MR target gene that is up-regulated in response to physiological concentrations of aldosterone. The cnksr3 promoter exhibits two functional aldosterone-responsive regions, which were bound by the MR as assessed by chromatin immunoprecipitation (ChIP). In vivo, CNKSR3 was highly expressed in the renal cortical collecting duct (CCD), the prime target segment of aldosterone-regulated sodium retention in the kidney. CCD cell lines stably over-expressing or silencing CNKSR3 were electrophysiologically analyzed and show that CNKSR3 expression correlated with and is required for ENaC-mediated transepithelial sodium transport. In parallel, CNKSR3 expression led to decreased MEK phosphorylation. We conclude that CNKSR3, a homologue of scaffold proteins involved in MAPK pathway regulation, is a direct target of MR and is required for the maintenance of transepithelial sodium transport in the kidney.-Ziera, T., Irlbacher, H., Fromm, A., Latouche, C., Krug, S. M., Fromm, M., Jaisser, F., Borden, S. A. Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel. FASEB J. 23, 3936-3946 (2009). www.fasebj.org	[Ziera, Tim; Irlbacher, Horst; Borden, Steffen A.] Bayer Schering Pharma AG, Therapeut Res Womens Hlth, D-13353 Berlin, Germany; [Fromm, Anja; Krug, Susanne M.; Fromm, Michael] Free Univ Berlin, Inst Clin Physiol, Charite, D-1000 Berlin, Germany; [Fromm, Anja; Krug, Susanne M.; Fromm, Michael] Humboldt Univ, Berlin, Germany; [Latouche, Celine; Jaisser, Frederic] Univ Paris 06, INSERM, U872, Ctr Rech Cordeliers,Team 1, Paris, France	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Borden, SA (corresponding author), Bayer Schering Pharma AG, Therapeut Res Womens Hlth, Mullerstr 178, D-13353 Berlin, Germany.	steffen.borden@bayerhealthcare.com	Latouche, Celine/C-4998-2013; Krug, Susanne M/AAY-6221-2020; Jaisser, Frederic/P-4287-2017; Fromm, Michael/K-6203-2013	Krug, Susanne M/0000-0002-1293-2484; Jaisser, Frederic/0000-0001-9051-1901; Fromm, Michael/0000-0003-4497-7983; Fromm, Anja/0000-0003-4091-9612	Societe Francaise de Nephrologie; Leducq Fondation	Societe Francaise de Nephrologie; Leducq Fondation	We thank N. Farman for microdissecting nephron segments from mouse kidneys, F. Prinz for lentivirus production, and D. Henderson for critical reading of the manuscript. Funding for INSERM U872 Team 1 was from the Societe Francaise de Nephrologie and the the Leducq Fondation (Transatlantic Network of Excellence in Cardiovascular Disease).	Afhuppe W, 2009, J STEROID BIOCHEM, V113, P105, DOI 10.1016/j.jsbmb.2008.11.015; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Brennan FE, 2006, ENDOCRINOLOGY, V147, P2809, DOI 10.1210/en.2005-1481; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; FARMAN N, 1983, AM J PHYSIOL, V244, pF325, DOI 10.1152/ajprenal.1983.244.3.F325; FARMAN N, 1982, AM J PHYSIOL, V242, pF69, DOI 10.1152/ajprenal.1982.242.1.F69; FROMM M, 1993, AM J PHYSIOL, V264, pE68, DOI 10.1152/ajpendo.1993.264.1.E68; FUHRMANN U, 1995, CONTRACEPTION, V51, P45, DOI 10.1016/0010-7824(94)00003-F; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KROZOWSKI ZS, 1983, P NATL ACAD SCI-BIOL, V80, P6056, DOI 10.1073/pnas.80.19.6056; Lanigan TM, 2003, FASEB J, V17, P2048, DOI 10.1096/fj.02-1096com; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Muller OG, 2003, J AM SOC NEPHROL, V14, P1107, DOI 10.1097/01.ASN.0000061777.67332.77; Muller O, 2007, GENOMICS, V89, P370, DOI 10.1016/j.ygeno.2006.11.001; Nakhoul NL, 1998, AM J PHYSIOL-RENAL, V275, pF998, DOI 10.1152/ajprenal.1998.275.6.F998; Naray-Fejes-Toth A, 2004, P NATL ACAD SCI USA, V101, P17434, DOI 10.1073/pnas.0408146101; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; Naray-Fejes-Toth A, 2000, KIDNEY INT, V57, P1290, DOI 10.1046/j.1523-1755.2000.00964.x; Naray-Fejes-Toth A, 2008, AM J PHYSIOL-RENAL, V295, pF18, DOI 10.1152/ajprenal.00573.2007; NARAYFEJESTOTH A, 1994, AM J PHYSIOL, V266, pF76, DOI 10.1152/ajprenal.1994.266.1.F76; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oakley RH, 1997, ENDOCRINOLOGY, V138, P5028, DOI 10.1210/en.138.11.5028; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Pearce D, 2003, VITAM HORM, V66, P29, DOI 10.1016/S0083-6729(03)01002-1; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Rocheleau CE, 2005, P NATL ACAD SCI USA, V102, P11757, DOI 10.1073/pnas.0500937102; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Spindler B, 1997, PFLUG ARCH EUR J PHY, V434, P323, DOI 10.1007/s004240050403; Staub O, 2005, J AM SOC NEPHROL, V16, P3167, DOI 10.1681/ASN.2005050454; Tanaka K, 2007, HEART VESSELS, V22, P254, DOI 10.1007/s00380-006-0968-3; Therrien M, 1998, CELL, V95, P343, DOI 10.1016/S0092-8674(00)81766-3; Tian LJ, 2001, J PHYSIOL-LONDON, V537, P57, DOI 10.1111/j.1469-7793.2001.0057k.x; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wielputz MO, 2007, J BIOL CHEM, V282, P28264, DOI 10.1074/jbc.M702168200; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770; Ziogas A, 2005, J BIOL CHEM, V280, P24205, DOI 10.1074/jbc.M413327200	53	45	48	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3936	3946		10.1096/fj.09-134759	http://dx.doi.org/10.1096/fj.09-134759			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19567370				2022-12-25	WOS:000271272500029
J	Baglioni, S; Francalanci, M; Squecco, R; Lombardi, A; Cantini, G; Angeli, R; Gelmini, S; Guasti, D; Benvenuti, S; Annunziato, F; Bani, D; Liotta, F; Francini, F; Perigli, G; Serio, M; Luconi, M				Baglioni, Silvana; Francalanci, Michela; Squecco, Roberta; Lombardi, Adriana; Cantini, Giulia; Angeli, Roberta; Gelmini, Stefania; Guasti, Daniele; Benvenuti, Susanna; Annunziato, Francesco; Bani, Daniele; Liotta, Francesco; Francini, Fabio; Perigli, Giuliano; Serio, Mario; Luconi, Michaela			Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue	FASEB JOURNAL			English	Article						multipotential differentiation; immunophenotyping; mesenchymal stromal cells; ASCs	BONE-MARROW; IN-VITRO; STROMAL CELLS; ELECTROPHYSIOLOGICAL PROPERTIES; ENDOTHELIAL-CELLS; TEMPORAL-CHANGES; OBESE SUBJECTS; SELF-RENEWAL; DIFFERENTIATION; EXPRESSION	Adipose tissue is a dynamic endocrine organ with a central role in metabolism regulation. Functional differences in adipose tissue seem associated with the regional distribution of fat depots, in particular in subcutaneous and visceral omental pads. Here, we report for the first time the isolation of human adipose-derived adult stem cells from visceral omental and subcutaneous fat (V-ASCs and S-ASCs, respectively) from the same subject. Immunophenotyping shows that plastic culturing selects homogeneous cell populations of V-ASCs and S-ASCs from the corresponding stromal vascular fractions (SVFs), sharing typical markers of mesenchymal stem cells. Electron microscopy and electrophysiological and real-time RTPCR analyses confirm the mesenchymal stem nature of both V-ASCs and S-ASCs, while no significant differences in a limited pattern of cytokine/chemokine expression can be detected. Similar to S-ASCs, V-ASCs can differentiate in vitro toward adipogenic, osteogenic, chondrogenic, muscular, and neuronal lineages, as demonstrated by histochemical, immunofluorescence, real-time RT-PCR, and electrophysiological analyses, suggesting the multipotency of such adult stem cells. Our data demonstrate that both visceral and subcutaneous adipose tissues are a source of pluripotent stem cells with multigermline potential. However, the visceral rather than the subcutaneous ASC could represent a more appropriate in vitro cell model for investigating the molecular mechanisms implicated in the pathophysiology of metabolic disorders such as obesity.-Baglioni, S., Francalanci, M., Squecco, R., Lombardi, A., Cantini, G., Angeli, R., Gelmini, S., Guasti, D., Benvenuti, S., Annunziato, F., Bani, D., Liotta, F., Francini, F., Perigli, G., Serio, M., Luconi, M. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J. 23, 3494-3505 (2009). www.fasebj.org	[Baglioni, Silvana; Francalanci, Michela; Lombardi, Adriana; Cantini, Giulia; Gelmini, Stefania; Benvenuti, Susanna; Serio, Mario; Luconi, Michaela] Univ Florence, Dept Clin Physiopathol, Endocrinol Unit, I-50139 Florence, Italy; [Angeli, Roberta; Annunziato, Francesco; Liotta, Francesco] Univ Florence, Dept Internal Med, Ctr Res Transfer High Educ & Technol DENOTHE, I-50139 Florence, Italy; [Squecco, Roberta; Francini, Fabio] Univ Florence, Sch Med, Dept Physiol Sci, I-50139 Florence, Italy; [Guasti, Daniele; Bani, Daniele] Univ Florence, Sch Med, Dept Anat Histol & Forens Med, I-50139 Florence, Italy; [Perigli, Giuliano] Univ Florence, Sch Med, Dept Gen Surg, I-50139 Florence, Italy	University of Florence; University of Florence; University of Florence; University of Florence; University of Florence	Luconi, M (corresponding author), Univ Florence, Dept Clin Physiopathol, Endocrinol Unit, Viale Pieraccini 6, I-50139 Florence, Italy.	m.luconi@dfc.unifi.it	Squecco, Roberta/K-8961-2019; Luconi, Michaela/W-9522-2019; GELMINI, STEFANIA/K-8387-2018; Annunziato, Francesco/C-1155-2013; Cantini, Giulia/K-7626-2016	Luconi, Michaela/0000-0001-5186-064X; GELMINI, STEFANIA/0000-0002-4718-0833; DANIELE, GUASTI/0000-0002-2856-6829; Bani, Daniele/0000-0001-6302-901X; CANTINI, GIULIA/0000-0002-9159-9199; Annunziato, Francesco/0000-0001-8798-7589; francini, fabio/0000-0002-9255-1824	University of Florence; Tuscany Regional Study on Rosiglitazone (TRESOR)	University of Florence; Tuscany Regional Study on Rosiglitazone (TRESOR)	We thank Dr. B. Mazzinghi (University of Florence) and Dr. A. Morelli (University of Florence) for kindly providing MAP2 and desmin primers, respectively. We are indebted to Dr. F. Nuti (University of Florence) for providing anti-gamma-enolase antibody and to Dr. S. Frontera (University of Florence) for cell karyotyping. We thank Dr. G. Luciani (University of Florence) for technical assistance in electrophysiological experiments. This study has been supported by the Tuscany Regional Study on Rosiglitazone (TRESOR) project.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Astori G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-55; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94; Benvenuti S, 2006, EXP CELL RES, V312, P2592, DOI 10.1016/j.yexcr.2006.04.016; Boquest AC, 2006, STEM CELL REV, V2, P319, DOI 10.1007/BF02698059; Boushell LW, 2008, ARCH ORAL BIOL, V53, P109, DOI 10.1016/j.archoralbio.2007.09.012; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Formigli L, 2005, AM J PHYSIOL-CELL PH, V288, pC795, DOI 10.1152/ajpcell.00345.2004; FUJIOKA S, 1991, INT J OBESITY, V15, P853; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690; Hauner H, 1988, Horm Metab Res Suppl, V19, P35; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim DH, 2005, CYTOKINE, V31, P119, DOI 10.1016/j.cyto.2005.04.004; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; Lombardi A, 2008, ARTERIOSCL THROM VAS, V28, P718, DOI 10.1161/ATVBAHA.107.160713; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mantovani G, 2009, DIABETES, V58, P620, DOI 10.2337/db08-0585; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Park KS, 2007, STEM CELLS, V25, P2044, DOI 10.1634/stemcells.2006-0735; Pasquinelli G, 2007, ULTRASTRUCT PATHOL, V31, P23, DOI 10.1080/01913120601169477; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Scriba D, 2000, EUR J ENDOCRINOL, V143, P439, DOI 10.1530/eje.0.1430439; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180; Sumanasinghe RD, 2009, J CELL PHYSIOL, V219, P77, DOI 10.1002/jcp.21653; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Tricarico C, 1999, INT J BIOL MARKER, V14, P247, DOI 10.1177/172460089901400409; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; von Eyben FE, 2003, INT J OBESITY, V27, P941, DOI 10.1038/sj.ijo.0802309; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang K, 2005, STEM CELLS, V23, P1526, DOI 10.1634/stemcells.2004-0299; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	52	146	156	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3494	3505		10.1096/fj.08-126946	http://dx.doi.org/10.1096/fj.08-126946			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19584303	Green Submitted			2022-12-25	WOS:000270354300026
J	Benedict, C; Scheller, J; Rose-John, S; Born, J; Marshall, L				Benedict, Christian; Scheller, Juergen; Rose-John, Stefan; Born, Jan; Marshall, Lisa			Enhancing influence of intranasal interleukin-6 on slow-wave activity and memory consolidation during sleep	FASEB JOURNAL			English	Article						neuromodulation; cytokine; cognition; electroencephalogram power	DECLARATIVE MEMORY; EMOTIONAL MEMORY; DEFICIENT MICE; BRAIN; IL-6; OSCILLATIONS; AMYGDALA; RATS; HIPPOCAMPUS; EXPRESSION	The cytokine IL-6 has been considered to exert neuromodulating influences on the brain, with promoting influences on sleep. Sleep enhances the consolidation of memories, and, in particular, late nocturnal sleep also represents a period of enhanced IL-6 signaling, due to a distinctly enhanced availability of soluble IL-6 receptors during this period, enabling trans-signaling of IL-6 to neurons. Thus, a contribution of IL-6 to sleep-dependent memory consolidation is hypothesized. To test this hypothesis, we compared effects of intranasally administered IL-6 (vs. placebo) on sleep-dependent consolidation of declarative (neutral and emotional texts, 2-dimensional object location) and procedural (finger sequence tapping) memories in 17 healthy young men. IL-6 distinctly improved the sleep-related consolidation of emotional text material (P<0.03), which benefits mostly from sleep in the second night-half, in which rapid eye movement sleep (REM) dominates the non-REM-REM sleep cycle. During this second night-half, the amount of electroencephalogram slow-wave activity (0.5-4 Hz) distinctly increased after IL-6 (P<0.01). Other types of memory were not affected. The ability of IL-6 to enhance sleep-associated emotional memory consolidation highlights an example of a functional interaction between the central nervous and immune system.-Benedict, C., Scheller, J., Rose-John, S., Born, J., Marshall, L. Enhancing influence of intranasal interleukin-6 on slow-wave activity and memory consolidation during sleep. FASEB J. 23, 3629-3636 (2009). www.fasebj.org	[Benedict, Christian; Born, Jan; Marshall, Lisa] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Scheller, Juergen; Rose-John, Stefan] Univ Kiel, Dept Biochem, Kiel, Germany	University of Lubeck; University of Kiel	Marshall, L (corresponding author), Med Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	marshall@kfg.uni-luebeck.de	Born, Jan/K-2596-2016; Rose-John, Stefan/A-7998-2010; Scheller, Jürgen/K-5290-2015; Benedict, Christian/K-2190-2017	Born, Jan/0000-0002-1847-6248; Rose-John, Stefan/0000-0002-7519-3279; Benedict, Christian/0000-0002-8911-4068; , Lisa/0000-0002-3976-1822	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to N. Jakob, V. Ulrich, C. Otten, I. von Lutzau, H. Ruf, M. Rohwer, and A. Otterbein for their expert and invaluable laboratory work and to M. Molle for support with EEG data analyses. The study was funded by a grant from the Deutsche Forschungsgemeinschaft (SFB 654: Plasticity and Sleep). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors had full access to all data in the study and take responsibility for the integrity and accuracy of the data analysis.	Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Babiloni C, 2009, HUM BRAIN MAPP, V30, P2077, DOI 10.1002/hbm.20648; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Born J, 1997, J IMMUNOL, V158, P4454; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Braida D, 2004, BEHAV BRAIN RES, V153, P423, DOI 10.1016/j.bbr.2003.12.018; CHRISTENSEN PR, 1958, WORD FLUENCY FORM A; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Denecke H, 2002, PHARMACOL BIOCHEM BE, V73, P593, DOI 10.1016/S0091-3057(02)00823-7; Dimitrov S, 2006, FASEB J, V20, P2174, DOI 10.1096/fj.06-5754fje; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Guan ZW, 2005, BRAIN BEHAV IMMUN, V19, P526, DOI 10.1016/j.bbi.2005.01.005; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Krueger JM, 2003, ANN NY ACAD SCI, V992, P9, DOI 10.1111/j.1749-6632.2003.tb03133.x; LEMAY LG, 1990, AM J PHYSIOL, V258, pR798, DOI 10.1152/ajpregu.1990.258.3.R798; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; MacLean, 1992, J Sleep Res, V1, P35; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2002, INT REV NEUROBIOL, V52, P93; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947, DOI 10.1152/ajpregu.2000.278.4.R947; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rose-John S, 2003, ACTA BIOCHIM POL, V50, P603; Sallmann S, 2000, J NEUROSCI, V20, P8637; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Schurer-Necker E., 1994, GEDACHTNIS EMOTION Z; Seres J, 2004, NEUROIMMUNOMODULAT, V11, P316, DOI 10.1159/000079412; Sommer T, 2005, LEARN MEMORY, V12, P343, DOI 10.1101/lm.90405; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2005, BIOL PSYCHIAT, V58, P885, DOI 10.1016/j.biopsych.2005.05.008; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	49	58	61	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3629	3636		10.1096/fj.08-122853	http://dx.doi.org/10.1096/fj.08-122853			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19546306				2022-12-25	WOS:000270354300039
J	Frizzell, N; Rajesh, M; Jepson, MJ; Nagai, R; Carson, JA; Thorpe, SR; Baynes, JW				Frizzell, Norma; Rajesh, Mathur; Jepson, Matthew J.; Nagai, Ryoji; Carson, James A.; Thorpe, Suzanne R.; Baynes, John W.			Succination of Thiol Groups in Adipose Tissue Proteins in Diabetes SUCCINATION INHIBITS POLYMERIZATION AND SECRETION OF ADIPONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-MODIFICATION; ADIPOCYTE DIFFERENTIATION; WEIGHT-LOSS; GLYCATION; S-(2-SUCCINYL)CYSTEINE; ACRP30/ADIPONECTIN; BIOMARKER; PRODUCTS; OBESITY; MUSCLE	S-(2-Succinyl) cysteine (2SC) is formed by reaction of the Krebs cycle intermediate fumarate with cysteine residues in protein, a process termed succination of protein. Both fumarate and succination of proteins are increased in adipocytes cultured in high glucose medium (Nagai, R., Brock, J. W., Blatnik, M., Baatz, J. E., Bethard, J., Walla, M. D., Thorpe, S. R., Baynes, J. W., and Frizzell, N. (2007) J. Biol. Chem. 282, 34219-34228). We show here that succination of protein is also increased in epididymal, mesenteric, and subcutaneous adipose tissue of diabetic (db/db) mice and that adiponectin is a major target for succination in both adipocytes and adipose tissue. Cys-39, which is involved in cross-linking of adiponectin monomers to form trimers, was identified as a key site of succination of adiponectin in adipocytes. 2SC was detected on two of seven monomeric forms of adiponectin immunoprecipitated from adipocytes and epididymal adipose tissue. Based on densitometry, 2SC-adiponectin accounted for similar to 7 and 8% of total intracellular adiponectin in cells and tissue, respectively. 2SC was found only in the intracellular, monomeric forms of adiponectin and was not detectable in polymeric forms of adiponectin in cell culture medium or plasma. We conclude that succination of adiponectin blocks its incorporation into trimeric and higher molecular weight, secreted forms of adiponectin. We propose that succination of proteins is a biomarker of mitochondrial stress and accumulation of Krebs cycle intermediates in adipose tissue in diabetes and that succination of adiponectin may contribute to the decrease in plasma adiponectin in diabetes.	[Baynes, John W.] Univ S Carolina, Arnold Sch Publ Hlth, Publ Hlth Res Ctr 301F, Dept Exercise Sci, Columbia, SC 29208 USA; [Nagai, Ryoji] Japan Womens Univ, Lab Nutr Sci & Biochem, Tokyo 1128681, Japan	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Japan Womens University	Baynes, JW (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Publ Hlth Res Ctr 301F, Dept Exercise Sci, Columbia, SC 29208 USA.	john.baynes@sc.edu	Rajesh, Mathur/ABE-6500-2021; Carson, James/Q-5693-2019	Carson, James/0000-0003-3733-8796; Rajesh, Mathur/0000-0001-7641-7417	National Institutes of Health, NIDDK [DK-19971]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019971, R37DK019971] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK-19971.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Alt N, 2004, ARCH BIOCHEM BIOPHYS, V425, P200, DOI 10.1016/j.abb.2004.03.012; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; KINTER M, 2000, PROTEIN SEQUENCING I, P147, DOI DOI 10.1002/0471721980; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI RK, 1992, METABOLISM, V41, P545, DOI 10.1016/0026-0495(92)90216-W; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moien-Afshari F, 2008, DIABETOLOGIA, V51, P1327, DOI 10.1007/s00125-008-0996-x; Monnier VM, 2006, REJUV RES, V9, P264, DOI 10.1089/rej.2006.9.264; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Peake PW, 2007, J MOL ENDOCRINOL, V39, P45, DOI 10.1677/JME-07-0030; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Sato C, 2001, J BIOL CHEM, V276, P28849, DOI 10.1074/jbc.M104148200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; TANAKA A, 1980, J CHROMATOGR, V194, P21, DOI 10.1016/S0021-9673(00)81046-8; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105	32	71	72	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25772	25781		10.1074/jbc.M109.019257	http://dx.doi.org/10.1074/jbc.M109.019257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19592500	hybrid, Green Published			2022-12-25	WOS:000269738000035
J	Terauchi, AM; Lu, SF; Zaffagnini, M; Tappa, S; Hirasawa, M; Tripathy, JN; Knaff, DB; Farmer, PJ; Lemaire, SD; Hase, T; Merchant, SS				Terauchi, Aimee M.; Lu, Shu-Fen; Zaffagnini, Mirko; Tappa, Shane; Hirasawa, Masakazu; Tripathy, Jatindra N.; Knaff, David B.; Farmer, Patrick J.; Lemaire, Stephane D.; Hase, Toshiharu; Merchant, Sabeeha S.			Pattern of Expression and Substrate Specificity of Chloroplast Ferredoxins from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; NITRITE REDUCTASE; GENE-EXPRESSION; GLUTAMATE SYNTHASE; GREEN-ALGA; OXIDATION-REDUCTION; NITRATE REDUCTASE; NITROGEN-FIXATION; ELECTRON-TRANSFER; MAIZE ROOTS	Ferredoxin (Fd) is the major iron-containing protein in photosynthetic organisms and is central to reductive metabolism in the chloroplast. The Chlamydomonas reinhardtii genome encodes six plant type [Fe2S2] ferredoxins, products of PETF, FDX2-FDX6. We performed the functional analysis of these ferredoxins by localizing Fd, Fdx2, Fdx3, and Fdx6 to the chloroplast by using isoform-specific antibodies and monitoring the pattern of gene expression by iron and copper nutrition, nitrogen source, and hydrogen peroxide stress. In addition, we also measured the midpoint redox potentials of Fd and Fdx2 and determined the kinetic parameters of their reactions with several ferredoxin-interacting proteins, namely nitrite reductase, Fd:NADP+ oxidoreductase, and Fd: thioredoxin reductase. We found that each of the FDX genes is differently regulated in response to changes in nutrient supply. Moreover, we show that Fdx2 (E-m = -321 mV), whose expression is regulated by nitrate, is a more efficient electron donor to nitrite reductase relative to Fd. Overall, the results suggest that each ferredoxin isoform has substrate specificity and that the presence of multiple ferredoxin isoforms allows for the allocation of reducing power to specific metabolic pathways in the chloroplast under various growth conditions.	[Terauchi, Aimee M.; Lu, Shu-Fen; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, F-91405 Orsay, France; [Tappa, Shane; Farmer, Patrick J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Hirasawa, Masakazu; Knaff, David B.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Tripathy, Jatindra N.; Knaff, David B.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Hase, Toshiharu] Osaka Univ, Inst Prot Res, Div Enzymol, Suita, Osaka 5650871, Japan	University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Irvine; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Osaka University	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	sabeeha@chem.ucla.edu	Farmer, Patrick J/J-3757-2019; Lemaire, Stéphane D/A-3530-2008; Hase, Toshiharu/H-9271-2013	Farmer, Patrick J/0000-0001-9911-999X; Lemaire, Stéphane D/0000-0001-6442-0547; Zaffagnini, Mirko/0000-0001-5115-0859	Department of Energy [DE-FD02-04ER15529, DE-FG03-99ER20346]; National Science Foundation (NSF) [CHE0517080-3]; Agence Nationale de la Recherche [ANRJC05-45741]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Department of Energy Grants DE-FD02-04ER15529 ( to S. S. M.) and DE-FG03-99ER20346 ( to D. B. K.), National Science Foundation (NSF) Grant CHE0517080-3 ( to P. J. F.), and Agence Nationale de la Recherche Grant ANRJC05-45741 ( to M. Z. and S. D. L.).	Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Avila L, 1999, J BIOL INORG CHEM, V4, P664, DOI 10.1007/s007750050390; Bertini I, 2002, PROTEINS, V46, P110, DOI 10.1002/prot.10009; BOWSHER CG, 1992, PLANT J, V2, P893, DOI 10.1111/j.1365-313X.1992.00893.x; Camargo A, 2007, PLANT CELL, V19, P3491, DOI 10.1105/tpc.106.045922; Dayer R, 2008, GENETICS, V179, P41, DOI 10.1534/genetics.107.086041; DECOTTIGNIES P, 1995, ARCH BIOCHEM BIOPHYS, V316, P249, DOI 10.1006/abbi.1995.1035; DROUX M, 1987, ARCH BIOCHEM BIOPHYS, V252, P426, DOI 10.1016/0003-9861(87)90049-X; ERIKSSON M, 1995, PLANT PHYSIOL, V107, P479, DOI 10.1104/pp.107.2.479; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; Garcia-Sanchez MI, 2000, J BIOL INORG CHEM, V5, P713, DOI 10.1007/s007750000160; GarciaSanchez MI, 1997, EUR J BIOCHEM, V250, P364, DOI 10.1111/j.1432-1033.1997.0364a.x; GORMAN DS, 1966, PLANT PHYSIOL, V41, P1643, DOI 10.1104/pp.41.10.1643; Goyer A, 2002, EUR J BIOCHEM, V269, P272, DOI 10.1046/j.0014-2956.2001.02648.x; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; HASE T, 1991, PLANT PHYSIOL, V97, P1395, DOI 10.1104/pp.97.4.1395; HASE T, 2006, PHOTOSYSTEM, V1; Hirasawa M, 1998, ARCH BIOCHEM BIOPHYS, V354, P95, DOI 10.1006/abbi.1998.0630; HIRASAWA M, 1994, BBA-BIOENERGETICS, V1185, P336, DOI 10.1016/0005-2728(94)90249-6; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; HUTBER GN, 1977, FEMS MICROBIOL LETT, V1, P193, DOI 10.1111/j.1574-6968.1977.tb00612.x; ISSAKIDIS E, 1992, J BIOL CHEM, V267, P21577; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jacquot JP, 1997, FEBS LETT, V400, P293, DOI 10.1016/S0014-5793(96)01407-X; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; LAUDENBACH DE, 1988, J BACTERIOL, V170, P258, DOI 10.1128/jb.170.1.258-265.1988; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JC, 2008, GENETICS, V179, P137, DOI 10.1534/genetics.107.083824; Loppes R, 1999, PLANT MOL BIOL, V41, P701, DOI 10.1023/A:1006381527119; Matsumura T, 1997, PLANT PHYSIOL, V114, P653, DOI 10.1104/pp.114.2.653; McKay RML, 1997, PLANT PHYSIOL, V114, P615, DOI 10.1104/pp.114.2.615; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; MORTENSON LE, 1962, BIOCHEM BIOPH RES CO, V7, P448, DOI 10.1016/0006-291X(62)90333-9; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Sambrook J, 2001, MOL CLONING LAB MANU; SANDMANN G, 1990, PHOTOSYNTH RES, V26, P119, DOI 10.1007/BF00047083; SCHMITTER JM, 1988, EUR J BIOCHEM, V172, P405, DOI 10.1111/j.1432-1033.1988.tb13901.x; SCHRAUTEMIER B, 1985, FEBS LETT, V184, P304, DOI 10.1016/0014-5793(85)80627-X; STEIN M, 1993, PLANT PHYSIOL, V102, P1349, DOI 10.1104/pp.102.4.1349; SUZUKI A, 1985, PLANT PHYSIOL, V78, P374, DOI 10.1104/pp.78.2.374; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; Tripathy JN, 2007, PHOTOSYNTH RES, V94, P1, DOI 10.1007/s11120-007-9198-5; WADA K, 1989, J BIOCHEM, V105, P619, DOI 10.1093/oxfordjournals.jbchem.a122714; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	64	102	104	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25867	25878		10.1074/jbc.M109.023622	http://dx.doi.org/10.1074/jbc.M109.023622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19586916	Green Published, hybrid			2022-12-25	WOS:000269738000044
J	Brady, SN; Maggi, LB; Winkeler, CL; Toso, EA; Gwinn, AS; Pelletier, CL; Weber, JD				Brady, S. N.; Maggi, L. B., Jr.; Winkeler, C. L.; Toso, E. A.; Gwinn, A. S.; Pelletier, C. L.; Weber, J. D.			Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation	ONCOGENE			English	Article						NPM; ribosome; p19ARF; centrosome	CELL-CYCLE PROGRESSION; NUCLEOLAR PHOSPHOPROTEIN B23; ARF TUMOR-SUPPRESSOR; CENTROSOME DUPLICATION; RIBOSOME BIOGENESIS; DEPENDENT KINASE; NUCLEAR EXPORT; P19(ARF); P53; IDENTIFICATION	Nucleophosmin (NPM), an oligomeric phosphoprotein and nucleolar target of the ARF tumor suppressor, contributes to several critical cellular processes. Previous studies have shown that the human NPM's phosphorylation by cyclin E cyclin-dependent kinase 2 (cdk2) on threonine (Thr) 199 regulates its translocation from the centrosome during cell cycle progression. Given our previous finding that ARF directly binds NPM, impeding its transit to the cytoplasm and arresting cells before S-phase entry, we hypothesized that ARF might also inhibit NPM phosphorylation. However, ARF induction did not impair phosphorylation of the cdk2 target residue in murine NPM, Thr(198). Furthermore, phosphorylation of Thr(198) occurred throughout the cell cycle and was concomitant with increases in overall NPM expression. To investigate the cell's presumed requirement for NPM-Thr(198) phosphorylation in promoting the processes of growth and proliferation, we examined the effects of a non-phosphorylatable NPM mutant, T198A, in a clean cell system in which endogenous NPM had been removed by RNA interference. Here, we show that the T198A mutant is fully capable of executing NPM's described roles in nucleocytoplasmic shuttling, ribosome export and cell cycle progression. Moreover, the proliferative defects observed with stable NPM knockdown were restored by mutant NPM-T198A expression. Thus, we demonstrate that the reduction in NPM protein expression blocks cellular growth and proliferation, whereas phosphorylation of NPM-Thr(198) is not essential for NPM's capacity to drive cell cycle progression and proliferation. Oncogene (2009) 28, 3209-3220; doi: 10.1038/onc.2009.178; published online 29 June 2009	[Weber, J. D.] Washington Univ, Sch Med, Div Mol Oncol, Dept Internal Med,Siteman Canc Ctr, St Louis, MO 63110 USA; [Weber, J. D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Weber, JD (corresponding author), Washington Univ, Sch Med, Div Mol Oncol, Dept Internal Med,Siteman Canc Ctr, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	jweber@im.wustl.edu	Maggi, Leonard/L-5217-2019	Maggi, Leonard/0000-0003-0138-0984; Weber, Jason/0000-0002-1069-6983	National Institutes of Health and Department of Defense Era of Hope Scholar Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE [R01CA120436] Funding Source: NIH RePORTER	National Institutes of Health and Department of Defense Era of Hope Scholar Award in Breast Cancer Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Sheila Stewart, Gregory Longmore, J Alan Diehl, Martine Roussel, Charles Sherr and Gerard Zambetti for gifts of plasmid constructs, antibodies and primary TKO MEFs. In addition, we would like to thank Sheila Stewart, Helen Piwnica-Worms, Michael Tomasson and John Majors for insightful discussions throughout the course of this study. SNB was supported by the Cancer Biology Pathway. CLP was a trainee in the Lucille P Markey Special Emphasis Pathway in Human Pathobiology. JDW was funded through the National Institutes of Health and Department of Defense Era of Hope Scholar Award in Breast Cancer Research.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Cha H, 2004, BIOCHEM J, V378, P857, DOI 10.1042/BJ20031173; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Liu HT, 1999, CANCER LETT, V144, P45, DOI 10.1016/S0304-3835(99)00184-6; LIU QR, 1991, EUR J BIOCHEM, V200, P715, DOI 10.1111/j.1432-1033.1991.tb16236.x; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Namboodiri VMH, 2004, ACTA CRYSTALLOGR D, V60, P2325, DOI 10.1107/S0907444904023959; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Winey M, 1999, CURR BIOL, V9, pR449, DOI 10.1016/S0960-9822(99)80279-6; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; YUNG BYM, 1987, BIOCHIM BIOPHYS ACTA, V925, P74, DOI 10.1016/0304-4165(87)90149-8; Zatsepina OV, 1999, J CELL SCI, V112, P455	41	19	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3209	3220		10.1038/onc.2009.178	http://dx.doi.org/10.1038/onc.2009.178			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19561638	Green Accepted			2022-12-25	WOS:000269673400004
J	Akaike, T; Jin, MH; Yokoyama, U; Izumi-Nakaseko, H; Jiao, QB; Iwasaki, S; Iwamoto, M; Nishimaki, S; Sato, M; Yokota, S; Kamiya, Y; Adachi-Akahane, S; Ishikawa, Y; Minamisawa, S				Akaike, Toru; Jin, Mei-Hua; Yokoyama, Utako; Izumi-Nakaseko, Hiroko; Jiao, Qibin; Iwasaki, Shiho; Iwamoto, Mari; Nishimaki, Shigeru; Sato, Motohiko; Yokota, Shumpei; Kamiya, Yoshinori; Adachi-Akahane, Satomi; Ishikawa, Yoshihiro; Minamisawa, Susumu			T-type Ca2+ Channels Promote Oxygenation-induced Closure of the Rat Ductus Arteriosus Not Only by Vasoconstriction but Also by Neointima Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CALCIUM-CHANNEL; EXTRACELLULAR-MATRIX; CHRONIC-HYPOXIA; GROWTH-FACTOR; PROLIFERATION; EXPRESSION; MIGRATION; MYOCYTES; RABBIT	The ductus arteriosus (DA), an essential vascular shunt for fetal circulation, begins to close immediately after birth. Although Ca2+ influx through several membrane Ca2+ channels is known to regulate vasoconstriction of the DA, the role of the T-type voltage-dependent Ca2+ channel (VDCC) in DA closure remains unclear. Here we found that the expression of alpha 1G, a T-type isoform that is known to exhibit a tissue-restricted expression pattern in the rat neonatal DA, was significantly up-regulated in oxygenated rat DA tissues and smooth muscle cells (SMCs). Immunohistological analysis revealed that alpha 1G was localized predominantly in the central core of neonatal DA at birth. DA SMC migration was significantly increased by alpha 1G overexpression. Moreover, it was decreased by adding alpha 1G-specific small interfering RNAs or using R(-)-efonidipine, a highly selective T-type VDCC blocker. Furthermore, an oxygenation-mediated increase in an intracellular Ca2+ concentration of DA SMCs was significantly decreased by adding alpha 1G-specific siRNAs or using R(-)-efonidipine. Although a prostaglandin E receptor EP4 agonist potently promoted intimal thickening of the DA explants, R(-)-efonidipine (10(-6) M) significantly inhibited EP4-promoted intimal thickening by 40% using DA tissues at preterm in organ culture. Moreover, R(-)-efonidipine (10(-6) M) significantly attenuated oxygenation-induced vasoconstriction by similar to 27% using a vascular ring of fetal DA at term. Finally, R(-)-efonidipine significantly delayed the closure of in vivo DA in neonatal rats. These results indicate that T-type VDCC, especially alpha 1G, which is predominantly expressed in neonatal DA, plays a unique role in DA closure, implying that T-type VDCC is an alternative therapeutic target to regulate the patency of DA.	[Minamisawa, Susumu] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Akaike, Toru; Jin, Mei-Hua; Yokoyama, Utako; Jiao, Qibin; Sato, Motohiko; Ishikawa, Yoshihiro; Minamisawa, Susumu] Yokohama City Univ, Cardiovasc Res Inst, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Izumi-Nakaseko, Hiroko; Adachi-Akahane, Satomi] Toho Univ, Sch Med, Grad Sch Med Sci, Dept Pharmacol,Fac Med, Toho 1438540, Japan; [Iwasaki, Shiho; Iwamoto, Mari; Nishimaki, Shigeru; Yokota, Shumpei] Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa 2360004, Japan; [Kamiya, Yoshinori] Yokohama City Univ, Sch Med, Dept Anesthesiol, Yokohama, Kanagawa 2360004, Japan; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Cell Biol, Newark, NJ 07101 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Mol Med, Newark, NJ 07101 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Med Cardiol, Newark, NJ 07101 USA; [Minamisawa, Susumu] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Inst Biomed Engn, Tokyo 1628480, Japan	Waseda University; Yokohama City University; Toho University; Yokohama City University; Yokohama City University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Waseda University	Minamisawa, S (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho,TWIns, Tokyo 1628480, Japan.	sminamis@waseda.jp	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Kamiya, Yoshinori/0000-0001-9790-9867; Minamisawa, Susumu/0000-0003-4728-2116	National Institutes of Health [RO1GM067773]; Yokohama Foundation for Advanced Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Special Coordination Funds for Promoting Science and Technology, MEXT; MEXT; Waseda University Grant; Mother and Child Health Foundation; Miyata Cardiology Research Promotion Founds; Takeda Science Foundation; Foundation for Growth Science; Japan Cardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Yokohama Academic Foundation; Inoue Foundation for Science; Naito Foundation; Uehara Memorial Foundation; Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067773] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590936] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama Foundation for Advanced Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University Grant; Mother and Child Health Foundation(Mother and Child Health Foundation); Miyata Cardiology Research Promotion Founds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Growth Science; Japan Cardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Yokohama Academic Foundation; Inoue Foundation for Science(Inoue Foundation for Science); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM067773 ( to Y. I.). This work was also supported by grants from the Yokohama Foundation for Advanced Medical Science ( to T. A., U. Y., Y. I., and S. M.), the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to S. I., U. Y., Y. I., and S. M.), the Special Coordination Funds for Promoting Science and Technology, MEXT ( to S. M.), "High-Tech Research Center" Project for Private Universities: matching fund subsidy from MEXT ( to S. M.), Waseda University Grant for Special Research Projects ( to S. M.), the Mother and Child Health Foundation ( to S. M.), Miyata Cardiology Research Promotion Founds ( to U. Y. and S. M.), Takeda Science Foundation ( to S. M.), Foundation for Growth Science ( to S. M.), Japan Cardiovascular Research Foundation ( to S. M.), Mitsubishi Pharma Research Foundation ( to S. M.), Yokohama Academic Foundation ( to T. A. and S. I.), Inoue Foundation for Science ( to T. A.), the Naito Foundation ( to T. A.), the Uehara Memorial Foundation ( to U. Y.), the Kitsuen Research Foundation ( to Y. I.), and the Japan Space Forum ( to Y. I.).	Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Corsini A, 1996, J CARDIOVASC PHARM, V28, P687, DOI 10.1097/00005344-199611000-00012; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; DEREEDER EG, 1989, ATHEROSCLEROSIS, V79, P29, DOI 10.1016/0021-9150(89)90030-0; Devlin MG, 2002, CLIN EXP PHARMACOL P, V29, P372, DOI 10.1046/j.1440-1681.2002.03670.x; Fearon IM, 2000, PFLUG ARCH EUR J PHY, V441, P181, DOI 10.1007/s004240000424; FleckensteinGrun G, 1996, PFLUG ARCH EUR J PHY, V432, pR53; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Gollasch M, 2000, J HYPERTENS, V18, P989, DOI 10.1097/00004872-200018080-00001; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Hong ZG, 2006, CIRCULATION, V114, P1372, DOI 10.1161/CIRCULATIONAHA.106.641126; Keck M, 2005, AM J PHYSIOL-LUNG C, V288, pL917, DOI 10.1152/ajplung.00403.2004; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Lijnen P, 1999, J CARDIOVASC PHARM, V33, P595, DOI 10.1097/00005344-199904000-00012; Louis H, 2006, CLIN EXP PHARMACOL P, V33, P131, DOI 10.1111/j.1440-1681.2006.04339.x; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NAKANISHI T, 1993, CIRC RES, V72, P1218, DOI 10.1161/01.RES.72.6.1218; Patel MK, 2005, BRIT J PHARMACOL, V145, P811, DOI 10.1038/sj.bjp.0706237; Rabinovitch M, 1996, SEMIN PERINATOL, V20, P531, DOI 10.1016/S0146-0005(96)80067-X; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Ruiz-Torres A, 2003, INT J CLIN PHARM TH, V41, P386; SCHMITT R, 1995, ARTERIOSCL THROM VAS, V15, P1161, DOI 10.1161/01.ATV.15.8.1161; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Smith GCS, 1998, PHARMACOL REV, V50, P35; SPERTI G, 1991, EUR J PHARM-MOLEC PH, V206, P279, DOI 10.1016/0922-4106(91)90110-4; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Tanaka H, 2004, J PHARMACOL SCI, V96, P499, DOI 10.1254/jphs.RCJ04001X; TristaniFirouzi M, 1996, J CLIN INVEST, V98, P1959, DOI 10.1172/JCI118999; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; YANG ZH, 1993, CIRCULATION, V88, P832, DOI 10.1161/01.CIR.88.3.832; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639	35	28	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24025	24034		10.1074/jbc.M109.017061	http://dx.doi.org/10.1074/jbc.M109.017061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19567868	Green Published, hybrid			2022-12-25	WOS:000269380200017
J	Ransom, M; Williams, SK; Dechassa, ML; Das, C; Linger, J; Adkins, M; Liu, CW; Bartholomew, B; Tyler, JK				Ransom, Monica; Williams, Stephanie K.; Dechassa, Mekonnen L.; Das, Chandrima; Linger, Jeffrey; Adkins, Melissa; Liu, Chengwei; Bartholomew, Blaine; Tyler, Jessica K.			FACT and the Proteasome Promote Promoter Chromatin Disassembly and Transcriptional Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE H2B; PHO5 PROMOTER; REGULATORY PARTICLE; CRYSTAL-STRUCTURE; 26S PROTEASOME; IN-VIVO; NUCLEOSOME; BINDING; ACTIVATION	The packaging of the eukaryotic genome into chromatin represses gene expression by blocking access of the general transcription machinery to the underlying DNA sequences. Accordingly, eukaryotes have developed a variety of mechanisms to disrupt, alter, or disassemble nucleosomes from promoter regions and open reading frames to allow transcription to occur. Although we know that chromatin disassembly from the yeast PHO5 promoter is triggered by the Pho4 activator, the mechanism is far from clear. Here we show that the Pho4 activator can occupy its nucleosome-bound DNA binding site within the PHO5 promoter. In contrast to the role of Saccharomyces cerevisiae FACT (facilitates chromatin transcription) complex in assembling chromatin within open reading frames, we find that FACT is involved in the disassembly of histones H2A/H2B from the PHO5 promoter during transcriptional induction. We have also discovered that the proteasome is required for efficient chromatin disassembly and transcriptional induction from the PHO5 promoter. Mutants of the degradation function of the proteasome have a defect in recruitment of the Pho4 activator, whereas mutants of the ATPase cap of the proteasome do recruit Pho4 but are still delayed for chromatin assembly. Finally, we rule out the possibility that the proteasome or ATPase cap is driving chromatin disassembly via a potential ATP-dependent chromatin remodeling activity.	[Ransom, Monica; Williams, Stephanie K.; Das, Chandrima; Linger, Jeffrey; Adkins, Melissa; Liu, Chengwei; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Dechassa, Mekonnen L.; Bartholomew, Blaine] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Illinois University System; Southern Illinois University	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jessica.tyler@ucdenver.edu	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810; Ransom, Monica/0000-0002-7527-7122; Linger, Jeffrey/0000-0003-3935-751X; Tyler, Jessica/0000-0001-9765-1659	National Institutes of Health [GM64475, CA082086]; NATIONAL CANCER INSTITUTE [T32CA082086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM64475 (to J.K.T.) and Training Grant T32 CA082086 (to M. R.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Burton BM, 2005, PROTEIN SCI, V14, P1945, DOI 10.1110/ps.051417505; COSTIGAN C, 1994, MOL CELL BIOL, V14, P2391, DOI 10.1128/MCB.14.4.2391; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Imbalzano AN, 1998, METHODS, V15, P303, DOI 10.1006/meth.1998.0634; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LI Q, 1995, MOL CELL BIOL, V15, P4375; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; White CL, 2004, J MOL BIOL, V342, P1391, DOI 10.1016/j.jmb.2004.07.080; Williams LR, 2007, SIGHT SOUND, V17, P93; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; XU QL, 1995, MOL CELL BIOL, V15, P6025; Zhu ZW, 1996, CELL, V87, P459, DOI 10.1016/S0092-8674(00)81366-5	50	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23461	23471		10.1074/jbc.M109.019562	http://dx.doi.org/10.1074/jbc.M109.019562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574230	hybrid, Green Published			2022-12-25	WOS:000269180000031
J	Dorn, M; Weiwad, M; Markwardt, F; Laug, L; Rudolph, R; Brandsch, M; Bosse-Doenecke, E				Dorn, Madlen; Weiwad, Matthias; Markwardt, Fritz; Laug, Linda; Rudolph, Rainer; Brandsch, Matthias; Bosse-Doenecke, Eva			Identification of a Disulfide Bridge Essential for Transport Function of the Human Proton-coupled Amino Acid Transporter hPAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SEROTONIN TRANSPORTER; CYSTEINE RESIDUES; GLUCOSE-TRANSPORTER; SUBSTRATE TRANSPORT; PAT1; PROLINE; COTRANSPORTER; PROTEIN; CARRIER; CACO-2	The proton-coupled amino acid transporter 1 (PAT1, SLC36A1) mediates the uptake of small neutral amino acids at the apical membrane of intestinal epithelial cells after protein digestion. The transporter is currently under intense investigation, because it is a possible vehicle for oral drug delivery. Structural features of the protein such as the number of transmembrane domains, the substrate binding site, or essential amino acids are still unknown. In the present study we use mutagenesis experiments and biochemical approaches to determine the role of the three putative extracellular cysteine residues on transport function and their possible involvement in the formation of a disulfide bridge. As treatment with the reducing reagent dithiothreitol impaired transport function of hPAT1 wild type protein, substitution of putative extracellular cysteine residues Cys-180, Cys-329, and Cys-473 by alanine or serine was performed. Replacement of the two highly conserved cysteine residues Cys-180 and Cys-329 abolished the transport function of hPAT1 in Xenopus laevis oocytes. Studies of wild type and mutant transporters expressed in human retinal pigment epithelial (HRPE) cells suggested that the binding of the substrate was inhibited in these mutants. Substitution of the third putative extracellular nonconserved cysteine residue Cys-473 did not affect transport function. All mutants were expressed at the plasma membrane. Biotinylation of free sulfhydryl groups using maleimide-PEG(11)-biotin and SDS-PAGE analysis under reducing and nonreducing conditions provided direct evidence for the existence of an essential disulfide bond between Cys-180 and Cys-329. This disulfide bridge is very likely involved in forming or stabilizing the substrate binding site.	[Dorn, Madlen; Rudolph, Rainer; Bosse-Doenecke, Eva] Univ Halle Wittenberg, Fac Sci 1, Inst Biochem Biotechnol, D-06120 Halle, Germany; [Dorn, Madlen; Laug, Linda; Brandsch, Matthias] Univ Halle Wittenberg, Biozentrum, D-06120 Halle, Germany; [Weiwad, Matthias] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Markwardt, Fritz] Univ Halle Wittenberg, Fac Med, Julius Bernstein Inst Physiol, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society; Martin Luther University Halle Wittenberg	Bosse-Doenecke, E (corresponding author), Univ Halle Wittenberg, Fac Sci 1, Inst Biochem Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	eva.bosse-doenecke@biochemtech.uni-halle.de	Markwardt, Fritz/F-7693-2013	Markwardt, Fritz/0000-0001-6761-2923	State Saxony-Anhalt Life Sciences Excellence Initiative [XB3599HP/0105T]	State Saxony-Anhalt Life Sciences Excellence Initiative	This work was supported by the State Saxony-Anhalt Life Sciences Excellence Initiative Grant XB3599HP/0105T ( to M. B. and E.B.-D.).	Anderson CMH, 2004, GASTROENTEROLOGY, V127, P1410, DOI 10.1053/j.gastro.2004.08.017; Asaka J, 2007, MOL PHARMACOL, V71, P1487, DOI 10.1124/mol.106.032938; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; Boll M, 2003, MOL MEMBR BIOL, V20, P261, DOI 10.1080/0968768031000100759; Boll M, 2003, GENOMICS, V82, P47, DOI 10.1016/S0888-7543(03)00099-5; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Brandsch M, 2006, AMINO ACIDS, V31, P119, DOI 10.1007/s00726-006-0307-0; Bretschneider F, 1999, Methods Enzymol, V294, P180; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Dorn M, 2009, FEBS LETT, V583, P1631, DOI 10.1016/j.febslet.2009.04.037; Foltz M, 2005, BIOCHEM J, V386, P607, DOI 10.1042/BJ20041519; Frandberg PA, 2001, BIOCHEM BIOPH RES CO, V281, P851, DOI 10.1006/bbrc.2001.4429; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; Lambert G, 2000, J MEMBRANE BIOL, V176, P143, DOI 10.1007/s002320001083; Larsen M, 2008, EUR J PHARM SCI, V35, P86, DOI 10.1016/j.ejps.2008.06.007; Metzner L, 2005, FASEB J, V19, P1468, DOI 10.1096/fj.05-3683com; Metzner L, 2004, J PHARMACOL EXP THER, V309, P28, DOI 10.1124/jpet.103.059014; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; Pajor AM, 1999, BIOCHEM J, V344, P205, DOI 10.1042/0264-6021:3440205; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Thwaites DT, 2007, BBA-BIOMEMBRANES, V1768, P179, DOI 10.1016/j.bbamem.2006.10.001; THWAITES DT, 1993, FEBS LETT, V333, P78, DOI 10.1016/0014-5793(93)80378-8; TURNER RJ, 1983, J BIOL CHEM, V258, P3565; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	39	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22123	22132		10.1074/jbc.M109.023713	http://dx.doi.org/10.1074/jbc.M109.023713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19549785	hybrid, Green Published			2022-12-25	WOS:000268783700036
J	Simmer, JP; Hu, YY; Lertlam, R; Yamakoshi, Y; Hu, JCC				Simmer, James P.; Hu, Yuanyuan; Lertlam, Rangsiyakorn; Yamakoshi, Yasuo; Hu, Jan C. -C.			Hypomaturation Enamel Defects in Klk4 Knockout/LacZ Knockin Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMELOGENESIS IMPERFECTA PHENOTYPE; KALLIKREIN-4 MESSENGER-RNA; PROSTATE-CANCER; RAT INCISOR; SERINE-PROTEASE; OVARIAN-CANCER; MATURATION AMELOBLASTS; ELECTRON-MICROSCOPY; BETA-GALACTOSIDASE; MOLECULAR-CLONING	Kallikrein 4 (Klk4) is believed to play an essential role in enamel biomineralization, because defects in KLK4 cause hypomaturation amelogenesis imperfecta. We used gene targeting to generate a knockin mouse that replaces the Klk4 gene sequence, starting at the translation initiation site, with a lacZ reporter gene. Correct targeting of the transgene was confirmed by Southern blot and PCR analyses. Histochemical X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) staining demonstrated expression of beta-galactosidase in maturation stage ameloblasts. No X-gal staining was observed in secretory stage ameloblasts or in odontoblasts. Retained enamel proteins were observed in the maturation stage enamel of the Klk4 null mouse, but not in the Klk4 heterozygous or wild-type mice. The enamel layer in the Klk4 null mouse was normal in thickness and contained decussating enamel rods but was rapidly abraded following weaning, despite the mice being maintained on soft chow. In function the enamel readily fractured within the initial rod and interrod enamel above the parallel enamel covering the dentino-enamel junction. Despite the lack of Klk4 and the retention of enamel proteins, significant levels of crystal maturation occurred (although delayed), and the enamel achieved a mineral density in some places greater than that detected in bone and dentin. An important finding was that individual enamel crystallites of erupted teeth failed to grow together, interlock, and function as a unit. Instead, individual crystallites seemed to spill out of the enamel when fractured. These results demonstrate that Klk4 is essential for the removal of enamel proteins and the proper maturation of enamel crystals.	[Simmer, James P.] Univ Michigan, Dent Res Lab, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan	Simmer, JP (corresponding author), Univ Michigan, Dent Res Lab, Sch Dent, Dept Biol & Mat Sci, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA.	jsimmer@umich.edu	Hu, Jan C-C./F-5679-2015	Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	National Institutes of Health; NIDCR [15846]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 15846 from NIDCR.	Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; BARTLETT JD, 2004, HDB PROTEOLYTIC ENZY, P561; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Borgono CA, 2007, BIOL CHEM, V388, P1215, DOI 10.1515/BC.2007.124; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Cerny R, 1996, J BONE MINER RES, V11, P883; Chai Y, 2000, DEVELOPMENT, V127, P1671; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364; Day CH, 2002, ONCOGENE, V21, P7114, DOI 10.1038/sj.onc.1205786; DEAKINS M., 1941, JOUR DENTAL RES, V20, P117, DOI 10.1177/00220345410200020201; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Fernando SC, 2006, REPRODUCTION, V132, P939, DOI 10.1530/rep.1.01013; Fukae M, 2007, J DENT RES, V86, P758, DOI 10.1177/154405910708600814; Fukae M, 2002, J DENT RES, V81, P668, DOI 10.1177/154405910208101003; FUKAE M, 1974, ARCH ORAL BIOL, V19, P381, DOI 10.1016/0003-9969(74)90179-4; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hu CC, 1998, CONNECT TISSUE RES, V39, P47, DOI 10.3109/03008209809023911; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu CC, 2000, J DENT RES, V79, P912, DOI 10.1177/00220345000790040501; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Hu JCC, 2000, J DENT RES, V79, P70, DOI 10.1177/00220345000790011301; KALLENBACH E, 1971, J ULTRA MOL STRUCT R, V35, P508, DOI 10.1016/S0022-5320(71)80008-4; KALLENBACH E, 1974, TISSUE CELL, V6, P173, DOI 10.1016/0040-8166(74)90030-5; KEREBEL B, 1979, J DENT RES, V58, P844, DOI 10.1177/00220345790580023701; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; Mange A, 2008, BIOCHEM BIOPH RES CO, V375, P107, DOI 10.1016/j.bbrc.2008.07.138; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; MJOR I, 1986, HUMAN ORAL EMBRYOLOG, P50; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; NYLEN MU, 1963, J CELL BIOL, V18, P109, DOI 10.1083/jcb.18.1.109; Obiezu CV, 2002, CLIN CHEM, V48, P1232; Obiezu CV, 2001, CLIN CANCER RES, V7, P2380; Ozdemir D, 2005, J DENT RES, V84, P1031, DOI 10.1177/154405910508401112; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Park CH, 2007, J PERIODONTOL, V78, P273, DOI 10.1902/jop.2007.060252; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; PROVENZA DV, 1988, FUNDAMENTALS ORAL HI, P151; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; REITH EJ, 1970, J ULTRA MOL STRUCT R, V30, P111, DOI 10.1016/S0022-5320(70)90068-7; ROBINSON C, 1990, CARIES RES, V24, P226, DOI 10.1159/000261272; Robinson C, 1989, Connect Tissue Res, V22, P139; ROSEN D, 1981, NEUROPATH APPL NEURO, V7, P331, DOI 10.1111/j.1365-2990.1981.tb00236.x; Ryu O, 2002, EUR J ORAL SCI, V110, P358, DOI 10.1034/j.1600-0722.2002.21349.x; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; SASAKI T, 1984, HISTOCHEMISTRY, V80, P263, DOI 10.1007/BF00495775; Simmer J. P., 2004, HDB PROTEOLYTIC ENZY, P1612; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SIMMER JP, 2004, BIOMINERALIZATION FO, P348; Sire JY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-246; Smid JR, 2001, EUR J ORAL SCI, V109, P260, DOI 10.1034/j.1600-0722.2001.00025.x; Smith C E, 1987, Adv Dent Res, V1, P162; Smith C E, 1996, Adv Dent Res, V10, P159; SMITH CE, 1989, ANAT REC, V224, P292, DOI 10.1002/ar.1092240219; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; SOGNNAES RF, 1949, J DENT RES, V28, P549, DOI 10.1177/00220345490280060401; Sun Z, 2008, J DENT RES, V87, P1133, DOI 10.1177/154405910808701212; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Turk BE, 2006, BIOCHEMISTRY-US, V45, P3863, DOI 10.1021/bi052252o; Wakida K, 1999, HISTOCHEM CELL BIOL, V111, P297, DOI 10.1007/s004180050360; WARSHAWSKY H, 1982, J DENT RES, V61, P1504; Weiss DJ, 1999, HISTOCHEM J, V31, P231, DOI 10.1023/A:1003642025421; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Xi ZJ, 2004, GYNECOL ONCOL, V94, P80, DOI 10.1016/j.ygyno.2004.03.044; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; YOUNG DC, 1993, ANAL BIOCHEM, V215, P24, DOI 10.1006/abio.1993.1549; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	89	115	118	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					19110	19121		10.1074/jbc.M109.013623	http://dx.doi.org/10.1074/jbc.M109.013623			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19578120	Green Published, hybrid			2022-12-25	WOS:000267711500059
J	Barrio, AM; Eriksson, O; Badhai, J; Frojmark, AS; Bongcam-Rudloff, E; Dahl, N; Schuster, J				Barrio, Alvaro Martinez; Eriksson, Oskar; Badhai, Jitendra; Frojmark, Anne-Sophie; Bongcam-Rudloff, Erik; Dahl, Niklas; Schuster, Jens			Targeted Resequencing and Analysis of the Diamond-Blackfan Anemia Disease Locus RPS19	PLOS ONE			English	Article								Background: The Ribosomal protein S19 gene locus (RPS19) has been linked to two kinds of red cell aplasia, Diamond-Blackfan Anemia (DBA) and Transient Erythroblastopenia in Childhood (TEC). Mutations in RPS19 coding sequences have been found in 25% of DBA patients, but not in TEC patients. It has been suggested that non-coding RPS19 sequence variants contribute to the considerable clinical variability in red cell aplasia. We therefore aimed at identifying non-coding variations associated with DBA or TEC phenotypes. Methodology/Principal Findings: We targeted a region of 19'980 bp encompassing the RPS19 gene in a cohort of 89 DBA and TEC patients for resequencing. We provide here a catalog of the considerable, previously unrecognized degree of variation in this region. We identified 73 variations (65 SNPs, 8 indels) that all are located outside of the RPS19 open reading frame, and of which 67.1% are classified as novel. We hypothesize that specific alleles in non-coding regions of RPS19 could alter the binding of regulatory proteins or transcription factors. Therefore, we carried out an extensive analysis to identify transcription factor binding sites (TFBS). A series of putative interaction sites coincide with detected variants. Sixteen of the corresponding transcription factors are of particular interest, as they are housekeeping genes or show a direct link to hematopoiesis, tumorigenesis or leukemia (e. g. GATA-1/2, PU.1, MZF-1). Conclusions: Specific alleles at predicted TFBSs may alter the expression of RPS19, modify an important interaction between transcription factors with overlapping TFBS or remove an important stimulus for hematopoiesis. We suggest that the detected interactions are of importance for hematopoiesis and could provide new insights into individual response to treatment.			Barrio, AM (corresponding author), Uppsala Univ, Swedish Univ Agr Sci, Linnaeus Ctr Bioinformat, Uppsala, Sweden.	jens.schuster@genpat.uu.se	Schuster, Jens/D-2005-2010	Schuster, Jens/0000-0002-4383-9880; Badhai, Jitendra/0000-0002-9526-3748; Bongcam-Rudloff, Erik/0000-0002-1947-8288	NHLBI NIH HHS [R01 HL079567, 5R01-HL079567-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079567] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; ALTER BP, 1996, ONCOLOGIST, V1, P361; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bairagya BB, 2008, INFECT GENET EVOL, V8, P360, DOI 10.1016/j.meegid.2008.02.009; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Campagnoli MF, 2008, HUM MUTAT; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; CMEJLA R, 2007, HUM MUTAT; Da Costa L, 2003, BLOOD, V101, P318, DOI 10.1182/blood-2002-04-1131; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Ellis SR, 2006, MED HYPOTHESES, V66, P643, DOI 10.1016/j.mehy.2005.09.010; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; FISCHER KD, 1993, J BIOL CHEM, V268, P23915; Fullerton SM, 2004, HUM GENET, V115, P36, DOI 10.1007/s00439-004-1106-x; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gingras ME, 2009, INVEST OPHTH VIS SCI, V50, P57, DOI 10.1167/iovs.08-2059; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; GRILLI M, 1993, INT REV CYTOL, V143, P1; Gustavsson P, 1997, NAT GENET, V16, P368, DOI 10.1038/ng0897-368; Gustavsson P, 1998, AM J HUM GENET, V63, P1388, DOI 10.1086/302100; Gustavsson P, 2002, BRIT J HAEMATOL, V119, P261, DOI 10.1046/j.1365-2141.2002.03776.x; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hromas R, 1996, CURR TOP MICROBIOL, V211, P159; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kastner P, 2008, INT J BIOCHEM CELL B, V40, P22, DOI 10.1016/j.biocel.2007.01.026; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; LARSSON L, 2008, GENES IMMUN; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Miller RD, 2005, GENOMICS, V86, P117, DOI 10.1016/j.ygeno.2005.04.012; MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527; NAN H, 2008, CANC CAUSES CONTROL; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Shoulders CC, 2004, NAT GENET, V36, P322, DOI 10.1038/ng0404-322; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; SKEPPNER G, 1993, ACTA PAEDIATR, V82, P574, DOI 10.1111/j.1651-2227.1993.tb12757.x; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Stojanovic N, 1999, NUCLEIC ACIDS RES, V27, P3899, DOI 10.1093/nar/27.19.3899; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Todd JA, 1996, NATURE, V384, P407, DOI 10.1038/384407a0; VLACHOS A, 2008, BR J HAEMATOL; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Willig TN, 1999, BLOOD, V94, P4294; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	64	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6172	10.1371/journal.pone.0006172	http://dx.doi.org/10.1371/journal.pone.0006172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587786	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035100004
J	Johansson, S; Salmon-Divon, M; Johansson, MH; Pickman, Y; Brodin, P; Karre, K; Mehr, R; Hoglund, P				Johansson, Sofia; Salmon-Divon, Mali; Johansson, Maria H.; Pickman, Yishai; Brodin, Petter; Karre, Klas; Mehr, Ramit; Hoglund, Petter			Probing Natural Killer Cell Education by Ly49 Receptor Expression Analysis and Computational Modelling in Single MHC Class I Mice	PLOS ONE			English	Article								Murine natural killer (NK) cells express inhibitory Ly49 receptors for MHC class I molecules, which allows for "missing self" recognition of cells that downregulate MHC class I expression. During murine NK cell development, host MHC class I molecules impose an "educating impact" on the NK cell pool. As a result, mice with different MHC class I expression display different frequency distributions of Ly49 receptor combinations on NK cells. Two models have been put forward to explain this impact. The two-step selection model proposes a stochastic Ly49 receptor expression followed by selection for NK cells expressing appropriate receptor combinations. The sequential model, on the other hand, proposes that each NK cell sequentially expresses Ly49 receptors until an interaction of sufficient magnitude with self-class I MHC is reached for the NK cell to mature. With the aim to clarify which one of these models is most likely to reflect the actual biological process, we simulated the two educational schemes by mathematical modelling, and fitted the results to Ly49 expression patterns, which were analyzed in mice expressing single MHC class I molecules. Our results favour the two-step selection model over the sequential model. Furthermore, the MHC class I environment favoured maturation of NK cells expressing one or a few self receptors, suggesting a possible step of positive selection in NK cell education. Based on the predicted Ly49 binding preferences revealed by the model, we also propose, that Ly49 receptors are more promiscuous than previously thought in their interactions with MHC class I molecules, which was supported by functional studies of NK cell subsets expressing individual Ly49 receptors.			Johansson, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	mehrra@mail.biu.ac.il; petter.hoglund@ki.se	Johansson, Sofia/B-9043-2011; Höglund, Petter/AAV-7443-2021; Salmon-Divon, Mali/AAG-4479-2019; Brodin, Petter/C-3317-2011	Johansson, Sofia/0000-0002-9295-6266; Salmon-Divon, Mali/0000-0002-7272-0846; Brodin, Petter/0000-0002-8103-0046; Mehr, Ramit/0000-0002-4303-6834				Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; BRODIN P, 2009, TRENDS IMMUNOL; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Fahlen L, 2001, J IMMUNOL, V166, P6585, DOI 10.4049/jimmunol.166.11.6585; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gorfine M, 2003, B MATH BIOL, V65, P1131, DOI 10.1016/S0092-8240(03)00062-4; Gumperz JE, 1996, J EXP MED, V183, P1817, DOI 10.1084/jem.183.4.1817; Hanke T, 2001, EUR J IMMUNOL, V31, P3370, DOI 10.1002/1521-4141(200111)31:11<3370::AID-IMMU3370>3.0.CO;2-2; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HOGLUND P, 1991, J EXP MED, V174, P327, DOI 10.1084/jem.174.2.327; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Johansson MH, 1998, EUR J IMMUNOL, V28, P4198, DOI 10.1002/(SICI)1521-4141(199812)28:12<4198::AID-IMMU4198>3.0.CO;2-9; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Kase A, 1998, J IMMUNOL, V161, P6133; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Michaelsson J, 2000, EUR J IMMUNOL, V30, P300; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Salcedo M, 1997, J IMMUNOL, V158, P3174; Salmon-Divon M, 2003, B MATH BIOL, V65, P199, DOI 10.1016/S0092-8240(02)00093-9; Salmon-Divon Mali, 2003, Clin Dev Immunol, V10, P183, DOI 10.1080/10446670310001642140; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; Valiante NM, 1997, IMMUNOL REV, V155, P155, DOI 10.1111/j.1600-065X.1997.tb00948.x; Wu MF, 1997, J IMMUNOL, V158, P1628; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	44	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6046	10.1371/journal.pone.0006046	http://dx.doi.org/10.1371/journal.pone.0006046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557128	gold, Green Submitted, Green Published			2022-12-25	WOS:000267356900008
J	Phuchareon, J; Ohta, Y; Woo, JM; Eisele, DW; Tetsu, O				Phuchareon, Janyaporn; Ohta, Yoshihito; Woo, Jonathan M.; Eisele, David W.; Tetsu, Osamu			Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2	PLOS ONE			English	Article								Adenoid cystic carcinoma (ACC) is the second most common malignant neoplasm of the salivary glands. Most patients survive more than 5 years after surgery and postoperative radiation therapy. The 10 year survival rate, however, drops to 40%, due to locoregional recurrences and distant metastases. Improving long-term survival in ACC requires the development of more effective systemic therapies based on a better understanding of the biologic behavior of ACC. Much preclinical research in this field involves the use of cultured cells and, to date, several ACC cell lines have been established. Authentication of these cell lines, however, has not been reported. We performed DNA fingerprint analysis on six ACC cell lines using short tandem repeat (STR) examinations and found that all six cell lines had been contaminated with other cells. ACC2, ACC3, and ACCM were determined to be cervical cancer cells (HeLa cells), whereas the ACCS cell line was composed of T24 urinary bladder cancer cells. ACCNS and CAC2 cells were contaminated with cells derived from non-human mammalian species: the cells labeled ACCNS were mouse cells and the CAC2 cells were rat cells. These observations suggest that future studies using ACC cell lines should include cell line authentication to avoid the use of contaminated or non-human cells.			Phuchareon, J (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Sch Med, Head & Neck Canc Res Lab, San Francisco, CA 94143 USA.	otetsu@ohns.ucsf.edu		Tetsu, Osamu/0000-0003-1820-7539				Azari S, 2007, BIOLOGICALS, V35, P195, DOI 10.1016/j.biologicals.2006.10.001; Bradley Patrick J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P127, DOI 10.1097/00020840-200404000-00013; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CARLSON ER, 2008, ORAL PATHOLOGY CLIN, P179; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Chen AM, 2007, INT J RADIAT ONCOL, V67, P988, DOI 10.1016/j.ijrobp.2006.10.044; Choi S, 2008, CLIN CANCER RES, V14, P5081, DOI 10.1158/1078-0432.CCR-08-0245; Chummun S, 2001, BRIT J PLAST SURG, V54, P476, DOI 10.1054/bjps.2001.3636; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dirks WG, 1999, IN VITRO CELL DEV-AN, V35, P558; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Franca CM, 2000, ORAL ONCOL, V36, P248, DOI 10.1016/S1368-8375(99)00087-1; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; GEY GO, 1952, CANCER RES, V12, P264; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Guan XF, 1997, INT J ORAL MAX SURG, V26, P116, DOI 10.1016/S0901-5027(05)80830-6; Harding MA, 2002, CANCER RES, V62, P6981; HE RG, 1986, J W CHINA STOMATOL, V6, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hotte SJ, 2005, J CLIN ONCOL, V23, P585, DOI 10.1200/JCO.2005.06.125; Hu YC, 2002, CANCER GENET CYTOGEN, V135, P120, DOI 10.1016/S0165-4608(01)00580-5; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; KHAFIF A, 2005, ENT-EAR NOSE THROAT, V84; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Laurie SA, 2006, J CLIN ONCOL, V24, P2673, DOI 10.1200/JCO.2005.05.3025; LI SL, 1990, CHUNG HUA KOU CHIANG, V25, P29; Lins AM, 1998, J FORENSIC SCI, V43, P1168; MacLeod RAF, 1999, INT J CANCER, V83, P555; Markovic O, 1998, IN VITRO CELL DEV-AN, V34, P1; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; OTOOLE CM, 1983, NATURE, V301, P429, DOI 10.1038/301429a0; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; SEIFERT G, 1990, PATHOL RES PRACT, V186, P555, DOI 10.1016/S0344-0338(11)80220-7; SHIRASUNA K, 1990, CANCER RES, V50, P4139; Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Takata T, 1999, CANCER, V86, P928, DOI 10.1002/(SICI)1097-0142(19990915)86:6<928::AID-CNCR6>3.3.CO;2-O; TANABE H, 1999, TISSUE CULT RES COMM, V18, P329, DOI DOI 10.11418/JTCA1981.18.4_329; Tanaka N, 2007, ONCOL REP, V17, P335; Yang Ming-liang, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P358	47	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6040	10.1371/journal.pone.0006040	http://dx.doi.org/10.1371/journal.pone.0006040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557180	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356900004
J	Souquiere, S; Mouinga-Ondeme, A; Makuwa, M; Hermine, O; Kazanji, M				Souquiere, Sandrine; Mouinga-Ondeme, Augustin; Makuwa, Maria; Hermine, Olivier; Kazanji, Mirdad			Dynamic Interaction between STLV-1 Proviral Load and T-Cell Response during Chronic Infection and after Immunosuppression in Non-Human Primates	PLOS ONE			English	Article								We used mandrills (Mandrillus sphinx) naturally infected with simian T-cell leukemia virus type 1 (STLV-1) as a model for evaluating the influence of natural STLV-1 infection on the dynamics and evolution of the immune system during chronic infection. Furthermore, in order to evaluate the role of the immune system in controlling the infection during latency, we induced immunosuppression in the infected monkeys. We first showed that the STLV-1 proviral load was higher in males than in females and increased significantly with the duration of infection: mandrills infected for 10-6 years had a significantly higher proviral load than those infected for 2-4 years. Curiously, this observation was associated with a clear reduction in CD4+ T-cell number with age. We also found that the percentage of CD4(+) T cells co-expressing the activation marker HLA-DR and the mean percentage of CD25(+) in CD4(+) and CD8(+) T cells were significantly higher in infected than in uninfected animals. Furthermore, the STLV-1 proviral load correlated positively with T-cell activation but not with the frequency of T cells secreting interferon gamma in response to Tax peptides. Lastly, we showed that, during immunosuppression in infected monkeys, the percentages of CD8(+) T cells expressing HLA-DR+ and of CD4(+) T cells expressing the proliferation marker Ki67 decreased significantly, although the percentage of CD8(+) T cells expressing HLA-DR+ and Ki67 increased significantly by the end of treatment. Interestingly, the proviral load increased significantly after immunosuppression in the monkey with the highest load. Our study demonstrates that mandrills naturally infected with STLV-1 could be a suitable model for studying the relations between host and virus. Further studies are needed to determine whether the different compartments of the immune response during infection induce the long latency by controlling viral replication over time. Such studies would provide important information for the development of immune-based therapeutic strategies.			Souquiere, S (corresponding author), Ctr Int Rech Med Franceville, Unite Retrovirol, BP 769, Franceville, Gabon.	m.kazanji@cirmf.org	Hermine, Olivier/Q-7072-2018	Hermine, Olivier/0000-0003-2574-3874				Akari H, 1998, AIDS RES HUM RETROV, V14, P367, DOI 10.1089/aid.1998.14.367; Asquith B, 2007, P NATL ACAD SCI USA, V104, P8035, DOI 10.1073/pnas.0608832104; Chen SM, 2006, INT IMMUNOL, V18, P269, DOI 10.1093/intimm/dxh366; d'Offay JM, 2007, COMPARATIVE MED, V57, P105; Etenna SLD, 2008, J CLIN MICROBIOL, V46, P3607, DOI 10.1128/JCM.01249-08; Fultz PN, 1997, VIROLOGY, V235, P271, DOI 10.1006/viro.1997.8705; Gabet AS, 2003, INT J CANCER, V107, P74, DOI 10.1002/ijc.11329; GeorgesCourbot MC, 1996, J MED PRIMATOL, V25, P313, DOI 10.1111/j.1600-0684.1996.tb00023.x; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 1996, J ACQ IMMUN DEF SYND, V13, pS132, DOI 10.1097/00042560-199600001-00022; Gessain A., 1996, HUMAN T CELL LYMPHOT, P33; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; HAYAMI M, 1984, INT J CANCER, V33, P179, DOI 10.1002/ijc.2910330205; HOMMA T, 1984, SCIENCE, V225, P716, DOI 10.1126/science.6087453; HUBBARD GB, 1993, LAB ANIM SCI, V43, P301; IJICHI S, 1990, ANN RHEUM DIS, V49, P718, DOI 10.1136/ard.49.9.718; Jacobson S, 2002, J INFECT DIS, V186, pS187, DOI 10.1086/344269; JENKS PJ, 1995, CLIN INFECT DIS, V21, P992, DOI 10.1093/clinids/21.4.992; Kawano N, 2006, TRANSPLANTATION, V82, P840, DOI 10.1097/01.tp.0000235186.30113.c7; Kazanji M, 2006, J GEN VIROL, V87, P1331, DOI 10.1099/vir.0.81582-0; Kazanji M, 2000, J VIROL, V74, P4860, DOI 10.1128/JVI.74.10.4860-4867.2000; Kohno T, 2005, CANCER SCI, V96, P527, DOI 10.1111/j.1349-7006.2005.00080.x; LAGRENADE L, 1990, LANCET, V336, P1345; LEE RV, 1985, NEW ENGL J MED, V312, P118; Li HC, 2004, J INFECT DIS, V190, P1275, DOI 10.1086/423941; Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998; Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997; Makuwa M, 2004, AIDS RES HUM RETROV, V20, P1137, DOI 10.1089/aid.2004.20.1137; Manns A, 1999, J INFECT DIS, V180, P1487, DOI 10.1086/315088; MAYHALL CG, 1981, J MED PRIMATOL, V10, P302; MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1; MONE J, 1992, AIDS RES HUM RETROV, V8, P1653, DOI 10.1089/aid.1992.8.1653; MORGAN OS, 1989, LANCET, V2, P1184; Nakamura N, 1998, TRANSPLANT P, V30, P1324, DOI 10.1016/S0041-1345(98)00261-9; Nerrienet E, 1998, AIDS RES HUM RETROV, V14, P785, DOI 10.1089/aid.1998.14.785; PARKER CE, 1992, VIROLOGY, V188, P628, DOI 10.1016/0042-6822(92)90517-S; SAKAKIBARA I, 1986, J MED PRIMATOL, V15, P311; SAKSENA NK, 1994, VIROLOGY, V198, P297, DOI 10.1006/viro.1994.1033; Slattery JP, 1999, GENOME RES, V9, P525; Souquiere S, 2001, J VIROL, V75, P7086, DOI 10.1128/JVI.75.15.7086-7096.2001; Souquiere S, 2009, J MED PRIMATOL, V38, P279, DOI 10.1111/j.1600-0684.2009.00356.x; Soyama A, 2008, LIVER TRANSPLANT, V14, P647, DOI 10.1002/lt.21414; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; TRAINADORGE V, 1992, AIDS RES HUM RETROV, V8, P97, DOI 10.1089/aid.1992.8.97; TSUJIMOTO H, 1985, JPN J CANCER RES, V76, P911; TSUJIMOTO H, 1987, CANCER RES, V47, P269; TSURUMI H, 1992, AM J HEMATOL, V41, P292, DOI 10.1002/ajh.2830410414; Ureta-Vidal A, 1999, INT J CANCER, V82, P832, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;832::AID-IJC11&gt;3.0.CO;2-P; VAN DS, 2001, MOL BIOL EVOL, V18, P661; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; YOSHIDA M, 1983, GANN, V74, P777; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475	53	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6050	10.1371/journal.pone.0006050	http://dx.doi.org/10.1371/journal.pone.0006050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557183	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356900011
J	Owens, GL; Windsor, DJ; Mui, J; Taylor, JS				Owens, Gregory L.; Windsor, Diana J.; Mui, Justin; Taylor, John S.			A Fish Eye Out of Water: Ten Visual Opsins in the Four-Eyed Fish, Anableps anableps	PLOS ONE			English	Article							COLOR-VISION; MOLECULAR-BASIS; FUNCTIONAL-CHARACTERIZATION; BLUEFIN KILLIFISH; GENE-EXPRESSION; PIGMENT GENE; GREEN; EVOLUTION; RED; DNA	The "four-eyed'' fish Anableps anableps has numerous morphological adaptations that enable above and below-water vision. Here, as the first step in our efforts to identify molecular adaptations for aerial and aquatic vision in this species, we describe the A. anableps visual opsin repertoire. We used PCR, cloning, and sequencing to survey cDNA using unique primers designed to amplify eight sequences from five visual opsin gene subfamilies, SWS1, SWS2, RH1, RH2, and LWS. We also used Southern blotting to count opsin loci in genomic DNA digested with EcoR1 and BamH1. Phylogenetic analyses confirmed the identity of all opsin sequences and allowed us to map gene duplication and divergence events onto a tree of teleost fish. Each of the gene-specific primer sets produced an amplicon from cDNA, indicating that A. anableps possessed and expressed at least eight opsin genes. A second PCR-based survey of genomic and cDNA uncovered two additional LWS genes. Thus, A. anableps has at least ten visual opsins and all but one were expressed in the eyes of the single adult surveyed. Among these ten visual opsins, two have key site haplotypes not found in other fish. Of particular interest is the A. anableps-specific opsin in the LWS subfamily, S180 gamma, with a SHYAA five key site haplotype. Although A. anableps has a visual opsin gene repertoire similar to that found in other fishes in the suborder Cyprinodontoidei, the LWS opsin subfamily has two loci not found in close relatives, including one with a key site haplotype not found in any other fish species. A. anableps opsin sequence data will be used to design in situ probes allowing us to test the hypothesis that opsin gene expression differs in the distinct ventral and dorsal retinas found in this species.			Owens, GL (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	taylorjs@uvic.ca		Tayor, John/0000-0001-6960-9293; Rennison, Diana/0000-0002-5944-0743; Owens, Gregory/0000-0002-4019-5215; Mui, Justin/0000-0001-8546-4266				Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; AVERY JA, 1982, NATURE, V298, P62, DOI 10.1038/298062a0; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chinen A, 2003, GENETICS, V163, P663; Davies WL, 2007, FASEB J, V21, P2713, DOI 10.1096/fj.06-8057com; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Kawamura Satoru, 1995, P105; Leonard DW, 1997, BIOPHYS J, V72, P1382, DOI 10.1016/S0006-3495(97)78784-8; Levenson DH, 2006, J COMP PHYSIOL A, V192, P833, DOI 10.1007/s00359-006-0121-x; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Meyer-Rochow VB, 2003, FISH ADAPTATIONS, P337; MILLER RR, 1979, COPEIA, P82; Minamoto T, 2005, COMP BIOCHEM PHYS B, V140, P197, DOI 10.1016/j.cbpc.2004.09.028; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neafsey DE, 2005, GENE, V350, P161, DOI 10.1016/j.gene.2005.02.011; Nelson JS, 1984, FISHES WORLD; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHWASSMANN HORST O., 1965, VISION RES, V5, P269, DOI 10.1016/0042-6989(65)90004-0; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SIVAK J, 1987, PROC R SOC SER B-BIO, V229, P467, DOI 10.1098/rspb.1987.0005; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; Ward MN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-210; YOKOYAMA R, 1990, VISION RES, V30, P807, DOI 10.1016/0042-6989(90)90049-Q; Yokoyama S, 1999, GENETICS, V153, P919; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yokoyama S, 2008, GENETICS, V179, P2037, DOI 10.1534/genetics.108.090449; Yokoyama S, 2007, GENE, V396, P196, DOI 10.1016/j.gene.2007.03.019; ZAHL PA, 1977, COPEIA, P791; Zhang H, 2000, FEBS LETT, V469, P39, DOI 10.1016/S0014-5793(00)01233-3; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	49	29	29	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5970	10.1371/journal.pone.0005970	http://dx.doi.org/10.1371/journal.pone.0005970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551143	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356500001
J	Kaafarani, I; Fernandez-Sauze, S; Berenguer, C; Chinot, O; Delfino, C; Dussert, C; Metellus, P; Boudouresque, F; Mabrouk, K; Grisoli, F; Figarella-Branger, D; Martin, PM; Ouafik, L				Kaafarani, Itidal; Fernandez-Sauze, Samantha; Berenguer, Caroline; Chinot, Olivier; Delfino, Christine; Dussert, Christophe; Metellus, Philippe; Boudouresque, Francoise; Mabrouk, Kamel; Grisoli, Francois; Figarella-Branger, Dominique; Martin, Pierre-Marie; Ouafik, L'Houcine			Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice	FASEB JOURNAL			English	Article						CLR/RAMP2; CLR/RAMP3; endothelial cells; pericytes; proangiogenic cells	PANCREATIC-CANCER; CELL-LINES; IN-VIVO; HUMAN CARCINOGENESIS; STEM-CELLS; PEPTIDE; EXPRESSION; ABNORMALITIES; PERICYTES; INVASION	Adrenomedullin ( AM) is a multifunctional peptide vasodilator that transduces its effects through calcitonin receptor-like receptor/receptor activity modifying protein-2 and -3 (CLR/RAMP2 and CLR/RAMP3). Previously, we reported on the development of an anti-AM antibody that potently inhibits tumor cell proliferation in vitro and tumor growth in vivo. Here, we report the effect of anti-AM receptor antibodies (alpha AMRs) on angiogenesis and tumor growth. We demonstrate that alpha AMRs decrease in a dose-dependent manner the growth of U87 glioblastoma cells and HT-29 colorectal cancer cells, but not A549 lung cancer cells, in vitro. In vivo, AM in Matrigel plugs induces angiogenesis by promoting recruitment of endothelial cells, pericytes, myeloid precursor cells, and macrophages and by promoting channel formation. Remarkably, systemic administration of alpha AMRs every 3 d markedly reduced neovascularization of Matrigel plugs in a dose-dependent fashion, as demonstrated by reduced numbers of the recruited cells and vessel structures. Several human tumor xenografts in athymic mice were used to examine the effect of alpha AMR treatment on tumor angiogenesis and growth. alpha AMR treatment significantly suppressed the growth of glioblastoma, lung, and colon tumors. Histological examination of alpha AMR-treated tumors showed evidence of disruption of tumor vascularity with decreased microvessel density, depletion of endothelial and pericyte cells, and increased tumor cell apoptosis. These findings support the conclusion that alpha AMR treatment inhibits tumor growth by suppression of angiogenesis and tumor growth and suggest that AMRs may be useful therapeutic targets.-Kaafarani, I., Fernandez-Sauze, S., Berenguer, C., Chinot, O., Delfino, C., Dussert, C., Metellus, P., Boudouresque, F., Mabrouk, K., Grisoli, F., Figarella-Branger, D., Martin, P.-M., Ouafik, L. H. Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice FASEB J. 23, 3424-3435 ( 2009). www.fasebj.org	[Ouafik, L'Houcine] Fac Med Nord, INSERM, UMR 911, CRO2, F-13916 Marseille 20, France; [Kaafarani, Itidal; Fernandez-Sauze, Samantha; Berenguer, Caroline; Chinot, Olivier; Delfino, Christine; Dussert, Christophe; Metellus, Philippe; Boudouresque, Francoise; Martin, Pierre-Marie; Ouafik, L'Houcine] Aix Marseille Univ, Fac Med, Secteur Nord, Expt Cancerol Lab, Marseille, France; [Martin, Pierre-Marie; Ouafik, L'Houcine] AP HM, Lab Transfert Oncol Biol, Marseille, France; [Mabrouk, Kamel] Aix Marseille Univ, Fac St Jerome, Equipe Chim Radicalaire Organ & Polymere Special, Lab Chim Provence,CNRS,UMR 6264, Marseille, France; [Grisoli, Francois] Hop La Timone, AP HM, Serv Neurochirurg, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ouafik, L (corresponding author), Fac Med Nord, INSERM, UMR 911, CRO2, Bd Pierre Dramard, F-13916 Marseille 20, France.	lhoucine.ouafik@univmed.fr	CHINOT, Olivier/M-9196-2018	CHINOT, Olivier/0000-0001-6317-9691; Ouafik, L'Houcine/0000-0002-4848-1232	INSERM; AP-HM; Institut National du Cancer (INCa) [RS019]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HM; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This study was supported by grants from INSERM, AP-HM, and Institut National du Cancer (INCa) ( grant RS019). The Association pour la Recherche contre le Cancer ( ARC) supported I. K., and the Association for Research on Brain Tumors ( ARTC Sud) supported the postdoctoral fellowship of S.F.-S. We thank V. Gagna for excellent secretarial assistance and M. Cayol for skillful technical assistance in animal handling.	Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Cuttitta F, 2002, MICROSC RES TECHNIQ, V57, P110, DOI 10.1002/jemt.10059; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Drew E, 2002, EXP HEMATOL, V30, P1211, DOI 10.1016/S0301-472X(02)00890-1; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Fernandez-Sauze S, 2004, INT J CANCER, V108, P797, DOI 10.1002/ijc.11663; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kapas S, 1995, BIOCHEM BIOPH RES CO, V217, P832, DOI 10.1006/bbrc.1995.2847; KAPAS S, 1995, J BIOL CHEM, V270, P25344, DOI 10.1074/jbc.270.43.25344; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; Lopez J, 2002, INT REV CYTOL, V221, P1; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller MJ, 1996, J BIOL CHEM, V271, P23345; Moody TW, 1997, PEPTIDES, V18, P1111, DOI 10.1016/S0196-9781(97)00179-4; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; NJUKI F, 1993, CLIN SCI, V85, P385, DOI 10.1042/cs0850385; Ouafik L, 2002, AM J PATHOL, V160, P1279, DOI 10.1016/S0002-9440(10)62555-2; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Rocchi P, 2001, CANCER RES, V61, P1196; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Zudaire E, 2006, AM J PATHOL, V168, P280, DOI 10.2353/ajpath.2006.050291	35	55	61	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3424	3435		10.1096/fj.08-127852	http://dx.doi.org/10.1096/fj.08-127852			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19546305				2022-12-25	WOS:000270354300020
J	Hegde, S; Ni, S; He, S; Yoon, D; Feng, GS; Watowich, SS; Paulson, RF; Hankey, PA				Hegde, S.; Ni, S.; He, S.; Yoon, D.; Feng, G. S.; Watowich, S. S.; Paulson, R. F.; Hankey, P. A.			Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation	ONCOGENE			English	Article						Stk; Ron; Gab2; Stat3; Pu.1; leukemia	RECEPTOR TYROSINE KINASE; FRIEND-VIRUS; LEUKEMIA VIRUS; CELLS; MICE; ACTIVATION; GROWTH; GENE; POLYCYTHEMIA; GATA-1	Leukemogenesis requires two classes of mutations, one that promotes proliferation and one that blocks differentiation. The erythroleukemia induced by Friend virus is a multi-stage disease characterized by an early proliferative stage driven by the interaction of the viral glycoprotein, gp55, with Sf-Stk and the EpoR, and a late block to differentiation resulting from retroviral insertion in the Pu.1 locus. We demonstrate here that activation of Stat3 by Sf-Stk in the early stage of disease is essential for the progression of erythroleukemia in the presence of differentiation signals induced by the EpoR, but is dispensable in the late stages of the disease. Furthermore, we identify Pu.1 as a Stat3 target gene in the early stages of erythroleukemia development. Our results support a model whereby the activation of Stat3 in the early stage of disease plays a pivotal role in regulating differentiation through the upregulation of Pu.1, thus inhibiting differentiation and favoring the expansion of infected erythroblasts and enhancing the pool of progenitors available for the acquisition of additional mutations, including insertional activation of Pu.1, resulting in full leukemic transformation. Oncogene (2009) 28, 3349-3359; doi: 10.1038/onc.2009.202; published online 6 July 2009	[Hegde, S.; Ni, S.; He, S.; Paulson, R. F.; Hankey, P. A.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Ni, S.; Paulson, R. F.; Hankey, P. A.] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; [He, S.; Paulson, R. F.; Hankey, P. A.] Penn State Univ, Grad Program Pathobiol, University Pk, PA 16802 USA; [Yoon, D.; Watowich, S. S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Yoon, D.; Watowich, S. S.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Yoon, D.; Watowich, S. S.] Grad Sch Biomed Sci, Program Immunol, Houston, TX USA; [Feng, G. S.] Burnham Inst Med Res, La Jolla, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sanford Burnham Prebys Medical Discovery Institute	Hankey, PA (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 115 Henning Bldg, University Pk, PA 16802 USA.	phc7@psu.edu	he, shihan/N-8067-2014	he, shihan/0000-0001-5806-8583; Watowich, Stephanie/0000-0003-1969-659X	National Institutes of Health [R01 HL066571]; Leukemia and Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066571, R01HL066471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant R01 HL066571 from the National Institutes of Health and by a scholar award from the Leukemia and Lymphoma Society to P Hankey.	Afrikanova I, 2002, ONCOGENE, V21, P1272, DOI 10.1038/sj.onc.1205183; CHESEBRO B, 1981, VIROLOGY, V112, P131, DOI 10.1016/0042-6822(81)90619-X; Choe KS, 2003, CANCER RES, V63, P6363; Constantinescu SN, 2003, J BIOL CHEM, V278, P43755, DOI 10.1074/jbc.M302974200; Fang C, 1998, VIROLOGY, V252, P46, DOI 10.1006/viro.1998.9453; Finkelstein LD, 2002, ONCOGENE, V21, P3562, DOI 10.1038/sj.onc.1205442; Kosmider O, 2005, CANCER CELL, V8, P467, DOI 10.1016/j.ccr.2005.11.009; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; MAGER DL, 1981, P NATL ACAD SCI-BIOL, V78, P1703, DOI 10.1073/pnas.78.3.1703; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Ney PA, 2000, BLOOD, V96, P3675, DOI 10.1182/blood.V96.12.3675.h8003675_3675_3680; Ni S, 2007, MOL CELL BIOL, V27, P3708, DOI 10.1128/MCB.01838-06; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Papetti M, 2007, MOL CANCER RES, V5, P1053, DOI 10.1158/1541-7786.MCR-07-0145; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Shimizu R, 2004, MOL CELL BIOL, V24, P10814, DOI 10.1128/MCB.24.24.10814-10825.2004; TAMBOURIN PE, 1973, BRIT J HAEMATOL, V24, P511, DOI 10.1111/j.1365-2141.1973.tb01677.x; Teal HE, 2006, ONCOGENE, V25, P2433, DOI 10.1038/sj.onc.1209288; Yang J, 2005, CANCER RES, V65, P939; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang J, 2006, BLOOD, V107, P73, DOI 10.1182/blood-2005-05-1784; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	24	30	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 24	2009	28	38					3349	3359		10.1038/onc.2009.202	http://dx.doi.org/10.1038/onc.2009.202			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	497ZD	19581930	Green Accepted			2022-12-25	WOS:000270103300002
J	Zakrzewska, M; Wiedlocha, A; Szlachcic, A; Krowarsch, D; Otlewski, J; Olsnes, S				Zakrzewska, Malgorzata; Wiedlocha, Antoni; Szlachcic, Anna; Krowarsch, Daniel; Otlewski, Jacek; Olsnes, Sjur			Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SITE-DIRECTED MUTAGENESIS; DIFFERENTIAL TYROSINE PHOSPHORYLATION; FACTOR-I; RECEPTOR-BINDING; DNA-SYNTHESIS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; TRANSLOCATION; SULFATE	Human FGF1 (fibroblast growth factor 1) is a powerful signaling molecule with a short half-life in vivo and a denaturation temperature close to physiological. Binding to heparin increases the stability of FGF1 and is believed to be important in the formation of FGF1.fibroblast growth factor receptor (FGFR) active complex. In order to reveal the function of heparin in FGF1.FGFR complex formation and signaling, we constructed several FGF1 variants with reduced affinity for heparin and with diverse stability. We determined their biophysical properties and biological activities as well as their ability to translocate across cellular membranes. Our study showed that increased thermodynamic stability of FGF1 nicely compensates for decreased binding of heparin in FGFR activation, induction of DNA synthesis, and cell proliferation. By stepwise introduction of stabilizing mutations into the K118E (K132E) FGF1 variant that shows reduced affinity for heparin and is inactive in stimulation of DNA synthesis, we were able to restore the full mitogenic activity of this mutant. Our results indicate that the main role of heparin in FGF-induced signaling is to protect this naturally unstable protein against heat and/or proteolytic degradation and that heparin is not essential for a direct FGF1-FGFR interaction and receptor activation.	[Olsnes, Sjur] Norwegian Radium Hosp, Dept Biochem, Inst Canc Res, N-0310 Oslo, Norway; [Olsnes, Sjur] Univ Oslo, Ctr Canc Biomed, N-0310 Oslo, Norway; [Zakrzewska, Malgorzata; Szlachcic, Anna; Otlewski, Jacek] Univ Wroclaw, Dept Prot Engn, PL-50137 Wroclaw, Poland; [Krowarsch, Daniel] Univ Wroclaw, Dept Prot Biotechnol, Fac Biotechnol, PL-50137 Wroclaw, Poland	University of Oslo; University of Oslo; University of Wroclaw; University of Wroclaw	Olsnes, S (corresponding author), Norwegian Radium Hosp, Dept Biochem, Inst Canc Res, N-0310 Oslo, Norway.	olsnes@radium.uio.no		Szlachcic, Anna/0000-0003-0574-1476; Krowarsch, Daniel/0000-0003-2856-218X; Zakrzewska, Malgorzata/0000-0001-8214-1533	Polish Ministry of Science and Higher Education [N N301 4192 33]; Norwegian Cancer Society	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by Polish Ministry of Science and Higher Education Grant N N301 4192 33, by the Norwegian Cancer Society, by Raquel and Chr. Bruuns legat, and by Torsteds legat.	Blaber SI, 1999, BIOPHYS J, V77, P470, DOI 10.1016/S0006-3495(99)76904-3; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; Citores L, 2001, J CELL SCI, V114, P1677; Culajay JF, 2000, BIOCHEMISTRY-US, V39, P7153, DOI 10.1021/bi9927742; DAMON DH, 1989, J CELL PHYSIOL, V138, P221, DOI 10.1002/jcp.1041380202; de Paz JL, 2001, CHEMBIOCHEM, V2, P673, DOI 10.1002/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7; Delehedde M, 2000, J BIOL CHEM, V275, P33905, DOI 10.1074/jbc.M005949200; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V138, P611, DOI 10.1016/S0006-291X(86)80540-X; GLEIZES PE, 1995, EUR J CELL BIOL, V66, P47; Gospodarowicz D., 1986, J CELL PHYSL, V128, P475, DOI DOI 10.1002/JCP.1041280317; HARPER JW, 1988, BIOCHEMISTRY-US, V27, P671, DOI 10.1021/bi00402a027; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; IMAMURA T, 1994, EXP CELL RES, V215, P363, DOI 10.1006/excr.1994.1353; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Klingenberg O, 1998, J BIOL CHEM, V273, P11164, DOI 10.1074/jbc.273.18.11164; Klingenberg O, 1999, J BIOL CHEM, V274, P18081, DOI 10.1074/jbc.274.25.18081; Lundin L, 2003, EXP CELL RES, V287, P190, DOI 10.1016/S0014-4827(03)00125-3; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Motomura K, 2008, BBA-GEN SUBJECTS, V1780, P1432, DOI 10.1016/j.bbagen.2008.08.001; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORTEGA S, 1991, J BIOL CHEM, V266, P5842; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; PRESTA M, 1992, BIOCHEM BIOPH RES CO, V185, P1098, DOI 10.1016/0006-291X(92)91739-D; Regan JC, 2009, NEURON, V61, P27, DOI 10.1016/j.neuron.2008.11.030; ROGHANI M, 1992, J BIOL CHEM, V267, P22156; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sorensen V, 2008, MOL CELL BIOL, V28, P4129, DOI 10.1128/MCB.02117-07; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Szlachcic A, 2009, ACTA CRYSTALLOGR D, V65, P67, DOI 10.1107/S0907444908039486; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; Waksman G, 1998, NAT STRUCT BIOL, V5, P527, DOI 10.1038/778; Wesche J, 2000, BIOCHEMISTRY-US, V39, P15091, DOI 10.1021/bi001831k; Wiedlocha A, 1995, J BIOL CHEM, V270, P30680, DOI 10.1074/jbc.270.51.30680; Wiedlocha A, 2005, MOL BIOL CELL, V16, P794; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Wiedlocha A, 1996, MOL CELL BIOL, V16, P270; WONG P, 1995, J BIOL CHEM, V270, P25805, DOI 10.1074/jbc.270.43.25805; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066; Zakrzewska M, 2004, PROTEIN ENG DES SEL, V17, P603, DOI 10.1093/protein/gzh076; Zakrzewska M, 2006, BIOCHEMISTRY-US, V45, P15338, DOI 10.1021/bi0618114; ZHAN X, 1993, J BIOL CHEM, V268, P9611; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	60	47	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25388	25403		10.1074/jbc.M109.001289	http://dx.doi.org/10.1074/jbc.M109.001289			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19574212	Green Published, hybrid			2022-12-25	WOS:000269734000071
J	Bue, CA; Barlowe, C				Bue, Catherine A.; Barlowe, Charles			Molecular Dissection of Erv26p Identifies Separable Cargo Binding and Coat Protein Sorting Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; TRANSPORT VESICLES; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; SECRETORY PATHWAY; GOLGI TRANSPORT; LECTIN ERGIC-53; COPII; ER	Efficient export of secretory alkaline phosphatase (ALP) from the endoplasmic reticulum depends on the conserved transmembrane sorting adaptor Erv26p/Svp26p. In the present study we investigated the mechanism by which Erv26p couples pro-ALP to the coat protein complex II (COPII) export machinery. Site-specific mutations were introduced into Erv26p, and mutant proteins were assessed in cell-free assays that monitor interactions with pro-ALP cargo and packaging into COPII vesicles. Mutations in the second and third loop domains of Erv26p inhibited interaction with pro-ALP, whereas mutations in the C-terminal tail sequence influenced incorporation into COPII vesicles and subcellular distribution. Interestingly mutations in the second loop domain also influenced Erv26p homodimer associations. Finally we demonstrated that Ktr3p, a cis-Golgi-localized mannosyltransferase, also relies on Erv26p for efficient COPII-dependent export from the endoplasmic reticulum. These findings demonstrate that Erv26p acts as a protein sorting adaptor for a variety of Type II transmembrane cargo proteins and requires domain-specific interactions with both cargo and coat subunits to promote efficient secretory protein transport.	[Bue, Catherine A.; Barlowe, Charles] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	barlowe@dartmouth.edu			National Institutes of Health [T32GM008704, GM052549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052549, T32GM008704, R37GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008704 ( to C. A. B.) and GM052549.	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; AUSUBEL RM, 1987, CURRENT PROTOCOLS MO; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Boulanger RR, 2003, J BIOL CHEM, V278, P23497, DOI 10.1074/jbc.M301105200; Bue CA, 2006, MOL BIOL CELL, V17, P4780, DOI 10.1091/mbc.E06-05-0455; CLARK DW, 1982, J BACTERIOL, V152, P865; Dancourt J, 2009, TRAFFIC, V10, P1006, DOI 10.1111/j.1600-0854.2009.00936.x; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hauri HP, 2000, J CELL SCI, V113, P587; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2002, J CELL SCI, V115, P619; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Olson LJ, 2008, J BIOL CHEM, V283, P10124, DOI 10.1074/jbc.M708994200; ONISHI HR, 1979, J BIOL CHEM, V254, P1943; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Sato K, 2003, MOL BIOL CELL, V14, P3055, DOI 10.1091/mbc.E03-02-0115; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yeung T, 1995, J BIOL CHEM, V270, P30567, DOI 10.1074/jbc.270.51.30567	49	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24049	24060		10.1074/jbc.M109.022590	http://dx.doi.org/10.1074/jbc.M109.022590			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574229	hybrid, Green Published			2022-12-25	WOS:000269380200019
J	Nakada, S; Sakakura, M; Takahashi, H; Okuda, S; Tokuda, H; Shimada, I				Nakada, Shingo; Sakakura, Masayoshi; Takahashi, Hideo; Okuda, Suguru; Tokuda, Hajime; Shimada, Ichio			Structural Investigation of the Interaction between LolA and LolB Using NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI LIPOPROTEINS; INNER MEMBRANE; HYDROPHOBIC CAVITY; FATTY-ACID; PROTEIN; LOCALIZATION; BINDING; RELEASE; TRANSPORTER	Lipoproteins that play critical roles in various cellular functions of Gram-negative bacteria are localized in the cells inner and outer membranes. Lol proteins (LolA, LolB, LolC, LolD, and LolE) are involved in the transportation of outer membrane-directed lipoproteins from the inner to the outer membrane. LolA is a periplasmic chaperone that transports lipoproteins, and LolB is an outer membrane receptor that accepts lipoproteins. To clarify the structural basis for the lipoprotein transfer from LolA to LolB, we examined the interaction between LolA and mLolB, a soluble mutant of LolB, using solution NMR spectroscopy. We determined the interaction mode between LolA and mLolB with conformational changes of LolA. Based upon the observations, we propose that the LolA center dot LolB complex forms a tunnel-like structure, where the hydrophobic insides of LolA and LolB are connected, which enables lipoproteins to transfer from LolA to LolB.	[Nakada, Shingo; Sakakura, Masayoshi; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Nakada, Shingo] Dainippon Sumitomo Pharma Ltd, Lab Genom Sci, Osaka 5640053, Japan; [Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Okuda, Suguru; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Okuda, Suguru/K-6571-2017	Okuda, Suguru/0000-0002-9184-5601				BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Braun V., 1994, BACTERIAL CELL WALL, P319, DOI 10.1016/S0167-7306(08)60417-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Hajduk PJ, 1997, J MED CHEM, V40, P3144, DOI 10.1021/jm9703404; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Nakada S, 2007, BIOMOL NMR ASSIGN, V1, P125, DOI 10.1007/s12104-007-9034-z; Nakada S, 2007, BIOMOL NMR ASSIGN, V1, P121, DOI 10.1007/s12104-007-9033-0; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Narita S, 2003, MOL MICROBIOL, V49, P167, DOI 10.1046/j.1365-2958.2003.03569.x; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Oguchi Y, 2008, J BIOL CHEM, V283, P25414, DOI 10.1074/jbc.M804736200; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tokuda H, 2007, PERIPLASM, P67; Wada R, 2004, BIOCHEM BIOPH RES CO, V323, P1069, DOI 10.1016/j.bbrc.2004.08.200; Watanabe S, 2008, J BIOL CHEM, V283, P25421, DOI 10.1074/jbc.M804737200; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	32	15	17	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24634	24643		10.1074/jbc.M109.001149	http://dx.doi.org/10.1074/jbc.M109.001149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19546215	Green Published, hybrid			2022-12-25	WOS:000269380200072
J	Kroeger, H; Miranda, E; MacLeod, I; Perez, J; Crowther, DC; Marciniak, SJ; Lomas, DA				Kroeger, Heike; Miranda, Elena; MacLeod, Ian; Perez, Juan; Crowther, Damian C.; Marciniak, Stefan J.; Lomas, David A.			Endoplasmic Reticulum-associated Degradation (ERAD) and Autophagy Cooperate to Degrade Polymerogenic Mutant Serpins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; CONFORMATIONAL DISEASE; ALPHA(1)-ANTITRYPSIN Z; PROTEASOME ACTIVITY; STRESS; ACCUMULATION; NEUROSERPIN; PATHWAY; SERPINOPATHIES	The serpinopathies are a family of diseases characterized by the accumulation of ordered polymers of mutant protein within the endoplasmic reticulum. They are a diverse group including alpha(1)-antitrypsin deficiency and the inherited dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB. We have used transient transfection of COS7 cells and mouse embryonic fibroblasts, PC12 cell lines that conditionally express wild type and mutant neuroserpin and fly models of FENIB to assess the cellular handling of wild type and mutant serpins. By using a polymer-specific monoclonal antibody, we show that mutant neuroserpin forms polymers after a delay of at least 30 min and that polymers can be cleared in PC12 cell lines and from the brain in a fly model of FENIB. At steady state, the fractions of intracellular polymerogenic G392E mutant neuroserpin in the monomeric and polymeric states are comparable. Inhibition of the proteasome with MG132 reveals that both mutant neuroserpin and alpha(1)-antitrypsin are degraded predominantly by endoplasmic reticulum-associated degradation (ERAD). Pharmacological and genetic inhibitions demonstrate that autophagy is responsible for bulk turnover of wild type and mutant serpins, but can be stimulated by rapamycin to compensate for proteasome inhibition. The significance of these findings to the treatment of serpinopathies is discussed.	[Kroeger, Heike; Miranda, Elena; MacLeod, Ian; Perez, Juan; Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Perez, Juan] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain; [MacLeod, Ian; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; Universidad de Malaga; University of Cambridge	Marciniak, SJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	sjm20@cam.ac.uk	Miranda, Elena/J-4999-2012; Marciniak, Stefan J/F-1855-2010	Miranda, Elena/0000-0002-0586-8795; Marciniak, Stefan/0000-0001-8472-7183	Medical Research Council [G0700990]; Engineering and Physical Sciences Research Council; Alzheimer Research Trust; Papworth National Health Service Trust; German Academic Exchange Service (DAAD); Ministerio de Ciencia e Innovacion [PR2008-0615, BFU 2006-11754]; MRC [G0700990, G0500306, G0601840] Funding Source: UKRI; Medical Research Council [G0500306, G0601840] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer Research Trust; Papworth National Health Service Trust; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the Medical Research Council, Engineering and Physical Sciences Research Council, the Alzheimer Research Trust, and the Papworth National Health Service Trust.; 1 Funded by the German Academic Exchange Service (DAAD).; 2 Supported by the Ministerio de Ciencia e Innovacion, Grants PR2008-0615 and BFU 2006-11754 (Spain).; 3 Supported by the MRC (Grant G0700990).; 5 An MRC Clinician Scientist (Grant G0601840).	Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Gooptu B, 2008, J EXP MED, V205, P1529, DOI 10.1084/jem.20072080; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lomas DA, 2002, J CLIN INVEST, V110, P1585, DOI 10.1172/JCI200216782; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MCCRACKEN AA, 1993, MOL BIOL CELL, V4, P729, DOI 10.1091/mbc.4.7.729; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070, DOI 10.1093/jnen/59.12.1070; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	103	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22793	22802		10.1074/jbc.M109.027102	http://dx.doi.org/10.1074/jbc.M109.027102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19549782	hybrid, Green Published			2022-12-25	WOS:000268963100033
J	Redhu, NS; Saleh, A; Shan, LY; Gerthoffer, WT; Kung, SK; Halayko, AJ; Lamkhioued, B; Gounni, AS				Redhu, Naresh Singh; Saleh, Ali; Shan, Lianyu; Gerthoffer, William T.; Kung, Sam K.; Halayko, Andrew J.; Lamkhioued, Bouchaib; Gounni, Abdelilah S.			Proinflammatory and Th2 Cytokines Regulate the High Affinity IgE Receptor (Fc epsilon RI) and IgE-Dependant Activation of Human Airway Smooth Muscle Cells	PLOS ONE			English	Article								Background: The high affinity IgE receptor (Fc epsilon RI) is a crucial structure for IgE-mediated allergic reactions. We have previously demonstrated that human airway smooth muscle (ASM) cells express the tetrameric (alpha beta gamma 2) Fc epsilon RI, and its activation leads to marked transient increases in intracellular Ca2+ concentration, release of Th-2 cytokines and eotaxin-1/CCL11. Therefore, it was of utmost importance to delineate the factors regulating the expression of Fc epsilon RI in human (ASM) cells. Methodology/Principal Findings: Incubation of human bronchial and tracheal smooth muscle (B/TSM) cells with TNF-alpha, IL-1 beta or IL-4 resulted in a significant increase in Fc epsilon RI-alpha chain mRNA expression (p<0.05); and TNF-alpha, IL-4 enhanced the Fc epsilon RI-alpha protein expression compared to the unstimulated control at 24, 72 hrs after stimulation. Interestingly, among all other cytokines, only TNF-alpha upregulated the Fc epsilon RI-gamma mRNA expression. Fc epsilon RI-gamma protein expression remained unchanged despite the nature of stimulation. Of note, as a functional consequence of Fc epsilon RI upregulation, TNF-alpha pre-sensitization of B/TSM potentially augmented the CC (eotaxin-1/CCL11 and RANTES/CCL5, but not TARC/CCL17) and CXC (IL-8/CXCL8, IP-10/CXCL10) chemokines release following IgE stimulation (p<0.05, n = 3). Furthermore, IgE sensitization of B/TSM cells significantly enhanced the transcription of selective CC and CXC chemokines at promoter level compared to control, which was abolished by Lentivirus-mediated silencing of Syk expression. Conclusions/Significance: Our data depict a critical role of B/TSM in allergic airway inflammation via potentially novel mechanisms involving proinflammatory, Th2 cytokines and IgE/Fc epsilon RI complex.			Redhu, NS (corresponding author), Univ Manitoba, Sect Resp Dis, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	LAMKHIOUED, Bouchaib/AAL-4201-2021; Gounni, Abdelilah Soussi/AAH-3456-2020	Halayko, Andrew/0000-0002-7865-4552; Gerthoffer, William/0000-0001-5154-4962; Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560	NHLBI NIH HHS [R01 HL077726] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077726] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Ganguly S, 2007, J BIOL CHEM, V282, P32758, DOI 10.1074/jbc.M705950200; Gomez G, 2005, J IMMUNOL, V174, P5987, DOI 10.4049/jimmunol.174.10.5987; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gounni AS, 2006, AM J PHYSIOL-LUNG C, V291, pL312, DOI 10.1152/ajplung.00005.2006; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Hakonarson H, 1998, P NATL ACAD SCI USA, V95, P5257, DOI 10.1073/pnas.95.9.5257; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Hirst SJ, 2002, AM J RESP CRIT CARE, V165, P1161, DOI 10.1164/ajrccm.165.8.2107158; Holgate ST, 2004, J ROY SOC MED, V97, P103, DOI 10.1258/jrsm.97.3.103; Jarai G, 2004, EUR J PHARMACOL, V497, P255, DOI 10.1016/j.ejphar.2004.06.055; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Katoh N, 2000, J CLIN INVEST, V105, P183, DOI 10.1172/JCI6895; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kraft S, 1998, J IMMUNOL, V161, P1000; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; Leath TM, 2005, DRUG DISCOV TODAY, V10, P1647, DOI 10.1016/S1359-6446(05)03646-9; LETOURNEUR O, 1995, J BIOL CHEM, V270, P8249, DOI 10.1074/jbc.270.14.8249; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; Mirkina I, 2007, IMMUNOL LETT, V109, P120, DOI 10.1016/j.imlet.2007.02.003; Moore PE, 2002, AM J PHYSIOL-LUNG C, V282, pL847, DOI 10.1152/ajplung.00245.2001; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Nechansky A, 1997, HYBRIDOMA, V16, P441, DOI 10.1089/hyb.1997.16.441; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Peat JK, 1996, ALLERGY, V51, P804, DOI 10.1111/j.1398-9995.1996.tb00026.x; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Schmidt D, 2000, J ALLERGY CLIN IMMUN, V105, P673, DOI 10.1067/mai.2000.105705; Terada N, 1995, J ALLERGY CLIN IMMUN, V96, P1161, DOI 10.1016/S0091-6749(95)70201-6; Thomas LH, 2007, CLIN IMMUNOL, V122, P229, DOI 10.1016/j.clim.2006.10.004; Tirumurugaan KG, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-26; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Widegren H, 2007, RESP MED, V101, P1982, DOI 10.1016/j.rmed.2007.04.005; Xia HZ, 1997, J IMMUNOL, V159, P2911; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6	48	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6153	10.1371/journal.pone.0006153	http://dx.doi.org/10.1371/journal.pone.0006153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582151	Green Submitted, gold, Green Published			2022-12-25	WOS:000267806400009
J	Majhi, SK; Hattori, RS; Yokota, M; Watanabe, S; Struessmann, CA				Majhi, Sullip K.; Hattori, Ricardo S.; Yokota, Masashi; Watanabe, Seiichi; Struessmann, Carlos A.			Germ Cell Transplantation Using Sexually Competent Fish: An Approach for Rapid Propagation of Endangered and Valuable Germlines	PLOS ONE			English	Article							SPERMATOGONIAL TRANSPLANTATION; ODONTESTHES-BONARIENSIS; STEM-CELLS; SPERMATOGENESIS; TESTIS; AQUACULTURE; DEFICIENCY; GENERATION; FERTILITY; TILAPIA	The transplantation of germ cells into adult recipient gonads is a tool with wide applications in animal breeding and conservation of valuable and/or endangered species; it also provides a means for basic studies involving germ cell (GC) proliferation and differentiation. Here we describe the establishment of a working model for xenogeneic germ cell transplantation (GCT) in sexually competent fish. Spermatogonial cells isolated from juveniles of one species, the pejerrey Odontesthes bonariensis (Atherinopsidae), were surgically transplanted into the gonads of sexually mature Patagonian pejerrey O. hatcheri, which have been partially depleted of endogenous GCs by a combination of Busulfan (40 mg/kg) and high water temperature (25 degrees C) treatments. The observation of the donor cells' behavior showed that transplanted spermatogonial cells were able to recolonize the recipients' gonads and resume spermatogenesis within 6 months from the GCT. The presence of donor-derived gametes was confirmed by PCR in 20% of the surrogate O. hatcheri fathers at 6 months and crosses with O. bonariensis mothers produced hybrids and pure O. bonariensis, with donor-derived germline transmission rates of 1.2 - 13.3%. These findings indicate that transplantation of spermatogonial cells into sexually competent fish can shorten considerably the production time of donor-derived gametes and offspring and could play a vital role in germline conservation and propagation of valued and/or endangered fish species.			Majhi, SK (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Tokyo, Japan.	carlos@kaiyodai.ac.jp	Hattori, Ricardo S/K-2870-2012; Strussmann, Carlos A/O-1932-2014; YOKOTA, Masashi/O-1947-2014; Wei, Qiwei/B-6928-2014	YOKOTA, Masashi/0000-0002-4121-4115; Wei, Qiwei/0000-0002-6366-1020; Majhi, Dr. Sullip Kumar/0000-0001-9389-7467				Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; Bouma GJ, 2005, J EXP ZOOL PART A, V303A, P698, DOI 10.1002/jez.a.197; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Jiang FX, 1995, INT J ANDROL, V18, P326, DOI 10.1111/j.1365-2605.1995.tb00570.x; Lacerda S. M. S. N., 2006, Animal Reproduction, V3, P146; Lacerda SMSN, 2008, CYBIUM, V32, P115; Maclean N, 2002, GENE, V295, P265, DOI 10.1016/S0378-1119(02)00735-7; Majhi SK, 2009, THERIOGENOLOGY, V71, P1162, DOI 10.1016/j.theriogenology.2008.12.008; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagler JJ, 2001, BIOL REPROD, V64, P644, DOI 10.1095/biolreprod64.2.644; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; Ogawa T, 1999, TISSUE CELL, V31, P461, DOI 10.1054/tice.1999.0060; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 2001, J MOL MED-JMM, V79, P368, DOI 10.1007/s001090100228; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Parenti LR, 2004, INTEGR COMP BIOL, V44, P333, DOI 10.1093/icb/44.5.333; Pukazhenthi B, 2006, REPROD FERT DEVELOP, V18, P77, DOI 10.1071/RD05117; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Schulz Rudiger Winfried, 2003, ARBS Annual Review of Biomedical Sciences, V5, P57; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinomiya A, 2001, J EXP ZOOL, V290, P402, DOI 10.1002/jez.1081; Somoza GM, 2008, AQUAC RES, V39, P784, DOI 10.1111/j.1365-2109.2008.01930.x; Strussmann CA, 1998, COMP BIOCHEM PHYS A, V119, P637, DOI 10.1016/S1095-6433(97)00477-7; Strussmann CA, 1997, AQUAC RES, V28, P291, DOI 10.1111/j.1365-2109.1997.tb01045.x; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Wang CQF, 2007, J CELL BIOL, V178, P549, DOI 10.1083/jcb.200704061	33	57	65	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6132	10.1371/journal.pone.0006132	http://dx.doi.org/10.1371/journal.pone.0006132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19572014	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806200007
J	Yang, X; Xie, L; Li, YX; Wei, CC				Yang, Xing; Xie, Lu; Li, Yixue; Wei, Chaochun			More than 9,000,000 Unique Genes in Human Gut Bacterial Community: Estimating Gene Numbers Inside a Human Body	PLOS ONE			English	Article							MICROBIOME; OBESITY; DIVERSITY; DIET	Background: Estimating the number of genes in human genome has been long an important problem in computational biology. With the new conception of considering human as a super-organism, it is also interesting to estimate the number of genes in this human super-organism. Principal Findings: We presented our estimation of gene numbers in the human gut bacterial community, the largest microbial community inside the human super-organism. We got 552,700 unique genes from 202 complete human gut bacteria genomes. Then, a novel gene counting model was built to check the total number of genes by combining culture-independent sequence data and those complete genomes. 16S rRNAs were used to construct a three-level tree and different counting methods were introduced for the three levels: strain-to-species, species-to-genus, and genus-and-up. The model estimates that the total number of genes is about 9,000,000 after those with identity percentage of 97% or up were merged. Conclusion: By combining completed genomes currently available and culture-independent sequencing data, we built a model to estimate the number of genes in human gut bacterial community. The total number of genes is estimated to be about 9 million. Although this number is huge, we believe it is underestimated. This is an initial step to tackle this gene counting problem for the human super-organism. It will still be an open problem in the near future. The list of genomes used in this paper can be found in the supplementary table.			Yang, X (corresponding author), Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China.	yxli@sibs.ac.cn; ccwei@sjtu.edu.cn	wei, chaochun/AAW-2846-2020	Wei, Chaochun/0000-0002-1031-034X				Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Das M, 2001, GENOMICS, V77, P71, DOI 10.1006/geno.2001.6620; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wei CC, 2005, GENOME RES, V15, P577, DOI 10.1101/gr.3329005; Wei CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-327; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X	24	98	106	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6074	10.1371/journal.pone.0006074	http://dx.doi.org/10.1371/journal.pone.0006074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562079	Green Published, gold, Green Submitted			2022-12-25	WOS:000267465900009
J	Katsoulidis, E; Carayol, N; Woodard, J; Konieczna, I; Majchrzak-Kita, B; Jordan, A; Sassano, A; Eklund, EA; Fish, EN; Platanias, LC				Katsoulidis, Efstratios; Carayol, Nathalie; Woodard, Jennifer; Konieczna, Iwona; Majchrzak-Kita, Beata; Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Fish, Eleanor N.; Platanias, Leonidas C.			Role of Schlafen 2 (SLFN2) in the Generation of Interferon alpha-induced Growth Inhibitory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA TRANSLATION; P38-ALPHA MAP KINASE; CELL-CYCLE ARREST; P70 S6 KINASE; I INTERFERONS; TRANSCRIPTIONAL ACTIVATION; RHEUMATOID-ARTHRITIS; MICROARRAY ANALYSIS; MAMMALIAN TARGET	The precise STAT-regulated gene targets that inhibit cell growth and generate the antitumor effects of Type I interferons (IFNs) remain unknown. We provide evidence that Type I IFNs regulate expression of Schlafens (SLFNs), a group of genes involved in the control of cell cycle progression and growth inhibitory responses. Using cells with targeted disruption of different STAT proteins and/or the p38 MAP kinase, we demonstrate that the IFN-dependent expression of distinct Schlafen genes is differentially regulated by STAT complexes and the p38 MAP kinase pathway. We also provide evidence for a key functional role of a member of the SLFN family, SLFN2, in the induction of the growth-suppressive effects of IFNs. This is shown in studies demonstrating that knockdown of SLFN2 enhances hematopoietic progenitor colony formation and reverses the growth-suppressive effects of IFN alpha on normal hematopoietic progenitors. Importantly, NIH3T3 or L929 cells with stable knockdown of SLFN2 form more colonies in soft agar, implicating this protein in the regulation of anchorage-independent growth. Altogether, our data implicate SLFN2 as a negative regulator of the metastatic and growth potential of malignant cells and strongly suggest a role for the SLFN family of proteins in the generation of the antiproliferative effects of Type I IFNs.	[Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, Chicago, IL 60611 USA; [Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Sch Med, Chicago, IL 60611 USA; [Jordan, Alison; Sassano, Antonella; Eklund, Elizabeth A.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Univ Hlth Network, Toronto Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, 710 N Fairbanks St,Olson 8250, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA100579, CA77816, CA121192]; Department of Veterans Affairs; Canadian Institutes of Health Research [MOP 15094]; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA100579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100579, CA77816, and CA121192. This work was also supported by a Merit Review Grant from the Department of Veterans Affairs and by Canadian Institutes of Health Research Grant MOP 15094.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Fish EN, 1999, J BIOL CHEM, V274, P571, DOI 10.1074/jbc.274.2.571; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1997, J IMMUNOL, V158, P2390; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510	45	55	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25051	25064		10.1074/jbc.M109.030445	http://dx.doi.org/10.1074/jbc.M109.030445			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19592487	hybrid, Green Published			2022-12-25	WOS:000269734000040
J	Zhang, Z; Albers, T; Fiumera, HL; Gameiro, A; Grewer, C				Zhang, Zhou; Albers, Thomas; Fiumera, Heather L.; Gameiro, Armanda; Grewer, Christof			A Conserved Na+ Binding Site of the Sodium-coupled Neutral Amino Acid Transporter 2 (SNAT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE EXPRESSION PATTERN; SYSTEM N; BACTERIAL HOMOLOG; PROFILE ALIGNMENT; CRYSTAL-STRUCTURE; NEUROTRANSMITTER; MECHANISM; IDENTIFICATION; TRANSLOCATION; SUPERFAMILY	The SLC38 family of solute transporters mediates the coupled transport of amino acids and Na+ into or out of cells. The structural basis for this coupled transport process is not known. Here, a profile-based sequence analysis approach was used, predicting a distant relationship with the SLC5/6 transporter families. Homology models using the LeuT(Aa) and Mhp1 transporters of known structure as templates were established, predicting the location of a conserved Na+ binding site in the center of membrane helices 1 and 8. This homology model was tested experimentally in the SLC38 member SNAT2 by analyzing the effect of a mutation to Thr-384, which is predicted to be part of this Na+ binding site. The results show that the T384A mutation not only inhibits the anion leak current, which requires Na+ binding to SNAT2, but also dramatically lowers the Na+ affinity of the transporter. This result is consistent with a previous analysis of the N82A mutant transporter, which has a similar effect on anion leak current and Na+ binding and which is also expected to form part of the Na+ binding site. In contrast, random mutations to other sites in the transporter had little or no effect on Na+ affinity. Our results are consistent with a cation binding site formed by transmembrane helices 1 and 8 that is conserved among the SLC38 transporters as well as among many other bacterial and plant transporter families of unknown structure, which are homologous to SLC38.	[Albers, Thomas; Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Fiumera, Heather L.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Shanghai Normal University	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu	Albers, Thomas/A-9082-2012		National Institutes of Health [7R01NS049335-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS049335, R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 7R01NS049335-05 (to C.G.).	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Clements JD, 2002, EUR J BIOCHEM, V269, P2101, DOI 10.1046/j.1432-1033.2002.02859.x; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FANG Y, 2009, NATURE IN PRESS; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; George RA, 2000, TRENDS BIOCHEM SCI, V25, P515, DOI 10.1016/S0968-0004(00)01643-1; Grewal S, 2009, J BIOL CHEM, V284, P11224, DOI 10.1074/jbc.M806470200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jung I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-298; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li M, 2002, FEBS LETT, V513, P247, DOI 10.1016/S0014-5793(02)02322-0; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776	50	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25314	25323		10.1074/jbc.M109.038422	http://dx.doi.org/10.1074/jbc.M109.038422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589777	hybrid, Green Published			2022-12-25	WOS:000269734000064
J	Lauer-Fields, JL; Chalmers, MJ; Busby, SA; Minond, D; Griffin, PR; Fields, GB				Lauer-Fields, Janelle L.; Chalmers, Michael J.; Busby, Scott A.; Minond, Dmitriy; Griffin, Patrick R.; Fields, Gregg B.			Identification of Specific Hemopexin-like Domain Residues That Facilitate Matrix Metalloproteinase Collagenolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; C-TERMINAL DOMAIN; SUBSTRATE-SPECIFICITY; TISSUE INHIBITOR; INDUCED FIT; FIBROBLAST COLLAGENASE; FLUOROGENIC SUBSTRATE; MASS-SPECTROMETRY; CATALYTIC-DOMAIN; PEPTIDE MODELS	Collagen serves as a structural scaffold and a barrier between tissues, and thus collagen catabolism (collagenolysis) is required to be a tightly regulated process in normal physiology. In turn, the destruction or damage of collagen during pathological states plays a role in tumor growth and invasion, cartilage degradation, or atherosclerotic plaque formation and rupture. Several members of the matrix metalloproteinase (MMP) family catalyze the hydrolysis of collagen triple helical structure. This study has utilized triple helical peptide (THP) substrates and inhibitors to dissect MMP-1 collagenolytic behavior. Analysis of MMP-1/THP interactions by hydrogen/deuterium exchange mass spectrometry followed by evaluation of wild type and mutant MMP-1 kinetics led to the identification of three noncatalytic regions in MMP-1 (residues 285-295, 302-316, and 437-457) and two specific residues (Ile-290 and Arg-291) that participate in collagenolysis. Ile-290 and Arg-291 contribute to recognition of triple helical structure and facilitate both the binding and catalysis of the triple helix. Evidence from this study and prior studies indicates that the MMP-1 catalytic and hemopexin-like domains collaborate in collagen catabolism by properly aligning the triple helix and coupling conformational states to facilitate hydrolysis. This study is the first to document the roles of specific residues within the MMP-1 hemopexin-like domain in substrate binding and turnover. Noncatalytic sites, such as those identified here, can ultimately be utilized to create THP inhibitors that target MMPs implicated in disease progression while sparing proteases with host-beneficial functions.	[Lauer-Fields, Janelle L.; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Chalmers, Michael J.; Minond, Dmitriy; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst Mol Screening Ctr, Jupiter, FL 33458 USA; [Chalmers, Michael J.; Busby, Scott A.; Minond, Dmitriy; Griffin, Patrick R.; Fields, Gregg B.] Scripps Florida, Dept Mol Therapeut, Jupiter, FL 33458 USA	University of Texas System; University of Texas Health San Antonio; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Fields, GB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr,542C 1 Med Sch Bldg, San Antonio, TX 78229 USA.	FieldsG@uthscsa.edu		Minond, Dmitriy/0000-0003-2473-5944; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [CA98799]; Robert A. Welch Foundation; Texas Higher Education STAR Program; Glenn/American Federation for Aging research scholarship; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Texas Higher Education STAR Program; Glenn/American Federation for Aging research scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98799. This work was also supported by the Robert A. Welch Foundation, the Texas Higher Education STAR Program ( to G. B. F.), and a Glenn/American Federation for Aging research scholarship ( to J.L.L.-F.).	ALLAN JA, 1991, J CELL SCI, V99, P789; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Dai SY, 2008, P NATL ACAD SCI USA, V105, P7171, DOI 10.1073/pnas.0710802105; DeSouza SJ, 1996, FASEB J, V10, P927, DOI 10.1096/fasebj.10.8.8666171; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Garcia RA, 2005, MOL PHARMACOL, V67, P1128, DOI 10.1124/mol.104.006346; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; HIROSE T, 1993, P NATL ACAD SCI USA, V90, P2569, DOI 10.1073/pnas.90.7.2569; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Knauper V, 2001, EUR J BIOCHEM, V268, P1888, DOI 10.1046/j.1432-1033.2001.02062.x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Korzhnev DM, 2009, J MOL BIOL, V386, P391, DOI 10.1016/j.jmb.2008.11.055; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields Janelle L, 2004, J Biomol Tech, V15, P305; Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Liu YH, 2008, BIOCHEMISTRY-US, V47, P6342, DOI 10.1021/bi800463q; Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597; Malkar NB, 2002, BIOCHEMISTRY-US, V41, P6054, DOI 10.1021/bi012071w; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tsukada H, 2002, J BIOL CHEM, V277, P27378, DOI 10.1074/jbc.M201367200; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Woessner J.F., 2000, PROTEIN PROFILE SER; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656	63	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24017	24024		10.1074/jbc.M109.016873	http://dx.doi.org/10.1074/jbc.M109.016873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574232	hybrid, Green Published			2022-12-25	WOS:000269380200016
J	Schumann, F; Hoffmeister, H; Bader, R; Schmidt, M; Witzgall, R; Kalbitzer, HR				Schumann, Frank; Hoffmeister, Helen; Bader, Reto; Schmidt, Maren; Witzgall, Ralph; Kalbitzer, Hans Robert			Ca2(+)-dependent Conformational Changes in a C-terminal Cytosolic Domain of Polycystin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTION NMR STRUCTURES; KIDNEY-DISEASE; CHEMICAL-SHIFT; CATION CHANNEL; PROTEIN; SPECTROSCOPY; DATABASE; SOLVENT; SERVER; ACID	The PKD1 and PKD2 genes are the genes that are mutated in patients suffering from autosomal dominant polycystic kidney disease. The human PKD2 gene codes for a968-amino acid long membrane protein called polycystin-2 that represents a cation channel whose activity can be regulated by Ca2+ ions. By CD, fluorescence, and NMR spectroscopy, we have studied a 117-amino acid-long fragment of the cytoplasmic domain of polycystin-2, polycystin-2-(680-796) that was proposed to contain a Ca2+-binding site. NMR structure determination reveals the existence of two Ca2+-binding sites in polycystin-2-(680-796) arranged in a typical and an a typical EF-hand motif. In the absence of Ca2+ the protein forms a dimer that is dissociated by Ca2+ binding. This dissociation may be related to the Ca2+ inactivation observed earlier. The calcium affinity of the protein was determined by fluorescence and NMR spectroscopy. At 293 K, the K-D values for the high and low affinity sites are 55 mu M and 179 mu M, respectively.	[Schumann, Frank; Bader, Reto; Schmidt, Maren; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; [Hoffmeister, Helen; Witzgall, Ralph] Univ Regensburg, Inst Anat, D-93040 Regensburg, Germany	University of Regensburg; University of Regensburg	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93040 Regensburg, Germany.	hans-robert.kalbitzer@biologie.uni-regensburg.de		Kalbitzer, Hans Robert/0000-0002-6514-2355; Witzgall, Ralph/0000-0002-5283-4846	Deutsche Forschungsgemeinschaft [SFB 699]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (Grant SFB 699) and the Fonds der Chemischen Industrie.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunner K, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-14; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Gronwald W, 2001, STRUCTURE, V9, P1029, DOI 10.1016/S0969-2126(01)00671-2; Gronwald W, 2007, J BIOMOL NMR, V37, P15, DOI 10.1007/s10858-006-9096-8; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Maurer T, 2004, J BACTERIOL, V186, P5906, DOI 10.1128/JB.186.17.5906-5918.2004; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Munte CE, 2008, FEBS J, V275, P1163, DOI 10.1111/j.1742-4658.2008.06277.x; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Schumann FH, 2009, BIOMOL NMR ASSIGN, V3, P141, DOI 10.1007/s12104-009-9160-x; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Weljie AM, 2004, J BIOL CHEM, V279, P35494, DOI 10.1074/jbc.M311520200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WIDER G, 1994, J MAGN RESON SER A, V108, P255, DOI 10.1006/jmra.1994.1120; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Witzgall R., 2007, V179, P363; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027	34	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24372	24383		10.1074/jbc.M109.025635	http://dx.doi.org/10.1074/jbc.M109.025635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19546223	Green Published, hybrid			2022-12-25	WOS:000269380200050
J	Chen, MZ; Zhu, XH; Sun, HQ; Mao, YTS; Wei, YJ; Yamamoto, M; Yin, HL				Chen, Mark Z.; Zhu, Xiaohui; Sun, Hui-Qiao; Mao, Yuntao S.; Wei, Yongjie; Yamamoto, Masaya; Yin, Helen L.			Oxidative Stress Decreases Phosphatidylinositol 4,5-Bisphosphate Levels by Deactivating Phosphatidylinositol-4-phosphate 5-Kinase beta in a Syk-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; PLASMA-MEMBRANE; PROTEIN; ACTIN; GAMMA; INJURY; MOBILIZATION; CYTOSKELETON; MECHANISMS; EXPRESSION	Phosphatidylinositol 4,5-bisphosphate (PIP2) has many essential functions and its homeostasis is highly regulated. We previously found that hypertonic stress increases PIP2 by selectively activating the beta isoform of the type I phosphatidylinositol phosphate 5-kinase (PIP5K beta) through Ser/Thr dephosphorylation and promoting its translocation to the plasma membrane. Here we report that hydrogen peroxide (H2O2) also induces PIP5K beta Ser/Thr dephosphorylation, but it has the opposite effect on PIP2 homeostasis, PIP5K beta function, and the actin cytoskeleton. Brief H2O2 treatments decrease cellular PIP2 in a PIP5K beta-dependent manner. PIP5K beta is tyrosine phosphorylated, dissociates from the plasma membrane, and has decreased lipid kinase activity. In contrast, the other two PIP5K isoforms are not inhibited by H2O2. We identified spleen tyrosine kinase (Syk), which is activated by oxidants, as a candidate PIP5K beta kinase in this pathway, and mapped the oxidant-sensitive tyrosine phosphorylation site to residue 105. The PIP5K beta Y105E phosphomimetic is catalytically inactive and cytosolic, whereas the Y105F non-phosphorylatable mutant has higher intrinsic lipid kinase activity and is much more membrane associated than wild type PIP5K beta. These results suggest that during oxidative stress, as modeled by H2O2 treatment, Syk-dependent tyrosine phosphorylation of PIP5K beta is the dominant post-translational modification that is responsible for the decrease in cellular PIP2.	[Chen, Mark Z.; Zhu, Xiaohui; Sun, Hui-Qiao; Mao, Yuntao S.; Wei, Yongjie; Yamamoto, Masaya; Yin, Helen L.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Yin, HL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.Yin@utsouthwestern.edu	Mao, Yuntao/E-9168-2012		National Institutes of Health [5P50-GM21681]; Robert A. Welch Foundation [I-1200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P50-GM21681 and Robert A. Welch Foundation I-1200 grant.	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Fridlyand LE, 2006, CURR DIABETES REV, V2, P241, DOI 10.2174/157339906776818541; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Halstead JR, 2006, CURR BIOL, V16, P1850, DOI 10.1016/j.cub.2006.07.066; Horton JW, 2006, AM J PHYSIOL-HEART C, V290, pH1642, DOI 10.1152/ajpheart.00586.2005; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Mesaeli N, 2000, ARCH BIOCHEM BIOPHYS, V382, P48, DOI 10.1006/abbi.2000.2012; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Renedo MA, 2001, EUR J IMMUNOL, V31, P1361, DOI 10.1002/1521-4141(200105)31:5<1361::AID-IMMU1361>3.0.CO;2-7; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tohyama Y, 2006, IUBMB LIFE, V58, P304, DOI 10.1080/15216540600746377; Turnage RH, 2002, WORLD J SURG, V26, P848, DOI 10.1007/s00268-002-4063-3; Wang L, 2005, CANCER RES, V65, P10289, DOI 10.1158/0008-5472.CAN-05-2231; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; WATTS RG, 1991, CELL MOTIL CYTOSKEL, V19, P159, DOI 10.1002/cm.970190304; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Yamamoto N, 2003, ANAL BIOCHEM, V315, P256, DOI 10.1016/S0003-2697(03)00026-5; Yanagi S, 2001, BIOCHEM BIOPH RES CO, V288, P495, DOI 10.1006/bbrc.2001.5788; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	44	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23743	23753		10.1074/jbc.M109.036509	http://dx.doi.org/10.1074/jbc.M109.036509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553680	Green Published, hybrid			2022-12-25	WOS:000269180000059
J	Chetrit, J; Ballion, B; Laquitaine, S; Belujon, P; Morin, S; Taupignon, A; Bioulac, B; Gross, CE; Benazzouz, A				Chetrit, Jonathan; Ballion, Berangere; Laquitaine, Steeve; Belujon, Pauline; Morin, Stephanie; Taupignon, Anne; Bioulac, Bernard; Gross, Christian E.; Benazzouz, Abdelhamid			Involvement of Basal Ganglia Network in Motor Disabilities Induced by Typical Antipsychotics	PLOS ONE			English	Article								Background: Clinical treatments with typical antipsychotic drugs (APDs) are accompanied by extrapyramidal motor side-effects (EPS) such as hypokinesia and catalepsy. As little is known about electrophysiological substrates of such motor disturbances, we investigated the effects of a typical APD, alpha-flupentixol, on the motor behavior and the neuronal activity of the whole basal ganglia nuclei in the rat. Methods and Findings: The motor behavior was examined by the open field actimeter and the neuronal activity of basal ganglia nuclei was investigated using extracellular single unit recordings on urethane anesthetized rats. We show that alpha-flupentixol induced EPS paralleled by a decrease in the firing rate and a disorganization of the firing pattern in both substantia nigra pars reticulata (SNr) and subthalamic nucleus (STN). Furthermore, alpha-flupentixol induced an increase in the firing rate of globus pallidus (GP) neurons. In the striatum, we recorded two populations of medium spiny neurons (MSNs) after their antidromic identification. At basal level, both striato-pallidal and striato-nigral MSNs were found to be unaffected by alpha-flupentixol. However, during electrical cortico-striatal activation only striato-pallidal, but not striato-nigral, MSNs were found to be inhibited by alpha-flupentixol. Together, our results suggest that the changes in STN and SNr neuronal activity are a consequence of increased neuronal activity of globus pallidus (GP). Indeed, after selective GP lesion, alpha-flupentixol failed to induce EPS and to alter STN neuronal activity. Conclusion: Our study reports strong evidence to show that hypokinesia and catalepsy induced by alpha-flupentixol are triggered by dramatic changes occurring in basal ganglia network. We provide new insight into the key role of GP in the pathophysiology of APD-induced EPS suggesting that the GP can be considered as a potential target for the treatment of EPS.			Chetrit, J (corresponding author), Univ Bordeaux, Bordeaux, France.	Abdelhamid.Benazzouz@u-bordeaux2.fr	Benazzouz, Abdelhamid/E-5050-2016	BALLION, Berengere/0000-0001-5210-2445; Laquitaine, Steeve/0000-0002-9647-3149; Taupignon, Anne/0000-0002-4662-7971; belujon, pauline/0000-0002-7966-8657				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ban T A, 1974, Adv Biochem Psychopharmacol, V9, P481; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Billings LM, 2003, BRAIN RES, V964, P237, DOI 10.1016/S0006-8993(02)04060-X; Boraud T, 1998, BRAIN RES, V787, P157, DOI 10.1016/S0006-8993(97)01563-1; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; BURBAUD P, 1995, EXP BRAIN RES, V105, P48; COSTALL B, 1972, NEUROPHARMACOLOGY, V11, P645, DOI 10.1016/0028-3908(72)90073-1; COSTALL B, 1971, NEUROPHARMACOLOGY, V10, P581, DOI 10.1016/0028-3908(71)90024-4; DELFS JM, 1995, NEUROSCIENCE, V66, P67, DOI 10.1016/0306-4522(94)00572-M; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Eltayb A, 2005, BIOL PSYCHIAT, V58, P337, DOI 10.1016/j.biopsych.2005.03.038; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; FARDE L, 1992, BR J PSYCHIAT SUPPL, P30; FEGER J, 1991, EUR J NEUROSCI, V3, P947, DOI 10.1111/j.1460-9568.1991.tb00030.x; FOWLER SC, 1990, BEHAV NEUROSCI, V104, P449, DOI 10.1037/0735-7044.104.3.449; FUJIMOTO K, 1992, NEUROSCI LETT, V142, P105, DOI 10.1016/0304-3940(92)90630-P; Galvan A, 2001, J NEURAL TRANSM, V108, P153, DOI 10.1007/s007020170085; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; Hauber W, 1999, BEHAV BRAIN RES, V106, P143, DOI 10.1016/S0166-4328(99)00102-3; Hauber W, 1998, NEUROSCIENCE, V86, P147, DOI 10.1016/S0306-4522(98)00009-8; Hauber W, 2001, EUR J NEUROSCI, V14, P1287, DOI 10.1046/j.0953-816x.2001.01759.x; HESS EJ, 1988, J NEUROSCI, V8, P2361; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Marshall JF, 2001, NEUROSCIENCE, V105, P365, DOI 10.1016/S0306-4522(01)00180-4; Mukherjee J, 2001, NEUROPSYCHOPHARMACOL, V25, P476, DOI 10.1016/S0893-133X(01)00251-2; Murer MG, 1997, SYNAPSE, V27, P278, DOI 10.1002/(SICI)1098-2396(199712)27:4<278::AID-SYN2>3.3.CO;2-S; Ni ZG, 2000, EUR J NEUROSCI, V12, P4338, DOI 10.1111/j.1460-9568.2000.01346.x; OSSOWSKA K, 1983, PHARMACOL BIOCHEM BE, V19, P169, DOI 10.1016/0091-3057(83)90035-7; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pitts SM, 2000, PHARMACOL BIOCHEM BE, V65, P433, DOI 10.1016/S0091-3057(99)00249-X; Reimold M, 2007, PSYCHOPHARMACOLOGY, V190, P241, DOI 10.1007/s00213-006-0611-0; RICHELSON E, 1984, J CLIN PSYCHIAT, V45, P331; Ruskin DN, 1997, NEUROSCIENCE, V81, P79, DOI 10.1016/S0306-4522(97)00113-9; SANBERG PR, 1984, PSYCHOPHARMACOLOGY, V82, P406, DOI 10.1007/BF00427696; SMITH Y, 1990, J COMP NEUROL, V296, P47, DOI 10.1002/cne.902960105; SMITH Y, 1989, BRAIN RES, V493, P160, DOI 10.1016/0006-8993(89)91011-1; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tseng KY, 2005, EUR J NEUROSCI, V22, P2579, DOI 10.1111/j.1460-9568.2005.04456.x; Wu YN, 2007, NEUROSCIENCE, V147, P183, DOI 10.1016/j.neuroscience.2007.02.045	51	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6208	10.1371/journal.pone.0006208	http://dx.doi.org/10.1371/journal.pone.0006208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587792	gold, Green Published, Green Submitted			2022-12-25	WOS:000268035100019
J	Huang, XG; Hui, MNY; Liu, Y; Yuen, DSH; Zhang, Y; Chan, WY; Lin, HR; Cheng, SH; Cheng, CHK				Huang, Xigui; Hui, Michelle N. Y.; Liu, Yun; Yuen, Don S. H.; Zhang, Yong; Chan, Wood Yee; Lin, Hao Ran; Cheng, Shuk Han; Cheng, Christopher H. K.			Discovery of a Novel Prolactin in Non-Mammalian Vertebrates: Evolutionary Perspectives and Its Involvement in Teleost Retina Development	PLOS ONE			English	Article							RECOMBINANT GOLDFISH PROLACTIN; GROWTH-HORMONE; HOMEOBOX GENE; IDENTIFICATION; EXPRESSION; SEQUENCES; BIPOLAR	Background: The three pituitary hormones, viz. prolactin ( PRL), growth hormone ( GH) and somatolactin ( SL), together with the mammalian placental lactogen ( PL), constitute a gene family of hormones with similar gene structure and encoded protein sequences. These hormones are believed to have evolved from a common ancestral gene through several rounds of gene duplication and subsequent divergence. Principal Findings: In this study, we have identified a new PRL-like gene in non-mammalian vertebrates through bioinformatics and molecular cloning means. Phylogenetic analyses showed that this novel protein is homologous to the previously identified PRL. A receptor transactivation assay further showed that this novel protein could bind to PRL receptor to trigger the downstream post-receptor event, indicating that it is biologically active. In view of its close phylogenetic relationship with PRL and also its ability to activate PRL receptor, we name it as PRL2 and the previously identified PRL as PRL1. All the newly discovered PRL2 sequences possess three conserved disulfide linkages with the exception of the shark PRL2 which has only two. In sharp contrast to the classical PRL1 which is predominantly expressed in the pituitary, PRL2 was found to be mainly expressed in the eye and brain of the zebrafish but not in the pituitary. A largely reduced inner nuclear layer of the retina was observed after morpholino knockdown of zebrafish PRL2, indicating its role on retina development in teleost. Significance: The discovery of this novel PRL has revitalized our understanding on the evolution of the GH/PRL/SL/PL gene family. Its unique expression and functions in the zebrafish eye also provide a new avenue of research on the neuroendocrine control of retina development in vertebrates.			Huang, XG (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	chkcheng@cuhk.edu.hk	lin, haoran/GXH-3030-2022; Cheng, Shuk Han/F-9943-2012; Chan, Wood Yee/R-6692-2018; CHENG, Ki Christopher/R-9641-2018	Chan, Wood Yee/0000-0002-7114-1463; CHENG, Ki Christopher/0000-0001-8970-9048; Cheng, Shuk Han/0000-0002-5822-7238				ANTHONY RV, 1995, J ANIM SCI, V73, P1861; Chan YH, 1996, BBA-GENE STRUCT EXPR, V1307, P8, DOI 10.1016/0167-4781(96)00032-2; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; Cheng CW, 2006, MECH DEVELOP, V123, P252, DOI 10.1016/j.mod.2005.12.001; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Cheung HYS, 2002, COMP BIOCHEM PHYS B, V131, P37, DOI 10.1016/S1096-4959(01)00478-X; Chow ESH, 2008, AQUAT TOXICOL, V87, P157, DOI 10.1016/j.aquatox.2008.01.019; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Force A, 1999, GENETICS, V151, P1531; Forsyth IA, 2002, J MAMMARY GLAND BIOL, V7, P291, DOI 10.1023/A:1022804817104; Huang XG, 2007, J ENDOCRINOL, V194, P373, DOI 10.1677/JOE-07-0076; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; KAWAUCHI H, 1988, INT CONGR SER, V819, P61; Kawauchi H, 2002, ENDOCRINOLOGY, V143, P4916, DOI 10.1210/en.2002-220810; KAWAUCHI H, 1988, ADV GROWTH HORMONE G, P51; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lin J, 2000, RECENT PROG HORM RES, V55, P37; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Manzon LA, 2002, GEN COMP ENDOCR, V125, P291, DOI 10.1006/gcen.2001.7746; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; NOSO T, 1993, GEN COMP ENDOCR, V91, P90, DOI 10.1006/gcen.1993.1108; Ohno S., 1970, P1; Rand-Weaver Mariann, 1993, Biochemistry and Molecular Biology of Fishes, V2, P39; RENTIERDELRUE F, 1989, DNA-J MOLEC CELL BIO, V8, P261, DOI 10.1089/dna.1.1989.8.261; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHIGEHIROKURAKU, 2009, MOL BIOL EVOL, V26, P47; SUZUKI R, 1991, GEN COMP ENDOCR, V81, P391, DOI 10.1016/0016-6480(91)90166-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wallis OC, 2005, J MOL EVOL, V60, P606, DOI 10.1007/s00239-004-0239-9; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; Wong AOL, 2002, GEN COMP ENDOCR, V126, P75, DOI 10.1006/gcen.2001.7771; Wullimann M.F., 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7; YAMAGUCHI K, 1988, J BIOL CHEM, V263, P9113; YAMASHITA K, 1993, GEN COMP ENDOCR, V91, P307, DOI 10.1006/gcen.1993.1131; YASUDA A, 1986, ARCH BIOCHEM BIOPHYS, V244, P528, DOI 10.1016/0003-9861(86)90621-1; YASUDA A, 1987, GEN COMP ENDOCR, V66, P280, DOI 10.1016/0016-6480(87)90278-4; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhu Y, 2007, GEN COMP ENDOCR, V150, P395, DOI 10.1016/j.ygcen.2006.10.009	45	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6163	10.1371/journal.pone.0006163	http://dx.doi.org/10.1371/journal.pone.0006163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584915	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806500003
J	Kang, HJ; Bennett, SN; Sumibcay, L; Arai, S; Hope, AG; Mocz, G; Song, JW; Cook, JA; Yanagihara, R				Kang, Hae Ji; Bennett, Shannon N.; Sumibcay, Laarni; Arai, Satoru; Hope, Andrew G.; Mocz, Gabor; Song, Jin-Won; Cook, Joseph A.; Yanagihara, Richard			Evolutionary Insights from a Genetically Divergent Hantavirus Harbored by the European Common Mole (Talpa europaea)	PLOS ONE			English	Article								Background: The discovery of genetically distinct hantaviruses in shrews (Order Soricomorpha, Family Soricidae) from widely separated geographic regions challenges the hypothesis that rodents (Order Rodentia, Family Muridae and Cricetidae) are the primordial reservoir hosts of hantaviruses and also predicts that other soricomorphs harbor hantaviruses. Recently, novel hantavirus genomes have been detected in moles of the Family Talpidae, including the Japanese shrew mole (Urotrichus talpoides) and American shrew mole (Neurotrichus gibbsii). We present new insights into the evolutionary history of hantaviruses gained from a highly divergent hantavirus, designated Nova virus (NVAV), identified in the European common mole (Talpa europaea) captured in Hungary. Methodology/Principal Findings: Pair-wise alignment and comparison of the full-length S- and L-genomic segments indicated moderately low sequence similarity of 54-65% and 46-63% at the nucleotide and amino acid levels, respectively, between NVAV and representative rodent- and soricid-borne hantaviruses. Despite the high degree of sequence divergence, the predicted secondary structure of the NVAV nucleocapsid protein exhibited the characteristic coiled-coil domains at the amino-terminal end, and the L-segment motifs, typically found in hantaviruses, were well conserved. Phylogenetic analyses, using maximum-likelihood and Bayesian methods, showed that NVAV formed a distinct clade that was evolutionarily distant from all other hantaviruses. Conclusions: Newly identified hantaviruses harbored by shrews and moles support long-standing virus-host relationships and suggest that ancestral soricomorphs, rather than rodents, may have been the early or original mammalian hosts.			Kang, HJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.	yanagiha@pbrc.hawaii.edu	Song, Jin/HHS-8731-2022	Arai, Satoru/0000-0001-5865-0717; Cook, Joseph/0000-0003-3985-0670; Mocz, Gabor/0000-0001-9855-2206	NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR018727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075057] Funding Source: NIH RePORTER; NCRR NIH HHS [G12 RR003061, P20 RR018727] Funding Source: Medline; NIAID NIH HHS [R01 AI075057] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alminaite A, 2006, J VIROL, V80, P9073, DOI 10.1128/JVI.00515-06; Arai S, 2008, P NATL ACAD SCI USA, V105, P16296, DOI 10.1073/pnas.0808942105; Arai S, 2008, AM J TROP MED HYG, V78, P348, DOI 10.4269/ajtmh.2008.78.348; Arai S, 2007, EMERG INFECT DIS, V13, P1420, DOI 10.3201/eid1309.070484; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046; CAREY DE, 1971, INDIAN J MED RES, V59, P1758; CHARLESTON MA, 1998, TREEMAP 2 0B MACINTO; Charleston NA, 2006, J BIOMED INFORM, V39, P62, DOI 10.1016/j.jbi.2005.08.006; Churchfield S., 1990, NATURAL HIST SHREWS; Clement J., 1994, V5, P295; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; GAVRILOVSKAYA IN, 1983, ARCH VIROL, V75, P313, DOI 10.1007/BF01314898; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gliwicz J, 2002, ACTA THERIOL, V47, P185, DOI 10.1007/BF03192487; Gorman M.L, 1990, NATURAL HIST MOLES; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hughes AL, 2000, MOL BIOL EVOL, V17, P1558, DOI 10.1093/oxfordjournals.molbev.a026254; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Kang HJ, 2009, VIROLOGY, V388, P8, DOI 10.1016/j.virol.2009.03.019; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Klempa B, 2007, EMERG INFECT DIS, V13, P520, DOI 10.3201/eid1303.061198; Kukkonen SKJ, 2005, ARCH VIROL, V150, P533, DOI 10.1007/s00705-004-0414-8; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mills JN, 1998, AM J TROP MED HYG, V58, P525; Nemirov K, 2002, VIRUS RES, V90, P207, DOI 10.1016/S0168-1702(02)00179-X; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Padula P, 2004, J VIROL, V78, P11972, DOI 10.1128/JVI.78.21.11972-11979.2004; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677; Plyusnina A, 2009, J GEN VIROL, V90, P205, DOI 10.1099/vir.0.006155-0; Plyusnina A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-4; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sanchez AJ, 2001, VIROLOGY, V286, P345, DOI 10.1006/viro.2001.0983; Sanchez-Villagra MR, 2006, CLADISTICS, V22, P59, DOI 10.1111/j.1096-0031.2006.00087.x; SCHMALJOHN CS, 1983, VIROLOGY, V131, P482, DOI 10.1016/0042-6822(83)90514-7; SCHMALJOHN CS, 1983, J INFECT DIS, V148, P1005, DOI 10.1093/infdis/148.6.1005; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Severson W, 2005, J VIROL, V79, P10032, DOI 10.1128/JVI.79.15.10032-10039.2005; Shinohara A, 2003, MOL PHYLOGENET EVOL, V27, P247, DOI 10.1016/S1055-7903(02)00416-5; Shinohara A, 2004, ZOOL SCI, V21, P1177, DOI 10.2108/zsj.21.1177; Song JW, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-114; Song JW, 2007, EMERG INFECT DIS, V13, P1784, DOI 10.3201/eid1311.070492; Song JW, 2007, EMERG INFECT DIS, V13, P980, DOI 10.3201/eid1307.070031; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TKACHENKO EA, 1983, ANN SOC BELG MED TR, V63, P267; Tsuchiya K, 2000, GENES GENET SYST, V75, P17, DOI 10.1266/ggs.75.17; Vapalahti O, 1999, J VIROL, V73, P5586, DOI 10.1128/JVI.73.7.5586-5592.1999; Xu XL, 2002, J VIROL, V76, P3301, DOI 10.1128/JVI.76.7.3301-3308.2002; Yadav PD, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-80; YANAGIHARA R, 1990, REV INFECT DIS, V12, P449; YANAGIHARA R, 1988, HDB VIRAL RICKETTSIA, P151; YATES TL, 1978, MAMMALIAN SPECIES, V105, P1; ZELLER HG, 1989, ARCH VIROL, V108, P211, DOI 10.1007/BF01310935; Zou Y, 2008, VIRUS RES, V137, P122, DOI 10.1016/j.virusres.2008.06.012; Zou Y, 2008, J MED VIROL, V80, P680, DOI 10.1002/jmv.21119	74	85	87	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6149	10.1371/journal.pone.0006149	http://dx.doi.org/10.1371/journal.pone.0006149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582155	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806400005
J	Steiner, UK; Van Buskirk, J				Steiner, Ulrich K.; Van Buskirk, Josh			Predator-Induced Changes in Metabolism Cannot Explain the Growth/Predation Risk Tradeoff	PLOS ONE			English	Article								Defence against predators is usually accompanied by declining rates of growth or development. The classical growth/predation risk tradeoff assumes reduced activity as the cause of these declines. However, in many cases these costs cannot be explained by reduced foraging effort or enhanced allocation to defensive structures under predation risk. Here, we tested for a physiological origin of defence costs by measuring oxygen consumption in tadpoles (Rana temporaria) exposed to predation risk over short and long periods of time. The short term reaction was an increase in oxygen consumption, consistent with the "fight-or-flight'' response observed in many organisms. The long term reaction showed the opposite pattern: tadpoles reduced oxygen consumption after three weeks exposure to predators, which would act to reduce the growth cost of predator defence. The results point to an instantaneous and reversible stress response to predation risk. This suggests that the tradeoff between avoiding predators and growing rapidly is not caused by changes in metabolic rate, and must be sought in other behavioural or physiological processes.			Steiner, UK (corresponding author), Univ Zurich, Inst Zool, Zurich, Switzerland.	usteiner@stanford.edu	Steiner, Ulrich/AAQ-2713-2021; Steiner, Ulrich K/C-7099-2015	Steiner, Ulrich/0000-0002-1778-5989; Steiner, Ulrich K/0000-0002-1778-5989; Van Buskirk, Josh/0000-0002-0486-3626	NIA NIH HHS [P01-AG0225000-01] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABEL D, 1992, COMP BIOCHEM PHYS A, V101, P425, DOI 10.1016/0300-9629(92)90491-8; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; Beckerman AP, 2007, OECOLOGIA, V152, P335, DOI 10.1007/s00442-006-0642-6; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; FEDER ME, 1981, COMP BIOCHEM PHYS A, V70, P497, DOI 10.1016/0300-9629(81)92561-5; Forstner H., 1983, POLAROGRAPHIC OXYGEN, P111, DOI [10.1007/978-3-642-81863-9_12, DOI 10.1007/978-3-642-81863-9_12]; Grantner A, 1998, J COMP PHYSIOL B, V168, P427, DOI 10.1007/s003600050162; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Hawkins LA, 2004, J FISH BIOL, V65, P88, DOI 10.1111/j.0022-1112.2004.00543.x; Holopainen IJ, 1997, J FISH BIOL, V50, P781, DOI 10.1006/jfbi.1996.0344; Imsland AK, 2000, J FISH BIOL, V57, P1213, DOI 10.1111/j.1095-8649.2000.tb00482.x; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; Miles DB, 2007, HORM BEHAV, V51, P548, DOI 10.1016/j.yhbeh.2007.02.005; Noonburg EG, 2005, EVOL ECOL RES, V7, P89; Pernet F, 2008, J EXP BIOL, V211, P969, DOI 10.1242/jeb.014639; R Development Core Team, 2009, R FDN STAT COMP; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Rovero F, 1999, ANIM BEHAV, V58, P707, DOI 10.1006/anbe.1999.1176; Sapolsky R.M., 2002, BEHAV ENDOCRINOLOGY, V2nd, P409; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SEMLITSCH RD, 1992, J ANIM ECOL, V61, P353, DOI 10.2307/5327; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; SPITZE K, 1992, AM NAT, V139, P229, DOI 10.1086/285325; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; Steiner UK, 2007, OECOLOGIA, V152, P201, DOI 10.1007/s00442-006-0645-3; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Stoks R, 2005, ECOL LETT, V8, P1307, DOI 10.1111/j.1461-0248.2005.00840.x; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2001, OECOLOGIA, V127, P222, DOI 10.1007/s004420000595; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; TUCKER VA, 1975, AM SCI, V63, P413; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Van Buskirk J, 2002, EVOLUTION, V56, P361; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537	46	72	73	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6160	10.1371/journal.pone.0006160	http://dx.doi.org/10.1371/journal.pone.0006160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582147	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806400015
J	Zayats, T; Young, TL; Mackey, DA; Malecaze, F; Calvas, P; Guggenheim, JA				Zayats, Tetyana; Young, Terri L.; Mackey, David A.; Malecaze, Francois; Calvas, Patrick; Guggenheim, Jeremy A.			Quality of DNA Extracted from Mouthwashes	PLOS ONE			English	Article								Background: A cost effective, safe and efficient method of obtaining DNA samples is essential in large scale genetic analyses. Buccal cells are an attractive source of DNA, as their collection is non-invasive and can be carried out by mail. However, little attention has been given to the quality of DNA extracted from mouthwashes. Methodology: Mouthwash-derived DNA was extracted from 500 subjects participating in a genetic study of high myopia. DNA quality was investigated using two standard techniques: agarose gel electrophoresis and quantitative polymerase chain reaction (qPCR). Principal Findings: Whereas the majority of mouthwash-derived DNA samples showed a single band of high molecular weight DNA by gel electrophoresis, 8.9% (95% CI: 7.1-10.7%) of samples contained only a smear of low-to-medium molecular weight, degraded DNA. The odds of DNA degradation in a subject's second mouthwash sample, given degradation of the first, was significantly greater than one (OR = 3.13; 95% CI: 1.22-7.39; Fisher's test P = 0.009), suggesting that DNA degradation was at least partially a subject-specific phenomenon. Approximately 12.4% (95% CI: 10.4-14.4%) of mouthwash-derived DNA failed to PCR amplify efficiently (using an,200 bp microsatellite marker). However, we found there was no significant difference in amplification success rate between DNA samples judged to be degraded or non-degraded by gel electrophoresis (Fisher's test P = 0.5). Conclusions: This study demonstrated that DNA degradation affects a significant minority of saline mouthwashes, and that the phenomenon is partially subject-specific. Whilst the level of degradation did not significantly prevent successful amplification of short PCR fragments, previous studies suggest that such DNA degradation would compromise more demanding applications.			Zayats, T (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, Wales.	guggenheim@cf.ac.uk	Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Guggenheim, Jeremy/0000-0001-5164-340X	NEI NIH HHS [R01 EY014685] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014685] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bergen AW, 2005, HUM MUTAT, V26, P262, DOI 10.1002/humu.20213; Cler L, 2006, MOL CELL PROBE, V20, P191, DOI 10.1016/j.mcp.2005.12.003; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; FAN JB, 2006, ILLUMINA UNIVERSAL B, P57; Farbrother JE, 2004, INVEST OPHTH VIS SCI, V45, P2873, DOI 10.1167/iovs.03-1155; Farbrother JE, 2004, INVEST OPHTH VIS SCI, V45, P2879, DOI 10.1167/iovs.03-1156; Feigelson HS, 2001, CANCER EPIDEM BIOMAR, V10, P1005; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; Glei M, 2005, BIOMARKERS, V10, P203, DOI 10.1080/13547500500138963; Haffajee AD, 2001, J CLIN PERIODONTOL, V28, P377, DOI 10.1034/j.1600-051x.2001.028005377.x; Harty LC, 2000, CANCER EPIDEM BIOMAR, V9, P501; Heath EM, 2001, ARCH PATHOL LAB MED, V125, P127; King IB, 2002, CANCER EPIDEM BIOMAR, V11, P1511; KIROV G, 2006, BMC GENOMICS, V7; Konig KG, 2000, INT DENT J, V50, P162, DOI 10.1111/j.1875-595X.2000.tb00555.x; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P701; LI YJ, 2009, INVESTIGATI IN PRESS; Lum A, 1998, CANCER EPIDEM BIOMAR, V7, P719; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; Shiloah J, 2000, J PERIODONTOL, V71, P562, DOI 10.1902/jop.2000.71.4.562; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	24	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6165	10.1371/journal.pone.0006165	http://dx.doi.org/10.1371/journal.pone.0006165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582144	Green Published, gold			2022-12-25	WOS:000267806400019
J	Laguna-Torres, VA; Gomez, J; Ocana, V; Aguilar, P; Saldarriaga, T; Chavez, E; Perez, J; Zamalloa, H; Forshey, B; Paz, I; Gomez, E; Ore, R; Chauca, G; Ortiz, E; Villaran, M; Vilcarromero, S; Rocha, C; Chincha, O; Jimenez, G; Villanueva, M; Pozo, E; Aspajo, J; Kochel, T				Alberto Laguna-Torres, V.; Gomez, Jorge; Ocana, Victor; Aguilar, Patricia; Saldarriaga, Tatiana; Chavez, Edward; Perez, Juan; Zamalloa, Hernan; Forshey, Brett; Paz, Irmia; Gomez, Elizabeth; Ore, Roel; Chauca, Gloria; Ortiz, Ernesto; Villaran, Manuel; Vilcarromero, Stalin; Rocha, Claudio; Chincha, Omayra; Jimenez, Gerardo; Villanueva, Miguel; Pozo, Edwar; Aspajo, Jackeline; Kochel, Tadeusz			Influenza-Like Illness Sentinel Surveillance in Peru	PLOS ONE			English	Article							EPIDEMIOLOGY	Background: Acute respiratory illnesses and influenza-like illnesses (ILI) are a significant source of morbidity and mortality worldwide. Despite the public health importance, little is known about the etiology of these acute respiratory illnesses in many regions of South America. In 2006, the Peruvian Ministry of Health (MoH) and the US Naval Medical Research Center Detachment (NMRCD) initiated a collaboration to characterize the viral agents associated with ILI and to describe the clinical and epidemiological presentation of the affected population. Methodology/Principal Findings: Patients with ILI ( fever >= 38 degrees C and cough or sore throat) were evaluated in clinics and hospitals in 13 Peruvian cities representative of the four main regions of the country. Nasal and oropharyngeal swabs, as well as epidemiological and demographic data, were collected from each patient. During the two years of this study ( June 2006 through May 2008), a total of 6,835 patients, with a median age of 13 years, were recruited from 31 clinics and hospitals; 6,308 were enrolled by regular passive surveillance and 527 were enrolled as part of outbreak investigations. At least one respiratory virus was isolated from the specimens of 2,688 (42.6%) patients, with etiologies varying by age and geographical region. Overall the most common viral agents isolated were influenza A virus (25.1%), influenza B virus (9.7%), parainfluenza viruses 1, 2, and 3, (HPIV-1,-2,-3; 3.2%), herpes simplex virus (HSV; 2.6%), and adenoviruses (1.8%). Genetic analyses of influenza virus isolates demonstrated that three lineages of influenza A H1N1, one lineage of influenza A H3N2, and two lineages of influenza B were circulating in Peru during the course of this study. Conclusions: To our knowledge this is the most comprehensive study to date of the etiologic agents associated with ILI in Peru. These results demonstrate that a wide range of respiratory pathogens are circulating in Peru and this fact needs to be considered by clinicians when treating patients reporting with ILI. Furthermore, these data have implications for influenza vaccine design and implementation in South America.			Laguna-Torres, VA (corresponding author), US Naval Med Res Ctr Detachment, Lima, Peru.	alberto.laguna@med.navy.mil	Rocha, Claudio A./N-4440-2017; Vilcarromero, Stalin/H-9263-2019; Gomez, Jorge/E-5258-2012	Rocha, Claudio A./0000-0003-4221-3883; Vilcarromero, Stalin/0000-0002-9097-0638; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Ortiz, Ernesto/0000-0002-6485-2005; Pozo, Edwar Jose/0000-0001-7183-5230; chincha, omayra/0000-0001-5016-8555; Paz, Irmia/0000-0003-3926-9982; Chavez-Cruzado, Edward/0000-0001-5379-8624; Gomez, Jorge/0000-0003-1342-3507				[Anonymous], 2002, Wkly Epidemiol Rec, V77, P350; AVILA M, 1990, REV INFECT DIS, V12, pS974; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; da Cunha Antonio Jose Ledo Alves, 2003, Indian Pediatr, V40, P7; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Garcia-Garcia J, 2006, SALUD PUBLICA MEXICO, V48, P244; *I NAC SAL OF GEN, 2000, INFL; MCMILLAN JA, 1993, PEDIATR INFECT DIS J, V12, P280, DOI 10.1097/00006454-199304000-00004; *MIN SAL PER, 2005, PLAN NAC PREP RESP F; Monto AS, 2002, AM J MED, V112, p4S; OCHOA EG, 1996, B PAN AM HLTH ORG, V30, P106; Portes Silvana A. R., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P337, DOI 10.1590/S0036-46651998000600001; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Saldarriaga Tatiana, 2008, Rev. perú. med. exp. salud publica, V25, P35; Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002; Swofford DL, 1998, PHYLOGENETIC ANAL US; *WHO, 2007, PROGR MUND OMS GRIP; *WHO, 2007, REC INFL VACC; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2003, INFL FACT SHEET	22	75	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6118	10.1371/journal.pone.0006118	http://dx.doi.org/10.1371/journal.pone.0006118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568433	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200017
J	Ranjbar, S; Boshoff, HI; Mulder, A; Siddiqi, N; Rubin, EJ; Goldfeld, AE				Ranjbar, Shahin; Boshoff, Helena I.; Mulder, Amara; Siddiqi, Noman; Rubin, Eric J.; Goldfeld, Anne E.			HIV-1 Replication Is Differentially Regulated by Distinct Clinical Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article								Background: Tuberculosis ( TB) is the largest cause of death in human immunodeficiency virus type 1 (HIV-1) infection, having claimed an estimated one third to one half of the 30 million AIDS deaths that have occurred worldwide. Different strains of Mycobacterium tuberculosis (MTb), the causative agent of TB, are known to modify the host immune response in a strain-specific manner. However, a MTb strain-specific impact upon the regulation of HIV-1 replication has not previously been established. Methology/Principal Findings: We isolated normal human peripheral blood mononuclear cells (PBMC) and co-infected them with HIV-1 and with either the well characterized CDC1551 or HN878 MTb clinical isolate. We show that HIV-1 co-infection with the CDC1551 MTb strain results in higher levels of virus replication relative to co-infection with the HN878 MTb strain ex vivo. Furthermore, we show that the distinct pattern of CDC1551 or HN878 induced HIV-1 replication is associated with significantly increased levels of TNF and IL-6, and of the transcription and nuclear translocation of the p65 subunit of the transcription factor NF-kappa B, by CDC1551 relative to HN878. Conclusions/Significance: These results provide a precedent for TB strain-specific effects upon HIV-1 replication and thus for TB strain-specific pathogenesis in the outcome of HIV-1/TB co-infection. MTb strain-specific factors and mechanisms involved in the regulation of HIV-1 during co-infection will be of importance in understanding the basic pathogenesis of HIV-1/TB co-infection.			Ranjbar, S (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	ranjbar@idi.harvard.edu; goldfeld@idi.harvard.edu	Goldfeld, Anne/AAF-1818-2019	Rubin, Eric/0000-0001-5120-962X	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL 059838] Funding Source: Medline; NIAID NIH HHS [P30 AI060354, AI 065285, P30 AI 060354, R56 AI065285, R01 AI065285] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R56AI065285, ZIAAI000783, R01AI065285] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Ait-Ali D, 2008, ENDOCRINOLOGY, V149, P2840, DOI 10.1210/en.2007-1192; Baba M, 2006, ANTIVIR RES, V71, P301, DOI 10.1016/j.antiviral.2006.01.002; Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Collins KR, 2000, J ACQ IMMUN DEF SYND, V24, P408, DOI 10.1097/00126334-200008150-00002; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Goldfeld AE, 2008, HDB TUBERCULOSIS IMM; Goletti D, 1996, J IMMUNOL, V157, P1271; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haraguchi Soichi, 2006, AIDS Res Ther, V3, P8, DOI 10.1186/1742-6405-3-8; Havlir DV, 2001, J CLIN MICROBIOL, V39, P298, DOI 10.1128/JCM.39.1.298-303.2001; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; ISRAEL N, 1989, J IMMUNOL, V143, P3956; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kinter AL, 2001, MOL MED, V7, P668, DOI 10.1007/BF03401957; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayaud C, 1999, THORAX, V54, P567, DOI 10.1136/thx.54.7.567; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nicod LP, 2007, SWISS MED WKLY, V137, P357; OGARRA A, 2008, HDB TUBERCULOSIS IMM; *ORG WH, 2007, GLOB TUB CONTR SURV; Park SK, 2004, NEPHROL DIAL TRANSPL, V19, P312, DOI 10.1093/ndt/gfg583; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Toossi Z, 2007, AIDS RES HUM RETROV, V23, P93, DOI 10.1089/aid.2006.0050; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; *UNAIDS, 2006, REP GLOB AIDS EP 200; *UNAIDS, 2007, TB HIV NETW POL CHAN; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vicenzi E, 2000, J LEUKOCYTE BIOL, V68, P405; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; *WORLD OH REP, 2004, P HIV TB C MEK SUB H; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	66	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6116	10.1371/journal.pone.0006116	http://dx.doi.org/10.1371/journal.pone.0006116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568431	gold, Green Published, Green Submitted			2022-12-25	WOS:000267572200015
J	Jayanthi, S; Mccoy, MT; Beauvais, G; Ladenheim, B; Gilmore, K; Wood, W; Becker, K; Cadet, JL				Jayanthi, Subramaniam; McCoy, Michael T.; Beauvais, Genevieve; Ladenheim, Bruce; Gilmore, Kristi; Wood, William, III; Becker, Kevin; Cadet, Jean Lud			Methamphetamine Induces Dopamine D1 Receptor-Dependent Endoplasmic Reticulum Stress-Related Molecular Events in the Rat Striatum	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; ACTIVATING TRANSCRIPTION FACTOR-3; FOCAL CEREBRAL-ISCHEMIA; APOPTOTIC CELL-DEATH; HEAT-SHOCK PROTEINS; ER STRESS; HEME OXYGENASE-1; OXIDATIVE STRESS; GENE-EXPRESSION	Methamphetamine (METH) is an illicit toxic psychostimulant which is widely abused. Its toxic effects depend on the release of excessive levels of dopamine (DA) that activates striatal DA receptors. Inhibition of DA-mediated neurotransmission by the DA D1 receptor antagonist, SCH23390, protects against METH-induced neuronal apoptosis. The initial purpose of the present study was to investigate, using microarray analyses, the influence of SCH23390 on transcriptional responses in the rat striatum caused by a single METH injection at 2 and 4 hours after drug administration. We identified 545 out of a total of 22,227 genes as METH-responsive. These include genes which are involved in apoptotic pathways, endoplasmic reticulum (ER) stress, and in transcription regulation, among others. Of these, a total of 172 genes showed SCH23390-induced inhibition of METH-mediated changes. Among these SCH23390-responsive genes were several genes that are regulated during ER stress, namely ATF3, HSP27, Hmox1, HSP40, and CHOP/Gadd153. The secondary goal of the study was to investigate the role of DA D1 receptor stimulation on the expression of genes that participate in ER stress-mediated molecular events. We thus used quantitative PCR to confirm changes in the METH-responsive ER genes identified by the microarray analyses. We also measured the expression of these genes and of ATF4, ATF6, BiP/GRP78, and of GADD34 over a more extended time course. SCH23390 attenuated or blocked METH-induced increases in the expression of the majority of these genes. Western blot analysis revealed METH-induced increases in the expression of the antioxidant protein, Hmox1, which lasted for about 24 hours after the METH injection. Additionally, METH caused DA D1 receptor-dependent transit of the Hmox1 regulator protein, Nrf2, from cytosolic into nuclear fractions where the protein exerts its regulatory functions. When taken together, these findings indicate that SCH23390 can provide protection against neuronal apoptosis by inhibiting METH-mediated DA D1 receptor-mediated ER stress in the rat striatum. Our data also suggest that METH-induced toxicity might be a useful model to dissect molecular mechanisms involved in ER stress-dependent events in the rodent brain.			Jayanthi, S (corresponding author), Natl Inst Drug Abuse, Mol Neuropsychiat Res Branch, NIH, DHHS,Intramural Res Program, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Becker, Kevin/0000-0002-6794-6656; Jayanthi, Subramaniam/0000-0002-5209-303X	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000616, ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000552, ZIADA000551] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/1523086041798051; Cappon GD, 2000, BRAIN RES, V863, P106, DOI 10.1016/S0006-8993(00)02107-7; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hai T, 1999, GENE EXPRESSION, V7, P321; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hill-Kapturczak N, 2007, ANTIOXID REDOX SIGN, V9, P2197, DOI 10.1089/ars.2007.1798; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jayanthi S, 1998, ANN NY ACAD SCI, V844, P92, DOI 10.1111/j.1749-6632.1998.tb08224.x; Jayanthi S, 2001, FASEB J, V15, P1745, DOI 10.1096/fj.01-0025com; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; KRAMER JC, 1967, J AMER MED ASSOC, V201, P305, DOI 10.1001/jama.201.5.305; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Li HY, 2007, CHEM RES TOXICOL, V20, P1242, DOI 10.1021/tx700076q; Linden T, 1998, NEUROSCI LETT, V247, P103, DOI 10.1016/S0304-3940(98)00278-X; Liu XY, 2008, CELL MOL NEUROBIOL, V28, P769, DOI 10.1007/s10571-007-9219-0; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Makishima T, 2000, J BIOCHEM-TOKYO, V128, P399, DOI 10.1093/oxfordjournals.jbchem.a022767; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Meriin AB, 2005, INT J HYPERTHER, V21, P403, DOI 10.1080/02656730500041871; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Moussa CEH, 2006, NEUROCHEM INT, V48, P226, DOI 10.1016/j.neuint.2005.09.007; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nakagomi S, 2003, J NEUROSCI, V23, P5187; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Nishii K, 1999, GENES CELLS, V4, P243, DOI 10.1046/j.1365-2443.1999.00256.x; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Oida Y, 2008, BRAIN RES, V1208, P217, DOI 10.1016/j.brainres.2008.02.068; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 1998, METAB BRAIN DIS, V13, P55, DOI 10.1023/A:1020631029168; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P773, DOI 10.1097/01.WCB.0000075009.47474.F9; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sanjay A, 1998, J BIOL CHEM, V273, P26094, DOI 10.1074/jbc.273.40.26094; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Shih AY, 2007, J NEUROCHEM, V101, P109, DOI 10.1111/j.1471-4159.2006.04345.x; SUGIMOTO A, 1995, EMBO J, V14, P4434, DOI 10.1002/j.1460-2075.1995.tb00122.x; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yang JP, 2009, J INVEST SURG, V22, P29, DOI 10.1080/08941930802566714; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang LJ, 2009, CANCER LETT, V274, P40, DOI 10.1016/j.canlet.2008.08.030; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	114	67	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6092	10.1371/journal.pone.0006092	http://dx.doi.org/10.1371/journal.pone.0006092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564919	Green Published, Green Submitted, gold			2022-12-25	WOS:000267515700011
J	Luo, HW; Sun, ZY; Arndt, W; Shi, J; Friedman, R; Tang, JJ				Luo, Haiwei; Sun, Zhiyi; Arndt, William; Shi, Jian; Friedman, Robert; Tang, Jijun			Gene Order Phylogeny and the Evolution of Methanogens	PLOS ONE			English	Article							RECONSTRUCTION; ARCHAEA; TREE; GENOMICS; ORIGIN	Methanogens are a phylogenetically diverse group belonging to Euryarchaeota. Previously, phylogenetic approaches using large datasets revealed that methanogens can be grouped into two classes, "Class I'' and "Class II''. However, some deep relationships were not resolved. For instance, the monophyly of "Class I'' methanogens, which consist of Methanopyrales, Methanobacteriales and Methanococcales, is disputable due to weak statistical support. In this study, we use MSOAR to identify common orthologous genes from eight methanogen species and a Thermococcale species (outgroup), and apply GRAPPA and FastME to compute distance-based gene order phylogeny. The gene order phylogeny supports two classes of methanogens, but it differs from the original classification of methanogens by placing Methanopyrales and Methanobacteriales together with Methanosarcinales in Class II rather than with Methanococcales. This study suggests a new classification scheme for methanogens. In addition, it indicates that gene order phylogeny can complement traditional sequence-based methods in addressing taxonomic questions for deep relationships.			Luo, HW (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	hluo2006@gmail.com	Tang, Jijun/ABH-6528-2020; Luo, Haiwei/AAE-1958-2021	Luo, Haiwei/0000-0001-8452-6066; Sun, Zhiyi/0000-0002-6106-5356; Friedman, Robert/0000-0002-1061-4909	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078991, R01GM043940] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abby S, 2007, TRENDS MICROBIOL, V15, P135, DOI 10.1016/j.tim.2007.01.007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bapteste E, 2008, MOL BIOL EVOL, V25, P83, DOI 10.1093/mlbev/msm229; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Bapteste E, 2004, TRENDS MICROBIOL, V12, P406, DOI 10.1016/j.tim.2004.07.002; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Chen X, 2005, IEEE ACM T COMPUT BI, V2, P302, DOI 10.1109/TCBB.2005.48; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-86; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; JIANG T, 2007, P 18 ANN S COMB PATT; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Luo HW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003837; McCann A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-312; Moret B M, 2001, Bioinformatics, V17 Suppl 1, pS165; Moret BME, 2002, J COMPUT SYST SCI, V65, P508, DOI 10.1016/S0022-0000(02)00007-7; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Palmer Jeffrey D., 1992, P99; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Wang LS, 2006, J MOL EVOL, V63, P473, DOI 10.1007/s00239-005-0216-y	31	23	30	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6069	10.1371/journal.pone.0006069	http://dx.doi.org/10.1371/journal.pone.0006069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562076	gold, Green Published, Green Submitted			2022-12-25	WOS:000267465900005
J	Barros, VC; Assumpcao, JG; Cadete, AM; Santos, VC; Cavalcante, RR; Araujo, RN; Pereira, MH; Gontijo, NF				Barros, Veruska Cavalcanti; Assumpcao, Jessica Goes; Cadete, Andre Miranda; Santos, Vania Cristina; Cavalcante, Reginaldo Roris; Araujo, Ricardo Nascimento; Pereira, Marcos Horacio; Gontijo, Nelder Figueiredo			The Role of Salivary and Intestinal Complement System Inhibitors in the Midgut Protection of Triatomines and Mosquitoes	PLOS ONE			English	Article								Saliva of haematophagous arthropods contain biomolecules involved directly or indirectly with the haematophagy process, and among them are encountered some complement system inhibitors. The most obvious function for these inhibitors would be the protection of the midgut against injury by the complement. To investigate this hypothesis, Triatoma brasiliensis nymphs were forced to ingest human serum in conditions in which the protection of midgut by the inhibitors is bypassed. In these conditions, the anterior midgut epithelium was injured by the complement, causing cell death. Once some insects such as Aedes aegypti have no salivary inhibitors, we hypothesized the existence of intestinal inhibitors. The inhibitory activity was investigated in the intestine of A. aegypti as well as in the saliva and intestine of other three triatomine species (T. brasiliensis, T. infestans and Rhodnius prolixus) using an immunological method able to determine the level of deposition of some complement factors (C1q, C3b, or C4b) on the surface of complement activator molecules linked to microplates. This methodology permitted to identify which points along the activation phase of the complement cascade were inhibited. As expected, soluble contents of A. aegypti's intestine was capable to inhibit C3b deposition by the classical and alternative pathways. Saliva or soluble intestinal contents, obtained from triatomines were unable to inhibit C1q deposition by the classical pathway. C4b deposition by the classical pathway was inhibited by the intestinal contents from the three triatomines. On the other hand, only T. brasiliensis saliva inhibited C4b deposition. Both, saliva and intestinal contents from all triatomines were able to inhibit C3b deposition in the classical and alternative pathways. None of the material extracted from the intestinal cell membranes from the triatomines inhibited C3b deposition in the classical pathway. The existence of complement inhibitors may have important biological consequences which are discussed in detail.			Barros, VC (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	nelder@icb.ufmg.br	Pereira, Marcos H/A-3774-2012; Gontijo, Nelder F/D-2539-2013; Araujo, Ricardo N/O-1967-2017; Pereira, Marcos Horácio/AAE-7076-2021	Pereira, Marcos H/0000-0003-4843-0088; Gontijo, Nelder F/0000-0003-3357-2497; Araujo, Ricardo N/0000-0002-1272-4386; Pereira, Marcos Horácio/0000-0003-4843-0088				Abdul-Rauf M, 1999, J INVERTEBR PATHOL, V73, P45, DOI 10.1006/jipa.1998.4792; Andrade BB, 2005, AN ACAD BRAS CIENC, V77, P665, DOI 10.1590/S0001-37652005000400008; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Bahia D, 2007, PARASITOL RES, V100, P449, DOI 10.1007/s00436-006-0307-8; Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; BURTON DR, 1980, NATURE, V288, P338, DOI 10.1038/288338a0; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CATTY D, 1988, ANTIBODIES PRACTICAL, P19; Cavalcante RR, 2003, PARASITOLOGY, V127, P87, DOI 10.1017/S0031182003003329; Colombara R, 1996, J CAPILLARY ELECTROP, V3, P147; Corena MD, 2005, J EXP BIOL, V208, P3263, DOI 10.1242/jeb.01739; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Devenport Martin, 2005, P297; EIRAS AE, 1991, B ENTOMOL RES, V81, P151, DOI 10.1017/S0007485300051221; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Garcia E.S., 1984, Memorias do Instituto Oswaldo Cruz, V79, P33; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gomes RB, 2007, T ROY SOC TROP MED H, V101, P127, DOI 10.1016/j.trstmh.2006.06.002; GROVES WE, 1968, ANAL BIOCHEM, V22, P195, DOI 10.1016/0003-2697(68)90307-2; Hardig Y, 1997, BIOCHEM J, V323, P469; Hostomska J, 2008, VECTOR-BORNE ZOONOT, V8, P443, DOI 10.1089/vbz.2007.0214; Kalvachova P, 1999, J MED ENTOMOL, V36, P341, DOI 10.1093/jmedent/36.3.341; MORGAN PB, 1997, COMPLEMENT PRACTICAL, P105; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Rathinavelu S, 2003, INFECT IMMUN, V71, P822, DOI 10.1128/IAI.71.2.822-829.2003; RIBEIRO JMC, 1987, EXP PARASITOL, V64, P347, DOI 10.1016/0014-4894(87)90046-4; RIBEIRO JMC, 1980, J INSECT PHYSIOL, V26, P303, DOI 10.1016/0022-1910(80)90138-9; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; Santos VC, 2008, J EXP BIOL, V211, P2792, DOI 10.1242/jeb.019836; Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94; SIM RB, 1997, COMPLEMENT PRACTICAL; Soares AC, 2006, J INSECT PHYSIOL, V52, P468, DOI 10.1016/j.jinsphys.2006.01.003; Terra W. R., 1996, P206; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Villiers CL, 2008, MOL IMMUNOL, V45, P3509, DOI 10.1016/j.molimm.2008.05.015; Villiers MB, 1999, IMMUNOPHARMACOLOGY, V42, P151, DOI 10.1016/S0162-3109(99)00017-X; Villiers MB, 2003, INT IMMUNOL, V15, P91, DOI 10.1093/intimm/dxg014; Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8; [No title captured]	46	39	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6047	10.1371/journal.pone.0006047	http://dx.doi.org/10.1371/journal.pone.0006047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557176	Green Published, gold, Green Submitted			2022-12-25	WOS:000267356900009
J	Pfeiffer, T; Hoffmann, R				Pfeiffer, Thomas; Hoffmann, Robert			Large-Scale Assessment of the Effect of Popularity on the Reliability of Research	PLOS ONE			English	Article								Based on theoretical reasoning it has been suggested that the reliability of findings published in the scientific literature decreases with the popularity of a research field. Here we provide empirical support for this prediction. We evaluate published statements on protein interactions with data from high-throughput experiments. We find evidence for two distinctive effects. First, with increasing popularity of the interaction partners, individual statements in the literature become more erroneous. Second, the overall evidence on an interaction becomes increasingly distorted by multiple independent testing. We therefore argue that for increasing the reliability of research it is essential to assess the negative effects of popularity and develop approaches to diminish these effects.			Pfeiffer, T (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA USA.	pfeiffer@fas.harvard.edu	Pfeiffer, Thomas/R-1339-2019	Pfeiffer, Thomas/0000-0002-0592-577X				Cokol M, 2007, EMBO REP, V8, P422, DOI 10.1038/sj.embor.7400970; Duan XJ, 2002, MOL CELL PROTEOMICS, V1, P104, DOI 10.1074/mcp.M100026-MCP200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; GOODMAN SN, 1988, AM J PUBLIC HEALTH, V78, P1568, DOI 10.2105/AJPH.78.12.1568; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Pfeiffer T, 2007, P NATL ACAD SCI USA, V104, P12052, DOI 10.1073/pnas.0701315104; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waldrop M, 2008, NATURE, V455, P22, DOI 10.1038/455022a; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289	20	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e5996	10.1371/journal.pone.0005996	http://dx.doi.org/10.1371/journal.pone.0005996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551148	gold, Green Published			2022-12-25	WOS:000267356500005
J	Turdi, S; Guo, R; Huff, AF; Wolf, EM; Culver, B; Ren, J				Turdi, Subat; Guo, Rui; Huff, Anna F.; Wolf, Eliza M.; Culver, Bruce; Ren, Jun			Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article								Objectives: Ample clinical and experimental evidence indicated that patients with Alzheimer's disease display a high incidence of cardiovascular events. This study was designed to examine myocardial histology, cardiomyocyte shortening, intracellular Ca(2+) homeostasis and regulatory proteins, electrocardiogram, adrenergic response, endoplasmic reticulum (ER) stress and protein carbonyl formation in C57 wild-type (WT) mice and an APPswe/PS1dE9 transgenic (APP/PS1) model for Alzheimer's disease. Methods: Cardiomyocyte mechanical properties were evaluated including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR), maximal velocity of shortening and relengthening (6dL/dt), intracellular Ca(2+) transient rise and decay. Results: Little histological changes were observed in APP/PS1 myocardium. Cardiomyocytes from APP/PS1 but not APP or PS1 single mutation mice exhibited depressed PS, reduced +/- dL/dt, normal TPS and TR compared with WT mice. Rise in intracellular Ca(2+) was lower accompanied by unchanged resting/peak intracellular Ca(2+) levels and intracellular Ca(2+) decay in APP/PS1 mice. Cardiomyocytes from APP/PS1 mice exhibited a steeper decline in PS at high frequencies. The responsiveness to adrenergic agonists was dampened although beta(1)-adrenergic receptor expression was unchanged in APP/PS1 hearts. Expression of the Ca(2+) regulatory protein phospholamban and protein carbonyl formation were downregulated and elevated, respectively, associated with unchanged SERCA2a, Na(+)-Ca(2+) exchanger and ER stress markers in APP/PS1 hearts. Our further study revealed that antioxidant N-acetylcysteine attenuated the contractile dysfunction in APP/PS1 mice. Conclusions: Our results depicted overt cardiomyocyte mechanical dysfunction in the APP/PS1 Alzheimer's disease model, possibly due to oxidative stress.			Turdi, S (corresponding author), Univ Wyoming, Div Pharmaceut Sci, Coll Hlth Sci, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	NCRR NIH HHS [5 P20 RR016474, P20 RR016474] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bleumink GS, 2004, AM HEART J, V147, P685, DOI 10.1016/j.ahj.2003.11.016; Brodde OE, 2006, J PHARMACOL SCI, V100, P323, DOI 10.1254/jphs.CRJ06001X; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Estorch M, 2006, Rev Esp Med Nucl, V25, P229, DOI 10.1157/13090655; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Giubilei F, 1998, ALZ DIS ASSOC DIS, V12, P356, DOI 10.1097/00002093-199812000-00017; Gu F, 2008, NEUROSCI LETT, V440, P44, DOI 10.1016/j.neulet.2008.05.050; GUO R, 2009, J MOL CELL CARDIOL; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Heron Melonie, 2007, Natl Vital Stat Rep, V56, P1; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Irie F, 2008, ARCH NEUROL-CHICAGO, V65, P89, DOI 10.1001/archneurol.2007.29; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky Joanna L, 2002, Curr Neurol Neurosci Rep, V2, P457, DOI 10.1007/s11910-002-0073-7; Jindahra Panitha, 2004, Journal of the Medical Association of Thailand, V87, P1176; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Nakajima M, 2004, DEV DYNAM, V230, P795, DOI 10.1002/dvdy.20098; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7; Picklo MJ, 2002, TOXICOL APPL PHARM, V184, P187, DOI 10.1006/taap.2002.9506; RASKIND MA, 1984, ARCH GEN PSYCHIAT, V41, P343; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Ren J, 2003, PHARMACOL RES, V47, P341, DOI 10.1016/S1043-6618(03)00005-7; Ren J, 2007, CIRCULATION, V116, P190; Roher AE, 2005, NEUROLOGY, V65, P974, DOI 10.1212/WNL.65.6.974; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; Wada-Isoe K, 2007, J NEUROL SCI, V260, P33, DOI 10.1016/j.jns.2007.03.016; WANG SJ, 1994, AGE AGEING, V23, P400, DOI 10.1093/ageing/23.5.400; WIELAND DM, 1981, J NUCL MED, V22, P22	41	25	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6033	10.1371/journal.pone.0006033	http://dx.doi.org/10.1371/journal.pone.0006033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551139	gold, Green Published, Green Submitted			2022-12-25	WOS:000267356500017
J	Jensen, KB; Lonsdorf, TB; Schalling, M; Kosek, E; Ingvar, M				Jensen, Karin B.; Lonsdorf, Tina B.; Schalling, Martin; Kosek, Eva; Ingvar, Martin			Increased Sensitivity to Thermal Pain Following a Single Opiate Dose Is Influenced by the COMT val(158)met Polymorphism	PLOS ONE			English	Article								Increased pain sensitivity after opioid administration (opioid-induced hyperalgesia) and/or repeated painful stimuli is an individually varying and clinically important phenomenon. The functional polymorphism (val(158)met) of the Catechol-O-methyltransferase (COMT) gene regulates the metabolism of dopamine/noradrenaline. Individuals homozygous for the met(158) allele have been reported to have increased pain sensitivity and there are findings of lower mu-opioid system activation during sustained pain. We hypothesized that met/met individuals would exhibit higher pain sensitization and opioid-induced hyperalgesia in response to repeated pain stimuli and an intravenous injection of an opioid drug. Participants were 43 healthy subjects who went through an experiment where five blocks of pain were induced to the hand using a heat probe. After each stimulus subjects rated the pain on a visual analogue scale (VAS) from 0 mm (no pain) to 100 mm (worst possible pain). Before the second stimulus there was an intravenous injection of a rapid and potent opioid drug. At baseline there was no difference in pain ratings between the COMTval(158)met genotypes, F(2, 39)<1. However, a repeated measures ANOVA for all five stimuli revealed a main effect for COMTval(158) met genotype, F(2, 36) = 4.17, p = 0.024. Met/met individuals reported significantly more pain compared to val/val, p = 0.010. A pairwise comparison of baseline and the opioid intervention demonstrated that analgesia was induced in all groups (p = 0.042) without a separating effect for genotype (n.s). We suggest that the initial response of the descending pain system is not influenced by the COMTval(158)met polymorphism but when the system is challenged the difference is revealed. An important clinical implication of this may be that the COMTval(158)met related differences may be more expressed in individuals where the inhibitory system is already challenged and sensitive, e. g. chronic pain patients. This has to be proven in future studies where the impact of the COMTval(158)met polymorphism on opioid treatment in patients is addressed.			Jensen, KB (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm Brain Inst, Osher Ctr Integrat Med, Stockholm, Sweden.	Karin.B.Jensen@ki.se	Lonsdorf, Tina/K-8657-2017; Jensen, Karin/G-6360-2012; Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Lonsdorf, Tina/0000-0003-1501-4846; Ingvar, Martin/0000-0002-9041-5714; Kosek, Eva/0000-0003-0488-8177; Jensen, Karin/0000-0003-2521-3160				BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; King T, 2005, NEUROSIGNALS, V14, P194, DOI 10.1159/000087658; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mao Jianren, 2006, Curr Pain Headache Rep, V10, P67, DOI 10.1007/s11916-006-0011-5; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; NAGEL I, 2008, FRONT HUM NEUROSCIEN, V2; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Rakvag TT, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-64; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; REYESGIBBLY CC, 2007, PAIN, V130, P5; Ross JR, 2008, CANCER-AM CANCER SOC, V112, P1390, DOI 10.1002/cncr.23292; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	18	84	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6016	10.1371/journal.pone.0006016	http://dx.doi.org/10.1371/journal.pone.0006016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547755	gold, Green Published			2022-12-25	WOS:000267347900013
J	Elimova, E; Kisilevsky, R; Ancsin, JB				Elimova, Elena; Kisilevsky, Robert; Ancsin, John B.			Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch	FASEB JOURNAL			English	Article						lipoprotein; amyloidosis; remodeling; acidic-pH binding site	HIGH-DENSITY-LIPOPROTEIN; GROWTH-FACTOR-BINDING; APOLIPOPROTEIN-E; AA-AMYLOIDOSIS; PRION PROTEIN; IN-VITRO; MACROPHAGE CHOLESTEROL; PERITONEAL-MACROPHAGES; ALZHEIMERS-DISEASE; ACUTE-INFLAMMATION	During inflammatory diseases, serum amyloid A (SAA), an acute-phase apolipoprotein of HDL, can assemble into tissue deposits called AA amyloids. The mechanism and physiological factors promoting amyloidosis are largely unknown but likely involve heparan sulfate (HS), a glycosaminoglycan colocalized with all types of amyloids. In this study, we explored HDL-SAA: HS interactions using in vitro and cell culture assays to identify HS-binding domains that promote the conversion of native SAA into AA amyloid. HS causes the remodeling of HDL-SAA at mildly acidic pH, producing SAA-rich aggregates. A sequence motif in SAA responsible for this conversion was identified that contains a pH-sensitive heparin/HS-binding site, functions as a ligand for a cell surface receptor, and acts as a structural focal point for SAA aggregation. Synthetic peptides corresponding to this region promoted the deposition of AA amyloid in a monocyte culture model for AA amyloidogenesis. The effects were peptide sequence specific and reliant on the protonation of H36. We conclude that a highly conserved motif required for SAA binding to macrophages can, under acidic pH conditions and in an HS-dependent manner, also act as a molecular switch, directing SAA misfolding into AA amyloid. Similar histidine-dependent HS-binding sites are also found in other amyloidogenic polypeptides.-Elimova, E., Kisilevsky, R., Ancsin, J. B. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB J. 23, 3436-3448 ( 2009). www.fasebj.org	[Kisilevsky, Robert; Ancsin, John B.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Elimova, Elena; Kisilevsky, Robert; Ancsin, John B.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Kisilevsky, Robert] Kingston Gen Hosp, Syl & Molly Apps Res Ctr, Kingston, ON K7L 2V7, Canada	McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Ancsin, JB (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada.	3jba1@queensu.ca			Canadian Institutes of Health Research [MOP-3153]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Elizabeth Hearn for her able technical support. This work was supported by grant MOP-3153 ( R. K.) from the Canadian Institutes of Health Research.	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; AXELRAD MA, 1982, LAB INVEST, V47, P139; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Benjwal S, 2005, BIOCHEMISTRY-US, V44, P10218, DOI 10.1021/bi050781m; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; BURSTEIN Y, 1974, BIOCHEMISTRY-US, V13, P205, DOI 10.1021/bi00698a030; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Caldwell EEO, 1996, INT J BIOCHEM CELL B, V28, P203, DOI 10.1016/1357-2725(95)00123-9; CARDIN AD, 1986, BIOCHEM BIOPH RES CO, V134, P783, DOI 10.1016/S0006-291X(86)80489-2; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Creighton T. E., 1993, PROTEINS STRUCTURE M; Dember LM, 2007, NEW ENGL J MED, V356, P2349, DOI 10.1056/NEJMoa065644; Dong J, 2001, BIOCHEMISTRY-US, V40, P2826, DOI 10.1021/bi002417n; Elimova E, 2004, FASEB J, V18, P1749, DOI 10.1096/fj.03-1436fje; ERICSSON LH, 1987, FEBS LETT, V218, P11, DOI 10.1016/0014-5793(87)81008-6; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; GOLDSMITH MR, 1979, ANAL BIOCHEM, V99, P33, DOI 10.1016/0003-2697(79)90041-1; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayat S, 2000, SCAND J IMMUNOL, V51, P141; Hondal RJ, 2001, J BIOL CHEM, V276, P15823, DOI 10.1074/jbc.M010405200; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Inoue S, 1996, LAB INVEST, V74, P1081; Inoue S, 1996, LAB INVEST, V74, P670; Inoue S, 2002, AMYLOID, V9, P115, DOI 10.3109/13506120208995244; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jayaraman S, 2006, BIOCHEMISTRY-US, V45, P4620, DOI 10.1021/bi0524565; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; KISILEVSKY R, 1983, LAB INVEST, V48, P53; Kisilevsky R, 2004, J MOL NEUROSCI, V24, P167, DOI 10.1385/JMN:24:1:167; Kisilevsky R, 2004, AM J PATHOL, V164, P2127, DOI 10.1016/S0002-9440(10)63771-6; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; KISILEVSKY R, 1992, LAB INVEST, V66, P778; KISILEVSKY R, 1994, AMYLOID, V1, P174, DOI 10.3109/13506129409148449; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kluve-Beckerman B, 2001, SCAND J IMMUNOL, V53, P393, DOI 10.1046/j.1365-3083.2001.00879.x; Kuang ZH, 2006, J MOL BIOL, V364, P690, DOI 10.1016/j.jmb.2006.09.006; LENDRUM AC, 1972, J CLIN PATHOL, V25, P373, DOI 10.1136/jcp.25.5.373; LEVIN M, 1973, J EXP MED, V138, P373, DOI 10.1084/jem.138.2.373; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Libeu CP, 2001, J BIOL CHEM, V276, P39138, DOI 10.1074/jbc.M104746200; Mahley RW, 1999, J LIPID RES, V40, P1; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Miles E W, 1977, Methods Enzymol, V47, P431; Miller GJ, 2001, J BIOL CHEM, V276, P28829, DOI 10.1074/jbc.M102561200; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; Ohashi K, 2002, NEPHRON, V90, P158, DOI 10.1159/000049037; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PRECIADOPATT L, 1994, EUR J BIOCHEM, V223, P35, DOI 10.1111/j.1432-1033.1994.tb18963.x; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rai SS, 1998, J BIOL CHEM, V273, P31131, DOI 10.1074/jbc.273.47.31131; Ratnaswamy G, 1999, CHEM BIOL, V6, P293, DOI 10.1016/S1074-5521(99)80075-1; Rocken C, 1997, AMYLOID, V4, P259, DOI 10.3109/13506129709003837; Sebollela A, 2005, J BIOL CHEM, V280, P31949, DOI 10.1074/jbc.M505314200; SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X; SNOW AD, 1987, LAB INVEST, V56, P665; SNOW AD, 1991, J HISTOCHEM CYTOCHEM, V39, P1321, DOI 10.1177/39.10.1940305; SNOW AD, 1985, LAB INVEST, V53, P37; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Tam SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003867; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; TAPE C, 1990, BIOCHIM BIOPHYS ACTA, V1043, P295, DOI 10.1016/0005-2760(90)90030-2; Tojo K, 2005, AMYLOID, V12, P103, DOI 10.1080/13506120500107097; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; van de Weert M, 2004, PHARM RES-DORDR, V21, P2354, DOI 10.1007/s11095-004-7689-z; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; WESTERMARK GT, 1992, BIOCHEM BIOPH RES CO, V182, P27, DOI 10.1016/S0006-291X(05)80107-X; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; ZOU S, 1992, COMP BIOCHEM PHYS B, V103, P889, DOI 10.1016/0305-0491(92)90210-I	93	45	46	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3436	3448		10.1096/fj.09-134981	http://dx.doi.org/10.1096/fj.09-134981			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19549924				2022-12-25	WOS:000270354300021
J	Nold-Petry, CA; Nold, MF; Nielsen, JW; Bustamante, A; Zepp, JA; Storm, KA; Hong, JW; Kim, SH; Dinarello, CA				Nold-Petry, Claudia A.; Nold, Marcel F.; Nielsen, Jason W.; Bustamante, Alex; Zepp, Jarod A.; Storm, Kathleen A.; Hong, Jae-Woo; Kim, Soo-Hyun; Dinarello, Charles A.			Increased Cytokine Production in Interleukin-18 Receptor alpha-deficient Cells Is Associated with Dysregulation of Suppressors of Cytokine Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL INTERSTITIAL FIBROSIS; GAMMA-INDUCING FACTOR; NEGATIVE REGULATOR; IL-18; BLOOD; BINDING; PROTEIN; MICE; PATHOGENESIS; INHIBITION	Since interleukin (IL)-18 is a proinflammatory cytokine, mice lacking IL-18 or its ligand-binding receptor (IL-18R) should exhibit decreased cytokine and chemokine production. Indeed, production of IL-1 alpha, IL-6, and MIP-1 alpha was reduced in IL-18 knock-out (ko) mouse embryonic fibroblast (MEF)-like cells. Unexpectedly, we observed a paradoxical 10-fold increase in IL-1 beta-induced IL-6 production in MEF cells from mice deficient in the IL-18R alpha-chain (IL-18R alpha) compared with wild type MEF. Similar increases were observed for IL-1 alpha, MIP-1 alpha, and prostaglandin E-2. Likewise, coincubation with a specific IL-18R alpha-blocking antibody augmented IL-1 beta-induced cytokines in wild type and IL-18 ko MEF. Stable lines of IL-18R alpha-depleted human A549 cells were generated using shRNA, resulting in an increase of IL-1 beta-induced IL-1 alpha, IL-6, and IL-8 compared to scrambled small hairpin RNA. In addition, we silenced IL-18R alpha with small interfering RNA in primary human blood cells and observed up to 4-fold increases in the secretion of lipopolysaccharide- and IL-12/IL-18-induced IL-1 beta, IL-6, interferon-gamma, and CD40L. Mechanistically, despite increases in Stat1 and IL-6, induction of SOCS1 and -3 (suppressor of cytokine signaling 1 and 3) was markedly reduced in the absence of IL-18R alpha. Consistent with these observations, activation of the p38 alpha/beta and ERK1/2 MAPKs and of protein kinase B/Akt increased in IL-18R alpha ko MEF, whereas the negative feedback kinase MSK2 was more active in IL-18 ko cells. These data reveal a role for SOCS1 and -3 in the seemingly paradoxical hyperresponsive state in cells deficient in IL-18R alpha, supporting the concept that IL-18R alpha participates in both pro-and anti-inflammatory responses and that an endogenous ligand engages IL-18R alpha to deliver an inhibitory signal.	[Nold-Petry, Claudia A.; Nold, Marcel F.; Nielsen, Jason W.; Bustamante, Alex; Zepp, Jarod A.; Kim, Soo-Hyun; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Storm, Kathleen A.] Source Mol Diagnost Inc, Boulder, CO 80301 USA; [Hong, Jae-Woo; Kim, Soo-Hyun] Konkuk Univ, Dept Biomed Sci & Technol, Seoul 143701, South Korea	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Konkuk University	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Box B168,12700 E 19th Ave, Aurora, CO 80045 USA.	cdinarello@mac.com	Dinarello, Charles/C-8524-2013	Nold, Marcel/0000-0001-9682-4618; Nold, Claudia/0000-0002-7439-3834; Hong, Jaewoo/0000-0003-3456-3672	National Institutes of Health [AI 15614, CA-04 6934]; Deutsche Forschungsgemeinschaft [747/1-1]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015614, R01AI015614, R56AI015614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 15614 and CA-04 6934 (Colorado Cancer Center) (to C. A. D.). This work was also supported by Deutsche Forschungsgemeinschaft Grant 747/1-1 (to M. F. N.).	Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Andoh T, 2008, J IMMUNOL, V180, P2322, DOI 10.4049/jimmunol.180.4.2322; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Bossu P, 2003, P NATL ACAD SCI USA, V100, P14181, DOI 10.1073/pnas.2336094100; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Debets R, 2000, J IMMUNOL, V165, P4950, DOI 10.4049/jimmunol.165.9.4950; DINARELLO CA, 1991, BRAIN RES, V562, P199, DOI 10.1016/0006-8993(91)90622-3; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; Fantuzzi G, 2001, EUR J IMMUNOL, V31, P369, DOI 10.1002/1521-4141(200102)31:2<369::AID-IMMU369>3.0.CO;2-Y; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hoshino K, 1999, J IMMUNOL, V162, P5041; Inaba M, 2005, BIOCHEM BIOPH RES CO, V328, P953, DOI 10.1016/j.bbrc.2005.01.046; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kinoshita K, 2004, J IMMUNOL, V173, P5312, DOI 10.4049/jimmunol.173.8.5312; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; Lin L, 2005, ARTHRITIS RHEUM, V52, P984, DOI 10.1002/art.20961; LONNEMAN G, 1995, KIDNEY INT, V47, P837, DOI 10.1038/ki.1995.126; LONNEMANN G, 1995, KIDNEY INT, V47, P845, DOI 10.1038/ki.1995.127; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; McLoughlin K, 2006, MOL MED, V12, P185, DOI 10.2119/2006-00018.McLoughlin; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Netea MG, 2002, J INFECT DIS, V185, P963, DOI 10.1086/339410; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Petry C, 2004, BBA-MOL CELL BIOL L, V1636, P108, DOI 10.1016/j.bbalip.2003.11.007; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Raeburn CD, 2002, AM J PHYSIOL-HEART C, V283, pH650, DOI 10.1152/ajpheart.00043.2002; Reddy P, 2003, J LAB CLIN MED, V141, P365, DOI 10.1016/S0022-2143(03)00028-3; Reznikov LL, 2002, J INTERF CYTOK RES, V22, P593, DOI 10.1089/10799900252982070; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Yoon DY, 2007, J BIOCHEM MOL BIOL, V40, P562; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zanin-Zhorov A, 2005, J IMMUNOL, V175, P276, DOI 10.4049/jimmunol.175.1.276; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	51	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25900	25911		10.1074/jbc.M109.004184	http://dx.doi.org/10.1074/jbc.M109.004184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19592492	Green Published, hybrid			2022-12-25	WOS:000269738000047
J	Thompson, NE; Glaser, BT; Foley, KM; Burton, ZF; Burgess, RR				Thompson, Nancy E.; Glaser, Bryan T.; Foley, Katherine M.; Burton, Zachary F.; Burgess, Richard R.			Minimal Promoter Systems Reveal the Importance of Conserved Residues in the B-finger of Human Transcription Factor IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; START SITE SELECTION; TATA-BINDING PROTEIN; RESPONSIVE MONOCLONAL-ANTIBODY; IMMUNOAFFINITY CHROMATOGRAPHY; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; INITIATION COMPLEX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	The "B-finger" of transcription factor IIB (TFIIB) is highly conserved and believed to play a role in the initiation process. We performed alanine substitutions across the B-finger of human TFIIB, made change-of-charge mutations in selected residues, and substituted the B-finger sequence from other organisms. Mutant proteins were examined in two minimal promoter systems (containing only RNA polymerase II, TATA-binding protein, and TFIIB) and in a complex system, using TFIIB-immunodepleted HeLa cell nuclear extract (NE). Mutations in conserved residues located on the sides of the B-finger had the greatest effect on activity in both minimal promoter systems, with mutations in residues Glu-51 and Arg-66 eliminating activity. The double change- of-charge mutant (E51R: R66E) did not show activity in either minimal promoter system. Mutations in the nonconserved residues at the tip of the B-finger did not significantly affect activity. However, all of the mutations in the B-finger showed at least 25% activity in the HeLa cell NE. Chimeric proteins, containing B-finger sequences from species with conserved residues on the side of the B-finger, showed wild-type activity in a minimal promoter system and in the HeLa cell NE. However, chimeric proteins whose sequence showed divergence on the sides of the B-finger had reduced activity. Transcription factor IIF(TFIIF) partially restored activity of the inactive mutants in the minimal promoter system, suggesting that TFIIF in HeLa cell NE helps to rescue the inactive mutations by interacting with either the B-finger or another component of the initiation complex that is influenced by the B-finger.	[Thompson, Nancy E.; Glaser, Bryan T.; Foley, Katherine M.; Burgess, Richard R.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Burton, Zachary F.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University	Thompson, NE (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	nethomps@wisc.edu		Burgess, Richard/0000-0001-9545-3165	National Institutes of Health [CA07175, CA23076, CA60896, GM28575, GM57461]; NATIONAL CANCER INSTITUTE [P01CA023076, R01CA060896, P30CA007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057461, R01GM028575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA07175, CA23076, CA60896, and GM28575 (to R.R.B. and the McArdle Laboratory) and GM57461 (to Z.F.B.). In compliance with the University of Wisconsin-Madison's Conflict of Interest Committee policy, the authors (R.R.B. and N.E.T.) acknowledge financial interest in NeoClone LLC (Madison, WI), which markets mAb IIB8.	Asturias FJ, 2004, CURR OPIN STRUC BIOL, V14, P121, DOI 10.1016/j.sbi.2004.03.007; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Deng W, 2006, BIOCHEM SOC T, V34, P1051, DOI 10.1042/BST0341051; Duellman SJ, 2004, PROTEIN EXPRES PURIF, V35, P147, DOI 10.1016/j.pep.2003.12.011; Fairley JA, 2002, MOL CELL BIOL, V22, P6697, DOI 10.1128/MCB.22.19.6697-6705.2002; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Gilman B, 2009, J BIOL CHEM, V284, P9093, DOI 10.1074/jbc.M900019200; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hampsey M, 2006, NAT STRUCT MOL BIOL, V13, P564, DOI 10.1038/nsmb0706-564; Hawkes NA, 1999, J BIOL CHEM, V274, P14337, DOI 10.1074/jbc.274.20.14337; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; PAN GH, 1994, J BIOL CHEM, V269, P30101; Panaghie G, 2000, J MOL BIOL, V299, P1217, DOI 10.1006/jmbi.2000.3808; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PINTO I, 1994, J BIOL CHEM, V269, P30569; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Shaw SP, 1996, MOL CELL BIOL, V16, P3651; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; Thompson NE, 2004, PROTEIN EXPRES PURIF, V36, P186, DOI 10.1016/j.pep.2004.02.020; THOMPSON NE, 1994, PROTEIN EXPRES PURIF, V5, P468, DOI 10.1006/prep.1994.1066; THOMPSON NE, 1995, J BIOL CHEM, V270, P4735, DOI 10.1074/jbc.270.9.4735; Thompson NE, 1999, PROTEIN EXPRES PURIF, V17, P260, DOI 10.1006/prep.1999.1128; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Tubon TC, 2004, MOL CELL BIOL, V24, P2863, DOI 10.1128/MCB.24.7.2863-2874.2004; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	51	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24754	24766		10.1074/jbc.M109.030486	http://dx.doi.org/10.1074/jbc.M109.030486			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19590095	hybrid, Green Published			2022-12-25	WOS:000269734000010
J	Karena, E; Frillingos, S				Karena, Ekaterini; Frillingos, Stathis			Role of Intramembrane Polar Residues in the YgfO Xanthine Permease HIS-31 AND ASN-93 ARE CRUCIAL FOR AFFINITY AND SPECIFICITY, AND ASP-304 AND GLU-272 ARE IRREPLACEABLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING ANALYSIS; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; SUBSTRATE-SELECTIVITY; LACTOSE PERMEASE; SIGNATURE MOTIF; TRANSPORTER; FAMILY; BACTERIAL; HELIX	Using the YgfO xanthine permease of Escherichia coli as a bacterial model for the study of the evolutionarily ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family, we performed a systematic Cys-scanning and site-directed mutagenesis of 14 putatively charged (Asp, Glu, His, Lys, or Arg) and 7 highly polar (Gln or Asn) residues that are predicted to lie in transmembrane helices (TMs). Of 21 single-Cys mutants engineered in the background of a functional YgfO devoid of Cys residues (C-less), only four are inactive or have marginal activity (H31C, N93C, E272C, D304C). The 4 residues are conserved throughout the family in TM1 (His-31), TM3 (Asn-93/Ser/Thr), TM8 (Glu-272), and putative TM9a (Asp-304/Asn/Glu). Extensive site-directed mutagenesis in wild-type background showed that H31N and H31Q have high activity and affinity for xanthine but H31Q recognizes novel purine bases and analogues, whereas H31C and H31L have impaired affinity for xanthine and analogues, and H31K or H31R impairs expression in the membrane. N93S and N93A are highly active but more promiscuous for recognition of analogues at the imidazole moiety of substrate, N93D has low activity, N93T has low affinity for xanthine or analogues, and N93Q or N93C is inactive. All mutants replacing Glu-272 or Asp-304, including E272D, E272Q, D304E, and D304N, are inactive, although expressed to high levels in the membrane. Finally, one of the 17 assayable single-Cys mutants, Q258C, was sensitive to inactivation by N-ethylmaleimide. The findings suggest that polar residues important for the function of YgfO cluster in TMs 1, 3, 8 and 9a.	[Karena, Ekaterini; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, Ioannina 45110, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, Ioannina 45110, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FRILLINGOS S, 1995, BIOCHEMISTRY-US, V34, P9368, DOI 10.1021/bi00029a012; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P13363, DOI 10.1021/bi961453c; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Pantazopoulou A, 2006, MOL MEMBR BIOL, V23, P337, DOI 10.1080/09687860600738239; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Stroud Robert M., 2009, Journal of Structural and Functional Genomics, V10, P193, DOI 10.1007/s10969-008-9058-3; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Tavoulari S, 2008, J MOL BIOL, V376, P681, DOI 10.1016/j.jmb.2007.12.015; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]	25	19	20	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24257	24268		10.1074/jbc.M109.030734	http://dx.doi.org/10.1074/jbc.M109.030734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19581302	Green Published, hybrid			2022-12-25	WOS:000269380200039
J	Sun, J; Khalid, S; Rozakis-Adcock, M; Fantus, IG; Jin, T				Sun, J.; Khalid, S.; Rozakis-Adcock, M.; Fantus, I. G.; Jin, T.			P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine	ONCOGENE			English	Article						insulin; beta-catenin; Wnt; PAK-1; c-Myc; ChIP	BETA-CATENIN; P21-ACTIVATED KINASE; COLORECTAL-CANCER; DIABETES-MELLITUS; COLON-CANCER; PHOSPHORYLATION; ACTIVATION; PAK1; RAS; EXPRESSION	Hyperinsulinemia and type II diabetes are associated with an increased risk of developing colorectal tumors. We found previously that in intestinal cells, insulin or insulin-like growth factor-1 stimulates c-Myc and cyclin D1 protein expression through both Akt-dependent and Akt-independent mechanisms. The effect of Akt is attributed to the stimulation of c-Myc translation by mammalian target of rapamycin. However, Akt-independent stimulation was, associated with an increase in beta-catenin (beta-cat) in the nucleus and an increased association between beta-cat and T-cell factor binding sites on the c-Myc promoter, detected by chromatin immunoprecipitation. In this study, we show that insulin stimulated the phosphorylation/activation of p-21-activated protein kinase-1 (PAK-1) in an Akt-independent manner in vitro and in an in vivo hyperinsulinemic mouse model. Significantly, shRNA (small hairpin RNA)-mediated PAK-1 knockdown attenuated both basal and insulin-stimulated c-Myc and cyclin D1 expression, associated with a marked reduction in extracellular signal-regulated kinase activation and beta-cat phosphorylation at Ser675. Furthermore, PAK-1 silencing led to a complete blockade of insulin-stimulated beta-cat binding to the c-Myc promoter and cellular growth. Finally, inhibition of MEK, a downstream target of PAK-1, blocked insulin-stimulated nuclear beta-cat accumulation and c-Myc expression. Our observations suggest that PAK-1 serves as an important linker between insulin and Wnt signaling pathways. Oncogene (2009) 28, 3132-3144; doi: 10.1038/onc.2009.167; published online 6 July 2009	[Sun, J.; Khalid, S.; Fantus, I. G.; Jin, T.] Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; [Khalid, S.; Fantus, I. G.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Sun, J.; Khalid, S.; Fantus, I. G.; Jin, T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sun, J.; Rozakis-Adcock, M.; Jin, T.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Sun, J.; Khalid, S.; Fantus, I. G.; Jin, T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Jin, T (corresponding author), Univ Hlth Network, Div Cell & Mol Biol, 10-354 Toronto Med Discovery Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	tianru.jin@utoronto.ca			Banting and Best Diabetes Centre (BBDC); Canadian Institutes of Health Research [MOP-89987]; Canadian Breast Cancer Research Alliance/CIHR [016512]	Banting and Best Diabetes Centre (BBDC); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance/CIHR(Canadian Institutes of Health Research (CIHR))	We thank Dr Jeffrey Field (University of Pennsylvania) for providing the dominant negative PAK-1 (K299R), constitutively active PAK-1 (T423E) and control plasmids. JS is a recipient of Banting and Best Diabetes Centre (BBDC) Novo Nordisk graduate studentship (2004-2008). This study was supported by an operating grant from Canadian Institutes of Health Research to TJ (MOP-89987) and a Translational Acceleration Research Grant from the Canadian Breast Cancer Research Alliance/CIHR (# 016512) to IGF.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Akinmade D, 2008, BRIT J CANCER, V98, P1132, DOI 10.1038/sj.bjc.6604261; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bustin SA, 2001, TRENDS MOL MED, V7, P447, DOI 10.1016/S1471-4914(01)02104-9; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Chang CK, 2003, DIABETOLOGIA, V46, P595, DOI 10.1007/s00125-003-1109-5; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Clements Wilson M, 2003, Clin Colorectal Cancer, V3, P113, DOI 10.3816/CCC.2003.n.018; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Elwing JE, 2006, AM J GASTROENTEROL, V101, P1866, DOI 10.1111/j.1572-0241.2006.00651.x; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Lewin HS, 2008, J MED LIBR ASSOC, V96, P155, DOI 10.3163/1536-5050.96.2.155; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Sun J, 2008, CELL SIGNAL, V20, P219, DOI 10.1016/j.cellsig.2007.10.010; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Yoshii S, 2001, MOL CELL BIOL, V21, P6796, DOI 10.1128/MCB.21.20.6796-6807.2001; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200; Zhou GL, 2004, CANCER BIOL THER, V3, P102, DOI 10.4161/cbt.3.1.691; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	67	49	50	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3132	3144		10.1038/onc.2009.167	http://dx.doi.org/10.1038/onc.2009.167			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19581924				2022-12-25	WOS:000269515100005
J	Fan, C; Ouyang, P; Timur, AA; He, P; You, SA; Hu, Y; Ke, T; Driscoll, DJ; Chen, QY; Wang, QK				Fan, Chun; Ouyang, Ping; Timur, Ayse A.; He, Ping; You, Sun-Ah; Hu, Ying; Ke, Tie; Driscoll, David J.; Chen, Qiuyun; Wang, Qing Kenneth			Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and Endothelial Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLIPPEL-TRENAUNAY-SYNDROME; CORONARY-ARTERY-DISEASE; HOLT-ORAM-SYNDROME; MOLECULAR CHARACTERIZATION; MYOCARDIAL-INFARCTION; ESCHERICHIA-COLI; CHROMOSOME 9P21; GENE-EXPRESSION; 4 SNPS; IDENTIFICATION	AGGF1 is an angiogenic factor, and its deregulation is associated with a vascular malformation consistent with Klippel-Trenaunay syndrome (KTS). This study defines the molecular mechanism for transcriptional regulation of AGGF1 expression. Transcription of AGGF1 starts at two nearby sites, -367 and -364 bp upstream of the translation start site. Analyses of 5'- and 3'-serial promoter deletions defined the core promoter/regulatory elements, including two repressor sites (from -1971 to -3990 and from -7521 to -8391, respectively) and two activator sites (a GATA1 consensus binding site from -295 to -300 and a second activator site from -129 to -159). Both the GATA1 site and the second activator site are essential for AGGF1 expression. A similar expression profile was found for GATA1 and AGGF1 in cells (including various endothelial cells) and tissues. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrated that GATA1 was able to bind to the AGGF1 DNA in vitro and in vivo. Overexpression of GATA1 increased expression of AGGF1. We identified one rare polymorphism -294C> T in a sporadic KTS patient, which is located in the GATA1 site, disrupts binding of GATA1 to DNA, and abolishes the GATA1 stimulatory effect on transcription of AGGF1. Knockdown of GATA1 expression by siRNA reduced expression of AGGF1, and resulted in endothelial cell apoptosis and inhibition of endothelial capillary vessel formation and cell migration, which was rescued by purified recombinant human AGGF1 protein. These results demonstrate that GATA1 regulates expression of AGGF1 and reveal a novel role for GATA1 in endothelial cell biology and angiogenesis.	[Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet NE40, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Fan, Chun; Timur, Ayse A.; He, Ping; You, Sun-Ah; Hu, Ying; Ke, Tie; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; [Fan, Chun; Timur, Ayse A.; He, Ping; You, Sun-Ah; Hu, Ying; Ke, Tie; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; [Driscoll, David J.] Mayo Clin, Div Pediat Cardiol, Rochester, MN 55905 USA; [Ouyang, Ping; Ke, Tie; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Ouyang, Ping; Ke, Tie; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Mayo Clinic; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, QK (corresponding author), Cleveland Clin, Ctr Cardiovasc Genet NE40, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.	wangq2@ccf.org	Ke, Tie/AIC-5771-2022	Ke, Tie/0000-0002-8888-8424	Cleveland Clinic Taussig Cancer Center; National Natural Science Foundation of China [30670857]	Cleveland Clinic Taussig Cancer Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Scott Hamilton CARES research grant from the Cleveland Clinic Taussig Cancer Center and by the National Natural Science Foundation of China (Grant 30670857).	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Barker KT, 2006, J MED GENET, V43, P613, DOI 10.1136/jmg.2006.040790; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry SA, 1998, AM J MED GENET, V79, P319, DOI 10.1002/(SICI)1096-8628(19981002)79:4<319::AID-AJMG15>3.3.CO;2-A; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Callebaut I, 2005, BIOINFORMATICS, V21, P699, DOI 10.1093/bioinformatics/bti065; Cerbai E, 2008, CIRC RES, V102, P1304, DOI 10.1161/CIRCRESAHA.108.178079; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Fan C, 2003, J Med Genet, V40, pe29, DOI 10.1136/jmg.40.3.e29; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Gutierrez S, 2006, AM J MED GENET A, V140A, P2832, DOI 10.1002/ajmg.a.31532; HICKEY MJ, 1993, J BIOL CHEM, V268, P3438; HICKSTEIN DD, 1992, P NATL ACAD SCI USA, V89, P2105, DOI 10.1073/pnas.89.6.2105; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hu Y, 2008, ANN HUM GENET, V72, P636, DOI 10.1111/j.1469-1809.2008.00458.x; Jacob AG, 1998, MAYO CLIN PROC, V73, P28; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Miquerol L, 2000, DEVELOPMENT, V127, P3941; PRANDINI MH, 1988, BIOCHEM BIOPH RES CO, V156, P595, DOI 10.1016/S0006-291X(88)80884-2; ROSMARIN AG, 1992, BLOOD, V79, P2598; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Shen Gong-Qing, 2006, V128, P209; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Szalai G, 2006, CELL MOL LIFE SCI, V63, P2460, DOI 10.1007/s00018-006-6190-8; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Timur AA, 2004, ANN HUM GENET, V68, P353, DOI 10.1046/j.1529-8817.2004.00095.x; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WANG Q, 1993, J MOL BIOL, V229, P306, DOI 10.1006/jmbi.1993.1036; WANG Q, 1993, MOL MICROBIOL, V7, P883, DOI 10.1111/j.1365-2958.1993.tb01179.x; WANG Q, 1993, EMBO J, V12, P2495, DOI 10.1002/j.1460-2075.1993.tb05904.x; Wang Q, 2001, CYTOGENET CELL GENET, V95, P183, DOI 10.1159/000059343; WANG Q, 1994, BIOTECHNIQUES, V17, P282; Wang Qing K., 2005, Lymphatic Research and Biology, V3, P226, DOI 10.1089/lrb.2005.3.226; WHELAN AJ, 1995, AM J MED GENET, V59, P492, DOI 10.1002/ajmg.1320590416; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	44	45	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23331	23343		10.1074/jbc.M109.036079	http://dx.doi.org/10.1074/jbc.M109.036079			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556247	Green Published, hybrid			2022-12-25	WOS:000269180000018
J	Mann, FM; Prisic, S; Hu, HY; Xu, MM; Coates, RM; Peters, RJ				Mann, Francis M.; Prisic, Sladjana; Hu, Huayou; Xu, Meimei; Coates, Robert M.; Peters, Reuben J.			Characterization and Inhibition of a Class II Diterpene Cyclase from Mycobacterium tuberculosis IMPLICATIONS FOR TUBERCULOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASE; ABIETADIENE SYNTHASE; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; MECHANISM	Mycobacterium tuberculosis remains a widespread and devastating human pathogen, whose ability to infiltrate macrophage host cells from the human immune system is an active area of investigation. We have recently reported the discovery of a novel diterpene from M. tuberculosis, edaxadiene, whose ability to arrest phagosomal maturation in isolation presumably contributes to this critical process in M. tuberculosis infections. (Mann, F. M., Xu, M., Chen, X., Fulton, D.B., Russell, D.G., and Peters, R.J. (2009) J. Am. Chem. Soc., in press). Here, we present characterization of the class II diterpene cyclase that catalyzes the committed step in edaxadiene biosynthesis, i.e. the previously identified halimadienyl-diphosphate synthase (HPS; EC 5.5.1.16). Intriguingly, our kinetic analysis suggests a potential biochemical regulatory mechanism that triggers edaxadiene production upon phagosomal engulfment. Furthermore, we report characterization of potential HPS inhibitors: specifically, two related transition state analogs (15-aza-14,15-dihydrogeranylgeranyl diphosphate (7a) and 15-aza-14,15-dihydrogeranylgeranyl thiolodiphosphate (7b)) that exhibit very tight binding. Although arguably not suitable for clinical use, these nevertheless provide a basis for pharmaceutical design against this intriguing biosynthetic pathway. Finally, we provide evidence indicating that this pathway exists only in M. tuberculosis and is not functional in the closely related Mycobacterium bovis because of an inactivating frameshift in the HPS-encoding gene. Thus, we hypothesize that the inability to produce edaxadiene may be a contributing factor in the decreased infectivity and/or virulence of M. bovis relative to M. tuberculosis in humans.	[Mann, Francis M.; Prisic, Sladjana; Xu, Meimei; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Hu, Huayou; Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Peters, RJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4216 Mol Biol Bldg, Ames, IA 50011 USA.	rjpeters@iastate.edu	Peters, Reuben J./D-1196-2010; Hu, Huayou/B-9521-2013	Peters, Reuben J./0000-0003-4691-8477; Hu, Huayou/0000-0003-4795-0866; Prisic, Sladjana/0000-0003-3137-4358	National Institutes of Health [GM076324, GM13956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324, R01GM013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076324 (to R.J.P.) and GM13956 (to R. M. C.).	Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; GARCIADELPORTILLO F, 1992, MOL MICROBIOL, V6, P3289, DOI 10.1111/j.1365-2958.1992.tb02197.x; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; GRANGE JM, 1994, VET MICROBIOL, V40, P137, DOI 10.1016/0378-1135(94)90052-3; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; Hayashi Y, 2008, BIOSCI BIOTECH BIOCH, V72, P523, DOI 10.1271/bbb.70615; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; Ikeda C, 2007, J BIOCHEM, V141, P37, DOI 10.1093/jb/mvm004; Kawaide H, 2000, J BIOL CHEM, V275, P2276, DOI 10.1074/jbc.275.4.2276; Kumar V., 2007, ROBBINS BASIC PATHOL, P516; MANN F, 2009, J AM CHEM S IN PRESS; Morrone D, 2009, FEBS LETT, V583, P475, DOI 10.1016/j.febslet.2008.12.052; Nakano C, 2005, CHEM COMMUN, P1016, DOI 10.1039/b415346d; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Phan RM, 2001, J ORG CHEM, V66, P6705, DOI 10.1021/jo010505n; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Ravn MM, 2000, EUR J ORG CHEM, V2000, P1401, DOI 10.1002/(SICI)1099-0690(200004)2000:8<1401::AID-EJOC1401>3.0.CO;2-P; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Xu MM, 2004, PLANT J, V39, P309, DOI 10.1111/j.1365-313X.2004.02137.x; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	28	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23574	23579		10.1074/jbc.M109.023788	http://dx.doi.org/10.1074/jbc.M109.023788			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574210	Green Published, hybrid			2022-12-25	WOS:000269180000043
J	Mirnikjoo, B; Balasubramanian, K; Schroit, AJ				Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.			Suicidal Membrane Repair Regulates Phosphatidylserine Externalization during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CELL-SURFACE; CHLOROQUINE; LYSOSOMES; FUSION; PHOSPHOLIPIDS; AUTOANTIGENS; RECOGNITION; ASYMMETRY; BODIES	One of the hallmarks of apoptosis is the redistribution of phosphatidylserine (PS) from the inner-to-outer plasma membrane (PM) leaflet, where it functions as a ligand for phagocyte recognition and the suppression of inflammatory responses. The mechanism by which apoptotic cells externalize PS has been assumed to involve "scramblases" that randomize phospholipids across the PM bilayer. These putative activities, however, have not been unequivocally proven to be responsible for the redistribution of lipids. Because elevated cytosolic Ca2+ is critical to this process and is also required for activation of lysosome-PM fusion during membrane repair, we hypothesized that apoptosis could activate a "pseudo"-membrane repair response that results in the fusion of lysosomes with the PM. Using a membrane-specific probe that labels endosomes and lysosomes and fluorescein-labeled annexin 5 that labels PS, we show that the appearance of PS at the cell surface during apoptosis is dependent on the fusion of lysosomes with the PM, a process that is inhibited with the lysosomotrophe, chloroquine. We demonstrate that apoptotic cells evoke a persistent pseudo-membrane repair response that likely redistributes lysosomal derived PS to the PM outer leaflet that leads to membrane expansion and the formation of apoptotic blebs. Our data suggest that inhibition of lysosome-PM fusion-dependent redistribution of PS that occurs as a result of chemotherapy- and radiotherapy-induced apoptosis will prevent PS-dependent anti-inflammatory responses that preclude the development of tumor- and patient-specific immune responses.	[Mirnikjoo, Banafsheh; Balasubramanian, Krishnakumar; Schroit, Alan J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			National Institutes of Health [CA98527]; Department of Defense [BCRPW81XWH-06-1-0347]; John Q. Gaines Foundation; NATIONAL CANCER INSTITUTE [R01CA098527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); John Q. Gaines Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98527 (to A. J. S.). This work was also supported by Department of Defense Grant BCRPW81XWH-06-1-0347 (to B. M.) and a grant from the John Q. Gaines Foundation.	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Briceno E, 2007, SURG NEUROL, V67, P388, DOI 10.1016/j.surneu.2006.08.080; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; CONNOR J, 1987, BIOCHEMISTRY-US, V26, P5099, DOI 10.1021/bi00390a031; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Dasgupta SK, 2006, TRANSL RES, V148, P19, DOI 10.1016/j.lab.2006.03.006; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; HART PD, 1983, J EXP MED, V158, P477, DOI 10.1084/jem.158.2.477; Klotz KH, 1996, J BIOL CHEM, V271, P2383, DOI 10.1074/jbc.271.5.2383; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Savarino A, 2006, LANCET ONCOL, V7, P792, DOI 10.1016/S1470-2045(06)70875-0; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; Shiratsuchi A, 2003, J BIOCHEM, V133, P211, DOI 10.1093/jb/mvg026; SHOEMAKER JP, 1978, CANCER RES, V38, P2700; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; STRUCK DK, 1980, J BIOL CHEM, V255, P5404; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	29	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22512	22516		10.1074/jbc.C109.022913	http://dx.doi.org/10.1074/jbc.C109.022913			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561081	Green Published, hybrid			2022-12-25	WOS:000268963100003
J	Ishimoto, K; Nakamura, H; Tachibana, K; Yamasaki, D; Ota, A; Hirano, K; Tanaka, T; Hamakubo, T; Sakai, J; Kodama, T; Doi, T				Ishimoto, Kenji; Nakamura, Hiroki; Tachibana, Keisuke; Yamasaki, Daisuke; Ota, Akemi; Hirano, Ken-ichi; Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko; Doi, Takefumi			Sterol-mediated Regulation of Human Lipin 1 Gene Expression in Hepatoblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; PHOSPHATIDIC-ACID PHOSPHATASE; DENSITY-LIPOPROTEIN RECEPTOR; SUBCELLULAR-LOCALIZATION; TRANSCRIPTION FACTOR; SREBP PATHWAY; MICE; ADIPOGENESIS; CHOLESTEROL; TARGET	Lipin 1 plays a crucial role in lipid metabolism in adipose tissue, skeletal muscle, and liver. Its physiological role involves two cellular functions: regulation of phosphatidate phosphatase activity and regulation of fatty acid oxidation. In this study, we have demonstrated that lipin 1 gene (LPIN1) expression is regulated by cellular sterols, which are key regulators of lipid metabolism. We have also characterized the sterol-response element and nuclear factor Y-binding sites in the human LPIN1 promoter. Using a luciferase assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay, we demonstrated that these elements are responsible for the transcription of LPIN1 gene, mediated by SREBP-1 (sterol regulatory element-binding protein 1) and nuclear factor Y. Furthermore, we investigated whether lipin 1 is involved in lipogenesis by transfection of LPIN1 small interfering RNA. We infer that sterol-mediated regulation of lipin 1 gene transcription modulates triglyceride accumulation. This modulation involves changes in the activity of phosphatidate phosphatase.	[Ishimoto, Kenji; Nakamura, Hiroki; Tachibana, Keisuke; Yamasaki, Daisuke; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Ishimoto, Kenji; Doi, Takefumi] Osaka Univ, Grad Sch Med, Dept Mol Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Ota, Akemi; Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko] Univ Tokyo, Lab Syst Biol & Med, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan	Osaka University; Osaka University; Osaka University; University of Tokyo	Doi, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	doi@phs.osaka-u.ac.jp		Sakai, Juro/0000-0003-4043-1035	National Institute of Biomedical Innovation	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Bhattacharya A, 2003, CANCER RES, V63, P8167; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fukui K, 2005, DIABETES, V54, P1958, DOI 10.2337/diabetes.54.7.1958; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ikeda Y, 2001, J BIOL CHEM, V276, P34259, DOI 10.1074/jbc.M103848200; Ishimoto K, 2006, FEBS LETT, V580, P4929, DOI 10.1016/j.febslet.2006.08.010; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Reue K, 2000, Curr Atheroscler Rep, V2, P390, DOI 10.1007/s11883-000-0077-1; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wassef H, 2004, J NUTR, V134, P2935, DOI 10.1093/jn/134.11.2935; Yao-Borengasser A, 2006, DIABETES, V55, P2811, DOI 10.2337/db05-1688; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	40	58	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22195	22205		10.1074/jbc.M109.028753	http://dx.doi.org/10.1074/jbc.M109.028753			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19553673	Green Published, hybrid			2022-12-25	WOS:000268783700044
J	Park, JS; Steinbach, SK; Desautels, M; Hemmingsen, SM				Park, Jae-Sook; Steinbach, Sarah K.; Desautels, Michel; Hemmingsen, Sean M.			Essential Role for Schizosaccharomyces pombe pik1 in Septation	PLOS ONE			English	Article							FISSION-YEAST; PHOSPHATIDYLINOSITOL 4-KINASE; CONTRACTILE RING; ACTOMYOSIN RING; EXOCYST COMPLEX; DIVISION SITE; LIGHT-CHAIN; CYTOKINESIS; PROTEINS; CDC4P	Background: Schizosaccharomyces pombe pik1 encodes a phosphatidylinositol 4-kinase, reported to bind Cdc4, but not Cdc4(G107S). Principal Findings: Gene deletion revealed that pik1 is essential. In cells with pik1 deleted, ectopic expression of a loss-of-function allele, created by fusion to a temperature-sensitive dihydrofolate reductase, allowed normal cell proliferation at 25 degrees C. At 36 degrees C, cells arrested with abnormally thick, misplaced or supernumerary septa, indicating a defect late in septation. In addition to being Golgi associated, ectopically expressed GFP-tagged Pik1 was observed at the medial cell plane late in cytokinesis. New alleles, created by site-directed mutagenesis, were expressed ectopically. Lipid kinase and Cdc4-binding activity assays were performed. Pik1(D709A) was kinase-dead, but bound Cdc4. Pik1(R838A) did not bind Cdc4, but was an active kinase. Genomic integration of these substitutions in S. pombe and complementation studies in Saccharomyces cerevisiae pik1-101 cells revealed that D709 is essential in both cases while R838 is dispensable. In S. pombe, ectopic expression of pik1 was dominantly lethal; while, pik1(D709A, R838A) was innocuous, pik1(R838A) was almost innocuous, and pik1(D709A) produced partial lethality and septation defects. The pik1 ectopic expression lethal phenotype was suppressed in cdc4(G107S). Thus, D709 is essential for kinase activity and septation. Conclusions: Pik1 kinase activity is required for septation. The Pik1 R838 residue is required for important protein-protein interactions, possibly with Cdc4.			Park, JS (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada.	Sean.Hemmingsen@nrc-cnrc.gc.ca	PARK, Jae-Sook/H-3016-2012	Steinbach, Sarah/0000-0003-2025-8159				ARMSTRONG J, 1993, MOL BIOL CELL, V4, P583, DOI 10.1091/mbc.4.6.583; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; Balasubramanian MK, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P243; Balasubramanian MK, 1998, GENETICS, V149, P1265; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brill JA, 2000, DEVELOPMENT, V127, P3855; Chang FS, 2005, J CELL BIOL, V171, P133, DOI 10.1083/jcb.200501086; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; D'souza VM, 2001, CELL STRUCT FUNCT, V26, P555, DOI 10.1247/csf.26.555; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Desautels M, 2001, J BIOL CHEM, V276, P5932, DOI 10.1074/jbc.M008715200; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Eng K, 1998, CURR BIOL, V8, P611, DOI 10.1016/S0960-9822(98)70248-9; Escobar-Cabrera E, 2005, BIOCHEMISTRY-US, V44, P12136, DOI 10.1021/bi050641c; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gachet Y, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P225; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Han P, 2002, CYTOTHERAPY, V4, P277, DOI 10.1080/146532402320219790; Hegewald H, 1996, ANAL BIOCHEM, V242, P152, DOI 10.1006/abio.1996.0443; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; KOHALMI SE, 1997, DIFFERENTIALLY EXPRE, P63; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Mahon ES, 2005, CELL SIGNAL, V17, P857, DOI 10.1016/j.cellsig.2004.11.006; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCCOLLUM D, 1995, J CELL BIOL, V130, P651, DOI 10.1083/jcb.130.3.651; MORENO S, 1991, METH ENZY, V194, P795; Motegi F, 2000, J CELL SCI, V113, P1813; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Rajagopalan S, 2004, METHODS, V33, P206, DOI 10.1016/j.ymeth.2003.11.015; Rajagopalan S, 2003, TRENDS GENET, V19, P403, DOI 10.1016/S0168-9525(03)00149-5; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schug S A, 1993, Pharmacoeconomics, V3, P260, DOI 10.2165/00019053-199303040-00002; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Slupsky CM, 2001, J BIOL CHEM, V276, P5943, DOI 10.1074/jbc.M008716200; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Vjestica A, 2008, MOL BIOL CELL, V19, P1125, DOI 10.1091/mbc.E07-07-0663; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	64	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2009	4	7							e6179	10.1371/journal.pone.0006179	http://dx.doi.org/10.1371/journal.pone.0006179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DL	19587793	gold, Green Submitted, Green Published			2022-12-25	WOS:000268035100006
J	Viswanathan, SR; Mermel, CH; Lu, J; Lu, CW; Golub, TR; Daley, GQ				Viswanathan, Srinivas R.; Mermel, Craig H.; Lu, Jun; Lu, Chi-Wei; Golub, Todd R.; Daley, George Q.			microRNA Expression during Trophectoderm Specification	PLOS ONE			English	Article								Background: Segregation of the trophectoderm from the inner cell mass of the embryo represents the first cell-fate decision of mammalian development. Transcription factors essential for specifying trophectoderm have been identified, but the role of microRNAs (miRNAs) in modulating this fate-choice has been largely unexplored. We have compared miRNA expression in embryonic stem cell (ESC)-derived trophectoderm and in staged murine embryos to identify a set of candidate miRNAs likely to be involved in trophectoderm specification. Results: We profiled embryonic stem cells (ESCs) as they were induced to differentiate into trophectodermal cells by ectopic expression of HRas/Q61L. We also profiled murine embryos at progressive stages of preimplantation development (zygote, 2-cell, 4-cell, 8-cell, morula, and blastocyst), which includes the time window in which the trophectoderm is specified in vivo. Q61L/H Conclusions: We describe miRNA expression changes that occur during trophectoderm specification and validate that our in vitro system faithfully recapitulates trophectoderm specification in vivo. By comparing our in vitro and in vivo datasets, we have identified a minimal set of candidate miRNAs likely to play a role in trophectoderm specification. These miRNAs are predicted to regulate a host of development-associated target genes, and many of these miRNAs have previously reported roles in development and differentiation. Additionally, we highlight a number of miRNAs whose tight developmental regulation may reflect a functional role in other stages of embryogenesis. Our embryo profiling data may be useful to investigators studying trophectoderm specification and other stages of preimplantation development.			Viswanathan, SR (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021; Mermel, Craig/AAZ-7322-2020	Viswanathan, Srinivas/0000-0003-1856-3023; Mermel, Craig/0000-0002-0816-3395	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ding XC, 2008, CELL CYCLE, V7, P3083, DOI 10.4161/cc.7.19.6778; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; WILLIAM MS, 2006, MAMMALIAN GENOME V, V17, P833; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Yang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S4; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011; ZIOMEK CA, 1980, CELL, V21, P935, DOI 10.1016/0092-8674(80)90457-2	57	64	66	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6143	10.1371/journal.pone.0006143	http://dx.doi.org/10.1371/journal.pone.0006143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19582159	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806300012
J	Chapalain, A; Chevalier, S; Orange, N; Murillo, L; Papadopoulos, V; Feuilloley, MGJ				Chapalain, Annelise; Chevalier, Sylvie; Orange, Nicole; Murillo, Laurence; Papadopoulos, Vassilios; Feuilloley, Marc G. J.			Bacterial Ortholog of Mammalian Translocator Protein (TSPO) with Virulence Regulating Activity	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; OUTER-MEMBRANE PROTEINS; PSEUDOMONAS-FLUORESCENS; IN-VIVO; BINDING; GROWTH; OPRF; STEROIDOGENESIS; SECONDARY; APOPTOSIS	The translocator protein (TSPO), previously designated as peripheral-type benzodiazepine receptor, is a protein mainly located in the outer mitochondrial membrane of eukaryotic cells. TSPO is implicated in major physiological functions and functionally associated with other proteins such as the voltage-dependent anionic channel, also designated as mitochondrial porin. Surprisingly, a TSPO-related protein was identified in the photosynthetic bacterium Rhodobacter sphaeroides but it was initially considered as a relict of evolution. In the present study we cloned a tspO gene in Pseudomonas fluorescens MF37, a non-photosynthetic eubacterium and we used bioinformatics tools to identify TSPO in the genome of 97 other bacteria. P. fluorescens TSPO was recognized by antibodies against mouse protein and by PK 11195, an artificial ligand of mitochondrial TSPO. As in eukaryotes, bacterial TSPO appears functionally organized as a dimer and the apparent Kd for PK 11195 is in the same range than for its eukaryotic counterpart. When P. fluorescens MF37 was treated with PK 11195 (10(-5) M) adhesion to living or artificial surfaces and biofilm formation activity were increased. Conversely, the apoptotic potential of bacteria on eukaryotic cells was significantly reduced. This effect of PK11195 was abolished in a mutant of P. fluorescens MF37 deficient for its major outer membrane porin, OprF. The present results demonstrate the existence of a bacterial TSPO that shares common structural and functional characteristics with its mammalian counterpart. This protein, apparently involved in adhesion and virulence, reveals the existence of a possible new inter kingdom signalling system and suggests that the human microbiome should be involuntarily exposed to the evolutionary pressure of benzodiazepines and related molecules. This discovery also represents a promising opportunity for the development of alternative antibacterial strategies.			Chapalain, A (corresponding author), Univ Rouen, Lab Cold Microbiol, UPRES, EA4312, Evreux, France.	marc.feuilloley@univ-rouen.fr	Chapalain, Annelise/M-5767-2014; Papadopoulos, Vassilios/AAI-2613-2019	Chapalain, Annelise/0000-0002-3270-0947; Papadopoulos, Vassilios/0000-0002-1183-8568; CHEVALIER, sylvie/0000-0001-6489-438X; MURILLO, Laurence/0000-0002-0934-4227	NIEHS NIH HHS [ES007747, R01 ES007747] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bodilis J, 2004, SYST APPL MICROBIOL, V27, P93, DOI 10.1078/0723-2020-00253; Buommino E, 1999, INFECT IMMUN, V67, P4794, DOI 10.1128/IAI.67.9.4794-4800.1999; BURINI JF, 1994, FEMS MICROBIOL LETT, V122, P13, DOI 10.1111/j.1574-6968.1994.tb07136.x; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI [10.1139/W07-110, 10.1139/w07-110]; Cusumano V, 1997, INFECT IMMUN, V65, P1683, DOI 10.1128/IAI.65.5.1683-1687.1997; Davey ME, 2000, APPL ENVIRON MICROB, V66, P5353, DOI 10.1128/AEM.66.12.5353-5359.2000; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; El Hamel C, 2001, BBA-BIOMEMBRANES, V1515, P12, DOI 10.1016/S0005-2736(01)00387-X; Freestone PPE, 2008, ADV APPL MICROBIOL, V64, P75, DOI 10.1016/S0065-2164(08)00402-4; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; GonzalezMarquez H, 1997, MICROBIOL-UK, V143, P1587, DOI 10.1099/00221287-143-5-1587; Hemery G, 2007, J IND MICROBIOL BIOT, V34, P49, DOI 10.1007/s10295-006-0160-x; Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146; Klebba PE, 2005, J BACTERIOL, V187, P8232, DOI 10.1128/JB.187.24.8232-8236.2005; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; LEFUR G, 1983, LIFE SCI, V32, P1849, DOI 10.1016/0024-3205(83)90063-2; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Lindemann P, 2004, PLANT CELL PHYSIOL, V45, P723, DOI 10.1093/pcp/pch088; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; *MARK ENT INC, US SLEEP MARK; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Mezghani-Abdelmoula S, 2004, MICROBIOL RES, V159, P355, DOI 10.1016/j.micres.2004.08.003; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Picot L, 2003, MICROB PATHOGENESIS, V35, P95, DOI 10.1016/S0882-4010(03)00092-5; Pimenta AL, 2006, RES MICROBIOL, V157, P885, DOI 10.1016/j.resmic.2006.06.005; Rebiere-Huet J, 2002, FEMS MICROBIOL LETT, V215, P121, DOI 10.1016/S0378-1097(02)00920-5; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Snyder MJ, 1998, CELL TISSUE RES, V294, P161, DOI 10.1007/s004410051166; Stowe-Evans EL, 2004, J BACTERIOL, V186, P4338, DOI 10.1128/JB.186.13.4338-4349.2004; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Wyckoff TJO, 2002, MICROBIOL-SGM, V148, P3423, DOI 10.1099/00221287-148-11-3423; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Yeliseev AA, 2000, J BIOL CHEM, V275, P5657, DOI 10.1074/jbc.275.8.5657; Zisterer DM, 1997, GEN PHARMACOL-VASC S, V29, P305, DOI 10.1016/S0306-3623(96)00473-9	45	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6096	10.1371/journal.pone.0006096	http://dx.doi.org/10.1371/journal.pone.0006096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564920	Green Published, Green Submitted, gold			2022-12-25	WOS:000267515700014
J	Reimer, R; Helmbold, H; Szalay, B; Hagel, C; Hohenberg, H; Deppert, W; Bohn, W				Reimer, Rudolph; Helmbold, Heike; Szalay, Beata; Hagel, Christian; Hohenberg, Heinrich; Deppert, Wolfgang; Bohn, Wolfgang			Nestin Modulates Glucocorticoid Receptor Function by Cytoplasmic Anchoring	PLOS ONE			English	Article								Nestin is the characteristic intermediate filament (IF) protein of rapidly proliferating progenitor cells and regenerating tissue. Nestin copolymerizes with class III IF-proteins, mostly vimentin, into heteromeric filaments. Its expression is downregulated with differentiation. Here we show that a strong nestin expression in mouse embryo tissue coincides with a strong accumulation of the glucocorticoid receptor (GR), a key regulator of growth and differentiation in embryonic development. Microscopic studies on cultured cells show an association of GR with IFs composed of vimentin and nestin. Cells lacking nestin, but expressing vimentin, or cells expressing vimentin, but lacking nestin accumulate GR in the nucleus. Completing these networks with an exogenous nestin, respectively an exogenous vimentin restores cytoplasmic anchoring of GR to the IF system. Thus, heteromeric filaments provide the basis for anchoring of GR. The reaction pattern with phospho-GR specific antibodies and the presence of the chaperone HSC70 suggest that specifically the unliganded receptor is anchored to the IF system. Ligand addition releases GR from IFs and shifts the receptor into the nucleus. Suppression of nestin by specific shRNA abolishes anchoring of GR, induces its accumulation in the nucleus and provokes an irreversible G1/S cell cycle arrest. Suppression of GR prior to that of nestin prevents entry into the arrest. The data give evidence that nestin/vimentin specific anchoring modulates growth suppression by GR. We hypothesize that expression of nestin is a major determinant in suppression of anti-proliferative activity of GR in undifferentiated tissue and facilitates activation of this growth control in a precise tissue and differentiation dependent manner.			Reimer, R (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-2000 Hamburg, Germany.	wolfgang.bohn@hpi.uni-hamburg.de						AKNER G, 1991, J STEROID BIOCHEM, V39, P419, DOI 10.1016/0960-0760(91)90235-W; AKNER G, 1990, EUR J CELL BIOL, V53, P390; Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; BODWELL JE, 1995, J STEROID BIOCHEM, V52, P135, DOI 10.1016/0960-0760(94)00157-H; BOHN W, 1992, EXP CELL RES, V201, P1, DOI 10.1016/0014-4827(92)90341-5; BOHN W, 1993, J STRUCT BIOL, V111, P48, DOI 10.1006/jsbi.1993.1035; Bohn W, 1996, SCANNING MICROSCOPY SUPPLEMENT 10, 1996, P285; BOHN W, 1996, SCANNING MICROSCOPY, V10, P293; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonanno G, 2004, TRANSFUSION, V44, P1087, DOI 10.1111/j.1537-2995.2004.03252.x; BUSE P, 1995, J BIOL CHEM, V270, P6505, DOI 10.1074/jbc.270.12.6505; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; CINTRA A, 1993, NEUROENDOCRINOLOGY, V57, P1133, DOI 10.1159/000126480; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DANIEL C, 2008, LAB INVEST      0211; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; ECKELT A, 1992, EUR J CELL BIOL, V58, P319; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Frojdman K, 1997, DIFFERENTIATION, V61, P243, DOI 10.1046/j.1432-0436.1997.6140243.x; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Gleiberman AS, 2005, DEV DYNAM, V234, P413, DOI 10.1002/dvdy.20536; Ha Y, 2003, ACTA NEUROCHIR, V145, P483, DOI 10.1007/s00701-003-0023-4; Hache RJG, 1999, J BIOL CHEM, V274, P1432, DOI 10.1074/jbc.274.3.1432; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MANNWEILER K, 1982, J MICROSC-OXFORD, V126, P145, DOI 10.1111/j.1365-2818.1982.tb00363.x; MARTINS VR, 1991, MOL ENDOCRINOL, V5, P217, DOI 10.1210/mend-5-2-217; Marvin NJ, 1998, J CELL SCI, V111, P1951; Matthews SG, 1998, DEV BRAIN RES, V107, P123, DOI 10.1016/S0165-3806(98)00008-X; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-18; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Neidhardt J, 2003, MOL CELL NEUROSCI, V23, P193, DOI 10.1016/S1044-7431(03)00012-5; Peschle C, 2001, Rev Clin Exp Hematol, V5, P3, DOI 10.1046/j.1468-0734.2001.00029.x; PRATT WB, 1989, CANCER RES, V49, pS2222; Pujols L, 2002, AM J PHYSIOL-CELL PH, V283, pC1324, DOI 10.1152/ajpcell.00363.2001; Ramalingam A, 1997, MOL ENDOCRINOL, V11, P577, DOI 10.1210/me.11.5.577; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Reichardt HM, 2000, ADV PHARMACOL, V47, P1; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; ROSER K, 1991, EXP CELL RES, V197, P200, DOI 10.1016/0014-4827(91)90423-R; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P10879, DOI 10.1021/bi00159a031; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Son GH, 2001, J NEUROCHEM, V79, P1013, DOI 10.1046/j.1471-4159.2001.00634.x; Sousa N, 1999, NEUROSCIENCE, V89, P1079, DOI 10.1016/S0306-4522(98)00311-X; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; SZAPARY D, 1994, J STEROID BIOCHEM, V51, P143, DOI 10.1016/0960-0760(94)90087-6; Vaittinen S, 2001, J NEUROPATH EXP NEUR, V60, P588, DOI 10.1093/jnen/60.6.588; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; VORGIAS CE, 1988, BIOSCIENCE REP, V8, P193, DOI 10.1007/BF01116464; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wintermantel TA, 2005, J STEROID BIOCHEM, V93, P107, DOI 10.1016/j.jsbmb.2004.12.033; Wintermantel TM, 2005, MOL ENDOCRINOL, V19, P340, DOI 10.1210/me.2004-0068; Yang J, 2001, BBA-GENE STRUCT EXPR, V1520, P251, DOI 10.1016/S0167-4781(01)00275-5; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	79	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6084	10.1371/journal.pone.0006084	http://dx.doi.org/10.1371/journal.pone.0006084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562035	Green Submitted, Green Published, gold			2022-12-25	WOS:000267465900015
J	Gahan, ME; Webster, DE; Wesselingh, SL; Strugnell, RA; Yang, J				Gahan, Michelle E.; Webster, Diane E.; Wesselingh, Steven L.; Strugnell, Richard A.; Yang, Ji			Bacterial Antigen Expression Is an Important Component in Inducing an Immune Response to Orally Administered Salmonella-Delivered DNA Vaccines	PLOS ONE			English	Article								Background: The use of Salmonella to deliver heterologous antigens from DNA vaccines is a well-accepted extension of the success of oral Salmonella vaccines in animal models. Attenuated S. typhimurium and S. typhi strains are safe and efficacious, and their use to deliver DNA vaccines combines the advantages of both vaccine approaches, while complementing the limitations of each technology. An important aspect of the basic biology of the Salmonella/DNA vaccine platform is the relative contributions of prokaryotic and eukaryotic expression in production of the vaccine antigen. Gene expression in DNA vaccines is commonly under the control of the eukaryotic cytomegalovirus (CMV) promoter. The aim of this study was to identify and disable putative bacterial promoters within the CMV promoter and evaluate the immunogenicity of the resulting DNA vaccine delivered orally by S. typhimurium. Methodology/Principal Findings: The results reported here clearly demonstrate the presence of bacterial promoters within the CMV promoter. These promoters have homology to the bacterial consensus sequence and functional activity. To disable prokaryotic expression from the CMV promoter a series of genetic manipulations were performed to remove the two major bacterial promoters and add a bacteria transcription terminator downstream of the CMV promoter. S. typhimurium was used to immunise BALB/c mice orally with a DNA vaccine encoding the C-fragment of tetanus toxin (TT) under control of the original or the modified CMV promoter. Although both promoters functioned equally well in eukaryotic cells, as indicated by equivalent immune responses following intramuscular delivery, only the original CMV promoter was able to induce an anti-TT specific response following oral delivery by S. typhimurium. Conclusions: These findings suggest that prokaryotic expression of the antigen and co-delivery of this protein by Salmonella are at least partially responsible for the successful oral delivery of C-fragment DNA vaccines containing the CMV promoter by S. typhimurium.			Gahan, ME (corresponding author), Univ Canberra, Fac Sci Appl, Ctr Biomed Mol & Chem Sci, Bruce, ACT, Australia.	michelle.gahan@canberra.edu.au	Webster, Diane/F-7326-2010	Gahan, Michelle/0000-0002-1511-687X; Strugnell, Richard/0000-0003-0614-5641				Anderson RJ, 2000, VACCINE, V18, P2193, DOI 10.1016/S0264-410X(00)00025-6; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Darji A, 2000, FEMS IMMUNOL MED MIC, V27, P341; Dietrich G, 2003, CURR OPIN MOL THER, V5, P10; Dunstan SJ, 1999, INFECT IMMUN, V67, P5133, DOI 10.1128/IAI.67.10.5133-5141.1999; FAIRWEATHER NF, 1990, INFECT IMMUN, V58, P1323, DOI 10.1128/IAI.58.5.1323-1326.1990; Flo J, 2001, VACCINE, V19, P1772, DOI 10.1016/S0264-410X(00)00375-3; Gahan ME, 2007, VACCINE, V25, P1476, DOI 10.1016/j.vaccine.2006.10.042; Goussard S, 2003, J MOL MICROB BIOTECH, V6, P211, DOI 10.1159/000077252; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; KEILTY S, 1987, J BIOL CHEM, V262, P6389; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Lewin A, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-19; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Loessner H, 2004, EXPERT OPIN BIOL TH, V4, P157, DOI 10.1517/14712598.4.2.157; Marshall DG, 2000, VACCINE, V18, P1298, DOI 10.1016/S0264-410X(99)00417-X; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Paglia P, 1998, BLOOD, V92, P3172, DOI 10.1182/blood.V92.9.3172.421k18_3172_3176; Pasetti MF, 1999, CLIN IMMUNOL, V92, P76, DOI 10.1006/clim.1999.4733; Schoen C, 2004, INT J MED MICROBIOL, V294, P319, DOI 10.1016/j.ijmm.2004.03.001; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; Weiner DB, 2008, VACCINE, V26, P5073, DOI 10.1016/j.vaccine.2008.07.024; Xu F, 2004, J DRUG TARGET, V11, P481, DOI 10.1080/10611860410001670053; Yang J, 2004, MOL MICROBIOL, V52, P243, DOI 10.1111/j.1365-2958.2003.03965.x; YANOFSKY C, 1981, NUCLEIC ACIDS RES, V9, P6647, DOI 10.1093/nar/9.24.6647	28	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6062	10.1371/journal.pone.0006062	http://dx.doi.org/10.1371/journal.pone.0006062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557169	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600010
J	Ratcliff, WC; Hawthorne, P; Travisano, M; Denison, RF				Ratcliff, William C.; Hawthorne, Peter; Travisano, Michael; Denison, R. Ford			When Stress Predicts a Shrinking Gene Pool, Trading Early Reproduction for Longevity Can Increase Fitness, Even with Lower Fecundity	PLOS ONE			English	Article								Background: Stresses like dietary restriction or various toxins increase lifespan in taxa as diverse as yeast, Caenorhabditis elegans, Drosophila and rats, by triggering physiological responses that also tend to delay reproduction. Food odors can reverse the effects of dietary restriction, showing that key mechanisms respond to information, not just resources. Such environmental cues can predict population trends, not just individual prospects for survival and reproduction. When population size is increasing, each offspring produced earlier makes a larger proportional contribution to the gene pool, but the reverse is true when population size is declining. Principal Findings: We show mathematically that natural selection can favor facultative delay in reproduction when environmental cues predict a decrease in total population size, even if lifetime fecundity decreases with delay. We also show that increased reproduction from waiting for better conditions does not increase fitness (proportional representation) when the whole population benefits similarly. Conclusions: We conclude that the beneficial effects of stress on longevity (hormesis) in diverse taxa are a side-effect of delaying reproduction in response to environmental cues that population size is likely to decrease. The reversal by food odors of the effects of dietary restriction can be explained as a response to information that population size is less likely to decrease, reducing the chance that delaying reproduction will increase fitness.			Ratcliff, WC (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	denis036@umn.edu	Travisano, Michael/AAI-4809-2020	Travisano, Michael/0000-0001-8168-0842; Hawthorne, Peter/0000-0003-1125-5239				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fisher R.A., 1930, GENETICAL THEORY NAT; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; Koons DN, 2008, AM NAT, V172, P797, DOI 10.1086/592867; Libert S, 2007, CELL, V131, P1231, DOI 10.1016/j.cell.2007.12.002; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; PERRIN N, 1990, FUNCT ECOL, V4, P53, DOI 10.2307/2389652; PIANKA ER, 1999, EVOLUTIONARY ECOLGY, P512; RAUSER CL, 2009, EXPT EVOLUTION CONCE; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 1997, EVOLUTION, V51, P1323, DOI [10.2307/2411062, 10.1111/j.1558-5646.1997.tb03980.x]; Voronezhskaya EE, 2004, DEVELOPMENT, V131, P3671, DOI 10.1242/dev.01237; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wilbur HM, 2006, AM NAT, V168, P398, DOI 10.1086/506258; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	31	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6055	10.1371/journal.pone.0006055	http://dx.doi.org/10.1371/journal.pone.0006055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557134	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356900014
J	Rapp, UR; Korn, C; Ceteci, F; Karreman, C; Luetkenhaus, K; Serafin, V; Zanucco, E; Castro, I; Potapenko, T				Rapp, Ulf R.; Korn, Christian; Ceteci, Fatih; Karreman, Christiaan; Luetkenhaus, Katharina; Serafin, Valentina; Zanucco, Emanuele; Castro, Ines; Potapenko, Tamara			Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer	PLOS ONE			English	Article								Background: Metastasis is a process by which cancer cells learn to form satellite tumors in distant organs and represents the principle cause of death of patients with solid tumors. NSCLC is the most lethal human cancer due to its high rate of metastasis. Methodology/Principal Findings: Lack of a suitable animal model has so far hampered analysis of metastatic progression. We have examined c-MYC for its ability to induce metastasis in a C-RAF-driven mouse model for non-small-cell lung cancer. c-MYC alone induced frank tumor growth only after long latency at which time secondary mutations in K-Ras or LKB1 were detected reminiscent of human NSCLC. Combination with C-RAF led to immediate acceleration of tumor growth, conversion to papillary epithelial cells and angiogenic switch induction. Moreover, addition of c-MYC was sufficient to induce macrometastasis in liver and lymph nodes with short latency associated with lineage switch events. Thus we have generated the first conditional model for metastasis of NSCLC and identified a gene, c-MYC that is able to orchestrate all steps of this process. Conclusions/Significance: Potential markers for detection of metastasis were identified and validated for diagnosis of human biopsies. These markers may represent targets for future therapeutic intervention as they include genes such as Gata4 that are exclusively expressed during lung development.			Rapp, UR (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, D-8000 Munich, Germany.	rapp@biochem.mpg.de	Serafin, Valentina/ABD-9083-2020	Castro, Ines/0000-0003-3635-5527; Serafin, Valentina/0000-0001-6283-7728				Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Chiloeches A, 2006, CLIN CANCER RES, V12, P1661, DOI 10.1158/1078-0432.CCR-06-0051; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fedorov LM, 2003, CANCER RES, V63, P2268; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Knies-Bamforth UE, 2004, CANCER RES, V64, P6563, DOI 10.1158/0008-5472.CAN-03-3176; Krane CM, 2001, P NATL ACAD SCI USA, V98, P14114, DOI 10.1073/pnas.231273398; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Liao Dezhong Joshua, 2006, J Carcinog, V5, P19, DOI 10.1186/1477-3163-5-19; Liu C, 2002, J BIOL CHEM, V277, P4519, DOI 10.1074/jbc.M107585200; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RAPP UR, 2007, NATURE P; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Russell RG, 2004, CANCER RES, V64, P7220, DOI 10.1158/0008-5472.CAN-04-2095; SANDGREN EP, 1991, P NATL ACAD SCI USA, V88, P93, DOI 10.1073/pnas.88.1.93; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Wang Y, 2002, MOL GENET GENOMICS, V268, P160, DOI 10.1007/s00438-002-0751-9; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; YOKOTA J, 1988, ONCOGENE, V2, P607; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	49	97	98	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6029	10.1371/journal.pone.0006029	http://dx.doi.org/10.1371/journal.pone.0006029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551151	Green Submitted, gold, Green Published			2022-12-25	WOS:000267356500013
J	Robinson, K; Asawachaicharn, N; Galloway, DA; Grandori, C				Robinson, Kristin; Asawachaicharn, Nichaya; Galloway, Denise A.; Grandori, Carla			c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress	PLOS ONE			English	Article								c-Myc interacts with components of the pre-replication complex and directly regulates DNA replication [1]. However the consequences of this novel c-Myc function on cell cycle dynamics and replication-associated damage are unknown. Here, we show that c-Myc overexpression in primary human fibroblasts markedly accelerates S-phase while c-Myc deficient fibroblasts exhibit a prolonged S-phase. We also show that the Werner DNA helicase protein (WRN) plays a critical role in supporting c-Myc-driven S-phase, as depletion of WRN in c-Myc overexpressing cells increases DNA damage specifically at sites of DNA synthesis. This excess DNA damage activates a "replication stress'' pathway involving ATR, CHK1, CHK2, and p53, leading to rapid senescence of WRN deficient c-Myc overexpressing cells. Indeed, depletion of p53 rescues this senescence response. We propose that WRN functions to repair abnormal replication structures caused by the acceleration of DNA replication by c-Myc. This work provides an additional mechanistic explanation for c-Myc-induced DNA damage and senescence, and reveals a vulnerability of c-Myc overexpressing cells that could potentially be exploited in cancer therapy.			Robinson, K (corresponding author), Fred Hutchinson Canc Res Ctr, Program Canc Biol, 1124 Columbia St, Seattle, WA 98104 USA.	cgrandor@fhcrc.org			NATIONAL CANCER INSTITUTE [R01CA064795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026661] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA064795, CA064795] Funding Source: Medline; NIA NIH HHS [AG026661-03, R01 AG026661] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Benanti JA, 2007, MOL CANCER RES, V5, P1181, DOI 10.1158/1541-7786.MCR-06-0372; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Choi DH, 2001, FASEB J, V15, P1014, DOI 10.1096/fj.00-0104com; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gerbi SA, 2002, CURR OPIN GENET DEV, V12, P243, DOI 10.1016/S0959-437X(02)00292-7; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Li Q, 1999, MOL CELL BIOL, V19, P5339; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Mai S, 1996, ONCOGENE, V12, P277; Mai S, 1996, CHROMOSOME RES, V4, P365, DOI 10.1007/BF02257272; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Pusch O, 1997, ONCOGENE, V15, P649, DOI 10.1038/sj.onc.1201236; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; SALK D, 1985, ADV EXP MED BIOL, V190, P305; Shimura T, 2006, ONCOGENE, V25, P5921, DOI 10.1038/sj.onc.1209624; SIDOROVA J, 2008, CELL CYCLE, V7; THIRIET C, 2008, J BIOL CHEM; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8	44	63	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5951	10.1371/journal.pone.0005951	http://dx.doi.org/10.1371/journal.pone.0005951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19554081	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500002
J	Rhodes, LE; Gledhill, K; Masoodi, M; Haylett, AK; Brownrigg, M; Thody, AJ; Tobin, DJ; Nicolaou, A				Rhodes, Lesley E.; Gledhill, Karl; Masoodi, Mojgan; Haylett, Ann K.; Brownrigg, Margaret; Thody, Anthony J.; Tobin, Desmond J.; Nicolaou, Anna			The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases	FASEB JOURNAL			English	Article						hydroxyeicosatetraenoic acids; prostaglandins; cyclooxygenase; lipoxygenase; leukocytes	ULTRAVIOLET-B-IRRADIATION; TANDEM MASS-SPECTROMETRY; HYDROXY-FATTY-ACIDS; ARACHIDONIC-ACID; 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; CHEMOTACTIC ACTIVITY; HUMAN KERATINOCYTES; LIPIDOMIC ANALYSIS; ATOPIC-DERMATITIS; COX-2 EXPRESSION	Sunburn is a commonly occurring acute inflammatory process, with dermal vasodilatation and leukocyte infiltration as central features. Ultraviolet (UV) B-induced hydrolysis of membrane phospholipids releases polyunsaturated fatty acids, and their subsequent metabolism by cyclooxygenases (COXs) and lipoxygenases (LOXs) may produce potent eicosanoid mediators modulating different stages of the inflammation. Our objective was to identify candidate eicosanoids formed during the sunburn reaction in relation to its clinical and histological course. We exposed skin of healthy humans (n=32) to UVB and, for 72 h, examined expression of proinflammatory and anti-inflammatory eicosanoids using LC/ESI-MS/MS, and examined immunohistochemical expression of COX-2, 12-LOX, 15-LOX, and leukocyte markers, while quantifying clinical erythema. We show that vasodilatory prostaglandins (PGs) PGE(2), PGF(2 alpha), and PGE(3) accompany the erythema in the first 24-48 h, associated with increased COX-2 expression at 24 h. Novel, potent leukocyte chemoattractants 11-, 12-, and 8-monohydroxy-eicosatetraenoic acid (HETE) are elevated from 4 to 72 h, in association with peak dermal neutrophil influx at 24 h, and increased dermal CD(3+) lymphocytes and 12- and 15-LOX expression from 24 to 72 h. Anti-inflammatory metabolite 15-HETE shows later expression, peaking at 72 h. Sunburn is characterized by overlapping sequential profiles of increases in COX products followed by LOX products that may regulate subsequent events and ultimately its resolution.-Rhodes, L. E., Gledhill, K., Masoodi, M., Haylett, A. K., Brownrigg, M., Thody, A. J., Tobin, D. J., Nicolaou, A. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J. 23, 3947-3956 (2009). www.fasebj.org	[Rhodes, Lesley E.; Haylett, Ann K.; Brownrigg, Margaret] Univ Manchester, Photobiol Unit, Salford Royal NHS Fdn Hosp, Manchester Acad Hlth Sci Ctr,Sch Translat Med, Manchester M6 8HD, Lancs, England; [Gledhill, Karl; Tobin, Desmond J.; Nicolaou, Anna] Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Masoodi, Mojgan; Nicolaou, Anna] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England; [Thody, Anthony J.] Newcastle Univ, Sch Clin & Lab Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; University of Bradford; University of Bradford; Newcastle University - UK	Rhodes, LE (corresponding author), Univ Manchester, Photobiol Unit, Salford Royal NHS Fdn Hosp, Manchester Acad Hlth Sci Ctr,Sch Translat Med, Manchester M6 8HD, Lancs, England.	lesley.e.rhodes@manchester.ac.uk	Gledhill, Karl/H-8935-2012; Nicolaou, Anna/D-4025-2018; Rhodes, Lesley E/H-5324-2015; MASOODI, MOJGAN/P-1499-2019; MASOODI, MOJGAN/B-8814-2012; Tobin, Desmond/A-5228-2009	Nicolaou, Anna/0000-0002-1314-413X; Rhodes, Lesley E/0000-0002-9107-6654; MASOODI, MOJGAN/0000-0001-9840-1731; Haylett, Ann/0000-0001-6625-7640; Tobin, Desmond/0000-0003-4566-9392	Wellcome Trust [WT077714]; National Institute for Health Research Manchester Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	The authors acknowledge The Wellcome Trust, project WT077714, for funding this research. The Dermatological Sciences Research Group is supported by the National Institute for Health Research Manchester Biomedical Research Centre. The authors thank Andrew Healey (University of Bradford Analytical Centre) for technical support.	BACON KB, 1988, BRIT J PHARMACOL, V95, P966, DOI 10.1111/j.1476-5381.1988.tb11727.x; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; BARR RM, 1984, BRIT J DERMATOL, V111, P23, DOI 10.1111/j.1365-2133.1984.tb04012.x; BLACK AK, 1978, BRIT J CLIN PHARMACO, V5, P431, DOI 10.1111/j.1365-2125.1978.tb01650.x; BLACK AK, 1985, BRIT J CLIN PHARMACO, V20, P185, DOI 10.1111/j.1365-2125.1985.tb05059.x; BLACK AK, 1980, BRIT J CLIN PHARMACO, V10, P453, DOI 10.1111/j.1365-2125.1980.tb01788.x; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; BURRALL BA, 1985, BIOCHEM BIOPH RES CO, V133, P208, DOI 10.1016/0006-291X(85)91862-5; CAMP RDR, 1983, BRIT J PHARMACOL, V80, P497, DOI 10.1111/j.1476-5381.1983.tb10721.x; Capdevila JH, 2000, J LIPID RES, V41, P163; CRUNKHORN P, 1971, BRIT J PHARMACOL, V41, P49, DOI 10.1111/j.1476-5381.1971.tb09934.x; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Di Nuzzo S, 1998, J INVEST DERMATOL, V110, P978, DOI 10.1046/j.1523-1747.1998.00220.x; DOWD PM, 1985, J INVEST DERMATOL, V84, P537, DOI 10.1111/1523-1747.ep12273537; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; GOETZL EJ, 1980, IMMUNOLOGY, V39, P491; Grundmann JU, 2004, SKIN PHARMACOL PHYS, V17, P37, DOI 10.1159/000074061; GSCHWENDT M, 1986, CARCINOGENESIS, V7, P449, DOI 10.1093/carcin/7.3.449; HAMMARSTROM S, 1979, J INVEST DERMATOL, V73, P180, DOI 10.1111/1523-1747.ep12581645; HAWK JLM, 1988, BRIT J DERMATOL, V118, P27, DOI 10.1111/j.1365-2133.1988.tb01746.x; HEDQVIST P, 1977, ANNU REV PHARMACOL, V17, P259, DOI 10.1146/annurev.pa.17.040177.001355; JUHLIN L, 1969, ACTA DERM-VENEREOL, V49, P251; KRAGBALLE K, 1987, DERMATOLOGICA, V174, P209, DOI 10.1159/000249181; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; LANDS WEM, 1992, FASEB J, V6, P2530, DOI 10.1096/fasebj.6.8.1592205; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Masoodi M, 2006, RAPID COMMUN MASS SP, V20, P3023, DOI 10.1002/rcm.2697; Profita M, 2002, J PHARMACOL EXP THER, V300, P868, DOI 10.1124/jpet.300.3.868; RAUD J, 1988, P NATL ACAD SCI USA, V85, P2315, DOI 10.1073/pnas.85.7.2315; Rhodes LE, 2001, J INVEST DERMATOL, V117, P880, DOI 10.1046/j.0022-202x.2001.01514.x; RHODES LE, 1995, J INVEST DERMATOL, V105, P532, DOI 10.1111/1523-1747.ep12323389; Rhodes LE, 2003, CARCINOGENESIS, V24, P919, DOI 10.1093/carcin/bgg038; RHODES LE, 1994, J INVEST DERMATOL, V103, P151, DOI 10.1111/1523-1747.ep12392604; RIEGER G, 1987, J INVEST DERMATOL, V89, P339; RUZICKA T, 1986, PHOTODERMATOLOGY, V3, P306; RUZICKA T, 1986, J INVEST DERMATOL, V86, P105, DOI 10.1111/1523-1747.ep12284061; RUZICKA T, 1983, J INVEST DERMATOL, V81, P300, DOI 10.1111/1523-1747.ep12519287; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Strickland I, 1997, J INVEST DERMATOL, V108, P763, DOI 10.1111/1523-1747.ep12292156; Teunissen MBM, 2002, J IMMUNOL, V168, P3732, DOI 10.4049/jimmunol.168.8.3732; Vachier I, 2002, BIOCHEM BIOPH RES CO, V290, P219, DOI 10.1006/bbrc.2001.6155; VANDERHOEK JY, 1980, J BIOL CHEM, V255, P64; WARREN JB, 1994, FASEB J, V8, P247, DOI 10.1096/fasebj.8.2.7509761; Yoo H, 2008, FEBS LETT, V582, P3249, DOI 10.1016/j.febslet.2008.08.017; ZIBOH VA, 1992, SEMIN DERMATOL, V11, P114	46	93	95	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2009	23	11					3947	3956		10.1096/fj.09-136077	http://dx.doi.org/10.1096/fj.09-136077			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19584301	Green Published			2022-12-25	WOS:000271272500030
J	Casimir, M; Lasorsa, FM; Rubi, B; Caille, D; Palmieri, F; Meda, P; Maechler, P				Casimir, Marina; Lasorsa, Francesco M.; Rubi, Blanca; Caille, Dorothee; Palmieri, Ferdinando; Meda, Paolo; Maechler, Pierre			Mitochondrial Glutamate Carrier GC1 as a Newly Identified Player in the Control of Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; REGULATED ANAPLEROSIS; METABOLIC-FATE; AMINO-ACID; TRANSPORTER; ISLET; RECONSTITUTION; DEHYDROGENASE	The SLC25 carrier family mediates solute transport across the inner mitochondrial membrane, a process that is still poorly characterized regarding both the mechanisms and proteins implicated. This study investigated mitochondrial glutamate carrier GC1 in insulin-secreting beta-cells. GC1 was cloned from insulin-secreting cells, and sequence analysis revealed hydropathy profile of a six-transmembrane protein, characteristic of mitochondrial solute carriers. GC1 was found to be expressed at the mRNA and protein levels in INS-1E beta-cells and pancreatic rat islets. Immunohistochemistry showed that GC1 was present in mitochondria, and ultrastructural analysis by electron microscopy revealed inner mitochondrial membrane localization of the transporter. Silencing of GC1 in INS-1E beta-cells, mediated by adenoviral delivery of short hairpin RNA, reduced mitochondrial glutamate transport by 48% (p < 0.001). Insulin secretion at basal 2.5 mM glucose and stimulated either by intermediate 7.5 mM glucose or non-nutrient 30 mM KCl was not modified by GC1 silencing. Conversely, insulin secretion stimulated with optimal 15 mM glucose was reduced by 23% (p < 0.005) in GC1 knocked down cells compared with controls. Adjunct of cell-permeant glutamate (5 mM dimethyl glutamate) fully restored the secretory response at 15 mM glucose (p < 0.005). Kinetics of insulin secretion were investigated in peri-fused isolated rat islets. GC1 silencing in islets inhibited the secretory response induced by 16.7 mM glucose, both during first (-25%, p < 0.05) and second (-33%, p < 0.05) phases. This study demonstrates that insulin-secreting cells depend on GC1 for maximal glucose response, thereby assigning a physiological function to this newly identified mitochondrial glutamate carrier.	[Maechler, Pierre] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, CH-1211 Geneva 4, Switzerland; [Lasorsa, Francesco M.; Palmieri, Ferdinando] Univ Bari, Dept Pharm Biol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Lasorsa, Francesco M.; Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	University of Geneva; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Maechler, P (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Fac Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch	lasorsa, francesco massimo m/B-7931-2008	lasorsa, francesco massimo m/0000-0001-8418-5222; Maechler, Pierre/0000-0002-2005-1433	Swiss National Science Foundation; European Foundation for the Study of Diabetes/Novo Nordisk research; Novartis Foundation; Novo Nordisk; Ministero dell'Universita e della Ricerca; Apulia Region; Juvenile Diabetes Research Foundation; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Foundation for the Study of Diabetes/Novo Nordisk research; Novartis Foundation(Novartis); Novo Nordisk(Novo Nordisk); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Apulia Region; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	This work was supported by the Swiss National Science Foundation (to P. Maechler and P. Meda), the European Foundation for the Study of Diabetes/Novo Nordisk research grant (to P. Maechler), the Novartis Foundation (to P. Maechler), Novo Nordisk (P. Meda), the Ministero dell'Universita e della Ricerca (to F. P.) and Apulia Region (to F. P.), the Juvenile Diabetes Research Foundation (P. Meda), and the European Union (P. Meda). This study was part of the Geneva Programme for Metabolic Disorders.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Bosco D, 2005, DIABETOLOGIA, V48, P1523, DOI 10.1007/s00125-005-1816-1; Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Eto K, 2003, AM J PHYSIOL-ENDOC M, V285, pE262, DOI 10.1152/ajpendo.00542.2002; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kowluru A, 2001, DIABETES, V50, P1580, DOI 10.2337/diabetes.50.7.1580; Lehtihet M, 2005, BIOCHEM BIOPH RES CO, V328, P601, DOI 10.1016/j.bbrc.2005.01.024; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Rubi B, 2001, J BIOL CHEM, V276, P36391, DOI 10.1074/jbc.M104999200; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1981, DIABETOLOGIA, V21, P135; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; Storto M, 2006, MOL PHARMACOL, V69, P1234, DOI 10.1124/mol.105.018390; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004	53	52	54	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25004	25014		10.1074/jbc.M109.015495	http://dx.doi.org/10.1074/jbc.M109.015495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584051	Green Published, hybrid			2022-12-25	WOS:000269734000036
J	Garcia-Castillo, J; Pedersen, K; Angelini, PD; Bech-Serra, JJ; Colome, N; Cunningham, MP; Parra-Palau, JL; Canals, F; Baselga, J; Arribas, J				Garcia-Castillo, Jesus; Pedersen, Kim; Angelini, Pier-Davide; Josep Bech-Serra, Joan; Colome, Nuria; Paul Cunningham, Matthew; Lluis Parra-Palau, Josep; Canals, Francesc; Baselga, Jose; Arribas, Joaquin			HER2 Carboxyl-terminal Fragments Regulate Cell Migration and Cortactin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHORYLATION; TUMOR-GROWTH; PROTEIN; INVASION; ADHESION; RECEPTOR; IDENTIFICATION; INVADOPODIA; EXPRESSION; PROTEOMICS	A group of breast cancer patients with a higher probability of developing metastasis expresses a series of carboxyl-terminal fragments (CTFs) of the tyrosine kinase receptor HER2. One of these fragments, 611-CTF, is a hyperactive form of HER2 that constitutively establishes homodimers maintained by disulfide bonds, making it an excellent model to study overactivation of HER2 during tumor progression and metastasis. Here we show that expression of 611-CTF increases cell motility in a variety of assays. Since cell motility is frequently regulated by phosphorylation/dephosphorylation, we looked for phosphoproteins mediating the effect of 611-CTF using two alternative proteomic approaches, stable isotope labeling with amino acids in cell culture and difference gel electrophoresis, and found that the latter is particularly well suited to detect changes in multiphosphorylated proteins. The difference gel electrophoresis screening identified cortactin, a cytoskeleton-binding protein involved in the regulation of cell migration, as a phosphoprotein probably regulated by 611-CTF. This result was validated by characterizing cortactin in cells expressing this HER2 fragment. Finally, we showed that the knockdown of cortactin impairs 611-CTF-induced cell migration. These results suggest that cortactin is a target of 611-CTF involved in the regulation of cell migration and, thus, in the metastatic behavior of breast tumors expressing this CTF.	[Paul Cunningham, Matthew; Lluis Parra-Palau, Josep; Canals, Francesc; Baselga, Jose; Arribas, Joaquin] Vall Hebron Univ Hosp, Med Oncol Res Program, Barcelona 08035, Spain; [Josep Bech-Serra, Joan; Colome, Nuria; Canals, Francesc] Vall Hebron Univ Hosp, Prote Lab, Res Inst Fdn, Barcelona 08035, Spain; [Josep Bech-Serra, Joan; Colome, Nuria; Canals, Francesc] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Barcelona 08035, Spain; [Angelini, Pier-Davide; Arribas, Joaquin] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; ICREA	Parra-Palau, JL (corresponding author), Vall Hebron Univ Hosp, Med Oncol Res Program, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	jarribas@ir.vhebron.net	Bech-Serra, Joan Josep/AAA-2330-2020; Garcia-Castillo, Jesus/GOE-4850-2022; Arribas, Joaquin/M-4482-2014	Bech-Serra, Joan Josep/0000-0003-3486-781X; Garcia-Castillo, Jesus/0000-0002-7520-6746; Arribas, Joaquin/0000-0002-0504-0664	Instituto de Salud Carlos III; Breast Cancer Research Foundation; La Marato de TV3; Juan de la Cierva Postdoctoral Program; Spanish Ministry of Education; ICREA Funding Source: Custom	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Breast Cancer Research Foundation; La Marato de TV3; Juan de la Cierva Postdoctoral Program; Spanish Ministry of Education(Spanish Government); ICREA(ICREA)	This work was supported by grants from the Instituto de Salud Carlos III (Intrasalud PI081154 and the network of cooperative cancer research), the Breast Cancer Research Foundation, and La Marato de TV3 (to J.A.).; Supported by a fellowship from the Juan de la Cierva Postdoctoral Program.; Supported by a predoctoral fellowship from the Spanish Ministry of Education.	Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chaudhuri P, 2005, CIRC RES, V97, P674, DOI 10.1161/01.RES.0000184667.82354.b1; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Dittmar T, 2002, FASEB J, V16, P1823, DOI 10.1096/fj.02-0096fje; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everley PA, 2005, ANN NY ACAD SCI, V1059, P1, DOI 10.1196/annals.1339.001; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hill A, 2006, ONCOGENE, V25, P6079, DOI 10.1038/sj.onc.1209628; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Molina MA, 2002, CLIN CANCER RES, V8, P347; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Rusnak DW, 2001, CANCER RES, V61, P7196; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Van den Bergh G, 2004, CURR OPIN BIOTECH, V15, P38, DOI 10.1016/j.copbio.2003.12.001; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan CX, 2003, PROTEIN EXPRES PURIF, V29, P217, DOI 10.1016/S1046-5928(03)00058-5	36	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25302	25313		10.1074/jbc.M109.001982	http://dx.doi.org/10.1074/jbc.M109.001982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589785	hybrid, Green Published			2022-12-25	WOS:000269734000063
J	Fielhaber, JA; Han, YS; Tan, J; Xing, S; Biggs, CM; Joung, KB; Kristof, AS				Fielhaber, Jill A.; Han, Ying-Shan; Tan, Jason; Xing, Shuo; Biggs, Catherine M.; Joung, Kwang-Bo; Kristof, Arnold S.			Inactivation of Mammalian Target of Rapamycin Increases STAT1 Nuclear Content and Transcriptional Activity in alpha 4-and Protein Phosphatase 2A-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDE SYNTHASE PROMOTER; IFN-GAMMA; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; CATALYTIC SUBUNIT; SIGNALING PATHWAY; INDUCED APOPTOSIS; INTERFERON-GAMMA; GROWTH-CONTROL; IMMUNE-SYSTEM; CELL-DEATH	Target of rapamycin (TOR) is a highly conserved serine/threonine kinase that controls cell growth, primarily via regulation of protein synthesis. In Saccharomyces cerevisiae, TOR can also suppress the transcription of stress response genes by a mechanism involving Tap42, a serine/threonine phosphatase subunit, and the transcription factor Msn2. A physical association between mammalian TOR (mTOR) and the transcription factor signal transducer and activator of transcription-1 (STAT1) was recently identified in human cells, suggesting a similar role form TOR in the transcription of interferon-gamma-stimulated genes. In the current study, we identified a macromolecular protein complex composed of mTOR, STAT1, the Tap42 homologue alpha 4, and the protein phosphatase 2A catalytic subunit (PP2Ac). Inactivation of mTOR enhanced its association with STAT1 and increased STAT1 nuclear content in PP2Ac-dependent fashion. Depletion of alpha 4, PP2A, or mTOR enhanced the induction of early (i.e. IRF-1) and late (i.e. caspase-1, hiNOS, and Fas) STAT1-dependent genes. The regulation of IRF-1 or caspase-1 by mTOR was independent of other known mTOR effectors p70 S6 kinase and Akt. These results describe a new role for mTOR and alpha 4/PP2A in the control of STAT1 nuclear content, and the expression of interferon-gamma-sensitive genes involved in immunity and apoptosis.	McGill Univ, Fac Med, Crit Care Div, Montreal, PQ H3A 1A1, Canada; McGill Univ, Fac Med, Div Resp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Fac Med, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	Kristof, AS (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, 687 Pine Ave W,L3-05, Montreal, PQ H3A 1A1, Canada.	arnold.kristof@mcgill.ca		Biggs, Catherine/0000-0002-4363-2660	National Institutes of Health [5R01CA125436]; McGill University Health Centre Confocal Core Facility; Canadian Institutes for Health Research; American Thoracic Society/Lymphangioleiomyomatosis Foundation Award; Tuberous Sclerosis Alliance; Tuberous Sclerosis Canada; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGill University Health Centre Confocal Core Facility; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); American Thoracic Society/Lymphangioleiomyomatosis Foundation Award; Tuberous Sclerosis Alliance; Tuberous Sclerosis Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01CA125436. This work was also facilitated by the McGill University Health Centre Confocal Core Facility (S. Laporte) and funded by the Canadian Institutes for Health Research and by an American Thoracic Society/Lymphangioleiomyomatosis Foundation Award in partnership with the Tuberous Sclerosis Alliance and Tuberous Sclerosis Canada.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; El-Hashemite N, 2005, AM J RESP CELL MOL, V33, P227, DOI 10.1165/rcmb.2005-0152RC; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huang SL, 2001, CANCER RES, V61, P3373; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kirchhoff S, 2002, J IMMUNOL, V168, P1226, DOI 10.4049/jimmunol.168.3.1226; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2003, J BIOL CHEM, V278, P33637, DOI 10.1074/jbc.M301053200; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Kristof AS, 2003, INTERSTITIAL LUNG DI, P851; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nien WL, 2007, MOL CELL ENDOCRINOL, V263, P10, DOI 10.1016/j.mce.2006.08.015; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	46	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24341	24353		10.1074/jbc.M109.033530	http://dx.doi.org/10.1074/jbc.M109.033530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19553685	Green Published, hybrid			2022-12-25	WOS:000269380200047
J	Ivashyna, O; Garcia-Saez, AJ; Ries, J; Christenson, ET; Schwille, P; Schlesinger, PH				Ivashyna, Olena; Garcia-Saez, Ana J.; Ries, Jonas; Christenson, Eric T.; Schwille, Petra; Schlesinger, Paul H.			Detergent-activated BAX Protein Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; INTENSITY DISTRIBUTION ANALYSIS; CYTOCHROME-C; MITOCHONDRIAL-MEMBRANE; CONFORMATIONAL-CHANGE; APOPTOSIS; OLIGOMERIZATION; LIPOSOMES; BINDING; CELLS	BAX is a pro-apoptotic member of the BCL-2 protein family. At the onset of apoptosis, monomeric, cytoplasmic BAX is activated and translocates to the outer mitochondrial membrane, where it forms an oligomeric pore. The chemical mechanism of BAX activation is controversial, and several in vitro and in vivo methods of its activation are known. One of the most commonly used in vitro methods is activation with detergents, such as n-octyl glucoside. During BAX activation with n-octyl glucoside, it has been shown that BAX forms high molecular weight complexes that are larger than the combined molecular weight of BAX monomer and one detergent micelle. These large complexes have been ascribed to the oligomerization of BAX prior to its membrane insertion and pore formation. This is in contrast to the in vivo studies that suggest that active BAX inserts into the outer mitochondrial membrane as a monomer and then undergoes oligomerization. Here, to simultaneously determine the molecular weight and the number of BAX proteins per BAX-detergent micelle during detergent activation, we have used an approach that combines two single-molecule sensitivity technique, fluorescence correlation spectroscopy, and fluorescence-intensity distribution analysis. We have tested a range of detergents as follows: n-octyl glucoside, dodecyl maltoside, Triton X-100, Tween 20, 3-[(3- cholamidopropyl)dimethylammonio]-1-propanesulfonic acid, and cholic acid. With these detergents we observe that BAX is a monomer before, during, and after interaction with micelles. We conclude that detergent activation of BAX is not congruent with oligomerization and that in physiologic buffer conditions BAX can assume two stable monomeric conformations, one inactive and one active.	[Ivashyna, Olena; Christenson, Eric T.; Schlesinger, Paul H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Garcia-Saez, Ana J.; Ries, Jonas; Schwille, Petra] Tech Univ Dresden, Biophys Grp, BIOTEC, D-01307 Dresden, Germany	Washington University (WUSTL); Technische Universitat Dresden	Schlesinger, PH (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	paul@cellbiology.wustl.edu	Schlesinger, Paul H/C-6049-2012; Schwille, Petra/A-4983-2010; Ries, Jonas/Q-5157-2019; Saez, Ana J. Garcia/U-1611-2019; Ries, Jonas/P-3027-2014	Christenson, Eric/0000-0001-7463-7694; Ries, Jonas/0000-0002-6640-9250	National Institutes of Health Grant [GM 067056]; Europaischer Fonds fur regionale Entwicklung; International Society of Optical Engineering (SPIE) educational scholarship; Marie Curie Intra-European fellowship; 6th European Framework Program; Europaischen Fonds fur Regional Entwiklung Grant [4212/0608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067056] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Europaischer Fonds fur regionale Entwicklung; International Society of Optical Engineering (SPIE) educational scholarship; Marie Curie Intra-European fellowship(European Commission); 6th European Framework Program(European Commission); Europaischen Fonds fur Regional Entwiklung Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067056 ( to P. H. S.) and by Europaischer Fonds fur regionale Entwicklung ( to P. S. and J. R.). This work was also supported by the International Society of Optical Engineering (SPIE) educational scholarship ( to O.I.), by Marie Curie Intra-European fellowship ( to A. J. G. S.) within the 6th European Framework Program, and by Europaischen Fonds fur Regional Entwiklung Grant 4212/0608 ( to J. R. and P. S.).	Anderluh G, 2003, TOXICON, V42, P225, DOI 10.1016/S0041-0101(03)00197-1; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Christenson E, 2008, J MOL BIOL, V381, P1168, DOI 10.1016/j.jmb.2008.06.037; Dewson G, 2003, ONCOGENE, V22, P2643, DOI 10.1038/sj.onc.1206326; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Haustein E, 2004, CURR OPIN STRUC BIOL, V14, P531, DOI 10.1016/j.sbi.2004.09.004; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MacKenzie KR, 2008, CURR OPIN STRUC BIOL, V18, P412, DOI 10.1016/j.sbi.2008.04.007; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Ohrt T, 2006, NUCLEIC ACIDS RES, V34, P1369, DOI 10.1093/nar/gkl001; Rika J., 1989, PHYS REV A, V39, P2646; Rodnin MV, 2008, BIOPHYS J, V94, P4348, DOI 10.1529/biophysj.107.126235; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TARTOF KD, 1987, FOCUS, V9, P12; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23935	23946		10.1074/jbc.M109.023853	http://dx.doi.org/10.1074/jbc.M109.023853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19564333	hybrid, Green Published			2022-12-25	WOS:000269380200007
J	Johnson, JL; Erickson, JW; Cerione, RA				Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.			New Insights into How the Rho Guanine Nucleotide Dissociation Inhibitor Regulates the Interaction of Cdc42 with Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-BINDING DOMAIN; CELL POLARITY; MOLECULAR-CLONING; PROTEIN CDC42HS; PLASMA-MEMBRANE; RAC; ACTIVATION; TRANSFORMATION; COMPLEX; GDP	The subcellular localization of the Rho family GTPases is of fundamental importance to their proper functioning in cells. The Rho guanine nucleotide dissociation inhibitor (RhoGDI) plays a key regulatory role by influencing the cellular localization of Rho GTPases and is essential for the transforming activity of oncogenic forms of Cdc42. However, the mechanism by which RhoGDI helps Cdc42 to undergo the transition between a membrane-associated protein and a soluble (cytosolic) species has been poorly understood. Here, we examine how RhoGDI influences the binding of Cdc42 to lipid bilayers. Despite having similar affinities for the signaling-inactive (GDP-bound) and signaling-active (GTP-bound) forms of Cdc42 in solution, we show that when RhoGDI interacts with Cdc42 along the membrane surface, it has a much higher affinity for GDP-bound Cdc42 compared with its GTP-bound counterpart. Interestingly, the rate for the dissociation of Cdc42.RhoGDI complexes from membranes is unaffected by the nucleotide-bound state of Cdc42. Moreover, the membrane release of Cdc42.RhoGDI complexes occurs at a similar rate as the release of Cdc42 alone, with the major effect of RhoGDI being to impede the re-association of Cdc42 with membranes. These findings lead us to propose a new model for how RhoGDI influences the ability of Cdc42 to move between membranes and the cytosol, which highlights the role of the membrane in helping RhoGDI to distinguish between the GDP-and GTP-bound forms of Cdc42 and holds important implications for how it functions as a key regulator of the cellular localization and signaling activities of this GTPase.	[Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Johnson, Jared/0000-0003-1802-6527	National Institutes of Health [GM040654, GM047458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM040654 and GM047458.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; THOM D, 1977, BIOCHEM J, V168, P187, DOI 10.1042/bj1680187; UEDA T, 1990, J BIOL CHEM, V265, P9373; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	60	59	60	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23860	23871		10.1074/jbc.M109.031815	http://dx.doi.org/10.1074/jbc.M109.031815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581296	Green Published, hybrid			2022-12-25	WOS:000269180000069
J	Obara, Y; Yamauchi, A; Takehara, S; Nemoto, W; Takahashi, M; Stork, PJS; Nakahata, N				Obara, Yutaro; Yamauchi, Arata; Takehara, Shin; Nemoto, Wataru; Takahashi, Maho; Stork, Philip J. S.; Nakahata, Norimichi			ERK5 Activity Is Required for Nerve Growth Factor-induced Neurite Outgrowth and Stabilization of Tyrosine Hydroxylase in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE-5; MAP KINASE; PHEOCHROMOCYTOMA CELLS; CORTICAL-NEURONS; RAP1 ACTIVATION; GENE-EXPRESSION; CYCLIC-AMP; T-CELLS; PATHWAY	Extracellular signal-regulated kinases (ERKs) play important physiological roles in proliferation, differentiation, and gene expression. ERK5 is approximately twice the size of ERK1/2, and its amino-terminal half contains the kinase domain that shares homology with ERK1/2 and TEY activation motif, whereas the carboxyl-terminal half is unique. In this study, we examined a physiological role of ERK5 in rat pheochromocytoma cells (PC12), comparing it with ERK1/2. Nerve growth factor (NGF) induced phosphorylation of both ERK5 and ERK1/2, whereas the cAMP analog dibutyryl cAMP (Bt(2)cAMP) caused only ERK1/2 phosphorylation. U0126, at 30 mu M, that blocks ERK1/2 signaling selectively attenuated neurite outgrowth induced by NGF and Bt(2)cAMP, but BIX02188 and BIX02189, at 30 mu M, that block ERK5 signaling and an ERK5 dominant-negative mutant suppressed only NGF-induced neurite outgrowth. Next, we examined the expression of tyrosine hydroxylase, a rate-limiting enzyme of catecholamine biosynthesis. Both NGF and Bt2cAMP increased tyrosine hydroxylase gene promoter activity in an ERK1/2-dependent manner but was ERK5-independent. However, when both ERK5 and ERK1/2 signalings were inhibited, tyrosine hydroxylase protein up-regulation by NGF and Bt2cAMP was abolished, because of the loss of stabilization of tyrosine hydroxylase protein by ERK5. Taking these results together, ERK5 is involved in neurite outgrowth and stabilization of tyrosine hydroxylase in PC12 cells, and ERK5, along with ERK1/2, plays essential roles in the neural differentiation process.	[Obara, Yutaro; Yamauchi, Arata; Takehara, Shin; Nemoto, Wataru; Nakahata, Norimichi] Tohoku Univ, Dept Cellular Signaling, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Obara, Yutaro; Nakahata, Norimichi] Tohoku Univ, 21st Century Ctr Excellence Program CRESCENDO, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Obara, Yutaro; Takahashi, Maho; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Tohoku University; Tohoku University; Oregon Health & Science University	Obara, Y (corresponding author), Tohoku Univ, Dept Cellular Signaling, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	obaray@mail.pharm.tohoku.ac.jp	Nemoto, Wataru/AAK-6004-2021	Nemoto, Wataru/0000-0003-1253-5523	Japan Society for the Promotion of Science [20790053, 19659011]; Japan-United States Brain Research Cooperative Program; Exploratory Research Program for Young Scientists of Tohoku University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan-United States Brain Research Cooperative Program; Exploratory Research Program for Young Scientists of Tohoku University	This work was supported in part by Grants-in-aid from the Japan Society for the Promotion of Science 20790053 (to Y.O.) and 19659011 (to N.N.), Japan-United States Brain Research Cooperative Program (to Y.O.), and Exploratory Research Program for Young Scientists of Tohoku University (to Y.O.).	Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Cavanaugh JE, 2004, EUR J BIOCHEM, V271, P2056, DOI 10.1111/j.1432-1033.2004.04131.x; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Garaude J, 2006, J IMMUNOL, V177, P7607, DOI 10.4049/jimmunol.177.11.7607; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Meng JW, 2002, J BIOL CHEM, V277, P43417, DOI 10.1074/jbc.M204074200; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Nishimoto S, 2005, EMBO REP, V6, P1064, DOI 10.1038/sj.embor.7400515; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Obara Y, 2002, J PHARMACOL EXP THER, V301, P803, DOI 10.1124/jpet.301.3.803; Obara Y, 2008, CELL SIGNAL, V20, P1275, DOI 10.1016/j.cellsig.2008.02.016; Obara Y, 2007, J NEUROCHEM, V101, P470, DOI 10.1111/j.1471-4159.2006.04390.x; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Pollack V, 2007, AM J PHYSIOL-RENAL, V293, pF1714, DOI 10.1152/ajprenal.00130.2007; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	48	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23564	23573		10.1074/jbc.M109.027821	http://dx.doi.org/10.1074/jbc.M109.027821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19581298	Green Published, hybrid			2022-12-25	WOS:000269180000042
J	Raducanu, A; Hunziker, EB; Drosse, I; Aszodi, A				Raducanu, Aurelia; Hunziker, Ernst B.; Drosse, Inga; Aszodi, Attila			beta 1 Integrin Deficiency Results in Multiple Abnormalities of the Knee Joint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE HYPERTROPHIC DIFFERENTIATION; HUMAN ARTICULAR CHONDROCYTES; FIBRONECTIN FRAGMENTS; CARTILAGE; EXPRESSION; OSTEOARTHRITIS; KINASE; INTEGRINS; TRANSGLUTAMINASE-2; CHONDROLYSIS	The lack of beta 1 integrins on chondrocytes leads to severe chondrodysplasia associated with high mortality rate around birth. To assess the impact of beta 1 integrin-mediated cell-matrix interactions on the function of adult knee joints, we conditionally deleted the beta 1 integrin gene in early limb mesenchyme using the Prx1-cre transgene. Mutant mice developed short limbed dwarfism and had joint defects due to beta 1 integrin deficiency in articular regions. The articular cartilage (AC) was structurally disorganized, accompanied by accelerated terminal differentiation, altered shape, and disrupted actin cytoskeleton of the chondrocytes. Defects in chondrocyte proliferation, cytokinesis, and survival resulted in hypocellularity. However, no significant differences in cartilage erosion, in the expression of matrix-degrading proteases, or in the exposure of aggrecan and collagen II cleavage neoepitopes were observed between control and mutant AC. We found no evidence for disturbed activation of MAPKs (ERK1/2, p38, and JNK) in vivo. Furthermore, fibronectin fragment-stimulated ERK activation and MMP-13 expression were indistinguishable in control and mutant femoral head explants. The mutant synovium was hyperplastic and frequently underwent chondrogenic differentiation. beta 1-null synoviocytes showed increased proliferation and phospho-focal adhesion kinase expression. Taken together, deletion of beta 1 integrins in the limb bud results in multiple abnormalities of the knee joints; however, it does not accelerate AC destruction, perturb cartilage metabolism, or influence intracellular MAPK signaling pathways.	[Raducanu, Aurelia; Aszodi, Attila] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Hunziker, Ernst B.] Univ Bern, Dept Clin Res, Ctr Regenerat Med Skeletal Tissues, CH-3010 Bern, Switzerland; [Drosse, Inga] Univ Munich, Dept Surg, D-80336 Munich, Germany	Max Planck Society; University of Bern; University of Munich	Aszodi, A (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany.	aszodi@biochem.mpg.de	Hunziker, Ernst B/GYA-1015-2022		Max Planck Society; Swiss National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Max Planck Society (to A. R. and A. A.) and the Swiss National Science Foundation (to E. B. H.).	Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Ding L, 2008, OSTEOARTHR CARTILAGE, V16, P1253, DOI 10.1016/j.joca.2008.02.015; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Holloway I, 2004, OSTEOARTHR CARTILAGE, V12, P17, DOI 10.1016/j.joca.2003.09.001; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; HUNZIKER EB, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P183; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; Lapadula G, 1998, CLIN RHEUMATOL, V17, P99, DOI 10.1007/BF01452253; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LIPMAN JM, 1984, EXPERIENTIA, V40, P553, DOI 10.1007/BF01982326; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; MODIS L, 1991, ORG EXTRACELLULAR MA, P269; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Ostergaard K, 1998, ANN RHEUM DIS, V57, P303, DOI 10.1136/ard.57.5.303; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Poole AR, 2003, BIOCHEM SOC SYMP, V70, P115, DOI 10.1042/bss0700115; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Stanton H, 2002, BIOCHEM J, V364, P181, DOI 10.1042/bj3640181; Tanaka K, 2007, MATRIX BIOL, V26, P409, DOI 10.1016/j.matbio.2007.04.005; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; XIE DL, 1994, ARCH BIOCHEM BIOPHYS, V311, P205, DOI 10.1006/abbi.1994.1228; Zemmyo M, 2003, ARTHRITIS RHEUM-US, V48, P2873, DOI 10.1002/art.11246	45	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23780	23792		10.1074/jbc.M109.039347	http://dx.doi.org/10.1074/jbc.M109.039347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19586917	Green Published, hybrid			2022-12-25	WOS:000269180000062
J	Kohli, RM; Abrams, SR; Gajula, KS; Maul, RW; Gearhart, PJ; Stivers, JT				Kohli, Rahul M.; Abrams, Shaun R.; Gajula, Kiran S.; Maul, Robert W.; Gearhart, Patricia J.; Stivers, James T.			A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; IN-VIVO; CRYSTAL-STRUCTURE; MUTATION SPECTRA; ENZYME APOBEC3G; AID; SPECIFICITY; GENOME; DOMAIN	Enzymes of the AID/APOBEC family, characterized by the targeted deamination of cytosine to generate uracil within DNA, mediate numerous critical immune responses. One family member, activation-induced cytidine deaminase ( AID), selectively introduces uracil into antibody variable and switch regions, promoting antibody diversity through somatic hyper-mutation or class switching. Other family members, including APOBEC3F and APOBEC3G, play an important role in retroviral defense by acting on viral reverse transcripts. These enzymes are distinguished from one another by targeting cytosine within different DNA sequence contexts; however, the reason for these differences is not known. Here, we report the identification of a recognition loop of 9-11 amino acids that contributes significantly to the distinct sequence motifs of individual family members. When this recognition loop is grafted from the donor APOBEC3F or 3G proteins into the acceptor scaffold of AID, the mutational signature of AID changes toward that of the donor proteins. These loop-graft mutants of AID provide useful tools for dissecting the biological impact of DNA sequence preferences upon generation of antibody diversity, and the results have implications for the evolution and specialization of the AID/APOBEC family.	[Kohli, Rahul M.; Gajula, Kiran S.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Abrams, Shaun R.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stivers, JT (corresponding author), 733 N Broadway, Baltimore, MD 21205 USA.	jstivers@jhmi.edu	Gearhart, Patricia/Y-7227-2019; Maul, Robert W./Y-6818-2019; Gajula, Kiran/I-1115-2019; Gajula, Kiran/F-5813-2010	Gajula, Kiran/0000-0002-2047-2457; Kohli, Rahul/0000-0002-7689-5678; Maul, Robert/0000-0002-6958-8514	National Institutes of Health [GM056834-13]; NIA, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM056834-13 (to J.T.S.) and by the Intramural Research Program of the NIA, National Institutes of Health.	Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183	43	105	108	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22898	22904		10.1074/jbc.M109.025536	http://dx.doi.org/10.1074/jbc.M109.025536			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19561087	hybrid, Green Published			2022-12-25	WOS:000268963100043
J	Lintern, KB; Guidato, S; Rowe, A; Saldanha, JW; Itasaki, N				Lintern, Katherine B.; Guidato, Sonia; Rowe, Alison; Saldanha, Jose W.; Itasaki, Nobue			Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TISSUE GROWTH-FACTOR; SENSITIZATION-ASSOCIATED GENE-1; BONE MORPHOGENETIC PROTEINS; CELL-DIFFERENTIATION; RESPONSE ELEMENTS; MAMMALIAN TOOTH; DIMER FORMATION; ANTAGONIST; SCLEROSTIN	Cross-talk of BMP and Wnt signaling pathways has been implicated in many aspects of biological events during embryogenesis and in adulthood. A secreted protein Wise and its orthologs (Sostdc1, USAG-1, and Ectodin) have been shown to modulate Wnt signaling and also inhibit BMP signals. Modulation of Wnt signaling activity by Wise is brought about by an interaction with the Wnt co-receptor LRP6, whereas BMP inhibition is by binding to BMP ligands. Here we have investigated the mode of action of Wise on Wnt and BMP signals. It was found that Wise binds LRP6 through one of three loops formed by the cystine knot. The Wise deletion construct lacking the LRP6-interacting loop domain nevertheless binds BMP4 and inhibits BMP signals. Moreover, BMP4 does not interfere with Wise-LRP6 binding, suggesting separate domains for the physical interaction. Functional assays also show that the ability of Wise to block Wnt1 activity through LRP6 is not impeded by BMP4. In contrast, the ability of Wise to inhibit BMP4 is prevented by additional LRP6, implying a preference of Wise in binding LRP6 over BMP4. In addition to the interaction of Wise with BMP4 and LRP6, the molecular characteristics of Wise, such as glycosylation and association with heparan sulfate proteoglycans on the cell surface, are suggested. This study helps to understand the multiple functions of Wise at the molecular level and suggests a possible role for Wise in balancing Wnt and BMP signals.	[Lintern, Katherine B.; Guidato, Sonia; Rowe, Alison; Itasaki, Nobue] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England; [Saldanha, Jose W.] Natl Inst Med Res, Div Math Biol, MRC, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Itasaki, N (corresponding author), Natl Inst Med Res, Div Dev Neurobiol, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	nitasak@nimr.mrc.ac.uk		Itasaki, Nobue/0000-0003-0587-9141	Medical Research Council (United Kingdom); MRC [MC_U117560543] Funding Source: UKRI; Medical Research Council [MC_U117560543] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Baeg GH, 2001, DEVELOPMENT, V128, P87; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bell SL, 2003, BIOCHEM J, V373, P893, DOI 10.1042/BJ20030096; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blish KR, 2008, MOL BIOL CELL, V19, P457, DOI 10.1091/mbc.E07-05-0433; Bonafede A, 2006, DEV BIOL, V299, P330, DOI 10.1016/j.ydbio.2006.02.054; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Coveney D, 2007, GENE EXPR PATTERNS, V7, P82, DOI 10.1016/j.modgep.2006.05.012; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Fischer L, 2002, J CELL BIOCHEM, V84, P816, DOI 10.1002/jcb.10091; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Guidato S, 2007, DEV BIOL, V310, P250, DOI 10.1016/j.ydbio.2007.07.033; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; ITASAKI N, 2009, DEV DYN IN PRESS; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; KELLER KM, 1989, BIOCHEMISTRY-US, V28, P8100, DOI 10.1021/bi00446a021; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Knosp WM, 2007, J BIOL CHEM, V282, P6843, DOI 10.1074/jbc.M610775200; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; O'Shaughnessy RFL, 2004, J INVEST DERMATOL, V123, P613, DOI 10.1111/j.0022-202X.2004.23410.x; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rost B, 1996, METHOD ENZYMOL, V266, P525; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shigetani Y, 2007, DEV DYNAM, V236, P2277, DOI 10.1002/dvdy.21234; Simmons DG, 2002, BIOL REPROD, V67, P1638, DOI 10.1095/biolreprod.102.006858; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thompson CC, 2006, CELL CYCLE, V5, P1913, DOI 10.4161/cc.5.17.3189; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yanagita M, 2007, THER APHER DIAL, V11, pS38, DOI 10.1111/j.1744-9987.2007.00520.x; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	77	95	101	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23159	23168		10.1074/jbc.M109.025478	http://dx.doi.org/10.1074/jbc.M109.025478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553665	hybrid, Green Published			2022-12-25	WOS:000268963100067
J	Chica, C; Diella, F; Gibson, TJ				Chica, Claudia; Diella, Francesca; Gibson, Toby J.			Evidence for the Concerted Evolution between Short Linear Protein Motifs and Their Flanking Regions	PLOS ONE			English	Article								Background: Linear motifs are short modules of protein sequences that play a crucial role in mediating and regulating many protein - protein interactions. The function of linear motifs strongly depends on the context, e. g. functional instances mainly occur inside flexible regions that are accessible for interaction. Sometimes linear motifs appear as isolated islands of conservation in multiple sequence alignments. However, they also occur in larger blocks of sequence conservation, suggesting an active role for the neighbouring amino acids. Results: The evolution of regions flanking 116 functional linear motif instances was studied. The conservation of the amino acid sequence and order/disorder tendency of those regions was related to presence/absence of the instance. For the majority of the analysed instances, the pairs of sequences conserving the linear motif were also observed to maintain a similar local structural tendency and/or to have higher local sequence conservation when compared to pairs of sequences where one is missing the linear motif. Furthermore, those instances have a higher chance to co-evolve with the neighbouring residues in comparison to the distant ones. Those findings are supported by examples where the regulation of the linear motif - mediated interaction has been shown to depend on the modifications ( e. g. phosphorylation) at neighbouring positions or is thought to benefit from the binding versatility of disordered regions. Conclusion: The results suggest that flanking regions are relevant for linear motif - mediated interactions, both at the structural and sequence level. More interestingly, they indicate that the prediction of linear motif instances can be enriched with contextual information by performing a sequence analysis similar to the one presented here. This can facilitate the understanding of the role of these predicted instances in determining the protein function inside the broader context of the cellular network where they arise.			Chica, C (corresponding author), EMBL Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany.	chica@embl.de		Gibson, Toby James/0000-0003-0657-5166; Chica, Claudia/0000-0002-3758-640X				Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Chica C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-229; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dinkel H, 2007, BIOINFORMATICS, V23, P3297, DOI 10.1093/bioinformatics/btm524; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; GIBSON T, 2009, TRENDS BIOC IN PRESS; Gutman R, 2005, NUCLEIC ACIDS RES, V33, pW255, DOI 10.1093/nar/gki496; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Perrodou E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-213; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Takei K, 2005, J BIOCHEM, V137, P243, DOI 10.1093/jb/mvi052; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	43	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6052	10.1371/journal.pone.0006052	http://dx.doi.org/10.1371/journal.pone.0006052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584925	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806500001
J	Fricke, S; Ackermann, M; Stolzing, A; Schimmelpfennig, C; Hilger, N; Jahns, J; Hildebrandt, G; Emmrich, F; Ruschpler, P; Posel, C; Kamprad, M; Sack, U				Fricke, Stephan; Ackermann, Manuela; Stolzing, Alexandra; Schimmelpfennig, Christoph; Hilger, Nadja; Jahns, Jutta; Hildebrandt, Guido; Emmrich, Frank; Ruschpler, Peter; Poesel, Claudia; Kamprad, Manja; Sack, Ulrich			Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment	PLOS ONE			English	Article								Background: Non adherent bone marrow derived cells (NA-BMCs) have recently been described to give rise to multiple mesenchymal phenotypes and have an impact in tissue regeneration. Therefore, the effects of murine bone marrow derived NA-BMCs were investigated with regard to engraftment capacities in allogeneic and syngeneic stem cell transplantation using transgenic, human CD4(+), murine CD4(-/-), HLA-DR3(+) mice. Methodology/Principal Findings: Bone marrow cells were harvested from C57Bl/6 and Balb/c wild-type mice, expanded to NA-BMCs for 4 days and characterized by flow cytometry before transplantation in lethally irradiated recipient mice. Chimerism was detected using flow cytometry for MHC-I (H-2D[b], H-2K[d]), mu/huCD4, and huHLA-DR3). Culturing of bone marrow cells in a dexamethasone containing DMEM medium induced expansion of non adherent cells expressing CD11b, CD45, and CD90. Analysis of the CD45(+) showed depletion of CD4(+), CD8(+), CD19(+), and CD117(+) cells. Expanded syngeneic and allogeneic NA-BMCs were transplanted into triple transgenic mice. Syngeneic NA-BMCs protected 83% of mice from death (n = 8, CD4(+) donor chimerism of 5.8 +/- 62.4% [day 40], P < 001). Allogeneic NA-BMCs preserved 62.5% (n = 8) of mice from death without detectable hematopoietic donor chimerism. Transplantation of syngeneic bone marrow cells preserved 100%, transplantation of allogeneic bone marrow cells 33% of mice from death. Conclusions/Significance: NA-BMCs triggered endogenous hematopoiesis and induced faster recovery compared to bone marrow controls. These findings may be of relevance in the refinement of strategies in the treatment of hematological malignancies.			Fricke, S (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany.	stephan.fricke@izi.fraunhofer.de	Stolzing, Alexandra/O-7815-2016; Fricke, Stephan/AAF-1629-2021; Sack, Ulrich/J-6301-2015; Stolzing, Alexandra/S-4208-2019	Stolzing, Alexandra/0000-0002-2975-5736; Sack, Ulrich/0000-0002-7813-0492; Stolzing, Alexandra/0000-0002-2975-5736				Aschan J, 2006, BRIT MED BULL, V77-78, P23, DOI 10.1093/bmb/ldl005; Bacigalupo Andrea, 2002, Haematologica, V87, P4; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; CLARKE E, 1991, EUR J HAEMATOL, V46, P296; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; DE RT, 1994, BLOOD, V83, P3795; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Epperly MW, 2005, EXP HEMATOL, V33, P353, DOI 10.1016/j.exphem.2004.11.010; Ferrara JLM, 2007, BEST PRACT RES CL HA, V20, P91, DOI 10.1016/j.beha.2006.11.004; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FRIEDENSTEIN AJ, 1992, BONE MINER, V18, P199, DOI 10.1016/0169-6009(92)90807-P; Handgretinger R, 2008, CYTOTHERAPY, V10, P443, DOI 10.1080/14653240802251507; Ho VT, 2008, BONE MARROW TRANSPL, V41, P229, DOI 10.1038/sj.bmt.1705899; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Kim JY, 2005, ONCOL REP, V13, P1177; Laub R, 1999, J EXP ANIM SCI, V39, P122; Laub R, 2001, TRANSPL P, V33, P2182, DOI 10.1016/S0041-1345(01)01934-0; Laub R, 2000, J IMMUNOL METHODS, V246, P37, DOI 10.1016/S0022-1759(00)00288-X; Ma Li-Jun, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P684; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; Martino R, 2000, HAEMATOLOGICA, V85, P1165; RICKARD DJ, 1995, BONE, V16, P671, DOI 10.1016/8756-3282(95)00099-Y; SCUTT A, 1995, PROSTAGLANDINS, V49, P383, DOI 10.1016/0090-6980(95)00070-Q; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Spargo LDJ, 2006, INT IMMUNOL, V18, P897, DOI 10.1093/intimm/dxl026; SPRANGERS B, 2008, LEUKEMIA; Stagg J., 2007, V180, P45; 't Anker PS, 2003, EXP HEMATOL, V31, P881, DOI 10.1016/S0301-472X(03)00202-9; Tamura K, 2008, DRUG TODAY, V44, P515, DOI 10.1358/dot.2008.44.7.1230943; Thalmeier K, 2001, CYTOTHERAPY, V3, P245, DOI 10.1080/146532401317070871; Tokcaer-Keskin Z, 2009, CAN J PHYSIOL PHARM, V87, P143, DOI 10.1139/Y08-111; Tschetter JR, 2000, J IMMUNOL, V165, P5987, DOI 10.4049/jimmunol.165.10.5987; Wlodarski KH, 2004, FOLIA BIOL-PRAGUE, V50, P167; ZHANG ZL, 2008, BONE MARROW TRANSPLA; Zhu Guang-Rong, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P115	38	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6157	10.1371/journal.pone.0006157	http://dx.doi.org/10.1371/journal.pone.0006157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582154	gold, Green Published, Green Submitted			2022-12-25	WOS:000267806400012
J	Xu, HY; Li, ZD; Li, MY; Wang, L; Hong, YH				Xu, Hongyan; Li, Zhendong; Li, Mingyou; Wang, Li; Hong, Yunhan			Boule Is Present in Fish and Bisexually Expressed in Adult and Embryonic Germ Cells of Medaka	PLOS ONE			English	Article								Background: The DAZ family genes boule, daz and dazl encode RNA binding proteins essential for fertility of diverse animals including human. dazl has bisexual expression in both mitotic and meiotic germ cells, whereas daz has male premeiotic expression, and boule is largely a unisexual meiotic regulator. Although boule has been proposed as the ancestor for dazl/daz by gene duplication, it has been identified only in invertebrates and mammals. It has, however, remained unclear when and how the DAZ family has evolved in vertebrates. Methodology and Principal Findings: This study was aimed at identifying and characterizing the DAZ family genes in fish as the basal vertebrate. We show that boule and dazl coexist in medaka and stickleback. Similar to the medaka dazl (Odazl), the medaka boule (Obol) is maternally supplied and segregates with primordial germ cells. Surprisingly, Obol is expressed in adult germ cells at pre-meiotic and meiotic stages of spermatogenesis and oogenesis. However, the maximal meiotic Obol expression in spermatocytes contrasts with the predominant pre-meiotic Odazl expression in spermatogonia, and the diffuse cytoplasmic Obol distribution in early oocytes contrasts with the Odazl concentration in the Balbinani's body. Conclusions: The identification of fish boule and dazl genes provides direct evidence for the early gene duplication during vertebrate evolution. Our finding that Obol exhibits bisexual expression in both embryonic and adult germ cells considerably extends the diversity of boule expression patterns and offers a new insight into the evolutions of DAZ family members, expression patterns and functions in animal fertility.			Xu, HY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009; Test Account, SLB-WOS/E-5790-2010	Li, Mingyou/0000-0002-8729-7964				Aizawa K, 2003, GENE EXPR PATTERNS, V3, P43, DOI 10.1016/S1567-133X(02)00075-3; Brekhman V, 2000, MOL HUM REPROD, V6, P465, DOI 10.1093/molehr/6.5.465; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Cheng MH, 1998, DEV BIOL, V204, P567, DOI 10.1006/dbio.1998.9098; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Elis S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-110; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Houston DW, 1998, DEVELOPMENT, V125, P171; Houston DW, 2000, DEVELOPMENT, V127, P447; Huang WJ, 2008, HUM REPROD, V23, P1280, DOI 10.1093/humrep/den099; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; IWAMATSU T, 1988, ZOOL SCI, V5, P20; Johnson AD, 2001, DEV BIOL, V234, P402, DOI 10.1006/dbio.2001.0264; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Li MY, 2009, MECH DEVELOP, V126, P366, DOI 10.1016/j.mod.2009.02.004; LIU LX, 2009, GENE EXPR P IN PRESS; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; Maruyama R, 2005, DEV BIOL, V277, P142, DOI 10.1016/j.ydbio.2004.08.053; Mita K, 2000, MECH DEVELOP, V94, P251, DOI 10.1016/S0925-4773(00)00295-1; Muller F, 2005, ZEBRAFISH, V2, P47, DOI 10.1089/zeb.2005.2.47; Niederberger C, 1997, MAMM GENOME, V8, P277, DOI 10.1007/s003359900409; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Otori M, 2006, MOL BIOL CELL, V17, P3147, DOI 10.1091/mbc.E05-11-1067; PENG J, 2009, J EXPT ZOOLOGY MOL B, V312, P17; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Xu HY, 2007, GENE EXPR PATTERNS, V7, P332, DOI 10.1016/j.modgep.2006.08.001; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; YAN Y, 2009, EXP CELL RE IN PRESS; Zhang QB, 2009, MOL GENET GENOMICS, V281, P67, DOI 10.1007/s00438-008-0394-6	46	65	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6097	10.1371/journal.pone.0006097	http://dx.doi.org/10.1371/journal.pone.0006097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564913	Green Published, gold, Green Submitted			2022-12-25	WOS:000267515700015
J	Marq, JB; Hausmann, S; Luban, J; Kolakofsky, D; Garcin, D				Marq, Jean-Baptiste; Hausmann, Stephane; Luban, Jeremy; Kolakofsky, Daniel; Garcin, Dominique			The Double-stranded RNA Binding Domain of the Vaccinia Virus E3L Protein Inhibits Both RNA- and DNA-induced Activation of Interferon beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PKR; RIG-I; RECOGNITION; RESPONSES; GENE; CELLS; EXPRESSION; RECEPTORS; INDUCTION; PROMOTER	Vaccinia virus, a large DNA virus that replicates in the cytoplasm, expresses its E3L protein to inhibit the cellular innate immune response and apoptosis. E3L is a bifunctional protein that contains an N-terminal DNA binding domain (BD) and a C-terminal double-stranded RNA (dsRNA)-BD (residues 100 190), both of which contribute to viral pathogenesis by blocking the activation of cellular genes that respond to the viral infection. We report that expression of the dsRNA-BD alone inhibits not only the dsRNA-induced activation of interferon beta(IFN beta) but also that of 5'-triphosphate single-stranded RNA and DNA-induced IFN beta activation even though E3L(100-190) does not bind the latter two pathogen-associated molecular patterns. This inhibition occurs in both human HeLa and A549 cells, where RIG-I appears to be required for dsDNA-induced IFN beta activation. Unexpectedly, the two residues most important for dsRNA binding are also critical for this domain's ability to inhibit all three nucleic acid-induced cellular responses.	[Marq, Jean-Baptiste; Hausmann, Stephane; Luban, Jeremy; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland	University of Geneva	Kolakofsky, D (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, 9 Ave Champel, CH-1211 Geneva, Switzerland.	Daniel.kolakofsky@unige.ch		Luban, Jeremy/0000-0001-5650-4054				Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Ho CK, 1996, VIROLOGY, V217, P272, DOI 10.1006/viro.1996.0114; Ho CK, 1996, J VIROL, V70, P2611, DOI 10.1128/JVI.70.4.2611-2614.1996; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; KING P, 1994, J BIOL CHEM, V269, P30609; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Strahle L, 2003, J VIROL, V77, P7903, DOI 10.1128/JVI.77.14.7903-7913.2003; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; VORLICKOVA M, 1985, J BIOMOL STRUCT DYN, V3, P67, DOI 10.1080/07391102.1985.10508399; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	35	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25471	25478		10.1074/jbc.M109.018895	http://dx.doi.org/10.1074/jbc.M109.018895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19584049	Green Published, hybrid			2022-12-25	WOS:000269738000004
J	Mahmoodzadeh, S; Fritschka, S; Dworatzek, E; Pham, TH; Becher, E; Kuehne, A; Davidson, MM; Regitz-Zagrosek, V				Mahmoodzadeh, Shokoufeh; Fritschka, Stephan; Dworatzek, Elke; Pham, Thi H.; Becher, Eva; Kuehne, Arne; Davidson, Mercy M.; Regitz-Zagrosek, Vera			Nuclear Factor-kappa B Regulates Estrogen Receptor-alpha-Transcription in the Human Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; HUMAN ER-ALPHA; UP-REGULATION; VENTRICULAR CARDIOMYOCYTES; DIFFERENTIAL REGULATION; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; OSTEOBLASTIC CELLS; PROMOTER USAGE; IN-VIVO	Estrogen receptor (ER)-mediated effects have been associated with the modulation of myocardial hypertrophy in animal models and in humans, but the regulation of ER expression in the human heart has not yet been analyzed. In various cell lines and tissues, multiple human estrogen receptor alpha (hER alpha) mRNA isoforms are transcribed from distinct promoters and differ in their 5'-untranslated regions. Using PCR-based strategies, we show that in the human heart the ER alpha mRNA is transcribed from multiple promoters, namely, A, B, C, and F, of which the F-promoter is most frequently used variant. Transient transfection reporter assays in a human cardiac myocyte cell line (AC16) with F-promoter deletion constructs demonstrated a negative regulatory region within this promoter. Site-directed mutagenesis and electrophoretic mobility shift assays indicated that NF-kappa B binds to this region. An inhibition of NF-kappa B activity by parthenolide significantly increased the transcriptional activity of the F-promoter. Increasing NF-kappa B expression by tumor necrosis factor-alpha reduced the expression of ER alpha, indicating that the NF-kappa B pathway inhibits expression of ER alpha in human cardiomyocytes. Finally, 17 beta-estradiol induced the transcriptional activity of hER alpha promoters A, B, C, and F. In conclusion, inflammatory stimuli suppress hER alpha expression via activation and subsequent binding of NF-kappa B to the ER alpha F-promoter, and 17 beta-estradiol/hER alpha may antagonize the inhibitory effect of NF-kappa B. This suggests interplay between estrogen/estrogen receptors and the pro-hypertrophic and inflammatory responses to NF-kappa B.	[Mahmoodzadeh, Shokoufeh] Charite, Inst Gender Med, Cardiovasc Res Ctr, D-10115 Berlin, Germany; [Regitz-Zagrosek, Vera] German Heart Inst, D-13353 Berlin, Germany; [Davidson, Mercy M.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10032 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; Columbia University	Mahmoodzadeh, S (corresponding author), Charite, Inst Gender Med, Cardiovasc Res Ctr, Hess Str 3-4, D-10115 Berlin, Germany.	s.mahmoodzadeh@charite.de		Regitz-Zagrosek, Vera/0000-0002-3566-3467; Mahmoodzadeh, Shokoufeh/0000-0002-3094-7874; Becher, Eva/0000-0003-0861-6208	Nationales Genom Forschungsnetz; Deutsche Forschungsgemeinschaft [GRK 754, FG 1054, RE 662/6-1]	Nationales Genom Forschungsnetz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Nationales Genom Forschungsnetz and the Deutsche Forschungsgemeinschaft (GRK 754, FG 1054, RE 662/6-1).	Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Brand K, 1997, EXP PHYSIOL, V82, P297, DOI 10.1113/expphysiol.1997.sp004025; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; CHO HS, 1991, MOL ENDOCRINOL, V5, P1323, DOI 10.1210/mend-5-9-1323; Clayton SJ, 1997, MOL CELL ENDOCRINOL, V128, P57, DOI 10.1016/S0303-7207(96)04016-6; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Denger S, 2001, MOL CELL ENDOCRINOL, V178, P155, DOI 10.1016/S0303-7207(01)00417-8; Donaghue C, 1999, MOL ENDOCRINOL, V13, P1934, DOI 10.1210/me.13.11.1934; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Evans MJ, 2001, CIRC RES, V89, P823, DOI 10.1161/hh2101.098543; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; FREYSCHUSS B, 1994, J ENDOCRINOL, V142, P285, DOI 10.1677/joe.0.1420285; Grandien K, 1996, MOL CELL ENDOCRINOL, V116, P207, DOI 10.1016/0303-7207(95)03716-0; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Holloway JN, 2004, MOL ENDOCRINOL, V18, P1396, DOI 10.1210/me.2004-0048; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Kawano S, 2006, AM J PHYSIOL-HEART C, V291, pH1337, DOI 10.1152/ajpheart.01175.2005; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Lambertini E, 2003, BIOCHEM J, V372, P831, DOI 10.1042/BJ20021633; Lambertini E, 2007, EXP CELL RES, V313, P1548, DOI 10.1016/j.yexcr.2007.02.002; Lentsch AB, 2000, J PATHOL, V190, P343; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Medina RA, 2003, BIOL RES, V36, P325, DOI 10.4067/S0716-97602003000300005; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Nordmeyer J, 2004, CIRCULATION, V110, P3270, DOI 10.1161/01.CIR.0000147610.41984.E8; O'Donnell SM, 2005, J CLIN INVEST, V115, P2341, DOI 10.1172/JCI22428; Okuda Y, 2003, ENDOCR J, V50, P97, DOI 10.1507/endocrj.50.97; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Pelligrino DA, 2001, JPN J PHARMACOL, V86, P137, DOI 10.1254/jjp.86.137; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Penolazzi L, 2004, J STEROID BIOCHEM, V91, P1, DOI 10.1016/j.jsbmb.2004.02.005; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Ropero AB, 2006, J MOL CELL CARDIOL, V41, P496, DOI 10.1016/j.yjmcc.2006.05.022; Sasaki H, 1999, ANTIOXID REDOX SIGN, V1, P317, DOI 10.1089/ars.1999.1.3-317; Schuur ER, 2001, J BIOL CHEM, V276, P15519, DOI 10.1074/jbc.M009001200; SHUPNIK MA, 1989, MOL ENDOCRINOL, V3, P660, DOI 10.1210/mend-3-4-660; Simoncini T, 2002, CIRCULATION, V105, P1368, DOI 10.1161/hc1102.105267; Tang ZQ, 1997, MOL CELL BIOL, V17, P1274, DOI 10.1128/MCB.17.3.1274; Tanimoto K, 1999, NUCLEIC ACIDS RES, V27, P903, DOI 10.1093/nar/27.3.903; Thompson DA, 1997, J STEROID BIOCHEM, V62, P143, DOI 10.1016/S0960-0760(97)00029-0; Treilleux I, 1997, MOL ENDOCRINOL, V11, P1319, DOI 10.1210/me.11.9.1319; Venkov CD, 1996, CIRCULATION, V94, P727, DOI 10.1161/01.CIR.94.4.727	53	22	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24705	24714		10.1074/jbc.M109.000463	http://dx.doi.org/10.1074/jbc.M109.000463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584059	hybrid, Green Published			2022-12-25	WOS:000269734000005
J	Ng, SW; Nelson, C; Parekh, AB				Ng, Siaw-Wei; Nelson, Charmaine; Parekh, Anant B.			Coupling of Ca2+ Microdomains to Spatially and Temporally Distinct Cellular Responses by the Tyrosine Kinase Syk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CRAC CHANNELS; MAST-CELLS; GENE-EXPRESSION; C-FOS; CALCIUM; RELEASE; INFLUX; HOMEOSTASIS; SELECTIVITY; ACTIVATION	Communication between the cell surface and the nucleus is essential for regulated gene expression. In neurons, Ca2+-dependent gene transcription is sensitive to local Ca2+ entry. In immune cells, excitation-transcription coupling is thought to involve global Ca2+ signals. Here, we show that in mast cells, Ca2+ microdomains from store-operated Ca2+ release-activated Ca2+ channels activate expression of the transcription factor c-fos. Local Ca2+ entry is sensed by the tyrosine kinase Syk, which signals to the nucleus through the transcription factor STAT5. Ca2+ microdomains also promote secretion of proinflammatory messengers, which, like gene expression, requires Syk. Syk therefore couples Ca2+ microdomains to the activation of two spatially and temporally distinct cellular responses, revealing the versatility of local Ca2+ signals in driving cell activation.	[Ng, Siaw-Wei; Nelson, Charmaine; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; MRC [G0601485] Funding Source: UKRI; Medical Research Council [G0601485] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council program grant (to A.B.P.).	Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Lee YN, 2004, J IMMUNOL, V173, P2571, DOI 10.4049/jimmunol.173.4.2571; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Parekh AB, 2007, CELL CALCIUM, V42, P111, DOI 10.1016/j.ceca.2007.02.012; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Straube S, 2002, PFLUG ARCH EUR J PHY, V444, P389, DOI 10.1007/s00424-002-0812-2; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	29	112	114	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24767	24772		10.1074/jbc.M109.011692	http://dx.doi.org/10.1074/jbc.M109.011692			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584058	hybrid, Green Published			2022-12-25	WOS:000269734000011
J	Ronen, D; Ravid, S				Ronen, Daniel; Ravid, Shoshana			Myosin II Tailpiece Determines Its Paracrystal Structure, Filament Assembly Properties, and Cellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ISOFORMS; CASEIN KINASE-II; SMOOTH-MUSCLE; COILED-COIL; NONMUSCLE; PHOSPHORYLATION; ROD; CYTOKINESIS; MECHANISMS; EXPRESSION	Non muscle myosin II (NMII) is a major motor protein present in all cell types. The three known vertebrate NMII isoforms share high sequence homology but play different cellular roles. The main difference in sequence resides in the C-terminal non-helical tailpiece (tailpiece). In this study we demonstrate that the tailpiece is crucial for proper filament size, overcoming the intrinsic properties of the coiled-coil rod. Furthermore, we show that the tailpiece by itself determines the NMII filament structure in an isoform-specific manner, thus providing a possible mechanism by which each NMII isoform carries out its unique cellular functions. We further show that the tailpiece determines the cellular localization of NMII-A and NMII-B and is important for NMII-C role in focal adhesion complexes. We mapped NMII-C sites phosphorylated by protein kinase C and casein kinase II and showed that these phosphorylations affect its solubility properties and cellular localization. Thus phosphorylation fine-tunes the tailpiece effects on the coiled-coil rod, enabling dynamic regulation of NMII-C assembly. We thus show that the small tailpiece of NMII is a distinct domain playing a role in isoform-specific filament assembly and cellular functions.	[Ronen, Daniel; Ravid, Shoshana] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res,Israel Canada, IL-91220 Jerusalem, Israel	Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res,Israel Canada, IL-91220 Jerusalem, Israel.	shoshr@ekmd.huji.ac.il						ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Clark K, 2008, FEBS LETT, V582, P2993, DOI 10.1016/j.febslet.2008.07.043; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; KELLEY CA, 1990, J BIOL CHEM, V265, P17876; KENDRICKJONES J, 1971, J MOL BIOL, V59, P527, DOI 10.1016/0022-2836(71)90316-0; Kolega J, 1999, CELL MOTIL CYTOSKEL, V43, P255, DOI 10.1002/(SICI)1097-0169(1999)43:3<255::AID-CM8>3.0.CO;2-T; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kubo T, 2008, J NEUROCHEM, V105, P113, DOI 10.1111/j.1471-4159.2007.05125.x; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rovner AS, 2002, J CELL BIOL, V156, P113, DOI 10.1083/jcb.200107131; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Sandquist JC, 2008, MOL BIOL CELL, V19, P5156, DOI 10.1091/mbc.E08-05-0533; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers J. R., 1999, MYOSINS; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Straussman R, 2001, J CELL SCI, V114, P3047; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744	47	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24948	24957		10.1074/jbc.M109.023754	http://dx.doi.org/10.1074/jbc.M109.023754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19553683	Green Published, hybrid			2022-12-25	WOS:000269734000029
J	Reis-Sobreiro, M; Gajate, C; Mollinedo, F				Reis-Sobreiro, M.; Gajate, C.; Mollinedo, F.			Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions	ONCOGENE			English	Article						lipid rafts; Fas/CD95 signaling; mitochondrial transmembrane potential; multiple myeloma; T-cell leukemia; resveratrol	DEATH-RECEPTOR; MULTIPLE-MYELOMA; SELECTIVE APOPTOSIS; CANCER; FAS; CELLS; EDELFOSINE; COMPLEX; REDISTRIBUTION; ACTIVATION	We have found that resveratrol (trans-3,4',5-trihydroxystilbene) induced apoptosis in multiple myeloma (MM) and T-cell leukemia cells through coclustering of Fas/CD95 death receptor and lipid rafts, whereas normal lymphocytes were spared. Tumor necrosis factor-related apoptosis-inducing ligand receptors, Fas-associated death domain-containing protein (FADD), procaspase-8, procaspase-10, c-Jun amino-terminal kinase and Bid were also recruited into lipid rafts on resveratrol incubation with MM and T-cell leukemia cells. Raft disruption inhibited resveratrol-induced apoptosis. Bcl-X-L overexpression prevented resveratrol-induced disruption of mitochondrial transmembrane potential (Delta Psi(m)) and apoptosis. A FADD dominant-negative mutant, that blocked Fas/CD95 downstream signaling, precluded resveratrol-induced Delta Psi(m) loss and apoptosis, indicating a sequence of Fas/CD95 signaling -> mitochondrion in the apoptotic response triggered by resveratrol. Cells deficient in Fas/CD95 did not undergo resveratrol-induced apoptosis. Pretreatment of MM cells with interferon-gamma upregulated Fas/CD95 and caspase-8, and potentiated resveratrol-induced apoptosis. Our data indicate that recruitment of Fas/CD95 death receptor and downstream signaling molecules into lipid rafts, followed by Delta Psi(m) disruption, underlies the apoptotic action of resveratrol in MM and T-cell leukemic cells. Combination of resveratrol with perifosine or bortezomib potentiated the apoptotic response induced by each single drug. These results also highlight the role of recruitment of Fas/CD95 signaling in lipid rafts in antimyeloma and antileukemia chemotherapy. Oncogene (2009) 28, 3221-3234; doi: 10.1038/onc.2009.183; published online 29 June 2009	[Reis-Sobreiro, M.; Gajate, C.; Mollinedo, F.] Univ Salamanca, Inst Biol Mol & Celular Canc, Ctr Invest Canc, CSIC, E-37007 Salamanca, Spain; [Gajate, C.] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Mollinedo, F (corresponding author), Univ Salamanca, Inst Biol Mol & Celular Canc, Ctr Invest Canc, CSIC, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	fmollin@usal.es	2009, Secribsal/A-1266-2012	Gajate, Consuelo/0000-0003-0604-6459; Reis Sobreiro, Mariana/0000-0003-0286-0824	Ministerio de Ciencia e Innovacion [SAF2008-02251, SAF2005-04293, RD06/0020/1037]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria and European Commission [FIS-FEDER 06/0813, 04/0843]; Junta de Castilla y Leon [CSI01A08, SAN673/SA32/08]; Experimental Therapeutics and Translational Oncology Program [GR15]; Fundacion de Investigacion Medica Mutua Madrilena (FMM); Fundacion 'la Caixa' [BM05-30-0]; Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior of Portugal); Ministerio de Ciencia e Innovacion of Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria and European Commission(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); Experimental Therapeutics and Translational Oncology Program; Fundacion de Investigacion Medica Mutua Madrilena (FMM); Fundacion 'la Caixa'(La Caixa Foundation); Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior of Portugal)(Portuguese Foundation for Science and Technology); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-02251, SAF2005-04293, RD06/0020/1037-Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III), Fondo de Investigacion Sanitaria and European Commission (FIS-FEDER 06/0813, 04/0843), Junta de Castilla y Leon (CSI01A08, SAN673/SA32/08, and GR15-Experimental Therapeutics and Translational Oncology Program), Fundacion de Investigacion Medica Mutua Madrilena (FMM) and Fundacion 'la Caixa' (BM05-30-0). MRS is recipient of a predoctoral fellowship from the Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior of Portugal). CG is supported by the Ramon y Cajal Program from the Ministerio de Ciencia e Innovacion of Spain. We thank Lienhard Schmitz (University of Bern, Switzerland) for providing the stably transfected Jurkat FADD-DN cell line.	Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Aziz MH, 2003, INT J ONCOL, V23, P17; Barille-Nion Sophie, 2003, Hematology Am Soc Hematol Educ Program, P248; Barjot C, 2007, LIFE SCI, V81, P1565, DOI 10.1016/j.lfs.2007.08.047; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Cabaner C, 1999, BRIT J PHARMACOL, V127, P813, DOI 10.1038/sj.bjp.0702606; Christian AE, 1997, J LIPID RES, V38, P2264; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Fulda S, 2005, EUR J CANCER, V41, P786, DOI 10.1016/j.ejca.2004.12.020; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gajate C, 2003, CLIN CANCER RES, V9, P1535; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Gajate C, 2009, BIOCHEM BIOPH RES CO, V380, P780, DOI 10.1016/j.bbrc.2009.01.147; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hofmann TG, 2001, INT J CANCER, V93, P185, DOI 10.1002/ijc.1316; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Lonial S, 2007, CLIN LYMPHOMA MYELOM, V8, pS18, DOI 10.3816/CLM.2007.s.029; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MOLLINEDO F, 1992, J IMMUNOL, V149, P323; Mollinedo F, 2007, EXPERT OPIN THER PAT, V17, P385, DOI 10.1517/13543776.17.4.385; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mollinedo Faustino, 2006, P13; Nieto-Miguel T, 2008, ONCOGENE, V27, P1779, DOI 10.1038/sj.onc.1210816; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; SHIMA Y, 1995, BLOOD, V85, P757, DOI 10.1182/blood.V85.3.757.bloodjournal853757; WESTENDORF JJ, 1995, BLOOD, V85, P3566, DOI 10.1182/blood.V85.12.3566.bloodjournal85123566	36	72	73	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3221	3234		10.1038/onc.2009.183	http://dx.doi.org/10.1038/onc.2009.183			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19561642				2022-12-25	WOS:000269673400005
J	Chaturvedi, D; Cohen, MS; Taunton, J; Patel, TB				Chaturvedi, Deepti; Cohen, Michael S.; Taunton, Jack; Patel, Tarun B.			The PKARI alpha Subunit of Protein Kinase A Modulates the Activation of p90(RSK1) and Its Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; CANCER-CELL-PROLIFERATION; AKAP SIGNALING COMPLEXES; CARNEY COMPLEX; REGULATORY SUBUNIT; ANCHORING PROTEIN; DOCKING SITE; ENDOCRINE OVERACTIVITY; SPOTTY PIGMENTATION; CATALYTIC SUBUNIT	Previously, we showed that interactions between p90(RSK1) (RSK1) and the subunits of type I protein kinase A (PKA) regulate the activity of PKA and cellular distribution of active RSK1 (Chaturvedi, D., Poppleton, H. M., Stringfield, T., Barbier, A., and Patel, T. B. (2006) Mol. Cell Biol. 26, 4586-4600). Here we examined the role of the PKARI alpha subunit of PKA in regulating RSK1 activation and cell survival. In mouse lung fibroblasts, silencing of the PKARI alpha increased the phosphorylation and activation of RSK1, but not of RSK2 and RSK3, in the absence of any stimulation. Silencing of PKARI alpha also decreased the nuclear accumulation of active RSK1 and increased its cytoplasmic content. The increased activation of RSK1 in the absence of any agonist and changes in its subcellular redistribution resulted in increased phosphorylation of its cytoplasmic substrate BAD and increased cell survival. The activity of PKA and phosphorylation of BAD (Ser-155) were also enhanced when PKARI alpha was silenced, and this, in part, contributed to increased cell survival in unstimulated cells. Furthermore, we show that RSK1, PKA subunits, D-AKAP1, and protein phosphatase 2A catalytic subunit (PP2Ac) exist in a complex, and dissociation of RSK1 from D-AKAP1 by either silencing of PKARI alpha, depletion of D-AKAP1, or by using a peptide that competes with PKARI alpha for binding to AKAPs, decreased the amount of PP2Ac in the RSK1 complex. We also demonstrate that PP2Ac is one of the phosphatases that dephosphorylates RSK, but not ERK1/2. Thus, in unstimulated cells, the increased phosphorylation and activation of RSK1 after silencing of PKARI alpha or depletion of D-AKAP1 are due to decreased association of PP2Ac in the RSK1 complex.	[Chaturvedi, Deepti; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Cohen, Michael S.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Loyola University Chicago; University of California System; University of California San Francisco	Patel, TB (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM 073181, GM 071434, AHA-ID-0830411Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434, R01GM073181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 073181 (to T. B. P.), GM 071434 (to J. T.), and AHA-ID-0830411Z (to D. C.).	Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Alto NM, 2004, CELL BIOCHEM BIOPHYS, P201; Boikos SA, 2007, CURR OPIN ONCOL, V19, P24, DOI 10.1097/CCO.0b013e32801195eb; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; CARNEY JA, 1995, SEMIN DERMATOL, V14, P90, DOI 10.1016/S1085-5629(05)80003-3; CARNEY JA, 1986, MAYO CLIN PROC, V61, P165, DOI 10.1016/S0025-6196(12)61843-6; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Clark DE, 2005, CANCER RES, V65, P3108; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Deng WL, 2004, J BIOL CHEM, V279, P47871, DOI 10.1074/jbc.M405443200; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Griffin KJ, 2004, CANCER RES, V64, P8811, DOI 10.1158/0008-5472.CAN-04-3620; Horvath A, 2008, CLIN CANCER RES, V14, P388, DOI 10.1158/1078-0432.CCR-07-1155; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Jin ZH, 2004, J BIOL CHEM, V279, P23837, DOI 10.1074/jbc.M402566200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Robinson-White AJ, 2008, J CLIN ENDOCR METAB, V93, P1020, DOI 10.1210/jc.2007-2331; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Veugelers M, 2004, P NATL ACAD SCI USA, V101, P14222, DOI 10.1073/pnas.0405535101; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; ZHAO Y, 1995, MOL CELL BIOL, V15, P4353; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200	47	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23670	23681		10.1074/jbc.M109.032813	http://dx.doi.org/10.1074/jbc.M109.032813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570980	hybrid, Green Published			2022-12-25	WOS:000269180000053
J	Hung, HC; Maurer, C; Zorn, D; Chang, WL; Weber, F				Hung, Hsiu-Cheng; Maurer, Christian; Zorn, Daniela; Chang, Wai-Ling; Weber, Frank			Sequential and Compartment-specific Phosphorylation Controls the Life Cycle of the Circadian CLOCK Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PER-TIM COMPLEX; E-BOX BINDING; DROSOPHILA CLOCK; POSTTRANSLATIONAL REGULATION; LIMITING AMOUNTS; TRANSCRIPTION; NUCLEAR; BMAL1; EXPRESSION; TIMELESS	The circadian clock facilitates a temporal coordination of most homeostatic activities and their synchronization with the environmental cycles of day and night. The core oscillating activity of the circadian clock is formed by a heterodimer of the transcription factors CLOCK (CLK) and CYCLE (CYC). Posttranslational regulation of CLK/CYC has previously been shown to be crucial for clock function and accurate timing of circadian transcription. Here we report that a sequential and compartment-specific phosphorylation of the Drosophila CLK protein assigns specific localization and activity patterns. Total and nuclear amounts of CLK protein were found to oscillate over the course of a day in circadian neurons. Detailed analysis of the cellular distribution and phosphorylation of CLK revealed that newly synthesized CLK is hypophosphorylated in the cytoplasm prior to nuclear import. In the nucleus, CLK is converted into an intermediate phosphorylation state that correlates with transactivation of circadian transcription. Hyperphosphorylation and degradation are promoted by nuclear export of the CLK protein. Surprisingly, CLK localized to discrete nuclear foci in cell culture as well as in circadian neurons of the larval brain. These subnuclear sites likely contain a storage form of the transcription factor, while homogeneously distributed nuclear CLK appears to be the transcriptionally active form. These results show that sequential post-translational modifications and subcellular distribution regulate the activity of the CLK protein, indicating a core post-translational timing mechanism of the circadian clock.	[Hung, Hsiu-Cheng; Maurer, Christian; Zorn, Daniela; Chang, Wai-Ling; Weber, Frank] Univ Heidelberg, Biochem Ctr Heidelberg BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Weber, F (corresponding author), Univ Heidelberg, Biochem Ctr Heidelberg BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	Frank.Weber@bzh.uni-heidelberg.de			Emmy-Noether [WE2608/1-3]; Deutsche Forschungsgemeinschaft [WE2608/2-1]	Emmy-Noether(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Emmy-Noether Grant WE2608/1-3 and by Grant WE2608/2-1 of the Deutsche Forschungsgemeinschaft (to F. W.).	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Ashmore LJ, 2003, J NEUROSCI, V23, P7810; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Hung HC, 2009, J BIOL RHYTHM, V24, P183, DOI 10.1177/0748730409333171; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Maurer C, 2009, FEBS LETT, V583, P1561, DOI 10.1016/j.febslet.2009.04.013; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07; Weber F, 2003, FEBS LETT, V555, P341, DOI 10.1016/S0014-5793(03)01269-9; Weber F, 2006, J NEUROCHEM, V98, P248, DOI 10.1111/j.1471-4159.2006.03865.x; Weber F, 2009, NATURWISSENSCHAFTEN, V96, P321, DOI 10.1007/s00114-008-0474-9; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	46	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23734	23742		10.1074/jbc.M109.025064	http://dx.doi.org/10.1074/jbc.M109.025064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19564332	hybrid, Green Published			2022-12-25	WOS:000269180000058
J	Jo, M; Lester, RD; Montel, V; Eastman, B; Takimoto, S; Gonias, SL				Jo, Minji; Lester, Robin D.; Montel, Valerie; Eastman, Boryana; Takimoto, Shinako; Gonias, Steven L.			Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; PLASMINOGEN-ACTIVATOR; TUMOR-METASTASIS; DOWN-REGULATION; GAMMA-CATENIN; HYPOXIA; CARCINOMA; PROTEIN; MIGRATION	Hypoxia induces expression of the urokinase receptor ( uPAR) and activates uPAR-dependent cell signaling in cancer cells. This process promotes epithelial-mesenchymal transition (EMT). uPAR overexpression in cancer cells also promotes EMT. In this study, we tested whether uPAR may be targeted to reverse cancer cell EMT. When MDA-MB 468 breast cancer cells were cultured in 1% O-2, uPAR expression increased, as anticipated. Cell-cell junctions were disrupted, vimentin expression increased, and E-cadherin was lost from cell surfaces, indicating EMT. Transferring these cells back to 21% O-2 decreased uPAR expression and reversed the signs of EMT. In uPAR-overexpressing MDA-MB 468 cells, EMT was reversed by silencing expression of endogenously produced urokinase-type plasminogen activator (uPA), which is necessary for uPAR-dependent cell signaling, or by targeting uPAR-activated cell signaling factors, including phosphatidylinositol 3-kinase, Src family kinases, and extracellular signal-regulated kinase. MDA-MB 231 breast cancer cells express high levels of uPA and uPAR and demonstrate mesenchymal cell morphology under normoxic culture conditions (21% O-2). Silencing uPA expression in MDA-MB-231 cells decreased expression of vimentin and Snail, and induced changes in morphology characteristic of epithelial cells. These results demonstrate that uPAR-initiated cell signaling may be targeted to reverse EMT in cancer.	[Jo, Minji; Lester, Robin D.; Montel, Valerie; Eastman, Boryana; Takimoto, Shinako; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu			National Institutes of Health NCI [CA-94900]; NATIONAL CANCER INSTITUTE [R01CA094900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-94900 from the NCI.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; Bukholm IK, 2000, J PATHOL, V190, P15; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gond CS, 2007, INT J ONCOL, V31, P19; GRAFF JR, 1995, CANCER RES, V55, P5195; Hajra KM, 2002, CANCER RES, V62, P1613; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Ma Z, 2001, J CELL SCI, V114, P3387; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PYKE C, 1991, AM J PATHOL, V138, P1059; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhong H, 1999, CANCER RES, V59, P5830; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	46	136	147	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22825	22833		10.1074/jbc.M109.023960	http://dx.doi.org/10.1074/jbc.M109.023960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546228	Green Published, hybrid			2022-12-25	WOS:000268963100036
J	Lutz, AK; Exner, N; Fett, ME; Schlehe, JS; Kloos, K; Lammermann, K; Brunner, B; Kurz-Drexler, A; Vogel, F; Reichert, AS; Bouman, L; Vogt-Weisenhorn, D; Wurst, W; Tatzelt, J; Haass, C; Winklhofer, KF				Lutz, A. Kathrin; Exner, Nicole; Fett, Mareike E.; Schlehe, Julia S.; Kloos, Karina; Laemmermann, Kerstin; Brunner, Bettina; Kurz-Drexler, Annerose; Vogel, Frank; Reichert, Andreas S.; Bouman, Lena; Vogt-Weisenhorn, Daniela; Wurst, Wolfgang; Tatzelt, Joerg; Haass, Christian; Winklhofer, Konstanze F.			Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; CELL-DEATH; DYSFUNCTION; DROSOPHILA; FISSION; MORPHOLOGY; PROTEIN; PHOSPHORYLATION; PATHOLOGY	Loss-of-function mutations in the parkin gene (PARK2) and PINK1 gene (PARK6) are associated with autosomal recessive parkinsonism. PINK1 deficiency was recently linked to mitochondrial pathology in human cells and Drosophila melanogaster, which can be rescued by parkin, suggesting that both genes play a role in maintaining mitochondrial integrity. Here we demonstrate that an acute down-regulation of parkin in human SH-SY5Y cells severely affects mitochondrial morphology and function, a phenotype comparable with that induced by PINK1 deficiency. Alterations in both mitochondrial morphology and ATP production caused by either parkin or PINK1 loss of function could be rescued by the mitochondrial fusion proteins Mfn2 and OPA1 or by a dominant negative mutant of the fission protein Drp1. Both parkin and PINK1 were able to suppress mitochondrial fragmentation induced by Drp1. Moreover, in Drp1- deficient cells the parkin/PINK1 knockdown phenotype did not occur, indicating that mitochondrial alterations observed in parkin- or PINK1-deficient cells are associated with an increase in mitochondrial fission. Notably, mitochondrial fragmentation is an early phenomenon upon PINK1/parkin silencing that also occurs in primary mouse neurons and Drosophila S2 cells. We propose that the discrepant findings in adult flies can be explained by the time of phenotype analysis and suggest that in mammals different strategies may have evolved to cope with dysfunctional mitochondria.	[Lutz, A. Kathrin; Exner, Nicole; Fett, Mareike E.; Schlehe, Julia S.; Laemmermann, Kerstin; Brunner, Bettina; Bouman, Lena; Tatzelt, Joerg; Haass, Christian; Winklhofer, Konstanze F.] Univ Munich, Deutsch Zentrum Neurodegenarat Erkrankungen, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Kloos, Karina; Kurz-Drexler, Annerose; Vogt-Weisenhorn, Daniela; Wurst, Wolfgang] Tech Univ Munich, Inst Dev Genet, Helmholtz Ctr Munich, D-8000 Munich, Germany; [Vogel, Frank] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Reichert, Andreas S.] Univ Frankfurt, D-60590 Frankfurt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Goethe University Frankfurt	Winklhofer, KF (corresponding author), Schillerstr 44, D-80336 Munich, Germany.	Konstanze.Winklhofer@med.uni-muenchen.de	Reichert, Andreas/A-4090-2012; Mueller-Rischart, Anne Kathrin/L-3219-2017	Tatzelt, Jorg/0000-0001-5017-5528; Wurst, Wolfgang/0000-0003-4422-7410; Reichert, Andreas/0000-0001-9340-3113; Winklhofer, Konstanze/0000-0002-7256-8231; Vogt Weisenhorn, Daniela/0000-0002-4566-6506	Deutsche Forschungsgemeinschaft (SFB 596 and CEF Macromolecular Complexes); German Ministry for Education and Research (Nationales Genomforschungsnetz plus "Functional Genomics of Parkinson's Disease"); Helmholtz Alliance Alliance "Mental Health in an Ageing Society,"; Virtual Institute of "Neurodegeneration and Ageing," the Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft (SFB 596 and CEF Macromolecular Complexes)(German Research Foundation (DFG)); German Ministry for Education and Research (Nationales Genomforschungsnetz plus "Functional Genomics of Parkinson's Disease")(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Alliance "Mental Health in an Ageing Society,"; Virtual Institute of "Neurodegeneration and Ageing," the Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 596 and CEF Macromolecular Complexes), German Ministry for Education and Research (Nationales Genomforschungsnetz plus "Functional Genomics of Parkinson's Disease"), the Helmholtz Alliance Alliance "Mental Health in an Ageing Society," the Virtual Institute of "Neurodegeneration and Ageing," the Center for Integrated Protein Science Munich, and the Hans and Ilse Breuer Foundation.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bogaerts V, 2008, GENES BRAIN BEHAV, V7, P129, DOI 10.1111/j.1601-183X.2007.00342.x; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; GRUNEWALD A, 2009, EXP NEUROL IN PRESS; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Hwa JJ, 2002, MECH DEVELOP, V116, P213, DOI 10.1016/S0925-4773(02)00141-7; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	50	308	313	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22938	22951		10.1074/jbc.M109.035774	http://dx.doi.org/10.1074/jbc.M109.035774			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19546216	hybrid, Green Published			2022-12-25	WOS:000268963100047
J	Barot, SK; Chung, A; Kim, JJ; Bernstein, IL				Barot, Sabiha K.; Chung, Ain; Kim, Jeansok J.; Bernstein, Ilene L.			Functional Imaging of Stimulus Convergence in Amygdalar Neurons during Pavlovian Fear Conditioning	PLOS ONE			English	Article								Background: Associative conditioning is a ubiquitous form of learning throughout the animal kingdom and fear conditioning is one of the most widely researched models for studying its neurobiological basis. Fear conditioning is also considered a model system for understanding phobias and anxiety disorders. A fundamental issue in fear conditioning regards the existence and location of neurons in the brain that receive convergent information about the conditioned stimulus (CS) and unconditioned stimulus (US) during the acquisition of conditioned fear memory. Convergent activation of neurons is generally viewed as a key event for fear learning, yet there has been almost no direct evidence of this critical event in the mammalian brain. Methodology/Principal Findings: Here, we used Arc cellular compartmental analysis of temporal gene transcription by fluorescence in situ hybridization (catFISH) to identify neurons activated during single trial contextual fear conditioning in rats. To conform to temporal requirements of catFISH analysis we used a novel delayed contextual fear conditioning protocol which yields significant single-trial fear conditioning with temporal parameters amenable to catFISH analysis. Analysis yielded clear evidence that a population of BLA neurons receives convergent CS and US information at the time of the learning, that this only occurs when the CS-US arrangement is supportive of the learning, and that this process requires N-methyl-D-aspartate receptor activation. In contrast, CS-US convergence was not observed in dorsal hippocampus. Conclusions/Significance: Based on the pattern of Arc activation seen in conditioning and control groups, we propose that a key requirement for CS-US convergence onto BLA neurons is the potentiation of US responding by prior exposure to a novel CS. Our results also support the view that contextual fear memories are encoded in the amygdala and that the role of dorsal hippocampus is to process and transmit contextual CS information.			Barot, SK (corresponding author), Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA.	ileneb@u.washington.edu		Kim, Jeansok/0000-0001-7964-106X	NIMH NIH HHS [R01 MH064457, R01 MH64457] Funding Source: Medline; NINDS NIH HHS [R01 NS37040, R01 NS037040] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037040] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggleton JP., 2000, AMYGDALA FUNCTIONAL; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Biedenkapp JC, 2009, LEARN MEMORY, V16, P38, DOI 10.1101/lm.1099109; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Gould TJ, 2002, BEHAV PHARMACOL, V13, P287, DOI 10.1097/00008877-200207000-00005; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HOEHNSARIC R, 1991, BIOL PSYCHIAT, V30, P170, DOI 10.1016/0006-3223(91)90171-H; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kim HC, 2002, IEEE T PLASMA SCI, V30, P188, DOI 10.1109/TPS.2002.1003987; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Lee H, 1998, J NEUROSCI, V18, P8444; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Matus-Amat P, 2007, BEHAV NEUROSCI, V121, P721, DOI 10.1037/0735-7044.121.4.721; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pavlov I.P., 1927, CONDITIONED REFLEXES; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scicli AP, 2004, BEHAV NEUROSCI, V118, P5, DOI 10.1037/0735-7044.118.1.5; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907	42	54	54	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6156	10.1371/journal.pone.0006156	http://dx.doi.org/10.1371/journal.pone.0006156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582153	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806400011
J	Walli, A; Teo, SLH; Boustany, A; Farwell, CJ; Williams, T; Dewar, H; Prince, E; Block, BA				Walli, Andreas; Teo, Steven L. H.; Boustany, Andre; Farwell, Charles J.; Williams, Tom; Dewar, Heidi; Prince, Eric; Block, Barbara A.			Seasonal Movements, Aggregations and Diving Behavior of Atlantic Bluefin Tuna (Thunnus thynnus) Revealed with Archival Tags	PLOS ONE			English	Article								Electronic tags were used to examine the seasonal movements, aggregations and diving behaviors of Atlantic bluefin tuna (Thunnus thynnus) to better understand their migration ecology and oceanic habitat utilization. Implantable archival tags (n = 561) were deployed in bluefin tuna from 1996 to 2005 and 106 tags were recovered. Movement paths of the fish were reconstructed using light level and sea-surface-temperature-based geolocation estimates. To quantify habitat utilization we employed a weighted kernel estimation technique that removed the biases of deployment location and track length. Throughout the North Atlantic, high residence times (167633 days) were identified in four spatially confined regions on a seasonal scale. Within each region, bluefin tuna experienced distinct temperature regimes and displayed different diving behaviors. The mean diving depths within the high-use areas were significantly shallower and the dive frequency and the variance in internal temperature significantly higher than during transit movements between the high-use areas. Residence time in the more northern latitude high-use areas was significantly correlated with levels of primary productivity. The regions of aggregation are associated with areas of abundant prey and potentially represent critical foraging habitats that have seasonally abundant prey. Throughout the North Atlantic mean diving depth was significantly correlated with the depth of the thermocline, and dive behavior changed in relation to the stratification of the water column. In this study, with numerous multi-year tracks, there appear to be repeatable patterns of clear aggregation areas that potentially are changing with environmental conditions. The high concentrations of bluefin tuna in predictable locations indicate that Atlantic bluefin tuna are vulnerable to concentrated fishing efforts in the regions of foraging aggregations.			Walli, A (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	walli@geoville.com		Lusseau, David/0000-0003-1245-3747				Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bigelow HB, 1953, FISHES GULF MAINE; BirdLife International, 2004, GLOB PROC TRACK WORK; BLOCK B, 2001, TUNAS ECOLOGICAL PHS; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Block BA, 1998, FASEB J, V12, pA676; Bode A, 2004, SCI MAR, V68, P165, DOI 10.3989/scimar.2004.68n1165; BOUSTANY A, 2006, THESIS STANFORD U; BOUSTANY A, 2006, COL VOL SCI PAP ICCA, V89; Boustany AM., 2001, ELECT TAGGING TRACKI, P89, DOI [10.1007/978-94-017-1402-0_4, DOI 10.1007/978-94-017-1402-0_4]; BUTLER CM, 2007, THESIS N CAROLINA ST; BUTLER MJA, 1964, BIOLOGY; CAMPBELL JW, 1992, DEEP-SEA RES, V39, P1669, DOI 10.1016/0198-0149(92)90023-M; CAREY FG, 1984, J EXP BIOL, V109, P1; Carlsson J, 2006, ICES J MAR SCI, V63, P1111, DOI 10.1016/j.icesjms.2006.04.009; Carrera P, 2001, FISH RES, V50, P151, DOI 10.1016/S0165-7836(00)00248-4; Cavaco MH., 2003, B SEA FISHER I, V1, P49; Chase BC, 2002, FISH B-NOAA, V100, P168; Checkley David M. Jr., 1999, Fisheries Oceanography, V8, P22; Cleveland W., 1993, VISUALIZING DATA; Cort J.L., 1991, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V35, P213; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; Dagorn L, 1999, CAN J FISH AQUAT SCI, V56, P984, DOI 10.1139/cjfas-56-6-984; DEMETRIO G, 2001, COL VOL SCI PAP ICCA, V54, P415; DRAGOVICH A, 1970, T AM FISH SOC, V99, P726, DOI 10.1577/1548-8659(1970)99<726:TFOBTT>2.0.CO;2; Draper N.R., 1998, WILEY SERIES PROBABI, V326; DUCKLOW HW, 1993, JGOFS N ATLANTIC B 2, P1; EGGLESTON DB, 1990, FISH B-NOAA, V88, P389; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Fitzgibbon QP, 2007, J EXP BIOL, V210, P290, DOI 10.1242/jeb.02641; FUSS CM, 1971, P GULF CAR FISH I 24, P19; Garrison LP, 2002, FISH OCEANOGR, V11, P267, DOI 10.1046/j.1365-2419.2002.00205.x; Gray CA, 2003, MAR ECOL PROG SER, V247, P211, DOI 10.3354/meps247211; Gunn J, 2001, ELECT TAGGING TRACKI, P109, DOI 10.1007/978-94-017-1402-0_5; GUNN JS, 2001, TUNAS ECOLOGICAL PHY; HILBORN R, 1992; Hochberg Y, 1987, MULTIPLE COMPARISON; ICCAT, 2005, ICCAT COLL VOL SCI P, VII, P44; *ICCAT, 2001, COL VOL SCI PAP ICCA, V20, P261; *ICCAT, 2006, COL VOL SCI PAP ICCA, V13, P1; Joint I, 2002, J MARINE SYST, V32, P219, DOI 10.1016/S0924-7963(02)00037-4; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; MATTHEWS FD, 1977, SSRF7006 NMFS NOAA, P19; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; MCNAY RS, 1994, J WILDLIFE MANAGE, V58, P422, DOI 10.2307/3809312; MENESES I, 1996, J MARINE SCI, V27; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; NEILSON JD, 2006, COL VOL SCI PAP ICCA, V76; NICHOLSON WR, 1975, 684 SSRF NOAA NMFS; Otis DL, 1999, J WILDLIFE MANAGE, V63, P1039, DOI 10.2307/3802819; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; RAO RR, 1989, J GEOPHYS RES-OCEANS, V94, P10801, DOI 10.1029/JC094iC08p10801; REYNOLDS TD, 1990, J WILDLIFE MANAGE, V54, P316, DOI 10.2307/3809049; ROBINSON G A, 1970, Bulletins of Marine Ecology, V6, P333; RODRIGUEZMARIN E, 2006, COL VOL SCI PAP ICCA, V59, P858; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rossby T, 1996, REV GEOPHYS, V34, P463, DOI 10.1029/96RG02214; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; SILVERMAN BW, 1986, DENSITY ANAL STAT DE; Smyth TJ, 2001, PROG OCEANOGR, V51, P269, DOI 10.1016/S0079-6611(01)00070-2; Sokal RR, 1995, BIOMETRY; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Tilstone GH, 2003, MAR ECOL PROG SER, V252, P89, DOI 10.3354/meps252089; TOWNSEND DW, 1992, J PLANKTON RES, V14, P467, DOI 10.1093/plankt/14.4.467; TURNER SC, 1994, ICCAT COLL VOL SCI P, V42, P170; Walli A., 2007, THESIS U CALIFORNIA; WARLEN SM, 1994, FISH B-NOAA, V92, P420; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317; Whitehead H, 2000, CAN J FISH AQUAT SCI, V57, P223, DOI 10.1139/cjfas-57-1-223; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; *WWF, 2006, PLUND BLUEF TUN MED; [No title captured]	88	125	130	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6151	10.1371/journal.pone.0006151	http://dx.doi.org/10.1371/journal.pone.0006151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582150	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806400007
J	Guo, SG; Shen, XY; Yan, GH; Ma, DZ; Bai, XC; Li, SP; Jiang, Y				Guo, Shuguang; Shen, Xiaoyun; Yan, Gonghong; Ma, Dongzhu; Bai, Xiaochun; Li, Suoping; Jiang, Yu			A MAP Kinase Dependent Feedback Mechanism Controls Rho1 GTPase and Actin Distribution in Yeast	PLOS ONE			English	Article								In the yeast Saccharomyces cerevisiae the guanosine triphosphatase (GTPase) Rho1 controls actin polarization and cell wall expansion. When cells are exposed to various environmental stresses that perturb the cell wall, Rho1 activates Pkc1, a mammalian Protein Kinase C homologue, and Mpk1, a mitogen activated protein kinase (MAPK), resulting in actin depolarization and cell wall remodeling. In this study, we demonstrate a novel feedback loop in this Rho1-mediated Pkc1-MAPK pathway that involves regulation of Rom2, the guanine nucleotide exchange factor of Rho1, by Mpk1, the end kinase of the pathway. This previously unrecognized Mpk1-depedent feedback is a critical step in regulating Rho1 function. Activation of this feedback mechanism is responsible for redistribution of Rom2 and cell wall synthesis activity from the bud to cell periphery under stress conditions. It is also required for terminating Rho1 activity toward the Pkc1-MAPK pathway and for repolarizing actin cytoskeleton and restoring growth after the stressed cells become adapted.			Guo, SG (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA.	yuj5@pitt.edu			NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129821] Funding Source: Medline; NIGMS NIH HHS [R01 GM068832, GM068832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2000, J CELL SCI, V113, P2685; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Cabib E, 1998, ANNU REV BIOCHEM, V67, P307, DOI 10.1146/annurev.biochem.67.1.307; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Manning BD, 1997, MOL BIOL CELL, V8, P1829, DOI 10.1091/mbc.8.10.1829; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Utsugi T, 2002, GENES CELLS, V7, P1, DOI 10.1046/j.1356-9597.2001.00495.x; Wang HM, 2003, MOL CELL BIOL, V23, P3116, DOI 10.1128/MCB.23.9.3116-3125.2003; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	37	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6089	10.1371/journal.pone.0006089	http://dx.doi.org/10.1371/journal.pone.0006089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564916	Green Published, gold, Green Accepted			2022-12-25	WOS:000267515700008
J	Subramanian, SV; Kennedy, MH				Subramanian, S. V.; Kennedy, Malinda H.			Perception of Neighborhood Safety and Reported Childhood Lifetime Asthma in the United States (US): A Study Based on a National Survey	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; COMMUNITY VIOLENCE; BIRTH-COHORT; STRESS; HEALTH; PREVALENCE; EXPRESSION; MORBIDITY; CHILDREN; CONTEXT	Background: Recent studies have emphasized the role of psychosocial stressors as a determinant of asthma, and neighborhoods can be a potential source of such stressors. We investigated the association between parental perception of neighborhood safety and reported lifetime asthma among children. Methodology/Principal Findings: Data for the study came from the 2003-04 National Survey of Children Health (NSCH); a nationally representative cross-sectional sample of children aged 0-17 years. Demographic, socioeconomic and behavioral covariates were included in the study. Models were estimated after taking account of weighting and complex survey design. Parental report of whether the child has ever been diagnosed with asthma by a physician was used to define the outcome. Parental report of perception of neighborhood safety was the main exposure. In unadjusted models, the odds ratio (OR) for reporting asthma associated with living in neighborhoods that were perceived to be sometimes or never safe was 1.36 (95% confidence intervals [CI] 1.21, 1.53) compared to living in neighborhoods that were perceived to be always safe. Adjusting for covariates including exposure to second hand tobacco smoke, mother's self-rated health, child's physical activity and television viewing attenuated this association (OR 1.25, 95% CI 1.08, 1.43). In adjusted models, the increased odds ratio for reporting asthma was also higher among those who perceived neighborhoods as being usually safe (OR 1.15 95% CI 1.06, 1.26), as compared to always safe, suggestive of a dose-response relationship, with the differentials for usually safe and never safe being statistically significant (p = 0.009). Conclusion: Psychosocial stressors may be important risk factors that may impact the pathogenesis of asthma and/or contribute to asthma morbidity by triggering exacerbations through neuroimmunologic mechanisms, as well as social mechanisms.			Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA.	svsubram@hsph.harvard.edu		Huicho, Luis/0000-0002-5272-5885	NHLBI NIH HHS [K25 HL081275] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; [Anonymous], [No title captured]; Beasley R, 2003, PEDIATR CLIN N AM, V50, P539, DOI 10.1016/S0031-3955(03)00050-6; Blumberg SJ, 2005, VITAL HLTH STAT, V1; BUSSE WE, 1994, AM J RESP CRIT CARE, V151, P249; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Clougherty JE, 2007, ENVIRON HEALTH PERSP, V115, P1140, DOI 10.1289/ehp.9863; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; Evans GW, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P365; EZZATIRICE TM, 1999, FED COMM STAT METH R; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; GRAHAM NMH, 1986, AM J EPIDEMIOL, V124, P389, DOI 10.1093/oxfordjournals.aje.a114409; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Harrison BDW, 1998, THORAX, V53, P519, DOI 10.1136/thx.53.6.519; Jeffrey J, 2006, PUBLIC HEALTH REP, V121, P720, DOI 10.1177/003335490612100612; Kawachi I, 2006, J TRAUMA STRESS, V19, P195, DOI 10.1002/jts.20108; Kawachi I, 2007, J EPIDEMIOL COMMUN H, V61, P3, DOI 10.1136/jech.2005.045203; Kawachi I., 2003, NEIGHBORHOODS HLTH; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; MITCHELL M, 2005, STRATEGICALLY USING; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; NADEL JA, 1984, ANNU REV MED, V35, P451, DOI 10.1146/annurev.med.35.1.451; O'Campo P, 2003, AM J EPIDEMIOL, V157, P9, DOI 10.1093/aje/kwf171; O'Neil R, 2001, J APPL DEV PSYCHOL, V22, P135, DOI 10.1016/S0193-3973(01)00073-9; PEARCE N, 1998, ASTHMA EPIDEMIOLOGY; Pedlow S., 2007, MULTIPLE IMPUTATION; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Sandberg S, 2000, LANCET, V356, P982, DOI 10.1016/S0140-6736(00)02715-X; Sandel M, 2006, ARCH DIS CHILD, V91, P942, DOI 10.1136/adc.2006.098376; *UCLA, 2008, APPL SURV DAT AN STA, V9; Walker B, 2003, J NATL MED ASSOC, V95, P152; Wolf JM, 2008, BRAIN BEHAV IMMUN, V22, P433, DOI 10.1016/j.bbi.2007.10.016; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; WRIGHT RJ, 2001, ENV HLTH PERSPECTIVE, V109; Wright RJ, 2007, CHEST, V132, p757S, DOI 10.1378/chest.07-1904; Wright RJ, 2007, PAEDIATR PERINAT EP, V21, P8, DOI 10.1111/j.1365-3016.2007.00879.x; Wright RJ, 2006, CLIN CHEST MED, V27, P413, DOI 10.1016/j.ccm.2006.04.003	44	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6091	10.1371/journal.pone.0006091	http://dx.doi.org/10.1371/journal.pone.0006091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	464OU	19564923	Green Submitted, Green Published, gold			2022-12-25	WOS:000267515700010
J	Guo, XZ; Mak, KK; Taketo, MM; Yang, YZ				Guo, Xizhi; Mak, Kinglun Kingston; Taketo, Makoto M.; Yang, Yingzi			The Wnt/beta-Catenin Pathway Interacts Differentially with PTHrP Signaling to Control Chondrocyte Hypertrophy and Final Maturation	PLOS ONE			English	Article								Sequential proliferation, hypertrophy and maturation of chondrocytes are required for proper endochondral bone development and tightly regulated by cell signaling. The canonical Wnt signaling pathway acts through beta-catenin to promote chondrocyte hypertrophy whereas PTHrP signaling inhibits it by holding chondrocytes in proliferating states. Here we show by genetic approaches that chondrocyte hypertrophy and final maturation are two distinct developmental processes that are differentially regulated by Wnt/beta-catenin and PTHrP signaling. Wnt/beta-catenin signaling regulates initiation of chondrocyte hypertrophy by inhibiting PTHrP signaling activity, but it does not regulate PTHrP expression. In addition, Wnt/beta-catenin signaling regulates chondrocyte hypertrophy in a non-cell autonomous manner and Gdf5/Bmp signaling may be one of the downstream pathways. Furthermore, Wnt/beta-catenin signaling also controls final maturation of hypertrophic chondrocytes, but such regulation is PTHrP signaling-independent.			Guo, XZ (corresponding author), NHGRI, Dev Genet Sect, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Mak, Kingston King-Lun/0000-0002-4733-9146; Guo, Xizhi/0000-0001-8047-6049	Intramural NIH HHS Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187, Z01HG000187] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Long FX, 2001, DEVELOPMENT, V128, P5099; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; NAKASE T, 1994, BONE MINER, V26, P109, DOI 10.1016/S0169-6009(08)80056-6; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; ZHU M, 2008, J BONE MINER RES	36	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6067	10.1371/journal.pone.0006067	http://dx.doi.org/10.1371/journal.pone.0006067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557172	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600015
J	Soderstrom, H; Jarhult, JD; Olsen, B; Lindberg, RH; Tanaka, H; Fick, J				Soderstrom, Hanna; Jarhult, Josef D.; Olsen, Bjorn; Lindberg, Richard H.; Tanaka, Hiroaki; Fick, Jerker			Detection of the Antiviral Drug Oseltamivir in Aquatic Environments	PLOS ONE			English	Article								Oseltamivir (Tamiflu (R)) is the most important antiviral drug available and a cornerstone in the defence against a future influenza pandemic. Recent publications have shown that the active metabolite, oseltamivir carboxylate (OC), is not degraded in sewage treatment plants and is also persistent in aquatic environments. This implies that OC will be present in aquatic environments in areas where oseltamivir is prescribed to patients for therapeutic use. The country where oseltamivir is used most is Japan, where it is used to treat seasonal flu. We measured the levels of OC in water samples from the Yodo River system in the Kyoto and Osaka prefectures, Japan, taken before and during the flu-season 2007/8. No OC was detected before the flu-season but 2-58 ng L(-1) was detected in the samples taken during the flu season. This study shows, for the first time, that low levels of oseltamivir can be found in the aquatic environment. Therefore the natural reservoir of influenza virus, dabbling ducks, is exposed to oseltamivir, which could promote the evolution of viral resistance.			Soderstrom, H (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	jerker.fick@chem.umu.se	Berglund Fick, Jerker/HDO-5788-2022; Lindberg, Richard/C-8882-2013; Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059; Olsen, Bjorn/0000-0002-4646-691X; Soderstrom, Hanna/0000-0003-1341-7879; Fick, Jerker/0000-0002-3949-7371				ACCINELLI C, 2007, INT J ENVIRON AN CH, V8, P570; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Singer AC, 2008, ENVIRON HEALTH PERSP, V116, P1563, DOI 10.1289/ehp.11310; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Sweetman S. C., 2007, MARTINDALE COMPLETE; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2005, WHO DRUG INFORM, V19, P273	14	56	57	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6064	10.1371/journal.pone.0006064	http://dx.doi.org/10.1371/journal.pone.0006064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557131	Green Submitted, Green Published, gold			2022-12-25	WOS:000267424600012
J	Rupp, J; Pfleiderer, L; Jugert, C; Moeller, S; Klinger, M; Dalhoff, K; Solbach, W; Stenger, S; Laskay, T; van Zandbergen, G				Rupp, Jan; Pfleiderer, Lisa; Jugert, Christiane; Moeller, Sonja; Klinger, Matthias; Dalhoff, Klaus; Solbach, Werner; Stenger, Steffen; Laskay, Tamas; van Zandbergen, Ger			Chlamydia pneumoniae Hides inside Apoptotic Neutrophils to Silently Infect and Propagate in Macrophages	PLOS ONE			English	Article								Background: Intracellular pathogens have developed elaborate strategies for silent infection of preferred host cells. Chlamydia pneumoniae is a common pathogen in acute infections of the respiratory tract (e.g. pneumonia) and associated with chronic lung sequelae in adults and children. Within the lung, alveolar macrophages and polymorph nuclear neutrophils (PMN) are the first line of defense against bacteria, but also preferred host phagocytes of chlamydiae. Methodology/Principal Findings: We could show that C. pneumoniae easily infect and hide inside neutrophil granulocytes until these cells become apoptotic and are subsequently taken up by macrophages. C. pneumoniae infection of macrophages via apoptotic PMN results in enhanced replicative activity of chlamydiae when compared to direct infection of macrophages, which results in persistence of the pathogen. Inhibition of the apoptotic recognition of C. pneumoniae infected PMN using PS-masking Annexin A5 significantly lowered the transmission of chlamydial infection to macrophages. Transfer of apoptotic C. pneumoniae infected PMN to macrophages resulted in an increased TGF-beta production, whereas direct infection of macrophages with chlamydiae was characterized by an enhanced TNF-alpha response. Conclusions/Significance: Taken together, our data suggest that C. pneumoniae uses neutrophil granulocytes to be silently taken up by long-lived macrophages, which allows for efficient propagation and immune protection within the human host.			Rupp, J (corresponding author), Univ Lubeck, Inst Med Microbiol & Hyg, Lubeck, Germany.	jan.rupp@uk-sh.de; Ger.Zandbergen@uniklinik-ulm.de	van Zandbergen, Ger/M-1571-2013; Solbach, Werner/O-8582-2015; Poubelle, Patrice E/G-6537-2013; Rupp, Jan/C-8794-2011; Solbach, Werner/F-9217-2012; Laskay, Tamás/E-9190-2013	Solbach, Werner/0000-0002-3608-8652; Rupp, Jan/0000-0001-8722-1233; Laskay, Tamás/0000-0002-4212-8366				Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Bartels C, 1999, CIRCULATION, V99, P879, DOI 10.1161/01.CIR.99.7.879; Blasi F, 2004, EUR RESPIR J, V23, P499, DOI 10.1183/09031936.04.00001004; Boman J, 1998, J INFECT DIS, V178, P274, DOI 10.1086/517452; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Byrne GI, 2003, P NATL ACAD SCI USA, V100, P8040, DOI 10.1073/pnas.1533181100; Cirino F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-23; Dreses-Werringloer U, 2006, AM J MED SCI, V332, P168, DOI 10.1097/00000441-200610000-00003; Gaydos CA, 1996, INFECT IMMUN, V64, P1614, DOI 10.1128/IAI.64.5.1614-1620.1996; Gieffers J, 2004, EUR RESPIR J, V23, P506, DOI 10.1183/09031936.04.00093304; Gieffers J, 2001, CIRCULATION, V103, P351; Gueinzius K, 2008, ATHEROSCLEROSIS, V198, P256, DOI 10.1016/j.atherosclerosis.2007.10.014; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P215, DOI 10.1006/mpat.1996.0056; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; MAASS M, 1995, AM J CLIN PATHOL, V103, P141; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Peters J, 2005, CELL MICROBIOL, V7, P1099, DOI 10.1111/j.1462-5822.2005.00534.x; Quinn TC, 1999, AM HEART J, V138, pS507, DOI 10.1016/S0002-8703(99)70287-5; REGISTER KB, 1987, INFECT IMMUN, V55, P2420, DOI 10.1128/IAI.55.10.2420-2427.1987; Rodriguez N, 2005, J IMMUNOL, V174, P4836, DOI 10.4049/jimmunol.174.8.4836; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rupp J, 2005, P NATL ACAD SCI USA, V102, P3447, DOI 10.1073/pnas.0407759102; Rupp J, 2005, FEMS MICROBIOL LETT, V242, P203, DOI 10.1016/j.femsle.2004.11.010; Rupp J, 2003, EUR RESPIR J, V22, P274, DOI 10.1183/09031936.03.00007303; RUPP J, 2007, CELL MICROBIOL; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Wizel B, 2002, J IMMUNOL, V169, P2524, DOI 10.4049/jimmunol.169.5.2524; Wolf K, 2005, INFECT IMMUN, V73, P4560, DOI 10.1128/IAI.73.8.4560-4570.2005; Yang J, 2003, INFECT IMMUN, V71, P614, DOI 10.1128/IAI.71.2.614-620.2003; YANG ZP, 1994, J INFECT DIS, V170, P464, DOI 10.1093/infdis/170.2.464; Ying SM, 2006, INFECT IMMUN, V74, P6057, DOI 10.1128/IAI.00760-06	36	50	53	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6020	10.1371/journal.pone.0006020	http://dx.doi.org/10.1371/journal.pone.0006020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547701	Green Published, gold, Green Submitted			2022-12-25	WOS:000267347900015
J	Balamurugan, K; Luu, VD; Kaufmann, MR; Hofmann, VS; Boysen, G; Barth, S; Bordoli, MR; Stiehl, DP; Moch, H; Schraml, P; Wenger, RH; Camenisch, G				Balamurugan, K.; Luu, V-D; Kaufmann, M. R.; Hofmann, V. S.; Boysen, G.; Barth, S.; Bordoli, M. R.; Stiehl, D. P.; Moch, H.; Schraml, P.; Wenger, R. H.; Camenisch, G.			Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response	ONCOGENE			English	Article						renal cell carcinoma; tumor immunity; paraneoplastic cerebellar degeneration; oxygen sensing	TRANSCRIPTIONAL ACTIVITY; SPONTANEOUS REGRESSION; TUMOR-IMMUNITY; HIF; HIF-1-ALPHA; ACTIVATION; PROTEIN; ALPHA; DOMAIN; HYDROXYLATION	The onconeuronal cerebellar degeneration-related antigen Cdr2 is associated with paraneoplastic syndromes. Neoplastic expression of Cdr2 in ovary and breast tumors triggers an autoimmune response that suppresses tumor growth by developing tumor immunity, but culminates in cerebellar degeneration when Cdr2-specific immune cells recognize neuronal Cdr2. We identified Cdr2 as a novel interactor of the hypoxia-inducible factor (HIF) prolyl-4-hydroxylase PHD1 and provide evidence that Cdr2 might represent a novel important tumor antigen in renal cancer. Strong Cdr2 protein expression was observed in 54.2% of papillary renal cell carcinoma (pRCC) compared with 7.8% of clear-cell RCC and no staining was observed in chromophobe RCC or oncocytoma. High Cdr2 protein levels correlated with attenuated HIF target gene expression in these solid tumors, and Cdr2 overexpression in tumor cell lines reduced HIF-dependent transcriptional regulation. This effect was because of both attenuation of hypoxic protein accumulation and suppression of the transactivation activity of HIF-1 alpha. pRCC is known for its tendency to avascularity, usually associated with a lower pathological stage and higher survival rates. We provide evidence that Cdr2 protein strongly accumulates in pRCC, attenuates the HIF response to tumor hypoxia and may become of diagnostic importance as novel renal tumor marker. Oncogene (2009) 28, 3274-3285; doi:10.1038/onc.2009.186; published online 6 July 2009	[Balamurugan, K.; Kaufmann, M. R.; Hofmann, V. S.; Barth, S.; Bordoli, M. R.; Stiehl, D. P.; Wenger, R. H.; Camenisch, G.] Univ Zurich UZH, Inst Physiol, Zurich, Switzerland; [Balamurugan, K.; Kaufmann, M. R.; Hofmann, V. S.; Barth, S.; Bordoli, M. R.; Stiehl, D. P.; Wenger, R. H.; Camenisch, G.] Univ Zurich UZH, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Luu, V-D; Boysen, G.; Moch, H.; Schraml, P.] Univ Zurich Hosp, Dept Pathol, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Camenisch, G (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gieri.camenisch@access.uzh.ch	Stiehl, Daniel/A-3622-2008; Kuppusamy, Balamurugan/AAC-6020-2022; Wenger, Roland H./B-7953-2009	Wenger, Roland H./0000-0001-7592-4839; Bordoli, Mattia/0000-0001-6917-8753; Stiehl, Daniel/0000-0002-0076-4874; Boysen, Gunther/0000-0002-7610-6085	SNF [3100AO-116047/1]; Sassella Stiftung; Krebsliga des Kantons Zurich; UZH University Research Priority; European Commission EUROXY [LSHCCT-2003-502932, SBF03.0647-2]	SNF; Sassella Stiftung; Krebsliga des Kantons Zurich; UZH University Research Priority; European Commission EUROXY	We would like to thank R Fischer and C Ruber (ETH Zurich, Switzerland) for the generation of monoclonal anti-Cdr2 antibodies, DM Katschinski (Georg August University Gottingen, Germany) for providing the custom-made mouse testis cDNA library, J Nesper (University of Konstanz, Germany) and MO Hottiger (University of Zurich, Switzerland) for help with the yeast two-hybrid screenings, DJ Peet (University of Adelaide, Australia) and N Sang (Thomas Jefferson University, PA, USA) for gifts of plasmids, P Carmeliet and M Schneider (Katholieke Universiteit Leuven and Flanders Institute for Biotechnology, Belgium) for Phd1 MEFs, I Flamme and F Oehme (Bayer HealthCare, Germany) for helpful discussions and P Spielmann, M Storz and S Behnke for excellent technical assistance. This work was supported by SNF 3100AO-116047/1 (RHW and GC), Sassella Stiftung (GC, KB and SB), Krebsliga des Kantons Zurich (GC),UZH University Research Priority Program 'Integrative Human Physiology' and the 6th Framework Programme of the European Commission EUROXY LSHCCT-2003-502932/SBF03.0647-2 (RHW).	Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Albert ML, 2000, ANN NEUROL, V47, P9; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Corradi JP, 1997, J NEUROSCI, V17, P1406; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Darnell JC, 2000, CANCER RES, V60, P2136; Darnell RB, 2003, NAT IMMUNOL, V4, P201, DOI 10.1038/ni0303-201; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Eble J, 2004, WHO CLASSIFICATION T; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erez N, 2003, CANCER RES, V63, P8777; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; KOSARY CL, 1993, NIH PUBLICATION; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moch H, 2002, VIRCHOWS ARCH, V441, P320, DOI 10.1007/s00428-002-0685-y; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; OLIVER RTD, 1989, BRIT J UROL, V63, P128, DOI 10.1111/j.1464-410X.1989.tb05147.x; Onishi Tetsuro, 2002, Int J Clin Oncol, V7, P159, DOI 10.1007/s101470200023; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; Santomasso BD, 2007, P NATL ACAD SCI USA, V104, P19073, DOI 10.1073/pnas.0704336104; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shin DH, 2008, ONCOGENE, V27, P1939, DOI 10.1038/sj.onc.1210826; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Struckmann K, 2008, J PATHOL, V214, P464, DOI 10.1002/path.2310; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; VOGELZANG NJ, 1992, J UROLOGY, V148, P1247, DOI 10.1016/S0022-5347(17)36874-X; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12	47	20	20	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3274	3285		10.1038/onc.2009.186	http://dx.doi.org/10.1038/onc.2009.186			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19581925				2022-12-25	WOS:000269893700002
J	Feng, X; Lu, X; Man, X; Zhou, W; Jiang, LQ; Knyazev, P; Lei, L; Huang, Q; Ullrich, A; Zhang, Z; Chen, Z				Feng, X.; Lu, X.; Man, X.; Zhou, W.; Jiang, L. Q.; Knyazev, P.; Lei, L.; Huang, Q.; Ullrich, A.; Zhang, Z.; Chen, Z.			Overexpression of Csk-binding protein contributes to renal cell carcinogenesis	ONCOGENE			English	Article						Csk-binding protein; renal cell carcinoma; carcinogenesis; RhoA; PDZ-binding motif	TRANSMEMBRANE ADAPTER PROTEIN; FAMILY TYROSINE KINASES; LIPID RAFTS; DOWN-REGULATION; CARCINOMA; SRC; ACTIVATION; PHOSPHOPROTEIN; CYTOSKELETON; EXPRESSION	C-terminal Src kinase (Csk)-binding protein (Cbp) is a transmembrane adaptor protein that localizes exclusively in lipid rafts, where it regulates Src family kinase (SFK) activities through recruitment of Csk. Although SFKs are well known for their involvement in cancer, the function of Cbp in carcinogenesis remains largely unknown. In this study, we reported overexpression of Cbp in more than 70% of renal cell carcinoma (RCC) specimens and in the majority of tested RCC cell lines. Depletion of Cbp in RCC cells by RNA interference led to remarkable inhibition of cell proliferation, migration, anchorage-independent growth as well as tumorigenicity in nude mice. Strikingly, silencing of Cbp negatively affected the sustaining of Erk1/2 activation but not c-Src activation induced by serum. Besides, the RhoA activity in RCC cells was remarkably impaired when Cbp was knocked down. Overexpression of wild-type Cbp, but not its mutant Cbp/Delta CP lacking C-terminal PDZ-binding motif, significantly enhanced RhoA activation and cell migration of RCC cells. These results provided new insights into the function of Cbp in modulating RhoA activation, by which Cbp might contribute to renal cell carcinogenesis. Oncogene (2009) 28, 3320-3331; doi:10.1038/onc.2009.185; published online 6 July 2009	[Feng, X.; Lu, X.; Zhou, W.; Jiang, L. Q.; Lei, L.; Huang, Q.; Zhang, Z.; Chen, Z.] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Feng, X.; Lu, X.; Zhou, W.; Lei, L.; Huang, Q.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Man, X.] Second Mil Med Univ, Int Cooperat Lab Signal Transduct, Eastern Hepotabiliary Surg Inst, Shanghai, Peoples R China; [Knyazev, P.; Ullrich, A.] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Naval Medical University; Max Planck Society	Chen, Z (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zhangzhe@sibs.ac.cn; zjchen@sibs.ac.cn			National Natural Science Foundation of China [30730055, 30623002]; National Key Scientific Program of China [2007CB914504]; Chinese Academy of Sciences [KSCX1-YW-R-67, KSCX2-YW-R108]; Program of Shanghai Subject Chief Scientist [08XD14051]; National High Technology Research and Development Programme of China [2006AA02A308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Program of Shanghai Subject Chief Scientist; National High Technology Research and Development Programme of China(National High Technology Research and Development Program of China)	We thank Dr Vaclav Horejsi (Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 14220 Prague 4, Czech Republic) for kindly and generously giving us the monoclonal antibody against Cbp. This work was supported by grants from National Natural Science Foundation of China (30730055 and 30623002), National Key Scientific Program of China (2007CB914504), the Chinese Academy of Sciences (KSCX1-YW-R-67, KSCX2-YW-R108), Program of Shanghai Subject Chief Scientist (08XD14051) and the National High Technology Research and Development Programme of China (2006AA02A308).	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Baumgartner M, 2003, BLOOD, V101, P1874, DOI 10.1182/blood-2002-02-0456; Bratslavsky G, 2007, CLIN CANCER RES, V13, P4667, DOI 10.1158/1078-0432.CCR-06-2510; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; D'Hondt V, 2005, EUR J CANCER, V41, P1246, DOI 10.1016/j.ejca.2004.11.025; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Hayashi M, 2005, J CLIN ENDOCR METAB, V90, P1712, DOI 10.1210/jc.2004-1547; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Jiang LQ, 2006, ONCOGENE, V25, P5495, DOI 10.1038/sj.onc.1209554; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Lam JS, 2005, UROLOGY, V66, P1, DOI 10.1016/j.urology.2005.06.112; Lindquist JA, 2003, IMMUNOL REV, V191, P165, DOI 10.1034/j.1600-065X.2003.00007.x; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Quest AFG, 2004, BIOCHEM CELL BIOL, V82, P129, DOI 10.1139/o03-071; Rathmell WK, 2008, EXPERT REV ANTICANC, V8, P63, DOI 10.1586/14737140.8.1.63; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Svec A, 2005, IMMUNOL LETT, V100, P94, DOI 10.1016/j.imlet.2005.05.002; Svec A, 2007, PATHOL RES PRACT, V203, P193, DOI 10.1016/j.prp.2007.01.005; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; Tedoldi S, 2006, BLOOD, V107, P213, DOI 10.1182/blood-2005-06-2273; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	40	15	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 17	2009	28	37					3320	3331		10.1038/onc.2009.185	http://dx.doi.org/10.1038/onc.2009.185			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	495LS	19581936	Bronze			2022-12-25	WOS:000269893700006
J	Engqvist, M; Drincovich, MF; Flugge, UI; Maurino, VG				Engqvist, Martin; Drincovich, Maria F.; Fluegge, Ulf-Ingo; Maurino, Veronica G.			Two D-2-Hydroxy-acid Dehydrogenases in Arabidopsis thaliana with Catalytic Capacities to Participate in the Last Reactions of the Methylglyoxal and beta-Oxidation Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LACTATE DEHYDROGENASE; ELECTRON-TRANSFER FLAVOPROTEIN; ALPHA-HYDROXYGLUTARIC ACID; GLYOXALASE-II; MITOCHONDRIA; GENE; ENZYME; D-2-HYDROXYGLUTARATE; METABOLISM; SYSTEM	The Arabidopsis thaliana locus At5g06580 encodes an ortholog to Saccharomyces cerevisiae D-lactate dehydrogenase (AtD-LDH). The recombinant protein is a homodimer of 59-kDa subunits with one FAD per monomer. A substrate screen indicated that AtD-LDH catalyzes the oxidation of D-and L-lactate, D-2-hydroxybutyrate, glycerate, and glycolate using cytochrome c as an electron acceptor. AtD-LDH shows a clear preference for D-lactate, with a catalytic efficiency 200- and 2000-fold higher than that for L-lactate and glycolate, respectively, and a Km value for D-lactate of similar to 160 mu M. Knock-out mutants showed impaired growth in the presence of D-lactate or methylglyoxal. Collectively, the data indicated that the protein is a D-LDH that participates in planta in the methylglyoxal pathway. Web-based bioinformatic tools revealed the existence of a paralogous protein encoded by locus At4g36400. The recombinant protein is a homodimer of 61-kDa subunits with one FAD per monomer. A substrate screening revealed highly specific D-2-hydroxyglutarate (D-2HG) conversion in the presence of an organic cofactor with a K-m value of similar to 580 mu M. Thus, the enzyme was characterized as a D-2HG dehydrogenase (AtD-2HGDH). Analysis of knock-out mutants demonstrated that AtD-2HGDH is responsible for the total D-2HGDH activity present in A. thaliana. Gene coexpression analysis indicated that AtD-2HGDH is in the same network as several genes involved in beta-oxidation and degradation of branched-chain amino acids and chlorophyll. It is proposed that AtD-2HGDH participates in the catabolism of D-2HG most probably during the mobilization of alternative substrates from proteolysis and/or lipid degradation.	[Engqvist, Martin; Fluegge, Ulf-Ingo; Maurino, Veronica G.] Univ Cologne, Inst Bot, D-50931 Cologne, Germany; [Drincovich, Maria F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Argentina	University of Cologne; National University of Rosario	Maurino, VG (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-50931 Cologne, Germany.	v.maurino@uni-koeln.de	Drincovich, Maria F/F-3902-2017; Drincovich, Maria F/Q-4195-2019	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Engqvist, Martin/0000-0003-2174-2225	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a Deutsche Forschungsgemeinschaft grant (to V. G. M.).	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Arai Y, 2002, PLANT CELL PHYSIOL, V43, P555, DOI 10.1093/pcp/pcf068; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P13, DOI 10.1016/j.bbabio.2005.03.003; Bari R, 2004, J EXP BOT, V55, P623, DOI 10.1093/jxb/erh079; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1560, DOI 10.1128/JB.94.5.1560-1564.1967; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCKMAN HL, 1975, J BACTERIOL, V124, P1454, DOI 10.1128/JB.124.3.1454-1461.1975; CAMMACK R, 1969, BIOCHEM J, V115, P55, DOI 10.1042/bj1150055; Carlier JP, 1997, LETT APPL MICROBIOL, V25, P371, DOI 10.1046/j.1472-765X.1997.00245.x; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; de Bari L, 2005, BIOCHEM BIOPH RES CO, V335, P1224, DOI 10.1016/j.bbrc.2005.08.022; Fahnenstich H, 2008, PLANT PHYSIOL, V148, P719, DOI 10.1104/pp.108.126789; Fernandez-Checa Jose C., 1993, P363; Frerman F. E., 2001, METABOLIC MOL BASES, P2357, DOI DOI 10.1036/OMMBID.131; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; GREGOLIN C, 1963, BIOCHIM BIOPHYS ACTA, V67, P201; Hammer VA, 1996, J NUTR, V126, P2218, DOI 10.1093/jn/126.9.2218; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Horikiri S, 2004, BIOSCI BIOTECH BIOCH, V68, P516, DOI 10.1271/bbb.68.516; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Ishizaki K, 2006, PLANT J, V47, P751, DOI 10.1111/j.1365-313X.2006.02826.x; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Keech O, 2005, PHYSIOL PLANTARUM, V124, P403, DOI 10.1111/j.1399-3054.2005.00521.x; LABEYRIE F, 1964, B SOC CHIM BIOL, V46, P1793; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; LINDAHL G, 1967, ARCH BIOCHEM BIOPHYS, V119, P347, DOI 10.1016/0003-9861(67)90463-8; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; LODI T, 1993, MOL GEN GENET, V238, P315, DOI 10.1007/BF00291989; LODI T, 1994, MOL GEN GENET, V244, P622, DOI 10.1007/BF00282752; Lucas KA, 2007, J BIOL CHEM, V282, P24980, DOI 10.1074/jbc.M701028200; Maiti MK, 1997, PLANT MOL BIOL, V35, P471, DOI 10.1023/A:1005891123344; MIZUSHIMA S, 1964, J GEN APPL MICROBIOL, V10, P33, DOI 10.2323/jgam.10.33; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; OGATA M, 1981, J BIOCHEM-TOKYO, V89, P1423, DOI 10.1093/oxfordjournals.jbchem.a133334; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Passarella S, 2008, FEBS LETT, V582, P3569, DOI 10.1016/j.febslet.2008.09.042; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; RAYMOND P, 1992, PLANT PHYSIOL BIOCH, V30, P153; Reed DW, 1999, J BACTERIOL, V181, P7580, DOI 10.1128/JB.181.24.7580-7587.1999; REEVES HC, 1962, J BACTERIOL, V84, P186, DOI 10.1128/JB.84.1.186-187.1962; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Struys EA, 2006, J INHERIT METAB DIS, V29, P21, DOI 10.1007/s10545-006-0317-9; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; SUN ZY, 1995, BBA-PROTEIN STRUCT M, V1252, P269, DOI 10.1016/0167-4838(95)00120-J; TALESA V, 1990, BIOCHEM INT, V22, P1115; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; TUBBS PK, 1961, BIOCHEM J, V81, P104, DOI 10.1042/bj0810104; van den Brink DM, 2004, MOL GENET METAB, V82, P33, DOI 10.1016/j.ymgme.2004.01.019; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu Y, 2006, J BIOL CHEM, V281, P26702, DOI 10.1074/jbc.M604758200; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zolman BK, 2001, J BIOL CHEM, V276, P31037, DOI 10.1074/jbc.M104679200	59	97	101	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25026	25037		10.1074/jbc.M109.021253	http://dx.doi.org/10.1074/jbc.M109.021253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19586914	hybrid, Green Published			2022-12-25	WOS:000269734000038
J	Epis, MR; Giles, KM; Barker, A; Kendrick, TS; Leedman, PJ				Epis, Michael R.; Giles, Keith M.; Barker, Andrew; Kendrick, Tulene S.; Leedman, Peter J.			miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MICRORNA EXPRESSION; MESSENGER-RNA; PHOSPHO-AKT; TRASTUZUMAB; PROGRESSION; MODULATION; INHIBITION; HER-2/NEU; MECHANISM	MicroRNAs (miRNAs) are short, non-coding RNAs that regulate gene expression and are aberrantly expressed in human cancer. The ERBB-2 tyrosine kinase receptor is frequently over-expressed in prostate cancer and is associated with disease progression and poor survival. We have identified two specific miR-331-3p target sites within the ERBB-2 mRNA 3'-untranslated region and show that miR-331-3p expression is decreased in prostate cancer tissue relative to normal adjacent prostate tissue. Transfection of multiple prostate cancer cell lines with miR-331-3p reduced ERBB-2 mRNA and protein expression and blocked downstream phosphatidylinositol 3-kinase/AKT signaling. Furthermore, miR-331-3p transfection blocked the androgen receptor signaling pathway in prostate cancer cells, reducing activity of an androgen-stimulated prostate-specific antigen promoter and blocking prostate-specific antigen expression. Our findings provide insight into the regulation of ERBB-2 expression in cancer and suggest that miR-331-3p has the capacity to regulate signaling pathways critical to the development and progression of prostate cancer cells.	Univ Western Australia, Lab Canc Med, Med Res Ctr, Western Australian Inst Med Res, Perth, WA 6000, Australia; Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia	University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peterl@waimr.uwa.edu.au	Leedman, Peter J/O-4044-2014; Barker, Andrew/A-4289-2013		National Health and Medical Research Council of Australia; Cancer Council of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia)	This work was supported by the National Health and Medical Research Council of Australia and the Cancer Council of Western Australia.	Albanell J, 2003, ADV EXP MED BIOL, V532, P253; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco AR, 2004, J CHEMOTHERAPY, V16, P52, DOI 10.1179/joc.2004.16.Supplement-1.52; Bradbury J, 2007, LANCET ONCOL, V8, P287, DOI 10.1016/S1470-2045(07)70090-6; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Festuccia C, 2008, INT J ONCOL, V33, P381, DOI 10.3892/ijo_00000019; Festuccia C, 2007, ENDOCR-RELAT CANCER, V14, P601, DOI 10.1677/ERC-07-0118; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Gravina GL, 2009, UROLOGY, V74, P452, DOI 10.1016/j.urology.2009.01.018; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Isharwal S, 2008, INT J CANCER, V123, P2636, DOI 10.1002/ijc.23838; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Liu YB, 2005, CANCER RES, V65, P3404, DOI 10.1158/0008-5472.CAN-04-4292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Selcuklu SD, 2009, CANCER GENET CYTOGEN, V189, P15, DOI 10.1016/j.cancergencyto.2008.09.009; Shi XB, 2004, PROSTATE, V60, P257, DOI 10.1002/pros.20039; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Small EJ, 2001, SEMIN ONCOL, V28, P71, DOI 10.1053/sonc.2001.26908; Solit DB, 2007, J CLIN ONCOL, V25, P241, DOI 10.1200/JCO.2006.08.8187; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Vernimmen D, 2003, BRIT J CANCER, V89, P899, DOI 10.1038/sj.bjc.6601200; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	54	131	137	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24696	24704		10.1074/jbc.M109.030098	http://dx.doi.org/10.1074/jbc.M109.030098			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584056	hybrid, Green Published			2022-12-25	WOS:000269734000004
J	Shiozawa, K; Konarev, PV; Neufeld, C; Wilmanns, M; Svergun, DI				Shiozawa, Kumiko; Konarev, Petr V.; Neufeld, Christian; Wilmanns, Matthias; Svergun, Dmitri I.			Solution Structure of Human Pex5.Pex14.PTS1 Protein Complexes Obtained by Small Angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR PEX5P; PEROXISOMAL CYCLING RECEPTOR; TARGETING SIGNAL-1 RECEPTOR; BIOLOGICAL MACROMOLECULES; SYNCHROTRON-RADIATION; RECOGNITION; MEMBRANE; TRANSLOCATION; DOMAINS; PEX14	The Pex5p receptor recognizes newly synthesized peroxisomal matrix proteins which have a C-terminal peroxisomal targeting signal to the peroxisome. After docking to protein complexes on the membrane, these proteins are translocated across the membrane. The docking mechanism remains unclear, as no structural data on the multicomponent docking complex are available. As the interaction of the cargo-loaded Pex5p receptor and the peroxisomal membrane protein Pex14p is the essential primary docking step, we have investigated the solution structure of these complexes by small angle x-ray scattering and static light scattering. Titration studies yielded a 1:6 stoichiometry for the Pex5p.Pex14p complex, and low resolution structural models were reconstructed from the x-ray scattering data. The free full-length human Pex5p is monomeric in solution, with an elongated, partially unfolded N-terminal domain. The model of the complex reveals that the N terminus of Pex5p remains extended in the presence of cargo and Pex14p, the latter proteins being significantly intermingled with the Pex5p moiety. These results suggest that the extended structure of Pex5p may play a role in interactions with other substrates such as lipids and membrane proteins during the formation of functional multiprotein complexes.	[Shiozawa, Kumiko; Konarev, Petr V.; Neufeld, Christian; Wilmanns, Matthias; Svergun, Dmitri I.] DESY, European Mol Biol Lab Hamburg Outstn, D-22603 Hamburg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Svergun, DI (corresponding author), DESY, European Mol Biol Lab Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	svergun@embl-hamburg.de	Konarev, Petr V/W-1380-2017	Svergun, Dmitri/0000-0003-0830-5696; Konarev, Petr/0000-0002-5606-1596; Wilmanns, Matthias/0000-0002-4643-5435	European Commission [LSHG-CT-2005512028]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Supported by Integrated Project 3D Repertoire LSHG-CT-2005512028 from the European Commission (to M.W.).	Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Brown LA, 2003, J CELL MOL MED, V7, P388, DOI 10.1111/j.1582-4934.2003.tb00241.x; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kumar A, 2001, J MOL BIOL, V307, P271, DOI 10.1006/jmbi.2000.4465; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Moscicka KB, 2007, FEBS LETT, V581, P1758, DOI 10.1016/j.febslet.2007.03.061; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G, 1982, GEN THEORY SMALL ANG, P17; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rubinstein M, 2003, POLYM PHYS; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Stanley WA, 2004, J SYNCHROTRON RADIAT, V11, P490, DOI 10.1107/S090904950402504X; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Stanley WA, 2007, ARCH BIOCHEM BIOPHYS, V461, P50, DOI 10.1016/j.abb.2007.02.026; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345	42	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25334	25342		10.1074/jbc.M109.002311	http://dx.doi.org/10.1074/jbc.M109.002311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584060	Green Published, hybrid			2022-12-25	WOS:000269734000066
J	Thompson, D; Hakala, K; DeMartino, GN				Thompson, David; Hakala, Kevin; DeMartino, George N.			Subcomplexes of PA700, the 19 S Regulator of the 26 S Proteasome, Reveal Relative Roles of AAA Subunits in 26 S Proteasome Assembly and Activation and ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; 20S PROTEASOME; DEPENDENT ACTIVATOR; CORE PARTICLE; PURIFICATION; DEGRADATION; PATHWAY; COMPLEX; BINDING; RECOGNITION	We have identified, purified, and characterized three subcomplexes of PA700, the 19 S regulatory complex of the 26 S proteasome. These subcomplexes (denoted PS-1, PS-2, and PS-3) collectively account for all subunits present in purified PA700 but contain no overlapping components or significant levels of non-PA700 proteins. Each subcomplex contained two of the six AAA subunits (Rpt1-6) that form the binding interface of PA700 with the 20 S proteasome, the protease component of the 26 S proteasome. Unlike intact PA700, no individual PA700 subcomplex displayed ATPase activity or proteasome activating activity. However, both activities were manifested by ATP-dependent in vitro reconstitution of PA700 from the subcomplexes. We exploited functional reconstitution to define and distinguish roles of different PA700 subunits in PA700 function by selective alteration of subunits within individual subcomplexes prior to reconstitution. Carboxypeptidase treatment of either PS-2 or PS-3, subcomplexes containing specific Rpt subunits previously shown to have important roles in 26 S proteasome assembly and activation, inhibited these processes but did not affect PA700 reconstitution or ATPase activity. Thus, the intact C termini of both subunits are required for 26 S proteasome assembly and activation but not for PA700 reconstitution. Surprisingly, carboxypeptidase treatment of PS-1 also inhibited 26 S proteasome assembly and activation upon reconstitution with untreated PS-2 and PS-3. These results suggest a previously unidentified role for other PA700 subunits in 26 S proteasome assembly and activation. Our results reveal relative structural and functional relationships among the AAA subunits of PA700 and new insights about mechanisms of 26 S proteasome assembly and activation.	[Thompson, David; Hakala, Kevin; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	HHgeorge.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; The Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by The Welch Foundation Grant I-500 (to G.N.D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen CA, 2008, PROTEOMICS, V8, P508, DOI 10.1002/pmic.200700588; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hastings R, 1999, MOL BIOL REP, V26, P35, DOI 10.1023/A:1006903903534; Hastings RA, 1999, J BIOL CHEM, V274, P25691, DOI 10.1074/jbc.274.36.25691; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; RYAN CA, 1974, J BIOL CHEM, V249, P5495; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	74	45	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24891	24903		10.1074/jbc.M109.023218	http://dx.doi.org/10.1074/jbc.M109.023218			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19589775	Green Published, hybrid			2022-12-25	WOS:000269734000023
J	Suree, N; Liew, CK; Villareal, VA; Thieu, W; Fadeev, EA; Clemens, JJ; Jung, ME; Clubb, RT				Suree, Nuttee; Liew, Chu Kong; Villareal, Valerie A.; Thieu, William; Fadeev, Evgeny A.; Clemens, Jeremy J.; Jung, Michael E.; Clubb, Robert T.			The Structure of the Staphylococcus aureus Sortase-Substrate Complex Reveals How the Universally Conserved LPXTG Sorting Signal Is Recognized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION; IMIDAZOLIUM ION-PAIR; MODEL-FREE APPROACH; CELL-WALL ENVELOPE; SURFACE-PROTEINS; ACTIVE-SITE; TRANSPEPTIDASE-SRTA; KINETIC MECHANISM	In Gram-positive bacteria, sortase enzymes assemble surface proteins and pili in the cell wall envelope. Sortases catalyze a transpeptidation reaction that joins a highly conserved LPXTG sorting signal within their polypeptide substrate to the cell wall or to other pilin subunits. The molecular basis of transpeptidation and sorting signal recognition are not well understood, because the intermediates of catalysis are short lived. We have overcome this problem by synthesizing an analog of the LPXTG signal whose stable covalent complex with the enzyme mimics a key thioacyl catalytic intermediate. Here we report the solution structure and dynamics of its covalent complex with the Staphylococcus aureus SrtA sortase. In marked contrast to a previously reported crystal structure, we show that SrtA adaptively recognizes the LPXTG sorting signal by closing and immobilizing an active site loop. We have also used chemical shift mapping experiments to localize the binding site for the triglycine portion of lipid II, the second substrate to which surface proteins are attached. We propose a unified model of the transpeptidation reaction that explains the functions of key active site residues. Since the sortase-catalyzed anchoring reaction is required for the virulence of a number of bacterial pathogens, the results presented here may facilitate the development of new anti-infective agents.	[Suree, Nuttee; Liew, Chu Kong; Villareal, Valerie A.; Thieu, William; Fadeev, Evgeny A.; Clemens, Jeremy J.; Jung, Michael E.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Suree, Nuttee; Villareal, Valerie A.; Thieu, William; Fadeev, Evgeny A.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	Liew, Chu Kong/H-1437-2011		National Institutes of Health [AI52217]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217 ( to R. T. C. and M. E. J.).	Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Iwahara J, 2005, PROTEIN SCI, V14, P1140, DOI 10.1110/ps.041154405; Iwahara J, 2002, EMBO J, V21, P1197, DOI 10.1093/emboj/21.5.1197; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Keller R., 2004, COMPUTER AIDED RESON, V1; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	72	143	151	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24465	24477		10.1074/jbc.M109.022624	http://dx.doi.org/10.1074/jbc.M109.022624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19592495	hybrid, Green Published			2022-12-25	WOS:000269380200059
J	Yuan, FH; El Hokayem, J; Zhou, W; Zhang, YB				Yuan, Fenghua; El Hokayem, Jimmy; Zhou, Wen; Zhang, Yanbin			FANCI Protein Binds to DNA and Interacts with FANCD2 to Recognize Branched Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; ANEMIA CORE COMPLEX; DAMAGE RESPONSE; MONOUBIQUITINATED FANCD2; REPLICATION FORKS; S-PHASE; REPAIR; PATHWAY; BRCA1; IDENTIFICATION	In this study, we report that the purified wild-type FANCI (Fanconi anemia complementation group I) protein directly binds to a variety of DNA substrates. The DNA binding domain roughly encompasses residues 200-1000, as suggested by the truncation study. When co-expressed in insect cells, a small fraction of FANCI forms a stable complex with FANCD2 (Fanconi anemia complementation group D2). Intriguingly, the purified FANCI-FANCD2 complex preferentially binds to the branched DNA structures when compared with either FANCI or FANCD2 alone. Co-immunoprecipitation with purified proteins indicates that FANCI interacts with FANCD2 through its C-terminal amino acid 1001-1328 fragment. Although the C terminus of FANCI is dispensable for direct DNA binding, it seems to be involved in the regulation of DNA binding activity. This notion is further enhanced by two C-terminal point mutations, R1285Q and D1301A, which showed differentiated DNA binding activity. We also demonstrate that FANCI forms discrete nuclear foci in HeLa cells in the absence or presence of exogenous DNA damage. The FANCI foci are colocalized perfectly with FANCD2 and partially with proliferating cell nuclear antigen irrespective of mitomycin C treatment. An increased number of FANCI foci form and become resistant to Triton X extraction in response to mitomycin C treatment. Our data suggest that the FANCI-FANCD2 complex may participate in repair of damaged replication forks through its preferential recognition of branched structures.	[Yuan, Fenghua; El Hokayem, Jimmy; Zhou, Wen; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Zhang, Yanbin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Zhang, YB (corresponding author), Gautier Bldg,Rm 310,1011 NW 15th St, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Yuan, Fenghua/F-8736-2011; Zhang, Yanbin/F-2998-2011; Zhou, Wen/A-5763-2010	Zhang, Yanbin/0000-0002-7263-5510; Zhou, Wen/0000-0002-5496-5815	University of Miami/Sylvester Pap Corps Cancer Research Development; Florida Bankhead-Coley Cancer Research Program	University of Miami/Sylvester Pap Corps Cancer Research Development; Florida Bankhead-Coley Cancer Research Program	This work was supported in part by a University of Miami/Sylvester Pap Corps Cancer Research Development Grant and the Florida Bankhead-Coley Cancer Research Program.	Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Demuth I, 2000, EUR J HUM GENET, V8, P861, DOI 10.1038/sj.ejhg.5200552; Dorsman JC, 2007, CELL ONCOL, V29, P211; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; Friedberg E. C., 2005, DNA REPAIR MUTAGENES, P9; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koester SK, 2001, METHOD CELL BIOL, V63, P253; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Levitus M, 2006, CELL ONCOL, V28, P3; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Meetei AR, 2004, CELL CYCLE, V3, P179; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Stone S, 2007, GENES CELLS, V12, P841, DOI 10.1111/j.1365-2443.2007.01096.x; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Thompson LH, 2005, ENVIRON MOL MUTAGEN, V45, P128, DOI 10.1002/em.20109; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	54	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24443	24452		10.1074/jbc.M109.016006	http://dx.doi.org/10.1074/jbc.M109.016006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19561358	Green Published, hybrid			2022-12-25	WOS:000269380200057
J	Monzani, E; Bazzotti, R; Perego, C; La Porta, CAM				Monzani, Elena; Bazzotti, Riccardo; Perego, Carla; La Porta, Caterina A. M.			AQP1 Is Not Only a Water Channel: It Contributes to Cell Migration through Lin7/Beta-Catenin	PLOS ONE			English	Article							BASOLATERAL MEMBRANE; PROTEIN COMPLEX; AQUAPORIN-1; LIN-7; LOCALIZATION; ASSOCIATION; EXPRESSION; ADHESION; LET-23; FAMILY	Background: AQP1 belongs to aquaporins family, water-specific, membrane-channel proteins expressed in diverse tissues. Recent papers showed that during angiogenesis, AQP1 is expressed preferentially by microvessels, favoring angiogenesis via the increase of permeability In particular, in AQP1 null mice, endothelial cell migration is impaired without altering their proliferation or adhesion. Therefore, AQP1 has been proposed as a novel promoter of tumor angiogenesis. Methods/Findings: Using targeted silencing of AQP1 gene expression, an impairment in the organization of F-actin and a reduced migration capacity was demonstrated in human endothelial and melanoma cell lines. Interestingly, we showed, for the first time, that AQP1 co-immunoprecipitated with Lin-7. Lin7-GFP experiments confirmed co-immunoprecipitation. In addition, the knock down of AQP1 decreased the level of expression of Lin-7 and beta-catenin and the inhibition of proteasome contrasted partially such a decrease. Conclusions/Significance: All together, our findings show that AQP1 plays a role inside the cells through Lin-7/beta-catenin interaction. Such a role of AQP1 is the same in human melanoma and endothelial cells, suggesting that AQP1 plays a global physiological role. A model is presented.			Monzani, E (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	caterina.laporta@unimi.it	Monzani, Elena/AAN-2505-2020; Perego, Carla/L-6147-2015; la porta, caterina/K-7345-2013	Perego, Carla/0000-0003-3027-1779; la porta, caterina/0000-0002-3010-8966				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P1, DOI 10.1016/j.tem.2005.11.009; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; ELENAMONZANI, 2007, EUR J CANCER, V43, P935; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; La Porta CAM, 2002, MELANOMA RES, V12, P297, DOI 10.1097/00008390-200208000-00001; Landon S, 2004, NATURE REV MOL BIOL, V5, P687; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Monzani E, 2007, CURR DRUG TARGETS, V8, P1132, DOI 10.2174/138945007782151342; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; PAPDOPOULOS MC, 2008, PFUGER ARCH, V456, P693; Perego C, 1999, EMBO J, V18, P2384, DOI 10.1093/emboj/18.9.2384; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Rodriguez A, 2006, FEBS LETT, V580, P4771, DOI 10.1016/j.febslet.2006.07.080; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519	33	89	99	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2009	4	7							e6167	10.1371/journal.pone.0006167	http://dx.doi.org/10.1371/journal.pone.0006167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468HA	19584911	Green Submitted, Green Published, gold			2022-12-25	WOS:000267806500004
J	Lima, SQ; Hromadka, T; Znamenskiy, P; Zador, AM				Lima, Susana Q.; Hromadka, Tomas; Znamenskiy, Petr; Zador, Anthony M.			PINP: A New Method of Tagging Neuronal Populations for Identification during In Vivo Electrophysiological Recording	PLOS ONE			English	Article								Neural circuits are exquisitely organized, consisting of many different neuronal subpopulations. However, it is difficult to assess the functional roles of these subpopulations using conventional extracellular recording techniques because these techniques do not easily distinguish spikes from different neuronal populations. To overcome this limitation, we have developed PINP (Photostimulation-assisted Identification of Neuronal Populations), a method of tagging neuronal populations for identification during in vivo electrophysiological recording. The method is based on expressing the light-activated channel channelrhodopsin-2 (ChR2) to restricted neuronal subpopulations. ChR2-tagged neurons can be detected electrophysiologically in vivo since illumination of these neurons with a brief flash of blue light triggers a short latency reliable action potential. We demonstrate the feasibility of this technique by expressing ChR2 in distinct populations of cortical neurons using two different strategies. First, we labeled a subpopulation of cortical neurons-mainly fast-spiking interneurons-by using adeno-associated virus (AAV) to deliver ChR2 in a transgenic mouse line in which the expression of Cre recombinase was driven by the parvalbumin promoter. Second, we labeled subpopulations of excitatory neurons in the rat auditory cortex with ChR2 based on projection target by using herpes simplex virus 1 (HSV1), which is efficiently taken up by axons and transported retrogradely; we find that this latter population responds to acoustic stimulation differently from unlabeled neurons. Tagging neurons is a novel application of ChR2, used in this case to monitor activity instead of manipulating it. PINP can be readily extended to other populations of genetically identifiable neurons, and will provide a useful method for probing the functional role of different neuronal populations in vivo.			Lima, SQ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136; Lima, Susana/0000-0003-2446-9869; Znamenskiy, Petr/0000-0002-4658-6807				Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Cauli B, 1997, J NEUROSCI, V17, P3894; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Preston CM, 2000, J GEN VIROL, V81, P1; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Turner JG, 2005, J NEUROPHYSIOL, V94, P2738, DOI 10.1152/jn.00362.2005; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3; Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105	46	239	240	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6099	10.1371/journal.pone.0006099	http://dx.doi.org/10.1371/journal.pone.0006099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19584920	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000267806400002
J	Xanthoulea, S; Thelen, M; Pottgens, C; Gijbels, MJJ; Lutgens, E; de Winther, MPJ				Xanthoulea, Sofia; Thelen, Melanie; Pottgens, Chantal; Gijbels, Marion J. J.; Lutgens, Esther; de Winther, Menno P. J.			Absence of p55 TNF Receptor Reduces Atherosclerosis, but Has No Major Effect on Angiotensin II Induced Aneurysms in LDL Receptor Deficient Mice	PLOS ONE			English	Article								Background: The aim of the current study was to investigate the role of p55 TNF Receptor (p55 TNFR), the main signaling receptor for the pro-inflammatory cytokine tumor necrosis factor (TNF), in the development of two vascular disorders: atherosclerosis and angiotensin (Ang) II-induced abdominal aortic aneurysms (AAA). Methodology/Principal Findings: p55 TNFR deficient mice were crossed to an LDL receptor deficient background and were induced for the development of either atherosclerosis or AngII-induced AAA, and compared to littermate controls, wild-type for p55 TNFR expression. p55 TNFR deficient mice developed 43% smaller atherosclerotic lesions in the aortic sinuses compared to controls. Moreover, expression of CD68, a macrophage specific marker, exhibited a 50% reduction in the aortic arches. Decreased atherosclerosis correlated with a strong down-regulation in the expression of adhesion molecules, such as VCAM-1 and ICAM-1, by p55 TNFR deficient endothelium. In addition, expression levels of the pro-inflammatory cytokines and chemokines TNF, IL-6, MCP-1 and RANTES were significantly reduced in aortas of p55 TNFR deficient mice. In contrast, in the AngII-induced model of AAA, p55 TNFR deficiency correlated with a slight trend towards increased aneurismal lethality, but the incidence of aortic rupture due to a dissecting aneurysm, and the expansion of the suprarenal aorta were not significantly different compared to controls. Conclusion/Significance: We found that p55 TNFR expression promotes atherosclerosis, among other mechanisms, by enhancing expression of endothelial adhesion molecules, while it seems to have no major role in the development of AngII-induced AAA.			Xanthoulea, S (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands.	dewinther@gen.unimaas.nl	de Winther, Menno/E-8721-2012; Lutgens, Esther/E-2919-2010	Lutgens, Esther/0000-0002-2609-5744; xanthoulea, sofia/0000-0003-4700-3404; Thelen, Melanie/0000-0003-0707-5921; de Winther, Menno/0000-0002-4038-6636				Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Blessing E, 2004, ATHEROSCLEROSIS, V176, P227, DOI 10.1016/j.atherosclerosis.2004.05.033; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Canault M, 2004, ATHEROSCLEROSIS, V172, P211, DOI 10.1016/j.atherosclerosis.2003.10.004; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; Fiane AE, 2003, CIRCULATION, V108, P849, DOI 10.1161/01.CIR.0000084550.16565.01; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Hamano K, 2003, WORLD J SURG, V27, P476, DOI 10.1007/s00268-002-6690-0; Hui-Yuen JS, 2006, J IMMUNOL, V176, P6294, DOI 10.4049/jimmunol.176.10.6294; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; King VL, 2009, CIRCULATION, V119, P426, DOI 10.1161/CIRCULATIONAHA.108.785949; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; MEMON RA, 1993, ENDOCRINOLOGY, V132, P2246, DOI 10.1210/en.132.5.2246; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Neumann B, 1996, J IMMUNOL, V156, P1587; Newburger Jane W, 2007, Curr Treat Options Cardiovasc Med, V9, P148, DOI 10.1007/s11936-007-0008-3; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Schreyer SA, 1996, J BIOL CHEM, V271, P26174, DOI 10.1074/jbc.271.42.26174; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xanthoulea S, 2005, CURR OPIN LIPIDOL, V16, P536, DOI 10.1097/01.mol.0000180167.15820.ae; XANTHOULEA S, 2008, CARDIOVASC RES; ZERNECKE A, 2008, ARTERIOSCLER THROMB; Zhang LS, 2007, ARTERIOSCL THROM VAS, V27, P1087, DOI 10.1161/01.ATV.0000261548.49790.63	37	39	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2009	4	7							e6113	10.1371/journal.pone.0006113	http://dx.doi.org/10.1371/journal.pone.0006113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GZ	19582157	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806400003
J	Zhang, HJ; Wang, YX; Wu, H; Jin, DY; Wen, YM; Zheng, BJ				Zhang, Hao-Jie; Wang, Yong-Xiang; Wu, Hao; Jin, Dong-Yan; Wen, Yu-Mei; Zheng, Bo-Jian			The Y271 and I274 Amino Acids in Reverse Transcriptase of Human Immunodeficiency Virus-1 Are Critical to Protein Stability	PLOS ONE			English	Article								Reverse transcriptase (RT) of human immunodeficiency virus (HIV)-1 plays a key role in initiating viral replication and is an important target for developing anti-HIV drugs. Our previous study showed that two mutations (Y271A and I274A) in the turn RT (Gln(269)-Arg(277))abrogated viral replication, but the replication capacity and RT activity was discordant. In this study, we further investigated why alanine substitutions at these two sites would affect viral replication. We found that both RT activity and RT protein were almost undetectable in viral particles of these two mutants, although the Pr160(gag-pol) mutants were properly expressed, transported and incorporated. Using protease inhibition assay, we demonstrated a correlation between the degradation of the RT mutants and the activity of viral protease. Our native gel analysis indicated that the mutations at 271 and 274 amino acids might cause conformational changes, leading to the formation of higher order oligomers instead of dimers, resulting in increased protein instability and susceptibility to viral protease. Thus, residues 271 and 274 are critical to RT stability and resistance to viral protease. The conservation of the two amino acid residues among different strains of HIV-1 lent further support to this conclusion. The knowledge gained here may prove useful in drug design.			Zhang, HJ (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	ymwen@shmu.edu.cn; bzheng@hkucc.hku.hk	wen, yu/AAJ-7482-2021					Abram ME, 2005, J VIROL, V79, P11952, DOI 10.1128/JVI.79.18.11952-11961.2005; Beard WA, 1996, J BIOL CHEM, V271, P12213, DOI 10.1074/jbc.271.21.12213; BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; COOK PR, 1993, J GEN VIROL, V74, P691, DOI 10.1099/0022-1317-74-4-691; Debyser Z, 1996, PROTEIN SCI, V5, P278; Divita G, 1995, BIOCHEMISTRY-US, V34, P16337, DOI 10.1021/bi00050a014; Gao HQ, 1998, J MOL BIOL, V277, P559, DOI 10.1006/jmbi.1998.1624; GOEL R, 1993, BIOCHEMISTRY-US, V32, P13012, DOI 10.1021/bi00211a009; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; HERMANN T, 1994, NUCLEIC ACIDS RES, V22, P4625, DOI 10.1093/nar/22.22.4625; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JACOBOMOLINA A, 1991, BIOCHEMISTRY-US, V30, P6351, DOI 10.1021/bi00240a001; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEBOWITZ J, 1994, PROTEIN SCI, V3, P1374, DOI 10.1002/pro.5560030903; Liao WH, 2007, J VIROL, V81, P5155, DOI 10.1128/JVI.01796-06; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Powell MD, 1999, J BIOL CHEM, V274, P19885, DOI 10.1074/jbc.274.28.19885; RESTLE T, 1990, J BIOL CHEM, V265, P8986; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; SRINIVASAKUMAR N, 1995, J VIROL, V69, P6106, DOI 10.1128/JVI.69.10.6106-6114.1995; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Takehisa J, 2007, J VIROL, V81, P7463, DOI 10.1128/JVI.00551-07; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wang YX, 2007, J MED VIROL, V79, P676, DOI 10.1002/jmv.20835; Wang YX, 2007, FEBS LETT, V581, P558, DOI 10.1016/j.febslet.2007.01.024; Wang YX, 2008, BIOCHEM BIOPH RES CO, V377, P915, DOI 10.1016/j.bbrc.2008.10.106; Wapling J, 2005, J VIROL, V79, P10247, DOI 10.1128/JVI.79.16.10247-10257.2005; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Yu Q, 1998, J VIROL, V72, P7676, DOI 10.1128/JVI.72.9.7676-7680.1998; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; ZHENG BJ, 1993, VACCINE, V11, P1191, DOI 10.1016/0264-410X(93)90042-V	46	137	142	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6108	10.1371/journal.pone.0006108	http://dx.doi.org/10.1371/journal.pone.0006108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578544	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806300001
J	Ammann, CG; Messer, RJ; Peterson, KE; Hasenkrug, KJ				Ammann, Christoph G.; Messer, Ronald J.; Peterson, Karin E.; Hasenkrug, Kim J.			Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFN alpha Responses by Plasmacytoid Dendritic Cells	PLOS ONE			English	Article								Background: Lactate dehydrogenase-elevating virus (LDV) is a natural infectious agent of mice. Like several other viruses, LDV causes widespread and very rapid but transient activation of both B cells and T cells in lymphoid tissues and the blood. The mechanism of this activation has not been fully described and is the focus of the current studies. Principal Findings: A known inducer of early lymphocyte activation is IFN alpha, a cytokine strongly induced by LDV infection. Neutralization of IFN alpha in the plasma from infected mice ablated its ability to activate lymphocytes in vitro. Since the primary source of virus-induced IFN alpha in vivo is often plasmacytoid dendritic cells (pDC's), we depleted these cells prior to LDV infection and tested for lymphocyte activation. Depletion of pDC's in vivo eradicated both the LDV-induced IFN alpha response and lymphocyte activation. A primary receptor in pDC's for single stranded RNA viruses such as LDV is the toll-like receptor 7 (TLR7) pattern recognition receptor. Infection of TLR7-knockout mice revealed that both the IFN alpha response and lymphocyte activation were dependent on TLR7 signaling in vivo. Interestingly, virus levels in both TLR7 knockout mice and pDC-depleted mice were indistinguishable from controls indicating that LDV is largely resistant to the systemic IFN alpha response. Conclusion: Results indicate that LDV-induced activation of lymphocytes is due to recognition of LDV nucleic acid by TLR7 pattern recognition receptors in pDC's that respond with a lymphocyte-inducing IFN alpha response.			Ammann, CG (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	khasenkrug@nih.gov	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249; Ammann, Christoph/0000-0002-6267-1286	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000753, ZIAAI000753] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; ALSHARIFI M, 2008, IMMUNOL CELL BIOL; Alsharifi M, 2006, J IMMUNOL, V177, P3235, DOI 10.4049/jimmunol.177.5.3235; ANDERSON GW, 1995, J NEUROVIROL, V1, P244, DOI 10.3109/13550289509114020; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CONTAG CH, 1988, MICROB PATHOGENESIS, V5, P287, DOI 10.1016/0882-4010(88)90101-5; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; HOWARD RJ, 1969, NATURE, V221, P873, DOI 10.1038/221873a0; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le-Thi-Phuong T, 2007, J GEN VIROL, V88, P3063, DOI 10.1099/vir.0.83242-0; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; LOWENTHAL JW, 1988, P NATL ACAD SCI USA, V85, P4468, DOI 10.1073/pnas.85.12.4468; Marques R, 2008, J IMMUNOL, V181, P3432, DOI 10.4049/jimmunol.181.5.3432; NOTKINS AL, 1962, P SOC EXP BIOL MED, V109, P988; ONYEKABA CO, 1989, VIRUS RES, V14, P297, DOI 10.1016/0168-1702(89)90023-3; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; PLAGEMANN PGW, 1995, SPRINGER SEMIN IMMUN, V17, P167; PLAGEMANN PGW, 1992, ADV VIRUS RES, V41, P99, DOI 10.1016/S0065-3527(08)60036-6; RILEY V, 1960, SCIENCE, V132, P545, DOI 10.1126/science.132.3426.545; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; STUECKEMANN JA, 1982, J GEN VIROL, V59, P263, DOI 10.1099/0022-1317-59-2-263; STUECKEMANN JA, 1982, J GEN VIROL, V59, P245, DOI 10.1099/0022-1317-59-2-245; vandenBroek MF, 1997, J IMMUNOL, V159, P1585	33	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6105	10.1371/journal.pone.0006105	http://dx.doi.org/10.1371/journal.pone.0006105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568424	Green Submitted, gold, Green Published			2022-12-25	WOS:000267572200008
J	Long, D; Mu, YG; Yang, DW				Long, Dong; Mu, Yuguang; Yang, Daiwen			Molecular Dynamics Simulation of Ligand Dissociation from Liver Fatty Acid Binding Protein	PLOS ONE			English	Article								The mechanisms of how ligands enter and leave the binding cavity of fatty acid binding proteins (FABPs) have been a puzzling question over decades. Liver fatty acid binding protein (LFABP) is a unique family member which accommodates two molecules of fatty acids in its cavity and exhibits the capability of interacting with a variety of ligands with different chemical structures and properties. Investigating the ligand dissociation processes of LFABP is thus a quite interesting topic, which however is rather difficult for both experimental approaches and ordinary simulation strategies. In the current study, random expulsion molecular dynamics simulation, which accelerates ligand motions for rapid dissociation, was used to explore the potential egress routes of ligands from LFABP. The results showed that the previously hypothesized "portal region" could be readily used for the dissociation of ligands at both the low affinity site and the high affinity site. Besides, one alternative portal was shown to be highly favorable for ligand egress from the high affinity site and be related to the unique structural feature of LFABP. This result lends strong support to the hypothesis from the previous NMR exchange studies, which in turn indicates an important role for this alternative portal. Another less favored potential portal located near the N-terminal end was also identified. Identification of the dissociation pathways will allow further mechanistic understanding of fatty acid uptake and release by computational and/or experimental techniques.	[Long, Dong; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Long, D (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	ygmu@ntu.edu.sg; dbsydw@nus.edu.sg	yang, daiwen/H-8408-2012; Mu, Yuguang/A-9558-2010	yang, daiwen/0000-0002-6804-0071; 				BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Friedman R, 2006, BIOPHYS J, V90, P1535, DOI 10.1529/biophysj.105.071571; Friedman R, 2005, BIOCHEMISTRY-US, V44, P4275, DOI 10.1021/bi048236t; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Jenkins AE, 2002, BIOCHEMISTRY-US, V41, P2022, DOI 10.1021/bi015769i; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirk WR, 1996, BIOPHYS J, V70, P69, DOI 10.1016/S0006-3495(96)79592-9; Likic VA, 2001, PROTEINS, V43, P65, DOI 10.1002/1097-0134(20010401)43:1<65::AID-PROT1018>3.0.CO;2-F; Likic VA, 1999, PROTEIN SCI, V8, P1649, DOI 10.1110/ps.8.8.1649; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Mihajlovic M, 2007, PROTEIN SCI, V16, P2042, DOI 10.1110/ps.072875307; Ory J, 1997, J BIOL CHEM, V272, P9793; PIGACHE A, 27 ACS NAT M AN CA U; Richieri GV, 1999, BIOCHEMISTRY-US, V38, P5888, DOI 10.1021/bi982703n; Richieri GV, 1996, J BIOL CHEM, V271, P31068, DOI 10.1074/jbc.271.49.31068; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Thompson J, 1999, BBA-MOL CELL BIOL L, V1441, P117, DOI 10.1016/S1388-1981(99)00146-8; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Tsfadia Y, 2007, FEBS LETT, V581, P1243, DOI 10.1016/j.febslet.2007.02.033; Velkov T, 2005, J BIOL CHEM, V280, P17769, DOI 10.1074/jbc.M410193200; Wang H, 2002, BIOCHEMISTRY-US, V41, P5453, DOI 10.1021/bi011914g; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Woolf TB, 1998, BIOPHYS J, V74, P694, DOI 10.1016/S0006-3495(98)73995-5; Woolf TB, 2000, BIOPHYS J, V78, P608, DOI 10.1016/S0006-3495(00)76621-5	31	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6081	10.1371/journal.pone.0006081	http://dx.doi.org/10.1371/journal.pone.0006081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564911	Green Submitted, gold, Green Published			2022-12-25	WOS:000267515700003
J	Beghdadi, W; Porcherie, A; Schneider, BS; Morisset, S; Dubayle, D; Peronet, R; Dy, M; Louis, J; Arrang, JM; Mecheri, S				Beghdadi, Walid; Porcherie, Adeline; Schneider, Bradley S.; Morisset, Severine; Dubayle, David; Peronet, Roger; Dy, Michel; Louis, Jacques; Arrang, Jean-Michel; Mecheri, Salaheddine			Histamine H-3 Receptor-Mediated Signaling Protects Mice from Cerebral Malaria	PLOS ONE			English	Article								Background: Histamine is a biogenic amine that has been shown to contribute to several pathological conditions, such as allergic conditions, experimental encephalomyelitis, and malaria. In humans, as well as in murine models of malaria, increased plasma levels of histamine are associated with severity of infection. We reported recently that histamine plays a critical role in the pathogenesis of experimental cerebral malaria (CM) in mice infected with Plasmodium berghei ANKA. Histamine exerts its biological effects through four different receptors designated H1R, H2R, H3R, and H4R. Principal Findings: In the present work, we explored the role of histamine signaling via the histamine H3 receptor (H3R) in the pathogenesis of murine CM. We observed that the lack of H3R expression (H3R(-/-) mice) accelerates the onset of CM and this was correlated with enhanced brain pathology and earlier and more pronounced loss of blood brain barrier integrity than in wild type mice. Additionally tele-methylhistamine, the major histamine metabolite in the brain, that was initially present at a higher level in the brain of H3R(-/-) mice was depleted more quickly post-infection in H3R(-/-) mice as compared to wild-type counterparts. Conclusions: Our data suggest that histamine regulation through the H3R in the brain suppresses the development of CM. Thus modulating histamine signaling in the central nervous system, in combination with standard therapies, may represent a novel strategy to reduce the risk of progression to cerebral malaria.			Beghdadi, W (corresponding author), Inst Pasteur, Unite Reponses Precoces Parasites & Immunopathol, Paris, France.	smecheri@pasteur.fr	MORISSET, Séverine/S-7450-2017; Mecheri, Salah/M-8315-2013	MORISSET, Séverine/0000-0002-9930-7824; Porcherie, Adeline/0000-0002-8177-2461; Schneider, Bradley S/0000-0001-7642-0018				AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; ARRANG JM, 1991, PEPTIDES, V12, P1113, DOI 10.1016/0196-9781(91)90067-Y; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; BERTACCINI G, 1991, ALIMENT PHARM THERAP, V5, P585; BHATTACHARYA U, 1988, INDIAN J MED RES, V88, P558; BURY TB, 1992, ALLERGY, V47, P624, DOI 10.1111/j.1398-9995.1992.tb02385.x; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; CLAPHAM J, 1994, EUR J PHARMACOL, V259, P107, DOI 10.1016/0014-2999(94)90498-7; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Enwonwu CO, 2000, J NEURAL TRANSM, V107, P1273, DOI 10.1007/s007020070017; Gantner F, 2002, J PHARMACOL EXP THER, V303, P300, DOI 10.1124/jpet.102.036939; GARBARG M, 1989, J NEUROCHEM, V53, P1724, DOI 10.1111/j.1471-4159.1989.tb09237.x; GRAU GE, 1986, J IMMUNOL, V136, P686; Herwig A, 2007, J NEUROENDOCRINOL, V19, P1001, DOI 10.1111/j.1365-2826.2007.01620.x; HILL SJ, 1990, PHARMACOL REV, V42, P45; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Ichigi J, 1999, J MOL NEUROSCI, V13, P93, DOI 10.1385/JMN:13:1-2:93; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Kaul DK, 1998, AM J TROP MED HYG, V58, P240, DOI 10.4269/ajtmh.1998.58.240; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; Lin JS, 2000, SLEEP MED REV, V4, P471, DOI 10.1053/smrv.2000.0116; MACKEY LJ, 1980, CLIN EXP IMMUNOL, V42, P412; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; ORR EL, 1989, J NEUROCHEM, V53, P111, DOI 10.1111/j.1471-4159.1989.tb07301.x; Pais TF, 2005, J NEUROIMMUNOL, V163, P73, DOI 10.1016/j.jneuroim.2005.02.009; Passani MB, 2004, TRENDS PHARMACOL SCI, V25, P618, DOI 10.1016/j.tips.2004.10.003; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; RING J, 1985, HISTAMINE ALLERGIC D, P44; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SCHWARTZ JC, 1992, HISTAMINE RECEPTOR; SCHWARTZ JC, 2002, NEUROPSYCHOPHARMACOL, P179; SENALDI G, 1994, INFECT IMMUN, V62, P1144, DOI 10.1128/IAI.62.4.1144-1149.1994; Serviere J, 2003, TOXICOL LETT, V145, P143, DOI 10.1016/S0378-4274(03)00264-9; STANLEY NC, 1990, J NEUROIMMUNOL, V29, P223, DOI 10.1016/0165-5728(90)90165-J; Stevens DR, 2001, BEHAV BRAIN RES, V124, P105, DOI 10.1016/S0166-4328(01)00219-4; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Theodorsson A, 2008, NEUROPEPTIDES, V42, P79, DOI 10.1016/j.npep.2007.09.008; TOHYAMA M, 1998, ATLAS NEUROACTIVE SU, P54; Tokita S, 2006, J PHARMACOL SCI, V101, P12, DOI 10.1254/jphs.FMJ06001X4; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zhang M.-Q., 1997, HISTAMINE H1 RECEPTO, P495; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434	55	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6004	10.1371/journal.pone.0006004	http://dx.doi.org/10.1371/journal.pone.0006004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547708	gold, Green Submitted, Green Published			2022-12-25	WOS:000267347900003
J	Kalthoff, D; Breithaupt, A; Helm, B; Teifke, JP; Beer, M				Kalthoff, Donata; Breithaupt, Angele; Helm, Barbara; Teifke, Jens P.; Beer, Martin			Migratory Status Is Not Related to the Susceptibility to HPAIV H5N1 in an Insectivorous Passerine Species	PLOS ONE			English	Article								Migratory birds have evolved elaborate physiological adaptations to travelling, the implications for their susceptibility to avian influenza are however unknown. Three groups of stonechats (Saxicola torquata) from (I) strongly migrating, (II) weakly migrating and (III) non-migrating populations were experimentally infected with HPAIV H5N1. The different bird groups of this insectivorous passerine species were infected in autumn, when the migrating populations clearly exhibit migratory restlessness. Following infection, all animals succumbed to the disease from 3 through 7 days post inoculation. Viral shedding, antigen distribution in tissues, and survival time did not differ between the three populations. However, notably, endothelial tropism of the HPAIV infection was exclusively seen in the group of resident birds. In conclusion, our data document for the first time the high susceptibility of an insectivorous passerine species to H5N1 infection, and the epidemiological role of these passerine birds is probably limited due to their high sensitivity to HPAIV H5N1 infection. Despite pronounced inherited differences in migratory status, the groups were generally indistinguishable in their susceptibility, survival time, clinical symptoms and viral shedding. Nevertheless, the migratory status partly influenced pathogenesis in the way of viral tropism.	[Kalthoff, Donata] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Breithaupt, Angele; Teifke, Jens P.; Beer, Martin] Friedrich Loeffler Inst, Inst Infectol, Greifswald, Germany; [Helm, Barbara] Max Planck Inst Ornithol Seewiesen & Andechs, Andechs, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Max Planck Society	Kalthoff, D (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	Martin.Beer@fli.bund.de	Breithaupt, Angele/B-6155-2013; Breithaupt, Angele/GON-7227-2022	Breithaupt, Angele/0000-0002-6373-5923; Teifke, Jens/0000-0001-7168-4970; Helm, Barbara/0000-0002-6648-1463; Hoffmann, Donata/0000-0003-4552-031X	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany [1-4.1]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany	This study was funded by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI project no. 1-4.1) in a national influenza research program. The study was approved by the Federal Ministry for support, however there was no further influence on the study or the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Berthold P, 2001, AUK, V2nd; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; GLOBIG A, 2009, TRANSBOUND IN PRESS; Gronesova P, 2008, SCAND J INFECT DIS, V40, P954, DOI 10.1080/00365540802400576; Helm B, 2006, ARDEA, V94, P33; Helm B, 2005, J ORNITHOL, V146, P348, DOI 10.1007/s10336-005-0009-5; Helm B, 2005, ANN NY ACAD SCI, V1046, P216, DOI 10.1196/annals.1343.019; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Hoffmann B, 2007, J CLIN MICROBIOL, V45, P600, DOI 10.1128/JCM.01681-06; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1132, DOI 10.3201/eid1407.071468; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Klopfleisch R, 2007, VET PATHOL, V44, P261, DOI 10.1354/vp.44-3-261; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Kwon YK, 2005, J WILDLIFE DIS, V41, P618, DOI 10.7589/0090-3558-41.3.618; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Magnino S, 2000, VET REC, V146, P740; Matsuda K, 2004, VET PATHOL, V41, P101, DOI 10.1354/vp.41-2-101; NEWMAN S, 2007, EMPRES WATCH     AUG, P1; NORMILE D, 2006, SCIENCE, V312, P845; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Perkins LEL, 2003, VET PATHOL, V40, P14, DOI 10.1354/vp.40-1-14; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Stutzenbaker CD, 1986, LEAD POISONING WILD, P88; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Tanimura N, 2006, VET PATHOL, V43, P500, DOI 10.1354/vp.43-4-500; TEILKE JP, 2007, VET PATHOL, V44, P137; Weber JM, 2009, J EXP BIOL, V212, P593, DOI 10.1242/jeb.015024; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wobeser G.A., 1994, INVESTIGATION MANAGE	42	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	4	7							e6170	10.1371/journal.pone.0006170	http://dx.doi.org/10.1371/journal.pone.0006170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YF	19584935	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000207566200001
J	Nakatani, T; Ohnishi, M; Razzaque, MS				Nakatani, Teruyo; Ohnishi, Mutsuko; Razzaque, M. Shawkat			Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model	FASEB JOURNAL			English	Article						parathyroid hormone; vitamin D; calcification; survival; kidney; NaPi2a	X-LINKED HYPOPHOSPHATEMIA; SOFT-TISSUE CALCIFICATION; MINERAL ION METABOLISM; SHOCK-PROTEIN 47; VITAMIN-D; PHOSPHATE HOMEOSTASIS; PARATHYROID-HORMONE; TUMORAL CALCINOSIS; MISSENSE MUTATION; I COTRANSPORTER	Hyp mice possess a mutation that inactivates the phosphate-regulating gene, which is homologous to the endopeptidases of the X-chromosome (PHEX). The mutation is associated with severe hypophosphatemia due to excessive urinary phosphate wasting. Such urinary phosphate wasting in Hyp mice is associated with an increased serum accumulation of fibroblast growth factor (FGF) 23. We wanted to determine the biological significance of increased serum FGF23 levels and concomitant hypophosphatemia in Hyp mice and to evaluate whether FGF23 activity could be modified by manipulating klotho (a cofactor of FGF23 signaling). We generated Hyp and klotho double-mutant mice (Hyp/klotho(-/-)). Severe hypophosphatemia of Hyp mice was reversed to hyperphosphatemia in Hyp/klotho(-/-) double mutants, despite the fact that the double mutants showed significantly increased serum levels of FGF23. Hyperphosphatemia in Hyp/klotho(-/-) mice was associated with increased renal expression of sodium/phosphate cotransporter 2a (NaPi2a) protein. Exogenous injection of bioactive parathyroid hormone 1-34 down-regulated renal expression of NaPi2a and consequently reduced serum levels of phosphate in Hyp/klotho(-/-) mice. Moreover, in contrast to the Hyp mice, the Hyp/klotho(-/-) mice showed significantly higher serum levels of 1,25-dihydroxyvitamin D and developed extensive calcification in soft tissues and vascular walls. Furthermore, compared with the Hyp mice, Hyp/klotho(-/-) mice were smaller in size, showed features of generalized tissue atrophy, and generally died by 15-20 wk of age. Our in vivo studies provide genetic evidence for a pathological role of increased FGF23 activities in regulating abnormal phosphate homeostasis in Hyp mice. Moreover, these results suggest that even when serum levels of FGF23 are significantly high, in the absence of klotho, FGF23 is unable to regulate systemic phosphate homeostasis. Our in vivo observations have significant clinical implications in diseases associated with increased FGF23 activity and suggest that the functions of FGF23 can be therapeutically modulated by manipulating the effects of klotho.-Nakatani, Y., Ohnishi, M., Razzaque, M. S. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J. 23, 3702-3711 (2009). www.fasebj.org	[Nakatani, Teruyo; Ohnishi, Mutsuko; Razzaque, M. Shawkat] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine	Razzaque, MS (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Room 304,188 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019		National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health [R01-DK077276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077276] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Parts of this research were supported by grant R01-DK077276 (to M. S. R.) from the National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health.	Bai XY, 2007, ENDOCRINOLOGY, V148, P4974, DOI 10.1210/en.2007-0243; Bai XY, 2002, MOL ENDOCRINOL, V16, P2913, DOI 10.1210/me.2002-0113; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Doherty TM, 2004, ENDOCR REV, V25, P629, DOI 10.1210/er.2003-0015; ECAROT B, 1992, J BONE MINER RES, V7, P523; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; Gaasbeek A, 2005, AM J MED, V118, P1094, DOI 10.1016/j.amjmed.2005.02.014; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Keusch I, 1998, KIDNEY INT, V54, P1224, DOI 10.1046/j.1523-1755.1998.00115.x; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lanske B, 2007, AGEING RES REV, V6, P73, DOI 10.1016/j.arr.2007.02.002; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Liu D, 2008, AM J NEPHROL, V28, P555, DOI 10.1159/000115290; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Memon F, 2008, KIDNEY INT, V74, P566, DOI 10.1038/ki.2008.218; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Pfister MF, 1998, P NATL ACAD SCI USA, V95, P1909, DOI 10.1073/pnas.95.4.1909; Razzaque MS, 2007, NAT CLIN PRACT ENDOC, V3, P788, DOI 10.1038/ncpendmet0667; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Razzaque MS, 2006, TRENDS MOL MED, V12, P298, DOI 10.1016/j.molmed.2006.05.002; Razzaque MS, 2009, NEPHROL DIAL TRANSPL, V24, P4, DOI 10.1093/ndt/gfn620; Razzaque MS, 1998, NEPHRON, V80, P434, DOI 10.1159/000045217; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Razzaque MS, 2005, NEPHROL DIAL TRANSPL, V20, P2032, DOI 10.1093/ndt/gfh991; Razzaque MS, 1997, J PATHOL, V183, P24; Razzaque MS, 1998, MODERN PATHOL, V11, P1183; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Tenenhouse HS, 1999, NEPHROL DIAL TRANSPL, V14, P333, DOI 10.1093/ndt/14.2.333; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2004, ENDOCRINOLOGY, V145, P3804, DOI 10.1210/en.2004-0192; Zha Y, 2008, AM J NEPHROL, V28, P755, DOI 10.1159/000128607; Zha Y, 2006, ENDOCRINOLOGY, V147, P5690, DOI 10.1210/en.2006-0302	46	86	88	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2009	23	11					3702	3711		10.1096/fj.08-123992	http://dx.doi.org/10.1096/fj.08-123992			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	512TC	19584304	Green Published			2022-12-25	WOS:000271272500008
J	Stollar, EJ; Garcia, B; Chong, PA; Rath, A; Lin, H; Forman-Kay, JD; Davidson, AR				Stollar, Elliott J.; Garcia, Bianca; Chong, P. Andrew; Rath, Arianna; Lin, Hong; Forman-Kay, Julie D.; Davidson, Alan R.			Structural, Functional, and Bioinformatic Studies Demonstrate the Crucial Role of an Extended Peptide Binding Site for the SH3 Domain of Yeast Abp1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION NETWORKS; RECOGNITION MODULES; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; SEQUENCE HOMOLOGY; DIPOLAR COUPLINGS; HIV-1 NEF; SPECIFICITY; AFFINITY; NMR	SH3 domains, which are among the most frequently occurring protein interaction modules in nature, bind to peptide targets ranging in length from 7 to more than 25 residues. Although the bulk of studies on the peptide binding properties of SH3 domains have focused on interactions with relatively short peptides (less than 10 residues), a number of domains have been recently shown to require much longer sequences for optimal binding affinity. To gain greater insight into the binding mechanism and biological importance of interactions between an SH3 domain and extended peptide sequences, we have investigated interactions of the yeast Abp1p SH3 domain (AbpSH3) with several physiologically relevant 17-residue target peptide sequences. To obtain a molecular model for AbpSH3 interactions, we solved the structure of the AbpSH3 bound to a target peptide from the yeast actin patch kinase, Ark1p. Peptide target complexes from binding partners Scp1p and Sjl2p were also characterized, revealing that the AbpSH3 uses a common extended interface for interaction with these peptides, despite K-d values for these peptides ranging from 0.3 to 6 mu M. Mutagenesis studies demonstrated that residues across the whole 17-residue binding site are important both for maximal in vitro binding affinity and for in vivo function. Sequence conservation analysis revealed that both the AbpSH3 and its extended target sequences are highly conserved across diverse fungal species as well as higher eukaryotes. Our data imply that the AbpSH3 must bind extended target sites to function efficiently inside the cell.	[Stollar, Elliott J.; Chong, P. Andrew; Rath, Arianna; Lin, Hong; Forman-Kay, Julie D.; Davidson, Alan R.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Stollar, Elliott J.; Garcia, Bianca; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Forman-Kay, Julie D.; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Forman-Kay, JD (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	forman@sickkids.ca; alan.davidson@utoronto.ca		Forman-Kay, Julie/0000-0001-8265-972X	National Cancer Institute of Canada; Canadian Institutes of Health Research [MOP-13609]; Hospital for Sick Children	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children	This work was funded by operating grants from the National Cancer Institute of Canada (to J. F. K.), the Canadian Institutes of Health Research (CIHR ARD Grant MOP-13609), a Restracomp award from the Hospital for Sick Children (to E. J. S.), and a CIHR Training Program in Protein Folding award (to E. J. S.).	Agrawal V, 2002, PROTEIN PEPTIDE LETT, V9, P185, DOI 10.2174/0929866023408760; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Beltrao P, 2005, PLOS COMPUT BIOL, V1, P202, DOI 10.1371/journal.pcbi.0010026; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Marles JA, 2004, MOL CELL, V14, P813, DOI 10.1016/j.molcel.2004.05.024; Mayer BJ, 2001, J CELL SCI, V114, P1253; Mittermaier A, 2001, J AM CHEM SOC, V123, P6892, DOI 10.1021/ja010595d; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Mott HR, 2005, BIOCHEMISTRY-US, V44, P10977, DOI 10.1021/bi050374a; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Stefan CJ, 2005, MOL CELL BIOL, V25, P2910, DOI 10.1128/MCB.25.8.2910-2923.2005; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	45	23	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26918	26927		10.1074/jbc.M109.028431	http://dx.doi.org/10.1074/jbc.M109.028431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19590096	Green Published, hybrid			2022-12-25	WOS:000269969600072
J	Herynk, MH; Lewis, MT; Hopp, TA; Medina, D; Corona-Rodriguez, A; Cui, Y; Beyer, AR; Fuqua, SAW				Herynk, M. H.; Lewis, M. T.; Hopp, T. A.; Medina, D.; Corona-Rodriguez, A.; Cui, Y.; Beyer, A. R.; Fuqua, S. A. W.			Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ER alpha transgenic mice	ONCOGENE			English	Article						breast cancer; estrogen receptor; K303R ER mutation; HER2/neu	ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; GLAND DEVELOPMENT; HINGE REGION; MUTATION; TUMORS; TRANSACTIVATION; OVEREXPRESSION; ACETYLATION; EXPRESSION	We identified a somatic mutation in estrogen receptor-alpha (ER alpha) in breast cancer causing a lysine to arginine transition (K303R) resulting in hypersensitivity to estrogen, altered associations with coactivators and corepressors and altered posttranslational modifications of ER alpha. We have developed a transgenic mouse expressing the K303R mutant ER alpha under control of the mouse mammary tumor virus (MMTV) promoter. At 4 months of age, K303R ER alpha transgenic animals demonstrate precocious alveolar budding compared with wild-type ER alpha transgenic mice or nontransgenic littermates. Despite these morphologic differences, K303R ER alpha transgenic mice displayed no differences in levels of ER alpha, progesterone receptor or proliferation at this time-point. Pregnancy or chronic estrogen plus progesterone exposure in K303R ER alpha transgenic mice also resulted in significantly more alveolar budding, increased beta-casein production and dilated ducts when compared with nontransgenic littermates. To examine the effects of mutant expression on tumorigenesis, mutant ER alpha mice were crossed with FVB-MMTVneu mice and significantly delayed time to neu-mediated tumorigenesis in bigenic animals. In contrast, mutant expression did not affect carcinogen-induced tumorigenesis. Collectively, these data demonstrate that aberrant estrogenic signaling through the K303R ER alpha mutation may lead to precocious alveolar budding in virgin mice, and to an expedited maturation and differentiation phenotype in the mammary glands of hormonally stimulated animals. Oncogene (2009) 28, 3177-3187; doi: 10.1038/onc.2009.174; published online 29 June 2009	[Herynk, M. H.; Lewis, M. T.; Hopp, T. A.; Medina, D.; Corona-Rodriguez, A.; Cui, Y.; Beyer, A. R.; Fuqua, S. A. W.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Fuqua, SAW (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, 1 Baylor Plaza,MS 600,N1200 Alkek, Houston, TX 77030 USA.	sfuqua@bcm.edu	Lewis, Michael T/A-9572-2009		NIH/NCI [CA72038, DAMD17-03-1-0417]; NATIONAL CANCER INSTITUTE [R01CA072038] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Gary Chamness for editorial assistance and Ms Robin Sample for administrative assistance. This work was supported by NIH/NCI CA72038 to SAWF, and by DAMD17-03-1-0417 to MHH.	Bershtein LM, 2003, B EXP BIOL MED+, V135, P580, DOI 10.1023/A:1025437620749; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; BORRAS M, 1994, J STEROID BIOCHEM, V48, P325, DOI 10.1016/0960-0760(94)90072-8; Conway K, 2005, BREAST CANCER RES, V7, pR871, DOI 10.1186/bcr1315; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Cui YK, 2006, MOL ENDOCRINOL, V20, P2020, DOI 10.1210/me.2005-0063; Cullinane CA, 2005, INT J CANCER, V117, P988, DOI 10.1002/ijc.21273; Davies MPA, 2005, BREAST CANCER RES, V7, pR113, DOI 10.1186/bcr965; DURBAN EM, 1985, DEV BIOL, V109, P288, DOI 10.1016/0012-1606(85)90456-7; Frech MS, 2005, CANCER RES, V65, P681; Fuqua SAW, 2000, CANCER RES, V60, P4026; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Guzman RC, 1999, P NATL ACAD SCI USA, V96, P2520, DOI 10.1073/pnas.96.5.2520; Herynk MH, 2007, CLIN CANCER RES, V13, P3235, DOI 10.1158/1078-0432.CCR-06-2608; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; IP MM, 2000, METHODS MAMMARY GLAN, V16; Jin ZM, 2002, J NUTR, V132, P3186, DOI 10.1093/jn/131.10.3186; Lavrovsky Y, 1998, TRANSGENIC RES, V7, P319, DOI 10.1023/A:1008838616203; MEDINA D, 1974, J NATL CANCER I, V53, P213, DOI 10.1093/jnci/53.1.213; Medina D, 2004, CLIN CANCER RES, V10, p380S, DOI 10.1158/1078-0432.CCR-031211; Mishra SK, 2003, J BIOL CHEM, V278, P19209, DOI 10.1074/jbc.M301968200; Rajkumar L, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1645; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Russo J, 2004, MATURITAS, V49, P2, DOI 10.1016/j.maturitas.2004.04.011; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Tekmal RR, 2007, J STEROID BIOCHEM, V106, P111, DOI 10.1016/j.jsbmb.2007.05.009; Tilli MT, 2003, AM J PATHOL, V163, P1713, DOI 10.1016/S0002-9440(10)63529-8; Tokunaga E, 2004, BREAST CANCER RES TR, V84, P289, DOI 10.1023/B:BREA.0000019963.67754.93; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Yang XH, 2003, CANCER RES, V63, P2425	30	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2009	28	36					3177	3187		10.1038/onc.2009.174	http://dx.doi.org/10.1038/onc.2009.174			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	492QF	19561644	Green Accepted			2022-12-25	WOS:000269673400001
J	van den Beucken, T; Koritzinsky, M; Niessen, H; Dubois, L; Savelkouls, K; Mujcic, H; Jutten, B; Kopacek, J; Pastorekova, S; van der Kogel, AJ; Lambin, P; Voncken, W; Rouschop, KMA; Wouters, BG				van den Beucken, Twan; Koritzinsky, Marianne; Niessen, Hanneke; Dubois, Ludwig; Savelkouls, Kim; Mujcic, Hilda; Jutten, Barry; Kopacek, Juraj; Pastorekova, Sylvia; van der Kogel, Albert J.; Lambin, Philippe; Voncken, Willem; Rouschop, Kasper M. A.; Wouters, Bradly G.			Hypoxia-induced Expression of Carbonic Anhydrase 9 Is Dependent on the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL CONTROL; GENE-EXPRESSION; TUMOR HYPOXIA; TRANSCRIPTIONAL REGULATION; ENDOPLASMIC-RETICULUM; PIMONIDAZOLE BINDING; HISTONE DEMETHYLASES; INDUCIBLE EXPRESSION; STRESS-RESPONSE; MELANOMA-CELLS	Adaptation to tumor hypoxia is mediated in large part by changes in protein expression. These are driven by multiple pathways, including activation of the hypoxia inducible factor-1 (HIF-1) transcription factor and the PKR-like endoplasmic reticulum kinase PERK, a component of the unfolded protein response. Through gene expression profiling we discovered that induction of the HIF-1 target gene CA9 was defective in mouse embryo fibroblasts derived from mice harboring an eIF2 alpha S51A knock-in mutation. This finding was confirmed in two isogenic human cell lines with an engineered defect in eIF2 alpha phosphorylation. We show that impaired CA9 expression was not due to changes in HIF activity or CA9 mRNA stability. Using chromatin immunoprecipitation we show that the eIF2 alpha-dependent translationally regulated gene ATF4 binds directly to the CA9 promoter and is associated with loss of the transcriptional repressive histone 3 lysine 27 tri-methylation mark. Loss or overexpression of ATF4 confirmed its role in CA9 induction during hypoxia. Our data indicate that expression of CA9 is regulated through both the HIF-1 and unfolded protein response hypoxia response pathways in vitro and in vivo.	[van den Beucken, Twan; Koritzinsky, Marianne; Wouters, Bradly G.] Princess Margaret Hosp, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 2M9, Canada; [van den Beucken, Twan; Koritzinsky, Marianne; Dubois, Ludwig; Savelkouls, Kim; Mujcic, Hilda; Jutten, Barry; Lambin, Philippe; Rouschop, Kasper M. A.; Wouters, Bradly G.] Maastricht Univ, Dept Radiat Oncol, Maastro Lab, NL-6200 MD Maastricht, Netherlands; [Niessen, Hanneke; Voncken, Willem] Maastricht Univ, Dept Mol Genet, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [van der Kogel, Albert J.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands; [Kopacek, Juraj; Pastorekova, Sylvia] Slovak Acad Sci, Inst Virol, Ctr Mol Med, Bratislava 84505, Slovakia; [Koritzinsky, Marianne; Wouters, Bradly G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5S 1A8, Canada; [Wouters, Bradly G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Wouters, Bradly G.] Ontario Inst Canc Res, Select Therapeut Program, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Maastricht University; Maastricht University; Radboud University Nijmegen; Slovak Academy of Sciences; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Wouters, BG (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Div Signaling Biol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	bwouters@uhnresearch.ca	Wouters, Bradly/T-1525-2017; Pastorekova, Silvia/C-6685-2018; Kopacek, Juraj/GRF-4984-2022; Niessen, Hanneke/B-7699-2009; van der Kogel, A.J./L-4441-2015	Wouters, Bradly/0000-0002-8187-592X; Niessen, Hanneke/0000-0002-2639-0938; van den Beucken, Twan/0000-0002-2233-7558; Kopacek, Juraj/0000-0003-3069-646X; Koritzinsky, Marianne/0000-0003-0547-2480; Lambin, Philippe/0000-0001-7961-0191; Rouschop, Kasper/0000-0002-4208-5415	Dutch Science Organization [912-03-047, 908-02-040, 016.046.362]; Dutch Cancer Society [2003-2821]; European Union 6th framework program; ZonMW VENI [016.056.015, 916.76.158]	Dutch Science Organization; Dutch Cancer Society(KWF Kankerbestrijding); European Union 6th framework program(European Commission); ZonMW VENI	This work was supported by the Dutch Science Organization (ZonMW-NWO Top Grant 912-03-047 to B. W. and Grants 908-02-040 and 016.046.362 to J. W. V.), the Dutch Cancer Society (KWF Grant UM 2003-2821 to B. W.), the European Union 6th framework program (Euroxy program to B. W.), and ZonMW VENI Grants 016.056.015 (to M. K.) and 916.76.158 (to K. R.).	Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Beasley NJP, 2001, CANCER RES, V61, P5262; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Dubois L, 2007, RADIOTHER ONCOL, V83, P367, DOI 10.1016/j.radonc.2007.04.018; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kaluz S, 1999, J BIOL CHEM, V274, P32588, DOI 10.1074/jbc.274.46.32588; Kaluz S, 2006, J CELL BIOCHEM, V97, P207, DOI 10.1002/jcb.20633; Kaluz S, 2002, CANCER RES, V62, P4469; Kopacek J, 2005, BBA-GENE STRUCT EXPR, V1729, P41, DOI 10.1016/j.bbaexp.2005.03.003; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2007, RADIOTHER ONCOL, V83, P353, DOI 10.1016/j.radonc.2007.04.031; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Lieskovska J, 1999, NEOPLASMA, V46, P17; Magagnin MG, 2006, DRUG RESIST UPDATE, V9, P185, DOI 10.1016/j.drup.2006.07.002; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Rijken PEJW, 2002, RADIAT RES, V157, P626, DOI 10.1667/0033-7587(2002)157[0626:QAOVPO]2.0.CO;2; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sobhanifar S, 2005, CANCER RES, V65, P7259, DOI 10.1158/0008-5472.CAN-04-4480; Sok J, 1999, MOL CELL BIOL, V19, P495; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2008, BJU INT, V101, P22, DOI 10.1111/j.1464-410X.2008.07644.x; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wykoff CC, 2000, CANCER RES, V60, P7075	54	45	45	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24204	24212		10.1074/jbc.M109.006510	http://dx.doi.org/10.1074/jbc.M109.006510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19564335	hybrid, Green Published			2022-12-25	WOS:000269380200034
J	Bianco, S; Lanvin, O; Tribollet, V; Macari, C; North, S; Vanacker, JM				Bianco, Stephanie; Lanvin, Olivia; Tribollet, Violaine; Macari, Claire; North, Sophie; Vanacker, Jean-Marc			Modulating Estrogen Receptor-related Receptor-alpha Activity Inhibits Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ERR-ALPHA; THERAPEUTIC TARGET; GENE-TRANSCRIPTION; NUCLEAR RECEPTORS; PROSTATE-CANCER; ORPHAN RECEPTOR; SP1 SITES; EXPRESSION	High expression of the estrogen receptor-related receptor (ERR)-alpha in human tumors is correlated to a poor prognosis, suggesting an involvement of the receptor in cell proliferation. In this study, we show that a synthetic compound (XCT790) that modulates the activity of ERR alpha reduces the proliferation of various cell lines and blocks the G(1)/S transition of the cell cycle in an ERR alpha-dependent manner. XCT790 induces, in a p53-independent manner, the expression of the cell cycle inhibitor p21(waf/cip1) at the protein, mRNA, and promoter level, leading to an accumulation of hypophosphorylated Rb. Finally, XCT790 reduces cell tumorigenicity in Nude mice.	[Bianco, Stephanie; Lanvin, Olivia; Tribollet, Violaine; Macari, Claire; Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, INRA, Ecole Normale Super Lyon,CNRS, F-69364 Lyon 07, France; [North, Sophie] Univ Bordeaux 1, F-33400 Talence, France; [North, Sophie] INSERM, U920, F-33400 Talence, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanacker, JM (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, INRA, Ecole Normale Super Lyon,CNRS, 46 Allee Italie, F-69364 Lyon 07, France.	Jean-Marc.Vanacker@ens-lyon.fr			Ligue Contre le Cancer (Comites Languedoc-Roussillon, Loire and Rhone); Association pour la Recherche sur le Cancer; Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer	Ligue Contre le Cancer (Comites Languedoc-Roussillon, Loire and Rhone); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association pour la Recherche sur les Tumeurs de la Prostate; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by Ligue Contre le Cancer (Comites Languedoc-Roussillon, Loire and Rhone), Association pour la Recherche sur le Cancer, Association pour la Recherche sur les Tumeurs de la Prostate, and Institut National du Cancer.	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Ariazi EA, 2002, CANCER RES, V62, P6510; Balaguer P, 2001, LUMINESCENCE, V16, P153, DOI 10.1002/bio.630; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carrier JC, 2004, J BIOL CHEM, V279, P52052, DOI 10.1074/jbc.M410337200; Carroll JS, 2003, CANCER RES, V63, P4322; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Laudet V, 2002, NUCL RECEPTOR FACTSB; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Lu DS, 2001, CANCER RES, V61, P6755; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; WU F, 2009, CHEM BIOL I IN PRESS; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855	43	74	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23286	23292		10.1074/jbc.M109.028191	http://dx.doi.org/10.1074/jbc.M109.028191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19546226	Green Published, hybrid			2022-12-25	WOS:000269180000013
J	Eto, K; Eda, K; Hayano, M; Goto, S; Nagao, K; Kawasaki, T; Kashimura, H; Tarui, H; Nishimura, O; Agata, K; Abe, S				Eto, Ko; Eda, Kazufumi; Hayano, Motoshi; Goto, Syota; Nagao, Kenta; Kawasaki, Toshihiro; Kashimura, Hiroshi; Tarui, Hiroshi; Nishimura, Osamu; Agata, Kiyokazu; Abe, Shin-ichi			Reduced Expression of an RNA-binding Protein by Prolactin Leads to Translational Silencing of Programmed Cell Death Protein 4 and Apoptosis in Newt Spermatogonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR PDCD4; MESSENGER-RNA; EUKARYOTIC TRANSLATION; MEIOSIS INITIATION; HNRNP A1; GENE; CYCLOOXYGENASE-2; RICH; TRANSFORMATION; TEMPERATURE	Recent studies indicate that the balance between cell survival and proapoptotic signals determines which cells commit to life or death. We have shown that the balance between follicle-stimulating hormone and prolactin determines differentiation or apoptosis in 7th generation spermatogonia during newt spermatogenesis; however, the molecular mechanisms specifying their fate are poorly understood. Here we show that the newt RNA-binding protein (nRBP) plays a critical role in determining their fate. nRBP was identified as a clone whose mRNA is decreased by prolactin, resulting in the reduction of the protein, which is otherwise expressed predominantly in the spermatogonia. nRBP protein associated with the mRNA for newt programmed cell death protein 4 (nPdcd4) at the 3'-untranslated region. nRBP reduction increased nPdcd4 mRNA but decreased its protein. In a cell-free system, cytoplasmic extracts containing reduced amounts of nRBP and nPdcd4 protein induced apoptosis, whereas adding nRBP protein to the extracts blocked apoptosis. Furthermore, overexpression of nRBP protected cells from apoptosis, stabilized the chimeric transcript containing the nPdcd4 3'-untranslated region, and accelerated its translation. These data suggest that, in the absence of nRBP, nPdcd4 mRNA is not stabilized and its translation is suppressed, leading to apoptosis in the spermatogonia.	[Eto, Ko; Eda, Kazufumi; Hayano, Motoshi; Goto, Syota; Nagao, Kenta; Kawasaki, Toshihiro; Kashimura, Hiroshi; Abe, Shin-ichi] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan; [Tarui, Hiroshi; Nishimura, Osamu; Agata, Kiyokazu] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Kumamoto University; RIKEN; Kyoto University	Eto, K (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan.	etoko@gpo.kumamoto-u.ac.jp	Nishimura, Osamu/AAC-1236-2020	Nishimura, Osamu/0000-0003-1969-2580; Hayano, Motoshi/0000-0001-6453-2741; Agata, Kiyokazu/0000-0002-5195-2576				Abe S, 2004, ZOOL SCI, V21, P691, DOI 10.2108/zsj.21.691; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Azzoni L, 1998, J IMMUNOL, V161, P3493; Bhatia R, 1999, CELL TISSUE RES, V297, P283, DOI 10.1007/s004410051356; Callard Gloria Vincz, 1991, P303; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Danno S, 2000, AM J PATHOL, V156, P1685, DOI 10.1016/S0002-9440(10)65039-0; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; DERRY JMJ, 1995, HUM MOL GENET, V4, P2307, DOI 10.1093/hmg/4.12.2307; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Eto K, 2006, BIOCHEM BIOPH RES CO, V350, P263, DOI 10.1016/j.bbrc.2006.09.028; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; MARTIN SJ, 1995, EMBO J, V14, P5191, DOI 10.1002/j.1460-2075.1995.tb00203.x; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; MICHAEL WM, 1995, CELL, V83, P415; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Onishi Y, 1998, GENE, V215, P453, DOI 10.1016/S0378-1119(98)00313-8; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Saribek B, 2006, BIOCHEM BIOPH RES CO, V349, P1190, DOI 10.1016/j.bbrc.2006.08.143; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Uochi T, 1998, GENE, V211, P245, DOI 10.1016/S0378-1119(98)00102-4; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yazawa T, 1999, GEN COMP ENDOCR, V113, P302, DOI 10.1006/gcen.1998.7207; Yazawa T, 2000, ENDOCRINOLOGY, V141, P2027, DOI 10.1210/en.141.6.2027; Yazawa T, 2002, BIOL REPROD, V66, P14, DOI 10.1095/biolreprod66.1.14	42	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23260	23271		10.1074/jbc.M109.018622	http://dx.doi.org/10.1074/jbc.M109.018622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19556246	hybrid, Green Published			2022-12-25	WOS:000269180000011
J	Franzke, CW; Bruckner-Tuderman, L; Blobel, CP				Franzke, Claus-Werner; Bruckner-Tuderman, Leena; Blobel, Carl P.			Shedding of Collagen XVII/BP180 in Skin Depends on Both ADAM10 and ADAM9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA; TRANSMEMBRANE PROTEINS; OXIDATIVE STRESS; CELL-SURFACE; MICE LACKING; EXPRESSION; DISINTEGRIN; ECTODOMAIN; XVII; KERATINOCYTES	Collagen XVII is a transmembrane collagen and the major autoantigen of the autoimmune skin blistering disease bullous pemphigoid. Collagen XVII is proteolytically released from the membrane, and the pathogenic epitope harbors the cleavage site for its ectodomain shedding, suggesting that proteolysis has an important role in regulating the function of collagen XVII in skin homeostasis. Previous studies identified ADAMs 9, 10, and 17 as candidate collagen XVII sheddases and suggested that ADAM17 is a major sheddase. Here we show that ADAM17 only indirectly affects collagen XVII shedding and that ADAMs9 and 10 are the most prominent collagen XVII sheddases in primary keratinocytes because (a) collagen XVII shedding was not stimulated by phorbol esters, known activators of ADAM17, (b) constitutive and calcium influx-stimulated shedding was sensitive to the ADAM10-selective inhibitor GI254023X and was strongly reduced in Adam10(-/-) cells, (c) there was a 55% decrease in constitutive collagen XVII ectodomain shedding from Adam9(-/-) keratinocytes, and (d) H2O2 enhanced ADAM9 expression and stimulated collagen XVII shedding in skin and keratinocytes of wild type mice but not of Adam9(-/-) mice. We conclude that ADAM9 and ADAM10 can both contribute to collagen XVII shedding in skin with an enhanced relative contribution of ADAM9 in the presence of reactive oxygen species. These results provide critical new insights into the identity and regulation of the major sheddases for collagen XVII in keratinocytes and skin and have implications for the treatment of blistering diseases of the skin.	[Franzke, Claus-Werner; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Franzke, Claus-Werner; Bruckner-Tuderman, Leena] Univ Freiburg, Dept Dermatol, D-79104 Freiburg, Germany; [Bruckner-Tuderman, Leena] Sch Life Sci, Freiburg Inst Adv Studies, D-79085 Freiburg, Germany	University of Freiburg	Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,Rm 426,535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu			National Institutes of Health [GM64750]; German Research Foundation; Deutsche Forschungsgemeinschaft (DFG) [FR 2524/1, Br 1475/9-1]; German Network Epidermolysis bullosa; Emerald Foundation; Excellence Initiative of the German Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Network Epidermolysis bullosa; Emerald Foundation; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM64750 (to C. P. B.). This work was also supported by scholarships from the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) (Grant FR 2524/1), the German Network Epidermolysis bullosa, and the Emerald Foundation (to C.-W.F.) and by the Excellence Initiative of the German Research Foundation (Freiburg Institute for Advanced Studies School of Life Sciences) and DFG Grant Br 1475/9-1 (to L.B.-T).	Areida SK, 2001, J BIOL CHEM, V276, P1594, DOI 10.1074/jbc.M008709200; Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borradori L, 1997, J CELL BIOL, V136, P1333, DOI 10.1083/jcb.136.6.1333; BRUCKNERTUDERMAN L, 1987, EUR J BIOCHEM, V165, P607, DOI 10.1111/j.1432-1033.1987.tb11483.x; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Karan D, 2003, INT J ONCOL, V23, P1365; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Ko SY, 2007, CANCER LETT, V245, P33, DOI 10.1016/j.canlet.2005.10.019; Kondo S, 1994, Exp Dermatol, V3, P29, DOI 10.1111/j.1600-0625.1994.tb00263.x; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; LI KH, 1993, J BIOL CHEM, V268, P8825; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers SR, 2007, WOUND REPAIR REGEN, V15, P693, DOI 10.1111/j.1524-475X.2007.00297.x; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Raychaudhuri SP, 1999, ACTA DERM-VENEREOL, V79, P9; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schlondorff J, 1999, J CELL SCI, V112, P3603; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Shigemura K, 2007, PROSTATE, V67, P722, DOI 10.1002/pros.20565; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Van den Bergh Francoise, 2003, Adv Dermatol, V19, P37; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yancey KB, 2005, J CLIN INVEST, V115, P825, DOI 10.1172/JCI200524855; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	51	70	74	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23386	23396		10.1074/jbc.M109.034090	http://dx.doi.org/10.1074/jbc.M109.034090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574220	Green Published, hybrid			2022-12-25	WOS:000269180000023
J	Kaur, J; Bachhawat, AK				Kaur, Jaspreet; Bachhawat, Anand K.			Gln-222 in Transmembrane Domain 4 and Gln-526 in Transmembrane Domain 9 Are Critical for Substrate Recognition in the Yeast High Affinity Glutathione Transporter, Hgt1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; MEMBRANE-PROTEIN STRUCTURE; AMINO-ACID-RESIDUES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; OLIGOPEPTIDE TRANSPORTERS; CONFORMATIONAL-CHANGES; TOPOLOGY PREDICTION; LEISHMANIA-DONOVANI; CRYSTAL-STRUCTURE	Hgt1p, a member of the oligopeptide transporter family, is a high affinity glutathione transporter from the yeast Saccharomyces cerevisiae. We have explored the role of polar or charged residues in the putative transmembrane domains of Hgt1p to obtain insights into the structural features of Hgt1p that govern its substrate specificity. A total of 22 charged and polar residues in the predicted transmembrane domains and other conserved regions were subjected to alanine mutagenesis. Functional characterization of these 22 mutants identified 11 mutants which exhibited significant loss in functional activity. All 11 mutants except T114A had protein expression levels comparable with wild type, and all except E744A were proficient in trafficking to the cell surface. Kinetic analyses revealed differential contributions toward the functional activity of Hgt1p by these residues and identified Asn-124 in transmembrane domain 1 (TMD1), Gln-222 in TMD4, Gln-526 in TMD9, and Glu-544, Arg-554, and Lys-562 in the intracellular loop region 537-568 containing the highly conserved proline-rich motif to be essential for the transport activity of the protein. Furthermore, mutants Q222A and Q526A exhibited a nearly 4- and 8-fold increase in the K-m for glutathione. Interestingly, although Gln-222 is widely conserved among other functionally characterized oligopeptide transporter family members including those having a different substrate specificity, Gln-526 is present only in Hgt1p and Pgt1, the only two known high affinity glutathione transporters. These results provide the first insights into the substrate recognition residues of a high affinity glutathione transporter and on residues/helices involved in substrate translocation in the structurally uncharacterized oligopeptide transporter family.	[Kaur, Jaspreet; Bachhawat, Anand K.] Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Bachhawat, AK (corresponding author), Inst Microbial Technol, Sector 39-A, Chandigarh 160036, India.	anand@imtech.res.in			Department of Biotechnology and Departments of Science and Technology, Government of India	Department of Biotechnology and Departments of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India))	This work was supported by grant-in-aid projects (to A. K. B.) from the Department of Biotechnology and Departments of Science and Technology, Government of India.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Falcon-Perez JM, 1999, J BIOL CHEM, V274, P23584, DOI 10.1074/jbc.274.33.23584; Falcon-Perez JM, 2001, J BACTERIOL, V183, P4761, DOI 10.1128/JB.183.16.4761-4770.2001; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Hauser M, 2000, J BIOL CHEM, V275, P3037, DOI 10.1074/jbc.275.5.3037; Hauser M, 2005, MOL MEMBR BIOL, V22, P215, DOI 10.1080/09687860500093248; Hiniker A, 2006, J BACTERIOL, V188, P7317, DOI 10.1128/JB.00383-06; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kasahara M, 1998, J BIOL CHEM, V273, P29106, DOI 10.1074/jbc.273.44.29106; Kasahara M, 1997, J BIOL CHEM, V272, P16721, DOI 10.1074/jbc.272.27.16721; KAUR J, 2009, FEMS YEAST IN PRESS; Kaur J, 2009, ANAL BIOCHEM, V384, P348, DOI 10.1016/j.ab.2008.10.005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387; Lubkowitz Mark, 2006, Genet Eng (N Y), V27, P35, DOI 10.1007/0-387-25856-6_3; Miyake T, 2002, MOL GENET GENOMICS, V266, P1004, DOI 10.1007/s00438-001-0625-6; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Osawa H, 2006, BIOCHEM J, V393, P267, DOI 10.1042/BJ20050920; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Srikanth CV, 2005, CURR GENET, V47, P345, DOI 10.1007/s00294-005-0571-7; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Thakur A, 2008, FEMS YEAST RES, V8, P916, DOI 10.1111/j.1567-1364.2008.00423.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Wiles AM, 2006, RES MICROBIOL, V157, P395, DOI 10.1016/j.resmic.2005.10.004; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096	46	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23872	23884		10.1074/jbc.M109.029728	http://dx.doi.org/10.1074/jbc.M109.029728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19589778	Green Published, hybrid			2022-12-25	WOS:000269180000070
J	Koharudin, LMI; Furey, W; Liu, H; Liu, YJ; Gronenborn, AM				Koharudin, Leonardus M. I.; Furey, William; Liu, Hao; Liu, Yong-Jian; Gronenborn, Angela M.			The Phox Domain of Sorting Nexin 5 Lacks Phosphatidylinositol 3-Phosphate (PtdIns(3)P) Specificity and Preferentially Binds to Phosphatidylinositol 4,5-Bisphosphate (PtdIns(4,5)P-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY PX DOMAIN; CRYSTAL-STRUCTURE; ENDOSOMAL LOCALIZATION; PROTEIN; RETROMER; CLATHRIN; SNX5; VISUALIZATION; CURVATURE; RECEPTORS	Subcellular retrograde transport of cargo receptors from endosomes to the trans-Golgi network is critically involved in a broad range of physiological and pathological processes and highly regulated by a genetically conserved heteropentameric complex, termed retromer. Among the retromer components identified in mammals, sorting nexin 5 and 1 (SNX5; SNX1) have recently been found to interact, possibly controlling the membrane binding specificity of the complex. To elucidate how the unique sequence features of the SNX5 phox domain (SNX5-PX) influence retrograde transport, we have determined the SNX5-PX structure by NMR and x-ray crystallography at 1.5 angstrom resolution. Although the core fold of SNX5-PX resembles that of other known PX domains, we found novel structural features exclusive to SNX5-PX. It is most noteworthy that in SNX5-PX, a long helical hairpin is added to the core formed by a new alpha 2'-helix and a much longer alpha 3-helix. This results in a significantly altered overall shape of the protein. In addition, the unique double PXXP motif is tightly packed against the rest of the protein, rendering this part of the structure compact, occluding parts of the putative phosphatidylinositol (PtdIns) binding pocket. The PtdIns binding and specificity of SNX5-PX was evaluated by NMR titrations with eight different PtdIns and revealed that SNX5-PX preferentially and specifically binds to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). The distinct structural and PtdIns binding characteristics of SNX5-PX impart specific properties on SNX5, influencing retromer-mediated regulation of retrograde trafficking of transmembrane cargo receptors.	[Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Furey, William; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Liu, Hao] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Liu, Yong-Jian] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3 Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Liu, Yongjian/J-7852-2018	Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [MH62092, NS058463]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH62092 and NS058463 (to Y. L.). This work was also supported by startup funds from the University of Pittsburgh School of Medicine (to A. M. G.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Mayeux R, 2008, LANCET NEUROL, V7, P2, DOI 10.1016/S1474-4422(07)70298-3; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876; Otsuki T, 1999, BIOCHEM BIOPH RES CO, V265, P630, DOI 10.1006/bbrc.1999.1731; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Song JK, 2007, PROTEIN SCI, V16, P807, DOI 10.1110/ps.072752407; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Towler MC, 2004, MOL BIOL CELL, V15, P3181, DOI 10.1091/mbc.E04-03-0249; Verges M, 2008, INT REV CEL MOL BIO, V271, P153, DOI 10.1016/S1937-6448(08)01204-5; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xu Y, 2001, BIOCHEM J, V360, P513, DOI 10.1042/0264-6021:3600513; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zhong Q, 2005, MOL BIOL CELL, V16, P2049, DOI 10.1091/mbc.e04-06-0504; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	59	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23697	23707		10.1074/jbc.M109.008995	http://dx.doi.org/10.1074/jbc.M109.008995			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19553671	hybrid, Green Published			2022-12-25	WOS:000269180000055
J	Wu, Y; Xiong, Y; Wang, S; Yi, H; Li, H; Pan, N; Horrigan, FT; Wu, YL; Ding, JP				Wu, Ying; Xiong, Yu; Wang, Sheng; Yi, Hong; Li, Hui; Pan, Na; Horrigan, Frank T.; Wu, Yingliang; Ding, Jiuping			Intersubunit Coupling in the Pore of BK Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; K+ CHANNEL; VOLTAGE SENSOR; BETA-1 SUBUNIT; CALCIUM; CONDUCTANCE; RESIDUE; FAMILY	The structural basis underlying the gating of large conductance Ca2+-activated K+ (BK) channels remains elusive. We found that substitution of Leu-312 in the S6 transmembrane segment of mSlo1 BK channels with hydrophilic amino acids of smaller side-chain volume favored the open state. The sensitivities of channels to calcium and voltage were modified by some mutations and completely abolished by others. Interpretation of the results in terms of an allosteric model suggests that the calcium-insensitive mutants greatly destabilize the closed relative to the open conformation and may also disrupt the allosteric coupling between Ca2+ or voltage sensors and the gate. Some Phe-315 mutations also favor the open state, suggesting that Leu-312 and Phe-315 may interact in the closed state, forming a major energy barrier that the channel has to overcome to open. Homology modeling and molecular dynamic simulations further support that the side chain of Leu-312 can couple strongly with the aromatic ring of Phe-315 in neighboring subunits (L-F coupling) to maintain the channel closed. Additionally, single-channel recordings indicate that the calcium-insensitive mutants, whose kinetics can be approximately characterized by a two-state closed-open (C-O) model, exhibit nearly 100% open probability under physiological conditions without alterations in single-channel conductance. These findings provide a basis for understanding the structure and gating of the BK channel pore.	[Yi, Hong; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wu, Ying; Xiong, Yu; Wang, Sheng; Li, Hui; Pan, Na; Ding, Jiuping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Horrigan, Frank T.] Baylor Coll Med, Houston, TX 77030 USA	Wuhan University; Huazhong University of Science & Technology; Baylor College of Medicine	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	ylwu@whu.edu.cn; jpding@mail.hust.edu.cn		Horrigan, Frank/0000-0001-6703-9581	National Institutes of Health [NS042901]; National Science Foundation of China [30770522, 30530140, 30770519]; Program of Introducing Talents of Discipline to Universities [B08029]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042901 (to F. T. H.). This work was also supported by National Science Foundation of China Grants 30770522, 30530140, and 30770519 and Program of Introducing Talents of Discipline to Universities Grant B08029.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CASE DA, 2004, AMBER, V8; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELLINGTON A, 2001, CURR PROTOC MOL BIOL; Guo ZH, 2008, BIOPHYS J, V94, P3714, DOI 10.1529/biophysj.107.120022; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Li H, 2007, J BIOL CHEM, V282, P17720, DOI 10.1074/jbc.M607063200; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; Lippiat JD, 2000, J PHYSIOL-LONDON, V529, P131, DOI 10.1111/j.1469-7793.2000.00131.x; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; Wang B, 2006, J GEN PHYSIOL, V128, P731, DOI 10.1085/jgp.200609596; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	27	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23353	23363		10.1074/jbc.M109.027789	http://dx.doi.org/10.1074/jbc.M109.027789			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561088	Green Published, hybrid			2022-12-25	WOS:000269180000020
J	Bonham, CA; Vacratsis, PO				Bonham, Christopher A.; Vacratsis, Panayiotis O.			Redox Regulation of the Human Dual Specificity Phosphatase YVH1 through Disulfide Bond Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; CATALYTIC MECHANISM; SULFENIC ACID; IN-VIVO; OXIDATION; CYSTEINE; GROWTH; IDENTIFICATION; INACTIVATION; DOMAIN	YVH1 was one of the first eukaryotic dual specificity phosphatases cloned, and orthologues posses a unique C-terminal zinc-coordinating domain in addition to a cysteine-based phosphatase domain. Our recent results revealed that human YVH1 (hYVH1) protects cells from oxidative stress. This function requires phosphatase activity and the zinc binding domain. This current study provides evidence that the thiol-rich zinc-coordinating domain may act as a redox sensor to impede the active site cysteine from inactivating oxidation. Furthermore, using differential thiol labeling and mass spectrometry, it was determined that hYVH1 forms intramolecular disulfide bonds at the catalytic cleft as well as within the zinc binding domain to avoid irreversible inactivation during severe oxidative stress. Importantly, zinc ejection is readily reversible and required for hYVH1 activity upon returning to favorable conditions. This inimitable mechanism provides a means for hYVH1 to remain functionally responsive for protecting cells during oxidative stimuli.	[Bonham, Christopher A.; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Vacratsis, PO (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	vacratsi@uwindsor.ca	Bonham, Christopher/K-3073-2012		Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery [298468]	Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant 298468 (to P.O.V.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Beeser AE, 2000, J BACTERIOL, V182, P3517, DOI 10.1128/JB.182.12.3517-3528.2000; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Das SK, 2006, DIABETES, V55, P2631, DOI 10.2337/db05-1369; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Grzyska PK, 2004, BIOCHEMISTRY-US, V43, P8807, DOI 10.1021/bi049473z; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Liu Y, 2009, GENETICS, V181, P907, DOI 10.1534/genetics.108.100099; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Muda M, 1999, J BIOL CHEM, V274, P23991, DOI 10.1074/jbc.274.34.23991; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; SHARDA PR, 2009, BIOCHEM J, V2, P391; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624	24	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22853	22864		10.1074/jbc.M109.038612	http://dx.doi.org/10.1074/jbc.M109.038612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19567874	Green Published, hybrid			2022-12-25	WOS:000268963100039
J	Currie, MA; Merino, F; Skarina, T; Wong, AHY; Singer, A; Brown, G; Savchenko, A; Caniuguir, AS; Guixe, V; Yakunin, AF; Jia, ZC				Currie, Mark A.; Merino, Felipe; Skarina, Tatiana; Wong, Andrew H. Y.; Singer, Alexander; Brown, Greg; Savchenko, Alexei; Caniuguir, Andre S.; Guixe, Victoria; Yakunin, Alexander F.; Jia, Zongchao			ADP-dependent 6-Phosphofructokinase from Pyrococcus horikoshii OT3 STRUCTURE DETERMINATION AND BIOCHEMICAL CHARACTERIZATION OF PH1645	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PHOSPHOFRUCTOKINASE; HYPERTHERMOPHILIC ARCHAEON; BIOCHEMICAL-CHARACTERIZATION; CONFORMATIONAL-CHANGE; THERMOTOGA-MARITIMA; BIFUNCTIONAL ENZYME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; FURIOSUS	Some hyperthermophilic archaea use a modified glycolytic pathway that employs an ADP-dependent glucokinase (ADPGK) and an ADP-dependent phosphofructokinase (ADP-PFK) or, in the case of Methanococcus jannaschii, a bifunctional ADP-dependent glucophosphofructokinase (ADP-GK/PFK). The crystal structures of three ADP-GKs have been determined. However, there is no structural information available for ADP-PFKs or the ADP-GK/PFK. Here, we present the first crystal structure of an ADP-PFK from Pyrococcus horikoshii OT3 (PhPFK) in both apo- and AMP-bound forms determined to 2.0-angstrom and 1.9-angstrom resolution, respectively, along with biochemical characterization of the enzyme. The overall structure of PhPFK maintains a similar large and small alpha/beta domain structure seen in the ADP-GK structures. A large conformational change accompanies binding of phosphoryl donor, acceptor, or both, in all members of the ribokinase superfamily characterized thus far, which is believed to be critical to enzyme function. Surprisingly, no such conformational change was observed in the AMP-bound PhPFK structure compared with the apo structure. Through comprehensive site-directed mutagenesis of the substrate binding pocket we identified residues that were critical for both substrate recognition and the phosphotransfer reaction. The catalytic residues and many of the substrate binding residues are conserved between PhPFK and ADP-GKs; however, four key residues differ in the sugar-binding pocket, which we have shown determine the sugar-binding specificity. Using these results we were able to engineer a mutant PhPFK that mimics the ADP-GK/PFK and is able to phosphorylate both fructose 6-phosphate and glucose.	[Currie, Mark A.; Wong, Andrew H. Y.; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Merino, Felipe; Caniuguir, Andre S.; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Skarina, Tatiana; Singer, Alexander; Brown, Greg; Savchenko, Alexei; Yakunin, Alexander F.] Midwest Ctr Struct Genom, Toronto, ON M5G 1L6, Canada	Queens University - Canada; Universidad de Chile	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca	Merino, Felipe/D-2740-2013; Yakunin, Alexander/J-1519-2014; Guixe, Victoria/I-1126-2013	Merino, Felipe/0000-0003-4166-8747; Guixe, Victoria/0000-0001-9643-1339; Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health [GM074942]; Genome Canada; Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1070111]; United States Department of Energy; Office of Biological Research [DE-AC02-06CH11357]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); United States Department of Energy(United States Department of Energy (DOE)); Office of Biological Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by Genome Canada (through the Ontario Genomics Initiative), Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) Grant 1070111, the United States Department of Energy, Office of Biological Research, under contract DE-AC02-06CH11357, and the Canadian Institutes of Health Research.	ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BERGER SA, 1990, NATURE, V343, P575, DOI 10.1038/343575a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabrera R, 2008, J MOL BIOL, V383, P588, DOI 10.1016/j.jmb.2008.08.029; CHARLES RS, 1994, DIABETES, V43, P784, DOI 10.2337/diab.43.6.784; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Guixe V, 1998, BIOCHEMISTRY-US, V37, P13269, DOI 10.1021/bi980576p; Hansen T, 2002, ARCH MICROBIOL, V177, P401, DOI 10.1007/s00203-002-0405-7; HELLINGA HW, 1987, NATURE, V327, P437, DOI 10.1038/327437a0; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torres JC, 1997, BIOCHEM J, V327, P675; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; ZHENG RL, 1992, J BIOL CHEM, V267, P23640	39	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22664	22671		10.1074/jbc.M109.012401	http://dx.doi.org/10.1074/jbc.M109.012401			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553681	hybrid, Green Published			2022-12-25	WOS:000268963100020
J	Sullivan, NJ; Sasser, AK; Axel, AE; Vesuna, F; Raman, V; Ramirez, N; Oberyszyn, TM; Hall, BM				Sullivan, N. J.; Sasser, A. K.; Axel, A. E.; Vesuna, F.; Raman, V.; Ramirez, N.; Oberyszyn, T. M.; Hall, B. M.			Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells	ONCOGENE			English	Article						interleukin-6; epithelial-mesenchymal transition; breast cancer; tumor microenvironment; metastasis	GROWTH-FACTOR; TUMOR PROGRESSION; CARCINOMA CELLS; E-CADHERIN; METASTASIS; ACTIVATION; EXPRESSION; APOPTOSIS; CYTOKINE; SERUM	Breast tumor interleukin-6 (IL-6) levels increase with tumor grade, and elevated serum IL-6 correlates with poor breast cancer patient survival. Epithelial-mesenchymal transition (EMT) phenotypes such as impaired E-cadherin expression or aberrant Vimentin induction are associated with enhanced metastasis and unfavorable clinical outcome in breast cancer. Despite this fact, few tumor microenvironment-derived extracellular signaling factors capable of provoking such a phenotypic transition have been identified. In this study, we showed that IL-6 promoted E-cadherin repression among a panel of estrogen receptor-alpha-positive human breast cancer cells. Furthermore, ectopic stable IL-6 expressing MCF-7 breast adenocarcinoma cells (MCF-7(IL-6)) exhibited an EMT phenotype characterized by impaired E-cadherin expression and induction of Vimentin, N-cadherin, Snail and Twist. MCF-7(IL-6) cells formed xenograft tumors that displayed loss of E-cadherin, robust Vimentin induction, increased proliferative indices, advanced tumor grade and undifferentiated histology. Finally, we showed aberrant IL-6 production and STAT3 activation in MCF-7 cells that constitutively express Twist, a metastatic regulator and direct transcriptional repressor of E-cadherin. To our knowledge, this is the first study that shows IL-6 as an inducer of an EMT phenotype in breast cancer cells and implicates its potential to promote breast cancer metastasis. Oncogene (2009) 28, 2940-2947; doi:10.1038/onc.2009.180; published online 6 July 2009	[Ramirez, N.; Oberyszyn, T. M.] Ohio State Univ, Dept Pathol, Coll Med, Columbus, OH 43210 USA; [Sullivan, N. J.; Sasser, A. K.; Hall, B. M.] Ohio State Univ, Integrated Biomed Sci Grad Program, Coll Med, Columbus, OH 43210 USA; [Sullivan, N. J.; Sasser, A. K.; Axel, A. E.; Ramirez, N.; Hall, B. M.] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc, Columbus, OH USA; [Vesuna, F.; Raman, V.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Johns Hopkins University	Oberyszyn, TM (corresponding author), Ohio State Univ, Dept Pathol, Coll Med, 1645 Neil Ave,129 Hamilton Hall, Columbus, OH 43210 USA.	oberyszyn.1@osu.edu	Oberyszyn, Tatiana/E-3774-2011; Vesuna, Farhad/G-3179-2010	Vesuna, Farhad/0000-0002-0356-5096; Oberyszyn, Tatiana/0000-0002-5308-0855	Elsa U Pardee Foundation; American Cancer Society-Ohio Division; Research Institute at Nationwide Children's Hospital; NATIONAL CANCER INSTITUTE [R01CA097226] Funding Source: NIH RePORTER	Elsa U Pardee Foundation; American Cancer Society-Ohio Division(American Cancer Society); Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the generous support of the Elsa U Pardee Foundation (BH), the American Cancer Society-Ohio Division (BH) and The Research Institute at Nationwide Children's Hospital (BH).	Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Barton BE, 2004, MOL CANCER THER, V3, P11; Blaskovich MA, 2003, CANCER RES, V63, P1270; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Conze D, 2001, CANCER RES, V61, P8851; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Jiang XP, 2000, CYTOKINE, V12, P458, DOI 10.1006/cyto.1999.0591; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kozlowski L, 2003, Rocz Akad Med Bialymst, V48, P82; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; OKA H, 1993, CANCER RES, V53, P1696; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pedersen KB, 2002, BRIT J CANCER, V87, P1281, DOI 10.1038/sj.bjc.6600624; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Singh A, 1999, ENDOCR-RELAT CANCER, V6, P139, DOI 10.1677/erc.0.0060139; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; VANDAM M, 1993, J BIOL CHEM, V268, P15285; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang GJ, 1999, ANTICANCER RES, V19, P1427	37	537	566	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2009	28	33					2940	2947		10.1038/onc.2009.180	http://dx.doi.org/10.1038/onc.2009.180			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19581928	Green Accepted			2022-12-25	WOS:000269142800002
J	Mamat, U; Schmidt, H; Munoz, E; Lindner, B; Fukase, K; Hanuszkiewicz, A; Wu, J; Meredith, TC; Woodard, RW; Hilgenfeld, R; Mesters, JR; Holst, O				Mamat, Uwe; Schmidt, Helgo; Munoz, Eva; Lindner, Buko; Fukase, Koichi; Hanuszkiewicz, Anna; Wu, Jing; Meredith, Timothy C.; Woodard, Ronald W.; Hilgenfeld, Rolf; Mesters, Jeroen R.; Holst, Otto			WaaA of the Hyperthermophilic Bacterium Aquifex aeolicus Is a Monofunctional 3-Deoxy-D-manno-oct-2-ulosonic Acid Transferase Involved in Lipopolysaccharide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-DEPENDENT DEACETYLASE; GENUS-SPECIFIC EPITOPE; ESCHERICHIA-COLI K-12; LIPID-A; RHIZOBIUM-LEGUMINOSARUM; STRUCTURAL-ANALYSIS; KDO TRANSFERASE; SULFOLOBUS-SOLFATARICUS; BORDETELLA-PERTUSSIS; 8-PHOSPHATE SYNTHASE	The hyperthermophile Aquifex aeolicus belongs to the deepest branch in the bacterial genealogy. Although it has long been recognized that this unique Gram-negative bacterium carries genes for different steps of lipopolysaccharide (LPS) formation, data on the LPS itself or detailed knowledge of the LPS pathway beyond the first committed steps of lipid A and 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) synthesis are still lacking. We now report the functional characterization of the thermostable Kdo transferase WaaA from A. aeolicus and provide evidence that the enzyme is monofunctional. Compositional analysis and mass spectrometry of purified A. aeolicus LPS, showing the incorporation of a single Kdo residue as an integral component of the LPS, implicated a monofunctional Kdo transferase in LPS biosynthesis of A. aeolicus. Further, heterologous expression of the A. aeolicus waaA gene in a newly constructed Escherichia coli Delta waaA suppressor strain resulted in synthesis of lipid IVA precursors substituted with one Kdo sugar. When highly purified WaaA of A. aeolicus was subjected to in vitro assays using mass spectrometry for detection of the reaction products, the enzyme was found to catalyze the transfer of only a single Kdo residue from CMP-Kdo to differently modified lipid A acceptors. The Kdo transferase was capable of utilizing a broad spectrum of acceptor substrates, whereas surface plasmon resonance studies indicated a high selectivity for the donor substrate.	[Mamat, Uwe; Schmidt, Helgo; Hanuszkiewicz, Anna; Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Lindner, Buko] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany; [Munoz, Eva] Med Univ Lubeck, Inst Chem, D-23538 Lubeck, Germany; [Schmidt, Helgo; Hilgenfeld, Rolf; Mesters, Jeroen R.] Med Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, D-23538 Lubeck, Germany; [Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; [Meredith, Timothy C.; Woodard, Ronald W.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	Forschungszentrum Borstel; Forschungszentrum Borstel; University of Lubeck; University of Lubeck; Osaka University; University of Michigan System; University of Michigan	Mamat, U (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, Pk Allee 4A-4C, D-23845 Borstel, Germany.	umamat@fz-borstel.de	Lindner, Buko/G-9731-2014; Meredith, Timothy/X-2713-2019; Hilgenfeld, Rolf/C-9675-2011	Meredith, Timothy/0000-0002-1901-6841; Woodard, Ronald/0000-0002-7472-3653; Mesters, Jeroen/0000-0001-8532-6699	Deutsche Forschungsgemeinschaft [MA 1408/2-1, ME 2741/1-1, Li-448/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA 1408/2-1 (to U. M.), Grant ME 2741/1-1 (to J.R.M. and R. H.), and Grant Li-448/4-1 (to B. L.). The BIAcore 3000 instrument was acquired with the support of Deutsche Forschungsgemeinschaft SFB470.	ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Blume A, 2006, J BIOL CHEM, V281, P32728, DOI 10.1074/jbc.M600424200; Bode CE, 1998, EUR J BIOCHEM, V254, P404, DOI 10.1046/j.1432-1327.1998.2540404.x; Brabetz N, 2000, J BACTERIOL, V182, P4654, DOI 10.1128/JB.182.16.4654-4657.2000; Brabetz W, 2000, EUR J BIOCHEM, V267, P5458, DOI 10.1046/j.1432-1327.2000.01619.x; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; BRADE H, 1983, EUR J BIOCHEM, V131, P195, DOI 10.1111/j.1432-1033.1983.tb07249.x; BRADE H, 1984, CARBOHYD RES, V134, P157, DOI 10.1016/0008-6215(84)85030-2; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Cacciapuoti G, 1999, PROTEIN EXPRES PURIF, V16, P125, DOI 10.1006/prep.1999.1076; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Duewel HS, 2001, J BIOL CHEM, V276, P8393, DOI 10.1074/jbc.M007884200; Duewel HS, 1999, BIOCHEM BIOPH RES CO, V263, P346, DOI 10.1006/bbrc.1999.1361; Fukase K, 1999, J ENDOTOXIN RES, V5, P46, DOI 10.1177/09680519990050012001; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gentile F, 2002, J BIOL CHEM, V277, P44050, DOI 10.1074/jbc.M206761200; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; HELANDER IM, 1988, EUR J BIOCHEM, V177, P483, DOI 10.1111/j.1432-1033.1988.tb14398.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HOLST O, 1995, EUR J BIOCHEM, V229, P194, DOI 10.1111/j.1432-1033.1995.tb20455.x; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; IMOTO M, 1987, B CHEM SOC JPN, V60, P2197, DOI 10.1246/bcsj.60.2197; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS, V2; Karbarz MJ, 2009, J BIOL CHEM, V284, P414, DOI 10.1074/jbc.M808390200; Karlsson R, 2004, J MOL RECOGNIT, V17, P151, DOI 10.1002/jmr.660; Kataoka M, 2006, HETEROCYCLES, V69, P395; KOHLBRENNER WE, 1985, J BIOL CHEM, V260, P4695; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; KOPETZKI E, 1989, MOL GEN GENET, V216, P149, DOI 10.1007/BF00332244; Kusumoto S, 2006, CHEM REC, V6, P333, DOI 10.1002/tcr.20098; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDUR A, 1978, EUR J BIOCHEM, V84, P579, DOI 10.1111/j.1432-1033.1978.tb12201.x; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; MAMAT U, 1993, MOL MICROBIOL, V10, P935, DOI 10.1111/j.1365-2958.1993.tb00965.x; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P1106, DOI 10.1021/bi048001h; Meredith TC, 2003, J BIOL CHEM, V278, P32771, DOI 10.1074/jbc.M303661200; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Noah C, 2001, J ENDOTOXIN RES, V7, P25, DOI 10.1179/096805101101532495; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY PH, 1982, METHOD ENZYMOL, V83, P535; Rund S, 2000, EUR J BIOCHEM, V267, P5717, DOI 10.1046/j.1432-1327.2000.01635.x; Sambrook J, 2001, MOL CLONING LAB MANU; Seydel U, 2005, FEBS J, V272, P327, DOI 10.1111/j.1742-4658.2004.04471.x; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200; ZAHRINGER U, 1994, ADV CARBOHYD CHEM BI, V50, P211, DOI 10.1016/S0065-2318(08)60152-3; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	79	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22248	22262		10.1074/jbc.M109.033308	http://dx.doi.org/10.1074/jbc.M109.033308			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19546212	Green Published, hybrid			2022-12-25	WOS:000268783700049
J	Ryu, YU; Bradley, NS				Ryu, Young U.; Bradley, Nina S.			Precocious Locomotor Behavior Begins in the Egg: Development of Leg Muscle Patterns for Stepping in the Chick	PLOS ONE			English	Article							SPONTANEOUS RHYTHMIC ACTIVITY; EMBRYONIC DAYS 9; SPINAL-CORD; MOTONEURON ACTIVITY; FICTIVE LOCOMOTION; BURST GENERATION; NEURAL ACTIVITY; MOTILITY; MOVEMENTS; ORGANIZATION	Background: The chicken is capable of adaptive locomotor behavior within hours after hatching, yet little is known of the processes leading to this precocious skill. During the final week of incubation, chick embryos produce distinct repetitive limb movements that until recently had not been investigated. In this study we examined the leg muscle patterns at 3 time points as development of these spontaneous movements unfolds to determine if they exhibit attributes of locomotion reported in hatchlings. We also sought to determine whether the deeply flexed posture and movement constraint imposed by the shell wall modulate the muscle patterns. Methodology/Principal Findings: Synchronized electromyograms for leg muscles, force and video were recorded continuously from embryos while in their naturally flexed posture at embryonic day (E) 15, E18 and E20. We tested for effects of leg posture and constraint by removing shell wall anterior to the foot. Results indicated that by E18, burst onset time distinguished leg muscle synergists from antagonists across a 10-fold range in burst frequencies (1-10 Hz), and knee extensors from ankle extensors in patterns comparable to locomotion at hatching. However, burst durations did not scale with step cycle duration in any of the muscles recorded. Despite substantially larger leg movements after shell removal, the knee extensor was the only muscle to vary its activity, and extensor muscles often failed to participate. To further clarify if the repetitive movements are likely locomotor-related, we examined bilateral coordination of ankle muscles during repetitive movements at E20. In all cases ankle muscles exhibited a bias for left/right alternation. Conclusions/Significance: Collectively, the findings lead us to conclude that the repetitive leg movements in late stage embryos are locomotor-related and a fundamental link in the establishment of precocious locomotor skill. The potential importance of differences between embryonic and posthatching locomotion is discussed.			Ryu, YU (corresponding author), Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA.	nbradley@usc.edu	Bradley, Nina/F-8830-2014	Bradley, Nina/0000-0002-9674-4834; Ryu, Young Uk/0000-0003-1601-4477	NICHD NIH HHS [R01 HD053367, R01 HD-053367] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053367] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEKOFF A, 1976, BRAIN RES, V106, P271, DOI 10.1016/0006-8993(76)91025-8; BEKOFF A, 1987, DEV PSYCHOBIOL, V20, P489, DOI 10.1002/dev.420200503; BEKOFF A, 1984, J NEUROSCI, V4, P2659; Bradley NS, 2008, J NEUROPHYSIOL, V99, P1733, DOI 10.1152/jn.01393.2007; Bradley NS, 2005, J NEUROPHYSIOL, V94, P4401, DOI 10.1152/jn.00804.2005; BRADLEY NS, 1990, DEV PSYCHOBIOL, V23, P763, DOI 10.1002/dev.420230802; Bradley NS, 1999, J NEUROPHYSIOL, V81, P1486, DOI 10.1152/jn.1999.81.4.1486; BRADLEY NS, 2003, J NEUROPHYSIOL; Cangiano L, 2003, J NEUROPHYSIOL, V89, P2931, DOI 10.1152/jn.01100.2002; CHAMBERS SH, 1995, EXP BRAIN RES, V103, P218; Chub N, 2006, J NEUROPHYSIOL, V95, P323, DOI 10.1152/jn.00162.2005; Chub N, 1998, J NEUROSCI, V18, P294; Cotel F, 2009, J NEUROSCI, V29, P2748, DOI 10.1523/JNEUROSCI.3462-08.2009; GLOVER JC, 1993, BRAIN RES BULL, V30, P265, DOI 10.1016/0361-9230(93)90254-9; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; HAMBURGE.V, 1966, J EXP ZOOL, V162, P133, DOI 10.1002/jez.1401620202; HAMBURGE.V, 1965, J EXP ZOOL, V159, P1, DOI 10.1002/jez.1401590102; HAMBURGER V, 1967, J EXP ZOOL, V166, P171, DOI 10.1002/jez.1401660203; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1963, Q REV BIOL, V38, P342, DOI 10.1086/403941; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1338; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; HOY MG, 1985, J NEUROPHYSIOL, V54, P1282, DOI 10.1152/jn.1985.54.5.1282; JACOBSON RD, 1982, J NEUROPHYSIOL, V48, P238, DOI 10.1152/jn.1982.48.1.238; JACOBSON RD, 1982, J NEUROPHYSIOL, V48, P257, DOI 10.1152/jn.1982.48.1.257; Johnston RM, 1996, J COMP PHYSIOL A, V179, P169, DOI 10.1007/BF00222784; KOSHLAND GF, 1989, J NEUROPHYSIOL, V62, P162, DOI 10.1152/jn.1989.62.1.162; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; MAIER A, 1993, CELL TISSUE RES, V274, P383, DOI 10.1007/BF00318757; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Milner LD, 1999, J NEUROSCI, V19, P3007; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589, DOI 10.1113/jphysiol.1996.sp021406; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; ODonovan MJ, 1997, SEMIN CELL DEV BIOL, V8, P21, DOI 10.1006/scdb.1996.0117; OKADO N, 1985, J COMP NEUROL, V232, P143, DOI 10.1002/cne.902320202; OROSZ MD, 1994, COMPUT BIOL MED, V24, P305, DOI 10.1016/0010-4825(94)90027-2; Sharp AA, 1999, J NEUROPHYSIOL, V82, P2406, DOI 10.1152/jn.1999.82.5.2406; Stein PSG, 2002, J NEUROSCI, V22, P6800; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; Stein PSG, 2004, J NEUROPHYSIOL, V91, P2380, DOI 10.1152/jn.01184.2003; Tabak J, 2000, J NEUROSCI, V20, P3041	43	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6111	10.1371/journal.pone.0006111	http://dx.doi.org/10.1371/journal.pone.0006111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578536	Green Published, Green Submitted, gold			2022-12-25	WOS:000267806300002
J	Morris, PF; Schlosser, LR; Onasch, KD; Wittenschlaeger, T; Austin, R; Provart, N				Morris, Paul Francis; Schlosser, Laura Rose; Onasch, Katherine Diane; Wittenschlaeger, Tom; Austin, Ryan; Provart, Nicholas			Multiple Horizontal Gene Transfer Events and Domain Fusions Have Created Novel Regulatory and Metabolic Networks in the Oomycete Genome	PLOS ONE			English	Article							EVOLUTION; ENZYMES; BIOSYNTHESIS; REDUCTASES; INSIGHTS; REVEALS	Complex enzymes with multiple catalytic activities are hypothesized to have evolved from more primitive precursors. Global analysis of the Phytophthora sojae genome using conservative criteria for evaluation of complex proteins identified 273 novel multifunctional proteins that were also conserved in P. ramorum. Each of these proteins contains combinations of protein motifs that are not present in bacterial, plant, animal, or fungal genomes. A subset of these proteins were also identified in the two diatom genomes, but the majority of these proteins have formed after the split between diatoms and oomycetes. Documentation of multiple cases of domain fusions that are common to both oomycetes and diatom genomes lends additional support for the hypothesis that oomycetes and diatoms are monophyletic. Bifunctional proteins that catalyze two steps in a metabolic pathway can be used to infer the interaction of orthologous proteins that exist as separate entities in other genomes. We postulated that the novel multifunctional proteins of oomycetes could function as potential Rosetta Stones to identify interacting proteins of conserved metabolic and regulatory networks in other eukaryotic genomes. However ortholog analysis of each domain within our set of 273 multifunctional proteins against 39 sequenced bacterial and eukaryotic genomes, identified only 18 candidate Rosetta Stone proteins. Thus the majority of multifunctional proteins are not Rosetta Stones, but they may nonetheless be useful in identifying novel metabolic and regulatory networks in oomycetes. Phylogenetic analysis of all the enzymes in three pathways with one or more novel multifunctional proteins was conducted to determine the probable origins of individual enzymes. These analyses revealed multiple examples of horizontal transfer from both bacterial genomes and the photosynthetic endosymbiont in the ancestral genome of Stramenopiles. The complexity of the phylogenetic origins of these metabolic pathways and the paucity of Rosetta Stones relative to the total number of multifunctional proteins suggests that the proteome of oomycetes has few features in common with other Kingdoms.			Morris, PF (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	pmorris@bgsu.edu		Morris, Paul/0000-0002-2989-041X				Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; ANANTHARAMANA V, 2007, ANN REV MICROBIOL, V61; Andersson JO, 2006, CURR BIOL, V16, pR804, DOI 10.1016/j.cub.2006.08.042; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bordenstein SR, 2007, CURR BIOL, V17, pR935, DOI 10.1016/j.cub.2007.09.022; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dorrance AE, 2003, PLANT DIS, V87, P139, DOI 10.1094/PDIS.2003.87.2.139; Durrens P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000200; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Judelson HS, 2007, ADV GENET, V57, P97, DOI 10.1016/S0065-2660(06)57003-8; Kamburov A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-460; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Makiuchi T, 2007, GENE, V394, P78, DOI 10.1016/j.gene.2007.02.009; MARCOTTE CJV, 2002, APPL BIOINFORMATICS, V2, P1; Martens C, 2008, P NATL ACAD SCI USA, V105, P3427, DOI 10.1073/pnas.0712248105; Miller C, 2000, GENOME BIOL; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Peixoto L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S8-S5; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; Tang GL, 2002, PLANT PHYSIOL, V130, P147, DOI 10.1104/pp.005660; Tsoka S, 2000, NAT GENET, V26, P141, DOI 10.1038/79847; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Wolf YI, 2000, GENOME BIOL, V1; Yanai I, 2002, GENOME BIOL, V3; Yiting Y, 2004, FRONT BIOSCI-LANDMRK, V9, P2964, DOI 10.2741/1451; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	42	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2009	4	7							e6133	10.1371/journal.pone.0006133	http://dx.doi.org/10.1371/journal.pone.0006133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GX	19582169	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806200008
J	Cohen, Z; Lavi, S				Cohen, Zoya; Lavi, Sara			Replication Independent Formation of Extrachromosomal Circular DNA in Mammalian Cell-Free System	PLOS ONE			English	Article								Extrachromosomal circular DNA (eccDNA) is a pool of circular double stranded DNA molecules found in all eukaryotic cells and composed of repeated chromosomal sequences. It was proposed to be involved in genomic instability, aging and alternative telomere lengthening. Our study presents novel mammalian cell-free system for eccDNA generation. Using purified protein extract we show that eccDNA formation does not involve de-novo DNA synthesis suggesting that eccDNA is generated through excision of chromosomal sequences. This process is carried out by sequence-independent enzymes as human protein extract can produce mouse-specific eccDNA from high molecular weight mouse DNA, and vice versa. EccDNA production does not depend on ATP, requires residual amounts of Mg(2+) and is enhanced by double strand DNA breaks.			Cohen, Z (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	lavisara@post.tau.ac.il	Cohen, Zoya/GQQ-8127-2022	Cohen, Zoya/0000-0002-1284-3035				ASSUM G, 1993, HUM GENET, V91, P489; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BERTELSEN AH, 1982, BIOCHEMISTRY-US, V21, P2076, DOI 10.1021/bi00538a015; Cohen S, 1997, ONCOGENE, V14, P977, DOI 10.1038/sj.onc.1200917; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen S, 1996, MOL CELL BIOL, V16, P2002; Cohen S, 1999, MOL CELL BIOL, V19, P6682; Cohen S, 2001, NUCLEIC ACIDS RES, V29, P2542, DOI 10.1093/nar/29.12.2542; Cohen Z, 2006, ONCOGENE, V25, P4515, DOI 10.1038/sj.onc.1209485; DEGROOTE F, 1989, CHROMOSOMA, V98, P201, DOI 10.1007/BF00329684; FAIRMAN MP, 1992, NUCLEIC ACIDS RES, V20, P4145, DOI 10.1093/nar/20.16.4145; GAUBATZ JW, 1990, MUTAT RES, V237, P271, DOI 10.1016/0921-8734(90)90009-G; HARDING RM, 1992, GENETICS, V132, P847; KIYAMA R, 1987, J MOL BIOL, V198, P589, DOI 10.1016/0022-2836(87)90202-6; Kouprina Natalay, 2006, V349, P85; KUNISADA T, 1985, MECH AGEING DEV, V29, P89, DOI 10.1016/0047-6374(85)90050-8; MOTEJLEK K, 1993, MUTAT RES, V293, P205, DOI 10.1016/0921-8777(93)90071-N; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Park PU, 1999, MOL CELL BIOL, V19, P3848; Regev A, 1998, ONCOGENE, V17, P3455, DOI 10.1038/sj.onc.1202250; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Sambrook J., 2002, MOL CLONING LAB MANU; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SMITH CA, 1972, J MOL BIOL, V69, P163, DOI 10.1016/0022-2836(72)90222-7; Smith J, 2003, NUCLEIC ACIDS RES, V31, P2157, DOI 10.1093/nar/gkg317	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6126	10.1371/journal.pone.0006126	http://dx.doi.org/10.1371/journal.pone.0006126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568438	Green Published, gold, Green Submitted			2022-12-25	WOS:000267572200023
J	Reuse, S; Calao, M; Kabeya, K; Guiguen, A; Gatot, JS; Quivy, V; Vanhulle, C; Lamine, A; Vaira, D; Demonte, D; Martinelli, V; Veithen, E; Cherrier, T; Avettand, V; Poutrel, S; Piette, J; de Launoit, Y; Moutschen, M; Burny, A; Rouzioux, C; De Wit, S; Herbein, G; Rohr, O; Collette, Y; Lambotte, O; Clumeck, N; Van Lint, C				Reuse, Sophie; Calao, Miriam; Kabeya, Kabamba; Guiguen, Allan; Gatot, Jean-Stephane; Quivy, Vincent; Vanhulle, Caroline; Lamine, Aurelia; Vaira, Dolores; Demonte, Dominique; Martinelli, Valerie; Veithen, Emmanuelle; Cherrier, Thomas; Avettand, Veronique; Poutrel, Solene; Piette, Jacques; de Launoit, Yvan; Moutschen, Michel; Burny, Arsene; Rouzioux, Christine; De Wit, Stephane; Herbein, Georges; Rohr, Olivier; Collette, Yves; Lambotte, Olivier; Clumeck, Nathan; Van Lint, Carine			Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; BROMODOMAIN PROTEIN BRD4; LONG TERMINAL REPEAT; HISTONE DEACETYLASE; T-CELLS; VALPROIC ACID; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; P-TEFB	The persistence of transcriptionally silent but replication-competent HIV-1 reservoirs in Highly Active Anti-Retroviral Therapy (HAART)-treated infected individuals, represents a major hurdle to virus eradication. Activation of HIV-1 gene expression in these cells together with an efficient HAART has been proposed as an adjuvant therapy aimed at decreasing the pool of latent viral reservoirs. Using the latently-infected U1 monocytic cell line and latently-infected J-Lat T-cell clones, we here demonstrated a strong synergistic activation of HIV-1 production by clinically used histone deacetylase inhibitors (HDACIs) combined with prostratin, a non-tumor-promoting nuclear factor (NF)-kappa B inducer. In J-Lat cells, we showed that this synergism was due, at least partially, to the synergistic recruitment of unresponsive cells into the expressing cell population. A combination of prostratin+HDACI synergistically activated the 59 Long Terminal Repeat (5'LTR) from HIV-1 Major group subtypes representing the most prevalent viral genetic forms, as shown by transient transfection reporter assays. Mechanistically, HDACIs increased prostratin-induced DNA-binding activity of nuclear NF-kappa B and degradation of cytoplasmic NF-kappa B inhibitor, I kappa Ba. Moreover, the combined treatment prostratin+HDACI caused a more pronounced nucleosomal remodeling in the U1 viral promoter region than the treatments with the compounds alone. This more pronounced remodeling correlated with a synergistic reactivation of HIV-1 transcription following the combined treatment prostratin+HDACI, as demonstrated by measuring recruitment of RNA polymerase II to the 5'LTR and both initiated and elongated transcripts. The physiological relevance of the prostratin+HDACI synergism was shown in CD8(+)-depleted peripheral blood mononuclear cells from HAART-treated patients with undetectable viral load. Moreover, this combined treatment reactivated viral replication in resting CD4(+) T cells isolated from similar patients. Our results suggest that combinations of different kinds of proviral activators may have important implications for reducing the size of latent HIV-1 reservoirs in HAART-treated patients.			Reuse, S (corresponding author), Univ Libre Bruxelles, IBMM, Mol Virol Lab, Gosselies, Belgium.	cvlint@ulb.ac.be	Avettand-Fenoel, Véronique/O-6285-2017; COLLETTE, Yves/F-2270-2013; CHERRIER, Thomas/F-8727-2018; Lambotte, Olivier/GRT-0160-2022	Avettand-Fenoel, Véronique/0000-0002-7022-2990; COLLETTE, Yves/0000-0001-5359-7099; CHERRIER, Thomas/0000-0002-0707-9204; de Launoit, Yvan/0000-0003-1837-9808; Moutschen, Michel/0000-0002-6405-1785; ROHR, Olivier/0000-0001-8992-2025				Adam E, 2003, MOL CELL BIOL, V23, P6200, DOI 10.1128/MCB.23.17.6200-6209.2003; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Butler IF, 2007, CURR HIV RES, V5, P23, DOI 10.2174/157016207779316297; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 2001, P NATL ACAD SCI USA, V98, P253, DOI 10.1073/pnas.98.1.253; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; COSTELLO R, 1993, EUR J IMMUNOL, V23, P608, DOI 10.1002/eji.1830230304; COSTELLO R, 1993, CELL GROWTH DIFFER, V4, P329; Coull JJ, 2002, J VIROL, V76, P12349, DOI 10.1128/JVI.76.23.12349-12354.2002; Crazzolara R, 2002, BRIT J HAEMATOL, V119, P965, DOI 10.1046/j.1365-2141.2002.03955.x; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Demonte D, 2004, BIOCHEM PHARMACOL, V68, P1231, DOI 10.1016/j.bcp.2004.05.040; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DOVER GJ, 1994, BLOOD, V84, P339; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Gulakowski RJ, 1997, ANTIVIR RES, V33, P87, DOI 10.1016/S0166-3542(96)01004-2; GUSTAFSON KR, 1992, J MED CHEM, V35, P1978, DOI 10.1021/jm00089a006; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Hezareh M, 2005, DRUG NEWS PERSPECT, V18, P496, DOI 10.1358/dnp.2005.18.8.944543; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Johnson HE, 2008, J NAT PROD, V71, P2041, DOI 10.1021/np800295m; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Katz RA, 2007, J VIROL, V81, P2592, DOI 10.1128/JVI.01643-06; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Margolis David M, 2007, Curr HIV/AIDS Rep, V4, P60, DOI 10.1007/s11904-007-0009-6; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ott M, 1998, J IMMUNOL, V160, P2872; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; PIERRES A, 1988, EUR J IMMUNOL, V18, P685, DOI 10.1002/eji.1830180505; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Quivy Vincent, 2007, Subcell Biochem, V41, P371; Rullas J, 2004, ANTIVIR THER, V9, P545; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Tunnicliff G, 1999, J PHYSIOL PHARMACOL, V50, P347; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; WEISS A, 1984, J IMMUNOL, V133, P123; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; WINSLOW BJ, 1993, VIROLOGY, V196, P849, DOI 10.1006/viro.1993.1545; Witvrouw Myriam, 2003, Antiviral Chemistry & Chemotherapy, V14, P321; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	93	198	208	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6093	10.1371/journal.pone.0006093	http://dx.doi.org/10.1371/journal.pone.0006093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564922	gold, Green Published, Green Submitted			2022-12-25	WOS:000267515700012
J	Rubio-Aliaga, I; Przemeck, GKH; Fuchs, H; Gailus-Durner, V; Adler, T; Hans, W; Horsch, M; Rathkolb, B; Rozman, J; Schrewe, A; Wagner, S; Hoelter, SM; Becker, L; Klopstock, T; Wurst, W; Wolf, E; Klingenspor, M; Ivandic, BT; Busch, DH; Beckers, J; de Angelis, MH				Rubio-Aliaga, Isabel; Przemeck, Gerhard K. H.; Fuchs, Helmut; Gailus-Durner, Valerie; Adler, Thure; Hans, Wolfgang; Horsch, Marion; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Wagner, Sibylle; Hoelter, Sabine M.; Becker, Lore; Klopstock, Thomas; Wurst, Wolfgang; Wolf, Eckhard; Klingenspor, Martin; Ivandic, Boris T.; Busch, Dirk H.; Beckers, Johannes; de Angelis, Martin Hrabe			Dll1 Haploinsufficiency in Adult Mice Leads to a Complex Phenotype Affecting Metabolic and Immunological Processes	PLOS ONE			English	Article								Background: The Notch signaling pathway is an evolutionary conserved signal transduction pathway involved in embryonic patterning and regulation of cell fates during development and self-renewal. Recent studies have demonstrated that this pathway is integral to a complex system of interactions, involving as well other signal transduction pathways, and implicated in distinct human diseases. Delta-like 1 (Dll1) is one of the known ligands of the Notch receptors. The role of the Notch ligands is less well understood. Loss-of-function of Dll1 leads to embryonic lethality, but reduction of Delta-like 1 protein levels has not been studied in adult stage. Methodology/Principal Findings: Here we present the haploinsufficient phenotype of Dll1 and a missense mutant Dll1 allele (Dll1(C413Y)). Haploinsufficiency leads to a complex phenotype with several biological processes altered. These alterations reveal the importance of Dll1 mainly in metabolism, energy balance and in immunology. The animals are smaller, lighter, with altered fat to lean ratio and have increased blood pressure and a slight bradycardia. The animals have reduced cholesterol and triglyceride levels in blood. At the immunological level a subtle phenotype is observed due to the effect and fine-tuning of the signaling network at the different levels of differentiation, proliferation and function of lymphocytes. Moreover, the importance of the proteolytic regulation of the Notch signaling network emphasized. Conclusions/Significance: In conclusion, slight alterations in one player of Notch signaling alter the entire organism, emphasizing the fine-tuning character of this pathway in a high number of processes.			Rubio-Aliaga, I (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-8050 Freising Weihenstephan, Germany.	beckers@helmholtz-muenchen.de; hrabe@helmholtz-muenchen.de	Rozman, Jan/A-2540-2010; de Angelis, Martin Hrabe/F-5531-2012; Klingenspor, Martin/D-6930-2011; Fuchs, Helmut/M-7347-2014; Beckers, Johannes/K-7237-2012; Przemeck, Gerhard K. H./A-5991-2012; Hölter, Sabine M./N-5868-2014; Becker, Lore/E-3717-2010; Becker, Lore/AAJ-1203-2020; Rathkolb, Birgit/F-7041-2013; Klingenspor, Martin/K-5033-2019; Gailus-Durner, Valerie/M-7337-2014	Rozman, Jan/0000-0002-8035-8904; de Angelis, Martin Hrabe/0000-0002-7898-2353; Klingenspor, Martin/0000-0002-4502-6664; Fuchs, Helmut/0000-0002-5143-2677; Beckers, Johannes/0000-0001-7874-3822; Przemeck, Gerhard K. H./0000-0003-3730-3454; Hölter, Sabine M./0000-0003-4878-5241; Becker, Lore/0000-0002-6890-4984; Wolf, Eckhard/0000-0002-0430-9510; Rubio-Aliaga, Isabel/0000-0003-1051-9511; Wurst, Wolfgang/0000-0003-4422-7410				Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Augustin M, 2005, MAMM GENOME, V16, P405, DOI 10.1007/s00335-004-3028-2; AVENELL A, 1994, EUR J CLIN NUTR, V48, P561; Bedogni G, 2002, ANN HUM BIOL, V29, P559, DOI 10.1080/03014460210137819; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Brown SDM, 2005, NAT GENET, V37, P1155, DOI 10.1038/ng1105-1155; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Chao J, 2001, BIOL CHEM, V382, P15, DOI 10.1515/BC.2001.003; Chen Z, 1997, J BONE MINER RES, V12, P144, DOI 10.1359/jbmr.1997.12.1.144; Choi JW, 2003, CLIN CHIM ACTA, V333, P79, DOI 10.1016/S0009-8981(03)00190-6; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Elvert R, 2006, INTEGR ZOOL, V1, P122, DOI 10.1111/j.1749-4877.2006.00026.x; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Frost HM, 1997, BONE, V21, P211, DOI 10.1016/S8756-3282(97)00124-5; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; Fuchs H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P13; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hahn FM, 1996, ARCH BIOCHEM BIOPHYS, V332, P30, DOI 10.1006/abbi.1996.0312; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hoelter SM, 2008, FRONT BIOSCI-LANDMRK, V13, P5810; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hu G, 1999, MOL CELL BIOL, V19, P724; Hutchinson S, 2005, J MOL BIOL, V346, P833, DOI 10.1016/j.jmb.2004.11.038; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; KALAYDJIEV S, 2006, STANDARDS MOUSE MODE, P237; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kiernan AE, 2007, GENETICS, V177, P307, DOI 10.1534/genetics.107.075960; Klempt M, 2006, MAMM GENOME, V17, P93, DOI 10.1007/s00335-005-0119-7; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leker RR, 2006, PATHOPHYSIOL HAEMO T, V35, P58, DOI 10.1159/000093545; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; Machka C, 2005, GENE EXPR PATTERNS, V6, P94, DOI 10.1016/j.modgep.2005.04.009; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Meyer CW, 2007, NATURWISSENSCHAFTEN, V94, P401, DOI 10.1007/s00114-006-0203-1; Meyer CW, 2007, J COMP PHYSIOL B, V177, P183, DOI 10.1007/s00360-006-0120-9; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nurmi SM, 2006, ANN NY ACAD SCI, V1090, P318, DOI 10.1196/annals.1378.035; Okabe H, 2003, CANCER RES, V63, P3043; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Petkova SB, 2008, PHYSIOL GENOMICS, V34, P304, DOI 10.1152/physiolgenomics.00185.2007; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rubio-Aliaga I, 2007, GENETICS, V175, P1451, DOI 10.1534/genetics.106.067298; Ryu CJ, 2004, MOL CELL BIOL, V24, P7015, DOI 10.1128/MCB.24.16.7015-7023.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; WILKIN DJ, 1990, J BIOL CHEM, V265, P4607; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	90	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6054	10.1371/journal.pone.0006054	http://dx.doi.org/10.1371/journal.pone.0006054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562077	Green Submitted, gold, Green Published			2022-12-25	WOS:000267465900003
J	Kan, NG; Junghans, D; Belmonte, JCI				Kan, Natalia G.; Junghans, Dirk; Izpisua Belmonte, Juan Carlos			Compensatory growth mechanisms regulated by BMP and FGF signaling mediate liver regeneration in zebrafish after partial hepatectomy	FASEB JOURNAL			English	Article						hepatocyte proliferation; liver-to-body weight ratio; liver mass restoration; Danio rerio	RAT-LIVER; FIN REGENERATION; IN-VIVO; EXPRESSION; SPECIFICATION; ENDODERM; INJURY; REQUIRES; PATHWAY; MUTANT	Here, we describe the zebrafish (Danio rerio) as a vertebrate model system to study liver regeneration with the added benefit of its powerful genetics and screening possibilities to uncover the molecular pathways underlying liver regeneration. We developed a partial hepatectomy (PH) protocol in zebrafish and investigated in detail the cellular and morphological changes during the process of liver regeneration. We show that the type of regenerative response is dependent on the size of the injury sustained by the zebrafish liver. Furthermore, we demonstrate for the first time that the mechanisms of liver regeneration in zebrafish after PH are strikingly similar to those of rodents and humans, with 100% recovery of the liver mass after 6-7 d postsurgery. This occurs via compensatory growth mediated by proliferation of hepatocytes throughout the entire liver remnant. By analyzing transgenic fish expressing dominant-negative forms of either bone morphogenetic protein (BMP) receptor or fibroblast growth factor (FGF) receptor 1, we demonstrate that the BMP and FGF signaling pathways are crucial regulators of the early events during liver regeneration after PH. Our study demonstrates that the mechanisms of liver regeneration in zebrafish are highly similar to the processes ongoing during mammalian liver regeneration and make the adult zebrafish a suitable model system to study the mechanisms of liver regeneration.-Kan, N. G., Junghans, D., Belmonte, J. C. I. Compensatory growth mechanisms regulated by BMP and FGF signaling mediate liver regeneration in zebrafish after partial hepatectomy. FASEB J. 23, 3516-3525 (2009). www.fasebj.org	[Kan, Natalia G.; Junghans, Dirk; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Junghans, Dirk; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu			G. Harold and Leila Y. Mathers Charitable Foundation; U. S. National Institutes of Health; Marato; Fundacion Cellex	G. Harold and Leila Y. Mathers Charitable Foundation; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marato; Fundacion Cellex	The authors greatly appreciate the generous gift of BMP2 and Noggin recombinant proteins from Dr. Senyon Choe ( Salk Institute, La Jolla, CA, USA). We thank Verdon Taylor, Gerald Pao and Karl-Dimiter Bissig for helpful discussions and constructive comments on the manuscript, Michael Schorpp (Max-Planck Institute of Immunobiology, Freiburg, Germany) for providing zebrafish; and May Schwarz for proofreading the manuscript. This work was supported by grants from the G. Harold and Leila Y. Mathers Charitable Foundation, the U. S. National Institutes of Health, the Marato, and Fundacion Cellex. N.G.K., D.J., and J.C.I.B. designed the research; N.G.K. and D.J. performed the research; N.G.K., D.J., and J.C.I.B analyzed the data; and N.G.K., D.J., and J.C.I.B. wrote the paper.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BARUCH Y, 1995, J HEPATOL, V23, P328, DOI 10.1016/0168-8278(95)80477-3; Burke ZD, 2006, CURR BIOL, V16, pR688, DOI 10.1016/j.cub.2006.08.011; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Driever W, 1996, DEVELOPMENT, V123, P37; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; GRISHAM JW, 1962, CANCER RES, V22, P842; Haffter P, 1996, DEVELOPMENT, V123, P1; Hioki O, 1996, J HEPATOL, V24, P217, DOI 10.1016/S0168-8278(96)80032-8; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Nakatsuka R, 2007, J BIOCHEM, V141, P113, DOI 10.1093/jb/mvm012; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499; Sturm J, 2004, LIVER INT, V24, P161, DOI 10.1111/j.1478-3231.2004.0896.x; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Weglarz TC, 2000, P NATL ACAD SCI USA, V97, P12595, DOI 10.1073/pnas.220430497; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	41	65	70	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3516	3525		10.1096/fj.09-131730	http://dx.doi.org/10.1096/fj.09-131730			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19546304	Green Published			2022-12-25	WOS:000270354300028
J	Bullen, HE; Tonkin, CJ; O'Donnell, RA; Tham, WH; Papenfuss, AT; Gould, S; Cowman, AF; Crabb, BS; Gilson, PR				Bullen, Hayley E.; Tonkin, Christopher J.; O'Donnell, Rebecca A.; Tham, Wai-Hong; Papenfuss, Anthony T.; Gould, Sven; Cowman, Alan F.; Crabb, Brendan S.; Gilson, Paul R.			A Novel Family of Apicomplexan Glideosome-associated Proteins with an Inner Membrane-anchoring Role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE TOXOPLASMA-GONDII; HOST-CELL INVASION; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; LIFE-CYCLE; XIV MYOSIN; EXPRESSION; MOTILITY; IDENTIFICATION; MEROZOITE	The phylum Apicomplexa are a group of obligate intracellular parasites responsible for a wide range of important diseases. Central to the lifecycle of these unicellular parasites is their ability to migrate through animal tissue and invade target host cells. Apicomplexan movement is generated by a unique system of gliding motility in which substrate adhesins and invasion-related proteins are pulled across the plasma membrane by an underlying actin-myosin motor. The myosins of this motor are inserted into a dual membrane layer called the inner membrane complex (IMC) that is sandwiched between the plasma membrane and an underlying cytoskeletal basket. Central to our understanding of gliding motility is the characterization of proteins residing within the IMC, but to date only a few proteins are known. We report here a novel family of six-pass transmembrane proteins, termed the GAPM family, which are highly conserved and specific to Apicomplexa. In Plasmodium falciparum and Toxoplasma gondii the GAPMs localize to the IMC where they form highly SDS-resistant oligomeric complexes. The GAPMs co-purify with the cytoskeletal alveolin proteins and also to some degree with the actin-myosin motor itself. Hence, these proteins are strong candidates for an IMC-anchoring role, either directly or indirectly tethering the motor to the cytoskeleton.	[Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Bullen, Hayley E.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Bullen, Hayley E.; Tonkin, Christopher J.; O'Donnell, Rebecca A.; Tham, Wai-Hong; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia; [Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Gould, Sven] Univ Melbourne, Sch Bot, Parkville, Vic 3050, Australia	Burnet Institute; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne	Gilson, PR (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	gilson@burnet.edu.au	Papenfuss, Anthony T/C-6297-2008; Tonkin, Christopher/K-6534-2019; Gould, Sven B/B-8192-2011; Crabb, Brendan/F-5287-2013; Tham, Wai-Hong/P-6474-2019; Cowman, Alan F/C-7642-2013; Tham, Wai-Hong/L-3173-2018	Papenfuss, Anthony T/0000-0002-1102-8506; Tonkin, Christopher/0000-0002-7036-6222; Tham, Wai-Hong/0000-0001-7950-8699; Cowman, Alan F/0000-0001-5145-9004; Tham, Wai-Hong/0000-0001-7950-8699; Gould, Sven/0000-0002-2038-8474; Bullen, Hayley/0000-0003-4923-3019	National Health and Medical Research Council of Australia; Wellcome Trust, UK	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK(Wellcome Trust)	This work was supported, in part, by the National Health and Medical Research Council of Australia and Wellcome Trust, UK.	Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 2004, METH MOL B, V270, P263; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Morrissette NS, 1997, J CELL SCI, V110, P35; Pinder JC, 2000, PARASITOL TODAY, V16, P240, DOI 10.1016/S0169-4758(00)01664-1; Pinder JC, 1998, J CELL SCI, V111, P1831; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Tardieux I, 2008, TRAFFIC, V9, P627, DOI 10.1111/j.1600-0854.2008.00703.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Wichroski MJ, 2002, INFECT IMMUN, V70, P4353, DOI 10.1128/IAI.70.8.4353-4361.2002	35	87	89	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					25353	25363		10.1074/jbc.M109.036772	http://dx.doi.org/10.1074/jbc.M109.036772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19561073	Green Published, hybrid			2022-12-25	WOS:000269734000068
J	Kapiloff, MS; Piggott, LA; Sadana, R; Li, JL; Heredia, LA; Henson, E; Efendiev, R; Dessauer, CW				Kapiloff, Michael S.; Piggott, Leslie A.; Sadana, Rachna; Li, Jinliang; Heredia, Lorena A.; Henson, Edward; Efendiev, Riad; Dessauer, Carmen W.			An Adenylyl Cyclase-mAKAP beta Signaling Complex Regulates cAMP Levels in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RYANODINE RECEPTOR; NUCLEAR-MEMBRANES; DISRUPTION; HYPERTROPHY; MOUSE; PHOSPHORYLATION; MECHANISM; ENVELOPE; STRESS	Protein kinase A-anchoring proteins (AKAPs) play important roles in the compartmentation of cAMP signaling, anchoring protein kinase A (PKA) to specific cellular organelles and serving as scaffolds that assemble localized signaling cascades. Although AKAPs have been recently shown to bind adenylyl cyclase (AC), the functional significance of this association has not been studied. In cardiac myocytes, the muscle protein kinase A-anchoring protein beta (mAKAP beta) coordinates cAMP-dependent, calcium, and MAP kinase pathways and is important for cellular hypertrophy. We now show that mAKAP beta selectively binds type 5 AC in the heart and that mAKAP beta-associated AC activity is absent in AC5 knock-out hearts. Consistent with its known inhibition by PKA phosphorylation, AC5 is inhibited by association with mAKAP beta-PKA complexes. AC5 binds to a unique N-terminal site on mAKAP-(245-340), and expression of this peptide disrupts endogenous mAKAP beta-AC association. Accordingly, disruption of mAKAP beta-AC5 complexes in neonatal cardiac myocytes results in increased cAMP and hypertrophy in the absence of agonist stimulation. Taken together, these results show that the association of AC5 with the mAKAP beta complex is required for the regulation of cAMP second messenger controlling cardiac myocyte hypertrophy.	[Kapiloff, Michael S.; Li, Jinliang; Heredia, Lorena A.; Henson, Edward] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Dept Med, Miami, FL 33101 USA; [Kapiloff, Michael S.; Li, Jinliang; Heredia, Lorena A.; Henson, Edward] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Dept Pediat, Miami, FL 33101 USA; [Piggott, Leslie A.; Sadana, Rachna; Efendiev, Riad; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Miami; University of Miami; University of Texas System; University of Texas Health Science Center Houston	Kapiloff, MS (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Dept Med, Miami, FL 33101 USA.	Mkapiloff@med.miami.edu; Carmen.W.Dessauer@uth.tmc.edu	; Dessauer, Carmen/N-6933-2018	Kapiloff, Michael/0000-0002-7005-6953; Dessauer, Carmen/0000-0003-1210-4280; Li, Jinliang/0000-0002-3018-0570	National Institutes of Health [GM60419, HL075398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 ( to C. W. D.) and HL075398 ( to M. S. K.).	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; BELCHEVA MM, 1995, J PHARMACOL EXP THER, V274, P1513; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; CARLISLE MJJ, 2004, BIOCHEM J, V381, P587; Chen YB, 1997, P NATL ACAD SCI USA, V94, P14100, DOI 10.1073/pnas.94.25.14100; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Dessauer CW, 2002, J BIOL CHEM, V277, P28823, DOI 10.1074/jbc.M203962200; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Tepe NM, 1999, FEBS LETT, V458, P236, DOI 10.1016/S0014-5793(99)01147-3; Yamamoto S, 1998, MICROSC RES TECHNIQ, V40, P479, DOI 10.1002/(SICI)1097-0029(19980301)40:6<479::AID-JEMT8>3.0.CO;2-K; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038	31	91	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23540	23546		10.1074/jbc.M109.030072	http://dx.doi.org/10.1074/jbc.M109.030072			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574217	hybrid, Green Published			2022-12-25	WOS:000269180000039
J	Lee, J; Tattoli, I; Wojtal, KA; Vavricka, SR; Philpott, DJ; Girardin, SE				Lee, Jooeun; Tattoli, Ivan; Wojtal, Kacper A.; Vavricka, Stephan R.; Philpott, Dana J.; Girardin, Stephen E.			pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; KAPPA-B; PHAGOSOME MATURATION; EXPRESSION CLONING; HOST RECOGNITION; DIPEPTIDE; INNATE; ACTIVATION; PEPTIDOGLYCAN; INDUCTION	Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides. The biological effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear. Using the human epithelial cell line HEK293T as a model system, we demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-beta-cyclodextrin. In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6. Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5. Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands. In support for this, we identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-kappa B signaling. Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder associated with mutations in Nod1 and Nod2. Together, our results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.	[Lee, Jooeun; Tattoli, Ivan; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Tattoli, Ivan; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Wojtal, Kacper A.; Vavricka, Stephan R.] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland	University of Toronto; University of Toronto; University of Zurich; University Zurich Hospital	Girardin, SE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Med Sci Bldg,Rm 6336, Toronto, ON M5S 1A8, Canada.	Stephen.girardin@utoronto.ca	Tattoli, Ivan/H-2600-2017	Tattoli, Ivan/0000-0001-7925-4609	Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Sandler Program for Asthma Research; National Science Foundation [320000-114009/1]; Swiss IBD Cohort [3347CO-108792]; Zurich Center of Integrative Human Physiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Sandler Program for Asthma Research; National Science Foundation(National Science Foundation (NSF)); Swiss IBD Cohort; Zurich Center of Integrative Human Physiology	This work was supported by grants from Canadian Institutes of Health Research (to D. J. P.), Crohn's and Colitis Foundation of Canada (to S. E. G.), and the Sandler Program for Asthma Research (to D. J. P.). This work was also supported by the Swiss National Science Foundation (Grant 320000-114009/1 to S. R. V. and K. A. W.), Grant 3347CO-108792 (Swiss IBD Cohort), and a grant of the Zurich Center of Integrative Human Physiology.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boll M, 1996, P NATL ACAD SCI USA, V93, P284, DOI 10.1073/pnas.93.1.284; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Drubin David G, 2005, Novartis Found Symp, V269, P35; DRUBIN DG, 2005, NOVART FDN SYMP, V269, P223; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; FOGLER WE, 1987, INT J IMMUNOPHARMACO, V9, P141, DOI 10.1016/0192-0561(87)90088-9; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479; LEDERER E, 1980, J MED CHEM, V23, P819, DOI 10.1021/jm00182a001; LEDERER E, 1986, DRUG EXP CLIN RES, V12, P429; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; MEHTA K, 1982, J RETICULOENDOTH SOC, V32, P155; Nayar R, 1986, Methods Enzymol, V132, P594; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; PHILLIPS NC, 1994, J IMMUNOTHER, V15, P185, DOI 10.1097/00002371-199404000-00004; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; SCHROIT AJ, 1982, CANCER RES, V42, P161; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Swaan PW, 2008, AM J RESP CELL MOL, V39, P536, DOI 10.1165/rcmb.2008-0059OC; TAKADA H, 1979, INFECT IMMUN, V25, P48, DOI 10.1128/IAI.25.1.48-53.1979; Traub S, 2004, J BIOL CHEM, V279, P8694, DOI 10.1074/jbc.M310556200; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; WOJTAL KA, 2009, DRUG METAB DISPOS; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; ZUCCHELLI M, 2009, INFLAMM BOWEL DIS	45	155	166	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23818	23829		10.1074/jbc.M109.033670	http://dx.doi.org/10.1074/jbc.M109.033670			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570976	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000269180000065
J	Zhu, B; Lee, SJ; Richardson, CC				Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.			An in Trans Interaction at the Interface of the Helicase and Primase Domains of the Hexameric Gene 4 Protein of Bacteriophage T7 Modulates Their Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STAPHYLOCOCCUS-AUREUS PRIMASE; ESCHERICHIA-COLI PRIMASE; TEMPLATE RECOGNITION; CRYSTAL-STRUCTURE; REPLICATION FORK; INITIATION SPECIFICITY; PRIMER SYNTHESIS; LINKER REGION; BINDING	DNA helicase and primase are essential for DNA replication. The helicase unwinds the DNA to provide single-stranded templates for DNA polymerase. The primase catalyzes the synthesis of oligoribonucleotides for the initiation of lagging strand synthesis. The two activities reside in a single polypeptide encoded by gene 4 of bacteriophage T7. Their coexistence within the same polypeptide facilitates their coordination during DNA replication. One surface of helix E within the helicase domain is positioned to interact with the primase domain and the linker connecting the two domains within the functional hexamer. The interaction occurs in trans such that helix E interacts with the primase domain and the linker of the adjacent subunit. Most alterations of residues on the surface of helix E (Arg(404), Lys(408), Tyr(411), and Gly(415)) eliminate the ability of the altered proteins to complement growth of T7 phage lacking gene 4. Both Tyr(411) and Gly(415) are important in oligomerization of the protein. Alterations G415V and K408A simultaneously influence helicase and primase activities in opposite manners that mimic events observed during coordinated DNA synthesis. The results suggest that Asp(263) located in the linker of one subunit can interact with Tyr(411), Lys(408), or Arg(404) in helix E of the adjacent subunit depending on the oligomerization state. Thus the switch in contacts between Asp(263) and its three interacting residues in helix E of the adjacent subunit results in conformational changes that modulate helicase and primase activity.	[Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C.C.R.).	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Chintakayala K, 2008, MOL MICROBIOL, V68, P360, DOI 10.1111/j.1365-2958.2008.06155.x; Chintakayala K, 2007, MOL MICROBIOL, V63, P1629, DOI 10.1111/j.1365-2958.2007.05617.x; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; He ZG, 2004, J BIOL CHEM, V279, P22190, DOI 10.1074/jbc.M401100200; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Jonson PH, 2001, PROTEIN ENG, V14, P397, DOI 10.1093/protein/14.6.397; Koepsell SA, 2008, MOL MICROBIOL, V68, P1570, DOI 10.1111/j.1365-2958.2008.06255.x; Koepsell SA, 2006, J BACTERIOL, V188, P4673, DOI 10.1128/JB.00316-06; Kornberg A., 1992, DNA REPLICATION; Kusakabe T, 1997, J BIOL CHEM, V272, P5943, DOI 10.1074/jbc.272.9.5943; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; ROTHSCHILD KJ, 1990, J BIOL CHEM, V265, P16985; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Thirlway J, 2006, J BACTERIOL, V188, P1534, DOI 10.1128/JB.188.4.1534-1539.2006; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; TOUGU K, 1994, J BIOL CHEM, V269, P4675	51	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23842	23851		10.1074/jbc.M109.026104	http://dx.doi.org/10.1074/jbc.M109.026104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19574219	Green Published, hybrid			2022-12-25	WOS:000269180000067
J	Yeh, E; Pinsky, BA; Banaei, N; Baron, EJ				Yeh, Ellen; Pinsky, Benjamin A.; Banaei, Niaz; Baron, Ellen Jo			Hair Sheep Blood, Citrated or Defibrinated, Fulfills All Requirements of Blood Agar for Diagnostic Microbiology Laboratory Tests	PLOS ONE			English	Article							AGALACTIAE CAMP FACTOR; HAEMOPHILUS-INFLUENZAE; CULTURE-MEDIUM; GOAT BLOOD; STORAGE	Background: Blood agar is used for the identification and antibiotic susceptibility testing of many bacterial pathogens. In the developing world, microbiologists use human blood agar because of the high cost and inhospitable conditions for raising wool sheep or horses to supply blood. Many pathogens either fail to grow entirely or exhibit morphologies and hemolytic patterns on human blood agar that confound colony recognition. Furthermore, human blood can be hazardous to handle due to HIV and hepatitis [1,2]. This study investigated whether blood from hair sheep, a hardy, low-maintenance variety of sheep adapted for hot climates, was suitable for routine clinical microbiology studies. Methods and Findings: Hair sheep blood obtained by jugular venipuncture was anticoagulated by either manual defibrination or collection in human blood bank bags containing citrate-phosphate-dextrose. Trypticase soy 5% blood agar was made from both forms of hair sheep blood and commercial defibrinated wool sheep blood. Growth characteristics, colony morphologies, and hemolytic patterns of selected human pathogens, including several streptococcal species, were evaluated. Specialized identification tests, including CAMP test, reverse CAMP test, and satellite colony formation with Haemophilus influenzae and Abiotrophia defectiva were also performed. Mueller-Hinton blood agar plates prepared from the three blood types were compared in antibiotic susceptibility tests by disk diffusion and E-test. Conclusions: The results of all studies showed that blood agar prepared from citrated hair sheep blood is suitable for microbiological tests used in routine identification and susceptibility profiling of human pathogens. The validation of citrated hair sheep blood eliminates the labor-intensive and equipment-requiring process of manual defibrination. Use of hair sheep blood, in lieu of human blood currently used by many developing world laboratories and as an alternative to cost-prohibitive commercial sheep blood, offers the opportunity to dramatically improve the safety and accuracy of laboratory diagnosis of pathogenic bacteria in resource-poor countries.			Yeh, E (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ejbaron@stanford.edu		Yeh, Ellen/0000-0003-3974-3816; Banaei, Niaz/0000-0001-8501-3000; Pinsky, Benjamin/0000-0001-8751-4810				Anand C, 2000, J CLIN MICROBIOL, V38, P591, DOI 10.1128/JCM.38.2.591-594.2000; Chawdhury FAH, 2006, SEX TRANSM DIS, V33, P181, DOI 10.1097/01.olq.0000187206.69006.6e; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; CLARRIDGE J E, 1989, Clinical Microbiology Newsletter, V11, P41, DOI 10.1016/0196-4399(89)90074-3; Clinical and Laboratory Standards Institute, PERF STAND ANT SUSC; EVANS NM, 1974, J MED MICROBIOL, V7, P359, DOI 10.1099/00222615-7-3-359; FRENKEL A, 1961, NATURE, V191, P728, DOI 10.1038/191728a0; GRATTEN M, 1994, J CLIN MICROBIOL, V32, P2871, DOI 10.1128/JCM.32.11.2871-2872.1994; Hogman CF, 1999, TRANSFUS MED REV, V13, P275, DOI 10.1016/S0887-7963(99)80058-3; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Min YH, 2008, ANTIMICROB AGENTS CH, V52, P1782, DOI 10.1128/AAC.01376-07; Murray P, 2007, MANUAL CLIN MICROBIO, P2256; NOTTER DR, 2000, J ANIM SCI S1, V1977, P1; Reidl J, 2000, MOL MICROBIOL, V35, P1573, DOI 10.1046/j.1365-2958.2000.01829.x; RUOFF KL, 1991, CLIN MICROBIOL REV, V4, P184, DOI 10.1128/CMR.4.2.184-190.1991; Russell FM, 2006, J CLIN MICROBIOL, V44, P3346, DOI 10.1128/JCM.02631-05; SCHOENIAN S, 2007, BEGINNERS GUIDE RAIS; STERZIK B, 1985, J GEN MICROBIOL, V131, P817; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; WAYS P, 1964, J LIPID RES, V5, P318	22	22	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6141	10.1371/journal.pone.0006141	http://dx.doi.org/10.1371/journal.pone.0006141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468GY	19578541	Green Submitted, gold, Green Published			2022-12-25	WOS:000267806300010
J	Rathcke, CN; Holmkvist, J; Husmoen, LLN; Hansen, T; Pedersen, O; Vestergaard, H; Linneberg, A				Rathcke, Camilla Noelle; Holmkvist, Johan; Husmoen, Lise Lotte N.; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik; Linneberg, Allan			Association of Polymorphisms of the CHI3L1 Gene with Asthma and Atopy: A Populations-Based Study of 6514 Danish Adults	PLOS ONE			English	Article							RANDOM-ACCESS IMMUNOANALYZER; SERUM YKL-40; PROMOTER REGION; CHITINASE; PROTEIN; INFLAMMATION; SARCOIDOSIS; 3-LIKE-1; DISEASE; LUNG	Background: YKL-40 is a chitinase-like glycoprotein encoded by the chitinase 3-like 1 gene, CHI3L1, localized at chromosome 1q32.1. Increased levels of serum YKL-40 have been reported to be a biomarker for asthma and a reduced lung function. Interestingly, the C-allele of the -131 C -> G (rs4950928) polymorphism of CHI3L1 has been shown to associate with bronchial hyperresponsiveness and reduced lung function suggesting that variations in CHI3L1 may influence risk of asthma. The objective of the present study was to investigate the association of common variation in the CHI3L1 locus with asthma, atopy and lung function in a large population-based sample of adults. Methods/Principal Findings: Eleven single nucleotide polymorphisms (SNPs) of CHI3L1 including rs4950928 were genotyped in 6514 individuals. Asthma was defined as self-reported history of physician-diagnosed asthma. Total IgE and specific IgE to inhalant allergens were measured on serum samples. Lung function was measured by spirometry. Homozygosity of the rs4950928 G allele as compared to homozygosity of the C allele was associated with self-reported physician diagnosed asthma (OR 1.5 (95% CI, 1.00-2.26)) and with prevalence of atopic asthma (OR 1.93 (95% CI, 1.21-3.07)) after adjustment for age, sex, smoking status, socio-economic class and BMI. Carriers of rs883125 G allele had a significantly lower prevalence of atopy (OR 0.82 (CI, 0.72; 0.94)) as compared to homozygosity of the C allele. None of the SNPs examined were significantly associated with FEV1. However, two SNPs (rs10399931 and rs4950930) appeared to be significantly associated with FEV1/FVC-ratio. Subgroup analyses of never-smokers did not consistently influence the associations in an either positively og negatively way. Conclusions: In contrast to previous studies, the rs4950928 G allele, and not the C allele, was found to be associated with asthma. A few other SNPs of the CHI3L1 was found to be significantly associated with atopy and FEV1/FVC ratio, respectively. Thus, more studies seem warranted to establish the role of CHI3L1 gene in asthma and atopy.			Rathcke, CN (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Endocrinol, Copenhagen, Denmark.	cnr@dadlnet.dk	Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Vestergaard, Henrik/0000-0003-3090-269X; Linneberg, Allan/0000-0002-0994-0184				Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cobbaert CM, 2005, CLIN CHEM LAB MED, V43, P772, DOI 10.1515/CCLM.2005.132; Couzin J, 2004, SCIENCE, V304, P1577, DOI 10.1126/science.304.5677.1577; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Hong JH, 2008, AM J RESP CELL MOL, V39, P530, DOI 10.1165/rcmb.2007-0410OC; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2005, RESP MED, V99, P396, DOI 10.1016/j.rmed.2004.09.016; Johansen JS, 2006, DAN MED BULL, V53, P172; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ollert M, 2005, CLIN CHEM, V51, P1241, DOI 10.1373/clinchem.2004.046565; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; World Health Organization, 2004, OB PREV MAN GLOB EP; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	22	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6106	10.1371/journal.pone.0006106	http://dx.doi.org/10.1371/journal.pone.0006106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568425	Green Published, Green Submitted, gold			2022-12-25	WOS:000267572200009
J	Pinne, M; Haake, DA				Pinne, Marija; Haake, David A.			A Comprehensive Approach to Identification of Surface-Exposed, Outer Membrane-Spanning Proteins of Leptospira interrogans	PLOS ONE			English	Article							CHANNEL-FORMING ACTIVITY; LYME-DISEASE SPIROCHETE; BORRELIA-BURGDORFERI; TREPONEMA-PALLIDUM; MOLECULAR-CLONING; INSERTIONAL INACTIVATION; SEQUENCE-ANALYSIS; SIGNAL PEPTIDES; LIPOPROTEIN; PREDICTION	Leptospirosis is a zoonosis with worldwide distribution caused by pathogenic spirochetes belonging to the genus Leptospira. The leptospiral life cycle involves transmission via fresh water and colonization of the renal tubules of their reservoir hosts or infection of accidental hosts, including humans. Bacterial outer membrane proteins (OMPs), particularly those with surface-exposed regions, play crucial roles in virulence mechanisms of pathogens and the adaptation to various environmental conditions, including those of the mammalian host. Little is known about the surface-exposed OMPs in Leptospira, particularly those with outer membrane-spanning domains. Herein, we describe a comprehensive strategy for identification and characterization of leptospiral transmembrane OMPs. The genomic sequence of L. interrogans serovar Copenhageni strain Fiocruz L1-130 allowed us to employ the beta-barrel prediction programs, PRED-TMBB and TMBETA-NET, to identify potential transmembrane OMPs. Several complementary methods were used to characterize four novel OMPs, designated OmpL36, OmpL37, OmpL47 and OmpL54. In addition to surface immunofluorescence and surface biotinylation, we describe surface proteolysis of intact leptospires as an improved method for determining the surface exposure of leptospiral proteins. Membrane integration was confirmed using techniques for removal of peripheral membrane proteins. We also demonstrate deficiencies in the Triton X-114 fractionation method for assessing the outer membrane localization of transmembrane OMPs. Our results establish a broadly applicable strategy for the elucidation of novel surface-exposed outer membrane-spanning proteins of Leptospira, an essential step in the discovery of potential virulence factors, diagnostic antigens and vaccine candidates.			Pinne, M (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA.	mpinne@ucla.edu			NIAID NIH HHS [AI-34431, R21 AI034431, R01 AI034431-12, R29 AI034431, R01 AI034431] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034431, R21AI034431, R01AI034431] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Casadio Rita, 2003, Briefings in Bioinformatics, V4, P341, DOI 10.1093/bib/4.4.341; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; El-Hage N, 2001, MICROBIOL-SGM, V147, P821, DOI 10.1099/00221287-147-4-821; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1999, INFECT IMMUN, V67, P6572; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Hazlett KRO, 2001, J EXP MED, V193, P1015, DOI 10.1084/jem.193.9.1015; Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021; Ishihara K, 2004, FEMS MICROBIOL LETT, V232, P181, DOI 10.1016/S0378-1097(04)00067-9; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P958, DOI 10.1073/pnas.82.4.958; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Myers CR, 2003, LETT APPL MICROBIOL, V37, P254, DOI 10.1046/j.1472-765X.2003.01389.x; Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880; Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NOORDHOEK GT, 1989, MICROB PATHOGENESIS, V6, P29, DOI 10.1016/0882-4010(89)90005-3; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Ostberg Y, 2002, J BACTERIOL, V184, P6811, DOI 10.1128/JB.184.24.6811-6819.2002; Parveen N, 2000, MOL MICROBIOL, V35, P1220, DOI 10.1046/j.1365-2958.2000.01792.x; Pinne M, 2004, MICROBIOL-SGM, V150, P549, DOI 10.1099/mic.0.26728-0; Pinne M, 2006, J BACTERIOL, V188, P4207, DOI 10.1128/JB.00302-06; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; PROBERT WS, 1995, INFECT IMMUN, V63, P1933, DOI 10.1128/IAI.63.5.1933-1939.1995; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1994, J BACTERIOL, V176, P21, DOI 10.1128/JB.176.1.21-31.1994; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; SCHULZ G, 2004, STRUCTURES GEN PORIN; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; SHANG ES, 1995, INFECT IMMUN, V63, P3174, DOI 10.1128/IAI.63.8.3174-3181.1995; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8; STADER J, 1988, J BACTERIOL, V170, P1973, DOI 10.1128/jb.170.4.1973-1974.1988; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; THOMAS W, 1992, INFECT IMMUN, V60, P3111, DOI 10.1128/IAI.60.8.3111-3116.1992; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Zuerner R, 2000, J MOL MICROB BIOTECH, V2, P455; ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2	84	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2009	4	6							e6071	10.1371/journal.pone.0006071	http://dx.doi.org/10.1371/journal.pone.0006071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463XB	19562037	Green Submitted, Green Published, gold			2022-12-25	WOS:000267465900007
J	Goh, S; Boberek, JM; Nakashima, N; Stach, J; Good, L				Goh, Shan; Boberek, Jaroslaw M.; Nakashima, Nobutaka; Stach, Jem; Good, Liam			Concurrent Growth Rate and Transcript Analyses Reveal Essential Gene Stringency in Escherichia coli	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID ELONGATION; INDUCED-FIT MECHANISM; CELL-DIVISION; MESSENGER-RNA; FTSZ; INHIBITION; EXPRESSION; TRANSFERASE; IDENTIFICATION	Background: Genes essential for bacterial growth are of particular scientific interest. Many putative essential genes have been identified or predicted in several species, however, little is known about gene expression requirement stringency, which may be an important aspect of bacterial physiology and likely a determining factor in drug target development. Methodology/Principal Findings: Working from the premise that essential genes differ in absolute requirement for growth, we describe silencing of putative essential genes in E. coli to obtain a titration of declining growth rates and transcript levels by using antisense peptide nucleic acids (PNA) and expressed antisense RNA. The relationship between mRNA decline and growth rate decline reflects the degree of essentiality, or stringency, of an essential gene, which is here defined by the minimum transcript level for a 50% reduction in growth rate (MTL50). When applied to four growth essential genes, both RNA silencing methods resulted in MTL50 values that reveal acpP as the most stringently required of the four genes examined, with ftsZ the next most stringently required. The established antibacterial targets murA and fabI were less stringently required. Conclusions: RNA silencing can reveal stringent requirements for gene expression with respect to growth. This method may be used to validate existing essential genes and to quantify drug target requirement.			Goh, S (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	lgood@rvc.ac.uk	Goh, Shan/A-7261-2010; Nakashima, Nobutaka/G-3777-2016	Goh, Shan/0000-0002-9028-0303; Nakashima, Nobutaka/0000-0002-5836-9148; Stach, James/0000-0001-8787-2407; Good, Liam/0000-0002-2798-8640				Addinall SG, 2005, J BACTERIOL, V187, P358, DOI 10.1128/JB.187.1.358-365.2005; Baba Tomoya, 2006, Mol Syst Biol, V2; Badarinarayana V, 2001, NAT BIOTECHNOL, V19, P1060, DOI 10.1038/nbt1101-1060; Benson RE, 2003, ANTIMICROB AGENTS CH, V47, P2875, DOI 10.1128/AAC.47.9.2875-2881.2003; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Dryselius R, 2005, J ANTIMICROB CHEMOTH, V56, P97, DOI 10.1093/jac/dki173; Dryselius R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-97; Eschenburg S, 2005, J BIOL CHEM, V280, P14070, DOI 10.1074/jbc.M414412200; Flardh K, 1997, MOL MICROBIOL, V24, P927, DOI 10.1046/j.1365-2958.1997.4001762.x; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Harry E., 2006, INT REV CYTOL, V253, P27; Harth G, 2007, P NATL ACAD SCI USA, V104, P7199, DOI 10.1073/pnas.0701725104; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Kulyte A, 2005, J MOL MICROB BIOTECH, V9, P101, DOI 10.1159/000088840; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAJERUS PW, 1964, P NATL ACAD SCI USA, V51, P1231, DOI 10.1073/pnas.51.6.1231; MARQUARDT JL, 1992, J BACTERIOL, V174, P5748, DOI 10.1128/JB.174.17.5748-5752.1992; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; MCCORMICK JR, 1994, J MOL BIOL, V239, P608, DOI 10.1006/jmbi.1994.1403; MENDIETA J, 2009, J MOL BIOL; Mizyed S, 2005, BIOCHEMISTRY-US, V44, P4011, DOI 10.1021/bi047704w; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Nikravesh A, 2007, MOL THER, V15, P1537, DOI 10.1038/sj.mt.6300209; Palacios P, 1996, MOL MICROBIOL, V20, P1093, DOI 10.1111/j.1365-2958.1996.tb02549.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POWELL GL, 1969, J BIOL CHEM, V244, P5616; Pragman AA, 2007, BIOCHEMISTRY-US, V46, P314, DOI 10.1021/bi0603266; Schonbrunn E, 2000, BIOCHEMISTRY-US, V39, P2164, DOI 10.1021/bi991091j; Tan XX, 2005, ANTIMICROB AGENTS CH, V49, P3203, DOI 10.1128/AAC.49.8.3203-3207.2005; Tasdemir D, 2007, BIOORGAN MED CHEM, V15, P6834, DOI 10.1016/j.bmc.2007.07.032; Tilley LD, 2007, J ANTIMICROB CHEMOTH, V59, P66, DOI 10.1093/jac/dkl444; Tsao DHH, 2006, BIOORGAN MED CHEM, V14, P7953, DOI 10.1016/j.bmc.2006.07.050; Varma A, 2004, J BACTERIOL, V186, P6768, DOI 10.1128/JB.186.20.6768-6774.2004; Vergidis PI, 2008, CURR OPIN INVEST DR, V9, P176; VOSKUIL JLA, 1994, J BACTERIOL, V176, P1886, DOI 10.1128/jb.176.7.1886-1893.1994; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740; Zhang Y, 1996, J BACTERIOL, V178, P3614, DOI 10.1128/jb.178.12.3614-3620.1996; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200	59	58	62	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6061	10.1371/journal.pone.0006061	http://dx.doi.org/10.1371/journal.pone.0006061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557168	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600009
J	Resina, S; Prevot, P; Thierry, AR				Resina, Sarah; Prevot, Paul; Thierry, Alain R.			Physico-Chemical Characteristics of Lipoplexes Influence Cell Uptake Mechanisms and Transfection Efficacy	PLOS ONE			English	Article								Background: Formulation of DNA/cationic lipid complexes (lipoplexes) designed for nucleic acid delivery mostly results in positively charged particles which are thought to enter cells by endocytosis. We recently developed a lipoplex formulation called Neutraplex that allows preparation of both cationic and anionic stable complexes with similar lipid content and ultrastructure. Methodology/Principal Findings: To assess whether the global net charge could influence cell uptake and activity of the transported oligonucleotides (ON), we prepared lipoplexes with positive and negative charges and compared: (i) their physicochemical properties by zeta potential analysis and dynamic light scattering, (ii) their cell uptake by fluorescence microscopy and flow cytometry, and (iii) the biological activity of the transported ON using a splicing correction assay. We show that positively or negatively charged lipoplexes enter cells cells using both temperature-dependent and -independent uptake mechanisms. Specifically, positively charged lipoplexes predominantly use a temperature-dependent transport when cells are incubated OptiMEM medium. Anionic lipoplexes favour an energy-independent transport and show higher ON activity than cationic lipoplexes in presence of serum. However, lipoplexes with high positive global net charge and OptiMEM medium give the highest uptake and ON activity levels. Conclusions: These findings suggest that, in addition to endocytosis, lipoplexes may enter cell via a temperature-independent mechanism, which could be mediated by lipid mixing. Such characteristics might arise from the specific lipoplex ultrastructure and should be taken into consideration when developing lipoplexes designed for in vivo or ex vivo nucleic acid transfer.			Resina, S (corresponding author), Univ Montpellier 2, UMR 5235, Dept Def Antivirales & Antitumorales, Lab DIMNP, Montpellier, France.	alain.thierry@sysdiag.cnrs.fr	thierry, alain/F-9492-2014					Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Alino SF, 1996, HUM GENE THER, V7, P531, DOI 10.1089/hum.1996.7.4-531; BARU M, 1995, GENE, V161, P143, DOI 10.1016/0378-1119(95)00281-A; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Caracciolo G, 2006, J PHYS CHEM B, V110, P20829, DOI 10.1021/jp0620926; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; de Lima MCP, 1999, MOL MEMBR BIOL, V16, P103; Duzgunes N, 1999, ADV DRUG DELIVER REV, V40, P3, DOI 10.1016/S0169-409X(99)00037-X; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; Goryacheva YA, 2005, B EXP BIOL MED+, V140, P733, DOI 10.1007/s10517-006-0069-4; Harashima H, 2001, EUR J PHARM SCI, V13, P85, DOI 10.1016/S0928-0987(00)00211-6; Hofland HEJ, 1996, P NATL ACAD SCI USA, V93, P7305, DOI 10.1073/pnas.93.14.7305; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Koynova R, 2006, P NATL ACAD SCI USA, V103, P14373, DOI 10.1073/pnas.0603085103; Lavigne C, 2004, METHOD ENZYMOL, V387, P189; Li S, 1997, GENE THER, V4, P891, DOI 10.1038/sj.gt.3300482; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Meryet-Figuieres M, 2007, BIOCHIMIE, V89, P1228, DOI 10.1016/j.biochi.2007.03.017; Midoux P, 2008, CURR GENE THER, V8, P335, DOI 10.2174/156652308786071014; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Pires P, 1999, BBA-BIOMEMBRANES, V1418, P71, DOI 10.1016/S0005-2736(99)00023-1; Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Resina S, 2007, J GENE MED, V9, P498, DOI 10.1002/jgm.1044; Schmutz M, 1999, P NATL ACAD SCI USA, V96, P12293, DOI 10.1073/pnas.96.22.12293; Shi Jing, 2004, Yaoxue Xuebao, V39, P551; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P7128, DOI 10.1073/pnas.80.23.7128; Tavitian B, 2002, PHARM RES-DORDR, V19, P367, DOI 10.1023/A:1015133205457; Templeton NS, 2002, BIOSCIENCE REP, V22, P283; Thierry AR, 2006, BBA-BIOMEMBRANES, V1758, P364, DOI 10.1016/j.bbamem.2005.10.010; Thierry AR, 2009, BBA-GEN SUBJECTS, V1790, P385, DOI 10.1016/j.bbagen.2009.03.017; Thierry AR, 1997, GENE THER, V4, P226, DOI 10.1038/sj.gt.3300350; THIERRY AR, 1993, BIOCHEM BIOPH RES CO, V190, P952, DOI 10.1006/bbrc.1993.1142; THIERRY AR, 1992, NUCLEIC ACIDS RES, V20, P5691, DOI 10.1093/nar/20.21.5691; THIERRY AR, 1995, P NATL ACAD SCI USA, V92, P9742, DOI 10.1073/pnas.92.21.9742; THIERRY AR, SUPRAMOLECULAR UNPUB; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Tranchant I, 2004, J GENE MED, V6, pS24, DOI 10.1002/jgm.509; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; WU B, 2009, MOL THER        0310; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006; ZHU N, 1993, SCIENCE, V261, P209, DOI 10.1126/science.7687073; Zuhorn IS, 2002, J BIOL CHEM, V277, P18021, DOI 10.1074/jbc.M111257200	50	60	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e6058	10.1371/journal.pone.0006058	http://dx.doi.org/10.1371/journal.pone.0006058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557145	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600006
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Reduced Attentional Scope in Cocaine Polydrug Users	PLOS ONE			English	Article								Cocaine is Europe's second preferred recreational drug after cannabis but very little is known about possible cognitive impairments in the upcoming type of recreational cocaine user (monthly consumption). We asked whether recreational use of cocaine impacts early attentional selection processes. Cocaine-free polydrug controls (n = 18) and cocaine polydrug users (n = 18) were matched on sex, age, alcohol consumption, and IQ (using the Raven's progressive matrices), and were tested by using the Global-Local task to measure the scope of attention. Cocaine polydrug users attended significantly more to local aspects of attended events, which fits with the idea that a reduced scope of attention may be associated with the perpetuation of the use of the drug.			Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280				American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ashby F. G., 2002, EMOTIONAL COGNITION, P245, DOI [DOI 10.1075/AICR.44.11ASH, 10.1075/aicr.44.11ash]; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; Boulougouris V, 2008, PROG BRAIN RES, V172, P517, DOI 10.1016/S0079-6123(08)00925-4; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P1570, DOI 10.1016/j.neuropsychologia.2007.12.014; Colzato LS, 2009, NEUROPSYCHOLOGY, V23, P125, DOI 10.1037/a0013821; Colzato LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003461; Colzato LS, 2005, EUR J NEUROSCI, V21, P591, DOI 10.1111/j.1460-9568.2005.03868.x; Colzato LS, 2004, NEUROSCI LETT, V360, P103, DOI 10.1016/j.neulet.2004.01.054; COLZATO LS, 2009, RECREATIONAL USE COC; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; *EUR MON CTR DRUGS, 2007, STAT DRUGS PROBL EUR; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Franken IHA, 2007, BIOL PSYCHOL, V75, P45, DOI 10.1016/j.biopsycho.2006.11.003; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Kalivas PW, 2003, ANN NY ACAD SCI, V1003, P169, DOI 10.1196/annals.1300.009; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Kubler A, 2005, EUR J NEUROSCI, V21, P1984, DOI 10.1111/j.1460-9568.2005.04027.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Logan Gordon D., 1994, P189; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Muller CP, 2007, PROG NEUROBIOL, V81, P133, DOI 10.1016/j.pneurobio.2007.01.001; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Pooley EC, 2007, MOL PSYCHIATR, V12, P556, DOI 10.1038/sj.mp.4001951; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Raven JC, 1988, MANUAL RAVENS PROGR; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; van der Post J, 2004, J PSYCHOPHARMACOL, V18, P109, DOI 10.1177/0269881104042832; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verkes RJ, 2001, PSYCHOPHARMACOLOGY, V153, P196, DOI 10.1007/s002130000563; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; von Geusau NA, 2004, PSYCHOPHARMACOLOGY, V175, P331, DOI 10.1007/s00213-004-1832-8; Yovel I, 2005, PSYCHOL SCI, V16, P123, DOI 10.1111/j.0956-7976.2005.00792.x	45	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2009	4	6							e6043	10.1371/journal.pone.0006043	http://dx.doi.org/10.1371/journal.pone.0006043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MJ	19557181	gold, Green Submitted, Green Published			2022-12-25	WOS:000267356900005
J	Nakamuta, JS; Danoviz, ME; Marques, FLN; dos Santos, L; Becker, C; Goncalves, GA; Vassallo, PF; Schettert, IT; Tucci, PJF; Krieger, JE				Nakamuta, Juliana S.; Danoviz, Maria E.; Marques, Fabio L. N.; dos Santos, Leonardo; Becker, Claudia; Goncalves, Giovana A.; Vassallo, Paula F.; Schettert, Isolmar T.; Tucci, Paulo J. F.; Krieger, Jose E.			Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; ISCHEMIC-MYOCARDIUM; MUSCLE-CELLS; OPTIMAL TIME; TRANSPLANTATION; HEART; SURVIVAL; REPAIR; INTRACORONARY	Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic fundamental issues remain poorly understood. In the present study we examined the effects of timing and routes of administration of bone marrow cells (BMC) post-myocardial infarction (MI) and the efficacy of an injectable biopolymer scaffold to improve cardiac cell retention and function. Methodology/Principal Findings: Tc-99m-labeled BMC (6x10(6) cells) were injected by 4 different routes in adult rats: intravenous (IV), left ventricular cavity (LV), left ventricular cavity with temporal aorta occlusion (LV+) to mimic coronary injection, and intramyocardial (IM). The injections were performed 1, 2, 3, or 7 days post-MI and cell retention was estimated by gamma-emission counting of the organs excised 24 hs after cell injection. IM injection improved cell retention and attenuated cardiac dysfunction, whereas IV, LV or LV* routes were somewhat inefficient (< 1%). Cardiac BMC retention was not influenced by timing except for the IM injection that showed greater cell retention at 7 (16%) vs. 1, 2 or 3 (average of 7%) days post-MI. Cardiac cell retention was further improved by an injectable fibrin scaffold at day 3 post-MI (17 vs. 7%), even though morphometric and function parameters evaluated 4 weeks later displayed similar improvements. Conclusions/Significance: These results show that cells injected post-MI display comparable tissue distribution profile regardless of the route of injection and that there is no time effect for cardiac cell accumulation for injections performed 1 to 3 days post-MI. As expected the IM injection is the most efficient for cardiac cell retention, it can be further improved by co-injection with a fibrin scaffold and it significantly attenuates cardiac dysfunction evaluated 4 weeks post myocardial infarction. These pharmacokinetic data obtained under similar experimental conditions are essential for further development of these novel approaches.			Nakamuta, JS (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.	krieger@incor.usp.br	Schettert, Isolmar/D-1355-2012; Navarro Marques, Fabio Luiz/ABI-7774-2020; Pereira, Alexandre/HHN-1038-2022; dos Santos, Leonardo/B-6509-2013; Krieger, Jose E/C-3117-2011; Marques, Fabio LN/C-4153-2012; Tucci, Paulo/D-1441-2015	Navarro Marques, Fabio Luiz/0000-0001-7383-926X; dos Santos, Leonardo/0000-0002-4340-6364; Krieger, Jose E/0000-0001-5464-1792; Marques, Fabio LN/0000-0001-7383-926X; Tucci, Paulo/0000-0001-9793-670X				Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; de Oliveira SA, 2006, EUR J CARDIO-THORAC, V29, pS259, DOI 10.1016/j.ejcts.2006.02.005; *AM PLC, INS PACKDG CER PROD; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Becker C, 2006, INT J CARDIOL, V113, P348, DOI 10.1016/j.ijcard.2005.11.060; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Chin BB, 2003, NUCL MED COMMUN, V24, P1149, DOI 10.1097/00006231-200311000-00005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Collins SD, 2007, CARDIOVASC REVASCULA, V8, P43, DOI 10.1016/j.carrev.2006.11.005; Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011; Fernandez P, 1999, J NUCL MED, V40, P1756; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gowdak LHW, 2008, INT J CARDIOL, V127, P295, DOI 10.1016/j.ijcard.2007.05.048; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; HOU D, 2005, CIRCULATION S, V1, P156; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jiang CY, 2008, J ZHEJIANG UNIV-SC B, V9, P630, DOI 10.1631/jzus.B0820004; Li RK, 2001, ANN THORAC SURG, V72, P1957, DOI 10.1016/S0003-4975(01)03216-7; Liu YG, 2004, MICROVASC RES, V68, P156, DOI 10.1016/j.mvr.2004.06.008; Lu L, 2004, BIOCHEM BIOPH RES CO, V320, P907, DOI 10.1016/j.bbrc.2004.06.034; Melo LG, 2004, CIRCULATION, V109, P2386, DOI 10.1161/01.CIR.0000128597.37025.00; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; Olivares EL, 2004, AM J PHYSIOL-HEART C, V287, pH464, DOI 10.1152/ajpheart.01141.2003; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x; Reinlib L, 2000, CIRCULATION, V101, pE182; Roy S, 2006, PHYSIOL GENOMICS, V25, P364, DOI 10.1152/physiolgenomics.00013.2006; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang SH, 2004, LIFE SCI, V74, P2853, DOI 10.1016/j.lfs.2003.10.035	49	66	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6005	10.1371/journal.pone.0006005	http://dx.doi.org/10.1371/journal.pone.0006005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547700	Green Submitted, gold, Green Published			2022-12-25	WOS:000267347900004
J	Kaddai, V; Gonzalez, T; Keslair, F; Gremeaux, T; Bonnafous, S; Gugenheim, J; Tran, A; Gual, P; Le Marchand-Brustel, Y; Cormont, M				Kaddai, Vincent; Gonzalez, Teresa; Keslair, Frederique; Gremeaux, Thierry; Bonnafous, Stephanie; Gugenheim, Jean; Tran, Albert; Gual, Philippe; Le Marchand-Brustel, Yannick; Cormont, Mireille			Rab4b Is a Small GTPase Involved in the Control of the Glucose Transporter GLUT4 Localization in Adipocyte	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; SMALL G-PROTEINS; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; SUBCELLULAR-LOCALIZATION; COMPARTMENT-ABLATION; MOLECULAR-MECHANISMS; REGULATED TRANSPORT; ENDOCYTIC PATHWAY; PLASMA-MEMBRANE	Background: Endosomal small GTPases of the Rab family, among them Rab4a, play an essential role in the control of the glucose transporter GLUT4 trafficking, which is essential for insulin-mediated glucose uptake. We found that adipocytes also expressed Rab4b and we observed a consistent decrease in the expression of Rab4b mRNA in human and mice adipose tissue in obese diabetic states. These results led us to study this poorly characterized Rab member and its potential role in glucose transport. Methodology/Principal Findings: We used 3T3-L1 adipocytes to study by imaging approaches the localization of Rab4b and to determine the consequence of its down regulation on glucose uptake and endogenous GLUT4 location. We found that Rab4b was localized in endosomal structures in preadipocytes whereas in adipocytes it was localized in GLUT4 and in VAMP2-positive compartments, and also in endosomal compartments containing the transferrin receptor (TfR). When Rab4b expression was decreased with specific siRNAs by two fold, an extent similar to its decrease in obese diabetic subjects, we observed a small increase (25%) in basal deoxyglucose uptake and a more sustained increase (40%) in presence of submaximal and maximal insulin concentrations. This increase occurred without any change in GLUT4 and GLUT1 expression levels and in the insulin signaling pathways. Concomitantly, GLUT4 but not TfR amounts were increased at the plasma membrane of basal and insulin-stimulated adipocytes. GLUT4 seemed to be targeted towards its non-endosomal sequestration compartment. Conclusion/Significance: Taken our results together, we conclude that Rab4b is a new important player in the control of GLUT4 trafficking in adipocytes and speculate that difference in its expression in obese diabetic states could act as a compensatory effect to minimize the glucose transport defect in their adipocytes.			Kaddai, V (corresponding author), Ctr Mediterraneen Med Mol, INSERM, Team 7, U895, Nice, France.	cormont@unice.fr	Gual, Philippe/P-9833-2019; Gual, Philippe/M-8787-2017	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; CORMONT, Mireille/0000-0001-6918-2410; GUGENHEIM, Jean/0000-0002-2624-3014; Gonzalez, Teresa/0000-0001-7558-6833				Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cormont M, 1996, MOL CELL BIOL, V16, P6879; Cormont M, 1996, ENDOCRINOLOGY, V137, P3408, DOI 10.1210/en.137.8.3408; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; CORMONT M, 1993, J BIOL CHEM, V268, P19491; Cormont M, 2001, MOL MEMBR BIOL, V18, P213; Cormont M, 2001, BIOCHEM J, V356, P143, DOI 10.1042/0264-6021:3560143; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Frei SB, 2006, MOL CELL BIOL, V26, P7299, DOI 10.1128/MCB.02405-05; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; GARVEY WT, 1993, DIABETES, V42, P1773, DOI 10.2337/diabetes.42.12.1773; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kaddai V, 2008, ACTA PHYSIOL, V192, P75, DOI 10.1111/j.1748-1716.2007.01787.x; KADDAI V, 2008, AM J PHYSIOL-ENDOC M, V192, pE162; Kessler A, 2000, DIABETOLOGIA, V43, P1518, DOI 10.1007/s001250051563; Knight JB, 2000, ENDOCRINOLOGY, V141, P208, DOI 10.1210/en.141.1.208; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Mari M, 2006, J CELL SCI, V119, P1297, DOI 10.1242/jcs.02850; Melvin DR, 1999, BIOCHEMISTRY-US, V38, P1456, DOI 10.1021/bi980988y; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Millar CA, 1997, BIOCHEM SOC T, V25, P974, DOI 10.1042/bst0250974; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Monzo P, 2005, METHOD ENZYMOL, V403, P107, DOI 10.1016/S0076-6879(05)03010-7; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Uhlig M, 2005, MOL CELL ENDOCRINOL, V235, P1, DOI 10.1016/j.mce.2005.02.004; Vollenweider P, 1997, ENDOCRINOLOGY, V138, P4941, DOI 10.1210/en.138.11.4941; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	45	23	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2009	4	4							e5257	10.1371/journal.pone.0005257	http://dx.doi.org/10.1371/journal.pone.0005257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437TW	19590752	Green Published, Green Submitted, gold			2022-12-25	WOS:000265510800010
J	Filtz, TM; Grubb, DR; McLeod-Dryden, TJ; Luo, JT; Woodcock, EA				Filtz, Theresa M.; Grubb, David R.; McLeod-Dryden, Tiffany J.; Luo, Jieting; Woodcock, Elizabeth A.			Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase C beta 1b	FASEB JOURNAL			English	Article						adenovirus; inhibitory minigene; splice variant; alpha(1)-adrenergci receptor; sarcolemmal localization	NEONATAL-RAT CARDIOMYOCYTES; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; MYOCARDIAL HYPERTROPHY; MYOCYTE HYPERTROPHY; SIGNALING PATHWAYS; HEART-FAILURE; G-PROTEINS; RECEPTOR; GROWTH	Activation of the heterotrimeric G protein Gq causes cardiomyocyte hypertrophy in vivo and in cell culture models. Hypertrophic responses induced by pressure or volume overload are exacerbated by increased Gq activity and ameliorated by Gq inhibition. Gq activates phospholipase C beta (PLC beta) subtypes, resulting in generation of the intracellular messengers inositol(1,4,5)tris-phosphate [Ins(1,4,5)P-3] and sn-1,2-diacylglycerol (DAG), which regulate intracellular Ca2+ and conventional protein kinase C subtypes, respectively. Gq can also signal independently of PLC beta, and the involvement of either Ins(1,4,5)P-3 or DAG in cardiomyocyte hypertrophy has not been unequivocally established. Overexpression of one splice variant of PLC beta 1, specifically PLC beta 1b, in neonatal rat cardiomyocytes causes increased cell size, elevated protein/DNA ratio, and heightened expression of the hypertrophy-related marker gene, atrial natriuretic peptide. The other splice variant, PLC beta 1a, had no effect. Expression of a 32-aa C-terminal PLC beta 1b peptide, which competes with PLC beta 1b for sarcolemmal association, prevented PLC activation and eliminated hypertrophic responses initiated by Gq or Gq-coupled alpha(1)-adrenergic receptors. In contrast, a PLC beta(1)a C-terminal peptide altered neither PLC activity nor cellular hypertrophy. We conclude that hypertrophic responses initiated by Gq are mediated specifically by PLC beta 1b. Preventing PLC beta 1b association with the sarcolemma may provide a useful therapeutic target to limit hypertrophy.-Filtz, T. M., Grubb, D. R., McLeod-Dryden, T. J., Luo, J., Woodcock, E. A. Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase C beta 1b. FASEB J. 23, 3564-3570 (2009). www.fasebj.org	[Filtz, Theresa M.; Grubb, David R.; McLeod-Dryden, Tiffany J.; Luo, Jieting; Woodcock, Elizabeth A.] Baker IDI Heart & Diabet Inst, Mol Cardiol Lab, Melbourne, Vic 8008, Australia	Baker Heart and Diabetes Institute	Woodcock, EA (corresponding author), Baker IDI Heart & Diabet Inst, Mol Cardiol Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	woodcock@bakeridi.edu.au		Filtz, Theresa/0000-0002-5348-1114	Australian National Health and Medical Research Council [526623, 418935]; Australian National Heart Foundation [G 08M 3695];  [417803]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Heart Foundation(National Heart Foundation of Australia); 	This work was supported by grants from the Australian National Health and Medical Research Council (526623 and 418935) and the Australian National Heart Foundation (G 08M 3695), as well as a research fellowship (417803) to E. A. W.	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Aikawa R, 1999, CIRC RES, V84, P458, DOI 10.1161/01.RES.84.4.458; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Arthur JF, 2001, J BIOL CHEM, V276, P37341, DOI 10.1074/jbc.M106572200; BAHK YY, 1994, J BIOL CHEM, V269, P8240; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; CannonCarlson S, 1997, ANAL BIOCHEM, V246, P146, DOI 10.1006/abio.1997.2002; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Esposito G., 2001, CARDIOVASC RES, V50, P65; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Fan GF, 2005, J BIOL CHEM, V280, P40337, DOI 10.1074/jbc.M506810200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hines WA, 1998, J MOL CELL CARDIOL, V30, P485, DOI 10.1006/jmcc.1997.0613; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lorell BH, 1997, CIRCULATION, V96, P3824; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Morris JB, 2006, J MOL CELL CARDIOL, V41, P17, DOI 10.1016/j.yjmcc.2006.03.011; Morris JB, 2004, J BIOL CHEM, V279, P8740, DOI 10.1074/jbc.M310012200; Niizeki T, 2008, AM J PHYSIOL-HEART C, V295, pH245, DOI 10.1152/ajpheart.00066.2008; Niizeki T, 2008, CIRC J, V72, P309, DOI 10.1253/circj.72.309; Nishimaru K, 2008, J MOL CELL CARDIOL, V44, P520, DOI 10.1016/j.yjmcc.2007.12.007; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham TM, 2003, J MOL CELL CARDIOL, V35, P287, DOI 10.1016/S0022-2828(03)00009-9; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Woodcock EA, 1997, MOL CELL BIOCHEM, V172, P121, DOI 10.1023/A:1006871722652; WU D, 1992, J BIOL CHEM, V25, P1811; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Xu AM, 2001, MOL CELL BIOL, V21, P2981, DOI 10.1128/MCB.21.9.2981-2990.2001	49	61	62	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3564	3570		10.1096/fj.09-133983	http://dx.doi.org/10.1096/fj.09-133983			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19564249				2022-12-25	WOS:000270354300032
J	Spry, C; Saliba, KJ				Spry, Christina; Saliba, Kevin J.			The Human Malaria Parasite Plasmodium falciparum Is Not Dependent on Host Coenzyme A Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTOTHENIC-ACID METABOLISM; FUNCTIONAL EXPRESSION; DUCK ERYTHROCYTES; AVIAN-MALARIA; KINASE; TRANSPORT; PATHWAYS; MEMBRANE; BLOOD; NA+	Pantothenate, a precursor of the fundamental enzyme cofactor coenzyme A (CoA), is essential for growth of the intraerythrocytic stage of human and avian malaria parasites. Avian malaria parasites have been reported to be incapable of de novo CoA synthesis and instead salvage CoA from the host erythrocyte; hence, pantothenate is required for CoA biosynthesis within the host cell and not the parasite itself. Whether the same is true of the intraerythrocytic stage of the human malaria parasite, Plasmodium falciparum, remained to be established. In this study we investigated the metabolic fate of [C-14]pantothenate within uninfected and P. falciparum-infected human erythrocytes. We provide evidence consistent with normal human erythrocytes, unlike rat erythrocytes (which have been reported to possess an incomplete CoA biosynthesis pathway), being capable of CoA biosynthesis from pantothenate. We also show that CoA biosynthesis is substantially higher in P. falciparum-infected erythrocytes and that P. falciparum, unlike its avian counterpart, generates most of the CoA synthesized in the infected erythrocyte, presumably necessitated by insufficient CoA biosynthesis in the host erythrocyte. Our data raise the possibility that malaria parasites rationalize their biosynthetic activity depending on the capacity of their host cell to synthesize the metabolites they require.	[Saliba, Kevin J.] Australian Natl Univ, Sch Med, Coll Med Biol & Environm, Canberra, ACT 0200, Australia; Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT 0200, Australia	Australian National University; Australian National University	Saliba, KJ (corresponding author), Australian Natl Univ, Sch Med, Coll Med Biol & Environm, GPO Box 4, Canberra, ACT 0200, Australia.	kevin.saliba@anu.edu.au	Saliba, Kevin J/C-9166-2009	Saliba, Kevin J/0000-0003-3345-8440; Spry, Christina/0000-0002-8156-7070	Australian National Health and Medical Research Council [224245]; UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases; Gwendolyn Woodroofe Ph.D. scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases; Gwendolyn Woodroofe Ph.D. scholarship	This work was supported in part by the Australian National Health and Medical Research Council Grant 224245 and the UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases.; Supported by a Gwendolyn Woodroofe Ph.D. scholarship.	Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; ANNOUS KF, 1995, J NUTR, V125, P2586; BENNETT TP, 1967, J PROTOZOOL, V14, P214, DOI 10.1111/j.1550-7408.1967.tb01985.x; BROHN FH, 1975, P NATL ACAD SCI USA, V72, P2456, DOI 10.1073/pnas.72.6.2456; CABANTCHIK ZI, 1990, BLOOD CELLS, V16, P421; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; GINSBURG H, 1983, MOL BIOCHEM PARASIT, V8, P177, DOI 10.1016/0166-6851(83)90008-7; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; GINSBURG H, 1994, BIOCHEM PHARMACOL, V48, P1847, DOI 10.1016/0006-2952(94)90582-7; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Handin RI, 2003, BLOOD PRINCIPLES PRA; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; KIRK K, 1994, J BIOL CHEM, V269, P3339; LADINSKY JL, 1967, CANCER RES, V27, P1689; Lehane AM, 2007, J BIOL CHEM, V282, P25395, DOI 10.1074/jbc.M704610200; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; MOFFATT JG, 1961, J AM CHEM SOC, V83, P663, DOI 10.1021/ja01464a036; Prasad PD, 1999, ARCH BIOCHEM BIOPHYS, V366, P95, DOI 10.1006/abbi.1999.1213; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; REIBEL DK, 1982, J NUTR, V112, P1144, DOI 10.1093/jn/112.6.1144; REIBEL DK, 1981, AM J PHYSIOL, V240, pE597, DOI 10.1152/ajpendo.1981.240.6.E597; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; ROBISHAW JD, 1984, AM J PHYSIOL, V246, pH532, DOI 10.1152/ajpheart.1984.246.4.H532; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2005, ANTIMICROB AGENTS CH, V49, P632, DOI 10.1128/AAC.49.2.632-637.2005; Saliba KJ, 2001, J BIOL CHEM, V276, P18115, DOI 10.1074/jbc.M010942200; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; STOKES GB, 1974, ARCH BIOCHEM BIOPHYS, V162, P638, DOI 10.1016/0003-9861(74)90226-4; Strauss E, 2005, CHEMBIOCHEM, V6, P284, DOI 10.1002/cbic.200400340; Strauss E, 2002, J BIOL CHEM, V277, P48205, DOI 10.1074/jbc.M204560200; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; TRAGER W, 1952, J EXP MED, V96, P465, DOI 10.1084/jem.96.5.465; TRAGER W, 1954, J PROTOZOOL, V1, P231, DOI 10.1111/j.1550-7408.1954.tb00822.x; Trager W, 1943, J EXP MED, V77, P411, DOI 10.1084/jem.77.5.411; UHLEMANN AC, 2000, MACS MORE, V4, P7; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; WITTWER CT, 1989, AM J CLIN NUTR, V50, P1072, DOI 10.1093/ajcn/50.5.1072; Wunsch S, 1998, J CELL BIOL, V140, P335, DOI 10.1083/jcb.140.2.335	46	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2009	284	37					24904	24913		10.1074/jbc.M109.025312	http://dx.doi.org/10.1074/jbc.M109.025312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493JZ	19584050	hybrid, Green Published			2022-12-25	WOS:000269734000024
J	Parrini, MC; Camonis, J; Matsuda, M; de Gunzburg, J				Parrini, Maria Carla; Camonis, Jacques; Matsuda, Michiyuki; de Gunzburg, Jean			Dissecting Activation of the PAK1 Kinase at Protrusions in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21-ACTIVATED KINASE; GROWTH-FACTOR; MEMBRANE LOCALIZATION; FLUORESCENT PROTEIN; ADAPTER PROTEIN; CDC42; MECHANISM; PIX; RAC1; AUTOPHOSPHORYLATION	The p21-activated kinase (PAK) 1 kinase, an effector of the Cdc42 and Rac1 GTPases, regulates cell protrusions and motility by controlling actin and adhesion dynamics. Its deregulation has been linked to human cancer. We show here that activation of PAK1 is necessary for protrusive activity during cell spreading. To investigate PAK1 activation dynamics at live protrusions, we developed a conformational biosensor, based on fluorescence resonance energy transfer. This novel PAK1 biosensor allowed the spatiotemporal visualization of PAK1 activation during spreading of COS-7 cells and during motility of normal rat kidney cells. By using this imaging approach in COS-7 cells, the following new insights on PAK1 regulation were unveiled. First, PAK1 acquires an intermediate semi-open conformational state upon recruitment to the plasma membrane. This semi-open PAK1 species is selectively autophosphorylated on serines in the N-terminal regulatory region but not on the critical threonine 423 in the catalytic site. Second, this intermediate PAK1 state is hypersensitive to stimulation by Cdc42 and Rac1. Third, interaction with PIX proteins contributes to PAK1 stimulation at membrane protrusions, in a GTPase-independent way. Finally, trans-phosphorylation events occur between PAK1 molecules at the membrane possibly playing a relevant role for its activation. This study leads to a model for the complex and accurate regulation of PAK1 kinase in vivo at cell protrusions.	[Parrini, Maria Carla] INSERM, U830, Inst Curie, Sect Rech, F-75248 Paris, France; [Parrini, Maria Carla; Camonis, Jacques; de Gunzburg, Jean] Inst Curie, Ctr Rech, F-75248 Paris, France; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Kyoto University	Parrini, MC (corresponding author), INSERM, U830, Inst Curie, Sect Rech, 26 Rue Ulm, F-75248 Paris, France.	parrini@curie.fr	Parrini, Maria Carla/J-5390-2016	Parrini, Maria Carla/0000-0002-7082-9792; Matsuda, Michiyuki/0000-0002-5876-9969	Association pour la Recherche sur la Cancer (ARC) [3131, 4845]; Agence Nationale de la Recherche; Association Christelle Bouillot	Association pour la Recherche sur la Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Christelle Bouillot	This work was supported in part by Grants 3131 and 4845 from the Association pour la Recherche sur la Cancer (ARC), Grants ANR05BLAN033802 and ANR08-BLAN-0290-01 from the Agence Nationale de la Recherche, and by the Association Christelle Bouillot (to J. C.).	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	36	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24133	24143		10.1074/jbc.M109.015271	http://dx.doi.org/10.1074/jbc.M109.015271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574218	Green Published, hybrid			2022-12-25	WOS:000269380200027
J	Paytubi, S; Wang, XM; Lam, YW; Izquierdo, L; Hunter, MJ; Jan, E; Hundal, HS; Proud, CG				Paytubi, Sonia; Wang, Xuemin; Lam, Yun W.; Izquierdo, Luis; Hunter, Mairi J.; Jan, Eric; Hundal, Harinder S.; Proud, Christopher G.			ABC50 Promotes Translation Initiation in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE PROTEIN; HEPATITIS-C VIRUS; ELONGATION FACTOR-III; ATP-DEPENDENT MANNER; RIBOSOME ENTRY SITE; KINASE GCN2; NUCLEAR-ENVELOPE; P-GLYCOPROTEIN; BIOGENESIS; COMPLEX	ABC50 is an ATP-binding cassette (ABC) protein, which, unlike most ABC proteins, does not possess membrane-spanning domains. ABC50 interacts with eukaryotic initiation factor 2 (eIF2), which plays a key role in translation initiation and its control. ABC50 binds to ribosomes, and this interaction requires both the N-terminal domain and at least one ABC domain. Knockdown of ABC50 by RNA interference impaired translation of both cap-dependent and -independent reporters, consistent with a positive role for ABC50 in the function of eIF2, which is required for both types of translation initiation. Mutation of the Walker box A or B motifs in both ABC regions of ABC50 yielded a mutant protein that exerted a dominant-interfering phenotype with respect to protein synthesis and translation initiation. Importantly, although dominant-interfering mutants of ABC50 impaired cap-dependent translation, translation driven by certain internal ribosome entry segments was not inhibited. ABC50 is located in the cytoplasm and nucleoplasm but not in the nucleolus. Thus, ABC50 is not likely to be directly involved in early ribosomal biogenesis, unlike some other ABC proteins. Taken together, the present data show that ABC50 plays a key role in translation initiation and has functions that are distinct from those of other non-membrane ABC proteins.	[Paytubi, Sonia; Wang, Xuemin; Hunter, Mairi J.; Hundal, Harinder S.; Proud, Christopher G.] Univ Dundee, Div Mol Physiol, Sch Life Sci, Dundee DD1 5EH, Scotland; [Lam, Yun W.] Univ Dundee, Div Gene Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Izquierdo, Luis] Univ Dundee, Div Biol Chem & Mol Microbiol, Sch Life Sci, Dundee DD1 5EH, Scotland; [Wang, Xuemin; Jan, Eric; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wang, Xuemin; Proud, Christopher G.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Dundee; University of Dundee; University of Dundee; University of British Columbia; University of Southampton	Proud, CG (corresponding author), Southampton Gen Hosp, MP 808,Duthie Bldg,Tremona Rd, Southampton SO16 6YD, Hants, England.	C.G.Proud@soton.ac.uk	Paytubi, Sonia/L-3372-2017; Izquierdo, Luis/L-9291-2015; Jan, Eric/O-1923-2019; Hundal, Hari/A-8990-2008	Paytubi, Sonia/0000-0002-5392-953X; Izquierdo, Luis/0000-0002-3704-9874; Hundal, Hari/0000-0002-7621-4932; Lam, Yun Wah/0000-0001-8929-5965; Proud, Christopher/0000-0003-0704-6442	UK Biotechnology and Biological Sciences Research Council; University of British Columbia; Biotechnology and Biological Sciences Research Council [C19142] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of British Columbia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a project grant from the UK Biotechnology and Biological Sciences Research Council ( to C. G. P.) and by funding from the University of British Columbia.	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; BELFIELD GP, 1995, J MOL EVOL, V41, P376, DOI 10.1007/BF01215185; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kozak L, 2002, J BIOL CHEM, V277, P33580, DOI 10.1074/jbc.M205415200; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; REIMER G, 1987, J CLIN INVEST, V79, P65, DOI 10.1172/JCI112809; Richard M, 1998, GENOMICS, V53, P137, DOI 10.1006/geno.1998.5480; Rivas-Estilla AM, 2002, J VIROL, V76, P10637, DOI 10.1128/JVI.76.21.10637-10653.2002; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANDBAKEN MG, 1990, J BIOL CHEM, V265, P15838; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Szakacs G, 2001, BIOCHEM J, V356, P71, DOI 10.1042/0264-6021:3560071; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yang HM, 1996, BBA-MOL CELL RES, V1310, P303, DOI 10.1016/0167-4889(95)00179-4; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068	46	74	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24061	24073		10.1074/jbc.M109.031625	http://dx.doi.org/10.1074/jbc.M109.031625			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19570978	Green Published, hybrid			2022-12-25	WOS:000269380200020
J	Wohlgamuth-Benedum, JM; Rubio, MAT; Paris, Z; Long, SJ; Poliak, P; Lukes, J; Alfonzo, JD				Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Paris, Zdenek; Long, Shaojun; Poliak, Pavel; Lukes, Julius; Alfonzo, Juan D.			Thiolation Controls Cytoplasmic tRNA Stability and Acts as a Negative Determinant for tRNA Editing in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST NFS1P; ISCS; BIOSYNTHESIS; PROTEINS; LOCALIZATION; DEGRADATION; BIOGENESIS; ANTICODON; GENOME; DNA	Kinetoplastids encode a single nuclear tryptophanyl tRNA that contains a CCA anticodon able to decode the UGG codons used in cytoplasmic protein synthesis but cannot decode the mitochondrial UGA codons. Following mitochondrial import, this problem is circumvented in Trypanosoma brucei by specifically editing the tRNA(Trp) anticodon to UCA, which can now decode the predominant mitochondrial UGA tryptophan codons. This tRNA also undergoes an unusual thiolation at position 33 of the anticodon loop, the only known modification at U33 in any tRNA. In other organisms, tRNA thiolation is mediated by the cysteine desulfurase, Nfs1 (IscS). However, T. brucei encodes two Nfs homologues, one cytoplasmic and the other mitochondrial. We show by a combination of RNA interference and Northern and Western analyses that the mitochondria-targeted TbNfs, and not TbNfs-like protein, is essential for thiolation of both cytosolic and mitochondrial tRNAs. Given the exclusive mitochondrial localization of TbNfs, how it mediates thiolation in the cytoplasm remains unclear. Furthermore, thiolation specifically affects thiolated tRNA stability in the cytoplasm but more surprisingly acts as a negative determinant for the essential C to U editing in T. brucei. This provides a first line of evidence for mitochondrial C to U editing regulation in this system.	[Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Wohlgamuth-Benedum, Jessica M.; Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Ohio State RNA Grp, Columbus, OH 43210 USA; [Paris, Zdenek; Long, Shaojun; Poliak, Pavel; Lukes, Julius] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Paris, Zdenek; Long, Shaojun; Poliak, Pavel; Lukes, Julius] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Alfonzo, JD (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave,376 Biosci Rm 440, Columbus, OH 43210 USA.	alfonzo.1@osu.edu	Lukes, Julius/H-6760-2012; Paris, Zdenek/G-7349-2014	Lukes, Julius/0000-0002-0578-6618; Paris, Zdenek/0000-0003-1019-7719	National Institutes of Health Grant from NIGMS [GM084065]; National Science Foundation [MCB-0620707]; Grant Agency of the Czech Republic [204/06/1558]; Czech Ministry of Education [LC07032, 2B06129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084065 from NIGMS ( to J. D. A.). This work was also supported by Grant MCB-0620707 from the National Science Foundation ( to J. D. A.), Grant 204/06/1558 from the Grant Agency of the Czech Republic, and Grants LC07032 and 2B06129 from the Czech Ministry of Education ( to J. L.).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; DELACRUZ VF, 1984, J BIOL CHEM, V259, P5136; Grosshans H, 2001, J BIOL CHEM, V276, P46333, DOI 10.1074/jbc.M107141200; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kapushoc ST, 2000, J BIOL CHEM, V275, P37907, DOI 10.1074/jbc.M007838200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; Rubio MAT, 2005, TOP CURR GENET, V12, P71, DOI 10.1007/b106363; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Smid O, 2006, J BIOL CHEM, V281, P28679, DOI 10.1074/jbc.M513781200; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200	32	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23947	23953		10.1074/jbc.M109.029421	http://dx.doi.org/10.1074/jbc.M109.029421			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19574216	Green Published, hybrid			2022-12-25	WOS:000269380200008
J	Doz, E; Rose, S; Court, N; Front, S; Vasseur, V; Charron, S; Gilleron, M; Puzo, G; Fremaux, I; Delneste, Y; Erard, F; Ryffel, B; Martin, OR; Quesniaux, VFJ				Doz, Emilie; Rose, Stephanie; Court, Nathalie; Front, Sophie; Vasseur, Virginie; Charron, Sabine; Gilleron, Martine; Puzo, Germain; Fremaux, Isabelle; Delneste, Yves; Erard, Francois; Ryffel, Bernhard; Martin, Olivier R.; Quesniaux, Valerie F. J.			Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; MYO-INOSITOL MANNOSIDES; TRAP MASS-SPECTROMETRY; DC-SIGN; STRUCTURAL-CHARACTERIZATION; ACYLATION STATE; ELECTROSPRAY-IONIZATION; DENDRITIC CELLS; BOVIS BCG; TUBERCULOSIS	Mycobacterium tuberculosis modulates host immune responses through proteins and complex glycolipids. Here, we report that the glycosylphosphatidylinositol anchor phosphatidyl-myo-inositol hexamannosides PIM6 or PIM2 exert potent anti-inflammatory activities. PIM strongly inhibited the Toll-like receptor (TLR4) and myeloid differentiation protein 88 (MyD88)-mediated release of NO, cytokines, and chemokines, including tumor necrosis factor (TNF), interleukin 12 (IL-12) p40, IL-6, keratinocyte-derived chemokine, and also IL-10 by lipopolysaccharide (LPS)-activated macrophages. This effect was independent of the presence of TLR2. PIM also reduced the LPS-induced MyD88-independent, TIR domain-containing adaptor protein inducing interferon beta(TRIF)-mediated expression of co-stimulatory receptors. PIM inhibited LPS/TLR4-induced NF kappa B translocation. Synthetic PIM1 and a PIM2 mimetic recapitulated these in vitro activities and inhibited endotoxin-induced airway inflammation, TNF and keratinocyte-derived chemokine secretion, and neutrophil recruitment in vivo. Mannosyl, two acyl chains, and phosphatidyl residues are essential for PIM anti-inflammatory activity, whereas the inosityl moiety is dispensable. Therefore, PIM exert potent antiinflammatory effects both in vitro and in vivo that may contribute to the strategy developed by mycobacteria for repressing the host innate immunity, and synthetic PIM analogs represent powerful antiinflammatory leads.	[Doz, Emilie; Rose, Stephanie; Court, Nathalie; Front, Sophie; Vasseur, Virginie; Charron, Sabine; Erard, Francois; Ryffel, Bernhard; Quesniaux, Valerie F. J.] CNRS, MIE UMR6218, F-45071 Orleans 2, France; [Doz, Emilie; Rose, Stephanie; Court, Nathalie; Front, Sophie; Vasseur, Virginie; Charron, Sabine; Erard, Francois; Ryffel, Bernhard; Quesniaux, Valerie F. J.] Univ Orleans, F-45071 Orleans 2, France; [Martin, Olivier R.] Inst Chim Organ & Analyt, UMR6005, F-45071 Orleans, France; [Gilleron, Martine; Puzo, Germain] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Gilleron, Martine; Puzo, Germain] Univ Toulouse, F-31077 Toulouse, France; [Fremaux, Isabelle; Delneste, Yves] Ctr Rech Cancerol Nantes Angers, F-49933 Angers, France; [Fremaux, Isabelle; Delneste, Yves] Univ Angers, INSERM, U892, F-49933 Angers, France; [Delneste, Yves] Univ Hosp Angers, F-49933 Angers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Quesniaux, VFJ (corresponding author), CNRS, MIE UMR6218, 3B Rue Ferollerie, F-45071 Orleans 2, France.	quesniaux@cnrs-orleans.fr	DELNESTE, Yves/K-7367-2015; Delneste, Yves/O-3956-2016	DELNESTE, Yves/0000-0002-2142-596X; Doz-Deblauwe, Emilie/0000-0002-3126-4004; GILLERON, Martine/0000-0002-2581-3302	CNRS [ANR-05-MIIM-038-02, TB-SIGN]; European Union FEDER [1649-32264]	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union FEDER(European Commission)	This work was supported by CNRS, ANR-05-MIIM-038-02 Grant TB-SIGN, and European Union FEDER Grant 1649-32264.	Ainge GD, 2006, BIOORGAN MED CHEM, V14, P7615, DOI 10.1016/j.bmc.2006.07.003; Ainge GD, 2006, BIOORGAN MED CHEM, V14, P5632, DOI 10.1016/j.bmc.2006.04.037; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Boonyarattanakalin S, 2008, J AM CHEM SOC, V130, P16791, DOI 10.1021/ja806283e; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; de Diego J, 1997, J IMMUNOL, V159, P4983; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Dyer BS, 2007, J ORG CHEM, V72, P3282, DOI 10.1021/jo0625599; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Heldwein KA, 2002, MICROBES INFECT, V4, P937, DOI 10.1016/S1286-4579(02)01611-8; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P466, DOI 10.1016/j.jasms.2006.10.012; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P479, DOI 10.1016/j.jasms.2006.10.020; ILANGUMARAN S, 1995, J IMMUNOL, V155, P1334; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lefort J, 1998, J IMMUNOL, V161, P474; Liu XY, 2006, J AM CHEM SOC, V128, P3638, DOI 10.1021/ja0565368; Maeda N, 2003, J BIOL CHEM, V278, P5513, DOI 10.1074/jbc.C200586200; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pitarque S, 2005, BIOCHEM J, V392, P615, DOI 10.1042/BJ20050709; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Savoy F, 2006, IMMUNOBIOLOGY, V211, P767, DOI 10.1016/j.imbio.2006.06.001; Schnyder-Candrian S, 2005, J IMMUNOL, V175, P262, DOI 10.4049/jimmunol.175.1.262; SINGHGILL G, 2005, Patent No. 2005049631; Stadelmaier A, 2003, CARBOHYD RES, V338, P2557, DOI 10.1016/j.carres.2003.06.002; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Stijlemans B, 2007, J IMMUNOL, V179, P4003, DOI 10.4049/jimmunol.179.6.4003; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Togbe D, 2007, EUR J IMMUNOL, V37, P768, DOI 10.1002/eji.200636371; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; VERCELLONE A, 1989, J BIOL CHEM, V264, P7447; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577	58	53	54	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23187	23196		10.1074/jbc.M109.037846	http://dx.doi.org/10.1074/jbc.M109.037846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19561082	hybrid, Green Published			2022-12-25	WOS:000269180000003
J	Longerich, S; Filippo, JS; Liu, DQ; Sung, P				Longerich, Simonne; Filippo, Joseph San; Liu, Dongqing; Sung, Patrick			FANCI Binds Branched DNA and Is Monoubiquitinated by UBE2T-FANCL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; ANEMIA PATHWAY; UBIQUITIN LIGASE; FANCONIS ANEMIA; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; MITOSIS; SWITCH; BRCA1	FANCI is integral to the Fanconi anemia (FA) pathway of DNA damage repair. Upon the occurrence of DNA damage, FANCI becomes monoubiquitinated on Lys-523 and relocalizes to chromatin, where it functions with monoubiquitinated FANCD2 to facilitate DNA repair. We show that FANCI and its C-terminal fragment possess a DNA binding activity that prefers branched structures. We also demonstrate that FANCI can be ubiquitinated on Lys-523 by the UBE2T-FANCL pair in vitro. These findings should facilitate future efforts directed at elucidating molecular aspects of the FA pathway.	[Longerich, Simonne; Filippo, Joseph San; Liu, Dongqing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [PO1 CA92584, PO1 CA129186, RO1 ES015252]; NATIONAL CANCER INSTITUTE [P01CA129186, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 CA92584, PO1 CA129186, and RO1 ES015252.	Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; AUERBACH AD, 1988, BLOOD, V72, P366; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Dorsman JC, 2007, CELL ONCOL, V29, P211; GERMAN J, 1987, BLOOD, V69, P1637; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Meetei AR, 2004, CELL CYCLE, V3, P179; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; POLL EHA, 1985, HUM GENET, V71, P206, DOI 10.1007/BF00284574; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Wang WD, 2008, NAT STRUCT MOL BIOL, V15, P1128, DOI 10.1038/nsmb1108-1128; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004	30	70	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23182	23186		10.1074/jbc.C109.038075	http://dx.doi.org/10.1074/jbc.C109.038075			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19589784	Green Published, hybrid			2022-12-25	WOS:000269180000002
J	Xiong, Y; Huo, YQ; Chen, C; Zeng, HY; Lu, XF; Wei, CL; Ruan, CG; Zhang, XY; Hu, ZQ; Shibuya, M; Luo, JC				Xiong, Yan; Huo, Yingqing; Chen, Chao; Zeng, Huiyan; Lu, Xiaofan; Wei, Chaoliang; Ruan, Changgeng; Zhang, Xiaoyu; Hu, Zhenqian; Shibuya, Masabumi; Luo, Jincai			Vascular Endothelial Growth Factor (VEGF) Receptor-2 Tyrosine 1175 Signaling Controls VEGF-induced von Willebrand Factor Release from Endothelial Cells via Phospholipase C-gamma 1-and Protein Kinase A-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEIBEL-PALADE BODIES; VONWILLEBRAND-FACTOR; ACTIVATION; ANGIOGENESIS; MIGRATION; PERMEABILITY; BARRIER; AUTOPHOSPHORYLATION; PROLIFERATION; INHIBITION	There is increasing evidence that vascular endothelial growth factor (VEGF) contributes to inflammation independent of its angiogenic functions. Targeting some of the components in endothelial Weibel-Palade bodies (WPBs) effectively inhibits VEGF-induced inflammation, but little is known about how VEGF regulates WPB exocytosis. In this study, we showed that VEGF receptor-2 (VEGFR2), but not VEGFR1, is responsible for VEGF-induced release of von Willebrand factor (vWF), a major marker of WPBs. This is in good contrast to VEGF-stimulated interleukin-6 release from endothelium, which is selectively mediated through VEGFR1. We further demonstrated that VEGFR2-initiated phospholipase C-gamma 1 (PLC gamma 1)/calcium signaling is important but insufficient for full vWF release, suggesting the possible participation of another effector pathway. We found that cAMP/protein kinase A (PKA) signaling is required for full vWF release. Importantly, a single mutation of Tyr(1175) in the C terminus of VEGFR2, a tyrosine residue crucial for embryonic vasculogenesis, abolished vWF release, concomitant with defective activations of both PLC gamma 1 and PKA. These data suggest that Tyr(1175) mediates both PLC gamma 1-dependent and PKA-dependent signaling pathways. Taken together, our results not only reveal a novel Tyr(1175)-mediated signaling pathway but also highlight a potentially new therapeutic target for the management of vascular inflammation.	[Xiong, Yan; Huo, Yingqing; Chen, Chao; Lu, Xiaofan; Zhang, Xiaoyu; Hu, Zhenqian; Luo, Jincai] Peking Univ, Inst Mol Med, Lab Vasc Biol, Beijing 10087, Peoples R China; [Wei, Chaoliang] Peking Univ, Inst Mol Med, Lab Calcium Signaling, Beijing 10087, Peoples R China; [Zeng, Huiyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Ruan, Changgeng] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo 2720827, Japan	Peking University; Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Soochow University - China; Tokyo Medical & Dental University (TMDU)	Luo, JC (corresponding author), Peking Univ, Inst Mol Med, Lab Vasc Biol, New Life Sci Bldg,Rm 234, Beijing 100871, Peoples R China.	jincailuo@pku.edu.cn	Zhang, xiaoyu/GXA-3206-2022; Wei, Chaoliang/A-9008-2013; Jin Cai, Luo/A-7900-2011	, Yan/0000-0003-2339-130X	National Science Funds [30671030, 90607004]; Major State Basic Research Development Programs of China [2007CB512100]	National Science Funds; Major State Basic Research Development Programs of China(National Basic Research Program of China)	This work was supported in part by National Science Funds Grants 30671030 and 90607004 and the Major State Basic Research Development Programs of China Grant 2007CB512100.	Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Bhushan M, 1999, BRIT J DERMATOL, V141, P1054, DOI 10.1046/j.1365-2133.1999.03205.x; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Brockington A, 2004, NEUROPATH APPL NEURO, V30, P427, DOI 10.1111/j.1365-2990.2004.00600.x; BROWN LF, 1995, J INVEST DERMATOL, V104, P744, DOI 10.1111/1523-1747.ep12606974; CAREW MA, 1992, BIOCHEM J, V286, P631, DOI 10.1042/bj2860631; Desloges N, 2008, MED MICROBIOL IMMUN, V197, P353, DOI 10.1007/s00430-007-0068-8; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lorenzi O, 2008, J THROMB HAEMOST, V6, P1962, DOI 10.1111/j.1538-7836.2008.03138.x; Ma YF, 2005, J BIOL CHEM, V280, P26011, DOI 10.1074/jbc.M409081200; Mahadev K, 2008, CARDIOVASC RES, V78, P376, DOI 10.1093/cvr/cvn034; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; Meyer RD, 2002, J BIOL CHEM, V277, P27081, DOI 10.1074/jbc.M110544200; Mirzapoiazova T, 2006, AM J PHYSIOL-LUNG C, V291, pL718, DOI 10.1152/ajplung.00014.2006; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pickkers P, 2005, SHOCK, V24, P508, DOI 10.1097/01.shk.0000190827.36406.6e; Rahimi N, 2006, EXP EYE RES, V83, P1005, DOI 10.1016/j.exer.2006.03.019; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; SADLER JE, 1991, ANN NY ACAD SCI, V614, P114; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; ZHOU QS, 1992, THROMB RES, V68, P109, DOI 10.1016/0049-3848(92)90026-7	44	43	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23217	23224		10.1074/jbc.M109.019679	http://dx.doi.org/10.1074/jbc.M109.019679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19570985	Green Published, hybrid			2022-12-25	WOS:000269180000006
J	Keshwani, MM; Gao, XX; Harris, TK				Keshwani, Malik M.; Gao, Xinxin; Harris, Thomas K.			Mechanism of PDK1-catalyzed Thr-229 Phosphorylation of the S6K1 Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BINDING POCKET; DOCKING SITE; B ALPHA; ACTIVATION; PDK1; EXPRESSION; 3-KINASE; DOMAIN; IDENTIFICATION	PDK1 (phosphoinositide-dependent protein kinase-1) catalyzes phosphorylation of Thr-229 in the T-loop of S6K1 alpha II (the 70-kDa 40 S ribosomal protein S6 kinase-1 alpha II isoform), and Thr-229 phosphorylation is synergistic with C-terminal Thr-389 phosphorylation to activate S6K1 alpha II regulatory functions in protein translation preinitiation complexes. Unlike its common AGC kinase subfamily member S6K1 alpha II, PDK1 does not contain the synergistic C-terminal phosphorylation site, and it has been proposed that phosphorylated Thr-389 in S6K1 alpha II may initially serve to trans-activate PDK1-catalyzed Thr-229 phosphorylation. Herein, we report direct binding and kinetic studies that showed PDK1 to exhibit nearly equal binding affinities and steady-state kinetic turnover numbers toward native (K-d(S6K1) = 1.2 mu M and k(cat) = 1.1 s(-1)) and the phosphomimicking T389E mutant S6K1 alpha II (K-d(S6K1) = 1.5 mu M and k(cat) = 1.2 s(-1)), although similar to 2-fold enhanced specificity was displayed for the T389E mutant (k(cat)/K-m(S6K1) = 0.08 mu M-1 s(-1) compared with 0.04 mu M-1 s(-1)). Considering that transient kinetic binding studies showed all nucleotide and S6K1 alpha II substrates and products to rapidly associate with PDK1 (k(on) = 1-6 mu M-1 s(-1)), it was concluded that positioning a negative charge at residue Thr389 reduced similar to 2-fold the occurrence of nonproductive binding events that precede formation of a reactive ternary complex for Thr-229 phosphorylation. In addition, steady-state kinetic data were most simply accommodated by an Ordered Bi Bi mechanism with competitive substrate inhibition, where (i) the initially formed PDK1-ATP complex phosphorylates the nucleotide-free form of the S6K1 alpha II kinase and (ii) initial binding of S6K1 alpha II precludes ATP binding to PDK1.	[Gao, Xinxin; Harris, Thomas K.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33136 USA; [Keshwani, Malik M.; Harris, Thomas K.] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA	University of Miami; University of Miami	Harris, TK (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA.	tkharris@miami.edu	Gao, Xinxin/D-3795-2009		National Institutes of Health; NIGMS [GM69868]; Maytag Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Maytag Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant GM69868 (to T. K. H.). This work was also supported by a Maytag Fellowship (to M. M. K.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; SEGAL IH, 1975, ENZYME KINETICS; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, MOL CELL BIOL, V15, P2333	39	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22611	22624		10.1074/jbc.M109.032177	http://dx.doi.org/10.1074/jbc.M109.032177			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19570988	Green Published, hybrid			2022-12-25	WOS:000268963100014
J	Liu, XS; Chopp, M; Zhang, RL; Hozeska-Solgot, A; Gregg, SC; Buller, B; Lu, M; Zhang, ZG				Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Hozeska-Solgot, Ann; Gregg, Sara C.; Buller, Ben; Lu, Mei; Zhang, Zheng Gang			Angiopoietin 2 Mediates the Differentiation and Migration of Neural Progenitor Cells in the Subventricular Zone after Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ADULT MAMMALIAN FOREBRAIN; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; IN-VIVO; NEUROBLAST MIGRATION; INDUCED NEUROGENESIS; SUBEPENDYMAL CELLS; RECEPTOR-BINDING	Ischemic stroke stimulates neurogenesis in the adult rodent brain. The molecules underlying stroke-induced neurogenesis have not been fully investigated. Using real-time reverse transcription-PCR, we found that stroke substantially up-regulated angiopoietin 2 (ANG2), a proangiogenic gene, expression in subventricular zone neural progenitor cells. Incubation of neural progenitor cells with recombinant human ANG2 significantly increased the number of beta-III tubulin-positive cells, a marker of immature neurons, but did not alter the number of glial fibrillary acidic protein (GFAP)-positive cells, a marker of astrocytes, suggesting that ANG2 promotes neuronal differentiation. Blockage of the ANG2 receptor, Tie2, with small interference RNA (siRNA)-Tie2 attenuated recombinant human ANG2 (rhANG2)-increased beta-III tubulin mRNA levels compared with levels in the progenitor cells transfected with control siRNA. Chromatin immunoprecipitation analysis revealed that CCAAT/enhancer-binding protein (C/EBP beta) up-regulated by rhANG2 bound to beta-III tubulin, which is consistent with published data that there are several C/EBP beta binding sites in the promoter of beta-III tubulin gene. In addition, rhANG2 enhanced migration of neural progenitor cells measured by single neurosphere assay. Blockage of Tie2 with siRNA-Tie2 and a Tie2-neutralizing antibody did not suppress ANG2-enhanced migration. However, inhibition of matrix metalloproteinases with GM6001 blocked ANG2-enhanced migration. Collectively, our data suggest that interaction of ANG2, a proangiogenic factor, with its receptor Tie2 promotes neural progenitor cell differentiation into neuronal lineage cells, whereas ANG2 regulates neural progenitor cell migration through matrix metalloproteinases, which do not require its receptor Tie2.	[Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Hozeska-Solgot, Ann; Gregg, Sara C.; Buller, Ben; Zhang, Zheng Gang] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael; Buller, Ben] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institutes of Health [PO1 NS23393, PO1 NS42345, RO1 HL064766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042345, P01NS023393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 NS23393, PO1 NS42345, and RO1 HL064766.	Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Calella AM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-4; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Luskin MB, 1998, J NEUROBIOL, V36, P221; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mao Y, 1999, MOL BRAIN RES, V63, P366, DOI 10.1016/S0169-328X(98)00271-X; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reznikov K, 1997, DEV DYNAM, V210, P328, DOI 10.1002/(SICI)1097-0177(199711)210:3<328::AID-AJA12>3.0.CO;2-6; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Uittenbogaard M, 2007, J NEUROSCI RES, V85, P1, DOI 10.1002/jnr.21093; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang RG, 2002, ACTA PHARMACOL SIN, V23, P405; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e	71	73	75	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22680	22689		10.1074/jbc.M109.006551	http://dx.doi.org/10.1074/jbc.M109.006551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19553662	Green Published, hybrid			2022-12-25	WOS:000268963100022
J	Feng, JN; Sun, GH; Yan, J; Noltner, K; Li, WY; Buzin, CH; Longmate, J; Heston, LL; Rossi, J; Sommer, SS				Feng, Jinong; Sun, Guihua; Yan, Jin; Noltner, Katie; Li, Wenyan; Buzin, Carolyn H.; Longmate, Jeff; Heston, Leonard L.; Rossi, John; Sommer, Steve S.			Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations	PLOS ONE			English	Article								Background: Schizophrenia is a severe disabling brain disease affecting about 1% of the population. Individual microRNAs (miRNAs) affect moderate downregulation of gene expression. In addition, components required for miRNA processing and/or function have also been implicated in X-linked mental retardation, neurological and neoplastic diseases, pointing to the wide ranging involvement of miRNAs in disease. Methods and Findings: To explore the role of miRNAs in schizophrenia, 59 microRNA genes on the X-chromosome were amplified and sequenced in males with (193) and without (191) schizophrenia spectrum disorders to test the hypothesis that ultra-rare mutations in microRNA collectively contribute to the risk of schizophrenia. Here we provide the first association of microRNA gene dysfunction with schizophrenia. Eight ultra-rare variants in the precursor or mature miRNA were identified in eight distinct miRNA genes in 4% of analyzed males with schizophrenia. One ultra-rare variant was identified in a control sample (with a history of depression) (8/193 versus 1/191, p = 0.02 by one-sided Fisher's exact test, odds ratio = 8.2). These variants were not found in an additional 7,197 control X-chromosomes. Conclusions: Functional analyses of ectopically expressed copies of the variant miRNA precursors demonstrate loss of function, gain of function or altered expression levels. While confirmation is required, this study suggests that microRNA mutations can contribute to schizophrenia.			Feng, JN (corresponding author), City Hope Natl Med Ctr, Div Mol Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ssommer@medomics.com		Longmate, Jeffrey/0000-0002-0869-7928	NHLBI NIH HHS [HL07470] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007470] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; Chan SP, 2007, DEV CELL, V13, P605, DOI 10.1016/j.devcel.2007.10.010; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Jablensky A, 2000, EUR ARCH PSY CLIN N, V250, P274, DOI 10.1007/s004060070002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Klein ME, 2005, CURR OPIN NEUROBIOL, V15, P507, DOI 10.1016/j.conb.2005.08.011; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Scharf JM, 2008, NEUROLOGY, V70, P1495, DOI 10.1212/01.wnl.0000296833.25484.bb; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; SOMMER SS, 1989, MAYO CLIN PROC, V64, P1361, DOI 10.1016/S0025-6196(12)65378-6; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sun GH, 2007, METHOD ENZYMOL, V427, P123, DOI 10.1016/S0076-6879(07)27007-7; Vogel F., 1997, HUMAN GENETICS PROBL; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025	39	84	90	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2009	4	7							e6121	10.1371/journal.pone.0006121	http://dx.doi.org/10.1371/journal.pone.0006121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465HA	19568434	Green Published, Green Submitted, gold			2022-12-25	WOS:000267572200019
J	Vallier, L; Touboul, T; Chng, ZZ; Brimpari, M; Hannan, N; Millan, E; Smithers, LE; Trotter, M; Rugg-Gunn, P; Weber, A; Pedersen, RA				Vallier, Ludovic; Touboul, Thomas; Chng, Zhenzhi; Brimpari, Minodora; Hannan, Nicholas; Millan, Enrique; Smithers, Lucy E.; Trotter, Matthew; Rugg-Gunn, Peter; Weber, Anne; Pedersen, Roger A.			Early Cell Fate Decisions of Human Embryonic Stem Cells and Mouse Epiblast Stem Cells Are Controlled by the Same Signalling Pathways	PLOS ONE			English	Article							DEFINITIVE ENDODERM; VISCERAL ENDODERM; NEURAL INDUCTION; SELF-RENEWAL; DIFFERENTIATION; RECEPTOR; GASTRULATION; INHIBITOR; ORGANIZER; MESODERM	Human embryonic stem cells have unique value for regenerative medicine, as they are capable of differentiating into a broad variety of cell types. Therefore, defining the signalling pathways that control early cell fate decisions of pluripotent stem cells represents a major task. Moreover, modelling the early steps of embryonic development in vitro may provide the best approach to produce cell types with native properties. Here, we analysed the function of key developmental growth factors such as Activin, FGF and BMP in the control of early cell fate decisions of human pluripotent stem cells. This analysis resulted in the development and validation of chemically defined culture conditions for achieving specification of human embryonic stem cells into neuroectoderm, mesendoderm and into extra-embryonic tissues. Importantly, these defined culture conditions are devoid of factors that could obscure analysis of developmental mechanisms or render the resulting tissues incompatible with future clinical applications. Importantly, the growth factor roles defined using these culture conditions similarly drove differentiation of mouse epiblast stem cells derived from post implantation embryos, thereby reinforcing the hypothesis that epiblast stem cells share a common embryonic identity with human pluripotent stem cells. Therefore the defined growth factor conditions described here represent an essential step toward the production of mature cell types from pluripotent stem cells in conditions fully compatible with clinical use ant also provide a general approach for modelling the early steps of mammalian embryonic development.			Vallier, L (corresponding author), Univ Cambridge, Dept Surg & Lab Regenerat Med, Cambridge, England.	lv225@cam.ac.uk	Hannan, Nicholas/A-8731-2013; Hannan, Nicholas/ABG-6497-2020; vallier, ludovic/C-6368-2011	Vallier, Ludovic/0000-0002-3848-2602; Hannan, Nicholas/0000-0002-9843-1559; Trotter, Matthew/0000-0003-3702-915X; Rugg-Gunn, Peter/0000-0002-9601-5949	Medical Research Council [G0800784, G0600275, G0701448, G0300723] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0800784, G0600275, G0300723, G0701448] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BRONS IGM, 2007, NATURE IN PRESS; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chang CB, 2007, DEVELOPMENT, V134, P3861, DOI 10.1242/dev.007179; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	37	192	206	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2009	4	6							e6082	10.1371/journal.pone.0006082	http://dx.doi.org/10.1371/journal.pone.0006082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464OU	19564924	gold, Green Submitted, Green Published			2022-12-25	WOS:000267515700004
J	Milenkovic, T; Filippis, I; Lappe, M; Przulj, N				Milenkovic, Tijana; Filippis, Ioannis; Lappe, Michael; Przulj, Natasa			Optimized Null Model for Protein Structure Networks	PLOS ONE			English	Article							RESIDUES; THERMOSTABILITY; PREDICTION; STABILITY; ALGORITHM; TOPOLOGY; PACKING	Much attention has recently been given to the statistical significance of topological features observed in biological networks. Here, we consider residue interaction graphs (RIGs) as network representations of protein structures with residues as nodes and inter-residue interactions as edges. Degree-preserving randomized models have been widely used for this purpose in biomolecular networks. However, such a single summary statistic of a network may not be detailed enough to capture the complex topological characteristics of protein structures and their network counterparts. Here, we investigate a variety of topological properties of RIGs to find a well fitting network null model for them. The RIGs are derived from a structurally diverse protein data set at various distance cut-offs and for different groups of interacting atoms. We compare the network structure of RIGs to several random graph models. We show that 3-dimensional geometric random graphs, that model spatial relationships between objects, provide the best fit to RIGs. We investigate the relationship between the strength of the fit and various protein structural features. We show that the fit depends on protein size, structural class, and thermostability, but not on quaternary structure. We apply our model to the identification of significantly over-represented structural building blocks, i.e., network motifs, in protein structure networks. As expected, choosing geometric graphs as a null model results in the most specific identification of motifs. Our geometric random graph model may facilitate further graph-based studies of protein conformation space and have important implications for protein structure comparison and prediction. The choice of a well-fitting null model is crucial for finding structural motifs that play an important role in protein folding, stability and function. To our knowledge, this is the first study that addresses the challenge of finding an optimized null model for RIGs, by comparing various RIG definitions against a series of network models.			Milenkovic, T (corresponding author), Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA.	natasha@ics.uci.edu	Filippis, Ioannis/D-7687-2013; Przulj, Natasa/AAO-2850-2020	Przulj, Natasa/0000-0002-1290-853X				Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Artzy-Randrup Yael, 2004, Science, V305, P1107; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartoli L, 2007, PHYS BIOL, V4, pL1, DOI 10.1088/1478-3975/4/4/L01; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; COOK SA, 1971, STOC 71, P151, DOI DOI 10.1145/800157.805047; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; GODZIK A, 1994, COMPUT APPL BIOSCI, V10, P587; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; HERINGA J, 1995, PROTEIN ENG, V8, P21, DOI 10.1093/protein/8.1.21; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kamagata K, 2006, J MOL BIOL, V357, P1647, DOI 10.1016/j.jmb.2006.01.072; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mehlhorn K., 1999, LEDA PLATFORM COMBIN; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Paszkiewicz KH, 2006, BIOINFORMATICS, V22, P1353, DOI 10.1093/bioinformatics/btl095; PENROSE M, 2003, GEOMETRIC RANDOM GRA; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Przulj N, 2006, J R SOC INTERFACE, V3, P711, DOI 10.1098/rsif.2006.0147; Raghunathan G, 1997, PROTEIN SCI, V6, P2072; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Soyer A, 2000, PHYS REV LETT, V85, P3532, DOI 10.1103/PhysRevLett.85.3532; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213; Vassura M, 2007, LECT NOTES ARTIF INT, V4578, P497; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	46	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2009	4	6							e5967	10.1371/journal.pone.0005967	http://dx.doi.org/10.1371/journal.pone.0005967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463ID	19557139	Green Published, Green Submitted, gold			2022-12-25	WOS:000267424600001
J	Uronis, JM; Muhlbauer, M; Herfarth, HH; Rubinas, TC; Jones, GS; Jobin, C				Uronis, Joshua M.; Muehlbauer, Marcus; Herfarth, Hans H.; Rubinas, Tara C.; Jones, Gieira S.; Jobin, Christian			Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility	PLOS ONE			English	Article								It is well established that the intestinal microbiota plays a key role in the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC) collectively referred to as inflammatory bowel disease (IBD). Epidemiological studies have provided strong evidence that IBD patients bear increased risk for the development of colorectal cancer (CRC). However, the impact of the microbiota on the development of colitis-associated cancer (CAC) remains largely unknown. In this study, we established a new model of CAC using azoxymethane (AOM)-exposed, conventionalized-Il10(-/)-mice and have explored the contribution of the host intestinal microbiota and MyD88 signaling to the development of CAC. We show that 8/13 (62%) of AOM-Il10(-/-) mice developed colon tumors compared to only 3/15 (20%) of AOM-wild-type (WT) mice. Conventionalized AOM-Il10(-/-) mice developed spontaneous colitis and colorectal carcinomas while AOM-WT mice were colitis-free and developed only rare adenomas. Importantly, tumor multiplicity directly correlated with the presence of colitis. Il10(-/)-mice mono-associated with the mildly colitogenic bacterium Bacteroides vulgatus displayed significantly reduced colitis and colorectal tumor multiplicity compared to Il10(-/)-mice. Germ-free AOM-treated Il10 2/2 mice showed normal colon histology and were devoid of tumors. Il10(-/-); Myd88(-/)-mice treated with AOM displayed reduced expression of Il12p40 and Tnfa mRNA and showed no signs of tumor development. We present the first direct demonstration that manipulation of the intestinal microbiota alters the development of CAC. The TLR/MyD88 pathway is essential for microbiota-induced development of CAC. Unlike findings obtained using the AOM/DSS model, we demonstrate that the severity of chronic colitis directly correlates to colorectal tumor development and that bacterial-induced inflammation drives progression from adenoma to invasive carcinoma.			Uronis, JM (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	job@med.unc.edu	Herfarth, Hans/K-7547-2019	Jones, Gieira/0000-0001-9537-6470	NCRR NIH HHS [P40 RR018603] Funding Source: Medline; NIDDK NIH HHS [R01 DK073338, T32 DK007737, R01 DK 47700, R01 DK 73338, P30 DK034987, R01 DK047700, 5 T32 DK007737] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, R01DK073338, P30DK034987, T32DK007737] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Chichlowski M, 2009, COMPARATIVE MED, V59, P10; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Haller D, 2004, J PEDIATR GASTR NUTR, V38, P123, DOI 10.1097/00005176-200402000-00004; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jess T, 2006, GASTROENTEROLOGY, V130, P1039, DOI 10.1053/j.gastro.2005.12.037; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kraehenbuhl JP, 2004, SCIENCE, V303, P1624, DOI 10.1126/science.1096222; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rubin DT, 2008, INFLAMM BOWEL DIS, V14, P265, DOI 10.1002/ibd.20297; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Rutter MD, 2006, GASTROENTEROLOGY, V130, P1030, DOI 10.1053/j.gastro.2005.12.035; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	30	318	344	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2009	4	6							e6026	10.1371/journal.pone.0006026	http://dx.doi.org/10.1371/journal.pone.0006026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462MF	19551144	Green Published, Green Submitted, gold			2022-12-25	WOS:000267356500010
J	Roselli, F; Hutzler, P; Wegerich, Y; Livrea, P; Almeida, OFX				Roselli, Francesco; Hutzler, Peter; Wegerich, Yvonne; Livrea, Paolo; Almeida, Osborne F. X.			Disassembly of Shank and Homer Synaptic Clusters Is Driven by Soluble beta-Amyloid(1-40) through Divergent NMDAR-Dependent Signalling Pathways	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; LONG-TERM POTENTIATION; A-BETA; NATURAL OLIGOMERS; PSD-95; KINASE; DEGRADATION; ACTIVATION; DOMAIN	Disruption of the postsynaptic density (PSD), a network of scaffold proteins located in dendritic spines, is thought to be responsible for synaptic dysfunction and loss in early-stage Alzheimer's disease (AD). Extending our previous demonstration that derangement of the PSD by soluble amyloid-beta (A beta) involves proteasomal degradation of PSD-95, a protein important for ionotropic glutamate receptor trafficking, we now show that A beta also disrupts two other scaffold proteins, Homer1b and Shank1, that couple PSD-95 with ionotropic and metabotropic glutamate receptors. Treatment of fronto-cortical neurons with soluble A beta results in rapid (within 1 h) and significant thinning of the PSD, decreased synaptic levels of Homer1b and Shank1, and reduced synaptic mGluR1 levels. We show that de novo protein synthesis is required for the declustering effects of A beta on Homer1b (but not Shank1) and that, in contrast to PSD-95, A beta-induced Homer1b and Shank1 cluster disassembly does not depend on proteasome activity. The regulation of Homer1b and Shank1 by A beta diverges in two other respects: i) whereas the activity of both NMDAR and VDCC is required for A beta-induced declustering of Homer1b, A beta-induced declustering of Shank1 only requires NMDAR activity; and ii) whereas the effects of A beta on Homer1b involve engagement of the PI-3K pathway and calcineurin phosphatase (PP2B) activity, those on Shank1 involve activation of the ERK pathway. In summary, soluble Ab recruits discrete signalling pathways to rapidly reduce			Roselli, F (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	fraroselli@mpipsykl.mpg.de; osa@mpipsykl.mpg.de	roselli, francesco/G-6701-2013; Almeida, Osborne F.X. F/E-8402-2010; roselli, francesco/O-8847-2019	Almeida, Osborne F.X. F/0000-0001-7331-6928; roselli, francesco/0000-0001-9935-6899; Livrea, Paolo/0000-0001-7410-3860				Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Baxter AW, 2006, J NEUROSCI, V26, P5456, DOI 10.1523/JNEUROSCI.4101-05.2006; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kammermeier PJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-1; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Rasband W., 2006, IMAGEJ; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Takagi N, 2003, J NEUROCHEM, V84, P67, DOI 10.1046/j.1471-4159.2003.01500.x; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Van Keuren-Jensen K, 2006, J NEUROSCI, V26, P7575, DOI 10.1523/JNEUROSCI.5083-05.2006; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005	58	64	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2009	4	6							e6011	10.1371/journal.pone.0006011	http://dx.doi.org/10.1371/journal.pone.0006011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462JI	19547699	Green Published, Green Submitted, gold			2022-12-25	WOS:000267347900010
J	Zhang, HH; Huang, JX; Duvel, K; Boback, B; Wu, SL; Squillace, RM; Wu, CL; Manning, BD				Zhang, Hui H.; Huang, Jingxiang; Duevel, Katrin; Boback, Bernard; Wu, Shulin; Squillace, Rachel M.; Wu, Chin-Lee; Manning, Brendan D.			Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway	PLOS ONE			English	Article								Background: The signaling pathways imposing hormonal control over adipocyte differentiation are poorly understood. While insulin and Akt signaling have been found previously to be essential for adipogenesis, the relative importance of their many downstream branches have not been defined. One direct substrate that is inhibited by Akt-mediated phosphorylation is the tuberous sclerosis complex 2 (TSC2) protein, which associates with TSC1 and acts as a critical negative regulator of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). Loss of function of the TSC1-TSC2 complex results in constitutive mTORC1 signaling and, through mTORC1-dependent feedback mechanisms and loss of mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets. Methodology/Principal Findings: We find that, despite severe insulin resistance and the absence of Akt signaling, TSC2-deficient mouse embryo fibroblasts and 3T3-L1 pre-adipocytes display enhanced adipocyte differentiation that is dependent on the elevated mTORC1 activity in these cells. Activation of mTORC1 causes a robust increase in the mRNA and protein expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), which is the master transcriptional regulator of adipocyte differentiation. In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis. Finally, renal angiomyolipomas from patients with tuberous sclerosis complex contain both adipose and smooth muscle-like components with activated mTORC1 signaling and elevated PPAR gamma expression. Conclusions/Significance: This study demonstrates that activation of mTORC1 signaling is a critical step in adipocyte differentiation and identifies TSC2 as a primary target of Akt driving this process. Therefore, the TSC1-TSC2 complex regulates the differentiation of mesenchymal cell lineages, at least in part, through its control of mTORC1 activity and PPAR gamma expression.			Zhang, HH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Huang, Jingxiang/B-4515-2008; Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792; Zhang, Hua/0000-0001-9731-2737	NATIONAL CANCER INSTITUTE [R01CA122617, P01CA120964] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA122617-04, R01 CA122617, CA120964, CA122617, P01 CA120964] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; El-Chaar D, 2004, INT J OBESITY, V28, P191, DOI 10.1038/sj.ijo.0802554; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HUANG J, 2008, MOL CELL BIOL, V28; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li XH, 2005, ACTA PHARMACOL SIN, V26, P1081, DOI 10.1111/j.1745-7254.2005.00161.x; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PEDERSEN O, 1992, J CLIN INVEST, V89, P1964, DOI 10.1172/JCI115804; Pederson T, 2000, BIOCHEM BIOPH RES CO, V276, P162, DOI 10.1006/bbrc.2000.3429; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; [王志刚 WANG Zhigang], 2008, [东北师大学报. 自然科学版, Journal of Northeast Normal University], V40, P1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	78	286	295	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2009	4	7							e6189	10.1371/journal.pone.0006189	http://dx.doi.org/10.1371/journal.pone.0006189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DN	19915715	Green Published, Green Submitted, gold			2022-12-25	WOS:000268035300005
